PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Ramos, JA; Brull, SJ				Ramos, Juan A.; Brull, Sorin J.			Psychogenic non-epileptic seizures in the post-anesthesia recovery unit	REVISTA BRASILEIRA DE ANESTESIOLOGIA			English	Article						Convulsion; Non-epileptic; Complications; Anesthetic anesthesia recovery period; Recovery room pseudoseizures; Postoperative	PSEUDOEPILEPTIC SEIZURES; DIAGNOSIS; EPILEPSY; PSEUDOSTATUS	Introduction: Psychogenic non-epileptic seizures (PNES or "pseudoseizures'') remain an obscure topic in the peri-operative setting. They are sudden and time-limited motor and cognitive disturbances, which mimic epileptic seizures, but are psychogenically mediated. Pseudoseizures occur more frequently than epilepsy in the peri-operative setting. Early diagnosis and management may prevent iatrogenic injury. Case: 48 year-old female with a history of depression and "seizures'' presented for gynecologic surgery. She described her seizure history as "controlled'' without anticonvulsant therapy. The patient underwent uneventful general anesthesia and recovered neurologically intact. During the first two postoperative hours, the patient experienced 3 episodes of seizure-like activity with generalized shaking of extremities and pelvic thrusting; her eyes were firmly closed. No tongue biting or incontinence was noted. The episodes lasted approximately 3 min each, one of which resolved spontaneously and the other two following intravenous lorazepam. During these episodes, the patient had stable hemodynamics and adequate ventilation such that endotracheal intubation was deemed unwarranted. Post-ictally, the patient was neurologically intact. Computed axial tomography of the head, metabolic assay, and electroencephalogram showed no abnormalities. A presumptive diagnosis of PNES was made. Discussion: Psychogenic non-epileptic seizures mimic shivering, and should be considered early in the differential diagnosis of postoperative shaking, as they may be more likely than epilepsy in this setting. Pseudoseizure patterns include asynchronous convulsive episodes lasting more than 90 s, forced eye closure with resistance to opening, and retained pupillary responses. Autonomic manifestations such as tachycardia, cyanosis and incontinence are usually absent. A psychiatric background is common. Knowledge and correct diagnosis of pseudoseizures is of great importance for anesthesiologists to prevent morbidity and iatrogenic injury such as respiratory arrest caused by anticonvulsant therapy, in addition to the risks associated with endotracheal intubation and prolonged hospital stays. The diagnosis of pseudoseizures must be thoroughly documented and relayed in transfer of care to avoid misdiagnosis and iatrogenic complications. Treatment recommendations are anecdotal; psychiatric interventions are the hallmark of treatment. Anesthetic recommendations include techniques involving the minimum required short-acting agents, along with high levels of peri-operative psychological support and reassurance. (C) 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda.	[Ramos, Juan A.; Brull, Sorin J.] Mayo Clin, Dept Anesthesiol, Jacksonville, FL 32224 USA		Ramos, JA (corresponding author), Mayo Clin, Dept Anesthesiol, Jacksonville, FL 32224 USA.	juan_ramos66@hotmail.com	Brull, Sorin/E-8578-2010	Brull, Sorin/0000-0003-2607-2590			Benbadis SR, 2000, SEIZURE-EUR J EPILEP, V9, P280, DOI 10.1053/seiz.2000.0409; Benbadis SR, 2005, EPILEPSY BEHAV, V6, P264, DOI 10.1016/j.yebeh.2004.12.007; De Witte J, 2002, ANESTHESIOLOGY, V96, P467, DOI 10.1097/00000542-200202000-00036; Ettinger A., 2013, PSYCHOGENIC NONEPILE; Horn E P, 1999, Curr Opin Anaesthesiol, V12, P449, DOI 10.1097/00001503-199908000-00010; HOWELL SJL, 1989, Q J MED, V71, P507; Kerr MP, 2011, EPILEPSIA, V52, P2133, DOI 10.1111/j.1528-1167.2011.03276.x; Kuyk J, 1997, SEIZURE, V6, P243, DOI 10.1016/S1059-1311(97)80072-6; Ng L, 2003, BRIT J ANAESTH, V91, P598, DOI 10.1093/bja/aeg201; OZKARA C, 1993, EPILEPSIA, V34, P294, DOI 10.1111/j.1528-1157.1993.tb02414.x; PARRY T, 1992, ANAESTHESIA, V47, P534, DOI 10.1111/j.1365-2044.1992.tb02290.x; Reuber M, 2000, ANAESTHESIA, V55, P74, DOI 10.1046/j.1365-2044.2000.01127.x	12	5	5	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-7094	1806-907X		REV BRAS ANESTESIOL	Rev. Bras. Anestesiol.	JUL-AUG	2016	66	4					426	429		10.1016/j.bjane.2013.10.005			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	DS5SU	WOS:000380843400017	27343796	Green Published, gold			2022-02-06	
J	Kisser, JE; Allen, AJ; Katzel, LI; Wendell, CR; Siegel, EL; Lefkowitz, D; Waldstein, SR				Kisser, Jason E.; Allen, Allyssa J.; Katzel, Leslie I.; Wendell, Carrington R.; Siegel, Eliot L.; Lefkowitz, David; Waldstein, Shari R.			Relations of blood pressure and head injury to regional cerebral blood flow	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Cerebral blood flow; Hypertension; Traumatic brain injury; SPECT	TRAUMATIC BRAIN-INJURY; GENDER-DIFFERENCES; ALZHEIMER-DISEASE; OLDER MEN; HYPERTENSION; VULNERABILITY; METAANALYSIS; DYSFUNCTION; DISORDER	Hypertension confers increased risk for cognitive decline, dementia, and cerebrovascular disease. These associations have been attributed, in part, to cerebral hypoperfusion. Here we posit that relations of higher blood pressure to lower levels of cerebral perfusion may be potentiated by a prior head injury. Participants were 87 community-dwelling older adults -69% men, 90% white, mean age = 66.9 years, 27.6% with a history of mild traumatic brain injury (mTBI) defined as a loss of consciousness <= 30 min resulting from an injury to the head, and free of major medical (other than hypertension), neurological or psychiatric comorbidities. All engaged in clinical assessment of systolic and diastolic blood pressure (SBP, DBP) and single photon emission computed tomography (SPELT). Computerized coding of the SPECT images yielded relative ratios of blood flow in left and right cortical and select subcortical regions. Cerebellum served as the denominator. Sex-stratified multiple regression analyses, adjusted for age, education, race, alcohol consumption, smoking status, and depressive symptomatology, revealed significant interactions of blood pressure and head injury to cerebral blood flow in men only. Specifically, among men with a history of head injury, higher systolic blood pressure was associated with lower levels of perfusion in the left orbital (beta = -3.21, p = 0.024) and left dorsolateral (beta = -2.61, p = 0.042) prefrontal cortex, and left temporal cortex (beta = -3.36, p = 0.014); higher diastolic blood pressure was marginally associated with lower levels of perfusion in the left dorsolateral prefrontal cortex (beta = -2.79, p = 0.051). Results indicate that men with a history of head injury may be particularly vulnerable to the impact of higher blood pressure on cerebral perfusion in left anterior cortical regions, thus potentially enhancing risk for adverse brain and neurocognitive outcomes. Published by Elsevier B.V.	[Kisser, Jason E.; Allen, Allyssa J.; Wendell, Carrington R.; Waldstein, Shari R.] Univ Maryland Baltimore Cty, Dept Psychol, 1000 Hilltop Circle,MP312, Baltimore, MD 21250 USA; [Katzel, Leslie I.] VA Maryland Healthcare Syst, Baltimore VA Med Ctr, Dept Gerontol 4B189, 10 North Greene St, Baltimore, MD 21201 USA; [Siegel, Eliot L.] Univ Maryland, Sch Med, Radiol & Nucl Med, Baltimore, MD 21201 USA; [Siegel, Eliot L.] VA Maryland Healthcare Syst, Dept Radiol 114, 10 North Greene St, Baltimore, MD 21201 USA; [Lefkowitz, David] SimonMed Imaging, 1433 Keel Dr, Corona Del Mar, CA 92625 USA		Kisser, JE (corresponding author), Univ Maryland Baltimore Cty, Dept Psychol, 1000 Hilltop Circle,MP312, Baltimore, MD 21250 USA.	Jk6@umbc.edu; allyssaallen@gmail.com; lkatzel@grecc.umatyland.edu; carringtonwendell@gmail.com; esiegel@umaryland.edu; dlefkowitz@gmail.com; waldstei@umbc.edu	Kisser, Jason/AAA-8217-2021		National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R29 AG15112, 5RO1 AG015112, NIH P30-AG02874]; Bristol Myers Squibb Medical Imaging, Inc.Bristol-Myers Squibb [NIH K24 AG00930]; VA Merit Grant; Department of Veterans Affairs Baltimore Geriatric Research Education and Clinical Center (GRECC); Geriatrics and Gerontology Education and Research Program of the University of Maryland, Baltimore; National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center NIH [R29 AG15112, P60-AG12583, P30-AG02874, RO1 AG015112]; Baltimore VA Medical Center Geriatrics Research Education and Clinical Center (GRECC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K07HL108742, R01HL098332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK090401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG020677, K01AG043581, R01AG015112, R29AG015112, P60AG012583, R01AG034161, P30AG028747] Funding Source: NIH RePORTER	The study was supported by the National Institutes of Health (NIH) grants R29 AG15112, 5RO1 AG015112, NIH P30-AG02874, Bristol Myers Squibb Medical Imaging, Inc., NIH K24 AG00930; a VA Merit Grant, the Department of Veterans Affairs Baltimore Geriatric Research Education and Clinical Center (GRECC), and the Geriatrics and Gerontology Education and Research Program of the University of Maryland, Baltimore.; Les Katzel reports support by the Baltimore VA Medical Center Geriatrics Research Education and Clinical Center (GRECC), National Institute on Aging (NIA) Claude D. Pepper Older Americans Independence Center NIH grants P60-AG12583, P30-AG02874, R29 AG15112, and RO1 AG015112. He has no other disclosures or conflicts of interest.	Beason-Held LL, 2007, STROKE, V38, P1766, DOI 10.1161/STROKEAHA.106.477109; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blumenfeld H, 2010, NEUROANATOMY THROUGH CLINICAL CASES, SECOND EDITION, P1; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; CERVOSNAVARRO J, 1991, CRIT REV NEUROBIOL, V6, P149; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; de la Torre JC, 2002, STROKE, V33, P1152, DOI 10.1161/01.STR.0000014421.15948.67; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Fuster, 2015, PREFRONTAL CORTEX; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Hanyu H, 2004, AM J NEURORADIOL, V25, P1199; Jennings JR, 1998, HYPERTENSION, V31, P1216, DOI 10.1161/01.HYP.31.6.1216; Jennings JR, 2005, NEUROLOGY, V64, P1358, DOI 10.1212/01.WNL.0000158283.28251.3C; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lis CG, 1997, NEUROL RES, V19, P471, DOI 10.1080/01616412.1997.11740844; Mathias JL, 1999, J CLIN EXP NEUROPSYC, V21, P200, DOI 10.1076/jcen.21.2.200.930; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Nolte J., 1995, HUMAN BRAIN PHOTOGRA; Raz N, 2003, BEHAV NEUROSCI, V117, P1169, DOI 10.1037/0735-7044.117.6.1169; Reckelhoff JF, 2001, HYPERTENSION, V37, P1199, DOI 10.1161/01.HYP.37.5.1199; Sacco RL, 2001, NEUROLOGY, V57, pS31, DOI 10.1212/WNL.57.suppl_2.S31; SALERNO JA, 1995, J GERONTOL A-BIOL, V50, pM147, DOI 10.1093/gerona/50A.3.M147; Schmitt F.A., 1992, NEUROPSYCHOLOGY, V6, P159; Schoenberg MR, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P1, DOI 10.1007/978-0-387-76978-3; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Skoog I, 2006, NEUROL RES, V28, P605, DOI 10.1179/016164106X130506; Spalletta G, 2001, J NEURAL TRANSM, V108, P1203, DOI 10.1007/s007020170010; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Tunvirachaisakul C, 2011, ASIAN BIOMED, V5, P407, DOI 10.5372/1905-7415.0503.053; Waldstein SR, 2010, J HYPERTENS, V28, P993, DOI 10.1097/HJH.0b013e328335c34f; Waldstein SR, 2006, INT J OBESITY, V30, P201, DOI 10.1038/sj.ijo.0803114; Waldstein SR, 2004, STROKE, V35, P1294, DOI 10.1161/01.STR.0000127774.43890.5b; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wintermark M, 2005, STROKE, V36, pE83, DOI 10.1161/01.STR.0000177884.72657.8b	38	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JUN 15	2016	365						9	14		10.1016/j.jns.2016.03.033			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DN8FC	WOS:000377313600003	27206865	Green Accepted			2022-02-06	
J	Yamamura, H; Morioka, T; Yamamoto, T; Mizobata, Y				Yamamura, Hitoshi; Morioka, Takasei; Yamamoto, Tomonori; Mizobata, Yasumitsu			Head computed tomographic measurement as a predictor of outcome in patients with subdural hematoma with cerebral edema	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article							QUANTITATIVE-ANALYSIS; WATER-CONTENT; CELLULAR EDEMA; BRAIN-TISSUE; WHITE-MATTER; PATHOGENESIS; PROGRESSION; PERFUSION; INJURY	Background: The ability to predict outcome in patients with cerebral edema is important because it can influence treatment strategy. We evaluated whether differences in head computed tomographic (CT) measurements in Hounsfield units (HU) of white matter and gray matter can be used as a predictor of outcome in patients with subdural hematoma with cerebral edema. Methods: We evaluated 34 patients who had subdural hematoma with cerebral edema following acute closed head trauma and had undergone head CT within a few hours of admission. We divided them into the survival (n = 24) group and death (n = 10) group, and measured the HU of white matter and gray matter at injury and non-injury sites. Results: There were no significant differences in operation time or blood loss during surgery between the two groups. Only the HU of white matter in the injury site of patients in the death group were decreased significantly. A cut-off value of 31.5 for HU of white matter showed 80.0 % sensitivity and 99.9 % specificity for death; the area under the curve was 0.91. Discussion: Our results are more evidence of the support of neurogenic edema in trauma rather than an important clinical tool at this stage. However, HU values in WM may be one factor in the decision-making process that affects patient outcome. Changing the treatment strategy in patients with a low HU value in the WM at the injury site may bring about an improvement in patient outcome. Conclusion: Measurement in HU of white matter at the injury site might be useful as a predictor of outcome in patients with subdural hematoma with cerebral edema.	[Yamamura, Hitoshi] Hirosaki Univ, Grad Sch Med, Dept Crit Care Med, 5 Zaifuchou, Hirosaki, Aomori 0368562, Japan; [Morioka, Takasei; Yamamoto, Tomonori; Mizobata, Yasumitsu] Osaka City Univ, Grad Sch Med, Dept Crit Care Med, 1-4-3 Asahimachi, Osaka 5458585, Japan		Yamamura, H (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Crit Care Med, 5 Zaifuchou, Hirosaki, Aomori 0368562, Japan.	yamamura@hirosaki-u.ac.jp					Altman D.G., 1990, PRACTICAL STAT MED R; Bartels RHMA, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0479-x; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bor-Seng-Shu E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/750809; Bouma GJ, 1998, ACT NEUR S, V71, P272; BULLOCK R, 1985, J NEUROSURG, V63, P64, DOI 10.3171/jns.1985.63.1.0064; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Choi SP, 2008, EMERG MED J, V25, P666, DOI 10.1136/emj.2007.053306; Dzialowski I, 2007, RADIOLOGY, V243, P720, DOI 10.1148/radiol.2432060137; Hom J, 2011, AM J NEURORADIOL, V32, P41, DOI 10.3174/ajnr.A2244; Huang APH, 2011, J TRAUMA, V71, P1593, DOI 10.1097/TA.0b013e31822c8865; Kim H, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0186-2; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Lin WL, 2000, J CEREBR BLOOD F MET, V20, P37, DOI 10.1097/00004647-200001000-00007; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; McCourt R, 2014, STROKE, V45, P1292, DOI 10.1161/STROKEAHA.113.003194; Metter RB, 2011, RESUSCITATION, V82, P1180, DOI 10.1016/j.resuscitation.2011.04.001; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; MORIMOTO Y, 1993, CRIT CARE MED, V21, P104, DOI 10.1097/00003246-199301000-00020; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Torbey MT, 2000, STROKE, V31, P2163, DOI 10.1161/01.STR.31.9.2163; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Yamamura H, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-37; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008	24	5	5	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	JUN 7	2016	24								83	10.1186/s13049-016-0271-y			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DR9CF	WOS:000380194000002	27412565	Green Published, gold			2022-02-06	
J	Binder, H; Lang, N; Tiefenboeck, TM; Bukaty, A; Hajdu, S; Sarahrudi, K				Binder, Harald; Lang, Nikolaus; Tiefenboeck, Thomas M.; Bukaty, Adam; Hajdu, Stefan; Sarahrudi, Kambiz			Tracheostomy following anterior cervical spine fusion in trauma patients	INTERNATIONAL ORTHOPAEDICS			English	Article						Tracheostomy; ACSF; Retrospective study; Trauma; Infection	CORD INJURY; FIXATION; CARE	Purpose Traumatic injuries to the cervical spine are frequently accompanied by cervical spinal cord injuries-often necessitating tracheostomy. The purpose of this study was to evaluate patient characteristics and outcomes after undergoing anterior cervical spine fusion (ACSF) with tracheostomy. Methods All patients with cervical spine injury (CSI) who underwent ACSF and tracheostomy between December 1992 and June 2014 were included in this retrospective data analysis. The study group consisted of 32 men (84 %) and six women (16 %), with an average age of 47 +/- 20 years. Blunt trauma to the cervical spine was the cause of CSI in all 38 patients. Results The mean Injury Severity Score (ISS) was 30.50 +/- 6.25. Eighteen patients sustained severe concomitant injuries related to the spinal injury. In 15 patients (39.5 %), traumatic brain injury (TBI) with fractures of the cranium and/or intracranial lesions were observed. The mean Glasgow Coma Scale (GCS) score was 11 +/- 4.5 (range 3-15). Two tracheostomies (5.3 %) were performed simultaneously with ACSF. The remaining 36 were performed with an average "delay" of 15 +/- ten days. We observed no difference in time to tracheostomy among patients initially presenting with an American Spinal Injury Association (ASIA) score of either A, B, C or D. Only two patients (5.3 %) were identified as having an infection at the site of ACSF after placement of a tracheostomy. There were no deaths directly related to airway difficulties in our cohort. Conclusions Our data show that tracheostomy is safely performed after an average of 15 days post-ACSF, thereby being associated with a very low rate of complications. However, future prospective randomised studies are needed to identify the optimal timing of tracheostomy placement after ACSF. Level of evidence: IV; retrospective case series.	[Binder, Harald; Lang, Nikolaus; Tiefenboeck, Thomas M.; Hajdu, Stefan; Sarahrudi, Kambiz] Med Univ Vienna, Dept Trauma Surg, Waehringerguertel 18-20, A-1090 Vienna, Austria; [Bukaty, Adam] Med Univ Vienna, Div Gen Anaesthesia & Intens Care Med, A-1090 Vienna, Austria		Sarahrudi, K (corresponding author), Med Univ Vienna, Dept Trauma Surg, Waehringerguertel 18-20, A-1090 Vienna, Austria.	harald.binder@meduniwien.ac.at; nikolaus.lang@meduniwien.ac.at; thomas.tiefenboeck@meduniwien.ac.at; adam.bukaty@meduniwien.ac.at; stefan.hajdu@meduniwien.ac.at; kambiz.sarahrudi@meduniwien.ac.at		Binder, Harald/0000-0002-9212-7214; Tiefenboeck, Thomas/0000-0002-8698-8341			Aebi M, 2007, AO SPINE MANUAL PRIN, V1; Babu R, 2013, J TRAUMA ACUTE CARE, V74, P961, DOI 10.1097/TA.0b013e3182826ea4; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Ball PA, 2001, SPINE, V26, pS27, DOI 10.1097/00007632-200112151-00006; Barquist ES, 2006, J TRAUMA, V60, P91, DOI 10.1097/01.ta.0000196743.37261.3f; Berney S, 2008, J TRAUMA, V64, P749, DOI 10.1097/.TA.0b013e31802c8234; Branco BC, 2011, J TRAUMA, V70, P111, DOI 10.1097/TA.0b013e3181d9a559; Como JJ, 2005, J TRAUMA, V59, P912, DOI 10.1097/01.ta.0000187660.03742.a6; Croce MA, 2001, ANN SURG, V233, P851, DOI 10.1097/00000658-200106000-00016; JACKSON AB, 1994, ARCH PHYS MED REHAB, V75, P270, DOI 10.1016/0003-9993(94)90027-2; Kluger Y, 1996, Eur J Emerg Med, V3, P95, DOI 10.1097/00063110-199606000-00007; Kollef MH, 1999, CRIT CARE MED, V27, P1714, DOI 10.1097/00003246-199909000-00003; Marino RJ, 2003, J SPINAL CORD MED S1, V26, pS50; Mirza SK, 1999, CLIN ORTHOP RELAT R, P104, DOI 10.1097/00003086-199902000-00011; NORTHRUP BE, 1995, SPINE, V20, P2449, DOI 10.1097/00007632-199511001-00014; O'Keeffe T, 2004, J TRAUMA, V57, P855, DOI 10.1097/01.TA.0000083006.48501.B2; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; TEASDALE G, 1974, LANCET, V2, P81; Velmahos GC, 2003, AM SURGEON, V69, P891	20	5	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	JUN	2016	40	6					1157	1162		10.1007/s00264-015-2913-5			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	DN9VP	WOS:000377429100014	26194918				2022-02-06	
J	Cho, JS; Shin, SD; Lee, EJ; Song, KJ; Noh, H; Kim, YJ; Lee, SC; Park, JO; Kim, SC; Hwang, SS				Cho, Jin Seong; Shin, Sang Do; Lee, Eui Jun; Song, Kyoung Jun; Noh, Hyun; Kim, Yu Jin; Lee, Seung Chul; Park, Ju Ok; Kim, Seong Chun; Hwang, Seung-sik			Alcohol Intake and Reduced Mortality in Patients with Traumatic Brain Injury	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Alcohol; Brain Injuries; Mortality	SERUM ETHANOL LEVELS; EMERGENCY-ROOM; RISK; CONSUMPTION; IMPACT; DIFFERENCE; MODERATE; OUTCOMES; LEVEL	Background: The purpose of our study was to determine whether alcohol intake influences short-term mortality in patients with traumatic brain injury (TBI), using a comprehensive trauma database. Methods: We collected data from 7 emergency departments (EDs) between June 1, 2008 and May 31, 2010, using the same data form. Cases were included if they met the following criteria: (i) older than 15 and (ii) injuries including TBI. Demographics and outcomes were compared between patients with and without alcohol intake. We present the risk of mortality using hazard ratios and 95% confidence intervals. Results: A total of 76,596 trauma patients visited the EDs during the study period; 12,980 patients were older than 15 and had TBI. There were 4,009 (30.9%) patients in the alcohol-intake group, of whom 3,306 (82.5%) patients were male, 1,450 (36.2%) patients were moved by ambulance, and 1,218 (30.4%) patients' injuries were intentional. The most frequent injury mechanism was falling down with alcohol intake and blunt injury without alcohol intake. Mortality rate was 1.0% with alcohol intake and 2.0% without alcohol intake. After adjusting for all factors related to mortality, the hazard ratio of mortality was 0.72 in the alcohol-intake group. Conclusions: Mortality rate due to TBI in the alcohol-intake group appears to be lower compared to that in the no-alcohol-intake group after adjusting for main confounding variables.	[Cho, Jin Seong] Gachon Univ, Gil Med Ctr, Emergency Med, Inchon, South Korea; [Shin, Sang Do; Lee, Eui Jun; Song, Kyoung Jun] Seoul Natl Univ Hosp, Emergency Med, Seoul, South Korea; [Noh, Hyun] Inje Univ, Coll Med, Emergency Med, Seoul, South Korea; Seoul Paik Hosp, Seoul, South Korea; [Kim, Yu Jin] Seoul Natl Univ, Bundang Hosp, Emergency Med, Songnam, South Korea; [Lee, Seung Chul] Dongguk Univ, Coll Med, Emergency Med, Ilsan, South Korea; [Park, Ju Ok] Hallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Emergency Med, Hwaseong, South Korea; [Kim, Seong Chun] Gyeongsang Natl Univ Hosp, Emergency Med, Jinju, South Korea; [Hwang, Seung-sik] Inha Univ, Sch Med, Social & Prevent Med, Inchon, South Korea		Cho, JS (corresponding author), Gachon Univ, Gil Med Ctr, Emergency Med, Inchon, South Korea.	truecho@hanmail.net	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085; Cho, Jin-Seong/0000-0001-6762-4692	Korea Centers for Disease Control and Prevention	The study was supported by Korea Centers for Disease Control and Prevention. The authors have no conflicts of interest.	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Asmaro K, 2013, CURR DRUG TARGETS, V14, P74, DOI 10.2174/138945013804806505; Berry C, 2010, AM SURGEON, V76, P1067; Cherpitel CJ, 2006, EUR ADDICT RES, V12, P42, DOI 10.1159/000088582; Friedman LS, 2014, ALCOHOL, V48, P391, DOI 10.1016/j.alcohol.2014.01.008; *ICECI COORD MAINT, 2003, INT CLASS EXT CAUS I; Kim J, 2009, ACAD EMERG MED, V16, P454, DOI 10.1111/j.1553-2712.2009.00412.x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLeod R, 1999, ADDICTION, V94, P1719, DOI 10.1046/j.1360-0443.1999.941117199.x; Messingham KAN, 2002, ALCOHOL, V28, P137, DOI 10.1016/S0741-8329(02)00278-1; Noh H, 2007, J KOREAN SOC EMERG M, V18, P307; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Raj R, 2015, J NEUROSURG, V23, P1; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Sommers MS, 2000, ALCOHOL CLIN EXP RES, V24, P1406, DOI 10.1097/00000374-200009000-00012; Sorock GS, 2006, ALCOHOL, V40, P193, DOI 10.1016/j.alcohol.2007.01.002; Stubig T, 2012, ALCOHOL, V46, P681, DOI 10.1016/j.alcohol.2012.07.002; Taylor B, 2010, DRUG ALCOHOL DEPEN, V110, P108, DOI 10.1016/j.drugalcdep.2010.02.011; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Treno AJ, 1998, ADDICTION, V93, P113, DOI 10.1046/j.1360-0443.1998.93111311.x; World Health Organization (WHO), 2007, ALC INJ EM DEP	26	5	5	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0145-6008	1530-0277		ALCOHOL CLIN EXP RES	Alcoholism (NY)	JUN	2016	40	6					1290	1294		10.1111/acer.13065			5	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	DR3OA	WOS:000379811300016	27097604				2022-02-06	
J	Miller, DJ; Blum, AB; Levine, WN; Ahmad, CS; Popkin, CA				Miller, Daniel J.; Blum, Alexander B.; Levine, William N.; Ahmad, Christopher S.; Popkin, Charles A.			Preparticipation Evaluation of the Young Athlete: What an Orthopaedic Surgeon Needs to Know	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						sports medicine; preparticipation evaluation; sudden cardiac death; sickle cell trait	HUMAN GROWTH-HORMONE; PERFORMANCE-ENHANCING DRUGS; SPORTS-RELATED CONCUSSION; PHYSICAL-EXAMINATION; BODY-COMPOSITION; CREATINE SUPPLEMENTATION; CARDIOVASCULAR-ABNORMALITIES; SCREENING-PROGRAM; FOOTBALL PLAYERS; MARFAN-SYNDROME	The preparticipation evaluation (PPE) is a widely used tool for detecting health conditions that may delay or disqualify athletic participation. The medical interview is the most valuable tool for identifying athletes who may be at increased risk for injury. Physical examination is tailored to identifying cardiac abnormalities or factors that may place an athlete at increased risk for injury. Although practiced in Europe, universal cardiac screening with electrocardiography is not currently recommended in the United States largely due to the high rate of false-positive results. Neuropsychological testing for management of concussion and laboratory testing for sickle cell trait may be indicated in select groups of athletes. Health care providers should view the PPE as a chance for anticipatory guidance and athlete-directed health counseling. Despite widespread acceptance of the PPE, the quality of such examinations varies significantly, which is an area for possible improvement and further research.	[Miller, Daniel J.; Blum, Alexander B.; Levine, William N.; Ahmad, Christopher S.; Popkin, Charles A.] Columbia Univ, Ctr Shoulder Elbow & Sports Med, New York, NY USA; [Miller, Daniel J.; Levine, William N.; Ahmad, Christopher S.; Popkin, Charles A.] Columbia Univ, Ctr Shoulder Elbow & Sports Med, Dept Orthoped Surg, 622 West 168th St,PH-11, New York, NY 10032 USA; [Blum, Alexander B.] Evergreen Hlth, Baltimore, MD USA		Popkin, CA (corresponding author), Columbia Univ, Ctr Shoulder Elbow & Sports Med, Dept Orthoped Surg, 622 West 168th St,PH-11, New York, NY 10032 USA.	cp2654@columbia.edu		Miller, Daniel/0000-0002-8848-6724; Ahmad, Christopher S./0000-0001-9235-5228	Arthrex; Major League Baseball; Stryker	One or more of the authors has declared the following potential conflict of interest or source of funding: C.S.A. serves as a paid consultant to Arthrex and has received research or institutional support from Arthrex, Major League Baseball, and Stryker.	American Academy of Family Physicians; American Academy of Pediatrics; American College of Sports Medicine; American Medical Society for Sports Medicine; American Orthopaedic Society for Sports Medicine; and American Osteopathic Academy of Sports Medicine, 2010, AM AC FAM PHYS PREP; Anderson SJ, 1997, PEDIATRICS, V99, P904; Antonio J, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-36; Bahrke MS, 1998, CHILD ADOL PSYCH CL, V7, P821, DOI 10.1016/S1056-4993(18)30214-1; Baumann GP, 2012, ENDOCR REV, V33, P155, DOI 10.1210/er.2011-1035; Bents RT, 2004, PHYSICIAN SPORTSMED, V32, P30, DOI 10.3810/psm.2004.09.551; Birzniece V, 2015, INTERN MED J, V45, P239, DOI 10.1111/imj.12629; Bloodworth AJ, 2012, SCAND J MED SCI SPOR, V22, P293, DOI 10.1111/j.1600-0838.2010.01239.x; Calfee R, 2006, PEDIATRICS, V117, pE577, DOI 10.1542/peds.2005-1429; Carek PJ, 1999, CLIN J SPORT MED, V9, P124, DOI 10.1097/00042752-199907000-00002; Carlsen KH, 2008, ALLERGY, V63, P387, DOI 10.1111/j.1398-9995.2008.01662.x; CAVANAUGH RM, 1993, CLIN PEDIATR, V32, P542, DOI 10.1177/000992289303200906; CHANDLER JV, 1980, MED SCI SPORT EXER, V12, P65; Chandra N, 2013, J AM COLL CARDIOL, V61, P1027, DOI 10.1016/j.jacc.2012.08.1032; Chapman RF, 2014, J APPL PHYSIOL, V116, P595, DOI 10.1152/japplphysiol.00634.2013; Chilibeck PD, 2007, APPL PHYSIOL NUTR ME, V32, P1052, DOI 10.1139/H07-072; Conley KM, 2014, J ATHL TRAINING, V49, P102, DOI 10.4085/1062-6050-48.6.05; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Dascombe BJ, 2010, J SCI MED SPORT, V13, P274, DOI 10.1016/j.jsams.2009.03.005; Docherty JR, 2008, BRIT J PHARMACOL, V154, P606, DOI 10.1038/bjp.2008.124; DURANT RH, 1992, AM J DIS CHILD, V146, P85, DOI 10.1001/archpedi.1992.02160130087027; Erdman KA, 2007, CLIN J SPORT MED, V17, P458, DOI 10.1097/JSM.0b013e31815aed33; GERGEN PJ, 1988, PEDIATRICS, V81, P1; Gibbs JC, 2013, MED SCI SPORT EXER, V45, P985, DOI 10.1249/MSS.0b013e31827e1bdc; Glover DW, 2007, AM J CARDIOL, V100, P1709, DOI 10.1016/j.amjcard.2007.07.018; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; Gottschalk AW, 2011, SPORTS MED ARTHROSC, V19, P2, DOI 10.1097/JSA.0b013e31820b95fc; Graham MR, 2008, HORM RES, V69, P343, DOI 10.1159/000117390; Graham MR, 2007, GROWTH HORM IGF RES, V17, P328, DOI 10.1016/j.ghir.2007.04.003; Green Gary A, 2014, Virtual Mentor, V16, P547, DOI 10.1001/virtualmentor.2014.16.07.stas1-1407; Gregory AJM, 2007, PEDIATR CLIN N AM, V54, P797, DOI 10.1016/j.pcl.2007.07.001; Guill MF, 2004, PEDIATR REV, V25, P299, DOI 10.1542/pir.25-9-299; Harmer PA, 2010, BRIT J SPORT MED, V44, P26, DOI 10.1136/bjsm.2009.068924; Harmon KG, 2012, BRIT J SPORT MED, V46, P325, DOI 10.1136/bjsports-2011-090896; Harris KM, 2012, AM J CARDIOL, V110, P1185, DOI 10.1016/j.amjcard.2012.06.004; Headlee Donella, 2014, S D Med, V67, P273; Heuberger JAAC, 2013, BRIT J CLIN PHARMACO, V75, P1406, DOI 10.1111/bcp.12034; Hewett TE, 2006, CLIN J SPORT MED, V16, P298, DOI 10.1097/00042752-200607000-00003; Hulkower S, 2005, J FAM PRACTICE, V54, P628; Jordan LB, 2011, AM J PREV MED, V41, pS406, DOI 10.1016/j.amepre.2011.09.014; Kim HJ, 2011, AMINO ACIDS, V40, P1409, DOI 10.1007/s00726-011-0878-2; Kreider RB, 1998, MED SCI SPORT EXER, V30, P73, DOI 10.1097/00005768-199801000-00011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leenders N, 1999, INT J SPORT NUTR, V9, P251, DOI 10.1123/ijsn.9.3.251; LEWIS JF, 1989, AM J CARDIOL, V64, P1029, DOI 10.1016/0002-9149(89)90802-3; Likness LP, 2011, J AM OSTEOPATH ASSOC, V111, P373, DOI 10.7556/jaoa.2011.111.6.373; Liu H, 2008, ANN INTERN MED, V148, P747, DOI 10.7326/0003-4819-148-10-200805200-00215; Lively MW, 1999, CLIN J SPORT MED, V9, P3, DOI 10.1097/00042752-199901000-00002; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Ma R, 2012, J BONE JOINT SURG AM, V94A, P1618, DOI 10.2106/JBJS.K.01127; MACINTYRE JG, 1987, SPORTS MED, V4, P129, DOI 10.2165/00007256-198704020-00004; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 2013, HEART RHYTHM, V10, P374, DOI 10.1016/j.hrthm.2012.11.024; Maughan RJ, 2007, J SPORT SCI, V25, pS103, DOI 10.1080/02640410701607395; McCambridge Teri M, 2010, Pediatrics, V125, P1287, DOI 10.1542/peds.2010-0658; Meehan WP, 2013, PEDIATR EMERG CARE, V29, P624, DOI 10.1097/PEC.0b013e31828e9cea; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Metzl J D, 2001, Pediatr Rev, V22, P199, DOI 10.1542/pir.22-6-199; Metzl JD, 2001, PEDIATRICS, V108, P421, DOI 10.1542/peds.108.2.421; Metzl JD, 2008, PEDIATR REV, V29, P75, DOI 10.1542/pir.29-3-75; Morente-Sanchez J, 2013, SPORTS MED, V43, P395, DOI 10.1007/s40279-013-0037-x; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Pate RR, 2000, ARCH PEDIAT ADOL MED, V154, P904, DOI 10.1001/archpedi.154.9.904; Pecci M, 2009, AM J SPORT MED, V37, P406, DOI 10.1177/0363546508325663; Pelliccia A, 2008, J AM COLL CARDIOL, V52, P1990, DOI 10.1016/j.jacc.2008.08.055; Peterson AR, 2011, PEDIATR REV, V32, pE53, DOI 10.1542/pir.32-5-e53; Pfister GC, 2000, JAMA-J AM MED ASSOC, V283, P1597, DOI 10.1001/jama.283.12.1597; Powell JW, 1999, J ATHL TRAINING, V34, P277; Randsborg Per-Henrik, 2013, J Bone Joint Surg Am, V95, pe42, DOI 10.2106/JBJS.L.00369; Rennie MJ, 2003, BRIT J SPORT MED, V37, P100, DOI 10.1136/bjsm.37.2.100; Rich JD, 1999, INT J SPORTS MED, V20, P563, DOI 10.1055/s-1999-8841; RICKERT VI, 1992, CLIN PEDIATR, V31, P723, DOI 10.1177/000992289203101206; Rico-Sanz J, 2000, MED SCI SPORT EXER, V32, P379, DOI 10.1097/00005768-200002000-00018; Riding NR, 2015, EUR J PREV CARDIOL, V22, P263, DOI 10.1177/2047487313506549; RISSER WL, 1985, TEX MED, V81, P35; Seto CK, 2011, CLIN SPORT MED, V30, P491, DOI 10.1016/j.csm.2011.03.008; Shirley LCDRED, 2009, J AM ACAD ORTHOP SUR, V17, P572, DOI 10.5435/00124635-200909000-00004; Singh A, 2006, PEDIATR REV, V27, P418, DOI 10.1542/pir.27-11-418; Smith J, 1998, MAYO CLIN PROC, V73, P419; Sponseller PD, 2010, J BONE JOINT SURG AM, V92A, P1868, DOI 10.2106/JBJS.I.00892; Stone MH, 1999, INT J SPORT NUTR, V9, P146, DOI 10.1123/ijsn.9.2.146; Tarini BA, 2012, HEALTH SERV RES, V47, P446, DOI 10.1111/j.1475-6773.2011.01357.x; Tokish JM, 2004, AM J SPORT MED, V32, P1543, DOI 10.1177/0363546504268041; Tscholl P, 2010, AM J SPORT MED, V38, P133, DOI 10.1177/0363546509344071; Veliz P, 2013, J STUD ALCOHOL DRUGS, V74, P714, DOI 10.15288/jsad.2013.74.714; Washington RL, 2005, PEDIATRICS, V115, P1103, DOI 10.1542/peds.2005-0085; Wingfield K, 2004, CLIN J SPORT MED, V14, P109, DOI 10.1097/00042752-200405000-00002; Womack J, 2010, J FAM PRACTICE, V59, P437; Zafonte R, 2011, JAMA-J AM MED ASSOC, V306, P79, DOI 10.1001/jama.2011.819	90	5	5	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2016	44	6					1605	1615		10.1177/0363546515598994			11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DO5KJ	WOS:000377821700039	26330569				2022-02-06	
J	Puljula, J; Vaaramo, K; Tetri, S; Juvela, S; Hillbom, M				Puljula, Jussi; Vaaramo, Kalle; Tetri, Sami; Juvela, Seppo; Hillbom, Matti			Risk for All-cause and Traumatic Death in Head Trauma Subjects A Prospective Population-based Case-control Follow-up Study	ANNALS OF SURGERY			English	Article						alcohol-related death; follow-up study; head trauma; long-term mortality; traumatic brain injury	BRAIN-INJURY; ALCOHOL-USE; YOUNG-ADULTS; MILD; MORTALITY	Objective: To investigate long-term mortality for subjects with acute head trauma. Background: It is not known why long-term mortality after head trauma without traumatic brain injury is elevated. Methods: All subjects admitted to Oulu University Hospital emergency room in 1999 with an acute head trauma (n = 737) were followed up until February 2014 and compared with age and sex-matched general population controls (n = 2196). Dates and causes of death were obtained from the official Cause-of-Death Statistics. Cox proportional hazard regression models and Kaplan-Meier survival curves were used to identify predictors for alcohol-related, nonalcohol-related, and all-cause death. Results: Alcohol-related deaths were more frequent among the subjects with head trauma (27.8%) than among the population controls (6.9%). Head trauma with or without traumatic brain injury (TBI) shortened mean life expectancy by 8.7 years and by as much as 13 years if only those without TBI were considered. The risk of alcohol-related death was 7-fold (hazard ratio 6.79; 95% confidence interval, 3.94-11.71) among subjects without TBI as compared with general population. Of all future deaths among these cases 17.1% were because of a new trauma, a significantly higher frequency (P<0.005) than that observed in the general population (3% of all deaths). Alcohol-related cause of death was significantly more common among the subjects who were under the influence of alcohol at the time of the index trauma than among the sober subjects. Conclusions: Head trauma subjects without TBI have an elevated risk of alcohol-related death. Alcohol-related traumas are a major cause of death among these subjects.	[Puljula, Jussi; Vaaramo, Kalle; Hillbom, Matti] Univ Oulu, Dept Neurol, Oulu, Finland; [Puljula, Jussi; Vaaramo, Kalle; Tetri, Sami; Hillbom, Matti] Oulu Univ Hosp, Oulu, Finland; [Tetri, Sami] Univ Oulu, Dept Neurosurg, Oulu, Finland; [Juvela, Seppo] Univ Helsinki, Dept Clin Neurosci, Helsinki, Finland		Puljula, J (corresponding author), Oulu Univ Hosp, Dept Neurol, Kajaanintie 50, Oys Oulu 90029, Finland.	jussi.puljula@fimnet.fi		Juvela, Seppo/0000-0003-4944-4983			Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Boden JM, 2011, ADDICTION, V106, P906, DOI 10.1111/j.1360-0443.2010.03351.x; Borges G, 2006, ADDICTION, V101, P993, DOI 10.1111/j.1360-0443.2006.01462.x; Cherpitel CJ, 2003, J STUD ALCOHOL, V64, P641, DOI 10.15288/jsa.2003.64.641; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 2013, AM J PSYCHIAT, V170, P351, DOI 10.1176/appi.ajp.2012.12121602; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Giza CC, 2001, J ATHL TRAINING, V36, P228; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Lahti RA, 2001, FORENSIC SCI INT, V115, P15, DOI 10.1016/S0379-0738(00)00300-5; McMillan TM, 2014, J NEUROL NEUROSUR PS, V85, P1214, DOI 10.1136/jnnp-2013-307279; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Olson-Madden JH, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/174579; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Rose AK, 2007, ALCOHOL ALCOHOLISM, V42, P544, DOI 10.1093/alcalc/agm073; Rose AK, 2014, PSYCHOPHARMACOLOGY, V231, P2273, DOI 10.1007/s00213-013-3377-1; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Savola O, 2004, ALCOHOL ALCOHOLISM, V39, P340, DOI 10.1093/alcalc/agh064; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stock AK, 2016, ADDICT BIOL, V21, P136, DOI 10.1111/adb.12170; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; Vaaramo K, 2015, J NEUROTRAUM, V32, P1579, DOI 10.1089/neu.2014.3757; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151	27	5	5	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	JUN	2016	263	6					1235	1239		10.1097/SLA.0000000000001392			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	DO4PO	WOS:000377765400038	26334638				2022-02-06	
J	Sears, JM; Bowman, SM; Rotert, M; Blanar, L; Hogg-Johnson, S				Sears, Jeanne M.; Bowman, Stephen M.; Rotert, Mary; Blanar, Laura; Hogg-Johnson, Sheilah			Improving occupational injury surveillance by using a severity threshold: development of a new occupational health indicator	INJURY PREVENTION			English	Article							TRAUMATIC BRAIN-INJURY; WORKERS-COMPENSATION; UNITED-STATES; TRENDS; ILLNESS; VALIDATION; REGISTRY	Background Hospital discharge data are used for occupational injury surveillance, but observed hospitalisation trends are affected by trends in healthcare practices and workers' compensation coverage that may increasingly impair ascertainment of minor injuries relative to severe injuries. The objectives of this study were to (1) describe the development of a severe injury definition for surveillance purposes and (2) assess the impact of imposing a severity threshold on estimated occupational and non-occupational injury trends. Methods Three independent methods were used to estimate injury severity for the severe injury definition. 10 population-based hospital discharge databases were used to estimate trends (1998-2009), including the National Hospital Discharge Survey (NHDS) and State Inpatient Databases (SID) from the Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality. Negative binomial regression was used to model injury trends with and without severity restriction and to test trend divergence by severity. Results Trend estimates for occupational injuries were biased downwards in the absence of severity restriction, more so than for non-occupational injuries. Imposing a severity threshold resulted in a markedly different historical picture. Conclusions Severity restriction can be used as an injury surveillance methodology to increase the accuracy of trend estimates, which can then be used by occupational health researchers, practitioners and policymakers to identify prevention opportunities and to support state and national investments in occupational injury prevention efforts. The newly adopted state-based occupational health indicator, 'Work-Related Severe Traumatic Injury Hospitalizations', incorporates a severity threshold that will reduce temporal ascertainment threats to accurate trend estimates.	[Sears, Jeanne M.; Blanar, Laura] Univ Washington, Dept Hlth Serv, Box 357660, Seattle, WA 98195 USA; [Sears, Jeanne M.; Blanar, Laura] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Sears, Jeanne M.; Hogg-Johnson, Sheilah] Inst Work & Hlth, Toronto, ON, Canada; [Bowman, Stephen M.] Univ Arkansas Med Sci, Coll Publ Hlth, Dept Hlth Policy & Management, Little Rock, AR 72205 USA; [Hogg-Johnson, Sheilah] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada		Sears, JM (corresponding author), Univ Washington, Dept Hlth Serv, Box 357660, Seattle, WA 98195 USA.	jeannes@uw.edu	Bowman, Stephen/AAF-2154-2019		National Institute for Occupational Safety and HealthUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [R21OH010307]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTHUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH) [R21OH010307] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health (R21OH010307).	Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Azaroff LS, 2004, INT J HEALTH SERV, V34, P271, DOI 10.2190/4H2X-XD53-GK0J-91NQ; Azaroff LS, 2002, AM J PUBLIC HEALTH, V92, P1421, DOI 10.2105/AJPH.92.9.1421; Bailer AJ, 1997, J SAFETY RES, V28, P177, DOI 10.1016/S0022-4375(97)00007-8; Burton Jr. J. F., 2015, WORKERS COMPENSATION; Clark DE, 2010, ICDPIC STATA MODULE; Colantonio A, 2009, J TRAUMA, V66, P179, DOI 10.1097/TA.0b013e3181715d66; Cryer C, 2010, INJURY PREV, V16, P254, DOI 10.1136/ip.2009.023903; Cryer C, 2008, DEV INDICATORS INJUR; Cryer PC, 1999, INT J CONS PROD SAFE, V6, P183; CSTE (Council of State and Territorial Epidemiologists), 2015, OCC HLTH IND GUID TR; Dennison C, 2000, Vital Health Stat 1, P1; Derk S. J., 2007, Morbidity and Mortality Weekly Report, V56, P393; Friedman LS, 2007, OCCUP ENVIRON MED, V64, P454, DOI 10.1136/oem.2006.029322; Groenewold MR, 2013, HEALTH SERV RES, V48, P1939, DOI 10.1111/1475-6773.12066; Guo XG, 2010, IND LABOR RELAT REV, V63, P340, DOI 10.1177/001979391006300209; Langley John, 2003, Traffic Inj Prev, V4, P291, DOI 10.1080/714040487; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; National Center for Health Statistics (NCHS) Expert Group on Injury Severity Measurement, 2004, DISC DOC INJ SEV MEA; National Institute for Occupational Safety and Health, WORKPL SAF HLTH TOP; National Trauma Data Bank, 2012, NAT TRAUM DAT STAND; Qiu Yue, 2015, WORKERS COMPENSATION; Sears JM, 2015, J OCCUP REHABIL, V25, P742, DOI 10.1007/s10926-015-9582-5; Sears JM, 2014, AM J IND MED, V57, P928, DOI 10.1002/ajim.22329; Sears JM, 2013, AM J IND MED, V56, P742, DOI 10.1002/ajim.22179; Sears JM, 2012, J OCCUP ENVIRON MED, V54, P356, DOI 10.1097/JOM.0b013e3182444fe7; Sears JM, 2011, J OCCUP ENVIRON MED, V53, P1243, DOI 10.1097/JOM.0b013e31822cff63; SOROCK GS, 1993, AM J IND MED, V23, P427, DOI 10.1002/ajim.4700230306; Stephenson S, 2005, ACCIDENT ANAL PREV, V37, P825, DOI 10.1016/j.aap.2005.03.024; STIPDA, 2007, CONS REC INJ SURV ST; Thomas KE, 2012, STATE INJURY INDICAT; Thomsen Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P1; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; U.S. Department of Labor Bureau of Labor Statistics, 2008, FAT OCC INJ NONF OCC; U.S. House of Representatives Committee on Education and Labor, 2008, MAJ STAFF REP HIDD T; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Washington State Department of Health Center for Health Statistics, 2012, CHARS LTD FIL LAYOUT	38	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1353-8047	1475-5785		INJURY PREV	Inj. Prev.	JUN	2016	22	3					195	201		10.1136/injuryprev-2015-041807			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DN5MU	WOS:000377113800006	26658981	Bronze			2022-02-06	
J	Shafiei, E; Fakharian, E; Omidi, A; Akbari, H; Delpisheh, A				Shafiei, Elham; Fakharian, Esmaeil; Omidi, Abdollah; Akbari, Hossein; Delpisheh, Ali			Effect of Mild Traumatic Brain Injury and Demographic Factors on Psychological Outcome	ARCHIVES OF TRAUMA RESEARCH			English	Article						Mild Traumatic Brain Injury; Psychological Symptoms; Brief Symptom Inventory	BRIEF SYMPTOM INVENTORY; POST-CONCUSSIVE SYMPTOMS; QUALITY-OF-LIFE; 1ST 6 MONTHS; PSYCHIATRIC-DISORDERS; HEAD-INJURY; FOLLOW-UP; CHILDREN; ANXIETY; ADOLESCENTS	Background: It is well-known that severe brain injury can make people susceptible to psychological symptoms. However, mild traumatic brain injury (MTBI) is still open for discussion. Objectives: This study aimed to compare psychological symptoms of MTBI patients with those without MTBI considering demographic auxiliary variables. Patients and Methods: This prospective cohort study was conducted on 50 MTBI patients and 50 healthy subjects aged 15-65 years. Psychological assessment was carried out six months post-injury using a series of self-report measures including the brief symptom inventory (BSI) scale. Other information of the individuals in the two groups was recorded prospectively. Data were analyzed using the chi-square test, t-test, and multiple linear regression tests. Results: There was a significant difference between the MTBI patients and healthy subjects in all subscales and total score of BSI. Our findings showed that obsession-compulsion and anxiety subscales were significantly more common in the MTBI patients than in the healthy subjects. Also, multivariate regression analysis six months post-injury showed that head trauma and substance abuse can have an effect on psychological symptoms. Conclusions: Mild traumatic brain injuries despite of the normal CT scan and history of substance abuse are closely related to psychological symptoms. Therefore, it is recommended that patients with brain trauma 6 months post-injury and subjects with a history of substance abuse be evaluated for psychological distress to support better rehabilitation.	[Shafiei, Elham; Fakharian, Esmaeil] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran; [Omidi, Abdollah] Kashan Univ Med Sci, Dept Clin Psychol, Kashan, Iran; [Akbari, Hossein] Kashan Univ Med Sci, Dept Epidemiol & Biostat, Sch Publ Hlth, Kashan, Iran; [Delpisheh, Ali] Ilam Univ Med Sci, Res Ctr, Prevent Psychosocial Injuries, Ilam, Iran		Fakharian, E (corresponding author), Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran.	efakharian@gmail.com	shafiei, elham/I-2933-2018; Fakharian, Esmaeil/A-1338-2018; Akbari, Hossein/G-4737-2017; Omidi, Abdollah/G-8161-2017	Akbari, Hossein/0000-0001-7486-8580; Omidi, Abdollah/0000-0001-5538-7693; Delpisheh, Ali/0000-0001-7201-7854	trauma research center of Kashan University of Medical Sciences [92153]	This article is a part of PhD dissertation supported by trauma research center of Kashan University of Medical Sciences (grant no: 92153).	Alway Y, 2012, NEUROPSYCHOL REHABIL, V22, P374, DOI 10.1080/09602011.2011.648757; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Baum G, 2014, QUAL LIFE RES, V23, P2031, DOI 10.1007/s11136-014-0647-2; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chaves C, 2012, BRAIN INJURY, V26, P882, DOI 10.3109/02699052.2012.666373; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Fakharian E, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.17629; Finset A, 1999, PSYCHOSOM MED, V61, P576, DOI 10.1097/00006842-199907000-00024; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Hajek CA, 2010, BRAIN INJURY, V24, P100, DOI 10.3109/02699050903508226; Hessel A, 2001, DIAGNOSTICA, V47, P27, DOI 10.1026//0012-1924.47.1.27; Hollier LJ, 2014, J CRANIOFAC SURG, V259, P616, DOI 10.1097/SCS.0000000000001095; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Marin JR, 2015, AM J EMERG MED, V33, P299, DOI 10.1016/j.ajem.2014.11.017; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P272, DOI 10.1176/appi.neuropsych.12040078; Max JE, 2013, J NEUROPSYCH CLIN N, V25, P187, DOI 10.1176/appi.neuropsych.12010011; Max JE, 2011, J NEUROPSYCH CLIN N, V23, P29, DOI 10.1176/appi.neuropsych.23.1.29; Mohammadkhani P, 2010, INT J CLIN HLTH PSYC, V10, P541; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; POLISSAR NL, 1994, BRAIN INJURY, V8, P249, DOI 10.3109/02699059409150977; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rezaei S., 2012, Iranian Journal of Psychiatry and Clinical Psychology, V18, P13; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Titus DJ, 2015, EXP NEUROL, V263, P254, DOI 10.1016/j.expneurol.2014.10.020; Urban R, 2014, PSYCHIAT RES, V216, P146, DOI 10.1016/j.psychres.2014.01.027; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, J PEDIATR PSYCHOL, V27, P393, DOI 10.1093/jpepsy/27.4.393	38	5	5	0	10	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	JUN	2016	5	2							e29729	10.5812/atr.29729			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	DY6KH	WOS:000385217700008	27703960	Bronze, Green Submitted, Green Published			2022-02-06	
J	Veeramuthu, V; Hariri, F; Narayanan, V; Tan, LK; Ramli, N; Ganesan, D				Veeramuthu, Vigneswaran; Hariri, Firdaus; Narayanan, Vairavan; Tan, Li Kuo; Ramli, Norlisah; Ganesan, Dharmendra			Microstructural Change and Cognitive Alteration in Maxillofacial Trauma and Mild Traumatic Brain Injury: A Diffusion Tensor Imaging Study	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							CLOSED-HEAD INJURIES; AXONAL INJURY; FRACTURES; DYSFUNCTION; CONCUSSION; ACCIDENT; SPECTRUM; MALAYSIA; GLIOSIS; LESIONS	Purpose: The aim of the present study was to establish the incidence of maxillofacial (MF) injury accompanying mild traumatic brain injury (mTBI) and the associated neurocognitive deficits and white matter changes. Materials and Methods: A prospective review of 41 patients with mTBI and maxillofacial injury (with or without intracranial lesion) due to motor vehicle accidents who had admission computed tomography (CT), neurocognitive evaluation, and quantitative diffusion tensor imaging available was performed during admission and at 6 months of follow-up. Descriptive statistics were used for the demographic data, and a paired t test and repeated measure analysis of variance were used to establish the intergroup differences and susceptibility. Results: The included patients were relatively young adults, with a mean age of 27.3 +/- 8.8 years and 11.3 +/- 2.1 years of education. Of the 41 patients, 20 (48.8%) had maxillofacial injuries involving the soft tissue and muscles, 18 (43.9%) had facial bone fractures, and 3 (7.3%) had mixed injuries. Of the 41 patients with MF injuries, 28 (68.3%) had intracranial abnormalities found on the admission CT scan. Executive function and attention were significantly altered across the time points, with patients with both MF injury and an intracranial lesion doing poorly at baseline but with improvement 6 months later. In contrast, the patients with no visible intracranial lesion but with MF injuries remained impaired, with signs of a slowed recovery. The fractional anisotropy of the genu of the corpus callosum, anterior limb of the internal capsule, and cingulum for patients with MF injuries but without an intracranial lesion showed trends of reduced integrity over time. Conclusions: The presence ofMF injury without any intracranial traumatic lesions in patients with mTBI increases the risk of short-and long-term neurocognitive derangement compared with patients with mTBI, MF injury, and intracranial traumatic lesions. (C) 2016 American Association of Oral and Maxillofacial Surgeons	[Veeramuthu, Vigneswaran] Univ Malaya, Fac Med, Div Neurosurg, Clin Neuropsychol, Kuala Lumpur, Malaysia; [Hariri, Firdaus] Univ Malaya, Fac Dent, Dept Oro Maxillofacial Surg & Med Sci, Oral & Maxillofacial Surg, Kuala Lumpur, Malaysia; [Narayanan, Vairavan; Ganesan, Dharmendra] Univ Malaya, Fac Med, Div Neurosurg, Neurosurg, Kuala Lumpur, Malaysia; [Tan, Li Kuo] Univ Malaya, Fac Med, Res Imaging Ctr, Biomed Imaging, Kuala Lumpur, Malaysia; [Ramli, Norlisah] Univ Malaya, Fac Med, Res Imaging Ctr, Neuroradiol, Kuala Lumpur, Malaysia		Veeramuthu, V (corresponding author), Univ Malaya, Fac Med, Div Neurosurg, Kuala Lumpur 50603, Malaysia.	vicveera@gmail.com	RAMLI, NORLISAH MOHD/G-5209-2010; GANESAN, DHARMENDRA/B-8437-2010; NARAYANAN, VAIRAVAN/B-9191-2010; Tan, Li Kuo/B-5494-2010; Hariri, F/B-8524-2010; Veeramuthu, Vigneswaran/F-2220-2015	RAMLI, NORLISAH MOHD/0000-0001-7497-8093; NARAYANAN, VAIRAVAN/0000-0002-1118-5042; Tan, Li Kuo/0000-0002-6912-172X; Hariri, F/0000-0001-7536-7462; Veeramuthu, Vigneswaran/0000-0003-2052-0858	University of MalayaUniversiti Malaya	We thank Professor Dr. Vicknes Waran Mathaneswaran, University of Malaya, through whom valuable funding and resources were made available.	Alexander AL, 2011, BRAIN CONNECT, V1, P423, DOI 10.1089/brain.2011.0071; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Banks P., 1992, KILLEYS FRACTURE MID, V5th ed; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Dube A, 2014, IJDMS, V1, P2; Glynn SM, 2007, J TRAUMA, V62, P410, DOI 10.1097/01.ta.0000231556.05899.b0; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Hashim H, 2011, DENT TRAUMATOL, V27, P19, DOI 10.1111/j.1600-9657.2010.00958.x; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Isik D, 2012, ULUS TRAVMA ACIL CER, V18, P200, DOI 10.5505/tjtes.2012.01047; Islam S, 2010, INJURY, V41, P92, DOI 10.1016/j.injury.2009.07.012; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/415740; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Manson PN, 2009, PLAST RECONSTR SURG, V124, P2096, DOI 10.1097/PRS.0b013e3181bf8394; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Nahum A M, 1975, Clin Plast Surg, V2, P59; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; Nordin R, 2015, J ORAL MAX SURG MED, V27, P166, DOI 10.1016/j.ajoms.2014.01.001; Palmer JD, 1996, NEUROSURGERY 96 MANU, P516; Pappachan B, 2012, J MAXILLOFAC ORAL SU, V11, P224, DOI 10.1007/s12663-011-0289-7; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Rahman Sajjad A, 2014, Dent Res J (Isfahan), V11, P336; Rajandram RK, 2014, DENT TRAUMATOL, V30, P128, DOI 10.1111/edt.12052; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Stern RA, 2003, NEUROPSYCHOLOGICAL A; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Winegar BA, 2013, RADIOGRAPHICS, V33, P3, DOI 10.1148/rg.331125080	42	5	5	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	JUN	2016	74	6								10.1016/j.joms.2016.01.042			10	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	DN4GD	WOS:000377020800024	26917201				2022-02-06	
J	Yin, WJ; Xu, ZL; Sheng, JG; Zhang, CQ; Zhu, ZH				Yin, Wenjing; Xu, Zhengliang; Sheng, Jiagen; Zhang, Changqing; Zhu, Zhenhong			Logistic regression analysis of risk factors for femoral head osteonecrosis after healed intertrochanteric fractures	HIP INTERNATIONAL			English	Article						Close reduction and internal fixation; Femoral head osteonecrosis; Intertrochanteric fractures; Logistic models; Risk factors	AVASCULAR NECROSIS; HIP-FRACTURES; COMPLICATIONS	Purpose: To evaluate the potential risk factors of the development of femoral head osteonecrosis after healed intertrochanteric fractures. Methods: We retrospectively reviewed all patients who were operated upon with closed reduction and internal fixation for intertrochanteric fractures by our medical group from December 1993 to December 2012. Patients with healed fractures were identified. Age, gender, comorbidities favouring osteonecrosis, causes of injuries, fracture patterns, the location of the primary fracture line, time from injury to surgery, fixation methods, and the development of femur head osteonecrosis of these patients were summarised. Univariate and multivariate logistic regression analysis were performed to evaluate the correlation between potential risk factors and the development of femoral head osteonecrosis. Results: A total of 916 patients with healed intertrochanteric fractures were identified. Femoral head osteonecrosis was found in 8 cases (0.87%). According to the results of univariate logistic regression, a more proximal fracture line, fixation with dynamic hip screws and age were found to be statistically significant factors. The results of multivariate logistic regression analysis indicated that the statistically significant predictors of femoral head osteonecrosis were younger age (odds ratio [OR] = 17.103; 95% confidence interval [CI], 1.988-147.111), a more proximal fracture line (OR = 31.439; 95% CI, 3.700-267.119) and applying dynamic hip screw as the internal fixation (OR = 11.114; 95% CI, 2.064-59.854). Conclusions: Regular follow-up is commended in young patients with a proximal fracture line who underwent closed reduction and internal fixation with dynamic hip screw, even though the bone had healed.	[Yin, Wenjing; Xu, Zhengliang; Sheng, Jiagen; Zhang, Changqing; Zhu, Zhenhong] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China		Zhu, ZH (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	zhenhongzhu@outllook.com		Sheng, Jiagen/0000-0001-7090-0280; Zhu, Zhen-Hong/0000-0002-2292-949X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272004]	The study was supported by the National Natural Science Foundation of China (Grant no. 81272004).	Babis GC, 2011, ORTHOPEDICS, V34, P39, DOI 10.3928/01477447-20101123-19; Baixauli EJ, 1999, J ORTHOP TRAUMA, V13, P134, DOI 10.1097/00005131-199902000-00011; Barquet A, 2014, INJURY, V45, P1848, DOI 10.1016/j.injury.2014.10.054; Bartonicek J, 2007, J ORTHOP TRAUMA, V21, P229, DOI 10.1097/BOT.0b013e31804afb0b; Burgers PTPW, 2014, INT ORTHOP, V38, P1045, DOI 10.1007/s00264-013-2218-5; Chen CM, 2001, ARCH ORTHOP TRAUM SU, V121, P505, DOI 10.1007/s004020100276; Davidovitch RI, 2010, J TRAUMA, V68, P236, DOI 10.1097/TA.0b013e3181c428ce; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; JOHNELL O, 1997, AM J MED, V103, P20, DOI DOI 10.1016/S0002-9343(97)90023-1; Kaplan K, 2008, J AM ACAD ORTHOP SUR, V16, P665, DOI 10.5435/00124635-200811000-00007; Mallina R, 2013, GERIATR ORTHOP SURG, V4, P74, DOI 10.1177/2151458513507771; Mattan Y, 2002, ISRAEL MED ASSOC J, V4, P434; Min Byung-Woo, 2011, Orthopedics, V34, P349, DOI 10.3928/01477447-20110317-13; NAITO S, 1993, BONE, V14, P745, DOI 10.1016/8756-3282(93)90206-P; Razik F, 2012, INT ORTHOP, V36, P2127, DOI 10.1007/s00264-012-1619-1; Rosengren BE, 2010, ACTA ORTHOP, V81, P453, DOI 10.3109/17453674.2010.492762; Shih L Y, 1992, J Orthop Trauma, V6, P382, DOI 10.1097/00005131-199209000-00021; STROMQVIST B, 1983, ACTA ORTHOP SCAND, V54, P1, DOI 10.3109/17453678309154169; TAYLOR GM, 1955, J BONE JOINT SURG AM, V37, P306, DOI 10.2106/00004623-195537020-00009; van Zeeland MLP, 2011, J TRAUMA, V70, pE67, DOI 10.1097/TA.0b013e3181edbf7a; Verettas DAJ, 2010, INJURY, V41, P279, DOI 10.1016/j.injury.2009.09.012	22	5	6	1	7	WICHTIG PUBLISHING	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1120-7000	1724-6067		HIP INT	Hip Int.	JUN	2016	26	3					215	219		10.5301/hipint.5000346			5	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	DW6RY	WOS:000383780100002	27013487				2022-02-06	
J	Aboulafia-Brakha, T; Allain, P; Ptak, R				Aboulafia-Brakha, Tatiana; Allain, Philippe; Ptak, Radek			Emotion Regulation After Traumatic Brain Injury: Distinct Patterns of Sympathetic Activity During Anger Expression and Recognition	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						anger; emotion regulation; skin conductance; STAXI; traumatic brain injury	ANGRY RUMINATION; AGGRESSION QUESTIONNAIRE; BORDERLINE PERSONALITY; AFFECTIVE RESPONSIVITY; SOCIAL-PERCEPTION; FACIAL EXPRESSION; FOLLOW-UP; AROUSAL; REAPPRAISAL; EMPATHY	Objective: To assess psychological and psychophysiological correlates of emotion recognition and anger experience in participants with traumatic brain injury (TBI). Participants: Twenty participants with TBI presenting with anger problems and 22 healthy controls. Procedures: Participants were administered tasks assessing emotion recognition (The French Evaluation Task) and anger expression (Anger regulation task). The latter, designed to elicit and modulate anger feelings through verbal recall of a self-experienced event, involved 4 recall conditions that followed a resting period: neutral, uninstructed anger recall, anger rumination, and anger reappraisal. Measures: Skin conductance levels during recall and a self-report anger questionnaire between each condition. Results: In the TBI and control groups, self-reported anger was similarly modulated across emotion regulation conditions. However, only in the TBI group did skin conductance levels significantly increase between neutral and uninstructed anger recall conditions. Conclusions: Impaired emotion regulation in TBI participants could be related to increased levels of autonomic system activity during emotional experience. However, anger feelings in these participants can also be modulated with the use of emotion regulation strategies, including adaptive strategies such as reappraisal. Thus, promoting awareness and management of physiological activation and encouraging cognitive restructuring can be recommended as a component of interventions targeting emotion regulation in TBI patients.	[Aboulafia-Brakha, Tatiana; Ptak, Radek] Univ Hosp Geneva, Dept Clin Neurosci, Div Neurorehabil, Ave Beau Sejour 26, CH-1211 Geneva 14, Switzerland; [Aboulafia-Brakha, Tatiana; Ptak, Radek] Univ Geneva, Sch Med, Dept Clin Neurosci, Lab Cognit Neurorehabil, Geneva, Switzerland; [Aboulafia-Brakha, Tatiana; Ptak, Radek] Univ Geneva, Fac Psychol & Educ Sci, Geneva, Switzerland; [Allain, Philippe] Univ Angers, LUNAM Univ, Psychol Lab, EA 4638, Angers, France; [Allain, Philippe] Univ Hosp Angers, Dept Neurol, Neuropsychol Unit, Angers, France		Aboulafia-Brakha, T (corresponding author), Univ Hosp Geneva, Dept Clin Neurosci, Div Neurorehabil, Ave Beau Sejour 26, CH-1211 Geneva 14, Switzerland.	Tatiana.Aboulafia@hcuge.ch		Ptak, Radek/0000-0003-4708-9201; ALLAIN, Philiooe/0000-0003-0668-0986	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [PMCDP1_151305]	This study was supported by the Swiss National Science Foundation (grant PMCDP1_151305 to TAB).	Aboulafia-Brakha T, 2013, NEUROPSYCHOL REHABIL, V23, P216, DOI 10.1080/09602011.2012.747443; Alderman N, 2003, NEUROPSYCHOL REHABIL, V13, P211, DOI 10.1080/09602010244000327; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Borteyrou X, 2008, ENCEPHALE, V34, P249, DOI 10.1016/j.encep.2007.06.001; Bryant FB, 2001, J RES PERS, V35, P138, DOI 10.1006/jrpe.2000.2302; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; de Sousa A, 2012, J CLIN EXP NEUROPSYC, V34, P606, DOI 10.1080/13803395.2012.667067; de Sousa A, 2011, CORTEX, V47, P526, DOI 10.1016/j.cortex.2010.02.004; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Denson TF, 2013, PERS SOC PSYCHOL REV, V17, P103, DOI 10.1177/1088868312467086; Denson TF, 2012, BEHAV THER, V43, P355, DOI 10.1016/j.beth.2011.08.001; Denson TF, 2011, PERS SOC PSYCHOL B, V37, P850, DOI 10.1177/0146167211401420; Denson TF, 2009, SYD SYM SOC PSYCHOL, P233; Dethier M, 2013, J INT NEUROPSYCH SOC, V19, P367, DOI 10.1017/S1355617712001555; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dixon-Gordon KL, 2013, J BEHAV THER EXP PSY, V44, P271, DOI 10.1016/j.jbtep.2012.12.001; Fabiansson EC, 2012, NEUROIMAGE, V59, P2974, DOI 10.1016/j.neuroimage.2011.09.078; Fernandez C, 2012, APPL PSYCHOPHYS BIOF, V37, P73, DOI 10.1007/s10484-012-9180-7; Foster PS, 2001, INT J PSYCHOPHYSIOL, V41, P11, DOI 10.1016/S0167-8760(00)00163-X; Gerin W, 2006, PSYCHOSOM MED, V68, P64, DOI 10.1097/01.psy.0000195747.12404.aa; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Herwig U, 2010, NEUROIMAGE, V50, P734, DOI 10.1016/j.neuroimage.2009.12.089; Hopkins MJ, 2002, BRAIN INJURY, V16, P245, DOI 10.1080/02699050110103346; Jallais C, 2010, BEHAV RES METHODS, V42, P318, DOI 10.3758/BRM.42.1.318; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Limberg A, 2011, BIOL PSYCHIAT, V69, P574, DOI 10.1016/j.biopsych.2010.10.024; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; Marci CD, 2007, COGN AFFECT BEHAV NE, V7, P243, DOI 10.3758/CABN.7.3.243; Mauss IB, 2007, INT J PSYCHOPHYSIOL, V66, P116, DOI 10.1016/j.ijpsycho.2007.03.017; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Mayne TJ, 1999, J CLIN PSYCHOL, V55, P353, DOI 10.1002/(SICI)1097-4679(199903)55:3<353::AID-JCLP7>3.0.CO;2-B; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2013, NEUROPSYCHOL REHABIL, V23, P267, DOI 10.1080/09602011.2012.751340; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; McDonald S, 2011, INT J PSYCHOPHYSIOL, V82, P124, DOI 10.1016/j.ijpsycho.2011.01.014; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann DR, 2011, J HEAD TRAUMA REHAB, V26, P375, DOI 10.1097/HTR.0b013e3181f8d52d; NOVACO RW, 1976, J CONSULT CLIN PSYCH, V44, P681, DOI 10.1037/0022-006X.44.4.681; NOVACO RW, 1976, AM J PSYCHIAT, V133, P1124; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Ottaviani C, 2011, PSYCHOPHYSIOLOGY, V48, P453, DOI 10.1111/j.1469-8986.2010.01122.x; PRIGATANO GP, 1992, J CONSULT CLIN PSYCH, V60, P360, DOI 10.1037/0022-006X.60.3.360; Ray RD, 2008, J PERS SOC PSYCHOL, V94, P133, DOI 10.1037/0022-3514.94.1.133; Recchia S, 2010, ENCEPHALE, V36, P202, DOI 10.1016/j.encep.2009.02.006; Rushby JA, 2013, INT J PSYCHOPHYSIOL, V89, P460, DOI 10.1016/j.ijpsycho.2013.05.009; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Schmahl CG, 2004, PSYCHIAT RES, V126, P33, DOI 10.1016/j.psychres.2004.01.005; Spielberger CD., 1970, STATE TRAIT ANXIETY; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Stephens CL, 2010, BIOL PSYCHOL, V84, P463, DOI 10.1016/j.biopsycho.2010.03.014; TEASDALE G, 1974, LANCET, V2, P81; Walker AJ, 2010, BRAIN INJURY, V24, P517, DOI 10.3109/02699051003601721	57	5	5	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E21	E31		10.1097/HTR.0000000000000171			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800003	26394298				2022-02-06	
J	Colton, K; Yang, S; Hu, PF; Chen, HH; Bonds, B; Stansbury, LG; Scalea, TM; Stein, DM				Colton, Katharine; Yang, S.; Hu, P. F.; Chen, H. H.; Bonds, B.; Stansbury, L. G.; Scalea, T. M.; Stein, D. M.			Pharmacologic Treatment Reduces Pressure Times Time Dose and Relative Duration of Intracranial Hypertension	JOURNAL OF INTENSIVE CARE MEDICINE			English	Article						intracranial pressure; traumatic brain injury; hypertonic saline; hyperosmolar therapy	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; HYPERTONIC SALINE; PROPOFOL; FENTANYL; SUFENTANIL; INCREASES; MANNITOL; SEDATION; EDEMA	Introduction: Past work has shown the importance of the pressure times time dose (PTD) of intracranial hypertension (intracranial pressure [ICP] > 19 mm Hg) in predicting outcome after severe traumatic brain injury. We used automated data collection to measure the effect of common medications on the duration and dose of intracranial hypertension. Methods: Patients >17 years old, admitted and requiring ICP monitoring between 2008 and 2010 at a single, large urban tertiary care facility, were retrospectively enrolled. Timing and dose of ICP-directed therapy were recorded from paper and electronic medical records. The ICP data were collected automatically at 6-second intervals and averaged over 5 minutes. The percentage of time of intracranial hypertension (PTI) and PTD (mm Hg h) were calculated. Results: A total of 98 patients with 664 treatment instances were identified. Baseline PTD ranged from 27 (before administration of propofol and fentanyl) to 150 mm Hg h (before mannitol). A small dose of hypertonic saline (HTS; 250 mL 3%) reduced PTD by 38% in the first hour and 37% in the second hour and reduced the time with ICP >19 by 38% and 39% after 1 and 2 hours, respectively. A large dose of HTS reduced PTD by 40% in the first hour and 63% in the second (PTI reduction of 36% and 50%, respectively). An increased dose of propofol or fentanyl infusion failed to decrease PTD but reduced PTI between 14% (propofol alone) and 30% (combined increase in propofol and fentanyl, after 2 hours). Barbiturates failed to decrease PTD but decreased PTI by 30% up to 2 hours after administration. All reductions reported are significantly changed from baseline, P < .05. Conclusion: Baseline PTD values before drug administration reflects varied patient criticality, with much higher values seen before the use of mannitol or barbiturates. Treatment with HTS reduced PTD and PTI burden significantly more than escalation of sedation or pain management, and this effect remained significant at 2 hours after administration.	[Colton, Katharine; Yang, S.; Hu, P. F.; Chen, H. H.; Bonds, B.; Stansbury, L. G.; Scalea, T. M.; Stein, D. M.] Univ Maryland, Sch Med, Shock Trauma Anesthesia Res Organized Res Ctr, Baltimore, MD 21201 USA; [Colton, Katharine; Yang, S.; Hu, P. F.; Chen, H. H.; Bonds, B.; Stansbury, L. G.; Scalea, T. M.; Stein, D. M.] R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Colton, Katharine] Duke Univ, Sch Med, Durham, NC USA		Colton, K (corresponding author), Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, 22 South Greene St,T4M14, Baltimore, MD 21201 USA.	krcolton@gmail.com	Yang, Shiming/I-3695-2015	Yang, Shiming/0000-0003-0338-4268; Stein, Deborah/0000-0003-3683-3963	 [FA8650-11-2-6D06];  [FA8650-12-2-6D09];  [FA8650-13-2-6D15]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded in part by the grants FA8650-11-2-6D06, FA8650-12-2-6D09, and FA8650-13-2-6D15.	Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cai JS, 2011, NEUROCHEM RES, V36, P1724, DOI 10.1007/s11064-011-0487-1; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; Ding ZY, 2013, CELL BIOCHEM BIOPHYS, V67, P615, DOI 10.1007/s12013-013-9549-0; Eskandari R, 2013, J NEUROSURG, V119, P338, DOI 10.3171/2013.4.JNS121541; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Ghori Kamran A, 2007, Crit Care Resusc, V9, P166; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kawaguchi Masahiko, 2005, J Anesth, V19, P150, DOI 10.1007/s00540-005-0305-5; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; Lauer KK, 1997, CAN J ANAESTH, V44, P929, DOI 10.1007/BF03011963; Lee JH, 2013, NEUROCHEM RES, V38, P2276, DOI 10.1007/s11064-013-1136-7; Leone M, 2004, ANESTH ANALG, V99, P1193, DOI 10.1213/01.ANE.0000132546.79769.91; Lu J, 2005, ACT NEUR S, V95, P281; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Rossaint J, 2009, CRIT CARE, V13, DOI 10.1186/cc7795; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Sorani MD, 2008, J NEUROTRAUM, V25, P291, DOI 10.1089/neu.2007.0411; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019	23	5	5	1	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0885-0666	1525-1489		J INTENSIVE CARE MED	J. Intensive Care Med.	MAY	2016	31	4					263	269		10.1177/0885066614555692			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ4QT	WOS:000374193100006	25320157				2022-02-06	
J	Hyden, J; Petty, B				Hyden, John; Petty, Benjamin			Sideline Management of Concussion	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Sideline; Concussion; SCAT3; Balance; Vision; Symptom scale	SPORTS-RELATED CONCUSSION; FOOTBALL PLAYERS; HIGH-SCHOOL; RECURRENT CONCUSSION; REACTION-TIME; SYMPTOMS; STATEMENT; COHORT	Concussion associated with sport is a common occurrence with an estimated 1.6 to 3.8 million sports-related concussions yearly in the United States. The sideline assessment of concussion focuses on four areas: cognitive ability, balance, associated symptoms, and visual tracking. Tools available on the sideline to assist in the diagnosis of concussion are discussed in this article. Some of these tools are validated and reliable and some are developing and have yet to be proven to be sensitive enough for routine use. These tools along with a thorough history and physical examination enable a sideline physician to accurately diagnose concussion.	[Hyden, John; Petty, Benjamin] Campbell Clin Orthopaed, 1400 South Germantown Rd, Germantown, TN 38138 USA; [Hyden, John; Petty, Benjamin] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA		Hyden, J (corresponding author), 1400 South Germantown Rd, Germantown, TN 38138 USA.	jhyden@campbellclinic.com					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Burk JM, 2013, CLIN J SPORT MED, V23, P312, DOI 10.1097/JSM.0b013e318285633f; Covassin T, 2003, J ATHL TRAINING, V38, P238; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Okonkwo DO, 2014, NEUROSURGERY, V75, P582; Ragan BG, 2009, ATHLETIC TRAIN SPORT, V1, P180; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Slobounov S, 2006, CYBERPSYCHOL BEHAV, V9, P188, DOI 10.1089/cpb.2006.9.188; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Yeh JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091230	35	5	5	3	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2016	27	2					395	+		10.1016/j.pmr.2015.12.004			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	DN4RU	WOS:000377055700004	27154852				2022-02-06	
J	Jae-Ok, K; Voaklander, D				Jae-Ok, Koh; Voaklander, Don			Effects of Competition Rule Changes on the Incidence of Head Kicks and Possible Concussions in Taekwondo	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						taekwondo; concussion; head injury; rule change	VIDEO ANALYSIS; BLOWS; INJURIES	Objective: Competition rules related to head kicks (HKs) in sparing-taekwondo (S-TKD) were changed in 2009, resulting in more points awarded to the head attacker. The objective of this research is to measure the incidence of HKs and to analyze the characteristics of situations leading up to and after HKs in a postrule change competition. Design: Descriptive epidemiology study using video analysis. Setting: The final matches of the World Taekwondo Championships (WTCs) in 2011 and 2013. Participants: A total of 1760 athletes participated in both WTCs. Sixty-four athletes, who had won elimination-round matches and were 15 years or older, competed in final matches. Main Outcome Measures: The final matches-a total of 64 matches including 95 rounds-were analyzed using an anatomical and outcome coding scheme for HKs. Results: Overall, a total of 30 athletes experienced receiving one or more HKs during 2WTCs (469 HKs per 1000 athlete-exposures (A-E), 95% confidence interval = 296, 642). Female athletes showed higher incidences of HKs than male. A trend of increasing incidence of HKs was observed in the females. The HKs occurred more frequently among competitors in lightweight categories and those of similar height (49%). Conclusions: Overall, the frequency of HKs seems to have increased compared with matches before 2009. A sharp increase in the numbers of HKs is evident among the elite female athletes. To prevent receiving an HK, updated game strategies such as training for blocking skills, and safety guidelines for HKs, or revisions to rules are needed. Clinical Relevance: The recent changes to competition rules promoting the use of HKs may have resulted in an increasing frequency of HKs compared with research findings before these changes. Multiple HKs occur frequently in S-TKD; care needs to be taken to avoid possible acute/chronic consequences.	[Jae-Ok, Koh] Daegu Haany Univ, Dept Oriental Sports Med, Gyongsan, South Korea; [Voaklander, Don] Univ Alberta, Sch Publ Hlth, Injury Prevent Ctr, 4075 RTF,8308-114 St, Edmonton, AB T6G 2E1, Canada		Voaklander, D (corresponding author), Univ Alberta, Sch Publ Hlth, Injury Prevent Ctr, 4075 RTF,8308-114 St, Edmonton, AB T6G 2E1, Canada.	don.voaklander@ualberta.ca		Koh, Jae Ok/0000-0002-3639-0739			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Dick R, 2007, J ATHL TRAINING, V42, P221; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Harmon KG, 2012, BRIT J SPORT MED, V46, P158, DOI 10.1136/bjsports-2012-090999; Koh JO, 2004, CLIN J SPORT MED, V14, P72, DOI 10.1097/00042752-200403000-00004; Koh JO, 2004, BRAIN INJURY, V18, P1287, DOI 10.1080/02699050410001719907; Koh JO, 2002, J SPORT MED PHYS FIT, V42, P348; KOH JO, 2011, J KOREAN PHYS ED ASS, V25, P153; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2011, CLIN J SPORT MED, V21, P6, DOI 10.1097/JSM.0b013e318204db50; Ok Koh Jae, 2011, [Korean Journal of Sport Science, 체육과학연구], V22, P2088; Pieter W, 1995, J HUM MOVEMENT STUD, V28, P1; Pieter W., 2009, COMBAT SPORTS MED, P263; Pieter W, 2012, BRIT J SPORT MED, V46, P485, DOI 10.1136/bjsports-2012-091011	17	5	5	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2016	26	3					239	244		10.1097/JSM.0000000000000244			6	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DL4KX	WOS:000375605800014	26247547				2022-02-06	
J	Triebel, KL; Novack, TA; Kennedy, R; Martin, RC; Dreer, LE; Raman, R; Marson, DC				Triebel, Kristen L.; Novack, Thomas A.; Kennedy, Richard; Martin, Roy C.; Dreer, Laura E.; Raman, Rema; Marson, Daniel C.			Neurocognitive Models of Medical Decision-Making Capacity in Traumatic Brain Injury Across Injury Severity	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injury; cognitive; consent capacity; decision making; medical ethics; neuropsychological assessment	COGNITIVE PREDICTORS; ALZHEIMERS-DISEASE; HEAD-INJURY; MILD; CONSENT; COMPETENCE; RECOGNITION; CONCUSSION; ABILITIES; RECOVERY	Objective: To identify neurocognitive predictors of medical decision-making capacity (MDC) in participants with mild and moderate/severe traumatic brain injury (TBI). Setting: Academic medical center. Participants: Sixty adult controls and 104 adults with TBI (49 mild, 55 moderate/severe) evaluated within 6 weeks of injury. Design: Prospective cross-sectional study. Main Measures: Participants completed the Capacity to Consent to Treatment Instrument to assess MDC and a neuropsychological test battery. We used factor analysis to reduce the battery test measures into 4 cognitive composite scores (verbal memory, verbal fluency, academic skills, and processing speed/executive function). We identified cognitive predictors of the 3 most clinically relevant Capacity to Consent to Treatment Instrument consent standards (appreciation, reasoning, and understanding). Results: In controls, academic skills (word reading, arithmetic) and verbal memory predicted understanding; verbal fluency predicted reasoning; and no predictors emerged for appreciation. In the mild TBI group, verbal memory predicted understanding and reasoning, whereas academic skills predicted appreciation. In the moderate/severe TBI group, verbal memory and academic skills predicted understanding; academic skills predicted reasoning; and academic skills and verbal fluency predicted appreciation. Conclusions: Verbal memory was a predictor of MDC in controls and persons with mild and moderate/severe TBI. In clinical practice, impaired verbal memory could serve as a "red flag" for diminished consent capacity in persons with recent TBI.	[Triebel, Kristen L.; Martin, Roy C.; Marson, Daniel C.] Univ Alabama Birmingham, Div Neuropsychol, Dept Neurol, Sparks Ctr 650,1720 7th Ave S, Birmingham, AL 35294 USA; [Novack, Thomas A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA; [Kennedy, Richard] Univ Alabama Birmingham, Dept Med, Div Gerontol Geriatr & Palliat Care, Birmingham, AL 35294 USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Raman, Rema] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Div Neuropsychol, Dept Neurol, Sparks Ctr 650,1720 7th Ave S, Birmingham, AL 35294 USA.	dmar-son@uab.edu	triebel, kristen/A-6569-2019; Kennedy, Richard/K-1525-2018	triebel, kristen/0000-0001-9161-7847; Kennedy, Richard/0000-0003-4638-126X; Martin, Roy/0000-0001-9328-0846	UAB Research Foundation for the Capacity to Consent to Treatment Instrument; National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD053074]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER	Dr Marson receives income from royalties paid to the UAB Research Foundation for the Capacity to Consent to Treatment Instrument.; Supported by the National Institute on Child Health and Human Development (1R01HD053074) (Marson, PI).	APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; BINDER LM, 1993, J CLIN EXP NEUROPSYC, V15, P170, DOI 10.1080/01688639308402555; Bowie CR, 2008, BIOL PSYCHIAT, V63, P505, DOI 10.1016/j.biopsych.2007.05.022; Corporation TP, 2001, WECHSLER TEST ADULT; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Dellasega Cheryl, 1996, J Ethics Law Aging, V2, P65; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Fisk GD, 1998, BRAIN INJURY, V12, P683; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Gurrera RJ, 2006, NEUROLOGY, V66, P1367, DOI 10.1212/01.wnl.0000210527.13661.d1; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Marson DC, 1996, NEUROLOGY, V46, P666, DOI 10.1212/WNL.46.3.666; Martin RC, 2008, MOVEMENT DISORD, V23, P1867, DOI 10.1002/mds.22170; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Okonkwo OC, 2008, J INT NEUROPSYCH SOC, V14, P297, DOI 10.1017/S1355617708080338; Okonkwo OC, 2006, J AM GERIATR SOC, V54, P1745, DOI 10.1111/j.1532-5415.2006.00916.x; Ortoleva C, 2012, J HEAD TRAUMA REHAB, V27, P302, DOI 10.1097/HTR.0b013e3182236299; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Sumowski JF, 2013, ARCH PHYS MED REHAB, V94, P2562, DOI 10.1016/j.apmr.2013.07.023; Triebel KL, 2012, NEUROLOGY, V78, P1472, DOI 10.1212/WNL.0b013e3182553c38; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wechsler D., 1997, WMS 3 WECHSLER MEMOR, V3rd edn; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wolfson, 1993, HALSTEAD REITAN NEUR	50	5	6	0	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2016	31	3					E49	E59		10.1097/HTR.0000000000000163			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FK	WOS:000379787800006	26394290	Green Accepted			2022-02-06	
J	Williams, RM; Dowling, M; O'Connor, KL				Williams, Richelle M.; Dowling, Margaret; O'Connor, Kathryn L.			Head Impact Measurement Devices: A Clinical Review	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; accelerometers; subconcussive; head impacts; review	COLLEGIATE FOOTBALL PLAYERS; HIGH-SCHOOL FOOTBALL; ICE HOCKEY PLAYERS; SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; YOUTH FOOTBALL; INSTRUMENTED MOUTHGUARD; NEUROLOGIC FUNCTION; EXPOSURE; ACCELERATION	Context: Concussive injuries are at the forefront of sports medicine research. Recently, researchers have used a variety of head-and helmet-based impact-monitoring devices to quantify impacts sustained during contact sport participation. This review provides an up-to-date collection of head accelerometer use at the youth, high school, and collegiate levels. Evidence Acquisition: PubMed was searched for articles published between 1980 and 2015 using the terms accelerometer and concussion, impact sensor and concussion, head impact telemetry system, head impact telemetry, and linear acceleration and concussion. An additional Google search was performed to capture devices without publications. Study Design: Clinical review. Level of Evidence: Level 4. Results: Twenty-four products track and/or record head impact for clinical or research use. Ten of these head impact devices have publications supporting their utility. Conclusion: Head impact measuring devices can describe athlete exposure in terms of magnitude and/or frequency, highlighting their utility within a multimodal approach for concussion assessment and diagnosis.	[Williams, Richelle M.; O'Connor, Kathryn L.] Univ Michigan, Sch Kinesiol, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Williams, Richelle M.; Dowling, Margaret; O'Connor, Kathryn L.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Dowling, Margaret] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA		Williams, RM (corresponding author), Univ Michigan, Sch Kinesiol, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	richellm@umich.edu		Williams, Richelle/0000-0003-4728-7443; Van Pelt, Kathryn/0000-0002-5494-2357	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R15NS081691]; Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DoD)United States Department of Defense; U.S. Army Medical Research Acquisition Activity, Chandler Street, Ford Detrick, MD; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS081691] Funding Source: NIH RePORTER	The following authors declared potential conflicts of interest: Richelle M. Williams, MS, ATC, has grants/grants pending from NIH (1R15NS081691); Margaret Dowling, MPH, and Kathryn L. O'Connor, BA, have grants/grants pending from Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DoD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award NO W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (DHP funds.)	Allison MA, 2015, ANN BIOMED ENG, V43, P1896, DOI 10.1007/s10439-014-1197-z; Barth JT, 2001, J ATHL TRAINING, V36, P253; Bauer JA, 2001, J SPORT SCI, V19, P171, DOI 10.1080/026404101750095312; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Broglio SP, 2012, ANN BIOMED ENG, V40, P37, DOI 10.1007/s10439-011-0396-0; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brolinson P Gunnar, 2006, Curr Sports Med Rep, V5, P23; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Daniel Ray W, 2014, Biomed Sci Instrum, V50, P291; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2009, IEEE ENG MED BIO, P1123, DOI 10.1109/IEMBS.2009.5333423; Eckner JT, 2011, J NEUROTRAUM, V28, P2079, DOI 10.1089/neu.2011.1910; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, PM&R, V3, pS445, DOI 10.1016/j.pmrj.2011.08.009; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hasegawa K, 2014, DENT TRAUMATOL, V30, P259, DOI 10.1111/edt.12082; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Moon D W, 1971, Med Sci Sports, V3, P44; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Naunheim R, 2002, J TRAUMA, V53, P691, DOI 10.1097/00005373-200210000-00012; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Reid S E, 1974, J Sports Med, V2, P86; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson Steven, 2009, Biomed Sci Instrum, V45, P113; Schmidt JD, 2015, CLIN J SPORT MED, V25, P494, DOI 10.1097/JSM.0000000000000143; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wu LC, 2014, IEEE T BIO-MED ENG, V61, P2659, DOI 10.1109/TBME.2014.2320153; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	69	5	5	2	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAY-JUN	2016	8	3					270	273		10.1177/1941738116641912			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EG8CM	WOS:000391283300010	27060184	Green Published			2022-02-06	
J	Wiri, S; Needham, C				Wiri, Suthee; Needham, Charles			Reconstruction of improvised explosive device blast loading to personnel in the open	SHOCK WAVES			English	Article						Air blast injury; Air blast effects; Traumatic brain injury; Computational fluid dynamics		Significant advances in reconstructing attacks by improvised explosive devices (IEDs) and other blast events are reported. A high-fidelity three-dimensional computational fluid dynamics tool, called Second-order Hydrodynamic Automatic Mesh Refinement Code, was used for the analysis. Computer-aided design models for subjects or vehicles in the scene accurately represent geometries of objects in the blast field. A wide range of scenario types and blast exposure levels were reconstructed including free field blast, enclosed space of vehicle cabin, IED attack on a vehicle, buried charges, recoilless rifle operation, rocket-propelled grenade attack and missile attack with single subject or multiple subject exposure to pressure levels from 27.6 kPa (4 psi) to greater than 690 kPa (100 psi). To create a full 3D pressure time-resolved reconstruction of a blast event for injury and blast exposure analysis, a combination of intelligence data and Blast Gauge data can be used to reconstruct an actual in-theatre blast event. The methodology to reconstruct an event and the "lessons learned" from multiple reconstructions in open space are presented. The analysis uses records of blast pressure at discrete points, and the output is a spatial and temporal blast load distribution for all personnel involved.	[Wiri, Suthee; Needham, Charles] Appl Res Associates Inc, Southwest Div, 4300 San Mateo Blvd NE,Ste A-220, Albuquerque, NM 87110 USA		Wiri, S (corresponding author), Appl Res Associates Inc, Southwest Div, 4300 San Mateo Blvd NE,Ste A-220, Albuquerque, NM 87110 USA.	swiri@ara.com					Crepeau J. E., 2010, DTRATR022; Crepeau J. E., 2008, 2 ORDER HYDRODYNAMIC, VI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0	5	5	5	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-1287	1432-2153		SHOCK WAVES	Shock Waves	MAY	2016	26	3					279	286		10.1007/s00193-016-0644-1			8	Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Mechanics	DM6UP	WOS:000376488400007					2022-02-06	
J	Zhang, Y; Liu, XJ; Xue, HQ; Liu, XR; Dai, AH; Song, Y; Ke, KF; Cao, MH				Zhang, Yu; Liu, Xiaojuan; Xue, Huaqing; Liu, Xiaorong; Dai, Aihua; Song, Yan; Ke, Kaifu; Cao, Maohong			Upregulation of PRDM5 Is Associated with Astrocyte Proliferation and Neuronal Apoptosis Caused by Lipopolysaccharide	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Lipopolysaccharide; Neuroinflammation; PRDM5; Astrocyte Proliferation; Neuronal apoptosis	TRAUMATIC BRAIN-INJURY; TUMOR-SUPPRESSOR PRDM5; CELL-CYCLE; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; EXPRESSION; NEUROINFLAMMATION; NEUROPROTECTION; INFLAMMATION; CANCER	PRDM5 (PR domain containing 5) belongs to PRDM family which consists of transcriptional regulators that modulate cellular processes such as cell growth, differentiation and apoptosis. However, the function of PRDM5 in central nervous system (CNS) inflammatory response is unknown. In recent study, an adult rat neuroinflammation model via lipopolysaccharide (LPS) lateral ventricle injection was constructed. PRDM5 expression was increased in activated astrocytes and apoptotic neurons of the adult rat cerebral cortex after LPS injection. In vitro studies showed that the remarkable upregulation of PRDM5 might be involved in rat primary astrocyte proliferation and rat primary neuronal apoptosis in the cerebral cortex following LPS administration. In addition, using PRDM5 RNA interference both in rat primary asrtocytes and neurons, further indicated that PRDM5 was required for astrocyte proliferation and neuronal apoptosis induced by LPS. Our findings on the cellular signaling pathway may provide a new therapeutic strategy against neuroinflammation in the CNS.	[Zhang, Yu; Liu, Xiaorong; Dai, Aihua; Song, Yan; Ke, Kaifu; Cao, Maohong] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xiaojuan] Nantong Univ, Coll Med, Dept Pathogen Biol, Nantong 226001, Jiangsu, Peoples R China; [Zhang, Yu; Liu, Xiaojuan; Xue, Huaqing; Liu, Xiaorong; Dai, Aihua; Song, Yan; Ke, Kaifu; Cao, Maohong] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China		Ke, KF; Cao, MH (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China.; Ke, KF; Cao, MH (corresponding author), Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China.	kekaifu_ntfy@126.com; cmhongnt@sina.com			National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471188]	This work was supported by the National Natural Scientific Foundation of China (no. 81471188).	Agostinho P, 2003, EUR J NEUROSCI, V17, P1189, DOI 10.1046/j.1460-9568.2003.02546.x; Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Bamberger ME, 2002, NEUROSCIENTIST, V8, P276, DOI 10.1177/1073858402008003013; Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Bonda DJ, 2009, AGING-US, V1, P382, DOI 10.18632/aging.100044; Bonow RH, 2009, PHARMACOGENOMICS J, V9, P116, DOI 10.1038/tpj.2008.15; Cheng XH, 2013, J MOL NEUROSCI, V51, P148, DOI 10.1007/s12031-013-9969-8; Choudhury GR, 2015, NEUROBIOL DIS; Deng QD, 2004, ONCOGENE, V23, P4903, DOI 10.1038/sj.onc.1207615; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Duan Z, 2007, MOL CELL BIOL, V27, P6889, DOI 10.1128/MCB.00762-07; Felts PA, 2005, BRAIN, V128, P1649, DOI 10.1093/brain/awh516; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Jiang J, 2010, NEUROCHEM INT, V56, P561, DOI 10.1016/j.neuint.2009.12.019; Kabadi SV, 2012, J NEUROTRAUM, V29, P813, DOI 10.1089/neu.2011.1980; Kato H, 2003, BRAIN RES BULL, V60, P215, DOI 10.1016/S0361-9230(03)00036-4; KOEP LJ, 1970, J NEUROPATH EXP NEUR, V29, P254; Koguchi K, 2002, GLIA, V37, P93, DOI 10.1002/glia.10017; Ledeboer A, 2002, AM J PHYSIOL-REG I, V282, pR1762, DOI 10.1152/ajpregu.00766.2001; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martino G, 2004, LANCET NEUROL, V3, P372, DOI 10.1016/S1474-4422(04)00771-9; Meani N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004273; Minghetti L, 2005, CURR OPIN NEUROL, V18, P315, DOI 10.1097/01.wco.0000169752.54191.97; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Nomura Y, 1998, TOXICOL LETT, V103, P65, DOI 10.1016/S0378-4274(98)00286-0; Roussos P, 2015, ALZHEIMERS DEMENT, V11, P1163, DOI 10.1016/j.jalz.2014.10.013; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Shivapurkar N, 2001, HUM PATHOL, V32, P169, DOI 10.1053/hupa.2001.21560; Shu XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027346; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song Y, 2014, CELL MOL NEUROBIOL, V34, P839, DOI 10.1007/s10571-014-0060-y; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Tan SX, 2014, TUMOR BIOL, V35, P4509, DOI 10.1007/s13277-013-1593-2; Wang LW, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-175; Watanabe Y, 2007, CLIN CANCER RES, V13, P4786, DOI 10.1158/1078-0432.CCR-07-0305; Wu XM, 2012, J MOL NEUROSCI, V47, P357, DOI 10.1007/s12031-012-9761-1	40	5	5	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAY	2016	59	1					146	157		10.1007/s12031-016-0744-5			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DL0JK	WOS:000375318500016	27074744				2022-02-06	
J	Zupan, B; Neumann, D				Zupan, Barbra; Neumann, Dawn			Exploring the Use of Isolated Expressions and Film Clips to Evaluate Emotion Recognition by People with Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 111; Emotion recognition; isolated facial expressions; isolated vocal emotion expressions; contextual cues; film clips; traumatic brain injury	FACIAL AFFECT RECOGNITION; SOCIAL-PERCEPTION; DIFFERENT MEDIA; DEFICITS; MIND; COMPREHENSION; IMPAIRMENTS; MODEL	The current study presented 60 people with traumatic brain injury (TBI) and 60 controls with isolated facial emotion expressions, isolated vocal emotion expressions, and multimodal (i.e., film clips) stimuli that included contextual cues. All stimuli were presented via computer. Participants were required to indicate how the person in each stimulus was feeling using a forced-choice format. Additionally, for the film clips, participants had to indicate how they felt in response to the stimulus, and the level of intensity with which they experienced that emotion.	[Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Neumann, Dawn] Indiana Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN USA; [Neumann, Dawn] Rehabil Hosp Indiana, Indianapolis, IN USA		Zupan, B (corresponding author), Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada.	bzupan@brocku.ca			Humanities Research Institute at Brock University in St. Catharines, Ontario, Canada; Cannon Research Center at Carolinas Rehabilitation in Charlotte, North Carolina, USA	This work was supported by the Humanities Research Institute at Brock University in St. Catharines, Ontario, Canada and by the Cannon Research Center at Carolinas Rehabilitation in Charlotte, North Carolina, USA.	Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Astesano C, 2004, COGNITIVE BRAIN RES, V18, P172, DOI 10.1016/j.cogbrainres.2003.10.002; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Banziger T, 2007, LECT NOTES COMPUT SC, V4738, P476; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Bornhofen C, 2008, NEUROPSYCHOL REHABIL, V18, P22, DOI 10.1080/09602010601061213; Busselle R, 2008, COMMUN THEOR, V18, P255, DOI 10.1111/j.1468-2885.2008.00322.x; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Collignon O, 2008, BRAIN RES, V1242, P126, DOI 10.1016/j.brainres.2008.04.023; Cunningham DW, 2009, J VISION, V9, DOI 10.1167/9.13.7; Dimoska A, 2010, J INT NEUROPSYCH SOC, V16, P369, DOI 10.1017/S1355617709991445; Edgar C, 2012, PERS INDIV DIFFER, V52, P295, DOI 10.1016/j.paid.2011.10.024; Elfenbein HA, 2002, EMO SOC BEH, P37; Ferstl EC, 2005, J COGNITIVE NEUROSCI, V17, P724, DOI 10.1162/0898929053747658; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Hagemann D, 1999, PERS INDIV DIFFER, V26, P627, DOI 10.1016/S0191-8869(98)00159-7; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P62, DOI 10.1016/j.neuropsychologia.2005.04.011; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Kotz SA, 2007, BRAIN RES, V1151, P107, DOI 10.1016/j.brainres.2007.03.015; LaBar KS, 2003, CEREB CORTEX, V13, P1023, DOI 10.1093/cercor/13.10.1023; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mayes AK, 2009, BRAIN TOPOGR, V22, P145, DOI 10.1007/s10548-009-0106-5; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S., 2005, BRAIN IMPAIR, V6, P58, DOI [DOI 10.1375/BRIM.6.1.56.65481, 10.1375/brim.6.1.56.65481]; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Nowicki S, 1998, GENET SOC GEN PSYCH, V124, P39; Nowicki S., 2008, MANUAL RECEPTIVE TES; O'Toole AJ, 2002, TRENDS COGN SCI, V6, P261, DOI 10.1016/S1364-6613(02)01908-3; Paulmann S, 2008, BRAIN LANG, V104, P262, DOI 10.1016/j.bandl.2007.03.002; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; RUSSELL JA, 1994, PSYCHOL BULL, V115, P102, DOI 10.1037/0033-2909.115.1.102; Sato W, 2007, J NONVERBAL BEHAV, V31, P119, DOI 10.1007/s10919-007-0025-7; Schultz J, 2009, EXP BRAIN RES, V194, P465, DOI 10.1007/s00221-009-1721-9; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543; Wranik T, 2010, INTERNATIONAL HANDBOOK OF ANGER, P243, DOI 10.1007/978-0-387-89676-2_15; Zagalo N., 2004, P SRMC 04 ACM MULT 2, P33; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6; Zupan B, 2009, J COMMUN DISORD, V42, P1, DOI 10.1016/j.jcomdis.2008.06.001	48	5	5	0	2	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2016		111							e53774	10.3791/53774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS0BJ	WOS:000380259900023	27213280	Green Published			2022-02-06	
J	Tay, EL; Lee, SWH; Jamaluddin, SF; Tam, CL; Wong, CP				Tay, Ee Lin; Lee, Shaun Wen Huey; Jamaluddin, Sabariah Faizah; Tam, Cai Lian; Wong, Chee Piau			The epidemiology of childhood brain injury in the state of Selangor and Federal Territory of Kuala Lumpur, Malaysia	BMC PEDIATRICS			English	Article						Traumatic brain injury; Incidence; Road traffic accident; Children	UNITED-STATES; POPULATION; PREVALENCE; CHILDREN	Background: There are limited studies describing the epidemiology of childhood brain injury, especially in developing countries. This study analyses data from the Malaysian National Trauma Database (NTrD) registry to estimate the incidence of childhood brain injury among various demographic groups within the state of Selangor and Federal Territory of Kuala Lumpur. Methods: This study analysed all traumatic brain injury cases for children ages 0-19 included in the 2010 NTrD report. Results: A total of 5,836 paediatric patients were admitted to emergency departments (ED) of reporting hospitals for trauma. Of these, 742 patients (12.7 %) suffered from brain injuries. Among those with brain injuries, the mortality rate was 11.9 and 71.2 % were aged between 15 and 19. Traffic accidents were the most common mode of injury (95.4 %). Out of the total for traffic accidents, 80.2 % of brain injuries were incurred in motorcycle accidents. Severity of injury was higher among males and patients who were transferred or referred to the reporting centres from other clinics. Glasgow Coma Scale (GCS) total score and type of admission were found to be statistically significant, chi(2) (5, N = 178) = 66.53, p < 0.001, in predicting patient outcomes. According to this analysis, the overall rate of childhood brain injury for this one year period was 32 per 100,000 children while the incidence of significant (moderate to severe) brain injury was approximately 8 per 100,000 children. Conclusions: This study provides an overview of traumatic brain injury rates among children within the most populous region of Malaysia. Most brain injuries occurred among older male children, with traffic, specifically motorcycle-related, accidents being the main mode of injury. These findings point to risk factors that could be targeted for future injury prevention programs.	[Tay, Ee Lin; Tam, Cai Lian; Wong, Chee Piau] Monash Univ, Tan Sri Jeffrey Cheah Sch Med & Hlth Sci, Malaysia Campus, Petaling Jaya, Malaysia; [Lee, Shaun Wen Huey] Monash Univ, Sch Pharm, Malaysia Campus, Petaling Jaya, Malaysia; [Jamaluddin, Sabariah Faizah] Sungai Buloh Hosp, Emergency & Trauma Dept, Petaling Jaya, Malaysia		Wong, CP (corresponding author), Monash Univ, Tan Sri Jeffrey Cheah Sch Med & Hlth Sci, Malaysia Campus, Petaling Jaya, Malaysia.	wong.chee.piau@monash.edu	JAMALUDDIN, SABARIAH FAIZAH/AAY-2902-2020; Lee, Shaun/E-9934-2014; Jamaluddin, Sabariah/ABB-6372-2020	Lee, Shaun/0000-0001-7361-6576; JAMALUDDIN, SABARIAH/0000-0002-3788-7915			[Anonymous], 2014, INTERCENSAL MID YEAR; Assiry KA, 2014, ONLINE J MED MED SCI, V5, P44; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Choo WY, 2011, COUNTRY REPORT; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Faul M, 2010, CTR DIS CONTR PREV; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hoofien D, 2001, BRAIN INJURY, V15, P189; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; Lim TO, 2011, NATL HEALTHCARE ESTA; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Martinez R, 2013, HEALTH AFFAIR, V32, P2082, DOI 10.1377/hlthaff.2013.0884; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Nurul Huda J, 2013, REAAA C KUAL LUMP CO; Rohana J, 1998, Med J Malaysia, V53, P217; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; TEASDALE G, 1974, LANCET, V2, P81; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	22	5	5	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2431			BMC PEDIATR	BMC Pediatr.	APR 27	2016	16								56	10.1186/s12887-016-0590-1			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DK7JN	WOS:000375101100002	27122016	Green Published, gold			2022-02-06	
J	Abookasis, D; Volkov, B; Shochat, A; Kofman, I				Abookasis, David; Volkov, Boris; Shochat, Ariel; Kofman, Itamar			Noninvasive assessment of hemodynamic and brain metabolism parameters following closed head injury in a mouse model by comparative diffuse optical reflectance approaches	NEUROPHOTONICS			English	Article						traumatic brain injury; diffuse reflectance; optical systems; absorption and scattering; cerebral hemodynamics; brain metabolism	CEREBRAL-BLOOD-FLOW; LASER-SPECKLE; OXYGEN-SATURATION; LIGHT-SCATTERING; TURBID MEDIA; SPECTROSCOPY; HEMOGLOBIN; EFFICIENT; ISCHEMIA; DYNAMICS	Optical techniques have gained substantial interest over the past four decades for biomedical imaging due to their unique advantages, which may suggest their use as alternatives to conventional methodologies. Several optical techniques have been successfully adapted to clinical practice and biomedical research to monitor tissue structure and function in both humans and animal models. This paper reviews the analysis of the optical properties of brain tissue in the wavelength range between 500 and 1000 nm by three different diffuse optical reflectance methods: spatially modulated illumination, orthogonal diffuse light spectroscopy, and dual-wavelength laser speckle imaging, to monitor changes in brain tissue morphology, chromophore content, and metabolism following head injury. After induction of closed head injury upon anesthetized mice by weight-drop method, significant changes in hemoglobin oxygen saturation, blood flow, and metabolism were readily detectible by all three optical setups, up to 1 h post-trauma. Furthermore, the experimental results clearly demonstrate the feasibility and reliability of the three methodologies, and the differences between the system performances and capabilities are also discussed. The long-term goal of this line of study is to combine these optical systems to study brain pathophysiology in high spatiotemporal resolution using additional models of brain trauma. Such combined use of complementary algorithms should fill the gaps in each system's capabilities, toward the development of a noninvasive, quantitative tool to expand our knowledge of the principles underlying brain function following trauma, and to monitor the efficacy of therapeutic interventions in the clinic. (C) 2016 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Abookasis, David; Volkov, Boris; Shochat, Ariel; Kofman, Itamar] Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel		Abookasis, D (corresponding author), Ariel Univ, Dept Elect & Elect Engn, IL-40700 Ariel, Israel.	davida@ariel.ac.il					Abookasis D, 2008, PROC SPIE, V6842, DOI 10.1117/12.760516; Abookasis D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116007; Abookasis D, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116709; Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adibhatla RM, 2006, AAPS J, V8, pE314; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Arifler D, 2015, BIOMED OPT EXPRESS, V6, P933, DOI 10.1364/BOE.6.000933; Armitage GA, 2010, J CEREBR BLOOD F MET, V30, P1432, DOI 10.1038/jcbfm.2010.73; Bear MF, 1996, NEUROSCIENCE EXPLORI; Bi RZ, 2013, OPT LETT, V38, P1401, DOI 10.1364/OL.38.001401; Bigio I., 2016, QUANTITATIVE BIOMEDI; Boas D.A., 2011, HDB BIOMEDICAL OPTIC; Boas DA, 2011, PHILOS T R SOC A, V369, P4407, DOI 10.1098/rsta.2011.0250; Boas DA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3285504; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Briers D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066018; Briers J D, 1996, J Biomed Opt, V1, P174, DOI 10.1117/12.231359; Briers JD, 2001, PHYSIOL MEAS, V22, pR35, DOI 10.1088/0967-3334/22/4/201; Bullock R., 1997, HEAD INJURY, P89; Calabro KW, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.075005; Cao Q, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101318; Cen HY, 2010, OPT EXPRESS, V18, P17412, DOI 10.1364/OE.18.017412; Cheng HY, 2007, OPT LETT, V32, P2188, DOI 10.1364/OL.32.002188; Cheng HY, 2003, APPL OPTICS, V42, P5759, DOI 10.1364/AO.42.005759; Choi B, 2004, MICROVASC RES, V68, P143, DOI 10.1016/j.mvr.2004.04.003; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; Cuccia DJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3088140; Cuccia DJ, 2005, OPT LETT, V30, P1354, DOI 10.1364/OL.30.001354; Czernicki Z., 2009, BRAIN EDEMA; Deutsch A, 2004, PROC SPIE, V5317, P116, DOI 10.1117/12.528601; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Duncan DD, 2008, J OPT SOC AM A, V25, P9, DOI 10.1364/JOSAA.25.000009; Dunn AK, 2003, OPT LETT, V28, P28, DOI 10.1364/OL.28.000028; FERCHER AF, 1981, OPT COMMUN, V37, P326, DOI 10.1016/0030-4018(81)90428-4; FISHMAN RA, 1975, NEW ENGL J MED, V293, P706, DOI 10.1056/NEJM197510022931407; Fujimoto J.G., 2009, BIOMEDICAL OPTICAL I; Gioux S, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3614566; GRAAFF R, 1992, APPL OPTICS, V31, P1370, DOI 10.1364/AO.31.001370; Grossman R. G., 1990, NEUROBEHAVIORAL CONS; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Guha A, 2004, POSTGRAD MED J, V80, P650, DOI 10.1136/pgmj.2004.019570; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Humeau-Heurtier A, 2013, OPT COMMUN, V291, P482, DOI 10.1016/j.optcom.2012.11.054; Jia YL, 2011, MICROVASC RES, V81, P73, DOI 10.1016/j.mvr.2010.11.003; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; Kim A, 2010, OPT EXPRESS, V18, P5580, DOI 10.1364/OE.18.005580; Koenig F, 1998, UROLOGY, V51, P342, DOI 10.1016/S0090-4295(97)00612-2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau C, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3116708; Laughney AM, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.036012; Laughney AM, 2012, CLIN CANCER RES, V18, P6315, DOI 10.1158/1078-0432.CCR-12-0136; Lee Bruce, 2005, NeuroRx, V2, P372; Lee MW, 2014, BIOMED OPT EXPRESS, V5, P3628, DOI 10.1364/BOE.5.003628; Levy H, 2012, BIOMED OPT EXPRESS, V3, P777, DOI 10.1364/BOE.3.000777; Li PC, 2006, OPT LETT, V31, P1824, DOI 10.1364/OL.31.001824; Lin AJ, 2011, ANN BIOMED ENG, V39, P1349, DOI 10.1007/s10439-011-0269-6; Liu HL, 2000, APPL OPTICS, V39, P5231, DOI 10.1364/AO.39.005231; Luo ZC, 2009, OPT LETT, V34, P1480, DOI 10.1364/OL.34.001480; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maikala RV, 2010, INT J IND ERGONOM, V40, P125, DOI 10.1016/j.ergon.2009.02.011; Mallia RJ, 2010, APPL SPECTROSC, V64, P409, DOI 10.1366/000370210791114347; Maloney-Wilensky E, 2009, CRIT CARE MED, V37, P2057, DOI 10.1097/CCM.0b013e3181a009f8; Marmarou A, 2003, ACT NEUR S, V86, P7; McIntosh TK, 1996, LAB INVEST, V74, P315; Meisner JK, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.096011; Miao P, 2014, OPT LETT, V39, P3907, DOI 10.1364/OL.39.003907; Miao P, 2010, IEEE T BIO-MED ENG, V57, P1152, DOI 10.1109/TBME.2009.2037434; Mourant JR, 1998, APPL OPTICS, V37, P3586, DOI 10.1364/AO.37.003586; Nachabe R, 2010, BIOMED OPT EXPRESS, V1, P1432, DOI 10.1364/BOE.1.001432; Nadeau KP, 2013, OPT LETT, V38, P3566, DOI 10.1364/OL.38.003566; Nishidate I, 2011, OPT LETT, V36, P3239, DOI 10.1364/OL.36.003239; O'Sullivan TD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.071311; Oliveira Carla Oliveira de, 2008, Rev Bras Ter Intensiva, V20, P411; Parthasarathy AB, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526368; Pavlov AN, 2015, J INNOV OPT HEAL SCI, V8, DOI 10.1142/S1793545815500418; Ponticorvo A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.9.090501; Prahl S., 1999, HEMOGLOBIN ABSORPTIO; Richardson J.T.E., 2002, CLIN NEUROPSYCHOLOGI, V2nd; Rodnitzky R.L., 1982, ARCH NEUROL-CHICAGO, V39, P675; Rohrbach DJ, 2015, BIOMED OPT EXPRESS, V6, P1761, DOI 10.1364/BOE.6.001761; Salo D., 2014, MULTISPECTRAL IMAGIN; Shafer R, 2011, J NEUROINTERV SURG, V3, P395, DOI 10.1136/jnis.2010.004184; Sharma M, 2014, BIOMED OPT EXPRESS, V5, P40, DOI 10.1364/BOE.5.000040; Shi LY, 2016, J BIOPHOTONICS, V9, P38, DOI 10.1002/jbio.201500192; Shochat A, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.1.015001; Singh-Moon RP, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.096003; Sordillo LA, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.5.056004; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314; Strangman G, 2003, NEUROIMAGE, V18, P865, DOI 10.1016/S1053-8119(03)00021-1; Ter Minassian A, 1999, ANESTHESIOLOGY, V91, P985; Tichauer KM, 2009, J APPL PHYSIOL, V106, P1506, DOI 10.1152/japplphysiol.91156.2008; TORNHEIM PA, 1981, J NEUROSURG, V55, P407, DOI 10.3171/jns.1981.55.3.0407; Tuchin V, 2002, HDB OPTICAL BIOMEDIC; TUCHIN VV, 2007, TISSUE OPTICS LIGHT; Udomphorn Y, 2008, PEDIATR NEUROL, V38, P225, DOI 10.1016/j.pediatrneurol.2007.09.012; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vishwanath K, 2011, APPL SPECTROSC, V65, P206, DOI 10.1366/10-06052; Wang L.V., 2007, BIOMEDICAL OPTICS PR; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Watte R, 2013, OPT EXPRESS, V21, P32630, DOI 10.1364/OE.21.032630; Wilson RH, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.030901; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Wu C., 2012, J SIGNAL INF PROCESS, V3, P92; Xie JR, 2010, APPL OPTICS, V49, P5407, DOI 10.1364/AO.49.005407; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; YAMAKAMI I, 1991, J CEREBR BLOOD F MET, V11, P655, DOI 10.1038/jcbfm.1991.117; Yang O, 2012, OPT LETT, V37, P3957, DOI 10.1364/OL.37.003957; Yaseen MA, 2015, BIOMED OPT EXPRESS, V6, P4994, DOI 10.1364/BOE.6.004994; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yoshida K, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.5.051026; Yuan S, 2005, APPL OPTICS, V44, P1823, DOI 10.1364/AO.44.001823; Zakharov P, 2009, OPT EXPRESS, V17, P13904, DOI 10.1364/OE.17.013904; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003; Zonios G, 1999, APPL OPTICS, V38, P6628, DOI 10.1364/AO.38.006628	115	5	5	1	11	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	2329-423X	2329-4248		NEUROPHOTONICS	Neurophotonics	APR-JUN	2016	3	2							025003	10.1117/1.NPh.3.2.025003			12	Neurosciences; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Optics	DV9IH	WOS:000383253600005	27175372	Bronze, Green Published			2022-02-06	
J	Hon, HH; Elmously, A; Stehly, CD; Stoltzfus, JC; Granson, MA; Stawicki, SP; Hoey, BA				Hon, H. H.; Elmously, A.; Stehly, C. D.; Stoltzfus, J. C.; Granson, M. A.; Stawicki, S. P.; Hoey, B. A.			Inappropriate preinjury warfarin use in trauma patients: A call for a safety initiative	JOURNAL OF POSTGRADUATE MEDICINE			English	Article						Anticoagulation; appropriate use; indications; patient safety; side effects; therapeutic window; warfarin	ELDERLY-PATIENTS; BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; ATRIAL-FIBRILLATION; PLUS ASPIRIN; ANTICOAGULATION; MORTALITY; IMPACT; COMPLICATIONS; METAANALYSIS	Introduction: Warfarin continues to be widely prescribed for a variety of conditions. It has been shown that preinjury warfarin may worsen outcomes in trauma patients. We hypothesized that a substantial proportion of injured patients seen at our institution were receiving preinjury warfarin for inappropriate indications and that a significant number of such patients had subtherapeutic or supratherapeutic international normalized ratios as well as increased mortality. Materials and Methods: A retrospective review of registry data from a Level I trauma center was conducted for the period from January 2004 to July 2013. Included were patients aged >= 22 years (based on the youngest recorded patient on warfarin in this study). Abstracted variables included patient age, Injury Severity Score (ISS), Maximum Abbreviated Injury Score for Head (MAISH), mortality, hospital length of stay (HLOS), indication(s) for anticoagulant therapy, admission Glasgow Coma Scale (GCS), and admission international normalized ratio (INR). Suitability of warfarin indication(s) was determined using the most recent American College of Chest Physicians (ACCP) Guidelines. Inappropriate warfarin administration was defined as use inconsistent with these guidelines. For outcome comparisons, a case-control design with 1: 1 ratio was used, matching patients taking preinjury warfarin to a random sample of trauma patients who were not taking warfarin. Severe traumatic brain injury (sTBI) was defined as MAISH >= 4. Results: A total of 700 out of 14,583 patients aged >= 22 years were receiving preinjury warfarin (4.8% incidence, WG). This group was age-and ISS-matched with 700 patients (4.8% total sample) who were not taking warfarin (NWG) in a total case-control sample of 1,400. The two groups were similar in age, gender, ISS, and initial GCS. According to the ACCP guidelines, 115/700 (16.4%) patients in the warfarin group were receiving anticoagulation for inappropriate indications. Nearly 65% of the patients were outside of their intended INR therapeutic window (43.4% subtherapeutic, 21.6% supratherapeutic). Overall, median HLOS was greater among patients taking preinjury warfarin (4 days vs 2 days, P < 0.010). Mortality was higher in the WG (7.4% or 52/700) than in the NWG (1.9% or 13/700, P < 0.010). Patients with sTBI in the WG had significantly greater mortality (12.8% or 34/266) than those with sTBI in the NWG (5.3% or 9/169, P < 0.013). Conclusion: A significant proportion of trauma patients admitted to our institution were noted to take warfarin for inappropriate indications. Moreover, many patients taking warfarin had either subtherapeutic or supratherapeutic INR. Although warfarin use did not independently predict mortality, preinjury warfarin use was associated with greater mortality and HLOS in the subset of patients with sTBI. Safety initiatives directed at better initiation and management of warfarin are needed.	[Hon, H. H.; Elmously, A.; Stehly, C. D.; Stawicki, S. P.; Hoey, B. A.] St Lukes Univ Hlth Network, Dept Surg, Bethlehem, PA USA; [Hon, H. H.; Stehly, C. D.; Stawicki, S. P.; Hoey, B. A.] St Lukes Univ Hlth Network, Reg Level Trauma Ctr 1, Bethlehem, PA USA; [Stoltzfus, J. C.] St Lukes Univ Hlth Network, Res Inst, Bethlehem, PA USA; [Granson, M. A.; Stawicki, S. P.] St Lukes Univ Hlth Network, Dept Res & Innovat, Bethlehem, PA USA		Stawicki, SP (corresponding author), St Lukes Univ Hlth Network, Dept Res & Innovat, Res Adm EW2, 801 Ostrum St, Bethlehem, PA 18015 USA.	stanislaw.stawicki@sluhn.org		Stawicki, Stanislaw/0000-0002-8893-6668			Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Andreotti F, 2006, EUR HEART J, V27, P519, DOI 10.1093/eurheartj/ehi485; BERN MM, 1990, ANN INTERN MED, V112, P423, DOI 10.7326/0003-4819-76-3-112-6-423; Birriel T Javier, 2015, J Basic Clin Pharm, V6, P122, DOI 10.4103/0976-0105.168052; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Evans DC, 2012, J AM COLL SURGEONS, V215, pS57, DOI 10.1016/j.jamcollsurg.2012.06.164; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Gerlach AT., 2009, OPUS 12 SCI, V3, P6; Gidwani S, 2006, EMERG MED J, V23, P140, DOI 10.1136/emj.2005.033464; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hennessy S, 1999, AM J EPIDEMIOL, V149, P195; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Kennedy DM, 2000, J TRAUMA, V48, P451, DOI 10.1097/00005373-200003000-00012; Kohn L., 2000, ERR IS HUMAN BUILDIN, P1, DOI [10.17226/9728, DOI 10.17226/9728]; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Pieracci FM, 2007, J TRAUMA, V63, P519, DOI 10.1097/TA.0b013e31812e519b; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Rothberg MB, 2005, ANN INTERN MED, V143, P241, DOI 10.7326/0003-4819-143-4-200508160-00005; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Smith EA, 2015, J POSTGRAD MED, V61, P214, DOI 10.4103/0022-3859.159434; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Song X, 2012, AM J HEALTH-SYST PH, V69, P329, DOI 10.2146/ajhp110203; SORANO GG, 1993, HAEMOSTASIS, V23, P77; Stawicki SP, 2014, FUNDAMENTALS PATIENT, P1; Stawicki Stanislaw P, 2015, J Emerg Trauma Shock, V8, P224, DOI 10.4103/0974-2700.161658; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021; Yusuf S, 2001, J AM COLL CARDIOL, V37, P475	32	5	5	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0022-3859			J POSTGRAD MED	J. Postgrad. Med.	APR-JUN	2016	62	2					73	79		10.4103/0022-3859.175004			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK6CY	WOS:000375010300003	26821565	Green Published, gold			2022-02-06	
J	Izzo, G; Tirelli, A; Angrisani, E; Cannaviello, G; Cannaviello, L; Puzziello, A; Vatrella, A; Vitale, M				Izzo, Giulia; Tirelli, Assunta; Angrisani, Elisabetta; Cannaviello, Giovanni; Cannaviello, Lucio; Puzziello, Alessandro; Vatrella, Alessandro; Vitale, Mario			Pituitary dysfunction and its association with quality of life in traumatic brain injury	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Traumatic brain injury; Pituitary; Quality of life; GH	FINE-NEEDLE CYTOLOGY; BRAF(V600E) MUTATION; LYMPHOID INFILTRATE; THYROID-NODULES; FLOW-CYTOMETRY; HYPOPITUITARISM; PREVALENCE; DIAGNOSIS; GOITER; TESTS	Background: Traumatic brain injury (TBI) is a major cause of death and disability and may cause transient or persistent, isolated or multiple hypopituitarism in a variable percentage of cases. Objectives: The primary aim of this study was to determine the incidence of isolated and multiple anterior pituitary hormone deficiency in subjects with TBI in a single institution. The secondary aim was to determine a correlation between pituitary deficiency and quality of life (QOL) after TBI. Methods: Thirty-five patients, aged between 18 and 63 years, were evaluated 6months to 5 years after TBI. We evaluated the QOL by SF-12 (R) questionnaire and measured serum basal GH, IGF1, LH, FSH, testosterone (in males), 17-beta-estradiol (in women), PRL, fT4 and TSH. In patients with low IGF1, a GHRH + Arginine test was performed. Results: Single or multiple pituitary failure was found in 13 patients (37%). Low testosterone was found in 7 males, low FSH and/or LH in 4, low IGF1 in 7 patients. Hypogonadotropic hypogonadism and GH insufficiency assessed by GHRH + Arginine test were found respectively in 3 and 2 patients. One patient displayed a concomitant GH insufficiency and low TSH level. Twenty six patients showed a reduction in QOL. A correlations between altered QOL and hormonal deficiency was not observed. Conclusions: Isolated or multiple hypopituitarism resulting from TBI are frequent. Alterations in QOL and pituitary function resulting from TBI are not associated. (c) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Izzo, Giulia; Puzziello, Alessandro; Vatrella, Alessandro; Vitale, Mario] Univ Salerno, Dept Med & Surg, Via Allende, I-84081 Salerno, Italy; [Angrisani, Elisabetta] AOU San Giovanni di Dio & Ruggi Aragona, SC Endocrinol, Salerno, Italy; [Tirelli, Assunta; Cannaviello, Giovanni; Cannaviello, Lucio] AOU San Giovanni di Dio & Ruggi Aragona, SC Med Riabilitat, Salerno, Italy		Vitale, M (corresponding author), Univ Salerno, Dept Med & Surg, Via Allende, I-84081 Salerno, Italy.	giulia_izzo@hotmail.it; assunta.tirelli@libero.it; e.angrisani@virgilio.it; cannaviellog@gmail.com; lucio.cannaviello@sangiovannieruggi.it; apuzziello@unisa.it; avatrella@unisa.it; mavitale@unisa.it	Cannaviello, Giovanni/AAX-1196-2020; puzziello, alessandro/AAS-1420-2021; Vatrella, Alessandro/K-8001-2016	IZZO, GIULIA/0000-0002-4673-9957; Vatrella, Alessandro/0000-0001-8265-3037; Puzziello, Alessandro/0000-0002-1970-7386; Cannaviello, Giovanni/0000-0001-8553-5781			Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Berg C, 2010, EXP CLIN ENDOCR DIAB, V118, P139, DOI 10.1055/s-0029-1225611; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Caleo A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S41; Cozzolino I, 2012, Infez Med, V20 Suppl 2, P35; Di Crescenzo V, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S43; Di Crescenzo Vincenzo, 2013, Infez Med, V21, P224; Di Matola T., 2014, BMJ CASE REP, V2014; Guerra A, 2014, INT J SURG, V12, pS91, DOI 10.1016/j.ijsu.2014.05.045; Guerra A, 2014, THYROID, V24, P254, DOI 10.1089/thy.2013.0235; Guerra A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S37; Guerra A, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S44; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Laperuta P, 2014, INT J SURG, V12, pS16, DOI 10.1016/j.ijsu.2014.05.043; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Vigliar E, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S49; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wilkinson C. W., 2012, FRONT NEUROL, V3, P11, DOI DOI 10.3389/FNEUR.2012.00011; WOOLF PD, 1992, CRIT CARE MED, V20, P216, DOI 10.1097/00003246-199202000-00011; Zeppa P, 2005, ANAL QUANT CYTOL, V27, P118; Zeppa P, 2001, ANAL QUANT CYTOL, V23, P178; Zeppa P, 2006, ANAL QUANT CYTOL, V28, P148; Zeppa P, 2014, CANCER CYTOPATHOL, V122, P553, DOI 10.1002/cncy.21420; Zeppa P, 2014, ACTA CYTOL, V58, P318, DOI 10.1159/000360067; Zeppa P, 2009, CANCER CYTOPATHOL, V117, P174, DOI 10.1002/cncy.20022	29	5	7	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	APR	2016	28			S1			S103	S108		10.1016/j.ijsu.2015.05.056			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DI8EG	WOS:000373733500019	26708846	Bronze			2022-02-06	
J	Meyfroidt, G; Taccone, FS				Meyfroidt, Geert; Taccone, Fabio S.			Another failed attempt of neuroprotection: progesterone for moderate and severe traumatic brain injury	MINERVA ANESTESIOLOGICA			English	Article						Brain injuries; Progesterone; Neuroprotection; Treatment outcome	CLINICAL-TRIAL; NERVOUS-SYSTEM; OUTCOMES	Two large phase-III prospective, multicenter, controlled, double-blind, randomized clinical trials (the PROTECT III study; the SYNAPSE study) evaluated the effectiveness of an early administration of progesterone in patients with moderate to severe traumatic brain injury (TBI). In the PROTECT III Trial, patients were included if the admission Glasgow Coma Scale (GCS) was within 4-12, whereas the SYNAPSE Trial only included patients with GCS 4-8. The total dose of progesterone was nearly similar in both studies and drug administration was initiated early after injury (within 4 hours for a total of 96 hours in PROTECT; within 8 hours for 120 hours in SYNAPSE). In the PROTECT Trial, primary outcome was 6-month favourable neurological outcome (defined using the Glasgow Outcome Scale), while in the SYNAPSE Trial it was the 6-month Glasgow Outcome Scale (GOS). Secondary outcomes, in both studies, included 6-month mortality. The PROTECT Trial was interrupted for futility after the second interim analysis (882 patients randomized out of the 1140 initially planned); the SYNAPSE Trial included 1195 patients. In PROTECT, the proportion of patients with favourable outcome was similar between groups (51% for progesterone vs. 56% for placebo; RR 3.03 [95% CI 1.96-4.66]); in SYNAPSE, no difference in GOS between the progesterone and placebo group was found (OR 0.96 [95% CI 0.771.18]). There was no difference in 6-month mortality or any of the other secondary outcomes between groups in the two trials. These studies demonstrated that early progesterone administration did not provide any benefit on the neurological recovery of TBI patients.	[Meyfroidt, Geert] Univ Hosp Leuven, Dept Intens Care Med, Herestr 49, B-3000 Leuven, Belgium; [Taccone, Fabio S.] ULB, Hop Erasme, Dept Intens Care, Brussels, Belgium		Meyfroidt, G (corresponding author), Univ Hosp Leuven, Dept Intens Care Med, Herestr 49, B-3000 Leuven, Belgium.	geert.meyfroidt@uzleuven.be					Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Shakeri M, 2013, CLIN NEUROL NEUROSUR, V115, P2019, DOI 10.1016/j.clineuro.2013.06.013; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Uysal N, 2013, TURK NEUROSURG, V23, P129, DOI 10.5137/1019-5149.JTN.5582-11.1; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	22	5	5	0	3	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	APR	2016	82	4					486	491					6	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	EA6SX	WOS:000386760400015	26126980				2022-02-06	
J	Mosti, C; Spiers, MV; Kloss, JD				Mosti, Caterina; Spiers, Mary V.; Kloss, Jacqueline D.			A practical guide to evaluating sleep disturbance in concussion patients	NEUROLOGY-CLINICAL PRACTICE			English	Article							TRAUMATIC BRAIN-INJURY; INSOMNIA; DISORDERS; VALIDATION; INSTRUMENT; CONTEXT; INDEX; DIARY	Purpose of review: To provide an introduction and review of sleep metrics appropriate for use with an outpatient concussed population. Recent findings: Although sleep issues are frequently identified in concussion, sleep disturbance is rarely assessed in outpatient settings. Given that sleep disturbance may be indicative of, or contribute to, delayed neuro-cognitive recovery, measurement tools for sleep, rest, and activity behavior may be of both practical and research utility. Summary: Because sleep disturbance symptoms may vary between or within an individual throughout the course of recovery, it is recommended that sleep be measured at regular intervals over the entirety of recovery. Included is a discussion on how to select appropriate measures based on patient symptomology in addition to common practical concerns. Additional clinical considerations, a review of traditional pencil and paper methods of continuous sleep behavior monitoring, as well as technologies for measuring sleep and activity behavior are also included.	[Mosti, Caterina; Spiers, Mary V.; Kloss, Jacqueline D.] Drexel Univ, Philadelphia, PA 19104 USA			c48@drexel.du					American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ayalon L, 2007, NEUROLOGY, V68, P1136, DOI 10.1212/01.wnl.0000258672.52836.30; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carney CE, 2012, SLEEP, V35, P287, DOI 10.5665/sleep.1642; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Lovell M, 2000, IMPACT IMMEDIATE POS; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Monk TH, 2003, SLEEP, V26, P208, DOI 10.1093/sleep/26.2.208; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Panossian LA, 2009, MED CLIN N AM, V93, P407, DOI 10.1016/j.mcna.2008.09.001; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Smith MT, 2005, CLIN PSYCHOL REV, V25, P559, DOI 10.1016/j.cpr.2005.04.004; World Health Organization, 1992, ICD 10 CLASSIFICATIO	21	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0402	2163-0933		NEUROL-CLIN PRACT	Neurol.-Clin. Pract.	APR	2016	6	2					129	137		10.1212/CPJ.0000000000000225			9	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	EI6JT	WOS:000392602400012	29377030	Green Published			2022-02-06	
J	Ouchterlony, D; Masanic, C; Michalak, A; Topolovec-Vranic, J; Rutka, JA				Ouchterlony, Donna; Masanic, Cheryl; Michalak, Alicja; Topolovec-Vranic, Jane; Rutka, John A.			Treating Benign Paroxysmal Positional Vertigo in the Patient With Traumatic Brain Injury: Effectiveness of the Canalith Repositioning Procedure	JOURNAL OF NEUROSCIENCE NURSING			English	Article						traumatic brain injury; disability; outcome; therapy; health; concussion	DIZZINESS; MANAGEMENT; DIAGNOSIS; MANEUVER; SF-36; BPPV; FORM	Objective: The aim of this study was to determine the effectiveness of the canalith repositioning procedure (CRP) in the treatment of benign paroxysmal positional vertigo (BPPV) among patients after mild-to-moderate traumatic brain injury. Methods: An unblinded, nonrandomized, case comparison interventional study with repeated measures (1, 5, 9, and 12 weeks postenrollment) of three groups of patients with traumatic brain injury (BPPV, n = 21; nonspecific dizziness, n = 23; no dizziness, n = 12) was conducted. Patients in the BPPV group received the CRP at baseline and repeatedly until a negative Dix-Hallpike Maneuver was observed. Participants in the other two groups did not receive the CRP. Results: Symptom resolution at the 12-week follow-up was observed in 75% of patients in the BPPV group versus 8.3% in the nonspecific dizziness group (p = .0006). A significant Group x Time interaction was observed for the Dizziness Handicap Inventory (F = 4.2, p = .003) and 36-item Short Form Health Questionnaire physical component scores (F = 2.16, p = .035) with the BPPV group showing significantly improved scores by the 12-week follow-up. Although there were between-group differences on the 36-item Short Form Health Questionnaire mental health component scores (F = 4.06, p = .022), changes over time were not significant in the groups. Conclusions: Treatment with the CRP for posttraumatic BPPV resulted in significant symptom resolution and improvement in perceived physical health status.	[Ouchterlony, Donna; Masanic, Cheryl; Michalak, Alicja; Rutka, John A.] St Michaels Hosp, Trauma & Neurosurg Program, Injury Clin, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Ouchterlony, Donna] Univ Toronto, Family & Community Med, Toronto, ON M5S 1A1, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Trauma & Neurosurg Program, Toronto, ON M5S 1A1, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Li Ka Shing Knowledge Inst, Toronto, ON M5S 1A1, Canada; [Topolovec-Vranic, Jane] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5S 1A1, Canada		Ouchterlony, D (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, Injury Clin, 30 Bond St, Toronto, ON M5B 1W8, Canada.; Ouchterlony, D (corresponding author), Univ Toronto, Family & Community Med, Toronto, ON M5S 1A1, Canada.	douchterlony@gmail.com	Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212	CUMBA Foundation	The authors wish to acknowledge Mr. Richard Currie and the CUMBA Foundation for the support of this study.	Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Baloh RW, 1998, OTOLARYNG HEAD NECK, V119, P55, DOI 10.1016/S0194-5998(98)70173-1; Bertholon P, 2005, ANN OTO RHINOL LARYN, V114, P105, DOI 10.1177/000348940511400204; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; DIX MR, 1952, ANN OTO RHINOL LARYN, V61, P987, DOI 10.1177/000348945206100403; Epley JM, 2001, ANN NY ACAD SCI, V942, P179; EPLEY JM, 1992, OTOLARYNG HEAD NECK, V107, P399, DOI 10.1177/019459989210700310; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Gordon CR, 2004, ACTA NEUROL SCAND, V110, P166, DOI 10.1111/j.1600-0404.2004.00296.x; Hartvigsen Jan, 2014, Arch Phys Med Rehabil, V95, pS286, DOI 10.1016/j.apmr.2013.07.029; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Kaplan DM, 2005, OTOLARYNG HEAD NECK, V133, P769, DOI 10.1016/j.otohns.2005.07.017; Katsarkas A, 1999, ACTA OTO-LARYNGOL, V119, P745, DOI 10.1080/00016489950180360; Labuguen RH, 2006, AM FAM PHYSICIAN, V73, P244; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lopez-Escamez JA, 2003, OTOL NEUROTOL, V24, P637, DOI 10.1097/00129492-200307000-00018; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Motin M, 2005, BRAIN INJURY, V19, P693, DOI 10.1080/02699050400013600; Nunez RA, 2000, OTOLARYNG HEAD NECK, V122, P647, DOI 10.1067/mhn.2000.105185; Parnes LS, 2003, CAN MED ASSOC J, V169, P681; Prokopakis E, 2013, AUDIOL NEURO-OTOL, V18, P83, DOI 10.1159/000343579; Viirre E, 2005, LARYNGOSCOPE, V115, P184, DOI 10.1097/01.mlg.0000150707.66569.d4; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; White JA, 2005, OTOLARYNG HEAD NECK, V133, P278, DOI 10.1016/j.otohns.2005.03.080	28	5	7	0	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2016	48	2					90	99		10.1097/JNN.0000000000000186			10	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	DG5WB	WOS:000372148900006	26895567				2022-02-06	
J	Salinsky, M; Parko, K; Rutecki, P; Boudreau, E; Storzbach, D				Salinsky, Martin; Parko, Karen; Rutecki, Paul; Boudreau, Eilis; Storzbach, Daniel			Attributing seizures to TBI: Validation of a brief patient questionnaire	EPILEPSY & BEHAVIOR			English	Article						Psychogenic seizures; Epilepsy; TBI; Veterans	TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; VETERANS	Puipose: Traumatic brain injury (TBI) is an important cause of epilepsy and has also been associated with psychogenic nonepileptic seizures (PNES). We designed a brief questionnaire assessing patient beliefs regarding TBI as the cause of their seizures (Patient Seizure Etiology Questionnaire; PSEQ). This study reports content validity for the PSEQ Methods: Ninety Veterans undergoing comprehensive evaluation at 3 VA epilepsy centers completed the PSEQ a series of questions regarding possible causes for their seizures, including TB1. The PSEQ was scored as YES vs. NO for TBI as the proposed cause of seizures. For each patient, two expert reviewers independently completed a structured chart review to determine whether TBI was the proposed cause of seizures (n = 180 reviews). Kappa statistic was used to assess agreement between the PSEQ and each chart review and between the PSEQ and combined chart reviews where both reviewers agreed on a TBI seizure etiology. Results: The PSEQ scored higher overall rates for a TBI seizure etiology than did expert chart reviews (40% vs. 28%; p < 0.001). The PSEQ agreed with 82% of 180 independent chart reviews (sensitivity 88%; specificity 79%). Kappa statistic for agreement was 0.60. The two reviewers agreed on a probable TB1 seizure etiology for SR of chart reviews. The PSEQ sensitivity increased to 100% when both reviewers were in agreement. Conclusion: The PSEQ provides a direct, standardized measure of patient beliefs regarding TBlas the cause of their seizures and has moderate-substantial agreement with expert chart reviews. Published by Elsevier Inc.	[Salinsky, Martin; Boudreau, Eilis; Storzbach, Daniel] Portland VA Med Ctr, Portland, OR USA; [Salinsky, Martin; Boudreau, Eilis] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Parko, Karen] San Francisco VA Med Ctr, San Francisco, CA USA; [Rutecki, Paul] William S Middleton Vet Affairs Med Ctr, Madison, WI USA		Salinsky, M (corresponding author), Portland VAMC Epilepsy Ctr Excellence, 3710 SW US Vet Hosp Rd P3ECOE, Portland, OR 97239 USA.	Salinsky@ohsu.edu			Department of Veterans AffairsUS Department of Veterans Affairs [5101CX000721-04]	The authors thank S. Chen FNP, R. Kotloski MD PhD, and C. Evrard FNP for their participation in this project. This work was supported by grant # 5101CX000721-04 from the Department of Veterans Affairs.	Annegers JF, 1996, TREATMENT EPILEPSY P, P166; [Anonymous], 2014, EPILEPSY CENTERS OF; Barry E, 1998, EPILEPSIA, V39, P427, DOI 10.1111/j.1528-1157.1998.tb01395.x; FLEISS JL, 1969, PSYCHOL BULL, V72, P323, DOI 10.1037/h0028106; LaFrance WC, 2013, EPILEPSIA, V54, P718, DOI 10.1111/epi.12053; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mahler B, 2015, EPILEPSIA, V56, P1438, DOI 10.1111/epi.13096; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Raymont V, 2010, NEUROLOGY, P224; Salinsky M, 2015, J HEAD TRAUMA REHAB, V30, pE65, DOI 10.1097/HTR.0000000000000057; Salinsky M, 2012, EPILEPSY BEHAV, V25, P345, DOI 10.1016/j.yebeh.2012.07.013; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Westbrook LE, 1998, EPILEPSIA, V39, P978, DOI 10.1111/j.1528-1157.1998.tb01447.x	13	5	5	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	APR	2016	57		A				141	144		10.1016/j.yebeh.2016.02.003			4	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	DJ5NW	WOS:000374256700024	26953843				2022-02-06	
J	Schoeneberg, C; Wegner, A; Kauther, MD; Stuermer, M; Probst, T; Lendemans, S				Schoeneberg, C.; Wegner, A.; Kauther, M. D.; Stuermer, M.; Probst, T.; Lendemans, S.			No improved survival rate in severely injured patients by prehospital intubation. A retrospective data analysis and matched-pair analysis	UNFALLCHIRURG			German	Article						Trauma; Severely injured; Glascow coma scale; Intubation; Mortality	TRAUMATIC BRAIN-INJURY; RAPID-SEQUENCE INTUBATION; ENDOTRACHEAL INTUBATION; SEVERITY SCORE; AIRWAY MANAGEMENT; GERMAN SOCIETY; TIME; VENTILATION; MORTALITY; REGISTRY	Training programs for the treatment of trauma patients generally recommend establishing a secure airway if the patient presents with a Glasgow coma scale (GCS) score of less than 9; however, the evidence for its effectiveness is rather sparse. This study analyzed the effect of preclinical intubation on mortality of patients with a GCS < 9 in an emergency medical situation. This retrospective analysis included patients who were primarily admitted to a German level 1 trauma center between 2002 and 2012 with an injury severity score (ISS) a parts per thousand yenaEuro parts per thousand 16, a GCS < 9 and primary transport from the site of the accident. Data were collected from the trauma registry of the German Society for Trauma Surgery and from hospital records. A total of 455 patients were included and a matched-pair analysis of 62 patients was conducted. Both analytical methods showed no significant reduction in mortality rate after prehospital intubation. In the retrospective analysis intubated patients presented with a significantly lower systolic blood pressure on admission, received a higher amount of fluid volume at all phases of treatment and arrived at the hospital after a prolonged rescue time. In the matched-pair analysis, intubated patients also received a higher amount of fluid volume and showed better peripheral oxygen saturation on admission. No further differences between the groups could be found. It appears that preclinical intubation in trauma patients with a GCS < 9 does not result in a better outcome. The preclinical intubation resulted in a reduced systolic blood pressure on arrival at hospital, a prolonged preclinical rescue time and a greater amount of infused fluid volume.	[Schoeneberg, C.; Lendemans, S.] Alfried Krupp Krankenhaus Essen, Klin Unfallchirurg & Orthopadie, Hellweg 100, D-45276 Essen, Germany; [Wegner, A.; Kauther, M. D.; Stuermer, M.] Univ Duisburg Essen, Univ Klinikum Essen, Klin Orthopadie & Unfallchirurg, Essen, Germany; [Probst, T.] Stadt Kliniken Neuss, Klin Unfallchirurg Orthopadie & Handchirurg, Neuss, Germany		Schoeneberg, C (corresponding author), Alfried Krupp Krankenhaus Essen, Klin Unfallchirurg & Orthopadie, Hellweg 100, D-45276 Essen, Germany.	carsten.schoeneberg@krupp-krankenhaus.de	Schoeneberg, Carsten/AAS-9274-2021; Kauther, Max/A-1505-2016	Schoeneberg, Carsten/0000-0001-5633-1616; Kauther, Max/0000-0003-3795-6068			Advanced Trauma Life Support, 2012, STUD COURS MAN; Albrecht E, 2006, EUR J TRAUMA, V32, P516, DOI DOI 10.1007/S00068-006-6001-Z; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berlac P, 2008, ACTA ANAESTH SCAND, V52, P897, DOI 10.1111/j.1399-6576.2008.01673.x; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; CHAMPION HR, 1981, CRIT CARE MED, V9, P672, DOI 10.1097/00003246-198109000-00015; Clarke JR, 2002, J TRAUMA, V52, P420, DOI 10.1097/00005373-200203000-00002; Cobas MA, 2009, ANESTH ANALG, V109, P489, DOI 10.1213/ane.0b013e3181aa3063; Cudnik MT, 2007, PREHOSP EMERG CARE, V11, P224, DOI 10.1080/10903120701205208; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2010, J TRAUMA, V69, P294, DOI 10.1097/TA.0b013e3181dc6c7f; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Eckert MJ, 2004, J TRAUMA, V57, P750, DOI 10.1097/01.TA.0000147499.73570.12; German Trauma Society (DGU), S3 GUID TREATM PAT S; Hussmann B, 2013, INJURY, V44, P611, DOI 10.1016/j.injury.2012.02.004; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kulla M, 2012, EMERG MED J, V29, P497, DOI 10.1136/emj.2010.107391; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Nakstad AR, 2011, AM J EMERG MED, V29, P639, DOI 10.1016/j.ajem.2010.01.013; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Osler T, 1997, J TRAUMA INJURY INFE, V143, P925; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Taghavi S, 2013, J TRAUMA ACUTE CARE, V74, P1246, DOI 10.1097/TA.0b013e31828dab10; TEASDALE G, 1974, LANCET, V2, P81; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; von Elm E, 2009, BRIT J ANAESTH, V103, P371, DOI 10.1093/bja/aep202; Wang HE, 2009, RESUSCITATION, V80, P50, DOI 10.1016/j.resuscitation.2008.08.016	28	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	APR	2016	119	4					314	322		10.1007/s00113-015-0116-6			9	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	DI5VG	WOS:000373568000011	26601848				2022-02-06	
J	Strahle, J; Selzer, BJ; Geh, N; Srinivasan, D; Strahle, M; Martinez-Sosa, M; Muraszko, KM; Garton, HJL; Maher, CO				Strahle, Jennifer; Selzer, Bela J.; Geh, Ndi; Srinivasan, Dushyanth; Strahle, MaryKathryn; Martinez-Sosa, Meleine; Muraszko, Karin M.; Garton, Hugh J. L.; Maher, Cormac O.			Sports participation with arachnoid cysts	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						arachnoid cyst; concussion; incidence; injury; safety; sports; congenital	CHRONIC SUBDURAL-HEMATOMA; COMPUTED-TOMOGRAPHY SCANS; SCHOOL FOOTBALL PLAYERS; OF-THE-LITERATURE; HEAD-INJURY; INCIDENTAL FINDINGS; CLINICAL ARTICLE; SPONTANEOUS RUPTURE; CONCUSSION RATES; NATURAL-HISTORY	OBJECTIVE There is currently no consensus on the safety of sports participation for patients with an intracranial arachnoid cyst (AC). The authors' goal was to define the risk of sports participation for children with this imaging finding. METHODS A survey was prospectively administered to 185 patients with ACs during a 46-month period at a single institution. Cyst size and location, treatment, sports participation, and any injuries were recorded. Eighty patients completed at least 1 subsequent survey following their initial entry into the registry, and these patients were included in a prospective registry with a mean prospective follow-up interval of 15.9 +/- 8.8 months. RESULTS A total 112 patients with ACs participated in 261 sports for a cumulative duration of 4410 months or 1470 seasons. Of these, 94 patients participated in 190 contact sports for a cumulative duration of 2818 months or 939 seasons. There were no serious or catastrophic neurological injuries. Two patients presented with symptomatic subdural hygromas following minor sports injuries. In the prospective cohort, there were no neurological injuries CONCLUSIONS Permanent or catastrophic neurological injuries are very unusual in AC patients who participate in athletic activities. In most cases, sports participation by these patients is safe.	[Strahle, Jennifer; Selzer, Bela J.; Geh, Ndi; Srinivasan, Dushyanth; Strahle, MaryKathryn; Martinez-Sosa, Meleine; Muraszko, Karin M.; Garton, Hugh J. L.; Maher, Cormac O.] Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Rm 3552 Taubman Ctr, Ann Arbor, MI 48109 USA		Maher, CO (corresponding author), Univ Michigan, Dept Neurosurg, 1500 E Med Ctr Dr,Rm 3552 Taubman Ctr, Ann Arbor, MI 48109 USA.	cmaher@med.umich.edu					Al-Holou WN, 2013, J NEUROSURG, V118, P222, DOI 10.3171/2012.10.JNS12548; Al-Holou WN, 2010, J NEUROSURG-PEDIATR, V5, P578, DOI 10.3171/2010.2.PEDS09464; Albuquerque FC, 1997, NEUROSURGERY, V41, P951, DOI 10.1097/00006123-199710000-00036; AUER LM, 1981, J NEUROSURG, V54, P366, DOI 10.3171/jns.1981.54.3.0366; Bailes JE, 2003, NEUROSURGERY, V53, P243, DOI 10.1227/01.NEU.0000072303.16102.E1; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; Bilginer B, 2009, CHILD NERV SYST, V25, P119, DOI 10.1007/s00381-008-0728-z; Bristol Ruth E, 2007, Neurosurg Focus, V22, pE2; Cakir E, 2004, NEUROCIRUGIA, V15, P72; Cayli SR, 2000, BRIT J NEUROSURG, V14, P568, DOI 10.1080/02688690050206738; Choong CT, 1998, BRAIN DEV-JPN, V20, P319, DOI 10.1016/S0387-7604(98)00039-4; CHOUX M, 1978, CHILD BRAIN, V4, P15; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Cress M, 2013, NEUROSURGERY, V72, P716, DOI 10.1227/NEU.0b013e318285b3a4; CULLIS PA, 1983, J NEUROL NEUROSUR PS, V46, P454, DOI 10.1136/jnnp.46.5.454; Demetriades AK, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005710; Di Rocco C, 2010, CHILD NERV SYST, V26, P173, DOI 10.1007/s00381-009-1041-1; Dodd RL, 2002, PEDIATR NEUROSURG, V37, P152, DOI 10.1159/000064394; Domenicucci M, 2009, J NEUROSURG, V110, P1250, DOI 10.3171/2008.4.17509; Donaldson JW, 2000, PEDIATR NEUROSURG, V32, P137, DOI 10.1159/000028918; Ergiin R, 1997, ACTA NEUROCHIR WIEN, V139, P692; Eskandary H, 2005, SURG NEUROL, V63, P550, DOI 10.1016/j.surneu.2004.07.049; GALASSI E, 1980, SURG NEUROL, V14, P211; Gamradt SC, 2008, CLIN J SPORT MED, V18, P97, DOI 10.1097/JSM.0b013e31815aecfb; Gelabert-Gonzalez M, 2002, CHILD NERV SYST, V18, P609, DOI 10.1007/s00381-002-0651-7; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Gomez E, 1996, AM J SPORT MED, V24, P684, DOI 10.1177/036354659602400521; Goswami Pranjal, 2008, Indian J Radiol Imaging, V18, P222, DOI 10.4103/0971-3026.41831; Gupta R, 2004, J CLIN NEUROSCI, V11, P317, DOI 10.1016/j.jocn.2003.03.003; Hopkin J, 2006, BRIT J NEUROSURG, V20, P111, DOI 10.1080/02688690600682671; Kawanishi A, 1999, NEUROL MED-CHIR, V39, P231, DOI 10.2176/nmc.39.231; Kertmen H, 2012, PEDIATR NEUROSURG, V48, P55, DOI 10.1159/000339354; Kim BS, 2002, AM J NEURORADIOL, V23, P1674; KULALI A, 1989, Neurosurgical Review, V12, P508, DOI 10.1007/BF01790696; LESOIN F, 1983, ACTA NEUROCHIR, V69, P43, DOI 10.1007/BF02055852; Levy ML, 2002, NEUROSURGERY, V50, P197; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Maher CO, 2013, J NEUROSURG-PEDIATR, V12, P434, DOI 10.3171/2013.8.PEDS13206; MAIXNER VJ, 1992, CHILD NERV SYST, V8, P207, DOI 10.1007/BF00262847; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Miele Vincent J, 2006, Neurosurg Focus, V21, pE9; Mori K, 2002, J NEUROTRAUM, V19, P1017, DOI 10.1089/089771502760341938; MORI T, 1995, NEUROSURGERY, V36, P938, DOI 10.1227/00006123-199505000-00008; NAFFZIGER HC, 1924, JAMA-J AM MED ASSOC, V82, P1751; Ortega HW, 2012, CLIN PEDIATR, V51, P872, DOI 10.1177/0009922812450508; Parsch CS, 1997, NEUROSURGERY, V40, P483, DOI 10.1097/00006123-199703000-00010; Pasternack JS, 1996, PEDIATRICS, V98, P445; Poirrier ALML, 2004, EUR J PAEDIATR NEURO, V8, P247, DOI 10.1016/j.ejpn.2004.04.005; Prabhu VC, 2002, NEUROSURGERY, V50, P195; Rajesh A, 2012, J PEDIATR NEUROSCI, V7, P33, DOI 10.4103/1817-1745.97620; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Robles LA, 2006, INJ EXTRA, V37, P375; Rogers AJ, 2013, PEDIATRICS, V132, pE356, DOI 10.1542/peds.2013-0299; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sener RN, 1997, COMPUT MED IMAG GRAP, V21, P341; Tamburrini G, 2008, CHILD NERV SYST, V24, P635; Tsuzuki N, 2003, NEUROSURGERY, V53, P242, DOI 10.1227/01.NEU.0000072303.16102.E1; Vigil DV, 1998, CLIN J SPORT MED, V8, P234, DOI 10.1097/00042752-199807000-00013; Weber F, 2006, J NEUROL SCI, V240, P81, DOI 10.1016/j.jns.2005.09.008; WEINBERG PE, 1973, RADIOLOGY, V106, P329, DOI 10.1148/106.2.329; Wester K, 2008, J NEUROL NEUROSUR PS, V79, P72, DOI 10.1136/jnnp.2007.117358; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; YAMANOUCHI Y, 1986, CHILD NERV SYST, V2, P40, DOI 10.1007/BF00274033; YOKOYAMA K, 1989, CLIN NUCL MED, V14, P350, DOI 10.1097/00003072-198905000-00009; Zar J H, 1996, BIOSTAT ANAL, P524; Zeng T, 2011, CHIN J TRAUMATOL, V14, P174, DOI 10.3760/cma.j.issn.1008-1275.2011.03.010	69	5	5	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2016	17	4					410	417		10.3171/2015.7.PEDS15189			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DH3EF	WOS:000372669600007	26636254	Bronze			2022-02-06	
J	Richter, F; Koulen, P; Kaja, S				Richter, Frank; Koulen, Peter; Kaja, Simon			N-Palmitoylethanolamine Prevents the Run-down of Amplitudes in Cortical Spreading Depression Possibly Implicating Proinflammatory Cytokine Release	SCIENTIFIC REPORTS			English	Article							TUMOR-NECROSIS-FACTOR; DIFFUSION-BARRIERS; ACTIVATION; EXPRESSION; MIGRAINE; ACYLETHANOLAMINE; NEUROPROTECTION; INTERLEUKIN-1; INFLAMMASOME; MECHANISMS	Cortical spreading depression (CSD), a wave of neuronal depolarization in the cerebral cortex following traumatic brain injury or cerebral ischemia, significantly aggravates brain damage. Here, we tested whether N-palmitoylethanolamine (PEA), a substance that effectively reduces lesion volumes and neurological deficits after ischemic stroke, influences CSD. CSD was elicited chemically in adult rats and occurrence, amplitude, duration and propagation velocity of CSD was determined prior to and for 6 hours after intraperitoneal injection of PEA. The chosen systemic administration of PEA stabilized the amplitude of CSD for at least four hours and prevented the run-down of amplitudes that is typically observed and was also seen in untreated controls. The propagation velocity of the CSD waves was unaltered indicating stable neuronal excitability. The stabilization of CSD amplitudes by PEA indicates that inhibition or prevention of CSD does not underlie PEA's profound neuroprotective effect. Rather, PEA likely inhibits proinflammatory cytokine release thereby preventing the run-down of CSD amplitudes. This contribution of PEA to the maintenance of neuronal excitability in healthy tissue during CSD potentially adds to neuroprotection outside a damaged area, while other mechanisms control PEA-mediated neuroprotection in damaged tissue resulting from traumatic brain injury or cerebral ischemia.	[Richter, Frank] Univ Jena, Jena Univ Hosp, Inst Physiol Neurophysiol 1, Jena, Germany; [Koulen, Peter; Kaja, Simon] Univ Missouri, Dept Ophthalmol, Vis Res Ctr, Sch Med, 2411 Holmes St, Kansas City, MO 64108 USA; [Koulen, Peter] Univ Missouri, Sch Med, Dept Basic Med Sci, 2411 Holmes St, Kansas City, MO 64108 USA; [Kaja, Simon] Loyola Univ Chicago, Dept Ophthalmol, Stritch Sch Med, 2160 South First Ave, Maywood, IL 60153 USA; [Kaja, Simon] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, 2160 South First Ave, Maywood, IL 60153 USA; [Kaja, Simon] Vet Affairs Edward Hines Jr Hosp, Res Serv, 5000 S Fifth Ave, Hines, IL 60141 USA		Kaja, S (corresponding author), Univ Missouri, Dept Ophthalmol, Vis Res Ctr, Sch Med, 2411 Holmes St, Kansas City, MO 64108 USA.; Kaja, S (corresponding author), Loyola Univ Chicago, Dept Ophthalmol, Stritch Sch Med, 2160 South First Ave, Maywood, IL 60153 USA.; Kaja, S (corresponding author), Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, 2160 South First Ave, Maywood, IL 60153 USA.; Kaja, S (corresponding author), Vet Affairs Edward Hines Jr Hosp, Res Serv, 5000 S Fifth Ave, Hines, IL 60141 USA.	skaja@luc.edu	Kaja, Simon/C-2267-2015	Kaja, Simon/0000-0001-6878-521X	National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY022774]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG010485, AG022550, AG027956]; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Institute of General Medical Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [RR022570, RR027093]; Felix and Carmen Sabates Missouri Endowed Chair in Vision Research; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Vision Research Foundation of Kansas City; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR027093, S10RR022570] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY022774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG027956, P01AG010485, P01AG022550] Funding Source: NIH RePORTER	Research reported in this publication was supported by grants from the National Eye Institute (EY022774), the National Institute on Aging (AG010485, AG022550 and AG027956), the National Center for Research Resources and National Institute of General Medical Sciences (RR022570 and RR027093) of the National Institutes of Health (PK). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This material is the result of work supported with resources and the use of facilities at the Edward Hines Jr. VA Hospital, Hines, IL. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. Additional support by the Dr. John P. and Therese E. Mulcahy Endowed Professor in Ophthalmology (SK), the Felix and Carmen Sabates Missouri Endowed Chair in Vision Research (PK), a Challenge Grant from Research to Prevent Blindness (PK) and the Vision Research Foundation of Kansas City (PK) is gratefully acknowledged. The authors would like to thank Ms. Konstanze Ernst for technical and scientific support.	Abraham H, 2001, BRAIN RES, V906, P115, DOI 10.1016/S0006-8993(01)02569-0; Ahmad A, 2012, BRAIN RES, V1477, P45, DOI 10.1016/j.brainres.2012.08.006; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Barker BR, 2011, CURR OPIN IMMUNOL, V23, P591, DOI 10.1016/j.coi.2011.07.005; Becker K, 2005, NEUROREPORT, V16, P993, DOI 10.1097/00001756-200506210-00022; Capasso R, 2001, BRIT J PHARMACOL, V134, P945, DOI 10.1038/sj.bjp.0704339; Costa B, 2008, PAIN, V139, P541, DOI 10.1016/j.pain.2008.06.003; Di Paola R, 2012, J LEUKOCYTE BIOL, V91, P911, DOI 10.1189/jlb.0911485; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; DORFMAN LJ, 1979, NEUROLOGY, V29, P317, DOI 10.1212/WNL.29.3.317; Duncan RS, 2011, CLIN OPHTHALMOL, V5, P543, DOI 10.2147/OPTH.S18309; Duncan RS, 2010, MOLECULES, V15, P1168, DOI 10.3390/molecules15031168; Duncan RS, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-50; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Fernandez MV, 2016, J LEUKOCYTE BIOL, V99, P723, DOI 10.1189/jlb.3A0614-313RRR; Fride E, 2002, PROSTAG LEUKOTR ESS, V66, P221, DOI 10.1054/plef.2001.0360; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Garg P, 2011, NEUROSCI LETT, V492, P134, DOI 10.1016/j.neulet.2011.01.073; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Henry RJ, 2014, J NEUROIMMUNOL, V276, P126, DOI 10.1016/j.jneuroim.2014.09.002; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Kazemi H, 2012, IRAN J BASIC MED SCI, V15, P926; KRAIG RP, 1978, NEUROSCIENCE, V3, P1045, DOI 10.1016/0306-4522(78)90122-7; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Liu R, 2012, NEUROL RES, V34, P331, DOI 10.1179/1743132812Y.0000000020; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Martens-Mantai T, 2014, SYNAPSE, V68, P574, DOI 10.1002/syn.21769; Mathiesen T, 1997, J NEUROSURG, V87, P215, DOI 10.3171/jns.1997.87.2.0215; Mazel T, 2002, PHYSIOL RES, V51, pS85; MIES G, 1993, NEUROREPORT, V4, P709, DOI 10.1097/00001756-199306000-00027; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Naderi N, 2012, NEUROCHEM RES, V37, P778, DOI 10.1007/s11064-011-0672-2; Richter F., 2015, SOC NEUROSCIENCE M A, V760; Richter F, 2014, ANN NEUROL, V76, P43, DOI 10.1002/ana.24176; Roitbak T, 1999, GLIA, V28, P40, DOI 10.1002/(SICI)1098-1136(199910)28:1<40::AID-GLIA5>3.0.CO;2-6; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Sacco S, 2015, EUR J NEUROL, V22, P1001, DOI 10.1111/ene.12701; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Sykova E, 1999, GLIA, V25, P56, DOI 10.1002/(SICI)1098-1136(19990101)25:1<56::AID-GLIA6>3.0.CO;2-4; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638	47	5	5	1	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	2045-2322			SCI REP-UK	Sci Rep	MAR 23	2016	6								23481	10.1038/srep23481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH2HZ	WOS:000372607000002	27004851	Green Published, gold			2022-02-06	
J	Post, A; Karton, C; Hoshizaki, TB; Gilchrist, MD; Bailes, J				Post, Andrew; Karton, Clara; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Bailes, Julian			Evaluation of the protective capacity of baseball helmets for concussive impacts	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						concussion; baseball; helmet	TRAUMATIC BRAIN-INJURY; AMERICAN FOOTBALL HELMETS; FINITE-ELEMENT MODEL; DEFORMATION METRICS; HEAD IMPACTS; HYBRID-III; ACCELERATION; BIOMECHANICS; TISSUE	The purpose of this research was to examine how four different types of baseball helmets perform for baseball impacts when performance was measured using variables associated with concussion. A helmeted Hybrid III headform was impacted by a baseball, and linear and rotational acceleration as well as maximum principal strain were measured for each impact condition. The method was successful in distinguishing differences in design characteristics between the baseball helmets. The results indicated that there is a high risk of concussive injury from being hit by a ball regardless of helmet worn.	[Post, Andrew; Karton, Clara; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland; [Bailes, Julian] Northshore Neurol Inst, Evantson, IL USA		Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.	apost@uottawa.ca					Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Athiviraham A, 2012, AM J SPORT MED, V40, P2808, DOI 10.1177/0363546512461754; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hutchison M. G., 2011, THESIS; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven Svein, 2013, Front Bioeng Biotechnol, V1, P15; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Murugavel M, 2014, J NEUROTRAUMA; Nicholls RL, 2004, SPORTS MED, V34, P17, DOI 10.2165/00007256-200434010-00003; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2014, P 7 WORLD C BIOM BOS; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2014, J BIOMECH, V47, P1074, DOI 10.1016/j.jbiomech.2013.12.026; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Rousseau P., 2014, THESIS; Ruan J, 1994, THESIS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Shin SS, 2014, PROG NEUROL SURG, V28, P86, DOI 10.1159/000358767; Viano D. C., 1993, CLIN J SPORT MED, P217, DOI [DOI 10.1097/00042752-199310000-00002, 10.1097/00042752-199310000-00002]; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Willinger R, 1995, P IRCOBI C BRUNN SWI, P245; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C., 1995, P STAPP CAR CRASH J, P121	41	5	5	1	46	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	MAR 11	2016	19	4					366	375		10.1080/10255842.2015.1029921			10	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	CY8IA	WOS:000366650800003	25855861	Green Submitted			2022-02-06	
J	Erickson, B; Hosseini, MA; Mudhar, PS; Soleimani, M; Aboonabi, A; Arzanpour, S; Sparrey, CJ				Erickson, Brett; Hosseini, Masih A.; Mudhar, Parry Singh; Soleimani, Maryam; Aboonabi, Arina; Arzanpour, Siamak; Sparrey, Carolyn J.			The dynamics of electric powered wheelchair sideways tips and falls: experimental and computational analysis of impact forces and injury	JOURNAL OF NEUROENGINEERING AND REHABILITATION			English	Article						Mobility devices; Simulation; Optical tracking; Dummy; Rigid body dynamics; Head injury criteria; Seatbelt	HIP PROTECTORS; ACCIDENTS; DUMMY; BELT; BIOMECHANICS; SIMULATION; BEHAVIOR; MOMENTS; HEIGHT; ADULTS	Background: To reduce the occurrence of wheelchair falls and to develop effective protection systems, we aimed to quantify sideways tip and fall dynamics of electric power wheelchairs (EPWs). We hypothesized that driving speed, curb height and angle of approach would affect impact forces and head injury risk for wheelchair riders. We further expected that fall dynamics and head injury risk would be greater for unrestrained riders compared to restrained riders. Methods: Sideways wheelchair tip and fall dynamics were reconstructed using a remotely operated rear wheel drive EPW and a Hybrid III test dummy driving at different approach angles (5 to 63 degrees) over an adjustable height curb (0.30 to 0.41 m) at speeds of 0.6-1.5 m/s. Rigid body dynamics models (Madymo, TASS International, Livonia, MI) were developed in parallel with the experiments to systematically study and quantify the impact forces and the sideways tip or fall of an EPW user in different driving conditions. Results: Shallower approach angles (25 degrees) (p < 0.05) and higher curbs (0.4 m) (p < 0.05) were the most significant predictors of tipping for restrained passengers. Unrestrained passengers were most affected by higher curbs (0.4 m) (p < 0.005) and fell forward from the upright wheelchair when the approach angle was 60 degrees. Head impact forces were greater in unrestrained users (6181 +/- 2372 N) than restrained users (1336 +/- 827 N) (p = 0.00053). Unrestrained users had significantly greater head impact severities than restrained users (HIC = 610 +/- 634 vs HIC = 29 +/- 38, p = 0.00013) and several tip events resulted in HICs > 1000 (severe head injury) in unrestrained users. Conclusions: Sideways tips and forward falls from wheelchairs were most sensitive to curb height and approach angle but were not affected by driving speed. Sideways tips and falls resulted in impact forces that could result in concussions or traumatic brain injury and require injury prevention strategies. Seat belts eliminated the risk of falling from an upright chair and reduced head impact forces in sideways wheelchair tips in this study; however, their use must be considered within the ethical and legal definitions of restraints.	[Erickson, Brett; Hosseini, Masih A.; Mudhar, Parry Singh; Arzanpour, Siamak; Sparrey, Carolyn J.] Simon Fraser Univ, Sch Mechatron Syst Engn, 250-13450 102 Ave, Surrey, BC V3T 0A3, Canada; [Soleimani, Maryam; Aboonabi, Arina] MobiSafe Syst Inc, Room 5330 250-13450 102 Ave, Surrey, BC V3T 0A3, Canada; [Sparrey, Carolyn J.] Vancouver Coastal Hlth Res Inst, ICORD, Vancouver, BC, Canada; [Sparrey, Carolyn J.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada		Sparrey, CJ (corresponding author), Simon Fraser Univ, Sch Mechatron Syst Engn, 250-13450 102 Ave, Surrey, BC V3T 0A3, Canada.; Sparrey, CJ (corresponding author), Vancouver Coastal Hlth Res Inst, ICORD, Vancouver, BC, Canada.; Sparrey, CJ (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	csparrey@sfu.ca		Hosseini, Masih/0000-0003-2785-5247; Sparrey, Carolyn/0000-0002-5524-4577	Natural Sciences and Engineering Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)	The authors thank Philip Chan for his assistance with setting up and conducting the experimental tip and fall tests. The authors gratefully acknowledge the financial support of the Natural Sciences and Engineering Council (NSERC) of Canada.	Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; Bertocci GE, 2004, INJURY, V35, P417, DOI 10.1016/S0020-1383(03)00062-7; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Bhan S, 2014, J BIOMECH, V47, P2391, DOI 10.1016/j.jbiomech.2014.04.026; CALDER CJ, 1990, AM J PHYS MED REHAB, V69, P184, DOI 10.1097/00002060-199008000-00003; Chaves ES, 2007, ASSIST TECHNOL, V19, P94, DOI 10.1080/10400435.2007.10131868; Chen WY, 2011, ARCH PHYS MED REHAB, V92, P892, DOI 10.1016/j.apmr.2011.01.008; Cheng K, 2003, 49 ANN M ORTH RES SO; Choi WJ, 2015, J BIOMECH, V48, P911, DOI 10.1016/j.jbiomech.2015.02.025; Choi WJ, 2010, CLIN BIOMECH, V25, P63, DOI 10.1016/j.clinbiomech.2009.08.009; Chou CC, 1974, SAE TECHNICAL PAPER; Corfman TA, 2003, ARCH PHYS MED REHAB, V84, P1797, DOI 10.1016/S0003-9993(03)00467-2; Fast A, 1997, AM J PHYS MED REHAB, V76, P370, DOI 10.1097/00002060-199709000-00004; Gaal RP, 1997, J REHABIL RES DEV, V34, P58; Gastmans C, 2006, J MED ETHICS, V32, P148, DOI 10.1136/jme.2005.012708; Graham DF, 2015, EXP GERONTOL, V66, P39, DOI 10.1016/j.exger.2015.04.006; Hajiaghamemar M, 2015, ANN BIOMED ENG, V43, P2143, DOI 10.1007/s10439-015-1255-1; Hu L, 2013, P FISITA 2012 WORLD, P133; Kakara H, 2013, ACCIDENT ANAL PREV, V59, P432, DOI 10.1016/j.aap.2013.06.015; Kannus P, 1999, BONE, V25, P229, DOI 10.1016/S8756-3282(99)00154-4; Kaye HS, 2000, MOBILITY DEVICE USE; Kirby RL, 2015, ARCH PHYS MED REHAB, V96, P2017, DOI 10.1016/j.apmr.2015.07.009; KIRBY RL, 1995, AM J PHYS MED REHAB, V74, P308, DOI 10.1097/00002060-199507000-00009; Kirschbaum J., 2001, DESIGNING SIDEWALK 2; Koo HJ, 2005, POLYM TEST, V24, P309, DOI 10.1016/j.polymertesting.2004.11.005; Kumar Sri, 2012, Biomed Sci Instrum, V48, P239; Laing AC, 2008, OSTEOPOROSIS INT, V19, P1067, DOI 10.1007/s00198-008-0571-9; Laing AC, 2006, J ORTHOP RES, V24, P1405, DOI 10.1002/jor.20172; Mertz H. J, 1996, HEAD INJURY RISK ASS; Mertz HJ, 1984, INJURY ASSESSMENT VA, V74, P14; Monson K, 2007, J NEUROTRAUM, V24, P1241; Nahum A, 1980, EXPT STUDIES SIDE IM; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Opalek Judy M, 2009, J Trauma Nurs, V16, P98, DOI 10.1097/JTN.0b013e3181ac920e; Post A, 2014, INT J CRASHWORTHINES, V19, P301, DOI 10.1080/13588265.2014.897413; Rentschler AJ, 2002, ANAL ANSI RESNA WHEE; Robinovitch SN, 2005, J GERONTOL A-BIOL, V60, P1553, DOI 10.1093/gerona/60.12.1553; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Shojaati M., 2003, P 3 SWISS TRANSP RES, P19; Sosner J, 1997, AM J PHYS MED REHAB, V76, P304, DOI 10.1097/00002060-199707000-00009; Sran MM, 2008, SPINE, V33, P1856, DOI 10.1097/BRS.0b013e31817bab05; Steenhuis M., 2008, HERON, V53, P51; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; TASS International, 2013, MADYMO REF MAN 7 5; Thompson A, 2014, MED ENG PHYS, V36, P110, DOI 10.1016/j.medengphy.2013.10.006; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0	46	5	5	1	33	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1743-0003		J NEUROENG REHABIL	J. NeuroEng. Rehabil.	MAR 2	2016	13								20	10.1186/s12984-016-0128-7			10	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology; Rehabilitation	DF3CD	WOS:000371220400001	26935331	gold, Green Published			2022-02-06	
J	Albertine, P; Borofsky, S; Brown, D; Patel, S; Lee, W; Caputy, A; Taheri, MR				Albertine, Paul; Borofsky, Samuel; Brown, Derek; Patel, Smita; Lee, Woojin; Caputy, Anthony; Taheri, M. Reza			Small subdural hemorrhages: is routine intensive care unit admission necessary?	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; MORTALITY; SEIZURES; RISK	With advancing technology, the sensitivity of computed tomography (CT) for the detection of subdural hematoma (SDH) continues to improve. In some cases, the finding is limited to one or 2 images of the CT examination. At our institution, all patients with an SDH require intensive care unit (ICU) admission, regardless of size. In this report, we tested the hypothesis that patients with a small traumatic SDH on their presenting CT examination do not require the intensive monitoring offered in the ICU and can instead be managed on a hospital unit with a lower level of monitoring. This is a retrospective study of patients evaluated and treated at a level I trauma center for acute traumatic intracranial hemorrhage between 2011 and 2014. The clinical and imaging profile of 87 patients with traumatic SDH were studied. Patients with small isolated traumatic subdural hemorrhage (tSDH) (<10cm(3) blood volume) spent less time in the ICU, demonstrated neurologic and medical stability during hospitalization, and did not require any neurosurgical intervention. It is our recommendation that patients with isolated tSDH (<10 cm(3)) do not require ICU monitoring. Patients with small tSDH and additional intracranial hemorrhages overall show low rates of medical decline (4%) and neurologic decline (4%) but may still benefit from ICU observation. Patients with tSDH greater than 10 cm(3) overall demonstrated poor clinical courses and outcome and would benefit ICU monitoring. (C) 2015 Elsevier Inc. All rights reserved.	[Albertine, Paul; Borofsky, Samuel; Brown, Derek; Patel, Smita; Lee, Woojin; Caputy, Anthony; Taheri, M. Reza] George Washington Univ, Dept Radiol, First Floor,900 23rd St NW, Washington, DC 20037 USA		Borofsky, S (corresponding author), George Washington Univ, Dept Radiol, First Floor,900 23rd St NW, Washington, DC 20037 USA.	sborofsky@gwu.edu					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Bullock MR, 2006, NEUROSURGERY S3, V58, pS216; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cortnum S, 2010, NEUROSURGERY, V66, P900, DOI [10.1227/01.NEU.0000367722.66098.21, 10.1227/01. NEU.0000367722.66098.21]; Gebel JM, 1998, STROKE, V29, P1799, DOI 10.1161/01.STR.29.9.1799; Gerard C, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0275-0; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Matis GK, 2013, J NEUROSCI RURAL PRA, V4, P245, DOI [10.4103/0976-3147.118757, 10.4103/0976-3147.116450]; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; Wiedemayer H, 2002, BRAIN INJURY, V16, P323, DOI 10.1080/02699050110102077; Zhu GW, 2009, J INT MED RES, V37, P983, DOI 10.1177/147323000903700402	17	5	5	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	MAR	2016	34	3					521	524		10.1016/j.ajem.2015.12.035			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DI4TB	WOS:000373491100031	26795895				2022-02-06	
J	Esmer, E; Delank, KS; Siekmann, H; Schulz, M; Derst, P				Esmer, E.; Delank, K. S.; Siekmann, H.; Schulz, M.; Derst, P.		TraumaRegister DGU	Facial injuries in polytrauma - which injuries can be expected? A retrospective evaluation from the TraumaRegister DGU (R)	NOTFALL & RETTUNGSMEDIZIN			German	Article						Polytrauma; Facial bone injuries; TraumaRegister DGU (R); Emergency treatment; Injury patterns	URBAN TRAUMA CENTER; CRANIOFACIAL TRAUMA; MAXILLOFACIAL INJURIES; OPTIC-NERVE; FRACTURES; EPIDEMIOLOGY; MANAGEMENT; PATIENT; LESIONS	During the acute phase of emergency treatment for polytrauma patients, stabilization of vital parameters is the focus. For this reason, facial bone injuries are often diagnosed late. However, the facial bones are adjacent to neural structures and sensory organs such as the eyes, nose, and ears. In addition, the face expresses emotions and displays important personality traits. For these reasons, once emergency measures are complete, patients are entitled to expect a clear, structured, interdisciplinary treatment approach from neurosurgical, ENT, maxillofacial, and ophthalmological perspectives according to the injury pattern. Thus, the current study aimed to present epidemiological data as well as facial injury patterns in polytraumatized patients. The current study used the TraumaRegister DGUA (R) (TR-DGU) to retrospectively evaluate the records of 37,398 patients treated between 2002 and 2011. Facial injuries were subclassified as eye injuries, bony eye injuries, nasal injuries, jaw injuries, oral injuries, ear injuries, and complex facial bone injuries. For the evaluation of prognostically relevant parameters potentially responsible for facial injuries, patients with and without facial injuries were compared. The incidence of facial injuries was 25.4 % and, thus, they occurred in every fourth severely injured patient. Of these, complex facial injuries were most common with 35 %. In contrast, soft tissue injuries around the eyes, mouth, and ears were very seldom seen with < 2 %. Facial injuries occurred more frequently in motorists, bicyclists, and pedestrians, and occurred often in cases of relevant traumatic brain injuries with GCS < 8. Due to functional and aesthetic reasons, facial injuries should be excluded during the head-neck examination of polytraumatized patients, without delays to preclinical treatment. In cases of suspected facial injuries, the inclusion of qualified specialists in the trauma room is reasonable. However, in the acute phase of treatment, stabilization of vital parameters and treatment of accompanying injuries (TBI) are of primary importance.	[Esmer, E.] Asklepios Klinikum Harburg, Abt Orthopadie & Unfallchirurg, Eissendorfer Pferdeweg 52, D-21075 Hamburg, Germany; [Delank, K. S.; Siekmann, H.; Schulz, M.; Derst, P.] Univ Halle Wittenberg, Dept Orthopadie Unfall & Wiederherstellungschirur, D-06108 Halle, Germany; Sekt Notfall Intens Med & Schwerverletztenversorg, Berlin, Germany		Esmer, E (corresponding author), Asklepios Klinikum Harburg, Abt Orthopadie & Unfallchirurg, Eissendorfer Pferdeweg 52, D-21075 Hamburg, Germany.	EmrahEsmer@gmx.de					ALQURAINY IA, 1991, BRIT J ORAL MAX SURG, V29, P368, DOI 10.1016/0266-4356(91)90002-M; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Bunger B, 1980, DTSCH Z MUND KIEFER, V4, P27; BUSUITO MJ, 1986, J TRAUMA, V26, P826, DOI 10.1097/00005373-198609000-00008; Cannell H, 1996, Eur J Emerg Med, V3, P43, DOI 10.1097/00063110-199603000-00008; Cornelius CP, 1996, J CRANIO MAXILL SURG, V24, P1, DOI 10.1016/S1010-5182(96)80070-9; COVINGTON DS, 1994, J TRAUMA, V37, P243, DOI 10.1097/00005373-199408000-00016; Dempf R, 2000, UNFALLCHIRURG, V103, P301, DOI 10.1007/s001130050540; Down KE, 1995, INT J ORAL MAX SURG, V24, P409, DOI 10.1016/S0901-5027(05)80469-2; Ellis E, 1998, INT J ORAL MAX SURG, V27, P255, DOI 10.1016/S0901-5027(05)80506-5; Ellis E, 2000, EMERG MED CLIN N AM, V18, P411, DOI 10.1016/S0733-8627(05)70137-1; Frink M, 2007, ZBL CHIR, V132, P49, DOI 10.1055/s-2006-958706; GREENSPAN L, 1985, J TRAUMA, V25, P60, DOI 10.1097/00005373-198501000-00010; Hartel J, 1991, Dtsch Z Mund Kiefer Gesichtschir, V15, P111; HAUSAMEN JE, 1988, ORTHOPADE, V17, P17; HAYTER JP, 1991, BRIT J ORAL MAX SURG, V29, P370, DOI 10.1016/0266-4356(91)90003-N; Helm M, 2007, ANAESTHESIST, V56, P1142, DOI 10.1007/s00101-007-1253-2; Hogg NJV, 2000, J TRAUMA, V49, P425, DOI 10.1097/00005373-200009000-00007; Hosemann W, 2005, HNO, V53, P479, DOI 10.1007/s00106-005-1241-2; Iida S, 2001, INT J ORAL MAX SURG, V30, P286, DOI 10.1054/ijom.2001.0056; JONES WD, 1977, J TRAUMA, V17, P339, DOI 10.1097/00005373-197705000-00001; Joos U, 2001, Mund Kiefer Gesichtschir, V5, P86, DOI 10.1007/s100060000283; Kuhne CA, 2007, ORAL MAXILLOFAC SURG, V11, P201, DOI 10.1007/s10006-007-0063-7; MERVILLE LC, 1989, WORLD J SURG, V13, P419, DOI 10.1007/BF01660755; Muraoka M, 1998, ACTA OTO-LARYNGOL, P261; Neumann H J, 1991, Fortschr Kiefer Gesichtschir, V36, P9; Reith W, 2008, RADIOLOGE, V48, P1150, DOI 10.1007/s00117-008-1691-0; Robotti E, 1992, J Neurosurg Sci, V36, P89; Ruchholtz S, 1996, UNFALLCHIRURG, V99, P633, DOI 10.1007/s001130050036; Sargent L A, 1999, J Craniomaxillofac Trauma, V5, P19; SCHERER M, 1989, J TRAUMA, V29, P388, DOI 10.1097/00005373-198903000-00020; Scholz R, 1991, Fortschr Kiefer Gesichtschir, V36, P79; SCHUCHARDT K, 1960, STOMA, V13, P159; TEMEL A, 1988, ACTA OPHTHALMOL, V66, P117; THALLER SR, 1992, PLAST RECONSTR SURG, V90, P562, DOI 10.1097/00006534-199210000-00003; Waldhart E, 2000, MUND KIEFER GESIC S1, V4, P118; Weider L, 1999, AM SURGEON, V65, P790	37	5	5	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6222	1436-0578		NOTFALL RETTUNGSMED	Notfall Rettungsmed.	MAR	2016	19	2					92	98		10.1007/s10049-015-0101-1			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DH1HR	WOS:000372535500003					2022-02-06	
J	Hermans, E; Biert, J; van Vugt, AB; Edwards, MJR				Hermans, Erik; Biert, Jan; van Vugt, Arie Barend; Edwards, Michael John Richard			Research on relation of mortality and hemodynamics in patients with an acute pelvic ring fracture	JOURNAL OF ACUTE DISEASE			English	Article						Pelvic fracture; Mortality; Hemorrhage; Treatment	INITIAL MANAGEMENT; UNSTABLE PATIENTS; TRAUMA PATIENTS; DAMAGE CONTROL; INJURIES; HEMORRHAGE; PATTERN; SURGERY; CARE	Objective: To study the treatment pathway of hemodynamic unstable patients with a pelvic ring fracture and analyze the causes of death in this group. Methods: Retrospectively, all data of hemodynamic unstable patients with a pelvic ring fracture in the period 1 January 2003 till 1 June 2010 were analyzed. For all patients the treatment protocol was assessed and compared with our protocol. Results: The data of 268 patients were analyzed. Among them, 89 cases presented as hemodynamic unstable. A total of 22/89 patients died (25%). Seven patients died because of an isolated circulatory problem, 1 of an isolated neurotrauma. Fourteen patients died because of a combination of vital injuries, in which 11 sustained extensive hemorrhage. Hemorrhage contributed to mortality in 18/22 patients (82%). In 12 of the 22 patients who died, the treatment protocol was not followed. This was significantly higher than in the group survivors (P < 0.01). Conclusions: Mortality in patients with a pelvic fracture is most often caused by hemorrhage or sequelae from hemorrhage. A standardized treatment protocol reduces mortality.	[Hermans, Erik; Biert, Jan; Edwards, Michael John Richard] Radboud Univ Nijmegen, Med Ctr, Dept Surg, Div Trauma Surg, POB 9101, NL-6500 HB Nijmegen, Netherlands; [van Vugt, Arie Barend] Medisch Spectrum Twente, Dept Surg, Haaksbergerstraat 55, NL-7513 ER Enschede, Netherlands		Hermans, E (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Surg, Div Trauma Surg, POB 9101, NL-6500 HB Nijmegen, Netherlands.	erik.hermans@radboudumc.nl					Abrassart S, 2013, ORTHOP TRAUMATOL-SUR, V99, P175, DOI 10.1016/j.otsr.2012.12.014; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balogh ZJ, 2012, LANCET, V380, P1109, DOI 10.1016/S0140-6736(12)60991-X; Becker SC, 2013, UNFALLCHIRURG, V116, P198, DOI 10.1007/s00113-012-2329-2; Chesser TJS, 2012, INJURY, V43, P667, DOI 10.1016/j.injury.2012.04.003; CLARKE G, 1993, INJURY, V24, P628, DOI 10.1016/0020-1383(93)90131-O; [Committee on Trauma ATLS American College of Surgeons], 2012, ADV TRAUM LIF SUPP D; COPES WS, 1989, P ANN C ASS, P205; Cullinane DC, 2011, J TRAUMA, V71, P1850, DOI 10.1097/TA.0b013e31823dca9a; DALAL SA, 1989, J TRAUMA, V29, P981, DOI 10.1097/00005373-198907000-00012; Dormagen JB, 2010, ACTA RADIOL, V51, P107, DOI 10.3109/02841850903286703; Frank L R, 2000, JEMS, V25, P38; FRANK LR, 2000, JEMS, V25, P44; Gansslen A, 2012, ACTA CHIR ORTHOP TR, V79, P193; Gansslen A, 1996, INJURY, V27, P13, DOI 10.1016/S0020-1383(96)90106-0; Gansslen Axel, 2003, Curr Opin Crit Care, V9, P515; Giannoudis PV, 2004, INJURY, V35, P671, DOI 10.1016/j.injury.2004.03.003; Hamill J, 2000, AUST NZ J SURG, V70, P338, DOI 10.1046/j.1440-1622.2000.01822.x; Koller H, 2013, ARCH ORTHOP TRAUM SU, V133, P343, DOI 10.1007/s00402-012-1664-7; Langford JR, 2013, J AM ACAD ORTHOP SUR, V21, P458, DOI 10.5435/JAAOS-21-08-458; Marzi I, 2014, SCAND J SURG, V103, P104, DOI 10.1177/1457496914525604; OESTERN HJ, 1994, UNFALLCHIRURG, V97, P177; Pavic R, 2012, COLLEGIUM ANTROPOL, V36, P1445; Pohlemann T, 2004, J ORTHOP TRAUMA, V18, P102, DOI 10.1097/00005131-200402000-00008; Routt M L Chip Jr, 2006, J Orthop Trauma, V20, pS3, DOI 10.1097/01.bot.0000202386.86880.21; Ruatti S, 2015, INJURY, V46, P1059, DOI 10.1016/j.injury.2015.01.041; Schep NWL, 2004, J TRAUMA, V57, P1299, DOI 10.1097/01.TA.0000133573.53587.2E; Spanjersberg WR, 2009, INJURY, V40, P1031, DOI 10.1016/j.injury.2009.06.164; Stahel PF, 2013, J TRAUMA ACUTE CARE, V75, P882, DOI 10.1097/TA.0b013e3182a9005f; Suzuki T, 2009, INJURY, V40, P343, DOI 10.1016/j.injury.2008.12.006; Tan ECTH, 2010, INJURY, V41, P1239, DOI 10.1016/j.injury.2010.03.013; Tile, 1996, J Am Acad Orthop Surg, V4, P143; van der Vlies CH, 2012, J TRAUMA ACUTE CARE, V73, P1208, DOI 10.1097/TA.0b013e318265ca9f; van Vugt AB, 2006, J BONE JOINT SURG BR, V88B, P427, DOI 10.1302/0301-620x.88b4.16693; Vardon F, 2014, ANN FR ANESTH, V33, P344, DOI 10.1016/j.annfar.2014.03.008; Waibel BH, 2010, CRIT CARE MED, V38, pS421, DOI 10.1097/CCM.0b013e3181ec5cbe; White CE, 2009, INJURY, V40, P1023, DOI 10.1016/j.injury.2008.11.023	37	5	5	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2221-6189			J ACUTE DIS	J. Acute Dis.	MAR 1	2016	5	2					117	122		10.1016/j.joad.2015.11.004			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	ER0PJ	WOS:000398489500006		gold			2022-02-06	
J	Osborne-Crowley, K; McDonald, S; Rushby, JA				Osborne-Crowley, Katherine; McDonald, Skye; Rushby, Jacqueline A.			Role of Reversal Learning Impairment in Social Disinhibition following Severe Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain injuries; Social disinhibition; Orbitofrontal cortex (OFC); Reversal learning; Social reinforcement; Feedback-related negativity (FRN); Reward prediction error	FEEDBACK-RELATED NEGATIVITY; REWARD PREDICTION ERROR; VARIANT FRONTOTEMPORAL DEMENTIA; FACIAL EMOTION RECOGNITION; WHITE-MATTER DAMAGE; CLOSED HEAD-INJURY; ORBITOFRONTAL CORTEX; FRONTAL-CORTEX; PREFRONTAL CORTEX; LESIONS	Objectives: The current study aimed to determine whether reversal learning impairments and feedback-related negativity (FRN), reflecting reward prediction error signals generated by negative feedback during the reversal learning tasks, were associated with social disinhibition in a group of participants with traumatic brain injury (TBI). Methods: Number of reversal errors on a social and a non-social reversal learning task and FRN were examined for 21 participants with TBI and 21 control participants matched for age. Participants with TBI were also divided into low and high disinhibition groups based on rated videotaped interviews. Results: Participants with TBI made more reversal errors and produced smaller amplitude FRNs than controls. Furthermore, participants with TBI high on social disinhibition made more reversal errors on the social reversal learning task than did those low on social disinhibition. FRN amplitude was not related to disinhibition. Conclusions: These results suggest that impairment in the ability to update behavior when social reinforcement contingencies change plays a role in social disinhibition after TBI. Furthermore, the social reversal learning task used in this study may be a useful neuropsychological tool for detecting susceptibility to acquired social disinhibition following TBI. Finally, that the FRN amplitude was not associated with social disinhibition suggests that reward prediction error signals are not critical for behavioral adaptation in the social domain.	[Osborne-Crowley, Katherine; McDonald, Skye; Rushby, Jacqueline A.] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		Osborne-Crowley, K (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia.	k.osbornecrowley@unsw.edu.au	Rushby, Jacqueline/D-1820-2010	Rushby, Jacqueline/0000-0002-5018-638X; Osborne-Crowley, Katherine/0000-0003-0295-1849			Adolphs R, 1996, J NEUROSCI, V16, P7678; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; BENSON P J, 1991, European Journal of Cognitive Psychology, V3, P105, DOI 10.1080/09541449108406222; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Boksem MAS, 2010, SOC NEUROSCI-UK, V5, P118, DOI 10.1080/17470910903202666; Brooks N, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI [10.1136/jnnp.46.4.336, DOI 10.1136/JNNP.46.4.336]; BUTTER CM, 1968, PHYSIOL BEHAV, V3, P213, DOI 10.1016/0031-9384(68)90087-5; Chase HW, 2011, J COGNITIVE NEUROSCI, V23, P936, DOI 10.1162/jocn.2010.21456; Cicerone KD, 1997, ARCH CLIN NEUROPSYCH, V12, P173, DOI 10.1016/S0887-6177(96)00022-4; Cohen MX, 2007, J NEUROSCI, V27, P371, DOI 10.1523/JNEUROSCI.4421-06.2007; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837; Dias R, 1997, J NEUROSCI, V17, P9285; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; FRANZEN EA, 1973, NEUROPSYCHOLOGIA, V11, P141, DOI 10.1016/0028-3932(73)90002-X; Gehring W.J., 2004, ERRORS CONFLICTS BRA, P14; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Gould KR, 2011, J HEAD TRAUMA REHAB, V26, P79, DOI 10.1097/HTR.0b013e3182036799; Gregory CA, 1999, NEUROPSY NEUROPSY BE, V12, P128; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2007, PSYCHOPHYSIOLOGY, V44, P913, DOI 10.1111/j.1469-8986.2007.00561.x; Holroyd CB, 2009, COGN AFFECT BEHAV NE, V9, P59, DOI 10.3758/CABN.9.1.59; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Hornberger M, 2011, BRAIN, V134, P2502, DOI 10.1093/brain/awr173; Howitt, 2004, SAGE DICT STAT PRACT, DOI 10.4135/; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Kaplan JT, 2001, COGNITION, V82, P157, DOI 10.1016/S0010-0277(01)00150-0; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kringelbach ML, 2003, NEUROIMAGE, V20, P1371, DOI 10.1016/S1053-8119(03)00393-8; Krueger CE, 2011, NEUROPSYCHOLOGY, V25, P249, DOI 10.1037/a0021681; Larson MJ, 2007, J INT NEUROPSYCH SOC, V13, P615, DOI 10.1017/S1355617707070762; Lipszyc J, 2014, ARCH CLIN NEUROPSYCH, V29, P289, DOI 10.1093/arclin/acu004; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1610, DOI 10.1152/jn.1999.82.3.1610; Namiki C, 2008, NEUROCASE, V14, P474, DOI 10.1080/13554790802459494; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sambrook TD, 2015, PSYCHOL BULL, V141, P213, DOI 10.1037/bul0000006; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 2011, ANN NY ACAD SCI, V1239, P87, DOI 10.1111/j.1749-6632.2011.06210.x; Schoenbaum G, 2009, NAT REV NEUROSCI, V10, P885, DOI 10.1038/nrn2753; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; TATE RL, 1989, ACTA NEUROL SCAND, V79, P97, DOI 10.1111/j.1600-0404.1989.tb03719.x; van der Helden J, 2010, CEREB CORTEX, V20, P1596, DOI 10.1093/cercor/bhp224; Walsh MM, 2011, P NATL ACAD SCI USA, V108, P19048, DOI 10.1073/pnas.1117189108; Walsh MM, 2011, COGN AFFECT BEHAV NE, V11, P131, DOI 10.3758/s13415-011-0027-0; Yasuda A, 2004, NEUROREPORT, V15, P2561, DOI 10.1097/00001756-200411150-00027	67	5	5	0	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2016	22	3					303	313		10.1017/S1355617715001277			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	DG5IJ	WOS:000372110700003	26754292	Green Submitted			2022-02-06	
J	Robinson, JD				Robinson, Jennifer D.			Management of Refractory Intracranial Pressure	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Intracranial pressure; Monitoring; Nursing; Neurocritical care	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; NURSING INTERVENTIONS; HYPERTHERMIA; HYPERTENSION; SEDATION	Patients with refractory intracranial pressure represent a challenge to the multidisciplinary critical care team. Myriad diagnoses-such as traumatic brain injury, subarachnoid hemorrhage, intracranial hemorrhage, and ischemic stroke-are among the causes commonly seen in patients with elevated intracranial pressure. Clinicians tasked with caring for these patients must be aware of available interventions and management strategies to improve outcomes. Nurses, as the bedside clinicians most frequently assessing these patients, are ideally situated to detect changes and act efficiently to lower refractory intracranial pressure.	[Robinson, Jennifer D.] Yale New Haven Med Ctr, Neurosci, 360 State St 1207, New Haven, CT 06510 USA		Robinson, JD (corresponding author), Yale New Haven Med Ctr, Neurosci, 360 State St 1207, New Haven, CT 06510 USA.	jennifer.robinson@yale.edu					American Association of Blood Banks, 2008, ANN REP SUMM TEST 20, P1; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kindle, 2015, PRACT NEUR CAR; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; Lobato RD, 2005, NEUROCIRUGIA, V16, P217; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Mayer SA, 2002, J INTENSIVE CARE MED, V17, P55, DOI 10.1046/j.1525-1489.2002.17201.x; McGrane S, 2012, MINERVA ANESTESIOL, V78, P369; Mcilvoy LH, 2005, AACN ADV CRIT CARE, V16, P488, DOI 10.1097/00044067-200510000-00006; McNett MM, 2013, J NEUROSCI NURS, V45, P120, DOI 10.1097/JNN.0b013e3182901f0a; McNett MM, 2010, J NEUROSCI NURS, V42, P71, DOI 10.1097/JNN.0b013e3181ce5b8a; NELSON E, 1982, J CLIN PHARMACOL, V22, P141, DOI 10.1002/j.1552-4604.1982.tb02662.x; Olson DM, 2013, J NEUROSCI NURS, V45, P186, DOI 10.1097/JNN.0b013e3182986400; Tang A, 2015, J SURG RES, V194, P565, DOI 10.1016/j.jss.2014.11.017; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P151; Thompson Hilaire J, 2007, J Neurosci Nurs, V39, P196	22	5	6	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	MAR	2016	28	1					67	+		10.1016/j.cnc.2015.09.004			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DD1TR	WOS:000369705200006	26873759				2022-02-06	
J	Salehpour, F; Bazzazi, AM; Aghazadeh, J; Abbasivash, R; Forouhideh, Y; Mirzaei, F; Alavi, SAN				Salehpour, Firooz; Bazzazi, Amir Mohammad; Aghazadeh, Javad; Abbasivash, Rahman; Forouhideh, Yalda; Mirzaei, Farhad; Alavi, Seyed Ahmad Naseri			Can Serum Glucose Level in Early Admission Predict Outcome in Patients with Severe Head Trauma?	WORLD NEUROSURGERY			English	Article						Trauma; Serum glucose level; Severe head trauma; Traumatic brain injury	STRESS-INDUCED HYPERGLYCEMIA; BRAIN-INJURED PATIENTS; BLOOD-GLUCOSE; CHILDREN; MORTALITY; INSULIN	BACKGROUND: Traumatic brain injury is a major general health concern. This study aims to evaluate a possible relationship between the serum level of glucose during admission and the outcome of patients with severe traumatic brain injury. METHODS: In this prospective study, 80 patients with severe traumatic brain injury were recruited from the emergency department of Urmia Imam Khomeini Hospital. Serum level of glucose was measured at the time of admission and its correlation was investigated with the Glasgow Coma Scale score (on admission, 24 hours, 48 hours, and 1 week later, and at discharge) and Glasgow Outcome Score. In addition, the value of admission serum glucose was compared between deceased and discharged patients. RESULTS: Eighty patients with severe head trauma, 71 men (88%) and 9 women (11.2%) with a mean age of 31.71 +/- 15.66 years, were enrolled into the study. The in-hospital mortality rate was 25% (n = 20). There was no significant correlation between serum glucose level and Glasgow Coma Scale score (at different intervals) or Glasgow Outcome Score. The mean serum level of glucose was comparable between deceased and discharged patients (186.10 +/- 51.36 vs. 187.98 +/- 76.03 mg/dL, respectively; P = 0.91). CONCLUSIONS: Admission serum glucose is not a significant indicator of outcome in patients with severe head trauma.	[Salehpour, Firooz; Aghazadeh, Javad; Mirzaei, Farhad] Tabriz Univ Med Sci, Fac Med, Dept Neurosurg, Tabriz, Iran; [Bazzazi, Amir Mohammad] Tabriz Alinasab Hosp, Dept Neurosurg, Tabriz, Iran; [Abbasivash, Rahman] Urmia Univ Med Sci, Dept Anesthesiol, Orumiyeh, Iran; [Forouhideh, Yalda] Urmia Univ Med Sci, Orumiyeh, Iran; [Alavi, Seyed Ahmad Naseri] Tabriz Univ Med Sci, Fac Med, Tabriz, Iran		Alavi, SAN (corresponding author), Tabriz Univ Med Sci, Fac Med, Tabriz, Iran.	dr.arsalan2010@gmail.com	mirzaaghazadeh, javad/M-8412-2017; Alavi, Seyed Ahmad Naseri/M-7909-2015; salehpour, firooz/L-8833-2017	mirzaaghazadeh, javad/0000-0002-1582-9087; Alavi, Seyed Ahmad Naseri/0000-0002-3602-4966; salehpour, firooz/0000-0003-0693-6400			Asilioglu N, 2011, J PEDIAT-BRAZIL, V87, P325, DOI [10.1590/S0021-75572011000400009, 10.2223/JPED.2097]; Babbitt CJ, 2013, PEDIATR EMERG CARE, V29, P279, DOI 10.1097/PEC.0b013e3182850409; Bochicchio GV, 2007, J TRAUMA, V63, P1353, DOI 10.1097/TA.0b013e31815b83c4; Bochicchio GV, 2005, J TRAUMA, V58, P921, DOI 10.1097/01.TA.0000162141.26392.07; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; DuBose Joseph J, 2011, Adv Surg, V45, P187; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; JENNETT B, 1975, LANCET, V1, P480; Kerby JD, 2012, ANN SURG, V256, P446, DOI 10.1097/SLA.0b013e3182654549; KING LR, 1971, ANN SURG, V173, P337, DOI 10.1097/00000658-197103000-00003; Klein GW, 2008, J PEDIATR-US, V153, P379, DOI 10.1016/j.jpeds.2008.04.012; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; Liu-DeRyke X, 2009, NEUROCRIT CARE, V11, P151, DOI 10.1007/s12028-009-9228-6; Lodha R, 2009, INDIAN PEDIATR, V46, P809; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mohr AM, 2010, AM SURGEON, V76, P896; Mowery NT, 2009, J TRAUMA, V66, P145, DOI 10.1097/TA.0b013e3181938c5e; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; PENTELENYI T, 1979, INJURY, V10, P201, DOI 10.1016/0020-1383(79)90009-3; Preiser JC, 2010, CRIT CARE MED, V38, P1388, DOI 10.1097/CCM.0b013e3181d8a38b; SCHELP AO, 1995, ARQ NEURO-PSIQUIAT, V53, P690, DOI 10.1590/S0004-282X1995000400025; Sumas ME, 1999, PRINCIPLES NEUROSURG, P117; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Melo JRT, 2009, ARQ NEURO-PSIQUIAT, V67, P804, DOI 10.1590/S0004-282X2009000500004; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; YAMAGUCHI N, 1992, CAN J PHYSIOL PHARM, V70, P167, DOI 10.1139/y92-024; Yendamuri S, 2003, J TRAUMA, V55, P33, DOI 10.1097/01.TA.0000074434.39928.72; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007	30	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2016	87						132	135		10.1016/j.wneu.2015.11.048			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3HR	WOS:000373390200019	26704213				2022-02-06	
J	Johansson, AEM; Haugstad, T; Berg, M; Johansson, U				Johansson, Annica E. M.; Haugstad, Tor; Berg, Marie; Johansson, Ulla			Participation in the workforce after a traumatic brain injury: a matter of control	DISABILITY AND REHABILITATION			English	Article							QUALITY-OF-LIFE; OCCUPATIONAL ADAPTATION; HOLISTIC APPROACH; SELF-IDENTITY; RETURN; WORK; HEALTH; TRAJECTORIES; PRODUCTIVITY; EXPERIENCES		[Johansson, Annica E. M.; Haugstad, Tor; Berg, Marie] Sunnaas Rehabil Hosp, Res Dept, N-1450 Nesoddtangen, Norway; [Johansson, Annica E. M.; Haugstad, Tor; Berg, Marie] Univ Oslo, Fac Div Ulleval Univ Hosp, Oslo, Norway; [Johansson, Ulla] Uppsala Univ, Cty Council Gavleborg, Ctr Res & Dev, Gavle, Sweden; [Johansson, Ulla] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden		Johansson, AEM (corresponding author), Sunnaas Rehabil Hosp, Res Dept, Bjornemyrveien 11, N-1450 Nesoddtangen, Norway.	annica.johansson@sunnaas.no			Norwegian Labour and Welfare Service (NAV) and the Norwegian Directorate of Health	The Norwegian Labour and Welfare Service (NAV) and the Norwegian Directorate of Health provided financial support for this study. No conflict of interest has been declared by the authors.	Andelic N, 2012, NEUROEPIDEMIOLOGY, V38, P259, DOI 10.1159/000338032; Anderson H., 1997, CONVERSATION LANGUAG; Anke A, 2015, J HEAD TRAUMA REHAB, V30, pE38, DOI 10.1097/HTR.0000000000000080; Antonovsky A., 1987, UNRAVELING MYSTERY H; Arango-Lasprilla JC, 2012, BRAIN INJURY, V26, P825, DOI 10.3109/02699052.2012.655364; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bogdan R.C., 1998, QUALITATIVE RES ED I, V3rd; Bonneterre V., 2013, Annals of Physical and Rehabilitation Medicine, V56, P652, DOI 10.1016/j.rehab.2013.10.001; Bootes K, 2010, WORK, V36, P207, DOI [10.3233/WOR-2010-01021, 10.3233/WOR-2010-1021]; Bryson-Campbell M, 2013, WORK, V44, P57, DOI [10.3233/WOR-2012-1561, 10.3233/WOR-2012-01561]; Charmaz K., 2014, BROKERAGE CLOSURE IN; Dawson DR, 2007, DISABIL REHABIL, V29, P301, DOI 10.1080/09638280600756687; Ekbladh E., 2008, THESIS; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Erikson A., 2009, EXPERIENCES DAILY OC; Eriksson Gunilla, 2005, Scand J Occup Ther, V12, P40, DOI 10.1080/11038120510027630; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/jech.2005.041616; Erlandsson L. K., 2009, LIFE BALANCE MULTIDI, P115; Fisher AG, 1998, AM J OCCUP THER, V52, P509, DOI 10.5014/ajot.52.7.509; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Glaser B., 1967, DISCOVERY GROUNDED T; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Guidette S., 2008, THESIS; Haggstrom A, 2008, J REHABIL MED, V40, P89, DOI 10.2340/16501977-0138; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hoogerdijk B, 2011, SCAND J OCCUP THER, V18, P122, DOI 10.3109/11038121003645985; Jackson RL, 2007, QUALITAT RES REP COM, V8, P21, DOI DOI 10.1080/17459430701617879; Johansson AEM, 2011, WORK, V40, P375, DOI 10.3233/WOR-2011-1249; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Kvale S, 2009, COMMUNICATION; Lee YS, 2005, J MARRIAGE FAM, V67, P328, DOI 10.1111/j.0022-2445.2005.00119.x; Lovstad M, 2012, BRAIN INJURY, V26, P1586, DOI 10.3109/02699052.2012.698787; Matuska KM, 2008, J OCCUP SCI, V15, P9, DOI 10.1080/14427591.2008.9686602; Nayar S, 2012, J OCCUP SCI, V19, P76, DOI 10.1080/14427591.2011.581626; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Patton M.Q., 2002, QUALITATIVE RES EVAL, V3rd ed., P598, DOI [10.2307/330063, DOI 10.2307/330063]; Quale AJ, 2010, REHABIL PSYCHOL, V55, P12, DOI 10.1037/a0018415; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; SCHKADE JK, 1992, AM J OCCUP THER, V46, P829, DOI 10.5014/ajot.46.9.829; SCHULTZ S, 1992, AM J OCCUP THER, V46, P917, DOI 10.5014/ajot.46.10.917; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Sigurdardottir S, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000039; Stamm T, 2008, QUAL HEALTH RES, V18, P658, DOI 10.1177/1049732308316348; Stergiou-Kita M, 2012, DISABIL REHABIL, V34, P179, DOI 10.3109/09638288.2011.591881; Thomas EJ, 2014, QUAL HEALTH RES, V24, P1033, DOI 10.1177/1049732314542809; Vestling M, 2013, WORK, V45, P201, DOI 10.3233/WOR-121554; Wagman P, 2012, J OCCUP SCI, V19, P106, DOI 10.1080/14427591.2011.575760	50	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	FEB 27	2016	38	5					423	432		10.3109/09638288.2015.1044034			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DA5HS	WOS:000367834600003	25958997				2022-02-06	
J	Su, XY; Li, ZF; Wang, ML; Li, ZZ; Wang, QB; Lu, WX; Li, XL; Zhou, YF; Xu, HM				Su, Xinyang; Li, Zefu; Wang, Meilin; Li, Zhenzhu; Wang, Qingbo; Lu, Wenxian; Li, Xiaoli; Zhou, Youfei; Xu, Hongmei			The protective effect of different airway humidification liquids to lung after tracheotomy in traumatic brain injury: The role of pulmonary surfactant protein-A (SP-A)	GENE			English	Article						Brain injuries; Tracheotomy; Humidification; Surfactant protein A; Ambroxol	INFLAMMATION; CELLS; ACTIVATION; AMBROXOL	The purpose of this study was to establish a rat model of a brain injury with tracheotomy and compared the wetting effects of different airway humidification liquids, afterward, the best airway humidification liquid was selected for the clinical trial, thus providing a theoretical basis for selecting a proper airway humidification liquid in a clinical setting. Rats were divided into a sham group, group A (0.9% NaCl), group B (0.45% NaCl), group C (0.9% NaCl + ambroxol) and group D (0.9% NaCl + Pulmicort). An established rat model of traumatic brain injury with tracheotomy was used. Brain tissue samples were taken to determine water content, while lung tissue samples were taken to determine wet/dry weight ratio (W/D), histological changes and expression levels of SP-A mRNA and SP-A protein. 30 patients with brain injury and tracheotomy were selected and divided into two groups based on the airway humidification liquid instilled in the trachea tube, 0.45% NaCl and 0.9% NaCl + ambroxol. Blood was then extracted from the patients to measure the levels of SP-A, interleukin-6 (IL-6), interleukin-8 (IL-8) and tumour necrosis factor-alpha (TNF-alpha). The difference between group C and other groups in lung W/D and expression levels of SP-A mRNA and SP-A protein was significant (P <0.05). In comparison, the histological changes showed that the lung tissue damage was smallest in group C compared to the three other groups. Aspect of patients, 0.45% NaCl group and 0.9% NaCl + ambroxol group were significantly different in the levels of SP-A, IL-6, IL-8 and TNF-alpha (P <0.01). In the present study, 0.9% NaCl + ambroxol promote the synthesis and secretion of pulmonary surfactant, and has anti-inflammatory and antioxidant effects, which inhibit the release of inflammatory factors and cytokines, making it an ideal airway humidification liquid. (c) 2015 Elsevier B.V. All rights reserved.	[Su, Xinyang; Li, Xiaoli] Binzhou Med Univ, Dept Nursing, Yantai, Peoples R China; [Li, Zefu; Li, Zhenzhu; Wang, Qingbo] Binzhou Med Univ, Affiliated Hosp, Dept Neurosurg Med, Binzhou 256603, Peoples R China; [Wang, Meilin] Binzhou Med Univ, Affiliated Hosp, Dept Nursing Dept, Binzhou 256603, Peoples R China; [Lu, Wenxian] Binzhou Med Univ, Dept Clin Med, Yantai, Peoples R China; [Zhou, Youfei] Binzhou Med Univ, Dept Rehabil Med, Yantai, Peoples R China; [Xu, Hongmei] Binzhou Med Univ, Affiliated Hosp, Dept Org & Personnel Dept, Binzhou 256603, Peoples R China		Xu, HM (corresponding author), Binzhou Med Univ, Affiliated Hosp, Dept Org & Personnel Dept, Binzhou 256603, Peoples R China.	hmx58@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171119]; Affiliated Hospital of Binzhou Medical University [BYFYHL-201501]	This research was supported by National Natural Science Foundation of China (Grant No. 81171119) and Nursing Research-funded projects of Affiliated Hospital of Binzhou Medical University (BYFYHL-201501).	Ackerman M.H., 2003, AM J CRIT CARE, V7, P261; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; DESIMONI MG, 1990, J EXP MED, V171, P1773, DOI 10.1084/jem.171.5.1773; Donnelly R, 2001, CLIN PHARMACOKINET, V40, P427, DOI 10.2165/00003088-200140060-00004; Dulla C.G., 2015, NEUROSCIENTIST; Famuyide ME, 2009, PEDIATR RES, V66, P162, DOI 10.1203/PDR.0b013e3181aabd66; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Huang B., 2011, CHINESE MED INNOVATI, V8, P148; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Hvizdos KM, 2000, DRUGS, V60, P1141, DOI 10.2165/00003495-200060050-00010; JAREK MJ, 1993, CRIT CARE MED, V21, P543, DOI 10.1097/00003246-199304000-00015; Kalsotra A, 2007, J CEREBR BLOOD F MET, V27, P963, DOI 10.1038/sj.jcbfm.9600396; KING M, 1989, BIORHEOLOGY, V26, P737; Kola A, 2005, INTENS CARE MED, V31, P5, DOI 10.1007/s00134-004-2431-1; Kovalkova NA, 2015, TERAPEVT ARKH, V87, P115, DOI 10.17116/terarkh2015871115-119; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; Li Q, 2012, NEUROCRIT CARE, V16, P267, DOI 10.1007/s12028-011-9642-4; Madan T, 2010, MOL IMMUNOL, V47, P1923, DOI 10.1016/j.molimm.2010.02.027; Malerba M, 2008, EXPERT OPIN DRUG MET, V4, P1119, DOI [10.1517/17425255.4.8.1119, 10.1517/17425255.4.8.1119 ]; Marion D W, 1999, Clin Neurosurg, V45, P184; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Mikerov AN, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-77; Nardini E, 2005, J CELL PHYSIOL, V204, P889, DOI 10.1002/jcp.20360; Pata YS, 2003, INT J PEDIATR OTORHI, V67, P881, DOI 10.1016/S0165-5876(03)00132-0; Seguen Valerie, 2012, Soins, P44; Shu Lin-hua, 2013, Zhonghua Er Ke Za Zhi, V51, P779; Stubbe HD, 2004, J CEREBR BLOOD F MET, V24, P1400, DOI 10.1097/01.WCB.0000141516.61418.82; Tang RB, 2000, J ASTHMA, V37, P409, DOI 10.3109/02770900009055466; Vermeij JD, 2013, J NEUROTRAUM, V30, P2073, DOI 10.1089/neu.2013.3060; Wang LY, 2010, CLIN IMMUNOL, V137, P157, DOI 10.1016/j.clim.2010.05.012; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Wu W, 2014, ASIAN PAC J ALLERGY, V32, P337, DOI 10.12932/AP0450.32.4.2014	37	5	8	1	26	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	FEB 10	2016	577	1					89	95		10.1016/j.gene.2015.11.024			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB1ZR	WOS:000368308600012	26611525				2022-02-06	
J	Allen, KA				Allen, Kimberly A.			Pathophysiology and Treatment of Severe Traumatic Brain Injuries in Children	JOURNAL OF NEUROSCIENCE NURSING			English	Article						antiseizure prophylaxis; barbiturate therapy; child; hyperosmolar therapy; intracranial pressure; nursing care; pathophysiology; primary injury; secondary injury; trauma; traumatic brain injury; treatment	REFRACTORY INTRACRANIAL HYPERTENSION; EARLY DECOMPRESSIVE CRANIECTOMY; NEAR-INFRARED SPECTROSCOPY; CERVICAL-SPINE INJURIES; TISSUE OXYGEN-TENSION; TRANSCRANIAL DOPPLER; CEREBRAL AUTOREGULATION; PEDIATRIC-PATIENTS; SUBDURAL-HEMATOMA; AXONAL INJURY	Traumatic brain injuries (TBIs) in children are a major cause of morbidity and mortality worldwide. Severe TBIs account for 15,000 admissions annually and a mortality rate of 24% in children in the United States. The purpose of this article is to explore pathophysiologic events, examine monitoring techniques, and explain current treatment modalities and nursing care related to caring for children with severe TBI. The primary injury of a TBI is because of direct trauma from an external force, a penetrating object, blast waves, or a jolt to the head. Secondary injury occurs because of alterations in cerebral blood flow, and the development of cerebral edema leads to necrotic and apoptotic cellular death after TBI. Monitoring focuses on intracranial pressure, cerebral oxygenation, cerebral edema, and cerebrovascular injuries. If abnormalities are identified, treatments are available to manage the negative effects caused to the cerebral tissue. The mainstay treatments are hyperosmolar therapy; temperature control; cerebrospinal fluid drainage; barbiturate therapy; decompressive craniectomy; analgesia, sedation, and neuromuscular blockade; and antiseizure prophylaxis.	[Allen, Kimberly A.] Univ Illinois, Women Children & Family Hlth Sci, Chicago, IL 60607 USA		Allen, KA (corresponding author), Univ Illinois, Women Children & Family Hlth Sci, Chicago, IL 60607 USA.	allenk@uic.edu			NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32NR007106] Funding Source: NIH RePORTER; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [T32 NR007106] Funding Source: Medline		ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Amigoni A, 2011, INTERACT CARDIOV TH, V12, P707, DOI 10.1510/icvts.2010.253328; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; [Anonymous], 2010, 10 LEAD CAUS DEATH I; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Ashcraft J., 2011, PEDIAT ADV LIFE SUPP; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; BLACK S P, 1956, Mo Med, V53, P849; Blissitt PA, 2009, AACN AANN PROTOCOLS, P103; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bohman LE, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0392-x; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brown AW, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2007.12.001; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; COHN R, 1948, ARCH NEURO PSYCHIATR, V59, P360, DOI 10.1001/archneurpsyc.1948.02300380089007; Cushing H, 1903, AM J MED SCI, V125, P1017, DOI 10.1097/00000441-190306000-00006; De Georgia MA, 2015, J INTENSIVE CARE MED, V30, P473, DOI 10.1177/0885066614529254; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Drayna PC, 2011, PEDIATR EMERG CARE, V27, P432, DOI 10.1097/PEC.0b013e3182188442; Duhaime AC, 2012, J NEUROTRAUM, V29, P629, DOI 10.1089/neu.2011.1927; Easter JS, 2011, J EMERG MED, V41, P142, DOI 10.1016/j.jemermed.2009.11.034; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Emergency Nurses Association, 2007, TRAUM NURS COR COURS; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; Falk AC, 2012, CHILD NERV SYST, V28, P1069, DOI 10.1007/s00381-012-1772-2; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; Figaji AA, 2010, NEUROCRIT CARE, V12, P56, DOI 10.1007/s12028-009-9298-5; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; Finch GD, 1998, J PEDIATR ORTHOPED, V18, P811, DOI 10.1097/00004694-199811000-00022; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Geyer Kristen, 2013, Pediatr Nurs, V39, P283; Glick RP, 2011, PEDIATR NEUROSURG, V47, P152, DOI 10.1159/000330709; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hazinski M. F., 2013, NURSING CARE CRITICA; HEKMATPANAH J, 1970, J NEUROSURG, V32, P21, DOI 10.3171/jns.1970.32.1.0021; HIRSCH CS, 1975, J NEUROSURG, V42, P530, DOI 10.3171/jns.1975.42.5.0530; Hockenberry M.J., 2007, WONGS NURSING CARE I; HOLBACH KH, 1972, EUR NEUROL, V8, P158, DOI 10.1159/000114570; Holbourn AHS, 1943, LANCET, V2, P438; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; IARC monographs on the evaluation of carcinogenic risks to human, 2012, IARC MON EV CARC RIS, V100B; Jamous MA, 2009, PEDIATR NEUROSURG, V45, P181, DOI 10.1159/000218200; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; Josan VA, 2006, CHILD NERV SYST, V22, P1268, DOI 10.1007/s00381-006-0064-0; Kilbaugh TJ, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/189142; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kleinman ME, 2010, PEDIATRICS, V126, pE1361, DOI 10.1542/peds.2010-2972D; Klimo P, 2010, J NEUROSURG-PEDIATR, V6, P107, DOI 10.3171/2010.3.PEDS109; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kondo K, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-147; LEVENTHAL HR, 1960, J PEDIATR-US, V56, P447, DOI 10.1016/S0022-3476(60)80356-3; Maloney-Wilensky E, 2010, CHILD NERV SYST, V26, P419, DOI 10.1007/s00381-009-1037-x; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Marcoux KK, 2005, AACN ADV CRIT CARE, V16, P212, DOI 10.1097/00044067-200504000-00012; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; McFadyen J Grant, 2012, Int J Crit Illn Inj Sci, V2, P121, DOI 10.4103/2229-5151.100888; Mellion SA, 2013, PEDIATR CRIT CARE ME, V14, P239, DOI 10.1097/PCC.0b013e318271c3b2; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer PG, 2005, CHILD NERV SYST, V21, P133, DOI 10.1007/s00381-004-1016-1; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Morrow SE, 2010, SEMIN PEDIATR SURG, V19, P279, DOI 10.1053/j.sempedsurg.2010.07.001; Morton RP, 2013, J NEUROSURG-PEDIATR, V12, P406, DOI 10.3171/2013.7.PEDS12631; Narotam PK, 2006, J PEDIATR SURG, V41, P505, DOI 10.1016/j.jpedsurg.2005.11.069; Ngo QN, 2009, PEDIATR CRIT CARE ME, V10, P346, DOI 10.1097/PCC.0b013e3181a320cd; NITECKI S, 1994, J PEDIATR SURG, V29, P1409, DOI 10.1016/0022-3468(94)90131-7; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; Piatt JH, 2012, J NEUROSURG-PEDIATR, V10, P257, DOI 10.3171/2012.7.PEDS11532; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Purins K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00064; Ramaiah VK, 2013, CHILD NERV SYST, V29, P629, DOI 10.1007/s00381-012-1984-5; Reddy MK, 2009, FASEB J, V23, P1384, DOI 10.1096/fj.08-116947; Robertson CL, 2004, DEV BRAIN RES, V151, P141, DOI 10.1016/j.devbrainres.2004.04.007; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rohlwink UK, 2012, NEUROSURGERY, V70, P1220, DOI 10.1227/NEU.0b013e318243fc59; Rohlwink UK, 2010, CHILD NERV SYST, V26, P453, DOI 10.1007/s00381-009-1033-1; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Shao JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051634; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Steinborn M, 2010, EMERG RADIOL, V17, P309, DOI 10.1007/s10140-010-0860-4; Stevens Wendy J, 2004, J Neurosci Nurs, V36, P332; Stewart O W, 1944, Proc R Soc Med, V37, P381; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Stiefel MF, 2006, J NEUROSURG, V105, P281, DOI 10.3171/ped.2006.105.4.281; Stippler M, 2012, J NEUROSURG-PEDIATR, V10, P383, DOI 10.3171/2012.8.PEDS12165; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Thomale UW, 2010, CHILD NERV SYST, V26, P1563, DOI 10.1007/s00381-010-1103-4; Thompson H., 2011, AANN CLIN PRACTICE G, P38; Tontisirin N, 2007, CHILD NERV SYST, V23, P1163, DOI 10.1007/s00381-007-0339-0; Top APC, 2011, CRIT CARE, V15, DOI 10.1186/cc9995; Trabold F, 2004, INTENS CARE MED, V30, P108, DOI 10.1007/s00134-003-2057-8; Melo JRT, 2011, CHILD NERV SYST, V27, P979, DOI 10.1007/s00381-010-1367-8; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Ushewokunze S, 2009, CHILD NERV SYST, V25, P341, DOI 10.1007/s00381-008-0752-z; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; Verlhac S, 2011, PEDIATR RADIOL, V41, pS153, DOI 10.1007/s00247-011-2038-y; Vernon-Levett P., 2006, CORE CURRICULULM PED; Ward A A Jr, 1964, Clin Neurosurg, V12, P95; WEED LEWIS H., 1929, ARCH SURG, V18, P1049; Weintraub D, 2012, NEUROREHABILITATION, V30, P219, DOI 10.3233/NRE-2012-0748; Wiegand C, 2007, DEV MED CHILD NEUROL, V49, P935, DOI 10.1111/j.1469-8749.2007.00935.x; Wilensky Eileen Maloney, 2005, J Neurosci Nurs, V37, P278; Yaron M, 2003, HIGH ALT MED BIOL, V4, P53, DOI 10.1089/152702903321488988; YOXALL CW, 1995, PEDIATR RES, V38, P319, DOI 10.1203/00006450-199509000-00008; Zuluaga MT, 2010, PEDIATR CRIT CARE ME, V11, P514, DOI 10.1097/PCC.0b013e3181c51cf1	127	5	5	3	19	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	FEB	2016	48	1					15	27		10.1097/JNN.0000000000000176			13	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	DB4AT	WOS:000368455800003	26720317	Green Accepted			2022-02-06	
J	Haltmeier, T; Schnuriger, B; Benjamin, E; Maeder, MB; Kunzler, M; Siboni, S; Inaba, K; Demetriades, D				Haltmeier, Tobias; Schnueriger, Beat; Benjamin, Elizabeth; Maeder, Monika Brodmann; Kuenzler, Michael; Siboni, Stefano; Inaba, Kenji; Demetriades, Demetrios			Isolated blunt severe traumatic brain injury in Bern, Switzerland, and the United States: A matched cohort study	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	16th European Congress of Trauma and Emergency Surgery (ECTES)	MAY 10-12, 2015	Amsterdam, NETHERLANDS			Traumatic brain injury; prehospital management; emergency physician; prehospital intubation; outcome	PREHOSPITAL ENDOTRACHEAL INTUBATION; RAPID-SEQUENCE INTUBATION; CRITICAL-CARE PARAMEDICS; HEAD-INJURY; PHYSICIANS; TRACHEOSTOMY; VENTILATION; MORTALITY; ANESTHESIOLOGIST; PRESSURE	BACKGROUND: The ideal prehospital management of patients with severe traumatic brain injury (TBI) including the impact of endotracheal intubation (ETI) and physicians on scene is unclear. Prehospital management differs substantially in Switzerland and the United States: in Switzerland, there is usually a physician on scene who may provide ETI and other advanced life support procedures, whereas in the United States, prehospital management (including ETI) is performed by paramedics. METHODS: This is a retrospective cohort-matched study of patients with isolated blunt severe TBI (head Abbreviated Injury Scale [AIS] score, 4-5) and no major extracranial injuries, using Bern University Hospital data from the Swiss PEBITA [Patient-relevant Endpoints after Brain Injury from Traumatic Accidents] (TBI-specific) database and the US National Trauma Data Bank from 2009 to 2010. A 1:4 cohort matching of Bern and US patients was performed. Matching criteria were sex, age ( 10 years), exact field Glasgow Coma Scale (GCS) score, exact head MS score, and injury type (subdural hematoma, epidural hematoma, intraparenchymal hemorrhage, intraventricular hemorrhage, brain edema/swelling, brain stem injury). The matched cohorts were compared with univariable analysis (Fisher's exact test and Mann-Whitney U-test). RESULTS: Matching of the Bern (n = 128) and US (n = 86,375) cohort resulted in 355 matched cases (71 Bern and 284 US patients). Bern patients had significantly longer scene times (median, 23.0 minutes vs. 9.0 minutes, p < 0.001) and more frequent prehospital ETI (31.0% vs. 18.7%,p = 0.034) and air transportation (39.4% vs. 19.4%,p < 0.001). No significant difference in procedures (craniotomy/craniectomy, intracranial pressure monitoring, tracheotomy), intensive care unit and total hospital lengths of stay, ventilator days, and in-hospital mortality (14.1% vs. 15.8%, p = 0.855) was found between the two cohorts. CONCLUSION: When taking into account the limitation that patient- and injury-related factors, but not in-hospital treatment variables, were matched, the more frequent prehospital ETI and presence of a physician on scene in the Swiss cohort compared with the US cohort had no significant effect on outcomes, including intensive care unit and total hospital lengths of stay, ventilator days, and in-hospital mortality. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Haltmeier, Tobias; Benjamin, Elizabeth; Siboni, Stefano; Inaba, Kenji; Demetriades, Demetrios] Los Angeles Cty & Univ Southern Calif, Med Ctr, Div Acute Care Surg & Surg Crit Care, Dept Surg, Los Angeles, CA USA; [Schnueriger, Beat] Univ Hosp Bern, Inselspital, Univ Clin Visceral Surg & Med, CH-3010 Bern, Switzerland; [Maeder, Monika Brodmann; Kuenzler, Michael] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland		Demetriades, D (corresponding author), Univ So Calif, LA Cty USC Med Ctr, Dept Surg, Div Acute Care Surg & Surg Crit Care, 1200 N State St,Inpatient Tower C,Rm C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	Kunzler, Michael/C-1039-2013; INABA, KENJI/AAC-8532-2020; Benjamin, Elizabeth/AAD-2457-2020; Siboni, Stefano/AAF-5456-2019	Kunzler, Michael/0000-0001-7792-5595; Siboni, Stefano/0000-0003-0532-3135; Haltmeier, Tobias/0000-0001-6049-9235; Brodmann Maeder, Monika Maria/0000-0001-5608-7887			Affairs SFDoF, 2015, GEOGR FACTS FIG; Alali AS, 2014, J TRAUMA ACUTE CARE, V76, P6; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Albrecht R, 2015, HANDING TRAUMA PATIE; [Anonymous], 2002, AM SURGEON; [Anonymous], 2013, GEN TRAUMA CARE RELA; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bochicchio GV, 2003, J TRAUMA, V54, P307, DOI 10.1097/01.TA.0000046252.97590.BE; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; Davis DF, 2008, CURR OPIN CRIT CARE, V14, P142, DOI 10.1097/MCC.0b013e3282f63c40; Davis DP, 2011, PREHOSP EMERG CARE, V15, P184, DOI 10.3109/10903127.2010.545473; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; Dick Wolfgang F, 2003, Prehosp Disaster Med, V18, P29; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Durbin CG, 2010, RESP CARE, V55, P1056; Garner A, 2001, INJURY, V32, P455, DOI 10.1016/S0020-1383(01)00013-4; Gurkin MA, 2002, AM SURGEON, V68, P324; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Huang YH, 2013, INJURY, V44, P1226, DOI 10.1016/j.injury.2012.12.029; Karamanos E, 2014, PREHOSP DISASTER MED, V29, P32, DOI 10.1017/S1049023X13008947; Katz SH, 2001, ANN EMERG MED, V37, P32, DOI 10.1067/mem.2001.112098; Kirves H, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-60; Koh WY, 1997, ANAESTH INTENS CARE, V25, P365, DOI 10.1177/0310057X9702500407; Lechleuthner A, 1994, Prehosp Disaster Med, V9, P193; Lee A, 2003, INJURY, V34, P815, DOI 10.1016/S0020-1383(02)00395-9; MALACRIDA RL, 1993, INJURY, V24, P451, DOI 10.1016/0020-1383(93)90147-X; MOESCHLER O, 1992, J TRAUMA, V33, P754, DOI 10.1097/00005373-199211000-00027; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Osterwalder JJ, 2003, J TRAUMA, V55, P355, DOI 10.1097/01.TA.0000034231.94460.1F; Perkins ZB, 2013, J TRAUMA ACUTE CARE, V74, P1074, DOI 10.1097/TA.0b013e3182827305; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Samaha T, 1996, ANN FR ANESTH, V15, P36, DOI 10.1016/0750-7658(96)89400-7; Shafi S, 2005, J TRAUMA, V59, P1140, DOI 10.1097/01.ta.0000196434.88182.77; Shafi S, 2005, J TRAUMA, V59, P5; Timmermann A, 2008, CURR OPIN ANESTHESIO, V21, P222, DOI 10.1097/ACO.0b013e3282f5f4f7; United States Census Bureau, 2015, STAT AR MEAS INT POI; von Vopelius-Feldt J, 2014, EMERG MED J, V31, P1016, DOI 10.1136/emermed-2013-202721; von Vopelius-Feldt J, 2014, EMERG MED J, V31, P1009, DOI 10.1136/emermed-2013-202895; Yeh DD, 2012, ANZ J SURG, V82, P484, DOI 10.1111/j.1445-2197.2012.06130.x	42	5	5	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2016	80	2					296	301		10.1097/TA.0000000000000892			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	DK9EY	WOS:000375234800024	26491802				2022-02-06	
J	Jang, SH; Kim, SH; Kwon, HG				Jang, Sung Ho; Kim, Seong Ho; Kwon, Hyeok Gyu			Recovery of an Injured Cingulum via the Lateral Cholinergic Pathway in a Patient with Traumatic Brain Injury	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						Cingulum; Traumatic Axonal Injury; Cognition; Diffusion Tensor Tractography; Lateral Cholinergic Pathway	DIFFUSION TENSOR TRACTOGRAPHY; NEURAL CONNECTION; STEM	We report on a patient with traumatic brain injury who showed recovery of an injured cingulum via the lateral cholinergic pathway, using diffusion tensor tractography (DTT). A 63-year-old man underwent craniotomy for subarachnoid hemorrhage and subdural hemorrhage in both frontotemporal lobes, which occurred by hitting his head against a floor after falling from approximately 2 m. The Wechsler Intelligence Scale and the Seoul neuropsychological screening battery were used for evaluation of cognitive function. At 4 weeks after onset, the patient exhibited mild cognitive impairment (total IQ, 85; verbal immediate recall, 26.76 percentile; visual immediate recall, 29.81 percentile; verbal delayed recall, 24.51 percentile; visual delayed recall, 11.70 percentile). By contrast, at the 9-month evaluation, the cognitive impairment had improved as much as total IQ, 96; verbal immediate recall, 56.75 percentile; visual immediate recall, 89.49 percentile; verbal delayed recall, 78.23 percentile; and visual delayed recall, 89.07 percentile. On 4-week DTT, discontinuations were observed superior to the genu of the corpus callosum in both cingula. However, on 9-month DTT, the discontinued anterior part of the right cingulum was elongated inferoposteriorly through an unusual neural tract, which ran through the external capsule and the white matter of the temporo-occipital lobes. The results of this study seem to suggest a mechanism for recovery of an injured cingulum after brain injury.	[Jang, Sung Ho; Kwon, Hyeok Gyu] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Taegu 705717, South Korea; [Kim, Seong Ho] Yeungnam Univ, Coll Med, Dept Neurosurg, Taegu 705717, South Korea		Kwon, HG (corresponding author), Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, 317-1 Daemyung Dong, Taegu 705717, South Korea.				National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2015R1A2A2 A01004073]	Supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2015R1A2A2 A01004073). Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article.	Concha L, 2005, AM J NEURORADIOL, V26, P2267; David W, 1981, MANUAL WECHSLER ADUL; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; Jang SH, 2015, NEURAL REGEN RES, V10, P323, DOI 10.4103/1673-5374.152391; Kang Y.W., 2003, SEOUL NEUROPSYCHOLOG; Lucas-Meunier E, 2003, PFLUG ARCH EUR J PHY, V446, P17, DOI 10.1007/s00424-002-0999-2; Selden NR, 1998, BRAIN, V121, P2249, DOI 10.1093/brain/121.12.2249; Seo JP, 2014, NEURAL REGEN RES, V9, P498, DOI 10.4103/1673-5374.130068; Seo JP, 2013, NEUROREHABILITATION, V33, P257, DOI 10.3233/NRE-130953; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeo SS, 2012, NEUROREHABILITATION, V31, P143, DOI 10.3233/NRE-2012-0783; Yoo JS, 2014, BRAIN INJURY, V28, P1257, DOI 10.3109/02699052.2014.901557	13	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	2016	95	2					E18	E21		10.1097/PHM.0000000000000402			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DB6MF	WOS:000368628400002	26495813				2022-02-06	
J	Kohli, A; Chao, E; Spielman, D; Sugano, D; Srivastava, A; Dayama, A; Lederman, A; Stern, M; Reddy, SH; Teperman, S; Stone, ME				Kohli, Anirudh; Chao, Edward; Spielman, Daniel; Sugano, Dordaneh; Srivastava, Abhishek; Dayama, Anand; Lederman, Andrew; Stern, Michelle; Reddy, Srinivas H.; Teperman, Sheldon; Stone, Melvin E., Jr.			Factors Associated with Return to Work Postinjury: Can the Modified Rankin Scale Be Used to Predict Return to Work?	AMERICAN SURGEON			English	Article							TRAUMATIC BRAIN-INJURY; STROKE; MODELS; LIFE	The ability to return to work (RTW) postinjury is one of the primary goals of rehabilitation. The modified Rankin Scale (mRS) is a validated simple scale used to assess the functional status of stroke patients during rehabilitation. We sought to determine the applicability of mRS in predicting RTW postinjury in a general trauma population. The trauma registry was queried for patients, aged 18 to 65 years, discharged from 2012 to 2013. A telephone interview for each patient included questions about employment status and physical ability to determine the mRS. Patients who had RTW postinjury were compared with those who had not (nRTW). Two hundred and thirty-four patients met the inclusion criteria. Of these, 171 (72.5%) patients RTWand 63 (26.7%) did nRTW. Patients who did nRTW were significantly older, had longer length of stay and higher rates of in-hospital complications. Multivariate analysis revealed that older patients were less likely to RTW (odds ratio = 0.961, P = 0.011) and patients with a modified Rankin score <= 2 were 15 times more likely to RTW (odds ratio = 14.932, P < 0.001). In conclusion, an mRS <= 2 was independently associated with a high likelihood of returning to work postinjury. This is the first study that shows applicability of the mRS for predicting RTW postinjury in a trauma population.	[Kohli, Anirudh; Chao, Edward; Spielman, Daniel; Sugano, Dordaneh; Srivastava, Abhishek; Dayama, Anand; Reddy, Srinivas H.; Teperman, Sheldon; Stone, Melvin E., Jr.] Albert Einstein Coll Med, Dept Surg, Jacobi Med Ctr, Bronx, NY 10467 USA; [Lederman, Andrew; Stern, Michelle] Albert Einstein Coll Med, Dept Phys Med & Rehabil, Jacobi Med Ctr, Bronx, NY 10467 USA		Stone, ME (corresponding author), Albert Einstein Coll Med, Dept Surg, Jacobi Med Ctr, 40 West 116th St A712, New York, NY 10026 USA.	melvinomd@gmail.com		Spielman, Daniel/0000-0003-2602-0416			[Anonymous], 1988, BRIT MED J, V296, P316; Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Hong KS, 2009, STROKE, V40, P3828, DOI 10.1161/STROKEAHA.109.561365; Johansson U, 2001, DISABIL REHABIL, V23, P474; Jorge LL, 2015, DISABIL REHABIL, V37, P268, DOI 10.3109/09638288.2014.914585; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; Paciaroni M, 2000, EUR NEUROL, V43, P30, DOI 10.1159/000008125; Patel RD, 2014, STROKE S1, V45; Peters GO, 2013, DISABIL REHABIL, V35, P455, DOI 10.3109/09638288.2012.697251; RANKIN J, 1957, Scott Med J, V2, P200; RAO N, 1992, ARCH PHYS MED REHAB, V73, P911; Riberto M, 2004, ACTA FISIATR, V11, P72, DOI [DOI 10.5935/0104-7795.20040003, 10.5935/0104-7795.20040003]; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schultz IZ, 2007, J OCCUP REHABIL, V17, P327, DOI 10.1007/s10926-007-9071-6; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Stergiou-Kita M, 2010, BRAIN INJURY, V24, P948, DOI 10.3109/02699052.2010.491495; Sumer MM, 2003, ACTA NEUROL SCAND, V107, P276, DOI 10.1034/j.1600-0404.2003.02008.x; Tanaka H, 2011, ARCH PHYS MED REHAB, V92, P743, DOI 10.1016/j.apmr.2010.12.009; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wilson JR, 2014, SPINE J, V14, P1192, DOI 10.1016/j.spinee.2013.08.005	23	5	5	0	4	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	FEB	2016	82	2					95	101					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	DI1QB	WOS:000373269500010	26874129				2022-02-06	
J	Muehlan, H; Wilson, L; von Steinbuchel, N				Muehlan, Holger; Wilson, Lindsay; von Steinbuechel, Nicole			A Rasch Analysis of the QOLIBRI Six-Item Overall Scale	ASSESSMENT			English	Article						health-related quality of life; outcome instrument; traumatic brain injury; condition-specific quality of life; Rasch analysis	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; MODERATE	Objective: The Quality Of Life after BRain Injury (QOLIBRI) consortium has developed a short six-item scale (QOLIBRI-OS) to screen health-related quality of life after traumatic brain injury. The goal of the current study is to examine further psychometric qualities of the Quality Of Life after BRain Injury-Overall Scale (QOLIBRI-OS) at the item level using Rasch analysis with particular emphasis on the operating characteristics of the items. Method: A total of 921 participants with traumatic brain injury were recruited. The analysis sample was restricted to 795 participants with Glasgow Coma Score and Glasgow Outcome Score-Extended available in order to ensure a well-characterized sample. Results: Overall fit statistics indicate sufficient reliability of the QOLIBRI-OS. The assumption of unidimensionality could be confirmed with reservation. The range of item locations is small, whereas item thresholds cover a wide range of the latent trait. The majority of parameter estimations for all class intervals of the respective test are in accordance with the model assumptions. Conclusion: The results show that, despite marginal misfits to the model, the six items representing the QOLIBRI-OS could establish a Rasch scale.	[Muehlan, Holger] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Wilson, Lindsay] Univ Stirling, Stirling FK9 4LA, Scotland; [von Steinbuechel, Nicole] Univ Med Goettingen, Gottingen, Germany		Muehlan, H (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Hlth & Prevent, Robert Blum St 13, D-17487 Greifswald, Germany.	holger.muehlan@uni-greifswald.de	Wilson, Lindsay/O-8883-2019; Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328			Andrich D., 2007, RUMM 2020 RASCH UNID; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bock W, 2006, SCHADEL HIRN VERLETZ; Fisher W., 1992, RASCH MEAS T, V6, P238; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Hambleton RK, 2006, MED CARE, V44, pS182, DOI 10.1097/01.mlr.0000245443.86671.c4; Maas AIR, 2000, CNS DRUGS, V13, P139, DOI 10.2165/00023210-200013020-00007; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Power M, 2005, QUAL LIFE RES, V14, P2197, DOI 10.1007/s11136-005-7380-9; Prieto Luis, 2003, Health Qual Life Outcomes, V1, P27, DOI 10.1186/1477-7525-1-27; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Sasse N, 2014, DISABIL REHABIL, V36, P2152, DOI 10.3109/09638288.2014.893029; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; von Steinbuchel Nicole, 2006, Eur J Ageing, V3, P116, DOI 10.1007/s10433-006-0024-2; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong GKC, 2014, J CLIN NEUROSCI, V21, P954, DOI 10.1016/j.jocn.2013.09.010; Zitnay GA, 2008, J NEUROTRAUM, V25, P1135, DOI 10.1089/neu.2008.0599	26	5	5	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	FEB	2016	23	1					124	130		10.1177/1073191115569844			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	DB5ZN	WOS:000368592900012	25676283				2022-02-06	
J	Poppl, D; Fries, W; Deck, R; Reuther, P				Poeppl, D.; Fries, W.; Deck, R.; Reuther, P.			Participation after Stroke: Results of a Multicentric Follow-up Study in Outpatient Neurorehabilitation (Part 1)	AKTUELLE NEUROLOGIE			German	Article						stroke; measurement of outcomes; outpatient neurological rehabilitation	TRAUMATIC BRAIN-INJURY; REHABILITATION; VALIDATION; HEALTH; SEXUALITY; OUTCOMES; SINGER; IMPACT; CARE	Objective: We report here the results of a multicentric study to evaluate the sustained effects of outpatient neurorehabilitation under special consideration of the ultimate goal of rehabilitation as anchored in German social law, namely "participation and self-determined conduct of life". Method: In a multicentric observational study, patients at 17 outpatient neurorehabilitation centres dealing with patients recovering from stroke or traumatic brain injury were asked to fill in a questionnaire. This was carried out 4 times: on admission to and discharge from the rehabilitation centre and on month 4 and 12 post rehabilitation. Additionally, clinical experts were also asked to rate the patients' status at admission and discharge. Results and conclusions: The results of a representative sample of German outpatients in neurorehabilitation centres clearly suggest that positive and sustained effects in terms of the ultimate goal of rehabilitation, namely "participation and self-determined conduct of life" as specified under social law can be achieved by this approach to rehabilitation. The effects are observable and verifiable even 12 months after discharge. There are differences in the outcome parameters investigated; the results draw attention to numerous clinical implications.	[Poeppl, D.] Ambulante Reha Krankenhaus Geilenkirchen, Psychol, Martin Heyden Str 32, D-52511 Geilenkirchen, Germany; [Fries, W.] Neurokompetenz GbR, Munich, Germany; [Deck, R.] Univ Lubeck, Inst Sozialmed Lubeck, Lubeck, Germany; [Reuther, P.] Ambulantes Neurol Rehabil Zentrum, Ahrweiler, Germany		Poppl, D (corresponding author), Ambulante Reha Krankenhaus Geilenkirchen, Psychol, Martin Heyden Str 32, D-52511 Geilenkirchen, Germany.	poeppl@neuro-therapie.de					Bender R, 2007, Dtsch Med Wochenschr, V132 Suppl 1, pe61, DOI 10.1055/s-2007-959045; Bolsche F, 2002, Rehabilitation (Stuttg), V41, P175; Bolsche F, 2003, FORTSCHR NEUROL PSYC, V71, P458; BORTZ J, 1999, STAT SOZIALWISSENSCH, V5; Bundesarbeitsgemeinschaft fur Rehabilitation, 2005, RAHM AMBUL NEUR REH; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P656, DOI 10.1007/s00103-012-1659-0; Cicerone KD, 2004, J HEAD TRAUMA REHAB, V19, P494, DOI 10.1097/00001199-200411000-00006; Cohen J., 2013, STAT POWER ANAL BEHA; Deck R, 1999, FORDERSCHWERPUNKT RE, P84; Deck R, 2004, REHABILITATION NACHS, P55; Devlin NJ, 2013, EUR J HEALTH ECON, V14, pS1, DOI 10.1007/s10198-013-0502-3; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Faller H, 1999, FORDERSCHWERPUNKT RE, P13; Farin E, 2012, REHABILITATION, V51, pS3, DOI 10.1055/s-0032-1327725; Funke N, 2009, SINGER MANUAL STUFEN; Gerdes N, 2012, REHABILITATION, V51, P289, DOI 10.1055/s-0031-1287805; Gerdes N, 2009, REHABILITATION, V48, P190, DOI 10.1055/s-0029-1231061; Goranson TE, 2003, BRAIN INJURY, V17, P759, DOI 10.1080/0269905031000088513; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Heuschmann PU, 2010, AKTUEL NEUROL, V37, P333, DOI 10.1055/s-0030-1248611; HOHMANN J, 1998, GESUNDHEITS SOZIAL R; Huappe, 2007, PRAXIS KLIN VERHALTE, V76, P113; Huff W, 2003, NERVENARZT, V74, P104, DOI 10.1007/s00115-002-1417-x; Huller E, 2005, REHABILITATION TEILH, P12; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Leonhart R, 2004, Rehabilitation (Stuttg), V43, P241; Magasi S, 2010, ARCH PHYS MED REHAB, V91, pS17, DOI 10.1016/j.apmr.2010.07.011; MAHONEY F I, 1965, Md State Med J, V14, P61; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; Morfeld M, 2007, REHABILITATION PHYS, P1; Poppl D, 2015, REHABILITATION, V54, P22, DOI 10.1055/s-0034-1394451; Poppl D, 2014, REHABILITATION, V53, P168, DOI 10.1055/s-0033-1353193; Poppl D, 2013, FORTSCHR NEUROL PSYC, V81, P570, DOI 10.1055/s-0033-1335916; Poppl D, 2012, EVALUATION ERGEBNISQ; Pott C., 2014, THESIS; Powell J, 2004, J NEUROL NEUROSUR PS, V75, P1119, DOI 10.1136/jnnp.2002.000414; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Reuther P, 2007, NEUROLOGIE REHABILIT, V11, P225; Salter KL, 2007, INT J REHABIL RES, V30, P339, DOI 10.1097/MRR.0b013e3282f144b7; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schneider K, 2009, NERVENHEILKUNDE, V28, P114, DOI 10.1055/s-0038-1628584; SCHUMACHER M, 2002, METHODIK KLIN STUDIE; Schweinsberg ESZ, 2015, REHABILITATION, V54, P160, DOI 10.1055/s-0035-1545358; Stolwyk RJ, 2013, J HEAD TRAUMA REHAB, V28, P164, DOI 10.1097/HTR.0b013e31828197d1; Tschacher W, 2000, PSYCHOTHER RES, V10, P296, DOI 10.1093/ptr/10.3.296; Vodusek DB, 2011, NERVENARZT, V82, P787, DOI 10.1007/s00115-010-3199-x; Wendel C, 2012, Z NEUROPSYCHOL, V23, P65, DOI 10.1024/1016-264X/a000067; Wirtz M, 2004, Rehabilitation (Stuttg), V43, P109	50	5	5	0	7	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0302-4350	1438-9428		AKTUEL NEUROL	Aktuelle Neurol.	FEB	2016	43	1					14	23		10.1055/s-0041-110202			10	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DE0AB	WOS:000370285900022					2022-02-06	
J	Sadegh, R; Karimialavijeh, E; Shirani, F; Payandemehr, P; Bahramimotlagh, H; Ramezani, M				Sadegh, Robab; Karimialavijeh, Ehsan; Shirani, Farzaneh; Payandemehr, Pooya; Bahramimotlagh, Hooman; Ramezani, Mahtab			Head CT scan in Iranian minor head injury patients: evaluating current decision rules	EMERGENCY RADIOLOGY			English	Article						Head injury; Computed tomography; Decision modeling	TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; MILD; VALIDATION; MANAGEMENT; PROPOSAL; METHODOLOGY; GUIDELINES	The objective of this study is to select one of the seven available clinical decision rules for minor head injury, for managing Iranian patients. This was a prospective cohort study evaluating medium- or high-risk minor head injury patients presenting to the Emergency Department. Patients with minor head trauma who were eligible for brain imaging based on seven available clinical decision rules (National Institute for Health and Clinical Excellence (NICE), National Emergency X-Radiography Utilization Study (NEXUS)-II, Neurotraumatology Committee of the World Federation of Neurosurgical Societies (NCWFNS), New Orleans, American College of Emergency Physicians (ACEP) Guideline, Scandinavian, and Canadian computed tomography (CT) head rule) were selected. Subjects were underwent a non-contrast axial spiral head CT scan. The outcome was defined as abnormal and normal head CT scan. Univariate analysis and stepwise linear regression were applied to show the best combination of risk factors for detecting CT scan abnormalities. Five hundred patients with minor head trauma were underwent brain CT scan. The following criteria were derived by stepwise linear regression: Glasgow Coma Scale (GCS) less than 15, confusion, signs of basal skull fracture, drug history of warfarin, vomiting more than once, loss of consciousness, focal neurologic deficit, and age over 65 years. This model has 86.15 % (75.33-93.45 %) sensitivity and 46.44 % (46.67-51.25 %) specificity in detecting minor head injury patients with CT scan abnormalities (95 % confidence interval). Of seven decision rules, only the Canadian CT Head Rule possesses seven of the eight high-risk factors associated with abnormal head CT results which were identified by this study. This study underlines the Canadian CT Head Rule's utility in Iranian minor head injury patients. Our study encourages researchers to evaluate available guidelines in different communities.	[Sadegh, Robab] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Emergency Med, Tehran, Iran; [Karimialavijeh, Ehsan; Shirani, Farzaneh] Univ Tehran Med Sci, Shariati Hosp, Dept Emergency Med, POB 14117-13137, Tehran, Iran; [Payandemehr, Pooya] Univ Tehran Med Sci, Sina Hosp, Dept Emergency Med, Tehran, Iran; [Bahramimotlagh, Hooman] Univ Tehran Med Sci, Sina Hosp, Dept Radiol, Tehran, Iran; [Ramezani, Mahtab] Shahidbeheshti Univ Med Sci, Tehran, Iran		Karimialavijeh, E (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Dept Emergency Med, POB 14117-13137, Tehran, Iran.	e-karimi@sina.tums.ac.ir	Payandemehr, Pooya/J-9588-2017; Karimialavijeh, Ehsan/J-6839-2017; Karimialavijeh, Ehsan/R-7019-2016; Sadegh, Robab/T-5731-2018	Payandemehr, Pooya/0000-0003-3556-4052; Karimialavijeh, Ehsan/0000-0003-0814-9048; Karimialavijeh, Ehsan/0000-0003-0814-9048; Bahrami-Motlagh, Hooman/0000-0002-0593-8511; Sadegh, Robab/0000-0002-2163-8834; Ramezani, Mahtab/0000-0002-1148-3998			[Anonymous], 1996, J Neurosurg Sci, V40, P11; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Borczuk Pierre, 1997, Emergency Medicine Clinics of North America, V15, P563, DOI 10.1016/S0733-8627(05)70318-7; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Clement CM, 2006, ANN EMERG MED, V48, P245, DOI 10.1016/j.annemergmed.2006.04.008; Culotta VP, 1996, NEUROSURGERY, V38, P245, DOI 10.1097/00006123-199602000-00002; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P410, DOI 10.1136/jnnp.2003.016113; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Gomez PA, 1996, BRIT J NEUROSURG, V10, P453, DOI 10.1080/02688699647078; Gupta R, 2005, EMERG RADIOL, V11, P328, DOI 10.1007/s10140-005-0419-y; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Khaji A, 2006, NEUROSCIENCES, V11, P248; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Morton MJ, 2012, ANN EMERG MED, V60, P361, DOI 10.1016/j.annemergmed.2011.12.026; Mower WR, 2002, ANN EMERG MED, V40, P505, DOI 10.1067/mem.2002.129245; Murshid WR, 1998, ACTA NEUROCHIR, V140, P56, DOI 10.1007/s007010050058; Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Sacco F, 2003, ALASKA MED, V46, P58; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Smits M, 2007, RADIOLOGY, V245, P831, DOI 10.1148/radiol.2452061509; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, ANN EMERG MED, V38, P160, DOI 10.1067/mem.2001.116796; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Wu SR, 2006, EMERG RADIOL, V13, P61, DOI 10.1007/s10140-006-0514-8; Yates D., 2007, HEAD INJURY TRIAGE A	32	5	5	0	3	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	FEB	2016	23	1					9	16		10.1007/s10140-015-1349-y			8	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	DR1BG	WOS:000379640400003	26407978				2022-02-06	
J	Volman, V; Ng, LJ				Volman, Vladislav; Ng, Laurel J.			Perinodal glial swelling mitigates axonal degradation in a model of axonal injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						axonal injury; traumatic brain injury; glia cell response to injury; models of injury; degeneration	TRAUMATIC BRAIN-INJURY; DEMYELINATING NEUROPATHIES; EXCITABILITY PROPERTIES; MYELINATED NERVE; COMPUTED DEPENDENCE; FUNCTIONAL-CHANGES; ACTION-POTENTIALS; HUMAN MOTOR; FIBERS; CONDUCTION	Mild traumatic brain injury (mTBI) has been associated with the damage to myelinated axons in white matter tracts. Animal models and in vitro studies suggest that axonal degradation develops during a latent period following a traumatic event. This delay has been attributed to slowly developing axonal membrane depolarization that is initiated by injury-induced ionic imbalance and in turn, leads to the activation of Ca2+ proteases via pathological accumulation of Ca2+. However, the mechanisms mitigating the transition to axonal degradation after injury remain elusive. We addressed this question in a detailed biophysical model of axonal injury that incorporated ion exchange and glial swelling mechanisms. We show that glial swelling, which often co-occurs with mTBI, promotes axonal survival by regulating extracellular K+ dynamics, extending the range of injury parameters in which axons exhibit stable membrane potential postinjury. In addition, glial swelling was instrumental in reducing axonal sensitivity to repetitive stretch injury that occurred several minutes following the first one. Results of this study suggest that acute post-traumatic swelling of perinodal astrocytes helps prevent or postpone axonal degradation by maintaining physiologically relevant levels of extracellular K+	[Volman, Vladislav; Ng, Laurel J.] L3 Appl Technol Inc, Simulat Engn & Testing, 10180 Barnes Canyon Rd,Suite 100, San Diego, CA 92121 USA		Volman, V (corresponding author), L3 Appl Technol Inc, Simulat Engn & Testing, 10180 Barnes Canyon Rd,Suite 100, San Diego, CA 92121 USA.	Vladislav.Volman@1-3com.com			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-D-0011]	Support for this study was sponsored by the U.S. Army Medical Research and Materiel Command under contract W81XWH-11-D-0011.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Barreto E, 2011, J BIOL PHYS, V37, P361, DOI 10.1007/s10867-010-9212-6; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Boucher PA, 2012, J COMPUT NEUROSCI, V33, P301, DOI 10.1007/s10827-012-0387-7; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Coggan JS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/065002; Coggan JS, 2010, P NATL ACAD SCI USA, V107, P20602, DOI 10.1073/pnas.1013798107; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; De Pitta M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002293; DIETZEL I, 1982, EXP BRAIN RES, V46, P73; FRANKENHAEUSER B, 1956, J PHYSIOL-LONDON, V131, P341, DOI 10.1113/jphysiol.1956.sp005467; Fujita M, 2012, J NEUROTRAUM, V29, P2172, DOI 10.1089/neu.2012.2357; Garcia-Grajales JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116532; Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Halnes G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003386; Hille B, 2001, ION CHANNELS EXCITAB, V3rd; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Janigro D, 1997, J NEUROSCI, V17, P2813; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Jin BJ, 2013, J GEN PHYSIOL, V141, P119, DOI 10.1085/jgp.201210883; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Lachance M, 2014, J COMPUT NEUROSCI, V37, P523, DOI 10.1007/s10827-014-0521-9; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Li JM, 2007, J BIOMECH, V40, P569, DOI 10.1016/j.jbiomech.2006.02.009; Lopreore CL, 2008, BIOPHYS J, V95, P2624, DOI 10.1529/biophysj.108.132167; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Mierzwa A, 2010, J NEUROSCI, V30, P15962, DOI 10.1523/JNEUROSCI.4047-10.2010; MOORE JW, 1978, BIOPHYS J, V21, P147, DOI 10.1016/S0006-3495(78)85515-5; Morris CE, 2012, PROG BIOPHYS MOL BIO, V110, P245, DOI 10.1016/j.pbiomolbio.2012.07.003; Nadkarni S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000088; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Ostby I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000272; Oyehaug L, 2012, J COMPUT NEUROSCI, V32, P147, DOI 10.1007/s10827-011-0345-9; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; RANSOM BR, 1985, J NEUROSCI, V5, P532; Rickett T, 2011, J MED SYST, V35, P787, DOI 10.1007/s10916-010-9468-1; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; ROBERTSON JD, 1959, Z ZELLFORSCH MIK ANA, V50, P553, DOI 10.1007/BF00336572; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Singh A, 2009, J NEUROTRAUM, V26, P627, DOI 10.1089/neu.2008.0621; Somjen GG, 2008, J COMPUT NEUROSCI, V25, P349, DOI 10.1007/s10827-008-0083-9; Song YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034936; Stephanova DI, 2000, BIOL CYBERN, V83, P161, DOI 10.1007/s004220000151; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P2334, DOI 10.1016/j.clinph.2005.07.013; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P1159, DOI 10.1016/j.clinph.2005.01.005; Stephanova DI, 2005, CLIN NEUROPHYSIOL, V116, P1153, DOI 10.1016/j.clinph.2004.12.011; Stephanova DI, 1997, BIOL CYBERN, V76, P311, DOI 10.1007/s004220050342; Stephanova D, 2008, EUR BIOPHYS J BIOPHY, V37, P183, DOI 10.1007/s00249-007-0215-6; Stirling DP, 2010, TRENDS MOL MED, V16, P160, DOI 10.1016/j.molmed.2010.02.002; Stys PK, 2005, J NEUROL SCI, V233, P3, DOI 10.1016/j.jns.2005.03.031; Sun WJ, 2012, J NEUROTRAUM, V29, P611, DOI 10.1089/neu.2011.2086; SWADLOW HA, 1980, ARCH NEUROL-CHICAGO, V37, P114, DOI 10.1001/archneur.1980.00500510072016; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Ullah G, 2009, J COMPUT NEUROSCI, V26, P171, DOI 10.1007/s10827-008-0130-6; Volman V, 2012, FRONT COMPUT NEUROSC, V6, P1; Volman V, 2014, J COMPUT NEUROSCI, V37, P439, DOI 10.1007/s10827-014-0515-7; Volman V, 2013, NEURAL COMPUT, V25, P2646, DOI 10.1162/NECO_a_00491; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; WAXMAN SG, 1986, TRENDS NEUROSCI, V9, P250, DOI 10.1016/0166-2236(86)90069-X; WAXMAN SG, 1972, NATURE-NEW BIOL, V238, P217, DOI 10.1038/newbio238217a0; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yu N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002664; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	80	5	5	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	FEB 1	2016	115	2					1003	1017		10.1152/jn.00912.2015			15	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	DF2EW	WOS:000371154800035	26683073				2022-02-06	
J	Vrettos, T; Poimenidi, E; Athanasopoulos, P; Balasis, S; Karagiorgos, N; Siklis, T; Gatzounis, G; Fligkou, F				Vrettos, T.; Poimenidi, E.; Athanasopoulos, P.; Balasis, S.; Karagiorgos, N.; Siklis, T.; Gatzounis, G.; Fligkou, F.			The effect of permissive hypotension in combined traumatic brain injury and blunt abdominal trauma: an experimental study in swines	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Traumatic brain injury; Permissive hypotension; Hemorrhagic shock; Swine	LARGE ANIMAL-MODEL; HEMORRHAGIC-SHOCK; FLUID-PERCUSSION; BLOOD-PRESSURE; RESUSCITATION; VOLUME; TOLERANCE; PROPOFOL; TIME; PIGS	OBJECTIVE: Optimal hemodynamic resuscitation strategy of the trauma patient with uncontrolled hemorrhage and severe head injury in the pre-hospital setting remains a special challenge. Permissive hypotension prior to definite surgical haemostasis promotes coagulation, decreases blood loss and favors survival. However, hypotension is associated with poor outcome in severe head injury. The purpose of this experimental animal study was to assess the impact of permissive hypotension on survival, hemodynamic profile and brain oxygenation parameters before and/or after definite surgical haemostasis. PATIENTS AND METHODS: Six-week-old pigs (n=12) underwent general anesthesia and brain injury was produced by the fluid percussion model. Animals were instrumented to measure hemodynamic parameters and cerebral blood flow. All animals (n=12) were subjected to laparotomy and a surgical knot was placed through the abdominal aorta wall. Uncontrolled hemorrhage was simulated by pulling out the intentionally left protruding free ends of the suture (goal MAP=30 mmHg). Animals were randomly divided into two groups; group A (n=6) was subjected to aggressive fluid resuscitation (goal SAP >80 mmHg) and group B (n=6) was left hypotensive (permissive hypotension). Animals who survived one hour of hypotensive shock underwent definite surgical haemostasis and were resuscitated for one hour. We measured survival, hemodynamic and brain oxygenation parameters at different time points before and after surgical haemostasis. RESULTS: All animals from Group A and 50% from Group B died before surgical haemostasis. In surviving animals (Group B, 50%, p=0.033), MAP, CO, rCBF, SjO(2) and AVDO(2) were restored to pre-procedural levels. CONCLUSIONS: Permissive hypotension by delaying fluid resuscitation up to definite surgical haemostasis improves survival, hemodynamics and allows restoration of cerebral oxygenation in severe head injury.	[Vrettos, T.; Poimenidi, E.; Siklis, T.; Fligkou, F.] Univ Hosp Patras, Dept Anesthesiol & Crit Care Med, Patras, Greece; [Balasis, S.] Univ Hosp Patras, Dept Orthopaed, Patras, Greece; [Athanasopoulos, P.] St Andrew Gen Hosp Patras, Dept Gen Surg, Patras, Greece; [Karagiorgos, N.; Gatzounis, G.] Univ Patras, Sch Med, Dept Neurosurg, GR-26110 Patras, Greece		Vrettos, T (corresponding author), Univ Hosp Patras, Dept Anesthesiol & Crit Care Med, Patras, Greece.	teovret@gmail.com		Gatzounis, Georgios/0000-0002-4022-6691			Adembri C, 2007, CNS DRUG REV, V13, P333, DOI 10.1111/j.1527-3458.2007.00015.x; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Boulanger L, 2007, AM SURGEON, V73, P1269; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carrillo P, 1998, J TRAUMA, V45, P239, DOI 10.1097/00005373-199808000-00007; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DRONEN SC, 1993, AM J EMERG MED, V11, P331, DOI 10.1016/0735-6757(93)90162-5; Hildebrand F, 2013, SHOCK, V40, P247, DOI 10.1097/SHK.0b013e3182a3cd74; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Kaafarani HMA, 2014, SCAND J SURG, V103, P81, DOI 10.1177/1457496914524388; Klein KU, 2011, BRIT J ANAESTH, V107, P735, DOI 10.1093/bja/aer227; Laven BA, 2004, J UROLOGY, V172, P2471, DOI 10.1097/01.ju.0000138158.16968.8d; Li T, 2011, ANESTHESIOLOGY, V114, P111, DOI 10.1097/ALN.0b013e3181fe3fe7; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Sillesen M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0046-2; Stafford PW, 1998, J TRAUMA, V45, P248; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; Stern SA, 2000, J NEUROSURG, V93, P305, DOI 10.3171/jns.2000.93.2.0305	22	5	5	0	4	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	FEB	2016	20	4					620	630					11	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DI2SP	WOS:000373349200007	26957262				2022-02-06	
J	Yoo, SD; Kim, DH; Lee, SA; Joo, HI; Yeo, JA; Chung, SJ				Yoo, Seung Don; Kim, Dong Hwan; Lee, Seung Ah; Joo, Hye In; Yeo, Jin Ah; Chung, Sung Joon			Bilateral Cranial IX and X Nerve Palsies After Mild Traumatic Brain Injury	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Basilar skull fracture; Cranial nerve diseases	OCCIPITAL CONDYLE FRACTURES; GLOSSOPHARYNGEAL; PARALYSIS; ANATOMY; SKULL; HEAD	We report a 57-year-old man with bilateral cranial nerve IX and X palsies who presented with severe dysphagia. After a mild head injury, the patient complained of difficult swallowing. Physical examination revealed normal tongue motion and no uvular deviation. Cervical X-ray findings were negative, but a brain computed tomography revealed a skull fracture involving bilateral jugular foramen. Laryngoscopy indicated bilateral vocal cord palsy. In a videofluoroscopic swallowing study, food residue remained in the vallecula and pyriform sinus, and there was reduced motion of the pharynx and larynx. Electromyography confirmed bilateral superior and recurrent laryngeal neuropathy.	[Yoo, Seung Don; Kim, Dong Hwan; Lee, Seung Ah; Joo, Hye In; Yeo, Jin Ah; Chung, Sung Joon] Kyung Hee Univ, Dept Rehabil Med, 892 Dongnam Ro, Seoul 05278, South Korea		Chung, SJ (corresponding author), Kyung Hee Univ, Dept Rehabil Med, 892 Dongnam Ro, Seoul 05278, South Korea.	sungjoon.chung@gmail.com	Yoo, Seung Don/AAI-8609-2020	Yoo, Seung Don/0000-0003-4513-2560; gim, donghwan/0000-0002-3812-5509			Bozkurt G, 2010, CHILD NERV SYST, V26, P719, DOI 10.1007/s00381-009-1070-9; Brown H, 2002, EXP BIOL MED, V227, P570, DOI 10.1177/153537020222700804; Capuano C, 2004, ACTA NEUROCHIR, V146, P779, DOI 10.1007/s00701-004-0289-1; Coello AF, 2010, J NEUROSURG, V113, P547, DOI 10.3171/2010.6.JNS091620; Legros B, 2000, J TRAUMA, V48, P342, DOI 10.1097/00005373-200002000-00031; Lehn AC, 2012, NEUROLOGIST, V18, P152, DOI 10.1097/NRL.0b013e318247bb6f; SHARMA BS, 1994, CLIN NEUROL NEUROSUR, V96, P197, DOI 10.1016/0303-8467(94)90063-9; Tuli S, 1997, NEUROSURGERY, V41, P368, DOI 10.1097/00006123-199708000-00006; Urculo E, 1996, J NEUROSURG, V84, P522, DOI 10.3171/jns.1996.84.3.0522; Wen HT, 1997, J NEUROSURG, V87, P555, DOI 10.3171/jns.1997.87.4.0555	10	5	5	0	3	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	FEB	2016	40	1					168	171		10.5535/arm.2016.40.1.168			4	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	FG9UH	WOS:000410784800022	26949684	gold, Green Published			2022-02-06	
J	Bakker, K; Catroppa, C; Anderson, V				Bakker, Kathleen; Catroppa, Cathy; Anderson, Vicki			Anosmia and olfactory outcomes following paediatric traumatic brain injury	BRAIN INJURY			English	Article						olfactory dysfunction; Traumatic brain injury; anosmia; child; smell	DYSFUNCTION; IMPAIRMENT; RECOGNITION; PERFORMANCE; CHILDHOOD; CHILDREN; AGE	Objective: Research into olfactory dysfunction (OD) following paediatric traumatic brain injury (TBI) is limited. The current study investigated the frequency of OD following paediatric TBI and the relationship between OD and injury characteristics including severity, site of impact and cause of injury. It was hypothesized that children with moderate/severe TBI would demonstrate greater OD than those with mild TBI. Design/method: Thirty-seven children aged 8-16 with TBI were recruited to a prospective longitudinal study at a metropolitan children's hospital. Olfactory assessment, using the University of Pennsylvania Smell Identification Test, was completed at 0-3 months post-injury. Results: Nineteen per cent of participants demonstrated impaired olfaction, while a small number (5%) were anosmic. A significant relationship between OD and severity of injury was found. No other injury variables demonstrated a significant relationship with olfactory outcomes. Conclusions: OD was relatively common in this paediatric TBI cohort and the hypothesized relationship with severity of injury was supported. It is recommended that information about OD after TBI be routinely provided to children and families. Further research is needed in larger cohorts to support the implementation of routine clinical assessment, understand the relationship between OD and other injury characteristics, determine the functional implications of OD and document recovery trajectories.	[Bakker, Kathleen] Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Melbourne, Vic, Australia; [Bakker, Kathleen; Catroppa, Cathy; Anderson, Vicki] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bakker, Kathleen; Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Catroppa, Cathy; Anderson, Vicki] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia; [Catroppa, Cathy; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic 3010, Australia		Bakker, K (corresponding author), Royal Childrens Hosp, Victorian Paediat Rehabil Serv, Flemington Rd, Parkville, Vic 3052, Australia.	kath.bakker@rch.org.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436	Victorian Neurotrauma Initiative, Murdoch Childrens Research Institute; Victorian Government Operational Infrastructure Scheme; University of Melbourne, AustraliaUniversity of Melbourne	The authors report no conflicts of interest. The project received funding from the Victorian Neurotrauma Initiative, Murdoch Childrens Research Institute, the Victorian Government Operational Infrastructure Scheme and The University of Melbourne, Australia.	Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Bakker K, 2014, J NEUROTRAUM, V31, P308, DOI 10.1089/neu.2013.3045; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Cameron EL, 2013, INT J PEDIATR OTORHI, V77, P346, DOI 10.1016/j.ijporl.2012.11.022; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Dalton P, 2011, LARYNGOSCOPE, V121, P1843, DOI 10.1002/lary.21928; Dalton P, 2009, ANN NY ACAD SCI, V1170, P537, DOI 10.1111/j.1749-6632.2009.03919.x; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; Doty RL, 2006, OLFACTION AND THE BRAIN, P235, DOI 10.1017/CBO9780511543623.015; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Doty RL, 1995, SMELL IDENTIFICATION, Vthird; Drummond M., 2007, BRAIN IMPAIR, V8, P31; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Harris R, 2006, AM J RHINOL, V20, P101, DOI 10.1177/194589240602000119; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Jackson JH, 1864, LOND HOSP REP, V1, P470; JACOBI G, 1986, Acta Paediatrica Hungarica, V27, P173; Karsz FR, 2008, J CLIN PSYCHIAT, V69, P1462, DOI 10.4088/JCP.v69n0914; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Mackay-Sim A, 2001, AUSTR J OTOLARYNGOLO, V4, P174; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Pink B, 2011, SOCIOECONOMIC INDEXE; Renzi G, 2002, ANN PLAS SURG, V48, P355, DOI 10.1097/00000637-200204000-00003; Roberts G, 2008, J PAEDIATR CHILD H, V44, P276, DOI 10.1111/j.1440-1754.2007.01251.x; Roberts M A, 1996, Appl Neuropsychol, V3, P86, DOI 10.1207/s15324826an0302_7; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schecklmann M, 2013, J NEURAL TRANSM, V120, P121, DOI 10.1007/s00702-012-0855-2; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; TEASDALE G, 1974, LANCET, V2, P81; Volker MA, 2006, PSYCHOL SCHOOLS, V43, P653, DOI 10.1002/pits.20176; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZASLER ND, 1992, J HEAD TRAUMA REHAB, V7, P66	43	5	5	0	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2016	30	2					191	198		10.3109/02699052.2015.1089597			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DF3MM	WOS:000371248400010	26618224				2022-02-06	
J	Nance, ML; Callahan, JM; Tharakan, SJ; Malamet, P; Houseknecht, EM; Mahoney, KR; Wiebe, DJ				Nance, Michael L.; Callahan, James M.; Tharakan, Sasha J.; Malamet, Peter; Houseknecht, Eileen M.; Mahoney, Kaitilin R.; Wiebe, Douglas J.			Utility of neurocognitive testing of mild traumatic brain injury in children treated and released from the emergency department	BRAIN INJURY			English	Article						Concussion; paediatric; neurocognitive testing	POSTCONCUSSION SYNDROME; CONCUSSION; IMPACT; SENSITIVITY; ADOLESCENTS; RECOVERY; SYMPTOMS	Primary objective: To assess feasibility and utility of neurocognitive testing of children evaluated and discharged from the ED with mild traumatic brain injury (MTBI). Methods: Paediatric blunt trauma patients (aged 11-18 years) evaluated in the ED for MTBI and control patients with isolated lower extremity injury were prospectively enrolled. All patients were administered a validated neurocognitive test (ImPACT((c))). Wilcoxon sign rank tests were used to compare reported symptoms and neurocognitive performance between subjects and controls, as well as to matched normative data. Results: Thirty-nine subjects and 46 controls were enrolled. The MTBI patients had a mean age of 13.9 years (53.8% male). An abnormal symptom score was reported in 89.7% of MTBI subjects (mean score = 29.4, normal <= 8), differing significantly (p < 0.05) from controls, in whom 39.1% demonstrated an abnormal score (mean score = 8.7). In all neurocognitive test domains, visual motor speed and reaction time, MTBI patients demonstrated lower scores than normative data (p < 0.05). Conclusions: Patients with MTBI were more likely than control subjects to have scores on any or all neurocognitive domains below the 25th percentile and 10th percentile. In the ED setting, acute neurocognitive testing of MTBI in children is feasible. This highlights the importance of structured follow-up for this treated and released population.	[Nance, Michael L.; Tharakan, Sasha J.; Malamet, Peter; Houseknecht, Eileen M.; Mahoney, Kaitilin R.] Univ Penn, Dept Surg, Ruth & Raymond Perelman Sch Med, Philadelphia, PA 19104 USA; [Callahan, James M.] Univ Penn, Dept Pediat, Div Emergency Med, Ruth & Raymond Perelman Sch Med, Philadelphia, PA 19104 USA; [Wiebe, Douglas J.] Univ Penn, Ruth & Raymond Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Wiebe, Douglas J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA		Nance, ML (corresponding author), Childrens Hosp Philadelphia, Dept Surg, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	nance@email.chop.edu	Wiebe, Douglas J/Q-1168-2017		National Science Foundation (NSF) Center for Child Injury Prevention Studies (CChIPS) at the Children's Hospital of Philadelphia (CHOP)National Science Foundation (NSF)	The authors would like to acknowledge the National Science Foundation (NSF) Center for Child Injury Prevention Studies (CChIPS) at the Children's Hospital of Philadelphia (CHOP) for sponsoring this study and its Industry Advisory Board (IAB) members for their support, valuable input and advice. The views presented are those of the authors and not necessarily the views of CChIPS, CHOP, the NSF or the IAB members.	Babcock L, 2013, PEDIATR EMERG CARE, V29, P458, DOI 10.1097/PEC.0b013e31828a202d; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nance ML, 2009, ANN SURG, V249, P859, DOI 10.1097/SLA.0b013e3181a41ae5; Peterson SE, 2009, ANN EMERG MED, V53, P796, DOI 10.1016/j.annemergmed.2008.10.015; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sosin DM, 1996, BRAIN INJURY, V10, P47; Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Thomas DG, 2011, ACAD EMERG MED, V18, P246, DOI 10.1111/j.1553-2712.2011.01015.x; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	22	5	5	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2016	30	2					184	190		10.3109/02699052.2015.1075591			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DF3MM	WOS:000371248400009	26714064				2022-02-06	
J	Alnemari, AM; Mansour, TR; Buehler, M; Gaudin, D				Alnemari, Ahmed M.; Mansour, Tarek R.; Buehler, Mark; Gaudin, Daniel			Neural basis of pedophilia: Altered sexual preference following traumatic brain injury	INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS			English	Article						Brain injury; Hypersexuality; Pedophilia	HYPERSEXUALITY; BEHAVIOR		[Alnemari, Ahmed M.; Mansour, Tarek R.; Gaudin, Daniel] Univ Toledo, Med Ctr, Dept Surg, Div Neurosurg, 3000 Arlington Ave, Toledo, OH 43614 USA; [Buehler, Mark] Univ Toledo, Med Ctr, Dept Radiol, 3000 Arlington Ave, Toledo, OH 43614 USA		Gaudin, D (corresponding author), Univ Toledo, Med Ctr, 3000 Arlington Ave,MS 1088, Toledo, OH 43614 USA.	Ahmed.Alnemari@rockets.utoledo.edu; Tarek.Mansour2@rockets.utoledo.edu; mark.buehler@utoledo.edu; daniel.gaudin@utoledo.edu		Mansour, Tarek R./0000-0003-0758-3387			BERLIN FS, 1981, JOHNS HOPKINS MED J, V149, P119; BLUMER D, 1970, AM J PSYCHIAT, V126, P1099; Blumer D., 1975, PSYCHIAT ASPECTS NEU, P151; Boller F., 1982, J NEUROL NEUROSUR PS, V45, P663; CLARK JT, 1984, SCIENCE, V225, P847, DOI 10.1126/science.6474156; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; LILLY R, 1983, NEUROLOGY, V33, P1141, DOI 10.1212/WNL.33.9.1141; Limbert J., 1992, CAN J HUM SEX, V1, P187; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Mutarelli EG, 2006, ARQ NEURO-PSIQUIAT, V64, P146, DOI 10.1590/S0004-282X2006000100032; NAUTA W J H, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P125; PARDRIDGE WM, 1982, ANN INTERN MED, V96, P488, DOI 10.7326/0003-4819-96-4-488; POECK K, 1965, ACTA NEUROL SCAND, V41, P233, DOI 10.1111/j.1600-0404.1965.tb04295.x; REGESTEIN QR, 1978, J NERV MENT DIS, V166, P794, DOI 10.1097/00005053-197811000-00007; SABHESAN S, 1989, ARCH SEX BEHAV, V18, P349, DOI 10.1007/BF01541953; SHRABERG D, 1978, J NERV MENT DIS, V166, P130, DOI 10.1097/00005053-197802000-00008; Terzian H., 2016, NEUROLOGY, P1955	17	5	5	6	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2210-2612			INT J SURG CASE REP	Int. J. Surg. Case Rep.		2016	25						221	224		10.1016/j.ijscr.2016.06.035			4	Surgery	Emerging Sources Citation Index (ESCI)	Surgery	DX3MY	WOS:000384278400056	27394398	Green Published, gold			2022-02-06	
J	Antonopoulos, CN; Kadoglou, NPE				Antonopoulos, Constantine N.; Kadoglou, Nikolaos P. E.			Biomarkers in Silent Traumatic Brain Injury	CURRENT PHARMACEUTICAL DESIGN			English	Article						Traumatic brain injury; biomarkers; diffusion tensor imaging; neurofilaments; cleaved-tau; microtubule-associated protein 2; neuron-specific enolase; S100B	NEURON-SPECIFIC ENOLASE; AMYLOID PRECURSOR PROTEIN; MICROTUBULE-ASSOCIATED PROTEIN-2; MILD HEAD-INJURY; SERUM-LEVELS; CEREBROSPINAL-FLUID; AXONAL DAMAGE; CLEAVED-TAU; CT FINDINGS; S100B	Traumatic brain injury (TBI) has been recognized among the leading causes of mortality and morbidity in young adults. Traditionally, the diagnosis of TBI has been based on neuroimaging. However, a significant portion of insulted patients appear to be apparently asymptomatic. As a result, more elaborate indices of silent TBI are required in order to immediately detect focal and diffuse asymptomatic TBI. Such valid indices will potentially increase the efficacy of therapeutic strategies in TBI patients. In this review of the literature, we present novel circulating biomolecules, as potential biomarkers of silent TBI, like neurofilaments, Cleaved-Tau (C-Tau), Microtubule-Associated Protein 2 (MAP2), Neuron-Specific Enolase, S100B and ferritin. In addition to this, assessment of white matter abnormalities and white matter integrity by diffusion tensor imaging (DTI) have emerged as promising sensitive neuroimaging methods of silent TBI. An integrated research is needed to fully understand the interplay between all the aforementioned indices and DTI. The potential diagnostic, therapeutic and prognostic values of the all aforementioned indices will be analyzed in the proposed review.	[Antonopoulos, Constantine N.] Univ Athens, Dept Vasc Surg, GR-10679 Athens, Greece; [Kadoglou, Nikolaos P. E.] UCL, Heart Hosp, London WC1E 6BT, England		Kadoglou, NPE (corresponding author), UCL, Inst Cardiovasc Sci, Paul OGorman Bldg, London WC1E 6BT, England.	nikoskad@yahoo.com	Kadoglou, Nikolaos/AAA-8639-2021	Antonopoulos, Constantine N./0000-0003-0696-695X; Kadoglou, Nikolaos/0000-0002-7830-3488	Hellenic Cardiological Society	Dr. Nikolaos Kadoglou was granted by the Hellenic Cardiological Society.	Aghaei I, 2014, IRAN J BASIC MED SCI, V17, P729; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Buonora JE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00068; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Chabok SY, 2012, J TRAUMA ACUTE CARE, V72, P1654, DOI 10.1097/TA.0b013e318246887e; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Kontos HA, 2001, STROKE, V32, P2712, DOI 10.1161/hs1101.098653; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Levis J., 2009, CLIN EMERGENCY MED C; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Ma M, 2008, AM J EMERG MED, V26, P763, DOI 10.1016/j.ajem.2007.10.029; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mercier E, 2013, BMJ-BRIT MED J, V346, P1757; Mondello S, 2012, BRAIN INJURY, V26, P1629, DOI 10.3109/02699052.2012.700083; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Park D, 2012, J NEUROSCI RES, V90, P461, DOI 10.1002/jnr.22769; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Simon D, 2015, BRAIN INJURY, V29, P612, DOI 10.3109/02699052.2014.995228; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Veeramuthu V, 2015, J NEUROTRAUMA; Wolf H, 2015, J NEUROTRAUM, V32, P23, DOI 10.1089/neu.2013.3202; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2015, MOL CELL NE IN PRESS; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	59	5	5	0	10	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	6					680	687		10.2174/1381612822666151204000458			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DG4VN	WOS:000372071300004	26635272				2022-02-06	
J	Armistead-Jehle, P; Grills, CE; Bieu, RK; Kulas, JF				Armistead-Jehle, Patrick; Grills, Chad E.; Bieu, Rachel K.; Kulas, Joseph F.			Clinical utility of the memory complaints inventory to detect invalid test performance	CLINICAL NEUROPSYCHOLOGIST			English	Article						Memory Complaints Inventory; symptom validity test; performance validity test	SYMPTOM VALIDITY TEST; SCALES; FIBROMYALGIA; DEPRESSION; IMPAIRMENT; SCORES; RBS	Objective: This investigation was designed to examine the classification statistics of Memory Complaints Inventory (MCI) scores relative to the Medical Symptom Validity Test (MSVT) and the Non-Verbal Medical Symptom Validity Test (NV-MSVT), as well as various validity scales on the Personality Assessment Inventory (PAI) and Minnesota Multiphasic Personality Inventory-2 Restructured Form(MMPI-2-RF). Method: The sample consisted of 339 active duty service members with a history of concussion who completed performance validity tests (PVTs), symptom validity tests (SVTs), and the MCI. Results: Those who failed the MSVT and NV-MSVT had significantly higher scores across all MCI scales. In addition, those who scored above specified cut scores on the evaluated PAI and MMPI-2-RF validity scales also had significantly higher MCI scale scores. Receiver operator characteristics analysis demonstrated acceptable area under the curve (AUC) across the evaluated SVTs for the mean of all MCI subtests with values ranging from (.77 to .86), with comparable findings for PVTs (MSVT AUC=.75; NV-MSVT AUC=.72). Conclusions: In general the MCI scales demonstrated better classification statistics relative to SVTs vs. PVTs, which is consistent with the nature of the MCI as a self-report instrument.	[Armistead-Jehle, Patrick] Munson Army Hlth Ctr, Concuss Clin, Dept Behav Hlth, Ft Leavenworth, KS USA; [Grills, Chad E.] US Army Hlth Clin, Brain Injury Clin, Schofield Barracks, HI USA; [Bieu, Rachel K.; Kulas, Joseph F.] Vet Affairs Connecticut Healthcare Syst, Dept Psychol, West Haven, CT USA; [Kulas, Joseph F.] Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA		Armistead-Jehle, P (corresponding author), Munson Army Hlth Ctr, Concuss Clin, Dept Behav Hlth, Ft Leavenworth, KS USA.	patrick.j.armistead-jehle.civ@mail.mil	Armistead-Jehle, Patrick/AAU-5741-2020	Armistead-Jehle, Patrick/0000-0002-6784-1432			Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P725, DOI 10.1093/arclin/acs071; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P101, DOI 10.1093/arclin/acr081; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Carone Dominic A, 2009, Appl Neuropsychol, V16, P309, DOI 10.1080/09084280903297883; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Gervais RO, 2010, ARCH CLIN NEUROPSYCH, V25, P274, DOI 10.1093/arclin/acq018; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green P., 2003, GREENS WORD MEMORY T; Green P, 2004, GREENS MED SYMPTOM V; Green P., 2004, MEMORY COMPLAINTS IN; Green P.J.E., 2008, MANUAL NONVERBAL MED; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Henry M., 2009, J CLIN EXPT NEUROPSY, V8, P1; Howe L, 2009, CLIN NEUROPSYCHOL, V23, P329, DOI 10.1080/13854040801945060; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kucharski LT, 2007, J PERS ASSESS, V88, P25, DOI 10.1207/s15327752jpa8801_04; Kurtz JE, 2007, J PERS ASSESS, V88, P1, DOI 10.1080/00223890709336828; Landro NI, 2000, ARCH CLIN NEUROPSYCH, V15, P37, DOI 10.1016/S0887-6177(98)00151-6; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McCracken LM, 2001, J PAIN SYMPTOM MANAG, V21, P392, DOI 10.1016/S0885-3924(01)00267-6; Merten T, 2005, ARCH CLIN NEUROPSYCH, V20, P719, DOI 10.1016/j.acn.2005.04.004; Mol MEM, 2006, INT J GERIATR PSYCH, V21, P432, DOI 10.1002/gps.1487; Morey, 1991, PERSONALITY ASSESSME; Morey L. C., 2003, ESSENTIALS PAI ASSES; Munoz M, 2005, CLIN J PAIN, V21, P287; Pearman A, 2004, J GERONTOL B-PSYCHOL, V59, pP4, DOI 10.1093/geronb/59.1.P4; Pearman A, 2009, J ADULT DEV, V16, P101, DOI 10.1007/s10804-009-9063-1; Pearson, 2001, WECHSL TEST AD READ; Rogers R, 1998, ASSESSMENT, V5, P399, DOI 10.1177/107319119800500409; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Singhal A, 2009, ARCH CLIN NEUROPSYCH, V24, P721, DOI 10.1093/arclin/acp074; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Victor T. L., 2013, MILD TRAUMATIC BRAIN, P231; Wager John G, 2010, Appl Neuropsychol, V17, P305, DOI 10.1080/09084282.2010.525093	42	5	5	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2016	30	4					610	628		10.1080/13854046.2016.1177597			19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO6YO	WOS:000377929600009	27117938				2022-02-06	
J	Arulvelan, A; Manikandan, S; Easwer, HV; Krishnakumar, K				Arulvelan, Appavoo; Manikandan, Sethuraman; Easwer, Hari Venkat; Krishnakumar, Kesavapisharady			Cerebral vascular effects of loading dose of dexmedetomidine: A Transcranial Color Doppler study	INDIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Cerebral vascular resistance; dexmedetomidine; transcranial color Doppler	BLOOD-FLOW; HEALTHY-VOLUNTEERS; PERFUSION-PRESSURE; CARBON-DIOXIDE; AGONIST; AUTOREGULATION; VELOCITY; ANESTHESIA; DOG	Background: Dexmedetomidine has been widely used in critical care settings because of its property of maintaining stable hemodynamics and inducing conscious sedation. The use of dexmedetomidine is in increasing trend particularly in patients with neurological disorders. Very few studies have focused on the cerebral hemodynamic effects of dexmedetomidine. This study is aimed to address this issue. Methods: Thirty patients without any intracranial pathology were included in this study. Middle cerebral artery flow velocity obtained from transcranial color Doppler was used to assess the cerebral hemodynamic indices. Mean flow velocity (mFV), pulsatility index (PI), cerebral vascular resistant index (CVRi), estimated cerebral perfusion pressure (eCPP), and zero flow pressure (ZFP) were calculated bilaterally at baseline and after infusion of injection Dexmedetomidine 1 mcg/Kg over 10 min. Results: Twenty-six patients completed the study protocol. After administration of loading dose of dexmedetomidine, mFV and eCPP values were significantly decreased in both hemispheres (P < 0.05); PI, CVRi, and ZFP values showed significant increase (P < 0.05) after dexmedetomidine infusion. Conclusion: Increase in PI, CVRi, and ZFP suggests that there is a possibility of an increase in distal cerebral vascular resistance (CVR) with loading dose of dexmedetomidine. Decrease in mFV and eCPP along with an increase in CVR may lead to a decrease in cerebral perfusion. This effect can be exaggerated in patients with preexisting neurological illness. Further studies are needed to evaluate the effect of dexmedetomidine on various other pathological conditions involving brain like traumatic brain injury and vascular malformations.	[Arulvelan, Appavoo; Manikandan, Sethuraman; Easwer, Hari Venkat; Krishnakumar, Kesavapisharady] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Anesthesiol, Trivandrum 695011, Kerala, India		Arulvelan, A (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum 695011, Kerala, India.	drarulvelan@gmail.com					Asano Y, 1997, AM J PHYSIOL-HEART C, V272, pH2547, DOI 10.1152/ajpheart.1997.272.6.H2547; Bekker A, 2005, NEUROSURGERY, V57, P1, DOI 10.1227/01.NEU.0000163476.42034.A1; Czosnyka M, 1996, J NEUROSURG, V84, P79, DOI 10.3171/jns.1996.84.1.0079; Dagal A, 2009, CURR OPIN ANESTHESIO, V22, P547, DOI 10.1097/ACO.0b013e32833020be; Endoh H, 2002, ANESTH ANALG, V94, P169, DOI 10.1097/00000539-200201000-00032; FALE A, 1994, ANESTH ANALG, V79, P892; Ganjoo P, 1998, ANESTHESIOLOGY, V88, P429, DOI 10.1097/00000542-199802000-00022; Gerlach AT, 2007, ANN PHARMACOTHER, V41, P245, DOI 10.1345/aph.1H314; Hancock SM, 2003, ANESTH ANALG, V96, P847, DOI 10.1213/01.ANE.0000047273.85729.A7; Ishiyama T, 1998, ANESTH ANALG, V86, P766, DOI 10.1097/00000539-199804000-00017; KONTOS HA, 1989, STROKE, V20, P1; Moppett IK, 2008, BRIT J ANAESTH, V100, P240, DOI 10.1093/bja/aem374; Schlunzen L, 2004, ACTA ANAESTH SCAND, V48, P1268, DOI 10.1111/j.1399-6576.2004.00505.x; SCHREGEL W, 1995, ULTRASCHALL MED, V16, P60, DOI 10.1055/s-2007-1003988; ULRICH K, 1985, STROKE, V16, P880, DOI 10.1161/01.STR.16.5.880; ULRICH PT, 1995, J NEUROL SCI, V129, P120, DOI 10.1016/0022-510X(94)00252-J; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; VANDERLINDEN J, 1991, J THORAC CARDIOV SUR, V102, P95; WAHL M, 1993, ACTA NEUROCHIR, P3; Weyland A, 2000, J NEUROSURG ANESTH, V12, P210, DOI 10.1097/00008506-200007000-00002; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a; ZORNOW MH, 1993, J CEREBR BLOOD F MET, V13, P350, DOI 10.1038/jcbfm.1993.45; ZORNOW MH, 1990, ANESTH ANALG, V70, P624	23	5	5	0	4	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0972-5229	1998-359X		INDIAN J CRIT CARE M	Indian J. Crit. Care Med.	JAN	2016	20	1					9	13		10.4103/0972-5229.173680			5	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DJ1IB	WOS:000373955400003	26955211	Bronze, Green Published			2022-02-06	
J	Bernier, RA; Hillary, FG				Bernier, R. A.; Hillary, F. G.			Trends in alcohol use during moderate and severe traumatic brain injury: 18 years of neurotrauma in Pennsylvania	BRAIN INJURY			English	Article						Adult brain injury; alcohol use; traumatic brain injury	COGNITIVE RESERVE; SUBSTANCE-ABUSE; ETHANOL; CONSUMPTION; MORTALITY; OUTCOMES; INTOXICATION; EXPOSURE; MILD; TIME	Primary objective: Alcohol is a known risk factor for TBI, yet little is known about how rates of alcohol use at time of injury differ across demographics and the stability of alcohol-related injury over time. Further, findings examining the relationship between alcohol and outcome are mixed. This study aimed to examine changes in alcohol-positive moderate-to-severe traumatic brain injury (+aTBI) over two decades with focus on demographic factors, changes in +aTBI frequency over time, mortality and acute outcome. Methods: This retrospective study examined data collected from 1992-2009 by the Pennsylvania Trauma Outcome Study (PTOS). Results: Results reveal that the proportion of +aTBI has been generally stable across years. However, there is an interaction of +aTBI incidence with mechanism of injury and age, with a downward trend in +aTBI within MVA and fall and individuals 18-30 and 71+ years. Further, consistent with several findings in the literature, alcohol was associated with higher rates of survival and better FSD scores during acute recovery. Conclusions: This study discusses findings in the context of a greater literature on TBI-related alcohol and outcome. The injury-alcohol profiles highlighted could be used to inform future allocation of resources toward prevention of, intervention for and care of individuals who sustain TBI.	[Bernier, R. A.; Hillary, F. G.] Penn State Univ, Dept Psychol, 313 Bruce V Moore Bldg, University Pk, PA 16802 USA; [Hillary, F. G.] Penn State Univ, Milton S Hershey Med Ctr, Hershey, PA 17033 USA		Hillary, FG (corresponding author), Penn State Univ, Dept Psychol, 313 Bruce V Moore Bldg, University Pk, PA 16802 USA.	fgh3@psu.edu	Hillary, Frank/AAN-8622-2021	Bernier, Rachel/0000-0002-2759-9186			Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1375, DOI 10.1016/j.jocn.2015.02.030; Chen CM, 2012, J STUD ALCOHOL DRUGS, V73, P531, DOI 10.15288/jsad.2012.73.531; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Faul M, 2010, TRAUMATIC BRAIN INJU; Goodman MD, 2013, J SURG RES, V184, P1053, DOI 10.1016/j.jss.2013.04.058; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Governor's Budget Office, 2015, CURR PROP COMM BUDG; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; He M, 2013, CHIN J TRAUMATOL, V16, P136, DOI 10.3760/cma.j.issn.1008-1275.2013.03.002; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P478, DOI 10.1093/arclin/acu027; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P278, DOI 10.1007/s00508-014-0521-9; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Plurad D, 2010, J EMERG MED, V38, P12, DOI 10.1016/j.jemermed.2007.09.048; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Sosin DM, 1996, BRAIN INJURY, V10, P47; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, P112, DOI 10.1097/01.wad.0000213815.20177.19; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Teng SX, 2015, BRAIN BEHAV IMMUN, V45, P145, DOI 10.1016/j.bbi.2014.11.006; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7	27	5	5	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	4					414	421		10.3109/02699052.2015.1127998			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK1BF	WOS:000374646200006	26910778				2022-02-06	
J	Brassel, S; Kenny, B; Power, E; Elbourn, E; McDonald, S; Tate, R; MacWhinney, B; Turkstra, L; Holland, A; Togher, L				Brassel, Sophie; Kenny, Belinda; Power, Emma; Elbourn, Elise; McDonald, Skye; Tate, Robyn; MacWhinney, Brian; Turkstra, Lyn; Holland, Audrey; Togher, Leanne			Conversational topics discussed by individuals with severe traumatic brain injury and their communication partners during sub-acute recovery	BRAIN INJURY			English	Article						Traumatic brain injury; communication; conversation topics; content analysis; qualitative; recovery	QUALITATIVE CONTENT-ANALYSIS; CLOSED-HEAD INJURY; DISCOURSE; PEOPLE; REHABILITATION; GENDER; IMPACT; ADULTS; TRIAL	Primary objective: To investigate the nature and patterns of conversational topics discussed by individuals with severe TBI and familiar communication partners at 3 and 6 months post-injury, and to examine changes occurring in conversational topics during sub-acute recovery.Research design: Qualitative content analysis was used to explore the nature of topics and generate conversational themes. Topic analysis provided an understanding of conversational topic management by identifying patterns of topic initiation and maintenance.Methods: Twenty-two people with severe TBI and a familiar communication partner engaged in a 10-minute casual conversation on self-selected topics at 3 and 6 months post-injury.Main outcomes and results: Three main conversational themes were identified: connecting; re-engaging; and impacts of injury. The nature of topics related to these themes changed over time to reflect participants' sub-acute rehabilitation experiences. Most conversational dyads maintained similar conversational and topic patterns during sub-acute recovery.Conclusions: Qualitative analysis provides a new insight into the conversational topics of individuals with severe TBI. Many participants engaged in appropriate conversations and discussed mutually important topics with familiar communication partners. Findings may inform speech-language pathology intervention in sub-acute recovery to improve conversational discourse abilities of individuals with severe TBI and support their communication partners.	[Brassel, Sophie; Kenny, Belinda; Power, Emma; Elbourn, Elise; Togher, Leanne] Univ Sydney, Discipline Speech Pathol, Fac Hlth Sci, Lidcombe, NSW 2141, Australia; [Brassel, Sophie; Kenny, Belinda; Power, Emma; Elbourn, Elise; McDonald, Skye; Tate, Robyn; Togher, Leanne] NHMRC Ctr Res Excellence Brain Recovery, Sydney, NSW, Australia; [McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Tate, Robyn] Univ Sydney, Fac Med, Sydney, NSW, Australia; [MacWhinney, Brian] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Turkstra, Lyn] Univ Wisconsin, Dept Communicat Disorders, Madison, WI USA; [Holland, Audrey] Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ USA		Brassel, S (corresponding author), Univ Sydney, Discipline Speech Pathol, Fac Hlth Sci, Lidcombe, NSW 2141, Australia.	sophie.brassel@sydney.edu.au	Turkstra, Lyn/ABC-5831-2021; Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015	Togher, Leanne/0000-0002-4518-6748; Power, Emma/0000-0002-2638-0406; Brassel, Sophie/0000-0002-4270-2559; Turkstra, Lyn/0000-0002-6948-6921	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia	The authors alone are responsible for the writing of this paper. The data collected will form part of a longitudinal project investigating communication recovery following TBI that is funded by the National Health and Medical Research Council (NHMRC). The relationship between the research team and funding provider constitutes no conflicts of interest.	AphasiaBank, CHAT TRANSCR TRAIN M; ARIES EJ, 1983, SEX ROLES, V9, P1183, DOI 10.1007/BF00303101; Australian Bureau of Statistics, 2013, ANZSCO AUSTR NZ STAN; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Body R, 2005, CLIN LINGUIST PHONET, V19, P379, DOI 10.1080/02699200400027189; Boles L, 1998, APHASIOLOGY, V12, P547, DOI 10.1080/02687039808249557; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; BRINTON B, 1984, J SPEECH HEAR RES, V27, P350, DOI 10.1044/jshr.2703.350; Carcary Marian, 2009, Electronic Journal of Business Research Methods, V7, P11; Chamberlain DJ, 2006, J ADV NURS, V54, P407, DOI 10.1111/j.1365-2648.2006.03840.x; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho C.A., 1993, CLIN APHASIOLOGY, V21, P183; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Denzin N.K., 2000, HDB QUALITATIVE RES; Dombovy ML, 1997, BRAIN INJURY, V11, P305, DOI 10.1080/026990597123467; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Eggins S., 1997, ANAL CASUAL CONVERSA; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Enderby P., 2008, FRENCHAY DYSARTHRIA; Friedland D, 1998, BRAIN INJURY, V12, P1, DOI 10.1080/026990598122818; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Gentleman D, 2001, TRAUMA, V3, P193; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; HAAS A, 1982, PSYCHOL REP, V51, P453, DOI 10.2466/pr0.1982.51.2.453; Helps Y, 2008, INJURY RES STAT SERI, V45; Kersel DA, 2001, BRAIN INJURY, V15, P283, DOI 10.1080/02699050010005887; Kertesz A., 2006, W APHASIA BATTERY RE; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; MAXWELL JA, 1992, HARVARD EDUC REV, V62, P279, DOI 10.17763/haer.62.3.8323320856251826; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; Milne J, 2005, J WOUND OSTOMY CONT, V32, P413, DOI 10.1097/00152192-200511000-00014; Mozeiko J, 2010, HDB LANGUAGE SPEECH; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Perkins M. R., 1995, CASE STUDIES CLIN LI; Ponsford J, 2012, INPSYCH, V34; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; SAFFRAN EM, 1989, BRAIN LANG, V37, P440, DOI 10.1016/0093-934X(89)90030-8; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; SANDELOWSKI M, 1993, RES NURS HEALTH, V16, P213, DOI 10.1002/nur.4770160308; Sehulster JR, 2006, AM J PSYCHOL, V119, P407, DOI 10.2307/20445351; Shorland J, 2010, BRAIN INJURY, V24, P569, DOI 10.3109/02699051003610441; Snow P, 1997, APHASIOLOGY, V11, P947, DOI 10.1080/02687039708249421; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L, 1996, DISABIL REHABIL, V18, P559, DOI 10.3109/09638289609166317; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Togher L, 2010, LONGITUDINAL COMMUNI; TOGHER L, 2006, BRAIN IMPAIR, V7, P190, DOI DOI 10.1375/brim.7.3.190; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tu LV, 2011, BRAIN INJURY, V25, P560, DOI 10.3109/02699052.2011.571655; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; VENTOLA E, 1979, J PRAGMATICS, V3, P267, DOI 10.1016/0378-2166(79)90034-1; Weber R.P., 1990, BASIC CONTENT ANAL, V2nd	60	5	5	1	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	11					1329	1342		10.1080/02699052.2016.1187288			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DZ8TP	WOS:000386144900006	27466829				2022-02-06	
J	Cetin, I; Tezdig, I; Tarakcioglu, MC; Kadak, MT; Demirel, OF; Ozer, OF				Cetin, Ihsan; Tezdig, Ihsan; Tarakcioglu, Mahmut Cem; Kadak, Muhammed Tayyib; Demirel, Omer Faruk; Ozer, Omer Faruk			Serum levels of glial fibrillary acidic protein and Nogo-A in children with autism spectrum disorders	BIOMARKERS			English	Article						Autism; ELISA; GFAP; Nogo-A	DORSOLATERAL PREFRONTAL CORTEX; BRAIN-DEVELOPMENT; BIPOLAR DISORDER; GENE-EXPRESSION; TRAUMATIC BRAIN; MESSENGER-RNA; ADULT-RAT; SCHIZOPHRENIA; DEPRESSION; INJURY	Context: Improved biomarkers would facilitate the diagnosis and treatment of autism spectrum disorders (ASD). Objective: Our objective was to examine the levels of Nogo-A and glial fibrillary acidic protein (GFAP) in children with ASD. Materials and methods: Serum concentrations of GFAP and Nogo-A were determined by enzyme-linked immunosorbent assay. Results: In this preliminary study, we found that serum Nogo-A was not found significantly different between groups, while serum levels of GFAP were significantly lower in ASD than controls. Discussion and conclusions: It will be of great interest to determine other potential causes of elevated serum levels of GFAP, and whether this elevation has any phenotypic effect.	[Cetin, Ihsan] Batman Univ, Sch Hlth, Dept Nutr & Dietet, Batman, Turkey; [Tezdig, Ihsan] Batman Univ, Inst Sci, Dept Chem, Batman, Turkey; [Tarakcioglu, Mahmut Cem] Istanbul Univ, Clin Child & Adolescent Psychiat, Bakirkoy Dr Sadi Konuk Training & Educ Hosp, Istanbul, Turkey; [Kadak, Muhammed Tayyib] Istanbul Univ, Cerrahpasa Sch Med, Dept Child & Adolescent Psychiat, Istanbul, Turkey; [Demirel, Omer Faruk] Istanbul Univ, Cerrahpasa Sch Med, Dept Psychiat, Istanbul, Turkey; [Ozer, Omer Faruk] BezmiAlem Vakif Univ, Dept Biochem, Istanbul, Turkey		Cetin, I (corresponding author), Batman Univ, Inst Sci, Dept Chem, Batman, Turkey.	cetiniihsan@gmail.com; tayyibkadak@gmail.com	Kadak, Muhammed Tayyib/V-6364-2017; demirel, omer faruk/AAB-2989-2020; Ozer, Omer Faruk/Y-2516-2018; tarakcioglu, Mahmut cem/Y-9941-2018	Kadak, Muhammed Tayyib/0000-0003-0016-311X; Ozer, Omer Faruk/0000-0002-9034-4805; tarakcioglu, Mahmut cem/0000-0002-0159-1864; demirel, omer faruk/0000-0003-3012-1252	Batman University Scientific Research Project Coordination Center [BTUBAP-2014-YL1]	This research work was supported by Grants from Batman University Scientific Research Project Coordination Center (BTUBAP-2014-YL1).	AHLSEN G, 1993, BIOL PSYCHIAT, V33, P734, DOI 10.1016/0006-3223(93)90124-V; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Baykara B, 2008, TURK PSIKIYATR DERG, V19, P225; Buffo A, 2000, J NEUROSCI, V20, P2275; Cannell JJ, 2010, ACTA PAEDIATR, V99, P1128, DOI 10.1111/j.1651-2227.2010.01883.x; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Comi AM, 1999, J CHILD NEUROL, V14, P388, DOI 10.1177/088307389901400608; Croen LA, 2005, ARCH PEDIAT ADOL MED, V159, P151, DOI 10.1001/archpedi.159.2.151; DAHL D, 1982, ANAL BIOCHEM, V126, P165, DOI 10.1016/0003-2697(82)90123-3; DELACOURTE A, 1990, NEUROLOGY, V40, P33, DOI 10.1212/WNL.40.1.33; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Fatemi SH, 2004, SCHIZOPHR RES, V69, P317, DOI 10.1016/j.schres.2003.08.014; Fontoura P, 2006, J NEUROL SCI, V245, P201, DOI 10.1016/j.jns.2005.07.020; Frick LR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/608654; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Huber AB, 2002, J NEUROSCI, V22, P3553; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; KESHAVAN MS, 1994, J PSYCHIATR RES, V28, P239, DOI 10.1016/0022-3956(94)90009-4; Kirkman NJ, 2008, J AUTISM DEV DISORD, V38, P333, DOI 10.1007/s10803-007-0398-9; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; Mannix R, 2014, J NEUROTRAUM, V31, P1072, DOI 10.1089/neu.2013.3265; Morgan JT, 2012, BRAIN RES, V1456, P72, DOI 10.1016/j.brainres.2012.03.036; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Papa L, 2016, J NEUROTRAUM, V33, P58, DOI 10.1089/neu.2015.3869; Pelinka LE, 2004, J TRAUMA, V57, P1006, DOI 10.1097/01.TA.0000108998.48026.C3; Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0; Rolando C, 2012, J NEUROSCI, V32, P17788, DOI 10.1523/JNEUROSCI.3142-12.2012; Silva SC, 2004, J NEUROIMMUNOL, V152, P176, DOI 10.1016/j.jneuroim.2004.03.015; Singer HS, 2006, J NEUROIMMUNOL, V178, P149, DOI 10.1016/j.jneuroim.2006.05.025; Singh VK, 1997, PEDIATR NEUROL, V17, P88, DOI 10.1016/S0887-8994(97)00045-3; Sweeten TL, 2003, PEDIATRICS, V112, pE420, DOI 10.1542/peds.112.5.e420; Tetreault NA, 2012, J AUTISM DEV DISORD, V42, P2569, DOI 10.1007/s10803-012-1513-0; Toro CT, 2006, NEUROSCI LETT, V404, P276, DOI 10.1016/j.neulet.2006.05.067; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Webster MJ, 2005, NEUROSCIENCE, V133, P453, DOI 10.1016/j.neuroscience.2005.02.037; Webster MJ, 2001, BRAIN BEHAV IMMUN, V15, P388, DOI 10.1006/brbi.2001.0646; Zorner B, 2010, ANN N Y ACAD SCI S1, V1198, P22	42	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1354-750X	1366-5804		BIOMARKERS	Biomarkers		2016	21	7					614	618		10.3109/1354750X.2016.1171901			5	Biotechnology & Applied Microbiology; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Toxicology	DY8SA	WOS:000385399600006	27097671				2022-02-06	
J	Charrette, AL; Lorenz, LS; Fong, J; O'Neil-Pirozzi, TM; Lamson, K; Demore-Taber, M; Lilley, R				Charrette, Ann L.; Lorenz, Laura S.; Fong, Jeffrey; O'Neil-Pirozzi, Therese M.; Lamson, Karen; Demore-Taber, Michelle; Lilley, Ross			Pilot study of intensive exercise on endurance, advanced mobility and gait speed in adults with chronic severe acquired brain injury	BRAIN INJURY			English	Article						Activity; community integration; functional status; stroke; traumatic brain injury	RANDOMIZED CONTROLLED-TRIAL; CONCURRENT VALIDITY; WALK TEST; REHABILITATION; RELIABILITY; STROKE; INDIVIDUALS; PROGRAMS; PROFESSIONALS; IMPROVEMENTS	Background and purpose: Effects of high-intensity exercise on endurance, mobility and gait speed of adults with chronic moderate-to-severe acquired brain injury (ABI) were investigated. It was hypothesized that intensive exercise would be associated with improvements in impairment and activity limitation measures.Participants: Fourteen adults with chronic ABI in supported independent living who could stand with minimal or no assist and walk with or without ambulation device were studied. Eight presented with low ambulatory status.Methods: This was a single group pre- and post-intervention study. Participants received a 6-week exercise intervention for 60-90 minutes, 3 days/week assisted by personal trainers under physical therapist supervision. Measures (6MWT, HiMAT and 10MWT) were collected at baseline, post-intervention and 6 weeks later. Repeated measures T-test and Wilcoxon Signed Ranks test were used.Results: Post-intervention improvements were achieved on average on all three measures, greater than minimal detectable change (MDC) for this population. Three participants transitioned from low-to-high ambulatory status and maintained the change 6 weeks later.Discussion and conclusion: People with chronic ABI can improve endurance, demonstrate the ability to do advanced gait and improve ambulatory status with 6 weeks of intensive exercise. Challenges to sustainability of exercise programmes for this population remain.	[Charrette, Ann L.] MCPHS Univ, Sch Phys Therapy, Worcester, MA USA; [Charrette, Ann L.; Lorenz, Laura S.; O'Neil-Pirozzi, Therese M.; Lamson, Karen; Demore-Taber, Michelle; Lilley, Ross] Support Living Inc Res Council, Lexington, MA USA; [Lorenz, Laura S.] Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA USA; [Fong, Jeffrey] MCPHS Univ, Sch Pharm, Worcester, MA USA; [O'Neil-Pirozzi, Therese M.] Northeastern Univ, Dept Commun Sci & Disorders, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Lamson, Karen] MCPHS Univ, Lib & Learning Resources, Worcester, MA USA; [Demore-Taber, Michelle] Advocates, Brain Injury Serv Program, Framingham, MA USA; [Lilley, Ross] AccesSportAmerica, Acton, MA USA		Charrette, AL (corresponding author), 207J 10 Lincoln Sq, Worcester, MA 01608 USA.	ann.charrette@mcphs.edu		Lorenz, Laura/0000-0003-0898-4537	Massachusetts Rehabilitation Commission	The authors would like to thank the research participants and express appreciation for support from Supportive Living Inc. (SLI) staff, Advocates staff, and AccesSportAmerica trainers for this study. We would also like to acknowledge funding support for the study and for ongoing exercise programming at the SLI Brain Injury Wellness Center from the Massachusetts Rehabilitation Commission as well as in-kind donations from AccesSportAmerica. We also express appreciation to members of the SLI Research Council for their review and discussion of the study design, data and this paper. The authors also thank the peer reviewers, whose careful review was much appreciated.	Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Centers for Disease Control and Prevention (CDC), MEAS PHYS ACT INT PE; Centers for Disease Control and Prevention-CDC, MEAS PHYS ACT INT; Eng JJ, 2004, ARCH PHYS MED REHAB, V85, P113, DOI 10.1016/S0003-9993(03)00436-2; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Fulk George D., 2008, Physiotherapy Theory and Practice, V24, P195, DOI 10.1080/09593980701588284; Hassett LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006123.pub2; Hayes HA, 2011, J NEUROL PHYS THER, V35, P2, DOI 10.1097/NPT.0b013e31820b5a9d; Hellweg S, 2008, BRAIN INJURY, V22, P365, DOI 10.1080/02699050801998250; Killington MJ, 2010, BRAIN INJURY, V24, P970, DOI 10.3109/02699052.2010.489792; Kraus JF, 2005, TXB TRAUMATIC BRAIN, P3; Kraus LE, GUIDELINES DISABILIT; Langhammer B, 2008, BRAIN INJURY, V22, P135, DOI 10.1080/02699050801895423; Moore, 2009, ACSMS EXERCISE MANAG, P287; Morris S, 2009, EUR J PHYSIOTHER, V11, P218, DOI 10.3109/14038190902856778; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2007, ARCH PHYS MED REHAB, V88, P315, DOI 10.1016/j.apmr.2006.12.006; Mossberg KA, 2010, J HEAD TRAUMA REHAB, V25, P173, DOI 10.1097/HTR.0b013e3181dc98ff; Patterson SL, 2007, ARCH PHYS MED REHAB, V88, P115, DOI 10.1016/j.apmr.2006.10.025; Pawlowski J, 2013, ARCH PHYS MED REHAB, V94, P1184, DOI 10.1016/j.apmr.2013.01.005; Rimmer JH, 2010, AM J PHYS MED REHAB, V89, P249, DOI 10.1097/PHM.0b013e3181c9fa9d; Sander AM, 2010, J HEAD TRAUMA REHAB, V25, P121, DOI 10.1097/HTR.0b013e3181cd1635; Saunders DH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003316.pub5; Schmid A, 2007, STROKE, V38, P2096, DOI 10.1161/STROKEAHA.106.475921; Thornton M, 2005, BRAIN INJURY, V19, P989, DOI 10.1080/02699050500109944; van de Port IGL, 2007, AM J PHYS MED REHAB, V86, P935, DOI 10.1097/PHM.0b013e31802ee464; Van Loo MA, 2004, BRAIN INJURY, V18, P1041, DOI 10.1080/02699050410001672314; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; Watson MJ, 2002, PHYSIOTHERAPY, V88, P386, DOI [10.1016/S0031-9406(05)61264-3, DOI 10.1016/S0031-9406(05)61264-3, 10.1016/S0031_9406(05)61264_3]; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Wolf SL, 1999, PHYS THER, V79, P1122, DOI 10.1093/ptj/79.12.1122; World Health Organization, 2002, COMM LANG FUNCT DIS	33	5	5	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1213	1219		10.1080/02699052.2016.1187766			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300007	27466692				2022-02-06	
J	Duong, TQ; Watts, LT				Duong, Timothy Q.; Watts, Lora T.			A brief report on MRI investigation of experimental traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						MRI; traumatic brain injury; magnetic resonance imaging; diffusion tensor imaging; cerebral blood flow	VETERANS	Traumatic brain injury is a major cause of death and disability. This is a brief report based on a symposium presentation to the 2014 Chinese Neurotrauma Association Meeting in San Francisco, USA. It covers the work from our laboratory in applying multimodal MRI to study experimental traumatic brain injury in rats with comparisons made to behavioral tests and histology. MRI protocols include structural, perfusion, manganese-enhanced, diffusion-tensor MRI, and MRI of blood-brain barrier integrity and cerebrovascular reactivity.	[Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, Res Imaging Inst, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, Res Imaging Inst, Dept Ophthalmol, San Antonio, TX 78229 USA		Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, South Texas Vet Hlth Care Syst, Res Imaging Inst, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Duong, Tim/AAL-8357-2021	Duong, Tim/0000-0001-6403-2827			Caruso D, 2014, J REHABIL RES DEV, V51, P1103, DOI 10.1682/JRRD.2013.05.0119; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Li W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114173; Long J, 2014, P INT SOC MAGN RES M; Long JA, 2015, J CEREBR BLOOD F MET, V35, P1852, DOI 10.1038/jcbfm.2015.143; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Watts LT, 2015, J NEUROTRAUM, V32, P1001, DOI 10.1089/neu.2014.3737; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	17	5	5	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	JAN	2016	11	1					15	17		10.4103/1673-5374.169604			3	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DD7ZF	WOS:000370142800003	26981069	Green Published, gold			2022-02-06	
J	Eckner, JT; Rettmann, A; Narisetty, N; Greer, J; Moore, B; Brimacombe, S; He, XM; Broglio, SP				Eckner, James T.; Rettmann, Ashley; Narisetty, Naveen; Greer, Jacob; Moore, Brandon; Brimacombe, Susan; He, Xuming; Broglio, Steven P.			Stability of an ERP-based measure of brain network activation (BNA) in athletes: A new electrophysiological assessment tool for concussion	BRAIN INJURY			English	Article						Athlete; brain network activation; concussion; electroencephalography; event-related potential; reliability	SPORTS-RELATED CONCUSSION; EVENT-RELATED POTENTIALS; WHITE-MATTER INTEGRITY; IMPAIRMENT; FOOTBALL	Primary objective: To determine test-re-test reliabilities of novel Evoked Response Potential (ERP)-based Brain Network Activation (BNA) scores in healthy athletes.Research design: Observational, repeated-measures study.Methods and design: Forty-two healthy male and female high school and collegiate athletes completed auditory oddball and go/no-go ERP assessments at baseline, 1 week, 6 weeks and 1 year. The BNA algorithm was applied to the ERP data, considering electrode location, frequency band, peak latency and normalized amplitude to generate seven unique BNA scores for each testing session.Main outcomes and results: Mean BNA scores, intra-class correlation coefficient (ICC) values and reliable change (RC) values were calculated for each of the seven BNA networks. BNA scores ranged from 46.3 34.9 to 69.9 +/- 22.8, ICC values ranged from 0.46-0.65 and 95% RC values ranged from 38.3-68.1 across the seven networks.Conclusions: The wide range of BNA scores observed in this population of healthy athletes suggests that a single BNA score or set of BNA scores from a single after-injury test session may be difficult to interpret in isolation without knowledge of the athlete's own baseline BNA score(s) and/or the results of serial tests performed at additional time points. The stability of each BNA network should be considered when interpreting test-re-test BNA score changes.	[Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA; [Eckner, James T.; Rettmann, Ashley; Greer, Jacob; Moore, Brandon; Brimacombe, Susan; Broglio, Steven P.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Rettmann, Ashley; Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Rettmann, Ashley; Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [Narisetty, Naveen; He, Xuming] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Broglio, Steven P.] Univ Michigan, Injury Ctr, Ann Arbor, MI 48109 USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			ElMindA, LTD.; Rehabilitation Medicine Scientist Training Program [5 K12 HD001097]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 K23 HD078502, 1R15NS081691-01, 3R15NS081691-01S1]; National Collegiate Athletics Association, the United States Department of Defense [14132004]; University of Michigan Injury Center; Foundation for Physical Medicine and Rehabilitation; National Collegiate Athletic Association; United States Department of DefenseUnited States Department of Defense [14132004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, K23HD078502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS081691] Funding Source: NIH RePORTER	This research was funded by ElMindA, LTD. Dr. Eckner's effort on this project was partially supported by career development awards from the Rehabilitation Medicine Scientist Training Program (5 K12 HD001097) and the National Institutes of Health (1 K23 HD078502). Dr. Eckner has received research support from ElMindA, LTD. His active research funding includes the National Institutes of Health (1 K23 HD078502), the National Collegiate Athletics Association, the United States Department of Defense (14132004), the University of Michigan Injury Center and the Foundation for Physical Medicine and Rehabilitation. Ms. Rettmann has received research support from ElMindA, LTD. Mr. Greer has received research support from ElMindA, LTD. Mr. Moore has received research support from ElMindA, LTD. Ms. Brimacombe has received research support from ElMindA, LTD. Dr. He has received research support from ElMindA, LTD. Dr. Broglio has received research support from ElMindA, LTD. His active research funding includes the National Institutes of Health (1R15NS081691-01, 3R15NS081691-01S1), the National Collegiate Athletic Association, the United States Department of Defense (14132004) and the University of Michigan Injury Center. Mr. Narisetty reports no conflicts of interest.	ANASTASI A, 1998, PSYCHOL TESTING; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2010, PHYSICIAN SPORTSMED, V38, P27, DOI 10.3810/psm.2010.10.1805; Institute of Medicine & National Research Council, 2014, SPORTS RELATED CONCU; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2015, BRAIN IMAGING BEHAV; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reches A, 2014, NEUROIMAGE, V88, P228, DOI 10.1016/j.neuroimage.2013.11.020; Reches A., 2013, FUNCT NEUROL REHABIL, V3, P295; Reches A, 2014, J MOL NEUROSCI, V54, P59, DOI 10.1007/s12031-014-0250-6; Shahaf G, 2012, CLIN NEUROPHYSIOL, V123, P1568, DOI 10.1016/j.clinph.2011.12.010; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512	25	5	6	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	9					1075	1081		10.3109/02699052.2016.1160152			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DV5BN	WOS:000382940600005	27245767	Green Accepted			2022-02-06	
J	Ezaki, J; Shimada, R; Shibuya, M; Kibayashi, K				Ezaki, Jiro; Shimada, Ryo; Shibuya, Misato; Kibayashi, Kazuhiko			Hippocampal neuronal degeneration in the traumatic brain injury mouse: non-trivial effect of scalp incision	NEUROLOGICAL RESEARCH			English	Article						Neuronal degeneration; Hippocampus; Weight drop; Traumatic brain injury; Scalp incision	CLOSED-HEAD INJURY; MICE; MODEL; RATS; ISOFLURANE; PATHOPHYSIOLOGY; ISCHEMIA; PATHWAY; DEATH	Objectives: In experimental models of traumatic brain injury (TBI), posttraumatic hippocampal neuronal degeneration in the cornu ammonis 1 (CA1), and/or the cornu ammonis 3 (CA3) regions are regarded as the most notable phenotypic appearances relating to the pathophysiology of human post-concussion syndrome. However, these morphological changes are often also seen in subjects without TBI, namely 'sham' groups. The frequencies and reasons of appearance of hippocampal neuronal degeneration in mice with TBI and/or sham are not clear. Methods: We compared the frequencies of hippocampal neuronal degeneration among three groups: TBI (mice with external force impact performed by Marmarou's weight drop model after scalp incision), sham (mice with scalp incision alone), and control (mice with neither external force impact nor scalp incision), using hematoxylin and eosin stain in day 6 (n = 5 in each group.) Isoflurane was used for anesthesia in all mice. Results: The frequencies were 80, 100, and 20% in CA1, and 20, 40, and 60% in CA3, for TBI, sham, and control, respectively. In CA1, a significant difference of the frequency was observed between sham and control (p = 0.048), but not, between TBI and sham (p = 1.000) in Fisher's exact test. In CA3, no significant difference in the frequency was observed between the three groups. Conclusion: Scalp incision, rather than external impact force, might affect the CA1 hippocampal neuronal degeneration in mice with TBI. In addition, factor(s) other than external impact force or scalp incision may also cause hippocampal neuronal degeneration in both CA1 and CA3. Careful interpretation is needed concerning hippocampal neuronal degeneration induced by a weight drop device observed in mice with TBI.	[Ezaki, Jiro; Shimada, Ryo; Shibuya, Misato; Kibayashi, Kazuhiko] Tokyo Womens Med Univ, Sch Med, Dept Legal Med, Tokyo, Japan		Ezaki, J (corresponding author), 8-1 Kawada Cho,Shinjyuku Ku, Tokyo 1628666, Japan.	jezaki@research.twmu.ac.jp	Kazuhiko, Kibayashi/F-5173-2013	Kazuhiko, Kibayashi/0000-0001-6510-5215	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [26293164]	This work was supported by Japan Society for the Promotion of Science [Grant-in-Aid for Scientific Research (B) Number 26293164].	Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bickler PE, 2003, ANESTH ANALG, V97, P564, DOI 10.1213/01.ANE.0000068880.82739.7B; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; DELATORRE JC, 1995, NEUROSURGERY, V37, P273, DOI 10.1227/00006123-199508000-00012; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; KAKU Y, 1993, J CEREBR BLOOD F MET, V13, P402, DOI 10.1038/jcbfm.1993.54; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Li LX, 2011, BRAIN RES BULL, V86, P390, DOI 10.1016/j.brainresbull.2011.09.005; Li YJ, 2013, NEUROSCI LETT, V545, P17, DOI 10.1016/j.neulet.2013.04.008; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Nadler Y, 2008, GLIA, V56, P552, DOI 10.1002/glia.20638; Nawashiro H, 1998, NEUROREPORT, V9, P1691, DOI 10.1097/00001756-199806010-00004; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; Reshef A, 2008, J NEUROTRAUM, V25, P569, DOI 10.1089/neu.2007.0341; Ribak CE, 1996, DEV BRAIN RES, V91, P245, DOI 10.1016/0165-3806(95)00183-2; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	23	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.		2016	38	11					994	1002		10.1080/01616412.2016.1228746			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA1CQ	WOS:000386330500008	27615406				2022-02-06	
S	Gazalah, H; Mantash, S; Ramadan, N; Al Lafi, S; El Sitt, S; Darwish, H; Azari, H; Fawaz, L; Ghanem, N; Zibara, K; Boustany, RM; Kobeissy, F; Soueid, J		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Gazalah, Hussein; Mantash, Sarah; Ramadan, Naify; Al Lafi, Sawsan; El Sitt, Sally; Darwish, Hala; Azari, Hassan; Fawaz, Lama; Ghanem, Noel; Zibara, Kazem; Boustany, Rose-Mary; Kobeissy, Firas; Soueid, Jihane			Postnatal Neural Stem Cells in Treating Traumatic Brain Injury	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Neural stem cells; Neonatal mouse brain; Neurosphere; Controlled cortical impact; Traumatic brain injury; Perfusion; Immunofluorescence; Rotarod; Pole climbing	DIFFERENTIATION; MODEL	Traumatic brain injury (TBI) is one of the leading causes of death and disabilities worldwide. It affects approximately 1.5 million people each year and is associated with severe post-TBI symptoms such as sensory and motor deficits. Several neuro-therapeutic approaches ranging from cell therapy interventions such as the use of neural stem cells (NSCs) to drug-based therapies have been proposed for TBI management. Successful cell-based therapies are tightly dependent on reproducible preclinical animal models to ensure safety and optimal therapeutic benefits. In this chapter, we describe the isolation of NSCs from neonatal mouse brain using the neurosphere assay in culture. Subsequently, dissociated neurosphere-derived cells are used for transplantation into the ipsilateral cortex of a controlled cortical impact (CCI) TBI model in C57BL/6 mice. Following intra-cardiac perfusion and brain removal, the success of NSC transplantation is then evaluated using immunofluorescence in order to assess neurogenesis along with gliosis in the ipsilateral coronal brain sections. Behavioral tests including rotarod and pole climbing are conducted to evaluate the motor activity post-treatment intervention.	[Gazalah, Hussein; Mantash, Sarah; Ramadan, Naify; El Sitt, Sally; Boustany, Rose-Mary; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon; [Mantash, Sarah; Zibara, Kazem] Lebanese Univ, ER045, Lab Stem Cells, DSST,PRASE, Beirut, Lebanon; [Al Lafi, Sawsan; Ghanem, Noel] Amer Univ Beirut, Dept Biol, Beirut, Lebanon; [Darwish, Hala] Amer Univ Beirut, Hariri Sch Nursing, Abou Haidar Neurosci Inst, Beirut, Lebanon; [Azari, Hassan] Shiraz Univ Med Sci, Shiraz Sch Med, Dept Anat Sci, Neural Stem Cell & Regenerat Neurosci Lab, Shiraz, Iran; [Azari, Hassan] Shiraz Univ Med Sci, Shiraz Stem Cell Inst, Shiraz, Iran; [Fawaz, Lama] Amer Univ Beirut, Dept Expt Pathol Microbiol & Immunol, Beirut, Lebanon; [Zibara, Kazem] Lebanese Univ, Fac Sci 1, Beirut, Lebanon; [Boustany, Rose-Mary; Soueid, Jihane] Amer Univ Beirut, Neurogenet Program, Med Ctr, Special Kids Clin, Beirut, Lebanon; [Boustany, Rose-Mary; Soueid, Jihane] Amer Univ Beirut, Div Pediat Neurol, Med Ctr, Special Kids Clin,Dept Pediat, Beirut, Lebanon; [Boustany, Rose-Mary; Soueid, Jihane] Amer Univ Beirut, Div Pediat Neurol, Med Ctr, Special Kids Clin,Dept Adolescent Med, Beirut, Lebanon; [Kobeissy, Firas] Banyan Biomarkers Inc, Alachua, FL USA; [Kobeissy, Firas] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA		Gazalah, H (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Beirut, Lebanon.		Kobeissy, Firas/E-7042-2017; Azari, Hassan/V-6092-2017	Kobeissy, Firas/0000-0002-5008-6944; Ramadan, Naify/0000-0001-7339-0263; Ghanem, Noel/0000-0001-8343-0118; Darwish, Hala/0000-0001-5744-6466; Zibara, Kazem/0000-0002-9887-072X; Azari, Hassan/0000-0002-8021-3166			Azari Hassan, 2010, J Vis Exp, DOI 10.3791/2393; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Decimo I, 2012, CURR PHARM DESIGN, V18, P1755, DOI 10.2174/138161212799859611; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; FLECKNELL PA, 1993, BRIT J ANAESTH, V71, P885, DOI 10.1093/bja/71.6.885; Hamedi A, 2015, J NAT MED-TOKYO, V69, P387, DOI 10.1007/s11418-015-0905-9; Han J, 2015, CELL REP, V10, P1158, DOI 10.1016/j.celrep.2015.01.049; Kindler V, 2005, J LEUKOCYTE BIOL, V78, P836, DOI 10.1189/jlb.0505272; Lam PK, 2013, J CLIN NEUROSCI, V20, P300, DOI 10.1016/j.jocn.2012.03.028; Ma Juan, 2007, Neurosci Bull, V23, P209, DOI 10.1007/s12264-007-0031-0; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	15	5	5	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						689	710		10.1007/978-1-4939-3816-2_38	10.1007/978-1-4939-3816-2		22	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500040	27604746				2022-02-06	
J	Gunther, A; Witte, OW; Freesmeyer, M; Drescher, R				Gunther, Albrecht; Witte, Otto W.; Freesmeyer, Martin; Drescher, Robert			Clinical Presentation, Magnetic Resonance Angiography, Ultrasound Findings, and Stroke Patterns in Patients with Vertebral Artery Dissection	EUROPEAN NEUROLOGY			English	Article						Vertebral artery dissection; Traumatic; Spontaneous; Stroke pattern; Mural hematoma	CEREBROVASCULAR DISSECTIONS; DIAGNOSIS; HYPOPLASIA; FEATURES	Background/Aims: Vertebral artery dissection (VAD) is an important cause of ischemic stroke. In this observational study, clinical data, magnetic resonance (MR) and ultrasound (US) imaging findings and ischemic patterns were analyzed. Methods: Forty-seven patients with a diagnosis of VAD underwent clinical examination, US, MR of the brain and neck and MR angiography (MRA) of the cervical arteries. Vascular abnormalities and ischemic brain lesions were noted. Data were evaluated separately and compared for spontaneous and traumatic VAD subgroups. Results: The most common overall clinical symptom was vertigo followed by neck pain. In the traumatic subgroup, vertigo was relatively rare (p = 0.022). Most common MRA findings were vessel irregularity and vessel occlusions. Ischemic lesions occurred significantly more frequently after spontaneous than after traumatic VAD (p = 0.009). Unilateral VAD was significantly more common in non-dominant vertebral arteries (p < 0.001). Mortality after trauma was not only due to VAD complications but also due to other trauma-related injuries. Conclusion: The variability of MR and US imaging findings in patients with VAD is illustrated. The algorithm of management should be based on a multimodality approach involving patient history and clinical neurological examination. Several types of vessel abnormalities and ischemic lesion in diverse locations may point to arterial dissection, and the differential diagnosis of VAD must be kept in mind. (C) 2016 S. Karger AG, Basel	[Gunther, Albrecht; Witte, Otto W.] Jena Univ Hosp, Hans Berger Clin Neurol, Klinikum 1, DE-07740 Jena, Germany; [Freesmeyer, Martin; Drescher, Robert] Jena Univ Hosp, Clin Nucl Med, Jena, Germany		Gunther, A (corresponding author), Jena Univ Hosp, Hans Berger Clin Neurol, Klinikum 1, DE-07740 Jena, Germany.	albrecht.guenther@med.uni-jena.de	Freesmeyer, Martin/ABC-5554-2021; Witte, Otto/P-4127-2018	Freesmeyer, Martin/0000-0002-6462-3851; Witte, Otto/0000-0003-2101-4105			Benninger DH, 2004, STROKE, V35, P482, DOI 10.1161/01.STR.0000109766.27393.52; Bin Saeed A, 2000, CAN J NEUROL SCI, V27, P292, DOI 10.1017/S0317167100001025; Brott TG, 2013, CATHETER CARDIO INTE, V81, pE75, DOI 10.1002/ccd.22983; Debette S, 2011, NEUROLOGY, V77, P1174, DOI 10.1212/WNL.0b013e31822f03fc; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Dittrich, 2016, LEITLINIEN DIAGNOSTI; Dittrich R, 2006, J NEUROL, V253, P424, DOI 10.1007/s00415-005-0051-5; Flis CM, 2007, EUR RADIOL, V17, P820, DOI 10.1007/s00330-006-0346-7; Fukuhara K, 2015, INT J STROKE, V10, P30, DOI 10.1111/ijs.12546; Fusco MR, 2011, NEUROSURGERY, V68, P517, DOI 10.1227/NEU.0b013e3181fe2fda; Fusco MR, 2011, NEUROSURGERY, V68, P242, DOI 10.1227/NEU.0b013e3182012323; Goyal MS, 2009, CURR OPIN NEUROL, V22, P80, DOI 10.1097/WCO.0b013e328320d2b2; Grond-Ginsbach C, 2009, CURR MOL MED, V9, P210, DOI 10.2174/156652409787581547; Hamza R, 2013, J VASC SURG, V58, P1398, DOI 10.1016/j.jvs.2012.08.100; HICKS PA, 1994, OPHTHALMOLOGY, V101, P1786; Hosoya T, 1999, STROKE, V30, P1083, DOI 10.1161/01.STR.30.5.1083; Huang YC, 2009, SURG NEUROL, V72, P20, DOI 10.1016/j.surneu.2008.10.002; Katsanos AH, 2013, EUR NEUROL, V70, P78, DOI 10.1159/000351786; Kobayashi H, 2016, J NEUROL SCI, V362, P244, DOI 10.1016/j.jns.2016.01.062; Leclerc X, 1999, AM J NEURORADIOL, V20, P1482; Lleva P, 2012, J CLIN NEUROSCI, V19, P1112, DOI 10.1016/j.jocn.2011.11.018; Lucas C, 1998, STROKE, V29, P2646, DOI 10.1161/01.STR.29.12.2646; Markus HS, 2015, LANCET NEUROL, V14, P361, DOI 10.1016/S1474-4422(15)70018-9; Matsumoto J, 2014, J STROKE CEREBROVASC, V23, P2857, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.013; Meves SH, 2009, CEREBROVASC DIS, V28, P626, DOI 10.1159/000253148; Miaux Y, 1996, AM J NEURORADIOL, V17, P191; Morimoto K, 2009, JPN J RADIOL, V27, P151, DOI 10.1007/s11604-008-0313-0; Naggara O, 2010, AM J NEURORADIOL, V31, P1707, DOI 10.3174/ajnr.A2165; Park JH, 2007, J NEUROL NEUROSUR PS, V78, P954, DOI 10.1136/jnnp.2006.105767; Peterson C, 2010, J MANIP PHYSIOL THER, V33, P207, DOI 10.1016/j.jmpt.2010.01.012; Provenzale JM, 2011, AM J ROENTGENOL, V196, P45, DOI 10.2214/AJR.10.5384; SILBERT PL, 1995, NEUROLOGY, V45, P1517, DOI 10.1212/WNL.45.8.1517; Vicenzini E, 2010, J ULTRAS MED, V29, P1811, DOI 10.7863/jum.2010.29.12.1811; Zhou MK, 2015, NEUROLOGY, V84, P818, DOI 10.1212/WNL.0000000000001284	34	5	5	0	6	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-3022	1421-9913		EUR NEUROL	Eur. Neurol.		2016	76	5-6					284	294		10.1159/000452303			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ED4NH	WOS:000388825700014	27798932				2022-02-06	
J	Gupta, G; Wadhwa, C; Garg, R; Dhaiya, RS; Kaushal, RK				Gupta, Gulzar; Wadhwa, Chetan; Garg, Rajveer; Dhaiya, Ranbir S.; Kaushal, Rakesh K.			Impact of Coagulation Profile on Outcome of Head Injury	JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH			English	Article						Coagulopathy; Disseminated intravascular score; Glasgow outcome score	TRAUMATIC BRAIN-INJURY; COAGULOPATHY; MODERATE	Introduction: Worldwide, head injury is recognized as a major public health problem. Head injury patients often develop consumptive coagulopathy in the absence of other trauma or haemorrhages. The release of tissue factor from the damaged brain is postulated as the cause of coagulopathy. Aim: To know the impact of coagulation profile derangements and their effect on the outcome of head injury patients. Materials and Methods: Fifty patients in the age group of 2070 years admitted with isolated head injury were taken. Samples of complete haemogram (CBC), prothrombin time (PTI), partial thromboplastin time (PTK), D-Dimers and fibrinogen were taken within 24 hour of admission. Coagulopathy was defined as platelet counts <100,000 cells/mm(2) and PTI >15 seconds or a DIC score more than 4. The outcome in each group was measured according to Glasgow outcome score. Coagulation abnormalities were analysed. Results: In case of severe head injury, p-values in patients who died with regard to DIC score, Prothrombin time and APTT were found to be significant (p<0.05). For D-Dimers, fibrinogen and platelets counts the p-value was not significant. In case of moderate head injury, p-values in patients who died with regard to DIC score, platelet count, Prothrombin time, D-Dimer and APTT were found to be significant (0.05). For fibrinogen level it was insignificant. The mean DIC score and mean GOS in the severe head injury patients was significant (p<0.001). Conclusion: Patients with isolated head injury are at risk of development of coagulation abnormalities, which is associated with poor outcome. Based on our results we also emphasize the importance of early diagnosis of coagulation abnormalities in isolated head injury patients.	[Gupta, Gulzar; Wadhwa, Chetan; Garg, Rajveer; Kaushal, Rakesh K.] Dayanand Med Coll Hosp, Dept Neurosurg, Ludhiana, Punjab, India; [Dhaiya, Ranbir S.] Dept Surg, Rohtak, Haryana, India		Garg, R (corresponding author), DMC Hosp Civil Lines, Dept Neurosurg, Civil Lines, Ludhiana 141001, Punjab, India.	dr.rg2482@gmail.com					Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Chalya P. L., 2011, Tanzania Journal of Health Research, V13, P93; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Gan BK, 2004, ANN ACAD MED SINGAP, V33, P63; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; OLSON JD, 1989, NEUROSURGERY, V24, P825, DOI 10.1227/00006123-198906000-00007; Rangarajan Kanchana, 2010, J Emerg Trauma Shock, V3, P4, DOI 10.4103/0974-2700.58652; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	14	5	5	0	0	PREMCHAND SHANTIDEVI RESEARCH FOUNDATION	DELHI	71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA	2249-782X	0973-709X		J CLIN DIAGN RES	J. Clin. Diagn. Res.	JAN	2016	10	1					PC4	PC6		10.7860/JCDR/2016/14638.7029			3	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	EQ1RG	WOS:000397846700073	26894120	Green Published, gold			2022-02-06	
J	Nguyen, HS; Doan, NB; Gelsomino, MJ; Shabani, S; Mueller, WM				Ha Son Nguyen; Doan, Ninh B.; Gelsomino, Michael J.; Shabani, Saman; Mueller, Wade M.			Good outcomes in a patient with a Duret hemorrhage from an acute subdural hematoma	INTERNATIONAL MEDICAL CASE REPORTS JOURNAL			English	Article						Duret hemorrhage; brain stem hemorrhage; subdural hematoma	TRAUMATIC BRAIN-INJURY; STEM HEMORRHAGE; HERNIATION; CT	Background: Secondary brain stem injury is associated with transtentorial herniation, and manifests as "Duret" hemorrhages. Such an injury has been considered a terminal brain stem event with a high morbidity and mortality, sometimes discouraging continuation of care. However, there have been rare instances where patients have had reasonable recovery. We report another case, emphasizing that such an injury by itself should not deter aggressive measures, as good outcomes remain a possibility. Case presentation: A 37-year-old male sustained a right subdural hematoma after a mechanical fall while intoxicated. He presented initially with a Glasgow Coma Scale 15. Three days later, he exhibited acute neurological deterioration to Glasgow Coma Scale 4, requiring intubation and mannitol. Repeat scan demonstrated enlarging right subdural hematoma with worsening shift; brain stem hemorrhage was noted at pontomesencephalic junction. Patient was immediately taken for subdural hematoma evacuation. The following day, patient was able to sluggishly follow commands in all four extremities. He had a short stay for inpatient rehabilitation and underwent autologous cranioplasty at 3 months. On examination, he was awake, alert, and oriented to self, time, and location; he exhibited dysarthric speech, right ptosis, but followed commands in all four extremities with no focal motor weakness. Conclusion: In contrast to the common belief, patients suffering from a "Duret" hemorrhage can still have a good outcome. "Duret" hemorrhages may not represent a fatal injury. The finding from this paper suggests the finding of "Duret" hemorrhages on imaging should not deter aggressive measures especially in patients with lesions causing significant mass effects. Overall clinical status should drive surgical options and clinical course.	[Ha Son Nguyen; Doan, Ninh B.; Gelsomino, Michael J.; Shabani, Saman; Mueller, Wade M.] Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA		Nguyen, HS (corresponding author), Med Coll Wisconsin, Dept Neurosurg, 9200 West Wisconsin Ave, Milwaukee, WI 53226 USA.	hsnguyen@mcw.edu		Nguyen, Ha/0000-0002-3515-278X			Beier AD, 2014, J NEUROSURG-PEDIATR, V14, P421, DOI 10.3171/2014.7.PEDS13376; Chew KL, 2012, FORENSIC SCI MED PAT, V8, P436, DOI 10.1007/s12024-012-9329-y; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Fujimoto Y, 2000, NEUROL MED-CHIR, V40, P508, DOI 10.2176/nmc.40.508; Huddleston BJ, 2010, ACTA CYTOL, V54, P958; Ishizaka S, 2014, BRAIN INJURY, V28, P374, DOI 10.3109/02699052.2013.864422; Kamijo Y, 2005, AM J EMERG MED, V23, P908, DOI 10.1016/j.ajem.2005.07.014; Lonjaret L, 2012, J CLIN NEUROSCI, V19, P1293, DOI 10.1016/j.jocn.2012.01.014; Mathai K, 2009, INDIAN J NEUROTRAUM, V6, P141, DOI 10.1016/S0973-0508(09)80009-9; MEYER CA, 1991, RADIOLOGY, V179, P813, DOI 10.1148/radiology.179.3.2027997; Parizel PM, 2002, INTENS CARE MED, V28, P85, DOI 10.1007/s00134-001-1160-y; Park KJ, 2009, NEUROL MED-CHIR, V49, P594, DOI 10.2176/nmc.49.594; Stiver SI, 2009, J NEUROSURG, V110, P1242, DOI 10.3171/2008.8.JNS08314	13	5	6	0	1	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-142X			INT MED CASE REP J	INT. MED. CASE REP. J.		2016	9						15	18		10.2147/IMCRJ.S95809			4	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	DV2OU	WOS:000382761000002	26869816	Green Submitted, gold, Green Published			2022-02-06	
S	Ha, YW; Jeong, JA; Kim, Y; Churchill, DG		Sigel, A; Sigel, H; Sigel, RKO		Ha, Yonghwang; Jeong, Jeong A.; Kim, Youngsam; Churchill, David G.			Sodium and Potassium Relating to Parkinson's Disease and Traumatic Brain Injury	ALKALI METAL IONS: THEIR ROLE FOR LIFE	Metal Ions in Life Sciences		English	Article; Book Chapter						Ion flux; Na+-K+ pump; Renin-angiotensin system; Sodium channel; alpha-synuclein	RENIN-ANGIOTENSIN SYSTEM; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALPHA-SYNUCLEIN PHOSPHORYLATION; ENHANCES FIRING FREQUENCIES; SUBSTANTIA-NIGRA NEURONS; GATED CALCIUM-CHANNELS; INTRACELLULAR SODIUM; OXIDATIVE IMPAIRMENT; ACUTE HYPONATREMIA; DOPAMINE NEURONS	Alkali metals, especially sodium and potassium, are plentiful and vital in biological systems. They take on important roles in health and disease. Such roles include the regulation of homeostasis, osmosis, blood pressure, electrolytic equilibria, and electric current. However, there is a limit to our present understanding; the ions have a great ability and capacity for action in health and disease, much greater than our current understanding. For the regulation of physiological homeostasis, there is a crucial regulator (renin-angiotensin system, RAS), found at both peripheral and central levels. Misregulation of the Na+-K+ pump, and sodium channels in RAS are important for the understanding of disease progression, hypertension, diabetes, and neurodegenerative diseases, etc. In particular, RAS displays direct or indirect interaction important to Parkinson's disease (PD). In this chapter, the relationship between the regulation of sodium/potassium concentration and PD was sought. In addition, some recent biochemical and clinical findings are also discussed that help describe sodium and potassium in the context of traumatic brain injury (TBI). TBI is caused from the heavy striking of the head; this strongly affects ion flux in the affected tissue (brain) and damages cellular regulation systems. Thus, inappropriate concentrations of ions (hyper- and hyponatremia, and hyper- and hypokalemia) will perturb homeostasis giving rise to important and far reaching effects. These changes also impact osmotic pressure and the concentration of other metal ions, such as the calcium(II) ion.	[Ha, Yonghwang; Jeong, Jeong A.; Kim, Youngsam; Churchill, David G.] Korea Adv Inst Sci & Technol, Dept Chem, 373-1 Guseong Dong, Daejeon 305701, South Korea		Churchill, DG (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, 373-1 Guseong Dong, Daejeon 305701, South Korea.	dchurchill@kaist.ac.kr					ABUKISHK RA, 1990, J PHYSIOL-LONDON, V430, pP89; Ahmed SSSJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011252; Alvarez-Fischer D, 2008, J NEUROCHEM, V107, P701, DOI 10.1111/j.1471-4159.2008.05651.x; Aronson PS, 2011, J AM SOC NEPHROL, V22, P1981, DOI 10.1681/ASN.2011040414; Asanuma M, 2008, CURR PHARM DESIGN, V14, P1428, DOI 10.2174/138161208784480153; Asanuma M, 2007, EXP NEUROL, V206, P172, DOI 10.1016/j.expneurol.2007.05.006; Ayus JC, 2006, KIDNEY INT, V69, P1319, DOI 10.1038/sj.ki.5000187; Bandulik S, 2013, ENDOCRINOLOGY, V154, P2712, DOI 10.1210/en.2013-1101; Basak S, 2015, ACS CHEM NEUROSCI, V6, P239, DOI 10.1021/cn500168x; Bradshaw K, 2008, BJA EDUC, V8, P129, DOI 10.1093/bjaceaccp/mkn019; BRASCH H, 1993, HYPERTENSION, V22, P699, DOI 10.1161/01.HYP.22.5.699; Bregonzio C, 2004, ANN NY ACAD SCI, V1018, P351, DOI 10.1196/annals.1296.044; Carboni E, 2015, METALLOMICS, V7, P395, DOI 10.1039/c4mt00339j; Carlson SW, 2014, J NEUROPATH EXP NEUR, V73, P734, DOI 10.1097/NEN.0000000000000092; Chan CS, 2010, MOVEMENT DISORD, V25, pS63, DOI 10.1002/mds.22801; Chau KY, 2009, J NEUROCHEM, V110, P1005, DOI 10.1111/j.1471-4159.2009.06191.x; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; Crichton RR, 2008, COORDIN CHEM REV, V252, P1189, DOI 10.1016/j.ccr.2007.10.019; da Silva J. J. R. Frausto, 1991, BIOL CHEM ELEMENTS I; Deutch AY, 2006, NAT MED, V12, P17, DOI 10.1038/nm0106-17; Di X, 1996, J NEUROTRAUM, V13, P497, DOI 10.1089/neu.1996.13.497; Dragicevic E, 2015, NEUROSCIENCE, V284, P798, DOI 10.1016/j.neuroscience.2014.10.037; Edgerton JR, 2011, J NEUROSCI, V31, P10919, DOI 10.1523/JNEUROSCI.6062-10.2011; FERRIER CP, 1989, EUR J CLIN PHARMACOL, V36, P443, DOI 10.1007/BF00558067; Filipeanu CM, 2001, BRIT J PHARMACOL, V132, P1590, DOI 10.1038/sj.bjp.0703984; Filippidis AS, 2014, J NEUROTRAUM, V31, P1258, DOI 10.1089/neu.2013.3063; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Floyd CL, 2005, GLIA, V51, P35, DOI 10.1002/glia.20183; Follett J, 2013, NEUROTOX RES, V23, P378, DOI 10.1007/s12640-012-9366-z; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; GARNER MG, 1987, HYPERTENSION, V10, P628, DOI 10.1161/01.HYP.10.6.628; Gildea JJ, 2014, KIDNEY INT, V86, P118, DOI 10.1038/ki.2014.5; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Grammatopoulos TN, 2007, BIOCHEM BIOPH RES CO, V363, P846, DOI 10.1016/j.bbrc.2007.09.043; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Ha Y, 2014, BIOCHEM BIOPH RES CO, V443, P1085, DOI 10.1016/j.bbrc.2013.12.099; Ha Y, 2014, J NEUROSCI RES, V92, P359, DOI 10.1002/jnr.23323; Ha Y, 2011, NEUROSCI RES, V71, P168, DOI 10.1016/j.neures.2011.07.003; Ha Y, 2011, MONATSH CHEM, V142, P385, DOI 10.1007/s00706-010-0438-6; HATASHITA S, 1990, STROKE, V21, P582, DOI 10.1161/01.STR.21.4.582; Hurley MJ, 2013, BRAIN, V136, P2077, DOI 10.1093/brain/awt134; Hurley MJ, 2012, PHARMACOL THERAPEUT, V133, P324, DOI 10.1016/j.pharmthera.2011.11.006; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; Kalupahana NS, 2012, OBES REV, V13, P136, DOI 10.1111/j.1467-789X.2011.00942.x; Kanaide H, 2003, CIRC RES, V93, P1015, DOI 10.1161/01.RES.0000105920.33926.60; Ke C, 2000, ACT NEUR S, V76, P405; Ke CS, 2002, EXP NEUROL, V178, P194, DOI 10.1006/exnr.2002.8037; Khatri N, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00199; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Kurtz A, 2000, PFLUG ARCH EUR J PHY, V440, P889, DOI 10.1007/s004240000373; Leehey DJ, 2000, KIDNEY INT, V58, pS93, DOI 10.1046/j.1523-1755.2000.07715.x; Li M, 2013, INJURY, V44, P1213, DOI 10.1016/j.injury.2012.05.021; Liss B, 2005, NAT NEUROSCI, V8, P1742, DOI 10.1038/nn1570; Llorens-Cortes C, 2002, J RENIN-ANGIO-ALDO S, V3, pS39, DOI 10.3317/jraas.2002.029; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Madelin G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04763; Maggiore U, 2009, CRIT CARE, V13, DOI 10.1186/cc7953; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Martel P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020402; Maul B, 2005, FASEB J, V19, P1474, DOI 10.1096/fj.05-3742com; Mclntosh T. K., 1987, J NEUROCHEM, V49, P1530; Meeker JD, 2008, ENVIRON HEALTH PERSP, V116, P1473, DOI 10.1289/ehp.11490; Mercer JN, 2007, J NEUROSCI, V27, P13552, DOI 10.1523/JNEUROSCI.3430-07.2007; Mertens B, 2010, J RENIN-ANGIO-ALDO S, V11, P49, DOI 10.1177/1470320309347789; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Muller T, 2013, EXPERT REV NEUROTHER, V13, P969, DOI 10.1586/14737175.2013.827488; Namiranian K., 2011, J CEREB BLOOD FLOW M, pe1; Nathan BR, 2007, NEUROCRIT CARE, V6, P72, DOI 10.1385/NCC:6:1:72; Nomura M, 2007, PHYSIOL BEHAV, V91, P223, DOI 10.1016/j.physbeh.2007.03.001; Ohsawa M, 2014, KIDNEY INT, V86, P570, DOI 10.1038/ki.2014.95; PAWLOSKI CM, 1990, AM J PHYSIOL, V259, pR531, DOI 10.1152/ajpregu.1990.259.3.R531; Penton D, 2012, ENDOCRINOLOGY, V153, P4740, DOI 10.1210/en.2012-1527; Reinert M, 2000, J NEUROSURG, V93, P800, DOI 10.3171/jns.2000.93.5.0800; Rodriguez-Pallares J, 2012, AGE, V34, P863, DOI 10.1007/s11357-011-9284-7; Saavedra JM, 2007, STRESS, V10, P185, DOI 10.1080/10253890701350735; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Sander SE, 2012, NEUROPHARMACOLOGY, V62, P1052, DOI 10.1016/j.neuropharm.2011.10.016; Sealey JE, 1990, HYPERTENSION PATHOPH, P1287; Sergeant C, 2005, NUCL INSTRUM METH B, V231, P234, DOI 10.1016/j.nimb.2005.01.063; Shieh CC, 2000, PHARMACOL REV, V52, P557; SLATER JDH, 1964, POSTGRAD MED J, V40, P479, DOI 10.1136/pgmj.40.466.479; Subramaniam M, 2014, ACTA PHYSIOL, V210, P108; Subramaniam M, 2014, J NEUROSCI, V34, P13586, DOI 10.1523/JNEUROSCI.5069-13.2014; Sulzer D, 2007, NEURON, V55, P8, DOI 10.1016/j.neuron.2007.06.023; Takahashi H, 2011, HYPERTENS RES, V34, P1147, DOI 10.1038/hr.2011.105; Tchekalarova J, 1999, J PHYSIOL-PARIS, V93, P191, DOI 10.1016/S0928-4257(99)80151-X; Ussing H. H., 1959, ALKALI METAL IONS BI, V13, P1; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Walker PA, 2010, REGEN MED, V5, P65, DOI 10.2217/RME.09.73; Wang G, 2008, FRONT BIOSCI-LANDMRK, V13, P3685, DOI 10.2741/2959; Wang S, 2005, NEUROPHARMACOLOGY, V48, P984, DOI 10.1016/j.neuropharm.2005.01.009; Wang Y, 2008, MED HYPOTHESES, V71, P546, DOI 10.1016/j.mehy.2008.05.021; Wardas J, 2009, PHARMACOL REP, V61, P1251; WAYNER MJ, 1976, PHARMACOL BIOCHEM BE, V5, P103, DOI 10.1016/0091-3057(76)90336-1; Wright JW, 2013, PFLUG ARCH EUR J PHY, V465, P133, DOI 10.1007/s00424-012-1102-2; Wu X, 2015, INJURY, V46, P35, DOI 10.1016/j.injury.2014.08.002; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhao XR, 2008, J NEUROTRAUM, V25, P1195, DOI 10.1089/neu.2008.0635; Zhou TT, 2012, INT J BIOL SCI, V8, P630, DOI 10.7150/ijbs.3684	103	5	6	0	12	SPRINGER	DORDRECHT	PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	1559-0836		978-3-319-21756-7; 978-3-319-21755-0	METAL IONS LIFE SCI			2016	16						585	601		10.1007/978-3-319-21756-7_16	10.1007/978-3-319-21756-7		17	Biochemistry & Molecular Biology	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology	BE3XN	WOS:000371342100018	26860312				2022-02-06	
J	Hori, YS; Fukuhara, T; Aoi, M; Namba, Y				Hori, Yusuke S.; Fukuhara, Toru; Aoi, Mizuho; Namba, Yoichiro			Eosinopenia in Children following Traumatic Intracranial Hemorrhage Is Associated with Poor Prognosis and Prolonged Hospital Admission	PEDIATRIC NEUROSURGERY			English	Article						Intracranial hemorrhage; Prognostic factors; Traumatic brain injury	C-REACTIVE PROTEIN; BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; SERUM CORTISOL; STRESS; INFARCTION; MORTALITY; STROKE; HYDROCORTISONE	Background: Neutrophilia is associated with brain injury and is frequently accompanied by eosinopenia. Although eosinopenia is a poor prognostic indicator for various diseases, its significance in intracranial events has not been investigated. Methods: We retrospectively included 22 pediatric patients (= 18 years old) who experienced traumatic intracranial hemorrhage between 2002 and 2015. Patients were divided into two groups based on the presence or absence of eosinopenia on admission, i. e. the proportion of eosinophils to total white blood cells < 1.0%. Results: The mean Glasgow Coma Scale score was marginally lower in the eosinopenia group (14.1 vs. 12.0, p = 0.06). The mean Glasgow Outcome Scale-Extended (GOSE) score was significantly lower in the eosinopenia group (7.5 vs. 5.7, p = 0.02), and the mean length of hospital stay tended to be longer in patients with eosinopenia (7.8 vs. 28.4, p = 0.10). In our multivariate logistic regression analysis, eosinopenia was the only significant risk factor for poor outcome (GOSE score 1-7, OR 29.7, p = 0.03) and prolonged hospital stay (> 2 weeks, OR 7.1, p = 0.047). Conclusion: These results demonstrate the significance of eosinopenia as a novel prognostic factor in traumatic intracranial hemorrhage in children. (C) 2015 S. Karger AG, Basel	[Hori, Yusuke S.; Fukuhara, Toru; Aoi, Mizuho; Namba, Yoichiro] Okayama Med Ctr, Natl Hosp Org, Dept Neurol Surg, Okayama, Japan		Hori, YS (corresponding author), Okayama Med Ctr, Natl Hosp Org, Dept Neurol Surg, Kita Ku, Tamasu 1711-1, Okayama 7011192, Japan.	ys-hori@umin.ac.jp		Hori, Yusuke S./0000-0002-8195-8979			Alharfi IM, 2013, J NEUROTRAUM, V30, P361, DOI 10.1089/neu.2012.2410; BROHEE D, 1990, INT J NEUROSCI, V53, P53, DOI 10.3109/00207459008986587; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; DALE DC, 1975, J CLIN INVEST, V56, P808, DOI 10.1172/JCI108159; Di Napoli M, 2014, STROKE, V45, P59, DOI 10.1161/STROKEAHA.113.001721; DIAZJOUANEN E, 1975, AM J MED, V58, P620, DOI 10.1016/0002-9343(75)90497-0; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Holland M, 2010, RESPIROLOGY, V15, P165, DOI 10.1111/j.1440-1843.2009.01651.x; Juvela S, 2012, ACTA NEUROCHIR, V154, P397, DOI 10.1007/s00701-011-1243-7; KIRKEBY K, 1956, AM J MED SCI, V232, P50, DOI 10.1097/00000441-195607000-00009; Lopponen P, 2014, J NEUROSURG, V121, P1374, DOI 10.3171/2014.7.JNS132678; MURROS K, 1993, J NEUROL SCI, V116, P12, DOI 10.1016/0022-510X(93)90083-B; Rahimi S, 2014, ACTA NEUROCHIR, V156, P187, DOI 10.1007/s00701-013-1929-0; SHENKIN HA, 1968, J CLIN ENDOCR METAB, V28, P15, DOI 10.1210/jcem-28-1-15; Smith RL, 2012, PEDIATR CRIT CARE ME, V13, P85, DOI 10.1097/PCC.0b013e3182192c30; Stubbs PJ, 1999, CLIN SCI, V96, P589, DOI 10.1042/cs0960589; Terradas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042860; Terruzzi A, 2008, NEUROL SCI, V29, P245, DOI 10.1007/s10072-008-0975-5; Tokgoz S, 2013, J STROKE CEREBROVASC, V22, P1169, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.011; Yang XB, 2014, CLIN NEUROL NEUROSUR, V123, P127, DOI 10.1016/j.clineuro.2014.05.019; Zi WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072758	24	5	5	0	1	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291	1423-0305		PEDIATR NEUROSURG	Pediatr. Neurosurg.		2016	51	2					57	60		10.1159/000441390			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DF2NN	WOS:000371180700001	26636657				2022-02-06	
J	Inozemtseva, O; Perez-Solis, L; Matute, E; Juarez, J				Inozemtseva, Olga; Perez-Solis, Lina; Matute, Esmeralda; Juarez, Jorge			Differential Improvement of Executive Functions During Abstinence in Cocaine-Dependent Patients: A Longitudinal Study	SUBSTANCE USE & MISUSE			English	Article						Executive functions; cocaine dependence; longitudinal study; ecological measures; treatment adherence	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; SELF-AWARENESS; CRACK-COCAINE; ECOLOGICAL VALIDITY; INHIBITORY CONTROL; ADDICTION; DEFICITS; ABUSERS; USERS	Background: In substance abusers, deficits in executive functioning (EF) are relevant to understanding the behavioral regulation of substance consumption and the failure to remain abstinent. Objective: To determine the course of EF impairment, measured with traditional and ecological instruments, after 1 and 3months of abstinence in patients with cocaine dependence. Methods: 26 cocaine-only-dependent in-patients (cocaine-dependent group, CDG) and 24 nondependent controls (control group, CG) recruited from a typical population were assessed using several EF tests and questionnaires [Stroop, verbal and graphic fluency, Wisconsin Card-Sorting Test (WCST), Tower of London (TOL), and Behavior Rating Inventory of Executive Function-Adult Version (BRIEF-A)] after three periods of abstinence: 1week, 1 month, and 3months. Results: At 1week (baseline), CDG underperformed CG on most EF measures (WCST categories completed; TOL-total number of moves, execution time, and rule violations; and various BRIEF-A subscales). At 1 month, CDG moderately improved its performance on several measures, meanwhile the improvement in the 12 patients who would eventually complete the 3-month abstinence proved particularly significant when compared to their baseline values. In the a posteriori comparison of the baseline values of noncompleters versus completers, scores for the former were lower on the EF tasks, but higher on the BRIEF-A. Both groups, showed significantly worse scores than CG on both instruments. Conclusions/importance: Cocaine-dependent patients showed marked difficulties in the EF associated mainly with adaptive behavior to their environment. Cocaine-dependent patients with better EF at baseline improved significantly during abstinence and had better treatment adherence. Results suggest that executive improvement and treatment adherence in cocaine abusers in abstinence is related to intrinsic cognitive characteristics of patients.	[Inozemtseva, Olga; Perez-Solis, Lina; Matute, Esmeralda; Juarez, Jorge] Univ Guadalajara, Inst Neurociencias, Francisco de Quevedo 180, Guadalajara 44130, Jalisco, Mexico; [Inozemtseva, Olga; Matute, Esmeralda] Univ Guadalajara, Dept Educ, Zapopan, Mexico		Inozemtseva, O (corresponding author), Univ Guadalajara, Inst Neurociencias, Francisco de Quevedo 180, Guadalajara 44130, Jalisco, Mexico.	oinozem@gmail.com	Inozemtseva, Olga/AAE-1839-2020		Consejo Nacional de Ciencia y TecnologiaConsejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2006, 62366]	This work was supported by the Consejo Nacional de Ciencia y Tecnologia [Grant number CB-2006#62366].	Adinoff B, 2003, AM J PSYCHIAT, V160, P1892, DOI 10.1176/appi.ajp.160.10.1892; Aharonovich E, 2006, DRUG ALCOHOL DEPEN, V81, P313, DOI 10.1016/j.drugalcdep.2005.08.003; Babor TF, 2001, AUDIT ALCOHOL USE DI; Bates ME, 2005, ALCOHOL CLIN EXP RES, V29, P367, DOI 10.1097/01.ALC.0000156131.88125.2A; Berg WK, 2002, J CLIN EXP NEUROPSYC, V24, P586, DOI 10.1076/jcen.24.5.586.1006; BERRY J, 1993, DRUG ALCOHOL DEPEN, V32, P231, DOI 10.1016/0376-8716(93)90087-7; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bolla K, 2004, J NEUROPSYCH CLIN N, V16, P456, DOI 10.1176/appi.neuropsych.16.4.456; Bolla KI, 2000, NEUROLOGY, V54, P2285, DOI 10.1212/WNL.54.12.2285; BROWN TG, 1993, J SUBST ABUSE TREAT, V10, P545, DOI 10.1016/0740-5472(93)90058-A; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Colzato LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001143; Crews FT, 2009, PHARMACOL BIOCHEM BE, V93, P237, DOI 10.1016/j.pbb.2009.04.018; Culbertson W, 2001, TOWER OF LONDON; De Oliveira LG, 2009, SUBST USE MISUSE, V44, P1941, DOI 10.3109/10826080902848897; Di Sclafani V, 2002, DRUG ALCOHOL DEPEN, V66, P161, DOI 10.1016/S0376-8716(01)00197-1; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; Ersche KD, 2008, PSYCHOPHARMACOLOGY, V197, P421, DOI 10.1007/s00213-007-1051-1; Ersche KD, 2006, NEUROPSYCHOPHARMACOL, V31, P1036, DOI 10.1038/sj.npp.1300889; Feil J, 2010, NEUROSCI BIOBEHAV R, V35, P248, DOI 10.1016/j.neubiorev.2010.03.001; Garcia-Molina A, 2007, AN PSICOL-SPAIN, V23, P289; Golden CJ, 1978, STROOP COLOR WORD TE; Guevara-Perez M. A., 2011, COMO TOMAMOS DECISIO, P129; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Hoff AL, 1996, PSYCHIAT RES, V60, P167, DOI 10.1016/0165-1781(96)02758-8; Johnson BA, 2005, J CEREBR BLOOD F MET, V25, P928, DOI 10.1038/sj.jcbfm.9600093; Jovanovski D, 2005, J CLIN EXP NEUROPSYC, V27, P189, DOI 10.1080/13803390490515694; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Matochik JA, 2003, NEUROIMAGE, V19, P1095, DOI 10.1016/S1053-8119(03)00244-1; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Ostrosky F., 2003, NEUROPSI ATENCION ME; Potvin S, 2014, J ADDICT MED, V8, P368, DOI 10.1097/ADM.0000000000000066; Rosselli M, 1996, J CLIN EXP NEUROPSYC, V18, P122, DOI 10.1080/01688639608408268; Rosselli M, 2001, INT J NEUROSCI, V110, P55, DOI 10.3109/00207450108994221; Roth RM, 2005, BRIEF A BEHAV RATING; Sanchez-Hervas E, 2010, ADICCIONES, V22, P59, DOI 10.20882/adicciones.215; van Gorp WG, 1999, ARCH GEN PSYCHIAT, V56, P85, DOI 10.1001/archpsyc.56.1.85; Velazquez Moctezuma J., 2004, TEMAS SELECTOS NEURO, P225; Verdejo-Garcia A, 2007, DRUG ALCOHOL DEPEN, V90, P48, DOI 10.1016/j.drugalcdep.2007.02.010; Verdejo-Garcia A, 2007, PSYCHOPHARMACOLOGY, V190, P517, DOI 10.1007/s00213-006-0632-8; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; Vonmoos M, 2014, NEUROPSYCHOPHARMACOL, V39, P2200, DOI 10.1038/npp.2014.71; Wechsler D., 2003, WECHSLER ADULT INTEL; Zarzuela A., 2004, INT J CLIN HLTH PSYC, V4, P271	50	5	6	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2016	51	11					1428	1440		10.1080/10826084.2016.1178293			13	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	DU6LF	WOS:000382325500004	27355934				2022-02-06	
J	Jiang, ST; Chen, WH; Zhang, YM; Zhang, YJ; Chen, AL; Dai, QF; Lin, SJ; Lin, HY				Jiang, Shuting; Chen, Weihao; Zhang, Yimin; Zhang, Yujuan; Chen, Ailian; Dai, Qiufu; Lin, Shujun; Lin, Hanyu			Acupuncture Induces the Proliferation and Differentiation of Endogenous Neural Stem Cells in Rats with Traumatic Brain Injury	EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE			English	Article								Purpose. To investigate whether acupuncture induced the proliferation and differentiation of endogenous neural stem cells (NSCs) in a rat model of traumatic brain injury (TBI). Methods. 104 Sprague-Dawley rats were randomly divided into normal, model, and acupuncture groups. Each group was subdivided into three-day (3 d), seven-day (7 d), and fourteen-day (14 d) groups. The rat TBI model was established using Feeney's freefall epidural impact method. The rats in the acupuncture group were treated at acupoints (Baihui, Shuigou, Fengfu, Yamen, and bilateral Hegu). The normal and model groups did not receive acupuncture. The establishment of the rat TBI model and the therapeutic effect of acupuncture were assessed using neurobehavioral scoring and hematoxylin-eosin staining. The proliferation and differentiation of NSCs in TBI rats were analyzed using immunofluorescence microscopy. Results. The levels of nestin-expressing cells and bromodeoxyuridine/glial fibrillary acidic protein-(BrdU/GFAP-) and BrdU/S100 calcium-binding protein B-positive and BrdU/microtubule-associated protein 2- and BrdU/galactocerebrosidase-positive cells were more significantly increased at various time points in the acupuncture group than in the model group (P < 0.01), except for a decreased level of BrdU/GFAP-positive cells at 7 d and 14 d. Conclusion. Acupuncture induced the proliferation and differentiation of NSCs, thereby promoting neural repair in the TBI rats.	[Jiang, Shuting; Chen, Weihao; Zhang, Yimin; Zhang, Yujuan; Dai, Qiufu; Lin, Shujun; Lin, Hanyu] Jinan Univ, Coll Med, 601 Huangpu West Ave, Guangzhou 510632, Guangdong, Peoples R China; [Chen, Ailian] Xiangzhou Dist Peoples Hosp, 178 Lanpu Rd, Zhuhai 519070, Guangdong, Peoples R China		Zhang, YM (corresponding author), Jinan Univ, Coll Med, 601 Huangpu West Ave, Guangzhou 510632, Guangdong, Peoples R China.	zhangymjnu@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273827, 8157150721]; Fundamental Research Funds for the Central Universities, ChinaFundamental Research Funds for the Central Universities [11615427]	This work was supported by the Natural Science Foundation of China (Grants nos. 81273827 and 8157150721) and the Fundamental Research Funds for the Central Universities, China (no. 11615427).	Abraha HD, 1997, ANN CLIN BIOCHEM, V34, P546, DOI 10.1177/000456329703400510; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Hermann A, 2006, STEM CELLS, V24, P949, DOI 10.1634/stemcells.2005-0192; Huang Y. J., 2007, CHINESE J REHABILITA, P380; Huh JW, 2003, J NEUROTRAUM, V20, P975, DOI 10.1089/089771503770195821; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Kool B, 2012, NEUROEPIDEMIOLOGY, V38, P179, DOI 10.1159/000337261; [李明军 Li Mingjun], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P5709; Mertins SD, 2001, CLIN CANCER RES, V7, P620; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wu L., 2010, CHINESE J REHABILITA, P201; Yang H. M., 2007, J CHONGQING MED U, P812; Yu H. R., 2005, CHINESE J ANATOMY, P526; Zhang Y., 2015, CHINA ACAD ART, P1, DOI DOI 10.1177/0734016815573309; Zhang Y. M., 2012, CHINESE J PATHOPHYSI, P1132; Zhang Y. M., 2014, CHINESE J GERONTOLOG, P6100; Zhang YM, 2016, ACUPUNCT MED, V34, P48, DOI 10.1136/acupmed-2014-010742; Zhang YM, 2013, CHIN J INTEGR MED, V19, P132, DOI 10.1007/s11655-013-1353-6	20	5	8	1	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1741-427X	1741-4288		EVID-BASED COMPL ALT	Evid.-based Complement Altern. Med.		2016	2016								2047412	10.1155/2016/2047412			8	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	DN9LV	WOS:000377402000001	27313641	Green Published, gold, Green Submitted			2022-02-06	
J	Jones, KM; Kydd, R; Broadbent, E; Theadom, A; Barker-Collo, S; Edwards, H; Feigin, VL				Jones, Kelly M.; Kydd, Rob; Broadbent, Elizabeth; Theadom, Alice; Barker-Collo, Suzanne; Edwards, Holly; Feigin, Valery L.		BIONIC Study Grp	Brain drawings following traumatic brain injury (TBI) and links to illness perceptions and health outcomes - Findings from a population-based study	PSYCHOLOGY & HEALTH			English	Article						drawings; post-concussion symptoms; illness perceptions; traumatic brain injury; quality of life	QUALITY-OF-LIFE; POST-CONCUSSION SYMPTOMS; MILD HEAD-INJURY; NEW-ZEALAND; DISEASE; QUESTIONNAIRE; PREDICTORS; SPECTRUM; ADULTS; LUPUS	Objective: Individuals' illness perceptions predict health behaviours and influence functional outcomes. This study examined associations between a novel assessment of illness perceptions, in the form of adult's brain drawings after traumatic brain injury (TBI) and questionnaire measures of illness perceptions, quality of life and post-concussive symptoms.Design: Population-based, prospective longitudinal study examining 245 adults with predominantly mild TBI with high risk of complications.Main outcome measures: Participants were asked to draw pictures of what they thought their brain looked like before injury and at baseline and one month post-injury. Drawing characteristics (height, width and percentage damage at one month) were examined in relation to each outcome of interest at six months.Results: Greater damage at one month was associated with more negative illness perceptions (rs=.23), poorer mental health (rs=-.21), and more total post-concussive symptoms (rs=.27 to r=.35) at six months. The extent of damage depicted reduced over time (p<.001). No associations were found between the amount of damage drawn and injury severity, nor the height or width of drawings and injury severity or illness perceptions.Conclusion: Drawings post-TBI offer a simple, cost- and time-effective way to begin discussions and improve understanding of peoples' illness perceptions.	[Jones, Kelly M.; Theadom, Alice; Feigin, Valery L.] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Auckland, New Zealand; [Kydd, Rob] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Broadbent, Elizabeth] Univ Auckland, Dept Psychol Med, Fac Med & Hlth Sci, Auckland, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Edwards, Holly] Kings Coll London, Inst Psychiat, London, England		Jones, KM (corresponding author), Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Fac Hlth & Environm Studies, Auckland, New Zealand.	kejones@aut.ac.nz	Jones, Kelly/I-5199-2019; Feigin, Valery/AAF-2313-2019	Feigin, Valery L./0000-0002-6372-1740; Broadbent, Elizabeth/0000-0003-3626-9100	Health Research Council of New ZealandHealth Research Council of New Zealand [HRC 09/063A]	This work was supported by the Health Research Council of New Zealand [grant number HRC 09/063A].	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Benton A. L., 1989, MILD HEAD INJURIES; BROADBENT EA, 2004, J PSYCHOSOM RES, V60, P631; Broadbent E, 2006, PSYCHOSOM MED, V68, P910, DOI 10.1097/01.psy.0000242121.02571.10; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Broadbent E, 2015, PSYCHOL HEALTH, V30, P1361, DOI 10.1080/08870446.2015.1070851; Broadbent E, 2009, J PSYCHOSOM RES, V66, P465, DOI 10.1016/j.jpsychores.2008.09.006; Burholt V, 2011, J PUBLIC HEALTH-UK, V33, P587, DOI 10.1093/pubmed/fdr006; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Daleboudt GMN, 2011, LUPUS, V20, P290, DOI 10.1177/0961203310385552; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Gabriels RL, 2000, J ASTHMA, V37, P565, DOI 10.3109/02770900009090811; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Guillemin M, 2004, HEALTH-LONDON, V8, P223, DOI 10.1177/1363459304041071; Guillemin M, 2004, QUAL HEALTH RES, V14, P272, DOI 10.1177/1049732303260445; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Lin MR, 2010, ARCH PHYS MED REHAB, V91, P474, DOI 10.1016/j.apmr.2009.10.031; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Locsin R C, 2003, Int Nurs Rev, V50, P156, DOI 10.1046/j.1466-7657.2003.00194.x; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Nowicka-Sauer K, 2007, CLIN RHEUMATOL, V26, P1523, DOI 10.1007/s10067-007-0619-9; Pesut D, 2014, CLIN RESPIR J, V8, P364, DOI 10.1111/crj.12082; Petrie KJ, 2006, CLIN MED, V6, P536, DOI 10.7861/clinmedicine.6-6-536; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; Petrie KJ, 2012, CURR DIR PSYCHOL SCI, V21, P60, DOI 10.1177/0963721411429456; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Reynolds L, 2007, J PSYCHOSOM RES, V63, P525, DOI 10.1016/j.jpsychores.2007.03.007; Scharloo M, 2005, HEAD NECK-J SCI SPEC, V27, P857, DOI 10.1002/hed.20251; Scharloo M, 2007, J ASTHMA, V44, P575, DOI 10.1080/02770900701537438; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Taft TH, 2011, QUAL LIFE RES, V20, P1391, DOI 10.1007/s11136-011-9883-x; Te Ao B, 2014, NEUROLOGY, V83, P1645, DOI 10.1212/WNL.0000000000000933; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Tiemensma J, 2012, J CLIN ENDOCR METAB, V97, P3123, DOI 10.1210/jc.2012-1235; Turp JC, 1998, J DENT RES, V77, P1465, DOI 10.1177/00220345980770061101; van Leeuwen BM, 2015, LARYNGOSCOPE, V125, P2660, DOI 10.1002/lary.25386; Var FA, 2012, INDIAN J PSYCHOL MED, V34, P223, DOI 10.4103/0253-7176.106014; War FA, 2013, INDIAN J NEUROTRAUM, V10, P115, DOI 10.1016/j.ijnt.2013.12.004; Ware J.E., 1994, SF 36 PHYS MENTAL SU; Weinman J, 1997, J PSYCHOSOM RES, V42, P113, DOI 10.1016/S0022-3999(96)00294-2; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wood R. L., 2007, J NEUROL NEUROSUR PS, V78, P644, DOI [10.1136/jnnp.2006.101105, DOI 10.1136/JNNP.2006.101105]; World Health Organization, 2004, ICD 10 INT STAT CLAS	64	5	5	1	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0887-0446	1476-8321		PSYCHOL HEALTH	Psychol. Health		2016	31	10					1182	1202		10.1080/08870446.2016.1193178			21	Public, Environmental & Occupational Health; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Psychology	DW8EV	WOS:000383887900004	27213245				2022-02-06	
J	Kearns, WD; Scott, S; Fozard, JL; Dillahunt-Aspillaga, C; Jasiewicz, JM				Kearns, William D.; Scott, Steven; Fozard, James L.; Dillahunt-Aspillaga, Christina; Jasiewicz, Jan M.			Decreased Movement Path Tortuosity Is Associated With Improved Functional Status in Patients With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						brain injuries; military personnel; movement variability in everyday ambulation; rehabilitation	PORTLAND ADAPTABILITY INVENTORY; REHABILITATION; VETERANS; UTILITY	Objective: To determine if movement path tortuosity in everyday ambulation decreases in Veterans being treated in a residential setting for traumatic brain injury. Elevated path tortuosity is observed in assisted living facility residents with cognitive impairment and at risk for falls, and tortuosity may decrease over the course of cognitive rehabilitation received by the Veterans. If observed, decreased tortuosity may be linked to improved clinical outcomes. Design: Longitudinal observational study without random assignment. Setting: Veterans Affairs Medical Center inpatient residential polytrauma treatment facility. Patients: Twenty-two Veterans enrolled in a postacute predischarge residential polytrauma treatment facility. Interventions: None, observation-only. Main Outcome Measure: Mayo-Portland Adaptability Index-4, and movement path tortuosity measured by Fractal Dimension (Fractal D). Fractal D was obtained continuously from an indoor movement tracking system primarily used to provide machine-generated prompts and reminders to facilitate activities of daily living. Patients were deemed "responders" (N = 10) if a significant linear decline in Fractal D occurred over the course of treatment, or nonresponders (N = 12) if no significant decline was observed. Results: Responders had lower discharge Mayo-Portland Adaptability Inventory scores (mean = 32.6, SD = 9.53) than non-responders (mean = 39.5, SD = 6.02) (F = 2.07, df = 20, P = .05). Responders and nonresponders did not differ on initial injury severity or other demographic measures. Conclusions: Fractal D, a relatively simple measure of movement path tortuosity can be linked to functional recovery from traumatic brain injury.	[Kearns, William D.; Fozard, James L.; Dillahunt-Aspillaga, Christina] Univ S Florida, James A Haley Vet Adm Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33620 USA; [Kearns, William D.; Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Coll Behav & Community Sci, Tampa, FL 33620 USA; [Kearns, William D.; Scott, Steven] James A Haley Vet Adm Hosp, Phys Med & Rehabil Serv, Tampa, FL USA; [Fozard, James L.] Univ S Florida, Sch Aging Studies, Coll Behav & Community Sci, Tampa, FL 33620 USA; [Jasiewicz, Jan M.] James A Haley Vet Adm Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL USA		Kearns, WD (corresponding author), Univ S Florida, James A Haley Vet Adm Hosp, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33620 USA.; Kearns, WD (corresponding author), Univ S Florida, Dept Rehabil & Mental Hlth Counseling, Coll Behav & Community Sci, Tampa, FL 33620 USA.	kearns@usf.edu	Kearns, William D/F-9810-2015	Kearns, William D/0000-0002-0241-814X	US Department of Veterans Affairs T-21 Non-Institutional Long-Term Care grant entitled "Design of a Patient Centered 'Welcome Home' for Independent Living" - Office of Geriatric and Extended CareUS Department of Veterans Affairs	This work was supported by the US Department of Veterans Affairs T-21 Non-Institutional Long-Term Care grant entitled "Design of a Patient Centered 'Welcome Home' for Independent Living" awarded by the Office of Geriatric and Extended Care to Jan M. Jasiewicz. The authors thank Mss Kristina Martinez and Jay Larsen for their efforts in compiling clinical measures for this article.	Algase DL, 2007, AGING MENT HEALTH, V11, P686, DOI 10.1080/13607860701366434; BERGMAN MM, 1998, COGNITIVE TECHNOLOGY, V3, P45; Craighead J, 2009, SAF SEC RESC ROB SSR; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jasiewicz J, 2011, J REHABIL RES DEV, V48, pVII, DOI 10.1682/JRRD.2011.07.0129; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; Kean J, 2013, ARCH PHYS MED REHAB, V94, P2417, DOI 10.1016/j.apmr.2013.08.006; Kearns William D., 2011, Gerontechnology, V10, P90, DOI 10.4017/gt.2011.10.2.004.00; Kearns WD, 2010, METHOD INFORM MED, V49, P592, DOI 10.3414/ME09-01-0079; Kearns William D, 2008, Gerontechnology, V7, P48, DOI 10.4017/gt.2008.07.01.005.00; Kearns W, 2012, AMB INTELL SMART ENV, V11, P331, DOI 10.3233/978-1-60750-837-3-331; Kearns WD, 2015, J HEAD TRAUMA REHAB, V30, pE8, DOI 10.1097/HTR.0000000000000021; Kearns WD, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.06.010; Kupersmith J, 2009, J REHABIL RES DEV, V46, pvii; Levin HS, 2003, BRAIN INJURY, V17, P665, DOI 10.1080/0269905031000107151; Malec J. F., 2003, MANUAL MAYO PORTLAND; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; McCulloch K, 2015, J HEAD TRAUMA REHAB, V30, P38, DOI 10.1097/HTR.0000000000000041; Murrey GJ, 2005, BRAIN INJURY, V19, P599, DOI 10.1080/02699050400025257; Nams VO, 2006, ANIM BEHAV, V72, P1197, DOI 10.1016/j.anbehav.2006.04.005; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Stuster J., 2002, DEV STANDARDIZED FIE, P25; Verghese J, 2002, NEW ENGL J MED, V347, P1761, DOI 10.1056/NEJMoa020441; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001	29	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					E13	E19		10.1097/HTR.0000000000000125			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000002	25931181				2022-02-06	
J	Kolakowsky-Hayner, SA; Bellon, K; Yang, Y				Kolakowsky-Hayner, Stephanie A.; Bellon, Kimberly; Yang, Yvonne			Unintentional injuries after TBI: Potential risk factors, impacts, and prevention	NEUROREHABILITATION			English	Article						Traumatic brain injury; unintentional injury prevention; repeat TBI; seizure; lack of balance and coordination; fatigue; alcohol and drug abuse	TRAUMATIC BRAIN-INJURY; LATE POSTTRAUMATIC SEIZURES; SLEEP-WAKE DISTURBANCES; SPINAL-CORD; SUBSEQUENT INJURIES; SUBSTANCE-ABUSE; HEAD-INJURY; ALCOHOL; EPILEPSY; FATIGUE	BACKGROUND: The top three causes of fatal unintentional injuries are falls, motor vehicle crashes, and being struck against or struck by objects or persons. These etiologies also happen to be the leading causes of TBI, a serious public health problem, in the US. Reduced cognitive functioning, poor decision making, increased risk taking, disinhibition, diminished safety skills and substance use, place individuals with TBI at an increased risk for subsequent unintentional injuries. The caregiving, psychological, social and financial burden of initial injuries is enormous. Unintentional injuries post-TBI add to that burden significantly. Many unintentional injuries can be prevented with simple education and environment and lifestyle changes. Injury prevention requires collaboration among many. OBJECTIVE: This literature review will share information regarding potential triggers or causes of unintentional injuries after TBI to identify potential issues. The many impacts of these injuries will be reviewed. Best practices in prevention will be presented. CONCLUSION: Ultimately, education, discussion, and awareness across multiple stakeholders can aid in preventing unintentional injuries after TBI.	[Kolakowsky-Hayner, Stephanie A.] Brain Trauma Fdn, Campbell, CA USA; [Kolakowsky-Hayner, Stephanie A.; Bellon, Kimberly; Yang, Yvonne] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA		Kolakowsky-Hayner, SA (corresponding author), Brain Trauma Fdn, 1 Broadway,6th Fl, New York, NY 10004 USA.; Kolakowsky-Hayner, SA (corresponding author), 1999 S Bascom Ave,Suite 1040, Campbell, CA 95008 USA.	sakhayner@braintrauma.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Bay Esther, 2006, Care Manag J, V7, P3, DOI 10.1891/cmaj.7.1.3; Beghi E, 2010, EPILEPSIA, V51, P671, DOI 10.1111/j.1528-1167.2009.02285.x; Bell K., 2009, FATIGUE TRAUMATIC BR; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bombardier C., 2011, ALCOHOL USE TRAUMATI; Borges G, 2013, SUBST USE MISUSE, V48, P484, DOI 10.3109/10826084.2013.778277; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Bushnik T, 2012, J HEAD TRAUMA REHAB, V27, pE36, DOI 10.1097/HTR.0b013e318273375c; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US F; Centers for Disease Control and Prevention National Center for Health Statistics, 2010, NAT HOSP AMB MED CAR; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; Clark RA, 2012, ARCH PHYS MED REHAB, V93, P636, DOI 10.1016/j.apmr.2011.11.002; Corrigan J. D., 2004, SUBSTANCE ABUSE ISSU; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Department of Motor Vehicles, DRIV SAF INF LAPS CO; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Englander J., 2010, SEIZURES TRAUMATIC B; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Faul M, 2010, TRAUMATIC BRAIN INJU; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Freivogel S, 2008, BRAIN INJURY, V22, P625, DOI 10.1080/02699050801941771; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Heron M, 2010, NATL VITAL STAT REPO, V62; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kolakowsky-Hayner SA, 2013, BRAIN INJURY, V27, P578, DOI 10.3109/02699052.2013.765595; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Krause JS, 2010, ARCH PHYS MED REHAB, V91, P1741, DOI 10.1016/j.apmr.2010.07.219; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1503, DOI 10.1016/j.apmr.2004.01.017; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Maric NP, 2010, J ENDOCRINOL INVEST, V33, P770, DOI [10.3275/7045, 10.1007/BF03350340]; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; Meeusen R, 2014, SPORTS MED, V44, P47, DOI 10.1007/s40279-014-0150-5; Moriello G, 2009, J NEUROL PHYS THER, V33, P111, DOI 10.1097/NPT.0b013e3181a6ab6b; Murphy M., 2013, REHABILITATION NURSI, P1; Neumann D., 2009, COGNITIVE PROBLEMS T; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Nicholl J, 2009, SEMIN NEUROL, V29, P247, DOI 10.1055/s-0029-1223878; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Peterson M., 2011, BALANCE PROBLEMS TBI; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Prins ML, 2012, INT J DEV NEUROSCI, V30, P185, DOI 10.1016/j.ijdevneu.2011.05.009; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Rinne MB, 2006, J REHABIL MED, V38, P224, DOI 10.1080/16501970600582989; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scherer M, 2007, BRAIN INJURY, V21, P93, DOI 10.1080/02699050601149104; Schutte C, 2010, INT J NEUROSCI, V120, P551, DOI 10.3109/00207454.2010.494789; Seif-Naraghi AH, 1999, J HEAD TRAUMA REHAB, V14, P146, DOI 10.1097/00001199-199904000-00005; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; Tateno A, 2003, J NEUROPSYCH CLIN N, V15, P155, DOI 10.1176/appi.neuropsych.15.2.155; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Vaaramoa K., 2013, EUROPEAN J NEUROLOGY, P1; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams G, 2012, BRAIN INJURY, V26, P1065, DOI 10.3109/02699052.2012.667586; Williams G, 2010, NEUROREHAB NEURAL RE, V24, P550, DOI 10.1177/1545968309357925; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2010, J HEAD TRAUMA REHAB, V25, P164, DOI 10.1097/HTR.0b013e3181dc120b; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; Wilson DA, 2014, EPILEPSY BEHAV, V32, P42, DOI 10.1016/j.yebeh.2013.12.035; Zatzick D, 2014, JAMA PEDIATR, V168, P532, DOI 10.1001/jamapediatrics.2013.4784	81	5	5	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	3					363	370		10.3233/NRE-161368			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DW7XA	WOS:000383865200004	27497469				2022-02-06	
J	Kopczak, A; Krewer, C; Schneider, M; Kreitschmann-Andermahr, I; Schneider, HJ; Stalla, GK				Kopczak, Anna; Krewer, Carmen; Schneider, Manfred; Kreitschmann-Andermahr, Ilonka; Schneider, Harald Joern; Stalla, Guenter Karl			The Development of Neuroendocrine Disturbances over Time: Longitudinal Findings in Patients after Traumatic Brain Injury and Subarachnoid Hemorrhage	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						hypopituitarism; traumatic brain injury; subarachnoid hemorrhage; neuroendocrinology; posttraumatic hypopituitarism	POSTTRAUMATIC HYPOPITUITARISM; PITUITARY DYSFUNCTION; CRITICAL ILLNESS; PREVALENCE; AUTOIMMUNITY; DATABASE; STRESS	Previous reports suggest that neuroendocrine disturbances in patients with traumatic brain injury (TBI) or aneurysmal subarachnoid hemorrhage (SAH) may still develop or resolve months or even years after the trauma. We investigated a cohort of n = 168 patients (81 patients after TBI and 87 patients after SAH) in whom hormone levels had been determined at various time points to assess the course and pattern of hormonal insufficiencies. Data were analyzed using three different criteria: (1) patients with lowered basal laboratory values; (2) patients with lowered basal laboratory values or the need for hormone replacement therapy; (3) diagnosis of the treating physician. The first hormonal assessment after a median time of three months after the injury showed lowered hormone laboratory test results in 35% of cases. Lowered testosterone (23.1% of male patients), lowered estradiol (14.3% of female patients) and lowered insulin-like growth factor I (IGF-I) values (12.1%) were most common. Using Criterion 2, a higher prevalence rate of 55.6% of cases was determined, which correlated well with the prevalence rate of 54% of cases using the physicians' diagnosis as the criterion. Intraindividual changes (new onset insufficiency or recovery) were predominantly observed for the somatotropic axis (12.5%), the gonadotropic axis in women (11.1%) and the corticotropic axis (10.6%). Patients after TBI showed more often lowered IGF-I values at first testing, but normal values at follow-up (p < 0.0004). In general, most patients remained stable. Stable hormone results at follow-up were obtained in 78% (free thyroxine (fT4) values) to 94.6% (prolactin values).	[Kopczak, Anna; Stalla, Guenter Karl] Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, Kraepelinstr 2-10, D-80804 Munich, Germany; [Krewer, Carmen; Schneider, Manfred] Schon Klin Bad Aibling, Kolbermoorer Str 72, D-83043 Bad Aibling, Germany; [Kreitschmann-Andermahr, Ilonka] Univ Duisburg Essen, Dept Neurosurg, Hufelandstr 55, D-45147 Essen, Germany; [Schneider, Harald Joern] Univ Munich, Dept Endocrinol, Ziemssenstr 1, D-80336 Munich, Germany		Kopczak, A (corresponding author), Max Planck Inst Psychiat, Clin Neuroendocrinol Grp, Kraepelinstr 2-10, D-80804 Munich, Germany.	anna_kopczak@psych.mpg.de; CKrewer@schoen-kliniken.de; MSchneider@schoen-kliniken.de; ilonka.kreitschmann@uk-essen.de; harald.schneider@med.uni-muenchen.de; stalla@psych.mpg.de	Krewer, Carmen/H-2845-2019	Krewer, Carmen/0000-0002-4153-0791; Kopczak, Anna/0000-0002-5037-2342	IpsenIpsen; PfizerPfizer; LillyEli Lilly; SandozNovartis; Pfizer GmbH Germany	Anna Kopczak received travel grants from Ipsen. Harald Jorn Schneider received research and travel grants and speaker fees from Pfizer and travel grants from Lilly and Sandoz. Ilonka Kreitschmann-Andermahr is a member of the German PAtients TReated with Omnitrope (R) (PATRO)(R) board. Carmen Krewer, Manfred Schneider and Gunter Karl Stalla declare no conflict of interest. The Structured Data Assessment of Hypopituitarism after TBI and SAH was supported financially by an independent investigator grant from Pfizer GmbH Germany to Gunter Karl Stalla, Clinical Neuroendocrinology Group, Max Planck Institute (MPI) of Psychiatry, Munich, Germany, the details of which are outlined in a contract between the MPI Munich and the pharmaceutical company. The grant covers the set-up of the database. Pfizer has no access to the data included in the database and does not have the right to analyze the data independently.	Agha A, 2005, AM J PHYS MED REHAB, V84, P381, DOI 10.1097/01.PHM.0000156898.47097.93; Agha Amar, 2005, Am J Med, V118, P1416; Boonen E, 2014, CURR OPIN ENDOCRINOL, V21, P185, DOI 10.1097/MED.0000000000000066; Guaraldi F, 2015, J CLIN MED, V4, P1025, DOI 10.3390/jcm4051025; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; JENNETT B, 1975, LANCET, V1, P480; JORGENSEN EV, 1993, J PEDIATR ENDOCRINOL, V6, P131; Kalantaridou SN, 2004, J REPROD IMMUNOL, V62, P61, DOI 10.1016/j.jri.2003.09.004; Karaca Z, 2013, PITUITARY, V16, P76, DOI 10.1007/s11102-012-0377-9; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; Kreitschmann-Andermahr Ilonka, 2005, Pituitary, V8, P219, DOI 10.1007/s11102-006-6044-2; Krewer C., 2015, NEUROENDOCR IN PRESS; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; Nemes O, 2015, HORM-INT J ENDOCRINO, V14, P383, DOI 10.14310/horm.2002.1564; Poll EM, 2013, STRESS, V16, P153, DOI 10.3109/10253890.2012.697946; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2007, LANCET, V369, P1461, DOI 10.1016/S0140-6736(07)60673-4; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Streetz-van der Werf C, 2015, J CLIN MED, V4, P965, DOI 10.3390/jcm4050965; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2008, CLIN ENDOCRINOL, V68, P573, DOI 10.1111/j.1365-2265.2007.03070.x; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; Vanhorebeek I, 2006, NAT CLIN PRACT ENDOC, V2, P20, DOI 10.1038/ncpendmet0071; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594	29	5	5	0	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	JAN	2016	17	1							2	10.3390/ijms17010002			12	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	DK0DW	WOS:000374583800002	26703585	gold, Green Published			2022-02-06	
J	Lebeer, J				Lebeer, Jo			Significance of the Feuerstein approach in neurocognitive rehabilitation	NEUROREHABILITATION			English	Article						Cognitive rehabilitation; Feuerstein's theory of structural cognitive modifiability; acquired brain damage; mediated learning experience; ecological plasticity; dynamic assessment	ENVIRONMENTAL ENRICHMENT; BRAIN; PLASTICITY; EXPERIENCE; CHILDREN; INJURY; NEED	BACKGROUND: The theory of Structural Cognitive Modifiability and Mediated Learning Experience of Reuven Feuerstein states that individuals with brain impairment, because of congenital or acquired origin, may substantially and structurally improve their cognitive functioning, by a systematic intervention based on a specific, criteria-based type of interaction ("mediated learning"). Three application systems are based on it: a dynamic-interactive assessment of learning capacity and processes of learning, the LPAD (Learning Propensity Assessment Device); a cognitive intervention program called "Instrumental Enrichment Program", which trains cognitive, metacognitive and executive functions; and a program, which is oriented at working in context, Shaping Modifying Environments. These programs have been applied in widely different target groups: from children and young adults with learning and developmental disabilities, at risk of school failure, or having failed at school, because of socio-economic disadvantage or congenital neurological impairment; disadvantaged youngsters and adults in vocational training, to elderly people at the beginning of a dementia process. Experience with cognitive rehabilitation of children and adults with acquired brain damage, has been relatively recent, first in the Feuerstein Institute's Brain Injury Unit in Jerusalem, later in other centers in different parts of the world; therefore scientific data are scarce. OBJECTIVES: The purpose of this paper is to examine how the Feuerstein-approach fits into the goals and proposed approaches of cognitive rehabilitation, and to explore its relevance for assessment and intervention in individuals with congenital or acquired brain damage. METHODS: The methodology of the Feuerstein approach consists of four pillars: dynamic assessment, cognitive activation, mediated learning and shaping a modifying environment. The criteria of mediated learning experience are explained with specific reference to people with acquired brain injury. The procedure of learning propensity assessment device uses visuo-spatial and verbal tasks known from neuropsychological assessment (such as Rey's complex figure drawing), as well as a in a pre-test - brief intervention - post-test format. Cognitive activation is done in various ways: a paper-and-pencil relatively content-free program called "instrumental enrichment", with transfer of learned principles into daily life situations, followed by metacognitive feedback. Four case histories of acquired brain damage are analyzed: a 19 year old man with extensive post-astrocytoma frontotemporal brain lesions; a 19 year old man with bilateral frontal and right temporal and parieto-occipital parenchymatous destruction after a traumatic brain injury; a 24 year old man with hemispherectomy for intractable epilepsy because of Sturge-Weber syndrome; and a 30-year old man with left porencephalic cyst after cerebral hemorrhage. RESULTS: Structural cognitive improvement could be demonstrated in positive change scores in visuo-spatial memory, associative and verbal memory, abstract thinking, and organizing tasks, even more than 10 years post-TBI. In some cases a rise in IQ has been documented. Improvement in daily life functioning and academic skills (re)learning has also been seen. CONCLUSIONS: Though impossible to claim scientific evidence, the case histories nevertheless suggest the importance of interactive assessment in designing intervention programs which have sufficient intensity, frequency, duration and consistency of mediation; furthermore, an essential ingredient is the ecological approach which requires working with the patient and the whole network around; a firm "belief system" or that modifiability is possible even with severe brain damage and many years after the injury; a cognitive, metacognitive and executive approach, and a quality of interaction according to criteria of mediated learning. They suggest that Feuerstein approach may offer interesting perspectives to cognitive rehabilitation. More extensive research is needed to provide a broader scientific evidence base.	[Lebeer, Jo] Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Unit Disabil Studies Inclus & Enablement, Campus Drie Eiken,Univ Pl 1, B-2610 Antwerp, Belgium		Lebeer, J (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Dept Primary & Interdisciplinary Care, Unit Disabil Studies Inclus & Enablement, Campus Drie Eiken,Univ Pl 1, B-2610 Antwerp, Belgium.	jo.lebeer@uantwerpen.be	Lebeer, Jo/ABB-7961-2021	Lebeer, Jo/0000-0001-5929-7783	European Commission, Life Long Learning Programme	This article has been written as part of the ENABLIN+project. This project has been funded with support from the European Commission, Life Long Learning Programme. This document reflects the views of the authors only, and the Commission cannot be held responsible for any use which may be made of the information contained therein. The author wishes to thank Eva Ohnesorge feedback on the case studies.	Ardoin SP, 2005, J PSYCHOEDUC ASSESS, V23, P362, DOI 10.1177/073428290502300405; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Berns GS, 2013, BRAIN CONNECT, V3, P590, DOI 10.1089/brain.2013.0166; Boosman H, 2014, J INT NEUROPSYCH SOC, V20, P1034, DOI 10.1017/S1355617714000897; Bronfenbrenner U., 1986, DEV ACTION CONTEXT P, P287, DOI [10.1007/978-3-662-02475-1, DOI 10.1007/978-3-662-02475-1]; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Dan B, 2016, DEV MED CHILD NEUROL, V58, P4, DOI 10.1111/dmcn.12985; Dorfzaun-Harif I., 2015, TRANSYLVANIAN J PSYC, V16, P3; DWECK CS, 1986, AM PSYCHOL, V41, P1040, DOI 10.1037/0003-066X.41.10.1040; FEUERSTEIN R, 1979, P361; FEUERSTEIN R, 1981, J SPEC EDUC, V15, P201, DOI 10.1177/002246698101500209; Feuerstein R., 2002, DYNAMIC ASSESSMENT C; Feuerstein R., 2006, CREATING ENHANCING C; Feuerstein R. S., 2000, EXPERIENCE MEDIATED, P147; Forsyth R J, 2004, Pediatr Rehabil, V7, P17; Forsyth R. J., 2004, AM J MENT DEFIC, V83, P539; GUTHKE J, 1992, INTERACTIVE ASSESSME, P64; Hadas-Lidor N., 2014, CLIN ED APPL REUVEN, P133; Hannan AJ, 2014, NEUROPATH APPL NEURO, V40, P13, DOI 10.1111/nan.12102; Haywood HC, 2012, J COGN EDUC PSYCHOL, V11, P217, DOI 10.1891/1945-8959.11.3.217; Haywood HC, 2007, DYNAMIC ASSESSMENT IN PRACTICE: CLINICAL AND EDUCATIONAL APPLICATIONS, P1; Kozulin A, 2002, SCHOOL PSYCHOL INT, V23, P7, DOI 10.1177/0143034302023001729; Kozulin A, 2010, RES DEV DISABIL, V31, P551, DOI 10.1016/j.ridd.2009.12.001; Lebeer J, 1998, DEV MED CHILD NEUROL, V40, P352; Lebeer J., 2011, DIFFERENT GLANCE DYN, P87; Lebeer J., 2013, TRANSYLVANIAN J PSYC, P175; Lebeer J. O., 2014, TRANSYLVANIAN J PSYC, P51; Levit A., 2010, ISRAELI J OCCUPTIONA, V19, P95; Lidz C, 2014, TRANSSYLVANIAN J PSY, P81; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Martin D., 2014, CLIN ED APPL REUVEN, P177; Merzenich M, 2000, NATURE, V404, P820, DOI 10.1038/35009174; Musso M, 1999, BRAIN, V122, P1781, DOI 10.1093/brain/122.9.1781; Pribram K. H., 1971, LANGUAGES BRAIN; Roe A., 1991, J NEUROSCI, V12, P3651; Rosenzweig MR, 1996, BEHAV BRAIN RES, V78, P57, DOI 10.1016/0166-4328(95)00216-2; Samuels M. T., 2001, ED CHILD PSYCHOL, V18, P19; SAVELL JM, 1986, REV EDUC RES, V56, P381; Sharma R., 2002, MY 2 YEARS LIFE ALEX; Sternberg R., 2014, TRANSYLVANIAN J PSYC, P9; Sternberg R. J., 2002, DYNAMIC TESTING NATU; Tzuriel D., 2014, TRANSSYLVANIAN J PSY, P15; Tzuriel D., 2003, J COGNITIVE ED PSYCH, V3, P297; Tzuriel D., 2005, TRANSSYLVANIAN J PSY, V1, P17; Tzuriel D., 2001, ISSUES IN EDUCATION, V7, P237; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VarghaKhadem F, 1997, BRAIN, V120, P159, DOI 10.1093/brain/120.1.159; Vedovelli C., 2014, CLIN ED APPL REUVEN, P195; WIEDL KH, 1978, DIAGNOSTICA, V24, P175	49	5	6	1	24	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	1					19	35		10.3233/NRE-161335			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DS9QD	WOS:000381117400003	27341359				2022-02-06	
J	Lee, VK; Nardone, R; Wasco, F; Panigrahy, A; Zuccoli, G				Lee, Vincent Kyu; Nardone, Raffaele; Wasco, Fern; Panigrahy, Ashok; Zuccoli, Giulio			Delayed activation of the primary orbitofrontal cortex in post-traumatic anosmia	BRAIN INJURY			English	Article						Functional MRI; anosmia; olfactory pathways; post-traumatic anosmia	BRAIN ACTIVATION; OLFACTION; INJURY	Background: Functional magnetic resonance imaging may help in elucidating the pathophysiology of post-traumatic anosmia. Method: Using an fMRI olfactory stimulus paradigm, this study compared BOLD activation of the brain in a 21-year old male research subject with post-traumatic anosmia and a 19-year old male normal healthy control participant. Outcomes: A delayed activation of the primary orbitofrontal cortex was found in the subject with traumatic anosmia, which may represent a crucial pathophysiological mechanism in the subject with traumatic anosmia due to axonal injury or traumatic transection at the lamina cribrosa level. Discussion: In healthy subjects the activation of secondary cortical areas may be due to the habituation effect in the primary olfactory cortex. This raises the possibility that, in the absence of secondary activation areas that may act as a feed-back habituation or desensitization in the patient one of the primary response areas is activated over the longer period of stimulation. The failed activation of these secondary areas in the patient may cause a feed-back habituation or desensitization in the patient and could also play a role in the disturbed perception of odours.	[Lee, Vincent Kyu; Wasco, Fern] UPMC, Childrens Hosp Pittsburgh, Pediat Imaging Res Ctr, Pittsburgh, PA USA; [Nardone, Raffaele] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria; [Panigrahy, Ashok; Zuccoli, Giulio] UPMC, Childrens Hosp Pittsburgh, Sect Neuroradiol, Pittsburgh, PA USA		Zuccoli, G (corresponding author), UPMC, Children Hosp Pittsburgh, Neuroradiol, 4401 Penn Ave, Pittsburgh, PA 15224 USA.; Zuccoli, G (corresponding author), UPMC, Children Hosp Pittsburgh, Radiol, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	giulio.zuccoli@gmail.com		/0000-0001-9734-8035			Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Dalton P, 2013, NEUROLOGY, V80, pS32, DOI 10.1212/WNL.0b013e3182872eb4; Henkin RI, 2002, J COMPUT ASSIST TOMO, V26, P39, DOI 10.1097/00004728-200201000-00008; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; Kern RC, 2000, LARYNGOSCOPE, V110, P2106, DOI 10.1097/00005537-200012000-00025; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Miyanari A, 2007, NEUROSCI LETT, V423, P6, DOI 10.1016/j.neulet.2007.06.039; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Stockhorst U, 2004, PHYSIOL BEHAV, V83, P3, DOI 10.1016/j.physbeh.2004.07.018; Wu AP, 2008, AM J RHINOL, V22, P606, DOI 10.2500/ajr.2008.22.3238	11	5	5	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1737	1741		10.1080/02699052.2016.1199895			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800030	27564536				2022-02-06	
J	O'Connor, MK; Mueller, L; Kwon, E; Drebing, CE; O'Connor, AA; Semiatin, A; Wang, SW; Daley, R				O'Connor, Maureen K.; Mueller, Lisa; Kwon, Eunice; Drebing, Charles E.; O'Connor, Ashley A.; Semiatin, Alicia; Wang, Shihwe; Daley, Ryan			Enhanced vocational rehabilitation for Veterans with mild traumatic brain injury and mental illness: Pilot study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cognitive rehabilitation; compensated work therapy; competitive employment; mental illness; mild traumatic brain injury; OIF/OEF; supported employment; Veterans; vocational rehabilitation; transitional work experience	RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; SUPPORTED EMPLOYMENT; COMMUNITY INTEGRATION; DEPRESSION; MANAGEMENT; SERVICES; WORK; SYMPTOMS; OUTCOMES	Work plays a significant role in how people identify themselves, and successful return to work is associated with significant psychological and rehabilitative benefits. Unfortunately, despite the many benefits of employment, Veterans who experience mild traumatic brain injury and have mental health issues often have significant difficulty getting their vocational needs met. Considering that a consistent relationship between cognitive dysfunction and difficulties with employability has been firmly established, cognitive rehabilitation may enhance engagement in vocational rehabilitation and return to work outcomes. In this pilot study, we evaluated a 12 wk cognitive rehabilitation intervention embedded within vocational rehabilitation services. Eighteen Veterans were randomly assigned to receive either the embedded cognitive rehabilitation intervention (n = 10) or a control condition offering supportive client-centered therapy that did not focus on employment or cognitive rehabilitation (n = 8); all Veterans (intervention and control groups) received vocational rehabilitation services. This pilot feasibility study demonstrated efficient implementation of an embedded cognitive rehabilitation intervention within vocational rehabilitation. The current pilot data revealed small to moderate effect sizes on employment outcomes. Given these preliminary findings, a larger outcome study is warranted.	[O'Connor, Maureen K.; Mueller, Lisa; Kwon, Eunice; Drebing, Charles E.; O'Connor, Ashley A.; Semiatin, Alicia; Wang, Shihwe; Daley, Ryan] Bedford Dept Vet Affairs Med Ctr, Vet Integrated Serv Network Mental Illness Res Ed, Dept Psychol, Bedford, MA USA; [O'Connor, Maureen K.] Boston Univ, Sch Med, Boston, MA 02118 USA		O'Connor, MK (corresponding author), 200 Springs Rd,116B, Bedford, MA 01730 USA.	maureen.oconnor@va.gov	Stevens, David/F-4683-2015; Daley, Ryan T./V-4012-2019	Daley, Ryan T./0000-0002-6779-1658; O'Connor, Maureen/0000-0002-2466-0367	ISI	This material was based on work supported by ISI, who donated seven laptop computers, software, and technical assistance.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Becker D. R., 2003, WORKING LIFE PEOPLE; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blankertz L, 1996, PSYCHIATR SERV, V47, P1216; Bond GR, 2001, PSYCHIATR SERV, V52, P313, DOI 10.1176/appi.ps.52.3.313; Bond GR, 2004, PSYCHIATR REHABIL J, V27, P345, DOI 10.2975/27.2004.345.359; Bond GR, 2001, J CONSULT CLIN PSYCH, V69, P489, DOI 10.1037//0022-006X.69.3.489; Bond GR, 1998, PSYCHIATR REHABIL J, V22, P11, DOI 10.1037/h0095271; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Donnell AJ, 2012, CLIN NEUROPSYCHOL, V26, P1092, DOI 10.1080/13854046.2012.713984; Drake RE, 1996, J CONSULT CLIN PSYCH, V64, P391, DOI 10.1037/0022-006X.64.2.391; Drebing CE, 2012, PSYCHOL SERV, V9, P49, DOI 10.1037/a0026662; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FABIAN ES, 1992, REHABIL COUNS BULL, V36, P84; Folstein MF., 2001, MMSE MINIMENTAL STAT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Levin H.S., 1989, MILD HEAD INJURY; LOSARDO ML, 1999, VETERANS NEED SERVIC; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McGurk SR, 2000, SCHIZOPHR RES, V45, P175, DOI 10.1016/S0920-9964(99)00198-X; McGurk SR, 2005, SCHIZOPHRENIA BULL, V31, P898, DOI 10.1093/schbul/sbi037; McGurk SR, 2007, AM J PSYCHIAT, V164, P437, DOI 10.1176/appi.ajp.164.3.437; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; MELAMED S, 1992, Brain Injury, V6, P233, DOI 10.3109/02699059209029665; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; MOWBRAY CT, 1994, COMMUNITY MENT HLT J, V30, P347, DOI 10.1007/BF02207488; Mueser KT, 1997, J NERV MENT DIS, V185, P419, DOI 10.1097/00005053-199707000-00001; O'Connor MK, 2011, J REHABIL RES DEV, V48, P597, DOI 10.1682/JRRD.2010.06.0117; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; O'Neill JH, 2004, ARCH PHYS MED REHAB, V85, pS68, DOI 10.1016/j.apmr.2003.08.114; Partridge T M, 1996, Work, V7, P63, DOI 10.3233/WOR-1996-7108; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rubin S. E., 2001, FDN VOCATIONAL REHAB, V5th; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; VOLLRATH M, 1994, J CLIN PSYCHOL, V50, P727; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 1986, J APPLIED REHABILITA, V17, P24; Wehman P, 2009, J REHABIL RES DEV, V46, P909, DOI 10.1682/JRRD.2008.08.0105	52	5	5	0	24	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	3					307	319					13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DL6EF	WOS:000375731700002	27270645	gold			2022-02-06	
S	Pareja, JCM; Keeley, K; Duhaime, AC; Dodge, CP		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		Pareja, Jennifer C. Munoz; Keeley, Kristen; Duhaime, Ann-Christine; Dodge, Carter P.			Modeling Pediatric Brain Trauma: Piglet Model of Controlled Cortical Impact	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Controlled cortical impact; CCI; Animal model; Traumatic brain injury; Piglet; Swine; Development	OXYGEN-SATURATION; HYPOXIA-ISCHEMIA; BLOOD-FLOW; INJURY; MATURATION; METABOLISM; RESPONSES; NEWBORN; SYSTEM	The brain has different responses to traumatic injury as a function of its developmental stage. As a model of injury to the immature brain, the piglet shares numerous similarities in regards to morphology and neurodevelopmental sequence compared to humans. This chapter describes a piglet scaled focal contusion model of traumatic brain injury that accounts for the changes in mass and morphology of the brain as it matures, facilitating the study of age-dependent differences in response to a comparable mechanical trauma.	[Pareja, Jennifer C. Munoz] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA; [Pareja, Jennifer C. Munoz] Univ Florida, Shands Childrens Hosp, Gainesville, FL 32611 USA; [Keeley, Kristen] Creighton Univ, Sch Med, Omaha, NE 68178 USA; [Duhaime, Ann-Christine] Harvard Med Sch, Dept Neurosurg, Boston, MA USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Dodge, Carter P.] Dartmouth Hitchcock, Dept Pediat Anesthesia, Lebanon, NH USA; [Dodge, Carter P.] Dartmouth Hitchcock Med Ctr, Lebanon, NH USA		Pareja, JCM (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA.; Pareja, JCM (corresponding author), Univ Florida, Shands Childrens Hosp, Gainesville, FL 32611 USA.						ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; BARKS JDE, 1992, BRAIN PATHOL, V2, P235, DOI 10.1111/j.1750-3639.1992.tb00697.x; Bauer R, 1999, PEDIATR NEUROSURG, V30, P62, DOI 10.1159/000028765; BUCKLEY NM, 1986, COMP BIOCHEM PHYS A, V83, P1, DOI 10.1016/0300-9629(86)90080-0; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; DICKERSON JW, 1967, PROC R SOC SER B-BIO, V166, P384, DOI 10.1098/rspb.1967.0002; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duhaime AC, 2006, J NEUROSURG, V104, P259, DOI 10.3171/ped.2006.104.4.259; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2006, DEV NEUROSCI-BASEL, V28, P380, DOI 10.1159/000094164; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Gavilanes AWD, 2001, CLIN NEUROPHYSIOL, V112, P52, DOI 10.1016/S1388-2457(00)00499-5; Ioroi T, 2002, EXP BRAIN RES, V144, P172, DOI 10.1007/s00221-002-1030-z; Kurth CD, 2002, J CEREBR BLOOD F MET, V22, P335, DOI 10.1097/00004647-200203000-00011; Loepke AW, 2005, ANESTH ANALG, V101, P340, DOI 10.1213/01.ANE.0000154199.67104.6A; Margulies S, 1990, J BIOMECH, V23, P17; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Saito T, 2005, PHYSIOL BEHAV, V84, P725, DOI 10.1016/j.physbeh.2005.02.018; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; WOOTTON R, 1982, BIOL NEONATE, V41, P209	21	5	5	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745		978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						345	356		10.1007/978-1-4939-3816-2_19	10.1007/978-1-4939-3816-2		12	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500021	27604727				2022-02-06	
J	Rabinowitz, AR; Merritt, V; Arnett, PA				Rabinowitz, Amanda R.; Merritt, Victoria; Arnett, Peter A.			A pilot investigation of the Motivation Behaviors Checklist (MBC): An observational rating scale of effort towards testing for baseline sports-concussion assessment	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Concussion; effort; mild traumatic brain injury; motivation; baseline testing; performance validity	TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; TEST-PERFORMANCE; IMPACT; NORMS; PLAY	Background: Baseline neuropsychological testing is commonly used in the management of sports-related concussion. However, underperformance due to poor effort could lead to invalid conclusions regarding postconcussion cognitive decline. We designed the Motivation Behaviors Checklist (MBC) as an observational rating scale to assess effort towards baseline neuropsychological testing. Here we present preliminary data in support of its reliability and validity. Method: MBC items were generated based on the consensus of a panel of graduate students, undergraduates, and a clinical neuropsychologist who conduct neuropsychological evaluations for a sports concussion management program. A total of 261 college athletes were administered a standard neuropsychological test battery in addition to the MBC. A subset of evaluations (n=101) was videotape and viewed by a second rater. Exploratory factor analysis (EFA) was used to refine the scale, and reliability and validity were evaluated. Results: EFA revealed that the MBC items represent four latent factors-Complaints, Poor Focus, Psychomotor Agitation, and Impulsivity. Reliability analyses demonstrated that the MBC has good inter-rater reliability (intraclass correlation coefficient, ICC=.767) and internal consistency (alpha=.839). The construct validity of the MBC is supported by large correlations with examiners' ratings of effort (rho=-.623) and medium-sized relationships with cognitive performance and self-ratings of effort (vertical bar rho vertical bar between .263 and .345). Discriminant validity was supported by nonsignificant correlations with measures of depression and postconcussion symptoms (rho=.056 and .082, respectively). Conclusions: These findings provide preliminary evidence that the MBC could be a useful adjunct to baseline neuropsychological evaluations for sports-concussion management.	[Rabinowitz, Amanda R.] Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA; [Merritt, Victoria; Arnett, Peter A.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Rabinowitz, AR (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	rabinowitz.a@gmail.com		Merritt, Victoria/0000-0001-5683-4168			Allen L. M., 1997, COMPUTERIZED ASSESSM; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Barth JT, 2011, HDB SPORT NEUROPSYCH, P75; Beck ATSB., 2000, BDI FAST SCREEN MED; Benedict R., 1997, BRIEF VISUAL MEMORY; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Conder RL, 1999, ARCH CLIN NEUROPSYCH, V14, P95, DOI 10.1093/arclin/14.1.95a; DiStefano C., 2009, PRACTICAL ASSESSMENT, V14, P1, DOI DOI 10.7275/DA8T-4G52; Duckworth AL, 2011, P NATL ACAD SCI USA, V108, P7716, DOI 10.1073/pnas.1018601108; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; HEATON RK, 1996, NEUROPSYCHOLOGICAL A; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kirkwood MW, 2009, ACTA PAEDIATR, V98, P1409, DOI 10.1111/j.1651-2227.2009.01448.x; Lovell M, 2000, IMPACT IMMEDIATE POS; Manly JJ, 2007, ARCH CLIN NEUROPSYCH, V22, P319, DOI 10.1016/j.acn.2007.01.006; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Rabinowitz AR, 2015, DEV NEUROPSYCHOL, V40, P29, DOI 10.1080/87565641.2014.1001066; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Ruff RM, 1996, ARCH CLIN NEUROPSYCH, V11, P329, DOI 10.1016/0887-6177(95)00033-X; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmitt TA, 2011, J PSYCHOEDUC ASSESS, V29, P304, DOI 10.1177/0734282911406653; Smith A., 1982, SYMBOL DIGIT MODALIT; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; The Psychological Corporation, 2001, WECHSLER TEST ADULT; Trenerry MR, 1989, STROOP NEUROPSYCHOLO; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127	32	5	5	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2016	38	6					599	610		10.1080/13803395.2015.1123224			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO5IZ	WOS:000377818100001	27167863				2022-02-06	
J	Salottolo, K; Carrick, M; Levy, AS; Morgan, BC; Mains, CW; Slone, DS; Bar-Or, D				Salottolo, Kristin; Carrick, Matthew; Levy, A. Stewart; Morgan, Brent C.; Mains, Charles W.; Slone, Denetta S.; Bar-Or, David			Aggressive operative neurosurgical management in patients with extra-axial mass lesion and Glasgow Coma Scale of 3 is associated with survival benefit: A propensity matched analysis	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Glasgow; Coma Score; Mortality; Traumatic brain injury; Craniotomy	TRAUMATIC BRAIN-INJURY; SCORE	Introduction: Prognosis in patients with traumatic brain injury (TBI) and Glasgow Coma Scale (GCS) score of 3 is poor, raising concern regarding the utility of aggressive operative neurosurgical management. Our purpose was to describe outcomes in a propensity matched population with TBI and GCS3 treated with operative neurosurgical procedures of craniotomy or craniectomy (CRANI). Methods: We conducted a five-year, multicenter retrospective cohort study of patients with an ED GCS 3 and a positive head CT identified by ICD-9CM diagnosis codes. Two populations were examined: (1) patients with extra-axial mass lesion (subdural or epidural haematoma), (2) patients without mass lesion (subarachnoid and intraparenchymal haemorrhage including contusion, other intracerebral haemorrhage or intracranial injury including diffuse axonal injury). In patients with extra-axial mass lesion, propensity score techniques were used to match patients 1: 1 by CRANI, and the following outcomes were analysed with conditional logistic regression: survival, favourable hospital disposition to home or rehabilitation, and development of complications. Results: There were 541 patients with TBI and GCS3; 19% had a CRANI, 83% were initiated within 4 h. In those with mass lesion, 27% (91/338) had a CRANI; after matching, a significant survival benefit was observed with CRANI vs. without CRANI (65% vs. 34% survival, OR: 3.9 (1.6-10.5) p < 0.001). There was borderline increased odds of favourable disposition (43% vs. 26%, OR: 2.4 (0.99-6.3, p = 0.052) with CRANI vs. without CRANI, and no difference in developing a complication (58% vs. 48%, OR: 1.5 (0.7-3.4), p = 0.30). Conclusions: Survival was achieved in 65% of patients that underwent surgical intervention for subdural and epidural haematoma, despite a presenting GCS of 3. These results demonstrate prompt operative neurosurgical management of mass lesion is warranted for selected patients with a GCS of 3, contributing to a significant 4-fold survival benefit. In the absence of mass lesion the effect of immediate neurosurgery on outcomes is inconclusive. (C) 2015 Elsevier Ltd. All rights reserved.	[Salottolo, Kristin; Carrick, Matthew; Bar-Or, David] Med Ctr Plano, Dept Trauma Res, Plano, TX 75075 USA; [Salottolo, Kristin; Bar-Or, David] Swedish Med Ctr, Trauma Res Dept, Englewood, CO 80113 USA; [Salottolo, Kristin; Slone, Denetta S.; Bar-Or, David] St Anthony Hosp, Dept Trauma Res, Lakewood, CO 80228 USA; [Carrick, Matthew; Morgan, Brent C.] Med Ctr Plano, Trauma Serv Dept, Plano, TX 75075 USA; [Levy, A. Stewart; Mains, Charles W.] St Anthony Hosp, Trauma Serv Dept, Lakewood, CO 80228 USA; [Slone, Denetta S.] Swedish Med Ctr, Trauma Serv Dept, Englewood, CO 80113 USA; [Levy, A. Stewart] Intermt Neurosurg, Trauma Serv Dept, Lakewood, CO 80228 USA; [Slone, Denetta S.; Bar-Or, David] Rocky Vista Univ, Trauma Serv Dept, Parker, CO 80134 USA		Bar-Or, D (corresponding author), Swedish Med Ctr, Trauma Res Dept, 501 E Hampden Ave,Rm 4-454, Englewood, CO 80113 USA.	ksalottolo@ampiopharma.com; matt.carrick@acutesurgical.com; stewartlevy@centura.org; brentandang@me.com; charleswmains@centura.org; sue.slone@healthonecares.com; dbaror@ampiopharma.com	Bar-Or, David/AAE-9328-2020				Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Demetriades D, 2004, ARCH SURG-CHICAGO, V139, P1066, DOI 10.1001/archsurg.139.10.1066; Feinberg M, 2015, SEMIN NEUROL, V35, P50, DOI 10.1055/s-0035-1544244; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Irvin CB, 2010, PREHOSP DISASTER MED, V25, P541, DOI 10.1017/S1049023X00008736; Ley EJ, 2011, AM SURGEON, V77, P1342; Lieberman JD, 2003, J TRAUMA, V55, P437, DOI 10.1097/01.TA.0000081882.79587.17; Marion DW, 2006, NEUROSURGERY, V58, P655; Moore L, 2006, J TRAUMA, V60, P43; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Prevention CfDCa, 2015, TRAUM BRAIN INJ US F; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4	19	5	6	0	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2016	47	1					70	76		10.1016/j.injury.2015.10.002			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CZ8HD	WOS:000367339900014	26499227				2022-02-06	
J	Seel, RT; Macciocchi, S; Velozo, CA; Shari, K; Thompson, N; Heinemann, AW; Sander, AM; Sleet, D				Seel, Ronald T.; Macciocchi, Stephen; Velozo, Craig A.; Shari, Kimether; Thompson, Nicole; Heinemann, Allen W.; Sander, Angelle M.; Sleet, David			The Safety Assessment Measure for persons with traumatic brain injury: Item pool development and content validity	NEUROREHABILITATION			English	Article						Unintentional injuries; brain injuries; cognition; diagnosis; rehabilitation	ATTENTION RATING-SCALE; QUALITATIVE RESEARCH; AFTER-DISCHARGE; PATIENT SAFETY; SEVERE TBI; REHABILITATION; RISK; RECOMMENDATIONS; COMMUNITY; HOSPITALIZATION	BACKGROUND: Persons with moderate to severe TBI are at increased risk for unintentional injury or harm in the home and community; however, there is currently no standard measure of safety risk they face now and in the future. OBJECTIVE: To develop comprehensive and content valid scales and item pools for assessing safety and risk for persons with moderate to severe traumatic brain injuries. METHOD: Qualitative psychometric methods for developing scales and items were used including literature review, item development and revision, focus groups with interdisciplinary rehabilitation staff (n = 26) for rating content validity, and cognitive interviewing of TBI family members (n = 9) for assuring item clarity. RESULTS: The Safety Assessment Measure is comprised of 6 primary scales - Cognitive Capacity, Visuomotor Capacity, Wheelchair Use, Risk Perception, Self-Regulation, and Compliance Failures with Safety Recommendations - in which family caregivers or clinicians rate the risk for unintentional injury or harm in adults who have sustained moderate or severe TBI. The scale item pools encompass a broad spectrum of everyday activities that pose risk in the home and community and were rated as having excellent levels of content validity. CONCLUSIONS: The Safety Assessment Measure scales and items cover a broad range of instrumental activities of daily living that can increase the risk of unintentional injuries or harm. Empirical evidence suggests that the Safety Assessment Measure items have excellent content validity. Future research should use modern psychometric methods to examine each scale unidimensionality, model fit, and precision.	[Seel, Ronald T.; Macciocchi, Stephen; Shari, Kimether; Thompson, Nicole] Shepherd Ctr, Atlanta, GA USA; [Macciocchi, Stephen] Univ Georgia, Athens, GA 30602 USA; [Velozo, Craig A.] Univ Florida, Gainesville, FL USA; [Velozo, Craig A.] Med Univ South Carolina, Charleston, SC USA; [Sleet, David] Ctr Dis Control & Injury Prevent, Atlanta, GA USA; [Heinemann, Allen W.] Northwestern Univ, Chicago, IL 60611 USA; [Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Sander, Angelle M.] Baylor Coll Med, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Houston, TX USA		Seel, RT (corresponding author), Shepherd Ctr, Crawford Res Inst, 6th Floor,2020 Peachtree Rd, Atlanta, GA 30309 USA.	ron_seel@shepherd.org	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Sleet, David/0000-0002-6165-3289	National Institute on Disability and Rehabilitation Research [H133G080153]	We certify that no party having a direct interest in the results of the research supporting this article has or will confer a benefit on us or on any organization with which we are associated. We certify that all financial and material support for this research and work are clearly identified in the title page of the manuscript. The contents of this article were developed under a grant from the National Institute on Disability and Rehabilitation Research (grant no. H133G080153). However, these contents do not necessarily represent the official policy of the Department of Education or the Centers for Disease Control and Prevention. No endorsement by the Federal Government is implied.	Bandura A, 1986, SOCIAL FDN THOUGHT A; Banja J., 1994, J HEAD TRAUMA REHAB, V9, P70; Blais AR, 2006, JUDGM DECIS MAK, V1, P33; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Centers for Disease Control and Prevention, 1999, TRAUM BRAIN INJ US R; Chiu T, 2006, OTJR-OCCUP PART HEAL, V26, P132, DOI 10.1177/153944920602600403; Cooney LM, 2004, ARCH INTERN MED, V164, P357, DOI 10.1001/archinte.164.4.357; DeVellis R., 2006, SCALE DEV THEORY APP; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Durgin CJ, 2000, J HEAD TRAUMA REHAB, V15, P1195, DOI 10.1097/00001199-200012000-00002; Frank G, 2010, OTJR-OCCUP PART HEAL, V30, P51, DOI 10.3928/15394492-20100325-02; Galski T, 2000, J HEAD TRAUMA REHAB, V15, P895, DOI 10.1097/00001199-200006000-00004; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Hart T, 2006, ARCH PHYS MED REHAB, V87, P647, DOI 10.1016/j.apmr.2006.01.016; Hart T, 2004, ARCH PHYS MED REHAB, V85, P1450, DOI 10.1016/j.apmr.2004.01.030; HART T, 2000, PATIENT COMPETENCY R; Kreutzer J., 2000, JUDGMENT SAFETY SCRE; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 2009, PM&R, V1, P723, DOI 10.1016/j.pmrj.2009.07.005; Lasch KE, 2010, QUAL LIFE RES, V19, P1087, DOI 10.1007/s11136-010-9677-6; Macciocchi SN, 2001, ARCH PHYS MED REHAB, V82, pS15, DOI 10.1053/apmr.2001.31005; Macciocchi SN, 2009, J HEAD TRAUMA REHAB, V24, P72, DOI 10.1097/HTR.0b013e31819a9088; Magasi S, 2012, QUAL LIFE RES, V21, P739, DOI 10.1007/s11136-011-9990-8; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Morrongiello BA, 2006, INJURY PREV, V12, P19, DOI 10.1136/ip.2005.008862; Ohman A, 2005, J REHABIL MED, V37, P273, DOI 10.1080/16501970510040056; Oliver R, 1993, Can J Occup Ther, V60, P78; Onwuegbuzie AJ, 2010, J MIX METHOD RES, V4, P56, DOI 10.1177/1558689809355805; Pai AB, 2012, PHYS MED REH CLIN N, V23, P349, DOI 10.1016/j.pmr.2012.02.009; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pietrapiana P, 2005, BRAIN INJURY, V19, P197, DOI 10.1080/02699050400017197; Polit DF, 2006, RES NURS HEALTH, V29, P489, DOI 10.1002/nur.20147; Reeve, 2005, ASSESSING QUALITY LI, P55; Reichard AA, 2007, J HEAD TRAUMA REHAB, V22, P390, DOI 10.1097/01.HTR.0000300234.36361.b1; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Ruchinskas RA, 2001, REHABIL PSYCHOL, V46, P262, DOI 10.1037/0090-5550.46.3.262; Seel RT, 2007, J HEAD TRAUMA REHAB, V22, P267, DOI 10.1097/01.HTR.0000290971.56130.c8; Seel RT, 2010, J HEAD TRAUMA REHAB, V25, P99, DOI 10.1097/HTR.0b013e3181ce3966; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sherer M., 1995, J INT NEUROPSYCH SOC, V1, P163; Simons-Morton B., 2006, INJURY VIOLENCE PREV; Sleet D., 2006, INJURY VIOLENCE PREV; Sleet D.A., 2007, HDB INJURY VIOLENCE; STONE MH, 1997, RASCH MEASUREMENT T, V11, P559; Tyson BT, 2012, PHYS MED REH CLIN N, V23, P315, DOI 10.1016/j.pmr.2012.02.007; United States Food and Drug Administration, 2009, GUID IND PAT REP OUT; Velozo CA, 2001, AM J PHYS MED REHAB, V80, P662, DOI 10.1097/00002060-200109000-00006; Velozo CA, 2012, ARCH PHYS MED REHAB, V93, pS154, DOI 10.1016/j.apmr.2012.06.001; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Whyte J, 2003, ARCH PHYS MED REHAB, V84, P268, DOI 10.1053/apmr.2003.50108; Willis GB, 2005, COGNITIVE INTERVIEWI; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	58	5	5	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	3					371	387		10.3233/NRE-161369			17	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DW7XA	WOS:000383865200005	27497470	Green Accepted			2022-02-06	
J	Simpson, GK; McCann, B; Lowy, M				Simpson, Grahame K.; McCann, Brett; Lowy, Michael			Treating male sexual dysfunction after traumatic brain injury: Two case reports	NEUROREHABILITATION			English	Article						Erectile disorder; delayed ejaculation; traumatic brain injury; sildenafil; viagra; sex therapy	EPIDEMIOLOGY; INDIVIDUALS; EJACULATION; MEN	BACKGROUND: Sexual dysfunction is common after traumatic brain injury (TBI) but evaluation of treatment interventions have been sparse. OBJECTIVE: To report on the treatment of sexual dysfunction for two males with severe TBI. METHODS AND RESULTS: Case one was treated for erectile dysfunction (ED). After a medical examination which found no underlying physiological problems, Sildenafil was prescribed. Scores on the Golombok Rust Inventory of Sexual Satisfaction Impotence subscale found that scores had improved from the dysfunction range at baseline to the functional range at 6 weeks follow-up. There was some reduction in this improvement at 3 months follow-up, maybe associated with a co-morbid deterioration of emotional state. Case two was treated for idiopathic delayed ejaculation (DE). A standard sex therapy intervention was employed that resulted in the resolution of the problem, documented on the Sex Behavior sub-scale of the Derogatis Inventory for Sexual Functioning-Self Report (comparing baseline to post intervention and follow-up scores). CONCLUSIONS: The case reports show promise for the treatment of sexual dysfunction after severe TBI using standard medical and sex therapy treatments. In the future, controlled evaluations are required to demonstrate the efficacy of such interventions.	[Simpson, Grahame K.] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Sydney, NSW, Australia; [Simpson, Grahame K.] Liverpool Hosp, Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia; [McCann, Brett; Lowy, Michael] Australasian Inst Sexual Hlth Med, Sydney, NSW, Australia		Simpson, GK (corresponding author), Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, Liverpool Brain Injury Rehabil Unit, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	grahame.simpson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni R, 2007, SEX DISABIL, V25, P125, DOI 10.1007/s11195-007-9047-7; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Aloni R., 2003, SEXUAL DIFFICULTIES; Althof SE, 2012, INT J IMPOT RES, V24, P131, DOI 10.1038/ijir.2012.2; Carson CC, 2007, UROL CLIN N AM, V34, P507, DOI 10.1016/j.ucl.2007.08.013; CRENSHAW TL, 1985, MED ASPECTS HUMAN SE, V19, P115; Derogatis L, 1987, DEROGATIS INTERVIEW; Dolberg OT, 2002, PSYCHOPHARMACOLOGY, V161, P404, DOI 10.1007/s00213-002-1097-z; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; GOLOMBOK S, 1992, INTERPERSONAL DIFFIC, P51; Gosling J, 1999, BRAIN INJURY, V13, P785; Griffith ER, 1993, SEXUALITY PERSON TRA; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Jannini EA, 2005, WORLD J UROL, V23, P68, DOI 10.1007/s00345-004-0486-9; Kaplan H.S., 1974, NEW SEX THERAPY; Kelly G, 2011, SEX DISABIL, V29, P313, DOI 10.1007/s11195-011-9213-9; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Lewis RW, 2010, J SEX MED, V7, P1598, DOI 10.1111/j.1743-6109.2010.01778.x; Lombardi G, 2012, J SEX MED, V9, P970, DOI 10.1111/j.1743-6109.2011.02615.x; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; McMahon C. G., 2010, SEXUAL MED SEXUAL DI, P825; McMahon CG, 2005, J SEX MED, V2, P368, DOI 10.1111/j.1743-6109.2005.20351.x; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; NATHAN SG, 1986, J SEX MARITAL THER, V12, P267; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Ownsworth T, 2008, BRAIN INJURY, V22, P858, DOI 10.1080/02699050802446697; Richardson D., 1986, SEXUAL THERAPY YOUR; Rosengarten A., SEXUAL HLTH MULTIDIS, P289; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P1331, DOI 10.1016/j.apmr.2012.03.037; Simpson G, 2003, BRAIN INJURY, V17, P723, DOI 10.1080/0269905031000110481; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; SIMPSON GK, 2012, CRITICAL REV PHYS ME, V23, P215; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Waldinger MD, 2005, WORLD J UROL, V23, P76, DOI 10.1007/s00345-004-0487-8; *WHO, 1996, OPT CAR DIS PEOPL RE; Zasler N. D., 2005, TXB TRAUMATIC BRAIN, P63; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004	41	5	5	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	38	3					281	289		10.3233/NRE-161319			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DM5PV	WOS:000376403300007	27030904				2022-02-06	
J	Temple, JL; Struchen, MA; Pappadis, MR				Temple, Jessica Lynn; Struchen, Margaret A.; Pappadis, Monique R.			Impact of pre-injury family functioning and resources on self-reported post-concussive symptoms and functional outcomes in persons with mild TBI	BRAIN INJURY			English	Article						Mild TBI; postconcussive symptoms; functional status; family functioning; family resources	TRAUMATIC BRAIN-INJURY; DISABILITY RATING-SCALE; HEAD-INJURY; YOUNG-CHILDREN; PATIENT COMPLAINTS; UNCOMPLICATED MILD; ASSESSMENT DEVICE; PRACTICAL SCALE; HEALTH SURVEY; FOLLOW-UP	Objective: This study investigates the contribution of pre-injury family functioning and resources on self-reported post-concussive symptoms and functional outcomes in persons with mild TBI (mTBI). Design: Participants with uncomplicated or complicated mTBIs were recruited from consecutive admissions to the emergency department of a level 1 trauma centre. Patients completed baseline assessments within 2 weeks of injury and an outcomes assessment at 3 months post-injury. Methods and procedures: One hundred and sixty-six adults with mTBI were included. Baseline measures of pre-injury history, family functioning and resources were obtained. Functional status assessments and self-reported measures of health, common TBI symptoms and psychological problems were administered at 3-months post-injury. Results: Data reduction of outcome measures using principle components analysis revealed two factors: self-reported post-concussive symptoms and current functional/participation status, explaining 60.53% of the variance. Family resources (beta = -0.239, t(150) = -2.84, p = 0.005) and age (beta = -0.170, t(150) = -2.19, p = 0.030), but not family functioning, were significant predictors of self-reported post-concussive symptoms at follow-up, R-2 = 0.051, F(5, 150) = 4.09, p = 0.002. Neither family resources nor functioning predicted current functional/participation status. Conclusions: Fewer family resources and younger age were associated with increased self reported post-concussive symptoms. Fewer resources may be a potential risk factor to heightened perception of post-concussive symptoms. Providing low-cost counselling or resource facilitation services may improve outcomes for those with limited resources after mTBI.	[Temple, Jessica Lynn; Struchen, Margaret A.] TIRR Mem Hermann, Dept Psychol & Neuropsychol, Houston, TX USA; [Temple, Jessica Lynn; Struchen, Margaret A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Pappadis, Monique R.] Univ Texas Med Branch, Div Rehabil Sci, Galveston, TX 77555 USA; [Pappadis, Monique R.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Struchen, MA (corresponding author), 1333 Moursund St, Houston, TX 77030 USA.	margaret.struchen@memorialhermann.org	Temple, Jessica/M-1949-2019	Pappadis, Monique R./0000-0003-4742-4380	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133B990014, H133B090023, H133A070043]	The authors report no conflicts of interest. This work was supported by grants from the National Institute on Disability and Rehabilitation Research, US Department of Education (grant nos. H133B990014, H133B090023 and H133A070043).	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; [Anonymous], 2013, NAT DAT 2013 PROF PE; Arbuckle J, 2006, SPSS AMOS VERSION 22; Barroilhet S, 2009, SOC PSYCH PSYCH EPID, V44, P1051, DOI 10.1007/s00127-009-0022-8; Bellon K, 2012, J HEAD TRAUMA REHAB, V27, P449, DOI 10.1097/HTR.0b013e31826674d6; Carnes S.L., 2005, FAM SYST HEALTH, V23, P186, DOI DOI 10.1037/1091-7527.23.2.186; Carr J, 2007, TRAUMA, V9, P21, DOI 10.1177/1460408607082845; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cohen J., 2013, STAT POWER ANAL BEHA; Derogatis L, 1983, BRIEF SYMPTOM INVENT, V13, P595, DOI DOI 10.1017/S0033291700048017; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; DiStefano C., 2009, PRACTICAL ASSESSMENT, V14, P1, DOI DOI 10.7275/DA8T-4G52; DUNST CJ, 1987, CHILD CARE HLTH DEV, V13, P111, DOI 10.1111/j.1365-2214.1987.tb00528.x; Dunst CJ, 1987, FAMILY RESOURCE SCAL; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; Ewing-Cobbs L, 2013, J INT NEUROPSYCH SOC, V19, P497, DOI 10.1017/S1355617713000210; Faul M, 2010, TRAUMATIC BRAIN INJU; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hill R., 1949, FAMILIES STRESS ADJU; IBM Corp, 2016, IBM SPSS STAT WINDOW; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kashluba S, 2004, ARCH CLIN NEUROPSYCH, V19, P805, DOI 10.1016/j.acn.2003.09.005; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lange RT, 2012, ARCH CLIN NEUROPSYCH, V27, P480, DOI 10.1093/arclin/acs059; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; McCauley SR, 2001, J INT NEUROPSYCH SOC, V7, P457, DOI 10.1017/S1355617701744025; Mellick D., 2000, CRAIG HANDICAP ASSES; MILLER IW, 1985, J MARITAL FAM THER, V11, P345, DOI 10.1111/j.1752-0606.1985.tb00028.x; Paniak C, 2002, ARCH CLIN NEUROPSYCH, V17, P319, DOI 10.1016/S0887-6177(01)00115-9; Paniak C, 2000, BRAIN INJURY, V14, P219; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sady MD, 2010, ARCH PHYS MED REHAB, V91, P1542, DOI 10.1016/j.apmr.2010.07.012; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Schumacker R. E., 2004, BEGINNERS GUIDE STRU, V2; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; TEASDALE G, 1974, LANCET, V2, P81; Van Horn ML, 2001, J PSYCHOEDUC ASSESS, V19, P54, DOI 10.1177/073428290101900104; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; Wade SL, 2006, J PEDIATR PSYCHOL, V31, P1072, DOI 10.1093/jpepsy/jsj077; Walrath CM, 2004, J PSYCHOEDUC ASSESS, V22, P209, DOI 10.1177/073428290402200302; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Yeates K O, 1997, J Int Neuropsychol Soc, V3, P617; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	60	5	5	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	13-14					1672	1682		10.3109/02699052.2015.1113561			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EG8YO	WOS:000391343800022	27740864				2022-02-06	
J	Toyinbo, PA; Vanderploeg, RD; Donnell, AJ; Mutolo, SA; Cook, KF; Kisala, PA; Tulsky, DS				Toyinbo, Peter A.; Vanderploeg, Rodney D.; Donnell, Alison J.; Mutolo, Sandra A.; Cook, Karon F.; Kisala, Pamela A.; Tulsky, David S.			Development and Initial Validation of Military Deployment-Related TBI Quality-of-Life Item Banks	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health-related quality of life; outcome assessment (healthcare); patient-reported outcomes; quality of life; rehabilitation; traumatic brain injury	PATIENT-REPORTED OUTCOMES; TRAUMATIC BRAIN-INJURY; RESPONSE THEORY; NATIONAL-GUARD; MODELS; PROMIS; PREVALENCE; ROTATIONS; CRITERIA; IMPACT	Objective: To investigate unique factors that affect health-related quality of life (QOL) in individuals with military deployment-related traumatic brain injury (MDR-TBI) and to develop appropriate assessment tools, consistent with the TBI-QOL/PROMIS/Neuro-QOL systems. Participants: Three focus groups from each of the 4 Veterans Administration (VA) Polytrauma Rehabilitation Centers, consisting of 20 veterans with mild to severe MDR-TBI, and 36 VA providers were involved in early stage of new item banks development. The item banks were field tested in a sample (N = 485) of veterans enrolled in VA and diagnosed with an MDR-TBI. Design: Focus groups and survey. Outcome Measures: Developed item banks and short forms for Guilt, Posttraumatic Stress Disorder/Trauma, and Military-Related Loss. Results: Three new item banks representing unique domains of MDR-TBI health outcomes were created: 15 new Posttraumatic Stress Disorder items plus 16 SCI-QOL legacy Trauma items, 37 new Military-Related Loss items plus 18 TBI-QOL legacy Grief/Loss items, and 33 new Guilt items. Exploratory and confirmatory factor analyses plus bifactor analysis of the items supported sufficient unidimensionality of the new item pools. Convergent and discriminant analyses results, as well as known group comparisons, provided initial support for the validity and clinical utility of the new item response theory-calibrated item banks and their short forms. Conclusion: This work provides a unique opportunity to identify issues specific to individuals with MDRTBI and ensure that they are captured in QOL assessment, thus extending the existing TBI-QOL measurement system.	[Toyinbo, Peter A.; Vanderploeg, Rodney D.; Mutolo, Sandra A.] James A Haley Vet Hosp, Hlth Serv Res & Dev, Rehabil Res & Dev, Ctr Innovat Disabil & Rehabil Res CINDRR, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.; Donnell, Alison J.] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Tampa, FL 33612 USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychiat & Behav Neurosci, Tampa, FL USA; [Vanderploeg, Rodney D.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; [Vanderploeg, Rodney D.; Donnell, Alison J.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Cook, Karon F.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Kisala, Pamela A.; Tulsky, David S.] NYU, Langone Med Ctr, Dept Rehabil Med, Rusk Inst, New York, NY USA; [Tulsky, David S.] NYU, Langone Med Ctr, Dept Orthoped Surg, New York, NY USA; [Tulsky, David S.] NYU, Dept Gen Med, Langone Med Ctr, New York, NY USA; [Tulsky, David S.] Kessler Fdn, W Orange, NJ USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	Rodney.Vanderploeg@va.gov		Toyinbo, Peter/0000-0003-3387-3943; Tulsky, David/0000-0002-4335-4509	Department of Veterans Affairs, Veterans Health Administration, and VA RR&D, Development of a Quality of Life Tool for Deployment-Related TBI [B6237R]; James A. Haley Veterans' HospitalUS Department of Veterans Affairs; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs	This research was supported by the Department of Veterans Affairs, Veterans Health Administration, and VA RR&D grant B6237R, Development of a Quality of Life Tool for Deployment-Related TBI, to Shirley Groer and Rodney D. Vanderploeg. Further support was provided by James A. Haley Veterans' Hospital and the Defense and Veterans Brain Injury Center.	Amtmann D, 2011, ARCH PHYS MED REHAB, V92, pS12, DOI 10.1016/j.apmr.2011.04.025; Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Carlozzi NE, 2011, ARCH PHYS MED REHAB, V92, pS52, DOI 10.1016/j.apmr.2010.12.046; Cella D, 2007, QUAL LIFE RES, V16, P133, DOI 10.1007/s11136-007-9204-6; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Choi SW, 2011, J STAT SOFTW, V39, P1; Cook KF, 2009, QUAL LIFE RES, V18, P447, DOI 10.1007/s11136-009-9464-4; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Edelen MO, 2007, QUAL LIFE RES, V16, P5, DOI 10.1007/s11136-007-9198-0; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; GIBBONS RD, 1992, PSYCHOMETRIKA, V57, P423, DOI 10.1007/BF02295430; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Kazis LE., 2000, MED OUTCOMES TRUST M, V5, P1; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lie HH, 2010, J CLIN EPIDEMIOL, V63, P1169, DOI 10.1016/j.jclinepi.2009.11.021; McDonald R, 1999, TEST THEORY UNIFIED; Muthen L.K., 2012, MPLUS USERS GUIDE, V7th, P1998; Paek I, 2013, APPL PSYCH MEAS, V37, P242, DOI 10.1177/0146621612468223; R Core Team, 2012, R LANG ENV STAT COMP; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reise S, 2011, EDUC PSYCHOL MEAS, V71, P684, DOI 10.1177/0013164410378690; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Reise SP, 2013, EDUC PSYCHOL MEAS, V73, P5, DOI 10.1177/0013164412449831; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Revelle W., 2013, PSYCH PROCEDURES PER; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; Rizopoulos D., 2012, LTM LATENT TRAIT MOD; Samejima F., 1969, PSYCHOMETRIC MONOGRA, V17, DOI DOI 10.1007/BF03372160; Samejima F., 1997, HDB MODERN ITEM RESP, P85, DOI [10.1007/978-1-4757-2691-6_5, DOI 10.1007/978-1-4757-2691-6_5]; Thomas JL, 2010, ARCH GEN PSYCHIAT, V67, P614, DOI 10.1001/archgenpsychiatry.2010.54; Tulsky DS, 2011, ARCH PHYS MED REHAB, V92, pS44, DOI 10.1016/j.apmr.2011.04.024; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zinbarg RE, 2006, APPL PSYCH MEAS, V30, P121, DOI 10.1177/0146621605278814	39	5	5	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					52	61		10.1097/HTR.0000000000000089			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000014	25310294				2022-02-06	
J	Troyanskaya, M; Pastorek, NJ; Scheibel, RS; Petersen, NJ; Walder, A; Henson, HK; Levin, HS				Troyanskaya, Maya; Pastorek, Nicholas J.; Scheibel, Randall S.; Petersen, Nancy J.; Walder, Annette; Henson, Helene K.; Levin, Harvey S.			Choosing appropriate comparison group participants in studies of veterans: Characteristics of orthopedically injured and uninjured Operation Enduring Freedom/Operation Iraqi Freedom/Operation New Dawn veterans	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Comparison group; Orthopedic injury; Veterans; Functioning	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HEAD-INJURY; MILD HEAD; CONCUSSION; OUTCOMES; BLAST; VALIDATION; COMMUNITY; SYMPTOMS	Introduction: Research addressing deployment-related traumatic brain injury (TBI) is fairly complex due to a high prevalence of comorbid conditions, multiple exposures, and the lack of acute medical records. Therefore, there is a need for a well-defined, matching comparison group. This study compared deployment-related characteristics, everyday functioning, and cognitive performance in recently deployed veterans who had not sustained any injuries with those who had orthopedic injuries during deployment, but who were without a history of TBI. Method: Participants included 45 individuals who had been deployed and who were without injuries and a group of 27 individuals who reported at least one orthopedic injury during deployment. The Mayo-Portland Adaptability Inventory-4, Community Integration Questionnaire, Veterans RAND 36 Item Health Survey, Brief Pain Inventory, Barratt Impulsiveness Scale-11, and posttraumatic stress disorder (PTSD) Checklist-Civilian (PCL-C) were used to assess daily functioning. Cognitive performance was measured using the Controlled Oral Word Association Test, Trail Making Test, Color-Word Interference Test, and Verbal Selective Reminding Test. The two groups were compared using t tests based on equal variances. The effect size was calculated. Results: There were no between-group differences, with all variables having p-values >.1 and small to medium effect sizes. Discussion: Orthopedic injuries sustained during deployment that did not require evacuation or hospitalization did not have any lasting effect on participants' health, cognition, and daily functioning relative to other deployed individuals with no history of injury. These results indicate the two groups are comparable and that their data could be potentially combined to create a single comparison group. Due to the small sample available for this study, the current results are considered preliminary, and further investigation is needed.	[Troyanskaya, Maya; Pastorek, Nicholas J.; Scheibel, Randall S.; Petersen, Nancy J.; Walder, Annette; Henson, Helene K.; Levin, Harvey S.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Troyanskaya, Maya; Pastorek, Nicholas J.; Scheibel, Randall S.; Henson, Helene K.; Levin, Harvey S.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Petersen, Nancy J.; Walder, Annette] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA		Troyanskaya, M (corresponding author), 6501 Fannin St,Suite NB132, Houston, TX 77030 USA.	mayat@bcm.edu		Pastorek, Nicholas/0000-0002-9290-380X	Department of Veterans Affairs, Veterans Health Administration, Office of Research and DevelopmentUS Department of Veterans Affairs; VA RR&D "Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks" [B6812C]; VA RR&D "A Longitudinal Study of Chronic TBI in OEF/OIF/OND Veterans and Service Members" [O1062-I]; An fMRI Study of Deployment-Related TBI in Veterans and Service Members [B1320-I]; VA HSR&D Center for Innovations in Quality, Effectiveness and Safety at the Michael E. DeBakey VA Medical Center, Houston, TX [CIN 13-413]; Veterans AffairsUS Department of Veterans Affairs [I01RX001062, I01RX001320] Funding Source: NIH RePORTER	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; [B6812C] (principal investigator, PI: H. S. Levin) VA RR&D "Traumatic Brain Injury Center of Excellence, Neurorehabilitation: Neurons to Networks"; [O1062-I] (PI: R.S. Scheibel) VA RR&D "A Longitudinal Study of Chronic TBI in OEF/OIF/OND Veterans and Service Members"; [B1320-I] (PIs: H. S. Levin and R. S. Scheibel) "An fMRI Study of Deployment-Related TBI in Veterans and Service Members"; and [CIN 13-413] (PI: L. A. Petersen) VA HSR&D Center for Innovations in Quality, Effectiveness and Safety at the Michael E. DeBakey VA Medical Center, Houston, TX.	Alexander MP, 1996, NEUROLOGY, V46, P1488, DOI 10.1212/WNL.46.5.1488-a; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bagalman, 2013, TRAUMATIC BRAIN INJU; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benton A., 1978, MULTILINGUAL APHASIA; BIJUR PE, 1990, PEDIATRICS, V86, P337; Brooks J, 1999, J TRAUMA, V46, P159, DOI 10.1097/00005373-199901000-00027; Brown L., 2010, TEST NONVERBAL INTEL; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cohen J., 2013, STAT POWER ANAL BEHA; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Dobie DJ, 2002, GEN HOSP PSYCHIAT, V24, P367, DOI 10.1016/S0163-8343(02)00207-4; Green P., 2005, WORD MEMORY TEST WIN; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Hanten G, 2013, J NEUROTRAUM, V30, P618, DOI 10.1089/neu.2012.2392; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kazis Lewis E, 2004, J Ambul Care Manage, V27, P263; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P110, DOI 10.1076/1385-4046(200002)14:1;1-8;FT110; Levin H.S., 2014, UNDERSTANDING TRAUMA; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288	50	5	5	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.		2016	38	7					811	819		10.1080/13803395.2016.1167172			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DO5IT	WOS:000377817500008	27171190				2022-02-06	
J	Truong, JQ; Ciuffreda, KJ				Truong, James Q.; Ciuffreda, Kenneth J.			Quantifying pupillary asymmetry through objective binocular pupillometry in the normal and mild traumatic brain injury (mTBI) populations	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); pupil asymmetry; pupillometry; pupil light reflex (PLR); afferent pupillary defect (APD); anisocoria	SUBACUTE STAGE; ANISOCORIA; LIGHT	Introduction: Little is known about human inter-ocular pupillary asymmetry (IOPA). Thus, the purpose of the present investigation was to assess objectively static and dynamic IOPA in normals and in individuals with mild traumatic brain injury (mTBI).Methods: The pupillary light reflex (PLR) was assessed in an adult population of normals and in those with mTBI using the Neuroptics DP-2000 binocular pupillometer. Four stimulus conditions were used to optimize the assessment. Two aspects of the pupil were assessed: baseline diameter prior to light stimulation and the dynamic amplitude of constriction following light stimulation.Results: There was no statistical difference in either the static or dynamic IOPA between the two groups. Thus, the data were combined for a better global parameter estimate. The mean average static IOPA was 0.26 mm (SD = 0.20 mm) or 4.17% (+/- 3.29%). The mean average dynamic IOPA was dependent on the light stimulus condition, with the average across all four test conditions being 0.11 mm (+/- 0.10 mm) or 1.84% (+/- 1.70%).Discussion: The inter-ocular pupillary effects of mTBI appear to be symmetrical rather than asymmetrical in nature. The findings provide clinicians and researchers a useful quantitative guideline to assess normal vs abnormal static and dynamic inter-ocular pupillary asymmetry (IOPA) in these two populations.	[Truong, James Q.; Ciuffreda, Kenneth J.] SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA		Truong, JQ (corresponding author), SUNY Coll Optometry, Dept Biol & Vis Sci, 33 West 42nd St, New York, NY 10036 USA.	james.q.truong@gmail.com					Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; ETTINGER ER, 1991, INVEST OPHTH VIS SCI, V32, P501; Kaufman PL., 2011, ADLERS PHYSL EYE, V11; KAWASAKI A, 1995, AM J OPHTHALMOL, V120, P622, DOI 10.1016/S0002-9394(14)72209-3; LAM BL, 1987, AM J OPHTHALMOL, V104, P69, DOI 10.1016/0002-9394(87)90296-0; Levin Leonard A, 2004, Ophthalmol Clin North Am, V17, P455, DOI 10.1016/j.ohc.2004.05.008; Loewenfeld I. E., 1993, PUPIL ANATOMY PHYSL; Loewenfeld IE, 1977, AM ACAD OPHTHALMOLOG, V83, P832; Orr JB, 2015, OPTOMETRY VISION SCI, V92, P834, DOI 10.1097/OPX.0000000000000627; Park JC, 2011, INVEST OPHTH VIS SCI, V52, P6624, DOI 10.1167/iovs.11-7586; Poirier MP, 2003, CLIN PEDIATR EMERG M, V4, P179, DOI DOI 10.1016/S1522-8401(03)00061-2; Stapert S, 2006, BRAIN INJURY, V20, P161, DOI 10.1080/02699050500442949; Stark L, 1968, NEUROLOGICAL CONTROL; Suchoff IB, 2001, VISUAL VESTIBULAR CO; Suter PS, 2011, VISION REHABILITATION: MULTIDISCIPLINARY CARE OF THE PATIENT FOLLOWING BRAIN INJURY, P1, DOI 10.1201/b10524; Thiagarajan P, 2015, BRAIN INJURY, V29, P1420, DOI 10.3109/02699052.2015.1045029; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; Zinn KM, 1972, THE PUPIL	20	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	11					1372	1377		10.1080/02699052.2016.1192220			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DZ8TP	WOS:000386144900010	27712127				2022-02-06	
J	Uteshev, VV; Tenovuo, O; Gaidhani, N				Uteshev, Victor V.; Tenovuo, Olli; Gaidhani, Nikhil			The Cholinergic Potential, the Vagus Nerve and Challenges in Treatment of Traumatic Brain Injury	CURRENT PHARMACEUTICAL DESIGN			English	Article						Trauma; brain; injury; cholinergic; nicotinic; acetylcholine; vagus; vagal; stimulation; inflammatory; immune	NICOTINIC ACETYLCHOLINE-RECEPTOR; POSITIVE ALLOSTERIC MODULATION; CULTURED CORTICAL-NEURONS; CARDIAC VAGAL NEURONS; DORSAL MOTOR NUCLEUS; SOLITARY TRACT; BINDING-SITES; ANTIINFLAMMATORY PATHWAY; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE	Existing treatments of traumatic brain injury (TBI) have failed to reverse tremendous losses in productivity, independence and overall quality of life among TBI victims and therefore, cannot be viewed as sufficient. Although there is no shortage of promising basic concepts that may translate to efficacious therapies after TBI, the accumulated knowledge has yet to deliver treatments that adequately meet clinical and social demands. In this article, we discuss novel concepts, recent advances and accompanying challenges in developing cholinergic and related therapies after TBI.	[Uteshev, Victor V.; Gaidhani, Nikhil] Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76248 USA; [Tenovuo, Olli] Univ Turku, Dept Neurol, FI-20520 Turku, Finland; [Tenovuo, Olli] Turku Univ Hosp, Dept Rehabil & Brain Trauma, FI-20520 Turku, Finland		Uteshev, VV (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76248 USA.	Victor.Uteshev@unthsc.edu					Adams JH, 2011, J NEUROTRAUM, V28, P701, DOI 10.1089/neu.2010.1733; ADAMS JH, 1985, MED SCI LAW, V25, P265, DOI 10.1177/002580248502500407; AGOSTONI E, 1957, J PHYSIOL-LONDON, V135, P182, DOI 10.1113/jphysiol.1957.sp005703; Air EL, 2009, J NEUROSURG-PEDIATR, V3, P73, DOI 10.3171/2008.10.PEDS08294; AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Alexopoulos AV, 2006, SEIZURE-EUR J EPILEP, V15, P491, DOI 10.1016/j.seizure.2006.06.002; Allitt BJ, 2015, J NEUROTRAUMA; Andresen MC, 2001, ANN NY ACAD SCI, V940, P132; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; ARENDASH GW, 1995, BRAIN RES, V674, P252, DOI 10.1016/0006-8993(94)01449-R; Asl SZ, 2013, J NEUROSURG, V119, P353, DOI 10.3171/2013.4.JNS121636; Aziz Q, 1998, GASTROENTEROLOGY, V114, P559, DOI 10.1016/S0016-5085(98)70540-2; Baez-Pagan CA, 2015, J NEUROIMMUNE PHARM, V10, P468, DOI 10.1007/s11481-015-9601-5; Banerjee C, 2000, NEUROBIOL DIS, V7, P666, DOI 10.1006/nbdi.2000.0317; Bansal V, 2012, INFLAMMATION, V35, P214, DOI 10.1007/s10753-011-9307-7; Bansal V, 2010, J NEUROTRAUM, V27, P2255, DOI 10.1089/neu.2010.1372; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Bitner RS, 2010, J PHARMACOL EXP THER, V334, P875, DOI 10.1124/jpet.110.167213; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Boess FG, 2007, J PHARMACOL EXP THER, V321, P716, DOI 10.1124/jpet.106.118976; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Boscan P, 2002, EXP PHYSIOL, V87, P259, DOI 10.1113/eph8702353; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Brown KL, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00166; Browning KN, 2011, AUTON NEUROSCI-BASIC, V161, P6, DOI 10.1016/j.autneu.2010.11.001; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Cai PY, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00107; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Chakrabarti M, 2015, REV NEUROSCI; Chakrabarti M, 2014, BRAIN RES BULL, V109, P22, DOI 10.1016/j.brainresbull.2014.09.004; CLARK KB, 1995, NEUROBIOL LEARN MEM, V63, P213, DOI 10.1006/nlme.1995.1024; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; CLARKE PBS, 1992, TRENDS PHARMACOL SCI, V13, P407, DOI 10.1016/0165-6147(92)90125-P; CLARKE PBS, 1993, PROG BRAIN RES, V98, P77; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Davis SF, 2004, BRAIN RES, V1017, P208, DOI 10.1016/j.brainres.2004.05.049; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Deck J, 2005, PHYSIOL GENOMICS, V22, P86, DOI 10.1152/physiolgenomics.00085.2004; Ebben MR, 2008, J CLIN SLEEP MED, V4, P255; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Egea J, 2015, BIOCHEM PHARMACOL, V97, P463, DOI 10.1016/j.bcp.2015.07.032; Eljamel S, 2001, NEUROSTIMULATION PRI; Elkabes S, 2014, EXP NEUROL, V259, P28, DOI 10.1016/j.expneurol.2014.01.008; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Engineer CT, 2015, BRAIN STIMUL, V8, P637, DOI 10.1016/j.brs.2015.01.408; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; ENNIS M, 1988, J NEUROSCI, V8, P3644; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; Feng L, 2014, J NEUROSCI RES, V92, P1560, DOI 10.1002/jnr.23436; Feng L, 2012, J NEUROPHYSIOL, V108, P1884, DOI 10.1152/jn.00296.2012; Ferreira M, 2001, J PHARMACOL EXP THER, V296, P260; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Garcia-Oscos F, 2015, J NEUROSCI RES, V93, P859, DOI 10.1002/jnr.23550; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; George MS, 2000, CNS SPECTRUMS, V5, P12, DOI 10.1017/S1092852900024986; Ghacibeh GA, 2006, COGN BEHAV NEUROL, V19, P119, DOI 10.1097/01.wnn.0000213908.34278.7d; Ghacibeh GA, 2006, EPILEPSY BEHAV, V8, P720, DOI 10.1016/j.yebeh.2006.03.008; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Guan YZ, 2015, MOL NEUROBIOL, V51, P1480, DOI 10.1007/s12035-014-8825-3; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; GWYN DG, 1985, J COMP NEUROL, V239, P163, DOI 10.1002/cne.902390204; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Hasko G, 1998, BRIT J PHARMACOL, V125, P1297, DOI 10.1038/sj.bjp.0702179; Hassert DL, 2004, BEHAV NEUROSCI, V118, P79, DOI 10.1037/0735-7044.118.1.79; Hays SA, 2014, STROKE, V45, P3097, DOI 10.1161/STROKEAHA.114.006654; Hays SA, 2013, PROG BRAIN RES, V207, P275, DOI 10.1016/B978-0-444-63327-9.00010-2; Henry TR, 2002, NEUROLOGY, V59, pS3, DOI 10.1212/WNL.59.6_suppl_4.S3; Holmes MD, 2003, NEUROLOGY, V61, P1126, DOI 10.1212/01.WNL.0000086812.62554.06; HOUSER CR, 1983, BRAIN RES, V266, P97, DOI 10.1016/0006-8993(83)91312-4; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Iimia A, 2013, NEUROIMAGE, V66, P489, DOI 10.1016/j.neuroimage.2012.10.066; Jeromin A, 2015, BIOMARK MED, V9, P619, DOI [10.2217/BMM.15.22, 10.2217/bmm.15.22]; JORDAN D, 1986, PROG BRAIN RES, V67, P295; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Kaas JH, 2008, EXP NEUROL, V209, P407, DOI 10.1016/j.expneurol.2007.06.014; Kahlow H, 2013, SEIZURE-EUR J EPILEP, V22, P827, DOI 10.1016/j.seizure.2013.06.011; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kalappa BI, 2011, AM J PHYSIOL-CELL PH, V301, pC347, DOI 10.1152/ajpcell.00473.2010; Kaneko S, 1997, BRAIN RES, V765, P135, DOI 10.1016/S0006-8993(97)00556-8; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Khaksari M, 2015, INT IMMUNOPHARMACOL, V28, P279, DOI 10.1016/j.intimp.2015.05.046; Khodaparast N, 2013, NEUROBIOL DIS, V60, P80, DOI 10.1016/j.nbd.2013.08.002; Khodaparast N., 2015, NEUROREHAB NEURAL RE; Khodaparast N, 2014, NEUROREHAB NEURAL RE, V28, P698, DOI 10.1177/1545968314521006; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Krahl SE, 1998, EPILEPSIA, V39, P709, DOI 10.1111/j.1528-1157.1998.tb01155.x; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; LEVIN MC, 1987, J COMP NEUROL, V261, P562, DOI 10.1002/cne.902610408; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; Li YX, 2002, J NEUROCHEM, V81, P853, DOI 10.1046/j.1471-4159.2002.00891.x; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; Liechty PG, 2006, SURG NEUROL, V65, P48, DOI 10.1016/j.surneu.2005.04.045; Llewellyn-Smith IJ, 1990, CENTRAL REGULATION A; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; Lopez NE, 2012, SHOCK, V38, P294, DOI 10.1097/SHK.0b013e31825f5fb2; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Lopez NE, 2012, J NEUROTRAUM, V29, P385, DOI 10.1089/neu.2011.2053; Lu J, 2001, J NEUROTRAUM, V18, P399, DOI 10.1089/089771501750170976; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MANIER M, 1987, NEUROSCI LETT, V80, P141, DOI 10.1016/0304-3940(87)90643-4; Marrosu F, 2003, EPILEPSY RES, V55, P59, DOI 10.1016/S0920-1211(03)00107-4; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; Marzec M, 2003, EPILEPSIA, V44, P930, DOI 10.1046/j.1528-1157.2003.56202.x; Matteoli G, 2014, GUT, V63, P938, DOI 10.1136/gutjnl-2013-304676; Mello-Carpes PB, 2013, NEUROBIOL LEARN MEM, V100, P56, DOI 10.1016/j.nlm.2012.12.002; Mendelowitz D, 1998, CLIN EXP PHARMACOL P, V25, P453, DOI 10.1111/j.1440-1681.1998.tb02233.x; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Meyer EM, 1998, BRAIN RES, V786, P252, DOI 10.1016/S0006-8993(97)00300-4; Meyfroidt G, 2015, MINERVA ANESTESIOL; Miyashita T, 2003, BRAIN RES, V987, P164, DOI 10.1016/S0006-8993(03)03323-7; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Murphy JV, 2003, ARCH PEDIAT ADOL MED, V157, P560, DOI 10.1001/archpedi.157.6.560; NARITOKU DK, 1995, EPILEPSY RES, V22, P53, DOI 10.1016/0920-1211(95)00035-9; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Neff RA, 2003, CIRC RES, V93, P565, DOI 10.1161/01.RES.0000090361.45027.5B; Neff RA, 1998, BRAIN RES, V792, P277, DOI 10.1016/S0006-8993(98)00149-8; Neff RA, 1998, CIRC RES, V83, P1241, DOI 10.1161/01.RES.83.12.1241; Neren D, 2015, NEUROCRIT CARE; Nichols JA, 2011, NEUROSCIENCE, V189, P207, DOI 10.1016/j.neuroscience.2011.05.024; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4; Olincy A, 2007, BIOCHEM PHARMACOL, V74, P1192, DOI 10.1016/j.bcp.2007.07.015; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; Ortler M, 2001, EPILEPSIA, V42, P133, DOI 10.1046/j.1528-1157.2001.23800.x; Papacostas S S, 2007, Electromyogr Clin Neurophysiol, V47, P61; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Patel NC, 2004, PEDIATR INFECT DIS J, V23, P681, DOI 10.1097/01.inf.0000131632.25375.c7; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; PERRY EK, 1995, NEUROSCIENCE, V64, P385, DOI 10.1016/0306-4522(94)00410-7; Pruitt D., 2015, J NEUROTRAUM; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; RADNA RJ, 1981, BRAIN RES, V213, P45, DOI 10.1016/0006-8993(81)91247-6; RADNA RJ, 1981, BRAIN RES, V213, P29, DOI 10.1016/0006-8993(81)91246-4; Ren K, 2007, NEUROSCIENCE, V148, P230, DOI 10.1016/j.neuroscience.2007.05.013; Ren K, 2007, NEUROSCIENCE, V145, P314, DOI 10.1016/j.neuroscience.2006.11.023; Reyes BAS, 2006, BRAIN RES, V1117, P69, DOI 10.1016/j.brainres.2006.08.051; Robinson LC, 2015, J NEUROSURG, V122, P532, DOI 10.3171/2014.10.JNS14640; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Roosevelt RW, 2006, BRAIN RES, V1119, P124, DOI 10.1016/j.brainres.2006.08.048; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Sackeim HA, 2001, NEUROPSYCHOPHARMACOL, V25, P713, DOI 10.1016/S0893-133X(01)00271-8; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shen JX, 2012, J MOL NEUROSCI; Shi C, 2013, NEUROL RES, V35, P263, DOI 10.1179/1743132813Y.0000000167; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; SHIMOHAMA S, 1986, J NEUROCHEM, V46, P288, DOI 10.1111/j.1471-4159.1986.tb12960.x; Shimohama S, 2001, BIOL PSYCHIAT, V49, P233, DOI 10.1016/S0006-3223(00)01100-8; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Skok MV, 2007, LIFE SCI, V80, P2334, DOI 10.1016/j.lfs.2007.02.005; Skok MV, 2009, J LEUKOCYTE BIOL, V86, P1, DOI 10.1189/JLB.0209106; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smith DC, 2006, J NEUROTRAUM, V23, P1549, DOI 10.1089/neu.2006.23.1549; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Spuck S, 2010, NEUROSURGERY, V67, DOI 10.1227/NEU.0b013e3181f88867; Spyer KM, 1994, NUCL SOLITARY TRACT; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Szelenyi J, 2007, ANN NY ACAD SCI, V1113, P311, DOI 10.1196/annals.1391.026; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Teaktong T, 2003, GLIA, V41, P207, DOI 10.1002/glia.10132; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Tyagi E, 2010, INNATE IMMUN-LONDON, V16, P3, DOI 10.1177/1753425909104680; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Uteshev VV, 2010, ACTA BIOCH BIOPH SIN, V42, P8, DOI 10.1093/abbs/gmp101; Uteshev VV, 1996, PFLUG ARCH EUR J PHY, V432, P607, DOI 10.1007/s004240050176; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; Van Bockstaele EJ, 1999, J COMP NEUROL, V412, P410, DOI 10.1002/(SICI)1096-9861(19990927)412:3<410::AID-CNE3>3.0.CO;2-F; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang JJ, 2003, J NEUROPHYSIOL, V89, P2473, DOI 10.1152/jn.00934.2002; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; Willemze RA, 2015, NAT REV GASTRO HEPAT, V12, P353, DOI 10.1038/nrgastro.2015.56; WILSON J T L, 1990, Brain Injury, V4, P349; WOODRUFFPAK DS, 1994, BRAIN RES, V645, P309, DOI 10.1016/0006-8993(94)91665-9; Zhou L, 2014, NEURAL REGEN RES, V9, P1585, DOI 10.4103/1673-5374.141783; Zuo YT, 2007, PHYSIOL BEHAV, V90, P583, DOI 10.1016/j.physbeh.2006.11.009	210	5	6	0	3	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	14					2083	2092		10.2174/1381612822666160127111630			10	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DK7ZV	WOS:000375146900012	26818869				2022-02-06	
S	VandeVord, PJ; Leonardi, AD; Ritzel, D		Kobeissy, F; Dixon, CE; Hayes, RL; Mondello, S		VandeVord, Pamela J.; Leonardi, Alessandra Dal Cengio; Ritzel, David			Bridging the Gap of Standardized Animals Models for Blast Neurotrauma: Methodology for Appropriate Experimental Testing	INJURY MODELS OF THE CENTRAL NERVOUS SYSTEM: METHODS AND PROTOCOLS	Methods in Molecular Biology		English	Article; Book Chapter						Blast; Neurotrauma; Static pressure; Dynamic pressure; Advance blast simulators; Standard methods; Animal models	TRAUMATIC BRAIN-INJURY; WAVE; SEQUELAE; EXPOSURE	Recent military combat has heightened awareness to the complexity of blast-related traumatic brain injuries (bTBI). Experiments using animal, cadaver, or biofidelic physical models remain the primary measures to investigate injury biomechanics as well as validate computational simulations, medical diagnostics and therapies, or protection technologies. However, blast injury research has seen a range of irregular and inconsistent experimental methods for simulating blast insults generating results which may be misleading, cannot be cross-correlated between laboratories, or referenced to any standard for exposure. Both the US Army Medical Research and Materiel Command and the National Institutes of Health have noted that there is a lack of standardized preclinical models of TBI. It is recommended that the blast injury research community converge on a consistent set of experimental procedures and reporting of blast test conditions. This chapter describes the blast conditions which can be recreated within a laboratory setting and methodology for testing in vivo models within the appropriate environment.	[VandeVord, Pamela J.] Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [Leonardi, Alessandra Dal Cengio] John D Dingell VAMC, Detroit, MI USA; [Ritzel, David] Dyn FX Consulting Ltd, Blacksburg, ON, Canada		VandeVord, PJ (corresponding author), Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.						Alphonse Vanessa D, 2014, Biomed Sci Instrum, V50, P248; Arciniegas David B, 2011, Dialogues Clin Neurosci, V13, P325; Baird JP, 1987, P ROY SOC LOND A MAT, V409, P1836; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bethe HA, 1947, BLAST WAVE LOS ALA S; BRODE HL, 1959, PHYS FLUIDS, V2, P217, DOI 10.1063/1.1705911; Bulmash G., 1984, ARBRLTR02555; Cawley PJ, 2010, ANN INTERN MED, V153, P278, DOI 10.7326/0003-4819-153-4-201008170-00026; CELANDER H, 1955, ACTA PHYSIOL SCAND, V33, P6, DOI 10.1111/j.1748-1716.1955.tb01188.x; CELANDER H, 1955, ACTA PHYSIOL SCAND, V33, P14, DOI 10.1111/j.1748-1716.1955.tb01189.x; Chai JK, 2013, SHOCK, V40, P297, DOI 10.1097/SHK.0b013e3182837831; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Courtney AC, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3702803; Courtney MW, 2011, NEUROIMAGE, V54, pS55, DOI 10.1016/j.neuroimage.2010.05.025; DEWEY JM, 1971, PROC R SOC LON SER-A, V324, P275, DOI 10.1098/rspa.1971.0140; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Glass II, 1959, HDB SUPER SONIC AERO, V6, P1488; Glasstone S., 1977, EFFECTS NUCL WEAPONS, V3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Golub V. V., 1994, Shock Waves, V3, P279, DOI 10.1007/BF01415825; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Heltemes KJ, 2011, MIL MED, V176, P147, DOI 10.7205/MILMED-D-10-00191; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iremonger M, 1997, SCI FDN TRAUMA, V1, P189; Kainuma M, 2005, Shock Waves, Vols 1 and 2, Proceedings, P505, DOI 10.1007/978-3-540-27009-6_75; Kitajima S, 2009, P 10 ANN INT C FLUID; Kochanek PM, 2009, J NEUROTRAUM, V26, P813, DOI 10.1089/neu.2008.0893; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Miller G, 2011, SCIENCE, V333, P517, DOI 10.1126/science.333.6042.517; Minota T, 1998, P 2 INT WORKSH SHOCK, P2; Murray CK, 2005, MIL MED, V170, P516, DOI 10.7205/MILMED.170.6.516; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Richmond DR, 1959, AT2911242 LOV FDN ME; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Ritzel DV, 2011, HFM207 NATORTO; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Sajja VSSS, 2015, SHOCK, V44, P71, DOI 10.1097/SHK.0000000000000311; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; SKEWS BW, 1967, J FLUID MECH, V29, P705, DOI 10.1017/S0022112067001132; Sternberg H, 1976, 6TH INT S DET WHIT O, P528; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	50	5	5	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA	1064-3745	1940-6029	978-1-4939-3816-2; 978-1-4939-3814-8	METHODS MOL BIOL	Methods Mol. Biol.		2016	1462						101	118		10.1007/978-1-4939-3816-2_7	10.1007/978-1-4939-3816-2		18	Biochemical Research Methods; Biochemistry & Molecular Biology; Neurosciences	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Neurosciences & Neurology	BH1UG	WOS:000398551500009	27604715				2022-02-06	
J	VandeVord, PJ; Sajja, VSSS; Ereifej, E; Hermundstad, A; Mao, SJ; Hadden, TJ				VandeVord, Pamela J.; Sajja, Venkata Siva Sai Sujith; Ereifej, Evon; Hermundstad, Amy; Mao, Shijie; Hadden, Timothy J.			Chronic Hormonal Imbalance and Adipose Redistribution Is Associated with Hypothalamic Neuropathology following Blast Exposure	JOURNAL OF NEUROTRAUMA			English	Article						+6 adipose tissue; ACTH; adiponectin; blast; hypothalamus; leptin	TRAUMATIC BRAIN-INJURY; PITUITARY DYSFUNCTION; INDUCED NEUROTRAUMA; GROWTH-HORMONE; ACTH; STRESS; AXIS; PCR	Endocrine disorders have been shown to be a consequence of blast traumatic brain injury in soldiers returning from military conflicts. Hormone deficiency and adrenocorticotropic hormone (ACTH) dysfunction can lead to symptoms such as fatigue, anxiety, irritability, insomnia, sexual dysfunction, and decreased quality of life. Given these changes following blast exposure, the current study focused on investigating chronic pathology within the hypothalamus following blast, in addition to systemic effects. An established rodent model of blast neurotrauma was used to induce mild blast-induced neurotrauma. Adipose tissue, blood, and brain samples were collected at one and three months following a single blast exposure. Adipose tissue and blood were evaluated for changes in ACTH, adiponectin, C-reactive protein, glial fibrillary acidic protein, interleukin (IL)-1, and leptin. The hypothalamus was evaluated for injury using immunohistochemical techniques. The results demonstrated that the weight of the blast animals was significantly less, compared with the sham group. The slower rate of increase in their weight was associated with changes in ACTH, IL-1, and leptin levels. Further, histological analysis indicated elevated levels of cleaved caspase-3 positive cells within the hypothalamus. The data suggest that long-term outcomes of brain injury occurring from blast exposure include dysfunction of the hypothalamus, which leads to compromised hormonal function, elevated biological stress-related hormones, and subsequent adipose tissue remodeling.	[VandeVord, Pamela J.; Sajja, Venkata Siva Sai Sujith; Ereifej, Evon; Hermundstad, Amy; Mao, Shijie] Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA; [Hadden, Timothy J.] John D Dingell VA Med Ctr, Res Serv, Detroit, MI USA		VandeVord, PJ (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, 447 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	pvord@vt.edu	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [B1104-P]	The research described here was supported in part by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service, Award # B1104-P to PJV. We would also like to thank Ryan Brady, Anthony De Gregorio and William Hubbard for their assistance in experimental set-up and processing.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Baxter D, 2013, ANN NEUROL, V74, P527, DOI 10.1002/ana.23958; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; FLOOD JF, 1976, PHARMACOL BIOCHEM BE, V5, P41, DOI 10.1016/0091-3057(76)90327-0; Gadek-Michalska A, 2013, PHARMACOL REP, V65, P1655; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Hoffman SW, 2009, CLIN NEUROPSYCHOL, V23, P1400, DOI 10.1080/13854040903369433; Holmes A, 2009, NEUROSCI BIOBEHAV R, V33, P773, DOI 10.1016/j.neubiorev.2008.11.005; Jankord R, 2008, APPL PHYSIOL NUTR ME, V33, P461, DOI 10.1139/H08-022; Kageyama K, 2002, AM J MED SCI, V324, P326, DOI 10.1097/00000441-200212000-00007; Kasturi BS, 2009, J NEUROTRAUM, V26, P1315, DOI [10.1089/neu.2008.0751, 10.1089/neu.2008-0751]; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Lanfranco F, 2006, EUR J ENDOCRINOL, V154, P731, DOI 10.1530/eje.1.02139; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLaughlin RJ, 2014, NEUROSCI BIOBEHAV R, V42, P116, DOI 10.1016/j.neubiorev.2014.02.006; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; OKUDA H, 1975, PHARMACOL BIOCHEM BE, V3, P149; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Sajja VSSS, 2012, NMR BIOMED, V25, P1331, DOI 10.1002/nbm.2805; Schaaf M J, 2000, Stress, V3, P201, DOI 10.3109/10253890009001124; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Spelman JF, 2012, J GEN INTERN MED, V27, P1200, DOI 10.1007/s11606-012-2061-1; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Wilkinson CW, 2012, FRONT NEUROL, V3, P1; Yang C, 2011, CYTOKINE, V54, P29, DOI 10.1016/j.cyto.2010.12.011	30	5	5	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					82	88		10.1089/neu.2014.3786			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200010	26274838	Green Published			2022-02-06	
J	Gram, MG; Gade, L; Wogensen, E; Mogensen, J; Mala, H				Gram, Marie Gajhede; Gade, Louise; Wogensen, Elise; Mogensen, Jesper; Mala, Hana			Equal effects of typical environmental and specific social enrichment on posttraumatic cognitive functioning after fimbria-fornix transection in rats	BRAIN RESEARCH			English	Article						Enriched environment; Social environment; Physical activity; Brain injury; Cognitive recovery; Dopamine antagonist	TRAUMATIC BRAIN-INJURY; SPATIAL DELAYED ALTERNATION; PREFRONTAL CORTEX; PARIETAL CORTEX; AND/OR ABLATION; HIPPOCAMPAL-FORMATION; DOUBLE DISSOCIATION; POSTERIOR PARIETAL; PHYSICAL-ACTIVITY; SWIMMING POOL	Enriched environment (EE) has been shown to have beneficial effects on cognitive recovery after brain injury. Typical EE comprises three components: (i) enlarged living area providing physical activation, (ii) sensory stimulation, and (iii) social stimulation. The present study assessed the specific contribution of the social stimulation. Animals were randomly divided into groups of (1) a typical EE, (2) pure social enrichment (SE), or (3) standard housing (SH) and subjected to either a sham operation or transection of the fimbria-fomix (FF). The effect of these conditions on acquisition of a delayed alternation task in a T-maze was assessed. The sham control groups were not affected by housing conditions. In the lesioned groups, both typical EE and SE improved the task acquisition, compared to SH. A baseline one-hour activity measurement confirmed an equal level of physical activity in the EE and SE groups. After delayed alternation testing, pharmacological challenges (muscarinergic antagonist scopolamine and dopaminergic antagonist SKF-83566) were used to assess cholinergic and dopaminergic contributions to task solution. Scopolamine led to a marked impairment in all groups. SKF-83566 significantly enhanced the performance of the lesioned group subjected to SE. The results demonstrate that housing in a typical as well as atypical EE can enhance cognitive recovery after mechanical injury to the hippocampus. The scopolamine challenge revealed a cholinergic dependency during task performance in all groups, regardless of lesion and housing conditions. The dopaminergic challenge revealed a difference in the neural substrates mediating recovery in the lesioned groups exposed to different types of housing. (C) 2015 Elsevier B.V. All rights reserved.	[Gram, Marie Gajhede; Gade, Louise; Wogensen, Elise; Mogensen, Jesper; Mala, Hana] Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, DK-1353 Copenhagen K, Denmark		Mogensen, J (corresponding author), Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, Oester Farimagsgade 2A, DK-1353 Copenhagen K, Denmark.	marie.gajhede@psy.ku.dk; louisegade1987@gmail.com; elise@wogensen.com; jesper.mogensen@psy.ku.dk; hana.mala@psy.ku.dk		Rytter, Hana Mala/0000-0002-2910-372X; Mogensen, Jesper/0000-0003-1959-581X	Danish Council for Independent ResearchDet Frie Forskningsrad (DFF)	The present study was supported by a Grant from the Danish Council for Independent Research. A special thank you goes to Linda Marschner, Linda Rettenwander, Mette Beier Jensen, Jes Buster Madsen, Katja Cat Trang Vu, Camilla Gjerulff, Julie Rohrberg, Nicklas Hansen and Zenia Iversen for assistance with behavioural training and testing.	ALOE L, 1986, P NATL ACAD SCI USA, V83, P6184, DOI 10.1073/pnas.83.16.6184; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Branchi I, 2004, BEHAV PHARMACOL, V15, P353, DOI 10.1097/00008877-200409000-00006; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Cain DP, 2006, BEHAV BRAIN RES, V170, P241, DOI 10.1016/j.bbr.2006.02.023; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; Cirulli F, 2003, NEUROSCI BIOBEHAV R, V27, P73, DOI 10.1016/S0149-7634(03)00010-1; D'Andrea I, 2007, BEHAV BRAIN RES, V183, P60, DOI 10.1016/j.bbr.2007.05.029; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIMATTIA BD, 1988, BEHAV NEUROSCI, V102, P471, DOI 10.1037/0735-7044.102.4.471; DIVAC I, 1978, J COMP NEUROL, V180, P59, DOI 10.1002/cne.901800105; Domenger D, 2006, BEHAV BRAIN RES, V175, P212, DOI 10.1016/j.bbr.2006.08.027; Doulames V, 2014, INT J NEUROSCI, V124, P369, DOI 10.3109/00207454.2013.848441; Elliott BM, 2005, BEHAV BRAIN RES, V165, P187, DOI 10.1016/j.bbr.2005.06.025; Frotscher M, 1996, ANN ANAT, V178, P311, DOI 10.1016/S0940-9602(96)80080-X; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; Gaskin S, 2007, HIPPOCAMPUS, V17, P586, DOI 10.1002/hipo.20295; Ginsberg SD, 2002, J NEUROTRAUM, V19, P99, DOI 10.1089/089771502753460277; Ginsberg SD, 1998, NEUROSCIENCE, V86, P1259, DOI 10.1016/S0306-4522(98)00136-5; Ginsberg SD, 1999, NEUROSCIENCE, V88, P1059, DOI 10.1016/S0306-4522(98)00288-7; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hannan AJ, 2014, NEUROPATH APPL NEURO, V40, P13, DOI 10.1111/nan.12102; Heidbreder CA, 2000, NEUROSCIENCE, V100, P749, DOI 10.1016/S0306-4522(00)00336-5; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; Johansson BB, 1996, EXP NEUROL, V139, P322, DOI 10.1006/exnr.1996.0106; KESNER RP, 1989, BEHAV NEUROSCI, V103, P956, DOI 10.1037/0735-7044.103.5.956; KING VR, 1992, BEHAV BRAIN RES, V50, P53; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; KOLB B, 1994, CEREB CORTEX, V4, P664, DOI 10.1093/cercor/4.6.664; LINDVALL O, 1974, BRAIN RES, V81, P325, DOI 10.1016/0006-8993(74)90947-0; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Mala Hana, 2005, Neural Plasticity, V12, P329, DOI 10.1155/NP.2005.329; Mala H, 2012, BRAIN RES, V1445, P40, DOI 10.1016/j.brainres.2012.01.035; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; MOGENSEN J, 1995, NEUROBIOL LEARN MEM, V63, P54, DOI 10.1006/nlme.1995.1005; Mogensen J, 2005, BRAIN RES BULL, V65, P41, DOI 10.1016/j.brainresbull.2004.11.010; Mogensen J, 2004, PHARMACOL BIOCHEM BE, V77, P381, DOI 10.1016/j.pbb.2003.11.017; Mogensen J, 2004, BRAIN RES BULL, V63, P217, DOI 10.1016/j.brainresbull.2004.02.008; Mogensen J, 2003, PHARMACOL BIOCHEM BE, V75, P381, DOI 10.1016/S0091-3057(03)00107-2; MOGENSEN J, 1987, ACTA NEUROBIOL EXP, V47, P45; Mogensen J, 2002, NEUROBIOL LEARN MEM, V78, P139, DOI 10.1006/nlme.2001.4055; Mogensen J., 2014, HORIZONS NEUROSCIENC, V15, P99; Mogensen J, 2008, BEHAV BRAIN RES, V186, P215, DOI 10.1016/j.bbr.2007.08.009; Mogensen J, 2007, BRAIN RES BULL, V73, P86, DOI 10.1016/j.brainresbull.2007.02.006; Mogensen J, 2009, SCAND J PSYCHOL, V50, P561, DOI 10.1111/j.1467-9450.2009.00781.x; Oddie SD, 2002, BRAIN RES BULL, V57, P565, DOI 10.1016/S0361-9230(01)00745-6; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Quinlan MG, 2008, HORM BEHAV, V53, P185, DOI 10.1016/j.yhbeh.2007.09.015; Risedal A, 2002, BRAIN RES BULL, V58, P315, DOI 10.1016/S0361-9230(02)00796-7; Robbins TW, 1996, J PSYCHOPHARMACOL, V10, P39, DOI 10.1177/026988119601000107; ROSENZWEIG MR, 1978, BRAIN RES, V153, P563, DOI 10.1016/0006-8993(78)90340-2; Salamone JD, 2002, PSYCHOPHARMACOLOGY, V160, P371, DOI 10.1007/s00213-001-0994-x; Schrijver NCA, 2004, BEHAV BRAIN RES, V152, P307, DOI 10.1016/j.bbr.2003.10.016; Schrijver NCA, 2002, PHARMACOL BIOCHEM BE, V73, P209, DOI 10.1016/S0091-3057(02)00790-6; Serafim AP, 2001, BRAZ J MED BIOL RES, V34, P1465, DOI 10.1590/S0100-879X2001001100015; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Veena J, 2009, J NEUROSCI RES, V87, P831, DOI 10.1002/jnr.21907; WHISHAW IQ, 1985, BEHAV NEUROSCI, V99, P979, DOI 10.1037/0735-7044.99.5.979; WHISHAW IQ, 1995, J NEUROSCI, V15, P5779; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; YOSHIDA M, 1988, EXPERIENTIA, V44, P700, DOI 10.1007/BF01941033; Zimmermann A, 2001, BEHAV BRAIN RES, V121, P11, DOI 10.1016/S0166-4328(00)00377-6; [No title captured]; [No title captured]	74	5	5	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 10	2015	1629						182	195		10.1016/j.brainres.2015.10.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB1ZU	WOS:000368308900017	26499260				2022-02-06	
J	Yu, W; Le, HW; Lu, YG; Hu, JA; Yu, JB; Wang, M; Shen, W				Yu, Wei; Le, Hai-Wei; Lu, Yi-Gao; Hu, Jun-An; Yu, Jian-Bo; Wang, Ming; Shen, Wei			High levels of serum mannose-binding lectins are associated with the severity and clinical outcomes of severe traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Biomarker; Complement system; Mannose-binding lectin; Prognosis; Severity	ACUTE ISCHEMIC-STROKE; COMPLEMENT-SYSTEM; INNATE IMMUNITY; DEFICIENCY; PROTECTION; RISK; MICE; DEGENERATION; METAANALYSIS; ACTIVATION	Background: Mannose-binding lectin (MBL) is a key component of innate immunity. The expression of cortical MBL is up-regulated after clinical and experimental head trauma. This study aimed to assess the association of serum MBL levels with injury severity and long-term clinical outcomes after severe traumatic brain injury (STBI). Methods: Serum MBL levels were measured in 122 patients and 100 healthy controls. Multivariate analyses were used to analyze the relationship between serum MBL levels and trauma severity reflected by Glasgow Coma Scale scores as well as between serum MBL levels and 6-month mortality and unfavorable outcome (Glasgow Outcome Scale score: 1-3). A receiver operating characteristic (ROC) curve was structured to evaluate the prognostic predictive performance of serum MBL levels. Results: Compared with healthy controls, serum MBL levels of patients were markedly elevated. Using multivariate analyses, serum MBL levels were found to be associated closely with Glasgow Coma Scale (GCS) scores and MBL emerged as an independent predictor for 6-month mortality and unfavorable outcome. Under ROC curve, serum MBL levels and GCS scores possessed similar prognostic predictive values. Conclusion: Increased serum level of MBL was independently associated with head trauma severity and long-term clinical outcomes of STBI. (C) 2015 Elsevier B.V. All rights reserved.	[Yu, Wei; Le, Hai-Wei; Lu, Yi-Gao; Hu, Jun-An; Shen, Wei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg,Peoples Hosp Beilun Dist,Belium Br, Ningbo 315800, Zhejiang, Peoples R China; [Yu, Jian-Bo; Wang, Ming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China		Shen, W (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg,Peoples Hosp Beilun Dist,Belium Br, 1288 Lushan East Rd, Ningbo 315800, Zhejiang, Peoples R China.	beilunhospital@126.com					Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Arumugam TV, 2009, NEUROSCIENCE, V158, P1074, DOI 10.1016/j.neuroscience.2008.07.015; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Cervera A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008433; de la Rosa X, 2014, STROKE, V45, P1453, DOI 10.1161/STROKEAHA.113.004111; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Fildes JE, 2008, J HEART LUNG TRANSPL, V27, P1353, DOI 10.1016/j.healun.2008.08.011; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Garred P, 2008, BIOCHEM SOC T, V36, P1461, DOI 10.1042/BST0361461; Guan LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119699; Harvey H, 2014, EXP BRAIN RES, V232, P3363, DOI 10.1007/s00221-014-4078-7; Huang Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130665; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; JENNETT B, 1975, LANCET, V1, P480; Lettiero B, 2012, J CONTROL RELEASE, V161, P283, DOI 10.1016/j.jconrel.2011.10.036; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Luo J, 2014, EARLY HUM DEV, V90, P557, DOI 10.1016/j.earlhumdev.2014.07.007; Marshall LF, 1991, J NEUROSURG S, V75, P14; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Morrison H, 2011, CURR NEUROVASC RES, V8, P52, DOI 10.2174/156720211794520260; Nonaka Masaru, 2014, Subcell Biochem, V80, P31, DOI 10.1007/978-94-017-8881-6_3; Odgaard L, 2015, CLIN EPIDEMIOL, V7, P225, DOI 10.2147/CLEP.S78141; Orsini F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00380; Osthoff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134107; Osthoff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021338; Scorza M., 2015, CLIN CHIM ACTA; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Wang ZY, 2014, NEUROCHEM RES, V39, P248, DOI 10.1007/s11064-013-1214-x; Woodruff TM, 2010, NEUROMOL MED, V12, P179, DOI 10.1007/s12017-009-8085-y; Xue J., 2015, J MATERN-FETAL NEO M, V7, P1; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Zhang ZG, 2015, MOL NEUROBIOL, V51, P230, DOI 10.1007/s12035-014-8682-0; Zhao Y, 2015, DIABETES TECHNOL THE, V17, P490, DOI 10.1089/dia.2014.0372	36	5	5	0	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	DEC 7	2015	451		B				111	116		10.1016/j.cca.2015.10.017			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	CY2KG	WOS:000366236900001	26525964				2022-02-06	
J	Harrington, R; Foster, M; Fleming, J				Harrington, Rosamund; Foster, Michele; Fleming, Jennifer			Experiences of pathways, outcomes and choice after severe traumatic brain injury under no-fault versus fault- based motor accident insurance	BRAIN INJURY			English	Article							SOCIOECONOMIC OUTCOMES; COMPENSATION; RECOVERY; CARE; METAANALYSIS; POPULATIONS; TRANSITION; SURGERY; HOME		[Harrington, Rosamund; Foster, Michele] Univ Queensland, Sch Nursing Midwifery & Social Work, Brisbane, Qld, Australia; [Harrington, Rosamund] Australian Catholic Univ, Sch Allied Hlth, Brisbane, Qld, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia		Harrington, R (corresponding author), Australian Catholic Univ, Sch Allied Hlth, Fac Hlth Sci, Occupat Therapy, 1100 Nudgee Rd,POB 456, Virginia, Qld 4014, Australia.	rosamund.harrington@acu.edu.au		Harrington, Rosamund/0000-0003-0535-6885			Australian Faculty of Occupational Medicine & Royal Australasian College of Physicians, 2001, COMP INJ HLTH OUTC; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Cairns L, 2012, INT J DISABILITY MAN, V7, P35, DOI DOI 10.1017/idm.2012.8; Cameron P, 2009, INJURY, V40, P905, DOI 10.1016/j.injury.2009.06.309; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cornwell P, 2009, BRAIN IMPAIR, V10, P325, DOI 10.1375/brim.10.3.325; Fronsko A, 2008, TRACSA BETT CHOIC BE; Gabbe BJ, 2007, MED J AUSTRALIA, V187, P14, DOI 10.5694/j.1326-5377.2007.tb01108.x; Gabbe BJ, 2012, EXPLORING PATIENT PE; GETHING L, 2002, LIFE INJURY QUALITY; Harrington R, 2013, Q BRAIN INJ SERV M Q; Harris I, 2005, JAMA-J AM MED ASSOC, V293, P1644, DOI 10.1001/jama.293.13.1644; Harris IA, 2008, J ORTHOP TRAUMA, V22, P216, DOI 10.1097/BOT.0b013e31815c11dc; Harrison M, 2013, AGENDA-J POLICY ANAL, V20, P55; Koljonen P, 2009, INT ORTHOP, V33, P315, DOI 10.1007/s00264-007-0493-8; Liamputtong P., 2005, QUALITATIVE RES METH; Luntz H, 2013, TORTS CASES COMMENTA, P1; Luntz H, 2013, TORTS LAW J, V20, P153; Master RJ, 2001, HEALTH AFFAIR, V20, P161, DOI 10.1377/hlthaff.20.6.161; McAllister S, 2013, SOC SCI MED, V85, P93, DOI 10.1016/j.socscimed.2013.02.041; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Motor Accident Insurance Commission, 2014, STAT INF 1 JAN 30 JU; Mur-Veeman I, 2003, HEALTH POLICY, V65, P227, DOI 10.1016/S0168-8510(02)00215-4; Murgatroyd DF, 2011, INJURY PREV, V17, P222, DOI 10.1136/ip.2010.029546; O'Donnell ML, 2010, MED J AUSTRALIA, V192, P328, DOI 10.5694/j.1326-5377.2010.tb03532.x; Paul C, 2013, SPINAL CORD, V51, P919, DOI 10.1038/sc.2013.110; Productivity Commission, 2011, 54 PROD COMM; Strettles B, 2005, ACCOMMODATION NSW AD; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; The Lancet, 2011, LANCET, V378, P373; Todd S, 2002, U NEW S WALES LAW J, V25, P895; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner BJ, 2011, DISABIL REHABIL, V33, P818, DOI 10.3109/09638288.2010.513422; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Walsh J, 2005, LONG TERM CARE ACTUA, P204; Winkler D, 2010, BRAIN IMPAIR, V11, P313, DOI 10.1375/brim.11.3.313; Winstanley J, 2006, J HEAD TRAUMA REHAB, V21, P453, DOI 10.1097/00001199-200611000-00001	39	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1561	1571		10.3109/02699052.2015.1075142			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800006	26382715				2022-02-06	
J	Park, K; Heo, H; Han, ME; Choi, K; Yi, JH; Kang, SJ; Kwon, YK; Shin, KS				Park, Kyungjoon; Heo, Hwon; Han, Ma Eum; Choi, Kyuhyun; Yi, Jee Hyun; Kang, Shin Jung; Kwon, Yunhee Kim; Shin, Ki Soon			Learning-induced synaptic potentiation in implanted neural precursor cell-derived neurons	SCIENTIFIC REPORTS			English	Article							LONG-TERM POTENTIATION; REGION-SPECIFIC DIFFERENTIATION; TEMPORAL-LOBE EPILEPSY; STEM-CELLS; ADULT HIPPOCAMPUS; PYRAMIDAL CELL; TRANSPLANTATION; PLASTICITY; MEMORY; MODEL	Neuronal loss caused by neurodegenerative diseases, traumatic brain injury and stroke results in cognitive dysfunctioning. Implantation of neural stem/precursor cells (NPCs) can improve the brain function by replacing lost neurons. Proper synaptic integration following neuronal differentiation of implanted cells is believed to be a prerequisite for the functional recovery. In the present study, we characterized the functional properties of immortalized neural progenitor HiB5 cells implanted into the rat hippocampus with chemically induced lesion. The implanted HiB5 cells migrated toward CA1 pyramidal layer and differentiated into vGluT1-positive glutamatergic neurons with morphological and electrophysiological properties of endogenous CA1 pyramidal cells. Functional synaptic integration of HiB5 cell-derived neurons was also evidenced by immunohistochemical and electrophysiological data. Lesion-caused memory deficit was significantly recovered after the implantation when assessed by inhibitory avoidance (IA) learning. Remarkably, IA learning preferentially produced long-term potentiation (LTP) at the synapses onto HiB5 cell-derived neurons, which occluded paring protocol-induced LTP ex vivo. We conclude that the implanted HiB5 cell-derived neurons actively participate in learning process through LTP formation, thereby counteracting lesion-mediated memory impairment.	[Park, Kyungjoon; Heo, Hwon; Han, Ma Eum; Choi, Kyuhyun; Yi, Jee Hyun; Kwon, Yunhee Kim; Shin, Ki Soon] Kyung Hee Univ, Dept Biol, Dept Life & Nanopharmaceut Sci, Seoul, South Korea; [Kang, Shin Jung] Sejong Univ, Dept Mol Biol, Seoul, South Korea		Park, K (corresponding author), Kyung Hee Univ, Dept Biol, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	kimyh@khu.ac.kr; kisoon_shin@khu.ac.kr	Shin, Ki Soon/AAK-1939-2020; Kwon, Yunhee Kim/AAV-8420-2021; Park, Kyungjoon/AAL-8086-2020	Shin, Ki Soon/0000-0002-5701-3596; Park, Kyungjoon/0000-0002-7518-636X; YI, JEE HYUN/0000-0002-9407-593X	Basic Science Research Program through the NRF - Ministry of Sciences, ICT & Future Planning [NRF-2012M3A9C6049934, NRF-2012M3A9C6049937, NRF-2012R1A2A2A01015843, 2011-0019354, 2015R1A5A1037656, NRF-2014R1A2A1A11050360]	This research was supported by Basic Science Research Program through the NRF funded by the Ministry of Sciences, ICT & Future Planning (NRF-2012M3A9C6049934, NRF-2012M3A9C6049937, NRF-2012R1A2A2A01015843, 2011-0019354, 2015R1A5A1037656 and NRF-2014R1A2A1A11050360).	Arrigoni E, 2004, BRIT J PHARMACOL, V142, P317, DOI 10.1038/sj.bjp.0705744; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Cunningham M, 2014, CELL STEM CELL, V15, P559, DOI 10.1016/j.stem.2014.10.006; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Englund U, 2000, NEUROREPORT, V11, P3973, DOI 10.1097/00001756-200012180-00014; Foster TC, 1996, BRAIN RES, V736, P243, DOI 10.1016/0006-8993(96)00707-X; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gray JA, 2000, CELL TRANSPLANT, V9, P153, DOI 10.1177/096368970000900203; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Heo H, 2009, J ETHNOPHARMACOL, V122, P20, DOI 10.1016/j.jep.2008.11.026; Hermann DM, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00291; Hofer S, 2012, STEM CELLS, V30, P1206, DOI 10.1002/stem.1097; Imitola J, 2004, AM J PATHOL, V164, P1615, DOI 10.1016/S0002-9440(10)63720-0; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; JARRARD LE, 1976, J COMP PHYSIOL PSYCH, V90, P1035, DOI 10.1037/h0078659; Sandoval CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017689; Kadar T, 1998, J NEURAL TRANSM, V105, P987, DOI 10.1007/s007020050107; Kandel ER, 2000, SCIENCE, V290, P1113, DOI 10.1126/science.290.5494.1113; Kwon YK, 1997, MOL CELLS, V7, P320; Lebeau G, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-22; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Lepski G, 2011, TRANSPLANTATION, V91, P390, DOI 10.1097/TP.0b013e3182063083; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lundberg C, 2002, EXP NEUROL, V175, P370, DOI 10.1006/exnr.2002.7888; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Martino G, 2011, BRAIN, V134, P1585, DOI 10.1093/brain/awr115; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Moser EI, 1995, BEHAV BRAIN RES, V71, P11, DOI 10.1016/0166-4328(95)00051-8; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Oliveira Alcyr A. Jr, 2005, Current Alzheimer Research, V2, P79, DOI 10.2174/1567205052772759; Park CH, 2000, J NEUROCHEM, V74, P244, DOI 10.1046/j.1471-4159.2000.0740244.x; Pereira JB, 2014, HIPPOCAMPUS, V24, P403, DOI 10.1002/hipo.22234; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; RENFRANZ PJ, 1991, CELL, V66, P713, DOI 10.1016/0092-8674(91)90116-G; Rosser AE, 2007, CURR OPIN NEUROL, V20, P688, DOI 10.1097/WCO.0b013e3282f132fc; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shetty AK, 2005, J NEUROSCI, V25, P8391, DOI 10.1523/JNEUROSCI.1538-05.2005; Shetty AK, 2008, J NEUROSCI RES, V86, P3062, DOI 10.1002/jnr.21764; Shetty AK, 2007, STEM CELLS, V25, P2396, DOI 10.1634/stemcells.2007-0313; SHIHABUDDIN LS, 1995, J NEUROSCI, V15, P6666; Shihabuddin LS, 1996, EXP NEUROL, V139, P61, DOI 10.1006/exnr.1996.0081; Sorensen AT, 2011, EXP NEUROL, V229, P274, DOI 10.1016/j.expneurol.2011.02.008; Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124; UEKI A, 1994, J NEUROL SCI, V125, P14, DOI 10.1016/0022-510X(94)90236-4; Ueki A, 1996, J NEUROL SCI, V142, P7, DOI 10.1016/0022-510X(96)00113-X; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007	53	5	5	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 4	2015	5								17796	10.1038/srep17796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CX7MG	WOS:000365885400001	26634434	gold, Green Published			2022-02-06	
J	Akula, P; Hua, Y; Gu, LX				Akula, Praveen; Hua, Yi; Gu, Linxia			Blast-induced Mild Traumatic Brain Injury through Ear Canal: A Finite Element Study	BIOMEDICAL ENGINEERING LETTERS			English	Article						Ear canal; Blast; Traumatic brain injury; Finite element modeling; Stress transfer		Purpose The role of ear canal in transmitting blast waves to the brain is not clear. The goal of this work is to characterize the influence of ear canal on blast-induced mild traumatic brain injury through a computational approach. Methods A three-dimensional human head model with single-side ear canal details was reconstructed from computed tomography images. The ear canal was positioned either facing the incident blast wave or facing away from the blast wave. Results The blast wave-head interaction has demonstrated that the overpressure within the ear canal was substantially amplified when the ear directly faced the blast wave. When it faced away from the blast wave, the overpressure within the ear canal was less than the actual incident blast pressure. Regardless of the substantial pressure differences within the ear canal induced by the blast wave, the resulting intracranial pressures were almost the same for both cases. Conclusions The blast wave-head interaction has demonstrated that the role of the ear canal in brain dynamics, and thus brain injury, was negligible. However, the peak overpressure within the ear canal exceeded the documented tympanic membrane rupture and inner ear damage thresholds. This was speculated to cause the degeneration of axons along the auditory pathway up to the midbrain. This work provided fundamental understanding of the load transmission through the ear canal and could serve as a platform for designing better protective armors.	[Akula, Praveen; Hua, Yi; Gu, Linxia] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Gu, Linxia] Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA		Gu, LX (corresponding author), Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.	lgu2@unl.edu	gu, linxia/A-5645-2013	gu, linxia/0000-0003-2637-0299	Edgerton Innovation Award at the University of Nebraska-Lincoln College of Engineering; U.S. Army Research Office project "Army-UNL Center for Trauma Mechanics" [W911NF-08-10483]	The authors gratefully acknowledge the financial support provided by the Edgerton Innovation Award at the University of Nebraska-Lincoln College of Engineering, and the U.S. Army Research Office project "Army-UNL Center for Trauma Mechanics" (Contract No. W911NF-08-10483).	Akula P., 2013, THESIS; Alley MD, 2011, NEUROIMAGE, DOI [10.1016/j.neuroimage.2010.05.03, DOI 10.1016/J.NEUROIMAGE.2010.05.03]; [Anonymous], 2008, ABAQUS BENCHMARK MAN; Arun P, 2012, INTERV MED APPL SCI, V4, P125, DOI 10.1556/IMAS.4.2012.3.2; Chafi MS, 2009, P I MECH ENG H, V223, P1003, DOI 10.1243/09544119JEIM631; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; HIRSCH FG, 1968, ANN NY ACAD SCI, V152, P147, DOI 10.1111/j.1749-6632.1968.tb11972.x; Hua Y, 2014, J COMPUT NONLIN DYN, V9, DOI 10.1115/1.4026156; Hua Y, 2014, COMPOS PART B-ENG, V56, P456, DOI 10.1016/j.compositesb.2013.08.070; JAMES DJ, 1982, 0482 AWRECDE; KELLER A P Jr, 1958, Laryngoscope, V68, P2015; Kleinschmit NN, 2011, THESIS; Kringlebotn M, 2000, ANN OTO RHINOL LARYN, V109, P940, DOI 10.1177/000348940010901007; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; MOREST DK, 1983, HEARING RES, V9, P145, DOI 10.1016/0378-5955(83)90024-2; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WHITE CS, 1970, SPACE LIFE SCI, V2, P158, DOI 10.1007/BF01101282; Zalewski T., 1906, Z OHRENHEILKUNDE, V52, P109; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	27	5	5	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	2093-9868	2093-985X		BIOMED ENG LETT	Biomed. Eng. Lett.	DEC	2015	5	4					281	288		10.1007/s13534-015-0204-0			8	Engineering, Biomedical	Emerging Sources Citation Index (ESCI)	Engineering	VG3LJ	WOS:000446425300005		Green Published			2022-02-06	
J	Dakoure, PWH; Diallo, M; Traore, ACV; Gandema, S; Barro, SD; Traore, IA; Zare, C				Dakoure, Patrick W. H.; Diallo, Malick; Traore, Andre-Charles V.; Gandema, Salifou; Barro, Sie Drissa; Traore, Ibrahim Alain; Zare, Cyprien			Trauma related to falls from trees treated in a specialized trauma centre in Burkina-Faso-one hundred and six cases treated in one year	INTERNATIONAL ORTHOPAEDICS			English	Article						Falls from tree; Trauma; Developing countries; Prevention		Purpose Falls from trees related traumas are rarely reported in literature. They are public health problems in developing countries where their frequency is still important. The aim of the study is to describe falls from trees related trauma patterns and to present preventative measures. Methods An annual ongoing prospective study was held in our trauma emergency department (ED) about all the patients who sustained an injury after a recent fall from tree. A questionnaire related to the patient and to the trauma was established. The data were encoded and analysed by a statistical software. Results One hundred six patients who sustained a fall from tree trauma, out of a total of 139, were studied. Most patients were under 15 years old (76.4 %); they were injured in fruits season (33 %) after a fall from a fruit tree (mango trees, Shea trees, Nere, etc.) and were received late (86 %). Injuries were polymorphic from traumatic brain injuries (51.8 %) and spine injuries (13.2 %) to thoraco-abdominal (21.6 %) and limbs injuries (46.2 %). Three housewives were pregnant at the time of the trauma with secondary abortions. Patients were managed medically (33.9 %), surgically (19.8 %) or by casting (34.9 %) with good outcome in 59 cases. Twelve patients refused medical care and two died. Conclusion Education programs must focus on picking fruits and leaves in order to make them safe and prevent injuries related to these traditional or professional activities.	[Dakoure, Patrick W. H.; Diallo, Malick; Traore, Andre-Charles V.; Gandema, Salifou; Barro, Sie Drissa; Traore, Ibrahim Alain; Zare, Cyprien] Univ Polytech Bobo Dioulasso, Inst Super Sci Sante, Nasso, Bobo Dioulasso, Burkina Faso		Diallo, M (corresponding author), Univ Polytech Bobo Dioulasso, Inst Super Sci Sante, 01 BP 1091, Nasso, Bobo Dioulasso, Burkina Faso.	patdakoure@yahoo.fr; malikijallo@yahoo.com; forghocharles@gmail.com; gandemasalif@yahoo.fr; drissab@yahoo.fr; itraore80@gmail.com; zcyprien@yahoo.fr		Diallo, Malick/0000-0003-3484-2268			BARSS P, 1984, BRIT MED J, V289, P1717, DOI 10.1136/bmj.289.6460.1717; Bedaya Ngaro S, 1975, MED AFR NOIRE, V22, P633; Bousso A, 2004, REV CHIR ORTHOP REPA, V90, P189; Diallo O, 2014, AFR J NEUROL SCI, V33, P43; Djientcheu VP, 2005, AFR J NEUROL SCI, V24, P107; Muula Adamson S, 2009, Int Arch Med, V2, P20, DOI 10.1186/1755-7682-2-20; Nabi DG, 2009, INJURY, V40, P591, DOI 10.1016/j.injury.2008.11.013; REIBER GD, 1993, AM J FOREN MED PATH, V14, P201, DOI 10.1097/00000433-199309000-00005; Zargar M, 2005, East Mediterr Health J, V11, P235	9	5	5	2	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0341-2695	1432-5195		INT ORTHOP	Int. Orthop.	DEC	2015	39	12					2451	2456		10.1007/s00264-015-2966-5			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	CW7ME	WOS:000365182500018	26300374				2022-02-06	
J	Lin, CM; Chang, CK; Chang, CP; Hsu, YC; Lin, MT; Lin, JW				Lin, Chien-Min; Chang, Cheng-Kuei; Chang, Ching-Ping; Hsu, Yu-Chih; Lin, Mao-Tsun; Lin, Jia-Wei			Protecting against ischaemic stroke in rats by heat shock protein 20-mediated exercise	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Article						Exercise; heat shock protein 20; neuroprotection; stroke	FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; IN-VIVO; MODEL; HSP20; EXPRESSION; APOPTOSIS; AGMATINE; DELIVERY; SYSTEM	Background Exercise preconditioning (EP+) has been widely accepted as a being of safe and effective preventive measure for stroke. The purpose of this study was to investigate whether EP+ improves outcomes of ischaemic stroke by promoting neuronal and glial expression of heat shock protein (HSP) 20. Materials and methods Adult male Sprague-Dawley rats (288 in number) were used to investigate the contribution of HSP20-containing neurons and HSP20-containing glial cells in the exercise-mediated neuroprotection in the stroke condition using middle cerebral artery occlusion. Results Exercise preconditioning, in addition to increasing the numbers of both the HSP20-containg neurons (88 +/- 8 vs. 43 +/- 4; n = 8 each group; P < 0.05) and the HSP20-containg astrocytes (102 +/- 10 vs. 56 +/- 5; n = 8; P < 0.05) significantly attenuated stroke-induced brain infarct (140 +/- 9 vs. 341 +/- 20 mm(3); n = 8 per group; P < 0.01), neuronal apoptosis (20 +/- 5 vs. 87 +/- 7; n = 8 per group; n = 8; P < 0.01), glial apoptosis (29 +/- 5 vs. 101 +/- 4; n = 8; P < 0.01), and neurological deficits (6.6 +/- 0.3 vs. 11.7 +/- 0.8; n = 8 per group; P < 0.01). Reducing the numbers of both HSP20-containing neurons and HSP20-contaiing glia by intracerebral injection of pSUPER small interfering RNA. expressing HSP20 significantly reversed the beneficial effects of EP+ in attenuating stroke-induced cerebral infarct, neuronal and glial apoptosis, and neurological deficits. Conclusions The numbers of both the HSP20-containing neurons and the HSP20-containing glia inversely correlated with the outcomes of ischaemic stroke. In addition, preischaemic treadmill exercise improves outcomes of ischaemic stroke by increasing the numbers of both the HSP20-containing neurons and the HSP20-containing glia.	[Lin, Chien-Min; Chang, Cheng-Kuei; Lin, Jia-Wei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei 23561, Taiwan; [Lin, Chien-Min; Chang, Cheng-Kuei; Lin, Jia-Wei] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Chang, Ching-Ping; Hsu, Yu-Chih] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Lin, Mao-Tsun] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan		Lin, JW (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei 23561, Taiwan.	ns246@tmu.edu.tw		Chang, Ching-Ping/0000-0003-0890-9414	Ministry of Science and Technology of Taiwan R.O.C. [NSC 101-2314-B-218-001-MY3]; Chi Mei Medical Center, Tainan, Taiwan [CMFHT 10401]	This study is partially supported by the Ministry of Science and Technology of Taiwan R.O.C. under Grant no. NSC 101-2314-B-218-001-MY3 and Chi Mei Medical Center, Tainan, Taiwan under Grant no. CMFHT 10401.	Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Boluyt MO, 2006, PROTEOMICS, V6, P3154, DOI 10.1002/pmic.200401356; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang CK, 2014, INT J MOL SCI, V15, P19018, DOI 10.3390/ijms151019018; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Ding QX, 2006, EUR J NEUROSCI, V24, P1265, DOI 10.1111/j.1460-9568.2006.05026.x; Fan GC, 2005, TRENDS CARDIOVAS MED, V15, P138, DOI 10.1016/j.tcm.2005.05.004; Fan GC, 2005, CIRCULATION, V111, P1792, DOI 10.1161/01.CIR.0000160851.41872.C6; Gartshore G, 1997, EXP NEUROL, V147, P353, DOI 10.1006/exnr.1997.6635; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Horowitz M, 2007, PROG BRAIN RES, V162, P433, DOI 10.1016/S0079-6123(06)62021-9; Hu SX, 2009, BRAIN RES, V1249, P191, DOI 10.1016/j.brainres.2008.10.054; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Liebelt B, 2010, NEUROSCIENCE, V166, P1091, DOI 10.1016/j.neuroscience.2009.12.067; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; Manrique C, 2009, J BIOTECHNOL, V142, P185, DOI 10.1016/j.jbiotec.2009.05.009; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Wang Che-Chuan, 2010, BMC Pharmacology, V10, P11, DOI 10.1186/1471-2210-10-11; Wolf PA, 1999, STROKE, V30, P1991, DOI 10.1161/01.STR.30.9.1991; Zhang Q, 2014, J STROKE CEREBROVASC, V23, P1696, DOI 10.1016/j.jstrokecerebrovasdis.2014.01.016	25	5	6	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972	1365-2362		EUR J CLIN INVEST	Eur. J. Clin. Invest.	DEC	2015	45	12					1297	1305		10.1111/eci.12551			9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	DA6QH	WOS:000367929600009	26479875				2022-02-06	
J	Lu, HC; Wang, L; Zhong, WZ; Qi, RF; Li, N; You, WC; Su, XF; Zhuang, Z; Cheng, HL; Shi, JX				Lu, Huchen; Wang, Lian; Zhong, Wuzhao; Qi, Rongfeng; Li, Ning; You, Wanchun; Su, Xingfeng; Zhuang, Zong; Cheng, Huilin; Shi, Jixin			Establishment of swine-penetrating craniocerebral gunshot wound model	JOURNAL OF SURGICAL RESEARCH			English	Article						Animal models of injury; Bullet wound; Penetrating brain injury; Gunshot wounds; Damage control	GLASGOW-COMA-SCALE; MISSILE INJURIES; CIVILIAN PRACTICE; BRAIN-INJURY; HEAD-INJURY; RAT MODEL; MORTALITY; INCAPACITATION; MORBIDITY; SCORE-3	Background: Bullet-induced brain wounds are common among military personnel in war zones and among civilians with gun accidents or crime-related gun injuries. The goal of this study was to develop a nonfatal porcine model of penetrating craniocerebral gunshot wound (PCGW) by firing a projectile in live swine to induce PCGW in such a realistic manner as to reconstruct their physical characteristics. Materials and methods: We established a nonfatal porcine model of PCGW based on a custom-designed experimental gun that emulates the shooting of a 5.56-mm NATO standard rifle at 800 m (317 m/s; 200.9 J). Commercial swine (n = 20) were subjected to a ballistic wound to the bilateral frontal lobe, and four swine were used as controls. Surviving swine were used in subsequent first-aid, management, and monitoring experiments for neurosurgeons. Various physiological variables were measured continuously. After computed tomography (CT) scanning and three-dimensional CT reconstructions, all pigs underwent primary lifesaving emergency interventions, including emergency decompressive craniotomies and hemorrhage control. Results: In our nonfatal porcine model of PCGW, injuries were comparable in their morphology to real gunshot wounds, as evidenced by analysis of wound characteristics and CT scan images. The survival rates of the pigs were 100% within 2 h, 95% within 6 h, 85% within 12 h, and 85% within 24 h (P < 0.01). Hemodynamics, hematology, blood routine biochemistry, coagulation, and other physiological parameters also exhibited significant changes in the PCGW pigs. Conclusions: This model makes possible the laboratory reproduction of real ballistic wounds in a live large animal model that is close to humans. (C) 2015 Elsevier Inc. All rights reserved.	[Lu, Huchen; Zhong, Wuzhao; Li, Ning; You, Wanchun; Su, Xingfeng; Zhuang, Zong; Cheng, Huilin; Shi, Jixin] Nanjing Univ, Sch Med, Jingling Hosp, Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China; [Wang, Lian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China; [Qi, Rongfeng] Nanjing Univ, Sch Med, Jingling Hosp, Dept Med Imaging, Nanjing 210000, Jiangsu, Peoples R China		Cheng, HL (corresponding author), Nanjing Univ, Sch Med, Jingling Hosp, Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China.	cheng_huilin@sina.cn; cheng_huilin@sina.cn	Su, Xin/X-2589-2018	Wang, Lian/0000-0001-9201-6517	Medical Research FoundationUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [06G042]	This work was supported by the Medical Research Foundation (No. 06G042). The authors thank Jiangyue Zhang from the John Hopkins University for the view of gunshot wounds.	ALLEN IV, 1982, INJURY, V14, P183, DOI 10.1016/0020-1383(82)90057-2; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bhat Abdul Rashid MAW, 2010, PAN ARAB J NEUROSURG, V14, P24; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; BYRNES DP, 1974, BRIT J SURG, V61, P169, DOI 10.1002/bjs.1800610302; Callender GR, 1935, MIL SURG, V77, P177; CAREY ME, 1987, MIL MED, V152, P6; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; Carey ME, 2011, J NEUROSURG, V114, P1495, DOI 10.3171/2011.1.JNS101259; CAVENESS WF, 1962, J NEUROSURG, V19, P122, DOI 10.3171/jns.1962.19.2.0122; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; Cushing H, 1918, Br Med J, V1, P221; DEIPOLI G, 1978, PANMINERVA MED, V20, P181; DiMaio VJM, 1998, GUNSHOT WOUNDS; GERBER AM, 1972, J NEUROSURG, V36, P43, DOI 10.3171/jns.1972.36.1.0043; Glapa M, 2009, AM SURGEON, V75, P223; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; Harvey EN, 1945, WAR MED, V8, P91; Hejna P, 2010, J FORENSIC SCI, V55, P254, DOI 10.1111/j.1556-4029.2009.01202.x; KARGER B, 1995, INT J LEGAL MED, V108, P117, DOI 10.1007/BF01844822; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KAUFMAN HH, 1995, NEUROSURG CLIN N AM, V6, P701, DOI 10.1016/s1042-3680(18)30426-1; Kazim Syed Faraz, 2011, J Emerg Trauma Shock, V4, P395, DOI 10.4103/0974-2700.83871; Knight B., 1996, FORENSIC PATHOLOGY; LEVI L, 1991, British Journal of Neurosurgery, V5, P241, DOI 10.3109/02688699109005183; LEVY ML, 1994, NEUROSURGERY, V35, P77, DOI 10.1227/00006123-199407000-00012; LEVY V, 1988, AM J FOREN MED PATH, V9, P215, DOI 10.1097/00000433-198809000-00007; Marcol W, 2012, J RECONSTR MICROSURG, V28, P561, DOI 10.1055/s-0032-1315779; Jimenez CM, 2013, WORLD NEUROSURG, V79, P749, DOI 10.1016/j.wneu.2012.06.025; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Nakao K, 2010, J NEUROTRAUM, V27, P1925, DOI 10.1089/neu.2010.1379; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Scott R, 1983, Clin Lab Med, V3, P273; Shackford SR, 2014, J TRAUMA ACUTE CARE, V76, P347, DOI 10.1097/TA.0b013e3182aaa5b8; SHAFFREY ME, 1992, J NEUROTRAUM, V9, pS279; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; Smith JE, 2014, INJURY, V45, P874, DOI 10.1016/j.injury.2013.12.004; Williams AG, 2014, CASE GEN PURPOSE RIF; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335	43	5	6	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	DEC	2015	199	2					698	706		10.1016/j.jss.2015.01.006			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CV7DW	WOS:000364433600058	26123115				2022-02-06	
J	Ogrenci, A; Eksi, MS; Koban, O; Karakus, M				Ogrenci, Ahmet; Eksi, Murat Sakir; Koban, Orkun; Karakus, Mustafa			Spontaneous rapid resolution of acute subdural hematoma in children	CHILDS NERVOUS SYSTEM			English	Article						Head trauma; Acute subdural hematoma; Resolution	HEAD-INJURY; REDISTRIBUTION; REDUCTION; PATIENT	Background Spontaneous rapid resolution of acute subdural hematoma developing secondary to trauma has been reported in the literature, yet it is very rare in pediatric population. The aim of the present review is to analyze mechanisms, characteristics, and outcomes of pediatric acute subdural hematoma cases with spontaneous rapid resolution in conjunction with an exemplary case of ours. A 3-year-old boy was admitted to our emergency department following mild head trauma secondary to a fall from 2 m. He was alert and has a GCS of 15. He had no motor or sensorial deficit on neurological examination. On the emergent brain computed tomography image, an acute subdural hematoma over left frontoparietal lobe was observed. There was a midline shift of 8.3 mm and the width of the hematoma at the thickest portion was 11.2 mm. Surgery was postponed with a close neurological follow-up of the patient in pediatric intensive care unit, due to his well neurological status without any increased ICP findings. On the fourth hour follow-up head CT image, amount of midline shift and hematoma thickness were observed to have regressed dramatically. At the second week, the hematoma resorbed totally with only conservative approach, and he was discharged to home in well status. Analysis of 12 pediatric patients revealed a mean and median ages of 6.87 and 3.9 years, respectively (range = 8 months-18 years). Causes for ASH development were fall, traffic accident, struggle, and child abuse. Main clinical presentations were with depressed sensorium, coma, stupor, drowsiness, headache, motor weakness, lethargy, and seizure. Close follow-up with conservative treatment should be mode of approach in pediatric patients with ASH, if neurological and radiological findings are favorable. However, if patients' neurological status deteriorates after admission to hospital, surgery should be conveyed with no further delay.	[Ogrenci, Ahmet; Karakus, Mustafa] Batman State Hosp, Dept Neurosurg, Batman, Turkey; [Eksi, Murat Sakir] Univ Calif San Francisco, Spine Ctr, Dept Orthoped Surg, San Francisco, CA 94143 USA; [Koban, Orkun] Goztepe Med Pk, Dept Neurosurg, Istanbul, Turkey		Eksi, MS (corresponding author), Univ Calif San Francisco, Spine Ctr, Dept Orthoped Surg, 500 Parnassus Ave,MU320 West, San Francisco, CA 94143 USA.	muratsakireksi@gmail.com	Eksi, Murat Sakir/I-3699-2012; Koban, Orkun/AAG-1769-2021	Eksi, Murat Sakir/0000-0002-3036-0061; Koban, Orkun/0000-0002-4721-0502	TUBITAK (The Scientific and Technological Research Council of Turkey)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [1059B191400255]	Murat Sakir Eksi, M.D., was supported by a grant from TUBITAK (The Scientific and Technological Research Council of Turkey), grant number: 1059B191400255.	Ahn ES, 2005, J NEUROSURG, V103, P175, DOI 10.3171/ped.2005.103.2.0175; Berker M, 2003, ACTA NEUROCHIR, V145, P715, DOI 10.1007/s00701-003-0090-6; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; Cooper P R, 1976, Surg Neurol, V5, P25; Cosar M, 2007, TURK NEUROSURG, V17, P224; Erol FS, 2004, PEDIATR NEUROSURG, V40, P238, DOI 10.1159/000082299; Huang Shu-Hung, 2005, Kaohsiung Journal of Medical Sciences, V21, P291; Inamasu J, 2002, AM J EMERG MED, V20, P376, DOI 10.1053/ajem.2002.33955; Kundra SN, 2005, NEUROL INDIA, V53, P124, DOI 10.4103/0028-3886.15083; KUROIWA T, 1993, J NEUROSURG, V78, P126, DOI 10.3171/jns.1993.78.1.0126; Lee CH, 2009, J KOREAN MED SCI, V24, P1224, DOI 10.3346/jkms.2009.24.6.1224; LEVATI A, 1982, J NEUROSURG, V57, P779, DOI 10.3171/jns.1982.57.6.0779; MAKIYAMA Y, 1985, Nihon University Journal of Medicine, V27, P123; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NAGAO T, 1986, NEUROSURGERY, V19, P465, DOI 10.1227/00006123-198609000-00024; Niikawa S, 1989, Neurol Med Chir (Tokyo), V29, P820, DOI 10.2176/nmc.29.820; Park Jae-Young, 2013, J Med Case Rep, V7, P67, DOI 10.1186/1752-1947-7-67; POLMAN CH, 1986, NEUROSURGERY, V19, P446, DOI 10.1227/00006123-198609000-00019; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Shigemori M, 1979, Acta Neurochir Suppl (Wien), V28, P195; SMITH WP, 1981, AM J ROENTGENOL, V136, P543, DOI 10.2214/ajr.136.3.543; Suzuki Y, 1998, NEUROL SURG TOKYO, V26, P1025; Tsui EYK, 2000, EUR J RADIOL, V36, P53, DOI 10.1016/S0720-048X(99)00167-9; Watanabe A, 2010, NEUROL MED-CHIR, V50, P924, DOI 10.2176/nmc.50.924; Zacko J, 2011, YOUMANS WINN NEUROLO, P3424	27	5	5	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2015	31	12					2239	2243		10.1007/s00381-015-2910-4			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CW6AM	WOS:000365079000007	26391785				2022-02-06	
J	Onyemaechi, NOC; Popoola, SO; Schuh, A; Iorbo, AT; Elachi, IC; Oluwadiya, KS				Onyemaechi, Ndubuisi O. C.; Popoola, Sunday O.; Schuh, Alexander; Iorbo, Alex T.; Elachi, Itodo C.; Oluwadiya, Kehinde S.			Mortality Pattern of Hospitalized Surgical Patients in a Nigerian Tertiary Hospital	INDIAN JOURNAL OF SURGERY			English	Article						Surgical mortality; Pattern; Hospitalized patients; Nigeria	QUALITY; VOLUME; AUDIT	There is paucity of reports describing the pattern of surgical mortality in Nigeria. The aim of this study was to determine the incidence and pattern of mortality associated with surgical care in our hospital and to identify areas of improvement. The records of all patients who died after admission for surgical care at the Federal Medical Centre Makurdi between January 2009 and December 2011 were studied retrospectively. Data extracted were patients' demographics, surgical diagnosis, co-morbidity, surgical procedures performed, duration of hospital admission and outcome of treatment. Data were analyzed with SPSS version 17. There were 2,273 admissions into the surgical wards within the study period. During this period, there were 151 deaths with a crude mortality rate of 6.6 %. Ninety-four (62.3 %) patients were males and 57 (37.7 %) were females (M: F= 1.6: 1). The age of the patients ranged from 8 days to 95 years with a mean age of 36.1 +/- 20.1 years. Acute abdomen (37, 24.5 %), traumatic brain injury (32, 21.2 %) and malignancy (28, 18.5 %) were the commonest surgical diagnosis. Trauma-related deaths accounted for 48 (31.8 %) of all the deaths. Road traffic crash (89.6 %) was the commonest cause of injury. Surgical operations were performed in 75 (49.7 %) of the patients who died, while 76 (50.3 %) did not have any operative intervention. Mortality in patients admitted into the surgical ward was 6.6 %. Trauma-related death was the commonest. Traumatic brain injury, typhoid perforation of the bowel and malignancy were the leading causes of surgical death in our centre.	[Onyemaechi, Ndubuisi O. C.] Univ Nigeria, Teaching Hosp Ituku Ozalla Enugu, Dept Surg, Enugu, Nigeria; [Popoola, Sunday O.; Oluwadiya, Kehinde S.] Ekiti State Univ, Teaching Hosp Ado Ekiti, Dept Surg, Ado Ekiti, Nigeria; [Schuh, Alexander] Neumarkt Clin, Musculoskeletal Ctr, Neumarkt, Germany; [Iorbo, Alex T.] Fed Med Ctr Makurdi, Dept Surg, Makurdi, Nigeria; [Elachi, Itodo C.] Benue State Univ, Teaching Hosp Makurdi, Dept Surg, Makurdi, Nigeria		Onyemaechi, NOC (corresponding author), Univ Nigeria, Teaching Hosp Ituku Ozalla Enugu, Dept Surg, Enugu, Nigeria.	bisionyemaechi@yahoo.com	ONYEMAECHI, NDUBUISI/AAO-7745-2021				Adetifa FA, 2009, J ETHIOP, V3, P1; Anderson Robert N, 2004, Natl Vital Stat Rep, V52, P1; Ayoade BA, 2013, WORLD J SURG, V37, P504, DOI 10.1007/s00268-012-1877-5; Biluts H, ETHIOP MED J, V47, P135; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Chukuezi AB, 2010, INT J SURG, V8, P381, DOI 10.1016/j.ijsu.2010.05.010; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; Ekere AU, 2004, INT ORTHOP, V28, P187, DOI 10.1007/s00264-004-0548-z; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; GLASS RE, 1987, ANN ROY COLL SURG, V69, P135; Goldacre JM, 2002, BMJ-BRIT MED J, V324, P1069; Ihegihu C. C., 2007, Tropical Journal of Medical Research, V11, P26; Lloyd H, 2005, BRIT J SURG, V92, P487, DOI 10.1002/bjs.4884; MCDONALD PJ, 1991, J ROY SOC MED, V84, P213, DOI 10.1177/014107689108400410; OLeary DP, 1997, ANN ROY COLL SURG, V79, P46; Semel ME, 2012, SURGERY, V151, P171, DOI 10.1016/j.surg.2011.07.021; Semmens JB, 2005, MED J AUSTRALIA, V183, P504, DOI 10.5694/j.1326-5377.2005.tb07150.x; Solagberu BA, AFR J MED SCI, V29, P315; Symons NRA, 2013, BRIT J SURG, V100, P1318, DOI 10.1002/bjs.9208; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	20	5	5	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0972-2068	0973-9793		INDIAN J SURG	Indian J. Surg	DEC	2015	77			3			S881	S885		10.1007/s12262-014-1048-z			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DF8OV	WOS:000371618600025	27011475	Green Published			2022-02-06	
J	Qasmi, SA; Ghaffar, A; Hussain, Z; Mushtaq, J				Qasmi, Shahzad Ahmed; Ghaffar, Abdul; Hussain, Zahid; Mushtaq, Junaid			Early autologous cranioplasty after decompressive hemi-craniectomy for severe traumatic brain injury	JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION			English	Article						Decompressive hemicraniectomy; Autologous cranioplasty; Traumatic brain injury	SEVERE HEAD-INJURY; COMPLICATIONS	Objective: To evaluate the outcome of early replacement of autologous bone flap for decompressive hemicraniectomy in severe traumatic brain injury patients. Methods: The observational cross-sectional prospective study was conducted at the Neurosurgical Unit of the Combined Military Hospital, Rawalpindi, Pakistan, from July 2011, to June 2014, and comprised patients who underwent cranioplasty after decompressive hemicraniectomy for trauma. Patients over 20 years of age and of either gender were included. Cranioplasty was timed in all these patients using native bone flap preserved in the abdominal wall after decompressive craniectomy. Parameters recorded were mortality, wound infection, subdural collection, wound dehiscence, ventriculomegaly, bone resorption, cosmetic deformity and neurological outcome. SPSS 17 was used for data analysis. Results: Of the 30 patients in the study, 28(93.3%) were males. The overall mean age was age 32.03+/-8.01 years (range: 20-48 years). Mean cranioplasty time was 66.2+/-11.50 days (range: 44-89 days). Major infection necessitating bone flap removal was found in 1(3.33%) patient, while minor scalp wound infections, treated with antibiotics and dressings were found in 2(6.66%). Cosmetic18 deformity was seen in 3(10%). Improved neurological outcome was noted in 21(70 %) patients; 6(20%) survived with a moderate to severe disability and 3(10%) remained in a vegetative state. No mortality was found after the procedure. Conclusion: Early autologous bone replacement for decompressive hemicraniectomy in severe traumatic brain injury patients offered cost-effective, acceptable surgical and improve dneurological outcome.	[Qasmi, Shahzad Ahmed; Ghaffar, Abdul; Hussain, Zahid; Mushtaq, Junaid] Combined Mil Hosp, Rawalpindi Cantonment, Pakistan		Qasmi, SA (corresponding author), Combined Mil Hosp, Rawalpindi Cantonment, Pakistan.	qasmi.shahzad@gmail.com					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Basheer N, 2010, INDIAN J NEUROTRAUM, V7, P139, DOI 10.1016/S0973-0508(10)80029-2; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Chibbaro S, 2011, WORLD NEUROSURG, V75, P558, DOI 10.1016/j.wneu.2010.10.020; Cho KC, 2011, J KOREAN NEUROTRAUMA, V7, P74; Chun HJ, 2011, J CRANIOFAC SURG, V22, P203, DOI 10.1097/SCS.0b013e3181f753bd; El Ghoul Wessam, 2015, Br J Neurosurg, V29, P64, DOI 10.3109/02688697.2014.957157; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Godil SS, 2011, J CRANIOFAC SURG, V22, P1307, DOI 10.1097/SCS.0b013e31821c6d37; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant FC, 1939, ANN SURG, V110, P488, DOI 10.1097/00000658-193910000-00002; Huang YH, 2013, INJURY, V44, P44, DOI 10.1016/j.injury.2011.11.005; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Martin KD, 2014, ACTA NEUROCHIR, V156, P813, DOI 10.1007/s00701-014-2021-0; Morina Arsim, 2011, Surg Neurol Int, V2, P72, DOI 10.4103/2152-7806.81735; RISH BL, 1979, NEUROSURGERY, V4, P381, DOI 10.1227/00006123-197905000-00002; Rodriguez AR, 2012, J NEUROLSURG, V73, P22; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; Senapati SB, 2012, INDIAN J NEUROTRAUM, V9, P136, DOI 10.1016/j.ijnt.2012.10.006; Sobani Zain A, 2011, Surg Neurol Int, V2, P123, DOI 10.4103/2152-7806.85055; Song J, 2014, ACTA NEUROCHIR, V156, P193, DOI 10.1007/s00701-013-1908-5; Tahir MZ, 2013, BRIT J NEUROSURG, V27, P479, DOI 10.3109/02688697.2012.757291; Wen L, 2007, J CRANIOFAC SURG, V18, P526, DOI 10.1097/scs.0b013e3180534348; YAMAURA A, 1977, Neurologia Medico-Chirurgica, V17, P43, DOI 10.2176/nmc.17pt1.43; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	26	5	5	0	1	PAKISTAN MEDICAL ASSOC	KARACHI	PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN	0030-9982			J PAK MED ASSOC	J. Pak. Med. Assoc.	DEC	2015	65	12					1325	1329					5	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	CY6OX	WOS:000366529800015	26627516				2022-02-06	
J	Rocha, NBF; Fonseca, DA; Marques, AB; Rocha, SA; Hoaken, PNS				Rocha, Nuno B. F.; Fonseca, Duarte A.; Marques, Alina B.; Rocha, Susana A.; Hoaken, Peter N. S.			Cognitive function is associated with prison behaviour among women in prison but not with subjective perception of adjustment to prison	CRIMINAL BEHAVIOUR AND MENTAL HEALTH			English	Article							LIFE-COURSE-PERSISTENT; TRAUMATIC BRAIN-INJURY; ANTISOCIAL-BEHAVIOR; NEUROPSYCHOLOGICAL MEASURES; EXECUTIVE FUNCTION; PREVALENCE; ATTENTION; VIOLENCE; ADOLESCENCE; ABILITIES	BackgroundThere is considerable evidence that aspects of cognitive function, especially executive function, are associated with antisocial behaviour and violence, but most research to date has measured current cognition and previous criminal behaviour. Furthermore, this research has been conducted almost exclusively with male offenders. AimThe aim of this study is to examine relationships between a wide range of cognitive functions and behaviours among women in prison. Our hypotheses were that cognitive functioning would be associated with both more-or-less contemporaneously observed behaviour problems and self-rated adjustment to the environment. MethodForty-five drug-free imprisoned female offenders were individually assessed on a battery of cognitive measures. Prison staff rated their behaviour on the Prison Behaviour Rating Scale and the women rated their own sense of adjustment to the environment on the Prison Adjustment Questionnaire. ResultsStepwise hierarchical regressions indicated that attention was independently associated with behaviours reflecting tension, depression, isolation, fear, victimisation and worry, whereas processing speed was independently associated with behaviours reflecting lack of energy, mental slowness and lack of awareness of the surrounding environment and total Prison Adjustment Questionnaire score. There was no relationship between cognitive functioning and subjective perception of adjustment to prison. Conclusions and Implications for Practice and Future ResearchResults indicate that cognition contributes to some of the behavioural problems displayed by inmates in the prison context. Future studies should evaluate the role of programmes to improve cognitive processes in also improving prison behaviour and also test for continuities and discontinuities with post-release integrative success. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Rocha, Nuno B. F.; Fonseca, Duarte A.] Inst Politecn Porto, Escola Super Tecnol Saude, P-4400330 Vila Nova De Gaia, Portugal; [Rocha, Nuno B. F.] Univ Porto, Fac Psicol & Ciencias Educ, P-4100 Oporto, Portugal; [Marques, Alina B.] Estabelecimento Pris Especial Santa Cruz Bispo, Oporto, Portugal; [Rocha, Susana A.] Inst Politecn Porto, Inst Super Contabilidade & Adm, Matosinhos, Portugal; [Hoaken, Peter N. S.] Univ Western Ontario, Fac Social Sci, London, ON, Canada		Rocha, NBF (corresponding author), Inst Politecn Porto, Escola Super Tecnol Saude, Rua Valente Perfeito 322, P-4400330 Vila Nova De Gaia, Portugal.	nrocha@eu.ipp.pt	Rocha, Nuno/M-9821-2013	Rocha, Nuno/0000-0002-3139-2786; Rocha, Susana/0000-0002-5833-165X			Arnsten AFT, 2012, J AM ACAD CHILD PSY, V51, P356, DOI 10.1016/j.jaac.2012.01.008; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Brickenkamp R., 2007, D2 TESTE ATENCAO; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cahill BS, 2012, BEHAV SCI LAW, V30, P154, DOI 10.1002/bsl.2004; Connors LL, 2012, J ATTEN DISORD, V16, P60, DOI 10.1177/1087054710379734; Cooke DJ, 1998, CRIM JUSTICE BEHAV, V25, P482, DOI 10.1177/0093854898025004005; Coolidge FL, 2011, BEHAV SCI LAW, V29, P741, DOI 10.1002/bsl.997; DAOUST SW, 2006, PSYCHOL SERV, V3, P88; de Frias CM, 2006, NEUROPSYCHOLOGY, V20, P206, DOI 10.1037/0894-4105.20.2.206; Depp CA, 2012, BIPOLAR DISORD, V14, P217, DOI 10.1111/j.1399-5618.2012.01011.x; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dunning David, 2004, Psychol Sci Public Interest, V5, P69, DOI 10.1111/j.1529-1006.2004.00018.x; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Gadon L, 2006, CLIN PSYCHOL REV, V26, P515, DOI 10.1016/j.cpr.2006.02.002; Hancock M, 2010, AGGRESSIVE BEHAV, V36, P338, DOI 10.1002/ab.20353; IBM Corp Released, 2011, IBM SPSS STAT WIND V; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Nuechterlein K. H., 2006, MCCB MATRICS CONSENS; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Reitan RM, 1992, TRAIL MAKING TEST MA; Retz W, 2012, EXPERT REV NEUROTHER, V12, P1241, DOI [10.1586/ERN.12.109, 10.1586/ern.12.109]; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Rosler M, 2009, EUR ARCH PSY CLIN N, V259, P98, DOI 10.1007/s00406-008-0841-8; Rosler M, 2004, EUR ARCH PSY CLIN N, V254, P365, DOI 10.1007/S00406-004-0516-Z; Ross E., 2012, THESIS; Ross EH, 2011, CAN J CRIMINOL CRIM, V53, P377, DOI 10.3138/cjccj.53.4.377; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Barbosa MFS, 2008, SPAN J PSYCHOL, V11, P259, DOI 10.1017/S1138741600004297; Schenk AM, 2012, AGGRESS VIOLENT BEH, V17, P430, DOI 10.1016/j.avb.2012.05.005; Schlack R, 2013, J ADOLESCENCE, V36, P587, DOI 10.1016/j.adolescence.2013.03.006; Sciberras E, 2012, CHILD PSYCHIAT HUM D, V43, P254, DOI 10.1007/s10578-011-0264-z; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Stein MB, 2002, BIOL PSYCHIAT, V52, P1079, DOI 10.1016/S0006-3223(02)01414-2; Surman CBH, 2013, ADHD-ATTEND DEFICIT, V5, P273, DOI 10.1007/s12402-012-0100-8; Tolman AW, 2012, SCHIZOPHRENIA BULL, V38, P304, DOI 10.1093/schbul/sbq077; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Warren JI, 2004, CRIM JUSTICE BEHAV, V31, P624, DOI 10.1177/0093854804267096; Wechsler D., 2008, WECHSLER ADULT INTEL; Wright K, 1985, 83IJCX0011 US DEP JU; Wykes T, 2011, AM J PSYCHIAT, V168, P472, DOI 10.1176/appi.ajp.2010.10060855	49	5	5	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0957-9664	1471-2857		CRIM BEHAV MENT HEAL	Crim. Behav. Ment. Health	DEC	2015	25	5					389	402		10.1002/cbm.1937			14	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	DB2RZ	WOS:000368358000006	25251039	Green Published			2022-02-06	
J	Konstantopoulos, K; Vogazianos, P; Thodi, C; Nikopoulou-Smyrni, P				Konstantopoulos, K.; Vogazianos, P.; Thodi, C.; Nikopoulou-Smyrni, P.			A normative study of the Children's Color Trails Test (CCTT) in the Cypriot population	CHILD NEUROPSYCHOLOGY			English	Article						Attention; Executive function; Children's Color Trails Test; Normal development; Normative data	ATTENTION; BEHAVIOR; IMPACT	Background: The Children's Color Trails Test (CCTT) is a neuropsychological test that measures attention, divided attention, and speed of mental processing. It has been increasingly used in the assessment of children in cross-cultural environments for neurological and psychiatric disorders such as seizures and closed head injuries, learning and/or language disabilities, attention deficit/hyperactivity disorder, children with manganese exposure, and children diagnosed with HIV virus. However, there is a paucity of studies presenting normative data. The aim of the present study was to provide normative data for the CCTT in the Cypriot population. Methods: A total of 709 native Cypriot children aged 7-16years, recruited from various public schools across the island, took part in the study. Exclusion criteria involved the existence of neurological, psychiatric, cardiological, and metabolic diseases, premature birth, history of maternal alcohol and drug abuse during pregnancy, low birth weight, hearing loss, visual problems, native language other than Greek, and abnormality in fine-motor movements. Results: Age and gender were found to be important factors for the interpretation of scores in all CCTT variables. Older children required less time and exhibited fewer errors, near misses, and prompts compared to younger children. There was a consistent pattern of a 3-4 seconds improvement (less time in seconds) in the CCTT completion time as age increased. Conclusions: CCTT is a promising tool for the measurement of attention in the native Cypriot population. Further research is needed in children diagnosed with various neurological and psychiatric diseases in order to estimate validity of the CCTT in clinical populations.	[Konstantopoulos, K.; Vogazianos, P.; Thodi, C.] European Univ Cyprus, Speech Therapy, CY-1516 Nicosia, Cyprus; [Nikopoulou-Smyrni, P.] Brunel Univ, Sch Hlth Sci & Social Care, London, England		Konstantopoulos, K (corresponding author), European Univ Cyprus, Speech Therapy, 1 Diogenes St,Block A,3rd Floor, CY-1516 Nicosia, Cyprus.	c.constantopoulos@euc.ac.cy	Vogazianos, Paris/AAD-5777-2019; konstantopoulos, kostas/E-9922-2011	Vogazianos, Paris/0000-0001-9991-6059; 			Bhang SY, 2013, ENVIRON RES, V126, P9, DOI 10.1016/j.envres.2013.05.006; Cho SC, 2011, PSYCHIAT INVEST, V8, P15, DOI 10.4306/pi.2011.8.1.15; Cho SC, 2010, J CHILD PSYCHOL PSYC, V51, P1050, DOI 10.1111/j.1469-7610.2010.02250.x; Fasfous AF, 2013, ARCH CLIN NEUROPSYCH, V28, P743, DOI 10.1093/arclin/act062; Kennel S, 2010, J PEDIATR NURS, V25, P3, DOI 10.1016/j.pedn.2008.06.010; Konstantopoulos K, 2013, APPL NEUROPSYCH-ADUL, V20, P47, DOI 10.1080/09084282.2012.670155; Llorente AM., 2003, CHILDRENS COLOR TRAI; Llorente AM, 2009, CLIN NEUROPSYCHOL, V23, P645, DOI 10.1080/13854040802427795; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; Mok N, 2008, APPL NEUROPSYCHOL, V15, P123, DOI 10.1080/09084280802083962; Oberg E, 2011, CHILD NEUROPSYCHOL, V17, P521, DOI 10.1080/09297049.2011.555760; Puthanakit T, 2013, PEDIATR INFECT DIS J, V32, P501, DOI 10.1097/INF.0b013e31827fb19d; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; 구훈정, 2008, [Korean Journal of Child & Adolescent Psychiatry, 소아 청소년 정신의학], V19, P28; Statistical Service of the Republic of Cyprus, 2012, ED STAT; Voigt RG, 2001, J PEDIATR-US, V139, P189, DOI 10.1067/mpd.2001.116050; White T., 1996, COLOR TRAILS TEST PR; WILLIAMS J, 1995, ARCH CLIN NEUROPSYCH, V10, P211, DOI 10.1016/0887-6177(94)00041-N	19	5	5	0	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0929-7049	1744-4136		CHILD NEUROPSYCHOL	Child Neuropsychol.	NOV 2	2015	21	6					751	758		10.1080/09297049.2014.924491			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CQ5AE	WOS:000360614900003	24898762				2022-02-06	
J	Bassil, F; Monvoisin, A; Canron, MH; Vital, A; Meissner, WG; Tison, F; Fernagut, PO				Bassil, Fares; Monvoisin, Arnaud; Canron, Marie-Helene; Vital, Anne; Meissner, Wassilios G.; Tison, Francois; Fernagut, Pierre-Olivier			Region-Specific Alterations of Matrix Metalloproteinase Activity in Multiple System Atrophy	MOVEMENT DISORDERS			English	Article						alpha-synuclein; matrix metalloproteinase; multiple system atrophy; parkinsonism; neurodegeneration	AMYOTROPHIC-LATERAL-SCLEROSIS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMYLOID BETA-PROTEIN; MYELIN BASIC-PROTEIN; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; MICROGLIAL ACTIVATION; CEREBROSPINAL-FLUID	Background: MSA is a sporadic progressive neurodegenerative disorder characterized by a variable combination of parkinsonism, cerebellar ataxia, and autonomic dysfunction. The pathological hallmark of MSA is the accumulation of alpha-synuclein aggregates in the cytoplasm of oligodendrocytes along with neuronal loss and neuroinflammation, as well as blood-brain barrier dysfunction and myelin deterioration. Matrix metalloproteinases are zinc-dependent endopeptidases involved in the remodeling of the extracellular matrix, demyelination, and blood-brain barrier permeability. Several lines of evidence indicate a role for these enzymes in various pathological processes, including stroke, multiple sclerosis, Parkinson's, and Alzheimer's disease. Methods: This study aimed to assess potential alterations of matrix metalloproteinase-1, -2, -3, and -9 expression or activity in MSA postmortem brain tissue. Results: Gelatin zymography revealed increased matrix metalloproteinase-2 activity in the putamen, but not in the frontal cortex, of MSA patients relative to controls. Immunohistochemistry revealed increased number of glial cells positive for matrix metalloproteinase-1, -2, and -3 in the putamen and frontal cortex of MSA patients. Double immunofluorescence revealed that matrix metalloproteinase-2 and -3 were expressed in astrocytes and microglia. Only matrix metalloproteinase-2 colocalized with alpha-synuclein in oligodendroglial cytoplasmic inclusions. Conclusion: These results demonstrate widespread alterations of matrix metalloproteinase expression in MSA and a pattern of increased matrix metalloproteinase-2 expression and activity affecting preferentially a brain region severely affected (putamen) over a relatively spared region (frontal cortex). Elevated matrix metalloproteinase expression may thus contribute to the disease process in MSA by promoting blood-brain barrier dysfunction and/or myelin degradation. (C) 2015 International Parkinson and Movement Disorder Society	[Bassil, Fares; Canron, Marie-Helene; Vital, Anne; Meissner, Wassilios G.; Tison, Francois; Fernagut, Pierre-Olivier] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Bassil, Fares; Canron, Marie-Helene; Vital, Anne; Meissner, Wassilios G.; Tison, Francois; Fernagut, Pierre-Olivier] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Monvoisin, Arnaud] Univ Poitiers Signalisat & Transports Ion Membran, CNRS, ERL7368, Poitiers, France; [Vital, Anne] CHU Bordeaux, Serv Anat Pathol, Bordeaux, France; [Meissner, Wassilios G.; Tison, Francois] CHU Bordeaux, Serv Neurol, Bordeaux, France; [Meissner, Wassilios G.; Tison, Francois] CHU Bordeaux, Ctr Reference Atrophie Multisyst, Bordeaux, France		Fernagut, PO (corresponding author), Inst Malad Neurodegenerat, UMR 5293, 146 Rue Leo Saignat,Bat 3B, F-33076 Bordeaux, France.	pierre-olivier.fernagut@u-bordeaux.fr	Bassil, Fares/F-4227-2018; Bassil, Fares/H-7073-2018; Meissner, Wassilios/C-7817-2015	CANRON, Marie-Helene/0000-0003-1032-7632; Meissner, Wassilios/0000-0003-2172-7527; Fernagut, Pierre-Olivier/0000-0002-7737-5439; Monvoisin, Arnaud/0000-0002-9915-4872	ARAMISE (French patients association for research on Multiple System Atrophy)	This work was supported by a grant from ARAMISE (French patients association for research on Multiple System Atrophy). The University Bordeaux Segalen and the CNRS provided infrastructural support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo WF, 2004, MOVEMENT DISORD, V19, P571, DOI 10.1002/mds.10714; Agrawal SM, 2008, SEMIN CELL DEV BIOL, V19, P42, DOI 10.1016/j.semcdb.2007.06.003; Ahmed Z, 2012, NEUROPATH APPL NEURO, V38, P4, DOI 10.1111/j.1365-2990.2011.01234.x; Asahina M, 2001, CLIN NEUROPATHOL, V20, P60; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Benesova Y, 2009, MULT SCLER J, V15, P316, DOI 10.1177/1352458508099482; Bruck W, 1997, ANN NEUROL, V42, P783, DOI 10.1002/ana.410420515; Chandler S, 1995, NEUROSCI LETT, V201, P223, DOI 10.1016/0304-3940(95)12173-0; Choi DH, 2011, J BIOL CHEM, V286, P14168, DOI 10.1074/jbc.M111.222430; Crocker SJ, 2006, J NEUROCHEM, V98, P812, DOI 10.1111/j.1471-4159.2006.03927.x; Deb S, 1996, J NEUROCHEM, V66, P1641; Dev R, 2010, EXPERT OPIN INV DRUG, V19, P455, DOI 10.1517/13543781003643486; DeVries HE, 1997, PHARMACOL REV, V49, P143; Fang LB, 2010, J NEUROL SCI, V294, P51, DOI 10.1016/j.jns.2010.04.005; Fang LB, 2009, J NEUROL SCI, V285, P62, DOI 10.1016/j.jns.2009.05.025; Flabeau Olivier, 2010, Ther Adv Neurol Disord, V3, P249, DOI 10.1177/1756285610375328; Gerhard A, 2003, NEUROLOGY, V61, P686, DOI 10.1212/01.WNL.0000078192.95645.E6; GOTTSCHALL PE, 1995, J NEUROSCI RES, V42, P335, DOI 10.1002/jnr.490420307; GOTTSCHALL PE, 1995, J NEUROCHEM, V64, P1513; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Horimoto Y, 2000, J NEUROL SCI, V173, P109, DOI 10.1016/S0022-510X(99)00308-1; Ihara M, 2001, J CEREBR BLOOD F MET, V21, P828, DOI 10.1097/00004647-200107000-00008; Ishizawa K, 2004, J NEUROPATH EXP NEUR, V63, P43, DOI 10.1093/jnen/63.1.43; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P657, DOI 10.1007/s00401-010-0672-3; Kaufman E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062354; Kiaei M, 2007, EXP NEUROL, V205, P74, DOI 10.1016/j.expneurol.2007.01.036; Kieseier BC, 1999, NEUROLOGY, V53, P20, DOI 10.1212/WNL.53.1.20; Kieseier BC, 2006, CURR OPIN NEUROL, V19, P437, DOI 10.1097/01.wco.0000245365.51823.72; Kikuchi A, 2002, NEUROBIOL DIS, V9, P244, DOI 10.1006/nbdi.2002.0466; Kim S, 2009, J NEUROCHEM, V109, P1483, DOI 10.1111/j.1471-4159.2009.06075.x; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Lee JE, 2013, PARKINSONISM RELAT D, V19, P450, DOI 10.1016/j.parkreldis.2012.12.002; Levin J, 2009, EXP NEUROL, V215, P201, DOI 10.1016/j.expneurol.2008.10.010; Li WJ, 2011, BRAIN RES, V1387, P141, DOI 10.1016/j.brainres.2011.02.078; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Liao MC, 2010, BIOCHEMISTRY-US, V49, P1127, DOI 10.1021/bi901994d; Lim GP, 1996, J NEUROCHEM, V67, P251; Lorenzl S, 2003, NEUROCHEM INT, V43, P191, DOI 10.1016/S0197-0186(03)00004-4; Lorenzl S, 2002, EXP NEUROL, V178, P13, DOI 10.1006/exnr.2002.8019; Lorenzl S, 2006, EXP NEUROL, V200, P166, DOI 10.1016/j.expneurol.2006.01.026; Marques F, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-38; Matsuo A, 1998, AM J PATHOL, V153, P735, DOI 10.1016/S0002-9440(10)65617-9; Miller VM, 2007, NEUROBIOL DIS, V26, P615, DOI 10.1016/j.nbd.2007.03.005; Mroczko B, 2013, J ALZHEIMERS DIS, V37, P273, DOI 10.3233/JAD-130647; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nuttall RK, 2007, GLIA, V55, P516, DOI 10.1002/glia.20478; Ou-Yang MH, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-134; PAPP MI, 1989, J NEUROL SCI, V94, P79, DOI 10.1016/0022-510X(89)90219-0; PERESS N, 1995, J NEUROPATH EXP NEUR, V54, P16, DOI 10.1097/00005072-199501000-00002; Probst-Cousin S, 1998, J NEUROPATH EXP NEUR, V57, P814, DOI 10.1097/00005072-199809000-00002; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Shibata N, 2010, ACTA HISTOCHEM CYTOC, V43, P69, DOI 10.1267/ahc.10005; Shubayev VI, 2006, MOL CELL NEUROSCI, V31, P407, DOI 10.1016/j.mcn.2005.10.011; Song SK, 2011, NEUROBIOL AGING, V32, P2183, DOI 10.1016/j.neurobiolaging.2009.12.017; Sung JY, 2005, J BIOL CHEM, V280, P25216, DOI 10.1074/jbc.M503341200; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Wakabayashi K, 1998, J NEUROL SCI, V156, P114, DOI 10.1016/S0022-510X(98)00018-5; Walker EJ, 2010, J NEUROSCI RES, V88, P764, DOI 10.1002/jnr.22257; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; YAMADA T, 1995, ACTA NEUROPATHOL, V89, P199; Yin KJ, 2006, J NEUROSCI, V26, P10939, DOI 10.1523/JNEUROSCI.2085-06.2006; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Yushchenko M, 2000, J NEUROIMMUNOL, V110, P244, DOI 10.1016/S0165-5728(00)00339-8	64	5	5	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	NOV	2015	30	13					1802	1812		10.1002/mds.26329			11	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB2HC	WOS:000368327900014	26260627				2022-02-06	
J	Sakel, M; Boukouvalas, A; Buono, R; Moten, M; Mirza, F; Chan, WY; Maidment, I; Cross, J; Smith, TO; Myint, PK; Fox, C				Sakel, M.; Boukouvalas, A.; Buono, R.; Moten, M.; Mirza, F.; Chan, W. -Y.; Maidment, I.; Cross, J.; Smith, T. O.; Myint, P. K.; Fox, C.			Does anticholinergics drug burden relate to global neuro-disability outcome measures and length of hospital stay?	BRAIN INJURY			English	Article						Anticholingeric; function; rehabilitation unit; length of stay; adverse event; spinal cord; traumatic brain injury	MILD COGNITIVE IMPAIRMENT; ELDERLY-PEOPLE; DEMENTIA	Primary objective: To assess the relationship between disability, length of stay (LOS) and anticholinergic burden (ACB) with people following acquired brain or spinal cord injury.Research design: A retrospective case note review assessed total rehabilitation unit admission.Methods and procedures: Assessment of 52 consecutive patients with acquired brain/spinal injury and neuropathy in an in-patient neuro-rehabilitation unit of a UK university hospital. Data analysed included: Northwick Park Dependency Score (NPDS), Rehabilitation complexity Scale (RCS), Functional Independence Measure and Functional Assessment Measure FIM-FAM (UK version 2.2), LOS and ACB. Outcome was different in RCS, NPDS and FIM-FAM between admission and discharge.Main outcomes and results: A positive change was reported in ACB results in a positive change in NPDS, with no significant effect on FIM-FAM, either Motor or Cognitive, or on the RCS. Change in ACB correlated to the length of hospital stay (regression correlation=-6.64; SE=3.89). There was a significant harmful impact of increase in ACB score during hospital stay, from low to high ACB on NPDS (OR=9.65; 95% CI=1.36-68.64) and FIM-FAM Total scores (OR=0.03; 95% CI=0.002-0.35).Conclusions: There was a statistically significant correlation of ACB and neuro-disability measures and LOS amongst this patient cohort.	[Sakel, M.; Mirza, F.] East Kent Univ NHS Hosp, Canterbury, Kent, England; [Boukouvalas, A.; Maidment, I.] Aston Univ, Birmingham B4 7ET, W Midlands, England; [Buono, R.; Myint, P. K.] Univ Aberdeen, Aberdeen, Scotland; [Moten, M.] Univ London Imperial Coll Sci Technol & Med, London, England; [Chan, W. -Y.] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England; [Cross, J.; Smith, T. O.; Fox, C.] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England		Sakel, M (corresponding author), East Kent Hosp Univ NHS Fdn Trust, Neurorehabil, Ethelbert Rd, Canterbury CT1 3NG, Kent, England.	m.sakel@nhs.net		cross, jane/0000-0002-7003-1916; Smith, Toby/0000-0003-1673-2954; Maidment, Ian/0000-0003-4152-9704; Fox, Chris/0000-0001-9480-5704			Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Blane K, 2013, NHS COMMISSIONIN 1 B; Campbell NL, 2013, J AM GERIATR SOC, V61, pS142; Campbell N, 2009, CLIN INTERV AGING, V4, P225; Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Fox C, 2010, JAMA-J AM MED ASSOC, V59, P1477; Fox C, 2014, AGE AGEING, V43, P604, DOI 10.1093/ageing/afu096; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Horn SD, 2012, ARCH PHYS MED REHAB, V93, pS127, DOI 10.1016/j.apmr.2011.10.031; Jessen F, 2010, EUR ARCH PSY CLIN N, V260, pS111, DOI 10.1007/s00406-010-0156-4; Kidd CA, 2014, ARCH GERONTOL GERIAT, V59, P155; Medcalf P, 2014, CLIN MED, V14, P349, DOI 10.7861/clinmedicine.14-4-349; Ness Jose, 2006, Am J Geriatr Pharmacother, V4, P42, DOI 10.1016/j.amjopharm.2006.03.008; Royal College of Physicians, 2010, MED REH 2011 REP WOR; Tannenbaum C, 2012, DRUG AGING, V29, P639, DOI 10.2165/11633250-000000000-00000; Wagg A, 2013, EUR UROL, V64, P74, DOI 10.1016/j.eururo.2013.01.002	16	5	5	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1426	1430		10.3109/02699052.2015.1060358			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200005	26287759	Green Accepted			2022-02-06	
J	Zhao, HX; Liao, Y; Xu, D; Wang, QP; Gan, Q; You, C; Yang, CH				Zhao, He-xiang; Liao, Yi; Xu, Ding; Wang, Qiang-ping; Gan, Qi; You, Chao; Yang, Chao-hua			The value of intraoperative intracranial pressure monitoring for predicting re-operation using salvage decompressive craniectomy after craniotomy in patients with traumatic mass lesions	BMC SURGERY			English	Article						Decompressive craniectomy; Severe traumatic brain injury; Intracranial pressure; Re-operation; Mass lesion	BRAIN-INJURY; SURGICAL-MANAGEMENT; HEAD TRAUMA; SECONDARY; AUTOREGULATION; HYPERTENSION; PATTERNS	Background: The risk factors of predicting the need for postoperative decompressive craniectomy due to intracranial hypertension after primary craniotomy remain unclear. This study aimed to investigate the value of intraoperative intracranial pressure (ICP) monitoring in predicting re-operation using salvage decompressive craniectomy (SDC). Methods: From January 2008 to October 2014, we retrospectively reviewed 284 patients with severe traumatic brain injury (STBI) who underwent craniotomy for mass lesion evacuation without intraoperative brain swelling. Intraoperative ICP was documented at the time of initial craniotomy and then again after the dura was sutured. SDC was used when postoperative ICP was continually higher than 25 mmHg for 1 h without a downward trend. Univariate and multivariate analyses were applied to both initial demographic and radiographic features to identify risk factors of SDC requirement. Results: Of 284, 41 (14.4 %) patients who underwent SDC had a higher Initial ICP than those who didn't (38.1 +/- 9.2 vs. 29.3 +/- 8.1 mmHg, P < 0.001), but there was no difference in ICP after the dura was sutured. The factors which have significant effects on SDC are higher initial ICP [odds ratio (OR): 1.100, 95 % confidence interval (CI): 1.052-1.151, P < 0.001], older age (OR: 1.039, 95 % CI: 1.002-1.077, P = 0.039), combined lesions (OR: 3.329, 95 % CI: 1.199-9.244, P = 0.021) and early hypotension (OR: 2.524, 95 % CI: 1.107-5.756, P = 0.028). The area under the curve of multivariate regression model was 0.771. Conclusions: The incidence of re-operation using SDC after craniotomy was 14.4 %. The independent risk factors of SDC requirement are initial ICP, age, early hypotension and combined lesions.	[Zhao, He-xiang; Xu, Ding; Wang, Qiang-ping; Gan, Qi; You, Chao; Yang, Chao-hua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Liao, Yi] Sichuan Univ, West China Hosp, Dept Neurointens Care Unit, Chengdu 610041, Sichuan, Peoples R China		Yang, CH (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China.	PRECISCD120@hotmail.com	Wang, Qiang/AAV-7131-2021				Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Huang APH, 2008, J NEUROTRAUM, V25, P1347, DOI 10.1089/neu.2008.0625; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Kuo JR, 2006, J CLIN NEUROSCI, V13, P218, DOI 10.1016/j.jocn.2005.01.012; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 2006, NEUROSURGERY, V58, P655; Matthew B.Potts, 2012, SCHMIDEK SWEET OPERA, P1551, DOI [10.1016/B978-1-4160-6839-6.10135-2., DOI 10.1016/B978-1-4160-6839-6.10135-2]; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Samant UB, 2008, J NEUROTRAUM, V25, P495, DOI 10.1089/neu.2007.0491; Servadei F, 2011, NEW ENGL J MED, V364, P1558, DOI 10.1056/NEJMe1102998; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Ter Minassian A, 2002, CRIT CARE MED, V30, P1616, DOI 10.1097/00003246-200207000-00036; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Tsai TH, 2013, KAOHSIUNG J MED SCI, V29, P540, DOI 10.1016/j.kjms.2013.01.010; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yuan Q, 2013, BRAIN INJURY, V27, P664, DOI 10.3109/02699052.2013.775497; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	38	5	6	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2482		BMC SURG	BMC Surg.	OCT 14	2015	15								111	10.1186/s12893-015-0100-7			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CT3OZ	WOS:000362717600001	26467905	gold, Green Published			2022-02-06	
J	Jung, S; Wollmer, MA; Kruger, THC				Jung, Stefanie; Wollmer, M. Axel; Kruger, Tillmann H. C.			The Hamburg-Hannover Agitation Scale (H(2)A): Development and validation of a self-assessment tool for symptoms of agitation	JOURNAL OF PSYCHIATRIC RESEARCH			English	Article						Agitation; Symptom; Assessment; Questionnaire; Manifestation; Prediction	BIPOLAR DISORDER; MIXED DEPRESSION; SUICIDE ATTEMPTS; MENTAL-ILLNESS; CONSENSUS; ASSOCIATION; PREDICTORS; MANAGEMENT; CRITERIA; VERSION	Background: Agitation has long been underestimated as a symptom occurring across psychiatric disorders. While several instruments exist for highly specific clinical, target groups (e.g. dementia, traumatic brain injury), no tool captures agitation in a broader range of psychiatric patients. The Hamburg -Hannover Agitation Scale (H(2)A) has been designed to satisfy this demand. This study concentrated on the development and validation of the scale in a psychiatric and a healthy control sample. Methods: The H(2)A was developed, tested in an expert sample, and revised. The German version was validated in a study involving two clinical institutions. Patients (n = 180) completed the H(2)A and several other questionnaires in order to test for congruent and discriminant validity. Healthy subjects (n = 685) completed the H(2)A only. The H(2)A was translated into English. Results: The H(2)A showed very satisfying quality criteria (reliability, selectivity, item difficulty) and regression analysis demonstrated the H(2)A's ability to distinguish between subjects with a psychiatric diagnosis and healthy subjects with or without psychiatric record. Factor analysis revealed a three-factorial structure representing a physiological/somatic, a mental and a mixed ('psychophysiological') dimension of agitation. Limitations: Although validation showed promising quality criteria and predictive value of the H(2)A, calibration tests with bigger and more balanced sample sizes are necessary. Conclusions: Agitation has become more clinically relevant as a symptom occurring in various affective disorders, yet its assessment is limited. The H(2)A was developed in order to meet this need. Validation of the H(2)A revealed very satisfactory item and scale quality criteria promoting its utility. (C) 2015 Published by Elsevier Ltd.	[Jung, Stefanie; Kruger, Tillmann H. C.] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, D-30625 Hannover, Germany; [Jung, Stefanie; Wollmer, M. Axel] Semmelweis Univ, Fac Med, Asklepios Clin North Ochsenzoll, H-1085 Budapest, Hungary		Kruger, THC (corresponding author), Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Carl Neuberg Str 1, D-30625 Hannover, Germany.	jung.stefanie@mh-hannover.de; m.wollmer@asklepios.com; krueger.tillmann@mh-hannover.de	Kruger, Tillmann HC/F-3493-2012; Wollmer, Marc A/B-5038-2009				Alderfer BS, 2003, J CLIN PSYCHIAT, V64, P3; Allen MH, 2004, GEN HOSP PSYCHIAT, V26, P42, DOI 10.1016/j.genhosppsych.2003.08.002; Allen MH, 2000, J CLIN PSYCHIAT, V61, P11; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Balazs J, 2006, J AFFECT DISORDERS, V91, P133, DOI 10.1016/j.jad.2005.12.049; Battaglia J, 2005, DRUGS, V65, P1207, DOI 10.2165/00003495-200565090-00003; Bogner J, 2000, AGITATED BEHAV SCALE; Bohus M, 2001, PSYCHOTHER PSYCH MED, V51, P201, DOI 10.1055/s-2001-13281; Brand S, 2011, J AFFECT DISORDERS, V131, P68, DOI 10.1016/j.jad.2010.12.007; Brislin R.W., 1986, WORDING TRANSLATION; Bryan CJ, 2008, J CLIN PSYCHOL, V64, P519, DOI 10.1002/jclp.20445; Bryan CJ, 2014, GEN HOSP PSYCHIAT, V36, P726, DOI 10.1016/j.genhosppsych.2014.09.013; Buyukdura JS, 2011, PROG NEURO-PSYCHOPH, V35, P395, DOI 10.1016/j.pnpbp.2010.10.019; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; COHENMANSFIELD J, 1990, PSYCHOL AGING, V5, P3, DOI 10.1037/0882-7974.5.1.3; Cummings J, 2015, INT PSYCHOGERIATR, V27, P7, DOI 10.1017/S1041610214001963; FAWCETT J, 1990, AM J PSYCHIAT, V147, P1189; Fishman R., 2009, 162 ANN M AM PSYCH A; Gonzalez D, 2013, CURR MED RES OPIN, V29, P241, DOI 10.1185/03007995.2013.766591; Gunderson J.G., 2008, BORDERLINE PERSONALI, V2nd ed.; Herrmann-Lingen C, 2011, HOSP ANXIETY DEPRESS; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IBM Corp, 2016, IBM SPSS STAT WINDOW; IBM Corp, 2012, IBM SPSS STAT WINDOW, V21st; Jung S., 2015, AGITATION DIFF UNPUB; Kahl KG, 2015, J CLIN PHARM; KAPLAN HI, 1995, COMPREHENSIVE TXB PS; Kasper S., 2013, CLINICUM NEUROPS NOV; Lesem MD, 2011, BRIT J PSYCHIAT, V198, P51, DOI 10.1192/bjp.bp.110.081513; Lindenmayer JP, 2000, J CLIN PSYCHIAT, V61, P5; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; Marder SR, 2006, J CLIN PSYCHIAT, V67, P13; McNair DM, 1971, PROFILE MOOD STATES; Meule A, 2011, DIAGNOSTICA, V57, P126, DOI 10.1026/0012-1924/a000042; Mintzer JE, 2006, J CLIN PSYCHIAT, V67, P3; Nishiyama Akiyoshi, 2013, Tokai J Exp Clin Med, V38, P93; Pacciardi Bruno, 2013, Front Psychiatry, V4, P26, DOI 10.3389/fpsyt.2013.00026; Parker G., 1996, MELANCHOLIA DISORDER, P130; Pascual JC, 2006, ACTAS ESP PSIQUIATRI, V34, P239; Prufer P, 1996, ZUMA NACHRICHTEN, V39, P95; R Development Core Team, 2012, R LANG ENV STAT COMP; Rhebergen D, 2015, Tijdschr Psychiatr, V57, P83; Ribeiro JD, 2014, PSYCHIAT RES, V218, P106, DOI 10.1016/j.psychres.2014.03.036; Rihmer Z, 2006, J AFFECT DISORDERS, V94, P3, DOI 10.1016/j.jad.2006.04.003; Sachs GS, 2006, J CLIN PSYCHIAT, V67, P5; Sani G, 2014, PSYCHOTHER PSYCHOSOM, V83, P213, DOI 10.1159/000358808; Sani G, 2014, J AFFECT DISORDERS, V164, P14, DOI 10.1016/j.jad.2014.03.054; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Swann AC, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0376-1; Swift RH, 2002, J PSYCHIAT RES, V36, P87, DOI 10.1016/S0022-3956(01)00052-8; Taschner K. L., 2013, KOMPENDIUM PRAKTISCH; Wollmer MA, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00036	54	5	5	0	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3956	1879-1379		J PSYCHIATR RES	J. Psychiatr. Res.	OCT	2015	69						158	165		10.1016/j.jpsychires.2015.08.006			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CS2UP	WOS:000361927800023	26343608				2022-02-06	
J	Kang, WH; Morrison, B				Kang, Woo Hyeun; Morrison, Barclay, III			Predicting changes in cortical electrophysiological function after in vitro traumatic brain injury	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article							HIPPOCAMPAL SLICE CULTURES; PAIRED-PULSE FACILITATION; RAT BARREL CORTEX; VISUAL-CORTEX; MECHANICAL INJURY; DENTATE GYRUS; UNITED-STATES; SYNAPTIC-TRANSMISSION; GLUTAMATE RECEPTORS; DOWN-REGULATION	Finite element (FE) models of traumatic brain injury (TBI) are capable of predicting injury-induced brain tissue deformation. However, current FE models are not equipped to predict the biological consequences of tissue deformation, which requires the determination of tolerance criteria relating the effects of mechanical stimuli to biologically relevant functional responses. To address this deficiency, we present functional tolerance criteria for the cortex for alterations in neuronal network electrophysiological function in response to controlled mechanical stimuli. Organotypic cortical slice cultures were mechanically injured via equibiaxial stretch with a well-characterized in vitro model of TBI at tissue strains and strain rates relevant to TBI (up to Lagrangian strain of 0.59 and strain rates up to 29 . At 4-6 days post-injury, electrophysiological function was assessed simultaneously throughout the cortex using microelectrode arrays. Electrophysiological parameters associated with unstimulated spontaneous network activity (neural event rate, duration, and magnitude), stimulated evoked responses (the maximum response , the stimulus current necessary for a half-maximal response , and the electrophysiological parameter that is representative of firing uniformity), and evoked paired-pulse ratios at varying interstimulus intervals were quantified for each cortical slice culture. Nonlinear regression was performed between mechanical injury parameters as independent variables (tissue strain and strain rate) and each electrophysiological parameter as output. Parsimonious best-fit equations were determined from a large pool of candidate equations with tenfold cross-validation. Changes in electrophysiological parameters were dependent on strain and strain rate in a complex manner. Compared to the hippocampus, the cortex was less spontaneously active, less excitable, and less prone to significant changes in electrophysiological function in response to controlled deformation (strain or strain rate). Our study provides functional data that can be incorporated into FE models to improve their predictive capabilities of the in vivo consequences of TBI.	[Kang, Woo Hyeun; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864	National Highway Traffic Safety Administration [DTNH22-08-C-00088]; Multidisciplinary University Research Initiative from the Army Research Office [W911MF-10-1-0526]	The authors would like to thank Shruthi Nammalwar for assisting in the preparation and maintenance of cortical slice cultures and Chaitanya Rastogi for help with statistical analysis and fitting the raw data. This work was supported in part by the National Highway Traffic Safety Administration (DTNH22-08-C-00088) and by a Multidisciplinary University Research Initiative from the Army Research Office (W911MF-10-1-0526).	Aare M, 2004, INT J CRASHWORTHINES, V9, P15, DOI 10.1533/ijcr.2004.0268; Abbott LF, 1997, SCIENCE, V275, P220; ALLOWAY KD, 1993, J NEUROPHYSIOL, V70, P892, DOI 10.1152/jn.1993.70.3.892; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Commins S, 1998, NEUROREPORT, V9, P4109, DOI 10.1097/00001756-199812210-00019; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; DISCENNA PG, 1994, HIPPOCAMPUS, V4, P569, DOI 10.1002/hipo.450040506; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Egert U, 2005, PRACTICAL METHODS IN CARDIOVASCULAR RESEARCH, P432, DOI 10.1007/3-540-26574-0_22; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Finkelstein E., 2006, INCIDENCE EC BURDEN; Flint AC, 1999, P NATL ACAD SCI USA, V96, P12144, DOI 10.1073/pnas.96.21.12144; Fueta Y, 1998, BRAIN RES, V779, P324, DOI 10.1016/S0006-8993(97)01214-6; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; GALBRAITH JA, 1993, J BIOMECH ENG-T ASME, V115, P13, DOI 10.1115/1.2895464; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Goforth PB, 2004, J NEUROTRAUM, V21, P719, DOI 10.1089/0897715041269704; Guo Y, 2008, HUM BRAIN MAPP, V29, P1092, DOI 10.1002/hbm.20450; Haigh SM, 2012, CEPHALALGIA, V32, P236, DOI 10.1177/0333102411433301; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Jia F, 2004, BRAIN RES, V1002, P158, DOI 10.1016/j.brainres.2004.01.001; JOY RM, 1993, BRAIN RES, V604, P273, DOI 10.1016/0006-8993(93)90379-2; JURASKA JM, 1979, J COMP NEUROL, V183, P257, DOI 10.1002/cne.901830204; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; Kao CQ, 2004, J NEUROTRAUM, V21, P259, DOI 10.1089/089771504322972059; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Kleinbaum DG, 1998, APPL REGRESSION ANAL, V3rd; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Lamy M, 2013, MED BIOL ENG COMPUT, V51, P353, DOI 10.1007/s11517-012-1004-7; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lea PM, 2002, PHARMACOL BIOCHEM BE, V73, P287, DOI 10.1016/S0091-3057(02)00825-0; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Lee S, 2010, J NEUROSCI, V30, P16796, DOI 10.1523/JNEUROSCI.1869-10.2010; Lewis DA, 2000, BRAIN RES REV, V31, P270, DOI 10.1016/S0165-0173(99)00042-9; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao HJ, 2013, J NEUROTRAUM, V30, P1521, DOI 10.1089/neu.2012.2520; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Maugineanu DG, 2000, BRAIN RES BULL, V51, P69, DOI 10.1016/S0361-9230(99)00209-9; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Moss WC, 2014, COMPUT METHOD BIOMEC, V17, P1173, DOI 10.1080/10255842.2012.739162; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Ning B, 2013, J MOL NEUROSCI, V49, P380, DOI 10.1007/s12031-012-9893-3; Nirula R, 2004, J TRAUMA, V57, P779, DOI 10.1097/01.TA.0000106506.34691.B6; Ounpraseuth Songthip, 2012, BMC Res Notes, V5, P656, DOI 10.1186/1756-0500-5-656; Pitcher JB, 2003, J PHYSIOL-LONDON, V546, P605, DOI 10.1113/jphysiol.2002.029454; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Reeves TM, 2012, SPRINGER PROTOCOLS H, V2, P313, DOI [DOI 10.1007/978-1-61779-782-8_30, 10.1007/978-1-61779-782-8_30]; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Schwartz TH, 1998, NEURON, V20, P541, DOI 10.1016/S0896-6273(00)80993-9; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Staiger JF, 2000, NEUROSCI RES, V37, P49, DOI 10.1016/S0168-0102(00)00094-8; STANFORD IM, 1995, EUR J PHARMACOL, V277, P229, DOI 10.1016/0014-2999(95)00083-W; Sun WZ, 2009, P NATL ACAD SCI USA, V106, P17986, DOI 10.1073/pnas.0903962106; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tanaka T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.102; Tavalin SJ, 1997, J NEUROPHYSIOL, V77, P632, DOI 10.1152/jn.1997.77.2.632; Tsujimoto S, 2008, NEUROSCIENTIST, V14, P345, DOI 10.1177/1073858408316002; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WELCH KMA, 1990, NEUROL CLIN, V8, P817, DOI 10.1016/S0733-8619(18)30319-0; Wu JY, 1999, J NEUROSCI, V19, P5005; Wu JY, 2001, J NEUROPHYSIOL, V86, P2461, DOI 10.1152/jn.2001.86.5.2461; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.ne.12.030189.000305	92	5	5	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	OCT	2015	14	5					1033	1044		10.1007/s10237-015-0652-6			12	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	CQ8MT	WOS:000360862600007	25628144				2022-02-06	
J	Nelson, DV; Esty, ML				Nelson, David V.; Esty, Mary Lee			Neurotherapy of Traumatic Brain Injury/Post-Traumatic Stress Symptoms in Vietnam Veterans	MILITARY MEDICINE			English	Article							DISORDER; CARE; WAR	Previous report suggested the beneficial effects of an adaptation of the Flexyx Neurotherapy System (FNS) for the amelioration of mixed traumatic brain injury/post-traumatic stress symptoms in veterans of the Afghanistan and Iraq wars. As a novel variant of electroencephalograph biofeedback, FNS falls within the bioenergy domain of complementary and alternative medicine. Rather than learning voluntary control over the production/inhibition of brain wave patterns, FNS involves offsetting stimulation of brain wave activity by means of an external energy source, specifically, the conduction of electromagnetic energy stimulation via the connecting electroencephalograph cables. Essentially, these procedures subliminally induce strategic distortion of ongoing brain wave activity to presumably facilitate resetting of more adaptive patterns of activity. Reported herein are two cases of Vietnam veterans with mixed traumatic brain injury/post-traumatic stress symptoms, each treated with FNS for 25 sessions. Comparisons of pre- and post-treatment questionnaire assessments revealed notable decreases for all symptoms, suggesting improvements across the broad domains of cognition, pain, sleep, fatigue, and mood/emotion, including post-traumatic stress symptoms, as well as for overall activity levels. Findings suggest FNS treatment may be of potential benefit for the partial amelioration of symptoms, even in some individuals for whom symptoms have been present for decades.	[Nelson, David V.] Sam Houston State Univ, Dept Psychol & Philosophy, Huntsville, TX 77341 USA; [Esty, Mary Lee] Brain Wellness & Biofeedback Ctr Washington, Bethesda, MD 20814 USA		Nelson, DV (corresponding author), Sam Houston State Univ, Dept Psychol & Philosophy, Box 2447, Huntsville, TX 77341 USA.						Basu S, PTSD STILL PLAGUES M; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Collura T., 2014, TECHNICAL FDN NEUROF; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1002/jts.2490060405; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kim CD, 2009, MCGEORGE LAW REV, V40, P449; Kochanek PM, 2013, LANCET NEUROL, V12, P1132, DOI 10.1016/S1474-4422(13)70245-X; Kulka RA, 1990, TRAUMA VIETNAM WAR G; May G, 2013, ANN CLIN PSYCHIATRY, V25, P289; McAllister TW, 2010, ANN NY ACAD SCI, V1208, P46, DOI 10.1111/j.1749-6632.2010.05720.x; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; Mueller HH, 2001, J CLIN PSYCHOL, V57, P933, DOI 10.1002/jclp.1060; Nelson DV, 2012, J NEUROPSYCH CLIN N, V24, P237, DOI 10.1176/appi.neuropsych.11020041; Nelson DV, 2015, J HEAD TRAU IN PRESS; Ochs L, 2006, J NEUROTHER, V10, P5, DOI DOI 10.1300/J184V10N02_02; Ochs L., 1997, FLEXYX NEUROTHERAPY; Rigon A., 2015, J NEUROTRAUMA; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tavel ME, 2014, AM J MED, V127, P484, DOI 10.1016/j.amjmed.2014.02.002; Thornton KE, 2009, APPL PSYCHOPHYS BIOF, V34, P59, DOI 10.1007/s10484-009-9075-4; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Yost TL, 2012, J NEUROSCI NURS, V44, P157, DOI 10.1097/JNN.0b013e31825106ba	30	5	5	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	OCT	2015	180	10					E1111	E1114		10.7205/MILMED-D-14-00696			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CV9UP	WOS:000364632900001	26444476	Bronze			2022-02-06	
J	Schnitzler, A; Ruet, A; Baron, S; Buzzi, JC; Genet, F				Schnitzler, A.; Ruet, A.; Baron, S.; Buzzi, J. -C.; Genet, F.			Botulinum toxin A for treating spasticity in adults: Costly for French hospitals?	ANNALS OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Botulinum toxin; Spasticity; Cost		Introduction: Intramuscular injection of botulinum toxin (BoNTA) is one of the primary treatments for focal spasticity. This treatment is considered costly and the level of reimbursement by health insurance has been decreasing in many countries for several years. The aim of this study was to determine the real cost of treating spasticity with BoNTA and to compare this with the level of reimbursement by the national health insurance in France in 2008 and with a new fee, specific to the injection of BoNTA in ambulatory services. Method: A single-center, retrospective study using the 2008 database from a French secondary-care day-hospital unit (treating spasticity in adults with sequelae of stroke, multiple sclerosis or traumatic brain injuries). The level of reimbursement by the French ministry of health for BoNTA treatment for adults with spasticity constituted the "calculated cost" and corresponded to the hospital's "budget". The "real cost" (incurred by the hospital) included the sum of staffing and material costs as well as the number of toxin vials used. The calculated costs for 2009 and 2013 were based on the levels of reimbursement during those years. The difference between real and calculated cost for 2009 and 2013 was estimated considering that the real cost of 2008 was stable. Results: In 2008, 364 patients received BoNTA, resulting in 870 day-hospital admissions. The calculated cost was 459,056 (sic)/year and the real cost was 567,438 (sic)/year (equivalent to 4.27 (sic)/day/patient). The total budget deficit (hospital income minus hospital costs) was 108,383 (sic). The deficit was estimated at 222,892 (sic) in 2009 and 241,188 (sic) in 2013. Conclusion: The daily cost of BoNTA treatment for spasticity is reasonable; however, because of the level of reimbursement by the national health insurance in France, the treatment is costly for French hospitals. (C) 2015 Elsevier Masson SAS. All rights reserved.	[Schnitzler, A.; Ruet, A.; Genet, F.] Univ Versailles St Quentin, AP HP, Hop Raymond Poincare, Dept Med Phys & Readaptat,HANDIResp EA 4047, 104,Blvd Raymond Poincare, F-92380 Garches, France; [Baron, S.; Buzzi, J. -C.] Univ Versailles St Quentin, AP HP, DIM, Hop Raymond Poincare, F-92380 Garches, France		Schnitzler, A (corresponding author), Univ Versailles St Quentin, AP HP, Hop Raymond Poincare, Dept Med Phys & Readaptat,HANDIResp EA 4047, 104,Blvd Raymond Poincare, F-92380 Garches, France.	alexis.schnitzler@rpc.aphp.fr	RUET, Alexis/L-8726-2015	RUET, Alexis/0000-0002-5080-5734			Bensmail D, 2014, ANN PHYS REHABIL MED, V57, pe46; Burbaud P, 2011, J NEUROL, V258, P1670, DOI 10.1007/s00415-011-5998-9; Andrés-Nogales F. de, 2014, Farm Hosp., V38, P193, DOI [10.7399/FH.2014.38.3.1163, 10.7399/fh.2014.38.3.1163]; Doan QV, 2013, EUR J NEUROL, V20, P773, DOI 10.1111/ene.12062; Esquenazi A, 2006, EUR J NEUROL, V13, P27, DOI 10.1111/j.1468-1331.2006.01651.x; Ghasemi M, 2013, INT J PREVENTIVE MED, V4, pS147; Houltram J, 2001, EUR J NEUROL, V8, P194, DOI 10.1046/j.1468-1331.2001.00052.x; Mellos G, 2014, ANN PHYS REHABIL MED, V57, pe51; Ruiz Francis J, 2004, Eur J Health Econ, V5, P227, DOI 10.1007/s10198-004-0224-7; Schnitzler A, 2014, NEUROREHAB NEURAL RE, V28, P36, DOI 10.1177/1545968313497828; Shaw L, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14260; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Svensson J, 2014, ACTA NEUROL SCAND, V129, P13, DOI 10.1111/ane.12139; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; Ward A, 2005, J REHABIL MED, V37, P252, DOI 10.1080/16501970510027312; Yelnik A. P., 2009, Annals of Physical and Rehabilitation Medicine, V52, P746, DOI 10.1016/j.rehab.2009.09.005; Zoons E, 2012, J NEUROL, V259, P2519, DOI 10.1007/s00415-012-6510-x	17	5	5	0	2	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	1877-0657	1877-0665		ANN PHYS REHABIL MED	Ann. Phys. Rehabil. Med.	OCT	2015	58	5					265	268		10.1016/j.rehab.2015.06.004			4	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	VD5WZ	WOS:000437159000001	26234276	hybrid			2022-02-06	
J	Shallwani, H; Waqas, M; Waheed, S; Siddiqui, M; Froz, A; Bari, ME				Shallwani, Hussain; Waqas, Muhammad; Waheed, Shahan; Siddiqui, Mubbashira; Froz, Asher; Bari, Muhammad Ehsan			Does base deficit predict mortality in patients with severe traumatic brain injury?	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Base deficit; Traumatic brain injury; Outcomes	EARLY PHYSIOLOGICAL PREDICTORS; HYPOVOLEMIC SHOCK; SERUM LACTATE; BLUNT TRAUMA; HEAD TRAUMA; TRANSFUSION; CLASSIFICATION; RESUSCITATION; MARKER; DEATH	Objective: Base Deficit (BD) is a marker of tissue hypoxia in polytrauma patients. It guides resuscitative measures, and predicts outcomes, complications and mortality. The aim of this study was to examine the presence of BD in patients with isolated severe traumatic brain injury (TBI), and to assess if it correlates with the outcomes in these patients. Method: This was a retrospective observational study. All patients over the age of 16 years presenting to Aga Khan University Hospital from 2009 to 2013 with isolated TBI, were included. Data was extracted from 2009 to 2013. Glasgow Outcome Scale (GOS) of 4 and 5 at last follow up was categorized as favorable outcome. Data was analyzed using SPSS version 19 and receiver operative curve (ROC) was generated for BD as a predictor of mortality and unfavorable outcome. Results: One hundred and eight patients were analyzed. Ninety-eight (90.7%) were males. Mean age was 36.69 +/- 17.65. Eighty-eight (81.5%) patients had BD, while 20 (18.5%) patients had base excess. 62 (58.5%) of the patients had unfavorable outcomes. BD on admission had a statistically significant negative correlation with Glasgow Coma Scale (GCS) on presentation (r = -0.239, p = 0.025) and Revised Trauma Score (RTS) (r = -0.214, p = 0.046). However, there was no statistically significant difference in means of BD between survivors and non survivors. Area under receiver operator curve (ROC) for BD as a predictor of mortality statistically non-significant. Conclusion: Although BD is correlated with GCS at presentation and RTS, it is not a reliable prognostic marker for outcome and mortality in patients with isolated TBI. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Shallwani, Hussain; Waqas, Muhammad; Siddiqui, Mubbashira; Bari, Muhammad Ehsan] Aga Khan Univ Hosp Karachi, Sect Neurosurg, Karachi, Pakistan; [Waheed, Shahan] Aga Khan Univ Hosp Karachi, Dept Emergency Med, Karachi, Pakistan; [Froz, Asher] Aga Khan Univ Hosp Karachi, Karachi, Pakistan		Bari, ME (corresponding author), Aga Khan Univ Hosp Karachi, Sect Neurosurg, Karachi, Pakistan.	hussainshallwani@hotmail.com; shaiq_waqas@hotmail.com; docshahan83@hotmail.com; mubbashira_siddiqui@hotmail.com; asher.froz@aku.edu; ehsan.bari@aku.edu	Waqas, Muhammad/A-5673-2013	Waqas, Muhammad/0000-0003-4500-7954			Arnold T. D., 2011, J TRAUMA, V71, P7; Arnold TDW, 2011, J TRAUMA, V71, P793, DOI 10.1097/TA.0b013e31822ad694; Callaway DW, 2009, J TRAUMA, V66, P1040, DOI 10.1097/TA.0b013e3181895e9e; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; DAVIS JW, 1988, J TRAUMA, V28, P1464, DOI 10.1097/00005373-198810000-00010; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Hindy-Francois C, 2009, J TRAUMA, V67, P1272, DOI 10.1097/TA.0b013e31819db828; Hodgman EI, 2012, J TRAUMA ACUTE CARE, V72, P844, DOI 10.1097/TA.0b013e31824ef9d2; Husain FA, 2003, AM J SURG, V185, P485, DOI 10.1016/S0002-9610(03)00044-8; Joseph B, 2015, BRAIN INJURY, V29, P11, DOI 10.3109/02699052.2014.945959; Jung J, 2009, PEDIATR EMERG CARE, V25, P579, DOI 10.1097/PEC.0b013e3181b9b38a; Kincaid EH, 1998, J AM COLL SURGEONS, V187, P384, DOI 10.1016/S1072-7515(98)00202-6; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Morris JA, 2002, AM SURGEON, V68, P693; Mutschler M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-28; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; Ouellet JF, 2012, J TRAUMA ACUTE CARE, V72, P1532, DOI 10.1097/TA.0b013e318256dd5a; Paydar S, 2011, J TRAUMA, V70, P1580, DOI 10.1097/TA.0b013e318219e07d; Rainer TH, 2011, RESUSCITATION, V82, P724, DOI 10.1016/j.resuscitation.2011.02.016; Rixen D, 2001, SHOCK, V15, P83, DOI 10.1097/00024382-200115020-00001; RUTHERFORD EJ, 1992, J TRAUMA, V33, P417, DOI 10.1097/00005373-199209000-00014; Schrieber M, 2007, J TRAUMA, V63, P1261; SIEGEL JH, 1990, ARCH SURG-CHICAGO, V125, P498; SIEGEL JH, 1995, J NEUROTRAUM, V12, P579, DOI 10.1089/neu.1995.12.579; Smith I, 2001, INTENS CARE MED, V27, P74, DOI 10.1007/s001340051352; Stewart CL, 2013, J PEDIATR SURG, V48, P2106, DOI 10.1016/j.jpedsurg.2013.05.009; Tremblay LB, 2002, AM SURGEON, V68, P689; Zehtabchi S, 2007, EMERG MED J, V24, P333, DOI 10.1136/emj.2006.044578	29	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	OCT	2015	22						125	130		10.1016/j.ijsu.2015.05.054			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CW1BB	WOS:000364723100022	26079501	Bronze			2022-02-06	
J	Malec, JF; Parrot, D; Altman, IM; Swick, S				Malec, James F.; Parrot, Devan; Altman, Irwin M.; Swick, Shannon			Outcome prediction in home- and community-based brain injury rehabilitation using the Mayo-Portland Adaptability Inventory	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Prediction; Brain injury; Outcome; Rehabilitation	INTERNATIONAL CLASSIFICATION; POSTACUTE REHABILITATION; PARTICIPATION; COMPLETERS; DISABILITY; PROGNOSIS; MODELS	The objective of the study was to develop statistical formulas to predict levels of community participation on discharge from post-hospital brain injury rehabilitation using retrospective data analysis. Data were collected from seven geographically distinct programmes in a home- and community-based brain injury rehabilitation provider network. Participantswere 642 individuals with post-traumatic brain injury. Interventions consisted of home- and community-based brain injury rehabilitation. The main outcome measurewas the Mayo-Portland Adaptability Inventory (MPAI-4) Participation Index. Linear discriminant models using admission MPAI-4 Participation Index score and log chronicity correctly predicted excellent (no to minimal participation limitations), very good (very mild participation limitations), good (mild participation limitations), and limited (significant participation limitations) outcome levels at discharge. Predicting broad outcome categories for post-hospital rehabilitation programmes based on admission assessment data appears feasible and valid. Equations to provide patients and families with probability statements on admission about expected levels of outcome are provided. It is unknown to what degree these prediction equations can be reliably applied and valid in other settings.	[Malec, James F.] Indiana Univ Sch Med, Phys Med & Rehabil, Indianapolis, IN 46254 USA; [Malec, James F.; Parrot, Devan] Rehabil Hosp Indiana, Indianapolis, IN 46254 USA; [Malec, James F.] Mayo Clin, Psychol, Indianapolis, IN 46254 USA; [Altman, Irwin M.] Rehab Without Walls, Phoenix, AZ USA; [Swick, Shannon] Rehab Without Walls, Marshall, MI USA		Malec, JF (corresponding author), Indiana Univ Sch Med, Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46254 USA.	jmalec@rhin.com					Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Chung P, 2014, J REHABIL MED, V46, P108, DOI 10.2340/16501977-1257; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Johnston MV, 2006, AM J PHYS MED REHAB, V85, P292, DOI 10.1097/01.phm.0000202079.58567.3b; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Lexell J, 2012, J REHABIL MED, V44, P65, DOI 10.2340/16501977-0897; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Malec JF, 2002, ARCH PHYS MED REHAB, V83, P1759, DOI 10.1053/apmr.2002.36072; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Resnik L, 2009, ARCH PHYS MED REHAB, V90, P856, DOI 10.1016/j.apmr.2008.11.010; Seel RT, 2012, ARCH PHYS MED REHAB, V93, pS138, DOI 10.1016/j.apmr.2012.04.021; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; World Health Organization, 2001, ICF INT CLASS FUNCT	24	5	5	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	SEP 3	2015	25	5					663	676		10.1080/09602011.2015.1013139			14	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	CP0ZW	WOS:000359606600002	25708369				2022-02-06	
J	Muo, R; Cancialosi, P; Galimberti, L; Cacciola, BC; Gilardone, M; Schindler, A				Muo, Rossella; Cancialosi, Patrizia; Galimberti, Laura; Cacciola, Barbara Carrubba; Gilardone, Marco; Schindler, Antonio			Validation of the Italian version of the American Speech-Language and Hearing Association-Functional Assessment of Communication Skills for adults (I-ASHA-FACS)	APHASIOLOGY			English	Article						ASHA-FACS; functional communication; aphasia; traumatic brain injury	TRAUMATIC BRAIN-INJURY; APHASIA; LIFE	Background: Impairment of communicative-linguistic and cognitive functions is common after stroke and traumatic brain injury (TBI). While assessment of language function is usually performed in clinical practice, standardised assessment of pragmatic, functional, and communicative competences is less common, even though suggested by many recent national and international guidelines. The "American Speech-Language and Hearing Association-Functional Assessment of Communication Skills for adults" (ASHA-FACS) is a measure of communication disability that investigates functional communication. It has been translated and adapted into Italian in 2001, but psychometric properties of Italian version of ASHA-FACS (I-ASHA-FACS) have not yet been investigated. Aims: To investigate psychometric properties of the I-ASHA-FACS scale and provide normative data. Methods & Procedures: Participants included 100 healthy adult persons without neurological disorders nor communicative-cognitive deficits and 80 post-acute outpatients with aphasia following stroke (n=60) or TBI (n=20). Mini Mental State Examination (MMSE) was used to exclude control participants with cognitive decline (MMSE > 24). I-ASHA-FACS was completed for all participants. All patients were also assessed with Functional Independent Measure (FIM) and either Aachener Aphasie Test (AAT) for persons with aphasia due to stroke or Levels of Cognitive Functions scale (LCF) for TBI persons. I-ASHA-FACS internal consistency, inter- and intra-rater reliability and construct validity were calculated; normative data were also calculated for healthy controls stratified by age and education. Cronbach's alpha was used for internal consistency analysis. Spearman's test was used to correlate I-ASHA-FACS and FIM, AAT, and LCF scores. Outcomes & Results: I-ASHA-FACS showed good internal consistency (alpha>.84) and strong intra- and inter-rater reliability (r>.97 and >.89). All healthy persons showed very high level of functional communication abilities in all domains of communication independence (higher than 6, on a 7-point scale) and all qualitative dimensions scores (higher than 4, on a 5-point scale). Correlations between I-ASHA-FACS scores and FIM were strong in aphasic persons, particularly in problem solving (r>.71) and comprehension (r>.73) subscales. Correlations between I-ASHA-FACS and AAT were generally from moderate to strong (r values ranging from r=.31 to r=.81), and particularly strong in spontaneous speech subtest (r>.70). Correlations between I-ASHA-FACS and LCF did not reach statistical significance. Conclusions: I-ASHA-FACS shows good internal consistency, strong intra- and inter-rater reliability and satisfactory validity. The application of I-ASHA-FACS to the Italian population of patients with communicative deficits due to aphasia or TBI is recommended.	[Muo, Rossella] AASL TO1 Rehabil Dept, Serv Logopedia, Turin, Italy; [Cancialosi, Patrizia] Hosp AOU Citta Salute & Sci Torino, Presidio CTO M Adelaide, SCO Med Fis & Riabilitaz, RRF Gravi Cerebroles Acquisite, Turin, Italy; [Galimberti, Laura] Azienda Pubbl Serv Persona, ISAH Ctr Riabilitaz Polivalente & Casa Riposo San, Imperia, Italy; [Cacciola, Barbara Carrubba] Studio Med Mirafiori, Turin, Italy; [Gilardone, Marco] Casa Cura Policlin, Dept Neurorehabil Sci, Milan, Italy; [Schindler, Antonio] Univ Milan, Dipartimento Sci Biomed, Milan, Italy; [Schindler, Antonio] Univ Milan, Clin L Sacco, Milan, Italy		Muo, R (corresponding author), AASL TO1 Rehabil Dept, Serv Logopedia, Turin, Italy.	rossella.muo@gmail.com	Muo, Rossella/N-1009-2019; Schindler, Antonio/K-9184-2017	Schindler, Antonio/0000-0002-8767-5179; Muo, Rossella/0000-0001-7172-5816			Aaronson N, 2002, QUAL LIFE RES, V11, P193; Baines KA., 1999, ASSESSMENT LANGUAGE; Bayles KA., 1994, FUNCTIONAL LINGUISTI; Clark LA, 2003, METHODOLOGICAL ISSUE, P207, DOI DOI 10.1037/14805-012; Cummings L., 2012, CLIN PRAGMATICS; de Carvalho IAM, 2008, ALZ DIS ASSOC DIS, V22, P375, DOI 10.1097/WAD.0b013e31818809b2; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Drummond SS, 2004, BRAIN INJURY, V18, P41, DOI 10.1080/0269905031000149461; Federazione Logopedisti Italiani (FLI), 2010, LIN GUID GEST LOG PA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frattali C, 1995, FUNCTIONAL ASSESSMEN; Frattali C M, 1995, ASHA, V37, P40; Fridriksson J, 2006, CLIN LINGUIST PHONET, V20, P401, DOI 10.1080/02699200500075781; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hagen C., 1979, LEVEL COGNITIVE FUNC; Holland AL, 1999, COMMUNICATION ABILIT; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Larkins BM, 2004, BRAIN INJURY, V18, P691, DOI 10.1080/02699050310001617389; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Luzzatti C., 1996, AACHENER APHASIE TES, V2nd; McDonald S, 2014, SOCIAL COMMUNICATION; Paul D., 2004, FUNCTIONAL ASSESSMEN; Royal College of Speech and Language Therapists (RCSLT), 2005, CLIN GUID; Saxton J, 2012, J ALZHEIMERS DIS, V28, P109, DOI 10.3233/JAD-2011-110947; Scottish Intercollegiate Guidelines Network (SIGN), 2013, 130 BRAIN INJ REH AD; Vernero I., 2002, CARTELLA LOGOPEDICA; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; World Health Organization, 2007, INT CLASS FUNCT DIS; Worrall L, 2002, J COMMUN DISORD, V35, P107, DOI 10.1016/S0021-9924(02)00060-6	30	5	5	0	23	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology	SEP 2	2015	29	9					1110	1130		10.1080/02687038.2015.1010475			21	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	CJ9EW	WOS:000355806300005					2022-02-06	
J	Snyder, SM; Howard, MO				Snyder, Susan M.; Howard, Matthew O.			Patterns of Inhalant Use among Incarcerated Youth	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LATENT CLASS ANALYSIS; SUBSTANCE USE; ADOLESCENTS; PREVALENCE; DISORDERS; ALCOHOL; ADULTS	Inhalant use is especially prevalent among antisocial youth and can have serious health consequences. However, the extant literature has not investigated how use of various inhalants may co-occur among incarcerated youth. This study begins to address this gap in the literature by using latent class analyses to form distinct typologies of inhalant use. Study participants were residents (N = 723) of 27 Missouri Division of Youth Services facilities. Interviews assessed psychiatric symptoms, antisocial traits, delinquency, trauma, suicidality, and substance use behaviors. The mean age of the mostly male, ethnically diverse sample was 15.5 (S. D. = 1.2) years old. The study revealed the following classes of inhalant use: (1) severe polyinhalant use; (2) moderate polyinhalant use; (3) gas and permanent marker use; and (4) low-use. Compared to the low-use class, members of the severe polyinhalant use class had experienced more than double the rate of head injuries, the highest rates of traumatic experiences, and the highest rates of mental illness diagnoses. The gas and markers class had the highest rate of reporting hearing voices, followed by the severe polyinhalant use class, and the moderate polyinhalant use class. Results of this study underscore the need to address the high rate of head injuries and mental health diagnoses that contribute to severe polyinhalant use.	[Snyder, Susan M.] Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA; [Howard, Matthew O.] Univ N Carolina, Sch Social Work, Chapel Hill, NC USA		Snyder, SM (corresponding author), Georgia State Univ, Sch Social Work, Atlanta, GA 30303 USA.	ssnyder7@gsu.edu	Snyder, Susan M/AAN-2386-2021	Snyder, Susan M/0000-0002-6909-336X			Barnes GM, 2002, J DRUG ISSUES, V32, P153, DOI 10.1177/002204260203200107; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Collins LM., 2010, LATENT CLASS LATENT; Derogatis L.R., 1993, BSI BRIEF SYMPTOM IN; ELLIOTT DS, 1989, MULTIPLE PROBLEM YOU; Freedenthal S, 2007, DRUG ALCOHOL DEPEN, V90, P81, DOI 10.1016/j.drugalcdep.2007.02.021; Garland EL, 2011, EXP CLIN PSYCHOPHARM, V19, P134, DOI 10.1037/a0022859; Grisso T, 2000, MASSACHUSETTS YOUTH; Hatcher L., 2003, STEP BY STEP BASIC S; Howard MO, 2008, DRUG ALCOHOL DEPEN, V93, P197, DOI 10.1016/j.drugalcdep.2007.08.023; Howard Matthew O, 2011, Addict Sci Clin Pract, V6, P18; Howard MO, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-8; Howard MO, 1999, ADDICT BEHAV, V24, P59, DOI 10.1016/S0306-4603(98)00039-2; Johnston L. D., 2015, MONITORING FUTURE NA; Kaba F, 2014, J ADOLESCENT HEALTH, V54, P615, DOI 10.1016/j.jadohealth.2013.12.013; Lanza S. T., 2003, HDB PSYCHOL, V2, P663; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; McCutcheon, 2002, APPL LATENT CLASS AN, P56, DOI [10.1017/CBO9780511499531.003, DOI 10.1017/CB09780511499531.003]; Mitchell M. L., 2012, RES DESIGN EXPLAINED; Monroe, 2013, J SOC SOC WORK RES, V4, P214, DOI [10.5243/jsswr.2013.15, DOI 10.5243/JSSWR.2013.15]; National Institute on Drug Abuse, 2012, DRUGFACTS INH; National Institute on Drug Abuse, 2012, NAT I DRUG AB RES RE; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Sickmund M, 2002, JUVENILE OFFENDERS R; Snyder SM, SUBSTANCE A IN PRESS; Snyder SM, SUBST USE M IN PRESS; Snyder SM, 2015, SUBST USE MISUSE, V50, P226, DOI 10.3109/10826084.2014.966845; Snyder SM, 2014, J PSYCHOACTIVE DRUGS, V46, P188, DOI 10.1080/02791072.2014.914610; Snyder SM, 2013, CHILD YOUTH SERV REV, V35, P753, DOI 10.1016/j.childyouth.2013.01.021; Tofighi D, 2008, ADVANCES IN LATENT VARIABLE MIXTURE MODELS, P317; Vitacco MJ, 2003, ASSESSMENT, V10, P143, DOI 10.1177/1073191103010002005; Whitt A, 2012, J PSYCHOACTIVE DRUGS, V44, P365, DOI 10.1080/02791072.2012.736803; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613; Wu LT, 2007, DRUG ALCOHOL DEPEN, V88, P146, DOI 10.1016/j.drugalcdep.2006.10.012; Wu LT, 2006, DRUG ALCOHOL DEPEN, V85, P1, DOI 10.1016/j.drugalcdep.2006.01.017; Yang CC, 2006, COMPUT STAT DATA AN, V50, P1090, DOI 10.1016/j.csda.2004.11.004	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2015	10	9							e0135303	10.1371/journal.pone.0135303			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CQ4ZT	WOS:000360613800028	26333159	Green Published, gold, Green Submitted			2022-02-06	
J	Bakhos, D; Villeneuve, A; Kim, S; Lebrun, H; Dufour, X				Bakhos, David; Villeneuve, Alexandre; Kim, Soo; Lebrun, Helene; Dufour, Xavier			Head Spear Gun Injury: An Atypical Suicide Attempt	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Craniofacial injury; osteo-meningeal defect; skull base; spear gun		Weapon injuries with spear gun are rare. The aim of this case report is to report the emergency and surgical management when this event occurs. A 35-year-old man attempted suicide with a spear gun. The entry of the shaft was localized through the submental area without an obvious exit point. The projectile passed through the tongue and palatal bone. A tracheotomy was performed. Preoperative cranial computed tomography (CT) showed the harpoon was gone upward through the submental area, the oral cavity, the ethmoid paranasal sinus, the cribriform plate, and the frontal region without vessel damages. Under general anesthesia, the harpoon was pulled out in order to extract the shaft tip and the articulated wishbone. Osteo-meningeal defect of the ethmoid roof was closed using a middle turbinate flap. There were no neurologic deficit and no cerebro-spinal rhinorrhea at his 3-year follow-up visit. The trajectory of the shaft is different between attempted suicide and accident. Cranial CT scan is helpful to show the trajectory of the shaft. Angiogram can be helpful to see the relations between the tip shaft and the vessels. The knowledge of the shaft tip and the imagery findings are important to decide the best surgical approach.	[Bakhos, David; Villeneuve, Alexandre; Kim, Soo] Univ Tours, Dept Head & Neck Surg, Tours Hosp, Tours, France; [Lebrun, Helene; Dufour, Xavier] Univ Poitiers, Poitiers Hosp, Dept Head & Neck Surg, Poitiers, France		Villeneuve, A (corresponding author), Tours Hosp, Dept Head & Neck Surg, Blvd Tonnelle, F-37000 Tours, France.	avilleneuve1986@gmail.com	Bakhos, David/P-5827-2016	Bakhos, David/0000-0003-1417-5082			Alper M, 1997, J ORAL MAXIL SURG, V55, P94, DOI 10.1016/S0278-2391(97)90458-4; Ban LH, 2008, J NEUROSURG, V108, P1021, DOI 10.3171/JNS/2008/108/5/1021; Fernandez-Melo R, 2002, NEUROCIRUGIA, V13, P397; GUTIERREZ A, 1983, SURG NEUROL, V19, P541, DOI 10.1016/0090-3019(83)90379-8; Hefer T, 1996, OTOLARYNG HEAD NECK, V115, P553, DOI 10.1016/S0194-5998(96)70010-4; Lopez F, 2000, CHILD NERV SYST, V16, P117, DOI 10.1007/s003810050025; Rocca A, 1987, J Neurosurg Sci, V31, P19	7	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2015	26	6					547	548		10.1097/SCS.0000000000002040			2	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	DA7WL	WOS:000368015800032	26335326				2022-02-06	
J	Bryce, S; Spitz, G; Ponsford, J				Bryce, Shayden; Spitz, Gershon; Ponsford, Jennie			Screening for Substance Use Disorders Following Traumatic Brain Injury: Examining the Validity of the AUDIT and the DAST	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol; AUDIT; DAST; drug; psychometrics; screening; substance use; TBI; traumatic brain injury; validity	ALCOHOL-USE DISORDERS; IDENTIFICATION TEST; PSYCHIATRIC-DISORDERS; DIAGNOSTIC-TESTS; DRUG-USE; ABUSE; INDIVIDUALS; INSTRUMENTS; FREQUENCY; CAGE	Objective: To examine the validity of the Alcohol Use Disorders Identification Test (AUDIT) and the Drug Abuse Screening Test (DAST)-2 widely recommended rating scales-in a traumatic brain injury (TBI) population at 24 months following injury. The Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders was used as the gold standard criterion. Setting: TBI rehabilitation program at Epworth Hospital, Victoria, Australia. Participants: A total of 113 individuals, 87 males and 26 females, with complicated mild to severe TBI. Design: Prospective study documenting substance use following TBI. Main measures: AUDIT, DAST, and Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders. Results: In individuals with TBI, a cutoff score of 11 on the AUDIT may be the most appropriate indicator of an alcohol use disorder whereas a cutoff score of 6 on the DAST may be the most appropriate indicator of drug use disorder. Both screening measures demonstrated excellent diagnostic accuracy at 24 months following injury. Conclusion: The optimal cutoff score for the AUDIT may need to be elevated for use following TBI. Nevertheless, both the AUDIT and the DAST are suitable measures for assessing substance use following TBI. Given the importance of uniformity in postinjury assessment, the AUDIT and the DAST may serve as future screening standards in TBI research.	[Bryce, Shayden; Spitz, Gershon; Ponsford, Jennie] Monash Univ, Sch Psychol Sci, Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia; [Spitz, Gershon; Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Richmond, Vic, Australia		Ponsford, J (corresponding author), Monash Univ, Sch Psychol Sci, Bldg 17,Wellington Rd, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480	Transport Accident Commission of Victoria	This research was part of a larger project funded by a grant from the Transport Accident Commission of Victoria.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arenth PM, 2001, BRAIN INJURY, V15, P499, DOI 10.1080/02699050010006002; Ashman TA, 2004, BRAIN INJURY, V18, P191, DOI 10.1080/0269905031000149506; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cassidy CM, 2008, CAN J PSYCHIAT, V53, P26, DOI 10.1177/070674370805300105; CHERPITEL CJ, 1995, J STUD ALCOHOL, V56, P695, DOI 10.15288/jsa.1995.56.695; Colak E, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/698320; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Dawe S, 2000, REV DIAGNOSTIC SCREE, P172; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; Fan Jerome, 2006, CJEM, V8, P19; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; GAVIN DR, 1989, BRIT J ADDICT, V84, P301; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; HajianTilaki KO, 1997, MED DECIS MAKING, V17, P94, DOI 10.1177/0272989X9701700111; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Kelly TM, 2004, ALCOHOL CLIN EXP RES, V28, P746, DOI 10.1097/01.ALC.0000125346.37075.85; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Kreutzer JS, 1996, J HEAD TRAUMA REHAB, V11, P58, DOI 10.1097/00001199-199610000-00006; Kumar R, 2011, INDIAN PEDIATR, V48, P277, DOI 10.1007/s13312-011-0055-4; Kwok C, 2013, CAN J ADDICT, V4, P14; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; MacKenzie DM, 1996, ALCOHOL ALCOHOLISM, V31, P591; McCann BS, 2000, AM J ADDICTION, V9, P1; Mdege ND, 2011, ADDICT BEHAV, V36, P1111, DOI 10.1016/j.addbeh.2011.07.007; O'Hare T, 2004, RES SOCIAL WORK PRAC, V14, P36, DOI 10.1177/1049731503257667; Obuchowski N A, 1998, Stat Methods Med Res, V7, P371, DOI 10.1191/096228098678080061; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Pilowsky DJ, 2012, SUBST ABUSE REHABIL, V3, P25, DOI 10.2147/SAR.S30057; Ponsford J, 2013, TRAUMATIC BRAIN INJU, P246; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2012, J HEAD TRAUMA REHAB, V27, P342, DOI 10.1097/HTR.0b013e318265a576; Ponsford J, 2010, BRAIN IMPAIR, V11, P253, DOI 10.1375/brim.11.3.253; Pradhan B, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-42; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002	47	5	5	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2015	30	5					E40	E48		10.1097/HTR.0000000000000091			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JE	WOS:000369605400005	25310295				2022-02-06	
J	Cartwright, MS; Dupuis, JE; Bargoil, JM; Foster, DC				Cartwright, Michael S.; Dupuis, Janae E.; Bargoil, Jessica M.; Foster, Dana C.			Can a combination of ultrasonographic parameters accurately evaluate concussion and guide return-to-play decisions?	MEDICAL HYPOTHESES			English	Article							TRAUMATIC BRAIN-INJURY; SPORT; STATEMENT; IMPACT	Mild traumatic brain injury, often referred to as concussion, is a common, potentially debilitating, and costly condition. One of the main challenges in diagnosing and managing concussion is that there is not currently an objective test to determine the presence of a concussion and to guide return-to-play decisions for athletes. Traditional neuroimaging tests, such as brain magnetic resonance imaging, are normal in concussion, and therefore diagnosis and management are guided by reported symptoms. Some athletes will under-report symptoms to accelerate their return-to-play and others will over-report symptoms out of fear of further injury or misinterpretation of underlying conditions, such as migraine headache. Therefore, an objective measure is needed to assist in several facets of concussion management. Limited data in animal and human testing indicates that intracranial pressure increases slightly and cerebrovascular reactivity (the ability of the cerebral arteries to auto-regulate in response to changes in carbon dioxide) decreases slightly following mild traumatic brain injury. We hypothesize that a combination of ultrasonographic measurements (optic nerve sheath diameter and transcranial Doppler assessment of cerebrovascular reactivity) into a single index will allow for an accurate and non-invasive measurement of intracranial pressure and cerebrovascular reactivity, and this index will be clinically relevant and useful for guiding concussion diagnosis and management. Ultrasound is an ideal modality for the evaluation of concussion because it is portable (allowing for evaluation in many settings, such as on the playing field or in a combat zone), radiation-free (making repeat scans safe), and relatively inexpensive (resulting in nearly universal availability). This paper reviews the literature supporting our hypothesis that an ultrasonographic index can assist in the diagnosis and management of concussion, and it also presents limited data regarding the initial use of this index in healthy controls. (C) 2015 Elsevier Ltd. All rights reserved.	[Cartwright, Michael S.; Bargoil, Jessica M.; Foster, Dana C.] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC 27157 USA; [Dupuis, Janae E.] Wake Forest Sch Med, Winston Salem, NC USA		Cartwright, MS (corresponding author), Wake Forest Sch Med, Dept Neurol, Main Floor Reynolds Tower, Winston Salem, NC 27157 USA.	mcartwri@wakehealth.edu	Cartwright, Michael/AAO-4303-2021		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS062892] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS062892] Funding Source: Medline		Bago-Rozankovic P, 2009, ACTA CLIN CROAT, V48, P299; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Heegaard W, 2007, EMERG MED CLIN N AM, V25, P655, DOI 10.1016/j.emc.2007.07.001; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lepur D, 2011, EUR J CLIN MICROBIOL, V30, P989, DOI 10.1007/s10096-011-1184-3; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Pomschar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055447; Shan R, 2015, J NEUROTRAUMA; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	25	5	6	0	7	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	SEP	2015	85	3					262	265		10.1016/j.mehy.2015.05.012			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CQ8OP	WOS:000360868100006	26031200	Green Accepted			2022-02-06	
J	Gatson, JW; Liu, MM; Rivera-Chavez, FA; Minei, JP; Wolf, SE				Gatson, Joshua W.; Liu, Ming-Mei; Rivera-Chavez, Fernando A.; Minei, Joseph P.; Wolf, Steven E.			Serum Levels of Neurofilament-H are Elevated in Patients Suffering From Severe Burns	JOURNAL OF BURN CARE & RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; THERMAL-INJURY; AXONAL INJURY; CEREBRAL MICROCIRCULATION; INFLAMMATORY RESPONSE; BIOMARKERS; BLOOD; S100B; PROTEIN; INTERLEUKIN-1-BETA	In previous studies, after injury, burn patients experienced an increase in neuro-inflammation, edema, and neuronal cell death. As demonstrated in other brain injury models, fluid-based biomarkers such as phosphorylated neurofilament-H (pNFL-H) have been shown to correlate with injury severity. In this study the authors hypothesized that burn-injured patients have an increase in pNFL-H in the blood during the acute and chronic time-points after injury. In this prospective clinical study, blood (8 cc) was collected from burn patients (n = 36; TBSA 10-60%) at Parkland hospital, Dallas, Texas, on days 1, 7, and 14 after injury. The serum levels of pNFL-H were measured using the enzyme-linked immunoassay. Compared to noninjured controls, the burn patients exhibited a significant increase in the serum levels of pNFL-H on days 7 (P < .0001) and 14 (P < .0001) after burn injury. No significant increase was observed on day 1 (P < .07) after injury. A positive correlation between TBSA and pNFL-H levels was observed for day 14 (r = .55; P < .03). Additionally, using the receiver operating characteristic analysis, the authors determined the area under the curve was 98% for both day 7 and 14. In conclusion, this study describes the serum profile of pNFL-H in patients suffering from severe burns during the acute (day 1) and chronic (days 7 and 14) time-points. These results suggest that detection of pNFL-H may be useful in determining which individuals suffer from nerve cell degeneration after burn.	[Gatson, Joshua W.; Liu, Ming-Mei; Rivera-Chavez, Fernando A.; Minei, Joseph P.; Wolf, Steven E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Dallas, TX 75390 USA		Gatson, JW (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	joshua.gatson@utsouthwestern.edu		Wolf, Steven/0000-0003-2972-3440			Agay D, 2008, EUR CYTOKINE NETW, V19, P1, DOI 10.1684/ecn.2008.0113; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Askay SW, 2008, CURR PAIN HEADACHE R, V12, P94, DOI 10.1007/s11916-008-0018-1; Babcock L, 2013, PEDIATR EMERG CARE, V29, P458, DOI 10.1097/PEC.0b013e31828a202d; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Barone CM, 2000, J BURN CARE REHABIL, V21, P20, DOI 10.1097/00004630-200021010-00005; Barone M, 1997, ACT NEUR S, V70, P267; Boylan K, 2009, J NEUROCHEM, V111, P1182, DOI 10.1111/j.1471-4159.2009.06386.x; CANNON JG, 1992, CRIT CARE MED, V20, P1414, DOI 10.1097/00003246-199210000-00009; Costine BA, 2012, J NEUROTRAUM, V29, P2689, DOI 10.1089/neu.2012.2428; DEBANDT JP, 1994, J TRAUMA, V36, P624, DOI 10.1097/00005373-199405000-00004; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Ehde DM, 2000, J BURN CARE REHABIL, V21, P105, DOI 10.1097/00004630-200021020-00005; Esselman PC, 2007, ARCH PHYS MED REHAB, V88, pS3, DOI 10.1016/j.apmr.2007.09.020; Flierl MA, 2009, CRIT CARE, V13, DOI 10.1186/cc7794; Forstl H, 2010, DTSCH ARZTEBL INT, V107, P835, DOI 10.3238/arztebl.2010.0835; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Gauglitz GG, 2008, SHOCK, V30, P503, DOI 10.1097/SHK.0b013e31816e3373; Gray E, 2013, MULT SCLER J, V19, P153, DOI 10.1177/1352458512451661; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Kuhle J, 2014, J NEUROL NEUROSURG P; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Liang HS, 2009, J NEUROTRAUM, V26, P1745, DOI [10.1089/neu.2008.0850, 10.1089/neu.2008-0850]; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Patterson DR, 2002, J BURN CARE REHABIL, V23, P424, DOI 10.1097/00004630-200211000-00008; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; Reyes R, 2006, NEUROSCI LETT, V407, P11, DOI 10.1016/j.neulet.2006.07.071; Ringger NC, 2011, J VET INTERN MED, V25, P132, DOI 10.1111/j.1939-1676.2010.0645.x; Sellner J, 2014, EUR J NEUROL, V21, P845, DOI 10.1111/ene.12390; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Skillback T, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt212; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; TAKEDA S, 1994, J CELL BIOL, V127, P173, DOI 10.1083/jcb.127.1.173; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; TROJANOWSKI JQ, 1986, J NEUROSCI, V6, P650; Wiechman SA, 2001, J BURN CARE REHABIL, V22, P417, DOI 10.1097/00004630-200111000-00012; WILLIAMS EE, 1991, BURNS, V17, P478, DOI 10.1016/0305-4179(91)90075-R; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhang QH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-118	42	5	5	0	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1559-047X	1559-0488		J BURN CARE RES	J. Burn Care Res.	SEP-OCT	2015	36	5					545	550		10.1097/BCR.0000000000000176			6	Critical Care Medicine; Dermatology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Dermatology; Surgery	CT0PP	WOS:000362498900003	25377862				2022-02-06	
J	Hernandez, H; Scholten, J; Moore, E				Hernandez, Haniel; Scholten, Joel; Moore, Elsie			Home Clinical Video Telehealth Promotes Education and Communication with Caregivers of Veterans with TBI	TELEMEDICINE AND E-HEALTH			English	Article						telerehabilitation; polytrauma; traumatic brain injury; rehabilitation; clinical video telehealth; telehealth; long-term care; chronic disease care; family and caregiver support	TRAUMATIC BRAIN-INJURY; POLYTRAUMA; FAMILIES; CARE	Ongoing communication and care coordination are essential among patients, their family, and interdisciplinary rehabilitation team members to address the complex and changing rehabilitation needs of traumatic brain injuries. Family members of patients with traumatic brain injury commonly assume a caregiver role following discharge from inpatient rehabilitation. The Department of Veterans Affairs has adopted clinical video telehealth to promote access to care, and use of clinical video telehealth for rehabilitation is expanding. Recent implementation of home clinical video telehealth can assist with the ongoing management and treatment of patients in their home setting. This report demonstrates enhanced education and care coordination by using clinical video telehealth with a Veterans Affairs-eligible beneficiary receiving treatment for traumatic brain injury.	[Hernandez, Haniel; Scholten, Joel; Moore, Elsie] Washington DC Vet Affairs Med Ctr, Polytrauma TBI Rehabil Phys Med & Rehabil Serv, Washington, DC 20422 USA		Hernandez, H (corresponding author), Washington DC Vet Affairs Med Ctr, Polytrauma TBI Rehabil Phys Med & Rehabil Serv, 50 Irving St NW, Washington, DC 20422 USA.	haniel.hernandez@va.gov			VA Office of Academic AffiliationsUS Department of Veterans Affairs [38 U.S.C 7406]; VA Office of Research and Development	Funding for this project was provided by the VA Office of Academic Affiliations (38 U.S.C 7406) and the VA Office of Research and Development.	[Anonymous], 2013, POLYTRAUMA BLAST REL; [Anonymous], 2012, CLIN BAS TEL OP MAN; [Anonymous], 2012, TEL OP MAN S; Chumbler NR, 2004, TELEMED J E-HEALTH, V10, P129, DOI 10.1089/1530562041641200; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Darkins A, 2006, J REHABIL RES DEV, V43, pVII, DOI 10.1682/JRRD.2006.03.0029; Girard P, 2007, J REHABIL RES DEV, V44, P1017, DOI 10.1682/JRRD.2006.12.0174; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Griffin JM, 2009, J REHABIL RES DEV, V46, P879, DOI 10.1682/JRRD.2008.08.0104; Masel B, 2009, CONCEPTUALIZING BRAI; Paterson B, 2001, Rehabil Nurs, V26, P48; VHA Telehealth Services, 2013, HOM TEL OP MAN	12	5	5	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	SEP 1	2015	21	9					761	766		10.1089/tmj.2014.0155			6	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	CQ0UY	WOS:000360314200011	25973532				2022-02-06	
J	Michael, FM; Mohapatra, AN; Venkitasamy, L; Chandrasekar, K; Seldon, T; Venkatachalam, S				Michael, Felicia Mary; Mohapatra, Alok Nath; Venkitasamy, Lavanya; Chandrasekar, Kirubhanand; Seldon, Tenzin; Venkatachalam, Sankar			Contusive spinal cord injury up regulates mu-opioid receptor (mor) gene expression in the brain and down regulates its expression in the spinal cord: possible implications in spinal cord injury research	NEUROLOGICAL RESEARCH			English	Article						Naloxone; Neurogenesis; Neuroprotection; Injury response in brain and spinal cord	CENTRAL-NERVOUS-SYSTEM; CEREBRAL ISCHEMIA/REPERFUSION; CELL-PROLIFERATION; BINDING-SITES; STEM-CELLS; NALOXONE; RAT; METHYLPREDNISOLONE; ANTAGONIST; MICROGLIA	Traumatic spinal cord injury (SCI) is one of the dreaded neurological conditions and finding a cure for it has been a hot area of research. Naloxone - a mu-opiate receptor (mor) antagonist was considered for SCI treatment based on its positive effects under shock conditions. In contrary to animal studies based reports about the potential benefits of naloxone in treating SCI, a large scale clinical trial [National Acute Spinal Cord Injury Study II (NASCIS II)] conducted in USA failed to witness any effectiveness. The inconsistency noticed was intriguing. Therefore, the objective of the present study was to re-examine the role of naloxone in treating SCI using a highly standardised Multicenter Animal Spinal Cord Injury Study (MASCIS) animal model of contusive SCI. Results indicated that naloxone produced negligible and insignificant neuroprotection. In an attempt to understand the cause for the failure, it was found that mu-opioid receptor (mor) gene expression was upregulated in the brain but was down regulated in the spinal cord after contusive SCI. Given that the beneficial effects of naloxone are through its action on the mor, the results indicate that unlike the brain, spinal cord might not be bracing to utilise the opiate system in the repair process. This could possibly explain the failure of naloxone treatment in NASCIS II. To conclude, opiate antagonists like naloxone may be neuroprotective for treating traumatic brain injuries, but not for traumatic/contusive spinal cord injuries.	[Michael, Felicia Mary; Mohapatra, Alok Nath; Venkitasamy, Lavanya; Chandrasekar, Kirubhanand; Seldon, Tenzin; Venkatachalam, Sankar] Univ Madras, Dept Anat, Dr ALM Postgrad Inst Basic Med Sci, Madras 600113, Tamil Nadu, India		Venkatachalam, S (corresponding author), Univ Madras, Dept Anat, Dr ALM Postgrad Inst Basic Med Sci, Taramani Campus, Madras 600113, Tamil Nadu, India.	venkatsankar@yahoo.com	mohapatra, alok nath/U-3067-2019	mohapatra, alok nath/0000-0002-9994-6407; Venkatasamy, Lavanya/0000-0002-5360-3943	Department of Biotechnology, Government of IndiaDepartment of Biotechnology (DBT) India	Department of Biotechnology, Government of India.	Acher C, 2012, ANN CARDIOTHORAC SUR, V1, P365, DOI 10.3978/j.issn.2225-319X.2012.08.06; ARIAS MJ, 1987, SURG NEUROL, V28, P335, DOI 10.1016/0090-3019(87)90054-1; Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Black P, 1991, J NEUROTRAUM, V8, P157, DOI 10.1089/neu.1991.8.157; BRACKEN MB, 1993, J NEUROSURG, V79, P500, DOI 10.3171/jns.1993.79.4.0500; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; Chang RCC, 2000, BRAIN RES, V854, P224, DOI 10.1016/S0006-8993(99)02267-2; Chatterjie N, 1996, NEUROCHEM RES, V21, P691, DOI 10.1007/BF02527726; Chen CJ, 2000, NEUROSCI LETT, V287, P113, DOI 10.1016/S0304-3940(00)01151-4; Chen CJ, 2001, NEUROREPORT, V12, P1245, DOI 10.1097/00001756-200105080-00038; Chen SR, 2006, BRAIN RES, V1081, P119, DOI 10.1016/j.brainres.2006.01.053; CZLONKOWSKI A, 1983, BRAIN RES, V267, P392, DOI 10.1016/0006-8993(83)90897-1; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Erman T, 2004, NEUROSURG QUART, V14, P249, DOI 10.1097/00013414-200412000-00010; FADEN AI, 1981, SCIENCE, V211, P493, DOI 10.1126/science.7455690; Faden AI, 1996, PHARMACOL TOXICOL, V78, P12, DOI 10.1111/j.1600-0773.1996.tb00173.x; FADEN AI, 1981, ANN NEUROL, V10, P326, DOI 10.1002/ana.410100403; FAULL RLM, 1987, NEUROSCIENCE, V20, P395, DOI 10.1016/0306-4522(87)90100-X; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; FLAMM ES, 1982, NEUROSURGERY, V10, P227, DOI 10.1227/00006123-198202000-00009; Franz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102896; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Holtz A, 2010, PATHOPHYSIOLOGY SPIN, P29; Kempermann G., 2011, ADULT NEUROGENESIS, P275; Khurshid N, 2010, FASEB J, V24, P3681, DOI 10.1096/fj.09-146746; Kunihara T, 2004, J VASC SURG, V40, P681, DOI 10.1016/j.jvs.2004.07.005; Liao SL, 2003, NEUROSCI LETT, V345, P169, DOI 10.1016/S0304-3940(03)00540-8; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Liu YX, 2002, J PHARMACOL EXP THER, V302, P1212, DOI 10.1124/jpet.102.035956; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; McIntosh TK, 1994, NEUROBIOLOGY CNS TRA, P165; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Oleson CV, 2009, ROCKWOOD GREEN WILKI, P1284; Paxinos G, 2013, RAT BRAIN STEROTAXIC, V7; Ra SM, 2002, NEUROSCI LETT, V333, P123, DOI 10.1016/S0304-3940(02)01031-5; Tabayashi K, 2005, SURG TODAY, V35, P1, DOI 10.1007/s00595-004-2889-z; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; Young Wise, 2009, P411, DOI 10.1007/978-1-60327-185-1_35; Zhang X, 1998, NEUROSCIENCE, V82, P223; Zileli M., 1988, NEUROL RES, V10, P233	43	5	7	0	8	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	SEP	2015	37	9					788	796		10.1179/1743132815Y.0000000057			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM5MC	WOS:000357731000005	26039701				2022-02-06	
J	Presson, N; Beers, SR; Morrow, L; Wagener, LM; Bird, WA; Van Eman, G; Krishnaswamy, D; Penderville, J; Borrasso, AJ; Benso, S; Puccio, A; Fissell, C; Okonkwo, DO; Schneider, W				Presson, Nora; Beers, Sue R.; Morrow, Lisa; Wagener, Lauren M.; Bird, William A.; Van Eman, Gina; Krishnaswamy, Deepa; Penderville, Joshua; Borrasso, Allison J.; Benso, Steven; Puccio, Ava; Fissell, Catherine; Okonkwo, David O.; Schneider, Walter			An exploratory analysis linking neuropsychological testing to quantification of tractography using High Definition Fiber Tracking (HDFT) in military TBI	BRAIN IMAGING AND BEHAVIOR			English	Article						High definition fiber tracking; Military TBI; Diffusion imaging; Traumatic brain injury	WHITE-MATTER INTEGRITY; DIFFUSION; FASCICULUS; INJURY	To realize the potential value of tractography in traumatic brain injury (TBI), we must identify metrics that provide meaningful information about functional outcomes. The current study explores quantitative metrics describing the spatial properties of tractography from advanced diffusion imaging (High Definition Fiber Tracking, HDFT). In a small number of right-handed males from military TBI (N = 7) and civilian control (N = 6) samples, both tract homologue symmetry and tract spread (proportion of brain mask voxels contacted) differed for several tracts among civilian controls and extreme groups in the TBI sample (high scorers and low scorers) for verbal recall, serial reaction time, processing speed index, and trail-making. Notably, proportion of voxels contacted in the arcuate fasciculus distinguished high and low performers on the CVLT-II and PSI, potentially reflecting linguistic task demands, and GFA in the left corticospinal tract distinguished high and low performers in PSI and Trail Making Test Part A, potentially reflecting right hand motor response demands. The results suggest that, for advanced diffusion imaging, spatial properties of tractography may add analytic value to measures of tract anisotropy.	[Presson, Nora; Wagener, Lauren M.; Bird, William A.; Van Eman, Gina; Krishnaswamy, Deepa; Fissell, Catherine; Schneider, Walter] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA; [Beers, Sue R.; Morrow, Lisa] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Krishnaswamy, Deepa] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Penderville, Joshua] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15260 USA; [Borrasso, Allison J.; Benso, Steven; Puccio, Ava; Okonkwo, David O.; Schneider, Walter] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Radiol, Sch Med, Pittsburgh, PA 15260 USA; [Schneider, Walter] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA		Presson, N (corresponding author), Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA.	presson@pitt.edu		Krishnaswamy, Deepa/0000-0002-3235-1222			Betz J, 2012, J NEUROTRAUM, V29, P1292, DOI 10.1089/neu.2011.2215; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dum R. P., 1991, ORIGIN CORTICOSPINAL; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Fernandez-Miranda JC, 2008, NEUROSURGERY, V62, P989, DOI [10.1227/01.NEU.0000297076.98175.67, 10.1227/01.neu.0000333767.05328.49]; Fernandez-Miranda J, 2015, BRAIN STRUCT FUNCT, V220, P1665, DOI 10.1007/s00429-014-0751-7; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Heaton R., 2004, PSYCHOL ASSESS RESOU; Jarbo K., 2011, NEUROIMAGE, V55, P1054; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S, 2005, MRI ATLAS HUMAN WHIT; Nieuwenhuys V, 2008, HUMAN CENTRAL NERVOU; Pandya D. N., 1985, EPILEPSY CORPUS CALL, P21; Presson N, 2015, MIL MED, V180, P109, DOI 10.7205/MILMED-D-14-00413; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Schmahmann J.D., 2006, FIBER PATHWAYS BRAIN; Shin SS, 2014, PROG NEUROL SURG, V28, P86, DOI 10.1159/000358767; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Taoka T, 2009, AM J NEURORADIOL, V30, P1700, DOI 10.3174/ajnr.A1698; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094; Wechsler D., 2008, WECHSLER ADULT INTEL; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wedeen VJ, 2000, P INT SOC MAGN RES M, V8, P82; Wiegell MR, 2000, RADIOLOGY, V217, P897, DOI 10.1148/radiology.217.3.r00nv43897; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126	32	5	5	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	SEP	2015	9	3					484	499		10.1007/s11682-015-9386-4			16	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CR8LQ	WOS:000361604300010	25953056				2022-02-06	
J	Rebetez, MML; Rochat, L; Ghisletta, P; Walder, B; Van der Linden, M				Rebetez, Marie My Lien; Rochat, Lucien; Ghisletta, Paolo; Walder, Bernhard; Van der Linden, Martial			Association between impulsivity, emotional/behavioural hyperactivation and functional outcome one year after severe traumatic brain injury	BRAIN INJURY			English	Article						12-month outcome; neurobehavioural changes; UPPS Impulsive Behaviour Scale	HEAD-INJURY; MULTIDIMENSIONAL APPROACH; INHIBITION; SCALE; VALIDITY; MODERATE; IMPAIRMENTS	Objective: To examine impulsivity changes after a severe traumatic brain injury (TBI) and to explore the relationships between impulsivity dimensions (urgency, lack of premeditation, lack of perseverance, sensation seeking), emotional/behavioural hyperactivation and 12-month outcome. Methods: Measures of emotional/behavioural hyperactivation and functional outcome were administered to 60 patients with severe TBI 12 months after the trauma. A scale designed to assess impulsivity changes after TBI was completed by the patients' significant others at the same time. Results: Scores on urgency and lack of perseverance were higher after the trauma, whereas the score on sensation seeking was lower and the score on lack of premeditation remained stable. Urgency was the only dimension of impulsivity related to both emotional/behavioural hyperactivation and functional outcome. The relationship between urgency and functional outcome was mediated by emotional/behavioural hyperactivation, suggesting that a high level of urgency results in emotional/behavioural hyperactivation, which in turn impacts functional outcome. Lack of perseverance was significantly associated with functional outcome, indicating that the higher the lack of perseverance, the lower the functional outcome. Conclusion: The results contribute to a better understanding of the 12-month outcome in patients with severe TBI. They also open interesting perspectives on management strategies for implementing targeted psychological interventions to decrease impulsive manifestations.	[Rebetez, Marie My Lien; Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, CH-1211 Geneva 4, Switzerland; [Rebetez, Marie My Lien; Rochat, Lucien; Van der Linden, Martial] Univ Geneva, Swiss Ctr Affect Sci, CH-1211 Geneva 4, Switzerland; [Ghisletta, Paolo] Univ Geneva, Methodol & Data Anal, CH-1211 Geneva 4, Switzerland; [Walder, Bernhard] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Van der Linden, Martial] Univ Liege, Cognit Psychopathol Unit, B-4000 Liege, Belgium		Rebetez, MML (corresponding author), Univ Geneva, Cognit Psychopathol & Neuropsychol Unit, Blvd Pont dArve 40, CH-1211 Geneva 4, Switzerland.	marie.rebetez@unige.ch	Ghisletta, Paolo/V-4782-2017; Ghisletta, Paolo/ABD-8592-2020	Ghisletta, Paolo/0000-0001-7731-2406; Ghisletta, Paolo/0000-0001-7731-2406; Rochat, Lucien/0000-0002-9992-2720	Gottfried and Julia Bangerter Rhyner Foundation; Swiss Insurance Association	The authors report no conflicts of interest. Funding was provided by the Gottfried and Julia Bangerter Rhyner Foundation and the Swiss Insurance Association.	Arnould A, 2013, NEUROPSYCHOL REV, V23, P210, DOI 10.1007/s11065-013-9236-3; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Burkard C, 2013, ACTA PSYCHOL, V144, P291, DOI 10.1016/j.actpsy.2013.07.008; Cohen J., 2013, STAT POWER ANAL BEHA; Cyders MA, 2014, CEREBRAL CORTEX; Cyders MA, 2008, PSYCHOL BULL, V134, P807, DOI 10.1037/a0013341; Demark J, 2002, BRAIN INJURY, V16, P91, DOI 10.1080/02699050110102059; Dimoska-Di Marco A, 2011, J CLIN EXP NEUROPSYC, V33, P471, DOI 10.1080/13803395.2010.533158; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Gay P, 2008, ACTA PSYCHOL, V129, P332, DOI 10.1016/j.actpsy.2008.08.010; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; Lippert-Gruner M, 2006, BRAIN INJURY, V20, P569, DOI 10.1080/02699050600664467; McCauley SR, 2001, J NEUROL NEUROSUR PS, V71, P643, DOI 10.1136/jnnp.71.5.643; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rochat L, 2008, ALZ DIS ASSOC DIS, V22, P278, DOI 10.1097/WAD.0b013e318166d692; Rochat L, 2013, J INT NEUROPSYCH SOC, V19, P890, DOI 10.1017/S1355617713000672; Rochat L, 2013, CORTEX, V49, P90, DOI 10.1016/j.cortex.2011.08.004; Rochat L, 2011, PSYCHOPATHOLOGY, V44, P158, DOI 10.1159/000322454; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Smith GT, 2007, ASSESSMENT, V14, P155, DOI 10.1177/1073191106295527; Soury S., 2005, Annales de Readaptation et de Medecine Physique, V48, P61, DOI 10.1016/j.annrmp.2004.08.007; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wood RL, 2001, BRAIN DAM B, P3; Zermatten A, 2005, J NERV MENT DIS, V193, P647, DOI 10.1097/01.nmd.0000180777.41295.65	38	5	5	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1175	1181		10.3109/02699052.2015.1035326			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400005	26186039				2022-02-06	
J	Simblett, SK; Gracey, F; Ring, H; Bateman, A				Simblett, Sara K.; Gracey, Fergus; Ring, Howard; Bateman, Andrew			Measuring coping style following acquired brain injury: A modification of the Coping Inventory for Stressful Situations Using Rasch analysis	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						coping style; acquired brain injury; psychometrics; Rasch analysis	QUALITY-OF-LIFE; AGE-DIFFERENCES; STRATEGIES; STROKE; BEHAVIOR	ObjectiveThe importance of coping style factors in the process of emotional adjustment following acquired brain injury (ABI) has been gaining increased attention. To assess ways of coping with distress accurately, clear conceptual definitions and measurement precision is vital. The purpose of this study was to investigate the psychometric properties of a well-known measure of coping, the Coping Inventory for Stressful Situations (CISS), for people who have experienced an ABI; and to modify the CISS, where necessary, to create a more reliable and valid measurement tool for this clinical group. MethodsPsychometric properties were investigated using Rasch analysis of responses from a sample of adults with ABI (n=207). The internal consistency reliability and construct validity of the scale were examined. ResultsAll originally proposed subscales were not valid or reliable and, as such, were incapable of interval-level measurement within this sample - Task: (2)(32, N=207)=105.1, p<.001; Emotion: (2)(32, N=204)=121.9, p<.001; Avoidance: (2)(32, N=207)=66.7, p<.001. Three valid and reliable subscales were derived measuring emotion-, task-, and avoidance-oriented coping styles by removing items that provided the most unreliable information and exploring fit to the Rasch model. ConclusionsThe original version of the CISS may not be a valid and reliable measure of coping style following ABI. Modified subscales of the three distinct coping domains have been proposed that would help to improve measurement of coping style following ABI in future research and clinical practice. Practitioner points How people cope with difficulties following an ABI has been shown to impact upon emotional outcomes and functional recovery. The original version of the CISS was found to be an imprecise measure of coping following ABI. A modified version of the CISS was found to be a valid and reliable measure of three styles of coping (task-focused, emotion-focused, and avoidance-focused) that conforms to the properties of interval-level measurement as represented by the Rasch model. This structure is in keeping with previous theoretical models of coping. We advise caution about including items (1, 6, 7, 22, 24, 28, 29, 33, 34, and 46) that were found to diverge from the expectations of the Rasch measurement model in total subscale scores for measuring change in coping style. A conversion table for the three modified subscales is included in this paper to convert total raw scores into Rasch transformed logit values. Identifying strengths and weaknesses in coping style could be a means of guiding psychological intervention to promote good recovery following ABI. The sample included mainly people who had experienced non-traumatic brain injuries (e.g., a stroke). This research could be extended to include broader sample of people with differing brain injury aetiologies and neurological disorders.	[Simblett, Sara K.; Gracey, Fergus; Ring, Howard; Bateman, Andrew] Natl Inst Hlth Res NIHR Collaborat Leadership App, Cambridge, England; [Simblett, Sara K.; Ring, Howard; Bateman, Andrew] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England; [Simblett, Sara K.] Kings Coll London, Inst Psychiat, London SE5 8BB, England; [Gracey, Fergus; Bateman, Andrew] Cambridgeshire Community Serv NHS Trust, Cambridge, England; [Ring, Howard] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England; [Bateman, Andrew] Cambridgeshire Community Serv NHS Trust, Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, England		Simblett, SK (corresponding author), Kings Coll London, Inst Psychiat, Addict Sci Bldg,2-4 Windsor Walk,Denmark Hill, London SE5 8BB, England.	sara.simblett@kcl.ac.uk		Gracey, Fergus/0000-0002-1416-7894; Bateman, Andrew/0000-0002-2547-5921	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; NIHR 'Research for Patient Benefit (RfPB)' Programme [PB-PG-0107-12011]	The research was funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust as part of a PhD awarded to the first author, Dr Sara Simblett, and an Academic Clinical Fellowship awarded to Dr Fergus Gracey. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. We are grateful to all the researchers involved in the AIM trial, headed by Dr Fergus Gracey, and funded by the NIHR 'Research for Patient Benefit (RfPB)' Programme (grant no. PB-PG-0107-12011), and the participants that took part in this trial, for providing additional responses to the Coping Inventory for Stressful Situations to enable this analysis. We are also very grateful to Anglia Stroke and Heart Network, the Oliver Zangwill Centre for Neuropsychological Rehabilitation, Ely, UK, and Cambridgeshire Community Services Neurorehabilitation Business Unit who provided extra support in the collection of data for this research.	Amarneh B, 2002, THESIS U CINCINNATI; Andrich D., 2005, RUMM2020 VERSION 4 W; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Artistico D, 2003, PSYCHOL AGING, V18, P68, DOI 10.1037/0882-7974.18.1.68; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Brands IMH, 2014, PSYCHOL ASSESSMENT, V26, P848, DOI 10.1037/a0036275; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Clarke P, 2005, J APPL GERONTOL, V24, P319, DOI 10.1177/0733464805277976; Cook SW, 1997, EDUC PSYCHOL MEAS, V57, P906, DOI 10.1177/0013164497057006002; Cosway R, 2000, J APPL BIOBEHAV RES, V5, P121, DOI 10.1111/j.1751-9861.2000.tb00069.x; DeRidder D, 1997, PSYCHOL HEALTH, V12, P417, DOI 10.1080/08870449708406717; Donnellan C, 2006, J NEUROL NEUROSUR PS, V77, P1208, DOI 10.1136/jnnp.2005.085670; Endler N. S., 1999, COPING INVENTORY STR, P33; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037/0022-3514.58.5.844; Endler NS, 1994, PSYCHOL ASSESSMENT, V6, P50, DOI [DOI 10.1037/1040-3590.6.1.50, 10.1037/1040-3590.6.1.50]; Finset A, 2000, BRAIN INJURY, V14, P887; Folkman, 1984, STRESS APPRAISAL COP, P150; FOLKMAN S, 1987, PSYCHOL AGING, V2, P171, DOI 10.1037/0882-7974.2.2.171; Frydenberg E, 1997, COPING SCALE ADULTS; Gregorio GW, 2014, J HEAD TRAUMA REHAB, V29, pE30, DOI 10.1097/HTR.0b013e31828f93db; Han K, 2009, EDUC PSYCHOL MEAS, V69, P675, DOI 10.1177/0013164409332220; HECKHAUSEN J, 1991, J GERONTOL, V46, pP165, DOI 10.1093/geronj/46.4.P165; Hobart J, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13120; Hurt CS, 2011, INT J GERIATR PSYCH, V26, P1030, DOI 10.1002/gps.2634; Kortte KB, 2003, REHABIL PSYCHOL, V48, P131, DOI 10.1037/0090-5550.48.3.131; Krpan KM, 2011, BRAIN INJURY, V25, P989, DOI 10.3109/02699052.2011.597045; Krpan KM, 2011, J INT NEUROPSYCH SOC, V17, P248, DOI 10.1017/S1355617710001499; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Long C J, 1983, Psychiatr Med, V1, P35; MALIA K, 1995, BRAIN INJURY, V9, P607, DOI 10.3109/02699059509008219; McWilliams LA, 2003, J CLIN PSYCHOL, V59, P423, DOI 10.1002/jclp.10080; Mendozzi L, 1998, CYBERPSYCHOL BEHAV, V1, P79; Mukherjee D, 2006, TOP STROKE REHABIL, V13, P26, DOI 10.1310/tsr1304-26; Nolen-Hoeksema S, 2011, PERS INDIV DIFFER, V51, P704, DOI 10.1016/j.paid.2011.06.012; Riley GA, 2010, NEUROPSYCHOL REHABIL, V20, P869, DOI 10.1080/09602011.2010.503041; Sanchez R, 2011, QUAL LIFE RES, V20, P19, DOI 10.1007/s11136-010-9727-0; Schreurs P. J. G., 1993, UTRECHT COPING LIST; Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Smith R. M., 2006, J APPL MEASUREMENT; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; Wolters G, 2010, NEUROPSYCHOL REHABIL, V20, P587, DOI 10.1080/09602011003683836	45	5	5	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0144-6657	2044-8260		BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	SEP	2015	54	3					249	265		10.1111/bjc.12070			17	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CN7OD	WOS:000358623000001	25546116	Green Accepted			2022-02-06	
J	Wilson, MJ; Harkrider, AW; King, KA				Wilson, Matthew J.; Harkrider, Ashley W.; King, Kristin A.			Effect of Repetitive, Subconcussive Impacts on Electrophysiological Measures of Attention	SOUTHERN MEDICAL JOURNAL			English	Article						concussion; attention; auditory electrophysiology; subconcussive impacts	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; WORKING-MEMORY; NEUROCOGNITIVE PERFORMANCE; CONCUSSION HISTORY; SPORTS CONCUSSION; HEAD IMPACTS; FOOTBALL; RECOVERY; ENCEPHALOPATHY	Objectives In this preliminary study, the auditory P3b response, when measured during a visually distracting task, was investigated as an index of change in cognitive function resulting from exposure to subconcussive impacts (SCIs) in collision sports over time. Methods Both pre- and postseason P3b responses were examined in seven first-year collegiate-level American football players. Comparisons were made between a group of seven third- and fourth-year players and a control group of seven noncontact athletes. Results No difference in P3b amplitude was revealed in pre- versus postseason data of the first-year players. Furthermore, no P3b amplitude differences were found when comparing first-year players with controls. P3b amplitudes of third- and fourth-year players versus first-year players were smaller along the midline electrode sites. Conclusions Preliminary results suggest exposure to SCIs during the course of a season does not affect brain function negatively, as measured by the P3b response; however, differences between first-year players and the group of third- and fourth-year players suggest that exposure to hundreds of SCIs in multiple seasons leads to changes in brain activation patterns. Subtle effects such as difficulty with attentional resource allocation may develop. Longitudinal studies are necessary before definitive conclusions can be drawn.	[Wilson, Matthew J.] No Illinois Univ, Sch Allied Hlth & Commun Disorders, De Kalb, IL 60115 USA; Univ Tennessee, Hlth Sci Ctr, Dept Audiol & Speech Pathol, Knoxville, TN USA		Wilson, MJ (corresponding author), No Illinois Univ, Sch Allied Hlth & Commun Disorders, 323 Wirtz Hall, De Kalb, IL 60115 USA.	mwilson@niu.edu					Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Conroy MA, 2007, J PSYCHOPHYSIOL, V21, P22, DOI 10.1027/0269-8803.21.1.22; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Di Russo F, 2010, PSYCHOPHYSIOLOGY, V47, P425, DOI 10.1111/j.1469-8986.2009.00950.x; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gardner A, 2010, ARCH CLIN NEUROPSYCH, V25, P174, DOI 10.1093/arclin/acq007; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Hoffman JR, 2011, J STRENGTH COND RES, V25, P2351, DOI 10.1519/JSC.0b013e31821743df; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Malojcic B, 2008, J NEUROTRAUM, V25, P30, DOI 10.1089/neu.2007.0384; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Ozen LJ, 2013, BRAIN INJURY, V27, P1244, DOI 10.3109/02699052.2013.804207; Polich, 2003, DETECTION CHANGE EVE, P83, DOI [DOI 10.1007/978-1-4615-0294-4_5, 10.1016/j.neulet.2006.11.066, DOI 10.1016/J.NEULET.2006.11.066]; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Smits M, 2009, HUM BRAIN MAPP, V30, P2789, DOI 10.1002/hbm.20709; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Wilson MJ, 2014, DEV NEUROPSYCHOL, V39, P113, DOI 10.1080/87565641.2013.870177; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Yurgil KA, 2013, PSYCHOPHYSIOLOGY, V50, P1263, DOI 10.1111/psyp.12140	47	5	5	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	SEP	2015	108	9					559	566					8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CQ4JT	WOS:000360571600011	26332482				2022-02-06	
J	Zamani, M; Namdar, B; Azizkhani, R; Ahmadi, O; Esmailian, M				Zamani, Majid; Namdar, Behnam; Azizkhani, Reza; Ahmadi, Omid; Esmailian, Mehrdad			Comparing the Antiemetic Effects of Ondansetron and Metoclopramide in Patients with Minor Head Trauma	EMERGENCY			English	Article						Head injuries, closed; nausea; vomiting; multiple trauma	CYCLIC VOMITING SYNDROME; NAUSEA; TRIAL	Introduction: Nausea and vomiting are the most common complications after minor head trauma that increases the risk of intracranial pressure rising. Therefore, the present study was aimed to compare the antiemetic effects of metoclopramide and ondansetron in the treatment of post-traumatic nausea and vomiting. Methods: The study was a controlled, randomized, double blind clinical trial, which was conducted in the first 6 months of 2014 in emergency department Al-Zahra and Kashani Hospitals in Isfahan, Iran. The patients with minor head trauma associated with nausea and vomiting were randomly divided into 2 groups: treatment with metoclopramide (10mg/2ml, slow injection) and treatment with ondansetron (4mg/2ml, slow injection). The comparison between the 2 groups was done regarding antiemetic efficacy and side effects using SPSS 21 statistical software. Results: 120 patients with minor head trauma were distributed and studied into two groups of 60 patients (mean age 35.6 +/- 14.1 years; 50.0% male). Administration of both ondansetron and metoclopramide significantly reduced the severity of nausea (P<0.001). Changes in the severity of nausea in both groups before and after the treatment revealed that nausea had been decreased significantly in both groups (P < 0.001). The incidence of fatigue (p=0.44), headache (p=0.58) and dystonia (p=0.06) had no significant difference in the two groups but the incidence of drowsiness and anxiety in the metoclopramide group was significantly higher (P < 0.001). Conclusion: The present study indicated that the treatment effectiveness of ondansetron and metoclopramide are similar. However, incidence of drowsiness and anxiety in the metoclopramide was considerably higher. Since these complications can have adverse effects on the treatment of patients with brain injury, it is suggested that it may be better to use ondansetron in these patients.	[Zamani, Majid; Namdar, Behnam; Azizkhani, Reza; Ahmadi, Omid; Esmailian, Mehrdad] Isfahan Univ Med Sci, Zahra Hosp, Dept Emergency Med, Esfahan, Iran		Namdar, B (corresponding author), Zahra Hosp, Dept Emergency Med, Soffeh Blvd, Esfahan, Iran.	behnamnamdar@ymail.com	Alavijeh, Majid Zamani/X-6936-2019; esmailian, mehrdad/K-3638-2016; Ahmadi, Omid/T-9431-2017	Alavijeh, Majid Zamani/0000-0003-1650-9808; esmailian, mehrdad/0000-0002-3510-4462; Ahmadi, Omid/0000-0002-9089-6909			Al-Ansari K, 2011, J PEDIATR GASTR NUTR, V53, P156, DOI 10.1097/MPG.0b013e3182132d8d; Barrett TW, 2011, AM J EMERG MED, V29, P247, DOI 10.1016/j.ajem.2009.09.028; Carlisle JB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004125.pub2; COOKE CE, 1994, AM J HOSP PHARM, V51, P762, DOI 10.1093/ajhp/51.6.762; Egerton-Warburton D, 2014, ANN EMERG MED, V64, P526, DOI 10.1016/j.annemergmed.2014.03.017; Faridaalaee G, 2015, EMERGENCY, V3, P70; Hejazi RA, 2014, EXP BRAIN RES, V232, P2549, DOI 10.1007/s00221-014-3989-7; Keller K, 2013, WIEN MED WOCHENSCHR, V163, P514, DOI 10.1007/s10354-013-0250-0; Livezey MR, 2014, XENOBIOTICA, V44, P309, DOI 10.3109/00498254.2013.835885; Naumann CR, 2012, J MATERN-FETAL NEO M, V25, P1488, DOI 10.3109/14767058.2011.644363; Olver I, 2011, SUPPORT CARE CANCER, V19, pS33, DOI 10.1007/s00520-010-0985-8; Patanwala AE, 2010, J EMERG MED, V39, P330, DOI 10.1016/j.jemermed.2009.08.060; Pitts SR, 2014, ANN INTERN MED, V161, DOI 10.7326/0003-4819-161-12-201412160-02003; Snow V, 2002, ANN INTERN MED, V137, P840, DOI 10.7326/0003-4819-137-10-200211190-00014; Yadav Deepak R, 2011, INT J PHARMTECH RES, V3, P516; Yi HS, 2013, ANN REHABIL MED-ARM, V37, P871, DOI 10.5535/arm.2013.37.6.871	16	5	5	0	3	SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED	TEHRAN	SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN	2345-4571			EMERGENCY	Emergency	FAL	2015	3	4					137	140					4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V9Z6K	WOS:000409498900002	26495402				2022-02-06	
J	Cho, SY				Cho, S. Y.			Dental luxation and avulsion injuries in Hong Kong primary school children	HONG KONG MEDICAL JOURNAL			English	Article							OF-THE-LITERATURE; PERMANENT TEETH; TRAUMA; SCHOOLCHILDREN; EPIDEMIOLOGY; PREVALENCE; TURKEY	Objectives: To identify the major causes and types of dental luxation and avulsion injuries, and their associated factors in primary school children in Hong Kong. Design: Case series. Setting: School dental clinic, New Territories, Hong Kong. Patients: The dental records of children with a history of dental luxation and/or avulsion injury between November 2005 and October 2012 were reviewed. Objective clinical and radiographical findings at the time of injury and at follow-up examinations were recorded using a standardised form. Data analysis was carried out using the Chi squared test and multinomial logistic regression. Results: A total of 220 children with 355 teeth of dental luxation or avulsion injury were recorded. Their age ranged from 6 to 14 years and the female-to-male ratio was 1:1.8. The peak occurrence was at the age of 9 years. Subluxation was the most common type of injury, followed by concussion. Maxillary central incisors were the most commonly affected teeth. The predominant cause was fall and most injuries occurred at school. Incisor relationship was registered in 199 cases: most of them were Class I. Comparison of the incisor relationship in study children and the general Chinese population in another study revealed a higher proportion of Class II and fewer Class III occlusions in the trauma group (P<0.0001). Conclusion: Most dental luxation and avulsion injuries in Hong Kong primary school children are caused by fall. Boys are more commonly affected than girls, and a Class II incisor relationship is a significant risk factor.	MacLehose Dent Ctr, Wanchai, Hong Kong, Peoples R China		Cho, SY (corresponding author), MacLehose Dent Ctr, G-F,286 Queens Rd East, Wanchai, Hong Kong, Peoples R China.	rony_cho@dh.gov.hk					Andersson L, 2013, PEDIATR DENT, V35, P102; Andersson L, 2011, DENT TRAUMATOL, V27, P269, DOI 10.1111/j.1600-9657.2011.00992.x; Andreasen F.M., 2007, TEXTBOK COLOUR ATLAS, V4, P372; Andreasen JO, 2006, DENT TRAUMATOL, V22, P83, DOI 10.1111/j.1600-9657.2006.00421.x; [Anonymous], 2010, INJ SURV 2008; Atabek D, 2014, DENT TRAUMATOL, V30, P154, DOI 10.1111/edt.12057; Bendo CB, 2010, J PUBLIC HEALTH DENT, V70, P313, DOI 10.1111/j.1752-7325.2010.00190.x; British standard incisor classification, 1983, BRIT STAND INC CLASS; Chan C C, 2000, Inj Prev, V6, P20, DOI 10.1136/ip.6.1.20; Chan YM, 2011, DENT TRAUMATOL, V27, P199, DOI 10.1111/j.1600-9657.2011.00989.x; Diaz JA, 2010, DENT TRAUMATOL, V26, P254, DOI 10.1111/j.1600-9657.2010.00878.x; Eyuboglu O, 2009, DENT TRAUMATOL, V25, P110, DOI 10.1111/j.1600-9657.2008.00668.x; Glendor U., 2007, TXB COLOR ATLAS TRAU, P217; Glendor U, 2008, DENT TRAUMATOL, V24, P603, DOI 10.1111/j.1600-9657.2008.00696.x; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Hecova H, 2010, DENT TRAUMATOL, V26, P466, DOI 10.1111/j.1600-9657.2010.00924.x; Kania MJ, 1996, ANGLE ORTHOD, V66, P423; LEW KK, 1993, AUST DENT J, V38, P442, DOI 10.1111/j.1834-7819.1993.tb04759.x; Noori AJ, 2009, DENT TRAUMATOL, V25, P442, DOI 10.1111/j.1600-9657.2009.00791.x; Petersson EE, 1997, SWED DENT J, V21, P55; Sandalli N, 2005, DENT TRAUMATOL, V21, P188, DOI 10.1111/j.1600-9657.2005.00309.x; Taiwo OO, 2011, DENT TRAUMATOL, V27, P230, DOI 10.1111/j.1600-9657.2011.00997.x; Toprak ME, 2014, DENT TRAUMATOL, V30, P280, DOI 10.1111/edt.12092; Zaragoza AA, 1998, J DENT CHILD, V65, P492; Zhang Y, 2014, DENT TRAUMATOL, V30, P211, DOI 10.1111/edt.12075	25	5	5	0	7	HONG KONG ACAD MEDICINE PRESS	HONG KONG	9/F/, ROOM 901, 99 WONG CHUK HANG RD, ABERDEEN, HONG KONG, 00000, PEOPLES R CHINA	1024-2708			HONG KONG MED J	Hong Kong Med. J.	AUG	2015	21	4					339	344		10.12809/hkmj144433			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CO7GT	WOS:000359328300009	26183452	gold			2022-02-06	
J	Dundon, NM; Dockree, SP; Buckley, V; Merriman, N; Carton, M; Clarke, S; Roche, RAP; Lalor, EC; Robertson, IH; Dockree, PM				Dundon, Neil M.; Dockree, Suvi P.; Buckley, Vanessa; Merriman, Niamh; Carton, Mary; Clarke, Sarah; Roche, Richard A. P.; Lalor, Edmund C.; Robertson, Ian H.; Dockree, Paul M.			Impaired auditory selective attention ameliorated by cognitive training with graded exposure to noise in patients with traumatic brain injury	NEUROPSYCHOLOGIA			English	Article							REHABILITATION; SPEECH; SIGNAL; ACCUMULATION; DYSFUNCTION; PLASTICITY; INVENTORY; SYMPTOMS; SEQUELAE; MEMORY	Patients who suffer traumatic brain injury frequently report difficulty concentrating on tasks and completing routine activities in noisy and distracting environments. Such impairments can have long-term negative psychosocial consequences. A cognitive control function that may underlie this impairment is the capacity to select a goal-relevant signal for further processing while safeguarding it from irrelevant noise. A paradigmatic investigation of this problem was undertaken using a dichotic listening task (study 1) in which comprehension of a stream of speech to one ear was measured in the context of increasing interference from a second stream of irrelevant speech to the other ear. Controls showed an initial decline in performance in the presence of competing speech but thereafter showed adaptation to increasing audibility of irrelevant speech, even at the highest levels of noise. By contrast, patients showed linear decline in performance with increasing noise. Subsequently attempts were made to ameliorate this deficit (study 2) using a cognitive training procedure based on attention process training (APT) that included graded exposure to irrelevant noise over the course of training. Patients were assigned to adaptive and non-adaptive training schedules or to a no-training control group. Results showed that both types of training drove improvements in the dichotic listening and in naturalistic tasks of performance in noise. Improvements were also seen on measures of selective attention in the visual domain suggesting transfer of training. We also observed augmentation of event-related potentials (ERPs) linked to target processing (P3b) but no change in ERPs evoked by distractor stimuli (P3a) suggesting that training heightened tuning of target signals, as opposed to gating irrelevant noise. No changes in any of the above measures were observed in a no-training control group. Together these findings present an ecologically valid approach to measure selective attention difficulties after brain injury, and provide a means to ameliorate these deficits. (C) 2015 Elsevier Ltd. All rights reserved.	[Dundon, Neil M.; Dockree, Suvi P.; Buckley, Vanessa; Carton, Mary; Clarke, Sarah] Headway Ireland, Dublin 7, Ireland; [Dundon, Neil M.] Univ Bologna, Dipartimento Psichol, Bologna, Italy; [Dockree, Suvi P.] Natl Rehabil Hosp, Dun Laoghaire, Ireland; [Clarke, Sarah] Beaumont Hosp, Dept Psychol, Dublin 9, Ireland; [Buckley, Vanessa; Merriman, Niamh; Lalor, Edmund C.; Robertson, Ian H.; Dockree, Paul M.] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland; [Roche, Richard A. P.] Natl Univ Ireland, Dept Psychol, Maynooth, Kildare, Ireland		Dockree, PM (corresponding author), Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland.	neil.dundon2@unibo.it; Suvi.Dockree@NRH.IE; buckleyv@headyway.ie; mary.carton@gmail.com; sarahclarke2@beaumontie.ie; edlalor@tcd.ie; iroberts@tcd.ie; dockreep@tcd.ie	Roche, Richard AP/C-4798-2009; Merriman, Niamh/I-8281-2016	Roche, Richard AP/0000-0001-6606-4187; Robertson, Ian H/0000-0001-8637-561X; Lalor, Edmund/0000-0002-2498-6631; Merriman, Niamh A./0000-0002-5327-7762	Health Research Board; Irish Research Council for the Humanities and Social Sciences, Ireland; Headway Ireland	This study was supported by funding from the Health Research Board and a co-fund award from the Irish Research Council for the Humanities and Social Sciences, Ireland and Headway Ireland. We are incredibly grateful to the patients from Headway, Dublin who volunteered for this research. None of the authors have any conflict of interest.	Arciniegas D, 1999, BRAIN INJURY, V13, P1, DOI 10.1080/026990599121827; Assmann Peter, 2004, VVolume 18, P231; Awh E, 2008, NAT NEUROSCI, V11, P5, DOI 10.1038/nn0108-5; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bregman A.S., 1990, AUDITORY SCENE ANAL; Burgess P.W., 1997, HAYLING BRIXTON TEST; Carlson LE, 2007, INT J BEHAV MED, V14, P249, DOI 10.1007/BF03003000; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; Cooke M, 2005, SPEECH SEPARATION BY HUMANS AND MACHINES, P305, DOI 10.1007/0-387-22794-6_21; Cooke M, 2001, SPEECH COMMUN, V35, P141, DOI 10.1016/S0167-6393(00)00078-9; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; de Wall C, 1994, Memory, V2, P149, DOI 10.1080/09658219408258942; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; GENTRY LR, 2002, MAGNETIC RESONANCE I, P1059; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; HALL JW, 1984, J ACOUST SOC AM, V76, P50, DOI 10.1121/1.391005; Hetrick WP, 2012, SCHIZOPHRENIA BULL, V38, P178, DOI 10.1093/schbul/sbq054; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Kelly SP, 2013, J NEUROSCI, V33, P19434, DOI 10.1523/JNEUROSCI.3355-13.2013; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kramer SE, 2009, SCAND J PSYCHOL, V50, P507, DOI 10.1111/j.1467-9450.2009.00747.x; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2007, J INT NEUROPSYCH SOC, V13, P143, DOI 10.1017/S1355617707070178; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; MILLER GA, 1947, PSYCHOL BULL, V44, P105, DOI 10.1037/h0055960; Nee DE, 2012, CEREB CORTEX; O'Connell RG, 2012, NAT NEUROSCI, V15, P1729, DOI 10.1038/nn.3248; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; O'Sullivan J.A., 2014, CEREB CORTEX; Peters RW, 1998, J ACOUST SOC AM, V103, P577, DOI 10.1121/1.421128; Polich J., 2003, THEORETICAL OVERVIEW, P83; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Power AJ, 2012, EUR J NEUROSCI, V35, P1497, DOI 10.1111/j.1460-9568.2012.08060.x; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Repovs G, 2006, NEUROSCIENCE, V139, P5, DOI 10.1016/j.neuroscience.2005.12.061; Robertson I., 1994, TEST EVERYDAY ATTENT; Ronnberg J, 2003, INT J AUDIOL, V42, pS68; Ruggles D, 2011, JARO-J ASSOC RES OTO, V12, P395, DOI 10.1007/s10162-010-0254-z; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Shimamura A. P., 2008, HDB METAMEM MEM, V11, P373; Simons RF, 2001, BIOL PSYCHOL, V56, P207, DOI 10.1016/S0301-0511(01)00078-3; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Sohlberg MM, 2001, ANN NY ACAD SCI, V931, P359; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Van Vleet T. M., 2014, NEUROCASE, P1; Voelbel G, 2014, ARCH CLIN NEUROPSYCH, V29; Wechsler D., 1998, WMS 3 UK ADM SCORING; White PM, 1997, PSYCHOPHYSIOLOGY, V34, P703, DOI 10.1111/j.1469-8986.1997.tb02145.x; Wilson BA, 2014, LIFE BRAIN INJURY SU	56	5	5	0	21	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	AUG	2015	75						74	87		10.1016/j.neuropsychologia.2015.05.012			14	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	CQ4TE	WOS:000360596700008	26004059				2022-02-06	
J	Kazerooni, R; Um, J; PharmD', AB; Lessig, S				Kazerooni, Rashid; Um, Jane; PharmD', Ashley Blake; Lessig, Stephanie			IncobotulinumtoxinA for Migraine: A Retrospective Case Series	CLINICAL THERAPEUTICS			English	Article						botulinum; headache; migraine; toxin; Xeomin	TOXIN TYPE-A; BOTULINUM TOXIN; ONABOTULINUMTOXINA	Purpose: IncobotulinumtoxinA is used for treating certain movement disorders but lacks published clinical data on use in chronic migraine. Methods: This retrospective case series was performed by using electronic chart reviews on patients receiving incobotulinumtoxinA for migraine at the Veterans Affairs San Diego Healthcare System between September 2013 and March 2014. Patients were administered 150 units each, with similar methods used for onabotulinumtoxinA injections. Findings: A total of 21 patients were included in the analysis. Patients were 40 years old on average, 67% white, and 52% female. Patients had trialed an average of 4.19 oral prophylactic agents for migraine with 43% having previous history of onabotulinumtoxinA use and 29% having a history of traumatic brain injury. Patients reported a decrease in headache days per month (19.1 vs 9.1; P < 0.001) and headache intensity (8.3 vs 4.1; P < 0.001) after incobotulinumtoxinA injections. Most patients experienced an improvement in headache frequency and/or intensity (81.8%). The duration of action for these patients averaged 81.9 days (median, 70 days). Published by Elsevier HS Journals, Inc.	[Kazerooni, Rashid; Um, Jane; PharmD', Ashley Blake; Lessig, Stephanie] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92161 USA; [Kazerooni, Rashid; Um, Jane; PharmD', Ashley Blake; Lessig, Stephanie] Univ Calif San Diego, San Diego, CA 92103 USA		Kazerooni, R (corresponding author), Vet Affairs San Diego Healthcare Syst, Pharmacoecon Program, 3350 La Jolla Village Dr 119, San Diego, CA 92161 USA.	rashid.kazerooni@va.gov			Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego	The authors thank the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego for the summer research grant which funded the work of the research assistant.	Allergan Inc, 2013, BOTOX ONABOTULINUMA; [Anonymous], 2010, QUICKSTATS PERC AD W; Ashkenazi A, 2004, ANNU REV MED, V55, P505, DOI 10.1146/annurev.med.55.091902.104440; Aurora SK, 2014, ACTA NEUROL SCAND, V129, P61, DOI 10.1111/ane.12171; Burstein R, 2014, CEPHALALGIA, V34, P853, DOI 10.1177/0333102414527648; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Jandhyala R, 2012, J DRUGS DERMATOL, V11, P731; Kazerooni R, 2015, AM J HEALTH-SYST PH, V72, P301, DOI 10.2146/ajhp140276; Merz Pharmaceuticals, 2014, XEOM INCOBOTULINUMTO; Olesen J, 2006, CEPHALALGIA, V26, P742, DOI 10.1111/j.1468-2982.2006.01172.x; Rappl T, 2013, CLIN COSMET INVESTI, V6, P211, DOI 10.2147/CCID.S41537; Silberstein S, 2000, HEADACHE, V40, P445, DOI 10.1046/j.1526-4610.2000.00066.x; Stovner LJ, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-5; World Health Organization, HEAD DIS HEAD DIS	14	5	5	0	4	ELSEVIER	BRIDGEWATER	685 ROUTE 202-206, BRIDGEWATER, NJ 08807 USA	0149-2918	1879-114X		CLIN THER	Clin. Ther.	AUG	2015	37	8					1860	1864		10.1016/j.clinthera.2015.05.509			5	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	CR9AC	WOS:000361644600025	26166734				2022-02-06	
J	Suarez, MW; Dever, DD; Gu, XH; Illian, PR; McClintic, AM; Mehic, E; Mourad, PD				Suarez, Martin W.; Dever, David D.; Gu, Xiaohan; Illian, P. Ray; McClintic, Abbi M.; Mehic, Edin; Mourad, Pierre D.			Transcranial vibro-acoustography can detect traumatic brain injury, in-vivo: Preliminary studies	ULTRASONICS			English	Article						Traumatic brain injury; Vibro-acoustography; Acoustic emissions; Diagnostic focused ultrasound; Frequency compounding		Vibro-acoustography (VA) uses two or more beams of confocal ultrasound to generate local vibrations within their target tissue through induction of a time-dependent radiation force whose frequency equals that of the difference of the applied frequencies. While VA has proven effective for assaying the mechanical properties of clinically relevant tissue such as breast lesions and tissue calcifications, its application to brain remains unexplored. Here we investigate the ability of VA to detect acute and focal traumatic brain injury (TBI) in-vivo through the use of transcranially delivered high-frequency (2 MHz) diagnostic focused ultrasound to rat brain capable of generating measurable low-frequency (200-270 kHz) acoustic emissions from outside of the brain. We applied VA to acute sham-control and TBI model rats (sham N = 6; TBI N = 6) and observed that acoustic emissions, captured away from the site of TBI, had lower amplitudes for TBI as compared to sham-TBI animals. The sensitivity of VA to acute brain damage at frequencies currently transmittable across human skulls, as demonstrated in this preliminary study, supports the possibility that the VA methodology may one day serve as a technique for detecting TBI. (C) 2015 Published by Elsevier B.V.	[Suarez, Martin W.; Dever, David D.; Gu, Xiaohan; Mehic, Edin; Mourad, Pierre D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Suarez, Martin W.; McClintic, Abbi M.; Mehic, Edin; Mourad, Pierre D.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Illian, P. Ray; Mourad, Pierre D.] Univ Washington, Appl Phys Lab, Seattle, WA 98195 USA; [Mourad, Pierre D.] Univ Washington, Div Engn & Math, Seattle, WA 98195 USA		Mourad, PD (corresponding author), Univ Washington, Dept Neurol Surg, Box 356470, Seattle, WA 98195 USA.	pierre@apl.washington.edu			U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-2-0109]	This work was funded by U.S. Army Medical Research and Materiel Command, Award # W81XWH-11-2-0109, titled "Toward Development of a Field-Deployable Imaging Device for TBI''.	Alizad A, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3323; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Cooley CZ, 2015, MAGN RESON MED, V73, P872, DOI 10.1002/mrm.25147; Dixon C.E., 1991, J NEUROSCI METHODS; Fatemi M., 1999, P NATL ACAD SCI US; Fischer Hannah, 2013, US MILITARY CASUALTY; Greenwald B.D., 2003, ARCH PHYS MED REHAB; Harper JD, 2014, UROLOGY, V84, P484, DOI 10.1016/j.urology.2014.04.041; Kassab M., 2006, J AM BOARD FAM MED, V20, P65; Kucewicz JC, 2008, ULTRASOUND MED BIOL, V34, P1200, DOI 10.1016/j.ultrasmedbio.2008.01.001; Lee Bruce, 2005, NeuroRx, V2, P372; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Miller T.C., 2010, MILITARY STILL FAILI; Murkin J M, 2009, Br J Anaesth, V103 Suppl 1, pi3, DOI 10.1093/bja/aep299; Pislaru C., 2008, INVEST RADIOL; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Robertson CS, 2010, J NEUROTRAUM, V27, P1597, DOI 10.1089/neu.2010.1340; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Urban M.W., 2011, CURR MED IMAG R 1101; Urban MW, 2006, IEEE T MED IMAGING, V25, P1284, DOI 10.1109/TMI.2006.882142; Urban MW, 2011, ULTRASONICS, V51, P689, DOI 10.1016/j.ultras.2011.02.001; US FDA, 2008, GUID IND FDA STAFF I; Xu ZNS, 2014, J ULTRAS MED, V33, P1763, DOI 10.7863/ultra.33.10.1763; Xu ZNS, 2013, J ULTRAS MED, V32, P485, DOI 10.7863/jum.2013.32.3.485; Young AER, 2000, BRIT J ANAESTH, V84, P38, DOI 10.1093/oxfordjournals.bja.a013379	27	5	5	0	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0041-624X	1874-9968		ULTRASONICS	Ultrasonics	AUG	2015	61						151	156		10.1016/j.ultras.2015.04.014			6	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CI1ZY	WOS:000354545200020	25964238				2022-02-06	
J	Niebuhr, T; Junge, M; Achmus, S				Niebuhr, Tobias; Junge, Mirko; Achmus, Stefanie			Expanding Pedestrian Injury Risk to the Body Region Level: How to Model Passive Safety Systems in Pedestrian Injury Risk Functions	TRAFFIC INJURY PREVENTION			English	Article						collision speed; passive safety systems; injury severity measure; body region level; pedestrians; injury risk function	SEVERITY SCORE; IMPACT SPEED; MOTOR-VEHICLE; COLLISIONS; DEATH; PROJECTION; FATALITY; VELOCITY	Objective: Assessment of the effectiveness of advanced driver assistance systems (ADAS) plays a crucial role in accident research. A common way to evaluate the effectiveness of new systems is to determine the potentials for injury severity reduction. Because injury risk functions describe the probability of an injury of a given severity conditional on a technical accident severity (closing speed, delta V, barrier equivalent speed, etc.), they are predestined for such evaluations. Methods: Recent work has stated an approach on how to model the pedestrian injury risk in pedestrian-to-passenger car accidents as a family of functions. This approach gave explicit and easily interpretable formulae for the injury risk conditional on the closing speed of the car. These results are extended to injury risk functions for pedestrian body regions. Starting with a double-checked German In-depth Accident Study (GIDAS) pedestrian-to-car accident data set (N = 444) and a functional-anatomical definition of the body regions, investigations on the influence of specific body regions on the overall injury severity will be presented. As the measure of injury severity, the ISSx, a rescaled version of the well-known Injury Severity Score (ISS), was used. Though traditional ISS is computed by summation of the squares of the 3 most severe injured body regions, ISSx is computed by the summation of the exponentials of the Abbreviated Injury Scale (AIS) severities of the 3 most severely injured body regions. The exponentials used are scaled to fit the ISS range of values between 0 and 75. Results: Three body regions (head/face/neck, thorax, hip/legs) clearly dominated abdominal and upper extremity injuries; that is, the latter 2 body regions had no influence at all on the overall injury risk over the range of technical accident severities. Thus, the ISSx is well described by use of the injury codes from the same body regions for any pedestrian injury severity. As a mathematical consequence, the ISSx becomes explicitly decomposable into the 3 body regions and so are the risk functions as body region-specific risk functions. The risk functions for each body region are stated explicitly for different injury severity levels and compared to the real-world accident data. Conclusions: The body region-specific risk functions can then be used to model the effect of improved passive safety systems. These modified body region-specific injury risk functions are aggregated to a new pedestrian injury risk function. Passive safety systems can therefore be modeled in injury risk functions for the first time. A short example on how the results can be used for assessing the effectiveness of new driver assistance systems concludes the article.	[Niebuhr, Tobias] Tech Univ Carolo Wilhelmina Braunschweig, Inst Math Stochast, D-38106 Braunschweig, Germany; [Junge, Mirko; Achmus, Stefanie] Volkswagen AG, Konzernforsch, Fahrerassistenz & Integrierte Sicherheit, Wolfsburg, Germany		Niebuhr, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Math Stochast, Pockelsstr 14, D-38106 Braunschweig, Germany.	t.niebuhr@tu-bs.de		Junge, Mirko/0000-0002-8410-1903			Agresti A., 1990, CATEGORICAL DATA ANA; Anderson RWG, 1997, ACCIDENT ANAL PREV, V29, P667, DOI 10.1016/S0001-4575(97)00036-5; ASHTON S, 1982, PEDESTRIAN ACCIDENTS; Association for the Advancement of Automotive Medicine, 2008, ABBR INJ SCAL 2005 U; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BULL JP, 1975, ACCIDENT ANAL PREV, V7, P249, DOI 10.1016/0001-4575(75)90026-3; Bull JP, 1980, C SAF PASS CARS I ME; Busch S., 2005, THESIS; Crandall J, 2000, Annu Proc Assoc Adv Automot Med, V44, P235; Cuerden R., 2007, P 20 INT TECHN C ENH; Elvik R., 7402004 TOI; Fildes B, 2004, P IRCOBI C GRAZ AUST; Fredriksson Rikard, 2012, Ann Adv Automot Med, V56, P25; Gable H. C., 2000, J CRASH PREVENTION I, V2, P19; Han Y, 2012, TRAFFIC INJ PREV, V13, P507, DOI 10.1080/15389588.2012.661111; Hannawald L, 2004, EQUAL EFFECTIVENESS; Helmer Thomas, 2010, Stapp Car Crash J, V54, P93; Henary Basem Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P105; Howard M, 2000, P 2000 INT IRCOBI C; Jamieson KG, 1966, NATL HLTH MED RES CO, V13; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Kroyer HRG, 2014, ACCIDENT ANAL PREV, V62, P143, DOI 10.1016/j.aap.2013.09.007; LANE PL, 1994, J TRAUMA, V36, P231, DOI 10.1097/00005373-199402000-00016; Langwieder K, 1980, 8 INT TECHN C ENH SA; Lawrence GJL, 2004, STUDY FEASIBIL UNPUB; Leaf WA, 1999, 809021 NHTSA DOT HS; Lefler DE, 2004, ACCIDENT ANAL PREV, V36, P295, DOI 10.1016/S0001-4575(03)00007-1; Longhitano D, 2005, SAE 2005 WORLD C APR; Longhitano D, 2005, 19 INT TECHN C ENH S; MacLennan PA, 2008, ACCIDENT ANAL PREV, V40, P1371, DOI 10.1016/j.aap.2008.02.008; Martin Jean-Louis, 2011, Ann Adv Automot Med, V55, P137; Mizuno K, 2000, SAE 2000 WORLD C MAR; Mizuno Y, 2005, 19 INT TECHN C ENH S; Neal-Stugess CE, 2007, 20 INT TECHN C ENH S; Niebuhr Tobias, 2013, Ann Adv Automot Med, V57, P145; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Otte D., 2003, 18 INT TECHN C ENH S; Page Y, 2005, 19 INT TECHN C ENH S; PASANEN E, 1992, HELSINKI U TECHNOLOG, V77; PETRUCELLI E, 1981, ACCIDENT ANAL PREV, V13, P29, DOI 10.1016/0001-4575(81)90040-3; Pfeiffer M, 2006, 2 INT C ESAR HAN GER; PITT R, 1990, ACCIDENT ANAL PREV, V22, P549, DOI 10.1016/0001-4575(90)90027-I; Richards D.C., 2010, RELATIONSHIP SPEED R; Ringdal KG, 2013, INJURY, V44, P691, DOI 10.1016/j.injury.2012.06.032; Rosen E, 2009, ACCIDENT ANAL PREV, V41, P536, DOI 10.1016/j.aap.2009.02.002; Roudsari Bahman S, 2005, Traffic Inj Prev, V6, P185; Rozenfeld M, 2014, INJURY PREV, V20, DOI 10.1136/injuryprev-2013-041042; Simms CK, 2006, P I MECH ENG D-J AUT, V220, P1085, DOI [10.1243/09544070JAUTO319, 10.1243/09544070JAUT0319]; Simms CK, 2004, INT J CRASHWORTHINES, V9, P219, DOI 10.1533/ijcr.2004.0283; Simms CK, 2009, SOLID MECH APPL, V166; SOMERS RL, 1983, ACCIDENT ANAL PREV, V15, P247, DOI 10.1016/0001-4575(83)90049-0; States J.D., 1980, ABBREVIATED INJURY S; States JD, 1969, 13 STAPP CAR CRASH C; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Sturtz G, 1976, STAPP CAR CRASH J, V20, P467; Sunnevang Cecilia, 2010, Ann Adv Automot Med, V54, P159; Tefft BC, 2013, ACCIDENT ANAL PREV, V50, P871, DOI 10.1016/j.aap.2012.07.022; Walz FH, 1983, 27 STAPP CAR CRASH C; Watanabe Ryosuke, 2012, Stapp Car Crash J, V56, P269; Wood D. P., 1988, P I MECH ENG D-J AUT, V202, P101; Wood DP, 2005, P I MECH ENG D-J AUT, V219, P183, DOI 10.1243/095440705X6703; Wood DP, 1991, AUTOMOTIVE ENG LITIG, V4; Yaksich SJ, 1964, PEDESTRAINS MILAGE S; Yang J, 1997, 1997 INT IRCOBI C BI; Yoganandan N, 1998, J BIOMECH ENG-T ASME, V120, P100, DOI 10.1115/1.2834288; YOGANANDAN N, 1995, J BIOMECH ENG-T ASME, V117, P48, DOI 10.1115/1.2792269; [No title captured]; [No title captured]	68	5	5	0	21	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1538-9588	1538-957X		TRAFFIC INJ PREV	Traffic Inj. Prev.	JUL 4	2015	16	5					519	531		10.1080/15389588.2014.973490			13	Public, Environmental & Occupational Health; Transportation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health; Transportation	CB0JJ	WOS:000349311600015	25438030				2022-02-06	
J	Edmed, SL; Sullivan, KA; Allan, AC; Smith, SS				Edmed, Shannon L.; Sullivan, Karen A.; Allan, Alicia C.; Smith, Simon S.			Assessment method influences the severity and type of symptoms reported after self-reported mild traumatic brain injury	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Assessment; Neurobehavioral symptom inventory; Concussion; Subjective symptoms; Postconcussive syndrome; Self-report symptoms; Head injuries; Mild traumatic brain injury	PERSISTENT POSTCONCUSSION SYNDROME; EXPECTATION; CONCUSSION; RECOMMENDATIONS; PERFORMANCE; INTERVIEW	Objective: To investigate the influence of assessment method (spontaneous report versus checklist) on the report of postconcussive syndrome (PCS) symptoms after mild traumatic brain injury (mTBI). Setting: Community. Participants: Thirty-six participants (58% female) with postacute self-reported mTBI (i.e., sustained 1-6 months prior to participation) and 36 age-, gender-, and ethnicity-matched controls with no history of mTBI. Design: Cross-sectional. Main measures: Spontaneous symptom report from open-ended questions and checklist endorsed symptoms from the Neurobehavioral Symptom Inventory (both measures administered online). Results: Assessment method significantly affected individual symptom item frequencies (small to large effects), the number of symptoms reported, the total severity score, domain severity scores (i.e., somatic/sensory, cognitive, and affective symptom domains), and the number of participants who met a PCS caseness criterion (large effects; checklist > spontaneous report). The types of symptoms that were different between the groups differed for the assessment methods: Compared to controls, the nonclinical mTBI group spontaneously reported significantly greater somatic/sensory and cognitive domain severity scores, whilst no domain severity scores differed between groups when endorsed on a checklist. Conclusions: Assessment method can alter the number, severity, and types of symptoms reported by individuals who have sustained an mTBI and could potentially influence clinical decisions.	[Edmed, Shannon L.; Sullivan, Karen A.; Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Sch Psychol & Counselling, Clin Neuropsychol Res Grp, Brisbane, Qld 4001, Australia; [Edmed, Shannon L.; Sullivan, Karen A.; Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Allan, Alicia C.; Smith, Simon S.] Queensland Univ Technol, Ctr Accid & Rd Safety, Brisbane, Qld 4001, Australia		Edmed, SL (corresponding author), Queensland Univ Technol, O Block B Wing,Kelvin Grove Campus,Victoria Pk Rd, Kelvin Grove, Qld 4059, Australia.	sl.edmed@connect.qut.edu.au	Smith, Simon/P-1859-2017	Smith, Simon/0000-0002-0362-9045; Edmed, Shannon/0000-0001-5550-9371	School of Psychology and Counselling, Queensland University of Technology	Funding for this project was contributed by the School of Psychology and Counselling, Queensland University of Technology.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Edmed SL, 2012, APPL NEUROPSYCH-ADUL, V19, P164, DOI 10.1080/09084282.2011.643961; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox-Wasylyshyn SM, 2005, RES NURS HEALTH, V28, P488, DOI 10.1002/nur.20100; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Gunstad J, 2002, J INT NEUROPSYCH SOC, V8, P37, DOI 10.1017/S1355617701020045; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Ho DE, 2011, J STAT SOFTW, V42, p[8, 1], DOI DOI 10.18637/JSS.V042.I08; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Krol AL, 2011, BRAIN INJURY, V25, P1300, DOI 10.3109/02699052.2011.624571; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Mulhern S, 2006, J PSYCHOSOM RES, V61, P439, DOI 10.1016/j.jpsychores.2006.03.004; Nolin P, 2006, BRAIN INJURY, V20, P1147, DOI 10.1080/02699050601049247; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Villemure R, 2011, BRAIN INJURY, V25, P53, DOI 10.3109/02699052.2010.531881; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; WHO, 1992, INT STAT CLASS DIS R; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WorldAPP, 2013, KEY SURV VERS 8 2	40	5	5	0	12	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	JUL 3	2015	37	6					641	652		10.1080/13803395.2015.1038984			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CM8GZ	WOS:000357938300008	26011761				2022-02-06	
J	Arat, YO; Arat, A; Aydin, K				Arat, Yonca Ozkan; Arat, Anil; Aydin, Kubilay			Cerebrovascular complications of transorbital penetrating intracranial injuries	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Cerebrovascular injury; fistula; penetrating intracranial injury; transorbital injury; traumatic aneurysm	CAROTID-CAVERNOUS FISTULA; OF-THE-LITERATURE; ENDOVASCULAR TREATMENT; ARTERIAL INJURIES; BRAIN-INJURY; STAB WOUNDS; CASE SERIES; FOLLOW-UP; ANEURYSMS; SHOTGUN	BACKGROUND: Cerebrovascular trauma secondary to transorbital intracranial penetrating injury (TIPVI) is rare. Relatively benign initial presentation may mask the underlying life-threatening vascular injury in transorbital intracranial penetrations. The aim of this study was to evaluate clinical features and endovascular treatment of TIPVI. METHODS: Six patients with angiographic documentation of TIPVI in subacute/chronic phase were reviewed retrospectively. Five were treated endovascularly; however endovascular treatment was aborted in one and conservative management was pursued. RESULTS: Except for one case presenting with vision loss and mild stroke, no significant neurologic deficit was present. Vascular lesions included two cases of carotid-cavernous fistulas, three traumatic aneurysms of cavernous carotid, anterior and middle cerebral arteries and a unique case of coalescing cavernous aneurysms following a through-and-through injury in which the aneurysms united within the thrombosed cavernous sinus on follow up. Fistulas were treated with covered stents, aneurysms with parent artery occlusion or flow diverters. All patients had uneventful recoveries. CONCLUSION: TIPVI may present in a delayed fashion after a seemingly benign presentation. A high index of suspicion is critical to rule out TIPVI with vascular imaging. Transcatheter angiographic techniques allow for both diagnosis and treatment of TIPVI with favorable results.	[Arat, Yonca Ozkan] Baskent Univ, Fac Med, Dept Ophthalmol, TR-06490 Ankara, Turkey; [Arat, Yonca Ozkan] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Arat, Anil] Hacettepe Univ, Fac Med, Dept Radiol, Sect Intervent Neuroradiol, TR-06100 Ankara, Turkey; [Aydin, Kubilay] Istanbul Univ, Istanbul Fac Med, Dept Radiol, Sect Intervent Neuroradiol, Istanbul, Turkey		Arat, A (corresponding author), Hacettepe Univ Hastanesi, Radyol Anabilim Dali, TR-06230 Ankara, Turkey.	anilarat@hotmail.com	ARAT, YONCA OZKAN/AAA-2259-2021; Aydin, Kubilay/A-9878-2008	arat, anil/0000-0001-7122-4675; ARAT, YONCA OZKAN/0000-0002-6578-7444			Abdelaziz L, 2012, BMJ CASE REP; Amirjamshidi A, 1997, SURG NEUROL, V47, P331, DOI 10.1016/S0090-3019(96)00357-6; [Anonymous], 2001, J TRAUMA S, V51, P26; Archondakis E, 2007, AM J NEURORADIOL, V28, P342; Aydin K, 2015, J NEUROINTERV SURG, V7, P202, DOI 10.1136/neurintsurg-2013-011090; Balasubramanian C, 2009, SURG NEUROL, V71, P238, DOI 10.1016/j.surneu.2007.07.050; Barua NU, 2007, BRIT J NEUROSURG, V21, P237, DOI 10.1080/02688690701222849; Bell RS, 2010, NEUROSURGERY, V66, P66, DOI 10.1227/01.NEU.0000361285.50218.A8; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Bodanapally UK, 2014, J NEUROSURG, V121, P1275, DOI 10.3171/2014.7.JNS132688; Brenke C, 2013, J NEUROL SURG PART A, V74, pE239, DOI 10.1055/s-0033-1348349; Chen PY, 2014, ULUS TRAVMA ACIL CER, V20, P382, DOI 10.5505/tjtes.2014.39338; Chibbaro S, 2006, ACTA NEUROCHIR, V148, P937, DOI 10.1007/s00701-006-0794-5; Civelek Erdinc, 2006, Ulus Travma Acil Cerrahi Derg, V12, P245; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; Erkol Z, 1996, ULUS TRAVMA ACIL CER, V2, P47; Erkutlu I, 2011, ULUS TRAVMA ACIL CER, V17, P79, DOI 10.5505/tjtes.2011.49092; Fabian TS, 1999, J TRAUMA, V47, P275, DOI 10.1097/00005373-199908000-00009; Fields CE, 2000, J TRAUMA, V48, P338, DOI 10.1097/00005373-200002000-00030; Fulkerson DH, 2010, CHILD NERV SYST, V26, P613, DOI 10.1007/s00381-010-1104-3; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; Gonul E, 2005, SURG NEUROL, V63, P24, DOI 10.1016/j.surneu.2004.05.043; GREENE KA, 1993, SURG NEUROL, V40, P499, DOI 10.1016/0090-3019(93)90054-5; Hiraishi T, 2009, NEUROL MED-CHIR, V49, P590, DOI 10.2176/nmc.49.590; Horowitz MB, 1999, SURG NEUROL, V51, P31, DOI 10.1016/S0090-3019(98)00029-9; Kawata H, 2009, JPN J CLIN OPHTHAL, V63, P665; KHALIL N, 1991, SURG NEUROL, V35, P294, DOI 10.1016/0090-3019(91)90008-W; Kim MS, 2014, J KOREAN NEUROSURG S, V55, P222, DOI 10.3340/jkns.2014.55.4.222; Kitakami A, 1999, NEUROL MED-CHIR, V39, P150, DOI 10.2176/nmc.39.150; Lin Hung-Lin, 2007, J Chin Med Assoc, V70, P36; Paiva WS, 2010, CLIN OPHTHALMOL, V4, P1103, DOI 10.2147/OPTH.S9638; Perez EA, 2006, ROCKWOOD GREENS FRAC, P446; Schreckinger M, 2011, J NEUROSURG, V114, P53, DOI 10.3171/2010.8.JNS10301; Skoch J, 2013, J NEUROL SURG REP, V74, P23, DOI 10.1055/s-0033-1346976; Song JK, 1999, AM J ROENTGENOL, V173, P1116, DOI 10.2214/ajr.173.4.10511189; Tokdemir M, 2007, BRAIN INJURY, V21, P997, DOI 10.1080/02699050701564509; Turbin RE, 2006, SURV OPHTHALMOL, V51, P449, DOI 10.1016/j.survophthal.2006.06.008; van Duinen Martin Th A, 2000, TRANSORBITAL INTRACT; Vaqas B, 2013, TRAUMA, V15, P252, DOI 10.1177/1460408613497145; Welman C, 2004, THESIS U CAPE TOWN; ZIMMER J, 1979, MIL MED, V144, P485	42	5	5	0	2	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JUL	2015	21	4					271	278		10.5505/tjtes.2015.48839			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CO7HR	WOS:000359330700007	26374414	Bronze, Green Published			2022-02-06	
J	Basarslan, SK; Gocmez, C; Kamasak, K; Ekici, MA; Ulutabanca, H; Dogu, Y; Menku, A				Basarslan, Seyit Kagan; Gocmez, Cuneyt; Kamasak, Kagan; Ekici, Mehmet Ali; Ulutabanca, Halil; Dogu, Yurdaer; Menku, Ahmet			The effects of erythropoietin, dextran and saline on brain edema and lipid peroxidation in experimental head trauma	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Antioxidants; brain edema; dextran; erythropoietin; saline; oxidative stress; severe head trauma	INJURY; PATHOPHYSIOLOGY	BACKGROUND: The aim of this study was to investigate the protective effects of erythropoietin, dextran/saline and erythropoietin in combination with dextran/saline on brain edema and lipid peroxidation following traumatic brain injury in rats. METHODS: In the study, 40 male 3-month-old albino Wistar rats, weighing 250-340 g, were divided into four groups, each consisting of ten rats. Traumatic brain injury was induced in all rats by the weight drop method, and erythropoietin (5,000 U/kg) and/or dextran and saline (8 ml/kg) solutions were injected intraperitoneally ten minutes after trauma. Control animals received an equal volume of serum physiologic. All rats were sacrificed 24 hours later. Glutathione peroxidase activity and malondialdehyde levels were measured in the left hemisphere, and edema was quantitated by the wet dry method. RESULTS: Brain edema and the levels of malondialdehyde, the last product of lipid peroxidation in tissues, were decreased variably, and the activity of glutathione peroxidase, an antioxidant enzyme, was increased in others compared with the control group. CONCLUSION: In this study, it was concluded that the brain edema that developed in rats on which head trauma was induced and the secondary brain damage caused by oxidative stress could be deceased using a combination of erythropoietin, dextran, and saline.	[Basarslan, Seyit Kagan] Mustafa Kemal Univ, Tip Fak, Beyin Cerrahisi Anabilim Dali, Antakya, Turkey; [Gocmez, Cuneyt; Kamasak, Kagan] Dicle Univ, Fac Med, Dept Neurosurg, Diyarbakir, Turkey; [Ekici, Mehmet Ali] Sevket Yilmaz Training & Res Hosp, Dept Neurosurg, Bursa, Turkey; [Ulutabanca, Halil; Menku, Ahmet] Erciyes Univ, Fac Med, Dept Neurosurg, Kayseri, Turkey; [Dogu, Yurdaer] Tekten Private Hosp, Dept Neurosurg, Denizli, Turkey		Basarslan, SK (corresponding author), Mustafa Kemal Univ, Tip Fak, Beyin Cerrahisi Anabilim Dali, Antakya, Turkey.	kaganbasarslan@hotmail.com	Ekici, Mehmet Ali/ABE-1571-2020				Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Berger S, REDUCTION POSTTRAUMA; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Dazgiin AP, 2006, TURK J MED SCI, V36, P215; Ehrenreich H, 2004, SCIENCE, V305, P184, DOI 10.1126/science.1100891; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FREI HJ, 1973, ACTA NEUROCHIR, V29, P15, DOI 10.1007/BF01414613; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Granacher Jr RP, 2007, TRAUMATIC BRAIN INJU; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HARA H, 1990, ACT NEUR S, V51, P251; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Kuralay F, 2008, TURK J MED SCI, V38, P519; Kuzugiiden S, 2007, TINER ILE RAT BEYNIN; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion DW, 2003, INTENSIVE CARE IN NEUROSURGERY, P47; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Marti HH, 1997, KIDNEY INT, V51, P416, DOI 10.1038/ki.1997.55; McCall J M, 1987, Acta Anaesthesiol Belg, V38, P373; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Miller JD, 1996, NEUROTRAUMA, P61; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; OZBEN T, 1998, FREE RADICALS OXIDAT; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932; Sahin S, 2006, METHOD FIND EXP CLIN, V28, P211, DOI 10.1358/mf.2006.28.4.990200; SCALEA TM, 2005, NEUROTRAUMA EVIDENCE, P3; Sharon L., 2010, MED SURG NURSING; Stancliffe RA, 2011, AM J CLIN NUTR, V94, P422, DOI 10.3945/ajcn.111.013342; Strandvik GF, 2009, ANAESTHESIA, V64, P990, DOI 10.1111/j.1365-2044.2009.05986.x; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; YASUDA Y, 1993, DEV GROWTH DIFFER, V35, P711	39	5	5	1	4	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	JUL	2015	21	4					235	240		10.5505/tjtes.2015.66502			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CO7HR	WOS:000359330700001	26374408	Bronze			2022-02-06	
J	Baugh, CM; Shapiro, ZE				Baugh, Christine M.; Shapiro, Zachary E.			Concussions and youth football: using a public health law framework to head off a potential public health crisis	JOURNAL OF LAW AND THE BIOSCIENCES			English	Article						concussion; health policy; public health law; sport; youth	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL; IMPROVE HEALTH; SPORTS; STATE; POLICY; MANAGEMENT; SYMPTOMS; COLLEGE; RISK	Concussion from sport is increasingly recognized as a public health priority. In response, all states and the District of Columbia have enacted youth concussion legislation. This paper first examines key developments in concussion-related policy and legislation and then uses the findings from recent scientific studies to highlight the need to incorporate evolving scientific evidence into concussion legislation in order to better protect youth and adolescent athletes. Next, the paper discusses the framework of empirical health law research and why it should be applied in the case of concussion legislation. Finally, this paper argues that empirical health law research should be considered in any decision about whether legislation can help improve the health and safety of young players, a particularly vulnerable population whose unique needs have not yet been adequately addressed.	[Baugh, Christine M.] Harvard Univ, Interfactulty Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.] Boston Childrens Hosp, Div Sports Med, Boston, MA 02115 USA; [Shapiro, Zachary E.] Harvard Univ, Sch Law, Cambridge, MA 02138 USA		Baugh, CM (corresponding author), Harvard Univ, Interfactulty Initiat Hlth Policy, Cambridge, MA 02138 USA.	cbaugh@g.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338			Alic Steve, 2015, US FOOTBALL     0216; Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; BAKER T, 2005, MED MALPRACTICE MYTH, P180; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2014, J LAW MED ETHICS, V42, P297, DOI 10.1111/jlme.12147; Baugh Christine M., 2014, J LAW MED ETHICS, V42, P311; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Burris S, 2010, MILBANK Q, V88, P169, DOI 10.1111/j.1468-0009.2010.00595.x; Burris SC, 2011, J LAW MED ETHICS, V39, P15, DOI 10.1111/j.1748-720X.2011.00558.x; Buzas David, 2014, ORTHOPEDIC J SPORTS, V2, P1; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Carucci Vic, 2009, NATL FOOTBALL L 0726; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Curran W J, 1969, Am J Public Health Nations Health, V59, P552, DOI 10.2105/AJPH.59.3.552; Curran William J., 1969, AM J PUB HLTH NATION, V59, P556; Davis Corey, 2005, AM J PUBLIC HEALTH, V95, P236; Davis CS, 2005, AM J PUBLIC HEALTH, V95, P233, DOI [10.2105/AJPH.2003.033563, 10.2105/AJPH.2003.031310]; Fainaru S., 2013, ESPN; Fainaru Steve, 2014, ESPN            0113; Fielding JE, 2002, J LAW MED ETHICS, V30, P22; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Gostin Lawrence., 2007, J HLTH CARE LAW POLI, V10, P1, DOI [10.2139/ssrn.242580, DOI 10.2139/SSRN.242580]; Gostin Lawrence O., 2007, J HLTH CARE L POLY, V10, P4; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harrison Emily, 2013, AM J PUBLIC HEALTH, V104, P822; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Harvey Hosea H., 2015, J L MED ETH IN PRESS; Hruby Patrick, 2012, THEPOSTGAME     0229; Irick Erin, 2013, NCAA SPORTS SPONSORS, P74; Ivy League Ad Hoc Concussion Committee, 2011, REP REG IV LEAG REV, P3; Jewell CJ, 2008, MILBANK Q, V86, P177, DOI 10.1111/j.1468-0009.2008.00519.x; Jones MM, 2007, AM J PUBLIC HEALTH, V97, P208, DOI 10.2105/AJPH.2005.083204; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; KLOSSNER DAVID, 2013, NCAA SPORTS MED HDB, V4, P56; KLOSSNER DAVID, 2013, NCAA SPORTS MED HDB, V4, P68; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lowrey KM, 2014, J LAW MED ETHICS, V42, P290, DOI 10.1111/jlme.12146; Lowrey KM, 2014, J BUSINESS TECH L, V10, P61; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mello MM, 2008, GEORGETOWN LAW J, V96, P649; Mello Michelle M., 2008, GEORGETOWN LAW J, V96, P653; Mello MM, 2005, J LAW MED ETHICS, V33, P414, DOI 10.1111/j.1748-720X.2005.tb00508.x; Moulton AD, 2009, AM J PUBLIC HEALTH, V99, P17, DOI 10.2105/AJPH.2007.130278; National Federation of State High School Associations, 2014, HIGH SCH SPORT PART; National Football League, OFF NFL PLAY RUL 68, P68; NCAA DOD, LUNCH MIND MATT CHAL; New Jake, 2014, INSIDEHIGHERED  1002; NFL, 2010, NFL             0523; Ninesigma, 2015, GE NFL HEAD HLTH CHA; Pop Warner National Office, 2012, RUL CHANG REG PRACT; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Schwarz Alan, 2010, NEWYORK TIMES   0922; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; SHAPIN STEVEN, 2010, NEVER PURE HIST STUD, P48; Simpson HM, 2003, J SAFETY RES, V34, P25, DOI 10.1016/S0022-4375(02)00077-4; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Struve CT, 2004, FORDHAM LAW REV, V72, P943; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211	71	5	5	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2053-9711			J LAW BIOSCI	J. Law Biosci.	JUL	2015	2	2					449	458		10.1093/jlb/lsv023			10	Ethics; Law; Medical Ethics; Medicine, Legal	Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	CY6IG	WOS:000366511800015	27774206	Green Submitted, Green Published, gold			2022-02-06	
J	Hyatt, KS; Davis, LL; Barroso, J				Hyatt, Kyong S.; Davis, Linda L.; Barroso, Julie			Finding the New Normal: Accepting Changes After Combat-Related Mild Traumatic Brain Injury	JOURNAL OF NURSING SCHOLARSHIP			English	Article						Combat-related mild traumatic brain injury; family reintegration; new normal; post-brain injury adjustment; soldiers	POSTTRAUMATIC-STRESS-DISORDER; HEALTH; VETERANS; IRAQ; REHABILITATION; ADJUSTMENT; POLYTRAUMA; SYMPTOMS; DISTRESS; LIFE	IntroductionMore than 300,000 soldiers have returned from Southwest Asia (i.e., Iraq and Afghanistan) with combat-related mild traumatic brain injuries (mTBIs). Despite less visible physical injuries, these soldiers demonstrate various physical and cognitive symptoms that impact their ability to reintegrate post-mTBI. This study explores family reintegration experiences, as described by married dyads, following a combat-related mTBI. MethodsNine soldiers with mTBI and their spouses participated, and a total of 27 interviews, both joint and individual, were conducted. Strauss and Corbin's grounded theory methodology and semistructured interviews were used to collect participants' perceptions and analyze the data. FindingsThe overarching theme of the reintegration experience is described as finding the new normal. A new normal was defined by participants as the couple's new, post-mTBI expectation of the family unit or family routine. Some participants indicated that they had accepted the post-mTBI changes and were working toward this new normal, whereas others indicated these changes were unacceptable and continued their efforts to return to pre-injury functioning. ConclusionsIndividuals with mTBI and their families may benefit from interventions that directly address mismatched expectations and promote the acceptance of a new normal.	[Hyatt, Kyong S.] Nurse Corps, Washington, DC USA; [Hyatt, Kyong S.] Walter Reed Natl Mil Med Ctr, Ctr Nursing Sci & Clin Inquiry, Bethesda, MD 20889 USA; [Davis, Linda L.] Duke Univ, Sch Nursing, Durham, NC USA; [Barroso, Julie] Univ Miami, Sch Nursing & Hlth Studies, Coral Gables, FL 33124 USA		Hyatt, KS (corresponding author), Walter Reed Natl Mil Med Ctr, Ctr Nursing Sci & Clin Inquiry, 8901 Rockville Pike, Bethesda, MD 20889 USA.		Davis, Linda Lindsey/T-7351-2019		TriService Nursing Research Program Graduate Award; TriService Nursing Research Program, Duke University [HU0001-10-1-TS05/N10-PO2]	We acknowledge the support of Dr. Charles Vacchiano, Dr. Susan Silva, Dr. Paul Lewis, and LCDR Billy Collins. Funding was received from TriService Nursing Research Program Graduate Award and this research was sponsored by the TriService Nursing Research Program grant number (HU0001-10-1-TS05/N10-PO2), Duke University. The views expressed herein are those of the authors and do not reflect the official policy of, nor should any official endorsement be inferred by the TriService Nursing Research Program, Duke University, the Department of the Army, Department of Defense, or the U.S. Government.	Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Bradshaw D., 2008, TRAUMATIC BRAIN INJU; Carlson K, 2009, ASSESSMENT TREATMENT; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention, 2006, FACTS AB TBI; Charmaz K., 2014, BROKERAGE CLOSURE IN; Committee on the Initial Assessment of Readjustment Needs of Military Personnel Veterans and Their Families, 2010, RET HOM IRAQ AFGH PR; Daggett V, 2009, J NEUROSCI NURS, V41, P59, DOI 10.1097/JNN.0b013e31819a7133; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Defense and Veterans Brain Injury Center, 2006, DEF VET BRAIN INJ CT; Defense Manpower Data Center, 2008, DOD PERS PROC STAT; Erez ABH, 2009, AM J OCCUP THER, V63, P634; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; GLECKMAN AD, 1995, BRAIN INJURY, V9, P385, DOI 10.3109/02699059509005778; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Livingston M G, 1987, Brain Inj, V1, P33, DOI 10.3109/02699058709034442; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Pandit N.R., 1996, QUALITATIVE REPORT, V2, P1; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Zasler N. D., 2007, REHABILITATION INJUR, V1, P207; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03; Zhang SR, 2009, J REHABIL MED, V41, P1062, DOI 10.2340/16501977-0462; [No title captured]	38	5	5	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6546	1547-5069		J NURS SCHOLARSHIP	J. Nurs. Scholarsh.	JUL	2015	47	4					300	309		10.1111/jnu.12143			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CL5QV	WOS:000357015800004	25975680				2022-02-06	
J	Igarashi, Y; Matsuda, Y; Fuse, A; Ishiwata, T; Naito, Z; Yokota, H				Igarashi, Yutaka; Matsuda, Yoko; Fuse, Akira; Ishiwata, Toshiyuki; Naito, Zenya; Yokota, Hiroyuki			Pathophysiology of microwave-induced traumatic brain injury	BIOMEDICAL REPORTS			English	Article						microwave; traumatic brain injury; blast injury; animal model	CONTROLLED CORTICAL IMPACT; MOBILE PHONE EMISSIONS; CONTINUOUS-WAVE; RAT-BRAIN; EXPOSURE; MODEL; RADIATION; HIPPOCAMPUS; PERMEABILITY; 900-MHZ	Microwave technology has been widely used in numerous applications; however, excessive microwave exposure causes adverse effects, particularly in the brain. The present study aimed to evaluate the change in the number of neural cells and presence of apoptotic cells in rats for one month after exposure to excessive microwave radiation. The rats were exposed to 3.0 kW of microwaves for 0.1 sec and were sacrificed after 24 h (n=3), or 3 (n=3), 7 (n=3), 14 (n=3) or 28 days (n=4) of exposure. The neural cells were counted in the motor cortex and hippocampus [cornu ammonis 1 (CA1) and CA2] and the percentage of positive cells stained with terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) were also measured, which detected apoptotic cell death in the choroid plexus in the lateral ventricle, motor cortex and hippocampus. In the CA1, the number of neural cells decreased significantly by day 28 compared with that in the control (60.7 vs. 50.6, P=0.0358), but did not decrease before day 28. There were no significant differences on any day in the CA2 and the motor cortex. The number of cells showed a significant increase on day 7 compared to the control in the choroid plexus (2.1 +/- 1.1 vs. 21.8 +/- 19.1%, P=0.0318). There were no significant differences from the controls in the percentage of TUNEL-positive cells in the motor cortex and hippocampus. The effects of microwave exposure on the brain remain unclear; however, microwave-induced neurotrauma shows the same pathological changes as blast traumatic brain injury.	[Igarashi, Yutaka; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, 1-1-5 Sendagi, Tokyo 1138603, Japan; [Matsuda, Yoko] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 1730015, Japan; [Matsuda, Yoko] Inst Gerontol, Tokyo 1730015, Japan; [Ishiwata, Toshiyuki; Naito, Zenya] Nippon Med Sch, Dept Pathol, Tokyo 1138602, Japan; [Ishiwata, Toshiyuki; Naito, Zenya] Nippon Med Sch, Dept Integrat Oncol Pathol, Tokyo 1138602, Japan		Igarashi, Y (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, 1-1-5 Sendagi, Tokyo 1138603, Japan.	igarashiy@nms.ac.jp			Japan Society for the Promotion of Science KAKENHIMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [25462835]	The present study was supported by Japan Society for the Promotion of Science KAKENHI (grant no. 25462835). The authors would like to thank Mr. Takayuki Asakura for performing the animal experiments.	Barnett J, 2007, HEALTH POLICY, V82, P240, DOI 10.1016/j.healthpol.2006.10.002; Cosquer B, 2005, BRAIN RES BRAIN RES, V161, P229; D'Andrea JA, 2003, BIOELECTROMAGNETICS, pS107, DOI 10.1002/bem.10179; DIMBYLOW PJ, 1994, PHYS MED BIOL, V39, P1537, DOI 10.1088/0031-9155/39/10/003; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Ferreri F, 2006, ANN NEUROL, V60, P188, DOI 10.1002/ana.20906; Fritze K, 1997, ACTA NEUROPATHOL, V94, P465, DOI 10.1007/s004010050734; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Ghanbari M, 2013, INT J FERTIL STERIL, V7, P21; Hamblin DL, 2004, CLIN NEUROPHYSIOL, V115, P171, DOI 10.1016/S1388-2457(03)00313-4; HIRSCH FG, 1952, AMA ARCH IND HYG OCC, V6, P512; KALANT H, 1959, Can Med Assoc J, V81, P575; Kang XK, 2001, J ELECTROMAGNET WAVE, V15, P61, DOI 10.1163/156939301X00643; Kaur C, 1996, ARCH HISTOL CYTOL, V59, P239, DOI 10.1679/aohc.59.239; Kesari KK, 2012, APPL BIOCHEM BIOTECH, V166, P379, DOI 10.1007/s12010-011-9433-6; Kesari KK, 2011, ELECTROMAGN BIOL MED, V30, P219, DOI 10.3109/15368378.2011.587930; Krause CM, 2007, BIOELECTROMAGNETICS, V28, P296, DOI 10.1002/bem.20300; Kumlin T, 2007, RADIAT RES, V168, P471, DOI 10.1667/RR1002.1; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCLAUGHLIN J T, 1957, Calif Med, V86, P336; RICHARDSON AW, 1951, AMA ARCH OPHTHALMOL, V45, P382; Rothman KJ, 1996, EPIDEMIOLOGY, V7, P291, DOI 10.1097/00001648-199605000-00013; SALFORD LG, 1994, MICROSC RES TECHNIQ, V27, P535, DOI 10.1002/jemt.1070270608; Sievert U, 2005, OTOLARYNG HEAD NECK, V132, P451, DOI 10.1016/j.otohns.2004.09.064; Wang H, 2013, INT J RADIAT BIOL, V89, P1100, DOI 10.3109/09553002.2013.817701; Wang LF, 2009, SYNAPSE, V63, P1010, DOI 10.1002/syn.20684; Xu SJ, 2006, NEUROSCI LETT, V398, P253, DOI 10.1016/j.neulet.2006.01.004; Zhao L, 2014, J MOL NEUROSCI, V53, P222, DOI 10.1007/s12031-014-0289-4; Zhao L, 2012, BIOMED ENVIRON SCI, V25, P182, DOI 10.3967/0895-3988.2012.02.009	31	5	5	1	5	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	2049-9434	2049-9442		BIOMED REP	Biomed. Rep.	JUL	2015	3	4					468	472		10.3892/br.2015.454			5	Medicine, Research & Experimental	Emerging Sources Citation Index (ESCI)	Research & Experimental Medicine	CT5FX	WOS:000362835300007	26171150	Green Published, hybrid			2022-02-06	
J	Lepreux, S; Auriacombe, S; Vital, C; Dubois, B; Vital, A				Lepreux, Sebastien; Auriacombe, Sophie; Vital, Claude; Dubois, Bruno; Vital, Anne			Dementia pugilistica: a severe tribute to a career	CLINICAL NEUROPATHOLOGY			English	Article						chronic traumatic encephalopathy; dementia pugilistica; neuropathology; tauopathy	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEUROPATHOLOGIC ASSESSMENT; NEUROFIBRILLARY TANGLES; ENCEPHALOPATHY; AFTERMATH; PATHOLOGY; BOXERS; CORTEX; SPORT	A 59-year-old man, ex-professional boxer, met clinical criteria for probable Alzheimer's disease. The patient agreed to be included in a clinico-pathological study with donation to the brain bank, and he died at 71. The brain was grossly atrophic, with a prominent atrophy of the entorhinal cortex and hippocampus, and with pallor of the substantia nigra. Immunohistochemistry with anti-beta A4 revealed abundant and diffuse deposits in the neo-cortex, whereas amyloid angiopathy was absent. Coupled anti-AT8 immunohistochemistry and Congo red staining showed no neuritic plaques. tau-AT8-positive glial tangles and neurofibrillary tangles involved preferentially the superficial cortical layers, and were irregularly concentrated in the depth of cortical sulci and near vessels. Neurofibrillary degeneration was marked in amygdala, hippocampus, substantia nigra, and locus ceruleus. Enlarged and/or distorted axons were numerous in hippocampus and mid-brain. TDP 43-positive neuronal inclusions were numerous in amygdala and hippocampus. There was no synucleinopathy. These observations are in accordance with the previously reported data on chronic traumatic encephalopathy. The discussion is focused on professional boxing as it becomes evident that repetitive trauma on the brain provokes the deposition of abnormal proteins involved in neurodegeneration.	[Lepreux, Sebastien; Vital, Anne] Bordeaux Univ Hosp, Dept Pathol, Bordeaux, France; [Auriacombe, Sophie] Univ Bordeaux, Inst Malad Neurodegenerat, Ctr Memoire Ressource & Rech Aquitaine, Bordeaux, France; [Vital, Claude; Vital, Anne] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Dubois, Bruno] Univ Paris 06, Ctr Malad Cognit & Comportementales, IM2A, ICM,Hop Salpetriere Paris, F-75252 Paris 05, France		Vital, A (corresponding author), Univ Bordeaux Segalen, Neuropathol BP42,146 Rue Leo Saignat, F-33076 Bordeaux, France.	anne.vital@chu-bordeaux.fr	AURIACOMBE, Sophie/T-5596-2019				Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Blumbergs P.C., 2008, GREENFIELDS NEUROPAT, P733; Boche D, 2010, ACTA NEUROPATHOL, V120, P369, DOI 10.1007/s00401-010-0719-5; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Kokjohn TA, 2013, J NEUROTRAUM, V30, P981, DOI 10.1089/neu.2012.2699; Ling H, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-24; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Ohhashi G, 2002, BRIT J SPORT MED, V36, P346, DOI 10.1136/bjsm.36.5.346; Patton RL, 2006, AM J PATHOL, V169, P1048, DOI 10.2353/ajpath.2006.060269; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rosen C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-20; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	27	5	5	0	13	DUSTRI-VERLAG DR KARL FEISTLE	DEISENHOFEN-MUENCHEN	BAHNHOFSTRASSE 9 POSTFACH 49, D-82032 DEISENHOFEN-MUENCHEN, GERMANY	0722-5091			CLIN NEUROPATHOL	Clin. Neuropathol.	JUL-AUG	2015	34	4					193	198		10.5414/NP300838			6	Clinical Neurology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	CN0KG	WOS:000358101900004	25828776				2022-02-06	
J	McBride, T				McBride, Thomas			Neuropsychological scores and WeeFIM cognitive ratings of children with traumatic brain injury: A brief report	BRAIN INJURY			English	Article						Children; cognitive; neuropsychological; traumatic brain injury; WeeFIM	REHABILITATION; RECOVERY; VALIDITY; BATTERY; TBI	Primal objective and hypothesis: To test the hypothesis that there is a significant relationship between WeeFIM ratings of cognitive functioning and performance on neuropsychological tests of children with traumatic brain injury (TBI). Design: Retrospective analysis of archival data. Participants: Data from 52 children with severe TBI collected during inpatient rehabilitation. Main outcome measures: Multiple regression analysis with Neuropsychological test scores from Wechsler Abbreviated Scale of Intelligence (WASI) and Children's Memory Scale (CMS) entered as predictor variables and WeeFIM cognitive ratings as criteria variables. Results: Analyses revealed significant relationships between WeeFIM cognitive rating and neuropsychological test scores. Delayed verbal memory was most highly associated with WeeFIM cognitive ratings. Conclusions: Results support the hypothesis of significant relationships between neuropsychological performance and WeeFIM ratings of children with TBI and support generalizability of neuropsychological performance to daily cognitive functioning.	Childrens Specialized Hosp, New Brunswick, NJ 08901 USA		McBride, T (corresponding author), Childrens Specialized Hosp, 200 Somerset St, New Brunswick, NJ 08901 USA.	tmcbride@childrens-specialized.org					[Anonymous], 2006, UN DAT SYST MED REH; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; CAPRUSO DX, 1992, NEUROL CLIN, V10, P879, DOI 10.1016/S0733-8619(18)30185-3; Catroppa C, 2002, BRAIN INJURY, V16, P369, DOI 10.1080/02699050110104444; Cohen M.J., 1997, CHILDRENS MEMORY SCA; Faul M, 2010, TRAUMATIC BRAIN INJU; Groth-Marnat G., 2003, HDB PSYCHOL ASSESSME; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Rice SA, 2005, ARCH PHYS MED REHAB, V86, P834, DOI 10.1016/j.apmr.2004.11.006; SmithKnapp K, 1996, BRAIN INJURY, V10, P651, DOI 10.1080/026990596124070; Suskauer SJ, 2009, J PEDIATR REHAB MED, V2, P297, DOI 10.3233/PRM-2009-0092; Temple RO, 2009, BRAIN INJURY, V23, P45, DOI 10.1080/02699050802590361; Wechsler D., 2011, WECHSLER ABBREVIATED	15	5	5	1	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					951	954		10.3109/02699052.2015.1022881			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800022	25962923				2022-02-06	
J	Pinkas, A; Turgeman, G; Tayeb, S; Yanai, J				Pinkas, Adi; Turgeman, Gadi; Tayeb, Shay; Yanai, Joseph			An avian model for ascertaining the mechanisms of organophosphate neuroteratogenicity and its therapy with mesenchymal stem cell transplantation	NEUROTOXICOLOGY AND TERATOLOGY			English	Article						Chick model; Chlorpyrifos; Mesenchymal stem cell therapy; Gene expression; Adult neurogenesis; Neurotransmitter systems; Pre-hatch exposure	MARROW STROMAL CELLS; TRAUMATIC BRAIN-INJURY; CHLORPYRIFOS EXPOSURE; NEUROBEHAVIORAL TERATOGENICITY; HUNTINGTONS-DISEASE; TOBACCO-SMOKE; STROKE MODEL; IN-VIVO; RAT; BEHAVIOR	Introduction: A fast and simple model which uses animals lower on the evolutionary scale is beneficial for progress in neuroteratological research. Here, we established this novel model and applied it in the study of the detrimental effects of pre-hatch exposure to chlorpyrifos on neurogenesis and several neurotransmitter systems in the chick and their reversal, using mesenchymal stem cell (MSC) transplantation. Methods: Chicken eggs were injected with the organophosphate chlorpyrifos, 10 mg/kg eggs - a dose below the threshold for dysmorphology - on incubation days (ID) 0 and Sand subsequently the embryos were subjected to intravenous transplantation of MSC on ID 13. Results: After hatching (day 1) the expression of the neurogenesis-related genes DCX (also confirmed by immunohistochemistry), BDNF, MAP 2, FGF 2, SOX 2 and VEGF in the lateral striatum area was decreased in the exposed group (p < 0.005). Among the studied neurotransmitter systems (serotonergic, dopaminergic and cholinergic), increased gene expression was demonstrated for tyrosine hydroxylase (TH) and tryptophan hydroxylase (TPH) with a corresponding decrease in serotonin receptor 1A (5HTR1A) (p < 0.05); no changes in gene expression of choline transporter, PKC beta and D2 were found following chlorpyrifos exposure. Conclusion: Transplantation of MSC reversed all the neurogenic and serotonergic alterations (p < 0.01). The study of chick embryo exposure to insults with subsequent MSC therapy provides a fast and simple model for elucidating the mechanisms of both the neuroteratogenicity and the therapy, steps that are critical for progress toward therapeutic applications. (C) 2015 Elsevier Inc. All rights reserved.	[Pinkas, Adi] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91120 Jerusalem, Israel; [Turgeman, Gadi] Ariel Univ, Dept Mol Biol, Ariel, Israel; [Tayeb, Shay] Hadassah Acad Coll, Dept Biotechnol, IL-9101001 Jerusalem, Israel; [Yanai, Joseph] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA			adi.pinkas@gmail.com	Pinkas, Adi/K-9815-2017	Pinkas, Adi/0000-0001-7899-3661; Yanai, Joseph/0000-0003-1685-0176; Turgeman, Gadi/0000-0002-6505-8612			Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Bakar B, 2012, INJURY, V43, P315, DOI 10.1016/j.injury.2011.08.021; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Barker RA, 2013, LANCET NEUROL, V12, P84, DOI 10.1016/S1474-4422(12)70295-8; BARRON S, 1991, PHARMACOL BIOCHEM BE, V39, P423, DOI 10.1016/0091-3057(91)90202-D; Bhalla D, 2011, EXPERT REV NEUROTHER, V11, P861, DOI [10.1586/ern.11.51, 10.1586/ERN.11.51]; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Brown AB, 2003, HUM GENE THER, V14, P1777, DOI 10.1089/104303403322611782; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen XP, 2011, J APPL TOXICOL, V31, P355, DOI 10.1002/jat.1598; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Dormady SP, 2001, J HEMATOTH STEM CELL, V10, P125, DOI 10.1089/152581601750098372; Dotan S, 2010, NEUROTOXICOL TERATOL, V32, P481, DOI 10.1016/j.ntt.2010.02.003; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Feng ZQ, 2009, NEUROSCI LETT, V462, P213, DOI 10.1016/j.neulet.2009.07.008; FERNANDEZ K, 1983, NEUROBEH TOXICOL TER, V5, P351; Ferrari G, 1998, SCIENCE, V279, P1528, DOI 10.1126/science.279.5356.1528; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamilton KL, 2005, NEUROTOXICOL TERATOL, V27, P95, DOI 10.1016/j.ntt.2004.09.004; Hardy SA, 2008, CURR STEM CELL RES T, V3, P43; Izrael M, 2004, J NEUROSCI RES, V78, P499, DOI 10.1002/jnr.20287; Kan I, 2011, STEM CELL REV REP, V7, P404, DOI 10.1007/s12015-010-9190-x; Katz S, 2008, J NEUROCHEM, V104, P38, DOI 10.1111/j.1471-4159.2007.05004.x; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Khatri M, 2009, STEM CELLS DEV, V18, P1485, DOI 10.1089/scd.2008.0223; Lee ST, 2006, J NEUROSCI METH, V152, P250, DOI 10.1016/j.jneumeth.2005.09.013; Levin ED, 2003, NEUROTOXICOL TERATOL, V25, P51, DOI 10.1016/S0892-0362(02)00322-7; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mileson BE, 1998, TOXICOL SCI, V41, P8; Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nasrallah FA, 2008, J NEUROSCI RES, V86, P208, DOI 10.1002/jnr.21477; NAVARRO HA, 1988, PEDIATR RES, V24, P465, DOI 10.1203/00006450-198810000-00009; Oh SH, 2015, CELL TRANSPLANT, V24, P1097, DOI 10.3727/096368914X679237; Ojo JO, 2014, NEUROPATHOLOGY, V34, P109, DOI 10.1111/neup.12061; Pearson R.G., 1972, AVIAN BRAIN; Phinney DG, 2005, CURR PHARM DESIGN, V11, P1255, DOI 10.2174/1381612053507495; Pinkas A.T.G., 2013, INT SOC STEM CELL RE, V2013; Puelles L., 2007, CHICK BRAIN STEREOTA; Rai KS, 2007, EUR J NEUROSCI, V26, P1765, DOI 10.1111/j.1460-9568.2007.05820.x; RILEY EP, 1989, ANN NY ACAD SCI, V562, P173, DOI 10.1111/j.1749-6632.1989.tb21015.x; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Rossignol J, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt545; Sakamoto M, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00121; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; SASTRY BVR, 1991, REPROD FERT DEVELOP, V3, P355, DOI 10.1071/RD9910355; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Slotkin TA, 2005, DEV BRAIN RES, V158, P115, DOI 10.1016/j.devbrainres.2005.06.008; Slotkin TA, 2004, TOXICOL APPL PHARM, V198, P132, DOI 10.1016/j.taap.2003.06.001; Slotkin TA, 2008, NEUROTOXICOL TERATOL, V30, P433, DOI 10.1016/j.ntt.2008.02.005; Slotkin TA, 2008, BRAIN RES BULL, V76, P424, DOI 10.1016/j.brainresbull.2008.01.001; Slotkin TA, 2007, REPROD TOXICOL, V23, P421, DOI 10.1016/j.reprotox.2006.07.010; Slotkin TA, 2010, BRAIN RES, V1353, P36, DOI 10.1016/j.brainres.2010.07.073; Slotkin TA, 2008, TOXICOL APPL PHARM, V233, P211, DOI 10.1016/j.taap.2008.08.020; Sobrian S. K., 1999, Neurotoxicology and Teratology, V21, P327; Spear LP, 1996, PHARMACOL BIOCHEM BE, V55, P455, DOI 10.1016/S0091-3057(96)00272-9; Sun J, 2015, EXP NEUROL, DOI 10.1016/j.expneurol.2015.03.011; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Taizi M, 2006, EXP HEMATOL, V34, P1698, DOI 10.1016/j.exphem.2006.07.005; Tfilin M, 2010, MOL PSYCHIATR, V15, P1164, DOI 10.1038/mp.2009.110; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Yamaguchi S, 2011, NEUROSCI RES, V69, P32, DOI 10.1016/j.neures.2010.09.002; YANAI J, 1995, BRAIN RES BULL, V38, P93, DOI 10.1016/0361-9230(95)00077-R; Yanai J, 2009, NEUROTOXICOL TERATOL, V31, P406, DOI 10.1016/j.ntt.2009.07.007; Yoo SW, 2008, EXP MOL MED, V40, P387, DOI 10.3858/emm.2008.40.4.387	67	5	5	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0892-0362	1872-9738		NEUROTOXICOL TERATOL	Neurotoxicol. Teratol.	JUL-AUG	2015	50						73	81		10.1016/j.ntt.2015.06.004			9	Neurosciences; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Toxicology	CP5ZT	WOS:000359964800009	26111651				2022-02-06	
J	Roberts, CM; Spitz, G; Ponsford, JL				Roberts, Caroline M.; Spitz, Gershon; Ponsford, Jennie L.			Retrospective Analysis of the Recovery of Orientation and Memory During Posttraumatic Amnesia	NEUROPSYCHOLOGY			English	Article						traumatic brain injury; posttraumatic amnesia; Westmead PTA Scale; memory; orientation	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; RETROGRADE-AMNESIA; GALVESTON ORIENTATION; DISORIENTATION; CONSOLIDATION; DURATION; REHABILITATION; COGNITION; SCALE	Objective: Prospective monitoring of posttraumatic amnesia (PTA) is recommended following moderate to severe traumatic brain injury (TBI). However, few studies have examined the typical order in which items recover on PTA scales. Different methods have been used to define recovery, and the order reported is not consistent across the literature. The purpose of this study was to improve understanding of the progression of PTA by reporting the duration to recovery of items and categories on the Westmead Post-Traumatic Amnesia Scale (WPTAS) according to different criteria. Method: A retrospective analysis was conducted of 66 patients with TBI who were administered the WPTAS during hospital admission. The duration to recovery of items and categories was determined according to 3 criteria: first correct, correct 3 times in a row, and consistently correct. Results: On the basis of the sample mean, date of birth (DOB), year, age, place, month, day, name, and memory for the 3 pictures recovered in this order according to all 3 criteria. However, the significance of differences between items and the order of recovery of categories depended on the criterion adopted. Although DOB recovered first in 74% of cases and the 3 pictures last in 63% of cases, there was a high degree of individual variability in the precise sequence of recovery. Conclusions: The traditional view of PTA recovering in the order of person, place, time, and memory does not adequately describe the profile of recovery on the WPTAS. Considering the recovery of individual items is necessary to understand and account for individuals differences in the order of recovery.	Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Ponsford, JL (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	jennie.ponsford@monash.edu	; Spitz, Gershon/H-7755-2014	Roberts, Caroline/0000-0003-1200-4415; Spitz, Gershon/0000-0002-7810-1480			Ahmed S, 2000, BRAIN INJURY, V14, P765; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BENSON DF, 1967, J NEUROL NEUROSUR PS, V30, P539, DOI 10.1136/jnnp.30.6.539; BERRIOS GE, 1982, COMPR PSYCHIAT, V23, P479, DOI 10.1016/0010-440X(82)90161-4; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Brown AS, 2002, PSYCHON B REV, V9, P403, DOI 10.3758/BF03196300; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; Cohen J., 2013, STAT POWER ANAL BEHA; DANIEL WF, 1987, CORTEX, V23, P169, DOI 10.1016/S0010-9452(87)80030-8; FORRESTER G, 1994, BRAIN INJURY, V8, P175, DOI 10.3109/02699059409150969; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; GEFFEN G, 1994, AUST OCCUP THER J, V41, P31, DOI DOI 10.1111/J.1440-1630.1994.TB01809.X; GEFFEN GM, 1991, NEUROREPORT, V2, P105, DOI 10.1097/00001756-199102000-00010; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Kean J, 2011, J HEAD TRAUMA REHAB, V26, P364, DOI 10.1097/HTR.0b013e3181ea4e2c; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Leach K, 2006, BRAIN INJURY, V20, P1241, DOI 10.1080/02699050601049874; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McFarland K, 2001, CLIN NEUROPSYCHOL, V15, P59, DOI 10.1076/clin.15.1.59.1916; Mysiw WJ, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199612000-00003; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Ponsford J, 2014, J HEAD TRAUMA REHAB, V29, P307, DOI 10.1097/HTR.0000000000000074; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ribot T., 1882, DIS MEMORY ESSAYS PO; Russell WR, 1935, LANCET, V2, P762; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Schnider A, 2000, NEUROPSYCHOLOGIA, V38, P175, DOI 10.1016/S0028-3932(99)00064-0; Shores E A, 1995, Appl Neuropsychol, V2, P167; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Tate R.L., 2000, BRAIN IMPAIR, V1, P116, DOI [10.1375/brim.1.2.116, DOI 10.1375/BRIM.1.2.116]; Tate RL, 2000, J NEUROL NEUROSUR PS, V68, P178, DOI 10.1136/jnnp.68.2.178; Tittle A, 2011, BRAIN INJURY, V25, P933, DOI 10.3109/02699052.2011.597042; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Weir N, 2006, BRAIN INJURY, V20, P927, DOI 10.1080/02699050600832684; WICKELGREN WA, 1974, MEM COGNITION, V2, P775, DOI 10.3758/BF03198154	42	5	5	1	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	JUL	2015	29	4					522	529		10.1037/neu0000178			8	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CL5CA	WOS:000356976200003	25621536				2022-02-06	
J	Vasa, RA; Suskauer, SJ; Thorn, JM; Kalb, L; Grados, MA; Slomine, BS; Salorio, CF; Gerring, JP				Vasa, Roma A.; Suskauer, Stacy J.; Thorn, Julia M.; Kalb, Luther; Grados, Marco A.; Slomine, Beth S.; Salorio, Cynthia F.; Gerring, Joan P.			Prevalence and predictors of affective lability after paediatric traumatic brain injury	BRAIN INJURY			English	Article						Affective lability; children; irritability; outbursts; traumatic brain injury	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILD-BEHAVIOR CHECKLIST; CLOSED-HEAD INJURY; PERSONALITY-CHANGE; ORBITOFRONTAL CORTEX; ADOLESCENTS; EMOTION; AMYGDALA; ANXIETY; YOUTH	Objective: Paediatric severe traumatic brain injury (TBI) is associated with significant post-injury affective and behavioural problems. Few studies have examined the prevalence and characteristics of affective lability after paediatric TBI. Methods: Ninety-seven children with severe TBI were evaluated 1 year post-injury for the presence of affective lability using the Children's Affective Lability Scale (CALS). Demographic, clinical and brain lesion characteristics were also assessed. Results: Affective lability significantly increased after injury. Eighty-six children had a pre-injury CALS score of 1 SD or less from the group pre-injury mean (M = 8.11, SD = 9.31), of which 35 and 15 children had a 1 SD and 2 SD increase in their CALS score from pre- to post-injury, respectively. A variety of affective shifts manifested post-injury including anxiety, silliness, dysphoria and irritability. The most severe symptoms were irritability and unpredictable temper outbursts. Risk factors for affective lability included elevated pre-injury affective lability and psychosocial adversity as well as greater damage to the orbitofrontal cortex. Post-injury affective lability was most frequently associated with a post-injury diagnosis of attention-deficit hyperactivity disorder. Conclusions: Affective lability is common after paediatric TBI and frequently manifests as irritability and unpredictable outbursts. Early intervention is needed to improve psychiatric outcomes.	[Vasa, Roma A.; Suskauer, Stacy J.; Grados, Marco A.; Slomine, Beth S.; Salorio, Cynthia F.; Gerring, Joan P.] Kennedy Krieger Inst, Baltimore, MD USA; [Vasa, Roma A.; Grados, Marco A.; Slomine, Beth S.; Salorio, Cynthia F.; Gerring, Joan P.] Johns Hopkins Sch Publ Hlth, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Suskauer, Stacy J.; Slomine, Beth S.; Salorio, Cynthia F.] Johns Hopkins Sch Publ Hlth, Dept Phys Med & Rehabil, Baltimore, MD USA; [Suskauer, Stacy J.; Thorn, Julia M.] Johns Hopkins Sch Publ Hlth, Dept Paediat, Baltimore, MD USA; [Kalb, Luther] Johns Hopkins Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Gerring, Joan P.] SUNY Syracuse, Sch Med Syracuse, Syracuse, NY USA; [Gerring, Joan P.] New York State Off Children & Family Serv, New York, NY USA		Vasa, RA (corresponding author), 3901 Greenspring Ave, Baltimore, MD 21211 USA.	vasa@kennedykrieger.org		Grados, Marco/0000-0002-6189-6264	NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K20 MH-00997]; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, K23HD061611]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, K23HD061611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K20MH000997] Funding Source: NIH RePORTER	The authors report no conflicts of interest. This work was supported by NIMH grant K20 MH-00997, and NICHD grants K12HD001097 and K23HD061611.	Achenbach T.M., 2001, MANUAL CHILD BEHAV C; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Blake P., 2006, ORBITOFRONTAL CORTEX, P579; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Ebesutani C, 2010, J PSYCHOPATHOL BEHAV, V32, P373, DOI 10.1007/s10862-009-9174-9; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; Gerson AC, 1996, PSYCHIAT RES, V65, P189, DOI 10.1016/S0165-1781(96)02851-X; Goldstein TR, 2007, J AM ACAD CHILD PSY, V46, P820, DOI 10.1097/chi.0b013e31805c1613; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Guidotti TL, 2012, ARCH ENVIRON OCCUP H, V67, P249, DOI 10.1080/19338244.2012.722469; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Hayes AF, 2007, BEHAV RES METHODS, V39, P709, DOI 10.3758/BF03192961; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405, DOI 10.1080/15374410701444363; Kendall PC, 2007, J ANXIETY DISORD, V21, P1004, DOI 10.1016/j.janxdis.2006.10.012; King CA, 2006, J AFFECT DISORDERS, V90, P111, DOI 10.1016/j.jad.2005.09.011; Leibenluft E, 2003, AM J PSYCHIAT, V160, P430, DOI 10.1176/appi.ajp.160.3.430; Leibenluft E, 2006, J CHILD ADOL PSYCHOP, V16, P456, DOI 10.1089/cap.2006.16.456; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Max JE, 2006, J NEUROPSYCH CLIN N, V18, P21, DOI 10.1176/appi.neuropsych.18.1.21; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; Mcrae K, 2012, SOC COGN AFFECT NEUR, V7, P11, DOI 10.1093/scan/nsr093; Mellers J.D.C., 2009, LISHMANS ORGANIC PSY, P3; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Norup A, 2015, ARCH PHYS MED REHAB, V96, P56, DOI 10.1016/j.apmr.2014.08.009; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; Renaud SM, 2012, HARVARD REV PSYCHIAT, V20, P298, DOI 10.3109/10673229.2012.747798; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Shaw P, 2014, AM J PSYCHIAT, V171, P276, DOI 10.1176/appi.ajp.2013.13070966; Simonoff E, 2012, J CHILD PSYCHOL PSYC, V53, P1157, DOI 10.1111/j.1469-7610.2012.02600.x; Sinopoli KJ, 2011, J CLIN EXP NEUROPSYC, V33, P805, DOI 10.1080/13803395.2011.562864; Sobanski E, 2010, J CHILD PSYCHOL PSYC, V51, P915, DOI 10.1111/j.1469-7610.2010.02217.x; Stoddard J, 2014, DEPRESS ANXIETY, V31, P566, DOI 10.1002/da.22151; Stringaris A, 2009, J AM ACAD CHILD PSY, V48, P404, DOI 10.1097/CHI.0b013e3181984f30; Swartz JR, 2014, NEUROIMAGE, V86, P212, DOI 10.1016/j.neuroimage.2013.08.018; TEASDALE G, 1974, LANCET, V2, P81; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Vasa RA, 2004, BIOL PSYCHIAT, V55, P208, DOI 10.1016/S0006-3223(03)00708-X; Vasa RA, 2002, J AM ACAD CHILD PSY, V41, P148, DOI 10.1097/00004583-200202000-00008; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; WILSON J T L, 1990, Brain Injury, V4, P349; Wright P, 2008, NEUROIMAGE, V39, P894, DOI 10.1016/j.neuroimage.2007.09.014; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64	54	5	5	0	24	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2015	29	7-8					921	928		10.3109/02699052.2015.1005670			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CO0BJ	WOS:000358814800018	25950263	Green Accepted			2022-02-06	
J	Martinez-Ramos, C; Gomez-Pinedo, U; Esparza, MAG; Soria, JM; Barcia, JA; Pradas, MM				Martinez-Ramos, Cristina; Gomez-Pinedo, Ulises; Garcia Esparza, Ma Angeles; Miguel Soria, Jose; Barcia, Juan A.; Monleon Pradas, Manuel			Neural tissue regeneration in experimental brain injury model with channeled scaffolds of acrylate copolymers	NEUROSCIENCE LETTERS			English	Article						Scaffold; Brain; Angiogenesis; Cryolesion; Tissue engineering	CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; SUBVENTRICULAR ZONE; ISCHEMIC-STROKE; IN-VITRO; ADULT; BIOCOMPATIBILITY; NEUROGENESIS; NEURONS; RATS	The objective of the present study was to evaluate the biocompatibility and cell hosting ability of a copolymer scaffold based on ethyl acrylate (EA) and hydroxyl ethyl acrylate (HEA) in vivo after an experimental brain injury. Wistar rats were subjected to cryogenic traumatic brain injury. We evaluated the tissue response to the implanted materials after 8 weeks. The materials were implanted devoid of cells; they provoked a minimal scar response by the host tissue and permitted the invasion of neurons and glia inside them. We also found new blood vessels surrounding and inside the implant. Thus, the copolymer scaffold proves to offer a suitable environment producing a cellular network potentially useful in brain repair after brain injury. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Martinez-Ramos, Cristina; Monleon Pradas, Manuel] Univ Politecn Valencia, Ctr Biomat, E-46071 Valencia, Spain; [Gomez-Pinedo, Ulises; Barcia, Juan A.] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Serv Neurocirugia, Madrid 28040, Spain; [Garcia Esparza, Ma Angeles; Miguel Soria, Jose] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Moncada 46113, Spain; [Barcia, Juan A.; Monleon Pradas, Manuel] Inst Nacl Salud Carlos III, CIBER Bioingn Biomat & Nanomed, Madrid, Spain; [Gomez-Pinedo, Ulises; Miguel Soria, Jose; Barcia, Juan A.; Monleon Pradas, Manuel] Inst Nacl Salud Carlos III, Red Terapia Celular TerCel, Madrid, Spain; [Barcia, Juan A.] Univ Complutense Madrid, Dept Cirugia, E-28040 Madrid, Spain		Pradas, MM (corresponding author), Univ Politecn Valencia, Ctr Biomat, POB 22012, E-46071 Valencia, Spain.	jabarcia@ucm.es; mmonleon@upvnet.upv.es	Esparza, M. Angeles Garcia/AAH-2495-2019; soria, jose/K-6722-2014; Garcia Esparza, M.Angeles/L-1121-2014; Lopez, Jose Miguel Soria/M-5266-2017; , ulises.gomez-pinedo/C-3414-2016; MartiAnez-Ramos, Cristina/G-1591-2015	Esparza, M. Angeles Garcia/0000-0001-6510-0879; soria, jose/0000-0001-9144-5096; Garcia Esparza, M.Angeles/0000-0001-6510-0879; Lopez, Jose Miguel Soria/0000-0001-9144-5096; , ulises.gomez-pinedo/0000-0003-3097-5557; MartiAnez-Ramos, Cristina/0000-0002-6540-4714; MONLEON PRADAS, MANUEL/0000-0001-6457-0414; Barcia Albacar, Juan Antonio/0000-0001-6562-4568	ERA-NET NEURON project [PRI-PIMNEU-2011-1372]; Programa de Ayudas a la Investigacion Cientifica Universidad CEU-Cardenal Herrera [PRCEU-UCH 34/12, PRCEU-UCH 38/10]; Programa CEU-Santader ayudas a grupos consolidados;  [MAT2011-28791-C03-01];  [MAT2011-28791-C03-02]	CMR, JAB, UGP, and MMP acknowledge financing through projects MAT2011-28791-C03-01 and MAT2011-28791-C03-02 and ERA-NET NEURON project PRI-PIMNEU-2011-1372. JMSL acknowledges funding through Programa de Ayudas a la Investigacion Cientifica Universidad CEU-Cardenal Herrera (PRCEU-UCH 34/12, PRCEU-UCH 38/10) and Programa CEU-Santader ayudas a grupos consolidados 2014-2015.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Arvidsson A, 2003, NEUROBIOL DIS, V14, P542, DOI 10.1016/j.nbd.2003.08.002; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6; Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Estelles JM, 2007, J MATER SCI, V42, P8629, DOI 10.1007/s10853-007-1727-2; Fan WM, 2008, MICROSURG, V28, P238, DOI 10.1002/micr.20488; Hashimoto T, 2005, J MATER SCI-MATER M, V16, P503, DOI 10.1007/s10856-005-0524-1; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0; Ito T, 2003, ASAIO J, V49, P417, DOI 10.1097/01.MAT.0000073971.34538.84; KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794; Marti-Fabregas J, 2010, NEUROLOGY, V74, P357, DOI 10.1212/WNL.0b013e3181cbccec; Martinez-Ramos C, 2008, TISSUE ENG PT A, V14, P1365, DOI 10.1089/ten.tea.2007.0295; MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; PAXINOS G, 1985, J NEUROSCI METH, V13, P139, DOI 10.1016/0165-0270(85)90026-3; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Hernandez JCR, 2008, J BIOMED MATER RES B, V84B, P541, DOI 10.1002/jbm.b.30902; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Soria JM, 2007, J BIOMED MATER RES A, V83A, P463, DOI 10.1002/jbm.a.31297; Soria JM, 2006, J BIOMED MATER RES A, V79A, P495, DOI 10.1002/jbm.a.30803; Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004; Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Taupin P, 2006, CR BIOL, V329, P465, DOI 10.1016/j.crvi.2006.04.001; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Vaisman B, 2010, J BIOMED MATER RES A, V92A, P419, DOI 10.1002/jbm.a.32342; Velayudhan S, 2005, ACTA BIOMATER, V1, P201, DOI 10.1016/j.actbio.2004.11.005; Wang B, 2006, NEUROSCI LETT, V401, P65, DOI 10.1016/j.neulet.2006.02.085; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]; Yeo A, 2008, J BIOMED MATER RES A, V84A, P208, DOI 10.1002/jbm.a.31454; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	36	5	5	1	27	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JUN 26	2015	598						96	101		10.1016/j.neulet.2015.05.021			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK9GY	WOS:000356549800017	25980992				2022-02-06	
J	Ramsay, H; Barnett, JH; Miettunen, J; Mukkala, S; Maki, P; Liuhanen, J; Murray, GK; Jarvelin, MR; Ollila, H; Paunio, T; Veijola, J				Ramsay, Hugh; Barnett, Jennifer H.; Miettunen, Jouko; Mukkala, Sari; Maeki, Pirjo; Liuhanen, Johanna; Murray, Graham K.; Jarvelin, Marjo-Riitta; Ollila, Hanna; Paunio, Tiina; Veijola, Juha			Association between Dopamine Receptor D2 (DRD2) Variations rs6277 and rs1800497 and Cognitive Performance According to Risk Type for Psychosis: A Nested Case Control Study in a Finnish Population Sample	PLOS ONE			English	Article							WORKING-MEMORY ABILITY; TRAUMATIC BRAIN-INJURY; NEUROCOGNITIVE DEFICITS; C957T POLYMORPHISM; PREFRONTAL CORTEX; ALZHEIMER-TYPE; YOUNG-PEOPLE; OULU BRAIN; SCHIZOPHRENIA; ATTENTION	Background There is limited research regarding the association between genes and cognitive intermediate phenotypes in those at risk for psychotic disorders. Methods We measured the association between established psychosis risk variants in dopamine D2 receptor (DRD2) and cognitive performance in individuals at age 23 years and explored if associations between cognition and these variants differed according to the presence of familial or clinical risk for psychosis. The subjects of the Oulu Brain and Mind Study were drawn from the general population-based Northern Finland 1986 Birth Cohort (NFBC 1986). Using linear regression, we compared the associations between cognitive performance and two candidate DRD2 polymorphisms (rs6277 and rs1800497) between subjects having familial (n=61) and clinical (n=45) risk for psychosis and a random sample of participating NFBC 1986 controls (n=74). Cognitive performance was evaluated using a comprehensive battery of tests at follow-up. Results Principal components factor analysis supported a three-factor model for cognitive measures. The minor allele of rs6277 was associated with poorer performance on a verbal factor (p=0.003) but this did not significantly interact with familial or clinical risk for psychosis. The minor allele of rs1800497 was associated with poorer performance on a psychomotor factor (p=0.038), though only in those at familial risk for psychotic disorders (interaction p=0.049). Conclusion The effect of two DRD2 SNPs on cognitive performance may differ according to risk type for psychosis, suggesting that cognitive intermediate phenotypes differ according to the type (familial or clinical) risk for psychosis.	[Ramsay, Hugh; Miettunen, Jouko; Veijola, Juha] Univ Oulu, Dept Psychiat, Ctr Clin Neurosci, Oulu, Finland; [Ramsay, Hugh] Hlth Serv Execut, Dublin, Ireland; [Barnett, Jennifer H.; Murray, Graham K.] Univ Cambridge, Dept Psychiat, Cambridge, England; [Barnett, Jennifer H.] Cambridge Cognit Ltd, Cambridge, England; [Miettunen, Jouko] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Miettunen, Jouko] Univ Oulu, Med Res Ctr Oulu, Oulu, Finland; [Miettunen, Jouko] Oulu Univ Hosp, Oulu, Finland; [Mukkala, Sari; Maeki, Pirjo; Veijola, Juha] Oulu Univ Hosp, Dept Psychiat, Oulu, Finland; [Maeki, Pirjo] Middle Ostrobothnia Cent Hosp, Dept Psychiat, Kiuru, Finland; [Maeki, Pirjo] Joint Municipal Author Wellbeing Raahe Dist, Mental Hlth Serv, Raahe Dist, Finland; [Maeki, Pirjo] Basic Hlth Care Dist Kallio, Mental Hlth Serv, Kallio, Finland; [Maeki, Pirjo] Northern Ostrobothnia Hosp Dist, Visala Hosp, Oulu, Finland; [Liuhanen, Johanna; Ollila, Hanna; Paunio, Tiina] Natl Inst Hlth & Welf, Publ Hlth Genom Unit, Helsinki, Finland; [Liuhanen, Johanna; Ollila, Hanna; Paunio, Tiina] Inst Mol Med, Helsinki, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Fac Med, London, England; [Paunio, Tiina] Univ Helsinki, Inst Clin Med, Dept Psychiat, Helsinki, Finland; [Paunio, Tiina] Helsinki Univ Cent Hosp, Helsinki, Finland		Ramsay, H (corresponding author), Univ Oulu, Dept Psychiat, Ctr Clin Neurosci, Oulu, Finland.	drhughramsay@gmail.com	Ollila, Hanna M/I-8552-2017; Miettunen, Jouko/AAC-4334-2019	Ollila, Hanna M/0000-0002-5302-6429; Miettunen, Jouko/0000-0003-0575-2669; Liuhanen, Johanna/0000-0002-1153-1013; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Murray, Graham/0000-0001-8296-1742	Cambridge Cognition Ltd.; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0701911] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0701911] Funding Source: researchfish	Cambridge Cognition Ltd. provided support in the form of salaries for author Jennifer H. Barnett but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aalto S, 2005, J NEUROSCI, V25, P2471, DOI 10.1523/JNEUROSCI.2097-04.2005; Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Benton A., 1976, MULTILINGUAL APHASIA; Berryhill ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055862; Betcheva ET, 2009, J HUM GENET, V54, P98, DOI 10.1038/jhg.2008.14; Bolton JL, 2010, BEHAV GENET, V40, P630, DOI 10.1007/s10519-010-9372-y; Bora E, 2014, ACTA PSYCHIAT SCAND; Cannon TD, 2008, ARCH GEN PSYCHIAT, V65, P28, DOI 10.1001/archgenpsychiatry.2007.3; Carrion RE, 2011, AM J PSYCHIAT, V168, P806, DOI 10.1176/appi.ajp.2011.10081209; Chien YL, 2013, J HUM GENET, V58, P229, DOI 10.1038/jhg.2012.157; Cohen J., 2013, STAT POWER ANAL BEHA; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; First M., 1997, STRUCTURED CLIN INTE; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; Fusar-Poli P, 2010, ARCH GEN PSYCHIAT, V67, P683, DOI 10.1001/archgenpsychiatry.2010.77; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 1996, AM J PSYCHIAT, V153, P321; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hawkins KA, 2004, SCHIZOPHR RES, V67, P115, DOI 10.1016/j.schres.2003.08.007; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hirvonen MM, 2009, SYNAPSE, V63, P907, DOI 10.1002/syn.20672; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Jukuri T, 2013, SCHIZOPHR RES, V143, P239, DOI 10.1016/j.schres.2012.11.020; Kapur S, 1999, AM J PSYCHIAT, V156, P286; Kelleher I, 2012, SCHIZOPHR BULL EPUB; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Lencz T, 2006, BIOL PSYCHIAT, V59, P863, DOI 10.1016/j.biopsych.2005.09.005; Mattay VS, 2000, NEUROIMAGE, V12, P268, DOI 10.1006/nimg.2000.0610; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McGlashan T.H., 2001, STRUCTURED INTERVIEW; Mukkala S, 2011, J CLIN EXP NEUROPSYC, V33, P385, DOI 10.1080/13803395.2010.524148; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Niendam TA, 2007, SCHIZOPHRENIA BULL, V33, P772, DOI 10.1093/schbul/sbm020; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rodriguez-Jimenez R, 2006, NEUROPSYCHOBIOLOGY, V54, P166, DOI 10.1159/000098652; SAHAKIAN B, 1989, BRIT J PSYCHIAT, V154, P797, DOI 10.1192/bjp.154.6.797; SAHAKIAN BJ, 1988, BRAIN, V111, P695, DOI 10.1093/brain/111.3.695; Sakurai H, 2012, SCHIZOPHR B, V1-11, DOI 10.1093/schbul/sbr131; Savitz J, 2006, GENES BRAIN BEHAV, V5, P311, DOI 10.1111/j.1601-183X.2005.00163.x; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Soderqvist S, 2013, J COGN NEUROSCI; Torres-Reyna O., GETTING STARTED FACT; TRITES R, 1989, GROOVED PEGBOARD, P51802; Trites R., 1989, GROOVED PEGBOARD INS; Veijola J, 2013, EARLY INTERV PSYCHIA, V7, P146, DOI 10.1111/j.1751-7893.2012.00360.x; Wechsler D, 1987, MEMORY SCALE REVISED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; White MJ, 2009, BEHAV GENET, V39, P285, DOI 10.1007/s10519-008-9255-7; Wood SJ, 2003, PSYCHOL MED, V33, P1239, DOI 10.1017/S0033291703008067; Xu HY, 2007, SCHIZOPHR RES, V90, P104, DOI 10.1016/j.schres.2006.10.001	60	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2015	10	6							e0127602	10.1371/journal.pone.0127602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1AM	WOS:000358147500009	26114663	Green Published, gold			2022-02-06	
J	Chen, LG; Sun, XC; Jiang, Y; Kuai, L				Chen, Ligang; Sun, Xiaochuan; Jiang, Yong; Kuai, Li			APOE epsilon 4 increases trauma induced early apoptosis via reducing delayed rectifier K+ currents in neuronal/glial co-cultures model	EXPERIMENTAL CELL RESEARCH			English	Article						Apolipoprotein E; Traumatic brain injury; Genetics; Early apoptosis; Delayed rectifier K+ current	APOLIPOPROTEIN-E; BRAIN-INJURY; IN-VITRO; HIPPOCAMPAL; RESPONSES; CHANNELS; SERUM	Traumatic brain injury (TB!) is a commonly encountered emergency and severe neurosurgical injury. Previous studies have shown that the presence of the apolipoprotein E (APOE) epsilon 4 allele has adverse outcomes across the spectrum of TBI severity. Our objective was to evaluate the effects of APOE alleles on trauma induced early apoptosis via modification of delayed rectifier K+ current (I-k(DR)) in neuronallglial co-cultures model. An ex vivo neuronallglial co-cultures model carrying individual APOE alleles (epsilon 2, epsilon 3, epsilon 4) of mechanical injury was developed. Flow cytometry and patch clamp recording were performed to analyze the correlations among APOE genotypes, early apoptosis and I-k(DR). We found that APOE epsilon 4 increased early apoptosis at 24 h (p < 0.05) compared to the ones transfected with APOE epsilon 3 and APOE epsilon 2. Noticeably, APOE epsilon 4 significantly reduced the amplitude of the I-k(DR) at 24 h compared to the APOE epsilon 3 and APOE epsilon 2 (p < 0.05) which exacerbate Ca2+ influx. This indicates a possible effect of APOE epsilon 4 on early apoptosis via inhibiting I-k(DR) following injury which may adversely affect the outcome of TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Chen, Ligang; Jiang, Yong; Kuai, Li] Luzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Luzhou 646000, Peoples R China; [Sun, Xiaochuan; Jiang, Yong] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing 400016, Peoples R China; [Jiang, Yong] Luzhou Med Coll, Luzhou 646000, Peoples R China		Sun, XC (corresponding author), Luzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Luzhou 646000, Peoples R China.	sunxch1445@gmail.com; jiangy0122@gmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371319, 81000528]; Program for New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-12-1057]; Foundation for outstanding youth academic technology leaders of Sichuan province [2014JQ0022]	This work was supported by the National Natural Science Foundation of China (81371319 and 81000528), the Program for New Century Excellent Talents in University (NCET-12-1057), and the Foundation for outstanding youth academic technology leaders of Sichuan province (2014JQ0022).	Ares MPS, 1997, J LIPID RES, V38, P2049; Ballesteros MA, 2007, INTENS CARE MED, V33, P58, DOI 10.1007/s00134-006-0361-9; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; DeKroon RM, 2003, J LIPID RES, V44, P1566, DOI 10.1194/jlr.M300097-JLR200; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; GIBBONS SJ, 1993, ANN NY ACAD SCI, V679, P22, DOI 10.1111/j.1749-6632.1993.tb18286.x; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hribar M, 2004, EUR J NEUROSCI, V20, P635, DOI 10.1111/j.1460-9568.2004.03520.x; Jiang Y, 2008, NEURAL REGEN RES, V3, P786; Jiang Y, 2006, NEUROSCI LETT, V408, P155, DOI 10.1016/j.neulet.2006.08.082; Lendon CL, 2000, EUR J NEUROSCI, V12, P2235, DOI 10.1046/j.1460-9568.2000.00113.x; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Minambres E, 2005, INTENS CARE MED, V31, P791, DOI 10.1007/s00134-005-2635-z; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Orrenius S, 1996, ADV NEUROL, V71, P137; Qin Y, 2006, SYNAPSE, V59, P82, DOI 10.1002/syn.20201; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; STORM JF, 1990, PROG BRAIN RES, V83, P161; Sun XC, 2008, CHIN J TRAUMATOL, V11, P247, DOI 10.1016/S1008-1275(08)60051-6; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; [吴海涛 Wu Haitao], 2010, [中华创伤杂志, Chinese Journal of Trauma], V26, P761; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 1999, J NEUROCHEM, V73, P933, DOI 10.1046/j.1471-4159.1999.0730933.x; Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	28	5	6	2	5	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	JUN 10	2015	334	2					294	300		10.1016/j.yexcr.2015.03.004			7	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	CJ6XH	WOS:000355638000011	25773779				2022-02-06	
J	Archer, KR; Coronado, RA; Haislip, LR; Abraham, CM; Vanston, SW; Lazaro, AE; Jackson, JC; Ely, EW; Guillamondegui, OD; Obremskey, WT				Archer, Kristin R.; Coronado, Rogelio A.; Haislip, Lori R.; Abraham, Christine M.; Vanston, Susan W.; Lazaro, Anthony E.; Jackson, James C.; Ely, E. Wesley; Guillamondegui, Oscar D.; Obremskey, William T.			Telephone-based goal management training for adults with mild traumatic brain injury: study protocol for a randomized controlled trial	TRIALS			English	Article						Randomized trial; Traumatic brain injury; Cognitive rehabilitation; Goal management training; Mindfulness	COGNITIVE REHABILITATION; SUSTAINED ATTENTION; EXECUTIVE FUNCTION; OLDER-ADULTS; POSTTRAUMATIC-STRESS; ECOLOGICAL VALIDITY; PRIMARY-CARE; QUESTIONNAIRE; DEPRESSION; FAILURES	Background: Approximately 1 million individuals experience a mild traumatic brain injury (TBI) and cost the United States nearly $17 billion each year. Many trauma survivors with mild TBI have debilitating and long-term physical, emotional, and cognitive impairments that are unrecognized at trauma centers. Early intervention studies are needed to address these impairments, especially cognitive deficits in executive functioning. Goal management training (GMT) is a structured cognitive rehabilitation program that has been found to improve executive functioning in patients with moderate to severe TBI. The current study adapted the GMT program for telephone delivery in order to improve the accessibility of rehabilitation services in a patient population with multiple barriers to care and significant yet unrecognized cognitive impairment. The primary objective of this study is to examine the efficacy of telephone-based GMT for improving executive functioning, functional status, and psychological health in trauma survivors with mild TBI. Methods/design: This study is a three-group randomized controlled trial being conducted at a Level I trauma center. Ninety trauma survivors with mild TBI and cognitive deficits in executive functioning will be randomized to receive telephone-based GMT, telephone-based education, or usual care. GMT and education programs will be delivered by a physical therapist. The first in-person session is 1 h and the remaining six telephone sessions are 30 min. A battery of well-established cognitive tests will be conducted and validated questionnaires will be collected that measure executive functioning, functional status, and depressive and posttraumatic stress disorder symptoms at 6 weeks, 4 months, and 7 months following hospital discharge. Discussion: This study supports a telephone-delivery approach to rehabilitation services in order to broaden the availability of evidence-based cognitive strategies.	[Archer, Kristin R.; Coronado, Rogelio A.; Haislip, Lori R.; Abraham, Christine M.; Vanston, Susan W.; Obremskey, William T.] Vanderbilt Univ, Sch Med, Dept Orthopaed Surg, Nashville, TN 37232 USA; [Archer, Kristin R.] Vanderbilt Univ, Sch Med, Dept Phys Med & Rehabil, Nashville, TN 37212 USA; [Lazaro, Anthony E.] Meharry Med Coll, Sch Med, Nashville, TN 37208 USA; [Jackson, James C.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Ctr Hlth Serv Res, Dept Med,Div Allergy Pulm & Crit Care, Nashville, TN 37232 USA; [Jackson, James C.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Jackson, James C.; Ely, E. Wesley] Tennessee Valley Healthcare Syst, Vet Affairs Tennessee Valley Geriatr Res Educ & C, Geriatr Res, Nashville, TN 37212 USA; [Guillamondegui, Oscar D.] Vanderbilt Univ, Sch Med, Dept Med, Div Trauma & Surg Crit Care, Nashville, TN 37232 USA		Archer, KR (corresponding author), Vanderbilt Univ, Sch Med, Dept Orthopaed Surg, 1215 21st Ave South,Med Ctr East,South Tower, Nashville, TN 37232 USA.	kristin.archer@vanderbilt.edu	Ely, E. Wesley/Z-2018-2019	Ely, E. Wesley/0000-0003-3957-2172; Coronado, Rogelio/0000-0002-7112-4903	National Institute on Disability and Rehabilitation Research (NIDDR) [H133G120052]	The authors would like to acknowledge Brian Levine, PhD and Charles Bombardier, PhD for their assistance with adapting GMT for telephone delivery and Rajesh Tummuru, MD, Christine Haug, Kenya Robinson, and Rosemary Sanders for procedural assistance and data management. This study has received funding from the National Institute on Disability and Rehabilitation Research (NIDDR) (H133G120052). The study sponsor is not involved in the concept, design, management, analysis, or dissemination procedures of this study.	Bodenburg S, 2008, J NERV MENT DIS, V196, P75, DOI 10.1097/NMD.0b013e31815faa2b; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Delis DC, 2001, D KEFS TECHNICAL MAN; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Duncan John, 1995, P721; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Galvin JE, 2007, ARCH NEUROL-CHICAGO, V64, P725, DOI 10.1001/archneur.64.5.725; Harrell FE Jr, 2017, REGRESSION MODELING; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Jackson JC, 2007, J TRAUMA, V62, P80, DOI 10.1097/TA.0b013e31802ce9bd; Jackson JC, 2011, J TRAUMA, V71, P860, DOI 10.1097/TA.0b013e3182151961; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Koehler R, 2011, COGNITIVE REHABILITATION THERAPY FOR TRAUMATIC BRAIN INJURY: EVALUATING THE EVIDENCE, P1; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Lannoo E, 1998, ACTA NEUROCHIR, V140, P245, DOI 10.1007/s007010050091; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Manly T, 2003, NEUROCASE, V9, P340, DOI 10.1076/neur.9.4.340.15553; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McHugh L, 2013, BRAIN INJURY, V27, P1595, DOI 10.3109/02699052.2013.834379; Mitchell M, 2008, J CLIN EXP NEUROPSYC, V30, P683, DOI 10.1080/13803390701679893; MONSCH AU, 1992, ARCH NEUROL-CHICAGO, V49, P1253, DOI 10.1001/archneur.1992.00530360051017; MOORE AD, 1995, BRAIN INJURY, V9, P109, DOI 10.3109/02699059509008185; Mozer E, 2008, CLIN INTERV AGING, V3, P391, DOI 10.2147/CIA.S950; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; PEREDNIA DA, 1995, JAMA-J AM MED ASSOC, V273, P483, DOI 10.1001/jama.273.6.483; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Qureshi SU, 2011, J NEUROPSYCH CLIN N, V23, P16, DOI 10.1176/appi.neuropsych.23.1.16; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Robertson LH, 1996, GOAL MANAGEMENT TRAI; Royall DR, 2002, J NEUROPSYCH CLIN N, V14, P377, DOI 10.1176/appi.neuropsych.14.4.377; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; TATE RL, 1991, J NERV MENT DIS, V179, P117, DOI 10.1097/00005053-199103000-00001; Theadom A, 2013, EUR J NEUROL, V20, P1135, DOI 10.1111/ene.12099; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; VANELDERENVANKEMENADE T, 1994, BRIT J CLIN PSYCHOL, V33, P367, DOI 10.1111/j.2044-8260.1994.tb01133.x; von Steinbuechel N, 2012, J NEUROL NEUROSUR PS, V83, P1041, DOI 10.1136/jnnp-2012-302361; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; WEINBERGER M, 1993, ARTHRITIS RHEUM, V36, P243, DOI 10.1002/art.1780360216; Weir S, 2010, EXPERT REV PHARM OUT, V10, P187, DOI [10.1586/erp.10.8, 10.1586/ERP.10.8]; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Zatzick DF, 2002, AM J PSYCHIAT, V159, P941, DOI 10.1176/appi.ajp.159.6.941; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	69	5	5	0	26	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1745-6215		TRIALS	Trials	JUN 2	2015	16								244	10.1186/s13063-015-0775-1			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	CJ5JX	WOS:000355524700001	26031289	gold, Green Published			2022-02-06	
J	Arslan, ED; Kaya, E; Sonmez, M; Kavalci, C; Solakoglu, A; Yilmaz, F; Durdu, T; Karakilic, E				Arslan, E. D.; Kaya, E.; Sonmez, M.; Kavalci, C.; Solakoglu, A.; Yilmaz, F.; Durdu, T.; Karakilic, E.			Assessment of traumatic deaths in a level one trauma center in Ankara, Turkey	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Trauma; Death; Trimodal distribution	753 CONSECUTIVE DEATHS; INJURY PREVENTION; EPIDEMIOLOGY; REASSESSMENT; MANAGEMENT; ARGUMENT	Trauma management shows significant progress in last decades. Determining the time and place of deaths indicate where to focus to improve our knowledge about trauma. We conducted this retrospective study from data of trauma victims who were brought to a major tertiary hospital which is a level one trauma center in Ankara, Turkey, and died even if during transport or in the hospital between 1 March 2010 and 1 March 2013. The patients' demographic characteristics, trauma mechanisms, time frames and causes of deaths determined by physicians were recorded. Traumas were grouped as "high energy trauma" (HET) and "low energy trauma" (LET). Falls from ground level were defined as LET. 209 traumatic deaths due to trauma or trauma-related conditions were found in the study period. 161 of 209 (78 %) patients suffered from HET. Motor vehicle collisions (MVC) (56 %) were the most common mechanism of trauma followed by burns (16 %), falls (11 %), gunshots (9 %) and stabs (6 %) in this group and traumatic brain injuries (TBI) (41 %) were the most common cause of death followed by circulatory collapse (22 %) and multi-organ failure (20 %). 36 % of deaths occurred before arrival at hospital, 25 % in the first 24 h of admission, 18 % between 2nd and 7th day and 21 % after first week. Trimodal distribution of traumatic deaths was not valid for all types of injuries and the most important factor to decrease traumatic deaths is still prevention. Also we have to keep on searching to improve our knowledge about trauma management.	[Arslan, E. D.] Diskapi Yildirim Beyazit Training & Res Hosp, Dept Emergency Med, Ankara, Turkey; [Kaya, E.; Sonmez, M.; Solakoglu, A.; Yilmaz, F.; Durdu, T.; Karakilic, E.] Ankara Numune Training & Res Hosp, Dept Emergency Med, Ankara, Turkey; [Kavalci, C.] Baskent Univ Hosp, Dept Emergency Med, Ankara, Turkey		Arslan, ED (corresponding author), Diskapi Yildirim Beyazit Training & Res Hosp, Dept Emergency Med, Ankara, Turkey.	engindeniz.arslan@gmail.com	yilmaz, Fevzi/ABD-1392-2021; yilmaz, fevzi/AAM-2132-2021; Yilmaz, Fevzi/ABD-2122-2021	yilmaz, fevzi/0000-0002-3675-7457; Solakoglu, Gorkem Alper/0000-0002-6936-4924			BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Bansal V, 2009, EUR J TRAUMA EMERG S, V35, P26, DOI 10.1007/s00068-008-8080-2; Brunett PH, 2011, TINTINALLIS EMERGENC, P1671; Brusselaers N, 2010, CRIT CARE, V14, DOI 10.1186/cc9300; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Durdu T, 2014, J CLIN ANAL MED, V5, P182, DOI 10.4328/JCAM.1279; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Flaherty S, 2003, J TRAUMA, V54, P70; Gunst Mark, 2010, Proc (Bayl Univ Med Cent), V23, P349; Kleber C, 2013, WORLD J SURG, V37, P1154, DOI 10.1007/s00268-013-1964-2; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009	18	5	5	0	5	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2015	41	3					319	323		10.1007/s00068-014-0439-y			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CJ7OY	WOS:000355687600015	26037980				2022-02-06	
J	Bates, K				Bates, Kimberly			Current Evidence-Based Paradigms for Diagnosis and Treatment	PRIMARY CARE			English	Article						Epilepsy; Elderly; Traumatic brain injury; Suicide; Antiepileptic drugs	QUALITY-OF-LIFE; ANTIEPILEPTIC DRUGS; RISK-FACTORS; EPILEPSY; ADOLESCENTS; DEPRESSION; CHILDREN; NONADHERENCE; ANXIETY; INJURY	Although epilepsy has a prevalence of 5 to 7 per 1000 persons in the United States, it continues to be a poorly understood condition. Given the number of patients in the United States with epilepsy, it is very likely that primary care physicians will continue to provide care for these patients. This article refreshes some of the knowledge around the diagnosis of epilepsy, discusses special populations that may require additional management considerations, highlights the association of epilepsy with multiple comorbidities, and discusses antiepileptic drug (AED) treatment, including issues surrounding adherence and safety of AED therapy.	Dept Grad Med Educ, Lawrenceville, GA 30046 USA		Bates, K (corresponding author), Dept Grad Med Educ, 1000 Med Ctr Blvd, Lawrenceville, GA 30046 USA.	kibates@gwinnettmedicalcenter.org					Alexopoulos A, 2011, EPILEPSY IN ADULTS; Baca CB, 2012, EPILEPSY BEHAV, V23, P47, DOI 10.1016/j.yebeh.2011.10.010; Centers for Disease Control and Prevention (CDC), 1800, MMWR Morb Mortal Wkly Rep, V62, P849; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Ekinci O, 2009, EPILEPSY BEHAV, V14, P8, DOI 10.1016/j.yebeh.2008.08.015; Faught RE, 2009, EPILEPSIA, V50, P501, DOI 10.1111/j.1528-1167.2008.01794.x; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0; Hovinga CA, 2008, EPILEPSY BEHAV, V13, P316, DOI 10.1016/j.yebeh.2008.03.009; Ivanova JI, 2010, PHARMACOECONOMICS, V28, P675, DOI 10.2165/11535570-000000000-00000; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kobau Rosemarie, 2012, Morbidity and Mortality Weekly Report, V61, P909; Levenson M, 2008, STAT REV EVALUATION; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Ottman R, 2011, EPILEPSIA, V52, P308, DOI 10.1111/j.1528-1167.2010.02927.x; Pugh MJV, 2009, J AM GERIATR SOC, V57, P237, DOI 10.1111/j.1532-5415.2008.02124.x; Stevanovic D, 2011, EPILEPSIA, V52, pE75, DOI 10.1111/j.1528-1167.2011.03133.x; Taylor RS, 2011, EPILEPSIA, V52, P2168, DOI 10.1111/j.1528-1167.2011.03213.x	18	5	5	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0095-4543	1558-299X		PRIMARY CARE	Primary Care	JUN	2015	42	2					217	+		10.1016/j.pop.2015.01.006			17	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CI1ZC	WOS:000354542900008	25979583				2022-02-06	
J	Pinto, FCG; de Oliveira, MF; Prist, R; Silva, MRE; da Silva, LFF; Neto, AC				Gomes Pinto, Fernando Campos; de Oliveira, Matheus Fernandes; Prist, Ricardo; Rocha e Silva, Mauricio; Ferraz da Silva, Luiz Fernando; Neto, Antonio Capone			Effect of volume replacement during combined experimental hemorrhagic shock and traumatic brain injury in prostanoids, brain pathology and pupil status	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						traumatic brain injury; volemic resuscitation; pathology; inflammation	HYPERTONIC SALINE SOLUTION; CEREBRAL BLOOD-FLOW; FLUID RESUSCITATION; LACTATED RINGERS; HEMODYNAMICS; PIGS	Traumatic brain injury (TBI) is the main cause of trauma-related deaths. Systemic hypotension and intracranial hypertension causes cerebral ischemia by altering metabolism of prostanoids. We describe prostanoid, pupilar and pathological response during resuscitation with hypertonic saline solution (HSS) in TBI. Method: Fifteen dogs were randomized in three groups according to resuscitation after TBI (control group; lactated Ringer's (LR) group and HSS group), with measurement of thromboxane, prostaglandin, macroscopic and microscopic pathological evaluation and pupil evaluation. Result: Concentration of prostaglandin is greater in the cerebral venous blood than in plasma and the opposite happens with concentration of thromboxane. Pathology revealed edema in groups with the exception of group treated with HSS. Discussion and conclusion: There is a balance between the concentrations of prostaglandin and thromboxane. HSS prevented the formation of cerebral edema macroscopically detectable. Pupillary reversal occurred earlier in HSS group than in LR group.	[Gomes Pinto, Fernando Campos] Univ Sao Paulo, Hosp Clin, Inst Psiquiatria, Div Neurocirurg Func, Sao Paulo, SP, Brazil; [de Oliveira, Matheus Fernandes] IAMSPE, Hosp Serv Publ Estadual Sao Paulo, Dept Neurocirurg, Sao Paulo, SP, Brazil; [Prist, Ricardo] Univ Sao Paulo, Fac Med, Div Pesquisa, Sao Paulo, SP, Brazil; [Rocha e Silva, Mauricio] Univ Sao Paulo, Dept Fisiol, Sao Paulo, SP, Brazil; [Ferraz da Silva, Luiz Fernando] Univ Sao Paulo, Dept Patol, Sao Paulo, SP, Brazil; [Ferraz da Silva, Luiz Fernando] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil; [Neto, Antonio Capone] Hosp Israelita Albert Einstein, Unidade Terapia Intens, Sao Paulo, SP, Brazil		de Oliveira, MF (corresponding author), Rua Luis Gois 1333,Apto 23, BR-04043150 Sao Paulo, SP, Brazil.	mafernoliv@yahoo.com.br	Silva, Luiz/D-2760-2012	Silva, Luiz/0000-0002-0181-6357; PINTO, FERNANDO/0000-0003-2384-2190			Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Al-Turki A, 1998, CRIT CARE MED, V26, P917, DOI 10.1097/00003246-199805000-00029; Anderson JT, 1997, J TRAUMA, V42, P592, DOI 10.1097/00005373-199704000-00003; ARMSTEAD WM, 1988, AM J PHYSIOL, V254, pH671, DOI 10.1152/ajpheart.1988.254.4.H671; Balbino M, 2010, J TRAUMA, V68, P859, DOI 10.1097/TA.0b013e3181af69d3; Bulger EM, 2007, ANN SURG, V245, P635, DOI 10.1097/01.sla.0000251367.44890.ae; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dekker SE, 2014, SURGERY, V156, P556, DOI 10.1016/j.surg.2014.04.016; DeWitt DS, 1998, CRIT CARE MED, V26, P819, DOI 10.1097/00003246-199805000-00008; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; ELIASTAM M, 1984, ANN EMERG MED, V13, P874, DOI 10.1016/S0196-0644(84)80464-3; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Gong WF, 2011, J TRAUMA, V71, P275, DOI 10.1097/TA.0b013e318226eb51; GRICE SC, 1987, STROKE, V18, P787, DOI 10.1161/01.STR.18.4.787; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; KONG DL, 1991, CRIT CARE MED, V19, P532, DOI 10.1097/00003246-199104000-00013; Leffler CW, 1997, NEWS PHYSIOL SCI, V12, P72; Phillips CR, 2009, CRIT CARE, V13, DOI 10.1186/cc7736; Pinto FCG, 2006, J TRAUMA, V60, P758, DOI 10.1097/01.ta.0000214581.89316.73; Rocha-e-Silva M, 2005, CLINICS, V60, P159; Schackford SR, 1993, ARCH SURG-CHICAGO, V128, P571; Shein SL, 2014, J NEUROTRAUM, V31, P1386, DOI 10.1089/neu.2013.2985; Tan PG, 2011, EMERG MED AUSTRALAS, V23, P665, DOI 10.1111/j.1742-6723.2011.01455.x; Van Aken HK, 2012, CURR OPIN ANESTHESIO, V25, P563, DOI 10.1097/ACO.0b013e3283572274; Wang JW, 2014, J SURG RES, V191, P448, DOI 10.1016/j.jss.2014.04.027	26	5	5	0	5	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	JUN	2015	73	6					499	505		10.1590/0004-282X20150039			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CK7YB	WOS:000356451700007	26083885	Green Submitted, gold			2022-02-06	
J	Jackson, JC; Morandi, A; Girard, TD; Merkle, K; Graves, AJ; Thompson, JL; Shintani, AK; Gunther, ML; Cannistraci, CJ; Rogers, BP; Gore, JC; Warrington, HJ; Ely, EW; Hopkins, RO				Jackson, James C.; Morandi, Alessandro; Girard, Timothy D.; Merkle, Kristen; Graves, Amy J.; Thompson, Jennifer L.; Shintani, Ayumi K.; Gunther, Max L.; Cannistraci, Christopher J.; Rogers, Baxter P.; Gore, John C.; Warrington, Hillary J.; Ely, E. Wesley; Hopkins, Ramona O.		VISualizing Icu SurvivOrs Neurorad	Functional brain imaging in survivors of critical illness: A prospective feasibility study and exploration of the association between delirium and brain activation patterns	JOURNAL OF CRITICAL CARE			English	Article						MRI; Delirium; Cognitive impairment; ICU; Sepsis; Neuroimaging	TERM COGNITIVE IMPAIRMENT; CARE-UNIT SURVIVORS; WORKING-MEMORY; METAANALYSIS; RELIABILITY; DYSFUNCTION; DURATION; VALIDITY; SEQUELAE; DECLINE	Purpose: We undertook this pilot prospective cohort investigation to examine the feasibility of functional magnetic resonance imaging (fMRI) assessments in survivors of critical illness and to analyze potential associations between delirium and brain activation patterns observed during a working memory task (N-back) at hospital discharge and 3-month follow-up. Materials and Methods: At hospital discharge and 3 months later, fMRI assessed subjects' functional activity during an N-back task. Multiple linear regression was used to examine associations between duration of delirium and brain activity, and elastic net regression was used to assess the relationship between brain activation patterns at 3 months and cognitive outcomes at 12 months. Results: Of 47 patients who underwent fMRI at discharge, 38 (80%) completed the protocol; of 37 who underwent fMRI at 3 months, 34 (91%) completed the protocol. At discharge, the mean (SD) percentage of correct responses on the most challenging version (the N2 version) of the N-back task was 70.4 (23.2; range of 20-100) compared with 76 (23.4; range of 33-100) at 3 months. No association was observed between delirium duration in the hospital and brain region activity in any brain region at discharge or 3 months after adjusting for relevant covariates (P values across all 11 brain regions of interest were > .25). Conclusions: Our data support the feasibility of using fMRI in survivors of critical illness at 3-month follow-up but not at discharge. In this small study, delirium was not associated with distinct or abnormal brain activation patterns, although overall performance on a cognitive task of working memory was poorer than observed in other cohorts of individuals with medically related executive dysfunction, mild cognitive impairment, and mild traumatic brain injury. (C) 2015 Published by Elsevier Inc.	[Jackson, James C.; Girard, Timothy D.; Warrington, Hillary J.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37232 USA; [Jackson, James C.; Girard, Timothy D.; Warrington, Hillary J.; Ely, E. Wesley] Vanderbilt Univ, Sch Med, Dept Med, Ctr Hlth Serv Res, Nashville, TN 37232 USA; [Jackson, James C.; Rogers, Baxter P.] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37232 USA; [Jackson, James C.] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Res Serv, Nashville, TN USA; [Morandi, Alessandro] Hosp Ancelle, Dept Rehabil, Cremona, Italy; [Morandi, Alessandro] Hosp Ancelle, Aged Care Unit, Cremona, Italy; [Girard, Timothy D.; Ely, E. Wesley] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr GRECC Serv, Nashville, TN USA; [Merkle, Kristen; Gunther, Max L.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37232 USA; [Graves, Amy J.] Vanderbilt Univ, Sch Med, Dept Urol Surg, Nashville, TN 37232 USA; [Thompson, Jennifer L.] Osaka Univ, Dept Clin Epidemiol & Biostat, Osaka, Japan; [Shintani, Ayumi K.] Tennessee Valley Healthcare Syst, Dept Vet Affairs Med Ctr, Nashville, TN USA; [Gunther, Max L.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37232 USA; [Gunther, Max L.] So Methodist Univ, Dept Psychol, Dallas, TX 75275 USA; [Cannistraci, Christopher J.; Rogers, Baxter P.; Gore, John C.] Vanderbilt Univ, Sch Engn, Dept Biomed Engn, Nashville, TN 37232 USA; [Rogers, Baxter P.; Gore, John C.] Vanderbilt Univ, Sch Engn, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA; [Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Intermt Med Ctr, Dept Med, Div Pulm & Crit Care, Murray, UT USA; [Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA		Jackson, JC (corresponding author), Vanderbilt Univ, 6109 Med Ctr East, Nashville, TN 37232 USA.	james.c.jackson@vanderbilt.edu	Girard, Timothy/I-3008-2019; Ely, E. Wesley/Z-2018-2019	Girard, Timothy/0000-0002-9833-4871; Ely, E. Wesley/0000-0003-3957-2172; Rogers, Baxter/0000-0002-5666-2797	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG027472, AG034257, RR024975, EB001628, TR000445]; Saint Thomas Foundation (Nashville, TN); Veterans Affairs Tennessee Valley Geriatric Research, Education, and Clinical Center; Vanderbilt Institute of Imaging Science; Vanderbilt Institute of Clinical and Translational Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB001628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034257, R01AG027472] Funding Source: NIH RePORTER	National Institutes of Health (AG027472, AG034257, RR024975, EB001628, TR000445); Saint Thomas Foundation (Nashville, TN); Veterans Affairs Tennessee Valley Geriatric Research, Education, and Clinical Center; Vanderbilt Institute of Imaging Science; and the Vanderbilt Institute of Clinical and Translational Research.	Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; Buckner RL, 2012, NEUROIMAGE, V62, P1137, DOI 10.1016/j.neuroimage.2011.10.035; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Choi SH, 2012, AM J PSYCHIAT, V169, P498, DOI 10.1176/appi.ajp.2012.11060976; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gunther ML, 2012, CRIT CARE MED, V40, P2022, DOI 10.1097/CCM.0b013e318250acc0; Hopkins RO, 2012, NEUROREHABILITATION, V31, P311, DOI 10.3233/NRE-2012-0798; Hopkins RO, 2006, BRAIN INJURY, V20, P263, DOI 10.1080/02699050500488199; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI 10.2307/1390807; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Jones C, 2006, INTENS CARE MED, V32, P923, DOI 10.1007/s00134-006-0112-y; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; MacLullich AM, 2012, INT REV PSYCHIATR, V21, P30; Miller KM, 2009, ARCH CLIN NEUROPSYCH, V24, P711, DOI 10.1093/arclin/acp063; Morandi A, 2012, CRIT CARE MED, V40, P2182, DOI 10.1097/CCM.0b013e318250acdc; Morandi Alessandro, 2010, Psychiatry (Edgmont), V7, P28; Nee DE, 2013, CEREB CORTEX, V23, P264, DOI 10.1093/cercor/bhs007; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Randolph C., 1998, REPEATABLE BATTERY A; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shen L, 2011, LECT NOTES COMPUT SC, V7012, P27, DOI 10.1007/978-3-642-24446-9_4; Sommer JC, 2014, STAT MED, V33, P1029, DOI 10.1002/sim.5997; Suchyta MR, 2010, BRAIN IMAGING BEHAV, V4, P22, DOI 10.1007/s11682-009-9082-3; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946; Woon FL, 2012, AM J RESP CRIT CARE, V186, P333, DOI 10.1164/rccm.201112-2261OC; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	5	5	2	17	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	JUN	2015	30	3							653.e1	10.1016/j.jcrc.2015.01.017			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG6HN	WOS:000353400100046	25769901	Green Accepted			2022-02-06	
J	Mahdavi, Z; Pierre-Louis, N; Ho, TT; Figueroa, SA; Olson, DM				Mahdavi, Zakraus; Pierre-Louis, Naregnia; Thuy-Tien Ho; Figueroa, Stephen A.; Olson, DaiWai M.			Advances in Cerebral Monitoring for the Patient with Traumatic Brain Injury	CRITICAL CARE NURSING CLINICS OF NORTH AMERICA			English	Article						Multimodal monitoring; Neurocritical care; Intensive care; Nursing; Traumatic brain injury	NERVE SHEATH DIAMETER; INTENSIVE-CARE-UNIT; INTRACRANIAL-PRESSURE; SUBARACHNOID HEMORRHAGE; TRANSCRANIAL DOPPLER; NEUROCRITICAL CARE; SEDATION ASSESSMENT; TISSUE OXYGENATION; COMA SCALE; 4 SCORE	A brief overview of the most common invasive and noninvasive monitoring tools collectively referred to using the term "multimodal monitoring" is provided. Caring for the critically ill patient with traumatic brain injury requires careful monitoring to prevent or reduce secondary brain injury. Concurrent to the growth of the subspecialty of neurocritical care, there has been a concerted effort to discover novel mechanisms to monitor the physiology of brain injury. The past 2 decades have witnessed an exponential growth in neurologic monitoring in terms of intracranial pressure, blood flow, metabolism, oxygenation, advanced neuroimaging, and electrophysiology.	[Mahdavi, Zakraus; Pierre-Louis, Naregnia; Thuy-Tien Ho; Figueroa, Stephen A.; Olson, DaiWai M.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA		Olson, DM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Daiwai.Olson@utsouthwestern.edu	Olson, DaiWai/I-5932-2019	Olson, DaiWai/0000-0002-9280-078X; Ho, Thuy-Tien/0000-0002-8549-5318; Figueroa, Stephen/0000-0002-6363-8496			Abu-Zidan Fikri M, 2011, J Emerg Trauma Shock, V4, P501, DOI 10.4103/0974-2700.86646; American Association of Neurosciene Nurses, 2010, AANN COR CURR NEUR N; Arbour Richard, 2003, AACN Clin Issues, V14, P185, DOI 10.1097/00044067-200305000-00009; Arbour R, 2009, HEART LUNG, V38, P336, DOI 10.1016/j.hrtlng.2008.10.010; BAILES JE, 1990, J NEUROSURG, V72, P559, DOI 10.3171/jns.1990.72.4.0559; Bilotta F, 2013, NEUROL RES, V35, P149, DOI 10.1179/1743132812Y.0000000155; Blumenfeld H., 2002, NEUROANATOMY CLIN CA; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P153, DOI 10.1097/MCC.0000000000000071; Cammarata G, 2011, J TRAUMA, V71, P779, DOI 10.1097/TA.0b013e3182220673; Carhuapoma JR, 2010, INTRACEREBRAL HEMORR; Caricato A, 2014, WORLD J RADIOL, V6, P636, DOI 10.4329/wjr.v6.i9.636; Chambers IR, 2001, BRIT J NEUROSURG, V15, P140; Chesnut R, 2013, INTENS CARE MED, V39, P1; Citerio G, 2007, INTENS CARE MED, V33, P1580, DOI 10.1007/s00134-007-0700-5; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Eide PK, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-66; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Griesdale DEG, 2015, J CRIT CARE, V30, P111, DOI 10.1016/j.jcrc.2014.07.026; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; HASE U, 1978, ACTA NEUROCHIR, V44, P69, DOI 10.1007/BF01401631; HAYASHI M, 1978, ACTA NEUROCHIR, V44, P81, DOI 10.1007/BF01401632; HAYREH S S, 1964, Br J Ophthalmol, V48, P522, DOI 10.1136/bjo.48.10.522; Helbok R, 2014, NEUROCRIT CARE; Heuer GG, 2004, J NEUROSURG, V101, P408, DOI 10.3171/jns.2004.101.3.0408; Hickey JV, 2009, CLIN PRACTICE NEUROL, P270; Iyer VN, 2009, MAYO CLIN PROC, V84, P694, DOI 10.1016/S0025-6196(11)60519-3; James ML, 2012, ANAESTH INTENS CARE, V40, P949, DOI 10.1177/0310057X1204000605; Katz M, 2003, PRACTICAL GUIDE TRAN; KAYE AH, 1981, J NEUROSURG, V54, P726, DOI 10.3171/jns.1981.54.6.0726; Kesinger MR, 2014, INJURY, V45, P1350, DOI 10.1016/j.injury.2014.04.037; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; Lashutka MK, 2004, ANN EMERG MED, V43, P585, DOI 10.1016/j.annemergmed.2003.12.006; Le Roux P, 2014, NEUROCRIT CARE; Littlejohns Linda R, 2003, Crit Care Nurse, V23, P17; Littlejohns LR, 2003, CRIT CARE NURSE, V23, P6; Macintyre I, 2014, J MED BIOGR, V22, P93, DOI 10.1177/0967772013479271; Major R, 2011, EMERG MED J, V28, P679, DOI 10.1136/emj.2009.087353; Manno EM, 1997, CRIT CARE CLIN, V13, P79, DOI 10.1016/S0749-0704(05)70297-9; Mascarenhas Sergio, 2012, Acta Neurochir Suppl, V114, P117, DOI 10.1007/978-3-7091-0956-4_21; Mazzoni P, 2006, MERRITTS NEUROLOGY H; Meeker Michele, 2005, J Neurosci Nurs, V37, P34; Meixensberger J, 2003, NEUROL RES, V25, P445, DOI 10.1179/016164103101201823; Olson D, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0014; Olson DaiWai M, 2004, J Neurosci Nurs, V36, P228; Olson DM, 2014, AUST CRIT CARE, V27, P145, DOI 10.1016/j.aucc.2013.09.001; Olson DM, 2014, NEUROCRIT CARE, V20, P15, DOI 10.1007/s12028-013-9847-9; Olson DM, 2013, J NEUROSCI NURS, V45, P186, DOI 10.1097/JNN.0b013e3182986400; Olson DM, 2009, NEUROCRIT CARE, V11, P20, DOI 10.1007/s12028-008-9184-6; Olson DM., 2007, CRITICAL CARE NURSIN, P359; Olson DM., 2007, THESIS U N CAROLINA; Poli S, 2013, STROKE, V44, P708, DOI 10.1161/STROKEAHA.112.672923; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; Sahuquillo J, 1999, J NEUROSURG, V90, P16, DOI 10.3171/jns.1999.90.1.0016; Schneider A, 2014, ACTA PAEDIATR, V103, P934, DOI 10.1111/apa.12698; Schytz HW, 2012, NEUROCRIT CARE, V17, P139, DOI 10.1007/s12028-012-9720-2; Singhal NS, 2014, J CRIT CARE, V29, P627, DOI 10.1016/j.jcrc.2014.02.014; Soehle M, 2007, ACTA NEUROCHIR, V149, P575, DOI 10.1007/s00701-007-1149-6; Srinivasan VM, 2014, J NEUROSURG, V120, P228, DOI 10.3171/2013.6.JNS121577; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Suehiro E, 2011, NEUROL MED-CHIR, V51, P551, DOI 10.2176/nmc.51.551; TEASDALE G, 1974, LANCET, V2, P81; Vespa PM, 2014, NEUROL CLIN, V32, P211, DOI 10.1016/j.ncl.2013.07.010; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611	66	5	5	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0899-5885	1558-3481		CRIT CARE NURS CLIN	Crit. Care Nurs. Clin. N. Am.	JUN	2015	27	2					213	+		10.1016/j.cnc.2015.02.002			12	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CJ5XD	WOS:000355565600006	25981724				2022-02-06	
J	Sharma, A; Jain, A; Sharma, A; Mittal, RS; Gupta, ID				Sharma, Anand; Jain, Akhilesh; Sharma, Achal; Mittal, R. S.; Gupta, I. D.			Study of Quality of Life in Traumatic Brain Injury	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						quality of life; insomnia; traumatic brain injury		Objective To assess quality of life (QOL) in individuals with mild and moderate traumatic brain injury (TBI) and their relationship with demographic, posttraumatic insomnia, and injury-related factors. Method The present study was a cross-sectional study conducted at Sawai Man Singh Medical College and group of hospitals over a period of 6 months from January 2013 to June 2013. The groups studied consists of 204 patients of mild and moderate TBI between 14 days and 1 year postinjury and equal number of controls by recruiting close relatives of the patients for comparison. Patients were assessed on semistructured sociodemographic proforma along with WHOQOL BREF, insomnia severity index, and GCS to assess QOL, insomnia, and severity of TBI, respectively. Result The number of participants included was 204. Mean age was 33.34 years. QOL was found impaired in all four domains of patients with TBI as compared with control group. The most unsatisfying domain among all was environmental health. None of the sociodemographic variables were associated with impaired QOL in TBI except duration and severity of head injury. Patients with longer duration (time since injury) of TBI and higher GCS had better QOL. Patients with insomnia had significantly poor QOL compared with those with TBI without insomnia. Conclusion QOL is an important aspect to be considered while management of TBI is performed especially during follow-ups. Impact of severity and the duration of injury with associated sleep problems have significant bearing on QOL.	[Sharma, Anand; Sharma, Achal; Mittal, R. S.; Gupta, I. D.] Sawai Man Singh Med Coll, Dept Neurosurg, Jaipur, Rajasthan, India; [Jain, Akhilesh] ESIC Model Hosp, Jaipur, Rajasthan, India		Sharma, A (corresponding author), Artemis Hlth Sci, Dept Neurosurg, Sector 51, Gurgaon 122001, Haryana, India.	dranandsharma100123@gmail.com					Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Berzon RA, 1998, OX MED PUBL, P3; Brown M, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199808000-00002; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Lahan Vivekananda, 2011, Indian J Psychol Med, V33, P172, DOI 10.4103/0253-7176.92060; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Reddy RP, 2014, INDIAN J PSYCHOL MED, V36, P40, DOI 10.4103/0253-7176.127246; Savard MH, 2005, PSYCHO-ONCOLOGY, V14, P429, DOI 10.1002/pon.860; Saxena S, 1998, NATL MED J INDIA, V11, P160; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; TEASDALE G, 1974, LANCET, V2, P81; Upadhyay D., 2007, WORLD APPL SCI J, V2, P687; vanBalen HGG, 1996, DISABIL REHABIL, V18, P181, DOI 10.3109/09638289609166298; Verma A, 2007, J CLIN SLEEP MED, V3, P357; War FA, 2013, INDIAN J NEUROTRAUM, V10, P115, DOI 10.1016/j.ijnt.2013.12.004; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	26	5	5	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	JUN	2015	12	1					2	9		10.1055/s-0035-1554948			8	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M7T	WOS:000218397600003					2022-02-06	
J	Singhi, S; Kumar, R; Singhi, P; Jayashree, M; Bansal, A				Singhi, Sunit; Kumar, Ramesh; Singhi, Pratibha; Jayashree, Muralidharan; Bansal, Arun			Bedside Burr Hole for Intracranial Pressure Monitoring Performed by Pediatric Intensivists in Children With CNS Infections in a Resource-Limited Setting: 10-Year Experience at a Single Center	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						bedside burr hole; children; coma; intracranial pressure monitoring; mortality; raised intracranial pressure	TRAUMATIC BRAIN-INJURY; VENTRICULOSTOMY-RELATED INFECTIONS; CLINICAL-PRACTICE; NON-NEUROSURGEONS; COMPLICATIONS; PLACEMENT; CARE; MANAGEMENT; HYPERTENSION; OUTCOMES	Objective: Intracranial pressure monitoring can help in early identification of raised intracranial pressure and in setting more informed goals for treatment. We describe our 10-year experience of bedside burr holes performed by pediatric intensivists to establish intracranial pressure monitoring in children with CNS infections in a resource-limited setting and the technical difficulties and complications encountered. Design: Descriptive study of prospectively recorded data. Setting: PICU of a tertiary care academic institute. Patients: Consecutive comatose patients with raised intracranial pressure who underwent intracranial pressure monitoring from 2004 to 2013. Intervention: An intraparenchymal (1.2 mm) or an intraventricular transducer (3.4 mm) (Codman) was placed by a pediatric intensivist through a micro burr hole using a standard protocol. Technical difficulties during the procedure and complications were recorded. Measurements and Main Results: Over 10 years, 265 intracranial pressure catheters were placed in 259 patients, mainly for acute CNS infections (n = 242, 93.4%). Median age of patients was 4.8 years, youngest being 6 weeks; 21 patients (8.1%) were younger than 1 year. Intraparenchymal transducer was used in 252 patients (97.3%). Median (interquartile range) duration of intracranial pressure monitoring was 96 hours (72-144 hr). Complications were seen in 3.5% of patients (n = 9/259); the incidence was 0.28 per 1,000 hours of intracranial pressure monitoring. Procedure-related ventriculitis occurred in three of seven patients (42.8%) with intraventricular catheter, in contrast to none in patients with intraparenchymal transducer. Overall mortality was 32.8% (n = 85). On Cox-regression analysis, blood component therapy was an independent predictor of poor outcome defined as death or severe neurodisability (adjusted hazard ratio, 1.58; 95% CI, 1.16-2.16; p = 0.004). Conclusions: In a resource-limited setting, pediatric intensivists can safely and successfully perform burr holes at bedside for establishing intraparenchymal intracranial pressure monitoring in children with acute CNS infections. However, our data do not support placement of ventriculostomy catheters by pediatric intensivists in similar settings.	[Singhi, Sunit; Kumar, Ramesh; Singhi, Pratibha; Jayashree, Muralidharan; Bansal, Arun] Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India		Singhi, S (corresponding author), Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Chandigarh, India.	sunit.singhi@gmail.com			Department of Pediatrics at Postgraduate Institute of Medical Education and Research, Chandigarh, India	The study was supported by funds from the Department of Pediatrics at Postgraduate Institute of Medical Education and Research, Chandigarh, India.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Anderson RCE, 2004, J NEUROSURG, V101, P53, DOI 10.3171/ped.2004.101.2.0053; Barber MA, 2012, J TRAUMA ACUTE CARE, V73, P558, DOI 10.1097/TA.0b013e318265cb75; Bekar A, 1998, NEUROSURG REV, V21, P254, DOI 10.1007/BF01105781; Blaha M, 2003, PEDIATR NEUROSURG, V39, P27, DOI 10.1159/000070877; Bochicchio M, 1996, INTENS CARE MED, V22, P1070, DOI 10.1007/BF01699230; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; EDDY VA, 1995, AM SURGEON, V61, P24; Exo J, 2011, PEDIATR CRIT CARE ME, V12, P560, DOI 10.1097/PCC.0b013e3181e8b3ee; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Firsching RJ, 2010, CENT EUR NEUROSURG, V71, P134, DOI 10.1055/s-0030-1248256; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Harris CH, 2002, AM SURGEON, V68, P787; Jensen RL, 1997, SURG NEUROL, V47, P16, DOI 10.1016/S0090-3019(96)00276-5; Kumar RR, 2012, INDIAN J PEDIATR, V79, P518, DOI 10.1007/s12098-011-0648-x; Latorre JGS, 2009, NEUROLOGIST, V15, P193, DOI 10.1097/NRL.0b013e31819f956a; Latronico N, 2003, Minerva Anestesiol, V69, P159; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Munch E, 1998, ACTA NEUROCHIR, V140, P1113, DOI 10.1007/s007010050224; Odetola FO, 2011, PEDIATR CRIT CARE ME, V12, pE350, DOI 10.1097/PCC.0b013e31820abc83; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; Pineda JA, 2011, PEDIATR CRIT CARE ME, V12, P600, DOI 10.1097/PCC.0b013e3182257a5e; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Rossi S, 1998, ACT NEUR S, V71, P91; Sadaka F, 2013, BRAIN INJURY, V27, P600, DOI 10.3109/02699052.2013.772238; Shetty R, 2008, J CHILD NEUROL, V23, P192, DOI 10.1177/0883073807308716; Singhi SC, 2009, INDIAN J PEDIATR, V76, P519, DOI 10.1007/s12098-009-0137-7; Tatman A, 1997, ARCH DIS CHILD, V77, P519, DOI 10.1136/adc.77.6.519; WINN HR, 1977, SURG NEUROL, V8, P41; YABLON JS, 1993, J CLIN MONITOR, V9, P171, DOI 10.1007/BF01617024; Young PJ, 2012, J TRAUMA ACUTE CARE, V73, P431, DOI 10.1097/TA.0b013e318262437b	37	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JUN	2015	16	5					453	460		10.1097/PCC.0000000000000353			8	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	CN2YM	WOS:000358289300008	25599146				2022-02-06	
J	Vidovic, V; Rovazdi, MC; Kraml, O; Kes, VB				Vidovic, Viktor; Rovazdi, Merisanda Casar; Kraml, Oto; Kes, Vanja Basic			PSEUDOBULBAR AFFECT IN MULTIPLE SCLEROSIS PATIENTS	ACTA CLINICA CROATICA			English	Article						Multiple sclerosis - complications; Pseudobulbar affect; CNS-LS	EMOTIONAL EXPRESSION DISORDER; PATHOLOGICAL LAUGHTER; PREVALENCE; PATHOPHYSIOLOGY; SCALE	The aim of the study was to determine the prevalence of pseudobulbar affect (PBA) in patients with multiple sclerosis (MS) and to analyze the link between PBA and patient age, sex, clinical course of MS, disease duration and degree of disability. The study was conducted on 79 MS patients that underwent inpatient rehabilitation at the Lipik Special Hospital for Medical Rehabilitation in the period from August 15, 2014 to February 15, 2015. PBA is a term used for an emotional disinhibition syndrome characterized by sudden and involuntary episodes of crying or laughing which are not in proportion to the stimulus applied or occur without stimulus. The condition can be present in patients with various neurological disorders, such as amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease, patients having recovered from stroke, or following traumatic brain injury. The estimated prevalence in patients with MS ranges from 10% to 46.2%. As a measuring instrument in the study, we used the Center for Neurologic Study-Lability Scale (CNS-LS), where a sum >= 17 denoted positive finding. The total number of respondents was 79, of which 33 (41.8%) met the CNS-LS criteria for the diagnosis of PBA. There was no statistically significant correlation between PBA, age and degree of disability, although PBA was more common in women and in patients with a secondary progressive form of the disease. We found that 42.4% of respondents with positive CNS-LS criteria for PBA did not inform their neurologist on the presence of sudden mood changes. The high frequency of PBA and the fact that a significant proportion of patients did not inform the neurologist on their affective disturbances call for an active approach to diagnosis and treatment.	[Vidovic, Viktor; Rovazdi, Merisanda Casar; Kraml, Oto] Lipik Special Hosp Med Rehabil, HR-34551 Lipik, Croatia; [Kes, Vanja Basic] Sestre Milosrdnice Univ Hosp Ctr, Univ Dept Neurol, Zagreb, Croatia		Vidovic, V (corresponding author), Lipik Special Hosp Med Rehabil, Marije Terezije 13, HR-34551 Lipik, Croatia.	viktor.vidovic@bolnica-lipik.hr					Brooks BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072232; CAROSCIO JT, 1987, NEUROL CLIN, V5, P1; Choi-Kwon S, 2012, NEUROLOGY, V78, P1130, DOI 10.1212/WNL.0b013e31824f8090; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Cummings JL, 2007, CNS SPECTRUMS, V12, P11; Cummings JL, 2006, CNS SPECTRUMS, V11, P1; Feinstein A, 1997, ARCH NEUROL-CHICAGO, V54, P1116, DOI 10.1001/archneur.1997.00550210050012; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GALLAGHER JP, 1989, ACTA NEUROL SCAND, V80, P114, DOI 10.1111/j.1600-0404.1989.tb03851.x; HOUSE A, 1989, BMJ-BRIT MED J, V298, P991, DOI 10.1136/bmj.298.6679.991; Kim JS, 1997, STROKE, V28, P2321; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Minden SL, 2014, NEUROLOGY, V82, P174, DOI 10.1212/WNL.0000000000000013; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Nieuwenhuis-Mark RE, 2008, COGN BEHAV NEUROL, V21, P111, DOI 10.1097/WNN.0b013e31816be8f8; Page S, 2011, ARCH PHYS MED REHAB, V92, P1710; Parvizi J, 2001, BRAIN, V124, P1708, DOI 10.1093/brain/124.9.1708; Parvizi J, 2007, MOVEMENT DISORD, V22, P798, DOI 10.1002/mds.21348; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Petracca GM, 2009, J NEUROPSYCH CLIN N, V21, P406, DOI 10.1176/appi.neuropsych.21.4.406; Phuong L, 2009, PARKINSONISM RELAT D, V15, P511, DOI 10.1016/j.parkreldis.2009.01.001; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; ROBINSON RG, 1993, AM J PSYCHIAT, V150, P286; Siddiqui MS, 2009, WORLD J BIOL PSYCHIA, V10, P234, DOI 10.1080/15622970701639445; Smi CK, 2006, STROKE, V37, P156, DOI 10.1161/01.STR.0000190892.93663.e2; Smith RA, 2004, MULT SCLER, V10, P1; STARKSTEIN SE, 1995, J NEUROL NEUROSUR PS, V59, P55, DOI 10.1136/jnnp.59.1.55; Strowd RE, 2010, J NEUROL, V257, P1382, DOI 10.1007/s00415-010-5550-3; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zeilig G, 1996, BRAIN INJURY, V10, P591, DOI 10.1080/026990596124160; Ziegler LH, 1930, ARCH NEURO PSYCHIATR, V24, P930, DOI 10.1001/archneurpsyc.1930.02220170050006	33	5	5	0	7	SESTRE MILOSRDNICE UNIV HOSPITAL	ZAGREB	VINOGRADSKA C 29, ZAGREB, HR-10000, CROATIA	0353-9466	1333-9451		ACTA CLIN CROAT	Acta Clin. Croat.	JUN	2015	54	2					159	163					5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP3CT	WOS:000359755100006	26415311				2022-02-06	
J	Francisco, EM; Holden, JK; Nguyen, RH; Fayoroy, OV; Tommerdahl, M				Francisco, Eric M.; Holden, Jameson K.; Nguyen, Richard H.; Fayoroy, Oleg V.; Tommerdahl, Mark			Percept of the duration of a vibrotactile stimulus is altered by changing its amplitude	FRONTIERS IN SYSTEMS NEUROSCIENCE			English	Article						tactile; somatosensory; duration discrimination; amplitude discrimination; vibrotactile	EMPTY AUDITORY INTERVALS; GLIAL-CELLS; TIME PERCEPTION; INTENSITY DISCRIMINATION; NEURAL CODES; WEBERS LAW; SI CORTEX; BRAIN; STIMULATION; ADAPTATION	There have been numerous studies conducted on time perception. However, very few of these have involved tactile stimuli to assess a subject's capacity for duration discrimination. Previous optical imaging studies in non human primates demonstrated that increasing the duration of a vibrotactile stimulus resulted in a consistently longer and more well defined evoked SI cortical response. Additionally, and perhaps more interestingly, increasing the amplitude of a vibrotactile stimulus not only evoked a larger magnitude optical intrinsic signal (OIS), but the return to baseline of the evoked response was much longer in duration for larger amplitude stimuli. This led the authors to hypothesize that the magnitude of a vibrotactile stimulus could influence the perception of its duration. In order to test this hypothesis, subjects were asked to compare two sets of vibrotactile stimuli. When vibrotactile stimuli differed only in duration, subjects typically had a difference limen (DL) of approximately 13%, and this followed Weber's Law for standards between 500 and 1500 ms, as increasing the value of the standard yielded a proportional increase in DL. However, the percept of duration was impacted by variations in amplitude of the vibrotactile stimuli. Specifically, increasing the amplitude of the standard stimulus had the effect of increasing the DL, while increasing the amplitude of the test stimulus had the effect of decreasing the DL. A pilot study, conducted on individuals who were concussed, found that increasing the amplitude of the standard did not have an impact on the DL of this group of individuals. Since this effect did not parallel what was predicted from the optical imaging findings in somatosensory cortex of non-human primates, the authors suggest that this particular measure or observation could be sensitive to neuroinflammation and that neuron-glial interactions, impacted by concussion, could have the effect of ignoring, or not integrating, the increased amplitude.	[Francisco, Eric M.; Holden, Jameson K.; Nguyen, Richard H.; Tommerdahl, Mark] Cort Metr LLC, Semora, NC USA; [Fayoroy, Oleg V.; Tommerdahl, Mark] Univ N Carolina, Dept Biomed Engn, CB 7575, Chapel Hill, NC 27599 USA		Tommerdahl, M (corresponding author), Univ N Carolina, Dept Biomed Engn, CB 7575, Chapel Hill, NC 27599 USA.	Mark_Tommerdahl@med.unc.edu		Favorov, Oleg V./0000-0002-8963-8339; Nguyen, Ruby/0000-0002-6598-8457	Office of Naval ResearchOffice of Naval Research	Partial support for the work was provided by the Office of Naval Research and through an award made to Cortical Metrics, PLC as one of the winners of the GE NFL Head Health Challenge.	ABEL SM, 1972, J ACOUST SOC AM, V52, P519, DOI 10.1121/1.1913139; ALLAN LG, 1971, PERCEPT PSYCHOPHYS, V9, P327, DOI 10.3758/BF03212659; ALLAN LG, 1974, PERCEPT PSYCHOPHYS, V16, P26, DOI 10.3758/BF03203244; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Bernstein HG, 2009, EXPERT REV NEUROTHER, V9, P1059, DOI 10.1586/ERN.09.59; Bizo LA, 2006, BEHAV PROCESS, V71, P201, DOI 10.1016/j.beproc.2005.11.006; Blakely W. A., 1933, DISCRIMINATION SHORT; Cannestra AF, 1998, J NEUROPHYSIOL, V80, P1522, DOI 10.1152/jn.1998.80.3.1522; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Chiu J., 2006, THESIS; Chiu JS, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-47; CLAUSEN J, 1950, J EXP PSYCHOL, V40, P756, DOI 10.1037/h0056354; CONNOR CE, 1990, J NEUROSCI, V10, P3823, DOI 10.1523/JNEUROSCI.10-12-03823.1990; CORNSWEET TN, 1965, J PHYSIOL-LONDON, V176, P294, DOI 10.1113/jphysiol.1965.sp007551; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; DENSEN ME, 1977, PERCEPT MOTOR SKILL, V44, P436, DOI 10.2466/pms.1977.44.2.436; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Folger SE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-87; Francisco E, 2008, EXP BRAIN RES, V191, P49, DOI 10.1007/s00221-008-1494-6; Francisco E, 2011, BRAIN RES, V1415, P76, DOI 10.1016/j.brainres.2011.07.043; Gescheider GA, 1997, SOMATOSENS MOT RES, V14, P181; GESCHEIDER GA, 1990, J ACOUST SOC AM, V87, P330, DOI 10.1121/1.399300; Gescheider GA, 1996, SOMATOSENS MOT RES, V13, P73, DOI 10.3109/08990229609028914; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Gosselin RD, 2010, NEUROSCIENTIST, V16, P519, DOI 10.1177/1073858409360822; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1991, P NATL ACAD SCI USA, V88, P11559, DOI 10.1073/pnas.88.24.11559; Grondin S., 2001, Acoustical Science and Technology, V22, P370, DOI 10.1250/ast.22.370; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P1422, DOI 10.3758/APP.72.5.1422; Guclu B, 2011, PSYCHOL REP, V108, P675, DOI 10.2466/11.22.27.PR0.108.3.675-687; HALPERN AR, 1982, PERCEPT PSYCHOPHYS, V31, P86, DOI 10.3758/BF03206204; HANNA TE, 1986, J ACOUST SOC AM, V80, P1335, DOI 10.1121/1.394385; HARRIS JD, 1952, J ACOUST SOC AM, V24, P750, DOI 10.1121/1.1906970; HENRY FM, 1948, J EXP PSYCHOL, V38, P734, DOI 10.1037/h0058552; Hirsch EC, 1998, ANN NEUROL, V44, pS115, DOI 10.1002/ana.410440717; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Holden JK, 2012, J NEUROSCI METH, V204, P215, DOI 10.1016/j.jneumeth.2011.11.007; Holthoff K, 1996, J NEUROSCI, V16, P2740, DOI 10.1523/jneurosci.16-08-02740.1996; Kohn A, 2000, NEUROSCIENCE, V95, P51; Kristofferson A. B., 1973, ATTENTION PERFORM, VIV, P737; Kwakye LD, 2011, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00129; Lapid E, 2008, PERCEPT PSYCHOPHYS, V70, P291, DOI 10.3758/PP.70.2.291; Lavoie P, 2004, BRAIN COGNITION, V54, P198, DOI 10.1016/j.bandc.2004.02.039; Lee J, 2005, J NEUROPHYSIOL, V94, P852, DOI 10.1152/jn.00976.2004; LHAMON WT, 1956, ARCH NEURO PSYCHIATR, V76, P625, DOI 10.1001/archneurpsyc.1956.02330300055008; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; MCGILL WJ, 1968, PERCEPT PSYCHOPHYS, V4, P105, DOI 10.3758/BF03209518; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Mioni G, 2013, BRAIN COGNITION, V81, P305, DOI 10.1016/j.bandc.2012.12.005; Mioni G, 2013, J CLIN EXP NEUROPSYC, V35, P90, DOI 10.1080/13803395.2012.755151; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Nguyen RH, 2013, BRAIN RES, V1498, P50, DOI 10.1016/j.brainres.2012.12.043; Nguyen RH, 2013, BRAIN RES, V1492, P53, DOI 10.1016/j.brainres.2012.11.021; Pardo CA, 2006, INT REV PSYCHIATR, V17, P485, DOI 10.1080/02646830500381930; Puts NAJ, 2013, J NEUROSCI METH, V218, P39, DOI 10.1016/j.jneumeth.2013.04.012; Rammsayer T, 2006, TEMPORAL INFORM PROC; Rammsayer T. H., 2010, P FECHNER DAY, V26, P439; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rammsayer T, 2012, CAN J EXP PSYCHOL, V66, P26, DOI 10.1037/a0025349; Rammsayer TH, 2014, ATTEN PERCEPT PSYCHO, V76, P1185, DOI 10.3758/s13414-014-0655-x; Rammsayer TH, 2010, ATTEN PERCEPT PSYCHO, V72, P1591, DOI 10.3758/APP.72.6.1591; Rothermundt M, 2004, MOL PSYCHIATR, V9, P897, DOI 10.1038/sj.mp.4001548; ROUSSEAU R, 1973, B PSYCHONOMIC SOC, V1, P115; SAGAR HJ, 1988, BRAIN, V111, P525, DOI 10.1093/brain/111.3.525; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Scholtyssek C, 2008, VISION RES, V48, P96, DOI 10.1016/j.visres.2007.10.012; Simons SB, 2007, J NEUROPHYSIOL, V97, P2121, DOI 10.1152/jn.00513.2006; Simons SB, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-43; SNOWDEN RJ, 1991, VISION RES, V31, P907, DOI 10.1016/0042-6989(91)90156-Y; STILLMAN JA, 1993, J ACOUST SOC AM, V93, P425, DOI 10.1121/1.405622; STONE H, 1965, PERCEPT MOTOR SKILL, V20, P657, DOI 10.2466/pms.1965.20.2.657; Stott L. H., 1933, DISCRIMINATION SHORT; Tannan V, 2007, BRAIN RES, V1186, P164, DOI 10.1016/j.brainres.2007.10.024; Tannan V, 2007, J NEUROSCI METH, V164, P131, DOI 10.1016/j.jneumeth.2007.04.011; Tannan V, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-18; Tannan V, 2006, BRAIN RES, V1102, P109, DOI 10.1016/j.brainres.2006.05.037; Tannan V, 2008, AUTISM RES, V1, P223, DOI 10.1002/aur.34; Teismann P, 2003, MOVEMENT DISORD, V18, P121, DOI 10.1002/mds.10332; Tommerdahl M, 2007, BRAIN RES, V1154, P116, DOI 10.1016/j.brainres.2007.04.032; Tommerdahl M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-19; Tommerdahl M, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-61; Tommerdahl M, 2010, NEUROSCI BIOBEHAV R, V34, P160, DOI 10.1016/j.neubiorev.2009.08.009; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VRIEZEN ER, 1990, NEUROPSYCHOLOGIA, V28, P1283, DOI 10.1016/0028-3932(90)90044-O; WAHL OF, 1980, PERCEPT MOTOR SKILL, V50, P535, DOI 10.2466/pms.1980.50.2.535; WEINSTEIN AD, 1958, J ABNORM SOC PSYCH, V57, P241, DOI 10.1037/h0043027; WHITTLE P, 1986, VISION RES, V26, P1677, DOI 10.1016/0042-6989(86)90055-6; Zhang Z, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-12; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zhang Z, 2011, CLIN J PAIN, V27, P755, DOI 10.1097/AJP.0b013e31821c98ec; Zhang Z, 2009, BRAIN RES, V1302, P97, DOI 10.1016/j.brainres.2009.09.037	94	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-5137		FRONT SYST NEUROSCI	Front. Syst. Neurosci.	MAY 21	2015	9								77	10.3389/fnsys.2015.00077			11	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	CU9AC	WOS:000363834200001	26052273	Green Published, gold			2022-02-06	
J	Gay, M; Ray, W; Johnson, B; Teel, E; Geronimo, A; Slobounov, S				Gay, Michael; Ray, William; Johnson, Brian; Teel, Elizabeth; Geronimo, Andrew; Slobounov, Semyon			Feasibility of EEG Measures in Conjunction With Light Exercise for Return-to-Play Evaluation After Sports-Related Concussion	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; 1ST	Current clinical assessment of sports-related concussion and the determination of "Return-to-Play" lacks assessment of the pathophysiological processes affecting the concussed brain. The objective of this study was to demonstrate the feasibility of electroencephalogram measures that detect neuronal damage and monitor the healing process, giving an improved approximation of pathophysiological recovery.	[Gay, Michael; Johnson, Brian; Teel, Elizabeth; Slobounov, Semyon] Penn State Univ, Dept Kinesiol, University Pk, PA 16802 USA; [Ray, William] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Geronimo, Andrew] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA		Gay, M (corresponding author), Penn State Univ, Dept Kinesiol, 19 Recreation Bldg, University Pk, PA 16802 USA.	mrg201@psu.edu		Gay, Michael/0000-0002-9192-8271; Teel, Elizabeth/0000-0002-2846-5884	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS056227] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS056227] Funding Source: Medline		Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Babiloni C, 2009, NEUROBIOL AGING, V30, P93, DOI 10.1016/j.neurobiolaging.2007.05.007; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bates AT, 2009, SCHIZOPHR RES, V115, P222, DOI 10.1016/j.schres.2009.09.036; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Crabbe JB, 2004, PSYCHOPHYSIOLOGY, V41, P563, DOI 10.1111/j.1469-8986.2004.00176.x; Fenton G, 1996, CLIN ELECTROENCEPHAL, V27, P955; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Jaiswal N, 2010, BRAIN RES, V1347, P80, DOI 10.1016/j.brainres.2010.05.086; Korb AS, 2008, BRAIN TOPOGR, V21, P138, DOI 10.1007/s10548-008-0070-5; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; MCCLELLAND RJ, 1994, J ROY SOC MED, V87, P508; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; Nagata K., 1990, IEEEE WORKSH 25 EL I, pS49; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Schneider S, 2010, MED SCI SPORT EXER, V42, P600, DOI 10.1249/MSS.0b013e3181b76ac8; Schneider S, 2009, PHYSIOL BEHAV, V98, P447, DOI 10.1016/j.physbeh.2009.07.010; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002	25	5	5	0	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.	MAY 19	2015	40	4					248	253		10.1080/87565641.2015.1014486			6	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	CN0WL	WOS:000358134600004	26179490	Green Accepted			2022-02-06	
J	Hong, S; Nho, JH; Lee, CJ; Kim, JB; Kim, B; Choi, HS				Hong, Sijohn; Nho, Jae-Hwi; Lee, Chang-Ju; Kim, Jun-Bum; Kim, ByungSung; Choi, Hyung-Suk			Posterior shoulder dislocation with ipsilateral proximal humerus type 2 physeal fracture: case report	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						humeral head; ipsilateral fracture and dislocation; posterior dislocation; Salter-Harris type II; type 2 physeal fracture	PROGNOSIS; CHILD	In pediatric patients, proximal humeral physeal fractures are uncommon injuries compared with distal physeal fractures. Usually, the growth plate is the most vulnerable site of fracture in the proximal humerus. Proximal humeral physeal fractures accompanying posterior shoulder dislocation are very rare. There are few recent reports on the combination of glenohumeral dislocation and proximal humerus fractures. Here, we describe a case of posterior shoulder dislocation with ipsilateral proximal humerus type 2 physeal fracture in a 9-year-old boy. We treated the patient by closed reduction and percutaneous pinning under general anesthesia. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.	[Hong, Sijohn; Nho, Jae-Hwi; Lee, Chang-Ju; Kim, Jun-Bum; Kim, ByungSung; Choi, Hyung-Suk] Soonchunhyang Univ Hosp, Dept Orthopaed Surg, Cheonan Si 330721, South Korea		Nho, JH (corresponding author), Soonchunhyang Univ Hosp, Dept Orthopaed Surg, 31 Soonchunhyang 6 Gil, Cheonan Si 330721, South Korea.	huuy@schmc.ac.kr	Nho, Jae-Hwi/A-3108-2017	Nho, Jae-Hwi/0000-0003-1053-456X	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund.	Cunningham Neil J, 2005, Emerg Med Australas, V17, P463, DOI 10.1111/j.1742-6723.2005.00778.x; HOHL JC, 1976, ORTHOP CLIN N AM, V7, P557; HOVELIUS L, 1987, J BONE JOINT SURG AM, V69A, P393; JASCHKE W, 1981, ZBL CHIR, V106, P618; Landin LA, 1997, J PEDIATR ORTHOP B, V6, P79, DOI 10.1097/01202412-199704000-00002; LEMPERG R, 1970, ACTA PAEDIATR SCAND, V59, P377, DOI 10.1111/j.1651-2227.1970.tb15531.x; Neer C S 2nd, 1965, Clin Orthop Relat Res, V41, P24; NICASTRO JF, 1982, J PEDIATR ORTHOPED, V2, P427, DOI 10.1097/01241398-198210000-00015; OBREMSKEY W, 1994, J TRAUMA, V36, P137, DOI 10.1097/00005373-199401000-00027; ROWE CR, 1956, J BONE JOINT SURG AM, V38, P957, DOI 10.2106/00004623-195638050-00001; Salter R B, 1992, Instr Course Lect, V41, P351; SHULMAN BH, 1951, PEDIATRICS, V8, P693	12	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	MAY	2015	24	3					215	218		10.1097/BPB.0000000000000160			4	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	CE8FZ	WOS:000352078400007	25714939				2022-02-06	
J	Lee, H; Sullivan, SJ; Schneiders, AG				Lee, Hopin; Sullivan, S. John; Schneiders, Anthony G.			Does a standardised exercise protocol incorporating a cognitive task provoke postconcussion-like symptoms in healthy individuals?	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Brain concussion; Postconcussion symptoms; Exercise; Cognitive load; Return-to-play	REPETITIVE HEAD-INJURY; CONCUSSION; MEMORY	Objectives: To explore whether an exercise protocol, alone and in combination with two selected cognitive tasks related to working memory, provokes postconcussion-like symptoms in healthy individuals. Design: Prospective single cohort semi-randomised crossover repeated measures (time x condition) design. Methods: 36 healthy individuals completed three submaximal exercise protocol conditions, namely: exercise alone, exercise with the paced auditory serial addition task, and exercise with Tetris. Self-reported symptoms were measured before exercise and 1-min and 15-min after the cessation of each exercise protocol using the Sports Concussion Assessment Tool 2-Postconcussion symptoms scale. Results: Analysis of variance indicated a significant increase in symptom scores over time (p < 0.001), but no effect between conditions (p = 0.371) or a significant time x condition interaction (p = 0.444). Conclusions: The combination of working memory tasks and a symptom provoking submaximal exercise protocol did not have an additional effect on the provocation of self-reported symptoms in healthy individuals. Furthermore, the two distinct methods of cognitive load delivery, controlled (paced auditory serial addition task) and pragmatic (Tetris), did not lead to a differential symptom response. These findings provide an initial insight into the scientific foundations for the symptom provocation model that is integral to the currently accepted clinical postconcussion return-to-play protocol. (C) 2014 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Lee, Hopin; Sullivan, S. John; Schneiders, Anthony G.] Univ Otago, Ctr Physiotherapy Res, Dunedin, New Zealand; [Lee, Hopin] Neurosci Res Australia NeuRA, Sydney, NSW, Australia; [Lee, Hopin] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Schneiders, Anthony G.] Cent Queensland Univ, Sch Human Hlth & Social Sci, Rockhampton, Qld 4702, Australia		Lee, H (corresponding author), Univ Otago, Ctr Physiotherapy Res, Dunedin, New Zealand.	hopinlee@gmail.com	Schneiders, Anthony/F-4212-2015	Schneiders, Anthony/0000-0002-1583-3879; Lee, Hopin/0000-0001-5692-0314			Akst J, 2011, SCIENTIST, V25; Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; Alla S, 2010, DEV VALIDATION OTAGO; Alla S, 2012, BRIT J SPORT MED, V46, P562, DOI 10.1136/bjsm.2010.081299; Alla S, 2011, BRIT J SPORT MED, V45, P132, DOI 10.1136/bjsm.2010.074088; Alla S, 2010, J SCI MED SPORT, V13, P24, DOI 10.1016/j.jsams.2008.12.629; BENGTSSON E, 1956, ACTA MED SCAND, V154, P91; Boot WR, 2008, ACTA PSYCHOL, V129, P387, DOI 10.1016/j.actpsy.2008.09.005; BORG G, 1987, EUR J APPL PHYSIOL O, V56, P679, DOI 10.1007/BF00424810; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Dwyer G., 2008, ACSMS HLTH RELATED P, VSecond; Furley P.A., 2010, INT REV SPORT EXER P, V3, P171, DOI [https://doi.org/10.1080/1750984X.2010.526238, DOI 10.1080/1750984X.2010.526238]; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; GOUVIER WD, 1992, ARCH CLIN NEUROPSYCH, V7, P193, DOI 10.1016/0887-6177(92)90162-G; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Holmes EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004153; Lee H, 2013, J SCI MED SPORT, V16, P2, DOI 10.1016/j.jsams.2012.03.013; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory Paul, 2005, Clin J Sport Med, V15, P48; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Quinn JG, 2008, COGN PROCESS, V9, P35, DOI 10.1007/s10339-007-0184-9; Sabini RC, 2011, PHYSICIAN SPORTSMED, V39, P23, DOI 10.3810/psm.2011.09.1917; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tombaugh TN, 2004, J CLIN EXP NEUROPSYC, V26, P257, DOI 10.1076/jcen.26.2.257.28080	30	5	5	1	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2015	18	3					245	249		10.1016/j.jsams.2014.04.003			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	CH4MS	WOS:000354008200003	24801275				2022-02-06	
J	Zazulia, A				Zazulia, Allyson			Antiplatelet and Anticoagulant Therapy After Intracerebral Hemorrhage	NEUROLOGIC CLINICS			English	Article						Intracerebral hemorrhage; Anticoagulation; Antiplatelet therapy; Atrial fibrillation; Prosthetic heart valve; Venous thromboembolism	VENOUS THROMBOEMBOLISM PROPHYLAXIS; TRAUMATIC BRAIN-INJURY; LONG-TERM PROGNOSIS; INTRACRANIAL HEMORRHAGE; ATRIAL-FIBRILLATION; PULMONARY-EMBOLISM; PREDICTING STROKE; RECURRENT STROKE; HEPARIN-THERAPY; RISK-FACTOR	Management of patients with an indication for long-term oral antithronnbotic therapy who have an intracerebral hemorrhage (ICH) presents a therapeutic dilemma. Should antithrombotic therapy be resumed, and if so, when, using what agent, and for whom? There is no consensus for answers to these questions. In the absence of randomized trials, management of antithrombotic therapy after ICH is based on a combination of observational data, pathophysiologic concepts, and decision analysis. At the heart of the decision is an assessment of the individual patient's risk of thromboembolism off antithrombotic therapy versus risk of ICH recurrence on antithrombotic therapy.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA		Zazulia, A (corresponding author), Washington Univ, Sch Med, Dept Neurol, 660 South Euclid Ave,Campus Box 8111, St Louis, MO 63110 USA.	zazuliaa@neuro.wustl.edu					Aguilar MI, 2007, MAYO CLIN PROC, V82, P82, DOI 10.1016/s0025-6196(11)60970-1; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Bailey RD, 2001, NEUROLOGY, V56, P773, DOI 10.1212/WNL.56.6.773; BECKER DM, 1992, ARCH INTERN MED, V152, P1985, DOI 10.1001/archinte.152.10.1985; Berwaerts J, 2000, STROKE, V31, P2558, DOI 10.1161/01.STR.31.11.2558; Biffi A, 2010, Neurology, V75, P693, DOI 10.1212/WNL.0b013e3181eee40f; BOEER A, 1991, J NEUROL NEUROSUR PS, V54, P466, DOI 10.1136/jnnp.54.5.466; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Campbell PG, 2011, WORLD NEUROSURG, V76, P100, DOI 10.1016/j.wneu.2011.02.010; CANNEGIETER SC, 1995, NEW ENGL J MED, V333, P11, DOI 10.1056/NEJM199507063330103; CANNEGIETER SC, 1994, CIRCULATION, V89, P635, DOI 10.1161/01.CIR.89.2.635; CHAMORRO A, 1995, NEUROLOGY, V45, P861, DOI 10.1212/WNL.45.5.861; CHEN ST, 1995, ACTA NEUROL SCAND, V91, P128; Chong BH, 2012, THROMB HAEMOSTASIS, V107, P241, DOI 10.1160/TH11-06-0439; Claassen DO, 2008, ARCH NEUROL-CHICAGO, V65, P1313, DOI 10.1001/archneur.65.10.1313; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; COUNSELL C, 1995, CEREBROVASC DIS, V5, P26, DOI 10.1159/000107814; de Jong G, 2002, STROKE, V33, P2072, DOI 10.1161/01.STR.0000022807.06923.A3; De Vleeschouwer S, 2005, ACTA CHIR BELG, V105, P268; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; DICKMANN U, 1988, KLIN WOCHENSCHR, V66, P1182, DOI 10.1007/BF01727666; Eckman MH, 2011, CIRC-CARDIOVASC QUAL, V4, P14, DOI 10.1161/CIRCOUTCOMES.110.958108; Eckman MH, 2003, STROKE, V34, P1710, DOI 10.1161/01.STR.0000078311.18928.16; Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Fang MC, 2004, ANN INTERN MED, V141, P745, DOI 10.7326/0003-4819-141-10-200411160-00005; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Flynn RWV, 2010, STROKE, V41, P2606, DOI 10.1161/STROKEAHA.110.589143; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Fukuda T, 2012, THROMB HAEMOSTASIS, V107, P253, DOI 10.1160/TH11-09-0668; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Goldstein JN, 2008, NEUROCRIT CARE, V9, P277, DOI 10.1007/s12028-008-9049-z; Gorelick PB, 2005, STROKE, V36, P1801, DOI 10.1161/01.STR.0000174189.81153.85; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; Hanger HC, 2007, J NEUROL NEUROSUR PS, V78, P836, DOI 10.1136/jnnp.2006.106500; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hart RG, 1999, CEREBROVASC DIS, V9, P215, DOI 10.1159/000015958; Hart RG, 2000, NEUROLOGY, V55, P907, DOI 10.1212/WNL.55.7.907; Hawryluk GWJ, 2010, J THROMB HAEMOST, V8, P1500, DOI 10.1111/j.1538-7836.2010.03882.x; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Huhtakangas J, 2013, STROKE, V44, P585, DOI 10.1161/STROKEAHA.112.671230; HULL RD, 1994, ARCH INTERN MED, V154, P289, DOI 10.1001/archinte.154.3.289; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Keir SL, 2002, CEREBROVASC DIS, V14, P197, DOI 10.1159/000065661; Kelly J, 2003, STROKE, V34, P2999, DOI 10.1161/01.STR.0000102561.86835.17; Kim JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089798; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Kurtoglu M, 2004, WORLD J SURG, V28, P807, DOI 10.1007/s00268-004-7295-6; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Labaf A, 2014, THROMB RES, V134, P354, DOI 10.1016/j.thromres.2014.06.007; Lacut K, 2005, NEUROLOGY, V65, P865, DOI 10.1212/01.wnl.0000176073.80532.a2; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lu GM, 2013, NAT MED, V19, P446, DOI 10.1038/nm.3102; Maeda K, 2012, J NEUROL SCI, V312, P82, DOI 10.1016/j.jns.2011.08.017; Martin M, 2013, ANN EMERG MED, V61, P58, DOI 10.1016/j.annemergmed.2012.03.025; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Naka H, 2013, J STROKE CEREBROVASC, V22, P834, DOI 10.1016/j.jstrokecerebrovasdis.2012.06.001; Ogata T, 2008, J NEUROL SCI, V272, P83, DOI 10.1016/j.jns.2008.04.032; Orken DN, 2009, NEUROLOGIST, V15, P329, DOI 10.1097/NRL.0b013e3181a93bac; Paciaroni M, 2011, J THROMB HAEMOST, V9, P893, DOI 10.1111/j.1538-7836.2011.04241.x; Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Poli D, 2014, NEUROLOGY, V82, P1020, DOI 10.1212/WNL.0000000000000245; Romualdi E, 2009, THROMB HAEMOSTASIS, V101, P290, DOI 10.1160/TH08-07-0474; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Salman RA, 2014, STROKE, V45, P3149, DOI 10.1161/STROKEAHA.114.005786; Sansing LH, 2009, NEUROLOGY, V72, P1397, DOI 10.1212/01.wnl.0000342709.31341.88; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Smith EE, 2004, NEUROLOGY, V63, P1606, DOI 10.1212/01.WNL.0000142966.22886.20; Tardy B, 1996, EUR RESPIR J, V9, P2012, DOI 10.1183/09031936.96.09102012; Taylor DW, 1999, LANCET, V353, P2179, DOI 10.1016/S0140-6736(99)05388-X; Tetri S, 2008, THROMB RES, V123, P206, DOI 10.1016/j.thromres.2008.01.018; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Ueno H, 2008, AM J NEURORADIOL, V29, P1483, DOI 10.3174/ajnr.A1120; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Viswanathan A, 2006, NEUROLOGY, V66, P206, DOI 10.1212/01.wnl.0000194267.09060.77; Wasay Mohammad, 2008, J Pak Med Assoc, V58, P362; Weimar C, 2011, CEREBROVASC DIS, V32, P283, DOI 10.1159/000330643; Whitlock RP, 2012, CHEST, V141, pE576S, DOI 10.1378/chest.11-2305; Yamagishi K, 2013, CEREBROVASC DIS, V36, P38, DOI [10.1159/000351151, 10.1159/000351205]; Yasaka M, 2003, THROMB HAEMOSTASIS, V89, P278; Yeh SJ, 2014, STROKE, V45, P2636, DOI 10.1161/STROKEAHA.114.005598; Yokota C, 2004, CEREBROVASC DIS, V18, P111, DOI 10.1159/000079258; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324; Zilliacus H, 1946, ACTA MED SCANDINAV S, V171, P1; Zimetbaum PJ, 2010, AM J MED, V123, P446, DOI 10.1016/j.amjmed.2009.11.015	92	5	5	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	MAY	2015	33	2					329	+		10.1016/j.ncl.2014.12.005			18	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CI3RI	WOS:000354664700004	25907909				2022-02-06	
J	Arbour, RB; Dissin, J				Arbour, Richard B.; Dissin, Jonathan			Predictive Value of the Bispectral Index for Burst Suppression on Diagnostic Electroencephalogram During Drug-Induced Coma	JOURNAL OF NEUROSCIENCE NURSING			English	Article						bispectral index; EEG burst suppression; metabolic suppression therapy; suppression ratio	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; SEDATION; MONITOR; EEG; ANESTHESIA; PROPOFOL	Study Purpose: To determine correlation and predictive value between data obtained with the bispectral index (BIS) and diagnostic electroencephalogram (EEG) in determining degree of burst suppression during drug-induced coma. This study seeks to answer the question: To what degree can EEG suppression and burst count as measured by diagnostic EEG during drug-induced coma be predicted from data obtained from the BIS such as BIS value, suppression ratio (SR), and burst count? Background/Significance: During drug-induced coma, cortical EEG is the gold standard for real-time monitoring and drug titration. Diagnostic EEG is, from setup through data analysis, labor intensive, costly, and difficult to maintain uniform clinician competency. BIS monitoring is less expensive, less labor-intensive, and easier to interpret data and establish/maintain competency. Validating BIS data versus diagnostic EEG facilitates effective brain monitoring during drug-induced coma at lower cost with similar outcomes. Method: This is a prospective, observational cohort study. Four consecutive patients receiving drug-induced coma/EEG monitoring were enrolled. BIS was initiated after informed consent. Variables recorded per minute included presence or absence of EEG burst suppression, burst count, BIS value over time, burst count, and SR. Pearson's product-moment and Spearman rank coefficient for BIS value and SR versus burst count were performed. Regression analysis was utilized to plot BIS values versus bursts/minute on EEG as well as SR versus burst count on EEG. EEG/BIS data were collected from digital data files and transcribed onto data sheets for corresponding time indices. Results: Four patients yielded 1,972 data sets over 33 hours of EEG/BIS monitoring. Regression coefficient of 0.6673 shows robust predictive value between EEG burst count and BIS SR. Spearman rank coefficient of -0.8727 indicates strong inverse correlation between EEG burst count and BIS SR. Pearson's correlation coefficient between EEG versus BIS burst count was .8256 indicating strong positive correlation. Spearman's rank coefficient of 0.8810 and Pearson's correlation coefficient of .6819 showed strong correlation between BIS value versus EEG burst count. Number of patients (4) limits available statistics and ability to generalize results. Graphs and statistics show strong correlation/predictive value for BIS parameters to EEG suppression. Conclusions: This study is the first to measure correlation and predictive value between BIS monitoring and diagnostic EEG for degree of EEG suppression and burst count in the adult population. Available statistic tests and graphing of variables from BIS and diagnostic EEG show strong correlation and predictive value between both monitoring technologies during drug-induced coma. These support using BIS value, SR, and burst count to predict degree of EEG suppression in real time for titrating metabolic suppression therapy.	[Arbour, Richard B.] Lancaster Gen Hosp, Lancaster, PA 17602 USA; [Dissin, Jonathan] Einstein Healthcare Network, Clin Stroke Serv, Philadelphia, PA USA		Arbour, RB (corresponding author), Lancaster Gen Hosp, Lancaster, PA 17602 USA.	RichNrs@aol.com					Anderson J, 2010, CLIN NURSE SPEC, V24, P140, DOI 10.1097/NUR.0b013e3181d82a48; Arbour R, 2004, AM J CRIT CARE, V13, P66, DOI 10.4037/ajcc2004.13.1.66; Arbour R., 2009, MONITORING TECHNOLOG, P175; Arbour Richard, 2006, Crit Care Nurs Clin North Am, V18, P227, DOI 10.1016/j.ccell.2006.02.001; Arbour Richard, 2003, AACN Clin Issues, V14, P185, DOI 10.1097/00044067-200305000-00009; Arbour RB, 2013, CRIT CARE NURS CLIN, V25, P297, DOI 10.1016/j.ccell.2013.02.010; Azim N, 2004, ANAESTHESIA, V59, P610, DOI 10.1111/j.1365-2044.2004.03736.x; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Claassen J, 2012, NEUROCRIT CARE, V17, P73, DOI 10.1007/s12028-012-9758-1; Courtman SP, 2003, INTENS CARE MED, V29, P2239, DOI 10.1007/s00134-003-1997-3; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Deogaonkar A, 2004, CRIT CARE MED, V32, P2403, DOI 10.1097/01.CCM.0000147442.14921.A5; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Honeybul S, 2011, J NEUROSURG SCI, V55, P343; Jaggi P, 2003, PEDIATR NEUROL, V28, P219, DOI 10.1016/S0887-8994(02)00633-1; Kennedy JD, 2012, CURR NEUROL NEUROSCI, V12, P419, DOI 10.1007/s11910-012-0289-0; Legriel S, 2009, NEUROCRIT CARE, V11, P338, DOI 10.1007/s12028-009-9246-4; Mondello Epifanio, 2002, J Clin Monit Comput, V17, P271, DOI 10.1023/A:1021250320103; Mourisse J, 2003, J CARDIOTHOR VASC AN, V17, P76, DOI 10.1053/jcan.2003.14; Ogilvie MP, 2011, J TRAUMA, V71, P1415, DOI 10.1097/TA.0b013e3182178b8b; Prins SA, 2007, CRIT CARE, V11, DOI 10.1186/cc6138; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Rhoney DH, 2001, NEUROL RES, V23, P237, DOI 10.1179/016164101101198398; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Roest A, 2009, NEUROCRIT CARE, V10, P318, DOI 10.1007/s12028-008-9178-4; ROSOW C, 1998, ANESTHESIOL CLIN N A, V2, P89; Sutter R, 2013, CRIT CARE MED, V41, P1124, DOI 10.1097/CCM.0b013e318275882f; Vivien B, 2002, ANESTH ANALG, V95, P1824, DOI 10.1097/00000539-200212000-00082; Wallace BE, 2001, J HEAD TRAUMA REHAB, V16, P165, DOI 10.1097/00001199-200104000-00006	30	5	5	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2015	47	2					113	122		10.1097/JNN.0000000000000124			10	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	CC7VU	WOS:000350577300009	25629593				2022-02-06	
J	Ayaz, SI; Thomas, C; Kulek, A; Tolomello, R; Mika, V; Robinson, D; Medado, P; Pearson, C; Prichep, LS; O'Neil, BJ				Ayaz, Syed Imran; Thomas, Craig; Kulek, Andrew; Tolomello, Rosa; Mika, Valerie; Robinson, Duane; Medado, Patrick; Pearson, Claire; Prichep, Leslie S.; O'Neil, Brian J.			Comparison of quantitative EEG to current clinical decision rules for head CT use in acute mild traumatic brain injury in the ED	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	Scientific Assembly Research Forum of the American-College-of-Emergency-Physicians (ACEP)	OCT 14-15, 2013	Seattle, WA	Amer Coll Emergency Phys			NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; ELECTRICAL-ACTIVITY; EMERGENCY-DEPARTMENT; MANAGEMENT; ADULTS; CLASSIFICATION; PERFORMANCE; CONCUSSION; GUIDELINES	Study objective: We compared the performance of a handheld quantitative electroencephalogram (QEEG) acquisition device to New Orleans Criteria (NOC), Canadian CT Head Rule (CCHR), and National Emergency X-Radiography Utilization Study II (NEXUS II) Rule in predicting intracranial lesions on head computed tomography (CT) in acute mild traumatic brain injury in the emergency department (ED). Methods: Patients between 18 and 80 years of age who presented to the ED with acute blunt head trauma were enrolled in this prospective observational study at 2 urban academic EDs in Detroit, MI. Data were collected for 10 minutes from frontal leads to determine a QEEG discriminant score that could maximally classify intracranial lesions on head CT. Results: One hundred fifty-two patients were enrolled from July 2012 to February 2013. A total 17.1% had acute traumatic intracranial lesions on head CT. Quantitative electroencephalogram discriminant score of greater than or equal to 31 was found to be a good cutoff (area under receiver operating characteristic curve = 0.84; 95% confidence interval [CI], 0.76-0.93) to classify patients with positive head CT. The sensitivity of QEEG discriminant score was 92.3 (95% CI, 73.4-98.6), whereas the specificity was 57.1 (95% CI, 48.0-65.8). The sensitivity and specificity of the decision rules were as follows: NOC 96.1 (95% CI, 78.4-99.7) and 15.8 (95% CI, 10.1-23.6); CCHR 46.1 (95% CI, 27.1-66.2) and 86.5 (95% CI, 78.9-91.7); NEXUS II 96.1 (95% CI, 78.4-99.7) and 31.7 (95% CI, 23.9-40.7). Conclusion: At a sensitivity of greater than 90%, QEEG discriminant score had better specificity than NOC and NEXUS II. Only CCHR had better specificity than QEEG discriminant score but at the cost of low (<50%) sensitivity. (C) 2014 Elsevier Inc. All rights reserved.	[Ayaz, Syed Imran; Thomas, Craig; Kulek, Andrew; Tolomello, Rosa; Mika, Valerie; Robinson, Duane; Medado, Patrick; Pearson, Claire; O'Neil, Brian J.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI 48201 USA; [Prichep, Leslie S.] NYU, Sch Med, Dept Psychiat, Brain Res Labs, New York, NY 10016 USA; [O'Neil, Brian J.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA		Ayaz, SI (corresponding author), Wayne State Univ, Sch Med, Dept Emergency Med, 4201 St Antoine,UHC 6G, Detroit, MI 48201 USA.	sayaz@med.wayne.edu	Mika, Valerie H./AAO-2816-2020				Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Boyle A, 2004, EMERG MED J, V21, P426, DOI 10.1136/emj.2002.002063; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; DeRenzo EG, 1998, J HLTH CARE LAW POLI, V1, P66; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Faul M, 2010, TRAUMATIC BRAIN INJU; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; National Collaborating Centre for Acute Care, 2007, NAT I HLTH CLIN EXC; Naunheim RS, 2011, AM J EMERG MED, V29, P845, DOI 10.1016/j.ajem.2010.03.010; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; O'Neil B, 2012, WEST J EMERG MED, V13, P394, DOI 10.5811/westjem.2011.12.6815; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Prichep LS, 2012, IEEE T NEUR SYS REH, V20, P806, DOI 10.1109/TNSRE.2012.2206609; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Semelka RC, 2007, J MAGN RESON IMAGING, V25, P900, DOI 10.1002/jmri.20895; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Shravat BP, 2006, EMERG MED J, V23, P109, DOI 10.1136/emj.2004.022327; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353	31	5	6	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757	1532-8171		AM J EMERG MED	Am. J. Emerg. Med.	APR	2015	33	4					493	496		10.1016/j.ajem.2014.11.015			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	CG6BP	WOS:000353380800003	25727167				2022-02-06	
J	Bennett, TD; Bratton, SL; Riva-Cambrin, J; Scaife, ER; Nance, ML; Prince, JS; Wilkes, J; Keenan, HT				Bennett, Tellen D.; Bratton, Susan L.; Riva-Cambrin, Jay; Scaife, Eric R.; Nance, Michael L.; Prince, Jeffrey S.; Wilkes, Jacob; Keenan, Heather T.			Cervical Spine Imaging in Hospitalized Children With Traumatic Brain Injury	PEDIATRIC EMERGENCY CARE			English	Article						craniocerebral trauma; spinal cord injuries; neck injuries	BLUNT TRAUMA; COMPUTED-TOMOGRAPHY; THERAPY; ASSOCIATION; MULTICENTER; MANAGEMENT; CLEARANCE; SURGERY; CANCER; RISK	Objectives: The purposes of this study, in children with traumatic brain injury (TBI), to describe cervical spine imaging practice, to assess for recent changes in imaging practice, and to determine whether cervical spine computed tomography (CT) is being used in children at low risk for cervical spine injury. Methods: The setting was children's hospitals participating in the Pediatric Health Information System database, from January 2001 to June 2011. Participants were children (younger than 18 y) with TBI who were evaluated in the emergency department, admitted to the hospital, and received a head CT scan on the day of admission. The primary outcome measures were cervical spine imaging studies. This study was exempted frominstitutional review board assessment. Results: A total of 30,112 children met study criteria. Overall, 52% (15,687/30,112) received cervical spine imaging. The use of cervical spine radiographs alone decreased between 2001 (47%) and 2011 (23%), with an annual decrease of 2.2% (95% confidence interval [CI], 1.1%-3.3%), and was largely replaced by an increased use of CT, with orwithout radiographs (8.6% in 2001 and 19.5% in 2011, with an annual increase of 0.9%; 95% CI, 0.1%-1.8%). A total of 2545 children received cervical spine CT despite being discharged alive from the hospital in less than 72 hours, and 1655 of those had a low-risk mechanism of injury. Conclusions: The adoption of CT clearance of the cervical spine in adults seems to have influenced the care of children with TBI, despite concerns about radiation exposure.	[Bennett, Tellen D.; Bratton, Susan L.; Keenan, Heather T.] Univ Utah, Primary Childrens Med Ctr, Dept Pediat Crit Care, Salt Lake City, UT USA; [Riva-Cambrin, Jay] Univ Utah, Primary Childrens Med Ctr, Dept Pediat Neurosurg, Salt Lake City, UT USA; [Scaife, Eric R.] Univ Utah, Primary Childrens Med Ctr, Dept Pediat Surg, Salt Lake City, UT USA; [Nance, Michael L.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat Surg, Philadelphia, PA 19104 USA; [Prince, Jeffrey S.] Univ Utah, Primary Childrens Med Ctr, Dept Pediat Radiol, Salt Lake City, UT USA; [Wilkes, Jacob] Univ Utah, Dept Pediat, Salt Lake City, UT USA		Bennett, TD (corresponding author), Univ Colorado, Childrens Hosp Colorado, Sch Med, Dept Pediat Crit Care,Adult & Child Ctr Outcomes, 13199 Montview Blvd,Suite 300,Campus Mail F443, Aurora, CO 80045 USA.	tell.bennett@hsc.utah.edu	Bratton, Susan L./O-2353-2013	Bratton, Susan L./0000-0002-4605-8078; Bennett, Tellen/0000-0003-1483-4236	Pediatric Critical Care Scientist Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development [5K12HD047349-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD047349] Funding Source: NIH RePORTER	Supported by the Pediatric Critical Care Scientist Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant Number 5K12HD047349-06.	*AM COLL SURG COMM, 2004, ADV TRAUM LIF SUPP D, P177; [Anonymous], 2002, NEUROSURGERY, V50, pS85; Baaj AA, 2010, J NEUROSURG-SPINE, V13, P61, DOI 10.3171/2010.3.SPINE09530; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Bennett TD, 2012, CRIT CARE MED, V40, P208, DOI 10.1097/CCM.0b013e31822e9d31; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Como JJ, 2009, J TRAUMA, V67, P651, DOI 10.1097/TA.0b013e3181ae583b; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Frank JB, 2002, SPINE, V27, P1176, DOI 10.1097/00007632-200206010-00008; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Goldin AB, 2007, PEDIATRICS, V119, P905, DOI 10.1542/peds.2006-2040; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Kokoska ER, 2001, J PEDIATR SURG, V36, P100, DOI 10.1053/jpsu.2001.20022; Kreykes NS, 2010, SEMIN PEDIATR SURG, V19, P257, DOI 10.1053/j.sempedsurg.2010.06.002; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Leonard JC, 2011, ANN EMERG MED, V58, P145, DOI 10.1016/j.annemergmed.2010.08.038; Mannix R, 2011, ACAD EMERG MED, V18, P906, DOI 10.1111/j.1553-2712.2011.01154.x; Muchow RD, 2012, J TRAUMA ACUTE CARE, V72, P403, DOI 10.1097/TA.0b013e31823a4bd7; Nigrovic LE, 2012, PEDIATR EMERG CARE, V28, P426, DOI 10.1097/PEC.0b013e3182531911; Patel JC, 2001, J PEDIATR SURG, V36, P373, DOI 10.1053/jpsu.2001.20720; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pieretti-Vanmarcke R, 2009, J TRAUMA, V67, P543, DOI 10.1097/TA.0b013e3181b57aa1; Platzer P, 2007, J TRAUMA, V62, P389, DOI 10.1097/01.ta.0000221802.83549.46; Polk-Williams A, 2008, J PEDIATR SURG, V43, P1718, DOI 10.1016/j.jpedsurg.2008.06.002; Rozzelle CJ, 2013, NEUROSURGERY, V72, P205, DOI 10.1227/NEU.0b013e318277096c; Scaife ER, 2010, SEMIN PEDIATR SURG, V19, P252, DOI 10.1053/j.sempedsurg.2010.06.004; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Tri-Analytics Inc. and The Johns Hopkins University, 1997, ICCDMAP 90 SOFTW US; Viccellio P, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e20; Weiss PF, 2009, J PEDIATR-US, V155, P812, DOI 10.1016/j.jpeds.2009.05.030	32	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	APR	2015	31	4					243	249		10.1097/PEC.0000000000000395			7	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	CE9ZP	WOS:000352202600003	25803749	Green Accepted			2022-02-06	
J	Caron, JG; Bloom, GA				Caron, Jeffrey G.; Bloom, Gordon A.			Ethical Issues Surrounding Concussions and Player Safety in Professional Ice Hockey	NEUROETHICS			English	Article						Concussions; Ice hockey; Professional sports; Safety	TRAUMATIC BRAIN-INJURY; SPORT; RISK; HEAD; DEPRESSION; VIOLENCE; NHL	Concussions in professional sports have received increased attention, which is partly attributable to evidence that found concussion incidence rates were much higher than previously thought (Echlin et al. Journal of Neurosurgical Focus 29:1-10, 2010). Further to this, professional hockey players articulated how their concussion symptoms affected their professional careers, interpersonal relationships, and qualities of life (Caron et al. Journal of Sport & Exercise Psychology 35:168-179, 2013). Researchers are beginning to associate multiple/repeated concussions with Chronic Traumatic Encephalopathy (CTE), a structural brain injury that is characterized by tau protein deposits in distinct areas of the brain (McKee et al. Brain 136:43-64, 2013). Taken together, concussions impact many people in the sporting community from current and former professional athletes and their families to medical and health professionals and researchers. In light of the growing awareness and sensitivity towards concussions, the purpose of this paper is to provide recommendations that are designed to improve player safety in professional hockey and address the ethical issues surrounding these suggestions.	[Caron, Jeffrey G.; Bloom, Gordon A.] McGill Univ, Kinesiol & Phys Educ, Montreal, PQ H2W 1S4, Canada		Caron, JG (corresponding author), McGill Univ, Kinesiol & Phys Educ, 475 Pine Ave West, Montreal, PQ H2W 1S4, Canada.	jeffrey.caron@mail.mcgill.ca					Anderson LC, 2005, J MED ETHICS, V31, P88, DOI 10.1136/jme.2002.000836; [Anonymous], 2013, MED SCI SPORT EXER, V45, P1618, DOI 10.1249/MSS.0b013e31829ba437; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Bloom GA, 1996, SOCIOL SPORT J, V13, P65, DOI 10.1123/ssj.13.1.65; Bloom GA, 2004, BRIT J SPORT MED, V38, P519, DOI 10.1136/bjsm.2004.011999; Brooks L., 2013, THE NEW YORK POST; Caron JG, 2013, J SPORT EXERCISE PSY, V35, P168, DOI 10.1123/jsep.35.2.168; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Coakley J.J., 2009, SPORTS SOC ISSUES CO, V10th ed.; COLBURN K, 1985, CAN J SOCIOL, V10, P153; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Dunn WR, 2007, AM J SPORT MED, V35, P840, DOI 10.1177/0363546506295177; Dupont K. P., 2013, BOSTON GLOBE; Echlin P. S., 2010, NEUROSURG FOCUS, V29, P1, DOI DOI 10.3171/2010.9FOCUS10187; Emery C. A., 2013, BRIT J SPORT MED, V18, P37; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gulli C., 2011, MACLEANS MAG, V124, P56; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hutchison M. G., 2013, BRIT J SPORT MED, DOI [10.1136/bjsports-2013-092234, DOI 10.1136/BJSP0RTS-2013-092234]; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Klein J. Z., 2013, NY TIMES; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lewinson RT, 2012, J SPORT SOC ISSUES, V36, P106, DOI 10.1177/0193723511434330; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Major League Lacrosse, 2013, CONC ED PROGR; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McLoughlin TF, 2009, J SPORT SCI MED, V8, P148; National Hockey League, 2013, RUL 48 ILL CHECK HED; Partridge B, 2014, NEUROETHICS-NETH, V7, P63, DOI 10.1007/s12152-013-9182-z; Public Broadcasting Service, 2013, LEAG DEN NFLS CONC C; Putukian M, 2003, CLIN SPORT MED, V22, P617, DOI 10.1016/S0278-5919(02)00100-X; Ruhe A., 2013, BRIT J SPORT MED, DOI [10.1136/bjsports-2012-091609, DOI 10.1136/BJSP0RTS-2012-091609]; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Schwartz D., 2011, CBC NEWS; Sheridan B., 2012, HEAD GAMES MOTION PI; Shoalts D., 2013, GLOBE MAIL; Trewartha G., 2014, BRIT J SPORT MED, DOI [10.1136/bjsports-2013-092972, DOI 10.1136/BJSP0RTS-2013-092972]; Watanabe Y, 2001, DISABIL REHABIL, V23, P370; Weinstein MD, 1995, SEX ROLES, V33, P831, DOI 10.1007/BF01544782; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Williams D, 2014, BRIT J SPORT MED, V48, P107, DOI 10.1136/bjsports-2012-091853; Young, 2004, SPORTING BODIES DAMA, P59; Young K., 2004, SPORTING BODIES DAMA, P1	58	5	5	3	37	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1874-5490	1874-5504		NEUROETHICS-NETH	Neuroethics	APR	2015	8	1					5	13		10.1007/s12152-014-9210-7			9	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	CH2UZ	WOS:000353881500002		Green Submitted			2022-02-06	
J	Hassett, L; Simpson, G; Cotter, R; Whiting, D; Hodgkinson, A; Martin, D				Hassett, Leanne; Simpson, Grahame; Cotter, Rachel; Whiting, Diane; Hodgkinson, Adeline; Martin, Diane			A prospective interrupted time series study of interventions to improve the quality, rating, framing and structure of goal-setting in community-based brain injury rehabilitation	CLINICAL REHABILITATION			English	Article						Goal-setting; traumatic brain injury; education; electronic assistive technologies; prospective studies	PROFESSIONALS; ACHIEVEMENT; BEHAVIOR; OUTCOMES	Objective: To investigate whether the introduction of an electronic goals system followed by staff training improved the quality, rating, framing and structure of goals written by a community-based brain injury rehabilitation team. Design: Interrupted time series design. Intervention: Two interventions were introduced six months apart. The first intervention comprised the introduction of an electronic goals system. The second intervention comprised a staff goal training workshop. Methods: An audit protocol was devised to evaluate the goals. A random selection of goal statements from the 12months prior to the interventions (Time 1 baseline) were compared with all goal statements written after the introduction of the electronic goals system (Time 2) and staff training (Time 3). All goals were de-identified for client and time-period, and randomly ordered. Results: A total of 745 goals (Time 1 n=242; Time 2 n=283; Time 3 n=220) were evaluated. Compared with baseline, the introduction of the electronic goals system alone significantly increased goal rating, framing and structure ((2) tests 144.7, 18.9, 48.1, respectively, p<0.001). The addition of staff training meant that the improvement in goal quality, which was only a trend at Time 2, was statistically significant at Time 3 ((2) 15.0, p001). The training also led to a further significant increase in the framing and structuring of goals over the electronic goals system ((2) 11.5, 12.5, respectively, p0.001). Conclusion: An electronic goals system combined with staff training improved the quality, rating, framing and structure of goal statements.	[Hassett, Leanne] Univ Sydney, Sydney, NSW 2006, Australia; [Simpson, Grahame] Ingham Inst Appl Med Res, Sydney, NSW, Australia; [Cotter, Rachel] Royal Rehab, Sydney, NSW, Australia; [Whiting, Diane; Hodgkinson, Adeline; Martin, Diane] Liverpool Brain Injury Rehabil Unit, Sydney, NSW, Australia		Hassett, L (corresponding author), Univ Sydney, Fac Hlth Sci, Discipline Physiotherapy, Sydney, NSW 2006, Australia.	leanne.hassett@sydney.edu.au	Whiting, Diane/AAN-2522-2021; Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060; Hassett, Leanne/0000-0002-3546-1822; Whiting, Diane/0000-0003-1912-6626			Badge H, 2013, GOAL TRAINING PROJEC; BARELI M, 1994, ADAPT PHYS ACT Q, V11, P86, DOI 10.1123/apaq.11.1.86; Bergquist TF, 2012, BRAIN INJURY, V26, P1307, DOI 10.3109/02699052.2012.706355; Bright FAS, 2012, DISABIL REHABIL, V34, P997, DOI 10.3109/09638288.2011.629712; Davis A, 1992, CLIN REHABIL, V6, P237; Duff J, 2004, CLIN REHABIL, V18, P275, DOI 10.1191/0269215504cr720oa; ELSWORTH JD, 1999, TOP STROKE REHABIL, V6, P51; Gauggel S, 2003, HDB MOTIVATIONAL COU, P439; Kuipers P., 2004, BRAIN IMPAIR, V5, P30, DOI DOI 10.1375/BRIM.5.1.30.35404; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; Liu C, 2004, CLIN REHABIL, V18, P398, DOI 10.1191/0269215504cr741oa; Marks JA, 1995, CLIN REHABIL, V9, P320; MCGRATH JR, 1992, CLIN REHABIL, V6, P225; McMillan TM, 1999, NEUROPSYCHOL REHABIL, V9, P241, DOI 10.1080/096020199389356; Menon A, 2009, J REHABIL MED, V41, P1024, DOI 10.2340/16501977-0451; Mogensen L, 2008, AUST OCCUP THER J, V55, P149; Novak I, 2009, PEDIATRICS, V124, pE606, DOI 10.1542/peds.2009-0288; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Playford ED, 2000, CLIN REHABIL, V14, P491, DOI 10.1191/0269215500cr343oa; Sabaz M, 2010, CHALLENGING BEHAV PR; Sabaz M, 2014, J HEAD TRAUMA REHAB, V29, pE19, DOI 10.1097/HTR.0b013e31828dc590; SCHUT HA, 1994, DISABIL REHABIL, V16, P223, DOI 10.3109/09638289409166616; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Smith A., 1961, ARCH NEUROL-CHICAGO, V5, P16, DOI DOI 10.1001/ARCHNEUR.1961.00450130006002; Sugavanam T, 2013, DISABIL REHABIL, V35, P177, DOI 10.3109/09638288.2012.690501; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Wade DT, 2009, CLIN REHABIL, V23, P291, DOI 10.1177/0269215509103551; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; World Health Organization, 2007, INT CLASS FUNCT DIS; [No title captured], DOI DOI 10.2307/2529310	31	5	5	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	APR	2015	29	4					327	338		10.1177/0269215514544040			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CE7EF	WOS:000351999700003	25125439				2022-02-06	
J	Hou, TT; Yang, XY; Xia, P; Pan, S; Liu, J; Qi, ZP				Hou, Ting-ting; Yang, Xiao-yu; Xia, Peng; Pan, Su; Liu, Jian; Qi, Zhi-ping			Exercise promotes motor functional recovery in rats with corticospinal tract injury: anti-apoptosis mechanism	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; spinal cord injury; corticospinal tract; exercise; functional recovery; apoptosis; Bcl-2; Bax; caspase-3; NSFC grants; neural regeneration	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; CELL-DEATH; ENRICHED ENVIRONMENT; BCL-2; PLASTICITY; NEURONS; EXPRESSION; MOVEMENTS; THERAPY	Studies have shown that exercise interventions can improve functional recovery after spinal cord injury, but the mechanism of action remains unclear. To investigate the mechanism, we established a unilateral corticospinal tract injury model in rats by pyramidotomy, and used a single pellet reaching task and horizontal ladder walking task as exercise interventions postoperatively. Functional recovery of forelimbs and forepaws in the rat models was noticeably enhanced after the exercises. Furthermore, TUNEL staining revealed significantly fewer apoptotic cells in the spinal cord of exercised rats, and western blot analysis showed that spinal cord expression of the apoptosis-related protein caspase-3 was significantly lower, and the expression of Bcl-2 was significantly higher, while the expression of Bax was not signifiantly changed after exercise, compared with the non-exercised group. Expression of these proteins decreased with time after injury, towards the levels observed in sham-operated rats, however at 4 weeks postoperatively, caspase-3 expression remained significantly greater than in sham-operated rats. The present findings indicate that a reduction in apoptosis is one of the mechanisms underlying the improvement of functional recovery by exercise interventions after corticospinal tract injury.	[Hou, Ting-ting; Yang, Xiao-yu; Xia, Peng; Pan, Su; Qi, Zhi-ping] Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun 130023, Jilin Province, Peoples R China; [Liu, Jian] Three Gorges Univ, Clin Med Coll 1, Dept Orthoped, Yichang, Hubei Province, Peoples R China		Yang, XY (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Orthoped, Changchun 130023, Jilin Province, Peoples R China.	yangxiaoyu88@sina.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81350013]	This study was financially supported by the National Natural Science Foundation of China, No. 81350013.	ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Beesoo R, 2014, MUTAT RES-FUND MOL M, V768, P84, DOI 10.1016/j.mrfmmm.2014.03.005; Belka C, 2002, INT J RADIAT BIOL, V78, P643, DOI 10.1080/09553000210137680; Carmel JB, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00051; Celnik PA, 2004, RESTOR NEUROL NEUROS, V22, P261; CHANG C, 2014, FILM COMMENT, V50, P72; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Darian-Smith C, 2014, J NEUROSCI, V34, P12267, DOI 10.1523/JNEUROSCI.1593-14.2014; Darian-Smith C, 2009, NEUROSCIENTIST, V15, P149, DOI 10.1177/1073858408331372; Dornbos D, 2012, CURR DRUG TARGETS, V13, P247; Egan KJ, 2014, NEUROREHAB NEURAL RE, V28, P800, DOI 10.1177/1545968314521694; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; Gokbel H, 2014, BRATISL MED J, V115, P416, DOI 10.4149/BLL_2014_0082; GOLDBLUM JR, 1995, MODERN PATHOL, V8, P866; Greenberg EF, 2014, BBA-MOL CELL RES, V1843, P2205, DOI 10.1016/j.bbamcr.2014.03.008; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; [郭华 Guo Hua], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P6580; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hou Q, 2003, APOPTOSIS, V8, P617, DOI 10.1023/A:1026187526113; Hung CH, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/527090; JONES TA, 1994, J NEUROSCI, V14, P2140; KANE DJ, 1993, SCIENCE, V262, P1274, DOI 10.1126/science.8235659; KANE DJ, 1995, J NEUROSCI RES, V40, P269, DOI 10.1002/jnr.490400216; Kent ML, 2014, SPINAL CORD, V52, P722, DOI 10.1038/sc.2014.92; Komitova M, 2005, EUR J NEUROSCI, V21, P2397, DOI 10.1111/j.1460-9568.2005.04072.x; Kwon BK, 2005, SPINE, V30, pS3, DOI 10.1097/01.brs.0000175186.17923.87; Lee BH, 2004, BRAIN RES, V1020, P37, DOI 10.1016/j.brainres.2004.05.113; [刘家良 Liu Jialiang], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P2480; Ma LJ, 2005, DISI JUNYI DAXUE XUE, V26, P2042; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; Maier IC, 2008, J NEUROSCI, V28, P9386, DOI 10.1523/JNEUROSCI.1697-08.2008; McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3; Metz GAS, 2000, BEHAV BRAIN RES, V116, P111, DOI 10.1016/S0166-4328(00)00245-X; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; Nishimura Y, 2012, EXP NEUROL, V235, P152, DOI 10.1016/j.expneurol.2011.08.013; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Saeed WK, 2014, WORLD J GASTROENTERO, V20, P12526, DOI 10.3748/wjg.v20.i35.12526; Seki T, 2003, NEUROSURGERY, V53, P192, DOI 10.1227/01.NEU.0000068988.28788.2C; Seki T, 2002, NEUROSURGERY, V50, P1075, DOI 10.1097/00006123-200205000-00024; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Tahamtan M, 2013, ARCH IRAN MED, V16, P697, DOI 0131612/AIM.004; Temajo NO, 2014, AUTOIMMUN REV, V13, P1013, DOI 10.1016/j.autrev.2014.08.030; [王贤辉 Wang Xianhui], 2003, [第四军医大学学报, Journal of the Fourth Military Medical University], V24, P2217; Ward RE, 2014, NEUROSCIENCE, V260, P227, DOI 10.1016/j.neuroscience.2013.12.024; [魏海刚 Wei Haigang], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P4362; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Wong CK, 2016, PROSTHET ORTHOT INT, V40, P8, DOI 10.1177/0309364614546926; Yamauchi T, 2007, BRAIN RES, V1169, P24, DOI 10.1016/j.brainres.2007.06.093; Yang HB, 1999, ANTICANCER RES, V19, P727; Yeo SS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00573; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhang H, 2013, ZHONGGUO KANGFU LILU, V19, P349; ZHONG LT, 1993, P NATL ACAD SCI USA, V90, P4533, DOI 10.1073/pnas.90.10.4533; ZHONG LT, 1993, MOL BRAIN RES, V19, P353, DOI 10.1016/0169-328X(93)90139-G; Zompa EA, 1997, J NEUROTRAUM, V14, P479, DOI 10.1089/neu.1997.14.479	60	5	6	2	12	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2015	10	4					644	650		10.4103/1673-5374.155441			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CH6OP	WOS:000354156200030	26170828	Green Published, gold			2022-02-06	
J	Johnson, LSM; Partridge, B; Gilbert, F				Johnson, L. Syd M.; Partridge, Brad; Gilbert, Frederic			Framing the Debate: Concussion and Mild Traumatic Brain Injury	NEUROETHICS			English	Article						Neuroethics; Mild traumatic brain injury; Concussion		Concussion and Mild Traumatic Brain Injury (mTBI) affect millions of people worldwide. mTBI has been called the "signature injury" of the recent conflicts in Iraq and Afghanistan, affecting thousands of active duty service men and women, and veterans. Sport-related concussion represents a significant public health problem, with elite and professional athletes, and millions of youth and amateur athletes worldwide suffering concussions annually. These brain injuries have received scant attention from neuroethicists, and the focus of this special issue is on defining the ethical considerations and developing and elucidating the neuroethical contributions to the discussion about concussion and mTBI.	[Johnson, L. Syd M.] Michigan Technol Univ, Dept Humanities, Houghton, MI 49931 USA; [Partridge, Brad] Univ Queensland, Brisbane St Lucia, Australia; [Gilbert, Frederic] Univ Tasmania, ARC Ctr Excellence Electromat Sci, Hobart, Tas, Australia		Johnson, LSM (corresponding author), Michigan Technol Univ, Dept Humanities, 1400 Townsend Dr, Houghton, MI 49931 USA.	lsjohnso@mtu.edu	Meijer, Anna/K-5118-2016; Gilbert, Frederic/D-5452-2012	Gilbert, Frederic/0000-0003-0524-8649			Caron JG, 2015, NEUROETHICS-NETH, V8, P5, DOI 10.1007/s12152-014-9210-7; Gilbert F, 2015, NEUROETHICS-NETH, V8, P47, DOI 10.1007/s12152-014-9219-y; Greenhow A, 2015, NEUROETHICS-NETH, V8, P65, DOI 10.1007/s12152-014-9216-1; Hardcastle VG, 2015, NEUROETHICS-NETH, V8, P55, DOI 10.1007/s12152-014-9221-4; Johnson LSM, 2015, NEUROETHICS-NETH, V8, P15, DOI 10.1007/s12152-014-9213-4; Malanowski S, 2015, NEUROETHICS-NETH, V8, P27, DOI 10.1007/s12152-014-9215-2; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Partridge B, 2015, NEUROETHICS-NETH, V8, P39, DOI 10.1007/s12152-014-9217-0	10	5	5	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1874-5490	1874-5504		NEUROETHICS-NETH	Neuroethics	APR	2015	8	1					1	4		10.1007/s12152-015-9233-8			4	Ethics; Medical Ethics; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Biomedical Social Sciences	CH2UZ	WOS:000353881500001					2022-02-06	
J	Pakkanen, T; Virkkunen, I; Silfvast, T; Randell, T; Huhtala, H; Yli-Hankala, A				Pakkanen, T.; Virkkunen, I.; Silfvast, T.; Randell, T.; Huhtala, H.; Yli-Hankala, A.			One-year outcome after prehospital intubation	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; AIRWAY MANAGEMENT; TASK-FORCE; PHYSICIAN; CARE; ANESTHESIOLOGISTS; GUIDELINES; IMPACT; AUDIT	BackgroundThe aim of physician staffed emergency medical services (EMS) is to supplement other EMS units in the care of prehospital patients. The need for advanced airway management in critical prehospital patients can be considered as one indicator of the severity of the patient's condition. Our primary aim was to study the long-term outcome of critically ill patients (excluding cardiac arrest) who were intubated by EMS physicians in the prehospital setting. MethodsData of 845 patients, whose airways were secured by the EMS physicians during a 5-year (2007-2011) period, were retrospectively evaluated. After exclusions, the outcome of 483 patients (8.9% of all patients treated by EMS) was studied. Evaluation was based on hospital patient records 1 year after the incident. For assessment of neurological outcome, a modified Glasgow Outcome Score (GOS) was used. Time and cause of death were recorded. Results55.3% of the study patients had a good neurological recovery (GOS 4-5) with independent life 1 year after the event. The overall 1-year mortality (GOS 1) was 35.0%. Poor neurological outcome (GOS 2-3) was found in 9.7% of the patients. Patients with intoxication or convulsions survived best, while those with suspected intracranial pathology had the worst prognosis. Of all survivors, 85% recovered well. ConclusionThe majority of the study patients had a favourable neurological recovery with independent life at 1 year after the incident. More than 80% of all deaths occurred within 30 days of the incident.	[Pakkanen, T.; Yli-Hankala, A.] Tampere Univ Hosp, Dept Anaesthesia, Tampere 33521, Finland; [Pakkanen, T.; Virkkunen, I.] Tampere Univ Hosp, Tays Emergency Med Serv, Tampere 33521, Finland; [Silfvast, T.; Randell, T.] Univ Helsinki, Helsinki Univ Hosp, Dept Anaesthesia & Intens Care, Helsinki, Finland; [Huhtala, H.] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Yli-Hankala, A.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland		Pakkanen, T (corresponding author), Tampere Univ Hosp, Dept Anaesthesia, POB 2000, Tampere 33521, Finland.	toni.pakkanen@fimnet.fi		Yli-Hankala, Arvi/0000-0002-5029-9181	VTR Study Grant - Special State Allocation via Tampere University Hospital [9N088]	This study was supported by a VTR Study Grant No. 9N088 from Special State Allocation via Tampere University Hospital.	Adnet F, 1998, ANN EMERG MED, V32, P454, DOI 10.1016/S0196-0644(98)70175-1; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Berlac P, 2008, ACTA ANAESTH SCAND, V52, P897, DOI 10.1111/j.1399-6576.2008.01673.x; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Chesters A, 2014, EMERG MED J, V31, P65, DOI 10.1136/emermed-2012-201846; Combes X, 2006, ACAD EMERG MED, V13, P828, DOI 10.1197/j.aem.2006.02.016; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; de Jongh MAC, 2012, INJURY, V43, P1362, DOI 10.1016/j.injury.2012.01.009; Fevang E, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-57; Franschman G, 2012, INJURY, V43, P1838, DOI 10.1016/j.injury.2012.05.020; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Gunning M, 2009, EMERG MED J, V26, P65, DOI 10.1136/emj.2008.059345; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Nakstad AR, 2011, AM J EMERG MED, V29, P639, DOI 10.1016/j.ajem.2010.01.013; Ringburg AN, 2007, J TRAUMA, V63, P258, DOI 10.1097/01.ta.0000240449.23201.57; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Sollid SJM, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-30; StatisticsFinland, 2014, CAUS DEATH; von Vopelius-Feldt J, 2013, EUR J EMERG MED, V20, P382, DOI 10.1097/MEJ.0b013e32835b08b7	23	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	APR	2015	59	4					524	530		10.1111/aas.12483			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	CE0YS	WOS:000351537900014	25790242				2022-02-06	
J	Sun, HY; Li, Q; Chen, XP; Tao, LY				Sun, Hui-yan; Li, Qiang; Chen, Xi-ping; Tao, Lu-yang			Mismatch negativity, social cognition, and functional outcomes in patients after traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injury; cognition disorders; diagnostic techniques; Wechsler Intelligence Scale; event-related potential; neuronal plasticity; electrophysiology; neuropsychology; activity of daily living; work capacity evaluation; electroencephalogram; neural regeneration; NSFC grant	EVENT-RELATED POTENTIALS; HEAD-INJURY; SEVERE TBI; RAT-BRAIN; SCHIZOPHRENIA; MMN; DEFICIT; ADULTS; NEUROSCIENCE; INDIVIDUALS	Mismatch negativity is generated automatically, and is an early monitoring indicator of neuronal integrity impairment and functional abnormality in patients with brain injury, leading to decline of cognitive function. Antipsychotic medication cannot affect mismatch negativity. The present study aimed to explore the relationships of mismatch negativity: with neurocognition, daily life and social functional outcomes in patients after brain injury. Twelve patients with traumatic brain injury and 12 healthy controls were recruited in this study. We examined neurocognition with the Wechsler Adult Intelligence Scale-Revised China, and daily and social functional outcomes with the Activity of Daily Living Scale and Social Disability Screening Schedule, respectively. Mismatch negativity was analyzed from electroencephalogram recording. The results showed that mismatch negativity amplitudes decreased in patients with traumatic brain injury compared with healthy controls. Mismatch negativity amplitude was negatively correlated with measurements of neurocognition and positively correlated with functional outcomes in patients after traumatic brain injury. Further, the most significant positive correlations were found between mismatch negativity in the fronto-central region and measures of functional outcomes. The most significant positive correlations were also found between mismatch negativity at the FCz electrode and daily living function. Mismatch negativity amplitudes were extremely positively associated with Social Disability Screening Schedule scores at the Fz electrode in brain injury patients. These experimental findings suggest that mismatch negativity might efficiently reflect functional outcomes in patients after traumatic brain injury.	[Sun, Hui-yan; Chen, Xi-ping; Tao, Lu-yang] Soochow Univ, Dept Forens Med, Suzhou, Jiangsu, Peoples R China; [Sun, Hui-yan; Li, Qiang] Chifeng Univ, Dept Forens Med, Chifeng, Inner Mongolia, Peoples R China		Tao, LY (corresponding author), Soochow Univ, Dept Forens Med, Suzhou, Jiangsu, Peoples R China.	13913561231@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81172911, 81373251]; National High Technology Research and Development Program of China (863 Program)National High Technology Research and Development Program of China [2015AA020503]; Science and Technology Development Project of Suzhou of China [SZP201304]; Priority Academic Program Development of Jiangsu Higher Education Institutes of China	This study was supported by grants from the National Natural Science Foundation of China, No. 81172911, 81373251; the National High Technology Research and Development Program of China (863 Program), No. 2015AA020503; the Science and Technology Development Project of Suzhou of China, No. SZP201304; and Priority Academic Program Development of Jiangsu Higher Education Institutes of China.	Baldeweg T, 2015, INT J PSYCHOPHYSIOL, V95, P145, DOI 10.1016/j.ijpsycho.2014.03.008; Beste C, 2014, NEUROIMAGE-CLIN, V4, P623, DOI 10.1016/j.nicl.2014.04.003; Bishop DVM, 2010, PSYCHOPHYSIOLOGY, V47, P697, DOI 10.1111/j.1469-8986.2009.00970.x; Burkey JM, 1998, AM J OTOL, V19, P59; Calcus A, 2015, CLIN NEUROPHYSIOL, V126, P1727, DOI 10.1016/j.clinph.2014.11.020; Campanella S, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00428; CATTS SV, 1995, AM J PSYCHIAT, V152, P213; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Choi W, 2015, CLIN NEUROPHYSIOL, V126, P1310, DOI 10.1016/j.clinph.2014.10.012; Doi R, 2007, AM J PHYS MED REHAB, V86, P641, DOI 10.1097/PHM.0b013e318115aca9; Duncan CC, 2011, INT J PSYCHOPHYSIOL, V82, P24, DOI 10.1016/j.ijpsycho.2011.02.013; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; El Karoui I, 2015, CEREB CORTEX, V25, P4203, DOI 10.1093/cercor/bhu143; [冯士军 Feng Shijun], 2013, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V17, P23; Freigang C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00146; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; GIARD MH, 1990, PSYCHOPHYSIOLOGY, V27, P627, DOI 10.1111/j.1469-8986.1990.tb03184.x; Jacobs HIL, 2013, HUM BRAIN MAPP, V34, P77, DOI 10.1002/hbm.21412; Jones SJ, 2000, BRAIN, V123, P1007, DOI 10.1093/brain/123.5.1007; Kaipio ML, 2013, NEUROREPORT, V24, P440, DOI 10.1097/WNR.0b013e32836164b4; Kaipio ML, 2001, NEUROREPORT, V12, P1517, DOI 10.1097/00001756-200105250-00043; Kodama T, 2010, J NEUROTRAUM, V27, P1577, DOI 10.1089/neu.2009.1119; Kujala T, 2007, BIOL PSYCHOL, V74, P1, DOI 10.1016/j.biopsycho.2006.06.001; Kujala T, 2010, PROG NEUROBIOL, V91, P55, DOI 10.1016/j.pneurobio.2010.01.006; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, NEUROPSYCHOLOGY, V23, P433, DOI 10.1037/a0015723; Lee SH, 2014, PROG NEURO-PSYCHOPH, V48, P213, DOI 10.1016/j.pnpbp.2013.10.010; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P398, DOI 10.1097/WNP.0b013e318150694b; Lew HL, 2007, J CLIN NEUROPHYSIOL, V24, P392, DOI 10.1097/WNP.0b013e31814a56e3; Li XY, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-7; Light GA, 2007, J COGNITIVE NEUROSCI, V19, P1624, DOI 10.1162/jocn.2007.19.10.1624; Lin YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034454; Manor T, 2008, NEUROL RES, V30, P1075, DOI 10.1179/174313208X346107; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Naatanen R, 2012, CLIN NEUROPHYSIOL, V123, P424, DOI 10.1016/j.clinph.2011.09.020; Neuhoff N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034909; Pachalska M, 2011, MED SCI MONITOR, V17, pCS120, DOI 10.12659/MSM.881970; Paukkunen AKO, 2011, CLIN NEUROPHYSIOL, V122, P2195, DOI 10.1016/j.clinph.2011.04.004; Pereira J, 2015, J SPORT SCI MED, V14, P118; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roy M, 2015, CURR OPIN PSYCHIATR, V28, P35, DOI 10.1097/YCO.0000000000000118; Sarno S, 2006, FUNCT NEUROL, V21, P21; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schmidt A, 2013, CEREB CORTEX, V23, P2394, DOI 10.1093/cercor/bhs238; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schulte-Korne G, 1998, NEUROREPORT, V9, P337, DOI 10.1097/00001756-199801260-00029; Schulte-Korne G, 2001, INT J PSYCHOPHYSIOL, V40, P77, DOI 10.1016/S0167-8760(00)00152-5; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Shafto MA, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0204-1; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Umbricht D, 1999, INT J NEUROPSYCHOP, V2, P299, DOI 10.1017/S1461145799001595; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; [王成 Wang Cheng], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P4469; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Yao SQ, 2007, PSYCHIAT CLIN NEUROS, V61, P379, DOI 10.1111/j.1440-1819.2007.01672.x; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Zarza-Lucianez A, 2007, REV NEUROLOGIA, V44, P465, DOI 10.33588/rn.4408.2006306	59	5	7	1	15	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	APR	2015	10	4					618	623		10.4103/1673-5374.155437			6	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	CH6OP	WOS:000354156200026	26170824	Green Published, gold			2022-02-06	
J	Auerbach, PS; Baine, JG; Schott, ML; Greenhaw, A; Acharya, MG; Smith, WS				Auerbach, Paul S.; Baine, Jennifer G.; Schott, Megan L.; Greenhaw, Amy; Acharya, Monika G.; Smith, Wade S.			Detection of Concussion Using Cranial Accelerometry	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; accelerometry; head injury; traumatic brain injury; football	TRAUMATIC BRAIN-INJURY; SPORT	Objective: To determine whether skull motion produced by pulsatile cerebral blood flow, as measured by cranial accelerometry, is altered during concussion. Design: In phase 1, to identify a specific pattern indicative of concussion, cranial accelerometry of subjects who sustained a concussion underwent analysis of waveforms, which was compared with accelerometry from subjects without a concussion (baseline). In phase 2, this concussion pattern was tested against prospectively acquired, blinded data. Setting: High school tackle football practice and game play. Participants: Eighty-four football players. Interventions: Subjects had accelerometry measurements and concurrent 2-lead electrocardiograms. In players with a concussion, multiple sequential measurements were obtained. Sport Concussion Assessment Tool 2 was used to assist clinical determination of concussion. Main Outcome Measures: Whether a characteristic waveform pattern of cranial accelerometry occurs in subjects with concussion. Results: Phase 1 demonstrated a consistent pattern correlated to concussion. Phase 2 found this pattern in 10 of 13 subjects with concussion (76.9% sensitivity). Seventy-nine of 82 baseline plus nine postseason (total = 91) recordings from nonconcussed subjects did not show the concussion pattern (87% specificity). Conclusions: In subjects with concussion, we observed a unique pattern determined by cranial accelerometry. This may provide a method to noninvasively detect and longitudinally observe concussion.	[Auerbach, Paul S.] Stanford Univ, Sch Med, Div Emergency Med, Dept Surg, Stanford, CA 94305 USA; [Baine, Jennifer G.] Stanford Univ, Sch Med, Dept Orthoped Surg, Stanford, CA 94305 USA; [Schott, Megan L.] Stanford Univ, Sch Med, Stanford Kaiser Affiliated Residency Emergency Me, Stanford, CA 94305 USA; [Greenhaw, Amy; Acharya, Monika G.] Los Altos High Sch, Los Altos, CA USA; [Smith, Wade S.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA USA		Auerbach, PS (corresponding author), Stanford Univ, Sch Med, Div Emergency Med, Alway Bldg M121,300 Pasteur Dr, Stanford, CA 94305 USA.	auerbach@stanford.edu					Gonzalez PG, 2011, PM&R, V3, pS413, DOI 10.1016/j.pmrj.2011.08.536; Khurana VG, 2012, J CLIN NEUROSCI, V19, P1, DOI 10.1016/j.jocn.2011.08.002; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	9	5	5	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2015	25	2					126	132		10.1097/JSM.0000000000000117			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CD3RP	WOS:000350998200008	25010149				2022-02-06	
J	Ghayoumi, Z; Yadegari, F; Mahmoodi-Bakhtiari, B; Fakharian, E; Rahgozar, M; Rasouli, M				Ghayoumi, Zahra; Yadegari, Fariba; Mahmoodi-Bakhtiari, Behrooz; Fakharian, Esmaeil; Rahgozar, Mehdi; Rasouli, Maryam			Persuasive Discourse Impairments in Traumatic Brain Injury	ARCHIVES OF TRAUMA RESEARCH			English	Article						Brain Injuries; Communication Disorders; Linguistics	CLOSED-HEAD-INJURY; NARRATIVE LANGUAGE; CHILDREN; ADOLESCENTS; POPULATION; VALIDATION; ADULTS; SKILLS	Background: Considering the cognitive and linguistic complexity of discourse production, it is expected that individuals with traumatic brain injury (TBI) should face difficulties in this task. Therefore, clinical examination of discourse has become a useful tool for studying and assessment of communication skills of people suffering from TBI. Among different genres of discourse, persuasive discourse is considered as a more cognitively demanding task. However, little is known about persuasive discourse in individuals suffering from TBI. Objectives: The purpose of this study was to evaluate the performance of adults with TBI on a task of spoken persuasive discourse to determine the impaired linguistic measures. Patients and Methods: Thirteen TBI nonaphasic Persian speaking individuals, ranged between 19 to 40 years (Mean = 25.64 years; SD = 6.10) and 59 healthy adults matched by age, were asked to perform the persuasive discourse task. The task included asking the participants to express their opinion on a topic, and after the analysis of the produced discourse, the two groups were compared on the basis of their language productivity, sentential complexity, maze ratio and cohesion ratio. Results: The TBI group produced discourses with less productivity, sentential complexity, cohesion ratio and more maze ratio compared the control group. Conclusions: As it is important to consider acquired communication disorders particularly discourse impairment of brain injured patients along with their other clinical impairments and regarding the fact that persuasive discourse is crucial in academic and social situations, the persuasive discourse task presented in this study could be a useful tool for speech therapists, intending to evaluate communication disorders in patients with TBI.	[Ghayoumi, Zahra; Yadegari, Fariba] Univ Social Welf & Rehabil, Dept Speech Therapy, Tehran, Iran; [Mahmoodi-Bakhtiari, Behrooz] Univ Tehran, Dept Performing Arts, Tehran, Iran; [Fakharian, Esmaeil] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran; [Rahgozar, Mehdi] Univ Social Welf & Rehabil, Dept Biostat & Comp, Tehran, Iran; [Rasouli, Maryam] Shahid Beheshti Univ Med Sci, Fac Nursing & Midwifery, Dept Pediat, Tehran, Iran		Yadegari, F (corresponding author), Univ Social Welf & Rehabil, Dept Speech Therapy, Tehran, Iran.	fa.yadegari@uswr.ac.ir	Ghayoumi-Anaraki, Zahra/N-7492-2018; rahgozar, mehdi/P-4913-2017; Fakharian, Esmaeil/A-1338-2018; yadegari, fariba/D-5460-2017; Rassouli, Maryam/J-8513-2018	Ghayoumi-Anaraki, Zahra/0000-0002-8733-1392; Rassouli, Maryam/0000-0002-5607-8064			Ansari NN, 2010, APPL NEUROPSYCHOL, V17, P190, DOI 10.1080/09084282.2010.499773; Ball M.J, 2009, HDB CLIN LINGUISTICS; Bartsch K, 2007, DEV PSYCHOL, V43, P111, DOI 10.1037/0012-1649.43.1.111; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; Biddle KR, 1996, J COMMUN DISORD, V29, P447, DOI 10.1016/0021-9924(95)00038-0; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Body R, 2004, BRAIN INJURY, V18, P707, DOI 10.1080/02699050310001596914; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; Coelho CA, 2005, BRAIN INJURY, V19, P1139, DOI 10.1080/02699050500110678; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; Davis GA, 2004, BRAIN LANG, V89, P508, DOI 10.1016/j.bandl.2004.01.003; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); FAGAN WT, 1982, RES TEACH ENGL, V16, P85; Fazel MR, 2012, ARCH TRAUMA RES, V1, P63, DOI 10.5812/atr.6770; Felton M, 2001, DISCOURSE PROCESS, V32, P135; Fiestas C. F., 2005, ISB4, P730; GLOSSER G, 1991, BRAIN LANG, V40, P67, DOI 10.1016/0093-934X(91)90117-J; Halliday M. K., 1976, COHESION ENGLISH; Hay E, 2005, AM J SPEECH-LANG PAT, V14, P324, DOI 10.1044/1058-0360(2005/031); Hux K, 2008, PERFORMING COOKIE TH, V16; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; Lu XF, 2010, INT J CORPUS LINGUIS, V15, P474, DOI 10.1075/ijcl.15.4.02lu; Marini A, 2011, APHASIOLOGY, V25, P1372, DOI 10.1080/02687038.2011.584690; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; McLeod J, 2013, INT J BUSINESS SOCIA, V3, P1, DOI DOI 10.18533/ijbsr.v3i12.338; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); Nilipour R, 2014, BASIC CLIN, P253; Nippold MA, 2005, LANG SPEECH HEAR SER, V36, P125, DOI 10.1044/0161-1461(2005/012); Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Rahimi-Movaghar V, 2011, AM SURGEON, V77, pE112; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Shetreet E, 2009, NEUROIMAGE, V48, P707, DOI 10.1016/j.neuroimage.2009.07.001; Theodoros D. G., 2001, TRAUMATIC BRAIN INJU; Wilson BM, 2002, BRAIN INJURY, V16, P1011, DOI 10.1080/02699050210147248	42	5	6	0	9	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	MAR	2015	4	1							e21473	10.5812/atr.21473			7	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	CP9GI	WOS:000360201400004	25798418	Green Submitted, Bronze, Green Published			2022-02-06	
J	Gilasi, HR; Soori, H; Yazdani, S; Tenjani, PT				Gilasi, Hamid Reza; Soori, Hamid; Yazdani, Shahram; Tenjani, Parisa Taheri			Fall-Related Injuries in Community-Dwelling Older Adults in Qom Province, Iran, 2010-2012	ARCHIVES OF TRAUMA RESEARCH			English	Article						Elderly; Hospitalization; Injury; Length of Stay	RISK-FACTORS; GERIATRIC TRAUMA; HEALTH-CARE; AGE; EPIDEMIOLOGY; FRACTURE; TRENDS; HOME; COMORBIDITY; PREVENTION	Background: Falls and related injuries are common health problems in the elderly. Fractures, brain and internal organ injuries and death are the common consequences of the falls, which result in dependence, decreased self-efficacy, fear of falling, depression, restricted daily activities, hospitalization and admission to the nursing home and impose costs on the individual and the society. Objectives: The purpose of this study was to determine the types of fall-related injuries and the related risk factors in the elderly population of Qom province, Iran. Patients and Methods: This retrospective study was performed on 424 elderly people (65 years and over) referred to Shahid Beheshti Hospital, Qom, Iran, due to falls between 2010 and 2012. The ICD-10 codes of external causes of injury from w00 to w19 related to falls were selected from the health information system of the hospital and demographic variables of the patients and external causes of falls were extracted after accessing the files of the patients. Data were analyzed using SPSS version 18 (SPSS Inc., USA). The duration of hospital stay and its relationship with underlying variables were investigated using t test and ANOVA. The level of significance was considered P < 0.05. Results: Among 424 elderly people, 180 cases (42.45%) were male and the mean age of the patients was 78.65 +/- 7.70 years. Fall on the same level from slipping, tripping, and stumbling was the most common external cause with 291 victims (68.60%), and hip fracture in 121 patients (29.00%), intertrochanteric fracture in 112 patients (26.90%), and traumatic brain injury in 51 patients (12.20%) were the most common causes of hospital stay. The mean hospital stay was 7.33 +/- 3.63 days. Conclusions: Lower limb fracture and traumatic brain injury were the most common causes of hospitalization, which resulted in the longest hospital stay and highest hospitalization costs in the elderly.	[Gilasi, Hamid Reza] Shahid Beheshti Univ Med Sci, Dept Epidemiol, Tehran, Iran; [Soori, Hamid] Shahid Beheshti Univ Med Sci, Safety Promot & Injury Prevent Res Ctr, Tehran, Iran; [Yazdani, Shahram] Shahid Beheshti Univ Med Sci, Fac Med Educ, Tehran, Iran; [Tenjani, Parisa Taheri] Shahid Beheshti Univ Med Sci, Ayatollah Taleghani Hosp, Dept Internal Med, Tehran, Iran		Soori, H (corresponding author), Shahid Beheshti Univ Med Sci, Safety Promot & Injury Prevent Res Ctr, Tehran, Iran.	hsoori@yahoo.com	Gilasi, hamid Reza/F-3270-2017; Yazdani, Shahram/ABF-2125-2020	Gilasi, hamid Reza/0000-0002-2554-9492; 	Shahid Beheshti University of Medical Sciences	This study was part of a thesis conducted in Shahid Beheshti University of Medical Sciences with the cooperation of the Department of Epidemiology of Shahid Beheshti University of Medical Sciences and Medical Document Center of Qom Shahid-Beheshti Hospital. This project was funded by Shahid Beheshti University of Medical Sciences.	Adam SH, 2008, ARCH GERONTOL GERIAT, V47, P377, DOI 10.1016/j.archger.2007.08.018; Alamgir H, 2012, INJURY, V43, P2065, DOI 10.1016/j.injury.2011.12.001; Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Aschkenasy MT, 2006, EMERG MED CLIN N AM, V24, P413, DOI 10.1016/j.emc.2006.01.005; Bleijlevens MHC, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-40; Bonne S, 2013, CLIN GERIATR MED, V29, P137, DOI 10.1016/j.cger.2012.10.008; Coronado VG, 2011, MMWR SURVEILL SUMM, V60, P1; Das C P, 2005, J Indian Med Assoc, V103, ppassim; DAS CP, 2005, J INDIAN MED ASSOC, V103, P140; Dumitrescu B, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-109; Etman A, 2012, AGE AGEING, V41, P190, DOI 10.1093/ageing/afr178; Fazel MR, 2012, ARCH TRAUMA RES, V1, P118, DOI 10.5812/atr.7709; Galor O, 2012, CLIOMETRICA, V6, P1, DOI 10.1007/s11698-011-0062-7; Ghodsi SM, 2003, INJURY, V34, P809, DOI 10.1016/S0020-1383(02)00376-5; Gilbert R, 2010, J PUBLIC HEALTH-UK, V32, P117, DOI 10.1093/pubmed/fdp077; Gill TM, 2013, AM J EPIDEMIOL, V178, P418, DOI 10.1093/aje/kws554; Grundstrom AC, 2012, ARCH GERONTOL GERIAT, V54, P421, DOI 10.1016/j.archger.2011.06.008; Halter JB., 2009, HAZZARDS GERIATRIC M; Hartholt KA, 2011, J TRAUMA, V71, P748, DOI 10.1097/TA.0b013e3181f6f5e5; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hu GQ, 2009, AM J PREV MED, V37, P188, DOI 10.1016/j.amepre.2009.04.023; Iaria M, 2009, BMC GERIATRICS S1, V9; Korhonen N, 2013, INJURY, V44, P867, DOI 10.1016/j.injury.2013.03.004; Li YH, 2013, BIOMED ENVIRON SCI, V26, P79, DOI 10.3967/0895-3988.2013.02.001; Limpawattana Panita, 2012, J Med Assoc Thai, V95 Suppl 7, pS235; M Abasi Moghadam, 1998, TEHRAN U MED J, V56, P82; Mitchell R, 2010, AUSTRALAS J AGEING, V29, P117, DOI 10.1111/j.1741-6612.2010.00413.x; Mitchell RJ, 2013, J SAFETY RES, V45, P7, DOI 10.1016/j.jsr.2012.11.005; Moayyeri A, 2006, OSTEOPOROSIS INT, V17, P1252, DOI 10.1007/s00198-006-0105-2; Mould-Quevedo JF, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-151; Nader F, 2007, J JAHROM U MED SCI, V4, P41; Nilson F, 2013, J SAFETY RES, V45, P141, DOI 10.1016/j.jsr.2012.10.014; Orces CH, 2014, INJURY PREV, V20, P421, DOI 10.1136/injuryprev-2014-041268; Orces CH, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001722; Pfortmueller CA, 2014, MINERVA MED, V105, P275; Pfortmueller CA, 2014, SCI WORLD J, DOI 10.1155/2014/256519; Salarvand S, 2010, SCI J KURDISTAN U ME, V15, P63; Sibley KM, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-22; Siracuse JJ, 2012, AM J SURG, V203, P335, DOI 10.1016/j.amjsurg.2011.09.018; Skalska A, 2013, EXP GERONTOL, V48, P140, DOI 10.1016/j.exger.2012.12.003; Soltani MH, 2012, IRANIAN J AGEING, V6, P58; Vu T, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-45; Ungar A, 2013, CLIN CASES MINER BON, V10, P91, DOI 10.11138/ccmbm/2013.10.2.091; Vu T, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-113; Watson W, 2010, N S W PUBLIC HLTH B, V22, P55; Watson WL, 2011, J SAFETY RES, V42, P487, DOI 10.1016/j.jsr.2011.07.009; Wendelboe AM, 2011, PUBLIC HLTH REP, V126, P861; World Health Organization, 2007, GLOB REP FALLS PREV; Zamani B, 2010, J KERMAN U MED SCI, V17, P137; Zhou Bai-Yu, 2013, Zhonghua Liu Xing Bing Xue Za Zhi, V34, P778	51	5	5	0	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	MAR	2015	4	1							e22925	10.5812/atr.22925			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	CP9GI	WOS:000360201400009	26064869	Green Published, Bronze, Green Submitted			2022-02-06	
J	Herrada-Pineda, T; Loyo-Varela, M; Revilla-Pacheco, F; Uribe-Leitz, M; Manrique-Guzman, S				Herrada-Pineda, Tenoch; Loyo-Varela, Mauro; Revilla-Pacheco, Francisco; Uribe-Leitz, Monika; Manrique-Guzman, Salvador			Traumatic occipitocervical and atlantoaxial dislocation with clivus fracture in a child. Case report	CIRUGIA Y CIRUJANOS			Spanish	Article						Cervical atlas dislocation; Axis dislocation; Clivus fracture; Post-traumatic subarachnoid haemorrhage; Traumatic brain injury	ATLANTOOCCIPITAL DISLOCATION; OCCIPITOATLANTAL DISLOCATION; CRANIOVERTEBRAL JUNCTION; SURVIVAL; DISTRACTION; INJURIES; FUSIONS	Background: Cranieovertebral junction lesions in the paediatric population are associated with a low survival rate, which has declined in recent years. Neurological disability is a major concern due to the high economical cost it represents. Paediatric patients are more susceptible to this lesion because of hyperextension capacity, flat articulation, and increased ligamentous laxity. Survival after these kinds of injuries has been more often reported in adults, but are limited in the paediatric population. Clinical case: A case is reported of an 8-year-old male with occipitocervical and atlantoaxial dislocation associated with clivus fracture, brain oedema, and post-traumatic subarachnoid haemorrhage (SAH). A halo vest system was placed with no traction. One month after the trauma the patient was surgically treated with C1 and C2 trans-articular screws, occipitocervical fixation with plate and screws, and C1- C2 fixation with tricortical bone graft and wires without complication. He has now returned to school and is self-sufficient. Conclusions: With better pre-hospital medical care and with improved surgical techniques the mortality rate has declined in this kind of lesion. (C) 2015 Academia Mexicana de Cirugia A.C. Published by Masson Doyma Mexico S.A.	[Herrada-Pineda, Tenoch] Ctr Med ABC, Dept Neurocirugia Pediat, Mexico City 01120, DF, Mexico; [Loyo-Varela, Mauro; Revilla-Pacheco, Francisco; Uribe-Leitz, Monika; Manrique-Guzman, Salvador] Ctr Med ABC, Dept Neurocirugia, Mexico City 01120, DF, Mexico		Manrique-Guzman, S (corresponding author), Ctr Med ABC, Dept Neurocirugia, Calle Sur 136 N 116 Consultorio 2-B Col Las Amer, Mexico City 01120, DF, Mexico.	manriquemd@yahoo.com	Manrique-Guzman, Salvador/A-3840-2016; Loyo-Varela, Mauro/AAQ-8983-2021; Revilla-Pacheco, Francisco/Q-9632-2019	Manrique-Guzman, Salvador/0000-0001-5792-6363; 			Ahmed R, 2008, CHILD NERV SYST, V24, P1209, DOI 10.1007/s00381-008-0607-7; Baron Eli M, 2006, Neurosurg Focus, V20, pE4; Benzel EC, 2012, WORLD NEUROSURG, V78, P715; BOOLS JC, 1986, AM J NEURORADIOL, V7, P901; DONAHUE DJ, 1994, PEDIATR NEUROSURG, V21, P105, DOI 10.1159/000120822; Ehlinger M, 2011, ORTHOP TRAUMATOL-SUR, V97, P335, DOI 10.1016/j.otsr.2010.10.001; Feiz-Erfan I, 2005, J NEUROSURG-SPINE, V2, P381, DOI 10.3171/spi.2005.2.3.0381; Gonzalez LF, 2005, J NEUROSURG-SPINE, V3, P318, DOI 10.3171/spi.2005.3.4.0318; Gonzalez LF, 2004, J NEUROSURG-SPINE, V1, P273, DOI 10.3171/spi.2004.1.3.0273; Hamai S, 2006, SPINE, V31, pE421, DOI 10.1097/01.brs.0000220224.01886.b3; JONES DN, 1990, AM J NEURORADIOL, V11, P1181; Kandziora F, 2010, UNFALLCHIRURG, V113, P931, DOI 10.1007/s00113-010-1876-7; Kleweno CP, 2008, SPINE, V33, pE659, DOI 10.1097/BRS.0b013e318182272a; Klimo P, 2013, J NEUROSURG-PEDIATR, V11, P160, DOI 10.3171/2012.9.PEDS12214; Menezes AH, 2008, CHILD NERV SYST, V24, P1101, DOI 10.1007/s00381-008-0605-9; Menezes AH, 2012, WORLD NEUROSURG, V78, P612, DOI 10.1016/j.wneu.2012.02.050; Sawin PD, 1998, J NEUROSURG, V88, P255, DOI 10.3171/jns.1998.88.2.0255; STEINMETZ MP, 2003, NEUROSURG FOCUS, V14, P1; Violas P, 2006, CLIN ORTHOP RELAT R, P286, DOI 10.1097/01.blo.0000201164.05561.e9; Weiner BK, 1997, SPINE, V22, P1033, DOI 10.1097/00007632-199705010-00019; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1	21	5	5	0	4	MEXICAN ACAD SURGERY	MEXICO D G	CENTRO MED NAC SIGLO XXI, EDIFICIO BLOQUE B, SOTANO, AVE CUAUHTEMOC NO 330, MEXICO D G, 06700, MEXICO	0009-7411			CIR CIR	Cir. Cir.	MAR-APR	2015	83	2					135	140		10.1016/j.circir.2015.04.009			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CS9KI	WOS:000362409600009	25986981	gold			2022-02-06	
J	Kim, SC; Song, KJ; Shin, SD; Lee, SC; Park, JO; Holmes, JF				Kim, Seong Chun; Song, Kyoung Jun; Shin, Sang Do; Lee, Seung Chul; Park, Ju Ok; Holmes, James F.			Preventable deaths in patients with traumatic brain injury	CLINICAL AND EXPERIMENTAL EMERGENCY MEDICINE			English	Article						Death; Brain injury; Errors; Process; Structure	MANAGEMENT	Objective The objective of this study is to evaluate the rate of and etiology for preventable deaths in patients with traumatic brain injuries (TBIs). Methods We conducted a retrospective, multicenter review of patients with TBIs who died within 7 days of their traumatic event from June 2008 to May 2009. Three board certified emergency physicians independently reviewed every case using a structured survey format. Cases were considered preventable deaths only if all physicians independently agreed the death was preventable. Management errors contributing to the preventable death were determined. Results Forty-one patients who died from TBI were eligible. Preventable deaths were identified in nine (22%; 95% confidence interval [CI], 11 to 28) cases. Fifty-six management errors were identified including 36 (64%; 95% CI, 50 to 77) in the emergency department and 13 (23%; 95% CI, 13 to 36) in the prehospital phase. Thirty (54%; 95% CI, 40 to 67) management errors were process-related, and 26 (46%; 95% CI, 33 to 60) were structure-related. Conclusion An important and measurable rate of preventable mortality occurs in the initial care of TBI patients. Errors were common and most occurred in the emergency department. In addition, errors were common in the prehospital phase but did not always lead to mortality. When analyzed by type of problem, both process-related and structure-related errors occurred in similar proportions.	[Kim, Seong Chun] Gyeongsang Natl Univ Hosp, Dept Emergency Med, Jinju, South Korea; [Song, Kyoung Jun; Shin, Sang Do; Park, Ju Ok] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Emergency Med, 101 Daehak Ro, Seoul 110744, South Korea; [Lee, Seung Chul] Dongkuk Univ, Coll Med, Dept Emergency Med, Ilsan, South Korea; [Holmes, James F.] Univ Calif Davis, Dept Emergency Med, Med Ctr JFH, Davis, CA USA		Song, KJ (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Emergency Med, 101 Daehak Ro, Seoul 110744, South Korea.	skciva@gmail.com			Korea Centers for Disease Control and Prevention	Korea Centers for Disease Control and Prevention supported this study financially.	American College of Surgeons, 2008, ADV TRAUM LIF SUPP D; [Anonymous], 2008, ABBR INJ SCAL 2005 R, P2008; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chiara Osvaldo, 2006, World J Emerg Surg, V1, P12, DOI 10.1186/1749-7922-1-12; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Jung KY, 2001, J KOREAN SOC EMERG M, V12, P45; Kim Y, 1999, J PREV MED PUBLIC HL, V32, P538; Lu J, 2005, ACT NEUR S, V95, P281; MACKENZIE EJ, 1992, J TRAUMA, V33, P292, DOI 10.1097/00005373-199208000-00021; MacKenzie EJ, 1999, J TRAUMA, V47, pS34, DOI 10.1097/00005373-199909001-00008; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; MARION DW, 1999, TRAUMATIC BRAIN INJU; Mullins RJ, 1999, J TRAUMA, V47, pS59, DOI 10.1097/00005373-199909001-00013; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Statistics Korea, 2011, STAT CAUS DEATH; 김윤, 2006, [Journal of The Korean Society of Emergency Medicine, 대한응급의학회지], V17, P385	17	5	5	1	1	SEOUL KOREAN SOC EMERGENCY MEDICINE	SEOUL	101-3305, BROWNSTONE SEOUL, 464 CHEONGPA-RO, JUNG-GU, SEOUL, 06351, SOUTH KOREA	2383-4625			CLIN EXP EMERG MED	Clin. Exp. Emerg. Med.	MAR	2015	2	1					51	58		10.15441/ceem.14.023			8	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	VC3KE	WOS:000433683600008	27752573	Green Published, hybrid, Green Submitted			2022-02-06	
J	Pasek, TA; Locasto, LW; Reichard, J; Sumrok, VCF; Johnson, EW; Kontos, AP				Pasek, Tracy Ann; Locasto, Lisa W.; Reichard, Joseph; Sumrok, Vanessa C. Fazio; Johnson, Eric W.; Kontos, Anthony P.			The Headache Electronic Diary for Children With Concussion	CLINICAL NURSE SPECIALIST			English	Article						children; concussion; e-diaries; electronic diary; headache; pain; pediatric	POSTTRAUMATIC MIGRAINE; PAIN; ADOLESCENTS	Purpose/Objectives: The purposes of the study were to (1) develop a prospective, real time, age-appropriate, and appealing prototype of an electronic headache pain diary for children and (2) evaluate the clinical feasibility and utility of the diary for the assessment and documentation of concussion headache. Design: A mixed-methods design of qualitative interviews and a quantitative survey was used. Setting: The setting was a sports medicine concussion clinic. Sample: The sample included 2 independent groups of 30 children (females n = 36, males n = 24) each aged 12 to 17 years, with postconcussion headache and pediatric concussion expert clinicians (n = 5). Methods: During phase 1 of the study, subjects were interviewed individually about their headaches and their ideas for an electronic diary. A prototype was developed using these children's interview data. In phase 2 of the study, both children and clinicians piloted the prototype. Clinicians' survey data regarding the feasibility and utility of the diary were examined using thematic and descriptive analyses. Results: The phase 1 sample recommended a diary with calendar and clock functions, head views, menus (eg, pain descriptors), soft colors, a choice of pain assessment scales, and the ability to personalize it. All of the children thought that the new Headache Electronic Diary for Children With Concussion (HED-CC) would be helpful to track their headache and reported that other children with concussions would be likely to use it. Participants recommended improvement of the head views and clock function. In phase 2 of the study, all clinicians reported that the new HED-CC measure was feasible and useful for the assessment and documentation of headache. Conclusions: The new HED-CC provides for thorough assessment and documentation of postconcussion headache. Proactive, real-time measurement helps children remember the details of their headache pain and correlating events/circumstances. An appealing, age-appropriate measure increases the likelihood of children's symptom tracking and data accuracy. The HED-CC will improve clinicians' understanding of postconcussion headache and guide treatment. Additional testing with a larger sample is required to establish clinical application benefits and improve reliability/validity of the new measure.	[Pasek, Tracy Ann] UPMC, Childrens Hosp Pittsburgh, Pain Pediat Intens Care Unit, Pittsburgh, PA USA; [Locasto, Lisa W.] Robert Morris Univ, Pittsburgh, PA USA; [Reichard, Joseph; Sumrok, Vanessa C. Fazio; Johnson, Eric W.; Kontos, Anthony P.] UPMC Sports Med Concuss Program, Pittsburgh, PA USA; [Johnson, Eric W.; Kontos, Anthony P.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA		Pasek, TA (corresponding author), 6513 Ten Point Cir, Level Green, PA 15085 USA.	Tapst12@mail.rmu.edu		Kontos, Anthony/0000-0002-3749-4310			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Connelly M, 2011, J PEDIATR PSYCHOL, V36, P852, DOI 10.1093/jpepsy/jsr017; Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1; International Association for the Study of Pain, 1995, PAIN CLIN UPDATES, VIII; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Larsson B, 2012, J HEADACHE PAIN, V13, P129, DOI 10.1007/s10194-011-0410-9; Larsson B, 2011, J PEDIATR PSYCHOL, V36, P863, DOI 10.1093/jpepsy/jsr034; Lewandowski AS, 2009, CLIN J PAIN, V25, P299, DOI 10.1097/AJP.0b013e3181965578; Lundqvist C, 2010, ACTA PAEDIATR, V99, P1054, DOI 10.1111/j.1651-2227.2010.01727.x; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; McGhee B HD, 2011, PEDIAT DRUG THERAPY; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Palermo TA, 2004, PAIN, V107, P213, DOI 10.1016/j.pain.2003.10.005; Pasek TA, 2009, CORE CURRICULUM PEDI, P119; Rullander AC, 2013, PAIN MANAG NURS, V14, P50, DOI 10.1016/j.pmn.2010.07.005; Stinson JN, 2013, PAIN RES MANAG, V18, P142, DOI 10.1155/2013/369541; Stinson JN, 2009, PAIN RES MANAG, V14, P59, DOI 10.1155/2009/915302; Stone AA, 2002, ANN BEHAV MED, V24, P236, DOI 10.1207/S15324796ABM2403_09; van den Brink M, 2001, HEADACHE, V41, P11, DOI 10.1046/j.1526-4610.2001.111006011.x; Wong-Baker FACES&REG;Foundation, 2014, WONG BAK FACES PAIN	22	5	5	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-6274	1538-9782		CLIN NURSE SPEC	Clin. Nurse Spec.	MAR-APR	2015	29	2					80	88		10.1097/NUR.0000000000000108			9	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	CB3XT	WOS:000349563500148	25654707				2022-02-06	
J	Sessoms, PH; Gottshall, KR; Sturdy, J; Viirre, E				Sessoms, Pinata H.; Gottshall, Kim R.; Sturdy, Jordan; Viirre, Erik			Head Stabilization Measurements as a Potential Evaluation Tool for Comparison of Persons With TBI and Vestibular Dysfunction With Healthy Controls	MILITARY MEDICINE			English	Article; Proceedings Paper	Military Health Systems Research Symposium (MHSRS)	AUG 13-16, 2012	Fort Lauderdale, FL				TRAUMATIC BRAIN-INJURY; TREADMILL WALKING; MOVEMENT CONTROL; LOCOMOTION; GAIT; STABILITY; TRUNK; REHABILITATION; INDIVIDUALS; DISORDERS	A large percentage of persons with traumatic brain injury incur some type of vestibular dysfunction requiring vestibular physical therapy. These injuries may affect the natural ability to stabilize the head while walking. A simple method of utilizing motion capture equipment to measure head movement while walking was used to assess improvements in head stabilization of persons undergoing computerized vestibular physical therapy and virtual reality training for treatment of their vestibular problems. Movement data from the head and sacrum during gait were obtained over several visits and then analyzed to determine improved oscillatory head movement relative to the sacrum. The data suggest that, over time with treatment, head stabilization improves and moves toward a pattern similar to that of a healthy control population. This simple analysis of measuring head stability could be transferred to smaller, portable systems that are easily utilized to measure head stability during gait for use in gait assessment and physical therapy training.	[Sessoms, Pinata H.; Sturdy, Jordan] Naval Hlth Res Ctr, Warfighter Performance Dept, San Diego, CA 92106 USA; [Gottshall, Kim R.] Naval Med Ctr San Diego, Phys Therapy Dept, San Diego, CA 92134 USA; [Viirre, Erik] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA		Sessoms, PH (corresponding author), Naval Hlth Res Ctr, Warfighter Performance Dept, 140 Sylvester Rd, San Diego, CA 92106 USA.			Sessoms, Pinata/0000-0002-6960-0659; Sturdy, Jordan/0000-0001-7619-5156	Bureau of Medicine and Surgery Wounded, Ill, and Injured grant R116 [60818]	The authors would like to thank John-David Collins, Kathrine Service, Aaron Wolf, and LCDR Jose Dominguez for their contributions to this research study. This work was supported by the Bureau of Medicine and Surgery Wounded, Ill, and Injured grant R116 under work unit no. 60818.	Cromwell RL, 2001, J ORTHOP SPORT PHYS, V31, P255, DOI 10.2519/jospt.2001.31.5.255; Demer JL, 1996, J VESTIBUL RES-EQUIL, V6, P295; Dingwell JB, 2001, J BIOMECH ENG-T ASME, V123, P27, DOI 10.1115/1.1336798; Fischer H, 2013, 75700 C RES SERV, P7; Gates DH, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-81; Gottshall K, 2011, NEUROREHABILITATION, V29, P167, DOI 10.3233/NRE-2011-0691; Gottshall KR, 2012, IEEE ENG MED BIO, P6141, DOI 10.1109/EMBC.2012.6347395; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kavanagh J, 2006, EXP BRAIN RES, V172, P454, DOI 10.1007/s00221-006-0353-6; Kermoian R, 2005, HUMAN WALKING, P119; Konz R, 2006, J REHABIL RES DEV, V43, P161, DOI 10.1682/JRRD.2004.11.0146; Lamontagne A, 2009, NEUROREHAB NEURAL RE, V23, P256, DOI 10.1177/1545968308324549; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Lee SJ, 2008, J APPL PHYSIOL, V104, P747, DOI 10.1152/japplphysiol.01380.2006; Marchetti GF, 2014, J NEUROL PHYS THER, V38, P119, DOI 10.1097/NPT.0000000000000015; Mulavara AP, 2012, J VESTIBUL RES-EQUIL, V22, P153, DOI 10.3233/VES-2011-0435; Mulavara AP, 2002, GAIT POSTURE, V16, P271, DOI 10.1016/S0966-6362(02)00016-4; National Center for Injury Prevention and Control C. f. d. C. a. i. P., 2003, REP C MILD TRAUM BRA; Paquet N, 2006, J VESTIBUL RES-EQUIL, V16, P279; Riley PO, 2007, GAIT POSTURE, V26, P17, DOI 10.1016/j.gaitpost.2006.07.003; Sheik-Nainar MA, 2007, HUM FACTORS, V49, P696, DOI 10.1518/001872007X215773; Van Emmerik REA, 2005, GAIT POSTURE, V22, P233, DOI 10.1016/j.gaitpost.2004.09.006; Whitney SL, 2006, CYBERPSYCHOL BEHAV, V9, P152, DOI 10.1089/cpb.2006.9.152; Whitney SL, 2009, GAIT POSTURE, V29, P194, DOI 10.1016/j.gaitpost.2008.08.002	24	5	6	1	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2015	180	3		S			135	142		10.7205/MILMED-D-14-00386			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	CD3OQ	WOS:000350988500025	25747644	Bronze			2022-02-06	
J	Smith, AM; Stuart, MJ; Dodick, DW; Roberts, WO; Alford, PW; Ashare, AB; Aubrey, M; Benson, BW; Burke, CJ; Dick, R; Eickhoff, C; Emery, CA; Flashman, LA; Gaz, D; Giza, CC; Greenwald, RM; Herring, S; Hoshizaki, TB; Hudziak, JJ; Huston, J; Krause, D; LaVoi, N; Leaf, M; Leddy, JJ; MacPherson, A; Mckee, AC; Mihalik, JP; Moessner, AM; Montelpare, WJ; Putukian, M; Schneider, KJ; Szalkowski, R; Tabrum, M; Whitehead, J; Wiese-Bjornstal, DM				Smith, Aynsley M.; Stuart, Michael J.; Dodick, David W.; Roberts, William O.; Alford, Patrick W.; Ashare, Alan B.; Aubrey, Mark; Benson, Brian W.; Burke, Chip J.; Dick, Randall; Eickhoff, Chad; Emery, Carolyn A.; Flashman, Laura A.; Gaz, Daniel; Giza, Chris C.; Greenwald, Rick M.; Herring, Stan; Hoshizaki, T. Blaine; Hudziak, James J.; Huston, John, III; Krause, Dave; LaVoi, Nicole; Leaf, Matt; Leddy, John J.; MacPherson, Alison; McKee, Ann C.; Mihalik, Jason P.; Moessner, Anne M.; Montelpare, William J.; Putukian, Margot; Schneider, Kathryn J.; Szalkowski, Ron; Tabrum, Mark; Whitehead, Jim; Wiese-Bjornstal, Diane M.			Ice Hockey Summit II: Zero Tolerance for Head Hits and Fighting	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion (SRC); hockey; fighting; head trauma; body checking; action	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; IMPACT EXPOSURE; CONSENSUS STATEMENT; RISK-FACTORS; EXERCISE; MECHANISMS; SEVERITY; RECOVERY	Objective: To present currently known basic science and on-ice influences of sport-related concussion (SRC) in hockey, building on the Ice Hockey Summit I action plan (2011) to reduce SRC. Methods: The prior summit proceedings included an action plan intended to reduce SRC. As such, the proceedings from Summit I served as a point of departure, for the science and discussion held during Summit II (Mayo Clinic, Rochester MN, October 2013). Summit II focused on (1) Basic Science of Concussions in Ice Hockey: Taking Science Forward; (2) Acute and Chronic Concussion Care: Making a Difference; (3) Preventing Concussions via Behavior, Rules, Education and Measuring Effectiveness; (4) Updates in Equipment: their Relationship to Industry Standards; and (5) Policies and Plans at State, National and Federal Levels to reduce SRC. Action strategies derived from the presentations and discussion described in these sectors were subsequently voted on for purposes of prioritization. The following proceedings include knowledge and research shared by invited faculty, many of whom are health care providers and clinical investigators. Results: The Summit II evidence-based action plan emphasizes the rapidly evolving scientific content of hockey SRC. It includes the most highly prioritized strategies voted on for implementation to decrease concussion. Conclusions: The highest priority action items identified from the Summit includes the following: (1) eliminate head hits from all levels of ice hockey, (2) change body-checking policies, and (3) eliminate fighting in all amateur and professional hockey.	[Smith, Aynsley M.; Stuart, Michael J.; Eickhoff, Chad; Gaz, Daniel; Krause, Dave] Mayo Clin, Ctr Sports Med, Rochester, MN 55905 USA; [Dodick, David W.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Roberts, William O.] Univ Minnesota Twin Cities, Dept Family Med & Community Hlth, Minneapolis, MN USA; [Alford, Patrick W.] Univ Minnesota Twin Cities, Dept Biomed Engn, Minneapolis, MN USA; [Ashare, Alan B.] St Elizabeths Med Ctr, Dept Radiol, Boston, MA USA; [Aubrey, Mark] Int Ice Hockey Federat & Hockey Canada, Ottawa, ON, Canada; [Aubrey, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Benson, Brian W.; Emery, Carolyn A.] Univ Calgary, Sport Med Ctr, Calgary, AB, Canada; [Burke, Chip J.] Univ Pittsburgh, Med Ctr St Margaret, Dept Orthoped, Pittsburgh, PA USA; [Dick, Randall] Natl Collegiate Athlet Assoc, Indianapolis, IN USA; [Flashman, Laura A.] Dartmouth Coll, Geisel Sch Med, Dept Psychiat, Hanover, NH 03755 USA; [Giza, Chris C.] Univ Calif Los Angeles, Div Pediat Neurol, Mattel Childrens Hosp, Los Angeles, CA USA; [Giza, Chris C.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Greenwald, Rick M.] Simbex LLC, Lebanon, NH USA; [Herring, Stan] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Hoshizaki, T. Blaine] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Hudziak, James J.] Univ Vermont, Dept Psychiat, Med Ctr, Burlington, VT USA; [Huston, John, III] Mayo Clin, Dept Radiol, Rochester, MN USA; [LaVoi, Nicole; Wiese-Bjornstal, Diane M.] Univ Minnesota Twin Cities, Sch Kinesiol, Minneapolis, MN USA; [Leaf, Matt; Tabrum, Mark] USA Hockey, Colorado Springs, CO USA; [Leddy, John J.] SUNY Buffalo, Dept Orthopaed, Buffalo, NY 14260 USA; [MacPherson, Alison] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [McKee, Ann C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Moessner, Anne M.] Mayo Clin, Dept Nursing, Rochester, MN USA; [Montelpare, William J.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE C1A 4P3, Canada; [Putukian, Margot] Princeton Univ, Dept Athlet Med, Princeton, NJ 08544 USA; [Schneider, Kathryn J.] Univ Calgary, Sport Injury Prevent Res Ctr, Calgary, AB, Canada; [Szalkowski, Ron] Team Wendy, Cleveland, OH USA; [Whitehead, Jim] Amer Coll Sports Med, Indianapolis, IN USA		Stuart, MJ (corresponding author), Mayo Clin, Ctr Sports Med, 200 First St SW, Rochester, MN 55905 USA.	stuart.michael@mayo.edu	Emery, Carolyn/AAI-2761-2020; Wiese-Bjornstal, Diane M./L-1408-2019	Wiese-Bjornstal, Diane M./0000-0003-4824-3311; Schneider, Kathryn/0000-0002-5951-5899; Roberts, William O/0000-0003-4517-4330	Brian Mark Family Fund; USA Hockey; International Ice Hockey Federation; Hockey Equipment Certification Council; Ontario Neurotrauma Foundation	Supporting Organizations: Brian Mark Family Fund, USA Hockey, International Ice Hockey Federation, Hockey Equipment Certification Council, and Ontario Neurotrauma Foundation.	Achyuta AKH, 2013, LAB CHIP, V13, P542, DOI 10.1039/c2lc41033h; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; [Anonymous], 2011, CONC FEM ATHL UNT ST; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bogduk N, 2009, LANCET NEUROL, V8, P959, DOI 10.1016/S1474-4422(09)70209-1; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Choe MC, 2012, CURR OPIN PEDIATR, V24, P689, DOI 10.1097/MOP.0b013e32835a1a44; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; Decloe MD, 2013, BR J SPORTS MED; Delacourte Andre, 2000, Current Opinion in Neurology, V13, P371, DOI 10.1097/00019052-200008000-00002; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Emery CA, 2010, INJURY PREV, V16, P113, DOI 10.1136/ip.2009.022764; Ernst A, 2005, OTOLARYNG HEAD NECK, V132, P554, DOI 10.1016/j.otohns.2004.09.034; Fijalkowski RJ, 2009, SAE TECHNICAL PAPER; Franklyn M, 2005, SAE TECHNICAL PAPER; Gaz DV, 2014, AM SOC TEST MATER, V1552, P219, DOI 10.1520/STP155220120149; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Griesbach GS, 2007, J NEUROTRAUM, V24, P1161, DOI 10.1089/neu.2006.0255; Grosberg A, 2011, LAB CHIP, V11, P4165, DOI 10.1039/c1lc20557a; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hemphill MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022899; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki B., 2013, J NEUROL NEUROPHYSIO, V5, P1, DOI DOI 10.4172/2155-9562.1000181; Hosmane S, 2011, LAB CHIP, V11, P3888, DOI 10.1039/c1lc20549h; Hudziak J, 2014, TWIN RES HUM GENET; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Kendall M, COMP DYNAMIC VERSUS; Klein J, 2010, NY TIMES, pD6; Klein J., 2010, HOCKEY URGED BAN ALL, pB19; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Lacny S, 2014, BR J SPORTS MED; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau B, 2010, EPIDEMIOL INJ OLYMPI, P411; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lin A, 2010, RAD SOC N AM; Lv QS, 2013, BRAIN RES, V1493, P80, DOI 10.1016/j.brainres.2012.11.028; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marcotte G, 1993, SAFETY ICE HOCKEY, V2, P100; Marino S, 2011, NEUROCRIT CARE, V14, P127, DOI 10.1007/s12028-010-9406-6; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mckay CD, 2014, CAN J PUBLIC HEALTH, V105, pE445, DOI 10.17269/cjph.105.4653; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meeuwisse WH., 1994, CLIN J SPORT MED, V4, P166, DOI [10.1097/00042752-199407000-00004, DOI 10.1097/00042752-199407000-00004]; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P215; Mihalik JP, 2010, MED SCI SPORT EXER, V42, P1431, DOI 10.1249/MSS.0b013e3181d2521a; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Miller J, 2010, MANUAL THER, V15, P334, DOI 10.1016/j.math.2010.02.007; Montelpare W, 2010, INT J SPORTS SCI COA, V5, P61; Oeur A, 2014, J NEUROSURG IN PRESS; Post A, 2014, COMPUT METHOD BIOMEC, V17, P1785, DOI 10.1080/10255842.2013.766724; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Reid SR, 1999, PEDIATR EMERG CARE, V15, P310, DOI 10.1097/00006565-199910000-00002; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schneider KJ, 2014, BR J SPORTS MED; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; Smith A, J STRENGTH COND RES; Smith AM., 2009, J ASTM INT, V6, P1; Smith AM, 2014, STP ASTM INT, V1552, P234; Smith AM, 2014, CLIN J SPORT MED, V24, P351, DOI 10.1097/JSM.0000000000000033; Smith AM, 2011, CLIN J SPORT MED, V21, P281, DOI 10.1097/JSM.0b013e318225bc15; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Terrell TR, 2008, CLIN J SPORT MED, V18, P10, DOI 10.1097/JSM.0b013e31815c1d4c; Terrell TR, 2014, BIOM SCI ENG CTR C B; Tierney RT, 2010, CLIN J SPORT MED, V20, P464, DOI 10.1097/JSM.0b013e3181fc0a81; Twardowski CP, 2014, AM SOC TEST MATER, V1552, P208, DOI 10.1520/STP155220120153; Vagnozzi R, 2010, BRAIN, V133, P3232, DOI 10.1093/brain/awq200; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	114	5	5	4	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2015	25	2					78	87		10.1097/JSM.0000000000000195			10	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CD3RP	WOS:000350998200003	25866860				2022-02-06	
J	Stocchetti, N; Magnoni, S; Zanier, ER				Stocchetti, N.; Magnoni, S.; Zanier, E. R.			My paper 20 years later: cerebral venous oxygen saturation studied with bilateral samples in the internal jugular veins	INTENSIVE CARE MEDICINE			English	Article						Jugular oxygen saturation; Cerebral blood flow; Traumatic brain injury	SEVERE HEAD-INJURY; ACUTE BRAIN-INJURY; BLOOD-FLOW; INTRACRANIAL HYPERTENSION; PERFUSION-PRESSURE; COMATOSE PATIENTS; MANAGEMENT; BULB; TISSUE; HYPERVENTILATION	Jugular oxygen saturation monitoring was introduced in neurointensive care after severe traumatic brain injury (TBI) to explore the adequacy of brain perfusion and guide therapeutic interventions. The brain was considered homogeneous, and oxygen saturation was taken as representative of the whole organ. We investigated whether venous outflow from the brain was homogeneous by measuring oxygen saturation simultaneously from the two jugular veins. In 32 comatose TBI patients both internal jugular veins (IJs) were simultaneously explored using intermittent samples; hemoglobin saturation was also recorded continuously by fiber-optic catheters in five patients. In five cases long catheters were inserted bilaterally upstream, up to the sigmoid sinuses. On average, measurements from the two sides were in agreement (mean and standard deviation of the differences between the saturation of the two IJs were respectively 5.32 and 5.15). However, 15 patients showed differences of more than 15 % in hemoglobin saturation at some point; three others showed differences larger than 10 %. No relationship was found between the computed tomographic scan data and the hemoglobin saturation pattern. Several groups have confirmed differences between oxygen saturation in the two jugular veins. After years of enthusiasm, interest for jugular saturation has decreased and more modern methods, such as tissue oxygenation monitoring, are now available. Jugular saturation monitoring has low sensitivity, with the risk of missing low saturation, but high specificity; moreover it is cheap, when used with intermittent sampling. Monitoring the adequacy of brain perfusion after severe TBI is essential. However the choice of a specific monitor depends on local resources and expertise.	[Stocchetti, N.] Univ Milan, Dept Physiopathol & Transplant, Milan, Italy; [Stocchetti, N.; Magnoni, S.] Fdn IRCCS Ca Granda Osped Maggiore Policli, Dept Anesthesiol & Intens Care, Neuro ICU, I-20122 Milan, Italy; [Zanier, E. R.] IRCCS Ist Mario Negri, Dept Neurosci, Milan, Italy		Stocchetti, N (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policli, Dept Anesthesiol & Intens Care, Neuro ICU, I-20122 Milan, Italy.	stocchet@policlinico.mi.it	Magnoni, Sandra/AAC-7479-2022; Stocchetti, Nino/O-7444-2017; Zanier, Elisa/AAA-8095-2020	Magnoni, Sandra/0000-0002-1723-0844; Stocchetti, Nino/0000-0003-3250-6834; Zanier, Elisa/0000-0002-3011-8718	departmental fund of Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico	The original research was conducted in the intensive care unit of Ospedale di Parma, Italy, by a group of enthusiast colleagues who co-authored the original paper. Everything was carried out in extra-hours in the absence of any financial support. To them (Franca Bridelli, Marisa Bacchi and Paolo Piazza, together with Alessandro Paparella and Paolo Zuccoli in memoriam) goes our gratitude. This research was supported by a departmental fund of Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico.	Beards SC, 1998, ANAESTHESIA, V53, P627; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BELL BA, 1984, NEUROSURGERY, V14, P238, DOI 10.1227/00006123-198402000-00023; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Coles JP, 2009, J CEREBR BLOOD F MET, V29, P965, DOI 10.1038/jcbfm.2009.22; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cormio M, 2001, J NEUROSURG ANESTH, V13, P250, DOI 10.1097/00008506-200107000-00014; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; CRUZ J, 1993, CRIT CARE MED, V21, P1225, DOI 10.1097/00003246-199308000-00025; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; DEARDEN NM, 1991, CURR OPIN ANESTHESIO, V4, P279; Gemma M, 1998, ACT NEUR S, V71, P320; Gibbs EL, 1942, J BIOL CHEM, V144, P325; GIBBS EL, 1945, AM J PSYCHIAT, V102, P184, DOI 10.1176/ajp.102.2.184; Gopinath SP, 1999, CRIT CARE MED, V27, P2337, DOI 10.1097/00003246-199911000-00003; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Inagawa H, 1995, NEUROCHEMICAL MONITO, P112; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; LARSON CP, 1967, SURGERY, V62, P31; Latronico N, 2000, NEUROSURGERY, V46, P1131, DOI 10.1097/00006123-200005000-00021; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Lewis SB, 1996, CRIT CARE MED, V24, P1334, DOI 10.1097/00003246-199608000-00011; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Metz C, 1998, J CEREBR BLOOD F MET, V18, P332, DOI 10.1097/00004647-199803000-00012; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Robertson CS, 1998, NEUROL RES, V20, pS91; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; Stocchetti N, 1999, INTENS CARE MED, V25, P371, DOI 10.1007/s001340050860; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; Stoquart-ElSankari S, 2009, J CEREBR BLOOD F MET, V29, P1208, DOI [10.1038/jcbfm.2009.29, 10.1038/sj.jcbfm.jcbfm200929]; Triginer C, 1995, INTENS CARE MED, V21, pS51; WARME PE, 1991, ACTA NEUROCHIR, V110, P57, DOI 10.1007/BF01402049	38	5	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAR	2015	41	3					412	417		10.1007/s00134-015-3650-3			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC9MS	WOS:000350695300003	25614058				2022-02-06	
J	Chow, JW; Yablon, SA; Stokic, DS				Chow, John W.; Yablon, Stuart A.; Stokic, Dobrivoje S.			Effect of Intrathecal Baclofen Bolus Injection on Ankle Muscle Activation During Gait in Patients With Acquired Brain Injury	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						stretch reflex; spasticity; hypertonia; stroke; traumatic brain injury; coactivation	DISTURBED MOTOR CONTROL; SPASTIC HYPERTONIA; STANCE PHASE; CEREBRAL-PALSY; STROKE; WALKING; POSTSTROKE; CHILDREN; THERAPY; COCONTRACTION	Background. Intrathecal baclofen (ITB) bolus injection effectively decreases spinal excitability but the impact on lower limb muscle activation during gait has not been thoroughly investigated. Objective. Examine activation of medial gastrocnemius (MG) and tibialis anterior (TA) muscles during gait before and after ITB bolus injection in patients with resting hypertonia after acquired brain injury. Methods. Lower extremity Ashworth score, temporospatial gait parameters, characteristics of the linear relationship between electromyogram (EMG) and lengthening velocity (LV) in MG during stance, and the duration and magnitude of TA-MG coactivation were assessed before and at 2, 4, and 6 hours after a 50-mu g ITB injection via lumbar puncture in 8 hemorrhagic stroke and 11 traumatic brain injury subjects. Results. Temporospatial gait parameters did not significantly differ across the evaluation points (P .170). However, Ashworth score (P < .001), frequency and gain of significant positive EMG-LV slope (P .020), and duration of TA-MG coactivation (P .013) significantly decreased in the more-affected leg after ITB bolus. EMG changes were not significantly different between patients who did (n = 10) and did not (n = 9) increase gait speed after the injection. The timing of the largest decrease in Ashworth score and the largest decrease in EMG parameters coincided in 36% of cases, on average. Conclusions. ITB bolus injection alters the activation of MG and TA during gait. However, the changes in muscle activation are not closely related to the changes in gait speed or resting muscle hypertonia. The analysis of ankle muscle activation during gait better characterizes the response to ITB bolus injection than gait kinematics.	[Chow, John W.; Stokic, Dobrivoje S.] Methodist Rehabil Ctr, Jackson, MS 39216 USA; [Yablon, Stuart A.] Univ Alberta, Edmonton, AB, Canada		Chow, JW (corresponding author), Methodist Rehabil Ctr, Ctr Neurosci & Neurol Recovery, 1350 East Woodrow Wilson Dr, Jackson, MS 39216 USA.	jchow@mmrcrehab.org		Stokic, Dobrivoje/0000-0002-1891-5730	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A020514, H133A980035]; Medtronic, Inc (Minneapolis, MN)Medtronic; Wilson Research Foundation (Jackson, MS)	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by the National Institute on Disability and Rehabilitation Research, US Department of Education (grants H133A020514 and H133A980035); the Medtronic, Inc (Minneapolis, MN); and the Wilson Research Foundation (Jackson, MS).	ABEL NA, 1994, ARCH PHYS MED REHAB, V75, P54; Becher JG, 1999, J NEUROL, V246, P1080, DOI 10.1007/s004150050516; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Boudarham J, 2013, J ELECTROMYOGR KINES, V23, P1036, DOI 10.1016/j.jelekin.2013.07.002; Bowden MG, 2008, NEUROREHAB NEURAL RE, V22, P672, DOI 10.1177/1545968308318837; Chow JW, 2012, ARCH PHYS MED REHAB, V93, P2287, DOI 10.1016/j.apmr.2012.03.020; Chow JW, 2012, CLIN NEUROPHYSIOL, V123, P1599, DOI 10.1016/j.clinph.2012.01.006; Crenna P, 1998, NEUROSCI BIOBEHAV R, V22, P571, DOI 10.1016/S0149-7634(97)00046-8; DAVIDOFF RA, 1985, ANN NEUROL, V17, P107, DOI 10.1002/ana.410170202; de Niet M, 2011, ARCH PHYS MED REHAB, V92, P1833, DOI 10.1016/j.apmr.2011.05.025; Dion L, 2003, NEUROREHAB NEURAL RE, V17, P83, DOI 10.1177/0888439003017002002; Falconer K, 1985, Electromyogr Clin Neurophysiol, V25, P135; Francisco GE, 2003, ARCH PHYS MED REHAB, V84, P1194, DOI 10.1016/S0003-9993(03)00134-5; Francisco GE, 2007, BRAIN INJURY, V21, P335, DOI 10.1080/02699050701311018; Frost G, 1997, J ELECTROMYOGR KINES, V7, P179, DOI 10.1016/S1050-6411(97)84626-3; HAWKINS D, 1990, J BIOMECH, V23, P487, DOI 10.1016/0021-9290(90)90304-L; Holz JH, 1998, INTRO SURFACE ELECTR; Horn TS, 2010, ARCH PHYS MED REHAB, V91, P30, DOI 10.1016/j.apmr.2009.08.148; Horn TS, 2005, ARCH PHYS MED REHAB, V86, P1127, DOI 10.1016/j.apmr.2004.11.013; Hutin E, 2010, NEUROREHAB NEURAL RE, V24, P442, DOI 10.1177/1545968309354535; Ivanhoe CB, 2006, ARCH PHYS MED REHAB, V87, P1509, DOI 10.1016/j.apmr.2006.08.323; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; KNUTSSON E, 1979, BRAIN, V102, P405, DOI 10.1093/brain/102.2.405; Kofler M, 2009, NEUROREHAB NEURAL RE, V23, P26, DOI 10.1177/1545968308317700; Kumru H, 2011, CLIN NEUROPHYSIOL, V122, P1229, DOI 10.1016/j.clinph.2010.09.010; Lamontagne A, 2000, J ELECTROMYOGR KINES, V10, P407, DOI 10.1016/S1050-6411(00)00028-6; Lamontagne A, 2002, GAIT POSTURE, V15, P244, DOI 10.1016/S0966-6362(01)00190-4; Lamontagne A, 2001, ARCH PHYS MED REHAB, V82, P1696, DOI 10.1053/apmr.2001.26810; Leung J, 2002, PHYSIOTHERAPY, V89, P39, DOI DOI 10.1016/S0031-9406(05)60668-2; Lin PY, 2006, ARCH PHYS MED REHAB, V87, P562, DOI 10.1016/j.apmr.2005.12.042; Meythaler JM, 1999, ARCH PHYS MED REHAB, V80, P13, DOI 10.1016/S0003-9993(99)90301-5; Meythaler JM, 1996, ARCH PHYS MED REHAB, V77, P461, DOI 10.1016/S0003-9993(96)90034-9; O'Neill RT, 2012, CLIN PHARMACOL THER, V91, P550, DOI 10.1038/clpt.2011.340; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Ordia JI, 2002, NEUROMODULATION, V5, P103, DOI 10.1046/j.1525-1403.2002.02015.x; Pierce SR, 2007, CLIN BIOMECH, V22, P1045, DOI 10.1016/j.clinbiomech.2007.08.003; Pohl M, 2003, J NEUROL, V250, P1195, DOI 10.1007/s00415-003-0178-1; Pohl M, 2002, J NEUROL, V249, P1254, DOI 10.1007/s00415-002-0825-y; Remy-Neris O, 2003, ARCH PHYS MED REHAB, V84, P643, DOI 10.1016/S0003-9993(02)04906-7; Rifici C, 1994, Funct Neurol, V9, P29; Saulino M, 2011, SPASTICITY: DIAGNOSIS AND MANAGEMENT, P229; Schiess MC, 2011, NEUROMODULATION, V14, P38, DOI 10.1111/j.1525-1403.2010.00308.x; Shiavi R, 1987, J Rehabil Res Dev, V24, P24; Stokic DS, 2005, ARCH PHYS MED REHAB, V86, P1801, DOI 10.1016/j.apmr.2005.03.027; Streiner D, 2001, Evid Based Ment Health, V4, P70; Unnithan V B, 1996, Electromyogr Clin Neurophysiol, V36, P487; YANG JF, 1984, ARCH PHYS MED REHAB, V65, P517; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	48	5	5	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	FEB	2015	29	2					163	173		10.1177/1545968314533615			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AX4QM	WOS:000346916600007	24803494				2022-02-06	
J	Haubrich, C; Diehl, RR; Kasprowicz, M; Diedler, J; Sorrentino, E; Srnielewski, P; Czosnyka, M				Haubrich, Christina; Diehl, Rolf R.; Kasprowicz, Magdalena; Diedler, Jennifer; Sorrentino, Enrico; Srnielewski, Piotr; Czosnyka, Marek			Traumatic brain injury: Increasing ICP attenuates respiratory modulations of cerebral blood flow velocity	MEDICAL ENGINEERING & PHYSICS			English	Article						Intracranial pressure; Intracranial pressure-volume reserve; Head injury; Cerebral blood; Flow velocity; Respiratory oscillations	INTRACRANIAL HYPERTENSION; PRESSURE; OSCILLATIONS; SYSTEM	In vitro experiments have suggested that respiratory oscillations (R waves) in cerebral blood flow velocity are reduced as soon as the intracranial pressure-volume reserve is exhausted. Could R waves hence, provide indication for increasing ICP after traumatic brain injury (TBI)? On days 1 to 4 after TBI, 22 sedated and ventilated patients were monitored for intracranial pressure (ICP) in brain parenchyma, Doppler flow velocity (FV) in the middle cerebral arteries (MCA), and arterial blood pressure (ABP). The analysis included the transfer function gains of R waves (respiratory rate of 9-20 cpm) between ABP and FV (GainFv) as well as between ABP and ICP (GainICP). Also, the index of the intracranial pressure-volume reserve (RAP) was calculated. The rise of ICP (day 1:14.10 +/- 6.22 mmHg; to day 4: 29.69 +/- 12.35 mmHg) and increase of RAP (day 1:0.72 +/- 0.22; to day 4: 0.85 +/- 0.18) were accompanied by a decrease of GainFv (right MCA; day 1: 1.78 +/- 1.0; day 4: 0.84 +/- 0.47; left MCA day 1: 1.74 +/- 1.10; day 4: 0.86 +/- 0.46; p < 0.01) but no significant change in GainICP day 1:1.50 +/- 0.77; day 4: 1.15 +/- 0.47; p = 0.07). The transfer of ventilatory oscillations to the intracerebral arteries after TBI appears to be dampened by increasing ICP and exhausted intracranial pressure-volume reserves. Results warrant prospective studies of whether respiratory waves in cerebral blood flow velocity may anticipate intracranial hypertension non-invasively. (C) 2015 IPEM. Published by Elsevier Ltd. All rights reserved.	[Haubrich, Christina] Univ Hosp Aachen, Dept Neurol, Aachen, Germany; [Diehl, Rolf R.] Dept Neurol, Essen, Germany; [Kasprowicz, Magdalena] Wroclaw Univ Technol, Inst Biomed Engn & Instrumentat, PL-50370 Wroclaw, Poland; [Diedler, Jennifer] Univ Tubingen, Dept Neurol, Tubingen, Germany; [Sorrentino, Enrico; Srnielewski, Piotr; Czosnyka, Marek] Addenbrookes Hosp, Dept Acad Neurosurg, Cambridge, England		Haubrich, C (corresponding author), Univ Hosp Aachen, Dept Neurol, Aachen, Germany.	chaubrich@ukaachen.de		Smielewski, Peter/0000-0001-5096-3938; Kasprowicz, Magdalena/0000-0002-2271-7737; czosnyka, marek/0000-0003-2446-8006	Feodor-Lynen scholarship of the Alexander-von-Humboldt FoundationAlexander von Humboldt Foundation; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G9439390, 65883]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986] Funding Source: researchfish	Dr. C. Haubrich was supported with a Feodor-Lynen scholarship of the Alexander-von-Humboldt Foundation; Dr. M. Kasprowicz was a scholar of the Foundation for Polish Science, Dr. M. Czosnyka and Dr. P. Smielewski are supported by MRC grant no.: G9439390, ID 65883. Dr. M. Czosnyka is on unpaid leave from Warsaw University.	CZOSNYKA M, 1994, ULTRASOUND MED BIOL, V20, P391, DOI 10.1016/0301-5629(94)90008-6; Czosnyka M, 1996, J NEUROL NEUROSUR PS, V60, P549, DOI 10.1136/jnnp.60.5.549; DIEHL RR, 1991, NEUROSCI LETT, V127, P5, DOI 10.1016/0304-3940(91)90880-3; Diehl RR, 1998, CLIN AUTON RES, V8, P7, DOI 10.1007/BF02267598; Giller CA, 1996, ULTRASOUND MED BIOL, V22, P373, DOI 10.1016/0301-5629(96)00024-5; Haubrich C, 2007, STROKE, V38, P2677, DOI 10.1161/STROKEAHA.107.485847; Hu XA, 2006, MED ENG PHYS, V28, P304, DOI 10.1016/j.medengphy.2005.07.006; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; MARMAROU A, 1975, J NEUROSURG, V43, P523, DOI 10.3171/jns.1975.43.5.0523; MARMAROU A, 1987, J NEUROSURG, V66, P883, DOI 10.3171/jns.1987.66.6.0883; NAKAGAWA Y, 1974, J NEUROSURG, V41, P427, DOI 10.3171/jns.1974.41.4.0427; Schmidt B, 1999, J CEREBR BLOOD F MET, V19, P990, DOI 10.1097/00004647-199909000-00006; Schuhmann MU, 2008, PEDIATR NEUROSURG, V44, P269, DOI 10.1159/000131675	13	5	5	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	FEB	2015	37	2					175	179		10.1016/j.medengphy.2014.11.009			5	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CB8KA	WOS:000349877200003	25553961				2022-02-06	
J	Khusid, MA				Khusid, Marina A.			Clinical Indications for Acupuncture in Chronic Post-Traumatic Headache Management	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; MIGRAINE PROPHYLAXIS; CHRONIC PAIN; EFFICACY; COSTS	Chronic post-traumatic headache (PTH) is one of the most common complaints after mild traumatic brain injury, yet evidence to date is insufficient to direct conventional treatment of headaches with this etiology. Therefore, the current guidelines recommend a symptomatic approach for the three patterns of PTHs: migraine-like, tension-like, and mixed symptomatology. To improve response rates and minimize the potential for polypharmacy, adverse effects, and risk of dependency, effective nonpharmacologic options should be employed to support faster and safer patient rehabilitation. Current evidence shows that acupuncture is at least as effective as drug therapy for migraine prophylaxis and neurovascular and tension-type headaches. Because of its safety, cost-effectiveness, and long-lasting benefits, adjunctive acupuncture should be offered to patients with chronic PTHs and may be a valuable primary treatment alternative for those with contraindications to pharmacotherapy. Future head-to-head, adequately powered, well-controlled randomized clinical trials are needed to investigate acupuncture efficacy for PTHs.	Deployment Hlth Clin Ctr, Silver Spring, MD 20910 USA		Khusid, MA (corresponding author), Deployment Hlth Clin Ctr, 8601 Georgia Ave,4th Floor, Silver Spring, MD 20910 USA.						Ambrosio EMM, 2012, COMPLEMENT THER MED, V20, P364, DOI 10.1016/j.ctim.2012.05.002; [Anonymous], 2009, VA DOD CLIN PRACT GU; Armed Forces Health Surveillance Center, 2009, MSMR, V16, P10; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fu LM, 2009, J ALTERN COMPLEM MED, V15, P133, DOI 10.1089/acm.2008.0135; Furlan AD, 2005, SPINE, V30, P944, DOI 10.1097/01.brs.0000158941.21571.01; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Jena S, 2008, CEPHALALGIA, V28, P969, DOI 10.1111/j.1468-2982.2008.01640.x; Kong JT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/187182; Li Y, 2012, CAN MED ASSOC J, V184, P401, DOI 10.1503/cmaj.110551; Linde K, 2009, COCHRANE DB SYST REV, V1; Linde K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub2; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Napadow V, 2007, PAIN, V130, P254, DOI 10.1016/j.pain.2006.12.003; Sandberg M, 2003, EUR J APPL PHYSIOL, V90, P114, DOI 10.1007/s00421-003-0825-3; Sun Y, 2008, ANESTH ANALG, V107, P2038, DOI 10.1213/ane.0b013e318187c76a; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; Wang LP, 2012, PAIN MED, V13, P623, DOI 10.1111/j.1526-4637.2012.01376.x; Wang LP, 2011, PAIN, V152, P1864, DOI 10.1016/j.pain.2011.04.006; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Witt CM, 2008, CEPHALALGIA, V28, P334, DOI 10.1111/j.1468-2982.2007.01504.x; Witt CM, 2011, EUR J PAIN, V15, P193, DOI 10.1016/j.ejpain.2010.06.008; Wong V, 2012, EUR J PHYS REHAB MED, V48, P71; Wong V, 2013, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD007700.PUB3; Yang CP, 2011, CEPHALALGIA, V31, P1510, DOI 10.1177/0333102411420585; Zhang RX, 2005, PHARMACOL BIOCHEM BE, V81, P146, DOI 10.1016/j.pbb.2005.03.002; Zhao L, 2011, CHIN J INTEGR MED, V17, P580, DOI 10.1007/s11655-011-0709-z	30	5	5	1	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2015	180	2					132	136		10.7205/MILMED-D-14-00195			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7MR	WOS:000349101900003	25643378	Bronze			2022-02-06	
J	Kraal, AZ; Waldron-Perrine, B; Pangilinan, PH; Bieliauskas, LA				Kraal, A. Zarina; Waldron-Perrine, Brigid; Pangilinan, Percival H.; Bieliauskas, Linas A.			Affect and Psychiatric Symptoms in a Veteran Polytrauma Clinic	REHABILITATION PSYCHOLOGY			English	Article						negative affect; polytrauma; positive affect; traumatic brain injury; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HOSPITAL ANXIETY; DEPRESSION SCALE; MILITARY TBI; REHABILITATION; PSYCHOLOGY; POPULATION; VALIDATION	Although the relationship between negative affect and psychiatric symptoms has been well-demonstrated in research, less is known about positive affect relative to negative affect, and its relationship to psychiatric symptoms, especially among veterans. This study examined how levels of positive and negative affect are associated with symptoms of depression, anxiety, and posttraumatic stress disorder (PTSD). Data were collected in a veteran polytrauma clinic; analyses were conducted using data from 94 veterans (87 males) with and without a mild traumatic brain injury (mTBI) diagnosis. Results demonstrate that positive and negative affect were separate dimensions and that both were independently related to each symptom measure. After removing the contribution of negative affect from symptom reports, strong relationships remained between positive affect and psychiatric symptoms. Furthermore, the magnitude of the associations for positive affect and for negative affect with symptoms of depression, anxiety, and PTSD were not impacted by a mTBI diagnosis. Altogether, findings suggest that both positive and negative affect should be uniquely considered when conceptualizing, assessing, and treating returning service members; in addition, positive affect may be an appropriate target of assessment and interventions of persons who have experienced polytrauma.	[Kraal, A. Zarina] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Waldron-Perrine, Brigid] Ann Arbor VA Healthcare Syst, Dept Neuropsychol, Ann Arbor, MI USA; [Pangilinan, Percival H.; Bieliauskas, Linas A.] Univ Michigan Hlth Syst, Dept Phys Med & Rehabil, Ann Arbor, MI USA; [Pangilinan, Percival H.; Bieliauskas, Linas A.] Ann Arbor VA Healthcare Syst, Ann Arbor, MI USA		Kraal, AZ (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	azkraal@umich.edu					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDERSSON E, 1993, SOC BEHAV PERSONAL, V21, P197, DOI 10.2224/sbp.1993.21.3.197; Andrewes HE, 2014, BRAIN INJURY, V28, P965, DOI 10.3109/02699052.2014.888764; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brouwers C, 2013, BIOL PSYCHOL, V92, P220, DOI 10.1016/j.biopsycho.2012.10.002; Brown KW, 1997, J PERS SOC PSYCHOL, V72, P907, DOI 10.1037/0022-3514.72.4.907; Burnam A, 2009, HEALTH AFFAIR, V28, P771, DOI 10.1377/hlthaff.28.3.771; Chida Y, 2008, PSYCHOSOM MED, V70, P741, DOI 10.1097/PSY.0b013e31818105ba; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Denzin Norman K, 1978, RES ACT THEORETICAL; Dunn L. M., 2007, PPVT 4 PEABODY PICTU; Friedemann-Sanchez G, 2008, ARCH PHYS MED REHAB, V89, P171, DOI 10.1016/j.apmr.2007.10.017; Friedman S, 2001, PSYCHIAT RES, V104, P247, DOI 10.1016/S0165-1781(01)00309-2; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; HUFNAGEL EM, 1994, INFORM SYST RES, V5, P48, DOI 10.1287/isre.5.1.48; Jaycox, 2008, INVISIBLE WOUNDS WAR; JOINER TE, 1995, SEX ROLES, V33, P91, DOI 10.1007/BF01547937; Kiecolt-Glaser JK, 2002, J CONSULT CLIN PSYCH, V70, P537, DOI 10.1037//0022-006X.70.3.537; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P1393, DOI 10.1001/archpsyc.64.12.1393; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Martin CR, 2003, PSYCHIAT RES, V120, P85, DOI 10.1016/S0165-1781(03)00162-8; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; Mineka S, 1998, ANNU REV PSYCHOL, V49, P377, DOI 10.1146/annurev.psych.49.1.377; Pelle AJ, 2011, QUAL LIFE RES, V20, P643, DOI 10.1007/s11136-010-9792-4; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Veterans Affairs Department, 2013, VHA HDB, V1172.01; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1989, PSYCHOL REV, V96, P234, DOI 10.1037/0033-295X.96.2.234; Weathers F. W., 1993, ANN M INT SOC TRAUMA; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	5	5	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2015	60	1					36	42		10.1037/rep0000017			7	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	CC4VV	WOS:000350353600004	25528470				2022-02-06	
J	Qian, A; Zhang, M; Zhao, G				Qian, A.; Zhang, M.; Zhao, G.			Dynamic detection of N-terminal pro-B-type natriuretic peptide helps to predict the outcome of patients with major trauma	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						B-type natriuretic peptide; Biological marker; Major trauma; Pro-brain natriuretic peptide; Prognosis	CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; BRAIN-INJURY; CIRCULATORY OVERLOAD; PROSPECTIVE COHORT; DIAGNOSTIC MARKER; HEART-FAILURE; SEPSIS; PROCALCITONIN; BNP	NT-proBNP and BNP have been demonstrated to be prognostic markers in cardiac disease and sepsis. However, the prognostic value and the dynamic changes of BNP or NT-proBNP in trauma patients remain unclear. The present study was conducted to investigate the dynamic changes of NT-proBNP in patients with major trauma (injury severity score a parts per thousand yen16), determine whether NT-proBNP could be used as a simple index to predict mortality in major trauma patients. This prospective observational study included 60 patients with major trauma. Serum NT-proBNP levels were measured on the 1st, 3rd and 7th day after injury The NT-proBNP levels in survivors were compared with those in non-survivors. The efficacy of NT-proBNP to predict survival was analyzed using receiver operating characteristic curves. An analysis of correlations between NT-proBNP and various factors, including injury severity score, Glasgow coma score, acute physiology and chronic health evaluation II, central venous pressure, creatine kinase-MB, cardiac troponin I and procalcitonin (PCT) was performed. NT-proBNP levels in patients with traumatic brain injury were compared with those in patients without traumatic brain injury. A comparison of NT-proBNP levels between patients with and without sepsis was also performed at each time point. NT-proBNP levels in non-survivors were significantly higher than those in survivors at all the indicated time points. In the group of non-survivors, NT-proBNP levels on the 7th day were markedly higher than those on the 1st day. In contrast, NT-proBNP levels in survivors showed a reduction over time. The efficacy of NT-proBNP to predict survival was analyzed using ROC curves, and there was no difference in the area under the ROC between NT-proBNP and APACHE II/ISS at the three time points. A significant correlation was found between NT-proBNP and ISS on the 1st day, NT-proBNP and CK-MB, Tn-I and APACHE II on the 3rd day, NT-proBNP and PCT on the 7th day. There were no significant differences in NT-proBNP levels between patients with or without brain trauma at all the indicated time points. NT-proBNP levels in patients with sepsis were significantly higher than those in patients without sepsis at all the indicated time points. These findings suggest that dynamic detection of serum NT-proBNP might help to predict death in patients with major trauma. A high level of NT-proBNP at admission or maintained for several days after trauma indicates poor survival.	[Qian, A.; Zhang, M.; Zhao, G.] Zhejiang Univ, Affiliated Hosp 2, Dept Emergency Med, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China		Zhao, G (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Emergency Med, Sch Med, Hangzhou 310009, Zhejiang, Peoples R China.	qiananyu@hotmail.com; zmhz@hotmail.com; anan222666@163.com					Al-Nawas B, 1996, Eur J Med Res, V1, P331; Almog Y, 2006, ANESTH ANALG, V102, P1809, DOI 10.1213/01.ane.0000217202.55909.5d; Bahrami S, 2010, CRIT CARE MED, V38, P161, DOI 10.1097/CCM.0b013e3181b78a06; Benoist JF, 1998, CLIN CHEM, V44, P1778; Burger Andrew J, 2005, Congest Heart Fail, V11, P30, DOI 10.1111/j.1527-5299.2005.03794.x; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Charpentier J, 2004, CRIT CARE MED, V32, P660, DOI 10.1097/01.CCM.0000114827.93410.D8; De'Ath HD, 2012, BRIT J SURG, V99, P789, DOI 10.1002/bjs.8728; Friese RS, 2007, J TRAUMA, V62, P1346, DOI 10.1097/TA.0b013e31804798c3; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Jason P, 2005, CRIT CARE MED, V33, P2094, DOI 10.1097/01.CCM.0000178351.03327.9F; Kirchhoff C, 2008, CRIT CARE, V12, DOI 10.1186/cc7013; Kleindienst Andrea, 2012, Acta Neurochir Suppl, V114, P277, DOI 10.1007/978-3-7091-0956-4_54; Kotanidou A, 2009, SHOCK, V31, P342, DOI 10.1097/SHK.0b013e31818635b6; Mair J, 2001, CLIN CHEM LAB MED, V39, P571, DOI 10.1515/CCLM.2001.093; Meyer B, 2007, CRIT CARE MED, V35, P2268, DOI 10.1097/01.CCM.0000284509.23439.5B; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-00011; Papp A, 2003, ACTA ANAESTH SCAND, V47, P1257, DOI 10.1046/j.1399-6576.2003.00235.x; Pfister R, 2004, EUR J HEART FAIL, V6, P289, DOI 10.1016/j.ejheart.2003.12.012; Post F, 2008, CRIT CARE MED, V36, P3030, DOI 10.1097/CCM.0b013e31818b9153; Stewart D, 2007, J TRAUMA, V63, P747, DOI 10.1097/01.ta.0000240458.46050.38; Sviri GE, 2006, ACTA NEUROCHIR, V148, P529, DOI 10.1007/s00701-005-0666-4; Tobian AAR, 2008, TRANSFUSION, V48, P1143, DOI 10.1111/j.1537-2995.2008.01656.x; Ueda S, 2006, SHOCK, V26, P134, DOI 10.1097/01.shk.0000226266.99960.d0; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Wu X, 2011, J TRAUMA, V71, P820, DOI 10.1097/TA.0b013e3182277b69; Zhou L, 2005, TRANSFUSION, V45, P1056, DOI 10.1111/j.1537-2995.2005.04326.x	27	5	7	1	11	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2015	41	1					57	64		10.1007/s00068-014-0406-7			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AZ4SU	WOS:000348214100007	26038166				2022-02-06	
J	Schmidt, J; Fleming, J; Ownsworth, T; Lannin, NA				Schmidt, Julia; Fleming, Jennifer; Ownsworth, Tamara; Lannin, Natasha A.			An occupation-based video feedback intervention for improving self-awareness: Protocol and rationale	CANADIAN JOURNAL OF OCCUPATIONAL THERAPY-REVUE CANADIENNE D ERGOTHERAPIE			English	Article						Awareness; Cognitive therapy; Occupational therapy; Rehabilitation; Self-regulation	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; EXECUTIVE FUNCTIONS; ALZHEIMERS-DISEASE; IMPAIRED AWARENESS; DISCREPANCY THEORY; REHABILITATION; ADULTS; DEFICITS; MODEL	Background. Impaired self-awareness can limit rehabilitation outcomes for people with traumatic brain injury (TBI). Video feedback on occupational performance has been found to improve self-awareness after TBI when delivered according to specific principles. Purpose. The purpose of this article is to describe an occupation-based video feedback intervention found to be effective in a randomized controlled trial to assist with translation into clinical practice. Key Issues. The intervention uses therapist-mediated video feedback on clients' occupational performance, aiming to facilitate self-reflection on performance and improve self-awareness. This paper describes the theoretical background, intervention principles, and protocol of the intervention. Implications. Therapists can use video feedback intervention, incorporating the principles in this article, to improve people's intellectual awareness and ability to recognize and correct errors during task performance after TBI without a negative impact on emotional status.	[Schmidt, Julia] Australian Catholic Univ, Sch Allied & Publ Hlth, Sydney, NSW 2059, Australia; [Schmidt, Julia; Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Schmidt, Julia] Royal Rehabil Ctr, Sydney, NSW, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Dept Occupat Therapy, Brisbane, Qld 4102, Australia; [Ownsworth, Tamara] Griffith Univ, Sch Appl Psychol, Mt Gravatt, Qld 4122, Australia; [Lannin, Natasha A.] La Trobe Univ, Dept Occupat Therapy, Melbourne, Vic, Australia; [Lannin, Natasha A.] Alfred Hlth, Occupat Therapy Dept, Melbourne, Vic, Australia		Schmidt, J (corresponding author), Australian Catholic Univ, Sch Allied & Publ Hlth, 40 Edward St, Sydney, NSW 2059, Australia.	julia.schmidt@acu.edu.au	Ownsworth, Tamara/ABB-6961-2021; Lannin, Natasha A/A-4195-2013	Ownsworth, Tamara/0000-0003-1835-7094; Lannin, Natasha A/0000-0002-2066-8345; Schmidt, Julia/0000-0003-2004-4871	Occupational Therapists Board of Queensland; Wenkart Foundation, Australia; Balnaves Fellowship by Cerebral Palsy Alliance, Australia	This trial has been partially funded through a grant awarded by the Occupational Therapists Board of Queensland. At the time of this study, J. Schmidt was supported by a fellowship provided by the Wenkart Foundation, Australia, and N. Lannin was supported by the Balnaves Fellowship provided by the Cerebral Palsy Alliance, Australia.	Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; Alexy WD, 1983, COGNITIVE REHABILITA, V1, P8; ALLEN C C, 1990, Brain Injury, V4, P7, DOI 10.3109/02699059009026143; Barco PP, 1991, COGNITIVE REHABILITA, P129; Barmigan K., 2008, BRIT J OCCUPATIONAL, V71, P13; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Cantor JB, 2005, J HEAD TRAUMA REHAB, V20, P527, DOI 10.1097/00001199-200511000-00005; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chevignard MP, 2008, NEUROPSYCHOL REHABIL, V18, P461, DOI 10.1080/09602010701643472; Christensen A., 2000, INT HDB NEUROPSYCHOL, P183; Cicerone K., 1989, REHABIL PSYCHOL, V34, P104, DOI 10.1037/h0091711; Dawson DR, 2009, CAN J OCCUP THER, V76, P115, DOI 10.1177/000841740907600209; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Fleming J., 2014, INT HDB OCCUPATIONAL, P225; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming J, 2009, INTERNATIONAL HANDBOOK OF OCCUPATIONAL THERAPY INTERVENTIONS, P225, DOI 10.1007/978-0-387-75424-6_20; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Hart T, 1998, J HEAD TRAUMA REHAB, V13, P16, DOI 10.1097/00001199-199810000-00004; HIGGINS ET, 1987, PSYCHOL REV, V94, P319, DOI 10.1037/0033-295X.94.3.319; HIGGINS ET, 1985, SOC COGNITION, V3, P51, DOI 10.1521/soco.1985.3.1.51; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Langer KG., 1992, NEUROPSYCHOL REHABIL, V2, P59, DOI [DOI 10.1080/09602019208401395, 10.1080/09602019208401395]; LeBaron SWM, 2000, FAM MED, V32, P13; Mandich, 2004, ENABLING OCCUPATION; Mateer C. A., 1999, COGNITIVE NEUROREHAB, P314; McNaughton S., 1987, PAUSE PROMPT PRAISE; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2006, CLIN PSYCHOL REV, V26, P783, DOI 10.1016/j.cpr.2006.05.003; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sherer M, 1998, NEUROREHABILITATION, V10, P25, DOI 10.3233/NRE-1998-10104; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Sohlberg MM, 2000, J CLIN EXP NEUROPSYC, V22, P656, DOI 10.1076/1380-3395(200010)22:5;1-9;FT656; Strong J., 1995, BRIT J OCCUPATIONAL, V58, P55; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Tailby R, 2003, NEUROPSYCHOLOGIA, V41, P1230, DOI 10.1016/S0028-3932(03)00036-8; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474	49	5	5	0	31	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0008-4174	1911-9828		CAN J OCCUP THER	Can. J. Occup. Ther.	FEB	2015	82	1					54	63		10.1177/0008417414550999			10	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CB4FU	WOS:000349584400009	25803948				2022-02-06	
J	Wojcik, BE; Curley, KC; Szeszel-Fedorowicz, W; Stein, CR; Humphrey, RJ				Wojcik, Barbara E.; Curley, Kenneth C.; Szeszel-Fedorowicz, Wioletta; Stein, Catherine R.; Humphrey, Rebecca J.			Spinal Injury Hospitalizations Among US Army Soldiers Deployed to Iraq and Afghanistan	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; IMPROVISED EXPLOSIVE DEVICE; MILITARY PERSONNEL; COMBAT WOUNDS; BLAST; CARE; FREEDOM; DEATH	This retrospective study examined spinal-related hospitalizations of U.S. Army soldiers deployed to Afghanistan and Iraq. Spinal cord injuries (SCI) and vertebral column injuries (VCI) were identified using International Classification of Disease, 9th Revision, Clinical Modification diagnosis codes. In our study, spinal hospitalizations represented 8.2% of total injury admissions. Risk factors for SCI and VCI incidences were determined using Poisson regression. Lack of previous deployment experience increased risk of having SCI by 33% and VCI by 24% in Iraq (similar increases, but not statistically significant in Afghanistan). Male soldiers had 4.85 times higher risk for SCI in Iraq and 69% higher risk in Afghanistan than female soldiers. In Afghanistan, almost 60% of spinal episodes included traumatic brain injury (TBI), compared to about 40% in Iraq. In both theaters, mild TBI accounted for more than 50% of all TBI-spinal episodes. Sixteen percent of SCI inpatient episodes in Afghanistan and 13% in Iraq were associated with paralysis, with median bed days of 46 and 33 days compared to a median of 6 days in both theaters for nonparalysis spinal injuries. The mortality rate was 2.5 times lower in Afghanistan than in Iraq.	[Wojcik, Barbara E.; Szeszel-Fedorowicz, Wioletta; Stein, Catherine R.; Humphrey, Rebecca J.] Ctr US Army Med Dept Strateg Studies, Ft Sam Houston, TX 78234 USA; [Curley, Kenneth C.] US Army Med Res & Mat Command, Combat Casualty Care Directorate RAD2, Ft Detrick, MD 21702 USA		Wojcik, BE (corresponding author), Ctr US Army Med Dept Strateg Studies, 2478 Stanley Rd Suite 47, Ft Sam Houston, TX 78234 USA.						Bederman SS, 2011, J TRAUMA, V71, pE71, DOI 10.1097/TA.0b013e3182092eac; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Blair JA, 2012, SPINE J, V12, P824, DOI 10.1016/j.spinee.2011.09.012; BORS E, 1951, JAMA-J AM MED ASSOC, V146, P225, DOI 10.1001/jama.1951.03670030003002; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brethauer SA, 2008, ARCH SURG-CHICAGO, V143, P564, DOI 10.1001/archsurg.143.6.564; Burns SP, 2009, CARE COMBAT AMPUTEE; Centers for Disease Control and Prevention National Center for Health Statistics, NAT CTR HLTH STAT BA; Comstock S, 2011, J TRAUMA, V71, pS413, DOI 10.1097/TA.0b013e318232e575; Dean Wendy, 2011, Regen Med, V6, P71, DOI 10.2217/rme.11.52; Defense Manpower Data Center; Data Analysis and Programs Division, 2001, GLOB WAR TERR REAS; DEVIVO MJ, 1989, ARCH INTERN MED, V149, P1761, DOI 10.1001/archinte.149.8.1761; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; Grenier E.S., 2012, J BONE JOINT SURG AM, V94, pE135, DOI DOI 10.2106/JBJS.K.00502; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Kang DG, 2012, SPINE J, V12, P849, DOI 10.1016/j.spinee.2011.11.014; Landy HJ, 2000, CONT MANAGEMENT SPIN; Lehman C, 2008, REHABIL NURS, V33, P192, DOI 10.1002/j.2048-7940.2008.tb00227.x; Lehman Jr RA, 2012, J SPINAL RES FDN, V7, P40; Lehman RA, 2012, J AM ACAD ORTHOP SUR, V20, pS13, DOI 10.5435/JAAOS-20-08-S13; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Manring MM, 2009, CLIN ORTHOP RELAT R, V467, P2168, DOI 10.1007/s11999-009-0738-5; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ramasamy A, 2008, J TRAUMA, V65, P910, DOI 10.1097/TA.0b013e3181848cf6; Schoenfeld AJ, 2012, J SPINAL RES FDN, V7, P33; Schoenfeld AJ, 2013, SPINE, V38, P1770, DOI 10.1097/BRS.0b013e31829ef226; Schoenfeld AJ, 2012, SPINE J, V12, P771, DOI 10.1016/j.spinee.2010.05.004; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Taber Katherine H, 2009, J Neuropsychiatry Clin Neurosci, V21, P1, DOI 10.1176/appi.neuropsych.21.1.iv; Weaver FM, 2009, ARCH PHYS MED REHAB, V90, P517, DOI 10.1016/j.apmr.2008.09.560	36	5	5	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	FEB	2015	180	2					216	223		10.7205/MILMED-D-14-00061			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7MR	WOS:000349101900015	25643390	Bronze			2022-02-06	
J	Fridley, J; Robertson, C; Gopinath, S				Fridley, Jared; Robertson, Claudia; Gopinath, Shankar			Quantitative Lobar Cerebral Blood Flow for Outcome Prediction after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; head injury prognosis; traumatic brain injury	XENON-ENHANCED CT; COMPUTED-TOMOGRAPHY; INTRAVENTRICULAR PRESSURE; CEREBROVASCULAR-DISEASE; CLINICAL-EXPERIENCE; HEAD-INJURIES; METABOLISM; INHALATION; PERFUSION; ISCHEMIA	The aim of this study was to examine cortical cerebral blood flow (CBF) in patients with traumatic brain injury (TBI) and determine whether lobar cortical CBF is a better predictor of long-term neurological outcome assessed by the Glasgow Outcome Scale (GOS) than global cortical CBF. Ninety-eight patients with TBI had a stable xenon computed tomography scan (Xe/CT-CBF study) performed at various time points after their initial injury. Spearman's correlation coefficients and Kruskall-Wallis' test were used to examine the relationship between patient age, emergency room Glasgow Coma Scale (GCS), Injury Severity Score, prehospital hypotension, prehospital hypoxia, mechanism of injury, type of injury, side of injury, global average CBF, lobar CBF, number of lobes with CBF below normal, and GOS (discharge, 3 and 6 months). Univariate ordinal regression was performed using these same variables and in combination with principle component analysis (PCA) to determine independent variables for multi-variate ordinal regression. Significant correlation between age, GCS, prehospital hypotension, type of injury, global average CBF, lobar CBF, number of lobes below normal CBF, and GOS was found. Individual lobar CBF was highly correlated with global CBF and the number of lobes below normal CBF. PCA found one principle component among these three CBF variables; therefore, average global CBF and number of lobes with CBF below normal were each chosen as independent variables for multiple ordinal regression, which found age, GCS, and prehospital hypotension, global average CBF, and number of lobes below normal CBF significantly associated with GOS. This study found global average CBF and lobar CBF significantly correlated with GOS at follow-up. There was, however, no individual cerebral lobe that was more predictive than any other, which puts into question the value of calculating lobar CBF versus global CBF in predicting GOS.	[Fridley, Jared; Robertson, Claudia; Gopinath, Shankar] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA		Gopinath, S (corresponding author), Baylor Coll Med, Dept Neurosurg, 1709 Dryden,Suite 750, Houston, TX 77030 USA.	shankarg@bcm.edu					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carlson A. P., 2010, OPEN NEUROSURG J, V3, P64; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; DRAYER BP, 1978, STROKE, V9, P123, DOI 10.1161/01.STR.9.2.123; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; Engelborghs K, 2000, J NEUROTRAUM, V17, P667, DOI 10.1089/089771500415418; Faul M, 2010, TRAUMATIC BRAIN INJU; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; GUR D, 1981, J COMPUT ASSIST TOMO, V5, P334, DOI 10.1097/00004728-198106000-00003; GUR D, 1982, STROKE, V13, P750, DOI 10.1161/01.STR.13.6.750; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; JENNETT B, 1975, LANCET, V1, P480; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kushi H, 1999, ACT NEUR S, V75, P67; LASSEN NA, 1966, LANCET, V2, P1113, DOI 10.1016/S0140-6736(66)92199-4; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MELAMED E, 1980, STROKE, V11, P31, DOI 10.1161/01.STR.11.1.31; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; OBRIST WD, 1975, STROKE, V6, P245, DOI 10.1161/01.STR.6.3.245; OBRIST WD, 1967, CIRC RES, V20, P124, DOI 10.1161/01.RES.20.1.124; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ponce LL, 2012, NEUROSURGERY, V70, P1492, DOI 10.1227/NEU.0b013e31824ce933; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; WEBSTER MW, 1986, J VASC SURG, V3, P298, DOI 10.1067/mva.1986.avs0030298; YONAS H, 1985, J NEUROSURG, V62, P324, DOI 10.3171/jns.1985.62.3.0324; YONAS H, 1991, J CEREBR BLOOD F MET, V11, P716, DOI 10.1038/jcbfm.1991.128; YONAS H, 1984, RADIOLOGY, V152, P435, DOI 10.1148/radiology.152.2.6739811; YONAS H, 1984, LANCET, V1, P1357; YONAS H, 1984, STROKE, V15, P443, DOI 10.1161/01.STR.15.3.443	42	5	5	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2015	32	2					75	82		10.1089/neu.2014.3350			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AY6QM	WOS:000347690700001	25019579				2022-02-06	
J	Amoako, AO; Amoako, AB; Pujalte, GGA				Amoako, Adae O.; Amoako, Agyenim B.; Pujalte, George G. A.			Family medicine residents' perceived level of comfort in treating common sports injuries across residency programs in the United States	OPEN ACCESS JOURNAL OF SPORTS MEDICINE			English	Article						athletic injuries; graduate medical education; sports medicine	EDUCATION	Background and objective: Family physicians are expected to be comfortable in treating common sports injuries. Evidence shows a limited level of comfort in treating these injuries in pediatric and internal medicine residents. Studies are lacking, however, in family medicine residents. The purpose of this study is to assess the comfort level of family medicine residents in treating common sports injuries in adults and children based on their perceived level of knowledge and attitudes. Methods: This is a cross-sectional study of family medicine residents in the United Sates. A written survey of 25 questions related to sports injury knowledge and factors affecting comfort level were collected. A chi-square test was implemented in calculating P-values. Results: Five hundred and fifty-seven residents responded to the survey. A higher percentage of doctors of osteopathy (86.6%, 82.5%, 69.6%, and 68.7%) compared to doctors of medicine (78.5%, 71.6%, 53.4%, and 52.8%) respectively identified ankle sprain, concussion, plantar fasciitis, and lateral epicondylitis as common injuries, and felt comfortable in treating them (P-values =0.015, 0.004, 0.0001, and 0.0002, respectively). Residents with high interest in sports medicine correctly identified the injuries as common and felt comfortable treating them as well (knowledge, P=0.027, 0.0029,< 0.0001, and 0.0001, respectively; comfort level, P=0.0016,< 0.0001, 0.0897, and 0.0010, respectively). Conclusion: Medical education background, factors that affect training, and an interest in sports medicine contribute to residents' knowledge and comfort level in treatment of common sports injuries.	[Amoako, Adae O.] Penn State Hershey Med Ctr, Dept Family & Community Med, Hershey, PA USA; [Amoako, Agyenim B.] Univ Arkansas Med Sci NorthWest, Dept Family Med, Fayetteville, AR USA; [Pujalte, George G. A.] Mayo Clin Hlth Syst, Div Primary Care, Sports Med, Waycross, GA USA; [Pujalte, George G. A.] Mayo Clin Hlth Syst, Div Orthoped, Sports Med, Waycross, GA USA		Amoako, AO (corresponding author), Penn State Hershey Med Ctr, Dept Family & Community Med, Family Med Residency Program, 500 Univ Dr, Hershey, PA 17033 USA.	adae_amoako@yahoo.com	Pujalte, George G.A./AAR-3996-2020	Pujalte, George G.A./0000-0002-7537-7457			Adirim TA, 2003, SPORTS MED, V33, P75, DOI 10.2165/00007256-200333010-00006; Bucholtz JR, 2004, ANN FAM MED, V2, pS51, DOI [DOI 10.1370/AFM.135, 10.1370/afm.135]; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P340; Demorest RA, 2005, PEDIATRICS, V115, P28, DOI 10.1542/peds.2004-0266; Dowling, 2005, OSTEOPATHIC APPROACH; Duane Marguerite, 2002, J Am Board Fam Pract, V15, P201; Hambidge SJ, 2002, PEDIATRICS, V109, P559, DOI 10.1542/peds.109.4.559; Lebensohn P, 2007, FAM MED, V39, P488; Lesho EP, 1999, ARCH FAM MED, V8, P477, DOI 10.1001/archfami.8.6.477; Matzkin E, 2005, J BONE JOINT SURG AM, V87A, P310, DOI 10.2106/JBJS.D.01779; Smits AK, 2006, FAM MED, V38, P172; Stirling JM, 1996, ARCH PEDIAT ADOL MED, V150, P211, DOI 10.1001/archpedi.1996.02170270093014; Sweeney CL, 2003, BRIT J SPORT MED, V37, P219, DOI 10.1136/bjsm.37.3.219	13	5	5	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1543			OPEN ACCESS J SPORTS	Open Access J. Sports Med.		2015	6						81	86		10.2147/OAJSM.S71457			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V04TQ	WOS:000213827700009	25848326	Green Published, gold			2022-02-06	
J	Anderson, K; Tinawi, S; Lamoureux, J; Feyz, M; de Guise, E				Anderson, Kirsten; Tinawi, Simon; Lamoureux, Julie; Feyz, Mitra; de Guise, Elaine			Detecting Migraine in Patients with Mild Traumatic Brain Injury Using Three Different Headache Measures	BEHAVIOURAL NEUROLOGY			English	Article							POSTTRAUMATIC MIGRAINE; CONCUSSION; RECOVERY	Posttraumatic migraine may represent an important subtype of headache among the traumatic brain injury (TBI) population and is associated with increased recovery times. However, it is underdiagnosed in patients with mild traumatic brain injury (mTBI). This study examined the effectiveness of the self-administered Nine-ItemScreener (Nine-ItemScreener-SA), the Headache Impact Test-6 (HIT-6), the 3-Item Migraine Screener, and the Rivermead Post-Concussion Questionnaire (RPQ) at discriminating between mTBI patients with (n = 23) andwithout (n = 20) migraines. The Nine-Item Screener demonstrated significant differences between migraine patients with and without migraine on nearly every question, especially on Question 9 (disability), sensitivity: 0.95 and specificity: 0.65 (95% CI, 0.64-0.90). The HIT-6 demonstrated significant differences between migraine and no-migraine patients on disability and pain severity, with disability having a sensitivity of 0.70 and specificity of 0.75 (95% CI, 0.54-0.83). Only Question 3 of the 3-Item ID Migraine Screener (photosensitivity) showed significant differences between migraine and no-migraine patients, sensitivity: 0.84 and specificity: 0.55 (CI, 0.52-0.82). The RPQ did not reveal greater symptoms in migraine patients compared with those without. Among headache measures, the Nine-Item Screener-SA best differentiated between mTBI patients with and without migraine. Disability may best identify migraine sufferers among the TBI population.	[Anderson, Kirsten; de Guise, Elaine] Univ Montreal, Dept Psychol, Montreal, PQ H3C 3J7, Canada; [Tinawi, Simon] McGill Univ, Ctr Hlth, Phys Med & Rehabil Serv, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ H3N 1X7, Canada; [Feyz, Mitra] McGill Univ, Traumat Brain Injury Program, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine] McGill Univ, Dept Neurol & Neurosurg, Ctr Hlth, Montreal, PQ H3G 1A4, Canada		de Guise, E (corresponding author), Univ Montreal, Dept Psychol, Pavillon Marie Victorin,CP 6128, Montreal, PQ H3C 3J7, Canada.	elaine.de.guise@umontreal.ca		Lamoureux, Julie/0000-0002-4986-2504	Research Institute of the McGill University Health Center	The authors thank the Research Institute of the McGill University Health Center for the support.	Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Monteith TS, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-013-0428-2; Olesen J, 2005, REV NEUROL-FRANCE, V161, P689; Tepper Stewart J, 2012, Continuum (Minneap Minn), V18, P807, DOI 10.1212/01.CON.0000418644.32032.7b; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003	21	5	5	0	1	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								693925	10.1155/2015/693925			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CK1DJ	WOS:000355945600001	26106255	gold, Green Published, Green Submitted			2022-02-06	
J	Ayati, SB; Bouazza-Marouf, K; Kerr, D				Ayati, S. Bentolhoda; Bouazza-Marouf, Kaddour; Kerr, David			In vitro localisation of intracranial haematoma using electrical impedance tomography semi-array	MEDICAL ENGINEERING & PHYSICS			English	Article						Electrical impedance tomography; Intracranial haematoma; Localisation; Size estimation	HEAD-INJURY; QUANTIFICATION; SYSTEM; VOLUME	Electrical Impedance Tomography is a non-invasive and portable method that has good potential as an alternative to the conventional modalities for early detection of intracranial haematomas in high risk patients. Early diagnosis can reduce treatment delays and most significantly can impact patient outcomes. Two eight-electrode layouts, a standard ring full array (FA) and a semi-array (SA), were investigated for their ability to detect, localise and quantify simulated intracranial haematomas in vitro on ovine models for the purpose of early diagnosis. SA layout speeds up electrode application and avoids the need to move and lift the patient's head. Haematomas were simulated using gel samples with the same conductivity as blood. Both layouts, FA and SA, could detect the presence of haematomas at any location within the skull. The mean of the relative radial position error with respect to the brain radius was 7% for FA and 6% for SA, for haematomas close to the electrodes, and 11% for SA for haematomas far from the electrodes at the back of the head. Size estimation was not as good; the worst size estimation error for FA being around 30% while the best for SA was 50% for simulated haematomas close to the electrodes. (C) 2014 IPEM. Published by Elsevier Ltd. All rights reserved.	[Ayati, S. Bentolhoda; Bouazza-Marouf, Kaddour; Kerr, David] Univ Loughborough, Wolfson Sch Mech & Mfg Engn, Loughborough LE11 3TU, Leics, England		Ayati, SB (corresponding author), Univ Loughborough, Wolfson Sch Mech & Mfg Engn, Loughborough LE11 3TU, Leics, England.	s.b.ayati@lboro.ac.uk	Kerr, David/A-2427-2010	Kerr, David/0000-0002-6721-7998			Ayati S. Bentolhoda, 2012, P IASTED INT S IM SI, P101; Bagshaw AP, 2003, NEUROIMAGE, V20, P752, DOI 10.1016/S1053-8119(03)00301-X; D'Antoni AV, 2014, CLIN ORIENTED ANATOM, P1134; Dinsmore J., 2013, CONTIN ED ANAESTH CR; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; HOLDER D, 2005, ELECT IMPEDANCE TOMO; Kandadai MA, 2012, MAT SCI ENG C-MATER, V32, P2664, DOI 10.1016/j.msec.2012.07.024; Liston AD, 2004, PHYSIOL MEAS, V25, P143, DOI 10.1088/0967-3334/25/1/022; Oh S, 2009, PHYSIOL MEAS, V30, P275, DOI 10.1088/0967-3334/30/3/004; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Sadleir R, 1998, PHYSIOL MEAS, V19, P501, DOI 10.1088/0967-3334/19/4/005; Sadleir RJ, 2008, PHYSIOL MEAS, V29, P913, DOI 10.1088/0967-3334/29/8/005; Taktak A, 1996, MED ENG PHYS, V18, P519, DOI 10.1016/1350-4533(95)00086-0; Tang T, 2010, ANN BIOMED ENG, V38, P2733, DOI 10.1007/s10439-010-0003-9; Treasure T, 2007, TRAUMA WHO CARES REP, P19; Tucker AS, 2011, PHYSIOL MEAS, V32, P151, DOI 10.1088/0967-3334/32/2/001; VOSS M, 1995, BRIT MED J, V311, P1395, DOI 10.1136/bmj.311.7017.1395; Wardlaw JM, 1999, POSTGRAD MED J, V75, P18, DOI 10.1136/pgmj.75.879.18; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504; Xu CH, 2011, PHYSIOL MEAS, V32, P585, DOI 10.1088/0967-3334/32/5/007; Yvert B, 1997, ELECTROEN CLIN NEURO, V102, P452, DOI 10.1016/S0921-884X(97)96611-X; Zlochiver S, 2007, MED ENG PHYS, V29, P93, DOI 10.1016/j.medengphy.2006.02.005	22	5	5	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	JAN	2015	37	1					34	41		10.1016/j.medengphy.2014.10.001			8	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	CB4GB	WOS:000349585100005	25455163	Green Accepted			2022-02-06	
J	Baltazar, GA; Pate, AJ; Panigrahi, B; Sharp, A; Smith, M; Chendrasekhar, A				Baltazar, Gerard Anthony; Pate, Amy J.; Panigrahi, Benita; Sharp, Audrey; Smith, Michael; Chendrasekhar, Akella			Higher haemoglobin levels and dedicated trauma admission are associated with survival after severe traumatic brain injury	BRAIN INJURY			English	Article						Acute care; head injury; outcome; surgery; trauma; traumatic brain injury	CRITICALLY-ILL; TRANSFUSION; ANEMIA	Background: Prevention of secondary brain injury is a key component of acute management of patients with severe traumatic brain injury (TBI). Haemoglobin concentration may have an impact on optimization of cerebral oxygenation. Patients with TBI may best be served by an organized trauma service. The objective is to determine if haemoglobin concentration or dedicated trauma admission has an impact on outcomes after severe TBI. Methods: This study retrospectively analysed consecutive patients with severe TBI admitted to a level-I trauma centre over 3 years. Patients <16 years-old and with length of stay (LOS) <24 hours were excluded. Data were collected on demographics; injury severity; LOS; admission service; survival to discharge; and haemoglobin levels from hospital days 1-7. Data were also collected on number of transfusions of packed red blood cells. The sample was stratified based on admission service and survival to discharge. Results: Of 147 patients (age = 54.1 +/- 3.7 years), overall mortality rate was 15.4% (n = 23). Overall, non-survivors had lower daily and 7-day mean haemoglobin levels (10.7 +/- 0.9 vs. 12.9 +/- 0.4 g dL(-1), p<0.001). Non-surgical admissions had lower haemoglobin levels and a higher mortality rate (28.9% vs. 12.2%, p<0.001) compared to dedicated trauma admissions. Conclusions: Among patients with severe TBI, higher haemoglobin levels and maintenance as a dedicated trauma admission are associated with higher survival to discharge.	[Baltazar, Gerard Anthony; Pate, Amy J.; Panigrahi, Benita] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Panigrahi, Benita; Sharp, Audrey; Smith, Michael; Chendrasekhar, Akella] Univ Richmond, Med Ctr, Staten Isl, NY USA		Baltazar, GA (corresponding author), 220 Manhattan Ave,Suite 3J, New York, NY 10025 USA.	gerardbaltazar@gmail.com		Baltazar, Gerard/0000-0001-6109-3843; Smith, Michael/0000-0003-3757-2726			[Anonymous], 2014, RAT TBI REL EM DEP V; [Anonymous], 2006, GET STATS TRAUMATIC; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Committee on Trauma American College of Surgeons, 2006, RES OPT CAR INJ PAT; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Desjardins P, 2012, CRIT CARE, V16, DOI 10.1186/cc11293; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Martini RP, 2013, RESP CARE, V58, P162, DOI 10.4187/respcare.01942; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Roberts DJ, 2012, CRIT CARE, V16, DOI 10.1186/cc11489; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	19	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					607	611		10.3109/02699052.2015.1004558			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000009	25789550				2022-02-06	
B	Behnken, MP; DeLisi, M; Trulson, CR; Vaughn, MG		DeLisi, M; Vaughn, MG		Behnken, Monic P.; DeLisi, Matt; Trulson, Chad R.; Vaughn, Michael G.			Blackout The traumatic brain injury association with career criminality withstands powerful confounds	ROUTLEDGE INTERNATIONAL HANDBOOK OF BIOSOCIAL CRIMINOLOGY	Routledge International Handbooks		English	Article; Book Chapter							PSYCHOPATHIC PERSONALITY-TRAITS; SELF-CONTROL THEORY; SUBSTANCE-ABUSE; GENERAL-POPULATION; JUVENILE-OFFENDERS; DELINQUENT CAREERS; SENSATION SEEKING; BEHAVIOR; METAANALYSIS; PREVALENCE		[Behnken, Monic P.] Iowa State Univ, Dept Sociol & Criminal Justice, Ames, IA 50011 USA; [DeLisi, Matt] Iowa State Univ, Criminal Justice Studies, Ames, IA USA; [DeLisi, Matt] Iowa State Univ, Sociol, Ames, IA USA; [DeLisi, Matt] Acad Criminal Justice Sci, Greenbelt, MD USA; [Trulson, Chad R.] Dept Criminal Justice, Ames, IA USA; [Trulson, Chad R.] Univ North Texas, Denton, TX USA; [Vaughn, Michael G.] St Louis Univ, Coll Publ Hlth & Social Justice, Social Work, St Louis, MO 63103 USA; [Vaughn, Michael G.] St Louis Univ, Sch Publ Hlth, Dept Epidemiol, St Louis, MO 63103 USA		Behnken, MP (corresponding author), Iowa State Univ, Dept Sociol & Criminal Justice, Ames, IA 50011 USA.		Vaughn, Michael/W-2694-2019; DeLisi, Matt/U-9128-2019	DeLisi, Matt/0000-0001-5964-5848			Arnett JJ, 1996, PERS INDIV DIFFER, V20, P693, DOI 10.1016/0191-8869(96)00027-X; Barnes JC, 2012, J CRIM JUST, V40, P94, DOI 10.1016/j.jcrimjus.2011.12.003; Beaver KM, 2013, PERS INDIV DIFFER, V55, P29, DOI 10.1016/j.paid.2013.01.020; Boisvert D, 2013, J CRIM JUST, V41, P262, DOI 10.1016/j.jcrimjus.2013.05.007; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; de Ridder DTD, 2012, PERS SOC PSYCHOL REV, V16, P76, DOI 10.1177/1088868311418749; DeLisi M., 2014, J CRIM JUST, V42, P1025; DeLisi M, 2008, INT J OFFENDER THER, V52, P520, DOI 10.1177/0306624X07308553; DeLisi M, 2013, J CRIM JUST, V41, P12, DOI 10.1016/j.jcrimjus.2012.10.002; DeLisi M, 2011, J CRIM JUST, V39, P289, DOI 10.1016/j.jcrimjus.2011.05.001; ELLIOTT DS, 1994, CRIMINOLOGY, V32, P1, DOI 10.1111/j.1745-9125.1994.tb01144.x; ELLIOTT FA, 1992, ARCH NEUROL-CHICAGO, V49, P595, DOI 10.1001/archneur.1992.00530300027006; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2009, J NEUROL, V256, P1591, DOI 10.1007/s00415-009-5134-2; Felde AB, 2006, BRAIN INJURY, V20, P41, DOI 10.1080/02699050500309718; Gordon JA, 2012, J OFFENDER REHABIL, V51, P497, DOI 10.1080/10509674.2012.702714; Gottfredson M. R., 1990, GEN THEORY CRIME; Hanlon RE, 2010, ARCH CLIN NEUROPSYCH, V25, P1, DOI 10.1093/arclin/acp099; HORVATH P, 1993, PERS INDIV DIFFER, V14, P41, DOI 10.1016/0191-8869(93)90173-Z; Jennings WG, 2013, J CRIM JUST, V41, P213, DOI 10.1016/j.jcrimjus.2013.05.003; Jennings WG, 2012, J CRIM JUST, V40, P472, DOI 10.1016/j.jcrimjus.2012.07.001; Kolakowsky-Hayner SA, 2001, BRAIN INJURY, V15, P53, DOI 10.1080/02699050150209138; Kremer C, 2009, J FORENSIC SCI, V54, P923, DOI 10.1111/j.1556-4029.2009.01072.x; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Lilienfeld S. O., 2006, HDB PSYCHOPATHY, P107; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; Long JS, 2000, AM STAT, V54, P217, DOI 10.2307/2685594; Mawson AR, 2005, AGGRESS VIOLENT BEH, V10, P375, DOI 10.1016/j.avb.2004.05.003; Miller L., 1995, J OFFENDER REHABILIT, V21, P91; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Mordre M, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-57; Perkes I, 2011, BRAIN INJURY, V25, P131, DOI 10.3109/02699052.2010.536193; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Portnoy J, 2013, J CRIM JUST, V41, P292, DOI 10.1016/j.jcrimjus.2013.06.018; Rocque M, 2012, J CRIM JUST, V40, P306, DOI 10.1016/j.jcrimjus.2012.05.003; Schilling CM, 2011, J CRIM JUST, V39, P3, DOI 10.1016/j.jcrimjus.2010.11.001; Schwartz JA, 2013, J ADOLESCENT HEALTH, V53, P520, DOI 10.1016/j.jadohealth.2013.06.007; Shiroma Eric J, 2010, J Correct Health Care, V16, P273, DOI 10.1177/1078345810378253; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Tapia M, 2010, J CRIM JUST, V38, P255, DOI 10.1016/j.jcrimjus.2010.03.002; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Tielbeek JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045086; Tillyer R, 2012, J CRIM JUST, V40, P285, DOI 10.1016/j.jcrimjus.2012.04.001; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; van Horn JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037454; Vaughn M., 2005, YOUTH VIOLENCE JUV J, V3, P235, DOI DOI 10.1177/1541204005276320; Vaughn MG, 2005, J EMOT BEHAV DISORD, V13, P152, DOI 10.1177/10634266050130030301; Vaughn MG, 2008, INT J LAW PSYCHIAT, V31, P407, DOI 10.1016/j.ijlp.2008.08.001; Vaughn MG, 2008, J CRIM JUST, V36, P33, DOI 10.1016/j.jcrimjus.2007.12.008; Vaughn MG, 2007, BEHAV SCI LAW, V25, P803, DOI 10.1002/bsl.789; Vaughn MG, 2014, CRIM BEHAV MENT HEAL, V24, P188, DOI 10.1002/cbm.1900; Vaughn MG, 2014, YOUTH VIOLENCE JUV J, V12, P3, DOI 10.1177/1541204013478973; Vaughn MG, 2011, J CRIM JUST, V39, P75, DOI 10.1016/j.jcrimjus.2010.12.001; Yancey JR, 2013, J CRIM JUST, V41, P309, DOI 10.1016/j.jcrimjus.2013.06.002; Young S, 2010, J FORENSIC PSYCHI PS, V21, P238, DOI 10.1080/14789940903311566; Young S, 2009, CRIM BEHAV MENT HEAL, V19, P54, DOI 10.1002/cbm.721	60	5	5	0	0	ROUTLEDGE	ABINGDON	2 PARK SQ, MILTON PARK, ABINGDON OX14 4RN, OXFORD, ENGLAND			978-1-138-30357-7; 978-1-315-85844-9; 978-0-415-72213-1	ROUT INT HANDB			2015							418	428					11	Psychology, Biological; Criminology & Penology; Law	Book Citation Index – Social Sciences & Humanities (BKCI-SSH)	Psychology; Criminology & Penology; Government & Law	BK4XF	WOS:000437709600029					2022-02-06	
J	Brown, JA; Hux, K; Kenny, C; Funk, T				Brown, Jessica Anne; Hux, Karen; Kenny, Carrie; Funk, Trisha			Consistency and idiosyncrasy of semantic categorization by individuals with traumatic brain injuries	DISABILITY AND REHABILITATION-ASSISTIVE TECHNOLOGY			English	Article						AAC; semantics; traumatic brain injury		Purpose: Information about semantic categorization consistency may help practitioners to implement augmentative and alternative communication (AAC) options for people with traumatic brain injuries (TBIs). The researchers sought to determine the consistency and extent of general consensus agreement with which adults with TBI organize semantic information. Methods: The researchers compared the semantic categorization consistency of 10 participants with severe TBI to 10 neurotypical adults matched on age and gender. Participants performed a semantic categorization task three times over a 1-month period. The experimental task consisted of two stages: (a) sorting ordinate exemplars into superordinate categories and (b) sorting subordinate exemplars into the previously established ordinate categories. Results: Results showed that participants with TBI were less consistent across trials and more idiosyncratic than neurotypical peers in placing exemplars within categories. Although some participants with TBI achieved higher general consensus agreement scores with experimental task repetition, their performance did not reach levels comparable to those of neurotypical participants. Conclusions: Individually, semantic categorization patterns of some people with severe TBI conform to those of neurotypical adults; patterns of others do not. Some, but not all, survivors demonstrate increased consistency given task repetition. These findings have implications for AAC design and instruction for people with TBI.	[Brown, Jessica Anne; Hux, Karen; Kenny, Carrie] Univ Nebraska Lincoln, Barkley Mem Ctr, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA; [Funk, Trisha] Qual Living, Omaha, NE USA		Brown, JA (corresponding author), Univ Nebraska Lincoln, Barkley Mem Ctr, Dept Special Educ & Commun Disorders, Lincoln, NE 68583 USA.	jessica.anne.brown@gmail.com	Hux, Karen/AAQ-2078-2020				ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; Beukelman D. R., 2005, AUGMENTATIVE ALTERNA; Brandenburg S, 1998, VOCALLY IMPAIRED CLI, P84; Constantinidou F, 2012, BRAIN INJURY, V26, P1549, DOI 10.3109/02699052.2012.698786; Damico JS, 2010, HDB LANGUAGE SPEECH; Fried-Oken M., 1992, J HEAD TRAUMA REHAB, V9, DOI [DOI 10.1097/00001199-199209000-00008, 10.1097/00001199-199209000-00008]; Garrett K. L., 1989, AUGMENT ALTERN COMM, V5, P55, DOI [10.1080/07434618912331274976, DOI 10.1080/07434618912331274976]; Goossens' C., 1989, AUGMENTATIVE ALTERNA, V5, P14, DOI [DOI 10.1080/07434618912331274926, 10.1080/074346189152661274926]; Goossens CA, 1986, AUGMENTATIVE COMMUNI; HUX K, 1993, J MED SPEECH-LANG PA, V1, P121; Kertesz A., 2007, WAB R W APHASIA BATT; Musselwhite CR, 1988, COMMUNICATION PROGRA, P177; Raposo A, 2012, NEUROIMAGE, V59, P1870, DOI 10.1016/j.neuroimage.2011.08.072; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; Snyder C, 2000, J MED SPEECH-LANG PA, V8, P187; Wallace SE, 2010, AUGMENT ALTERN COMM, V26, P242, DOI 10.3109/07434618.2010.521895; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	17	5	5	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1748-3107	1748-3115		DISABIL REHABIL-ASSI	Disabil. Rehabil.-Assist. Technol.		2015	10	5					378	384		10.3109/17483107.2014.921250			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V07PF	WOS:000214019000004	24839988				2022-02-06	
J	Curran, C; Dorstyn, D; Polychronis, C; Denson, L				Curran, Christine; Dorstyn, Diana; Polychronis, Con; Denson, Linley			Functional outcomes of community-based brain injury rehabilitation clients	BRAIN INJURY			English	Article						Brain injury; neurorehabilitation; outcome assessment; rehabilitation	SERVICE NEEDS; OLDER-ADULTS; EXPERIENCE; SCALE; STATE; TBI	Background: Community-based rehabilitation can help to maximize function following acquired brain injury (ABI); however, data on treatment outcome is limited in quantity. Objective: To describe and evaluate client outcomes of an outpatient programme for adults with moderate-to-severe traumatic and non-traumatic ABI. Methods: Two phase design involving retrospective and longitudinal study of programme completers with ABI (n = 47). Changes in functioning were measured with the Mayo-Portland Inventory (MPAI-4), administered pre- and immediately post-rehabilitation and at 3 years follow-up. Self-ratings were supplemented with MPAI-4 data from significant others (n = 32) and staff (n = 32). Results: Injured individuals and informants reported improved physical and psychosocial functioning immediately following the completion of community rehabilitation, with medium-to-large and significant treatment gains noted on the MPAI-4 ability, adjustment and participation sub-scales (Cohen's d range = 0.31-1.10). A deterioration in individuals' adjustment was further reported at follow-up, although this was based on limited data. Issues with longer-term rehabilitation service provision were additionally noted. Conclusions: The data support the need for continuity of care, including ongoing emotional support, to cater to the complex and dynamic needs of the ABI population. However, these results need to be considered in the context of a small sample size and quasi-experimental design.	[Curran, Christine; Dorstyn, Diana; Denson, Linley] Univ Adelaide, Sch Psychol, Fac Hlth Sci, Adelaide, SA 5000, Australia; [Polychronis, Con] Brain Injury Rehabil Community & Home Serv, Felixstow, SA, Australia		Dorstyn, D (corresponding author), Univ Adelaide, Sch Psychol, North Terrace Campus, Adelaide, SA 5000, Australia.	diana.dorstyn@adelaide.edu.au	Dorstyn, Diana/M-5707-2019	Dorstyn, Diana/0000-0002-7799-8177			Bender A, 2014, BRAIN INJURY, V28, P44, DOI 10.3109/02699052.2013.850177; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; Brasure M, 2013, J HEAD TRAUMA REHAB, V22, P26; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Cumming TB, 2013, INT J STROKE, V8, P38, DOI 10.1111/j.1747-4949.2012.00972.x; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Egan J, 2006, BRAIN INJURY, V20, P1283, DOI 10.1080/02699050601049692; Ferrin JM, 2007, REHABILITATION ED, V21, P87; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Heinemann AW, 2002, ARCH PHYS MED REHAB, V83, P1052, DOI 10.1053/apmr.2002.34283; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; Kersten P, 2010, DISABIL REHABIL, V32, P1028, DOI 10.3109/09638281003775568; Kim H, 2010, AM J OCCUP THER, V64, P709, DOI 10.5014/ajot.2010.09188; Kolakowsky-Hayner SA, 2000, NEUROREHABILITATION, V14, P151; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kuipers P., 2004, BRAIN IMPAIR, V5, P30, DOI DOI 10.1375/BRIM.5.1.30.35404; Leininger S, 2014, J HEAD TRAUMA REHAB, V29, P109, DOI 10.1097/HTR.0b013e3182860506; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2009, NEUROPSYCHOL REHABIL, V19, P790, DOI 10.1080/09602010903031203; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; McIntyre A, 2013, NEUROREHABILITATION, V32, P409, DOI 10.3233/NRE-130862; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Perdices M, 2009, NEUROPSYCHOL REHABIL, V19, P904, DOI 10.1080/09602010903040691; Pickelsimer EE, 2007, J HEAD TRAUMA REHAB, V22, P1, DOI 10.1097/00001199-200701000-00001; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Prvu Bettger JA, 2008, ARCH PHYS MED REHAB, V88, P1526; Snapinn SM, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-31; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Viechtbauer W, 2007, J EDUC BEHAV STAT, V32, P39, DOI 10.3102/1076998606298034; Wade D, 1992, MEASUREMENT NEUROLOG; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Winkler Dianne, 2006, Aust Health Rev, V30, P100; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M, 1998, COLLABORATIVE BRIAN	46	5	5	2	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	1					25	32		10.3109/02699052.2014.948067			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AW1WC	WOS:000346078000004	25180709				2022-02-06	
J	Ding, SH; Bao, YH; Lin, Y; Pan, YH; Fan, YL; Wan, JQ; Jiang, JY				Ding, Shenghao; Bao, Yinghui; Lin, Yong; Pan, Yaohua; Fan, Yiling; Wan, Jieqing; Jiang, Jiyao			Neuroprotective effect of functionalized multi-walled carbon nanotubes on spinal cord injury in rats	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY			English	Article						Spinal cord injury; multi-walled carbon nanotubes; BDNF; NgR; RhoA	NOGO-66 RECEPTOR ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; GENETIC MANIPULATION; REPAIR; REGENERATION; PLASTICITY; RECOVERY; DELIVERY; GROWTH; CELLS	Traumatic injuries to the brain and spinal cord affect a large percentage of the world's population. However, there are currently no effective treatments for these central nervous system (CNS) injuries. In our study, we evaluated the neuroprotective role of functionalized multi-walled carbon nanotubes (MWCNTs) carrying brain derived neurotrophic factor (BNDF), nogo-66 receptor (NgR) and Ras homolog gene family member A (RhoA) in spinal cord injury (SCI). Our results showed that transfection into rat cortical neurons with BDNF-DNA significantly elevated the expression of BDNF both in vitro and in vivo. Meanwhile, transfection with NgR-siRNA and RhoA-siRNA resulted in an obvious down-regulation of NgR and RhoA in neuron cells and in injured spinal cords. In addition, the functionalized MWCNTs carrying BDNF-DNA, NgR-siRNA and RhoA-siRNA exhibited remarkable therapeutic effects on injured spinal cord. Taken together, our study demonstrates that functionalized MWCNTs have a potential therapeutic application on repair and regeneration of the CNS.	[Ding, Shenghao; Bao, Yinghui; Lin, Yong; Pan, Yaohua; Fan, Yiling; Wan, Jieqing; Jiang, Jiyao] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, 160 Pujian Rd, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, 160 Pujian Rd, Shanghai 200127, Peoples R China.	jiyaojiang@126.com					Agasti SS, 2010, ADV DRUG DELIVER REV, V62, P316, DOI 10.1016/j.addr.2009.11.004; Beg S, 2011, J PHARM PHARMACOL, V63, P141, DOI 10.1111/j.2042-7158.2010.01167.x; Bekyarova E, 2005, J BIOMED NANOTECHNOL, V1, P3, DOI 10.1166/jbn.2005.004; Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Boyes WK, 2012, NEUROTOXICOLOGY, V33, P902, DOI 10.1016/j.neuro.2011.12.013; Cameron AA, 2006, J NEUROSCI, V26, P2923, DOI 10.1523/JNEUROSCI.4390-05.2006; Carballo-Vila M, 2009, J BIOMED MATER RES A, V90A, P94, DOI 10.1002/jbm.a.32058; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Cui HF, 2010, CHEM RES TOXICOL, V23, P1131, DOI 10.1021/tx100050h; FitzGerald J, 2007, J BONE JOINT SURG BR, V89B, P1413, DOI 10.1302/0301-620X.89B11; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Gaillard C, 2009, ADV MATER, V21, P2903, DOI 10.1002/adma.200900050; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Herzog D, 2011, J NEUROSCI, V31, P5120, DOI 10.1523/JNEUROSCI.4807-10.2011; Kaiser JP, 2008, J MATER SCI-MATER M, V19, P1523, DOI 10.1007/s10856-007-3296-y; Li F, 2014, INT J CLIN EXP MED, V7, P4967; Li SX, 2003, J NEUROSCI, V23, P4219; Linkov I, 2008, NANOMED-NANOTECHNOL, V4, P167, DOI 10.1016/j.nano.2008.01.001; Lipinski MM, 2015, NEURAL REGEN RES, V10, P892, DOI 10.4103/1673-5374.158344; Lo EH, 2010, NAT MED, V16, P1205, DOI 10.1038/nm.2226; Madura T, 2004, EMBO REP, V5, P412, DOI 10.1038/sj.embor.7400117; Marini AM, 2004, RESTOR NEUROL NEUROS, V22, P121; Pardridge William M, 2005, NeuroRx, V2, P3; Steward O, 2008, EXP NEUROL, V209, P446, DOI 10.1016/j.expneurol.2007.12.010; Tang BL, 2007, CELL MOL NEUROBIOL, V27, P75, DOI 10.1007/s10571-006-9119-8; Walthers CM, 2015, BIOMARK INSIGHTS, V10, P11, DOI [10.4137/BMI.S20063, 10.4137/BMIMI.S20063]; Wong I, 2010, BRAIN BEHAV IMMUN, V24, P585, DOI 10.1016/j.bbi.2010.01.001	28	5	7	0	8	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1936-2625			INT J CLIN EXP PATHO	Int. J. Clin. Exp. Pathol.		2015	8	12					15769	15777					9	Oncology; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Pathology	DF4VW	WOS:000371350600027	26884846				2022-02-06	
J	Elder, H; Kersten, P				Elder, Hinemoa; Kersten, Paula			Whakawhiti Korero, a Method for the Development of a Cultural Assessment Tool, Te Waka Kuaka, in Maori Traumatic Brain Injury	BEHAVIOURAL NEUROLOGY			English	Article							NEW-ZEALAND; ADOLESCENTS; CHILDREN	The importance of tools for the measurement of outcomes and needs in traumatic brain injury is well recognised. The development of tools for these injuries in indigenous communities has been limited despite the well-documented disparity of brain injury. The wairua theory of traumatic brain injury (TBI) in Maori proposes that a culturally defined injury occurs in tandem with the physical injury. A cultural response is therefore indicated. This research investigates a Maori method used in the development of cultural needs assessment tool designed to further examine needs associated with the culturally determined injury and in preparation for formal validation. Whakawhiti korero is a method used to develop better statements in the development of the assessment tool. Four wananga (traditional fora) were held including one with whanau (extended family) with experience of traumatic brain injury. The approach was well received. A final version, Te Waka Kuaka, is now ready for validation. Whakawhiti korero is an indigenous method used in the development of cultural needs assessment tool in Maori traumatic brain injury. This method is likely to have wider applicability, such as Mental Health and Addictions Services, to ensure robust process of outcome measure and needs assessment development.	[Elder, Hinemoa] Whare Wananga Awanuiarangi, Whakatane 3158, New Zealand; [Kersten, Paula] AUT, Auckland 1010, New Zealand		Elder, H (corresponding author), Whare Wananga Awanuiarangi, 13 Domain Dr, Whakatane 3158, New Zealand.	hinemoa@xtra.co.nz			Health Research Council of New ZealandHealth Research Council of New Zealand	This research was made possible by the Eru Pomare Postdoctoral Fellowship from the Health Research Council of New Zealand hosted by Te Whare Wananga o Awanuiarangi. One of the authors also thank and acknowledge participants and their whanau and all those from the Whanau Ora Collective of Te Tai Tokerau, Te Hiku Hauora, Whakawhiti Ora Pai, Ngati Hine Hauora, and Whaea Moe Milne and Mariameno Kapa for their support. The Ropu Kaitiaki (guardianship group) of the project, Professor Kathryn McPherson, Professor Richard Faull, Naida Glavish, Dr. Alfonso Caracuel, Associate Professor Joshua Sparrow, and Professor Paula Kersten, are also gratefully thanked.	Abel S, 2001, SOC SCI MED, V53, P1135, DOI 10.1016/S0277-9536(00)00408-1; Barker-Collo S. L., 2012, P WORLD C NEUR MELB; Barnes H M, 2000, Pac Health Dialog, V7, P13; Beatty PC, 2007, PUBLIC OPIN QUART, V71, P287, DOI 10.1093/poq/nfm006; Biggs Bruce, 1981, COMPLETE ENGLISH MAO; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558, 10.1136/ip.2009.022558a]; Elder H, 2013, BRAIN IMPAIR, V14, P415, DOI 10.1017/BrImp.2013.29; Elder H, 2013, BRAIN IMPAIR, V14, P406, DOI 10.1017/BrImp.2013.28; Elder H, 2012, AUSTRALAS PSYCHIATRY, V20, P20, DOI 10.1177/1039856211430147; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; Moko-Mead H., 2003, TIKANGA MAORI LIVING; Smith G. H., 2003, P KAUP MAOR S NZARE; Smith L. T., 1999, DECOLONIZING METHODO; Statistics New Zealand, 2013, CENS 2013; Stucki G, 2005, AM J PHYS MED REHAB, V84, P733, DOI 10.1097/01.phm.0000179521.70639.83; Turia T., 2011, BEST PRACTICE J, V37, P11; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	18	5	5	0	4	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								137402	10.1155/2015/137402			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CV1NB	WOS:000364023900001	26576070	Green Published, gold, Green Submitted			2022-02-06	
J	Fonda, JR; Hunt, PR; McGlinchey, RE; Rudolph, JL; Milberg, WP; Reynolds, MW; Yonan, C				Fonda, Jennifer R.; Hunt, Phillip R.; McGlinchey, Regina E.; Rudolph, James L.; Milberg, William P.; Reynolds, Matthew W.; Yonan, Charles			Identification of pseudobulbar affect symptoms in Veterans with possible traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						cross-sectional surveys; depression; emotional lability; lability scale; nervous system diseases; pseudobulbar affect; pseudobulbar syndromes; PTSD; traumatic brain injuries; Veterans	IRAQ; AFGHANISTAN; DEPLOYMENT; MILITARY; ASSOCIATION; PERSONNEL; LABILITY; SCALE	Pseudobulbar affect (PBA), a neurological syndrome characterized primarily by involuntary episodes of laughing and crying, can develop secondary to neurological conditions including traumatic brain injury (TBI). Veterans of the wars in Afghanistan and Iraq have an unprecedented risk for TBI, primarily from blast-related munitions. In this cross-sectional study with linkage to Department of Veterans Affairs (VA) clinical data, Veterans screening positive for TBI on the VA TBI screen (N = 4,282) were mailed packets containing two PBA symptom assessments: a single PBA symptom screen question and the Center for Neurologic Study-Lability Scale (CNS-LS) questionnaire. Seventy percent (n = 513) of the 728 Veteran respondents screened positive for PBA symptoms with a CNS-LS score of 13 or greater. There was strong concordance between PBA symptom prevalence measured with the single screening question and CNS-LS, with high sensitivity (0.87) and positive predictive value (0.93) and moderate specificity (0.79). Posttraumatic stress disorder (54% vs 32%), major depression (35% vs 22%), and anxiety disorder (20% vs 13%) were more common for Veterans with PBA symptoms than for those without. PBA symptoms were common in this Veteran cohort, were detected using simple screening tools, and often co-occurred with other psychiatric disorders common in Veterans.	[Fonda, Jennifer R.; McGlinchey, Regina E.; Rudolph, James L.; Milberg, William P.] Dept Vet Affairs Boston Healthcare Syst, Translat Res Ctr Traumat Brain Injury & Stress Di, Boston, MA USA; [Fonda, Jennifer R.; McGlinchey, Regina E.; Rudolph, James L.; Milberg, William P.] Dept Vet Affairs Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Fonda, Jennifer R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Hunt, Phillip R.; Reynolds, Matthew W.] Evidera, Retrospect Observat Studies, Lexington, MA USA; [McGlinchey, Regina E.; Milberg, William P.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Rudolph, James L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yonan, Charles] Avanir Pharmaceut Inc, Hlth Econ & Outcomes Res, Aliso Viejo, CA USA		Fonda, JR (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	jennifer.fonda@va.gov	Fonda, Jennifer R./ABG-2890-2021; McGlinchey, Regina E/R-1971-2016	Fonda, Jennifer R./0000-0001-9482-2918; 	Avanir Pharmaceuticals Inc.; VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]	This material was based on work supported by Avanir Pharmaceuticals Inc. Evidera provided support for the protocol and manuscript preparation, in collaboration with VA investigators. VA Boston Healthcare System and the Translational Research Center for TBI and Stress Disorders (TRACTS), which is a VA Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (grant B6796-C), are acknowledged for providing overall and infrastructural support.	Agresti A, 2003, ANAL CATEGORICAL DAT; Brooks BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072232; Colamonico J, 2012, ADV THER, V29, P775, DOI 10.1007/s12325-012-0043-7; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eber S, 2013, MIL MED, V178, P966, DOI 10.7205/MILMED-D-13-00175; Fear NT, 2008, AM J PREV MED, V35, P230, DOI 10.1016/j.amepre.2008.05.027; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; McGlinchey RE, 2005, NEUROPSYCHOLOGY, V19, P159, DOI 10.1037/0894-4105.19.2.159; Moore SR, 1997, J NEUROL NEUROSUR PS, V63, P89, DOI 10.1136/jnnp.63.1.89; Parvizi J, 2009, J NEUROPSYCH CLIN N, V21, P75, DOI 10.1176/appi.neuropsych.21.1.75; Ross D, 2008, MIDBR MUT PIC NEUR; Ruff RL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000312; Schiffer R, 2005, J NEUROPSYCH CLIN N, V17, P447, DOI 10.1176/appi.neuropsych.17.4.447; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Smith RA, 2004, MULT SCLER J, V10, P679, DOI 10.1191/1352458504ms1106oa; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tateno A, 2004, J NEUROPSYCH CLIN N, V16, P426, DOI 10.1176/appi.neuropsych.16.4.426; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Work SS, 2011, ADV THER, V28, P586, DOI 10.1007/s12325-011-0031-3; Wortzel HS, 2008, CNS DRUGS, V22, P531, DOI 10.2165/00023210-200822070-00001; Zou KH, 2007, CIRCULATION, V115, P654, DOI 10.1161/CIRCULATIONAHA.105.594929	27	5	5	1	10	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2015	52	7					839	849		10.1682/JRRD.2014.08.0191			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CY3RG	WOS:000366326700009	26744849	Bronze			2022-02-06	
J	Gao, L; Wu, XH				Gao, Liang; Wu, Xuehai			Prediction of clinical outcome in severe traumatic brain injury	FRONTIERS IN BIOSCIENCE-LANDMARK			English	Article						Traumatic brain injury; Magnetic Resonance Imaging; Traumatic Brain Injury; somatosensory evoked potential; Review	EXTERNAL VALIDATION; EVOKED-POTENTIALS; HEAD-INJURY; FOLLOW-UP; PROGNOSIS; MODERATE; IMPACT; DISPARITIES; INDICATORS; BIOMARKER	Traumatic brain injury (TBI) is the main cause of death and disability in adults worldwide. Early detection of TBI would be useful for evaluating and designing treatment strategies. Both single predictors from early clinical examination and multiple hospitalization variables/parameters can be used to determine the long-term prognosis of TBI. Predictive models like the IMPACT or CRASH prognosis calculator (based on large sample sizes) can predict mortality and unfavorable outcomes. Moreover, imaging techniques like MRI (Magnetic Resonance Imaging) can also predict consciousness recovery and mental recovery in severe TBI, while biomarkers associated with stress correlate with, and hence can be used to predict, severity and mortality. All predictors have limitations in clinical application. Further studies comparing different predictors and models are required to resolve limitations of current predictors.	[Gao, Liang] Tongji Univ, Shanghai People Hosp 10, Dept Neurosurg, Shanghai 200072, Peoples R China; [Wu, Xuehai] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China		Gao, L (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	lianggaoh@yeah.net					Amantini A, 2005, CLIN NEUROPHYSIOL, V116, P229, DOI 10.1016/j.clinph.2004.07.008; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bowman SM, 2007, MED CARE, V45, P686, DOI 10.1097/MLR.0b013e31803dcdf3; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Demakis GJ, 2010, APPL NEUROPSYCHOL, V17, P183, DOI 10.1080/09084282.2010.499752; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Eastvold AD, 2013, J HEAD TRAUMA REHAB, V28, P48, DOI 10.1097/HTR.0b013e31823c9317; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Hailong, 2000, Chin J Traumatol, V3, P226; Ferri J, 2004, NEUROLOGIA, V19, P285; Forsyth RJ, 2008, PEDIATR CRIT CARE ME, V9, P8, DOI 10.1097/01.PCC.0000298759.78616.3A; Gonzalez-Garcia E, 2007, REV NEUROLOGIA, V44, P404, DOI 10.33588/rn.4407.2006225; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Jacobs B, 2013, NEUROCRIT CARE, V19, P79, DOI 10.1007/s12028-012-9795-9; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; LB Oknina, 2011, ZH VOPR NEIROKHIR IM, V75, P30; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; MacPherson Valerie, 1992, Brain Injury, V6, P489, DOI 10.3109/02699059209008146; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Oknina L B, 2011, Zh Vopr Neirokhir Im N N Burdenko, V75, P19; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Pace MC, 2006, MINERVA ANESTESIOL, V72, P235; Pang BC, 2007, J NEUROTRAUM, V24, P136, DOI 10.1089/neu.2006.0113; PO Grande, 1992, SWEDISH SOC ANAESTHE, V6, P41; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; R Donato, 2010, CARDIOVASC PSYCHIAT, V92, P87; Thais MERD, 2014, J NEUROPSYCHOL, V8, P125, DOI 10.1111/jnp.12000; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Soares FMS, 2012, NEUROIMMUNOMODULAT, V19, P377, DOI 10.1159/000342141; Sleigh JW, 1999, J NEUROSURG, V91, P577, DOI 10.3171/jns.1999.91.4.0577; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tan H, 2001, Chin J Traumatol, V4, P156; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Yang Tian-jun, 2013, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V25, P301, DOI 10.3760/cma.j.issn.2095-4352.2013.05.016; Yatsushige H, 2010, ACTA NEUROCHIR SUPPL, V106, P265, DOI 10.1007/978-3-211-98811-4_50; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	52	5	5	0	8	FRONTIERS IN BIOSCIENCE INC	IRVINE	16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA	1093-9946	1093-4715		FRONT BIOSCI-LANDMRK	Front. Biosci.	JAN 1	2015	20						763	771		10.2741/4335			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CH9KJ	WOS:000354354200011	25553477				2022-02-06	
J	Gibson, R; Purdy, SC				Gibson, Robyn; Purdy, Suzanne C.			Mental health disorders after traumatic brain injury in a New Zealand caseload	BRAIN INJURY			English	Article						Community-based rehabilitation; psychiatric; psychological; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DISORDERS; HEAD-INJURY; PSYCHOTIC DISORDER; BIPOLAR DISORDER; DEPRESSION; RISK; SCHIZOPHRENIA; CHILDREN; ASSOCIATION	Primary objective: This study investigated psychological disorders for patients receiving traumatic brain injury (TBI) rehabilitation within a community-based TBI service in New Zealand. Research design: Cross-sectional study involving retrospective review of clinical notes for all referrals received in a 6-month period. This methodology was selected to gain a sample of individuals reflective of the range of patients seen in TBI rehabilitation services in New Zealand. Methods and procedures: The clinical records for 279 patients were reviewed for formal psychiatric diagnoses and references to moderate or severe psychological symptoms. Main outcomes and results: Of the clinical records, 57.7% noted significant psychological problems post-injury (n = 161) and 8.6% had a psychiatric diagnosis recorded, with 10.8% reporting psychological disorders pre-injury. In comparison, 15.1% had input from a clinical psychologist and 2.2% had involvement from a mental health team. Conclusions: The rate of psychological symptoms was significantly higher post-TBI than pre-TBI and few of the patients reporting significant psychological symptoms were receiving intervention from mental health professionals. Further research is needed regarding the ability of TBI rehabilitation professionals in New Zealand to identify and respond to the psychological implications of TBI and on the ability of TBI and mental health teams to liaise effectively.	[Gibson, Robyn; Purdy, Suzanne C.] Univ Auckland, Sch Psychol Speech Sci, Auckland 1, New Zealand; [Gibson, Robyn] Waitemata Dist Hlth Board, North Shore Hosp, Auckland, New Zealand		Gibson, R (corresponding author), Univ Auckland, Sch Psychol Speech Sci, Tamaki Campus,261 Morrin Rd,Glen Innes 1072, Auckland 1, New Zealand.	robyngibson10@gmail.com		Purdy, Suzanne/0000-0001-9978-8173			Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; Baguely I, 2007, J HEAD TRAUMA REHAB, V21, P45; Bowen A, 1998, BRAIN INJURY, V12, P177, DOI 10.1080/026990598122656; Brissos S, 2005, INT J PSYCHIAT CLIN, V9, P292, DOI 10.1080/13651500510029219; Burg JS, 2000, BRAIN INJURY, V14, P513; Cantagallo A, 1999, BRAIN INJURY, V13, P219, DOI 10.1080/026990599121593; Cattelani R, 1998, BRAIN INJURY, V12, P283, DOI 10.1080/026990598122584; Corrigan JD, 2008, BRAIN INJURY, V22, P223, DOI 10.1080/02699050801938967; David AS, 2005, J NEUROL NEUROSUR PS, V76, pI53, DOI 10.1136/jnnp.2004.060475; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Fujii D, 2004, J NEUROPSYCH CLIN N, V16, P306, DOI 10.1176/appi.neuropsych.16.3.306; Fujii D, 2002, J NEUROPSYCH CLIN N, V14, P130, DOI 10.1176/appi.neuropsych.14.2.130; GEORGE L, 1990, GENERATIONS J AM SOC, V0014; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hapke U, 2006, EUR ARCH PSY CLIN N, V256, P299, DOI 10.1007/s00406-006-0654-6; Hickling EJ, 1998, BRAIN INJURY, V12, P265, DOI 10.1080/026990598122566; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kishi Y, 2001, PSYCHOSOMATICS, V42, P382, DOI 10.1176/appi.psy.42.5.382; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Malaspina D, 2001, AM J PSYCHIAT, V158, P440, DOI 10.1176/appi.ajp.158.3.440; Max JE, 1999, J INT NEUROPSYCH SOC, V5, P58, DOI 10.1017/S1355617799511089; McGuire LM, 1998, BRAIN INJURY, V12, P207, DOI 10.1080/026990598122683; Molloy C, 2011, SCHIZOPHRENIA BULL, V37, P1104, DOI 10.1093/schbul/sbr091; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ GUID; Nybo T, 1999, BRAIN INJURY, V13, P759; Oakley-Brown MA, 2006, TE RAU HINENGARO NZ; Peleg G, 2009, BRAIN INJURY, V23, P800, DOI 10.1080/02699050903196696; Perino C, 2001, BRAIN INJURY, V15, P139, DOI 10.1080/026990501458371; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Schofield PW, 2006, BRAIN INJURY, V20, P1409, DOI 10.1080/02699050601130443; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Wasserman L, 2008, BRAIN INJURY, V22, P811, DOI 10.1080/02699050802372166; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	42	5	6	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	3					306	312		10.3109/02699052.2014.896471			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0HQ	WOS:000349307000004	25615795				2022-02-06	
J	Gill, IJ; Mullin, S; Simpson, J				Gill, Ian J.; Mullin, Stephen; Simpson, Jane			Are metacognitive processes associated with posttraumatic stress symptom severity following acquired brain injury?	DISABILITY AND REHABILITATION			English	Article						Metacognition; posttraumatic stress disorder; risk factors for PTSD; subarachnoid haemorrhage; traumatic brain injury	ANEURYSMAL SUBARACHNOID HEMORRHAGE; THOUGHT CONTROL STRATEGIES; QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; HOSPITAL ANXIETY; DISORDER SYMPTOMS; DEPRESSION SCALE; TRAUMATIC EVENT; PTSD CHECKLIST; CRISIS SUPPORT	Purpose: Although posttraumatic stress disorder (PTSD) after acquired brain injury (ABI) is relatively common, its causal mechanisms remain speculative and little research has considered psychological perspectives. The current study aimed to examine whether metacognitive variables were associated with posttraumatic stress symptom (PTSS) severity in individuals with an ABI. Methods: Participants who had a traumatic brain injury (n = 47) or subarachnoid haemorrhage (n = 93) completed questionnaires related to demographic, clinical, social support and metacognitive variables. Correlation analyses and a hierarchical multiple regression analysis, with total PTSS severity used as the outcome variable, were conducted. Results: Results demonstrated that metacognitive factors were correlated with PTSS severity and were able to explain an additional and significant amount of variance in PTSS severity within the regression analysis. Conclusions: The results provide preliminary support that metacognitive variables are associated with PTSS after ABI. Clinical implications within rehabilitative settings are discussed, as well as theoretical and research implications in the context of the study's limitations.	[Gill, Ian J.; Simpson, Jane] Univ Lancaster, Dept Clin Psychol, Div Hlth Res, Lancaster LA1 4YF, Lancs, England; [Mullin, Stephen] 5 Boroughs Partnership Fdn NHS Trust, Dept Clin Neuropsychol, Wigan, England		Gill, IJ (corresponding author), Univ Lancaster, Dept Clin Psychol, Div Hlth Res, Whewell Bldg,Fylde Ave, Lancaster LA1 4YF, Lancs, England.	ianjgill@hotmail.com		Simpson, Jane/0000-0001-5071-4077			Aben I, 2002, PSYCHOSOMATICS, V43, P386, DOI 10.1176/appi.psy.43.5.386; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; ANTONY MM, 2001, PRACTITIONERS GUIDE; Ashla PM, 2009, J NEUROPSYCH CLIN N, V21, P467, DOI 10.1176/appi.neuropsych.21.4.467; Bay E, 2011, J HEAD TRAUMA REHAB, V26, P355, DOI 10.1097/HTR.0b013e3181f20146; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Bennett H, 2010, J ANXIETY DISORD, V24, P318, DOI 10.1016/j.janxdis.2010.01.004; Berry E, 1998, BRIT J CLIN PSYCHOL, V37, P365, DOI 10.1111/j.2044-8260.1998.tb01392.x; Blake D.D., 1990, CLIN ADM PTSD SCALE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; BONTKE CF, 1996, J HEAD TRAUMA REHAB, V11, P95, DOI DOI 10.1097/00001199-199602000-00011; Brewin CR, 1996, PSYCHOL REV, V103, P670, DOI 10.1037/0033-295X.103.4.670; Briddon E, 2011, J ANXIETY DISORD, V25, P1001, DOI 10.1016/j.janxdis.2011.06.008; British Psychological Society, 2006, ASS CAP AD INT GUID; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Caspi Y, 2005, J LOSS TRAUMA, V10, P319, DOI 10.1080/15325020590956756; Chalton LD, 2009, BRAIN INJURY, V23, P77, DOI 10.1080/02699050802635273; Conway MA, 2005, J MEM LANG, V53, P594, DOI 10.1016/j.jml.2005.08.005; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Draper K, 2009, NEUROPSYCHOL REHABIL, V19, P645, DOI 10.1080/17405620802613935; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Ehring T, 2008, J CONSULT CLIN PSYCH, V76, P219, DOI 10.1037/0022-006X.76.2.219; Elklit A, 2001, PERS INDIV DIFFER, V31, P1291, DOI 10.1016/S0191-8869(00)00220-8; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Feinstein A, 2000, BRAIN COGNITION, V44, P78; Field A., 2012, DISCOVERING STAT USI; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Greenspan AI, 2006, BRAIN INJURY, V20, P733, DOI 10.1080/02699050600773276; Halligan SL, 2003, J CONSULT CLIN PSYCH, V71, P419, DOI 10.1037/0022-006X.71.3.419; Harvey AG, 2001, J TRAUMA STRESS, V14, P277, DOI 10.1023/A:1011108816888; Hedlund M, 2011, BRIT J NEUROSURG, V25, P693, DOI 10.3109/02688697.2011.578769; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holeva V, 2001, BEHAV THER, V32, P65, DOI 10.1016/S0005-7894(01)80044-7; Hutter B, 2000, NEUROPSYCHOLOGICAL S; JOSEPH S, 1992, BRIT J CLIN PSYCHOL, V31, P63, DOI 10.1111/j.2044-8260.1992.tb00968.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; King NS, 2008, BRAIN INJURY, V22, P1, DOI 10.1080/02699050701829696; King NS, 1997, J NEUROL NEUROSUR PS, V62, P82, DOI 10.1136/jnnp.62.1.82; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Lang CJG, 2004, ZBL NEUROCHIR, V65, P18, DOI 10.1055/s-2004-44884; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Mallery P., 2003, SPSS WINDOWS STEP ST, V4th; McMillan TM, 1996, BRAIN INJURY, V10, P749, DOI 10.1080/026990596124016; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Ogden JA, 1997, NEUROSURGERY, V41, P25, DOI 10.1097/00006123-199707000-00008; Park NW, 1999, NEUROPSYCHOLOGIA, V37, P1119, DOI 10.1016/S0028-3932(99)00034-2; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P772, DOI 10.1136/jnnp.72.6.772; Reynolds M, 1999, PSYCHOL MED, V29, P1089, DOI 10.1017/S003329179900104X; Roussis P, 2006, PERS INDIV DIFFER, V40, P111, DOI 10.1016/j.paid.2005.06.019; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Safren SA, 2004, AIDS PATIENT CARE ST, V17, P657; SBORDONE RJ, 1995, BRAIN INJURY, V9, P405, DOI 10.3109/02699059509005780; Sheldrick R, 2006, BRIT J HEALTH PSYCH, V11, P387, DOI 10.1348/135910705X71434; Steel JL, 2011, INJURY, V42, P288, DOI 10.1016/j.injury.2010.11.045; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tedstone JE, 2003, CLIN PSYCHOL REV, V23, P409, DOI 10.1016/S0272-7358(03)00031-X; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Weathers F. W., 1994, PTSD CHECKLIST CIVIL; Wells A, 2004, COGN BEHAV PRACT, V11, P365, DOI 10.1016/S1077-7229(04)80053-1; Wells A, 2004, BEHAV RES THER, V42, P385, DOI 10.1016/S0005-7967(03)00147-5; Wells A., 2000, EMOTIONAL DISORDERS; Wells A., 2009, METACOGNITIVE THERAP; Wells A, 2008, COGN BEHAV PRACT, V15, P85, DOI 10.1016/j.cbpra.2006.11.005; Wells A, 2011, AM J PSYCHIAT, V168, P327, DOI 10.1176/appi.ajp.2010.10101467; Wermer MJH, 2007, NEUROSURGERY, V60, P91, DOI 10.1227/01.NEU.0000249215.19591.86; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; WHO, 2004, INT STAT CLASS DIS R; Williams W H, 2003, Cogn Neuropsychiatry, V8, P1, DOI 10.1080/713752238; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Williams WH, 2002, J TRAUMA STRESS, V15, P397, DOI 10.1023/A:1020185325026; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; World Health Organization, 2004, ICD 10 INT STAT CLAS; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	88	5	5	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	8					692	700		10.3109/09638288.2014.939774			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CD9RL	WOS:000351435700006	25019599				2022-02-06	
J	Hayakawa, A; Matoba, K; Horioka, K; Murakami, M; Terazawa, K				Hayakawa, Akira; Matoba, Kotaro; Horioka, Kie; Murakami, Manabu; Terazawa, Koichi			Appropriate blood sampling sites for measuring Tg concentrations for forensic diagnosis	LEGAL MEDICINE			English	Article						Thyroglobulin; Forensic biochemistry; Postmortem change; Forensic diagnosis; Postmortem diffusion	POSTMORTEM CHEMISTRY UPDATE; PLASMA THYROGLOBULIN; ASPHYXIA; ASSAY; NECK	Previous studies have reported that thyroglobulin (Tg) concentrations in heart blood are high in cases of asphyxia caused by neck compression such as hanging, strangulation, and throttling and in those with fatal traumatic brain injuries. However, even in cases without these findings presumed to increase the Tg concentration in the previous studies, we previously reported that in some cases the Tg concentration in right heart blood (RHB) and left heart blood (LHB) exceeded the standard value for diagnosis (200 ng/mL) defined in previous studies and the Tg concentration in RHB was significantly higher than that in LHB. In the present study, in our 46 forensic autopsy cases without findings presumed to increase Tg concentration, we separately collected external iliac venous blood (IVB) and external iliac arterial blood (IAB) in addition to RHB and LHB, measured Tg concentrations in RHB, LHB, IVB, and LAB (TRHB, TLHB, TIVB, and TIAB, respectively), and investigated the appropriate blood sampling site for measuring Tg concentrations for forensic diagnosis. TRHB, TLHB, TIVB, and TIAB were 3863 +/- 674.1, 105.8 +/- 179.0, 109.2 +/- 166.8, and 43.7 +/- 90.9 ng/mL, respectively. There were statistically significant differences between TRHB and TLHB, TIVB and TIAB, TRHB and TIVB, and TLHB and TIAB. Tg is more readily diffused by the venous system (RHB, IVB) than by the arterial system (LHB, IAB) because the venous system retains more blood volume after death. Tg is more readily diffused to heart blood (RHB, LHB) than to peripheral blood (IVB, IAB) because of the proximity of the heart to the thyroid gland. Therefore, we conclude that Tg leaks into the vessels around the thyroid gland because of the influences of postmortem changes and subsequently diffuses through the blood after death, and therefore the Tg concentration increases after death. When Tg concentration values are used for forensic diagnosis, it is appropriate to measure them using peripheral arterial blood situated distant from the thyroid gland. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Hayakawa, Akira; Matoba, Kotaro; Horioka, Kie; Murakami, Manabu; Terazawa, Koichi] Hokkaido Univ, Grad Sch Med, Dept Forens Med, Sapporo, Hokkaido 0608638, Japan		Matoba, K (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Forens Med, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	k-matoba@med.hokudai.ac.jp	Hayakawa, Akira/AAP-7281-2020	Hayakawa, Akira/0000-0003-2542-6617			COE JI, 1993, AM J FOREN MED PATH, V14, P91, DOI 10.1097/00000433-199306000-00001; Dressler J, 2006, AM J FOREN MED PATH, V27, P280, DOI 10.1097/01.paf.0000221049.43363.99; Guyton A. C., 2011, TXB MED PHYSL, P907; Hayakawa A, 2014, LEGAL MED-TOKYO, V16, P164, DOI 10.1016/j.legalmed.2014.02.003; Knight B, 2004, KNIGHTS FORENSIC PAT, P55; Maeda H, 2011, LEGAL MED-TOKYO, V13, P55, DOI 10.1016/j.legalmed.2010.12.005; Muller E, 1997, FORENSIC SCI INT, V90, P165, DOI 10.1016/S0379-0738(97)00158-8; Palmiere C, 2012, INT J LEGAL MED, V126, P199, DOI 10.1007/s00414-011-0614-1; Palmiere C, 2012, INT J LEGAL MED, V126, P187, DOI 10.1007/s00414-011-0625-y; Senol E, 2008, AM J FOREN MED PATH, V29, P49, DOI 10.1097/PAF.0b013e31815b4c80; TAMAKI K, 1990, FORENSIC SCI INT, V44, P193, DOI 10.1016/0379-0738(90)90250-3; TAMAKI K, 1987, FORENSIC SCI INT, V33, P259, DOI 10.1016/0379-0738(87)90107-1; Uemura Koichi, 2008, J Forensic Leg Med, V15, P312, DOI 10.1016/j.jflm.2007.12.003; Zhu Bao-Li, 2006, Legal Medicine, V8, P94, DOI 10.1016/j.legalmed.2005.10.003; Zhu Bao-Li, 2006, Legal Medicine, V8, P86, DOI 10.1016/j.legalmed.2005.10.004; Zhu Bao-Li, 2007, Legal Medicine, V9, P241, DOI 10.1016/j.legalmed.2007.01.010	16	5	7	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1344-6223			LEGAL MED-TOKYO	Leg. Med.	JAN	2015	17	1					65	69		10.1016/j.legalmed.2014.09.003			5	Medicine, Legal; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Biomedical Social Sciences	CB6GZ	WOS:000349726800014	25287273				2022-02-06	
J	JuarezBecerril, O; SalgadoCeballos, H; AnguianoSolis, C; AlvaradoSanchez, B; Hernandez, MEL; DiazRuiz, A; TorresCastillo, S				JuarezBecerril, Oswaldo; SalgadoCeballos, Hermelinda; AnguianoSolis, Candy; AlvaradoSanchez, Belen; Lopez Hernandez, Monica Elba; DiazRuiz, Araceli; TorresCastillo, Sergio			Electro-Acupuncture at GV.4 Improves Functional Recovery in paralyzed rats after a Traumatic Spinal Cord Injury.	ACUPUNCTURE & ELECTRO-THERAPEUTICS RESEARCH			English	Article						Traumatic Spinal Cord Injury; Oxidative Stress; Electroacupuncture; Acupoint GV.4; AcupointGV.26; Lipid peroxidation; Motor function recovery	FOCAL CEREBRAL-ISCHEMIA; ANTIOXIDANT THERAPIES; OXIDATIVE STRESS; GENE-EXPRESSION; ACUPUNCTURE; STIMULATION; HYDROXYL; TISSUES; OXYGEN; BRAIN	In the present study, the effect of electro-acupuncture (EA) on the oxidative stress, the spinal cord tissue preservation and the recovery of motor function was evaluated after a traumatic spinal cord injury (TSCI). Long Evans rats were randomized into five groups: 1. Sham; 2. TSCI without treatment; 3. TSCI + EA (acupoint GV. 4); 4. TSCI + EA (acupoint GV. 26) and 5. TSCI + EA (GV. 4 + GV. 26). The EA was performed with an Electro-Acupunctoscope, AWQ-104L Digital, wave dense-dispersed, current intensity 2.5mA and frequency 2-100Hz for 30 minutes. The biochemical results showed a significant increase in the hydroxyl radical concentration in group 2 (3.1 +/- 1.4nmol) compared with groups 1 (1.8 +/- 0.5nmol) and 4 (2.4 +/- 1.1nmol) (p<0.05), whereas in group 4 (4.8 +/- 1.8nmol), there was a significant increase in lipid peroxidation when compared with group 1 (1.7 +/- 0.5nmol) (p< 0.05). The BBB motor function score in the paralyzed hind limbs (normal BBB= 21points) was greater in groups 3 (15.2 points) and 5 (13.5 points) in comparison with groups 2 (11.4 points) and 4 (9.3 points) (p< 0.05). The quantity of preserved spinal cord tissue was greater in group 3 (6582.7 +/- 20 mu m(2)) than in groups 2 (5262.4 +/- 20 mu m(2)), 4 (3995.6 +/- 26 mu m(2)) and 5 (4266.7 +/- 22 mu m(2)). Although EA in GV. 26 decreases hydroxyl radical concentration (50%), it significantly increases lipid peroxidation (45%), while stimulation of GV. 4 decreases oxidative stress (15%), preserves spinal cord tissue (25%) and improves recovery of motor function in the hind limbs of rats with paralysis (18.1%) compared with untreated group. These findings suggest that EA in GV. 4 may be a therapeutic alternative on TSCI.	[JuarezBecerril, Oswaldo; AnguianoSolis, Candy; AlvaradoSanchez, Belen; Lopez Hernandez, Monica Elba; TorresCastillo, Sergio] Univ Estatal Valle Ecatepec, Licenciatura Acupuntura Humana Rehabil, San Felipe, Estado De Mexic, Mexico; [SalgadoCeballos, Hermelinda] IMSS, SXXI, CMN, Unidad Invest Med Enfermedades Neurol, Mexico City, DF, Mexico; [SalgadoCeballos, Hermelinda; TorresCastillo, Sergio] Proyecto Camina AC, Mexico City, DF, Mexico; [DiazRuiz, Araceli] Inst Nacl Neurol & Neurocirug, Mexico City, DF, Mexico; [AlvaradoSanchez, Belen] Inst Politecn Nacl, Escuela Super Med, Mexico City, DF, Mexico		TorresCastillo, S (corresponding author), Calle Chidal 11,Col Cd Azteca 3a Secc, Ecatepec 55120, Estado De Mexic, Mexico.	sergiotorcas@yahoo.com.mx			COMECyT scholarship; Instituto Mexicano del Seguro Social (IMSS) [FIS/IMSS/PROT/G13/1239]	Oswaldo Juarez Becerril was supported by the COMECyT scholarship.; The work was supported by Instituto Mexicano del Seguro Social (IMSS), Grant No. FIS/IMSS/PROT/G13/1239	Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bao F, 2004, NEUROSCIENCE, V126, P285, DOI 10.1016/j.neuroscience.2004.03.054; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bastani NE, 2012, ARCH PHYS MED REHAB, V93, P2223, DOI 10.1016/j.apmr.2012.06.021; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cha MH, 2010, NEUROL RES, V32, pS96, DOI 10.1179/016164109X12537002794363; Chen J, 2007, NEUROSCI RES, V59, P399, DOI 10.1016/j.neures.2007.08.006; Chen YY, 2008, ACUPUNCTURE ELECTRO, V33, P19, DOI 10.3727/036012908803861212; Christie SD, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E5; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Ding Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-35; Dorsher PT, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nep010; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Gao Ming, 2005, Zhongguo Zhen Jiu, V25, P421; GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P761, DOI 10.1042/bj2240761; Haddad JJ, 2002, CELL SIGNAL, V14, P879, DOI 10.1016/S0898-6568(02)00053-0; Hall ED, 2003, J REHABIL RES DEV, V40, P81, DOI 10.1682/JRRD.2003.08.0081; Hall ED, 2011, NEUROTHERAPEUTICS, V8, P152, DOI 10.1007/s13311-011-0026-4; Hamann K, 2009, J NEUROCHEM, V111, P1348, DOI 10.1111/j.1471-4159.2009.06395.x; Han L, 2010, ACUPUNCTURE ELECTRO, V35, P29, DOI 10.3727/036012910803860986; Herman Patricia M, 2005, BMC Complement Altern Med, V5, P11, DOI 10.1186/1472-6882-5-11; Huang SF, 2011, NEUROSCI RES, V70, P294, DOI 10.1016/j.neures.2011.03.010; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Kim JI, 2008, NEUROSCI LETT, V446, P78, DOI 10.1016/j.neulet.2008.09.049; Kong QM, 2010, CELL MOL LIFE SCI, V67, P1817, DOI 10.1007/s00018-010-0277-y; Krause P, 2008, CLIN REHABIL, V22, P627, DOI 10.1177/0269215507084648; Li WJ, 2012, NEUROCHEM INT, V61, P1397, DOI 10.1016/j.neuint.2012.10.002; Li WJ, 2010, NEUROSCI RES, V67, P307, DOI 10.1016/j.neures.2010.04.012; Liu DX, 1999, FREE RADICAL BIO MED, V27, P478, DOI 10.1016/S0891-5849(99)00073-8; Liu Z, 2011, CURR MED CHEM, V18, P5165, DOI 10.2174/092986711797636144; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Mexican General Law in Health, 1995, MEXICAN GEN LAW HLTH; Michiels C, 2002, FREE RADICAL BIO MED, V33, P1231, DOI 10.1016/S0891-5849(02)01045-6; Migdal C, 2011, M S-MED SCI, V27, P405, DOI 10.1051/medsci/2011274017; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Onose G, 2010, J Med Life, V3, P262; Pogosyan AS, 2004, B EXP BIOL MED+, V138, P26, DOI 10.1007/BF02694465; Rho SW, 2008, MOL CELLS, V25, P178; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Scandalios JG, 2002, GENOME BIOL, V3; Tangjitjaroen W., 2011, American Journal of Traditional Chinese Veterinary Medicine, V6, P37; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vaishnav RA, 2010, J NEUROTRAUM, V27, P1311, DOI 10.1089/neu.2009.1172; Wong AMK, 2003, AM J PHYS MED REHAB, V82, P21, DOI 10.1097/00002060-200301000-00004; Wu Yonggang, 2002, J Tradit Chin Med, V22, P51; Yan Q, 2011, EXP TOXICOL PATHOL, V63, P151, DOI 10.1016/j.etp.2009.11.002; Yang ES, 2011, PFLUG ARCH EUR J PHY, V462, P645, DOI 10.1007/s00424-011-1017-3; Yao WP, 2012, J TRADIT CHIN MED, V32, P99, DOI 10.1016/S0254-6272(12)60040-5; Yip PK, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-6; Yu YP, 2010, BRAIN RES, V1336, P58, DOI 10.1016/j.brainres.2010.04.020; Zhong SB, 2009, EVID-BASED COMPL ALT, V6, P51, DOI 10.1093/ecam/nem062	52	5	6	0	6	COGNIZANT COMMUNICATION CORP	PUTNAM VALLEY	18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA	0360-1293	2167-9010		ACUPUNCTURE ELECTRO	Acupunct. Electro-Ther. Res.		2015	40	4					355	369		10.3727/036012916X14533115160688			15	Integrative & Complementary Medicine; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine; Neurosciences & Neurology	DE2WD	WOS:000370487000003	26934797				2022-02-06	
J	Kara, M; Yalcin, S; Yenigun, D; Tiftik, T; Malas, FU; Ozcakar, L				Kara, Murat; Yalcin, Suha; Yenigun, Didem; Tiftik, Tulay; Malas, Fevziye Unsal; Ozcakar, Levent			Heterotopic ossification and cubital tunnel syndrome in traumatic brain injury: Ultrasound 'sees' both	JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION			English	Article						Ultrasonography; ulnar nerve; head trauma; 3D computed tomography	SPINAL-CORD-INJURY; SONOGRAPHY; DIAGNOSIS	Reported here is a 50-year-old man with cubital tunnel syndrome due to heterotopic ossification after traumatic brain injury. Herein, underscoring the role of ultrasonographic evaluations in the diagnosis of our patient, we suggest that ultrasonographic imaging can be a useful first-line diagnostic method for the possibility of HO and its complications. Further, due to its high spatial resolution, lack of radiation and easy applicability, we imply that US seems to overweigh in the daily practice of rehabilitation physicians.	[Kara, Murat; Yalcin, Suha; Yenigun, Didem; Tiftik, Tulay; Malas, Fevziye Unsal] Ankara Phys Med & Rehabil Training & Res Hosp, Ankara, Turkey; [Ozcakar, Levent] Hacettepe Univ, Sch Med, Dept Phys & Rehabil Med, Ankara, Turkey		Yalcin, S (corresponding author), Ankara Phys Med & Rehabil Training & Res Hosp, Ankara, Turkey.	suhayalcin@yandex.com	Yalcin, Suha/S-1480-2016	Yalcin, Suha/0000-0003-3711-6106			Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689, DOI 10.5435/00124635-200911000-00003; Falsetti P, 2011, CLIN NEUROL NEUROSUR, V113, P22, DOI 10.1016/j.clineuro.2010.08.012; Falsetti P, 2011, J CLIN ULTRASOUND, V39, P12, DOI 10.1002/jcu.20742; Kara M, 2012, EUR J PHYS REHAB MED, V48, P665; Kara M, 2009, MUSCLE NERVE, V40, P664, DOI 10.1002/mus.21419; Kilic E, 2011, RHEUMATOL INT, V31, P139, DOI 10.1007/s00296-009-1352-2; Ozcakar L, 2009, SURG NEUROL, V72, P311, DOI 10.1016/j.surneu.2008.08.005; Park GY, 2004, ARCH PHYS MED REHAB, V85, P1000, DOI 10.1016/j.apmr.2003.09.016; Szabo RM, 2007, HAND CLIN, V23, P311, DOI 10.1016/j.hcl.2007.05.002; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309	11	5	5	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8127	1878-6324		J BACK MUSCULOSKELET	J. Back Musculoskelet. Rehabil.		2015	28	2					415	417		10.3233/BMR-140519			3	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Rehabilitation	CF0LT	WOS:000352236200027	25159289				2022-02-06	
J	Kirkwood, MW				Kirkwood, Michael W.			Pediatric validity assessment	NEUROREHABILITATION			English	Article						Validity testing; noncredible performance; suboptimal effort; malingering; neuropsychological assessment; children	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; DISABILITY CONSULTATIVE EXAM; POST-CONCUSSION SYMPTOMS; WORD MEMORY TEST; DIGIT SPAN; POSTCONCUSSION SYNDROME; PERFORMANCE VALIDITY; NEUROCOGNITIVE OUTCOMES; NONCREDIBLE EFFORT	BACKGROUND: Youth have been assumed historically to be less capable of deception than adults, even though acts of deception in childhood are not uncommon. Relatively little attention has focused on howfrequently they feign or exaggerate during healthcare evaluations. PURPOSE: The current article reviews the literature relevant to using validity tests in children and adolescents, as well as provides a case example of a young adolescent providing noncredible effort and exaggerated symptomatology during neuropsychological evaluation after a mild traumatic brain injury. CONCLUSION: Numerous case reports and case series have documented clearly that medical and neuropsychological noncredible presentations occur in children, likely more often than many practitioners believe. Thus far, research has found that the base rates of pediatric noncredible presentations are highest in children seen frequently by rehabilitation providers (i.e., children with persistent problems after mild traumatic brain injury and children from families seeking disability benefits on their behalf). Subjective clinical judgment is apt to be ineffective in consistently detecting noncredible presentations. Fortunately, recent research supports the use of several stand-alone validity tests in identifying noncredible pediatric data including the Test of Memory Malingering, Word Memory Test, and Medical Symptom Validity Test. If feigning and exaggeration are not considered in work-ups by rehabilitation practitioners, mismanagement and iatrogenic harm to the child can result.	[Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Aurora, CO USA		Kirkwood, MW (corresponding author), Childrens Hosp Colorado, Dept Rehabil Med, B285,13123 East 16th Ave, Aurora, CO 80045 USA.	Michael.Kirkwood@childrenscolorado.org					Araujo GC, 2014, CLIN NEUROPSYCHOL, V28, P786, DOI 10.1080/13854046.2014.896415; Armistead-Jehle P, 2012, ARCH CLIN NEUROPSYCH, V27, P828, DOI 10.1093/arclin/acs086; Armstrong I., 2014, APPL NEUROPSYCHOL, V25, P1; Axelrod BN, 2010, CLIN NEUROPSYCHOL, V24, P873, DOI 10.1080/13854040903527295; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baker D. A., 2015, VALIDITY TESTING ASS; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Beaupre M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/924692; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; BIJUR PE, 1990, PEDIATRICS, V86, P337; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone K.B., 2007, ASSESSMENT FEIGNED C; Carone D.A., 2013, MILD TRAUMATIC BRAIN; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassar JR, 1996, J AM ACAD CHILD PSY, V35, P700, DOI 10.1097/00004583-199606000-00005; Chafetz M, 2011, APPL NEUROPSYCHOL, V18, P143, DOI 10.1080/09084282.2011.570619; Chafetz MD, 2008, CLIN NEUROPSYCHOL, V22, P529, DOI 10.1080/13854040701346104; Chafetz MD, 2007, ARCH CLIN NEUROPSYCH, V22, P1, DOI 10.1016/j.acn.2006.10.003; Clarridge C., 2007, SEATTLE TIMES   0517; Conti RP, 2004, PSYCHOL REP, V94, P987; CROFT RD, 1989, ARCH DIS CHILD, V64, P740, DOI 10.1136/adc.64.5.740; DeRight J, 2015, CHILD NEUROPSYCHOL, V21, P1, DOI 10.1080/09297049.2013.864383; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; FAUST D, 1988, J CONSULT CLIN PSYCH, V56, P578, DOI 10.1037/0022-006X.56.4.578; FAUST D, 1988, PROF PSYCHOL-RES PR, V19, P508, DOI 10.1037/0735-7028.19.5.508; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Flaro L., 2007, PRAXIS RECHTSPSYCHOL, V17, P125; Flaro L., 2009, NEUROPSYCHOLOGY MALI, P369; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gouvier W D, 1988, Arch Clin Neuropsychol, V3, P273, DOI 10.1016/0887-6177(88)90019-4; Green CM, 2014, J CLIN EXP NEUROPSYC, V36, P261, DOI 10.1080/13803395.2013.879096; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P., 2003, MANUAL WORD MEMORY T; Green P., 2004, MANUAL MED SYMPTOM V; Green P, 2012, DETECTION OF MALINGERING DURING HEAD INJURY LITIGATION, SECOND EDITION, P201, DOI 10.1007/978-1-4614-0442-2_6; GREENFELD D, 1987, HOSP COMMUNITY PSYCH, V38, P73; Guilmette T.J., 2013, MILD TRAUMATIC BRAIN, P31; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Harrison AG, 2014, APPL NEUROPSYCH-CHIL, V3, P152, DOI 10.1080/21622965.2012.753570; Henry G. K., 2005, FORENSIC NEUROPSYCHO, P205; Hung R., 2014, ARCH PHYS MED REHAB, V95, P174; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johnson EA, 1997, CHILD DEV, V68, P1117, DOI 10.2307/1132295; Kirk JW, 2014, ASSESSMENT, V21, P562, DOI 10.1177/1073191114520626; Kirk JW, 2011, CHILD NEUROPSYCHOL, V17, P242, DOI 10.1080/09297049.2010.533166; Kirkwood M. W, 2012, PEDIAT FORENSIC NEUR, P136; Kirkwood M. W., 2015, VALIDITY TESTING ASS; Kirkwood MW, 2014, PEDIATRICS, V133, P643, DOI 10.1542/peds.2013-3195; Kirkwood MW, 2014, CHILD NEUROPSYCHOL, V20, P245, DOI 10.1080/09297049.2012.759553; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kirkwood MW, 2010, CHILD NEUROPSYCHOL, V16, P604, DOI 10.1080/09297049.2010.495059; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kozlowska K, 2007, J AM ACAD CHILD PSY, V46, P68, DOI 10.1097/01.chi.0000242235.83140.1f; Kutluay E, 2010, EPILEPSY BEHAV, V17, P272, DOI 10.1016/j.yebeh.2009.12.020; Larochette AC, 2012, APPL NEUROPSYCH-CHIL, V1, P38, DOI 10.1080/21622965.2012.665777; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Libow JA, 2000, PEDIATRICS, V105, P336, DOI 10.1542/peds.105.2.336; Lieb R, 2000, ACTA PSYCHIAT SCAND, V101, P194, DOI 10.1046/j.0902-4441.2000.ap90071.x; Loughan AR, 2012, ARCH CLIN NEUROPSYCH, V27, P716, DOI 10.1093/arclin/acs072; Lu PH, 2002, CLIN NEUROPSYCHOL, V16, P90, DOI 10.1076/clin.16.1.90.8328; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; McCaffrey R. J., 2009, NEUROPSYCHOLOGY MALI, P377; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nagle AM, 2006, ARCH CLIN NEUROPSYCH, V21, P777, DOI 10.1016/j.acn.2006.06.011; Newton P, 2000, BRIT J DEV PSYCHOL, V18, P297, DOI 10.1348/026151000165706; OFFORD DR, 1987, ARCH GEN PSYCHIAT, V44, P832; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Peebles R, 2005, CLIN PEDIATR, V44, P237, DOI 10.1177/000992280504400307; Ploetz DM, 2016, CHILD NEUROPSYCHOL, V22, P133, DOI 10.1080/09297049.2014.986446; Polak A, 1999, DEV PSYCHOL, V35, P561, DOI 10.1037/0012-1649.35.2.561; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Rambo PL, 2015, APPL NEUROPSYCH-CHIL, V4, P1, DOI 10.1080/21622965.2013.780238; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Sawchyn JM, 2000, ARCH CLIN NEUROPSYCH, V15, P1, DOI 10.1016/S0887-6177(98)00041-9; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; STOUTHAMERLOEBER M, 1986, J ABNORM CHILD PSYCH, V14, P551, DOI 10.1007/BF01260523; Stutts JT, 2003, J DEV BEHAV PEDIATR, V24, P276, DOI 10.1097/00004703-200308000-00009; Sweet JJ, 2013, J EXP PSYCHOPATHOL, V4, P6, DOI 10.5127/jep.022311; Talwar V, 2002, INT J BEHAV DEV, V26, P436, DOI 10.1080/01650250143000373; Talwar V, 2007, DEV PSYCHOL, V43, P804, DOI 10.1037/0012-1649.43.3.804; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; Wilson AE, 2003, SOC DEV, V12, P21, DOI 10.1111/1467-9507.00220; Wood BL, 2004, CURR OPIN PEDIATR, V16, P523, DOI 10.1097/01.mop.0000140997.24408.53; Woodrome SE, 2011, J INT NEUROPSYCH SOC, V17, P317, DOI 10.1017/S1355617710001700; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO., 2012, MILD TRAUMATIC BRAIN	105	5	5	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	4					439	450		10.3233/NRE-151232			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CN8YP	WOS:000358732300006	26409492				2022-02-06	
J	Li, K; Alonso, J; Chadha, N; Pulido, J				Li, Kitsum; Alonso, Jonathan; Chadha, Nisha; Pulido, Jennifer			Does Generalization Occur Following Computer-Based Cognitive Retraining?-An Exploratory Study	OCCUPATIONAL THERAPY IN HEALTH CARE			English	Article						Cognition; Instrumental activity of daily living; Occupational therapy; Stroke; Traumatic brain injury	ACQUIRED BRAIN-INJURY; MENTAL-STATE-EXAMINATION; WORKING-MEMORY; MULTICONTEXT APPROACH; TRAINING-PROGRAM; ASSESSMENT MOCA; IMPAIRMENT; PEOPLE; HEMORRHAGE; STROKE	Computer-based cognitive retraining (CBCR) intervention has gained great popularity in recent years. This study aimed to investigate the occurrence of skill generalization to daily living task for individuals with acquired brain injury (ABI) after completion of eight modules of a commercially available CBCR program, the Parrot Software. The study investigated changes in individuals' global cognition as measured by the Montreal Cognitive Assessment, and changes in individuals' performance during a medication-box sorting task, a novel instrumental activity of daily living. The medication-box sorting task resembled real life medication management with daily prescribed and over-the-counter medications. Twelve individuals with ABI from a community-based program completed the study. Results indicated that CBCR intervention brought about improvement in global cognition, but the improvement did not appear in any particular cognitive domain. Additionally, the gains in global cognition failed to enhance performance in themedication-box sorting task. This exploratory study demonstrated that while CBCR may be a promising intervention for improving global cognition in individuals with ABI, additional intervention might be needed for generalization to occur to a novel daily task. Future studies should look for the ultimate therapeutic outcome fromCBCRinterventions or include interventions that could bridge the gap between CBCR intervention and performance improvement in daily living occupations.	[Li, Kitsum; Alonso, Jonathan; Chadha, Nisha; Pulido, Jennifer] Dominican Univ Calif, Sch Hlth & Nat Sci, Dept Occupat Therapy, San Rafael, CA USA		Li, K (corresponding author), Dominican Univ Calif, Dept Occupat Therapy, 50 Acacia Ave, San Rafael, CA 94901 USA.	Kitsum.Li@dominican.edu					Averbuch S, 2005, COGNITION OCCUPATION, P13; Centers for Disease Control and Prevention, 2013, BRAIN INJURY; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen J., 2013, STAT POWER ANAL BEHA; Dong YH, 2010, J NEUROL SCI, V299, P15, DOI 10.1016/j.jns.2010.08.051; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Finn M, 2011, BRAIN IMPAIR, V12, P187; Gaitan A, 2013, INT J GERIATR PSYCH, V28, P91, DOI 10.1002/gps.3794; Giuffrida CG, 2009, AM J OCCUP THER, V63, P398, DOI 10.5014/ajot.63.4.398; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Kwok TCY, 2011, CLIN INTERV AGING, V6, P83, DOI 10.2147/CIA.S16802; Li K, 2013, OCCUP THER HEALTH CA, V27, P333, DOI 10.3109/07380577.2013.844877; Lindqvist E, 2010, TECHNOLOGY DISABILIT, V22, P89, DOI DOI 10.3233/TAD20100294; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; Melton AK, 2005, APHASIOLOGY, V19, P353, DOI 10.1080/02687030444000804; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Olson RA, 2008, SUPPORT CARE CANCER, V16, P1273, DOI 10.1007/s00520-008-0431-3; Pendlebury ST, 2010, STROKE, V41, P1290, DOI 10.1161/STROKEAHA.110.579888; Rees L, 2007, BRAIN INJURY, V21, P161, DOI 10.1080/02699050701201813; Schweizer TA, 2012, J NEUROL SCI, V316, P137, DOI 10.1016/j.jns.2012.01.003; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Slomine B, 2009, DEV DISABIL RES REV, V15, P133, DOI 10.1002/ddrr.56; Tam SF, 2004, BRAIN INJURY, V18, P461, DOI 10.1080/02699050310001646099; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Toglia JP., 2005, COGNITION OCCUPATION, P161; Topolovec-Vranic J, 2010, BRAIN INJURY, V24, P762, DOI 10.3109/02699051003709599; Weiner FF., 2009, ABOUT PARROT; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wong GKC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059946; Wong GKC, 2013, BRAIN INJURY, V27, P394, DOI 10.3109/02699052.2012.750746; Yip BCB, 2013, NEUROREHABILITATION, V32, P103, DOI [10.3233/NRE-130827, 10.3233/NRE-30827]; Yip BCB, 2009, BRAIN INJURY, V23, P1017, DOI 10.3109/02699050903379412	34	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0738-0577	1541-3098		OCCUP THER HEALTH CA	Occup. Ther. Health Care		2015	29	3					283	296		10.3109/07380577.2015.1010246			14	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	CR4TL	WOS:000361331900003	25993264	Green Submitted			2022-02-06	
J	Lubetzky, AV; Price, R; Ciol, MA; Kelly, VE; McCoy, SW				Lubetzky, Anat V.; Price, Robert; Ciol, Marcia A.; Kelly, Valerie E.; McCoy, Sarah W.			Relationship of multiscale entropy to task difficulty and sway velocity in healthy young adults	SOMATOSENSORY AND MOTOR RESEARCH			English	Article						Center of pressure; complexity index; nonlinear analysis; postural control	ACHILLES-TENDON VIBRATION; TIME-SERIES ANALYSIS; POSTURAL CONTROL; APPROXIMATE ENTROPY; CEREBRAL CONCUSSION; SAMPLE ENTROPY; COMPLEXITY; SYSTEM; VARIABILITY; REGULARITY	Purpose/background: Multiscale entropy (MSE) is a nonlinear measure of postural control that quantifies how complex the postural sway is by assigning a complexity index to the center of pressure (COP) oscillations. While complexity has been shown to be task dependent, the relationship between sway complexity and level of task challenge is currently unclear. This study tested whether MSE can detect short-term changes in postural control in response to increased standing balance task difficulty in healthy young adults and compared this response to that of a traditional measure of postural steadiness, root mean square of velocity (VRMS). Methods: COP data from 20 s of quiet stance were analyzed when 30 healthy young adults stood on the following surfaces: on floor and foam with eyes open and closed and on the compliant side of a Both Sides Up (BOSU) ball with eyes open. Complexity index (CompI) was derived from MSE curves. Results: Repeated measures analysis of variance across standing conditions showed a statistically significant effect of condition (p<0.001) in both the anterior-posterior and medio-lateral directions for both CompI and VRMS. In the medio-lateral direction there was a gradual increase in CompI and VRMS with increased standing challenge. In the anterior-posterior direction, VRMS showed a gradual increase whereas CompI showed significant differences between the BOSU and all other conditions. CompI was moderately and significantly correlated with VRMS. Conclusions: Both nonlinear and traditional measures of postural control were sensitive to the task and increased with increasing difficulty of standing balance tasks in healthy young adults.	[Lubetzky, Anat V.] NYU, Dept Phys Therapy, 380 2nd Ave,4th Floor, New York, NY 10010 USA; [Price, Robert; Ciol, Marcia A.; Kelly, Valerie E.; McCoy, Sarah W.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Lubetzky, AV (corresponding author), NYU, Dept Phys Therapy, 380 2nd Ave,4th Floor, New York, NY 10010 USA.	anat@nyu.edu		Kelly, Valerie E./0000-0002-0099-9219; Ciol, Marcia/0000-0001-6406-4706; Lubetzky, Anat/0000-0001-5869-025X	Walter C. and Anita C. Stolov Research Award, University of Washington, Department of Rehabilitation Medicine	We thank Deborah Kartin, PT, PhD for consultation and assistance with data collection. We thank Alex Bennett, DPT and Somer Kreisman, DPT for assistance with data collection. We thank Alex Bennett and Somer Kreisman, DPT students, for assistance with data collection. We also thank the anonymous referees for thoughtful comments. This work was funded by the Walter C. and Anita C. Stolov Research Award, University of Washington, Department of Rehabilitation Medicine. Study sponsors had no involvement in the research project or manuscript production.	Aoki M, 2014, GAIT POSTURE, V40, P435, DOI 10.1016/j.gaitpost.2014.05.013; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Dettmer M, 2015, SOMATOSENS MOT RES, V32, P128, DOI 10.3109/08990220.2015.1004045; Dettmer M, 2013, HUM MOVEMENT SCI, V32, P214, DOI 10.1016/j.humov.2012.12.002; Docherty CL, 2006, CLIN J SPORT MED, V16, P203, DOI 10.1097/00042752-200605000-00003; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Eikema DJA, 2013, NEUROSCIENCE, V234, P22, DOI 10.1016/j.neuroscience.2012.12.053; Fisher R., 1948, STAT TABLES BIOL AGR; Gruber AH, 2011, GAIT POSTURE, V34, P13, DOI 10.1016/j.gaitpost.2011.02.015; Horak FB, 2009, PHYS THER, V89, P484, DOI 10.2522/ptj.20080071; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Kang HG, 2009, J GERONTOL A-BIOL, V64, P1304, DOI 10.1093/gerona/glp113; Kirchner M, 2013, HUM MOVEMENT SCI, V32, P1467, DOI 10.1016/j.humov.2013.05.005; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Lambert S, 2010, ACTA OTO-LARYNGOL, V130, P820, DOI 10.3109/00016480903426592; Liu Q, 2012, ENTROPY-SWITZ, V14, P978, DOI 10.3390/e14060978; Lubetzky A, 2015, YOUNG ADULTS LARGELY; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Miller DJ, 2006, J BIOMECH, V39, P2873, DOI 10.1016/j.jbiomech.2005.10.019; NOBLE BJ, 1982, MED SCI SPORT EXER, V14, P406; Pau M, 2012, GAIT POSTURE, V35, P378, DOI 10.1016/j.gaitpost.2011.10.354; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Ramdani S, 2009, MED ENG PHYS, V31, P1023, DOI 10.1016/j.medengphy.2009.06.004; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; RITHNAJARIAN SJ, 1992, DIABETES CARE, V15, P1386, DOI 10.2337/diacare.15.10.1386; SOAMES RW, 1982, EUR J APPL PHYSIOL O, V49, P169, DOI 10.1007/BF02334065; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Turnock MJE, 2010, J MOTOR BEHAV, V42, P61, DOI 10.1080/00222890903397103; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; Yeh JR, 2014, GAIT POSTURE, V40, P581, DOI 10.1016/j.gaitpost.2014.06.016; Yentes JM, 2013, ANN BIOMED ENG, V41, P349, DOI 10.1007/s10439-012-0668-3	38	5	5	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0899-0220	1369-1651		SOMATOSENS MOT RES	Somatosens. Mot. Res.		2015	32	4					211	218		10.3109/08990220.2015.1074565			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DD4IM	WOS:000369885700003	26370065				2022-02-06	
J	Moreno, JA; McKerral, M				Moreno, Jhon Alexander; McKerral, Michelle			Differences according to Sex in Sociosexuality and Infidelity after Traumatic Brain Injury	BEHAVIOURAL NEUROLOGY			English	Article							ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR-PITUITARY FUNCTION; GROWTH-HORMONE DEFICIENCY; LONG-TERM; POSTTRAUMATIC HYPOPITUITARISM; INDIVIDUAL-DIFFERENCES; GENDER-DIFFERENCES; HIGH-RISK; TBI; PREVALENCE	Objective. To explore differences according to sex in sociosexuality and infidelity in individuals with TBI and in healthy controls. Participants. Forty-two individuals with mild, moderate, and severe TBI having completed a postacute TBI rehabilitation program, at least six months after injury, and 47 healthy controls. Main Measures. Sociosexual Orientation Inventory-Revised (SOI-R) and Attitudes toward Infidelity Scale. Results. Overall, men score significantly higher than women in sociosexuality. However, there was a nonsignificant trend towards a reduction of sociosexuality levels in men with TBI. Infidelity levels were comparable in healthy controls and individuals with TBI. In individuals with TBI, less acceptance of infidelity was significantly associated with an unrestricted sociosexual orientation, but not in healthy controls. Conclusions. As documented in previous cross-cultural studies, men have higher levels of sociosexuality than women. However, men with TBI showed a tendency towards the reduction of sociosexuality. The possibility of a latent explanatory variable is suggested (e.g., post-TBI neuroendocrinological changes). TBI does not seem to have an impact on infidelity, but individuals with TBI who express less acceptance of infidelity also report a more promiscuous mating strategy regarding their behavior, attitudes, and desire. Theoretical implications are discussed in terms of evolutionary theories of human sexuality and neuropsychology.	[Moreno, Jhon Alexander; McKerral, Michelle] CRLB, CRIR, Montreal, PQ H2H 2N8, Canada; [Moreno, Jhon Alexander; McKerral, Michelle] Univ Montreal, Dept Psychol, Ctr Rech Neuropsychol & Cognit CERNEC, Montreal, PQ H3C 3J7, Canada		Moreno, JA (corresponding author), CRLB, CRIR, 2275 Laurier Ave East, Montreal, PQ H2H 2N8, Canada.	jhon.alexander.moreno@umontreal.ca; michelle.mckerral@umontreal.ca			CRIR; CERNEC; Faculte des etudes superieures et postdoctorales de l'Universite de Montreal; CRLB	The authors wish to thank the CRIR, CERNEC, and Faculte des etudes superieures et postdoctorales de l'Universite de Montreal (scholarships to Jhon Alexander Moreno), the CRLB for partial funding of this study (grant to Michelle McKerral), and the participants who took part in the study.	Acerini CL, 2006, EUR J ENDOCRINOL, V155, P663, DOI 10.1530/eje.1.02284; Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Aimaretti G, 2005, J ENDOCRINOL INVEST, V28, P984, DOI 10.1007/BF03345336; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2005, THESCIENTIFICWORLDJO, V5, P777, DOI 10.1100/tsw.2005.100; Allen JS, 2007, J SEX RES, V44, P225, DOI 10.1080/00224490701443601; Baldelli Roberto, 2005, Pituitary, V8, P255, DOI 10.1007/s11102-006-6050-4; Barthel D, 2014, J AFFECT DISORDERS, V169, P203, DOI 10.1016/j.jad.2014.08.004; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beck-Peccoz Paolo, 2005, Nat Clin Pract Endocrinol Metab, V1, P12, DOI 10.1038/ncpendmet0018; Blow AJ, 2005, J MARITAL FAM THER, V31, P183, DOI 10.1111/j.1752-0606.2005.tb01555.x; Blow AJ, 2005, J MARITAL FAM THER, V31, P217, DOI 10.1111/j.1752-0606.2005.tb01556.x; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Casanueva FF, 2005, J ENDOCRINOL INVEST, V28, P299; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Chang YC, 2006, J FORMOS MED ASSOC, V105, P172, DOI 10.1016/S0929-6646(09)60341-7; Choudhury S, 2012, CRITICAL NEUROSCIENCE: A HANDBOOK OF THE SOCIAL AND CULTURAL CONTEXTS OF NEUROSCIENCE, P1; Cohen J, 1969, STAT POWER ANAL BEHA; Cohen M., 2003, SEXUAL DIFFICULTIES, P42; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Corneli Ginevra, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P301, DOI 10.1097/MED.0b013e3281e7e6e6; Cross CP, 2010, EVOL PSYCHOL-US, V8, P779, DOI 10.1177/147470491000800418; das Nair R., 2007, J INT NEUROPSYCH SOC, V13, P91; DAVIS CM, 1998, HDB SEXUALITY RELATE; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Duncan LA, 2007, EVOL HUM BEHAV, V28, P359, DOI 10.1016/j.evolhumbehav.2007.05.001; Edelstein RS, 2011, HORM BEHAV, V60, P248, DOI 10.1016/j.yhbeh.2011.05.007; EDWARDS OM, 1986, MEDICINE, V65, P281; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Fernandez-Rodriguez E., 2010, FRONTIERS ENDOCRINOL, V2; Fischtein DS, 2007, ARCH SEX BEHAV, V36, P451, DOI 10.1007/s10508-006-9157-9; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ghigo E, 2007, HORM RES, V68, P12, DOI 10.1159/000110464; Goldberg JF, 2010, BIPOLAR DISORD, V12, P32, DOI 10.1111/j.1399-5618.2009.00775.x; Gouvernement du Quebec/Ministere de la Sante et des Services Sociaux & Societe de l'assurance automobile du Quebec, 2005, OR MIN TCCL; Government of Canada. Public Health Agency of Canada, 2014, MAPP CONN UND NEUR C; Greco T, 2015, DEV NEUROBIOL, V75, P193, DOI 10.1002/dneu.22218; Guerrero AF, 2010, MIL MED, V175, P574, DOI 10.7205/MILMED-D-09-00189; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; Hofer J, 2010, J PERS SOC PSYCHOL, V99, P380, DOI 10.1037/a0020053; IBM, 2012, SPSS ADV STAT; Josephs Lawrence, 2012, Psychodyn Psychiatry, V40, P243; Keverne EB, 2014, NEUROSCIENCE, V264, P207, DOI 10.1016/j.neuroscience.2012.11.030; Kinsey A. C., 1948, SEXUAL BEHAV HUMAN M; Kinsey Alfred Charles, 1965, SEXUAL BEHAV HUMAN F; Klose M, 2008, PITUITARY, V11, P255, DOI 10.1007/s11102-008-0102-x; Knox D., 2000, COLL STUDENT J, V34, P162; Kokshoorn NE, 2011, EUR J ENDOCRINOL, V165, P225, DOI 10.1530/EJE-11-0365; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kolli S., 2010, BMJ CASE REPORTS; Kreitschmann-Andermahr I, 2011, EXP CLIN ENDOCR DIAB, V119, P15, DOI 10.1055/s-0030-1253414; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Liew A, 2008, NAT CLIN PRACT ENDOC, V4, P126, DOI 10.1038/ncpendmet0719; Lippa RA, 2009, ARCH SEX BEHAV, V38, P631, DOI 10.1007/s10508-007-9242-8; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; Makulski DD, 2008, J COMPUT ASSIST TOMO, V32, P324, DOI 10.1097/RCT.0b013e3181636ed4; Manly T, 2012, CURR OPIN NEUROL, V25, P656, DOI 10.1097/WCO.0b013e3283594872; Masel BE, 2004, GROWTH HORM IGF RES, V14, pS108, DOI 10.1016/j.ghir.2004.03.024; Masel Brent E, 2005, Pituitary, V8, P263, DOI 10.1007/s11102-006-6052-2; Mattingly BA, 2011, J SOC PSYCHOL, V151, P222, DOI 10.1080/00224540903536162; McIntyre M, 2006, J PERS SOC PSYCHOL, V91, P642, DOI 10.1037/0022-3514.91.4.642; Medic-Stoianoska M, 2007, ENDOCRINE, V31, P268, DOI 10.1007/s12020-007-0037-4; Mitchell A, 1997, Crit Care Nurse, V17, P34; Moreno A., 2014, P 91 AM C REH MED TR; Moreno A., 2012, SEXUALITY INT J PSYC, V47, P684; Moreno A., 2013, P 34 INT C PSYCH KNO; Moreno JA, 2013, NEUROREHABILITATION, V32, P69, DOI 10.3233/NRE-130824; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Popovic V, 2005, FRONT HORM RES, V33, P33, DOI 10.1159/000088399; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Prodam F, 2014, GROWTH HORM IGF RES, V24, P104, DOI 10.1016/j.ghir.2014.04.001; Quist MC, 2012, ARCH SEX BEHAV, V41, P1415, DOI 10.1007/s10508-011-9848-8; Rammsayer TH, 2013, ARCH SEX BEHAV, V42, P1173, DOI 10.1007/s10508-013-0114-0; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Saito T, 2009, ENDOCR J, V56, P945, DOI 10.1507/endocrj.K09E-202; Sandel ME, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P915; SANDEL ME, 2007, BRAIN INJURY MED PRI, P673; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Schaller M, 2008, J PERS SOC PSYCHOL, V95, P212, DOI 10.1037/0022-3514.95.1.212; Schmitt DP, 2005, BEHAV BRAIN SCI, V28, P247, DOI 10.1017/S0140525X05000051; Schneider HJ, 2007, J ENDOCRINOL INVEST, V30, pRC9, DOI 10.1007/BF03346291; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider Harald J, 2007, Pediatr Endocrinol Rev, V4, P205; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; SEAL DW, 1994, AIDS CARE, V6, P393, DOI 10.1080/09540129408258653; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Simpson G, 2001, BRAIN IMPAIR, V2, P97, DOI DOI 10.1375/BRIM.2.2.97; Simpson GK, 2013, J HEAD TRAUMA REHAB, V28, P202, DOI 10.1097/HTR.0b013e31828dc5ae; SIMPSON JA, 1992, J PERS, V60, P31, DOI 10.1111/j.1467-6494.1992.tb00264.x; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Sprecher S, 2013, ARCH SEX BEHAV, V42, P1395, DOI 10.1007/s10508-013-0145-6; Srinivasan L, 2009, BRAIN INJURY, V23, P639, DOI 10.1080/02699050902970778; Stone Arthur A., 1999, SCI SELF REPORT IMPL; Takahashi H, 2006, NEUROIMAGE, V32, P1299, DOI 10.1016/j.neuroimage.2006.05.049; Tanriverdi F, 2011, J ENDOCRINOL INVEST, V34, P541, DOI 10.3275/7805; Tanriverdi F, 2007, CLIN ENDOCRINOL, V66, P360, DOI 10.1111/j.1365-2265.2006.02737.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tanriverdi F, 2010, J NEUROTRAUM, V27, P301, DOI 10.1089/neu.2009.1102; Townsend JM, 1997, ARCH SEX BEHAV, V26, P243, DOI 10.1023/A:1024570814293; Treger S, 2011, J SEX RES, V48, P413, DOI 10.1080/00224499.2010.516845; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Trivers Robert, 2002, NATURAL SELECTION SO; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; Valdes-Socin H, 2009, Rev Med Liege, V64, P457; Waterhouse C., 2012, BRIT J NEUROSCIENCE, V8, P184; Wilson K, 2011, J SOC PSYCHOL, V151, P63, DOI 10.1080/00224540903366750; Yost MR, 2006, J SEX RES, V43, P163, DOI 10.1080/00224490609552311; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P397; Zheng WJ, 2014, ARCH SEX BEHAV, V43, P621, DOI 10.1007/s10508-013-0097-x	118	5	5	2	10	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2015	2015								914134	10.1155/2015/914134			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CU5NL	WOS:000363578800001	26543323	gold, Green Published, Green Submitted			2022-02-06	
J	Pascoe, MC; Howells, DW; Crewther, DP; Carey, LM; Crewther, SG				Pascoe, Michaela C.; Howells, David W.; Crewther, David P.; Carey, Leeanne M.; Crewther, Sheila G.			Fish oil supplementation associated with decreased cellular degeneration and increased cellular proliferation 6 weeks after middle cerebral artery occlusion in the rat	NEUROPSYCHIATRIC DISEASE AND TREATMENT			English	Article						apoptosis; polyunsaturated fatty acids; contralesional hemisphere; stroke; anxiety; depression	FOCAL CORTICAL INFARCTION; TRAUMATIC BRAIN-INJURY; BETA-AMYLOID DEPOSITS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; FUNCTIONAL RECOVERY; HYPERTENSIVE-RATS; PRECURSOR PROTEIN; SECONDARY DAMAGE; HYPOXIA-ISCHEMIA; OXIDATIVE STRESS	Anti-inflammatory long-chain omega-3 polyunsaturated fatty acids (n-3-LC-PUFAs) are both neuroprotective and have antidepressive effects. However the influence of dietary supplemented n-3-LC-PUFAs on inflammation-related cell death and proliferation after middle cerebral artery occlusion (MCAo)-induced stroke is unknown. We have previously demonstrated that anxiety-like and hyperactive locomotor behaviors are reduced in n-3-LC-PUFA-fed MCAo animals. Thus in the present study, male hooded Wistar rats were exposed to MCAo or sham surgeries and examined behaviorally 6 weeks later, prior to euthanasia and examination of lesion size, cell death and proliferation in the dentate gyrus, cornu ammonis region of the hippocampus of the ipsilesional hemispheres, and the thalamus of the ipsilesional and contralesional hemispheres. Markers of cell genesis and cell degeneration in the hippocampus or thalamus of the ipsilesional hemisphere did not differ between surgery and diet groups 6 weeks post MCAo. Dietary supplementation with n-3-LC-PUFA decreased cell degeneration and increased cell proliferation in the thalamic region of the contralesional hemisphere. MCAo-associated cell degeneration in the hippocampus and thalamus positively correlated with anxiety-like and hyperactive locomotor behaviors previously reported in these animals. These results suggest that anti-inflammatory n-3-LC-PUFA supplementation appears to have cellular protective effects after MCAo in the rat, which may affect behavioral outcomes.	[Pascoe, Michaela C.; Crewther, David P.] Swinburne Univ, Brain Sci Inst, Melbourne, Vic, Australia; [Howells, David W.; Carey, Leeanne M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Carey, Leeanne M.] La Trobe Univ, Sch Allied Hlth, Dept Occupat Therapy, Bundoora, Vic 3086, Australia; [Crewther, Sheila G.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia		Pascoe, MC (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Box 440, SE-40530 Gothenburg, Sweden.	michaela.pascoe@neuro.gu.se	Carey, Leeanne/AAZ-9844-2021; Crewther, Sheila G/A-2165-2008	Howells, David/0000-0002-2512-7724; Carey, Leeanne/0000-0001-6376-8613; Pascoe, Michaela/0000-0002-3831-5660			Ajami M, 2012, IRAN J PHARM RES, V11, P533; ASANUMA H, 1975, BRAIN RES, V98, P73, DOI 10.1016/0006-8993(75)90510-7; Astrom M, 1996, STROKE, V27, P270, DOI 10.1161/01.STR.27.2.270; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bas O, 2007, NEUROCHEM INT, V50, P548, DOI 10.1016/j.neuint.2006.11.005; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Benowitz LI, 2010, NEUROBIOL DIS, V37, P259, DOI 10.1016/j.nbd.2009.11.009; BLACK KL, 1979, PROSTAG LEUKOTR ESS, V3, P257, DOI 10.1016/0161-4630(79)90067-3; Blondeau N, 2009, NEUROPSYCHOPHARMACOL, V34, P2548, DOI 10.1038/npp.2009.84; BOGOUSSLAVSKY J, 1988, J NEUROL NEUROSUR PS, V51, P116, DOI 10.1136/jnnp.51.1.116; BURVILL PW, 1995, BRIT J PSYCHIAT, V166, P328, DOI 10.1192/bjp.166.3.328; Carey LM, 2011, NEUROREHAB NEURAL RE, V25, P443, DOI 10.1177/1545968310395777; Chen J, 1998, J NEUROSCI, V18, P4914; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Dastoor Z, 2001, J CELL SCI, V114, P1643; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Dief AE, 2008, ANATOMY, V2, P39, DOI DOI 10.2399/ANA.08.039; Dihne M, 2002, STROKE, V33, P3006, DOI 10.1161/01.STR.0000039406.64644.CB; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510, DOI 10.1523/JNEUROSCI.23-02-00510.2003; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; EVARTS EV, 1969, ANNU REV PHYSIOL, V31, P451, DOI 10.1146/annurev.ph.31.030169.002315; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Fong TG, 2009, NAT REV NEUROL, V5, P210, DOI 10.1038/nrneurol.2009.24; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Gomez-Pinilla F, 2008, NAT REV NEUROSCI, V9, P568, DOI 10.1038/nrn2421; Hiltunen M, 2009, NEUROBIOL DIS, V35, P103, DOI 10.1016/j.nbd.2009.04.009; Hooijmans CR, 2007, NEUROBIOL DIS, V28, P16, DOI 10.1016/j.nbd.2007.06.007; Hua K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052728; Iwai M, 2002, J CEREBR BLOOD F MET, V22, P411, DOI 10.1097/00004647-200204000-00005; Jones ML, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103754; Kilic E, 2008, J PINEAL RES, V45, P142, DOI 10.1111/j.1600-079X.2008.00568.x; Kurata K, 2005, J NEUROPHYSIOL, V94, P550, DOI 10.1152/jn.01034.2004; KUROIWA T, 1991, NEUROSCI LETT, V122, P141, DOI 10.1016/0304-3940(91)90842-H; KUROIWA T, 1991, BRAIN RES, V563, P33, DOI 10.1016/0006-8993(91)91511-X; LARSEN KD, 1979, BRAIN RES, V172, P209, DOI 10.1016/0006-8993(79)90533-X; Linden T, 2007, STROKE, V38, P1860, DOI 10.1161/STROKEAHA.106.471805; Lindner MD, 2003, J NEUROSCI, V23, P10913; Mackay J., 2004, ATLAS HEART DIS STRO; Magavi Sanjay S., 2008, V438, P335, DOI 10.1007/978-1-59745-133-8_25; Makinen S, 2008, J CEREBR BLOOD F MET, V28, P263, DOI 10.1038/sj.jcbfm.9600529; McManus J, 2007, AGE AGEING, V36, P613, DOI 10.1093/ageing/afm140; Milligan CE, 2000, NAT MED, V6, P385, DOI 10.1038/74644; Mohajerani MH, 2011, P NATL ACAD SCI USA, V108, pE183, DOI 10.1073/pnas.1101914108; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; National Health and Medical Research Council, 2004, AUSTR COD PRACT CAR, V7th ed; Nguemeni C, 2010, PHARMACOL RES, V61, P226, DOI 10.1016/j.phrs.2009.12.007; Northington FJ, 2001, DEV NEUROSCI-BASEL, V23, P186, DOI 10.1159/000046141; Pascoe MC, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00014; Pascoe MC, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.14973; Pascoe MC, 2011, CLIN NUTR, V30, P407, DOI 10.1016/j.clnu.2011.03.013; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 2004, RAT NERVOUS SYSTEM; Perez DL, 2011, J NEUROL NEUROPHYSIO, VS1; Popa-Wagner A, 2006, CURR NEUROVASC RES, V3, P3, DOI 10.2174/156720206775541732; Popa-Wagner A, 2011, AGEING RES REV, V10, P71, DOI 10.1016/j.arr.2009.10.008; Ramic M, 2006, BRAIN RES, V1111, P176, DOI 10.1016/j.brainres.2006.06.063; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; ROSS DT, 1990, NEUROSCIENCE, V35, P525, DOI 10.1016/0306-4522(90)90327-Z; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SCHREIBER SS, 1995, TRENDS NEUROSCI, V18, P446, DOI 10.1016/0166-2236(95)94495-Q; Soriano MA, 1996, NEUROREPORT, V7, P425, DOI 10.1097/00001756-199601310-00012; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Takatsuru Y, 2009, J NEUROSCI, V29, P10081, DOI 10.1523/JNEUROSCI.1638-09.2009; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Taupin P, 2007, REGEN MED, V2, P51, DOI 10.2217/17460751.2.1.51; van der Zijden JP, 2008, J CEREBR BLOOD F MET, V28, P832, DOI 10.1038/sj.jcbfm.9600576; van Groen T, 2005, STROKE, V36, P1551, DOI 10.1161/01.STR.0000169933.88903.cf; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; WANG D, 1990, BRAIN RES, V533, P78, DOI 10.1016/0006-8993(90)91798-L; Yu HR, 2011, ANAL BIOCHEM, V413, P24, DOI 10.1016/j.ab.2011.01.037; Zhang J, 2012, J NEUROCHEM, V120, P564, DOI 10.1111/j.1471-4159.2011.07496.x; Zhang YS, 2011, J CEREBR BLOOD F MET, V31, P572, DOI 10.1038/jcbfm.2010.127; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	77	5	5	0	11	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND		1178-2021		NEUROPSYCH DIS TREAT	Neuropsychiatr. Dis. Treat.		2015	11						153	164		10.2147/NDT.S72925			12	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	AY8EF	WOS:000347786500001	25609971	Green Published, Green Submitted, gold, Green Accepted			2022-02-06	
S	Puccio, AM; Alexander, S		Conley, YP		Puccio, Ava M.; Alexander, Sheila			Genomics, Transcriptomics, and Epigenomics in Traumatic Brain Injury Research	ANNUAL REVIEW OF NURSING RESEARCH, VOL 33: TRAUMATIC BRAIN INJURY	Annual Review of Nursing Research-Series		English	Article; Book Chapter							HISTONE DEACETYLASE INHIBITORS; WIDE ASSOCIATION; DNA METHYLATION; CEREBROSPINAL-FLUID; CEREBRAL-CORTEX; H3 ACETYLATION; COMPLEX TRAITS; HEAD-INJURY; GENE; EXPRESSION	The long-term effects and significant impact of the full spectrum of traumatic brain injury (TBI) has received increased attention in recent years. Despite increased research efforts, there has been little movement toward improving outcomes for the survivors of TBI. TBI is a heterogeneous condition with a complex biological response, and significant variability in human recovery contributes to the difficulty in identifying therapeutics that improve outcomes. Personalized medicine, identifying the best course of treatment for a given individual based on individual characteristics, has great potential to improve recovery for TBI survivors. The advances in medical genetics and genomics over the past 20 years have increased our understanding of many biological processes. A substantial amount of research has focused on the genomic, transcriptomic, and epigenomic profiles in many health and disease states, including recovery from TBI. The focus of this review chapter is to describe the current state of the science in genomic, transcriptomic, and epigenomic research in the TBI population. There have been some advancements toward understanding the genomic, transcriptomic, and epigenomic processes in humans, but much of this work remains at the preclinical stage. This current evidence does improve our understanding of TBI recovery, but also serves as an excellent platform upon which to build further study toward improved outcomes for this population.	[Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Alexander, Sheila] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA 15260 USA		Puccio, AM (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA.						Aschard H, 2012, HUM GENET, V131, P1591, DOI 10.1007/s00439-012-1192-0; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Bookman EB, 2011, GENET EPIDEMIOL, V35, P217, DOI 10.1002/gepi.20571; Burgos KL, 2013, RNA, V19, P712, DOI 10.1261/rna.036863.112; Cao P, 2013, CNS NEUROSCI THER, V19, P337, DOI 10.1111/cns.12082; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Clarke A, 2011, HUM GENET, V130, P27, DOI 10.1007/s00439-011-0988-7; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Cohen Idan, 2011, Genes Cancer, V2, P631, DOI 10.1177/1947601911417176; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Corvin A, 2010, PSYCHOL MED, V40, P1063, DOI 10.1017/S0033291709991723; Cummins FJ, 2010, J CARDIOVASC TRANSL, V3, P683, DOI 10.1007/s12265-010-9221-7; Darrah SD, 2013, EPILEPSY RES, V103, P180, DOI 10.1016/j.eplepsyres.2012.07.006; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Foley DL, 2009, AM J EPIDEMIOL, V169, P389, DOI 10.1093/aje/kwn380; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gonzalo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008777; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Hahnen E, 2008, EXPERT OPIN INV DRUG, V17, P169, DOI 10.1517/13543784.17.2.169; Hattacharjee S, 2010, AM J HUM GENET, V86, P331, DOI 10.1016/j.ajhg.2010.01.026; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ikram MA, 2009, NEW ENGL J MED, V360, P1718, DOI 10.1056/NEJMoa0900094; Jellinger KA, 2004, CURR OPIN NEUROL, V17, P719, DOI 10.1097/00019052-200412000-00012; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Khatri P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002375; Koponen S, 2004, NEUROLOGY, V63, P749, DOI 10.1212/01.WNL.0000134603.57107.2F; Kuo CH, 2014, ASIA PAC ALLERGY, V4, P14, DOI 10.5415/apallergy.2014.4.1.14; Laird MD, 2014, GLIA, V62, P26, DOI 10.1002/glia.22581; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Lee J, 2013, NEUROTHERAPEUTICS, V10, P664, DOI 10.1007/s13311-013-0206-5; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Lundberg J, 2009, NEUROSCI LETT, V457, P8, DOI 10.1016/j.neulet.2009.03.105; Luo F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-299; Majersik JJ, 2015, STROKE, V46, P279, DOI 10.1161/STROKEAHA.114.006839; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Merrick BA, 2004, CURR OPIN MOL THER, V6, P600; Mroz RM, 2007, J PHYSIOL PHARMACOL, V58, P453; Muller HH, 2007, GENET EPIDEMIOL, V31, P844, DOI 10.1002/gepi.20245; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; National Human Genome Research Institute, 2011, OV HUM GEN PROJ; Paoloni-Giacobino A, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13321; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Patz S, 2013, J NEUROTRAUM, V30, P1232, DOI 10.1089/neu.2012.2596; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Phan JH, 2006, PROG BRAIN RES, V158, P83, DOI 10.1016/S0079-6123(06)58004-5; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Rezola A., 2014, BRIEFINGS BIOINFORMA; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Shirodkar AV, 2011, CURR OPIN CARDIOL, V26, P209, DOI 10.1097/HCO.0b013e328345986e; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Stanhope SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042367; Strawbridge RJ, 2011, DIABETES, V60, P2624, DOI 10.2337/db11-0415; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang B, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.61; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Verrier JD, 2012, J NEUROCHEM, V122, P115, DOI 10.1111/j.1471-4159.2012.07705.x; Wang GH, 2013, NEUROTHERAPEUTICS, V10, P124, DOI 10.1007/s13311-012-0157-2; Wang YG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/641979; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S19; Zhang ZY, 2007, NEUROSCI LETT, V429, P1, DOI 10.1016/j.neulet.2007.09.061; Zhao W, 2013, J ALZHEIMERS DIS, V34, P417, DOI 10.3233/JAD-121894; Zondervan KT, 2007, HUM REPROD, V22, P717, DOI 10.1093/humrep/del446	88	5	5	0	1	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2922-2; 978-0-8261-7162-7	ANNU REV NURS RES-SE			2015	33						75	109		10.1891/0739-6686.33.75			35	Nursing	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Nursing	BI5YI	WOS:000412973800005	25946384				2022-02-06	
J	Raggi, A; Covelli, V; Leonardi, M; Meucci, P; Scaratti, C; Schiavolin, S; Willems, M; Sattin, D				Raggi, A.; Covelli, V.; Leonardi, M.; Meucci, P.; Scaratti, C.; Schiavolin, S.; Willems, M.; Sattin, D.			Determinants of disability using count-based approaches to ICF-based definition of neurological disability	NEUROREHABILITATION			English	Article						Disability; ICF classification; mental functions; mobility; barriers	INTERNATIONAL CLASSIFICATION; FUNCTIONAL PROFILES; PARKINSONS-DISEASE; MYASTHENIA-GRAVIS; PENSION; POPULATION; MIGRAINE	INTRODUCTION: The aim of this study was to explore the most relevant determinants of severe disability in a heterogeneous sample of patients with neurological conditions. OBJECTIVES: We used data from previous studies on patients with myasthenia gravis (MG), migraine, Parkinson's disease (PD), multiple sclerosis, traumatic brain injury (TBI), stroke and epilepsy (349 patients, aged 18-74 years; mean 48.0, SD 11.7). We calculated count-based extension indexes to address severe disability, and hierarchical logistic regression to assess the association between severe disability, sociodemographic and health status information. CONCLUSIONS: Results show that sociodemographic variables played a minor role, while health state information was a stronger determinant of severe disability. Compared to the reference value of TBI patients, those with MG, PD and epilepsy had higher odds to have severe difficulties undertaking daily activities despite the presence of environmental factors. Our results contrast with those of previous studies, mostly derived from general populations, showing the different impact of clinical and sociodemographic variables.	[Raggi, A.; Covelli, V.; Leonardi, M.; Meucci, P.; Scaratti, C.; Schiavolin, S.; Willems, M.; Sattin, D.] Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, I-20133 Milan, Italy		Raggi, A (corresponding author), Neurol Inst C Besta IRCCS Fdn, Neurol Publ Hlth & Disabil Unit, Via Celoria 11, I-20133 Milan, Italy.	araggi@istituto-besta.it	Sattin, Davide/K-5963-2016; Raggi, Alberto/K-5787-2016; COVELLI, VENUSIA/AAG-9232-2020; Scaratti, Chiara/K-5196-2018; leonardi, matilde/J-9997-2018; Schiavolin, Silvia/K-6595-2016	Sattin, Davide/0000-0001-7736-4337; Raggi, Alberto/0000-0002-7433-7779; COVELLI, VENUSIA/0000-0002-5965-2658; Scaratti, Chiara/0000-0002-6664-4787; leonardi, matilde/0000-0003-0552-8923; Schiavolin, Silvia/0000-0002-5391-7539			Almansa J, 2011, J CLIN EPIDEMIOL, V64, P1400, DOI 10.1016/j.jclinepi.2011.03.005; Bruusgaard D, 2010, SCAND J PUBLIC HEALT, V38, P686, DOI 10.1177/1403494810378916; Cerniauskaite M, 2012, AM J PHYS MED REHAB, V91, pS22, DOI 10.1097/PHM.0b013e31823d4d6f; Goljar N, 2010, DISABIL REHABIL, V32, pS50, DOI 10.3109/09638288.2010.517598; Johansson E, 2012, J EPIDEMIOL COMMUN H, V66, P901, DOI 10.1136/jech-2011-200317; Leonardi M, 2010, DISABIL REHABIL, V32, pS23, DOI 10.3109/09638288.2010.511687; Leonardi M, 2009, DISABIL REHABIL, V31, P2041, DOI 10.3109/09638280902893634; Leonardi M, 2009, INT J REHABIL RES, V32, P167, DOI 10.1097/MRR.0b013e32831e4587; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Raggi A, 2015, NEUROREHABILITATION, V36, P17, DOI 10.3233/NRE-141186; Raggi A, 2014, INT J REHABIL RES, V37, P180, DOI 10.1097/MRR.0000000000000054; Raggi A, 2011, INT J REHABIL RES, V34, P141, DOI 10.1097/MRR.0b013e328344ae09; Raggi A, 2010, DISABIL REHABIL, V32, pS33, DOI 10.3109/09638288.2010.511688; Raggi A, 2010, INT J REHABIL RES, V33, P225, DOI 10.1097/MRR.0b013e3283375e53; Stover M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-148; Svestkova O, 2010, DISABIL REHABIL, V32, pS59, DOI 10.3109/09638288.2010.511689; Svestkova O, 2010, DISABIL REHABIL, V32, pS68, DOI 10.3109/09638288.2010.511690; World Health Organization, 2007, INT CLASS FUNCT DIS; Yoshida D, 2012, J EPIDEMIOL, V22, P222, DOI 10.2188/jea.JE20110083	19	5	5	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	1					23	29		10.3233/NRE-141187			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CB0OT	WOS:000349326700005	25547763				2022-02-06	
J	Rehman, R; Kelly, PR; Husain, AM; Tran, TT				Rehman, Rizwana; Kelly, Pamela R.; Husain, Aatif M.; Tran, Tung T.			Characteristics of Veterans diagnosed with seizures within Veterans Health Administration	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						epidemiology; epilepsy; incidence; Operation Enduring Freedom; Operation Iraqi Freedom; Operation New Dawn; posttraumatic stress disorder; prevalence; psychogenic nonepileptic seizures; seizures; traumatic brain injury; VHA health data	PSYCHOGENIC NONEPILEPTIC SEIZURES; TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; NEW-ONSET EPILEPSY; RISK-FACTOR; IRAQ; SURVEILLANCE; AFGHANISTAN; PREVALENCE; CARE	The purpose of this report is to describe the demographics of Veterans diagnosed with seizures and taking antiepileptic drugs (AEDs) within the Veterans Health Administration (VHA) during fiscal year (FY) 2011 (October 1, 2010, to September 30, 2011), particularly with regard to comorbid traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD). Information collected included age; sex; Operation Iraqi Freedom/Operation Enduring Freedom/Operation New Dawn (OIF/OEF/OND) status; and relevant encounter diagnosis codes for seizures, TBI, and PTSD. During FY11, 87,377 Veterans with seizures on AEDs were managed within the VHA. Prevalence was 15.5 per 1,000, and annual incidence was 148.2 per 100,000. The percentages of comorbid TBI and PTSD were 15.8% and 24.1%, respectively. For OIF/OEF/OND Veterans, these percentages increased to 52.6% and 70.4%, respectively. PTSD and TBI are risk factors for both epilepsy and psychogenic nonepileptic seizures. Within the VHA, many Veterans experiencing seizures cannot be successfully treated with AEDs. The VHA Epilepsy Centers of Excellence promotes a multidisciplinary approach to increase and improve access to both epilepsy and mental health specialists for the care of epileptic and nonepileptic seizures.	[Rehman, Rizwana; Kelly, Pamela R.; Husain, Aatif M.; Tran, Tung T.] Durham Dept Vet Affairs Med Ctr, Southeast Epilepsy Ctr Excellence, Durham, NC USA; [Husain, Aatif M.; Tran, Tung T.] Duke Univ, Med Ctr, Durham, NC USA		Rehman, R (corresponding author), Durham VA Med Ctr, Southeast Epilepsy Ctr Excellence, Dept Med 111D, 508 Fulton St, Durham, NC 27705 USA.	rizwana.rehman@va.gov	Husain, Aatif/AAN-7058-2021		VHA Neurology Program Office	This material was based on work supported by the VHA Neurology Program Office.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2006, NEUR DIS PUBL HLTH C; Armed Forces Health Surveillance Center, 2011, NEUR INT; Bharucha NE, 1997, EPILEPSIA, V38, P614; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Congressional Budget Office, 2012, VET HLTH ADM TREATM; Copeland LA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-84; Dworetzky BA, 2005, EPILEPSIA, V46, P1418, DOI 10.1111/j.1528-1167.2005.13004.x; England MJ, 2012, EP SPECTR PROM HLTH; Epidemiology Program Post-Deployment Health Group Office of Public Health, 2015, EPIDEMIOLOGY PROGRAM; Ettinger AB, 2010, EPILEPSY BEHAV, V17, P70, DOI 10.1016/j.yebeh.2009.10.010; Hamid H, 2013, EPILEPSY BEHAV, V29, P578, DOI 10.1016/j.yebeh.2013.09.025; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holden E Wayne, 2005, Dis Manag, V8, P1, DOI 10.1089/dis.2005.8.1; Holden EW, 2005, EPILEPSIA, V46, P311, DOI 10.1111/j.0013-9580.2005.30604.x; Hopp JL, 2012, NEUROLOGIST, V18, P364, DOI 10.1097/NRL.0b013e31826e8ff5; Jakupcak M, 2009, J TRAUMA STRESS, V22, P303, DOI 10.1002/jts.20423; Kobau Rosemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; LaFrance WC, 2009, EPILEPSY BEHAV, V14, P591, DOI 10.1016/j.yebeh.2009.02.016; Perlin JB, 2004, AM J MANAG CARE, V10, P828; Public Health, 2013, VA HLTH CAR UT REC V; Pugh MJV, 2008, NEUROLOGY, V70, P2171, DOI 10.1212/01.wnl.0000313157.15089.e6; Pugh MJV, 2007, INT REV NEUROBIOL, V81, P221, DOI 10.1016/S0074-7742(06)81014-7; Pugh MJV, 2015, J HEAD TRAUMA REHAB, V30, P29, DOI 10.1097/HTR.0000000000000045; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salinsky M, 2011, NEUROLOGY, V77, P945, DOI 10.1212/WNL.0b013e31822cfc46; Storzbach D., 2013, VA EVIDENCE BASED SY; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; U.S. Institute of Medicine Committee on Gulf War and Health, 2009, GULF WAR HLTH, V7; [No title captured]	31	5	5	0	3	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2015	52	7					751	762		10.1682/JRRD.2014.10.0241			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CY3RG	WOS:000366326700001	26745205	Bronze			2022-02-06	
J	Roberts, BR; Hare, DJ; McLean, CA; Conquest, A; Lind, M; Li, QX; Bush, AI; Masters, CL; Morganti-Kossmann, MC; Frugier, T				Roberts, Blaine R.; Hare, Dominic J.; McLean, Catriona A.; Conquest, Alison; Lind, Monica; Li, Qiao-Xin; Bush, Ashley I.; Masters, Colin L.; Morganti-Kossmann, Maria-Christina; Frugier, Tony			Traumatic brain injury induces elevation of Co in the human brain	METALLOMICS			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HEAD-INJURY; SPECTROMETRY; ELEMENTS; DISEASE; IRON; ZINC	Traumatic brain injury (TBI) is the most common cause of death and disability in young adults, yet the molecular mechanisms that follow TBI are poorly understood. We previously reported a perturbation in iron (Fe) levels following TBI. Here we report that the distribution of cobalt (Co) is modulated in post-mortem human brain following injury. We also investigated how the distribution of other biologically relevant elements changes in TBI. Cobalt is increased due to TBI while copper (Cu), magnesium(Mg), manganese (Mn), phosphorus (P), potassium (K), rubidium (Rb), selenium(Se) and zinc (Zn) remain unchanged. The elevated Co has important implications for positron emission tomography neuroimaging. This is the first demonstration of the accumulation of Co in injured tissue explaining the previous utility of Co-55-PET imaging in TBI.	[Roberts, Blaine R.; Hare, Dominic J.; Lind, Monica; Li, Qiao-Xin; Bush, Ashley I.; Masters, Colin L.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging Facil, Broadway, NSW, Australia; [McLean, Catriona A.; Frugier, Tony] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic, Australia; [Conquest, Alison; Frugier, Tony] Alfred Hosp, Natl Trauma Inst, Melbourne, Vic, Australia; [Frugier, Tony] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3031, Australia		Frugier, T (corresponding author), Alfred Hosp, Dept Anat Pathol, Melbourne, Vic, Australia.	tony.frugier@unimelb.edu.au	Bush, Ashley/Y-2457-2019; Hare, Dominic/H-2481-2011; Bush, Ashley I/A-1186-2007	Bush, Ashley/0000-0001-8259-9069; Hare, Dominic/0000-0002-5922-7643; Bush, Ashley I/0000-0001-8259-9069; Frugier, Tony/0000-0002-1275-5158; Roberts, Blaine/0000-0001-5466-0053; Masters, Colin/0000-0003-3072-7940	Victorian Neurotrauma Initiative; National Trauma Research Institute; University of MelbourneUniversity of Melbourne; Florey Institute of Neuroscience and Mental Health; Victorian Institute of Forensic Medicine; National Health & Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Victorian Government's Operational Infrastructure Support Program; Victorian Neurotrauma Initiative, Neurosciences Australia	This study was supported by the Victorian Neurotrauma Initiative. Brain tissues were obtained from the Victorian Brain Bank Network, supported by The National Trauma Research Institute, The University of Melbourne, The Florey Institute of Neuroscience and Mental Health, The Victorian Institute of Forensic Medicine and funded by the Victorian Neurotrauma Initiative, Neurosciences Australia, the National Health & Medical Research Council of Australia and the Victorian Government's Operational Infrastructure Support Program.	ANDERSEN NEO, 1989, J CEREBR BLOOD F MET, V9, P381, DOI 10.1038/jcbfm.1989.57; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Birch CS, 2009, FREE RADICAL BIO MED, V47, P184, DOI 10.1016/j.freeradbiomed.2009.04.023; De Reuck J, 2001, J NEUROL SCI, V193, P1, DOI 10.1016/S0022-510X(01)00606-2; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Hu Y, 1998, ANAL CHIM ACTA, V373, P95, DOI 10.1016/S0003-2670(98)00399-7; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jansen HML, 1996, J NEUROL NEUROSUR PS, V60, P221, DOI 10.1136/jnnp.60.2.221; JANSEN HML, 1994, J NUCL MED, V35, P456; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; LARSEN N A, 1979, Journal of the Neurological Sciences, V42, P407, DOI 10.1016/0022-510X(79)90173-4; Moreira ES, 2011, FREE RADICAL BIO MED, V51, P876, DOI 10.1016/j.freeradbiomed.2011.05.034; PARR RM, 1964, BIOCHEM J, V91, P424, DOI 10.1042/bj0910424; Rajan MT, 1997, J NEUROL SCI, V146, P153, DOI 10.1016/S0022-510X(96)00300-0; RELMAN ARNOLD S., 1956, YALE JOUR BIOL AND MED, V29, P248; Scalabrino G, 2009, J NEUROCHEM, V111, P1309, DOI 10.1111/j.1471-4159.2009.06417.x; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Veasey SC, 2013, SLEEP, V36, P1471, DOI 10.5665/sleep.3038; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25	21	5	5	0	7	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1756-5901	1756-591X		METALLOMICS	Metallomics		2015	7	1					124	128		10.1039/c4mt00258j			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AX4JM	WOS:000346899100013	25424382	hybrid, Green Published			2022-02-06	
J	Roth, CR; Cornis-Pop, M; Beach, WA				Roth, Carole R.; Cornis-Pop, Micaela; Beach, Woodford A.			Examination of validity in spoken language evaluations: Adult onset stuttering following mild traumatic brain injury	NEUROREHABILITATION			English	Article						Adult onset stuttering; mild traumatic brain injury; psychogenic disorder; rehabilitation	POSTTRAUMATIC-STRESS-DISORDER; DIFFERENTIAL-DIAGNOSIS; SPEECH; THERAPY	BACKGROUND: Reports of increased incidence of adult onset stuttering in veterans and service members with mild traumatic brain injury (mTBI) from combat operations in Iraq and Afghanistan lead to a reexamination of the neurogenic vs. psychogenic etiology of stuttering. OBJECTIVE: This article proposes to examine the merit of the dichotomy between neurogenic and psychogenic bases of stuttering, including symptom exaggeration, for the evaluation and treatment of the disorder. METHODS: Two case studies of adult onset stuttering in service members with mTBI from improvised explosive device blasts are presented in detail. Speech fluency was disrupted by abnormal pauses and speech hesitations, brief blocks, rapid repetitions, and occasional prolongations. There was also wide variability in the frequency of stuttering across topics and conversational situations. Treatment focused on reducing the frequency and severity of dysfluencies and included educational, psychological, environmental, and behavioral interventions. RESULTS: Stuttering characteristics as well as the absence of objective neurological findings ruled out neurogenic basis of stuttering in these two cases and pointed to psychogenic causes. However, the differential diagnosis had only limited value for developing the plan of care. CONCLUSIONS: The successful outcomes of the treatment serve to illustrate the complex interaction of neurological, psychological, emotional, and environmental factors of post-concussive symptoms and to underscore the notion that there are many facets to symptom presentation in post-combat health.	[Roth, Carole R.] Naval Med Ctr San Diego, Speech Pathol Div, San Diego, CA USA; [Cornis-Pop, Micaela] Vet Hlth Adm, Rehabil Serv, Washington, DC USA; [Cornis-Pop, Micaela] Vet Hlth Adm, Prosthet Serv, Washington, DC USA; [Beach, Woodford A.] Virginia Commonwealth Univ, Med Ctr, Dept Speech Pathol, Richmond, VA 23284 USA		Beach, WA (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Speech Pathol, Richmond, VA 23284 USA.	wabeach@verizon.net					ANDREWS G, 1974, J SPEECH HEAR DISORD, V39, P312, DOI 10.1044/jshd.3903.312; ANDY OJ, 1992, BRAIN LANG, V42, P385, DOI 10.1016/0093-934X(92)90075-P; Baumgartner J., 1997, J MED SPEECH-LANG PA, V5, P75; BAUMGARTNER JM, 1999, STUTTERING RELATED D, P269; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Binder LM, 2012, ARCH CLIN NEUROPSYCH, V27, P557, DOI 10.1093/arclin/acs051; Bluemel C. S., 1935, STUTTERING ALLIED DI; Breuer J., 1936, NERVOUS MENTAL DIS M, V61; byWilliams D. E., 1978, DIAGNOSTIC METHODS S, P431; CANTER GJ, 1971, BRIT J DISORD COMMUN, V6, P139; Clifford S., 1978, AM SPEECH HEAR ASS R; CRAIG AR, 1984, BRIT J MED PSYCHOL, V57, P173, DOI 10.1111/j.2044-8341.1984.tb01597.x; De Nil L., 2007, STUTTERING RELATED D, P326; Deal J., 1991, TREATING DISORDERED, P217; DEAL JL, 1987, J SPEECH HEAR DISORD, V52, P299, DOI 10.1044/jshd.5203.299; DEAL JL, 1982, J SPEECH HEAR DISORD, V47, P301, DOI 10.1044/jshd.4703.301; DEMPSEY GL, 1978, INT J CLIN EXP HYP, V26, P125, DOI 10.1080/00207147808409313; Duffy J. R., 2009, GRAND ROUNDS TRAUM B; Duffy JR., 2013, MOTOR SPEECH DISORDE; Hathaway SR, 1940, J PSYCHOL, V10, P249, DOI 10.1080/00223980.1940.9917000; Head H, 1922, Br Med J, V1, P827; HELM NA, 1978, NEUROLOGY, V28, P1159, DOI 10.1212/WNL.28.11.1159; Helm-Estabrooks N, 1999, STUTTERING RELATED D, P255; HELMESTABROOKS N, 1986, ATYPICAL STUTTERER P, P193; Herer R. J., 1996, ENT-EAR NOSE THROAT, V75, P161; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jokel R, 2007, J MED SPEECH-LANG PA, V15, P243; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; LEBRUN Y, 1987, ACTA NEUROCHIR, V85, P103, DOI 10.1007/BF01456105; LUDLOW CL, 1987, ANN NEUROL, V22, P60, DOI 10.1002/ana.410220114; MAHR G, 1992, J SPEECH HEAR RES, V35, P283, DOI 10.1044/jshr.3502.283; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Ornstein A., 1983, J COMMUN DISORD, V18, P313; Parrish C., 2009, SIG 2 PERSPECTIVES N, V19, P47, DOI [DOI 10.1044/NNS1D19.2.47, 10.1044/nnsld19.2.47, DOI 10.1044/NNSLD19.2.47]; Quesal R. W., 2010, OASES OVERALL ASSESS; Riley G.D., 2009, STUTTERING SEVERITY; Ringo C. C., 1995, J MED SPEECH-LANG PA, V3, P111; ROSENBEK J, 1978, BRAIN LANG, V6, P82, DOI 10.1016/0093-934X(78)90046-9; ROSENBLUTH J, 1984, NODE RANVIER, P31; Roth C., 2011, NAV MAR CORPS COMB O; Roth C. R., 2011, AM SPEECH LANG HEAR; ROTH CR, 1989, J SPEECH HEAR DISORD, V54, P634, DOI 10.1044/jshd.5404.634; SAPIR S, 1990, J SPEECH HEAR DISORD, V55, P503, DOI 10.1044/jshd.5503.503; Seery CH, 2005, AM J SPEECH-LANG PAT, V14, P284, DOI 10.1044/1058-0360(2005/028); The Stuttering Foundation, 2011, STUTT FDN PUBL, V2nd; TIPPETT DC, 1991, J FLUENCY DISORD, V16, P3, DOI 10.1016/0094-730X(91)90031-7; Victor T. L., 2013, MILD TRAUMATIC BRAIN, P231; WALLEN V, 1961, J SPEECH HEAR DISORD, V26, P394, DOI 10.1044/jshd.2604.394; Woodcock R.W., 2007, WOODCOCK JOHNSON 3 T, V2nd; WOOLF G, 1967, BRIT J DISORD COMMUN, V2, P158; [No title captured]	51	5	5	0	21	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2015	36	4					415	426		10.3233/NRE-151230			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CN8YP	WOS:000358732300004	26409490				2022-02-06	
J	Slusarz, R; Jablonska, R; Krolikowska, A; Haor, B; Barczykowska, E; Biercewicz, M; Glowacka, M; Szrajda, J				Slusarz, Robert; Jablonska, Renata; Krolikowska, Agnieszka; Haor, Beata; Barczykowska, Ewa; Biercewicz, Monika; Glowacka, Mariola; Szrajda, Justyna			Measuring scales used for assessment of patients with traumatic brain injury: multicenter studies	PATIENT PREFERENCE AND ADHERENCE			English	Article						head trauma; assessment tools; numeric scales	GLASGOW COMA SCALE; QUALITY-OF-LIFE; PRACTICAL SCALE; AGE	Background: Application of adequate numeric scales is essential for assessment of a patient's condition. The scales most commonly used by the therapeutic team for assessment of a patient with traumatic brain injury (TBI) include deficit scales, functional scales, and scales assessing quality of life. The purpose of this study was to establish the relationships between the particular scales used for assessment of patients with TBI. Methods: This multicenter study included 159 patients with TBI. The direct observation technique was used. Two measurements were made (at hospital admission and discharge) using standardized assessment scales, ie, the Glasgow Coma Scale (GCS), the Functional Capacity Scale (FCS), the Functional Index "Repty" (FIR), and the Glasgow Outcome Scale. Results: Patients with mild impairment of consciousness were most numerous in the examined group at both admission and discharge, ie, 118 (78.8%) and 134 patients (89.3%), respectively. The mean score for functional capacity measured with the FCS was 34.41 points (71.7%) on the day of admission and 41.87 points (87.2%) on the day of discharge from hospital. A significant correlation was found between results obtained using the GCS and results on the FIR, on both the day of admission [R t(n-2) =7.612=0.530; P=0.00] and the day of discharge [R t(n-2) =8.998=0.595; P=0.00]. Further, a high correlation was found between the FCS and the FIR (r(s)=-0.854 on day of admission and r(s)=-0.840 on day of discharge). Conclusion: The majority of examined patients had mild impairment of consciousness. A moderate correlation was found between the GCS and the scales assessing activities of daily living. A high correlation was found between FCS and FIR, which may result from the similarities between the analyzed tools in the scope of their construction and application.	[Slusarz, Robert; Jablonska, Renata; Krolikowska, Agnieszka; Haor, Beata] Nicholas Copernicus Univ, Neurol & Neurosurg Nursing Dept, Coll Med, Torun, Poland; [Barczykowska, Ewa; Glowacka, Mariola] Nicholas Copernicus Univ, Dept Nursing, Coll Med, Torun, Poland; [Biercewicz, Monika] Nicholas Copernicus Univ, Clin Geriatr, Coll Med, Torun, Poland; [Szrajda, Justyna] Nicholas Copernicus Univ, Dept Hyg & Epidemiol, Coll Med, Torun, Poland		Slusarz, R (corresponding author), Nicholas Copernicus Univ, Neurol & Neurosurg Nursing Dept, Coll Med, Ul Technikow 3, PL-85094 Bydgoszcz, Poland.	zpielnin@cm.umk.pl			Clinical Nursing Department, Collegium Medicum, Nicolaus Copernicus University, Torun, Poland [953/2014]	Scientific activity of the Clinical Nursing Department, Collegium Medicum, Nicolaus Copernicus University, Torun, Poland (grant 953/2014). The authors would like to thank those who have contributed to this research. In particular, they are grateful to the nurses in the process of data collection, and to Roksana Rybicka, Senior Lecturer in the Applied Linguistics Department, for her support and valuable suggestions.	Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Cardarelli R, 2007, J AM OSTEOPATH ASSOC, V107, P299; Ciesielska N, 2013, J HEALTH SCI, V3, P393; Cipolle Mark D, 2014, Del Med J, V86, P237; Settervall CHC, 2012, ACTA PAUL ENFERM, V25, P364, DOI 10.1590/S0103-21002012000300008; Engberg Aase Worsaae, 2007, Ugeskr Laeger, V169, P199; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Jagnoor J, 2014, AUST FAM PHYSICIAN, V43, P758; JENNETT B, 1975, LANCET, V1, P480; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Kazmierczak K, 2011, NOWINY LEK, V80, P288; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; lusarz R, 2012, J NEUROLOGICAL NEURO, V1, P35; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Opara J A, 2014, J Med Life, V7, P124; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Potts MB, 2008, ACTA NEUROCHIR SUPPL, V102, P109, DOI 10.1007/978-3-211-85578-2_22; Rutkowska M, 2010, MEDYCYNA OGOLNA, V16, P192; Slusarz R, 2014, J NEUROSCI NURS, V46, P46, DOI 10.1097/JNN.0000000000000028; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; TEASDALE G, 1974, LANCET, V2, P81; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Wilmowska-Pietruszynska A., 2010, ORZECZNICTWO LEKARSK, V7, P1	25	5	5	0	3	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-889X			PATIENT PREFER ADHER	Patient Prefer. Adherence		2015	9									10.2147/PPA.S83551			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM2ST	WOS:000357533100001	26170636	Green Published, gold			2022-02-06	
J	Sun, CM; Shen, L; Li, XT; Liu, CJ; Zhou, YX				Sun, Chunming; Shen, Liang; Li, Xuetao; Liu, Chuanjin; Zhou, Youxin			Risk of pneumonia in central nervous system injury with alcohol intake: a meta-analysis	INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Central nervous system; pneumonia; alcohol; meta-analysis	TRAUMATIC BRAIN-INJURY; INTOXICATION; MORTALITY; COMPLICATIONS; HETEROGENEITY; SEVERITY; OUTCOMES; ABUSE	Objective: Central nervous system (CNS) injury can increased the risk of secondary mortality because of its late inflammatory complications. Alcohol intake increases the risk of damage and complications subsequent to a (CNS) injury. How about the risk of pneumonia after CNS injury under the effect of alcoholic drink? Though animal trails of material prosperity and studies for human have been investigated in recent decades, the outcome maintains poor understanding. Pneumonia is one of the serious complication at the time of hospitalization and it should be known as more as possible for steadying patient conditions in intensive care unit and shortening length of stay. Thus, we conducted a meta-analysis of published materials to assess the association between alcohol intake and pneumonia in CNS injury. Methods: Two authors searched the PUBMED, EMBASE, Cochrane Library, and web of science up to September, 2014 for published literatures without any limitations. Reference lists from identified studies were also screened carefully by us for additional data. The summary relative risks (RRs) and 95% confidence intervals (CI) were calculated by statistical analysis software (Stata 12.0) with fixed-effects models to estimate the risk. Result: The results indicated that a higher incidence of pneumonia was found in CNS injury under the influence of alcohol (RR = 1.32, 95% CI = 1.21-1.43), and the risk has no relation to blood alcohol concentration (BAC) (BAC >= 80 mg/dl vs < 80 mg/dl, BAC >= 100 mg/dl vs < 100 mg/dl). Conclusion: Traumatic brain injury (TBI) and spinal cord injury patients who are under the influence of alcoholic drink have a higher risk of pneumonia.	[Sun, Chunming; Shen, Liang; Li, Xuetao; Liu, Chuanjin; Zhou, Youxin] Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, Suzhou 215006, Jiangsu, Peoples R China		Zhou, YX (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Neurosurg, 188 Shizi Rd, Suzhou 215006, Jiangsu, Peoples R China.	Z_youxin@163.com					ANDERSEN JA, 1990, J TRAUMA, V30, P415, DOI 10.1097/00005373-199030040-00007; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Boe DM, 2003, ALCOHOL CLIN EXP RES, V27, P1838, DOI 10.1097/01.ALC.0000095634.82310.53; Burnham EL, 2010, ALCOHOL ALCOHOLISM, V45, P414, DOI 10.1093/alcalc/agq045; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; Christensen M A, 2001, J Neurosci Nurs, V33, P184; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Crutcher CL, 2014, J NEUROTRAUM, V31, P798, DOI 10.1089/neu.2014.3329; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Friedman LS, 2014, ALCOHOL, V48, P391, DOI 10.1016/j.alcohol.2014.01.008; Gandini S, 2011, EUR J CANCER, V47, P2607, DOI 10.1016/j.ejca.2011.04.023; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jawa RS, 2014, AM J SURG, V208, P781, DOI 10.1016/j.amjsurg.2014.04.007; Levy RS, 1996, J ORTHOP TRAUMA, V10, P21, DOI 10.1097/00005131-199601000-00004; Mehta AJ, 2012, AM J MED SCI, V343, P244, DOI 10.1097/MAJ.0b013e31823ede77; Osler T, 2012, ARCH SURG-CHICAGO, V147, P152, DOI 10.1001/archsurg.2011.888; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Porter RS, 2000, PEDIATR EMERG CARE, V16, P316, DOI 10.1097/00006565-200010000-00003; QUATTROCCHI K B, 1990, Journal of Neurotrauma, V7, P77, DOI 10.1089/neu.1990.7.77; Raasch CE, 2010, ALCOHOL CLIN EXP RES, V34, P2035, DOI 10.1111/j.1530-0277.2010.01291.x; Rootman DB, 2007, J TRAUMA, V62, P755, DOI 10.1097/TA.0b013e318031aa7f; Salim A, 2009, J TRAUMA, V67, P697, DOI 10.1097/TA.0b013e3181b5dcf2; Samokhvalov AV, 2010, EPIDEMIOL INFECT, V138, P1789, DOI 10.1017/S0950268810000774; Shih HC, 2003, AM J EMERG MED, V21, P91, DOI 10.1053/ajem.2003.50025; Siggins RW, 2011, J IMMUNOL, V186, P4306, DOI 10.4049/jimmunol.1002885; Spies CD, 1998, ALCOHOL ALCOHOLISM, V33, P661, DOI 10.1093/alcalc/33.6.661; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Vaaramo K, 2014, ACTA NEUROL SCAND, V129, P56, DOI 10.1111/ane.12150; Wang HE, 2011, PREHOSP EMERG CARE, V15, P338, DOI 10.3109/10903127.2011.569850; Wells G.S.B., 2012, NEWCASTLE OTTAWA SCA; Yaghoubian A, 2009, AM SURGEON, V75, P950; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048	35	5	5	0	6	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1940-5901			INT J CLIN EXP MED	Int. J. Clin. Exp. Med.		2015	8	9					15738	15744					7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DA6JX	WOS:000367911200083	26629070				2022-02-06	
J	Sveen, U; Andelic, N; Bautz-Holter, E; Roe, C				Sveen, Unni; Andelic, Nada; Bautz-Holter, Erik; Roe, Cecilie			Self-reported competency - validation of the Norwegian version of the patient competency rating scale for traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Activities of daily living; cognition; Patient Competency Rating Scale; psychometrics; questionnaires; traumatic brain injury	POST-CONCUSSION SYMPTOMS; RASCH MEASUREMENT MODEL; STRUCTURED INTERVIEWS; IMPAIRED AWARENESS; DAILY-LIFE; CONSCIOUSNESS; INDIVIDUALS; RELIABILITY; GUIDELINES; SEVERITY	Purpose: To evaluate the psychometric properties of the Norwegian version of the Patient Competency Rating Scale (PCRS) in patients with traumatic brain injury (TBI) at 12 months post-injury. Methods: Demographic and injury-related data were registered upon admission to the hospital in 148 TBI patients with mild, moderate, or severe TBI. At 12 months post-injury, competency in activities and global functioning were measured using the PCRS patient version and the Glasgow Outcome Scale-Extended (GOSE). Descriptive reliability statistics, factor analysis and Rasch modeling were applied to explore the psychometric properties of the PCRS. External validity was evaluated using the GOSE. Results: The PCRS can be divided into three subscales that reflect interpersonal/emotional, cognitive, and activities of daily living competency. The three-factor solution explained 56.6% of the variance in functioning. The internal consistency was very good, with a Cronbach's alpha of 0.95. Item 30, "controlling my laughter", did not load above 0.40 on any factors and did not fit the Rasch model. The external validity of the subscales was acceptable, with correlations between 0.50 and 0.52 with the GOSE. Conclusion: The Norwegian version of the PCRS is reliable, has an acceptable construct and external validity, and can be recommended for use during the later phases of TBI.	[Sveen, Unni; Andelic, Nada; Bautz-Holter, Erik; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0424 Oslo, Norway; [Sveen, Unni] Fac Hlth Sci, Oslo, Norway; [Sveen, Unni] Akershus Univ Coll, Oslo, Norway; [Andelic, Nada] Univ Oslo, Res Ctr Habilitat & Rehabil Models & Serv CHARM, Fac Med, Inst Hlth & Soc, Oslo, Norway		Sveen, U (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, POB 4950 Nydalen, N-0424 Oslo, Norway.	Unni.sveen@hioa.no		Andelic, Nada/0000-0002-3719-4406	Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Norway	The study was funded by the Department of Physical Medicine and Rehabilitation, Oslo University Hospital, Norway. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the article.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Andrich D., 1988, RASCH MODELS MEASURE; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Garcia-Molina A, 2013, MED CLIN-BARCELONA, V140, P527, DOI 10.1016/j.medcli.2012.09.047; Garcia-Molina A, 2010, PSICOTHEMA, V22, P430; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P161, DOI 10.1080/09602010802188393; Haws NA, 2013, APPL NEUROPSYCHOL AD; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; Hoofien D, 2006, ISR J PSYCHIATR REL, V43, P296; Joliffe I T, 1992, Stat Methods Med Res, V1, P69, DOI 10.1177/096228029200100105; Kolakowsky-Hayner S., 2010, PATIENT COMPETENCY R; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pallant JF, 2007, BRIT J CLIN PSYCHOL, V46, P1, DOI 10.1348/014466506X96931; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; SHERIN RJ, 1966, PSYCHOMETRIKA, V31, P535, DOI 10.1007/BF02289522; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Sveen U, 2010, SCAND J OCCUP THER, V17, P225, DOI 10.3109/11038120903171295; TEASDALE G, 1974, LANCET, V2, P81; Tennant A, 2004, VALUE HEALTH, V7, pS22, DOI 10.1111/j.1524-4733.2004.7s106.x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Wallace CA, 2000, BRAIN INJURY, V14, P549; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; World Health Organization, 2007, INT CLASS FUNCT DIS	41	5	5	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2015	37	3					239	246		10.3109/09638288.2014.913706			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	CA3EP	WOS:000348789500007	24773117				2022-02-06	
J	Tlustos, SJ; Chiu, CYP; Walz, NC; Wade, SL				Tlustos, Sarah J.; Chiu, C. Y. Peter; Walz, Nicolay C.; Wade, Shari L.			Neural substrates of inhibitory and emotional processing in adolescents with traumatic brain injury	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Childhood brain disorder; brain imaging; executive functions; head injury; emotion; adolescence		PURPOSE: Disturbances of emotional regulation and social difficulties are common in children and adolescents with traumatic brain injury (TBI). Recent research suggests that developments within "socio-emotional" brain systems during early adolescence and more protracted development of "cognitive control" systems have implications for emotional and behavioral regulation during adolescence. However, few functional neuroimaging studies have directly examined the interaction of these neuropsychological processes in adolescents with TBI. The current study examined how affective processing might modulate inhibitory processing in an Emotional Go/NoGo paradigm. METHOD: The study uses a cross-sectional, age, gender, and maternal education matched design. A response inhibition paradigm (i.e., the Go/NoGo task with emotional faces) was used to examine emotional-cognition interaction in 11 adolescents with complicated mild to moderate TBI, at least 12 months post injury, and 14 typically-developing (TD) adolescents using functional magnetic resonance imaging (fMRI). Participants saw adult facial expressions of emotions (happy, sad, fearful, and angry) and were instructed to respond ("go") on all expressions other than angry ("no-go"). RESULTS: Preliminary results (p = 0.001 uncorrected, cluster size = 50) showed higher levels of inhibition-related activation in TD adolescents than in adolescents with TBI in several brain regions including anterior cingulate and motor/premotor regions. CONCLUSION: These results suggest that TBI in adolescence might alter brain activation patterns and interrupt the development of brain networks governing emotion-cognition interactions.	[Tlustos, Sarah J.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Chiu, C. Y. Peter] Univ Cincinnati, Dept Psychol, Edwards One Room 4150F,ML 0376, Cincinnati, OH 45221 USA; [Chiu, C. Y. Peter] Univ Cincinnati, Dept Commun Sci & Disorders, Cincinnati, OH USA; [Walz, Nicolay C.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Walz, Nicolay C.; Wade, Shari L.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Wade, Shari L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Phys Med & Rehabil, Cincinnati, OH 45229 USA		Chiu, CYP (corresponding author), Univ Cincinnati, Dept Psychol, Edwards One Room 4150F,ML 0376, Cincinnati, OH 45221 USA.	peter.chiu@uc.edu			NIH from the National Institute of Mental Health [RO1-MH073764]; National Institute on Disability and Rehabilitation Research in the Department of Education [H1336050239]; Ohio Department of Public Safety; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH073764] Funding Source: NIH RePORTER	This work was supported in part by 1) NIH grant RO1-MH073764 from the National Institute of Mental Health; 2) H1336050239 from the National Institute on Disability and Rehabilitation Research in the Department of Education, and 3) EMS/Trauma grant from the Ohio Department of Public Safety. The information in this manuscript is an original contribution to the literature and has not previously been published, electronically or in print. The order of the first two authors was determined by a coin toss. We wish to thank Krista Lisdahl Medina, Ph.D. and Jeff Epstein, Ph.D. for their many helpful comments on earlier drafts of this manuscript.	Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Badgaiyan RD, 1998, NEUROIMAGE, V7, P255, DOI 10.1006/nimg.1998.0326; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Blakemore SJ, 2006, J CHILD PSYCHOL PSYC, V47, P296, DOI 10.1111/j.1469-7610.2006.01611.x; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Casey BJ, 2008, ANN NY ACAD SCI, V1124, P111, DOI 10.1196/annals.1440.010; Centers for Disease Control and Prevention, 2010, SURV SUMM MMWR; Chapman LA, 2010, REHABIL PSYCHOL, V55, P48, DOI 10.1037/a0018418; Croker V, 2005, BRAIN INJURY, V19, P787, DOI 10.1080/02699050500110033; Dahl R E, 2001, CNS Spectr, V6, P60; Elliott R, 2000, NEUROREPORT, V11, P1739, DOI 10.1097/00001756-200006050-00028; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Ganesalingam K, 2011, NEUROPSYCHOLOGY, V25, P466, DOI 10.1037/a0022768; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Goldstein M, 2007, NEUROIMAGE, V36, P1026, DOI 10.1016/j.neuroimage.2007.01.056; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Gur RC, 2002, J NEUROSCI METH, V115, P137, DOI 10.1016/S0165-0270(02)00006-7; Guy SC, 2004, BRIEF SR BEHAV RATIN; Hanten G, 2011, NEUROPSYCHOLOGIA, V49, P486, DOI 10.1016/j.neuropsychologia.2010.12.007; Hare TA, 2005, BIOL PSYCHIAT, V57, P624, DOI 10.1016/j.biopsych.2004.12.038; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Kramer ME, 2008, J INT NEUROPSYCH SOC, V14, P424, DOI 10.1017/S1355617708080545; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Luna B, 2004, ANN NY ACAD SCI, V1021, P296, DOI 10.1196/annals.1308.035; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; Nelson EE, 2005, PSYCHOL MED, V35, P163, DOI 10.1017/S0033291704003915; Newsome MR, 2008, NEUROPSYCHOLOGY, V22, P419, DOI 10.1037/0894-4105.22.4.419; Newsome MR, 2013, J INT NEUROPSYCH SOC, V19, P911, DOI 10.1017/S1355617713000817; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Psychology Software Tools Inc, E PRIME; Roberts G, 2013, BIOL PSYCHIAT, V74, P55, DOI 10.1016/j.biopsych.2012.11.004; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sanchez-Carrion R, 2008, NEUROIMAGE, V43, P421, DOI 10.1016/j.neuroimage.2008.08.003; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Schulz KP, 2014, NEUROIMAGE-CLIN, V5, P1, DOI 10.1016/j.nicl.2014.05.016; Schulz KP, 2009, HUM BRAIN MAPP, V30, P2821, DOI 10.1002/hbm.20706; Shafritz KM, 2006, NEUROIMAGE, V31, P468, DOI 10.1016/j.neuroimage.2005.11.053; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Tamm L, 2004, J AM ACAD CHILD PSY, V43, P1430, DOI 10.1097/01.chi.0000140452.51205.8d; Taylor SF, 2007, NEUROSCIENTIST, V13, P160, DOI 10.1177/1073858406298184; Tlustos SJ, 2011, J INT NEUROPSYCH SOC, V17, P181, DOI 10.1017/S1355617710001414; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Warriner Erin M, 2006, Curr Psychiatry Rep, V8, P73, DOI 10.1007/s11920-006-0083-2; Wechsler D, 2003, WECHSLER INTELLIGENC; Wessa M, 2007, AM J PSYCHIAT, V164, P638, DOI 10.1176/appi.ajp.164.4.638; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wilde EA, 2006, J CHILD NEUROL, V21, P769, DOI 10.1177/08830738060210090201; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	59	5	5	1	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2015	8	4					321	333		10.3233/PRM-150350			13	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7LK	WOS:000448290900006	26684072	Green Accepted			2022-02-06	
J	Ulsh, BA				Ulsh, Brant A.			ARE RISKS FROM MEDICAL IMAGING STILL TOO SMALL TO BE OBSERVED OR NONEXISTENT?	DOSE-RESPONSE			English	Article						medical imaging; linear no-threshold hypothesis; radiation risk; atomic bomb survivors; computed tomography	TRAUMATIC BRAIN-INJURY; SOLID CANCER INCIDENCE; ATOMIC-BOMB SURVIVORS; RELATIVE BIOLOGICAL EFFECTIVENESS; POSTTRAUMATIC MALIGNANT GLIOMA; DIAGNOSTIC NUCLEAR-MEDICINE; COMPUTED-TOMOGRAPHY SCANS; RADIATION-EXPOSURE; CHILDHOOD-CANCER; IONIZING-RADIATION	Several radiation-related professional societies have concluded that carcinogenic risks associated with doses below 50-100 mSv are either too small to be detected, or are nonexistent. This is especially important in the context of doses from medical imaging. Radiation exposure to the public from medical imaging procedures is rising around the world, primarily due to increased utilization of computed tomography. Professional societies and advisory bodies consistently recommend against multiplying small doses by large populations to predict excess radiation-induced cancers, in large part because of the potential for sensational claims of health impacts which do not adequately take the associated uncertainties into account. Nonetheless, numerous articles have predicted thousands of future cancers as a result of CT scanning, and this has generated considerable concern among patients and parents. In addition, some authors claim that we now have direct epidemiological evidence of carcinogenic risks from medical imaging. This paper critically examines such claims, and concludes that the evidence cited does not provide direct evidence of low-dose carcinogenicity. These claims themselves have adverse public health impacts by frightening the public away from medically justified exams. It is time for the medical and scientific communities to be more assertive in responding to sensational claims of health risks.	MH Chew & Associates, Livermore, CA 94550 USA		Ulsh, BA (corresponding author), MH Chew & Associates, Livermore, CA 94550 USA.	brant_ulsh@mhchew.com	Ulsh, Brant/S-8924-2017	Ulsh, Brant/0000-0001-6035-7894			Ait-Ali L, 2010, HEART, V96, P269, DOI 10.1136/hrt.2008.160309; American Association of Physicists in Medicine, 2011, AAPM POS STAT RAD RI; ANNEGERS JF, 1979, NEUROSURGERY, V4, P203, DOI 10.1227/00006123-197903000-00001; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; [Anonymous], 2009, RADIAT PROT DOSIM, V135, P137, DOI 10.1093/rpd/ncp107; Anselmi E, 2006, TUMORI J, V92, P175, DOI 10.1177/030089160609200215; Antosh M, 2014, DROSOPHILA MELANOGAS; Aroua A, 2010, 3 EUR IRPA C RAD NUC, P229; ARPS, 2008, LOW DOS RAD; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Bogdanich W, 2010, NY TIMES, pA12; Bogdanich W, 2009, NY TIMES, pA13; Boice JD, 1999, TERATOLOGY, V59, P227, DOI 10.1002/(SICI)1096-9926(199904)59:4<227::AID-TERA7>3.0.CO;2-E; Boutis K, 2013, PEDIATRICS; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2012, RADIOLOGY, V265, P330, DOI 10.1148/radiol.12121248; Brenner DJ, 2011, RADIOLOGY, V261, P193, DOI 10.1148/radiol.11102452; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2001, PEDIATR RADIOL, V31, P389, DOI 10.1007/s002470100480; Brenner DJ, 2001, MED PHYS, V28, P2387, DOI 10.1118/1.1415074; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Brent RL, 2013, SEMIN FETAL NEONATAL; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Brody AS, 2014, THORAX; CARPENTER AV, 1987, AM J PUBLIC HEALTH, V77, P1180, DOI 10.2105/AJPH.77.9.1180; Chen YH, 2012, J NEUROTRAUM, V29, P1328, DOI 10.1089/neu.2011.2235; CHOI NW, 1970, AM J EPIDEMIOL, V91, P467, DOI 10.1093/oxfordjournals.aje.a121158; Cohen M, 2013, J AM COLL RADIOL, V10, P817, DOI 10.1016/j.jacr.2013.03.029; Cuttler JM, 2010, DOSE-RESPONSE, V8, P378, DOI 10.2203/dose-response.10-003.Cuttler; Dauer LT, 2010, RADIAT PROT DOSIM, V140, P103, DOI 10.1093/rpd/ncq141; de Gonzalez AB, 2008, J MED SCREEN, V15, P153, DOI 10.1258/jms.2008.008052; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Dijkstra H, 2010, 3 EUR IRPA C RAD NUC, P275; DiTrapani G, 1996, ITAL J NEUROL SCI, V17, P283, DOI 10.1007/BF01997787; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Donnelly LF, 2001, PEDIATR RADIOL, V31, P388, DOI 10.1007/s002470100479; Doss M, 2013, DOSE-RESPONSE, V11, P480, DOI 10.2203/dose-response.13-005.Doss; Doss M, 2012, DOSE-RESPONSE, V10, P584, DOI 10.2203/dose-response.12-023.Doss; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2012, J AM COLL CARDIOL, V59, P553, DOI 10.1016/j.jacc.2011.08.079; Esz J, 2013, COMMUNICATION; Etard C, 2010, 3 EUR IRPA C RAD NUC, P239; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; FDA, 2010, IN RED UNN RAD EXP M; Fletcher JG, 2013, ABDOM IMAGING, V38, P22, DOI 10.1007/s00261-012-9933-z; Francois P, 2010, ACTA NEUROCHIR, V152, P1755, DOI 10.1007/s00701-010-0730-6; Hall EJ, 2012, BRIT J RADIOL, V85, pE1316, DOI 10.1259/bjr/13739950; Hall EJ, 2003, PEDIATR RADIOL, V33, P815, DOI 10.1007/s00247-003-1021-7; Hall EJ, 2002, PEDIATR RADIOL, V32, P700, DOI 10.1007/S00247-002-0774-8; Hammer GP, 2011, AM J ROENTGENOL, V197, P217, DOI 10.2214/AJR.10.4979; Hammer GP, 2009, RADIAT RES, V171, P504, DOI 10.1667/RR1575.1; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Henry PT, 2000, BRIT J NEUROSURG, V14, P64; HOCHBERG F, 1984, NEUROLOGY, V34, P1511, DOI 10.1212/WNL.34.11.1511; HPS, 2010, RAD RISK PERSP POS P; Hu JF, 1998, CANCER DETECT PREV, V22, P100, DOI 10.1046/j.1525-1500.1998.CDOA22.x; Huda W, 2007, AM J ROENTGENOL, V188, P540, DOI 10.2214/AJR.06.0101; Huda W, 2009, EMERG RADIOL, V16, P335, DOI 10.1007/s10140-009-0801-2; ICRP, 2004, ANN ICRP, V33, P1, DOI [10.1016/S0146-6453(03)00024-1, DOI 10.1016/S0146-6453(03)00024-1]; ICRP, 2005, LOW DOS EXTR RAD REL; Inskip PD, 1998, CANCER CAUSE CONTROL, V9, P109, DOI 10.1023/A:1008861722901; Inskip PD, 1995, EPIDEMIOL REV, V17, P382; Jaffurs D, 2009, PLAST RECONSTR SURG, V124, P1254, DOI 10.1097/PRS.0b013e3181b59d2d; Jenkins-Smith HC, 2009, HEALTH PHYS, V97, P519, DOI 10.1097/HP.0b013e3181ad7eec; Kellerer AM, 2006, HEALTH PHYS, V90, P554, DOI 10.1097/01.HP.0000184917.94232.cd; Khong P-L., 2013, Annals of the ICRP, V42, P9, DOI 10.1016/j.icrp.2012.10.001; Kizilay Z, 2010, PAM MED J, V3, P106; Kuefner MA, 2010, EUR RADIOL, V20, P2917, DOI 10.1007/s00330-010-1873-9; LAND CE, 1980, SCIENCE, V209, P1197, DOI 10.1126/science.7403879; Larson DB, 2011, RADIOLOGY, V259, P793, DOI 10.1148/radiol.11101939; Laskey WK, 2010, JACC-CARDIOVASC IMAG, V3, P517, DOI 10.1016/j.jcmg.2009.11.017; Luckey T.D, 1991, RAD HORMESIS; Lucky T. D., 1980, HORMESIS IONIZING RA; Ma SM, 2013, INT J RADIAT BIOL, V89, P326, DOI 10.3109/09553002.2013.756595; Magnavita N, 2003, NEUROL SCI, V24, P31, DOI 10.1007/s100720300018; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Martin CJ, 2005, BRIT J RADIOL, V78, P14, DOI 10.1259/bjr/31745335; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mayo Clinic, 2013, DISCOVERYS EDGE MAYO; McCollough CH, 2009, AM J ROENTGENOL, V193, P28, DOI 10.2214/AJR.09.2754; Mettler F. A., 2008, HEALTH PHYS, V95, P502, DOI DOI 10.1097/01.HP; Mettler FAJ, 2008, MED EFFECTS IONIZING, P117; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Monteiro GTR, 2006, EUR J CANCER, V42, P917, DOI 10.1016/j.ejca.2005.11.028; Moorthy RK, 2004, SURG NEUROL, V61, P180, DOI 10.1016/S0090-3019(03)00423-3; MR CT Comm Soc Pediat Radiology, 2001, PEDIATR RADIOL, V31, P387; Munley MT, 2011, RADIAT RES, V176, P842, DOI 10.1667/RR2649.1; Muratore CS., 2012, J SURG RES; National Council on Radiation Protection and Measurements (NCRP, 2009, 160 NCRP; *NCRP, 2001, EV LIN NONTHR DOS RE; Phan N, 2012, RADIAT RES, V177, P164, DOI 10.1667/RR2532.1; NRCNA, 2005, HLTH RISKS EXP LOW L; NRCNA, 2012, TRACK RAD EXP MED DI; Nygren C, 2001, CANCER CAUSE CONTROL, V12, P733, DOI 10.1023/A:1011227617256; Oikarinen H, 2009, EUR RADIOL, V19, P1161, DOI 10.1007/s00330-008-1256-7; Ozasa K, 2012, RADIAT RES, V179, pe0040; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; Parker HL, 1931, J AMER MED ASSOC, V97, P0535, DOI 10.1001/jama.1931.02730080027008; Pauwels EKJ, 2011, ACTA RADIOL, V52, P767, DOI 10.1258/ar.2011.100496; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Phan Nghi, 2011, Health Phys, V100, P286, DOI 10.1097/HP.0b013e318205831f; Phillips LE, 2002, NEUROLOGY, V58, P1849, DOI 10.1212/WNL.58.12.1849; Popper KR, 1934, LOGIC SCI DISCOVERY; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Preston-Martin S, 1998, INT J EPIDEMIOL, V27, P579, DOI 10.1093/ije/27.4.579; PRESTONMARTIN S, 1989, CANCER RES, V49, P6137; Redberg F., 2014, NEW YORK TIMES, V31, pA27; Redpath JL, 2006, RADIAT PROT DOSIM, V122, P528, DOI 10.1093/rpd/ncl449; Rehani M. M., 2012, Annals of the ICRP, V41, P154, DOI 10.1016/j.icrp.2012.06.029; Rodrigues D, 2006, BRIT J NEUROSURG, V20, P233, DOI 10.1080/02688690600852431; Ron E, 2003, HEALTH PHYS, V85, P47, DOI 10.1097/00004032-200307000-00011; Ron E, 2002, PEDIATR RADIOL, V32, P739, DOI 10.1007/s00247-002-0803-7; Rothman KJ, 1998, MODERN EPIDEMIOLOGY; Ruhm W, 2007, RADIAT PROT DOSIM, V126, P423, DOI 10.1093/rpd/ncm087; Rutherford GW, 2009, J HEAD TRAUMA REHAB, V24, P468, DOI 10.1097/HTR.0b013e3181c133d2; Sabel M, 1999, J NEUROSURG, V91, P1041, DOI 10.3171/jns.1999.91.6.1041; SAKAI N, 1981, Neurologia Medico-Chirurgica, V21, P329; Salvati M, 2004, TUMORI J, V90, P416, DOI 10.1177/030089160409000410; Sane SM, 2001, AAP NEWS, V18, P183; Sasaki MS, 2008, RADIAT RES, V170, P101, DOI 10.1667/RR1249.1; Sasaki MS, 2006, RADIAT ENVIRON BIOPH, V45, P79, DOI 10.1007/s00411-006-0051-6; SCHLEHOFER B, 1992, CANCER, V69, P2541, DOI 10.1002/1097-0142(19920515)69:10<2541::AID-CNCR2820691025>3.0.CO;2-H; SCHMITT HP, 1983, FORTSCHR NEUROL PSYC, V51, P227, DOI 10.1055/s-2007-1002228; Schulze-Rath R, 2008, RADIAT ENVIRON BIOPH, V47, P301, DOI 10.1007/s00411-008-0171-2; Scott BR., 2008, J AM PHYS SURG, V13, P8; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; Silva CL, 2007, RISK ANAL, V27, P755, DOI 10.1111/j.1539-6924.2007.00919.x; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Smith-Bindman R, 2012, JAMA-J AM MED ASSOC, V307, P2400, DOI 10.1001/jama.2012.5960; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sodickson A, 2013, BRIT MED J, V346, P1; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Sternberg S., 2001, US TODAY; Tabeie F, 2013, HEALTH PHYS, V104, P127, DOI 10.1097/HP.0b013e31826640e9; TAYLOR LS, 1980, HEALTH PHYS, V39, P851, DOI 10.1097/00004032-198012000-00001; The Joint Commission, 2011, SENT EV AL ISS 47 SE, P1; TROOST D, 1984, CLIN NEUROPATHOL, V3, P139; Ulsh BA, 2012, DOSE-RESPONSE, V10, P593, DOI 10.2203/dose-response.12-021.Ulsh; Ulsh BA, 2010, HEALTH PHYS, V99, P747, DOI 10.1097/HP.0b013e3181e32477; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, REPORT GEN ASSEMBLY; UNSCEAR, 2012, UN SCI COMM EFF AT R; UNSCEAR, 2013, BIOL MECH RAD AT LOW; UNSCEAR, 2006, EFF ION RAD VOL 2 SC, VII; Valentin J, 2001, ANN ICRP, V31, P1, DOI [10.1016/S0146-6453(02)00007-6, DOI 10.1016/S0146-6453(02)00007-6]; Walsh L, 2004, RADIAT ENVIRON BIOPH, V43, P225, DOI 10.1007/s00411-004-0263-6; Walsh L, 2004, RADIAT ENVIRON BIOPH, V43, P145, DOI 10.1007/s00411-004-0248-5; Walsh L, 2013, BR MED J; Walsh L, 2013, RADIAT ENVIRON BIOPH, V52, P29, DOI 10.1007/s00411-012-0445-6; Walton D., 1999, ARGUMENTATION, V13, P367, DOI [10.1023/A:1007780012323, DOI 10.1023/A:1007780012323]; Wiest PW, 2002, SEMIN ULTRASOUND CT, V23, P402, DOI 10.1016/S0887-2171(02)90011-9; Wrensch M, 2000, NEUROEPIDEMIOLOGY, V19, P234, DOI 10.1159/000026261; ZAMPIERI P, 1994, J NEURO-ONCOL, V19, P61, DOI 10.1007/BF01051049; Zarembo A, 2009, LOS ANGELES TIMES; Zhou B, 2010, INT J MED SCI, V7, P248; Zondervan RL, 2011, J AM COLL RADIOL, V8, P501, DOI 10.1016/j.jacr.2010.12.025	158	5	5	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1559-3258			DOSE-RESPONSE	Dose-Response	JAN-MAR	2015	13	1								10.2203/dose-response.14-030.Ulsh			27	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging; Toxicology	CO4RF	WOS:000359147600003	26673121	Green Published, gold			2022-02-06	
J	Yuan, L; Wei, X; Xu, C; Jin, Y; Wang, G; Li, Y; Tian, H; Chen, S				Yuan, L.; Wei, X.; Xu, C.; Jin, Y.; Wang, G.; Li, Y.; Tian, H.; Chen, S.			Use of multisequence 3.0-T MRI to detect severe traumatic brain injury and predict the outcome	BRITISH JOURNAL OF RADIOLOGY			English	Article							DIFFUSE AXONAL INJURY; HEAD-INJURY; PROGNOSTIC VALUE; SPECTROSCOPY; CHILDREN; CLASSIFICATION; BIOMARKERS; LESIONS; DAMAGE; CARE	Objective: The aim of this study was to evaluate multisequence 3.0-T MRI in the detection of severe traumatic brain injury (sTBI) and in predicting the outcome. Methods: 32 patients with sTBI were prospectively enrolled, and multisequence 3.0-T MRI was performed 4-8 weeks post injury. Quantitative data were recorded on each sequence. The ability to display the parenchymal lesions was compared with that of 64-slice spiral CT. The clinical and radiological results were correlated with the Glasgow Outcome Scale Extended scores 6 months after injury. Results: 3.0-T MRI could display more lesions than CT, especially when the lesion was deeply located. The lesion volumes and diffuse axonal injury (DAI) scores were different between good and poor outcome groups on fluid attenuated inversion recovery (p < 0.05). The apparent diffusion coefficient (ADC) values of the splenium of the corpus callosum and brain stem were also different (p < 0.05). Patients with unfavourable outcome showed a significantly higher volume of haemorrhage on susceptibility-weighted imaging than those with favourable outcomes and had haemorrhages generally located more deeply. Logistic regression analysis revealed that the location of haemorrhage and the ADC values of the splenium of the corpus callosum were independent risk factors for poor outcome, with an overall predictive accuracy of 91.4%. Conclusion: The joint use of conventional and advanced sequences of 3.0-T MRI can comprehensively detect the pathological changes occurring after sTBI. Haemorrhagic and non-haemorrhagic DAIs in deep structures strongly suggest poor outcome. Advances in knowledge: This article improves the understanding of advanced MRI sequences in the detection of patients with sTBI and prediction of prognosis.	[Yuan, L.; Xu, C.; Jin, Y.; Wang, G.; Tian, H.; Chen, S.] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China; [Wei, X.; Li, Y.] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Diagnost Radiol, Shanghai 200030, Peoples R China		Chen, S (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China.	chenshiwen@126.com					Akiyama Y, 2009, NEUROL MED-CHIR, V49, P97, DOI 10.2176/nmc.49.97; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barnes SRS, 2009, MAGN RESON IMAGING C, V17, P47, DOI 10.1016/j.mric.2008.12.002; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Colbert CA, 2010, RADIOLOGY, V256, P898, DOI 10.1148/radiol.10091842; Galanaud D, 2007, CURR OPIN NEUROL, V20, P627, DOI 10.1097/WCO.0b013e3282f169ec; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; HoehnBerlage M, 1995, NMR BIOMED, V8, P345, DOI 10.1002/nbm.1940080708; Hou DJ, 2007, J NEUROTRAUM, V24, P1558, DOI 10.1089/neu.2007.0339; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Leibson CL, 2012, J NEUROTRAUM, V29, P2038, DOI 10.1089/neu.2010.1713; Li J, 2010, J TRAUMA, V69, P1610, DOI 10.1097/TA.0b013e3181f5a9ed; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marshall LF, 1991, J NEUROSURG S, V75, P14; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Ng HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI [10.1016/0303-8467(94)90025-6, DOI 10.1016/0303-8467]; Nolan S, 2005, CRIT CARE NURS Q, V28, P188, DOI 10.1097/00002727-200504000-00010; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PASQUALIN A, 1991, NEUROSURGERY, V28, P370, DOI 10.1227/00006123-199103000-00006; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Tollard E, 2009, CRIT CARE MED, V37, P1448, DOI 10.1097/CCM.0b013e31819cf050; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; YOKOTA H, 1991, J TRAUMA, V31, P351, DOI 10.1097/00005373-199103000-00007; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac	44	5	6	0	2	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0007-1285	1748-880X		BRIT J RADIOL	Br. J. Radiol.		2015	88	1052							20150129	10.1259/bjr.20150129			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	CU1WN	WOS:000363313000023	26067919	Green Published			2022-02-06	
J	Zangbar, B; Wynne, J; Joseph, B; Pandit, V; Meyer, D; Kulvatunyou, N; Khalil, M; O'Keeffe, T; Tang, A; Lemole, M; Friese, RS; Rhee, P				Zangbar, Bardiya; Wynne, Julie; Joseph, Bellal; Pandit, Viraj; Meyer, David; Kulvatunyou, Narong; Khalil, Mazhar; O'Keeffe, Terence; Tang, Andrew; Lemole, Michael; Friese, Randall S.; Rhee, Peter			Traumatic intracranial aneurysm in blunt trauma	BRAIN INJURY			English	Article						Blunt traumatic brain injury; computed tomography angiography; psuedoaneurysm; traumatic brain injury; traumatic intracranial aneurysm	MIDDLE MENINGEAL ARTERY; ENDOVASCULAR TREATMENT; CT ANGIOGRAPHY; CEREBROVASCULAR INJURY; COMPUTED-TOMOGRAPHY; BRAIN; PSEUDOANEURYSMS; MANAGEMENT; CHILDHOOD	Introduction: Computed Tomography Angiography (CTA) is being used to identify traumatic intracranial aneurysms (TICA) in patients with findings such as skull fracture and intracranial haemorrhage on initial Computed Tomography (CT) scans after blunt traumatic brain injury (TBI). However, the incidence of TICA in patients with blunt TBI is unknown. The aim of this study is to report the incidence of TICA in patients with blunt TBI and to assess the utility of CTA in detecting these lesions. Methods: A 10-year retrospective study (2003-2012) was performed at a Level 1 trauma centre. All patients with blunt TBI who had an initial non-contrasted head CT scan and a follow-up head CTA were included. Head CTAs were then reviewed by a single investigator and TICAs were identified. The primary outcome measure was incidence of TICA in blunt TBI. Results: A total of 10 257 patients with blunt TBI were identified, out of which 459 patients were included in the analysis. Mean age was 47.3 +/- 22.5, the majority were male (65.1%) and median ISS was 16 [9-25]. Thirty-six patients (7.8%) had intracranial aneurysm, of which three patients (0.65%) had TICAs. Conclusion: The incidence of traumatic intracranial aneurysm was exceedingly low (0.65%) over 10-years. This study adds to the growing literature questioning the empiric use of CTA for detecting vascular injuries in patients with blunt TBI.	[Zangbar, Bardiya; Wynne, Julie; Joseph, Bellal; Pandit, Viraj; Meyer, David; Kulvatunyou, Narong; Khalil, Mazhar; O'Keeffe, Terence; Tang, Andrew; Lemole, Michael; Friese, Randall S.; Rhee, Peter] Univ Arizona, Dept Surg, Div Trauma, Tucson, AZ 85727 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu	Zangbar, Bardiya/K-7147-2014	Zangbar, Bardiya/0000-0003-1215-1693; Meyer, David/0000-0002-3816-0160			AARABI B, 1988, NEUROSURGERY, V22, P1056, DOI 10.1227/00006123-198806010-00014; [Anonymous], 2001, J TRAUMA, V51, pS26; Bozzetto-Ambrosi P, 2006, SURG NEUROL, V66, pS29, DOI 10.1016/j.surneu.2006.08.048; Bromberg WJ, 2010, J TRAUMA, V68, P471, DOI 10.1097/TA.0b013e3181cb43da; BUCKINGHAM MJ, 1988, NEUROSURGERY, V22, P398, DOI 10.1227/00006123-198802000-00022; Ciceri EFM, 2006, NEUROL SCI, V27, P317, DOI 10.1007/s10072-006-0703-y; Cohen JE, 2008, NEUROSURGERY, V63, P476, DOI 10.1227/01.NEU.0000324995.57376.79; Cohen Jose E, 2009, J Trauma, V67, pE111, DOI 10.1097/TA.0b013e318034205e; Dubey A, 2008, J CLIN NEUROSCI, V15, P609, DOI 10.1016/j.jocn.2007.11.006; Emmett KP, 2011, J TRAUMA, V70, P1058, DOI 10.1097/TA.0b013e318213f849; Gjertsen O, 2007, INTERV NEURORADIOL, V13, P167, DOI 10.1177/159101990701300207; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; Horiuchi T, 2007, NEUROSURG REV, V30, P263, DOI 10.1007/s10143-007-0073-9; JAKOBSSON KE, 1984, ACTA NEUROCHIR, V71, P91, DOI 10.1007/BF01401153; Jayaraman MV, 2004, RADIOLOGY, V230, P510, DOI 10.1148/radiol.2302021465; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Jussen D, 2012, NEURORADIOLOGY, V54, P1133, DOI 10.1007/s00234-011-1003-7; KARAMOSKOS P, 1989, AUST NZ J SURG, V59, P745, DOI 10.1111/j.1445-2197.1989.tb01668.x; Kikkawa Y, 2012, NEUROL MED-CHIR, V52, P41, DOI 10.2176/nmc.52.41; Larson P S, 2000, Neurosurg Focus, V8, pe4; LEE JP, 1990, J TRAUMA, V30, P619, DOI 10.1097/00005373-199005000-00017; Mao ZQ, 2012, ACTA NEUROCHIR, V154, P2187, DOI 10.1007/s00701-012-1487-x; Miley Jefferson T, 2008, J Vasc Interv Neurol, V1, P79; Quintana EM, 2012, RADIOLOGIA-MADRID, V54, P65, DOI 10.1016/j.rx.2011.01.004; NAKSTAD P, 1986, NEURORADIOLOGY, V28, P335, DOI 10.1007/BF00333440; Nakstad PH, 2008, INTERV NEURORADIOL, V14, P33, DOI 10.1177/159101990801400104; NAPEL S, 1992, RADIOLOGY, V185, P607, DOI 10.1148/radiology.185.2.1410382; Paiva WS, 2012, J TRAUMA ACUTE CARE, V72, pE115, DOI 10.1097/TA.0b013e318238bee5; PARKINSON D, 1980, J NEUROSURG, V52, P11, DOI 10.3171/jns.1980.52.1.0011; Pradilla G, 2013, WORLD NEUROSURG, V80, P845, DOI 10.1016/j.wneu.2012.12.001; Proust F, 1997, J NEUROSURG, V87, P950, DOI 10.3171/jns.1997.87.6.0950; Quintana F, 1996, AM J NEURORADIOL, V17, P283; Tan TC, 2001, BRIT J NEUROSURG, V15, P137; Teksam M, 2004, AM J NEURORADIOL, V25, P1485; Tsutsumi M, 2002, SURG NEUROL, V58, P325, DOI 10.1016/S0090-3019(02)00834-0; Tureyen K, 2001, BRIT J NEUROSURG, V15, P429, DOI 10.1080/02688690120082440; Uzan M, 1998, NEUROSURGERY, V43, P1314, DOI 10.1097/00006123-199812000-00024; Van Rooij WJ, 2013, INTERV NEURORADIOL, V19, P56, DOI 10.1177/159101991301900108; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; Wang X, 2008, NEUROL INDIA, V56, P47, DOI 10.4103/0028-3886.39312; Yang TC, 2007, EUR NEUROL, V58, P239, DOI 10.1159/000107970; Yang Yi, 2007, CHINA SECURITY, V3, P29; Zhang C, 2011, NEUROPEDIATRICS, V42, P204, DOI 10.1055/s-0031-1291221	44	5	6	1	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2015	29	5					601	606		10.3109/02699052.2015.1004559			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH3GL	WOS:000353917000008	25789607				2022-02-06	
J	Adler, C; Rauchenzauner, M; Staudt, M; Berweck, S				Adler, Caroline; Rauchenzauner, Markus; Staudt, Martin; Berweck, Steffen			Activities of Daily Living in Children with Hemiparesis: Influence of Cognitive Abilities and Motor Competence	NEUROPEDIATRICS			English	Article						hemiparesis; cognition; activities of daily living; quality of performance; hand motor function	HEMIPLEGIC CEREBRAL-PALSY; ASSISTING HAND ASSESSMENT; INDUCED MOVEMENT THERAPY; TRAUMATIC BRAIN-INJURY; CONGENITAL HEMIPLEGIA; PROCESS SKILLS; GROSS MOTOR; PERFORMANCE; RELIABILITY; CHILDHOOD	PurposeThe aim of the article is to investigate whether motor competence and cognitive abilities influence the quality of performance of activities of daily living (ADL) in children with hemiparesis. Patients and MethodsA total of 20 children with hemiparesis (age, 6-12 years; 11 congenital, 9 acquired during childhood) were studied. Motor competence was assessed with the Assisting Hand Assessment, cognitive abilities with the German version of the Wechsler Intelligence Scale for Children IV, and the quality of ADL performance with the Assessment of Motor and Process Skills (AMPS). ResultsThe motor skills scale of the AMPS correlated with motor competence, and the process skills scale of the AMPS correlated with cognitive abilities. ConclusionThe quality of ADL performance is influenced not only by motor competence but also by the cognitive abilities of a hemiparetic child. This suggests that, in addition to motor-oriented training programs, an optimal therapy for hemiparetic children should also consider cognitive approaches.	[Adler, Caroline; Staudt, Martin; Berweck, Steffen] Schon Klin Vogtareuth, Epilepsy Ctr Children & Adolescents, Clin Neuropediat & Neurorehabil, D-83569 Vogtareuth, Germany; [Rauchenzauner, Markus] St Vinzenz Krankenhaus, Dept Neuropediat, Zams, Austria; [Staudt, Martin] Univ Childrens Hosp, Dept Pediat Neurol & Dev Med, Tubingen, Germany		Adler, C (corresponding author), Schon Klin Vogtareuth, Epilepsy Ctr Children & Youth, Dept Neurorehabil, Krankenhausstr 20, D-83569 Vogtareuth, Germany.	cadler@schoen-kliniken.de	Berweck, Steffen/N-1422-2013		Hemihelp Deutschland e.V.; Schoen Klinik Vogtareuth	We thank all the children and their parents who made their contribution to this research. Also, many thanks to the team of psychologists, who administered the WISC assessments, and to the occupational therapists of the Schoen Klinik Vogtareuth, for doing all the AHA and AMPS assessments. Finally, we thank Hemihelp Deutschland e.V. and the Schoen Klinik Vogtareuth for financial support. The authors report no further declaration of interest.	Arnould C, 2007, J REHABIL MED, V39, P708, DOI 10.2340/16501977-0111; Auld ML, 2012, ARCH PHYS MED REHAB, V93, P696, DOI 10.1016/j.apmr.2011.10.025; Bodimeade HL, 2013, DEV MED CHILD NEUROL, V55, P926, DOI 10.1111/dmcn.12195; Braendvik SM, 2010, DEV MED CHILD NEUROL, V52, pe29, DOI 10.1111/j.1469-8749.2009.03490.x; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; Eliasson AC, 2005, DEV MED CHILD NEUROL, V47, P266, DOI 10.1111/j.1469-8749.2005.tb01132.x; Everts R, 2008, CHILD NEUROPSYCHOL, V14, P323, DOI 10.1080/09297040701792383; Hoare BJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004149.pub2; Holmefur M, 2009, J REHABIL MED, V41, P886, DOI 10.2340/16501977-0448; Kim WH, 2011, DEV MED CHILD NEUROL, V53, P68, DOI [10.1111/j.1469-8749.2010.03777.x, 10.1111/j.1469-8749.2011.04006.x]; Kizony R, 2002, OTJR-OCCUP PARTICI H, V22, P82, DOI 10.1177/153944920202200205; Krumlinde-Sundholm L., 2009, SCAND J OCCUP THER, V10, P16, DOI DOI 10.1080/11038120310004529; Krumlinde-Sundholm L, 2007, DEV MED CHILD NEUROL, V49, P259, DOI 10.1111/j.1469-8749.2007.00259.x; Krumlinde-Sundholm L, 2012, DEV MED CHILD NEUROL, V54, P807, DOI 10.1111/j.1469-8749.2012.04361.x; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lange B, 2009, AUST OCCUP THER J, V56, P89, DOI 10.1111/j.1440-1630.2007.00698.x; Linden A, 2005, ACTA NEUROL SCAND, V111, P48, DOI 10.1111/j.1600-0404.2004.00356.x; Missiuna C, 2010, PHYS OCCUP THER PEDI, V30, P205, DOI 10.3109/01942631003761554; Naygard L, 1998, SCAND J OCCUP THER, V5, P160; Rice J, 2009, DEV MED CHILD NEUROL, V51, P551, DOI 10.1111/j.1469-8749.2008.03182.x; Russo RN, 2011, THESIS FLINDERS U SC, P181; Sakzewski L, 2011, DEV MED CHILD NEUROL, V53, P313, DOI 10.1111/j.1469-8749.2010.03859.x; Sakzewski L, 2010, DEV MED CHILD NEUROL, V52, P811, DOI 10.1111/j.1469-8749.2009.03588.x; Schmidtendorf S, 2012, Z KINDER JUG-PSYCH, V40, P191, DOI 10.1024/1422-4917/a000169; Steenbergen B, 2007, DISABIL REHABIL, V29, P13, DOI 10.1080/09638280600947591; Steenbergen B, 2006, DEV MED CHILD NEUROL, V48, P780, DOI 10.1017/S0012162206001666; Steinlin M, 2012, NEUROPEDIATRICS, V43, P1, DOI 10.1055/s-0032-1307449; Van Zelst BR, 2006, DEV MED CHILD NEUROL, V48, P723, DOI 10.1017/S0012162206001551; Weierink L, 2013, RES DEV DISABIL, V34, P1678, DOI 10.1016/j.ridd.2013.01.035; WHO ICF-CY, 2011, INT KLASS FUNKT BEH	30	5	5	0	26	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0174-304X	1439-1899		NEUROPEDIATRICS	Neuropediatrics	DEC	2014	45	6					341	345		10.1055/s-0034-1382824			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics	AU2NU	WOS:000345456100001	25029016				2022-02-06	
J	Cirera, E; Perez, K; Santamarina-Rubio, E; Novoa, AM; Olabarria, M				Cirera, Eva; Perez, Katherine; Santamarina-Rubio, Elena; Novoa, Ana M.; Olabarria, Marta			Improvements in hip fracture incidence counterbalanced by the rise of other fracture types: Data from Spain 2000-2010	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Injury incidence; Older people; Trends; Fractures; Hip fracture; Traumatic brain injuries; Thoracic injuries; Upper extremity fractures; Lower extremity fractures; Population based data	PROXIMAL HUMERAL FRACTURES; TRAUMATIC BRAIN-INJURY; OLDER-ADULTS; EPIDEMIOLOGY; TRENDS; OUTCOMES; STATISTICS; WOMEN	Background: In recent years, the incidence of injury in older people has increased. The aim of this study is to address the hypothesis that this increase is due to an increase in the incidence of some injuries that, while less common than hip fractures, are sufficient jointly to counteract the decrease or stabilisation in hip fracture rates observed in most countries. Methods: We performed a descriptive study of trends using data from the National Hospital Discharge Register. We included individuals 65 years and older who were discharged from a Spanish hospital during the period 2000-2010 with at least one injury diagnosis in the primary diagnosis field on the discharge form. The dependent variables were the following injury groups, classified using the Barell Matrix: hip fracture, shoulder and upper arm fractures, forearm and elbow fractures, thoracic fractures, lower leg and ankle fractures, and TBI type 1 internal injury. Incidence rates were calculated per 100,000 inhabitants (data from National Statistics Institute) and stratified by sex and age group. Trends, in terms of Annual Percent Change (APC), were assessed using Poisson Regression with discharge year as the independent variable. Results: Hip fracture continues to be the most important injury type in older people. Thoracic fractures and TBI internal injuries are more common in men, while fractures in the upper extremities are more common in women. All injuries increased in frequency with age, except lower leg and ankle fractures, which decreased. While a secular decreasing trend in hip fracture was noted, the incidences of fractures of the shoulder and upper arm, forearm and elbow, and lower leg and ankle, as well as of TBI type 1 internal injuries have increased steadily. Conclusions: Although hip fracture continue to be the most common type of injury in older people, this study has allowed identifying other types of injury that are becoming increasingly common. These trends are driving paradigm changes in the burden of injuries requiring treatment within the hospital system, and must be taken into account in the design of preventative programs and actions. (C) 2014 Elsevier Ltd. All rights reserved.	[Cirera, Eva] Univ Cent Catalunya, Univ Vic, Vic 08500, Spain; [Cirera, Eva] Univ Pompeu Fabra, Barcelona, Spain; [Perez, Katherine; Santamarina-Rubio, Elena; Novoa, Ana M.; Olabarria, Marta] ASPB, Barcelona, Spain; [Perez, Katherine; Santamarina-Rubio, Elena; Olabarria, Marta] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Perez, Katherine; Santamarina-Rubio, Elena; Novoa, Ana M.; Olabarria, Marta] IIB St Pau, Barcelona, Spain		Cirera, E (corresponding author), Univ Cent Catalunya, Univ Vic, Dept Salut & Accio Social, C Sagrada Familia 7, Vic 08500, Spain.	eva.cirera@uvic.cat	Cirera, Eva/F-1407-2015	Cirera, Eva/0000-0002-0381-358X; Perez, Katherine/0000-0001-5892-2807			Aharonson-Daniel L, 2005, INJURY PREV, V11, P197, DOI 10.1136/ip.2005.008227; Alvarez-Nebreda ML, 2008, BONE, V42, P278, DOI 10.1016/j.bone.2007.10.001; Azagra R, 2014, OSTEOPOROSIS INT, V25, P1267, DOI 10.1007/s00198-013-2586-0; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; BERRY J, 2005, GUIDE STAT METHODS I; Cirera E, 2014, INJ PREV; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cuenca J, 2003, Chir Main, V22, P211, DOI 10.1016/S1297-3203(03)00057-X; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Dimai HP, 2013, OSTEOPOROSIS INT, V24, P2413, DOI 10.1007/s00198-013-2339-0; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hernandez JL, 2006, OSTEOPOROSIS INT, V17, P464, DOI 10.1007/s00198-005-0008-7; Icks A, 2008, OSTEOPOROSIS INT, V19, P1139, DOI 10.1007/s00198-007-0534-6; Ivers R, 2014, INJURY, V45, P921, DOI 10.1016/j.injury.2014.02.020; Kammerlander C, 2012, AGING CLIN EXP RES, V24, P448, DOI 10.3275/8273; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kannus P, 2008, BONE, V43, P340, DOI 10.1016/j.bone.2008.04.015; Kannus P, 2009, BONE, V44, P656, DOI 10.1016/j.bone.2008.12.007; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Guerra-Garcia MM, 2011, ATEN PRIM, V43, P82, DOI 10.1016/j.aprim.2010.04.010; [Ministerio de Sanidad Poli ' ticas Sociales e Igualdad. Servicio de Informacio ' n Sanitaria.], CAT NAC HOSP; Nevitt MC, 1993, J AM GERIATR SOC; O'Neill TW, 2005, BEST PRACT RES CL RH, V19, P879, DOI 10.1016/j.berh.2005.06.003; Okike K, 2013, INJURY, V44, P448, DOI 10.1016/j.injury.2012.09.002; Orces CH, 2009, AGEING RES, V1, pe1, DOI DOI 10.4081/AR.2010.E1; Pages-Castella A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-79; Palvanen M, 2004, OSTEOPOROSIS INT, V15, P649, DOI 10.1007/s00198-003-1585-y; Perez K, 2012, ACCIDENT ANAL PREV, V46, P37, DOI 10.1016/j.aap.2011.12.004; Piscitelli P, 2010, OSTEOPOROSIS INT, V21, P1323, DOI 10.1007/s00198-009-1084-x; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; SMITH GS, 1991, AM J EPIDEMIOL, V134, P1146, DOI 10.1093/oxfordjournals.aje.a116018; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Strauss EJ, 2007, INJURY, V38, P2, DOI 10.1016/j.injury.2007.08.005; Van Staa TP, 2001, BONE, V29, P517, DOI 10.1016/S8756-3282(01)00614-7; Vecsei V., 2005, EUR J TRAUMA, V31, P239; Watson WL, 2011, OSTEOPOROSIS INT, V22, P2623, DOI 10.1007/s00198-010-1511-z; Yee WY, 2006, EMERG MED J, V23, P42, DOI 10.1136/emj.2005.023754	40	5	5	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	DEC	2014	45	12					2076	2083		10.1016/j.injury.2014.09.016			8	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	CA1DB	WOS:000348652100048	25294117				2022-02-06	
J	Davis, JJ; Wall, JR				Davis, Jeremy J.; Wall, Jacqueline R.			Examining Verbal Memory on the Word Memory Test and California Verbal Learning Test-Second Edition	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Memory; Word Memory Test; California Verbal Learning Test-II	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; TRAUMATIC BRAIN-INJURY; IMPAIRMENT; DISORDER	This study compared the Word Memory Test (WMT) and California Verbal Learning Test-Second Edition (CVLT-II) in a sample (N = 76) of outpatient physiatry referrals who passed WMT validity indices. WMT and CVLT-II raw scores showed moderate to strong correlations. WMT scores were more likely to be below expectation than CVLT-II scores using norms from the respective test manuals. With impaired scores defined as 2 SDs below normative mean, the WMT and CVLT-II showed 67% overall agreement and kappa of 0.34. Forty percent of participants who scored within normal limits on the CVLT-II demonstrated an impaired score on the WMT. Despite evidence of utility, WMT memory subtests appear limited by current normative data.	[Davis, Jeremy J.] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Wall, Jacqueline R.] Univ Indianapolis, Indianapolis, IN 46227 USA		Davis, JJ (corresponding author), Univ Utah, Sch Med, Div Phys Med & Rehabil, 30 North 1900 East,1R55, Salt Lake City, UT 84132 USA.	jeremy.davis@hsc.utah.edu					Delis D.C., 2000, CALIFORNIA VERBAL LE; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; GERVAIS RO, 2001, J FORENSIC NEUROPSYC, V2, DOI DOI 10.1300/J151V02N02_01; Goodrich-Hunsaker NJ, 2009, NEUROPSYCHOLOGY, V23, P529, DOI 10.1037/a0015444; Gorissen M, 2005, SCHIZOPHR RES, V78, P199, DOI 10.1016/j.schres.2005.02.016; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P, 2011, APPL NEUROPSYCHOL, V18, P86, DOI 10.1080/09084282.2010.523389; Hui E., 2013, 33 ANN C NAT AC NEUR; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Martins M, 2010, APPL NEUROPSYCHOL, V17, P177, DOI 10.1080/09084281003715709; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Morel KR, 2008, CLIN NEUROPSYCHOL, V22, P350, DOI 10.1080/13854040701300531; Rienstra A, 2009, ARCH CLIN NEUROPSYCH, V24, P255, DOI 10.1093/arclin/acp035; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Wechsler D., 2009, WECHSLER MEMORY SCAL	20	5	5	2	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2014	29	8					747	753		10.1093/arclin/acu030			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AU9DD	WOS:000345890900003	25064762	Bronze			2022-02-06	
J	Deng, XQ; Chen, SA; Prabhu, R; Jiang, YY; Mao, Y; Horstemeyer, MF				Deng, Xingqiao; Chen, Shou An; Prabhu, R.; Jiang, Yuanyuan; Mao, Y.; Horstemeyer, M. F.			FINITE ELEMENT ANALYSIS OF THE HUMAN HEAD UNDER SIDE CAR CRASH IMPACTS AT DIFFERENT SPEEDS	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Human head model; traumatic brain injury; dummy model; biomechanical; head; brain	BRAIN-INJURY; MODEL; VALIDATION; DUMMY	Mechanical response of the human head under a side car crash impact is crucial for modeling traumatic brain injuries (TBI) or concussions. The current advances in computational methods and the finite element models of the human head provide a significant opportunity for biomechanical study of brain injuries; however, limited experimental data is available for delineating the injury relationship between the head injury criteria (HIC) and the tensile pressure or von Mises stress. In this research, we assess human head injuries in a side impact car crash using finite element (FE) simulations that quantify the tensile pressures and maximum strain profiles. In doing so, five FE analyses for the human head have been carried out to investigate the correlations between the HIC measured in the dummy model at different moving deformable barrier (MDB) velocities increasing from 10 mph to 30 mph in 5 mph increments and the pressure and von Mises stress of the skull, the skin, the cerebral spinal fluid (CSF) and the brain. The computational simulation results for the tensile pressures and von Mises stresses correlated well with the HIC15 and peak accelerations. Also a second-order polynomial seemed to fit the stress levels to the impact speeds and as such the presented method for using FE human head analysis could be used for reconstruction of head impacts in different side car crash conditions; furthermore, the head model would provide a tool for investigation of the cause and mechanisms of head injuries once the type and locations of injuries are quantified.	[Deng, Xingqiao; Chen, Shou An; Jiang, Yuanyuan] Xihua Univ, Sch Mech Engn & Automat, Chengdu 610039, Sichuan, Peoples R China; [Prabhu, R.; Mao, Y.; Horstemeyer, M. F.] Ctr Adv Vehicular Syst, Starkville, MS 39759 USA; [Prabhu, R.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Horstemeyer, M. F.] Mississippi State Univ, Dept Mech Engn, Mississippi State, MS 39762 USA		Deng, XQ (corresponding author), Xihua Univ, Sch Mech Engn & Automat, Chengdu 610039, Sichuan, Peoples R China.	dxq_zyc@hotmail.com	Mao, Yuxiong/K-3747-2015; Prabhu, Raj/M-7188-2017	Prabhu, Raj/0000-0002-6073-4802; Horstemeyer, Mark/0000-0003-4230-0063	Center for Advanced Vehicular Systems (CAVS) at Mississippi State University; Spring Sunshine Plan [10202258]; Xihua University [XZD0813-09-1]	The authors would like to acknowledge the Center for Advanced Vehicular Systems (CAVS) at Mississippi State University for support of this work. The authors would also like to thank the support of the Spring Sunshine Plan for the grant (Grant No. 10202258) and the key disciplinary of mechanical design and theory of Xihua University (XZD0813-09-1).	Asgharpour Z, 2014, J MECH BEHAV BIOMED, V33, P16, DOI 10.1016/j.jmbbm.2013.02.010; Bouvard JL, 2010, ACTA MECH, V213, P71, DOI 10.1007/s00707-010-0349-y; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Deck C, 2014, IRCOBI C 2007, P43; Deng XQ, 2013, ACCIDENT ANAL PREV, V55, P232, DOI 10.1016/j.aap.2013.03.016; Gabauer DJ, 2010, J SAFETY RES, V41, P9, DOI 10.1016/j.jsr.2009.10.006; Huang SN, 2010, ACCIDENT ANAL PREV, V42, P1136, DOI 10.1016/j.aap.2009.12.028; Johnson EAC, 2005, J BIOMECH, V38, P39, DOI 10.1016/j.jbiomech.2004.03.018; King AI, IRCOBI C; Li ZG, 2011, ANN BIOMED ENG, V39, P2984, DOI 10.1007/s10439-011-0409-z; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Michael WC, 2011, NEUROIMAGE, V54, P551; Miller K, 2000, TLS-TIMES LIT SUPPL, P33; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Roth S, 2010, COMPUT METH PROG BIO, V99, P25, DOI 10.1016/j.cmpb.2009.10.004; Shreiber DI, 1997, STAPP CAR CRASH J, V41, P277; Touria B, 2014, J MED IMAG HEALTH IN, V4, P36, DOI 10.1166/jmihi.2014.1217; WARD CC, 1975, P 19 STAPP CAR CRASH, P641; Yao JF, 2011, INT J VEHICLE DES, V57, P254, DOI 10.1504/IJVD.2011.044724; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	23	5	5	0	26	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	DEC	2014	14	6							1440002	10.1142/S0219519414400028			16	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	AW5HH	WOS:000346306100003					2022-02-06	
J	Echeverria, AB; Branco, BC; Goshima, KR; Hughes, JD; Mills, JL				Echeverria, Angela B.; Branco, Bernardino C.; Goshima, Kay R.; Hughes, John D.; Mills, Joseph L.			Outcomes of endovascular management of acute thoracic aortic emergencies in an academic level 1 trauma center	AMERICAN JOURNAL OF SURGERY			English	Article						Acute aortic; emergencies; TEVAR; Outcomes; Mortality	STENT GRAFT; REPAIR; ANEURYSMS; INJURIES; VOLUME	BACKGROUND: Thoracic aortic emergencies account for 10% of thoracic-related admissions in the United States and remain associated with high morbidity and mortality rates. Open repair has declined owing to the emergence of thoracic endovascular aortic repair (TEVAR), but data on emergency TEVAR use for acute aortic pathology remain limited. We therefore reviewed our experience. METHODS: We retrospectively evaluated emergency descending thoracic aortic endovascular interventions performed at a single academic level 1 trauma center between January 2005 and August 2013 including all cases of traumatic aortic injury, ruptured descending thoracic aneurysm, penetrating atherosclerotic ulcer, aortoenteric fistula, and acute complicated type B dissection. Demographics, clinical data, and outcomes were extracted. Stepwise logistic regression was used to identify independent risk factors for death. RESULTS: During the study period, 51 patients underwent TEVAR; 22 cases (43.1%) were performed emergently (11 patients [50.0%] traumatic aortic injury; 4 [18.2%] ruptured descending thoracic aneurysm; 4 [18.2%] complicated type B dissection; 2 [9.1%] penetrating aortic ulcer; and 1 [4.5%] aortoenteric fistula). Overall, 72.7% (n = 16) were male with a mean age of 54.8 +/- 15.9 years. Nineteen patients (86.4%) required only a single TEVAR procedure, whereas 2 (9.1%) required additional endovascular therapy, and 1 (4.5%) open thoracotomy. Four traumatic aortic injury patients required exploratory laparotomy for concomitant intra-abdominal injuries. During a mean hospital length of stay of 18.9 days (range, 1 to 76 days), 3 patients (13.6%) developed major complications. In-hospital mortality was 27.2%, consisting of 6 deaths from traumatic brain injury (1); exsanguination in the operating room before repair could be achieved (2); bowel ischemia (1) and multisystem organ failure (1); and family withdrawal of care (1). A stepwise logistic regression model identified 24-hour packed red blood cell requirements >= 4 units, admission mean arterial pressure <60 mm Hg, and 24-hour fresh frozen plasma to packed red blood cell (pRBC) ratio <1:1.5 as independent risk factors for death in this cohort. During a mean follow-up of 369 days (range, 35 to 957 days), no subsequent major complications or deaths occurred. All patients underwent serial computed tomographic angiography surveillance, and no device-related problems were identified during intermediate follow-up. CONCLUSIONS: Thoracic aortic emergencies remain challenging. Our experience in a moderate-volume center supports the utilization of TEVAR in the acute setting. Twenty-four-hour pRBC requirements >= 4 units, admission mean arterial pressure <60 mm Hg, and 24 hour fresh frozen plasma to pRBC ratio <1:1.5 were independently associated with death. (C) 2014 Elsevier Inc. All rights reserved.	[Echeverria, Angela B.; Branco, Bernardino C.] Univ Arizona, Dept Surg, Tucson, AZ 85724 USA; [Goshima, Kay R.; Hughes, John D.; Mills, Joseph L.] Univ Arizona, Dept Surg, Div Vasc & Endovasc Surg, Tucson, AZ 85724 USA		Mills, JL (corresponding author), Univ Arizona, Dept Surg, 1501 North Campbell Ave,POB 245072, Tucson, AZ 85724 USA.	jmills@u.arizona.edu	Mills, Joseph L./L-2023-2019; Mills, Joseph/J-2966-2019	Mills, Joseph/0000-0002-4955-4384			Azizzadeh A, 2014, J TRAUMA ACUTE CARE, V76, P510, DOI 10.1097/TA.0b013e3182aafe8c; Azizzadeh A, 2013, J VASC SURG, V57, P108, DOI 10.1016/j.jvs.2012.05.110; Bhamidipati CM, 2011, ANN THORAC SURG, V91, P1314, DOI 10.1016/j.athoracsur.2011.01.037; Caputo LM, 2014, INJURY, V45, P478, DOI 10.1016/j.injury.2013.09.038; Demetriades D, 2008, J TRAUMA, V64, P561, DOI 10.1097/TA.0b013e3181641bb3; Di Eusanio M, 2013, ANN THORAC SURG, V95, P1591, DOI 10.1016/j.athoracsur.2013.02.033; Garcia-Toca M, 2010, ARCH SURG-CHICAGO, V145, P679, DOI 10.1001/archsurg.2010.114; Klima DA, 2013, AM SURGEON, V79, P594; Mansour MA, 2012, AM J SURG, V203, P401, DOI 10.1016/j.amjsurg.2011.10.008; Martinelli O, 2013, J VASC SURG, V58, P832, DOI 10.1016/j.jvs.2013.02.243; Murphy SL, 2012, NATL VITAL STAT REP, V60, P7; Naughton PA, 2012, ARCH SURG-CHICAGO, V147, P243, DOI 10.1001/archsurg.2011.1476; Patel VI, 2013, J VASC SURG, V58, P346, DOI 10.1016/j.jvs.2013.01.035; Rahimi SA, 2010, J VASC SURG, V52, P891, DOI 10.1016/j.jvs.2010.05.014; Riesenman PJ, 2012, J VASC SURG, V56, P1274, DOI 10.1016/j.jvs.2012.04.035; Starnes BW, 2012, J VASC SURG, V55, P47, DOI 10.1016/j.jvs.2011.07.073; Steuer J, 2012, J VASC SURG, V56, P973, DOI 10.1016/j.jvs.2012.03.259; Walker KL, 2010, ANN THORAC SURG, V90, P1833, DOI 10.1016/j.athoracsur.2010.08.008	18	5	5	0	3	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610	1879-1883		AM J SURG	Am. J. Surg.	DEC	2014	208	6					974	979		10.1016/j.amjsurg.2014.08.008			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	AW2LU	WOS:000346120300029	25440483				2022-02-06	
J	Liu, ZW; Li, WQ; Wang, JK; Ma, XC; Liang, C; Liu, P; Chu, Z; Dang, YH				Liu, Zhong-wei; Li, Wen-qiang; Wang, Jun-kui; Ma, Xian-cang; Liang, Chen; Liu, Peng; Chu, Zheng; Dang, Yong-hui			Zirconium oxide ceramic foam: a promising supporting biomaterial for massive production of glial cell line-derived neurotrophic factor	JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B			English	Article						Zirconium oxide; Ceramic foam; Glial cell line-derived neurotrophic factor (GDNF); Parkinson's disease	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; FACTOR GDNF; RAT MODEL; GROWTH-FACTORS; NEURONS; EXPRESSION; INFUSION; BDNF; TRANSPLANTATION	This study investigated the potential application of a zirconium oxide (ZrO2) ceramic foam culturing system to the production of glial cell line-derived neurotrophic factor (GDNF). Three sets of ZrO2 ceramic foams with different pore densities of 10, 20, and 30 pores per linear inch (PPI) were prepared to support a 3D culturing system. After primary astrocytes were cultured in these systems, production yields of GDNF were evaluated. The biomaterial biocompatibility, cell proliferation and activation of cellular signaling pathways in GDNF synthesis and secretion in the culturing systems were also assessed and compared with a conventional culturing system. In this study, we found that the ZrO2 ceramic foam culturing system was biocompatible, using which the GDNF yields were elevated and sustained by stimulated cell proliferation and activation of signaling pathways in astrocytes cultured in the system. In conclusion, the ZrO2 ceramic foam is promising for the development of a GDNF mass production device for Parkinson's disease treatment.	[Liu, Zhong-wei; Wang, Jun-kui] Xi An Jiao Tong Univ, Dept Cardiol, Affiliated Hosp 3, Xian 710068, Peoples R China; [Li, Wen-qiang] Northwestern Polytech Univ, Sch Astronaut, Xian 710072, Peoples R China; [Ma, Xian-cang] Xi An Jiao Tong Univ, Dept Psychiat, Affiliated Hosp 1, Xian 710061, Peoples R China; [Liang, Chen] Xi An Jiao Tong Univ, Dept Neurosurg, Affiliated Hosp 1, Xian 710061, Peoples R China; [Liu, Peng; Chu, Zheng; Dang, Yong-hui] Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710061, Peoples R China; [Dang, Yong-hui] Xi An Jiao Tong Univ, Hlth Sci Ctr, Hlth Minist Forens Med, Key Lab, Xian 710061, Peoples R China; [Dang, Yong-hui] Xi An Jiao Tong Univ, Hlth Sci Ctr, MOE Key Lab Environm & Genes Related Dis, Xian 710061, Peoples R China		Dang, YH (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Coll Med & Forens, Xian 710061, Peoples R China.	liuzhongweicn@gmail.com; psydyh@mail.xjtu.edu.cn		Chu, Zheng/0000-0003-1805-3824	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171262, 81371473]	Project supported by the National Natural Science Foundation of China (Nos. 81171262 and 81371473)	Bakshi A, 2006, EUR J NEUROSCI, V23, P2119, DOI 10.1111/j.1460-9568.2006.04743.x; Beohar N, 2010, J AM COLL CARDIOL, V56, P1287, DOI 10.1016/j.jacc.2010.05.039; Burke RE, 2006, J NEURAL TRANSM-SUPP, P41; Cho KS, 2010, BIOCHEM BIOPH RES CO, V402, P48, DOI 10.1016/j.bbrc.2010.09.099; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; Foltynie T, 2013, J NEUROL, V260, P1433, DOI 10.1007/s00415-013-6915-1; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Golan M, 2011, INT J NEUROPSYCHOPH, V14, P1289, DOI 10.1017/S1461145710001550; Grundstrom E, 2000, NEUROREPORT, V11, P1781, DOI 10.1097/00001756-200006050-00037; Hebb AO, 2003, J NEUROSURG, V98, P1078, DOI 10.3171/jns.2003.98.5.1078; Heckmann L, 2008, BIOTECHNOL APPL BIOC, V49, P185, DOI 10.1042/BA20070071; Hidalgo-Figueroa M, 2012, J NEUROSCI, V32, P864, DOI 10.1523/JNEUROSCI.2693-11.2012; Hisaoka K, 2008, BRAIN RES, V1196, P53, DOI 10.1016/j.brainres.2007.12.019; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Li ZH, 2014, BIOTECHNOL ADV, V32, P243, DOI 10.1016/j.biotechadv.2013.10.006; Lo WC, 2008, J NUCL MED, V49, P1512, DOI 10.2967/jnumed.108.051896; Matsushita Y, 2008, J NEUROSCI RES, V86, P1959, DOI 10.1002/jnr.21657; Minnich JE, 2010, RESTOR NEUROL NEUROS, V28, P293, DOI 10.3233/RNN-2010-0528; Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009; Ortiz-Ortiz MA, 2011, ENVIRON TOXICOL PHAR, V31, P129, DOI 10.1016/j.etap.2010.09.013; Parsadanian A, 2006, EXP NEUROL, V200, P26, DOI 10.1016/j.expneurol.2006.01.014; Patel NK, 2005, ANN NEUROL, V57, P298, DOI 10.1002/ana.20374; Sale P, 2013, EUR J PHYS REHAB MED, V49, P161; Schenck M, 2007, UROLOGE, V46, P1262, DOI 10.1007/s00120-007-1385-7; Shingo T, 2002, J NEUROSCI RES, V69, P946, DOI 10.1002/jnr.10375; Sun M, 2005, BRAIN RES, V1052, P119, DOI 10.1016/j.brainres.2005.05.072; Tanaka Y, 2008, CELL BIOL INT, V32, P505, DOI 10.1016/j.cellbi.2007.12.012; Tokutake T, 2014, PARKINSONISM RELAT D, V20, P262, DOI 10.1016/j.parkreldis.2013.11.008; von Frenckell C, 2012, Rev Med Liege, V67 Spec No, P22; Wu XF, 2008, INT J NEUROPSYCHOPH, V11, P1123, DOI 10.1017/S1461145708009024; Yasuhara T, 2005, J NEUROSURG, V102, P80, DOI 10.3171/jns.2005.102.1.0080; Yasuhara T, 2007, ACTA MED OKAYAMA, V61, P51; Zesiewicz TA, 2007, CURR NEUROL NEUROSCI, V7, P302, DOI 10.1007/s11910-007-0046-y; Zuo Dong-qing, 2013, Zhonghua Zhong Liu Za Zhi, V35, P641	34	5	5	0	7	ZHEJIANG UNIV	HANGZHOU	EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA	1673-1581	1862-1783		J ZHEJIANG UNIV-SC B	J. Zhejiang Univ.-SCI. B	DEC	2014	15	12					1013	1022		10.1631/jzus.B1400163			10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Research & Experimental Medicine	AW3EJ	WOS:000346168300001	25471830	Bronze, Green Published			2022-02-06	
J	Martin, KJ; Lincoln, N; das Nair, R				Martin, Kristy-Jane; Lincoln, Nadina; das Nair, Roshan			Group-based memory rehabilitation for people with multiple sclerosis: Subgroup analysis of the ReMiND trial	INTERNATIONAL JOURNAL OF THERAPY AND REHABILITATION			English	Article						Multiple sclerosis; Memory; Rehabilitation; Randomised controlled trial	COGNITIVE REHABILITATION; NEUROLOGICAL DISABILITIES; EVERYDAY MEMORY; INTERVENTION; THERAPY	Background/Aim: Memory problems are frequently reported in people with multiple sclerosis (MS). These can be debilitating and affect individuals and their families. This subgroup analysis focused on the effectiveness of memory rehabilitation in patients with MS. Methods: Data were extracted from a single-blind randomised controlled trial, the ReMiND trial, which also included participants with traumatic brain injury and stroke. Participants were randomly allocated to compensation or restitution treatment programmes, or a self-help control. The programmes were manual-based and comprised two individual sessions and ten group sessions. Outcome measures included assessments of memory, mood and activities of daily living. A total of 39 patients with MS participated in this study (ten males (26%), 29 females (74%); mean +/- SD age: 48.3 +/- 10.8 years). Results: Comparison of groups showed no significant effect of treatment on memory, but there were significant differences between compensation and restitution on self-report symptoms of emotional distress at both five- (p=0.04) and seven-month (p=0.05) follow-up sessions. The compensation group showed less distress than the restitution group. Conclusions: Individuals with MS who received compensation memory rehabilitation reported significantly less emotional distress than those who received restitution. Further research is needed to explore why self-reported memory problems did not differ between groups.	[Martin, Kristy-Jane; das Nair, Roshan] Univ Nottingham, Sch Med, Div Rehabil & Ageing, Nottingham, England; [Lincoln, Nadina] Univ Nottingham, Sch Med, Div Rehabil & Ageing, Clin psychol, Nottingham, England		Martin, KJ (corresponding author), Univ Nottingham, Sch Med, Div Rehabil & Ageing, Nottingham, England.	kristy.martin@nottingham.ac.uk		Kneebone, Ian/0000-0003-3324-7264; das Nair, Roshan/0000-0001-8143-7893			[Anonymous], 1993, NEUROPSYCHOLOGY, V7, P364, DOI [DOI 10.1037/0894-4105.7.3.364, 10.1037/0894-4105.7.3.364]; Bland JM, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-264; Carr SE, 2014, CLIN REHABIL, V28, P552, DOI 10.1177/0269215513512336; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Coughlan AK, 1988, CLIN REHABIL, V2, P207, DOI DOI 10.1177/026921558800200305; das Nair R, 2013, NEUROPSYCHOL REHABIL, V23, P528, DOI 10.1080/09602011.2013.792290; das Nair R, 2012, CLIN REHABIL, V26, P894, DOI 10.1177/0269215511435424; das Nair R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008754.pub2; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Evans J, 1992, CLIN REHABIL, V6, P75, DOI DOI 10.1177/026921559200600110; Evans JJ, 2006, J NEUROL, V253, P520, DOI 10.1007/s00415-006-0014-5; GOLDERBERG DWP, 1988, USERS GUIDE GEN HLTH; Hildebrandt H, 2006, J NEUROL, V253, P512, DOI 10.1007/s00415-006-0013-6; Johansson B, 2012, SCAND J OCCUP THER, V19, P176, DOI 10.3109/11038128.2011.603352; Lexell EM, 2013, BRAIN INJURY, V27, P529, DOI 10.3109/02699052.2013.765598; Lincoln NB, 2002, J NEUROL NEUROSUR PS, V72, P93, DOI 10.1136/jnnp.72.1.93; Nelson HE, 1991, REVISED NATL ADULT R; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; O'Brien MC, 2013, NEUROPSYCHOL REHABIL, V23, P321, DOI 10.1080/09602011.2012.753920; Powell T, 2003, BRAIN INJURY WORKBOO; Regard M., 1981, COGNITIVE RIGIDITY F; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Robertson IH, 2010, COGNITIVE NEUROREHAB, P565; Rosti-Otajarvi EM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009131.pub2; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Spector A, 2011, AGING MENT HEALTH, V15, P945, DOI 10.1080/13607863.2011.586622; Stuifbergen AK, 2012, CLIN REHABIL, V26, P882, DOI 10.1177/0269215511434997; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; Syder D, 1993, SHEFFIELD SCREENING; Tate RL, 1997, BRAIN INJURY, V11, P907, DOI 10.1080/026990597122972; WATSON M, 1988, PSYCHOL MED, V18, P203, DOI 10.1017/S0033291700002026; Wilson BA, 1984, CLIN MANAGEMENT MEMO; Wilson BA, 1999, RIVERMEAD BEHAV MEMO; Wycherley RJ, 1998, WECHSLER ADULT INTEL	36	5	5	0	0	MARK ALLEN GROUP	LONDON	ST JUDES CHURCH, DULWICH RD, LONDON, SE24 0PB, ENGLAND	1741-1645	1759-779X		INT J THER REHABIL	Int. J. Ther. Rehabil.	DEC	2014	21	12					590	596		10.12968/ijtr.2014.21.12.590			7	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V06OY	WOS:000213950700011		Green Submitted, Green Accepted			2022-02-06	
J	Pineau, H; Marchand, A; Guay, S				Pineau, Helene; Marchand, Andre; Guay, Stephane			Objective Neuropsychological Deficits in Post-Traumatic Stress Disorder and Mild Traumatic Brain Injury: What Remains Beyond Symptom Similarity?	BEHAVIORAL SCIENCES			English	Article						neuropsychological deficits; PTSD; mTBI; comorbidity; symptom similarity		This exploratory study intends to characterize the neuropsychological profile in persons with post-traumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI) using objective measures of cognitive performance. A neuropsychological battery of tests for attention, memory and executive functions was administered to four groups: PTSD (n = 25), mTBI (n = 19), subjects with two formal diagnoses: Post-traumatic Stress Disorder and Mild Traumatic Brain Injury (mTBI/PTSD) (n = 6) and controls (n = 25). Confounding variables, such as medical, developmental or neurological antecedents, were controlled and measures of co-morbid conditions, such as depression and anxiety, were considered. The PTSD and mTBI/PTSD groups reported more anxiety and depressive symptoms. They also presented more cognitive deficits than the mTBI group. Since the two PTSD groups differ in severity of PTSD symptoms but not in severity of depression and anxiety symptoms, the PTSD condition could not be considered as the unique factor affecting the results. The findings underline the importance of controlling for confounding medical and psychological co-morbidities in the evaluation and treatment of PTSD populations, especially when a concomitant mTBI is also suspected.	[Pineau, Helene; Marchand, Andre] Univ Quebec, Dept Psychol, Montreal, PQ H2X 3P2, Canada; [Pineau, Helene] Lucie Bruneau Rehabil Ctr, Montreal, PQ H2H 2N8, Canada; [Marchand, Andre; Guay, Stephane] Inst Univ Sante Mental Montreal, Montreal, PQ H1N 3M5, Canada; [Guay, Stephane] Univ Montreal, Dept Criminol, Montreal, PQ H3C 3J7, Canada		Marchand, A (corresponding author), Univ Quebec, Dept Psychol, Montreal, PQ H2X 3P2, Canada.	h.pino@hotmail.com; marchand.andre@uqam.ca; stephane.guay@umontreal.ca	Guay, Stephane/AAD-6927-2022	Guay, Stephane/0000-0001-9638-3242	Research Program in Traumatology FRSQ-AERDPQ-AQESS-SAAQ [9953]	This research was funded by a grant to the second author from the Research Program in Traumatology FRSQ-AERDPQ-AQESS-SAAQ (No. 9953).	Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2004, J INT NEUROPSYCH SOC, V10, P794, DOI 10.1017/S1355617704105146; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Blake D.D., 1998, CLINICIAN ADMINISTER; BOHNEN N, 1992, ACTA NEUROL SCAND, V85, P116, DOI 10.1111/j.1600-0404.1992.tb04009.x; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2013, JAMA PSYCHIAT, V70, P839, DOI 10.1001/jamapsychiatry.2013.1137; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Delis DC., 2001, DELIS KAPLAN EXECUTI; First M., 1995, STRUCTURED CLIN INTE, V9, P92; Harvey AG, 2003, J INT NEUROPSYCH SOC, V9, P663, DOI 10.1017/S1355617703940069; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Isaac CL, 2006, CLIN PSYCHOL REV, V26, P939, DOI 10.1016/j.cpr.2005.12.004; Johnsen GE, 2008, J ANXIETY DISORD, V22, P464, DOI 10.1016/j.janxdis.2007.04.007; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Mylle J, 2004, J AFFECT DISORDERS, V78, P37, DOI 10.1016/S0165-0327(02)00218-5; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023	24	5	5	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-328X			BEHAV SCI-BASEL	Behav. Sci.	DEC	2014	4	4					471	486		10.3390/bs4040471			16	Psychology, Multidisciplinary	Emerging Sources Citation Index (ESCI)	Psychology	V28QY	WOS:000215443100009	25469837	Green Submitted, Green Published, gold			2022-02-06	
J	Wu, LM; Austin, J; Valdimarsdottir, H; Isola, L; Rowley, SD; Diefenbach, MA; Cammarata, M; Redd, WH; Rini, C				Wu, Lisa M.; Austin, Jane; Valdimarsdottir, Heiddis; Isola, Luis; Rowley, Scott D.; Diefenbach, Michael A.; Cammarata, Meredith; Redd, William H.; Rini, Christine			Cross-sectional study of patient-reported neurobehavioral problems following hematopoietic stem cell transplant and health-related quality of life	PSYCHO-ONCOLOGY			English	Article						cancer; oncology; cognitive function; apathy; neurobehavioral function; quality of life	TRAUMATIC BRAIN-INJURY; SYSTEMS BEHAVIOR SCALE; FUNCTIONAL ASSESSMENT; COGNITIVE DECLINE; APATHY; DEPRESSION; FATIGUE; IMPAIRMENT; DESIGN	ObjectiveAlthough hematopoietic stem cell transplant (HSCT) patients may experience neurocognitive impairment, experiences of neurobehavioral problems (including apathy and disinhibition) are understudied. These experiences reflect behavioral signs and symptoms of neurological dysfunction that can potentially reduce health-related quality of life (HRQOL). Understanding them is important because they may be confused with other diagnoses, including depression, potentially leading to inappropriate treatments. The objectives of this preliminary cross-sectional study were to describe HSCT patients' neurobehavioral functioning pre-HSCT and post-HSCT and to examine relations with HRQOL. MethodsPatients (n=42) 9months to 3years post-HSCT completed measures of neurobehavioral functioning to report apathy and disinhibition pre-HSCT (retrospectively) and post-HSCT (currently). Paired t-tests and McNemar tests were used to explore differences in the incidence of patient-reported neurobehavioral problems within and across time points. Regression analyses were conducted to examine relations between neurobehavioral functioning and physical and mental HRQOL. ResultsElevated levels of apathy were reported by many patients post-HSCT (36%) and increased significantly from pre-HSCT to post-HSCT (p=0.001). Hierarchical regression analysis indicated that higher levels of apathy were associated with reduced mental HRQOL (p<0.05) even after controlling for depressed mood and fatigue. ConclusionsFindings from this preliminary study highlight the importance of investigating neurobehavioral problems, particularly apathy, in HSCT patients. Because apathy is often confused with other diagnoses and may worsen HRQOL, understanding the nature of these symptoms has implications for interventions. Further research is needed in this important area. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Wu, Lisa M.; Valdimarsdottir, Heiddis; Redd, William H.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Austin, Jane] William Paterson Univ, Dept Psychol, Wayne, NJ USA; [Valdimarsdottir, Heiddis] Reykjavik Univ, Dept Psychol, Reykjavik, Iceland; [Isola, Luis] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Rowley, Scott D.] Hackensack Univ, John Theurer Canc Ctr, Med Ctr, Hackensack, NJ USA; [Diefenbach, Michael A.] Icahn Sch Med Mt Sinai, Dept Urol, New York, NY 10029 USA; [Cammarata, Meredith] Mem Sloan Kettering Canc Ctr, Dept Social Work, New York, NY 10021 USA; [Rini, Christine] Univ N Carolina, Dept Hlth Behav, Chapel Hill, NC USA; [Rini, Christine] UNC Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA		Wu, LM (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, 1 Gustave L Levy Pl,Box 1130, New York, NY 10029 USA.	lisa.wu@mssm.edu	Wu, Lisa/P-1202-2018	Wu, Lisa/0000-0003-2241-9905; Rini, Christine/0000-0002-3169-3626	American Cancer SocietyAmerican Cancer Society [RSGPB-07-285-01-CPPB, PF-12-041-01-CPPB]	We wish to thank Katie Basmajian, MA, AnnaMarie Vu, BA, and Jennifer Chee-Chait, BA, for their assistance in data collection and Daniella Lipnick, BA, for preliminary data cleaning and data analysis for this project. This research was supported by funding from the American Cancer Society (PI: Rini-grant #RSGPB-07-285-01-CPPB; PI: Wu-grant #PF-12-041-01-CPPB).	Alexopoulos GS, 2002, AM J GERIAT PSYCHIAT, V10, P98, DOI 10.1176/appi.ajgp.10.1.98; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; Basinski JR, 2010, BIOL BLOOD MARROW TR, V16, P824, DOI 10.1016/j.bbmt.2010.01.003; Benito-Leon E., 2012, MOVEMENT DISORD, V27, P211, DOI [DOI 10.1002/MDS.23872, DOI 10.1002/mds.23872]; Bush NE, 2000, BIOL BLOOD MARROW TR, V6, P576, DOI 10.1016/S1083-8791(00)70067-X; Butler C, 2005, J NEUROL NEUROSUR PS, V76, pI31, DOI 10.1136/jnnp.2004.060459; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; CELLA DF, 1993, J CLIN ONCOL, V11, P570, DOI 10.1200/JCO.1993.11.3.570; Chandran V, 2007, ANN RHEUM DIS, V66, P936, DOI 10.1136/ard.2006.065763; Chiaravalloti ND, 2003, COGN BEHAV NEUROL, V16, P54, DOI 10.1097/00146965-200303000-00007; Copelan EA, 2006, NEW ENGL J MED, V354, P1813, DOI 10.1056/NEJMra052638; Derogatiss LR, 1993, BSI BRIEF SYMPTOM IN; Eramudugolla R, 2012, DEMENT GERIATR COGN, V34, P282, DOI 10.1159/000345439; Friedman MA, 2009, ARCH CLIN NEUROPSYCH, V24, P689, DOI 10.1093/arclin/acp060; Grace J, 1999, ASSESSMENT, V6, P269, DOI 10.1177/107319119900600307; Graces J, 2001, FRONTAL SYSTEMS BEHA; Hofman M, 2007, ONCOLOGIST, V12, P4, DOI 10.1634/theoncologist.12-S1-4; Holtta EH, 2012, J AM MED DIR ASSOC, V13, P541, DOI 10.1016/j.jamda.2012.04.005; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Lane-Brown AT, 2009, NEUROPSYCHOL REHABIL, V19, P481, DOI 10.1080/09602010902949207; Lane-Brown AT, 2009, BRAIN INJURY, V23, P999, DOI 10.3109/02699050903379347; Lane-Brown A, 2010, J HEAD TRAUMA REHAB, V25, P459, DOI 10.1097/HTR.0b013e3181d98e1d; Lees HB, 2003, INT REV PSYCHIATR, V15, P359, DOI [10.1080/09540260310001606746, DOI 10.1080/09540260310001606746]; Levy MR, 2006, EUR J PSYCHIAT, V20, P107, DOI 10.4321/s0213-61632006000200006; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Malloy PF, 1996, ASSESSMENT, V3, P327, DOI DOI 10.1177/1073191196003003012; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; Mosher CE, 2009, PSYCHO-ONCOLOGY, V18, P113, DOI 10.1002/pon.1399; Murphy EA, 2010, BIOL BLOOD MARROW TR, V16, P147, DOI 10.1016/j.bbmt.2009.08.004; Rini C, 2014, HEALTH PSYCHOL, V33, P1541, DOI 10.1037/hea0000024; Scheier MF, 2006, J BEHAV MED, V29, P291, DOI 10.1007/s10865-005-9044-1; Schwarzs N, 1994, AUTOBIOGRAPHICAL MEM; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Silverman MM, 2007, SUICIDE LIFE-THREAT, V37, P264, DOI 10.1521/suli.2007.37.3.264; Syrjala KL, 2011, J CLIN ONCOL, V29, P2397, DOI 10.1200/JCO.2010.33.9119; Velligan DI, 2002, PSYCHIAT RES, V113, P227, DOI 10.1016/S0165-1781(02)00264-0; Wares JE, 2002, SCORE VERSION 2 SF 3; Wares JE, 2001, SF 36 PHYS MENTAL SU; Wus LM, 2012, PSYCHO-ONCOLOGY, V21, P1175, DOI [10.1002/pon.2012, DOI 10.1002/PON.2012]	40	5	6	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1057-9249	1099-1611		PSYCHO-ONCOLOGY	Psycho-Oncol.	DEC	2014	23	12					1406	1414		10.1002/pon.3554			9	Oncology; Psychology; Psychology, Multidisciplinary; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Psychology; Biomedical Social Sciences	AW0RX	WOS:000346002100010	24846770				2022-02-06	
J	Zhang, HQ; Chu, G; Pan, C; Hu, JZ; Guo, CF; Liu, JY; Wang, YX; Wu, JH				Zhang, Hongqi; Chu, Ge; Pan, Chao; Hu, Jianzhong; Guo, Chaofeng; Liu, Jinyang; Wang, Yuxiang; Wu, Jianhuang			A nutrient mixture reduces the expression of matrix metalloproteinases in an animal model of spinal cord injury by modulating matrix metalloproteinase-2 and matrix metalloproteinase-9 promoter activities	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						nutrient mixture; matrix metalloproteinases; spinal cord injury	TRAUMATIC BRAIN-INJURY; CEREBRAL BLOOD-FLOW; STEM-CELLS; REGENERATION; INFLAMMATION; METASTASIS; RECOVERY; RISK; MICE	This study aimed to determine whether a novel nutrient mixture (NM), composed of lysine, ascorbic acid, proline, green tea extracts and other micronutrients, attenuates impairments induced by spinal cord injury (SCI) and to investigate the related molecular mechanisms. A mouse model of SCI was established. Thirty-two mice were divided into four groups. The sham group received vehicle only. The SCI groups were treated orally with saline (saline group), a low dose (500 mu g 3 times/day) of NM (NM-LD group) or a high dose (2,000 mu g 3 times/day) of NM (NM-HD group). The levels of mouse hindlimb movement were determined every day in the first week post-surgery. The protein expression levels of matrix metalloproteinase (MMP)-2 and MMP-9 were determined by western blotting. Wild-type and mutant MMP-2- and MMP-9-directed luciferase constructs were generated and their luciferase activities were determined. NM significantly facilitated the recovery of hindlimb movement of the mice in comparison to that in the saline group. The expression levels of MMP-2 in the NM-LD and NM-HD groups were decreased by similar to 50% compared with the saline group as indicated by western blotting results. The expression levels of MMP-9 in the NM-LD and NM-HD groups were decreased to similar to 25 and similar to 10%, respectively. These results suggest that NM significantly inhibits the expression of MMP-2 and MMP-9 proteins. Reverse transcription quantitative polymerase chain reaction results indicated that NM reduced the levels of MMP-2 and MMP-9 mRNA. Furthermore, the luciferase results indicated that site-directed mutagenesis comprising a -1306 C to T (C/T) base change in the MMP-2 promoter and a -1562 C/T base change in the MMP-9 promoter abolished the inhibitory effects of NM on MMP-2 and MMP-9 promoters. These results suggest that NM attenuates SCI-induced impairments in mice movement by negatively affecting the promoter activity of MMP-2 and MMP-9 genes and thus decreasing the expression of MMP-2 and MMP-9 proteins.	[Zhang, Hongqi; Chu, Ge; Pan, Chao; Hu, Jianzhong; Guo, Chaofeng; Liu, Jinyang; Wang, Yuxiang; Wu, Jianhuang] Cent S Univ, Xiangya Hosp, Xiangya Spinal Surg Ctr, Dept Spine Surg, Changsha 410008, Hunan, Peoples R China		Zhang, HQ (corresponding author), Cent S Univ, Xiangya Hosp, Xiangya Spinal Surg Ctr, Dept Spine Surg, 87 Xiang Ya Rd, Changsha 410008, Hunan, Peoples R China.	spinesurgery@sina.com			national natural science foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171698, 81371956]	This study was supported by the national natural science foundation of China (grants No. 81171698 and No. 81371956).	Ahmad FU, 2014, WORLD NEUROSURG, V82, P207, DOI 10.1016/j.wneu.2013.01.008; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; Hansen CN, 2013, J NEUROSCI, V33, P13101, DOI 10.1523/JNEUROSCI.1576-13.2013; Kankaanranta H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090298; Kenney K, 2013, JAMA NEUROL, V70, P1333; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Lau BYB, 2013, EXP NEUROL, V250, P31, DOI 10.1016/j.expneurol.2013.09.004; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Markiewicz L, 2013, ACTA OPHTHALMOL, V91, pE516, DOI 10.1111/aos.12149; Miao XP, 2003, CANCER RES, V63, P3987; Nakano N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073494; Neirinckx V, 2014, STEM CELLS, V32, P829, DOI 10.1002/stem.1579; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Papa S, 2013, ACS NANO, V7, P9881, DOI 10.1021/nn4036014; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Roomi MW, 2013, INT J ONCOL, V43, P1027, DOI 10.3892/ijo.2013.2031; Stetler-Stevenson W G, 2001, Surg Oncol Clin N Am, V10, P383; STETLERSTEVENSON WG, 1990, CANCER METAST REV, V9, P289, DOI 10.1007/BF00049520; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Tang MP, 2014, NEUROPHARMACOLOGY, V81, P256, DOI 10.1016/j.neuropharm.2014.02.008; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yamamoto A, 2014, METHODS MOL BIOL, V1213, P321, DOI 10.1007/978-1-4939-1453-1_26; Zemper Eric D., 1994, Journal of Athletic Training, V29, P44	26	5	5	0	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2014	8	6					1835	1840		10.3892/etm.2014.2021			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AU9YN	WOS:000345948000029	25371741	Green Submitted, gold, Green Published			2022-02-06	
J	Begonia, MT; Prabhu, R; Liao, J; Whittington, WR; Claude, A; Willeford, B; Wardlaw, J; Wu, R; Zhang, S; Williams, LN				Begonia, M. T.; Prabhu, R.; Liao, J.; Whittington, W. R.; Claude, A.; Willeford, B.; Wardlaw, J.; Wu, R.; Zhang, S.; Williams, L. N.			Quantitative analysis of brain microstructure following mild blunt and blast trauma	JOURNAL OF BIOMECHANICS			English	Article						Mild traumatic brain injury; Blunt trauma; Blast trauma; Diffusion tensor imaging; Image analysis	AXONAL INJURY; FIBER TRACKING; TRACTOGRAPHY METRICS; STRESS STATE; MOUSE MODEL; DIFFUSION; STRAIN; CONCUSSION; MECHANISMS; SEQUELAE	We induced mild blunt and blast injuries in rats using a custom-built device and utilized in-house diffusion tensor imaging (DTI) software to reconstruct 3-D fiber tracts in brains before and after injury (1, 4, and 7 days). DTI measures such as fiber count, fiber length, and fractional anisotropy (FA) were selected to characterize axonal integrity. In-house image analysis software also showed changes in parameters including the area fraction (AF) and nearest neighbor distance (NND), which corresponded to variations in the microstructure of Hematoxylin and Eosin (H&E) brain sections. Both blunt and blast injuries produced lower fiber counts, but neither injury case significantly changed the fiber length. Compared to controls, blunt injury produced a lower FA, which may correspond to an early onset of diffuse axonal injury (DAI). However, blast injury generated a higher FA compared to controls. This increase in FA has been linked previously to various phenomena including edema, neuroplasticity, and even recovery. Subsequent image analysis revealed that both blunt and blast injuries produced a significantly higher AF and significantly lower NND, which correlated to voids formed by the reduced fluid retention within injured axons. In conclusion, DTI can detect subtle pathophysiological changes in axonal fiber structure after mild blunt and blast trauma. Our injury model and DTI method provide a practical basis for studying mild traumatic brain injury (mTBI) in a controllable manner and for tracking injury progression. Knowledge gained from our approach could lead to enhanced mTBI diagnoses, biofidelic constitutive brain models, and specialized pharmaceutical treatments. (C) 2014 Elsevier Ltd. All rights reserved.	[Begonia, M. T.; Prabhu, R.; Liao, J.; Williams, L. N.] Mississippi State Univ, Dept Agr & Biol Engn, Mississippi State, MS 39762 USA; [Prabhu, R.; Liao, J.; Whittington, W. R.; Williams, L. N.] CAVS, Starkville, MS 39759 USA; [Claude, A.; Willeford, B.] Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA; [Wardlaw, J.] Gateway Vet Surg, St Louis, MO 63131 USA; [Wu, R.; Zhang, S.] Mississippi State Univ, Dept Comp Sci & Engn, Mississippi State, MS 39762 USA		Williams, LN (corresponding author), Dept Agr & Biol Engn, 130 Creelman St, Mississippi State, MS 39762 USA.	lwilliams@abe.msstate.edu	Liao, Jun/AAW-3591-2021; Prabhu, Raj/M-7188-2017	Liao, Jun/0000-0003-1049-5783; Whittington, Wilburn/0000-0002-1635-9830; Prabhu, Raj/0000-0002-6073-4802	MSU Department of Agricultural and Biological Engineering	This research was supported by the MSU Department of Agricultural and Biological Engineering. The authors wish to thank Gary Sorrells from the Institute for Imaging 82 Analytical Technologies (I<SUP>2</SUP>AT) for performing DTI in this study. The authors also wish to recognize Dr. Jim Cooley, Stephany Mays, and Mike Bassett from the MSU College of Veterinary Medicine for their assistance with tissue extraction, histological processing, and animal care, respectively. In addition, the authors wish to thank Dr. Joseph Purswell, Brian Luck, Wayne Hodo, and Daniel Chesser for lending their respective technical expertise toward the design and fabrication of our test device.	Appelboom G, 2012, ACTA NEUROCHIR, V154, P131, DOI 10.1007/s00701-011-1210-3; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Begonia MT, 2010, ANN BIOMED ENG, V38, P3043, DOI 10.1007/s10439-010-0072-9; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Bigler E.D., 2012, PTSD MILD TRAUMATIC; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Budde MD, 2008, NMR BIOMED, V21, P589, DOI 10.1002/nbm.1229; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Correia S, 2008, NEUROIMAGE, V42, P568, DOI 10.1016/j.neuroimage.2008.05.022; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Ducreux D, 2007, NEUROIMAG CLIN N AM, V17, P137, DOI 10.1016/j.nic.2006.11.005; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Faul M, 2010, TRAUMATIC BRAIN INJU; Heemskerk AM, 2007, RADIOLOGY, V243, P413, DOI 10.1148/radiol.2432060491; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horstemeyer MF, 2000, THEOR APPL FRACT MEC, V33, P31, DOI 10.1016/S0167-8442(99)00049-X; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Lansdown DA, 2007, J APPL PHYSIOL, V103, P673, DOI 10.1152/japplphysiol.00290.2007; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Ozanne A, 2007, AM J NEURORADIOL, V28, P1271, DOI 10.3174/ajnr.A0541; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Prabhu R, 2011, J MECH BEHAV BIOMED, V4, P1067, DOI 10.1016/j.jmbbm.2011.03.015; Rosenbaum S., 2012, RAD SOC N AM 2012 SC; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Tate DF, 2010, BRAIN IMAGING BEHAV, V4, P68, DOI 10.1007/s11682-009-9086-z; van de Looij Y, 2012, NMR BIOMED, V25, P93, DOI 10.1002/nbm.1721; Vandevelde M., 2012, VET NEUROPATHOLOGY E; Weed BC, 2012, ANN BIOMED ENG, V40, P2255, DOI 10.1007/s10439-012-0588-2; Wu EX, 2007, MAGN RESON IMAGING, V25, P1048, DOI 10.1016/j.mri.2006.12.008; Zhang JY, 2012, TRENDS NEUROSCI, V35, P412, DOI 10.1016/j.tins.2012.04.010; Zhang S, 2004, MAGNET RESON MED, V51, P140, DOI 10.1002/mrm.10673; Zhang S, 2003, IEEE T VIS COMPUT GR, V9, P454, DOI 10.1109/TVCG.2003.1260740; Zhang S, 2010, ANN BIOMED ENG, V38, P3084, DOI 10.1007/s10439-010-0073-8; Zhu T, 2011, NEUROIMAGE, V56, P1398, DOI 10.1016/j.neuroimage.2011.02.010	61	5	7	0	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	NOV 28	2014	47	15					3704	3711		10.1016/j.jbiomech.2014.09.026			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	AU7UC	WOS:000345805500016	25446270				2022-02-06	
J	Allen, AR; Eilertson, K; Sharma, S; Baure, J; Allen, B; Leu, D; Rosi, S; Raber, J; Huang, TT; Fike, JR				Allen, Antino R.; Eilertson, Kirsten; Sharma, Sourabh; Baure, Jennifer; Allen, Barrett; Leu, David; Rosi, Susanna; Raber, Jacob; Huang, Ting-Ting; Fike, John R.			Delayed Administration of Alpha-Difluoromethylornithine Prevents Hippocampus-Dependent Cognitive Impairment after Single and Combined Injury in Mice	RADIATION RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; RADIATION-INDUCED IMPAIRMENT; OXIDATIVE STRESS; ORNITHINE-DECARBOXYLASE; ADULT NEUROGENESIS; POLYAMINES; OVEREXPRESSION; INHIBITOR; RESPONSES; EXPOSURE	Radiation exposure due to radiological terrorism and military circumstances are a continuing threat for the civilian population. In an uncontrolled radiation event, it is likely that there will be other types of injury involved, including trauma. While radiation combined injury is recognized as an area of great significance, overall there is a paucity of information regarding the mechanisms underlying the interactions between irradiation and other forms of injury, or what countermeasures might be effective in ameliorating such changes. The objective of this study was to determine if difluoromethylornithine (DFMO) could reduce the adverse effects of single or combined injury if administered beginning 24 h after exposure. Eight-week-old C57BL/J6 young-adult male mice received whole-body cesium-137 (137Cs) irradiation with 4 Gy. Immediately after irradiation, unilateral traumatic brain injury was induced using a controlled cortical impact system. Forty-four days postirradiation, animals were tested for hippocampus-dependent cognitive performance in the Morris water maze. After cognitive testing, animals were euthanized and their brains snap frozen for immunohistochemical assessment of neuroinflammation (activated microglia) and neurogenesis in the hippocampal dentate gyrus. Our data show that single and combined injuries induced variable degrees of hippocampus-dependent cognitive dysfunction, and when given 24 h post trauma, DFMO treatment ameliorated those effects. Cellular changes including neurogenesis and numbers of activated microglia were generally not associated with the cognitive changes. Further analyses also revealed that DFMO increased hippocampal protein levels of the antioxidants thioredoxin 1 and peroxiredoxin 3 compared to vehicle treated animals. While the mechanisms responsible for the improvement in cognition after DFMO treatment are not yet clear, these results constitute a basis for further development of DFMO as a countermeasure for ameliorating the of risks for cognitive dysfunction in individuals subjected to trauma and radiation combined injury. (C) 2014 by Radiation Research Society	[Allen, Antino R.] Univ Arkansas Med Sci, Div Radiat Hlth, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Eilertson, Kirsten] Gladstone Inst San Francisco, Bioinformat Core, San Francisco, CA 94158 USA; [Sharma, Sourabh; Baure, Jennifer; Allen, Barrett; Rosi, Susanna; Fike, John R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, Dept Neurol Surg, San Francisco, CA 94110 USA; [Rosi, Susanna] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Fike, John R.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA 94110 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Neurol, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, ONPRC, Dept Radiat Med, Div Neurosci, Portland, OR 97239 USA; [Leu, David; Huang, Ting-Ting] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94304 USA; [Huang, Ting-Ting] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA		Allen, AR (corresponding author), Univ Arkansas Med Sci, 4301 West Markham,Suite 441B-2, Little Rock, AR 72205 USA.	AAllen@uams.edu			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R33 AI080531]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R33AI080531] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health (NIH) grant R33 AI080531. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We thank Julian Habdank-Kolaczkowski for his assistance with the immunohistochemical experiments.	Achanta P, 2009, BEHAV NEUROSCI, V123, P1036, DOI 10.1037/a0016870; Allen AR, 2014, INT J RADIAT BIOL, V90, P214, DOI 10.3109/09553002.2014.859761; Baskaya MK, 1996, J NEUROTRAUM, V13, P85, DOI 10.1089/neu.1996.13.85; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Cao Z, 2007, J MOL BIOL, V372, P1022, DOI 10.1016/j.jmb.2007.07.018; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; FIKE JR, 1994, RADIAT RES, V138, P99, DOI 10.2307/3578852; FIKE JR, 1995, INT J RADIAT ONCOL, V32, P1035, DOI 10.1016/0360-3016(95)00030-3; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; GOBBEL GT, 1991, RADIAT RES, V128, P306, DOI 10.2307/3578054; Hattori F, 2003, J NEUROCHEM, V86, P860, DOI 10.1046/j.1471-4159.2003.01918.x; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Jenrow KA, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-6; Johnston A McD, 2004, J R Army Med Corps, V150, P22; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; Kim A, 2010, FREE RADICAL BIO MED, V48, P1501, DOI 10.1016/j.freeradbiomed.2010.02.028; Kraft AD, 2011, INT J ENV RES PUB HE, V8, P2980, DOI 10.3390/ijerph8072980; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Love S, 1999, BRAIN PATHOL, V9, P119; Malaterre J, 2004, EUR J NEUROSCI, V20, P317, DOI 10.1111/j.1460-9568.2004.03498.x; Matsushima S, 2006, CIRCULATION, V113, P1779, DOI 10.1161/CIRCULATIONAHA.105.582239; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2003, CURR OPIN NEUROL, V16, P129, DOI 10.1097/00019052-200304000-00002; Morgan DML, 1999, MOL BIOTECHNOL, V11, P229, DOI 10.1007/BF02788682; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pellmar TC, 2005, P M 099 RAD BIOEFF C, P1; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Peuchen S, 1997, PROG NEUROBIOL, V52, P261, DOI 10.1016/S0301-0082(97)00010-5; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2007, FREE RADICAL BIO MED, V42, P1133, DOI 10.1016/j.freeradbiomed.2007.01.020; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rosi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031094; Rosi S, 2012, HIPPOCAMPUS, V22, P544, DOI 10.1002/hipo.20920; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Smith KJ, 1999, BRAIN PATHOL, V9, P69; Sparapani M, 1996, EXP BRAIN RES, V108, P433; Takagi Y, 1999, P NATL ACAD SCI USA, V96, P4131, DOI 10.1073/pnas.96.7.4131; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang H, 2007, ARCH BIOCHEM BIOPHYS, V465, P119, DOI 10.1016/j.abb.2007.05.001	44	5	5	0	4	RADIATION RESEARCH SOC	LAWRENCE	810 E TENTH STREET, LAWRENCE, KS 66044 USA	0033-7587	1938-5404		RADIAT RES	Radiat. Res.	NOV	2014	182	5					489	498		10.1667/RR13753.1			10	Biology; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics; Biophysics; Radiology, Nuclear Medicine & Medical Imaging	AU4TL	WOS:000345604200003	25375198	Green Accepted			2022-02-06	
J	Chou, YC; Yeh, CC; Hu, CJ; Meng, NH; Chiu, WT; Chou, WH; Chen, TL; Liao, CC				Chou, Yi-Chun; Yeh, Chun-Chieh; Hu, Chaur-Jong; Meng, Nai-Hsin; Chiu, Wen-Ta; Chou, Wan-Hsin; Chen, Ta-Liang; Liao, Chien-Chang			Risk and Mortality of Traumatic Brain Injury in Stroke Patients: Two Nationwide Cohort Studies	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mortality; stroke; traumatic brain injury	POSTOPERATIVE ADVERSE OUTCOMES; MEDICAL COMPLICATIONS; SURGICAL-PATIENTS; POPULATION; EPILEPSY; COUNTRIES; DEMENTIA; SUICIDE; TRENDS; FALLS	Objective: Patients with stroke had higher incidence of falls and hip fractures. However, the risk of traumatic brain injury (TBI) and post-TBI mortality in patients with stroke was not well defined. Our study is to investigate the risk of TBI and post-TBI mortality in patients with stroke. Methods: Using reimbursement claims from Taiwan's National Health Insurance Research Database, we conducted a retrospective cohort study of 7622 patients with stroke and 30 488 participants without stroke aged 20 years and older as reference group. Data were collected on newly developed TBI after stroke with 5 to 8 years' follow-up during 2000 to 2008. Another nested cohort study including 7034 hospitalized patients with TBI was also conducted to analyze the contribution of stroke to post-TBI in-hospital mortality. Results: Compared with the nonstroke cohort, the adjusted hazard ratio of TBI risk among patients with stroke was 2.80 (95% confidence interval = 2.58-3.04) during the follow-up period. Patients with stroke had higher mortality after TBI than those without stroke (10.2% vs 3.2%, P < .0001) with an adjusted relative risk (RR) of 1.46 (95% confidence interval = 1.15-1.84). Recurrent stroke (RR = 1.60), hemorrhagic stroke (RR = 1.68), high medical expenditure for stroke (RR = 1.80), epilepsy (RR = 1.79), neurosurgery (RR = 1.94), and hip fracture (RR = 2.11) were all associated with significantly higher post-TBI mortality among patients with stroke. Conclusions: Patients with stroke have an increased risk of TBI and in-hospital mortality after TBI. Various characteristics of stroke severity were all associated with higher post-TBI mortality. Special attention is needed to prevent TBI among these populations.	[Chou, Yi-Chun; Meng, Nai-Hsin] China Med Univ Hosp, Dept Phys Med & Rehabil, Taichung, Taiwan; [Yeh, Chun-Chieh] China Med Univ, Sch Med, Taichung, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Chiu, Wen-Ta] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Chou, Yi-Chun; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei 110, Taiwan; [Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ Hosp, Ctr Hlth Policy Res, Taipei 110, Taiwan; [Hu, Chaur-Jong; Chen, Ta-Liang; Liao, Chien-Chang] Taipei Med Univ, Sch Med, Taipei, Taiwan		Liao, CC (corresponding author), Taipei Med Univ Hosp, Dept Anesthesiol, 252 Wuxing St, Taipei 110, Taiwan.	jacky48863027@yahoo.com.tw	Yeh, Chun Chieh/I-4893-2019	Yeh, Chun Chieh/0000-0001-6753-7564	Foundation for Anesthesia Education and Research fellowship; National Science CouncilMinistry of Science and Technology, Taiwan [NSC102-2314-B-038-021MY3]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant to Taipei Medical University. This study is also supported in part by National Science Council (NSC102-2314-B-038-021MY3) and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004).	Chang CC, 2012, EPILEPSIA, V53, P987, DOI 10.1111/j.1528-1167.2012.03448.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chou YC, 2012, J REHABIL MED, V44, P319, DOI 10.2340/16501977-0935; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Hu CJ, 2012, WORLD J SURG, V36, P2051, DOI 10.1007/s00268-012-1609-x; Hyndman D, 2004, J NEUROL NEUROSUR PS, V75, P994, DOI 10.1136/jnnp.2003.016014; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Ishibe N, 2009, J HEAD TRAUMA REHAB, V24, P424, DOI 10.1097/HTR.0b013e3181c13426; Kannus P, 1999, JAMA-J AM MED ASSOC, V281, P1895, DOI 10.1001/jama.281.20.1895; Kannus P, 2001, JAMA-J AM MED ASSOC, V286, P673, DOI 10.1001/jama.286.6.673; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Kumar S, 2010, LANCET NEUROL, V9, P105, DOI 10.1016/S1474-4422(09)70266-2; Lai SW, 2010, MEDICINE, V89, P295, DOI 10.1097/MD.0b013e3181f15efc; Liao CC, 2013, ANN SURG, V257, P433, DOI 10.1097/SLA.0b013e31827b9b25; Liao CC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/387164; Liao CC, 2012, J TRAUMA ACUTE CARE, V73, P1327, DOI 10.1097/TA.0b013e31826fc87f; Liao CC, 2012, J NEUROL NEUROSUR PS, V83, P1186, DOI 10.1136/jnnp-2012-302337; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Poole KES, 2002, STROKE, V33, P1432, DOI 10.1161/01.STR.0000014510.48897.7D; Rabadi MH, 2010, STROKE, V41, P2991, DOI 10.1161/STROKEAHA.110.587196; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; Simpson LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019431; Stenager EN, 1998, BRIT MED J, V316, P1206, DOI 10.1136/bmj.316.7139.1206; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Teasdale TW, 2001, J EPIDEMIOL COMMUN H, V55, P863, DOI 10.1136/jech.55.12.863; Wu CH, 2012, AM J MANAG CARE, V18; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547	32	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2014	29	6					514	521		10.1097/HTR.0000000000000007			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT7LI	WOS:000345117800012	24263175				2022-02-06	
J	Huang, CT; Lin, WC; Ho, CH; Tung, LC; Chu, CC; Chou, W; Wang, CH				Huang, Chin-Tsan; Lin, Wen-Chih; Ho, Chung-Han; Tung, Li-Chen; Chu, Chin-Chen; Chou, Willy; Wang, Chun-Hou			Incidence of Severe Dysphagia After Brain Surgery in Pediatric Traumatic Brain Injury: A Nationwide Population-Based Retrospective Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						dysphagia; medical service utilization; pediatrics; swallowing; traumatic brain injury	RISK-FACTORS; HEAD-INJURY; REHABILITATION; PROGRESSION; PREVALENCE; MORTALITY; CHILDREN; INSULT; ADULTS; AGE	Objectives: To investigate the incidence of dysphagia and medical resource utilization in a nationwide population of pediatric patients with traumatic brain injury (TBI). Setting: Subjects' data were obtained from the Taiwan National Health Insurance Research Database. Participants: Between 2000 and 2008, 6290 children less than 18 years old who had received surgery post-TBI were included in the study. Design: Retrospective study. Main Outcome Measure: Biographic data and medical utilization results. Results: Of all the children postsurgery after TBI, 12.3% were categorized as having severe dysphagia. The occurrence of severe dysphagia was not related to sex but was statistically and significantly related to a younger mean age. The relationship between age and dysphagia also showed an interestingly biphasic distribution, mostly in the subgroups of 1 to 3 and 16 to 18 years of age. The medical resource utilization was higher in severely dysphagia patients, but only 8.4% received intervention by a speech language pathologist. Conclusions: Severe dysphagia among postsurgical pediatric patients after TBI is relatively common, and those with severe dysphagia have a greater need for medical services. However, the ratio of such patients who receive swallowing treatment is still low in Taiwan. Clinicians are prompted to pay more attention to the impairment in functional oral intake of children postsurgery after TBI.	[Huang, Chin-Tsan; Tung, Li-Chen; Chou, Willy] Chi Mei Med Ctr, Dept Phys Med & Rehabil, Liouying, Taiwan; [Lin, Wen-Chih] Chiali Chi Mei Hosp, Dept Phys Med & Rehabil, Tainan, Taiwan; [Ho, Chung-Han] Chi Mei Med Ctr, Dept Med Res, Liouying, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Chu, Chin-Chen] Chi Mei Med Ctr, Dept Anesthesiol, Liouying, Taiwan; [Chu, Chin-Chen] Chia Nan Univ Pharm & Sci, Dept Recreat & Hlth Care Management, Tainan, Taiwan; [Wang, Chun-Hou] Chung Shan Med Univ, Sch Phys Therapy, Taichung 40201, Taiwan; [Wang, Chun-Hou] Chung Shan Med Univ Hosp, Taichung 40201, Taiwan		Wang, CH (corresponding author), Chung Shan Med Univ, Sch Phys Therapy, 110,Sec 1,Jianguo N Rd, Taichung 40201, Taiwan.	chwang@csmu.edu.tw		Ho, Chung-Han/0000-0001-5925-8477			Alhashemi HH, 2010, NEUROSCIENCES, V15, P231; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Cherney LR, 1996, SEMIN NEUROL, V16, P349, DOI 10.1055/s-2008-1040993; Cherney LR, 1989, J HEAD TRAUMA REHAB, V4, P42; Chou YC, 2012, J REHABIL MED, V44, P319, DOI 10.2340/16501977-0935; Cook RC, 2010, SEMIN PEDIATR SURG, V19, P242, DOI 10.1053/j.sempedsurg.2010.06.001; Eker C, 2000, BRAIN INJURY, V14, P605; Howe TH, 2010, RES DEV DISABIL, V31, P510, DOI 10.1016/j.ridd.2009.11.001; Howle AA, 2011, BRAIN IMPAIR, V12, P179; Lin CM, 2014, INJURY, V45, P690, DOI 10.1016/j.injury.2013.09.031; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Martin RE, 2009, DYSPHAGIA, V24, P218, DOI 10.1007/s00455-008-9193-9; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Morgan A, 2004, BRAIN INJURY, V18, P359, DOI 10.1080/02699050310001617424; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Morgan AT, 2010, CHILD CARE HLTH DEV, V36, P44, DOI 10.1111/j.1365-2214.2009.00961.x; Morgan AT, 2010, DEV NEUROREHABIL, V13, P192, DOI 10.3109/17518420903289535; Rowe LA, 1999, J HEAD TRAUMA REHAB, V14, P497, DOI 10.1097/00001199-199910000-00010; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992; YLVISAKER M, 1989, J HEAD TRAUMA REHAB, V4, P51	23	5	6	2	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2014	29	6					E31	E36		10.1097/HTR.0000000000000032			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT7LI	WOS:000345117800004	24590154				2022-02-06	
J	Nishiyama, M; Fujita, K; Maruyama, A; Nagase, H				Nishiyama, Masahiro; Fujita, Kyoko; Maruyama, Azusa; Nagase, Hiroaki			Two cases of traumatic head injury mimicking acute encephalopathy with biphasic seizures and late reduced diffusion	BRAIN & DEVELOPMENT			English	Article						AESD; Head injury; Acute encephalopathy	IMAGING FINDINGS; BRAIN-INJURY; CHILDREN	Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) presents a distinct clinical course of biphasic seizures and impaired consciousness. These symptoms are followed by reduced diffusion in the subcortical white matter on magnetic resonance imaging that is typically observed between 3 and 9 days after illness onset. Here, we report two cases of traumatic head injury with clinical and radiological features similar to those for AESD. The similarities between our cases and AESD may be useful in understanding the pathogenesis of AESD. (C) 2013 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Nishiyama, Masahiro; Fujita, Kyoko; Maruyama, Azusa; Nagase, Hiroaki] Hyogo Prefectural Kobe Childrens Hosp, Dept Neurol, Kobe, Hyogo 6540081, Japan		Nagase, H (corresponding author), Hyogo Prefectural Kobe Childrens Hosp, Dept Neurol, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	nagasehiroaki@msn.com					Hoshino A, 2012, BRAIN DEV-JPN, V34, P337, DOI 10.1016/j.braindev.2011.07.012; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Mizuguchi M, 2007, ACTA NEUROL SCAND, V115, P45, DOI 10.1111/j.1600-0404.2007.00809.x; Moritani T, 2005, AM J NEURORADIOL, V26, P216; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Suh DY, 2001, NEUROSURGERY, V49, P309, DOI 10.1097/00006123-200108000-00011; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; Young BG, 1996, NEUROLOGY, V47, P83	10	5	5	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	NOV	2014	36	10					928	931		10.1016/j.braindev.2013.12.006			4	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	CA8WR	WOS:000349202100015	24411946				2022-02-06	
J	O'Neil, B; Naunheim, R; DeLorenzo, R				O'Neil, Brian; Naunheim, Rosanne; DeLorenzo, Robert			CT Positive Brain Injury in Mild TBI Patients Presenting With Normal SAC Scores	MILITARY MEDICINE			English	Article							SPORT-RELATED CONCUSSION; COMPUTED-TOMOGRAPHY; HEAD-INJURY; MANAGEMENT; RECOVERY	Introduction: Traumatic brain injury accounts for over 1 million U.S. emergency department visits annually. A significant percentage of patients undergo CT scans to exclude intracranial bleeds. The Standardized Assessment of Concussion (SAC) is designed to rapidly determine whether a concussion has occurred, (0-30 scale, where 3 25 is considered normal). Although not intended to be used in isolation, results in the normal range are considered an indication of low suspicion of brain injury. This study evaluated the relationship between CT findings of structural injury (CT+) and performance on the SAC. Methods: We performed a prospective observational study on mild head-injured patients presenting to the emergency department who underwent CT scans and had SAC evaluations. Results: We enrolled 368 patients, of which 66 were read by a neuroradiologist as positive (CT+), with an average age of 46.7, and an average Glasgow Coma Scale of 14.85. 38.2% of these CT+ patients had a SAC score >= 25. There were no significant differences between time of injury and CT scan or SAC for those with high or low SAC scores. Both high and low SAC groups contained similar CT+ abnormalities (e.g., hematomas). Conclusions: These results indicate that a normal SAC score alone does not exclude intracranial injury.	[O'Neil, Brian] Wayne State Univ, Sch Med, Dept Emergency Med, Univ Hlth Ctr 6G, Detroit, MI 48201 USA; [Naunheim, Rosanne] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO 63110 USA; [DeLorenzo, Robert] US Army, Med Corps, Inst Surg Res, Tact Combat Casualty Care Res Program, Ft Sam Houston, TX 78234 USA		O'Neil, B (corresponding author), Wayne State Univ, Sch Med, Dept Emergency Med, Univ Hlth Ctr 6G, 4201 St Antoine, Detroit, MI 48201 USA.			De Lorenzo, Robert/0000-0003-4364-9590	BrainScope, Bethesda, Maryland; Department of DefenseUnited States Department of Defense [W911QY-12-C-0004]	The authors acknowledge the contributions of those who made this research possible, including the primary investigators and research technicians at all the clinical sites and the patients who volunteered. This research was supported in part by BrainScope, Bethesda, Maryland, who granted expenses related to data acquisition, and from the Department of Defense, contract No. W911QY-12-C-0004, Assessment of Head Injury in the Emergency Department.	[Anonymous], 2008, DEF VET BRAIN INJ CT; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Barr WB, 2012, BRAIN INJURY, V26, P58, DOI 10.3109/02699052.2011.608216; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Coldren RL, 2010, MIL MED, V175, P477, DOI 10.7205/MILMED-D-09-00258; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; Nassiri JD, 2002, MIL MED, V167, P873, DOI 10.1093/milmed/167.10.873; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50	20	5	5	0	2	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11					1250	1253		10.7205/MILMED-D-13-00585			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CA7LK	WOS:000349098600018	25373049				2022-02-06	
J	Prodan, CI; Vincent, AS; Dale, GL				Prodan, Calin I.; Vincent, Andrea S.; Dale, George L.			Coated-Platelet Levels Are Persistently Elevated in Patients With Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; platelets; stroke; thrombosis	HEAD-INJURY; STROKE; INFARCTION; SEROTONIN; LACUNAR; SURFACE; RISK	Objective: Coated-platelets are procoagulant platelets that are elevated in patients with large-vessel ischemic stroke and are associated with stroke recurrence. Because of recent reports showing an increased risk for stroke following traumatic brain injury (TBI), we undertook a pilot study to investigate coated-platelet synthesis in veterans with TBI. Design: Cross-sectional study. Participants: Forty patients with a diagnosis of mild TBI (mTBI) and 40 controls without a history of TBI and matched for age, gender, and ethnicity/race were enrolled in the study. Main Measure: Coated-platelet levels were determined in patients with mTBI and controls. The time period since most recent injury ranged from 6 months to 9 years. Results: Coated-platelet levels were significantly higher for mTBI patients than for controls (mean +/- SD = 52.0% +/- 14.0% vs 35.4% +/- 13.0%; P < .0001). No relationship between these levels and the length of time since the last injury was found (P = .5). Conclusions: Coated-platelet levels are markedly and persistently elevated in individuals with mTBI. These data suggest a link to previous findings of increased stroke risk and chronic inflammation among individuals who sustained a TBI.	[Prodan, Calin I.] Vet Adm Med Ctr, Oklahoma City, OK 73104 USA; [Prodan, Calin I.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, Oklahoma City, OK 73104 USA; [Dale, George L.] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Oklahoma City, OK 73104 USA; [Vincent, Andrea S.] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73019 USA		Prodan, CI (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, 920 SL Young Blvd,Ste 2040, Oklahoma City, OK 73104 USA.	calin-prodan@ouhsc.edu			Department of Veterans Affairs Clinical Science Research & Development Service [1I01CX000340]	The work was supported by the Department of Veterans Affairs Clinical Science Research & Development Service (grant no. 1I01CX000340).	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V88, P86; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Brooks MB, 2007, J THROMB HAEMOST, V5, P1972, DOI 10.1111/j.1538-7836.2007.02683.x; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Dale GL, 2005, J THROMB HAEMOST, V3, P2185, DOI 10.1111/j.1538-7836.2005.01274.x; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; *DEF VET BRAIN INJ, 2006, CLIN PRACT GUID REC; Faul M, 2010, TRAUMATIC BRAIN INJU; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Jenkins Alicia J, 2008, Diabetes Res Clin Pract, V81, pe8, DOI 10.1016/j.diabres.2008.04.004; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; McCrea M., 2008, MILD TRAUMATIC BRAIN; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Norgard NB, 2008, J CARDIOVASC PHARM, V52, P536, DOI 10.1097/FJC.0b013e3181907390; Prodan CI, 2008, J THROMB HAEMOST, V6, P609, DOI 10.1111/j.1538-7836.2008.02890.x; Prodan CI, 2007, J THROMB HAEMOST, V5, P2149, DOI 10.1111/j.1538-7836.2007.02691.x; Prodan CI, 2010, J THROMB HAEMOST, V8, P1185, DOI 10.1111/j.1538-7836.2010.03851.x; Prodan CI, 2013, PLATELETS, V24, P316, DOI 10.3109/09537104.2012.696747; Prodan CI, 2013, J CEREBR BLOOD F MET, V33, P287, DOI 10.1038/jcbfm.2012.168; Prodan CI, 2009, STROKE, V40, P2578, DOI 10.1161/STROKEAHA.109.549014; Prodan CI, 2006, PLATELETS, V17, P56, DOI 10.1080/09537100500181913; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Valaydon ZS, 2009, NEPHROLOGY, V14, P148, DOI 10.1111/j.1440-1797.2008.01026.x; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246	30	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2014	29	6					522	526		10.1097/HTR.0000000000000010			5	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT7LI	WOS:000345117800013	24336148				2022-02-06	
J	Spooner, SP; Tyner, SD; Sowers, C; Tsao, J; Stuessi, K				Spooner, Shawn P.; Tyner, Stuart D.; Sowers, Christopher; Tsao, Jack; Stuessi, Keith			Utility of a Sports Medicine Model in Military Combat Concussion and Musculoskeletal Restoration Care	MILITARY MEDICINE			English	Article							OPERATION-IRAQI-FREEDOM; INJURY; RETURN; DUTY; WAR	Combat-related concussions are significant sources of injury and morbidity among deployed military service members. Musculoskeletal injury also is one of the most prevalent battle and nonbattle-related deployed injury types. Both injuries threaten the service member's physical condition as well as unit and mission readiness due to reduced duty status or evacuation from military theater of operations. In August 2010, the Concussion Restoration Care Center (CRCC) was established at Camp Leatherneck, Afghanistan, to address the need for consistent and specialized evaluation and care of concussion and musculoskeletal injury. This performance improvement effort examined evaluation and treatment of concussion and musculoskeletal injury at the CRCC. Among 4,947 military personnel evaluated at the CRCC between August 2010 and May 2013, 97.9% were returned to duty and retained in theater. Members averaged 10 to 12 days of limited duty status to achieve complete recovery. Concussion injury was secondary to blast injury in 90% of cases. Sport/recreation, occupational, and other accidental injuries each represented 30% of the musculoskeletal injuries with only 10% reported as result of combat. The utilization patterns and outcome measures demonstrate the success and utility of a multidisciplinary clinical model of care for these two types of injuries in the far-forward deployed setting.	[Spooner, Shawn P.] Captain James A Lovell Fed Healthcare Ctr, N Chicago, IL 60064 USA; [Spooner, Shawn P.] Unity Point Clin, Des Moines, IA 50322 USA; [Spooner, Shawn P.] Unity Point Clin Sports Med Urbandale, Urbandale, IA 50322 USA; [Tyner, Stuart D.] US Army, Inst Surg Res, Ft Sam Houston, TX 78234 USA; [Stuessi, Keith] Naval Hosp Camp Pendleton, Camp Pendleton, CA 92055 USA; [Tsao, Jack] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA		Spooner, SP (corresponding author), Captain James A Lovell Fed Healthcare Ctr, 3001 Green Bay Rd, N Chicago, IL 60064 USA.						Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Defense and Veteran Brain Injury (DVBIC), 2008, DEF VET BRAIN INJ CT; Gerhardt RT, 2009, ANN EMERG MED, V53, P169, DOI 10.1016/j.annemergmed.2008.04.013; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Masters D, THESIS; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Taber KH, 2010, PTSD RES Q, V21, P1; Zouris JM, 2008, MIL MED, V173, P247, DOI 10.7205/MILMED.173.3.247	12	5	5	0	4	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	NOV	2014	179	11					1319	1324		10.7205/MILMED-D-14-00191			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CA7LK	WOS:000349098600030	25373061	Bronze			2022-02-06	
J	Zysko, D; Sutton, R; Timler, D; Furtan, S; Melander, O; Fedorowski, A				Zysko, Dorota; Sutton, Richard; Timler, Dariusz; Furtan, Stanislaw; Melander, Olle; Fedorowski, Artur			History of syncope predicts loss of consciousness after head trauma: Retrospective study	CARDIOLOGY JOURNAL			English	Article						head trauma; emergency department; loss of consciousness; syncope; vasovagal syncope	BRAIN-INJURY	Background: Head trauma may present as transient loss of consciousness (TLOC) currently classified as traumatic in origin, in contrast to non-traumatic forms, such as syncope. Whether past history of syncope predisposes to loss of consciousness after head injury has been poorly studied. Methods: A retrospective analysis of data obtained from 818 consecutive patients admitted to Emergency Departments was conducted. Face-to-face semi-structured interviews were performed, where patients' past history of syncope and head injury were explored. Head injury events were stratified as high-or low-energy trauma. Data regarding past syncopal events were explored in regard to number, age at the first occurrence, and syncope circumstances. Multivariate logistic regression model was applied to assess the relationship between loss of consciousness during head injury and past history of syncope. Results: Both past history of non-traumatic TLOC (odds ratio [OR] 3.78; 95% confidence interval [CI] 2.13-6.68, p < 0.001) and high-energy mechanism (OR 3.84; 95% CI 2.35-6.28, p < 0.001) predicted TLOC after head trauma. This relationship was even stronger when past episodes of TLOC were limited to those typical for reflex syncope (OR 4.34; 95% CI 2.34-7.89, p < 0.001). Further, the number of non-traumatic TLOC episodes in the patient's history was also predictive of TLOC after head injury (OR per 1 episode: 1.24; 95% CI 1.04-1.48, p = 0.015). Conclusions: Syncope in a patient's history predicts loss of consciousness after head injury. The clinical importance of this finding merits further investigation.	[Zysko, Dorota] Wroclaw Med Univ, Dept Emergency Med, PL-51618 Wroclaw, Poland; [Sutton, Richard] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Timler, Dariusz] Med Univ Lodz, Dept Emergency Med & Disaster Med, Lodz, Poland; [Furtan, Stanislaw] Univ Med Sci, Zgorzelec Cty Hosp, Dept Emergency Med, Legnica, Poland; [Melander, Olle] Lund Univ, Skane Univ Hosp, Dept Clin Sci, Clin Res Ctr, Malmo, Sweden; [Fedorowski, Artur] Lund Univ, Clin Res Ctr, Skane Univ Hosp, Dept Clin Sci, Malmo, Sweden; [Fedorowski, Artur] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden		Zysko, D (corresponding author), Wroclaw Med Univ, Dept Emergency Med, Ul Bartla 5, PL-51618 Wroclaw, Poland.	dzysko@wp.pl	Timler, Dariusz/S-9720-2016; Fedorowski, Artur/I-3937-2019	Timler, Dariusz/0000-0002-5415-5660; Fedorowski, Artur/0000-0002-5352-6327; Melander, Olle/0000-0002-2581-484X			Adamec I, 2013, NEUROL SCI, V34, P869, DOI 10.1007/s10072-012-1138-2; Barrow A, 2012, EMERG MED J, V29, P983, DOI 10.1136/emermed-2011-200523; Ditto B, 2012, CLIN AUTON RES, V22, P113, DOI 10.1007/s10286-011-0147-1; Icer M, 2013, ULUS TRAVMA ACIL CER, V19, P529, DOI 10.5505/tjtes.2013.77535; Kara H, 2014, CLIN INTERV AGING, V9, P17, DOI 10.2147/CIA.S56542; Kennedy DJ, 2013, PAIN MED, V14, P1854, DOI 10.1111/pme.12241; Kenny RA, 2013, PROG CARDIOVASC DIS, V55, P357, DOI 10.1016/j.pcad.2012.11.006; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Leong LB, 2013, EUR J EMERG MED, V20, P86, DOI 10.1097/MEJ.0b013e328351e5f4; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Pandor A, 2012, J NEUROTRAUM, V29, P707, DOI 10.1089/neu.2011.1967; Rahman YSA, 2010, PREHOSPITAL DISASTER, V25, P59, DOI 10.1017/S1049023X00007676; Roitman P, 2013, J TRAUMA STRESS, V26, P727, DOI 10.1002/jts.21862; Sharif-Alhoseini Mahdi, 2011, J Emerg Trauma Shock, V4, P472, DOI 10.4103/0974-2700.86631; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Sheehan A, 2012, EMERG MED J, V29, P899, DOI 10.1136/emermed-2011-200155; Son Ho Sung, 2014, Korean J Thorac Cardiovasc Surg, V47, P124, DOI 10.5090/kjtcs.2014.47.2.124; Song SY, 2012, KOREAN J ANESTHESIOL, V62, P209, DOI 10.4097/kjae.2012.62.3.209; Thomas-Gibson S, 2002, J ROY SOC MED, V95, P194, DOI 10.1258/jrsm.95.4.194; Vieira EP, J ORAL MAXILLOFAC SU, V69, P3032; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wolf H, 2014, J NEUROSURG, V120, P447, DOI 10.3171/2013.10.JNS13726; Zervou EK, 2005, TRANSFUSION MED, V15, P389, DOI 10.1111/j.1365-3148.2005.00600.x	24	5	5	0	4	VIA MEDICA	GDANSK	UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLAND	1897-5593	1898-018X		CARDIOL J	Cardiol. J.	NOV	2014	21	6					674	678		10.5603/CJ.2014.0099			5	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	CA8SI	WOS:000349190800014	25524736	Green Submitted, gold, Green Published			2022-02-06	
J	Archambault, PM; Gagnon, S; Gagnon, MP; Turcotte, S; Lapointe, J; Fleet, R; Cote, M; Beaupre, P; Le Sage, N; Emond, M; Legare, F				Archambault, Patrick Michel; Gagnon, Susie; Gagnon, Marie-Pierre; Turcotte, Stephane; Lapointe, Jean; Fleet, Richard; Cote, Mario; Beaupre, Pierre; Le Sage, Natalie; Emond, Marcel; Legare, France			Development and Validation of Questionnaires Exploring Health Care Professionals' Intention to Use Wiki-Based Reminders to Promote Best Practices in Trauma	JMIR RESEARCH PROTOCOLS			English	Article						knowledge translation; wiki; collaborative writing applications; decision support tools; health informatics; Theory of Planned Behavior; trauma care; traumatic brain injury; interprofessional collaboration		Background: Little is known about factors influencing professionals' use of wikis. Objective: We developed and validated two questionnaires to assess health care professionals' intention to use wiki-based reminders for the management of trauma patients. Methods: We developed questionnaires for emergency physicians (EPs) and allied health professions (AHPs) based on the Theory of Planned Behavior and adapted them to the salient beliefs of each, identified in an earlier study. Items measured demographics and direct and indirect theoretical constructs. We piloted the questionnaires with 2 focus groups (5 EPs and 5 AHPs) to identify problems of wording and length. Based on feedback, we adjusted the wording and combined certain items. A new convenience sample of 25 EPs and 26 AHPs then performed a test-retest of the questionnaires at a 2-week interval. We assessed internal consistency using Cronbach alpha coefficients and temporal stability of items with an agreement intraclass correlation coefficient (ICC). Results: Five EPs and 5 AHPs (3 nurses, 1 respiratory therapist, and 1 pharmacist) formed 2 focus groups; 25 EPs and 26 AHPs (12 nurses, 7 respiratory therapists, and 7 pharmacists) completed the test and retest. The EP questionnaire test-retest scores for consistency (Cronbach alpha) and stability (ICC) were intention (test: Cronbach alpha=.94; retest: Cronbach alpha=.98; ICC=.89), attitude (.74,.72,.70), subjective norm (.79,.78,.75), perceived behavioral control (.67,.65,.66), attitudinal beliefs (.94,.86,.60), normative beliefs (.83,.87,.79), and control beliefs barriers (.58,.67,.78) and facilitators (.97,.85,.30). The AHP questionnaire scores for consistency and stability were: intention (test Cronbach alpha=.69, retest Cronbach alpha=.81, ICC=.48), attitude (.85,.87,.83), subjective norm (.47,.82,.62), perceived behavioral control (.55,.62,.60), attitudinal beliefs (.92,.91,.82), normative beliefs (.85,.90,.74), and control beliefs barriers (.58,.55,.66) and facilitators (.72,.94, -. 05). To improve the psychometric properties of both questionnaires, we reformulated poorly consistent or unstable items. Conclusions: Our new theory-based questionnaires to measure health care professionals' intention to use wiki-based reminders have adequate validity and reliability for use in large surveys. In the long run, they can be used to develop a theory-based implementation intervention for a wiki promoting best practices in trauma care.	[Archambault, Patrick Michel; Fleet, Richard; Beaupre, Pierre; Le Sage, Natalie; Emond, Marcel; Legare, France] Univ Laval, Dept Med Familiale & Med Urgence, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada; [Archambault, Patrick Michel; Gagnon, Susie; Lapointe, Jean; Fleet, Richard; Cote, Mario; Beaupre, Pierre] Univ Levis, Ctr Hosp, Ctr Sante & Serv Sociaux Alphonse Desjardins, Levis, PQ, Canada; [Archambault, Patrick Michel] Univ Laval, Div Soins Intensifs, Quebec City, PQ, Canada; [Archambault, Patrick Michel; Gagnon, Marie-Pierre; Turcotte, Stephane; Le Sage, Natalie; Emond, Marcel; Legare, France] Ctr Rech CHU Quebec, Axe Sante Populat Prat Optimales Sante, Traumatol Urgence Soins Intensifs, Quebec City, PQ, Canada; [Gagnon, Marie-Pierre] Univ Laval, Fac Sci Infirm, Quebec City, PQ, Canada; [Lapointe, Jean] Inst Natl Excellence Sante & Serv Sociaux, Montreal, PQ, Canada; [Legare, France] Univ Laval, Implementat Shared Decis Making Primary Care, Quebec City, PQ, Canada		Archambault, PM (corresponding author), Univ Laval, Dept Med Familiale & Med Urgence, 1050 Ave Med, Quebec City, PQ G1V 0A6, Canada.	patrick.m.archambault@gmail.com	Le Sage, Natalie/G-7063-2016; Gagnon, Marie-Pierre/I-3013-2019; Emond, Marcel/G-5804-2014	Le Sage, Natalie/0000-0003-4762-8156; Gagnon, Marie-Pierre/0000-0002-0782-5457; Emond, Marcel/0000-0001-7158-8110	Career Scientist award from FRQS; CADRE program [PDA 1850]; Canadian Health Services Research Foundation (now the Canadian Foundation for Healthcare Improvement); Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); CSSS Alphonse-Desjardins; Gaston Godin; Ariane Blanger-Gravel; Claudine Blanchet; Simon Rioux; Cynthia Fournier; Claudie-Anne Giasson; Catherine Nadeau; Michsle Dugas; Andrea Bilodeau; Jean-Francois Rancourt	France Legare is Canada Research Chair in the Implementation of Shared Decision Making in Primary Care. Marie-Pierre Gagnon is Canada Research Chair in the Implementation of Information Technology in Health Care. Patrick Archambault and Richard Fleet hold a Junior 1 Career Scientist award from FRQS. Funding for this study was provided by a CADRE program (reference number: PDA 1850) supported by a partnership between the Canadian Health Services Research Foundation (now the Canadian Foundation for Healthcare Improvement) and the Canadian Institutes of Health Research. It was also supported by a CSSS Alphonse-Desjardins research grant. The funding bodies did not play any role in the design, collection, analysis, or interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication. We would like to thank Gaston Godin, Ariane Blanger-Gravel, Claudine Blanchet, Simon Rioux, Cynthia Fournier, Claudie-Anne Giasson, Catherine Nadeau, Michsle Dugas, Andrea Bilodeau, and Jean-Francois Rancourt for their support in various phases of this project. We would also like to thank Louisa Blair for editing our manuscript and translating our questionnaires. Finally, we would like to thank all the participants who generously took the time to participate in the focus group and who participated in the test-retest.	Archambault P, 2014, CAN J EMERG IN PRESS; Archambault PM, 2013, J MED INTERNET RES, V15, P4, DOI 10.2196/jmir.2787; Archambault Patrick M, 2011, Inform Prim Care, V19, P207; Archambault PM, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-45; Archambault PM, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1983; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Brokowski L, 2009, ANN PHARMACOTHER, V43, P1912, DOI 10.1345/aph.1M340; Chan J, 2011, J AM MED INFORM ASSN, V18, P276, DOI 10.1136/amiajnl-2010-000026; Conner M., 1996, PREDICTING HLTH BEHA, DOI [10.1186/1748-5908-5-45, DOI 10.1186/1748-5908-5-45]; Francis J., 2004, CONSTRUCTING QUESTIO; Gaddis GM, 2007, ACAD EMERG MED, V14, P1015, DOI 10.1197/j.aem.2007.07.010; Gagne C, 2000, J APPL SOC PSYCHOL, V30, P2173, DOI 10.1111/j.1559-1816.2000.tb02431.x; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Heilman J, 2014, 21 COCHR C; Heilman JM, 2011, J MED INTERNET RES, V13, P153, DOI 10.2196/jmir.1589; Holroyd BR, 2007, ACAD EMERG MED, V14, P942, DOI 10.1197/j.aem.2007.06.023; Hughes B, 2009, INT J MED INFORM, V78, P645, DOI 10.1016/j.ijmedinf.2009.04.008; Huijg JM, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-11; Iyer AK., 2011, THESIS; Jibuike OO, 2003, EMERG MED J, V20, P37, DOI 10.1136/emj.20.1.37; KROSNICK JA, 1991, APPL COGNITIVE PSYCH, V5, P213, DOI 10.1002/acp.2350050305; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lang ES, 2007, ANN EMERG MED, V49, P355, DOI 10.1016/j.annemergmed.2006.08.022; McGowan BS, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2138; McIntosh B, 2011, 2 LINE THERAPY PATIE; Meenan C, 2010, J DIGIT IMAGING, V23, P142, DOI 10.1007/s10278-009-9180-1; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; National Institutes of Health, GUID PART WIK NIH OF; Riley Jennifer, 2014, J Med Internet Res, V16, pe162, DOI 10.2196/jmir.3482; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Sandars J, 2007, POSTGRAD MED J, V83, P759, DOI 10.1136/pgmj.2007.063123; Scott SD, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-65; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578; Stiell IG, 2007, ACAD EMERG MED, V14, P955, DOI 10.1197/j.aem.2007.06.039; STRAUS S, 2009, KNOWLEDGE TRANSLATIO; Theal Jeremy, 2014, Healthc Q, V17, P24; Trzeciak S, 2006, CHEST, V129, P225, DOI 10.1378/chest.129.2.225; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; Willis GB, 2005, COGNITIVE INTERVIEWI; Wright Adam, 2010, AMIA Annu Symp Proc, V2010, P892; Wright A, 2009, J BIOMED INFORM, V42, P334, DOI 10.1016/j.jbi.2008.09.003; Yu R, 2011, SOC HOSP MED RES INN, P140	43	5	5	0	0	JMIR PUBLICATIONS, INC	TORONTO	59 WINNERS CIRCLE, TORONTO, ON M4L 3Y7, CANADA	1929-0748			JMIR RES PROTOC	JMIR RES. Protoc.	OCT-DEC	2014	3	4							e50	10.2196/resprot.3762			14	Health Care Sciences & Services; Public, Environmental & Occupational Health	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	V4C5I	WOS:000218807300025	25281856	gold, Green Submitted, Green Published			2022-02-06	
J	Barichello, T; Fagundes, GD; Generoso, JS; Dagostin, CS; Simoes, LR; Vilela, MC; Comim, CM; Petronilho, F; Quevedo, J; Teixeira, AL				Barichello, Tatiana; Fagundes, Glauco D.; Generoso, Jaqueline S.; Dagostin, Caroline S.; Simoes, Lutiana R.; Vilela, Marcia C.; Comim, Clarissa M.; Petronilho, Fabricia; Quevedo, Joao; Teixeira, Antonio L.			Environmental enrichment restores cognitive deficits induced by experimental childhood meningitis	REVISTA BRASILEIRA DE PSIQUIATRIA			English	Article						Pneumococcal meningitis; environmental enrichment; cytokines; BDNF	NEONATAL HYPOXIA-ISCHEMIA; TRAUMATIC BRAIN-INJURY; TERM-MEMORY FORMATION; STREPTOCOCCUS-PNEUMONIAE; PNEUMOCOCCAL MENINGITIS; BACTERIAL-MENINGITIS; NEUROTROPHIC FACTOR; OXIDATIVE STRESS; NERVOUS-SYSTEM; RAT-BRAIN	Objective: To evaluate the influence of environmental enrichment (EE) on memory, cytokines, and brain-derived neurotrophic factor (BDNF) in the brain of adult rats subjected to experimental pneumococcal meningitis during infancy. Methods: On postnatal day 11, the animals received either artificial cerebrospinal fluid (CSF) or Streptococcus pneumoniae suspension intracisternally at 1 x 10(6) CFU/mL and remained with their mothers until age 21 days. Animals were divided into the following groups: control, control + EE, meningitis, and meningitis + EE. EE began at 21 days and continued until 60 days of age (adulthood). EE consisted of a large cage with three floors, ramps, running wheels, and objects of different shapes and textures. At 60 days, animals were randomized and subjected to habituation to the open-field task and the step-down inhibitory avoidance task. After the tasks, the hippocampus and CSF were isolated for analysis. Results: The meningitis group showed no difference in performance between training and test sessions of the open-field task, suggesting habituation memory impairment; in the meningitis + EE group, performance was significantly different, showing preservation of habituation memory. In the step-down inhibitory avoidance task, there were no differences in behavior between training and test sessions in the meningitis group, showing aversive memory impairment; conversely, differences were observed in the meningitis + EE group, demonstrating aversive memory preservation. In the two meningitis groups, IL-4, IL-10, and BDNF levels were increased in the hippocampus, and BDNF levels in the CSF. Conclusions: The data presented suggest that EE, a non-invasive therapy, enables recovery from memory deficits caused by neonatal meningitis.	[Barichello, Tatiana; Fagundes, Glauco D.; Generoso, Jaqueline S.; Dagostin, Caroline S.; Simoes, Lutiana R.] Univ Extremo Catarinense UNESC, Lab Microbiol Expt, Criciuma, SC, Brazil; [Barichello, Tatiana; Petronilho, Fabricia; Quevedo, Joao] Univ Texas Houston, Ctr Expt Models Psychiat, Med Sch Houston, Houston, TX USA; [Vilela, Marcia C.] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [Comim, Clarissa M.] Univ Sul Santa Catarina UNISUL, Lab Expt Neurosci, Palhoca, SC, Brazil; [Petronilho, Fabricia] Univ Sul Santa Catarina, Lab Clin & Expt Pathophysiol, Tubarao, SC, Brazil; [Quevedo, Joao] Univ Extremo Sul Catarinense, Lab Neurosci, Criciuma, SC, Brazil; [Teixeira, Antonio L.] Univ Fed Minas Gerais, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil		Barichello, T (corresponding author), Univ Extremo Catarinense, Lab Microbiol Expt, Av Univ 1105, BR-88806000 Criciuma, SC, Brazil.	tba@unesc.net	Petronilho, Fabricia/D-8822-2013; Teixeira, Antonio L/N-3315-2014; Barichello, Tatiana/E-2725-2013; de Quevedo, Joao Luciano/E-5491-2013; Comim, Clarissa M/S-9007-2019; Simoes, Lutiana R/I-9896-2014; Generoso, Jaqueline S/N-3142-2013	Teixeira, Antonio L/0000-0002-9621-5422; de Quevedo, Joao Luciano/0000-0003-3114-6611; Comim, Clarissa M/0000-0003-4991-042X; Generoso, Jaqueline S/0000-0003-0571-6764; Barichello, Tatiana/0000-0001-7776-8454	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC)Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Universidade do Extremo Sul Catarinense (UNESC); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	The Laboratory of Experimental Microbiology is one of the centers of the Brazilian National Science and Technology Institutes for Translational Medicine (INCT-TM) and a member of the Centers of Excellence in Applied Neurosciences of Santa Catarina (NENASC). This research was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (JQ and TB), Fundacao de Amparo a Pesquisa e Inovacao do Estado de Santa Catarina (FAPESC) (JQ and TB), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (ALT) and Universidade do Extremo Sul Catarinense (UNESC) (JQ and TB). JQ and TB are CNPq Research Fellows. JSG and LRS are holders of studentships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The authors thank Samuel G. Elias for illustrating environmental enrichment.	Barichello T, 2013, REV BRAS PSIQUIATR, V35, P81, DOI 10.1016/j.rbp.2012.11.003; Barichello T, 2013, BRAIN RES BULL, V92, P56, DOI 10.1016/j.brainresbull.2012.05.014; Barichello T, 2012, EUR J PHARMACOL, V697, P158, DOI 10.1016/j.ejphar.2012.09.053; Barichello T, 2012, METAB BRAIN DIS, V27, P587, DOI 10.1007/s11011-012-9315-9; Barichello T, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/173035; Barichello T, 2010, NEUROSCI LETT, V478, P93, DOI 10.1016/j.neulet.2010.04.072; Barichello T, 2010, J NEUROIMMUNOL, V223, P73, DOI 10.1016/j.jneuroim.2010.04.004; Bevilaqua LRM, 2003, EUR J NEUROSCI, V17, P897, DOI 10.1046/j.1460-9568.2003.02524.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chiaretti A, 2004, ACTA PAEDIATR, V93, P1178, DOI 10.1080/08035250410031314; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Grandgirard D, 2010, CLIN PERINATOL, V37, P655, DOI 10.1016/j.clp.2010.05.004; Hendriksen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011943; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; Jurgens HA, 2012, BRAIN BEHAV IMMUN, V26, P1006, DOI 10.1016/j.bbi.2012.05.015; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; Kim KS, 2010, LANCET INFECT DIS, V10, P32, DOI 10.1016/S1473-3099(09)70306-8; Klein M, 2006, PROG NEUROBIOL, V80, P269, DOI 10.1016/j.pneurobio.2006.11.008; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; McQuaid RJ, 2013, PSYCHONEUROENDOCRINO, V38, P987, DOI 10.1016/j.psyneuen.2012.10.003; Meli DN, 2002, CURR OPIN INFECT DIS, V15, P253, DOI 10.1097/00001432-200206000-00007; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Pereira LO, 2007, NEUROBIOL LEARN MEM, V87, P101, DOI 10.1016/j.nlm.2006.07.003; Pang TYC, 2013, NEUROPHARMACOLOGY, V64, P515, DOI 10.1016/j.neuropharm.2012.06.029; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Rizzi S, 2011, BRAIN RES, V1415, P23, DOI 10.1016/j.brainres.2011.08.007; Rojas JJ, 2013, EXP NEUROL, V241, P25, DOI 10.1016/j.expneurol.2012.11.026; SCHWARTZ S, 1964, J COMP PHYSIOL PSYCH, V57, P72, DOI 10.1037/h0045518; Sellner Johann, 2010, Handb Clin Neurol, V96, P1, DOI 10.1016/S0072-9752(09)96001-8; Shin SS, 2013, J NEUROTRAUM, V30, P259, DOI 10.1089/neu.2012.2462; Sun HM, 2010, CURR NEUROVASC RES, V7, P268, DOI 10.2174/156720210793180819; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; Williamson LL, 2012, BRAIN BEHAV IMMUN, V26, P500, DOI 10.1016/j.bbi.2012.01.003	37	5	5	0	5	ASSOC BRASILEIRA PSIQUIATRIA	SAO PAULO	SUBSCRIPTION DEPARTMENT, RUA PEDRO DE TOLEDO, 967 - CASA 01, SAO PAULO, SP 04039-032  A, BRAZIL	1516-4446			REV BRAS PSIQUIATR	Rev. Bras. Psiquiatr.	OCT-DEC	2014	36	4					322	329		10.1590/1516-4446-2014-1443			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	AW1UJ	WOS:000346075800007	25076170	Green Submitted, gold, Green Published			2022-02-06	
J	Befeler, AR; Daniels, DJ; Helms, SA; Klimo, P; Boop, F				Befeler, Adam Ross; Daniels, David J.; Helms, Susan A.; Klimo, Paul, Jr.; Boop, Frederick			Head injuries following television-related accidents in the pediatric population	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						television trauma; pediatric neurosurgery; television tip-over; head injury	TIP-OVER; CHILDREN; MORBIDITY; MORTALITY	Object. Current data indicate the rate of head injuries in children caused by falling televisions is increasing. The authors describe these injuries and the cost incurred by them. Methods. In a single-institution retrospective review, all children treated for a television-related injury at Le Bonheur Children's Hospital, a Level I pediatric trauma center, between 2009 and 2013 were identified through the institution's trauma registry. The type, mechanism, and severity of cranial injuries, surgical interventions, outcome, and costs were examined. Results. Twenty-six patients were treated for a television-related injury during the study period. Most injuries (22 cases, 85%) occurred in children aged 2-4 years (mean age 3.3 years), and 19 (73%) of the 26 patients were male. Head injuries occurred in 20 patients (77%); these injuries ranged from concussion to skull fractures and subdural, subarachnoid, and intraparenchymal hemorrhages. The average Glasgow Coma Scale score on admission was 12 (range 7-15), and 3 patients (12%) had neurological deficits. Surgical intervention was required in 5 cases (19%). The majority of patients made a full recovery. There were no deaths. The total cost for television-related injuries was $1.4 million, with an average cost of $53,893 per accident. Conclusions. A high occurrence of head injuries was seen following television-related accidents in young children. This injury is ideal for a public education campaign targeting parents, health care workers, and television manufacturers.	[Befeler, Adam Ross; Daniels, David J.; Klimo, Paul, Jr.; Boop, Frederick] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA; [Helms, Susan A.; Klimo, Paul, Jr.; Boop, Frederick] Le Bonheur Childrens Hosp, Memphis, TN USA; [Klimo, Paul, Jr.; Boop, Frederick] Semmes Murphey Neurol & Spine Inst, Memphis, TN 38120 USA		Klimo, P (corresponding author), Semmes Murphey Neurol & Spine Inst, 6325 Humphreys Blvd, Memphis, TN 38120 USA.	pklimo@semmes-murphey.com		Befeler, Adam/0000-0002-6359-4294			Bernard PA, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.3.e32; De Roo AC, 2013, PEDIATRICS, V132, P267, DOI 10.1542/peds.2013-1086; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; Muniz AE, 2012, PEDIATR EMERG CARE, V28, P52, DOI 10.1097/PEC.0b013e31823f2541; Platt MS, 2011, J FORENSIC SCI, V56, P1364, DOI 10.1111/j.1556-4029.2011.01770.x; Shah S, 2007, INJURY PREV, V13, P316, DOI 10.1136/ip.2007.016048; Suresh N, 2010, INDIAN J PEDIATR, V77, P459, DOI 10.1007/s12098-010-0013-5; US Consumer Product Safety Commission, TOP 5 HIDD HAZ HOM; Yahya RR, 2005, J NEUROSURG, V103, P219, DOI 10.3171/ped.2005.103.3.0219	10	5	5	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	OCT	2014	14	4					414	417		10.3171/2014.7.PEDS1433			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AQ7CN	WOS:000342970300013	25084085				2022-02-06	
J	Jaja, BNR; Eghwrudjakpor, PO				Jaja, Blessing N. R.; Eghwrudjakpor, Patrick O.			Effect of demographic and injury etiologic factors on intensive care unit mortality after severe head injury in a low middle income country	ANNALS OF AFRICAN MEDICINE			English	Article						Head injury; intensive care; mortality; Nigeria; sub-Saharan Africa; traumatic brain injury		Background: Low- and middle-income countries bear the mortality burden of head injury compared with high-income countries. Not much has been studied about predictors of poor outcome after head injury in these countries. This study describes and quantifies the effect of demographics and injury causative factors on mortality in a cohort managed in a Nigerian tertiary hospital intensive care. Materials and Methods: A retrospective study was undertaken of all patients admitted into intensive care with severe head injury at the University of Port Harcourt Teaching Hospital, Nigeria between 1st January, 1997 and 31st December, 2006. Logistic regression analysis was performed to examine the effect of age, gender and injury etiology on risk of intensive care unit (ICU) mortality. Results: The number of ICU admission for severe head injury was 231 patients with a male to female ratio of 2.8:1. Patients mean age and standard deviation was 31.2 +/- 15.5 years. The mortality rate was 52.8%. Road traffic injury was the most common etiologic factor (84%). Logistic regression analysis indicated a 56% increase in the risk of ICU mortality between the ages of 21 and 40 years. The effect of age was found to be nonlinear (likelihood ratio P = 0.033). On multivariable analysis, patients gender (odds ratio 1.07; 95% confidence interval: 0.56-1.97) and etiology of injury were not significantly associated with risk of mortality. Gender was not a modifier of the effect of age (P = 0.218). Conclusion: The study indicated a strong prognostic effect of age. Gender and etiology of injury had no effect on ICU mortality among study cohort.	[Jaja, Blessing N. R.; Eghwrudjakpor, Patrick O.] Univ Port Harcourt, Teaching Hosp, Dept Surg, Port Harcourt, Rivers State, Nigeria		Jaja, BNR (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	jajabnr2000@yahoo.com					Adeleye AO, 2009, NEUROEPIDEMIOLOGY, V32, P136, DOI 10.1159/000182821; Afuwape OO, 2009, NIGER J CLIN PRACT, V12, P138; Aguemon AR, 2005, ANN FR ANESTH, V24, P36, DOI 10.1016/j.annfar.2004.11.011; Alkhoury F, 2011, AM SURGEON, V77, P277; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Ekere AU, 2004, INT ORTHOP, V28, P187, DOI 10.1007/s00264-004-0548-z; Emejulu J K C, 2008, Afr J Med Med Sci, V37, P383; Farace E, 2000, Neurosurg Focus, V8, pe6; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Keita M, 2010, Med Trop (Mars), V70, P172; Lam SW, 2012, BIOMARKERS, V17, P642, DOI 10.3109/1354750X.2012.712161; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Muyembe VM, 1999, E AFR MED J, V76, P200; Mwang'ombe N J, 2001, East Afr Med J, V78, P238; Odebode TO, 2008, NIGER J CLIN PRACT, V11, P265; Odebode TO, 2004, PEDIATR SURG INT, V20, P348, DOI 10.1007/s00383-004-1196-5; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Peden M., 2002, INJURY CHART BOOK GR; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Solagberu B A, 2003, West Afr J Med, V22, P177; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; WHO, 2004, WORLD REPORT ROAD TR; Zulu BMW, 2007, INJURY, V38, P576, DOI 10.1016/j.injury.2007.01.002	37	5	7	0	1	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1596-3519	0975-5764		ANN AFR MED	Ann. Afr. Med.	OCT-DEC	2014	13	4					204	209		10.4103/1596-3519.142292			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3Q2W	WOS:000218488900011	25287035				2022-02-06	
J	Pritt, ML; Hall, DG; Jordan, WH; Ballard, DW; Wang, KKW; Muller, UR; Watson, DE				Pritt, Michael L.; Hall, D. Greg; Jordan, William H.; Ballard, Darryl W.; Wang, Kevin K. W.; Mueller, Uwe R.; Watson, David E.			Initial Biological Qualification of SBDP-145 as a Biomarker of Compound-Induced Neurodegeneration in the Rat	TOXICOLOGICAL SCIENCES			English	Article						neurodegeneration; SBDP-145; alpha-2-spectrin; biomarker; calpain	TRAUMATIC BRAIN-INJURY; SPECTRIN BREAKDOWN PRODUCTS; ALPHA-II-SPECTRIN; CEREBROSPINAL-FLUID; CALPAIN; ACID; PROTEOLYSIS; ACTIVATION; TOXICITY; NEUROTOXICITY	Detection of compound-related neurodegeneration is currently limited to brain histopathology in veterinary species and functional measurements such as electroencephalography and observation of clinical signs in patients. The objective of these studies was to investigate whether concentrations of spectrin breakdown product 145 (SBDP-145) in cerebrospinal fluid (CSF) correlate with the severity of neurodegeneration in rats administered neurotoxic agents, as part of a longer term objective of developing in vivo biomarkers of neurotoxicity for use in non-clinical and clinical safety studies. Non-erythroid alpha-II spectrin is a cytoskeletal protein cleaved by the protease calpain when this enzyme is activated by dysregulation of calcium in injured cells. Calcium dysregulation is also associated with some toxicological responses in animals, and may be sufficient to activate neuronal calpain and produce SBDPs that can be released into CSF. Neurotoxicants (kainic acid, 2-chloropropionic acid, bromethalin, and pentylenetetrazole) known to affect different portions of the brain were administered to rats in dose-response and time-course studies in which neurodegeneration was measured by histopathology and SBDP-145 concentrations in CSF were measured by ELISA. We consistently observed >3-fold increases in SBDP-145 concentration in rats with minimal to slight neurodegenerative lesions, and 20 to 150-fold increases in animals with more severe lesions. In contrast, compounds that caused non-degenerative changes in central nervous system (CNS) did not increase SBDP-145 in CSF. These data support expanded use of SBDP-145 as a biomarker for monitoring compound-induced neurodegeneration in pre-clinical studies, and support the investigation of clinical applications of this biomarker to promote safe dosing of patients with compounds that have potential to cause neurodegeneration.	[Pritt, Michael L.; Hall, D. Greg; Ballard, Darryl W.; Watson, David E.] Lilly Res Labs, Indianapolis, IN 46285 USA; [Jordan, William H.] Vet Path Serv Inc, Mason, OH 45040 USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Mueller, Uwe R.] Neoclone, Madison, WI 53713 USA		Pritt, ML (corresponding author), Lilly Res Labs, Indianapolis, IN 46285 USA.	pritt_michael_l@lilly.com		Wang, Kevin/0000-0002-9343-6473			Cardali S, 2006, J Neurosurg Sci, V50, P25; DISTASI AMM, 1991, NEURON, V6, P445, DOI 10.1016/0896-6273(91)90252-U; FOX JEB, 1987, BLOOD, V69, P537; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; Jordan WH, 2011, TOXICOL PATHOL, V39, P58, DOI 10.1177/0192623310391480; Kew JNC, 2005, PSYCHOPHARMACOLOGY, V179, P4, DOI 10.1007/s00213-005-2200-z; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Mansouri B, 2007, EUR J PHARMACOL, V557, P106, DOI 10.1016/j.ejphar.2006.11.032; Mao RR, 2009, EPILEPSY BEHAV, V15, P441, DOI 10.1016/j.yebeh.2009.05.015; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Murray TK, 2003, J PHARMACOL EXP THER, V306, P752, DOI 10.1124/jpet.103.049445; Pi XJ, 2004, MOL BRAIN RES, V127, P60, DOI 10.1016/j.molbrainres.2004.05.006; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Simpson MG, 1996, NEUROTOXICOLOGY, V17, P471; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; Stracher A, 1999, ANN NY ACAD SCI, V884, P52, DOI 10.1111/j.1749-6632.1999.tb08635.x; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1111/j.1365-2613.2000.00169.x; VANLIER RBL, 1988, FUND APPL TOXICOL, V11, P664, DOI 10.1016/0272-0590(88)90129-7; Widdowson PS, 1997, TOXICOL APPL PHARM, V142, P248, DOI 10.1006/taap.1996.7940; Wyatt I, 1997, ARCH TOXICOL, V71, P668, DOI 10.1007/s002040050443; Zoltewicz JS, 2013, J NEUROTRAUM, V30, P1161, DOI 10.1089/neu.2012.2762	25	5	5	0	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1096-6080	1096-0929		TOXICOL SCI	Toxicol. Sci.	OCT	2014	141	2					398	408		10.1093/toxsci/kfu136			11	Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Toxicology	AQ8BD	WOS:000343045100010	25015659	Green Published, Bronze			2022-02-06	
J	Myczek, K; Yeung, ST; Castello, N; Baglietto-Vargas, D; LaFerla, FM				Myczek, Kristoffer; Yeung, Stephen T.; Castello, Nicholas; Baglietto-Vargas, David; LaFerla, Frank M.			Hippocampal Adaptive Response Following Extensive Neuronal Loss in an Inducible Transgenic Mouse Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; ROSTRAL MIGRATORY STREAM; TEMPORAL-LOBE EPILEPSY; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; DENTATE GYRUS; ADULT NEUROGENESIS; SUBVENTRICULAR ZONE	Neuronal loss is a common component of a variety of neurodegenerative disorders (including Alzheimer's, Parkinson's, and Huntington's disease) and brain traumas (stroke, epilepsy, and traumatic brain injury). One brain region that commonly exhibits neuronal loss in several neurodegenerative disorders is the hippocampus, an area of the brain critical for the formation and retrieval of memories. Long-lasting and sometimes unrecoverable deficits caused by neuronal loss present a unique challenge for clinicians and for researchers who attempt to model these traumas in animals. Can these deficits be recovered, and if so, is the brain capable of regeneration following neuronal loss? To address this significant question, we utilized the innovative CaM/Tet-DTA mouse model that selectively induces neuronal ablation. We found that we are able to inflict a consistent and significant lesion to the hippocampus, resulting in hippocampally-dependent behavioral deficits and a long-lasting upregulation in neurogenesis, suggesting that this process might be a critical part of hippocampal recovery. In addition, we provide novel evidence of angiogenic and vasculature changes following hippocampal neuronal loss in CaM/Tet-DTA mice. We posit that angiogenesis may be an important factor that promotes neurogenic upregulation following hippocampal neuronal loss, and both factors, angiogenesis and neurogenesis, can contribute to the adaptive response of the brain for behavioral recovery.	[LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA USA		LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferla@uci.edu	Baglietto-Vargas, David DBV/B-1425-2018; Yeung, Stephen/J-8910-2016; Baglietto-Vargas, David/I-2572-2019	Baglietto-Vargas, David DBV/0000-0003-1441-3175; Yeung, Stephen/0000-0002-9710-5567; Baglietto-Vargas, David/0000-0003-1441-3175	National Institutes of Health (NIH): NIH/NIA [AG027544-06, OD010420]; Larry Hillblom foundation [2013-A-016-FEL]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG027544] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [S10OD010420] Funding Source: NIH RePORTER	This study was supported by grants from the National Institutes of Health (NIH): NIH/NIA AG027544-06, OD010420 (FML), and by The Larry Hillblom foundation #2013-A-016-FEL (DBV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Baglietto-Vargas D, 2010, J ALZHEIMERS DIS, V21, P119, DOI 10.3233/JAD-2010-100066; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bauer R, 2004, EXP TOXICOL PATHOL, V56, P65, DOI 10.1016/j.etp.2004.04.002; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Beauchamp M, 2011, DEV NEUROPSYCHOL, V36, P578, DOI 10.1080/87565641.2011.555572; Bell BD, 2007, NEUROPSYCHOL REV, V17, P455, DOI 10.1007/s11065-007-9049-3; Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; BERKOVIC SF, 1991, ANN NEUROL, V29, P175, DOI 10.1002/ana.410290210; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blurton-Jones M, 2006, J COMP NEUROL, V499, P603, DOI 10.1002/cne.21122; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Campanella M, 2002, STROKE, V33, P586, DOI 10.1161/hs0202.103399; Castello NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091453; Castro AA, 2013, BRAIN RES, V1513, P103, DOI 10.1016/j.brainres.2013.03.029; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Crews L, 2010, J NEUROSCI, V30, P12252, DOI 10.1523/JNEUROSCI.1305-10.2010; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Deng W, 2009, J NEUROSCI, V29, P13532, DOI 10.1523/JNEUROSCI.3362-09.2009; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fisher A, 2000, NEUROSCIENCE, V95, P97; Fox NC, 1996, BRAIN, V119, P2001, DOI 10.1093/brain/119.6.2001; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fritz HG, 2004, EXP TOXICOL PATHOL, V56, P91, DOI 10.1016/j.etp.2004.04.001; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Gil JMAC, 2005, NEUROBIOL DIS, V20, P744, DOI 10.1016/j.nbd.2005.05.006; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Hendriks MPH, 2002, EPILEPSY BEHAV, V3, P165, DOI 10.1006/ebeh.2002.0320; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869; Jeltsch H, 2001, NEUROBIOL LEARN MEM, V76, P81, DOI 10.1006/nlme.2000.3986; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; JESTE DV, 1992, AM J PSYCHIAT, V149, P184; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Lamm O, 2014, J COMP NEUROL, V522, P2817, DOI 10.1002/cne.23607; Lazic SE, 2004, NEUROREPORT, V15, P811, DOI 10.1097/00001756-200404090-00014; Lee P, 1998, P NATL ACAD SCI USA, V95, P11371, DOI 10.1073/pnas.95.19.11371; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Marxreiter F, 2013, CELL MOL LIFE SCI, V70, P459, DOI 10.1007/s00018-012-1062-x; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Nagamoto-Combs K, 2007, J NEUROTRAUM, V24, P1719, DOI 10.1089/neu.2007.0377; Newsome MR, 2010, NEUROPSYCHOLOGY, V24, P139, DOI 10.1037/a0017432; Ohl F, 1999, COGNITIVE BRAIN RES, V7, P379, DOI 10.1016/S0926-6410(98)00042-1; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Reetz K, 2010, NEUROBIOL DIS, V39, P402, DOI 10.1016/j.nbd.2010.05.006; Reijmer YD, 2012, J AM GERIATR SOC, V60, P1426, DOI 10.1111/j.1532-5415.2012.04081.x; Schanzer A, 2004, BRAIN PATHOL, V14, P237; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Schuff N, 2009, ALZHEIMERS DEMENT, V5, P454, DOI 10.1016/j.jalz.2009.04.1233; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; Thompson PM, 2003, J NEUROSCI, V23, P994; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tomaiuolo F, 2004, J NEUROL NEUROSUR PS, V75, P1314, DOI 10.1136/jnnp.2003.017046; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Wittko IM, 2009, J NEUROSCI, V29, P8704, DOI 10.1523/JNEUROSCI.5527-08.2009; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yeung ST, 2014, NEUROSCIENCE, V259, P214, DOI 10.1016/j.neuroscience.2013.11.054; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8	92	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2014	9	9							e106009	10.1371/journal.pone.0106009			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO3TB	WOS:000341257700030	25184527	Green Published, gold			2022-02-06	
J	Barker, MD; Whyte, J; Pretz, CR; Sherer, M; Temkin, N; Hammond, FM; Saad, Z; Novack, T				Barker, Marie D.; Whyte, John; Pretz, Christopher R.; Sherer, Mark; Temkin, Nancy; Hammond, Flora M.; Saad, Zabedah; Novack, Thomas			Application and Clinical Utility of the Glasgow Coma Scale Over Time: A Study Employing the NIDRR Traumatic Brain Injury Model Systems Database	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Glasgow Coma Scale; intubation; outcome prediction; traumatic brain injury	FUNCTIONAL INDEPENDENCE MEASURE; LINEAR-REGRESSION PREDICTION; INTUBATED PATIENTS; NATIONAL-SURVEY; HEAD-INJURIES; VERBAL SCORE; MOTOR SCORES; REHABILITATION; MORTALITY; SEVERITY	Objective: To examine possible changes in Glasgow Coma Scale (GCS) scores related to changes in emergency management, such as intubation and chemical paralysis, and the potential impact on outcome prediction. Participants: 10 228 patients from the Traumatic Brain Injury Model Systems national database. Design: Retrospective study examining 5-year epochs from 1987 to 2012. Main Measures: GCS score assessed in the Emergency Department (GCS scores for intubated, but not paralyzed, patients were estimated with a formula using 2 of the 3 GCS components), Outcome: Functional Independence Measure (FIM) assessed at rehabilitation admission. Results: The rate of intubation prior to GCS scoring averaged 43% and did not increase across time. However, a clear increase over time was observed in the use of paralytics or heavy sedatives, with 27% of patients receiving this intervention in the most recent epoch. Estimated GCS scores classified 69% of intubated patients as severely brain injured and 8% as mildly injured. The GCS accounted for a modest, yet consistent, amount of variability (approximately 5%-7%) in FIM scores during most epochs. Conclusions: Given the frequency of intubation and/or paralysis following brain injury in this sample, estimating GCS or exploring other means to gauge injury severity is beneficial, particularly because a portion likely did not sustain severe brain injury. There is no evidence for declining predictive utility of the GCS over time.	[Barker, Marie D.; Novack, Thomas] Univ Alabama Birmingham, Birmingham, AL 35249 USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Pretz, Christopher R.] Craig Hosp, Englewood, CO USA; [Pretz, Christopher R.] Traumat Brain Injury Natl Data & Stat Ctr, Englewood, CO USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Temkin, Nancy] Univ Washington, Seattle, WA 98195 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hammond, Flora M.] Carolinas Rehabil, Charlotte, NC USA; [Saad, Zabedah] Univ No Colorado, Greeley, CO 80639 USA		Novack, T (corresponding author), Univ Alabama Birmingham, SRC 520,619 19th St S, Birmingham, AL 35249 USA.	novack@uab.edu		Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research (NIDRR), US Department of EducationUS Department of Education [H133A070039, H133A070040, H133A070042, H133A070043, H133A980023, H133A110006]	This research was supported in part by the Traumatic Brain Injury Model Systems (Grants H133A070039, H133A070040, H133A070042, H133A070043, H133A980023, and H133A110006) from the National Institute on Disability and Rehabilitation Research (NIDRR), US Department of Education. However, those contents do not necessarily represent the policy of the Department of Education, and you should not assume endorsement by the Federal Government.	[Anonymous], 1997, GUIDE UNIFORM DATA S; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Buechler CM, 1998, J TRAUMA, V45, P429, DOI 10.1097/00005373-199809000-00001; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Davis DP, 2006, J TRAUMA, V60, P985, DOI 10.1097/01.ta.0000205860.96209.1c; Diringer MN, 1997, ARCH NEUROL-CHICAGO, V54, P606, DOI 10.1001/archneur.1997.00550170078017; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Rutledge R, 1996, J TRAUMA, V41, P514, DOI 10.1097/00005373-199609000-00022; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; TEASDALE G, 1974, LANCET, V2, P81; The SAS Institute, GLM PROC; Udekwu P, 2004, J TRAUMA, V56, P1084, DOI 10.1097/01.TA.0000124283.02605.A5; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012	24	5	6	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2014	29	5					400	406		10.1097/HTR.0b013e31828a0a45			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP2GW	WOS:000341891700008	23535391				2022-02-06	
J	Cook, A; King, H; Polikandriotis, JA				Cook, Amanda; King, Harold; Polikandriotis, John A.			Where Do We Go from Here? An Inside Look into the Development of Georgia's Youth Concussion Law	JOURNAL OF LAW MEDICINE & ETHICS			English	Article							SPORTS-RELATED CONCUSSION; FOOTBALL PLAYERS; RECURRENT CONCUSSION; RISK; COLLEGIATE; COHORT; BRAIN	Currently, all 50 states and the District of Columbia have youth concussion laws based on the core principals of the 2009 Lystedt Law of Washington State. On April 23, 2013, the state of Georgia signed into law House Bill 284, The Return to Play Act of 2013 and became one of the last states to pass youth concussion legislation. This Act became effective on January 1, 2014. The purpose of this report is to highlight the legislative process of enacting Georgia House Bill 284 and compare it to the legislation of other states.	[Cook, Amanda] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [King, Harold] Childrens Healthcare Atlanta, Sports Med Athlet Training & Community Outreach, Atlanta, GA USA; [Polikandriotis, John A.] Childrens Healthcare Atlanta, Ambulatory Operat, Atlanta, GA USA		Cook, A (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.						Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hemecourt P. D., 2011, CLIN SPORTS MED, V30, P63; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; May KH, 2014, INT J SPORTS PHYS TH, V9, P242; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; National Federation of State High School Associations, 2012 2012 HIGH SCH A; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Putukian M, 2011, PM&R, V3, pS425, DOI 10.1016/j.pmrj.2011.08.003; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7	19	5	5	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1073-1105	1748-720X		J LAW MED ETHICS	J. Law Med. Ethics	FAL	2014	42	3			SI		284	289		10.1111/jlme.12145			6	Ethics; Law; Medical Ethics; Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Government & Law; Medical Ethics; Legal Medicine	AQ4ED	WOS:000342745000003	25264086				2022-02-06	
J	Guo, YJ; Zhou, Y; Zhang, SY; Wei, Q; Huang, Y; Xia, WQ; Wang, SH				Guo, Yi-Jing; Zhou, Yi; Zhang, Sheng-Yi; Wei, Qiong; Huang, Yan; Xia, Wen-Qing; Wang, Shao-Hua			Optimal target range for blood glucose in hyperglycaemic patients in a neurocritical care unit	DIABETES & VASCULAR DISEASE RESEARCH			English	Article						Hyperglycaemia; critical care; neurosciences; mortality	INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; STRESS HYPERGLYCEMIA; HOSPITAL MORTALITY; CLINICAL-TRIAL; ASSOCIATION; INFARCTION; OUTCOMES	Background: Hyperglycaemia is common among patients with critical neurological injury, even if they have no history of diabetes. The optimal target range for normalizing their blood glucose is unknown. Methods: Retrospective data were extracted from 890 hyperglycaemic individuals (glucose >200 mg/dL) admitted to neuroscience critical care unit (NCCU) and these patients were divided into two groups: intensive glucose control group with target glucose of <140 mg/dL achieved and moderate control with glucose levels 140-180 mg/dL. The groups were also stratified according to the hyperglycaemia type (pre-existing diabetes or stress-related). We defined the primary endpoint as death from any cause during NCCU admission. Results: In NCCU, tighter control of blood glucose at. 140 mg/dL was associated with increased, mortality of individuals with pre-existing diabetes compared with moderate control [29 of 310 patients (9.4%) vs 15 of 304 patients (4.9%), p = 0.034]. Patient age [adjusted odds ratio (OR) = 1.12; 95% confidence interval (CI) = 1.05-1.19; p < 0.001], level of glycated haemoglobin (adjusted OR = 1.24; 95% CI = 1.04-1.48; p = 0.017) and hypoglycaemia (adjusted OR = 10.3; 95% CI = 2.92-36.6; p < 0.001) were positively associated with higher mortality. Death rate was lower among stress-related hyperglycaemic patients with tighter glucose controlled at. 140 mg/dL [6 of 140 patients (4.3%) vs 15 of 136 patients (11.0%), p = 0.035]. Conclusion: A differential association is evident between glucose levels and mortality in diabetes and stress-related hyperglycaemia patients. However, given the observational nature of our work, no clinical recommendations can be given and prospective studies are required to further investigate these findings.	[Guo, Yi-Jing; Zhang, Sheng-Yi] Southeast Univ, Affiliated Zhongda Hosp, Dept Neurol, Nanjing 210009, Peoples R China; [Zhou, Yi; Wei, Qiong; Huang, Yan; Xia, Wen-Qing; Wang, Shao-Hua] Southeast Univ, Affiliated Zhongda Hosp, Dept Endocrinol, Nanjing 210009, Peoples R China		Wang, SH (corresponding author), Southeast Univ, Affiliated Zhongda Hosp, Dept Endocrinol, 87 DingJiaQiao Rd, Nanjing 210009, Peoples R China.	gyjwsh@yahoo.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30870870, 81070638, 81070916]; Social Development Project of JiangSu Province [SBE201170735]	This work was partially supported by the National Natural Science Foundation of China (No. 30870870, Shao-Hua Wang; No. 81070638, Shao-Hua Wang and No. 81070916, Yi-Jing Guo), and the Social Development Project of JiangSu Province (No. SBE201170735, Shao-Hua Wang).	Al-Tarifi A, 2011, ANN THORAC MED, V6, P207, DOI 10.4103/1817-1737.84774; Anderson RE, 1999, STROKE, V30, P160, DOI 10.1161/01.STR.30.1.160; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Baker EH, 2006, THORAX, V61, P284, DOI 10.1136/thx.2005.051029; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bilotta F, 2012, WORLD J DIABETES, V3, P130, DOI 10.4239/wjd.v3.i7.130; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Cheung NW, 2005, DIABETES CARE, V28, P2367, DOI 10.2337/diacare.28.10.2367; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Curkendall SM, 2009, ENDOCR PRACT, V15, P302, DOI 10.4158/EP08343.OR; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gillett Melissa J, 2009, Clin Biochem Rev, V30, P197; Graffagnino C, 2010, NEUROCRIT CARE, V13, P307, DOI 10.1007/s12028-010-9469-4; Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855; Juhl CB, 2010, DIABETES RES CLIN PR, V88, P22, DOI 10.1016/j.diabres.2010.01.007; Kreutziger J, 2009, INTENS CARE MED, V35, P1234, DOI 10.1007/s00134-009-1446-z; Krinsley JS, 2004, MAYO CLIN PROC, V79, P992, DOI 10.4065/79.8.992; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Meyfroidt G, 2010, CRIT CARE MED, V38, P1021, DOI 10.1097/CCM.0b013e3181cf710e; Ouyang YB, 2000, NEUROCHEM RES, V25, P661, DOI 10.1023/A:1007563104170; Oz G, 2007, AM J PHYSIOL-ENDOC M, V292, pE946, DOI 10.1152/ajpendo.00424.2006; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Rao J, 2006, Minerva Endocrinol, V31, P149; Salim A, 2009, AM SURGEON, V75, P25; SHANGRAW RE, 1989, METABOLISM, V38, P983, DOI 10.1016/0026-0495(89)90010-3; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; WOLFE RR, 1987, NEW ENGL J MED, V317, P403, DOI 10.1056/NEJM198708133170702	35	5	5	0	6	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1479-1641	1752-8984		DIABETES VASC DIS RE	Diabetes Vasc. Dis. Res.	SEP	2014	11	5					352	358		10.1177/1479164114530580			7	Endocrinology & Metabolism; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Cardiovascular System & Cardiology	AN6SY	WOS:000340728700005	24925103	Bronze			2022-02-06	
J	Hsieh, YC; Lin, SF; Huang, JL; Hung, CY; Lin, JC; Liao, YC; Lo, CP; Wang, KY; Wu, TJ				Hsieh, Yu-Cheng; Lin, Shien-Fong; Huang, Jin-Long; Hung, Chen-Ying; Lin, Jiunn-Cherng; Liao, Ying-Chieh; Lo, Chu-Pin; Wang, Kuo-Yang; Wu, Tsu-Juey			Moderate Hypothermia (33 degrees C) Decreases the Susceptibility to Pacing-Induced Ventricular Fibrillation Compared with Severe Hypothermia (30 degrees C) by Attenuating Spatially Discordant Alternans in Isolated Rabbit Hearts	ACTA CARDIOLOGICA SINICA			English	Article						Cardiac alternans; Conduction velocity; Hypothermia; Optical mapping	POTENTIAL DURATION RESTITUTION; TRAUMATIC BRAIN-INJURY; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; GLOBAL-ISCHEMIA; TEMPERATURE; REENTRY; ARRHYTHMOGENESIS; RESUSCITATION; MECHANISMS	Background: Severe hypothermia (SH, 30 degrees C) increases the risk of pacing-induced ventricular fibrillation (PIVF) by enhancing spatially discordant alternans (SDA). Whether moderate hypothermia (MH, 33 degrees C), which is clinically used for therapeutic hypothermia, also facilitates SDA remains unclear. We hypothesized that MH attenuates SDA occurrence compared with that achieved by SH, and decreases the susceptibility of PIVF. Methods: Using an optical mapping system, action potential duration (APD)/conduction velocity restitutions and thresholds of APD alternans were determined by Si pacing in Langendorff-perfused isolated rabbit hearts. In the MH group (n = 7), S-1 pacing was performed at baseline (37 degrees C), after 5-min MH, and after 5-min rewarming (37 degrees C). In the SH group (n = 9), pacing was also performed at baseline (37 degrees C), after 5-min SH, and after 5-min rewarming (37 degrees C). The thresholds of APD alternans were defined as the longest Si pacing cycle length at which APD alternans were detected. Results: Although the thresholds of APD alternans were not different between the MH (273 +/- 46 ms) and the SH (300 +/- 35 ms) (p = 0.281) groups, SDA threshold was shorter (at a faster heart rate) during MH (228 +/- 33 ms) than that during SH (289 +/- 42 ms) (p = 0.028). At APD alternans threshold, SH hearts showed more SDA than that during MH (SH: 7 hearts, MH: 2 hearts, p = 0.049). SDA could be induced in all 9 SH hearts (100%), while only 4 MH hearts (57%) had SDA (p = 0.029). The PIVF inducibility during SH (44 +/- 53%) was higher than that during MH (0%) (p = 0.043). Conclusions: Compared with SH, the MH group showed greater attenuation of SDA and decreased the susceptibility of PIVF. Therefore, MH is safer as a procedural guideline for use in clinical therapeutic hypothermia than SH.	[Hsieh, Yu-Cheng; Huang, Jin-Long; Hung, Chen-Ying; Lin, Jiunn-Cherng; Liao, Ying-Chieh; Wang, Kuo-Yang; Wu, Tsu-Juey] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung 40705, Taiwan; [Hsieh, Yu-Cheng; Huang, Jin-Long; Hung, Chen-Ying; Lin, Jiunn-Cherng; Liao, Ying-Chieh; Wang, Kuo-Yang; Wu, Tsu-Juey] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Dept Internal Med,Fac Med,Cardiovasc Res Ctr, Taipei 112, Taiwan; [Hsieh, Yu-Cheng; Lo, Chu-Pin] Providence Univ, Dept Financial & Computat Math, Taichung, Taiwan; [Lin, Shien-Fong] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Lin, Shien-Fong] Indiana Univ Sch Med, Dept Med, Div Cardiol, Indianapolis, IN 46202 USA; [Lin, Shien-Fong] Natl Chiao Tung Univ, Inst Biomed Engn, Hsinchu, Taiwan		Wu, TJ (corresponding author), Taichung Vet Gen Hosp, Ctr Cardiovasc, 1650,Sec 4,Taiwan Blvd, Taichung 40705, Taiwan.	tjwu@vghtc.gov.tw	Lin, Shien-fong/AAQ-1608-2020; Lo, Chu-Pin/AAQ-1317-2021	Lin, Shien-fong/0000-0003-1270-3961; Lo, Chu-Pin/0000-0001-6336-8767	National Science Council, Taipei, TaiwanMinistry of Science and Technology, Taiwan [100-2314-B-075A-008-MY3, 102-2314-B-075A-009-MY2]; Taichung Veterans General Hospital, Taichung, Taiwan [TCVGH-1013107C, TCVGH-1023106C, TCVGH-1033103C, TCVGH-1033105C]; National Chiao Tung University, Hsinchu, Taiwan [VGHUST103-G5-5-2]	This study was supported by grants from the National Science Council (100-2314-B-075A-008-MY3 and 102-2314-B-075A-009-MY2), Taipei, Taiwan; Taichung Veterans General Hospital (TCVGH-1013107C, TCVGH-1023106C, TCVGH-1033103C and TCVGH-1033105C), Taichung, Taiwan; and National Chiao Tung University (VGHUST103-G5-5-2), Hsinchu, Taiwan.	BADEER H, 1958, J THORAC SURG, V35, P265; Choi BR, 2007, HEART RHYTHM, V4, P1057, DOI 10.1016/j.hrthm.2007.03.037; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; de Diego C, 2008, AM J PHYSIOL-HEART C, V294, pH1417, DOI 10.1152/ajpheart.01233.2007; Dekker LRC, 1998, CIRCULATION, V97, P1724, DOI 10.1161/01.CIR.97.17.1724; DUDEL J, 1970, PFLUG ARCH EUR J PHY, V315, P136, DOI 10.1007/BF00586657; Egorov YV, 2012, AM J PHYSIOL-HEART C, V303, pH1035, DOI 10.1152/ajpheart.00786.2011; Hale SL, 1999, J CARDIOVASC ELECTR, V10, P405, DOI 10.1111/j.1540-8167.1999.tb00689.x; Harada M, 2008, AM J PHYSIOL-HEART C, V294, pH1896, DOI 10.1152/ajpheart.00986.2007; Hayashi H, 2007, BIOPHYS J, V92, P448, DOI 10.1529/biophysj.106.091009; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsieh YC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P410, DOI 10.1161/CIRCEP.111.000152; Hsieh YC, 2011, CIRC J, V75, P1706, DOI 10.1253/circj.CJ-10-1001; Hsieh YC, 2009, CIRC J, V73, P2214, DOI 10.1253/circj.CJ-09-0432; Hsieh YC, 2009, CIRC J, V73, P39, DOI 10.1253/circj.CJ-08-0540; Kjolbye AL, 2008, AM J PHYSIOL-HEART C, V294, pH41, DOI 10.1152/ajpheart.01089.2006; LIU B, 1991, CRYOBIOLOGY, V28, P96, DOI 10.1016/0011-2240(91)90011-C; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Mouritzen CV, 1966, J THORAC CARDIOVASC, V51, P579; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; NOLASCO JB, 1968, J APPL PHYSIOL, V25, P191, DOI 10.1152/jappl.1968.25.2.191; Pastore JM, 2000, CIRC RES, V87, P1157, DOI 10.1161/01.RES.87.12.1157; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Piktel JS, 2011, CIRC-ARRHYTHMIA ELEC, V4, P79, DOI 10.1161/CIRCEP.110.958355; Puglisi JL, 1996, AM J PHYSIOL-HEART C, V270, pH1772, DOI 10.1152/ajpheart.1996.270.5.H1772; Qu ZL, 2000, CIRCULATION, V102, P1664, DOI 10.1161/01.CIR.102.14.1664; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; SITSAPESAN R, 1991, J PHYSIOL-LONDON, V434, P469, DOI 10.1113/jphysiol.1991.sp018481; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Wu TJ, 2004, CIRCULATION, V110, P2110, DOI 10.1161/01.CIR.0000143834.51102.91; Wu TJ, 2002, CIRCULATION, V106, P1859, DOI 10.1161/01.CIR.0000031334.49170.FB; Wu TJ, 2008, J CARDIOVASC ELECTR, V19, P203, DOI 10.1111/j.1540-8167.2007.00979.x; Wu TJ, 2006, J CARDIOVASC ELECTR, V17, P1112, DOI 10.1111/j.1540-8167.2006.00557.x	34	5	7	1	3	TAIWAN SOC CARDIOLOGY	TAIPEI	13F-1, NO. 11, MIN-CHUAN WEST ROAD, TAIPEI, 104, TAIWAN	1011-6842			ACTA CARDIOL SIN	Acta Cardiol. Sin.	SEP	2014	30	5					455	465					11	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	AP3EQ	WOS:000341958800009	27122819				2022-02-06	
J	Isokuortti, H; Luoto, TM; Kataja, A; Brander, A; Siironen, J; Liimatainen, S; Iverson, GL; Ylinen, A; Ohman, J				Isokuortti, Harri; Luoto, Teemu M.; Kataja, Anneli; Brander, Antti; Siironen, Jari; Liimatainen, Suvi; Iverson, Grant L.; Ylinen, Aarne; Ohman, Juha			Necessity of monitoring after negative head CT in acute head injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Head injury; Traumatic brain injury; Computed tomography; Hospital discharge; Mortality	COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; MILD; TRAUMA; IMMEDIATE; RULE	Objective: The main objective of this study was to evaluate the incidence of delayed complications in acute head injury (HI) patients with an initial normal head computed tomography (CT). Materials and methods: This retrospective study included 3023 consecutive patients who underwent head CT due to an acute HI at the Emergency Department (ED) of Tampere University Hospital (August 2010-July 2012). Regardless of clinical injury severity, the patients with a normal head CT were selected (n = 2444, 80.9%). The medical records of these patients were reviewed to identify the individuals with a serious clinically significant complication related to the primary HI. The time window considered was the following 72 h after the primary head CT. A repeated head CT in the hospital ward, death, or return to the ED were indicative of a possible complication. Results: The majority (n = 1811, 74.1%) of the patients with a negative head CT were discharged home and 1.1% (n = 27) of these patients returned to ED within 72 h post-CT. A repeated head CT was performed on 12 (44.4%) of the returned patients and none of the scans revealed an acute lesion. Of the 632 (25.9%) CT-negative patients admitted to the hospital ward from the ED, a head CT was repeated in 46 (7.3%) patients within 72 h as part of routine practice. In the repeated CT sample, only one (0.2%) patient had a traumatic intracranial lesion. This lesion did not need neurosurgical intervention. The overall complication rate was 0.04%. Conclusion: In the present study, which includes head injuries of all severity, the probability of delayed life-threatening complications was negligible when the primary CT scan revealed no acute traumatic lesions. (C) 2014 Elsevier Ltd. All rights reserved.	[Isokuortti, Harri; Ylinen, Aarne] Univ Helsinki, Dept Neurol Sci, Helsinki, Finland; [Luoto, Teemu M.; Liimatainen, Suvi; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland; [Kataja, Anneli; Brander, Antti] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, Tampere, Finland; [Siironen, Jari] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland; [Iverson, Grant L.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn & Massachusetts Gen Hosp, Home Base Program, Boston, MA USA; [Ylinen, Aarne] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland		Isokuortti, H (corresponding author), Hosp Dist Helsinki & Uusimaa, Brain Injury Outpatient Clin, POB 302,Paciuksenkatu 21, Helsinki 00029, Finland.	harri.isokuortti@helsinki.fi	Luoto, Teemu/W-6468-2018	Luoto, Teemu/0000-0002-7329-3284; Ohman, Juha/0000-0002-6592-1367; Iverson, Grant/0000-0001-7348-9570			af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; Al-Reesi A, 2010, EUR J EMERG MED, V17, P280, DOI 10.1097/MEJ.0b013e32833483ed; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; de Boussard CN, 2006, J TRAUMA, V61, P577, DOI 10.1097/01.ta.0000224901.67930.ce; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Laalo JP, 2009, J NEUROTRAUM, V26, P2169, DOI 10.1089/neu.2009.1011; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Mucci B, 2005, EMERG MED J, V22, P538, DOI 10.1136/emj.2003.013755; National Institute for Health and Clinical Excellence (NICE), 2007, HEAD INJURY, P1; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Norlund A, 2006, BMJ-BRIT MED J, V333, P469, DOI 10.1136/bmj.38918.659120.4F; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Scottish Intercollegiate Guidelines Network (SIGN), 2009, EARL MAN PAT HEAD IN, P1; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	24	5	5	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2014	45	9					1340	1344		10.1016/j.injury.2014.04.012			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AN0NI	WOS:000340280900010	24810669				2022-02-06	
J	Wagner, AK				Wagner, Amy K.			A Rehabilomics framework for personalized and translational rehabilitation research and care for individuals with disabilities: Perspectives and considerations for spinal cord injury	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Rehabilomics; Personalized medicine; Biomarkers; Spinal cord injury; Disability	TRAUMATIC BRAIN-INJURY; SEVERE TBI; INTERNATIONAL CLASSIFICATION; ENVIRONMENTAL ENRICHMENT; GENETIC ASSOCIATIONS; DOPAMINE TRANSPORTER; CANDIDATE BIOMARKER; OUTCOME PREDICTION; HORMONE-LEVELS; YOUNG-ADULTS	Despite many people having similar clinical presentation, demographic factors, and clinical care, outcome can differ for those sustaining significant injury such as spinal cord injury (SCI) and traumatic brain injury (TBI). In addition to traditional demographic, social, and clinical factors, variability also may be attributable to innate (including genetic, transcriptomic proteomic, epigenetic) biological variation that individuals bring to recovery and their unique response to their care and environment. Technologies collectively called "-omics" enable simultaneous measurement of an enormous number of biomolecules that can capture many potential biological contributors to heterogeneity of injury/disease course and outcome. Due to the nature of injury and complex disease, and its associations with impairment, disability, and recovery, rehabilitation does not lend itself to a singular "protocolized" plan of therapy. Yet, by nature and by necessity, rehabilitation medicine operates as a functional model of "Personalized Care". Thus, the challenge for successful programs of translational rehabilitation care and research is to identify viable approaches to examine broad populations, with varied impairments and functional limitations, and to identify effective treatment responses that incorporate personalized protocols to optimize functional recovery. The Rehabilomics framework is a translational model that provides an "-omics" overlay to the scientific study of rehabilitation processes and multidimensional outcomes. Rehabilomics research provides novel opportunities to evaluate the neurobiology of complex injury or chronic disease and can be used to examine methods and treatments for person-centered care among populations with disabilities. Exemplars for application in SCI and other neurorehabilitation populations are discussed.	Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Safar Ctr Resuscitat Res, 3471 5th Ave Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu			NIDRR [H133A120087]	NIDRR H133A120087.	Aarabi B, 2012, J NEUROSURG-SPINE, V17, P38, DOI 10.3171/2012.4.AOSPINE1295; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; [Anonymous], 2014, IMPR ACC NIH SUPP CO; [Anonymous], 2014, CLIN TRANSL SCI AW; Arija-Blazquez A, 2013, EUR J APPL PHYSIOL, V113, P89, DOI 10.1007/s00421-012-2416-7; Basch E, 2005, J CLIN ONCOL, V23, P3552, DOI 10.1200/JCO.2005.04.275; Battaglino RA, 2012, BONE, V51, P600, DOI 10.1016/j.bone.2012.04.019; Berger RP, 2011, PM&R, V3, pS31, DOI 10.1016/j.pmrj.2011.03.016; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bock M, 2012, BREAST CANCER RES TR, V134, P1327, DOI 10.1007/s10549-012-2150-1; Bourassa-Moreau E, 2013, J TRAUMA ACUTE CARE, V74, P849, DOI 10.1097/TA.0b013e31827e1381; Brandao LA, 2013, NEUROIMAG CLIN N AM, V23, P449, DOI 10.1016/j.nic.2013.03.001; Broderick JE, 2008, PAIN, V139, P146, DOI 10.1016/j.pain.2008.03.024; Bruyere SM, 2005, REHABIL PSYCHOL, V50, P113, DOI 10.1037/0090-5550.50.2.113; Canazza A, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00019; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Connelly M, 2010, HEADACHE, V50, P779, DOI 10.1111/j.1526-4610.2009.01586.x; Curt A, 2012, Handb Clin Neurol, V109, P63, DOI 10.1016/B978-0-444-52137-8.00004-8; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Dicianno B, 2013, SPECIALTY MED HOMES; Ding D, 2012, IEEE ENG MED BIO, P5833, DOI 10.1109/EMBC.2012.6347320; Dobkin B, 2007, NEUROREHAB NEURAL RE, V21, P25, DOI 10.1177/1545968306295556; Doherty AL, 2014, J BONE MINER RES, V29, P251, DOI 10.1002/jbmr.2020; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Dunbar MS, 2010, NICOTINE TOB RES, V12, P226, DOI 10.1093/ntr/ntp198; Failla MD, 2014, FRONTIERS NEUROENGIN; Failla MD, 2013, BRAIN INJURY, V27, P696, DOI 10.3109/02699052.2013.775481; Fairman AD, 2010, PEDIATR CLIN N AM, V57, P959, DOI 10.1016/j.pcl.2010.07.015; Friedberg F, 2009, J BEHAV MED, V32, P209, DOI 10.1007/s10865-008-9189-9; Garringer JA, 2013, J NEUROTRAUM, V30, P1415, DOI 10.1089/neu.2012.2565; Gil-Dones F, 2009, BIOMARK INSIGHTS, V4, P135; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Haggerty AE, 2013, NEUROSCI BULL, V29, P445, DOI 10.1007/s12264-013-1362-7; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P969, DOI 10.1001/archneurol.2011.2883; Hosaka N, 2008, EUR SPINE J, V17, P281, DOI 10.1007/s00586-007-0477-9; Jamison RN, 2006, J PAIN, V7, P192, DOI 10.1016/j.jpain.2005.10.006; Jha A, 2008, J SPINAL CORD MED, V31, P171, DOI 10.1080/10790268.2008.11760708; Kay AB, 2011, J CLIN PATHOL, V64, P634, DOI 10.1136/jcp.2010.080655; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kumar R., 2014, J HEAD TRAUMA REHABI; Kwon BK, 2013, EXP NEUROL, V248, P30, DOI 10.1016/j.expneurol.2013.05.012; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Lithner CU, 2011, CURR ALZHEIMER RES, V8, P818; Lubieniecka JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019247; Lu HZ, 2008, BRAIN BEHAV IMMUN, V22, P1217, DOI 10.1016/j.bbi.2008.06.006; Lukasiewicz M, 2007, Expert Rev Neurother, V7, P939, DOI 10.1586/14737175.7.8.939; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Mahmood D, 2011, CHILD CARE HLTH DEV, V37, P861, DOI 10.1111/j.1365-2214.2011.01299.x; Marquardt G, 2011, NEUROL RES, V33, P421, DOI 10.1179/1743132810Y.0000000005; Meyer T, 2011, J REHABIL MED, V43, P765, DOI 10.2340/16501977-0865; Miller MA, 2010, BRAIN INJURY, V24, P1468, DOI 10.3109/02699052.2010.520299; Mitsunaga JK, 2012, ACTA CIR BRAS, V27, P417, DOI 10.1590/S0102-86502012000600010; More SV, 2013, CNS NEUROL DISORD-DR, V12, P680; Morse LR, 2013, OSTEOPOROSIS INT, V24, P961, DOI 10.1007/s00198-012-2072-0; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Natarajan RN, 2006, J BONE JOINT SURG AM, V88A, P36, DOI 10.2106/JBJS.F.00002; Natarajan RN, 2004, SPINE, V29, P2733, DOI 10.1097/01.brs.0000146471.59052.e6; National Data and Statistical Center, TRAUM BRAIN INJ MOD; Oudega M, 1800, Handb Clin Neurol, V109, P617, DOI 10.1016/B978-0-444-52137-8.00038-3; Oudega M, 2013, EXP NEUROL, V250, P151, DOI 10.1016/j.expneurol.2013.09.013; Oudega M, 2012, CELL TISSUE RES, V349, P269, DOI 10.1007/s00441-012-1440-6; Parmanto B, 2010, TELEMED J E-HEALTH, V16, P939, DOI 10.1089/tmj.2010.0033; Patlak M, 2010, POL ISS DEV PERS MED; Pistarini C, 2011, DISABIL REHABIL, V33, P2333, DOI 10.3109/09638288.2011.570414; Pramana G, 2014, TELEMED E-HEALTH, V20, P419, DOI 10.1089/tmj.2013.0214; Ptyushkin P, 2010, BRAIN INJURY, V24, P1519, DOI 10.3109/02699052.2010.523054; Ritfeld GJ, 2014, BIOMATERIALS, V35, P1924, DOI 10.1016/j.biomaterials.2013.11.062; Ritfeld GJ, 2012, CELL TRANSPLANT, V21, P1561, DOI 10.3727/096368912X640484; Salaffi F, 2005, REUMATISMO, V57, P238, DOI 10.4081/reumatismo.2005.238; Saltzman Jonah W, 2013, Curr Phys Med Rehabil Rep, V1, DOI 10.1007/s40141-013-0021-2; Saltzman JW, 2013, J NEUROTRAUM, V30, P434, DOI 10.1089/neu.2012.2501; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Scivoletto G, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-42; Shiffman S, 2006, ADDICTION, V101, P1822, DOI 10.1111/j.1360-0443.2006.01635.x; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Suffoletto B, 2013, J HEAD TRAUMA REHAB, V28, P302, DOI 10.1097/HTR.0b013e3182847468; Suffoletto B, 2012, ALCOHOL CLIN EXP RES, V36, P552, DOI 10.1111/j.1530-0277.2011.01646.x; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; Tep C, 2014, J NEUROSCI, V34, P2012, DOI 10.1523/JNEUROSCI.0054-14.2014; Thomas JG, 2011, SURG OBES RELAT DIS, V7, P548, DOI 10.1016/j.soard.2011.02.009; Vajn K, 2013, NEUROSCI BULL, V29, P402, DOI 10.1007/s12264-013-1361-8; Vaught J, 2012, CLIN CHIM ACTA, V413, P1569, DOI 10.1016/j.cca.2012.04.030; Vaught Jimmie, 2011, Journal of the National Cancer Institute Monographs, P1, DOI 10.1093/jncimonographs/lgr006; Vaught JB, 2012, CANCER EPIDEM BIOMAR, V21, P253, DOI 10.1158/1055-9965.EPI-11-1179; Wagner AK, 2010, EUR J PHYS REHAB MED, V46, P549; Wagner A. K., 2014, AJPMR           0604; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2002, NEUROSCI LETT, V334, P165, DOI 10.1016/S0304-3940(02)01103-5; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Wagner AK, 2013, NEUROBIOL LEARN MEM, V106, P71, DOI 10.1016/j.nlm.2013.07.006; Wagner Amy K, 2013, Pathophysiology, V20, P39, DOI 10.1016/j.pathophys.2012.02.007; Wagner AK, 2012, BRAIN INJURY, V26, P1226, DOI 10.3109/02699052.2012.667594; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wagner AK, 2011, PM&R, V3, pS28, DOI 10.1016/j.pmrj.2011.04.013; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Wagner AK, 2010, EPILEPSY RES, V90, P259, DOI 10.1016/j.eplepsyres.2010.06.001; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x; Widerstrom-Noga E, 2013, PAIN, V154, P204, DOI 10.1016/j.pain.2012.07.022; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092698; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	110	5	5	0	7	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	SEP	2014	37	5					493	502		10.1179/2045772314Y.0000000248			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AT8ZX	WOS:000345218500007	25029659	Green Published			2022-02-06	
J	Yu, L; Wu, XL; Wang, H; Long, D; Yang, JH; Zhang, YC				Yu, Li; Wu, Xiaoling; Wang, Hui; Long, Ding; Yang, Junhui; Zhang, Yuanchao			Diagnostic and prognostic significance of suPAR in traumatic brain injury	NEUROLOGY INDIA			English	Article						Prognosis; soluble urokinase plasminogen activator receptor; traumatic brain injury; urokinase plasminogen activator receptor	PLASMINOGEN-ACTIVATOR RECEPTOR; PREDICTS MORTALITY; SERUM LEVEL; HEAD-INJURY; BIOMARKERS; FIBRINOLYSIS; SURVIVAL; MARKERS; UPAR	Background: Soluble urokinase plasminogen activator receptor (suPAR) is a highly sensitive marker that reflects increased inflammation and is positively correlated with pro-inflammatory biomarkers. The aim of this prospective observational study was to explore the relationship between the plasma concentration of suPAR and traumatic brain injury (TBI). Materials and Methods: In all 112 patients with TBI were included. Patients coming within 12 h whose highest abbreviated injury score (AIS) was 3 or less (other than head injury) were considered to be isolated TBI. Blood samples were obtained on admission. In all ninety healthy volunteers were enrolled as control group. Levels of plasma suPAR were determined using an enzyme-linked immunosorbent assay (ELISA) kit according to the manufacturer's instructions. Plasma D-dimer was measured and Glasgow Coma Scale (GCS) score was assessed at the same time. Results: Plasma suPAR values were statistically significantly higher in TBI patients than in controls (patients; 14.89 +/- 6.94, controls; 2.79 +/- 0.69, P < 0.01). The suPAR levels were strongly associated with the severity of TBI patients. The suPAR levels increased in association with the severity of brain injury, significance being found among all three groups: severe, moderate and mild TBI. The suPAR levels in non-survivals were significantly increased compared to the survivals (P < 0.05). Plasma levels of suPAR were strongly correlated to the GCS score (r = -0.854) and the levels of D-dimer (r = 0.753, both P < 0.01). Receiver operating characteristic curve (ROC) analysis of suPAR levels indicated that suPAR values had a high diagnostic specificity and sensitivity to differentiate survivals from non-survivals, the area underneath the ROC curve (AUROC) was 0.801 (95% CI: 0.698-0.903). The optimal suPAR cut-off value in predicting mortality was 15.70 ng/ml (sensitivity: 70.4%; specificity: 65.9%). Conclusions: Plasma levels of suPAR are elevated in TBI patients. Prognosis was worse in the patient group with elevated suPAR. High suPAR levels indicate a poorer prognosis in TBI patients.	[Yu, Li; Wu, Xiaoling; Wang, Hui; Long, Ding; Yang, Junhui; Zhang, Yuanchao] Huazhong Univ Sci & Technol, Intens Care Unit, Wuhan Cent Hosp, Tongji Med Coll, Wuhan 430014, Hubei, Peoples R China		Yu, L (corresponding author), Huazhong Univ Sci & Technol, Intens Care Unit, Wuhan Cent Hosp, Tongji Med Coll, Wuhan 430014, Hubei, Peoples R China.	yuli641006@sina.com					Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Beschorner R, 2000, NEUROPATH APPL NEURO, V26, P522, DOI 10.1046/j.0305-1846.2000.287.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; de Bont JM, 2008, EUR J PAEDIATR NEURO, V12, P334, DOI 10.1016/j.ejpn.2007.09.007; Eugen-Olsen J, 2002, INT J TUBERC LUNG D, V6, P686; Eugen-Olsen J, 2011, J INTERN MED, V270, P29, DOI 10.1111/j.1365-2796.2011.02372.x; Fraser DD, 2011, PEDIATR CRIT CARE ME, V12, P319, DOI 10.1097/PCC.0b013e3181e8b32d; Huttunen R, 2011, J INTERN MED, V270, P32, DOI 10.1111/j.1365-2796.2011.02363.x; Kjellman A, 2011, J INTERN MED, V269, P299, DOI 10.1111/j.1365-2796.2010.02284.x; Koch A, 2011, CRIT CARE, V15, DOI 10.1186/cc10037; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kofoed K, 2008, EUR J CLIN MICROBIOL, V27, P375, DOI 10.1007/s10096-007-0447-5; Kofoed K, 2006, CLIN CHEM, V52, P1284, DOI 10.1373/clinchem.2006.067595; Machado-Vieira R, 2009, J CLIN PSYCHIAT, V70, P1662, DOI 10.4088/JCP.08m04659; Molkanen T, 2011, EUR J CLIN MICROBIOL, V30, P1417, DOI 10.1007/s10096-011-1236-8; Moller HJ, 2006, CRIT CARE MED, V34, P2561, DOI 10.1097/01.CCM.0000239120.32490.AB; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; Morales D, 2006, J NEUROTRAUM, V23, P976, DOI 10.1089/neu.2006.23.976; Ostrowski SR, 2005, J INFECT DIS, V191, P1331, DOI 10.1086/428854; Rabna P, 2009, TROP MED INT HEALTH, V14, P986, DOI 10.1111/j.1365-3156.2009.02328.x; Rezaei S, 2012, ARCH TRAUMA RES, V1, P93, DOI 10.5812/atr.6546; Sidenius N, 2000, BLOOD, V96, P4091; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tennant A, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-21; Thuno M, 2009, DIS MARKERS, V27, P157, DOI [10.1155/2009/504294, 10.3233/DMA-2009-0657]; Tsang KKT, 2012, BRIT J ORAL MAX SURG, V50, P298, DOI 10.1016/j.bjoms.2011.03.004; Uusitalo-Seppala R, 2012, J INTERN MED, V272, P247, DOI 10.1111/j.1365-2796.2012.02569.x; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Yokobori S, 2013, TRANSL STROKE RES, V4, P25, DOI 10.1007/s12975-012-0226-1	31	5	5	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	SEP-OCT	2014	62	5					498	502		10.4103/0028-3886.144439			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AU9TH	WOS:000345937000004	25387618				2022-02-06	
J	Gao, JB; Tang, WD; Wang, X; Shen, J				Gao, Jian-Bo; Tang, Wei-Dong; Wang, Xiao; Shen, Jia			Prognostic value of neuropeptide proenkephalin A in patients with severe traumatic brain injury	PEPTIDES			English	Article						Proenkephalin A; Traumatic brain injury; Clinical outcome	PRIMARY BILIARY-CIRRHOSIS; SUBARACHNOID HEMORRHAGE; LEUCINE-ENKEPHALIN; PRE-PROENKEPHALIN; SPINAL-CORD; PLASMA; GENE; MODULATION; STRATEGIES; MORTALITY	High plasma proenkephalin A levels have been associated with poor clinical outcome of aneurysmal subarachnoid hemorrhage. This prospective observatory study was designed to investigate the relationship between plasma proenkephalin A levels and 1-week mortality, 6-month mortality and 6-month unfavorable outcome (defined as Glasgow Outcome Scale score of 1-3) in patients with severe traumatic brain injury. This study recruited 128 patients and 128 sex- and age-matched healthy controls. Plasma proenkephalin A levels, as measured by chemoluminescence sandwich immunoassay, were statistically significantly higher in patients than in healthy controls (239.1 +/- 93.0 pmol/L vs.81.3 +/- 22.1 pmol/L; P < 0.001) and were correlated with Glasgow Coma Scale scores (r = -0.540, P < 0.001). It was identified as an independent prognostic predictor of 1-week mortality [odds ratio (OR), 1.214; 95% confidence interval (CI), 1.103-1.425; P < 0.001], 6-month mortality (OR, 1.162; 95% CI, 1.101-1.372; P < 0.001) and 6-month unfavorable outcome (OR, 1.116; 95% CI, 1.097-1.281; P < 0.001). Moreover, it had high predictive value for 1-week mortality [area under curve (AUC), 0.852; 95% CI, 0.778-0.908], 6-month mortality (AUC, 0.841; 95% CI, 0.766-0.899) and 6-month unfavorable outcome (AUC, 0.830; 95% CI, 0.754-0.891). Furthermore, its predictive value was similar to Glasgow Coma Scale score's (all P > 0.05). Yet, a combined logistic-regression model did not show that it statistically significantly improved the predictive value of Glasgow Coma Scale score (all P > 0.05). Thus, it was proposed that enhanced plasma proenkephalin A could be a useful, complementary tool to predict short- or long-term clinical outcome after severe traumatic brain injury. (C) 2014 Elsevier Inc. All rights reserved.	[Gao, Jian-Bo; Wang, Xiao] Fuyang Peoples Hosp, Dept Emergency Med, Fuyang 311400, Zhejiang, Peoples R China; [Tang, Wei-Dong] Fuyang Peoples Hosp, Dept Crit Care Med, Fuyang 311400, Zhejiang, Peoples R China; [Shen, Jia] Fuyang Peoples Hosp, Dept Neurosurg, Fuyang 311400, Zhejiang, Peoples R China		Gao, JB (corresponding author), Fuyang Peoples Hosp, Dept Emergency Med, 2-4 Guihua Rd, Fuyang 311400, Zhejiang, Peoples R China.	FangLongZhu@yeah.net					Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Barron BA, 2000, P SOC EXP BIOL MED, V224, P1, DOI 10.1046/j.1525-1373.2000.22358.x; BENNETT GJ, 1982, BRAIN RES, V240, P162, DOI 10.1016/0006-8993(82)90656-4; BORSOOK D, 1995, AM J PHYSIOL-ENDOC M, V269, pE393, DOI 10.1152/ajpendo.1995.269.3.E393; Chen XL, 2014, PEPTIDES, V56, P111, DOI 10.1016/j.peptides.2014.04.001; Denning GM, 2008, PEPTIDES, V29, P83, DOI 10.1016/j.peptides.2007.11.004; Doehner W, 2012, J AM COLL CARDIOL, V60, P346, DOI 10.1016/j.jacc.2012.04.024; DORES RM, 1984, PEPTIDES, V5, P9, DOI 10.1016/0196-9781(84)90260-2; EIDEN LE, 1987, CELL MOL NEUROBIOL, V7, P339, DOI 10.1007/BF00733787; ELAM R, 1984, BRAIN RES, V303, P313, DOI 10.1016/0006-8993(84)91217-4; Ernst A, 2006, PEPTIDES, V27, P1835, DOI 10.1016/j.peptides.2006.03.008; GLAZER EJ, 1981, J COMP NEUROL, V196, P377, DOI 10.1002/cne.901960303; Hiranuma T, 1998, N-S ARCH PHARMACOL, V357, P276, DOI 10.1007/PL00005168; Janecka A, 2004, CURR TOP MED CHEM, V4, P1, DOI 10.2174/1568026043451618; JANKOVIC BD, 1992, INT J NEUROSCI, V67, P241, DOI 10.3109/00207459208994788; JENNETT B, 1975, LANCET, V1, P480; Kamel L., 2007, Eastern Mediterranean Health Journal, V13, P257; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; KLEIN RL, 1986, NEUROPEPTIDES, V8, P143, DOI 10.1016/0143-4179(86)90041-7; KOBARI M, 1988, Neurological Research, V10, P120; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mosconi P, 2011, PATIENT, V4, P55, DOI 10.2165/11535550-000000000-00000; Nelson DW, 2012, J NEUROTRAUM, V29, P2613, DOI 10.1089/neu.2012.2468; NODA M, 1982, NATURE, V295, P202, DOI 10.1038/295202a0; NODA M, 1982, NATURE, V297, P431, DOI 10.1038/297431a0; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; SCHWARTZ JC, 1981, LIFE SCI, V29, P1715, DOI 10.1016/0024-3205(81)90182-X; SHARMA HS, 1993, NEUROPHARMACOLOGY, V32, P711, DOI 10.1016/0028-3908(93)90085-H; SPIVEY JR, 1994, AM J GASTROENTEROL, V89, P2028; THORNTON JR, 1989, GUT, V30, P1392, DOI 10.1136/gut.30.10.1392; THORNTON JR, 1988, BRIT MED J, V297, P1241, DOI 10.1136/bmj.297.6658.1241; van den Brink Olivier W V, 2003, Heart Lung Circ, V12, P178, DOI 10.1046/j.1444-2892.2003.00240.x	35	5	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	AUG	2014	58						42	46		10.1016/j.peptides.2014.06.006			5	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	AN0XR	WOS:000340307800008	24937655				2022-02-06	
J	Pula, JH; Fischer, M; Kattah, JC				Pula, John H.; Fischer, Matthew; Kattah, Jorge C.			Hemifield slide from traumatic optic chiasmopathy	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Bitemporal hemianopia; Bitemporal hemianopsia; Hemifield slide; Hemifield slip; Traumatic optic chiasmopathy	DIPLOPIA	A 56-year-old man suffered a high velocity linear acceleration closed head injury, resulting in skull fractures including bone dehiscence at the planum sphenoidale and tuberculum sellae. After regaining consciousness, he reported blurry vision and episodic diplopia. Visual field testing showed a bitemporal hemianopia. Ocular motility testing uncovered no misalignment. Brain MRI revealed post-traumatic encephalomalacia within the optic chiasm, resulting in the visual field defect and subsequent hemifield slide. Normally, cerebral processing of overlap between the visual fields prevents hemifield slide, which is caused by episodic loss of visual field overlap with subsequent slipping or sliding apart of images. (C) 2014 Elsevier Ltd. All rights reserved.	[Pula, John H.] NorthShore Univ Hlth Syst, Evanston, IL 60201 USA; [Fischer, Matthew; Kattah, Jorge C.] Univ Illinois, Coll Med, Peoria, IL 61656 USA		Pula, JH (corresponding author), NorthShore Univ Hlth Syst, 2650 Ridge Ave, Evanston, IL 60201 USA.	JPula@NorthShore.org					Borchert MS, 1996, J NEURO-OPHTHALMOL, V16, P107, DOI 10.1097/00041327-199606000-00005; Brazis PW, 1999, MAYO CLIN PROC, V74, P907, DOI 10.4065/74.9.907; DOMINGO Z, 1993, BRIT J NEUROSURG, V7, P141, DOI 10.3109/02688699309103470; Hassan A, 2002, CLIN EXP OPHTHALMOL, V30, P273, DOI 10.1046/j.1442-9071.2002.00534.x; KIRKHAM TH, 1972, P ROY SOC MED, V65, P517, DOI 10.1177/003591577206500606; Lee AG, 2003, CLIN PATHWAYS NEUROO, V2nd	6	5	5	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	AUG	2014	21	8					1446	1447		10.1016/j.jocn.2014.01.001			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM1JE	WOS:000339601400037	24613428				2022-02-06	
J	Zheng, ZL; Morykwas, M; Campbell, D; McGee, M; Hollingsworth, C; Adams, F; Mays, J; Tatter, S; Argenta, L				Zheng, Zhen-Lin; Morykwas, Michael; Campbell, Douglas; McGee, Maria; Hollingsworth, Charlotte; Adams, Farren; Mays, Jennifer; Tatter, Stephen; Argenta, Louis			Mechanical Tissue Resuscitation at the Site of Traumatic Brain Injuries Reduces the Volume of Injury and Hemorrhage in a Swine Model	NEUROSURGERY			English	Article						Magnetic resonance imaging analysis; Mechanical tissue resuscitation; Subatmospheric pressure treatment; Swine model; Traumatic brain injury	VACUUM-ASSISTED CLOSURE; CONTROLLED CORTICAL IMPACT; PERISTERNAL THORACIC WALL; PRESSURE WOUND THERAPY; BLOOD-FLOW; EDEMA; PATHOPHYSIOLOGY; FOOTBALL; RAT	BACKGROUND: Traumatic brain injuries (TBIs) continue to be a devastating problem with limited treatment options. Previous research applying controlled vacuum to TBI in a rat model resulted in smaller injuries and more rapid recovery. OBJECTIVE: To examine the effects of the application of a controlled vacuum (mechanical tissue resuscitation) to TBI in a large-animal model. The magnitude of vacuum, length of application, and length of delay between injury and the application of mechanical tissue resuscitation were investigated. METHODS: Localized, controlled cortical injuries were created in swine. Vacuums of -50 and -100 mm Hg were compared. Mechanical tissue resuscitation for 3 or 5 days was compared. Delays of 0, 3, or 6 hours between the creation of the TBI and the initiation of mechanical tissue resuscitation were examined. Analysis included histological assessments, computed tomographic perfusion, and magnetic resonance imaging (T2, proton magnetic spectra). RESULTS: A -100 mm Hg vacuum resulted in significantly smaller mean contused brain and hemorrhage volumes compared with -50 mm Hg and controls. Magnetic resonance spectra of treated animals returned to near baseline values. All 10 animals with 5-day mechanical tissue resuscitation treatment survived. Three of 6 animals treated for 3 days died after the discontinuation of treatment. A 3-hour delay resulted in similar results as immediate treatment. A 6-hour delay produced significant, but lesser responses. CONCLUSION: Application of mechanical tissue resuscitation to TBI was efficacious in the large-animal model. Application of -100 mm Hg for 5 days resulted in significantly improved outcomes. Delays of up to 3 hours between injury and the initiation of treatment did not diminish the efficacy of the mechanical tissue resuscitation treatment.	[Zheng, Zhen-Lin; Morykwas, Michael; McGee, Maria; Hollingsworth, Charlotte; Adams, Farren; Mays, Jennifer; Argenta, Louis] Wake Forest Univ Hlth Sci, Dept Plast & Reconstruct Surg, Winston Salem, NC 27157 USA; [Campbell, Douglas] Wake Forest Univ Hlth Sci, Dept Gen Surg, Winston Salem, NC 27157 USA; [Tatter, Stephen] Wake Forest Univ Hlth Sci, Dept Neurosurg, Winston Salem, NC 27157 USA		Argenta, L (corresponding author), Wake Forest Univ Hlth Sci, Dept Plast & Reconstruct Surg, Med Ctr Blvd, Winston Salem, NC 27157 USA.	largenta@wakehealth.edu	Tatter, Stephen/AAD-6524-2021	Tatter, Stephen/0000-0002-1063-0431	US ArmyUnited States Department of Defense [W81XWH-09-1-0437]; Cheek Research Endowment of Wake Forest University	This study was supported by grant W81XWH-09-1-0437 from the US Army and by the Cheek Research Endowment of the Wake Forest University. A patent covering the technique described in this article has been issued to some of the authors (LA, MM, ST) and Wake Forest Health Services. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Alessandri B, 1999, ACT NEUR S, V75, P21; Argenta LC, 2012, NEUROSURGERY, V70, P1281, DOI 10.1227/NEU.0b013e3182446760; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Dedmond BT, 2007, J ORTHOP TRAUMA, V21, P11, DOI 10.1097/BOT.0b013e31802cbc54; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Kraus FJ, 2004, ARCH PHYS MED REHAB, V85, P1740; Lee AT, 2005, J ORTHOP TRAUMA, V19, P748, DOI 10.1097/01.bot.0000154482.44336.19; Liu J, 2011, J BIOMED MATER RES B, V98B, P316, DOI 10.1002/jbm.b.31854; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Morykwas MJ, 1999, J BURN CARE REHABIL, V20, P15, DOI 10.1097/00004630-199901001-00003; Morykwas MJ, 1997, ANN PLAS SURG, V38, P553, DOI 10.1097/00000637-199706000-00001; Petzina R, 2006, EUR J CARDIO-THORAC, V30, P85, DOI 10.1016/j.ejcts.2006.04.009; Rogers J, 2010, NEUROIMAGE, V53, P1103, DOI 10.1016/j.neuroimage.2010.02.020; Rosenthal G, 2008, J NEUROSURG, V108, P575, DOI 10.3171/JNS/2008/108/3/0575; Stannard JP, 2006, J TRAUMA, V60, P1301, DOI 10.1097/01.ta.0000195996.73186.2e; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wackenfors A, 2004, WOUND REPAIR REGEN, V12, P600, DOI 10.1111/j.1067-1927.2004.12602.x; Wackenfors A, 2005, ANN THORAC SURG, V79, P1724, DOI 10.1016/j.athoracsur.2004.10.053; Wahlen MJ, 1998, ACTA NEUROCHIR S, V71, P212; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamaura I, 2002, SPINE, V27, P21, DOI 10.1097/00007632-200201010-00008; Yang Charlie C, 2006, J Surg Orthop Adv, V15, P19; Yin DL, 2009, J NEUROSCI METH, V176, P200, DOI 10.1016/j.jneumeth.2008.08.027	33	5	5	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2014	75	2					152	161		10.1227/NEU.0000000000000341			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AM8PE	WOS:000340138400030	24618796	Bronze			2022-02-06	
J	Kalluri, HSG; Dempsey, RJ				Kalluri, Haviryaji S. G.; Dempsey, Robert J.			D609-mediated inhibition of ATP synthesis in neural progenitor cells	NEUROREPORT			English	Article						cytochrome c oxidase; D609; oxidation	AMYLOID BETA-PEPTIDE; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; D609; GROWTH; PROLIFERATION; PROTECTION; XANTHATE; DAMAGE	Tricyclodecan-9-yl-xanthogenate (D609) is an antioxidative molecule with antiproliferative and neuroprotective properties in a variety of cells. Previously, we have shown that D609 decreased the proliferation of neural progenitor cells. In this study, we examined the antioxidative property of D609 on neural progenitor cells isolated from the subventricular zone of the rat brain. Cellular oxidation was assessed by measuring the ATP content of the cells. Our results show that D609 decreased the ATP content of the neural progenitor cells by approximate to 40%, suggesting the possible inhibition of cellular metabolic activity. Cytochrome c oxidase (Cox), also known as complex IV of the electron transport chain, is a terminal enzyme involved in the oxidation of substrates resulting in the generation of energy required for the cellular activity. Therefore, regulating the activity of Cox could interfere with the generation of ATP, consequently affecting the proliferation of cells. Consistent with this hypothesis, we also observed a decrease in the Cox activity following the incubation of neural progenitor cells with D609. These results suggest that D609 could inhibit the activity of Cox and subsequent ATP synthesis in the neural progenitor cells.	[Kalluri, Haviryaji S. G.; Dempsey, Robert J.] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA; [Dempsey, Robert J.] Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI 53792 USA		Kalluri, HSG (corresponding author), Univ Wisconsin, Dept Neurol Surg, Madison, WI 53792 USA.	h.kalluri@neurosurg.wisc.edu			Department of Neurological Surgery, University of Wisconsin, Madison; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 NS063959]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS063959] Funding Source: NIH RePORTER	This work was supported by funds from the Department of Neurological Surgery, University of Wisconsin, Madison and partly supported by NIH RO1 NS063959 (R.J.D.).	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Ansari MA, 2006, FREE RADICAL BIO MED, V41, P1694, DOI 10.1016/j.freeradbiomed.2006.09.002; Arsenault DJ, 2013, J BIOL CHEM, V288, P633, DOI 10.1074/jbc.M112.347682; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; Gusain A, 2012, MOL NEUROBIOL, V45, P455, DOI 10.1007/s12035-012-8254-0; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Kalluri HSG, 2007, EUR J NEUROSCI, V25, P1041, DOI 10.1111/j.1460-9568.2007.05336.x; Kalluri HSG, 2013, MOL NEUROBIOL, V47, P782, DOI 10.1007/s12035-012-8390-6; Kalluri HSG, 2010, NEUROREPORT, V21, P700, DOI 10.1097/WNR.0b013e32833b46f6; Kennedy A, 2010, J LIPID RES, V51, P1906, DOI 10.1194/jlr.M005447; Latchoumycandane C, 2012, J BIOL CHEM, V287, P17693, DOI 10.1074/jbc.M111.300012; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; Perluigi M, 2006, NEUROSCIENCE, V138, P1161, DOI 10.1016/j.neuroscience.2005.12.004; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Sultana R, 2004, FREE RADICAL RES, V38, P449, DOI 10.1080/1071576042000206478; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5; Zhou DH, 2001, J PHARMACOL EXP THER, V298, P103	20	5	5	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	JUL 9	2014	25	10					777	781		10.1097/WNR.0000000000000176			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AJ5MW	WOS:000337728800010	24918458	Green Accepted			2022-02-06	
J	Boretto, JG; Sammartino, MR; Gallucci, G; De Carli, P; Ring, D				Boretto, Jorge G.; Sammartino, Mario Rodriguez; Gallucci, Gerardo; De Carli, Pablo; Ring, David			Comparative Study of Simple and Complex Open Elbow Dislocations	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							RADIAL HEAD; FRACTURE; JOINT; INJURIES	Open elbow dislocations are rare injuries. Most of the evidence related to these dislocations is found in case reports or in series with closed injuries. We reviewed the experiences of three centers in the treatment of open elbow dislocations. We compared the results after operative treatment of simple and complex open dislocations in terms of (1) ROM, (2) functional score, and (3) complications. Eighteen patients were retrospectively included in this study: 11 with simple open elbow dislocations and seven with complex open elbow dislocations. Mean age was 40 years. Thirteen were men. Eight patients presented neurovascular injuries. Evaluation included ROM of the elbow and forearm as measured by hand-held goniometer. We then classified the results using the 100-point Broberg and Morrey functional rating index based on ROM, grip strength, elbow stability, and pain. Scores of 95 to 100 were considered excellent, 80 to 94 good, 60 to 79 fair, and less than 60 poor. Complications were recorded. Minimum followup was 6 months (mean, 25 months; range, 6-72 months). We found no differences between simple and complex open elbow dislocations related to ROM (median flexion/extension: 117A degrees versus 110A degrees, p = 0.12; forearm rotation: 160A degrees versus 170A degrees, p = 0.67). According to the Broberg and Morrey score, four patients had excellent results, five good, and one fair in the simple dislocation group, whereas in the complex dislocation group, four patients had excellent results, two good, and one fair (p = 0.8). No difference in complication rate was found between groups (p = 0.63). All complications in the simple dislocation group were neurovascular. In the complex dislocation group, there was one case of brachial artery occlusion, two cases of heterotopic ossification, one case of infection and nonunion, and one case of infection. No patients had recurrent elbow instability. No differences between simple and complex open elbow dislocations were found in terms of ROM, functional results, and rate of complications. Complications in the simple dislocation group were related to neurovascular injuries in contrast to the complex dislocation group where complications were associated with the bony injury. Level IV, prognostic study. See Instructions for Authors for a complete description of levels of evidence.	[Boretto, Jorge G.; Gallucci, Gerardo; De Carli, Pablo] Hosp Italiano Buenos Aires, Inst Ortopedia & Traumatol Dr Prof Carlos Ottolen, Dept Hand & Upper Extrem, Buenos Aires, DF, Argentina; [Sammartino, Mario Rodriguez] Clin Fracturas & Ortopedia, Orthoped & Traumatol Serv, Mar Del Plata, Buenos Aires, Argentina; [Ring, David] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Orthopaed Hand & Upper Extrem Serv, Boston, MA USA		Boretto, JG (corresponding author), Hosp Italiano Buenos Aires, Inst Ortopedia & Traumatol Dr Prof Carlos Ottolen, Dept Hand & Upper Extrem, Buenos Aires, DF, Argentina.	jboretto@hotmail.com	Ring, David/AAV-9035-2021; De Carli, Pablo/I-3261-2019; Boretto, Jorge/H-3368-2019	Ring, David/0000-0002-6506-4879; De Carli, Pablo/0000-0002-9474-8129; Boretto, Jorge/0000-0001-7701-3852			Ahmad R, 2007, EMERG MED J, V24, P860, DOI 10.1136/emj.2006.044016; Alonso JA, 2002, BMC MUSCULOSKELET DI, V3, DOI 10.1186/1471-2474-3-1; Anakwe RE, 2011, J BONE JOINT SURG AM, V93A, P1220, DOI 10.2106/JBJS.J.00860; Ayel JE, 2009, ORTHOP TRAUMATOL-SUR, V95, P343, DOI 10.1016/j.otsr.2009.04.013; Bachoura A, 2011, CLIN ORTHOP RELAT R, V469, P2621, DOI 10.1007/s11999-010-1737-2; Bachy M, 2012, ARCH PEDIATRIE, V19, P624, DOI 10.1016/j.arcped.2012.03.007; Black N, 1996, BRIT MED J, V312, P1215; BROBERG MA, 1986, J BONE JOINT SURG AM, V68A, P669, DOI 10.2106/00004623-198668050-00005; COLLINS DN, 1989, CLIN ORTHOP RELAT R, P48; Forthman C, 2007, J HAND SURG-AM, V32A, P1200, DOI 10.1016/j.jhsa.2007.06.019; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HENDERSON RS, 1952, J BONE JOINT SURG BR, V34, P636, DOI 10.1302/0301-620X.34B4.636; Hildebrand KA, 1999, ORTHOP CLIN N AM, V30, P63, DOI 10.1016/S0030-5898(05)70061-4; JOSEFSSON PO, 1987, CLIN ORTHOP RELAT R, P221; JOSEFSSON PO, 1986, ACTA ORTHOP SCAND, V57, P537, DOI 10.3109/17453678609014788; Kilburn J, 1962, J BONE JOINT SURG BR, V44, P119; LANSINGER O, 1984, ARCH ORTHOP TRAUM SU, V102, P183, DOI 10.1007/BF00575230; Martin DJ, 2005, EUR J EMERG MED, V12, P30, DOI 10.1097/00063110-200502000-00008; MEHLHOFF TL, 1988, J BONE JOINT SURG AM, V70A, P244, DOI 10.2106/00004623-198870020-00013; Morrey BF, 2005, J SHOULDER ELB SURG, V14, p174S, DOI 10.1016/j.jse.2004.09.031; Pugh DMW, 2004, J BONE JOINT SURG AM, V86A, P1122, DOI 10.2106/00004623-200406000-00002; Ring D, 1998, J BONE JOINT SURG AM, V80A, P566, DOI 10.2106/00004623-199804000-00014; Ring D, 2002, J BONE JOINT SURG AM, V84A, P547, DOI 10.2106/00004623-200204000-00006; Stoneback JW, 2012, J BONE JOINT SURG AM, V94A, P240, DOI 10.2106/JBJS.J.01663; Wiggers JK, 2014, CLIN ORTHOP RELAT R, V472, P2162, DOI 10.1007/s11999-013-3304-0	25	5	5	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	JUL	2014	472	7					2037	2043		10.1007/s11999-014-3491-3			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AI6XP	WOS:000337021300009	24515405	Green Published			2022-02-06	
J	Bramley, H; Mcfarland, C; Lewis, MM; Shaffer, ML; Cilley, R; Engbrecht, B; Santos, M; Rzucidlo, S; Shirk, B; Simmons, L; Dias, MS				Bramley, Harry; Mcfarland, Carol; Lewis, Mechelle M.; Shaffer, Michele L.; Cilley, Robert; Engbrecht, Brett; Santos, Mary; Rzucidlo, Susan; Shirk, Beverly; Simmons, Lynn; Dias, Mark S.			Short-term Outcomes of Sport- and Recreation-Related Concussion in Patients Admitted to a Pediatric Trauma Service	CLINICAL PEDIATRICS			English	Article						mild traumatic brain injury; concussion; computed tomography; sports injury; Glasgow Coma Scale	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY; POSITION STATEMENT; RADIATION RISKS; UNITED-STATES; CANCER-RISKS; BRAIN-INJURY; CT; CHILDREN; PREDICTION	The outcomes of patients admitted to the hospital following a sport-related concussion are largely unknown. Medical records of patients admitted to the pediatric trauma service between 2008 and 2011 after sustaining a sport-related concussion were reviewed. In all, 59 participants were in the high-velocity activities group, and 21 in the field or court sport group. Abnormal CT scans were found in 14 patients in the high-velocity group and 2 in the field or court sport group. The majority of participants in the field or court sport group were football players, all of whom had normal CT scans. Headache was predictive of an abnormal CT scan. Among the patients, 56% clinically improved and were discharged the following day. Patients with field or court sport-related concussion admitted to a pediatric trauma service appear to be at low risk for clinically significant intracranial pathology and do well in the acute setting.	[Bramley, Harry; Cilley, Robert; Engbrecht, Brett; Santos, Mary; Rzucidlo, Susan; Shirk, Beverly; Simmons, Lynn; Dias, Mark S.] Penn State Milton S Hershey Med Ctr, Hershey, PA 17033 USA; [Mcfarland, Carol; Lewis, Mechelle M.] Penn State Coll Med, Hershey, PA USA; [Shaffer, Michele L.] Seattle Childrens Res Inst, Ctr Clin & Translat Res, Childrens Core Biomed Stat, Seattle, WA USA; [Shaffer, Michele L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Bramley, H (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Pediat, Mail Code H085,500 Univ Dr, Hershey, PA 17033 USA.	hbramley@hmc.psu.edu		Santos, Mary Catherine/0000-0001-7015-4820	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS060722, ES019672]; Pennsylvania Department of Health Tobacco Settlement Funds [C06 RR016499]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES019672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060722] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by the National Institutes of Health (NS060722 and ES019672) and the Pennsylvania Department of Health Tobacco Settlement Funds (C06 RR016499). All analyses, interpretations, and conclusions are those of the authors and not the research sponsors. The authors have no financial relationships relevant to this article to disclose.	[Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; Atabaki SM, 2007, PEDIATR REV, V28, P215, DOI 10.1542/pir.28-6-215; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Boutis K, 2013, PEDIATRICS, V132, P305, DOI 10.1542/peds.2013-0378; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brenner DJ, 2004, RADIOLOGY, V232, P735, DOI 10.1148/radiol.2323031095; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Davis G, 2010, BRIT J SPORT MED, V44, P1139, DOI 10.1136/bjsm.2008.048215; Davis G, 2009, BRIT J SPORT MED, V43, P866, DOI 10.1136/bjsm.2008.048223; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Fenerty L, 2013, J TRAUMA ACUTE CARE, V74, P895, DOI 10.1097/TA.0b013e31827e19ca; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Klig JE, 2010, CURR OPIN PEDIATR, V22, P257, DOI 10.1097/MOP.0b013e328339736e; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Mattei TA, 2012, J NEUROSURG-PEDIATR, V10, P490, DOI 10.3171/2012.8.PEDS12116; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mitra Biswadev, 2012, Evid Based Med, V17, P28, DOI 10.1136/ebm.2011.100219; Parker L, 2001, PEDIATR HEMAT ONCOL, V18, P307, DOI 10.1080/088800101300312564; Paterson A, 2001, AM J ROENTGENOL, V176, P297, DOI 10.2214/ajr.176.2.1760297; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearce MS, 2011, J MED IMAG RADIAT ON, V55, P107, DOI 10.1111/j.1754-9485.2011.02240.x; Rehani MM, 2000, BRIT MED J, V320, P593, DOI 10.1136/bmj.320.7235.593; Stiell IG, 2010, CAN MED ASSOC J, V182, P1527, DOI 10.1503/cmaj.091974; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	33	5	5	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0009-9228	1938-2707		CLIN PEDIATR	Clin. Pediatr.	JUL	2014	53	8					784	790		10.1177/0009922814533403			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AJ4GP	WOS:000337631600012	24790025				2022-02-06	
J	Connery, AK; Baker, DA; Kirk, JW; Kirkwood, MW				Connery, Amy K.; Baker, David A.; Kirk, John W.; Kirkwood, Michael W.			The Effects of Multiple Mild Traumatic Brain Injuries on Acute Injury Presentation and Neuropsychological Recovery in Children	NEUROSURGERY			English	Article						Concussion; Mild traumatic brain injury; Multiple injuries; Neuropsychological testing; Pediatric	COLLEGIATE FOOTBALL PLAYERS; SELF-REPORTED CONCUSSIONS; SYMPTOM VALIDITY TEST; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURIES; PERFORMANCE; HISTORY; PREDICTORS; SAMPLE	BACKGROUND:Although research focused on mild traumatic brain injury (mTBI) has proliferated in recent years, few studies have examined the significance of a previous history of mTBI in children.OBJECTIVE:To compare the acute injury presentation and neuropsychological recovery in a pediatric sample after mTBI.METHODS:Participants 8 to 16 years of age were divided into 4 groups: no previous injury history, history of 1 mTBI, history of 2 mTBIs, and history of 3 mTBIs. Participants were evaluated within 3 months of the most recent injury by clinical interview and an abbreviated neuropsychological test battery.RESULTS:After the index mTBI, the groups did not differ in their likelihood to display a loss of consciousness, nor did they differ on neuropsychological test performance.CONCLUSION:Overall, contrary to our hypotheses, we found no demonstrable difference between those children with a self-reported mTBI history and those without after an index mTBI.	Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO 80045 USA; Univ Colorado, Sch Med, Aurora, CO USA		Connery, AK (corresponding author), Childrens Hosp Colorado, Concuss Program, B285,13123 E 16th Ave, Aurora, CO 80045 USA.	amy.connery@childrenscolorado.org					Anderson V, 2010, NEUROPSYCHOLOGIA, V48, P2041, DOI 10.1016/j.neuropsychologia.2010.03.025; [Anonymous], 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Bijur PE, 1996, J DEV BEHAV PEDIATR, V17, P143, DOI 10.1097/00004703-199606000-00001; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Brooks BL, 2013, J NEUROTRAUM, V30, P1469, DOI 10.1089/neu.2012.2720; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Delis DC., 1994, CALIFORNIA VERBAL LE; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Karantzoulis S, 2013, NEUROPSYCHOL REV, V23, P350, DOI 10.1007/s11065-013-9243-4; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	39	5	5	0	14	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	JUL	2014	75	1					31	36		10.1227/NEU.0000000000000346			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	AJ5LT	WOS:000337725100009	24618798				2022-02-06	
J	Ferreira, CD; Matushita, H; Silva, BRD; Netto, AU; Correia, LG; Holanda, MMD; Santos, RHP				Ferreira, Christian Diniz; Matushita, Hamilton; Duarte Silva, Bruno Roberto; Netto, Arlindo Ugulino; Correia, Luiz Gustavo; de Almeida Holanda, Maurus Marques; Pinheiro Santos, Rayan Haquim			Proposal of a new method to induce ventricular system dilation to simulate the features of hydrocephalus and provide an anatomical model for neuroendoscopy training	CHILDS NERVOUS SYSTEM			English	Article						Hydrocephalus; Neuroendoscopy; Ventricles; Experimentalmodels	ENDOSCOPIC TREATMENT; CYSTS	Create an anatomical model which simulates the real condition of a hydrocephalus and which can be used as a tool in the training of neurosurgeons in neuroendoscopy techniques and anatomical structure study. Case-control type study, with an experimental group consisting of ten brains, in which the injection of distilled water was performed; and the control group consisting of three brains with saline solution. Inclusion criteria were brains with no history of contagious diseases or traumatic injury. t student test showed that the relation between frontal horn and internal frontal diameter (FH/ID), with an average of 13 % before the experiment, had a significant difference (t = -3.47, df = 9, p < 0.01) from the relation after the subsequent experiment with an average of 20 %. The Evan's index also showed a significant difference (t = -3.57, df = 9, p < 0.01) with an initial and final average of 12 % and 19 %, respectively. Friedman test showed significant difference of the size of the temporal horn before and after the experiment (f = 8.1, df = 1, p < 0.01), indicating that there was significant increase of the temporal horn. The adequate use of the anomalous chemical-physical characteristics of the water molecule may provide a good mechanism to expand the ventricular cavity, in order to create an experimental model of hydrocephalus. The endoscope may be introduced by the usual ways, allowing anatomical observation and simulation of the same tactile sensitivity that one would find during the actual procedure.	[Ferreira, Christian Diniz; de Almeida Holanda, Maurus Marques; Pinheiro Santos, Rayan Haquim] Univ Fed Paraiba UFPB, Joao Pessoa, Paraiba, Brazil; [Matushita, Hamilton] Univ Sao Paulo, BR-09500900 Sao Paulo, Brazil; [Duarte Silva, Bruno Roberto] Fac Ciencias Med Paraiba FCM PB, Joao Pessoa, Paraiba, Brazil; [Netto, Arlindo Ugulino; Correia, Luiz Gustavo] Fac Med Nova Esperanca FAMENE, Joao Pessoa, Paraiba, Brazil		Ferreira, CD (corresponding author), Univ Fed Paraiba UFPB, Joao Pessoa, Paraiba, Brazil.	christiandiniz@hotmail.com					Alvarez- Pena C, 2000, REV CHIL NEUROCIR, V61, P89; Decq P, 1996, J NEUROSURG, V84, P696, DOI 10.3171/jns.1996.84.4.0696; Gaab MR, 1998, J NEUROSURG, V88, P496, DOI 10.3171/jns.1998.88.3.0496; Hellwig D, 1996, SURG NEUROL, V45, P272, DOI 10.1016/0090-3019(95)00417-3; Jongh Cobo E, 2005, REV CUBANA CIR, V44; Kobayashi N, 1997, NEUROL SURG TOKYO, V25, P35; Mathiesen T, 1997, J NEUROSURG, V86, P5, DOI 10.3171/jns.1997.86.1.0005; MATULA C, 1995, ACTA NEUROCHIR, V134, P190, DOI 10.1007/BF01417688; Perneczky A, 1998, NEUROSURGERY, V42, P219, DOI 10.1097/00006123-199802000-00001; PERNECZKY A, 1995, J NEUROSURG, V82, P898, DOI 10.3171/jns.1995.82.5.0898; Quagliano JV, 1979, QUIMICA; Santorcuato F, 2008, REV CHIL NEUROCIR, V30, P32; van WYLEN G., 2003, FUNDAMENTOS TERMODIN	13	5	5	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	JUL	2014	30	7					1209	1215		10.1007/s00381-013-2346-7			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	AK7TR	WOS:000338631100011	24389583				2022-02-06	
J	Lorton, F; Levieux, K; Vrignaud, B; Hamel, O; Jehle, E; Hamel, A; Gras-Leguen, C				Lorton, F.; Levieux, K.; Vrignaud, B.; Hamel, O.; Jehle, E.; Hamel, A.; Gras-Leguen, C.		Grp Francophone de Reanimation	New recommendations for the management of children after minor head trauma	ARCHIVES DE PEDIATRIE			French	Article							INJURY; S100B; INFANTS	Minor head trauma is a common cause for pediatric emergency department visits. In 2009, the Pediatric Emergency Care Applied Research Network (PECARN) published a clinical prediction rule for identifying children at very low risk of clinically important traumatic brain injuries (ciTBI) and for reducing CT use because of malignancy induced by ionizing radiation. The prediction rule for ciTBI was derived and validated on 42,412 children in a prospective cohort study. The Societe Francaise de Medecine d'Urgence (French Emergency Medicine Society) and the Groupe Francophone de Reanimation et Urgences Pediatriques (French-Language Pediatric Emergency Care Group) recommend this algorithm for the management of children after minor head trauma. Based on clinical variables (history, symptoms, and physical examination findings), the algorithm assists in medical decision-making: CT scan, hospitalization for observation or discharge, according to three levels of ciTBI risk (high, intermediate, or low risk). The prediction rule sensitivity for children younger than 2 years is 100 % [86.3-100] and for those aged 2 years and older it is 96.8 % [89-99.6]. Our aim is to present these new recommendations for the management of children after minor head trauma. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Lorton, F.; Levieux, K.; Vrignaud, B.; Gras-Leguen, C.] CHU Nantes, F-44093 Nantes 1, France; [Hamel, O.] CHU Nantes, Hotel Dieu, F-44093 Nantes 1, France; CHU Toulouse, Hop Purpan, F-37059 Toulouse 9, France; [Hamel, A.] CHU Nantes, Hop Femme Enfant Adolescent, F-44093 Nantes 1, France		Lorton, F (corresponding author), CHU Nantes, 9 Quai Moncousu, F-44093 Nantes 1, France.	fleur.lorton@chu-nantes.fr	Hamel, Antoine/AAH-7437-2020; Hamel, Antoine/ABA-6745-2021	Hamel, Antoine/0000-0003-3348-9060; GRAS-LE GUEN, Christele/0000-0001-9060-2344			[Anonymous], 1994, DIAGN STAT MAN MENT, V4; Babcock L, 2012, BRAIN INJURY, V26, P1372, DOI 10.3109/02699052.2012.694565; Bechtel K, 2009, PEDIATRICS, V124, pE697, DOI 10.1542/peds.2008-1493; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Chalumeau M, 2008, ARCH PEDIATR, V15, P218; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; *NAT I HLTH CLIN E, 2007, NICE CLIN GUID, V56; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; US Department of Health and Human Services, 2010, TRAUMATIC BRAIN INJU; Willis AP, 2008, CLIN RADIOL, V63, P165, DOI 10.1016/j.crad.2007.05.027	15	5	5	0	15	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0929-693X	1769-664X		ARCH PEDIATRIE	Arch. Pediatr.	JUL	2014	21	7					790	796		10.1016/j.arcped.2014.04.015			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	AM7WA	WOS:000340078200023	24935453				2022-02-06	
J	Silva, SFR; Silva, SL; Nascimento, AC; Parente, MM; Albuquerqu, CA; Rodrigues, AA; Campos, HH; Machado, EFS; Almeida, ERB				Silva, S. F. R.; Silva, S. L.; Nascimento, A. C.; Parente, M. M.; Albuquerqu, C. A.; Rodrigues, A. A.; Campos, H. H.; Machado, E. F. S.; Almeida, E. R. B.			Profile of Organ Donors in Ceara, Northeastern Brazil, From 1998 to 2012	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	13th Congress of the Brazilian-Transplantation-Society	OCT 12-15, 2013	Rio de Janiero, BRAZIL	Brazilian Transplantat Soc				The use of cadaver donors for transplantation is often the only alternative in the treatment of patients with organ failure. The purpose of this study was to draw a comprehensive profile of solid organ donors in Ceara, northeastern Brazil, from 1998 to 2012. The study was retrospective and based on secondary data regarding sex, age, blood typing, and cause of brain death obtained from the solid organ donor database of the Ceara Transplantation Center covering the period November 1998 to December 2012. During the study period, 976 donors (69% male) were used. Donors were distributed in 4 age groups as follows: 12.9% <18 years, 50.9% 18-40 years, 28.5% 41-60 years, and 7.7% >60 years. The average age was 35 16 years. On the average, female donors were older than male donors (38.4 +/- 17 y vs 33.5 +/- 16 y; P < .0001). Men were predominant in the age groups 18-40 y (75.3%; P < .0001) and 41-60 y (59.4%; P < .0001). The main causes of brain death were traumatic brain injury (TBI) (56.7%) and stroke (33.1%). The former was more common in men (P < .0001), the latter in women (P < .0001). TBI was' caused by traffic accidents (51.4%), of which 50.7% were motorcycle accidents, and urban violence (22.6%), of which 71.2% were associated with firearms. The number of donations increased in the study period (11.2 donors per million population in 1998-2002 to 68.1 in 2008-2012). In Ceara, solid organ donation is on the rise. The predominant donor profile was young men aged 18-40 years with brain death due to TBI caused by traffic accidents and urban violence.	[Machado, E. F. S.; Almeida, E. R. B.] Transplantat Ctr Ceara, Fortaleza, Ceara, Brazil; [Silva, S. F. R.; Silva, S. L.; Nascimento, A. C.; Parente, M. M.; Albuquerqu, C. A.; Rodrigues, A. A.] Univ Fortaleza, Fortaleza, Ceara, Brazil; [Campos, H. H.] Univ Fed Ceara, Fortaleza, Ceara, Brazil		Silva, SFR (corresponding author), Univ Fortaleza, Fortaleza, Ceara, Brazil.	silviafernandes@unifor.br	RAmirez, Evelio/S-8742-2019				Brazilian Organ Transplant Association (ABTO), 2010, RBT; Brazilian Organ Transplant Association (ABTO), 2011, RBT; Brazilian Organ Transplant Association (ABTO), 2013, RBT; Brazilian Organ Transplant Association (ABTO), 2012, RBT; Freire ILS, 2013, REV ENFERM UFPE LINE, V7, P184; Fusco CC, 2009, J BRAS TRANSPL, V12, P1109; Meers C, 2009, TRANSPL P, V41, P572, DOI 10.1016/j.transproceed.2008.12.029; Moraes EL, 2009, REV LAT-AM ENFERM, V17, P120; Moraes EL, 2006, J BRAS TRANSPL, V9, P561; Noronha MGO, 2012, REV AMRIGS, V56, P199; Paz ACdAC, 2011, REV ENFERM, P124; Waiselfisz J. J., MAPA VIOLENCIA 2013	12	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	JUL-AUG	2014	46	6					1692	1694		10.1016/j.transproceed.2014.05.008			3	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	AO1MS	WOS:000341076800009	25131014				2022-02-06	
J	Bay, EH; Chartier, KS				Bay, Esther H.; Chartier, Kattlynn S.			Chronic Morbidities After Traumatic Brain Injury: An Update for the Advanced Practice Nurse	JOURNAL OF NEUROSCIENCE NURSING			English	Article						chronic; disability; morbidity; mortality; rehabilitation; traumatic brain injury; treatment	MAJOR DEPRESSIVE DISORDER; HEAD-INJURY; POSTCONCUSSION SYNDROME; COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; INCREASED RISK; MILD; MODERATE; STRESS	Emerging data suggest that traumatic brain injury (TBI) is a disease process with considerable long-range morbidities requiring lifelong monitoring and treatment. Multiple chronic morbidities develop across the life span after TBI, including mental health disorders, headaches, seizures, and neuroendocrine imbalances as well as chronic diseases. Still, there has been limited focus on effective guides and strategies for helping persons with TBI meet their chronic health needs as they live with the consequences of TBI. The advanced practice nurse is well positioned to participate collaboratively in practices that promote health screening and chronic disease management after TBI to ameliorate distress and enhance quality of life as persons with TBI live with lifelong consequences.	[Bay, Esther H.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Chartier, Kattlynn S.] Univ Michigan, Ann Arbor, MI 48109 USA		Bay, EH (corresponding author), Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.	pdq@umich.edu					Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boult C, 2010, JAMA-J AM MED ASSOC, V304, P1936, DOI 10.1001/jama.2010.1623; Boult C, 2009, J AM GERIATR SOC, V57, P2328, DOI 10.1111/j.1532-5415.2009.02571.x; Bower JH, 2003, NEUROLOGY, V60, P1610, DOI 10.1212/01.WNL.0000068008.78394.2C; Buck HG, 2012, CHRONIC ILLN, V8, P278, DOI 10.1177/1742395312444741; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Centers for Disease Control, 2013, TRAUM BRAIN INJ FACT; Centers for Disease Control and Prevention (CDC), 2003, REP C MILD TRAUM BRA, P1; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; Davidson RJ, 2012, NAT NEUROSCI, V15, P689, DOI 10.1038/nn.3093; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Deb S, 2007, BRAIN INJURY, V21, P301, DOI 10.1080/02699050701253137; Deb Shoumitro, 2003, Evid Based Ment Health, V6, P59; Defense Centers of Excellence, 2011, CO OCC COND TOOLK MI; Englot DJ, 2012, J NEUROSURG, V117, P970, DOI 10.3171/2012.8.JNS122; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; Faul M., 2010, TRAUM BRAIN INJ US E; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; Finkelstein E., 2006, INCIDENCE EC BURDEN; Goldacre MJ, 2006, J NEUROL NEUROSUR PS, V77, P351, DOI 10.1136/jnnp.2005.077693; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harrison-Felix C, 2004, NEUROREHABILITATION, V19, P45; Harrison-Felix CL, 2009, ARCH PHYS MED REHAB, V90, P1506, DOI 10.1016/j.apmr.2009.03.015; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hudak AM, 2012, J HEAD TRAUMA REHAB, V27, P87, DOI 10.1097/HTR.0b013e3182114efd; Irimia A., 2012, FRONTIERS NEUROLOGY, V3; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kalanithi P, 2011, J NEUROSURG, V115, P1013, DOI 10.3171/2011.6.JNS101989; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Koehler R., 2011, COGN REH THER TRAUM; Larson EB, 2010, J HEAD TRAUMA REHAB, V25, P61, DOI 10.1097/HTR.0b013e3181c1d1e1; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Malec JF, 2010, ARCH PHYS MED REHAB, V91, P1087, DOI 10.1016/j.apmr.2010.04.002; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Neely ET, 2009, HEADACHE, V49, P1089, DOI 10.1111/j.1526-4610.2009.001460.x; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Rockhill C., 2012, J NEUROTRAUM, V29, P1; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Rugbjerg K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2494; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Shah MN, 2004, BRAIN INJURY, V18, P765, DOI 10.1080/02699050410001671801; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Skandsen T, 2011, J NEUROTRAUM, V28, P691, DOI 10.1089/neu.2010.1590; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Tate R. L., 2009, COCHRANE DB SYST REV; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor CA, 1999, AM J MED GENET, V88, P742, DOI 10.1002/(SICI)1096-8628(19991215)88:6<742::AID-AJMG29>3.0.CO;2-#; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	92	5	5	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2014	46	3					142	152		10.1097/JNN.0000000000000048			11	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	AH8HU	WOS:000336378900005	24670434				2022-02-06	
J	Bonnechere, B; Beyer, B; Rooze, M; Van Sint, JS				Bonnechere, Bruno; Beyer, Benoit; Rooze, Marcel; Van Sint, Jan Serge			What is the Safest Sprint Starting Position for American Football Players?	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Sports; sports medicine; brain concussion; biomechanics	TRAUMATIC BRAIN-INJURY; SPEAR TACKLERS SPINE; HIGH-SCHOOL FOOTBALL; STATES HIGH-SCHOOL; CERVICAL-SPINE; CONCUSSION; RETURN; HEAD	The main objective of this study was to perform a biomechanical analysis of three different sprint start patterns to determine the safest position in term of neck injury and Sport-Related Concussion (SRC). The second objective was to collect data on the learning process effect between football players and non-players. Three different sprint initial positions adopted by football players were studied (i.e., 4-, 3- and 2-point positions). Twenty five young healthy males, including 12 football players, participated to this study. A stereophotogrammetric system (i.e., Vicon) was used to record motion patterns and body segments positions. Various measurements related to head and trunk orientation, and player field-of-view were obtained (e. g., head height, trunk bending, time to reach upright position, head speed (vertical direction) and body speed (horizontal direction)). Learning process was found to have no influence on studied parameters. Head redress is also delayed when adopting a 4-point position leading to a reduce field-of-view during the start and increasing therefore the probability of collision. Concerning the three different positions, the 4-point position seems to be the more dangerous because leading to higher kinetic energy than the 2- and 3-point start positions. This study proposes a first biomechanical approach to understand risk/benefit balance for athletes for those three different start positions. Results suggested that the 4-point position is the most risky for football players.	[Bonnechere, Bruno; Beyer, Benoit; Rooze, Marcel; Van Sint, Jan Serge] Univ Libre Bruxelles, Lab Anat Biomech & Organogenesis, Brussels, Belgium		Bonnechere, B (corresponding author), Lab Anat Biomech & Organogenesis, CP 619,Lennik St 808, B-1070 Brussels, Belgium.	bbonnech@ulb.ac.be; bbeyer@ulb.ac.be; roozem@ulb.ac.be; sintjans@ulb.ac.be	Bonnechere, Bruno/A-3374-2014	BEYER, Benoit/0000-0002-3930-1703			Altaf F, 2012, INJURY, V43, P272, DOI 10.1016/j.injury.2011.04.001; Bhamra Js, 2012, Open Orthop J, V6, P548, DOI 10.2174/1874325001206010548; Brigham CD, 2003, J BONE JOINT SURG AM, V85A, P381, DOI 10.2106/00004623-200302000-00032; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cantu RC, 2000, NEUROSURGERY, V47, P673, DOI 10.1097/00006123-200009000-00029; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Cantu RC, 2013, CURR SPORT MED REP, V12, P14, DOI 10.1249/JSR.0b013e31827dc1fb; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; HECK JF, 1998, SPORTS MED UPDATE, V13, P4; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Lee S, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.8.FOCUS11183; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mayers L, 2012, CURR SPORT MED REP, V11, P277, DOI 10.1249/JSR.0b013e318272bbba; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; Rumpf MC, 2014, PHYS THER SPORT, V15, P53, DOI 10.1016/j.ptsp.2013.03.001; TORG JS, 1993, AM J SPORT MED, V21, P640, DOI 10.1177/036354659302100502; Weinstein E., 2013, J NEUROSURGERY PEDIA; Winter D.A., 2009, SEGMENT MASS CTR MAS; Zuckerman S.L., 2012, NEUROSURG FOCUS, V33	28	5	5	0	4	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	JUN	2014	13	2					423	429					7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AJ2NK	WOS:000337492800028	24790500				2022-02-06	
J	Cesca, E; Ghirardo, G; Kiblawi, R; Murer, L; Gamba, P; Zanon, GF				Cesca, Eleonora; Ghirardo, Giulia; Kiblawi, Rim; Murer, Luisa; Gamba, Piergiorgio; Zanon, Giovanni Franco			Delayed graft function in pediatric deceased donor kidney transplantation: Donor-related risk factors and impact on two-yr graft function and survival: A single-center analysis	PEDIATRIC TRANSPLANTATION			English	Article						kidney transplantation; children; chronic renal failure; graft function; graft survival; delayed graft function	RENAL-ALLOGRAFT SURVIVAL; LONG-TERM SURVIVAL; BRAIN-DEAD DONORS; RECIPIENTS; AGE; CHILDREN; OUTCOMES; INJURY	There is mounting evidence that the quality of organs from cadaver donors may be influenced by events occurring around the time of brain death. Aim of this present study was to analyze the correlation of DGF with brain-dead donor variables in a single-center pediatric population and to evaluate DGF influence on patients- and grafts outcome. End-points of the study were DGF prevalence, DGF donor-related risk factors, graft function, patient- and graft survival rate, respectively, at six, 12, and 24months FU. The univariate analysis showed that donor age above 15yr and vascular cause of donor brain death represented risk factors for DGF. The multivariate analysis confirmed as independent risk factors for DGF donor age >15yr. At sixmonths FU, DGF showed a negative impact on graft function. In conclusion, among all considered brain-dead donor resuscitation parameters, just non-traumatic cause of death turned out to be of impact for DGF. Donor age >15yr represented the only independent risk factor for prolonged DGF in our series of children. At two-yr FU, DGF showed a transient negative impact on six-month graft function.	[Cesca, Eleonora; Ghirardo, Giulia; Kiblawi, Rim; Murer, Luisa; Gamba, Piergiorgio; Zanon, Giovanni Franco] Univ Padua, I-35121 Padua, Italy		Cesca, E (corresponding author), Univ Padua, Via Giustiniani 3, I-35121 Padua, Italy.	elecesca@yahoo.it	gamba, piergiorgio/J-1935-2018; Murer, Luisa LM/I-8830-2018	gamba, piergiorgio/0000-0003-2068-342X; Murer, Luisa LM/0000-0002-3010-2337			[Anonymous], 2005, NAPRTCSANNUAL REP; Boom H, 2000, KIDNEY INT, V58, P859, DOI 10.1046/j.1523-1755.2000.00235.x; Bresnahan BA, 2001, TRANSPLANTATION, V72, P256, DOI 10.1097/00007890-200107270-00016; Cittanova ML, 1996, LANCET, V348, P1620, DOI 10.1016/S0140-6736(96)07588-5; Dubourg L, 2002, KIDNEY INT, V62, P1454, DOI 10.1046/j.1523-1755.2002.00576.x; Gallinat A, 2013, PEDIATR TRANSPLANT, V17, P179, DOI 10.1111/petr.12049; Giral M, 2007, TRANSPLANTATION, V83, P1174, DOI 10.1097/01.tp.0000259935.82722.11; Giral-Classe M, 1998, KIDNEY INT, V54, P972, DOI 10.1046/j.1523-1755.1998.00071.x; Giuliani S, 2009, PEDIATR TRANSPLANT, V13, P290, DOI 10.1111/j.1399-3046.2008.01034.x; Guesde R, 1998, LANCET, V352, P1178, DOI 10.1016/S0140-6736(98)05456-7; HAYES JM, 1988, TRANSPLANTATION, V45, P106, DOI 10.1097/00007890-198801000-00024; Heidotting NA, 2012, NEPHROL DIAL TRANSPL, V27, P1672, DOI 10.1093/ndt/gfr549; HOEVEN JA, 2003, KIDNEY INT, V64, P1874; Jung GO, 2010, TRANSPL P, V42, P705, DOI 10.1016/j.transproceed.2010.02.063; Marshall R, 1996, SURGERY, V120, P663, DOI 10.1016/S0039-6060(96)80014-6; McLaren AJ, 1999, CLIN TRANSPLANT, V13, P266, DOI 10.1034/j.1399-0012.1999.130308.x; Naesens M, 2007, AM J TRANSPLANT, V7, P2504, DOI 10.1111/j.1600-6143.2007.01949.x; North American Pediatric Renal Trials Collaborative Studies (NAPRTCS), 2010, ANN REPORT; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Pape L, 2006, NEPHROL DIAL TRANSPL, V21, P2596, DOI 10.1093/ndt/gfl119; Pape L, 2004, TRANSPLANTATION, V77, P1191, DOI 10.1097/01.TP.0000120099.92220.7A; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pessione F, 2003, TRANSPLANTATION, V75, P361, DOI 10.1097/01.TP.0000044171.97375.61; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Schnuelle P, 2001, TRANSPLANTATION, V72, P455, DOI 10.1097/00007890-200108150-00017; SCHWARTZ GJ, 1976, J PEDIATR-US, V88, P828, DOI 10.1016/S0022-3476(76)81125-0; Sharif A, 2013, AM J KIDNEY DIS, V62, P150, DOI 10.1053/j.ajkd.2012.11.050; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Suri D, 1999, J AM SOC NEPHROL, V10, P1317; van den Eijnden Mark M E D, 2003, Exp Clin Transplant, V1, P85	30	5	8	0	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1397-3142	1399-3046		PEDIATR TRANSPLANT	Pediatr. Transplant.	JUN	2014	18	4					357	362		10.1111/petr.12252			6	Pediatrics; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Transplantation	AG4LZ	WOS:000335392700016	24712721				2022-02-06	
J	Schildge, S; Bohrer, C; Pfurr, S; Mammadzada, K; Schachtrup, K; Schachtrup, C				Schildge, S.; Bohrer, C.; Pfurr, S.; Mammadzada, K.; Schachtrup, K.; Schachtrup, C.			Instructions from the Vascular System - Directing Neural Stem Cell Fate in Health and Disease	CURRENT MEDICINAL CHEMISTRY			English	Article						Blood circulatory system; endothelial cell; fibrinogen; regeneration; stem cell niche; vasculature	TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; ENDOTHELIAL PROGENITOR CELLS; EPITHELIUM-DERIVED FACTOR; PROGRESSIVE MULTIPLE-SCLEROSIS; DOUBLECORTIN-EXPRESSING CELLS; COLONY-STIMULATING FACTOR; LONG-TERM POTENTIATION; ACUTE ISCHEMIC-STROKE; NITRIC-OXIDE DONOR	The vascular system distributes oxygen and nutrients to all tissues in the body. Additionally, the vascular system also functions in hosting and instructing tissue-specific stem and progenitor cells. Both cell- or blood-derived signals from the vascular system regulate stem cell properties in health and disease. Studies in animal models and in human disease have begun to uncover that signals from the vascular system are not merely maintaining the stem cell niche, but also instruct stem cells for repair mechanisms outside their niche. The present article focuses on recent findings about cell- or blood-derived factors in the vascular system supporting stem cell niche maintenance or activation for tissue homeostasis and repair. We highlight the fact that certain aspects of vascular - stem cell communication are conserved between stem cell niches in different tissues. Within this context, we will especially emphasize on a potential role of the altered vascular system after CNS disease in instructing stem cell fate. Understanding the communication between the vascular system and neural stem cells might support the development for new therapeutic approaches for CNS disease.	[Schildge, S.; Bohrer, C.; Pfurr, S.; Mammadzada, K.; Schachtrup, C.] Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; [Schildge, S.; Bohrer, C.; Pfurr, S.; Mammadzada, K.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Schachtrup, K.] Univ Freiburg, Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency CCI, D-79104 Freiburg, Germany		Schachtrup, C (corresponding author), Univ Freiburg, Inst Anat & Cell Biol, Albertstr 17, D-79104 Freiburg, Germany.	christian.schachtrup@anat.uni-freiburg.de		Schachtrup, Kristina/0000-0002-9385-8254	Fazit Foundation; International Graduate Academy fellowship; Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01 EO 0803]; European CommissionEuropean CommissionEuropean Commission Joint Research Centre [PIRG08-GA-2010-276989]; NEUREX; German Research FoundationGerman Research Foundation (DFG) [SCHA 1442/3-1]	Supported by the Fazit Foundation Graduate fellowship to S.S., the International Graduate Academy fellowship to C.B., the Federal Ministry of Education and Research (BMBF 01 EO 0803) to K.S. and the European Commission FP7 Grant PIRG08-GA-2010-276989, NEUREX, and the German Research Foundation Grant SCHA 1442/3-1 to C.S.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012; Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams RA, 2007, CURR MED CHEM, V14, P2925, DOI 10.2174/092986707782360015; Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Aird WC, 1997, J CELL BIOL, V138, P1117, DOI 10.1083/jcb.138.5.1117; Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bai L, 2012, NAT NEUROSCI, V15, P862, DOI 10.1038/nn.3109; Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Beck K, 2012, CELL TISSUE RES, V347, P187, DOI 10.1007/s00441-011-1228-0; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Cai XX, 2011, BIOL CELL, V103, P435, DOI 10.1042/BC20110033; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Cao RH, 2001, P NATL ACAD SCI USA, V98, P6390, DOI 10.1073/pnas.101564798; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carvalho RLC, 2004, DEVELOPMENT, V131, P6237, DOI 10.1242/dev.01529; Chen CW, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/597439; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Chen Z, 2013, NEUROSCIENCE, V239, P139, DOI 10.1016/j.neuroscience.2012.12.043; Chernykh ER, 2006, B EXP BIOL MED+, V141, P117, DOI 10.1007/s10517-006-0109-0; Chi JT, 2003, P NATL ACAD SCI USA, V100, P10623, DOI 10.1073/pnas.1434429100; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d; Cleaver O, 2003, NAT MED, V9, P661, DOI 10.1038/nm0603-661; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Connick P, 2012, LANCET NEUROL, V11, P150, DOI 10.1016/S1474-4422(11)70305-2; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dietrich MO, 2012, NAT NEUROSCI, V15, P651, DOI 10.1038/nn.3091; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Drago D, 2013, BIOCHIMIE, V95, P2271, DOI 10.1016/j.biochi.2013.06.020; Dunac A, 2007, J NEUROL, V254, P327, DOI 10.1007/s00415-006-0362-1; Enge M, 2002, EMBO J, V21, P4307, DOI 10.1093/emboj/cdf418; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Erlandsson A, 2004, EXP CELL RES, V301, P201, DOI 10.1016/j.yexcr.2004.08.009; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; Fontan-Lozano A, 2007, J NEUROSCI, V27, P10185, DOI 10.1523/JNEUROSCI.2757-07.2007; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; Gerdoni E, 2007, ANN NEUROL, V61, P219, DOI 10.1002/ana.21076; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Glebova NO, 2005, ANNU REV NEUROSCI, V28, P191, DOI 10.1146/annurev.neuro.28.061604.135659; Goings GE, 2004, BRAIN RES, V996, P213, DOI 10.1016/j.brainres.2003.10.034; Goldberg JS, 2009, REGEN MED, V4, P879, DOI 10.2217/RME.09.61; Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963; Gomez-Gaviro MV, 2012, P NATL ACAD SCI USA, V109, P1317, DOI 10.1073/pnas.1016199109; Gordon D, 2010, J NEUROPATH EXP NEUR, V69, P1087, DOI 10.1097/NEN.0b013e3181f97392; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; GROSS PM, 1992, PROG BRAIN RES, V91, P219; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Haan N, 2013, J NEUROSCI, V33, P6170, DOI 10.1523/JNEUROSCI.2437-12.2013; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hayward NMEA, 2010, J NEUROTRAUM, V27, P2203, DOI 10.1089/neu.2010.1448; Heine VM, 2004, NEUROBIOL AGING, V25, P361, DOI 10.1016/S0197-4580(03)00090-3; Hennemann B, 2008, CYTOTHERAPY, V10, P303, DOI 10.1080/14653240801949994; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; HOLLENBERG CH, 1968, J CLIN INVEST, V47, P2485, DOI 10.1172/JCI105930; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hunt BJ, 1998, BRIT MED J, V316, P1328, DOI 10.1136/bmj.316.7141.1328; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037, DOI 10.1152/ajpendo.2001.281.5.E1037; Imai K, 1999, BRIT J HAEMATOL, V106, P905, DOI 10.1046/j.1365-2141.1999.01644.x; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995; Jeong SW, 2003, STROKE, V34, P2258, DOI 10.1161/01.STR.0000083698.20199.1F; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kalinkovich A, 2009, BRAIN BEHAV IMMUN, V23, P1059, DOI 10.1016/j.bbi.2009.03.008; Kamouchi M, 2011, CELL MOL NEUROBIOL, V31, P175, DOI 10.1007/s10571-010-9605-x; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Karow M, 2012, CELL STEM CELL, V11, P471, DOI 10.1016/j.stem.2012.07.007; Karussis D, 2010, ARCH NEUROL-CHICAGO, V67, P1187, DOI 10.1001/archneurol.2010.248; Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim H, 2009, STEM CELLS, V27, P1686, DOI 10.1002/stem.87; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kokoeva MV, 2007, J COMP NEUROL, V505, P209, DOI 10.1002/cne.21492; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Krueger M, 2010, GLIA, V58, P1, DOI 10.1002/glia.20898; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lassmann H, 2001, TRENDS MOL MED, V7, P115, DOI 10.1016/S1471-4914(00)01909-2; Lee DA, 2012, INT J DEV NEUROSCI, V30, P615, DOI 10.1016/j.ijdevneu.2012.07.003; Lee DA, 2012, NAT NEUROSCI, V15, P700, DOI 10.1038/nn.3079; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li MZ, 2012, TRENDS NEUROSCI, V35, P619, DOI 10.1016/j.tins.2012.06.003; Li Q, 2006, J NEUROSCI RES, V84, P1656, DOI 10.1002/jnr.21087; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Li ZY, 2012, J NEUROTRAUM, V29, P343, DOI 10.1089/neu.2011.1807; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Lu ZQ, 2009, J NEUROIMMUNOL, V206, P58, DOI 10.1016/j.jneuroim.2008.10.014; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Makita T, 2008, NATURE, V452, P759, DOI 10.1038/nature06859; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Massouh M, 2010, NEUROPHARMACOLOGY, V58, P877, DOI 10.1016/j.neuropharm.2009.12.021; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Mercier F, 2003, J COMP NEUROL, V455, P324, DOI 10.1002/cne.10496; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mosher KI, 2012, NAT NEUROSCI, V15, P1485, DOI 10.1038/nn.3233; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161; Nakagomi T, 2012, STEM CELLS DEV, V21, P2350, DOI 10.1089/scd.2011.0657; Nakagomi T, 2011, STEM CELLS DEV, V20, P2037, DOI 10.1089/scd.2011.0279; Nakagomi T, 2009, EUR J NEUROSCI, V29, P1842, DOI 10.1111/j.1460-9568.2009.06732.x; Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Nicoletti F, 1998, CLIN EXP IMMUNOL, V113, P96, DOI 10.1046/j.1365-2249.1998.00604.x; Niklasson M, 2010, EXP CELL RES, V316, P2779, DOI 10.1016/j.yexcr.2010.07.009; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Oomura Y, 2006, PEPTIDES, V27, P2738, DOI 10.1016/j.peptides.2006.07.001; Ozen I, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-30; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; Piao CS, 2012, DIFFERENTIATION, V83, P17, DOI 10.1016/j.diff.2011.08.006; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Pineda JR, 2013, EMBO MOL MED, V5, P548, DOI 10.1002/emmm.201202197; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Quaegebeur A, 2010, NEURON, V68, P321, DOI 10.1016/j.neuron.2010.10.024; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Reif A, 2004, EUR J NEUROSCI, V20, P885, DOI 10.1111/j.1460-9568.2004.03559.x; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Saino O, 2010, J NEUROSCI RES, V88, P2385, DOI 10.1002/jnr.22410; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Schachtrup C, 2007, P NATL ACAD SCI USA, V104, P11814, DOI 10.1073/pnas.0704045104; Schachtrup C, 2011, CELL CYCLE, V10, P1764, DOI 10.4161/cc.10.11.15828; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Seidenfaden R, 2006, MOL CELL NEUROSCI, V32, P187, DOI 10.1016/j.mcn.2006.04.003; Seyfried D, 2006, J NEUROSURG, V104, P313, DOI 10.3171/jns.2006.104.2.313; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SIMS DE, 1986, TISSUE CELL, V18, P153, DOI 10.1016/0040-8166(86)90026-1; SIMS DE, 1991, CAN J CARDIOL, V7, P431; Slevin M, 2000, STROKE, V31, P1863, DOI 10.1161/01.STR.31.8.1863; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Snethen H, 2008, REGEN MED, V3, P835, DOI 10.2217/17460751.3.6.835; Spritzer MD, 2007, DEV NEUROBIOL, V67, P1321, DOI 10.1002/dneu.20457; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stumm RK, 2002, J NEUROSCI, V22, P5865; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Sundholm-Peters NL, 2005, J NEUROPATH EXP NEUR, V64, P1089, DOI 10.1097/01.jnen.0000190066.13312.8f; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Takata M, 2012, CELL DEATH DIFFER, V19, P756, DOI 10.1038/cdd.2011.145; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tatar C, 2013, GLIA, V61, P192, DOI 10.1002/glia.22426; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; VARZANEH FE, 1994, METABOLISM, V43, P906, DOI 10.1016/0026-0495(94)90275-5; Villeda SA, 2013, AUTOIMMUN REV, V12, P674, DOI 10.1016/j.autrev.2012.10.014; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wagoner B, 2006, AM J PHYSIOL-REG I, V290, pR1557, DOI 10.1152/ajpregu.00860.2005; Wan M, 2012, STEM CELLS, V30, P2498, DOI 10.1002/stem.1208; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; Whitman MC, 2009, J COMP NEUROL, V516, P94, DOI 10.1002/cne.22093; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Wittkowski W, 1998, MICROSC RES TECHNIQ, V41, P29, DOI 10.1002/(SICI)1097-0029(19980401)41:1<29::AID-JEMT4>3.0.CO;2-P; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wurmser AE, 2004, SCIENCE, V304, P1253, DOI 10.1126/science.1099344; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yan J, 2012, J NEUROIMMUNOL, V246, P78, DOI 10.1016/j.jneuroim.2012.02.013; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yip HK, 2008, STROKE, V39, P69, DOI 10.1161/STROKEAHA.107.489401; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang HX, 2003, J CELL BIOL, V163, P1375, DOI 10.1083/jcb.200308040; Zhang J, 2005, EXP NEUROL, V195, P16, DOI 10.1016/j.expneurol.2005.03.018; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zhang RL, 2001, ANN NEUROL, V50, P602, DOI 10.1002/ana.1249; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhang RL, 2008, NEUROPHARMACOLOGY, V55, P345, DOI 10.1016/j.neuropharm.2008.05.027; Zhao YH, 2012, BRAIN RES, V1450, P157, DOI 10.1016/j.brainres.2012.02.053; Zheng JK, 2011, BLOOD, V117, P470, DOI 10.1182/blood-2010-06-291716; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	263	5	5	0	17	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.	JUN	2014	21	19					2190	2207		10.2174/0929867321666131227162215			18	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AG4MF	WOS:000335393300009	24372220				2022-02-06	
J	Leonard, AV; Thornton, E; Vink, R				Leonard, Anna Victoria; Thornton, Emma; Vink, Robert			NK1 Receptor Blockade Is Ineffective in Improving Outcome following a Balloon Compression Model of Spinal Cord Injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBSTANCE-P ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; EDEMA FORMATION; PROTEIN EXTRAVASATION; ISCHEMIC-STROKE; BLOOD-FLOW; RAT; BARRIER; RELEASE	The neuropeptide substance P (SP) is a well-known mediator of neurogenic inflammation following a variety of CNS disorders. Indeed, inhibition of SP through antagonism of its receptor, the tachykinin NK1 receptor, has been shown to be beneficial following both traumatic brain injury and stroke. Such studies demonstrated that administration of an NK1 receptor antagonist reduced blood-brain-barrier permeability, edema development and improved functional outcome. Furthermore, our recent studies have demonstrated a potential role for SP in mediating neurogenic inflammation following traumatic spinal cord injury (SCI). Accordingly, the present study investigates whether inhibition of SP may similarly play a neuroprotective role following traumatic SCI. A closed balloon compression injury was induced at T10 in New Zealand White rabbits. At 30 minutes post-injury an NK1 receptor antagonist was administered intravenously. Animals were thereafter assessed for blood spinal cord barrier (BSCB) permeability, spinal water content (edema), intrathecal pressure (ITP), and histological and functional outcome from 5 hours to 2 weeks post-SCI. Administration of an NK1 receptor antagonist was not effective in reducing BSCB permeability, edema, ITP, or functional deficits following SCI. We conclude that SP mediated neurogenic inflammation does not seem to play a major role in BSCB disruption, edema development and consequential tissue damage seen in acute traumatic SCI. Rather it is likely that the severe primary insult and subsequent hemorrhage may be the key contributing factors to ongoing SCI injury.	[Leonard, Anna Victoria; Thornton, Emma] Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia; [Vink, Robert] Univ S Australia, Div Hlth Sci, Adelaide, SA 5001, Australia		Leonard, AV (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide, SA, Australia.	anna.leonard@adelaide.edu.au	Vink, Robert/S-5616-2019; Vink, Robert/J-7351-2012	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667	Neil Sachse Foundation; University of Adelaide	The study was funded by the Neil Sachse Foundation (http://www.nsf.org.au/) and the University of Adelaide. AVL is the Neil Sachse Foundation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Barry CM, 2011, BRAIN RES, V1389, P143, DOI 10.1016/j.brainres.2011.02.082; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Caberlotto L, 2003, EUR J NEUROSCI, V17, P1736, DOI 10.1046/j.1460-9568.2003.02600.x; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Demediuk P, 1990, Adv Neurol, V52, P225; DIETL MM, 1991, BRAIN RES, V539, P211, DOI 10.1016/0006-8993(91)91623-9; Donkin J. D., 2006, EFFECTS NEUROPEPTIDE; Donkin JJ, 2009, J CEREB BLOOD FLOW M; Flanders AE, 1999, AM J NEURORADIOL, V20, P926; FREEDMAN J, 1988, NEUROSCIENCE, V27, P267, DOI 10.1016/0306-4522(88)90236-9; Fukuda S, 2005, BRAIN RES PROTOC, V14, P171, DOI 10.1016/j.brainresprot.2005.01.001; GOODMAN JH, 1976, J NEUROSURG, V44, P418, DOI 10.3171/jns.1976.44.4.0418; Harford-Wright E, 2010, NEUROSCI LETT, V481, P26, DOI 10.1016/j.neulet.2010.06.044; Harrison S, 2001, INT J BIOCHEM CELL B, V33, P555, DOI 10.1016/S1357-2725(01)00031-0; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Jaeger CB, 1997, EXP NEUROL, V144, P381, DOI 10.1006/exnr.1996.6405; Jiang MH, 2012, NEUROREPORT, V23, P786, DOI 10.1097/WNR.0b013e3283572206; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; KOYANAGI I, 1989, PARAPLEGIA, V27, P190, DOI 10.1038/sc.1989.28; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; Leonard AV, 2013, J NEUROTRAUMA; Lever IJ, 2003, NEUROPHARMACOLOGY, V45, P1101, DOI 10.1016/S0028-3908(03)00298-3; Leypold BG, 2008, AM J NEURORADIOL, V29, P1012, DOI 10.3174/ajnr.A0962; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; MALCANGIO M, 1994, BRIT J PHARMACOL, V113, P635, DOI 10.1111/j.1476-5381.1994.tb17037.x; Mao L, 2011, BRAIN INJURY, V25, P300, DOI 10.3109/02699052.2010.542432; MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409; NEMECEK S, 1977, ACTA NEUROCHIR, V37, P7, DOI 10.1007/BF01401922; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; Nyberg F, 2002, AMINO ACIDS, V23, P231, DOI 10.1007/s00726-001-0134-2; OSHAUGHNESSY CT, 1993, EUR J PHARMACOL, V236, P319, DOI 10.1016/0014-2999(93)90605-H; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SHARMA HS, 1993, NEUROSCIENCE, V57, P443, DOI 10.1016/0306-4522(93)90076-R; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; SHARMA HS, 1991, J NEUROL SCI, V102, P150, DOI 10.1016/0022-510X(91)90063-D; Shepard MJ, 1999, SPINAL CORD, V37, P833, DOI 10.1038/sj.sc.3100927; TARLOV IM, 1953, AMA ARCH NEUROL PSY, V70, P813, DOI 10.1001/archneurpsyc.1953.02320360128010; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034138, 10.1371/journal.pone.0042630]; Thornton E, 2010, MOLECULES, V15, P6598, DOI 10.3390/molecules15096598; Turner RJ, 2006, ACTA NEUROCHIR SUPPL, V96, P263; Turner RJ, 2011, BRAIN RES, V1393, P84, DOI 10.1016/j.brainres.2011.03.066; Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687; Vink R, 2003, ACT NEUR S, V86, P257; WANG R, 1993, SURG NEUROL, V39, P348, DOI 10.1016/0090-3019(93)90198-A; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; WINKLER T, 1994, NEUROSCI RES, V21, P91, DOI 10.1016/0168-0102(94)90072-8; YASHON D, 1973, J NEUROSURG, V38, P693, DOI 10.3171/jns.1973.38.6.0693	52	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2014	9	5							e98364	10.1371/journal.pone.0098364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4ML	WOS:000336839400069	24859234	Green Published, Green Submitted, Green Accepted, gold			2022-02-06	
J	Zhang, DM; Yue, Y; Jiang, SY; Li, AH; Guo, AS; Wu, XM; Xia, XP; Cheng, HB; Zhang, JL; Tao, T; Gu, XX				Zhang, Dongmei; Yue, Ying; Jiang, Shengyang; Li, Aihong; Guo, Aisong; Wu, Xinming; Xia, Xiaopeng; Cheng, Hongbing; Zhang, Jinlong; Tao, Tao; Gu, Xingxing			GART expression in rat spinal cord after injury and its role in inflammation	BRAIN RESEARCH			English	Article						Spinal cord injury; GART; Rats; Inflammatory	GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE; TRANSCRIPTION FACTOR; REACTIVE ASTROCYTES; FUNCTIONAL RECOVERY; BRAIN CORTEX; GENE; PATHOPHYSIOLOGY; HETEROGENEITY; BIOSYNTHESIS; EPIDEMIOLOGY	The glycinamide ribonucleotide transformylase (GART) gene, a trifunctional polypeptide, has phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, and phosphdribosylaminoimidazole synthetase activity, and is required for de novo purine biosynthesis. GART is highly conserved in vertebrates. Alternative splicing of GART results in two transcript variants encoding different isoforms. However, the expression and function of GART in the central nervous system lesion are still unclear. In this study, we used a traumatic spinal cord injury (SCI) model in adult Sprague-Dawley rats and investigated the dynamic changes of GART protein expression in the spinal cord. Western blot analysis revealed that GART was present in sham-operated spinal cord. It gradually increased, reached a peak at day 3 after SCI, and then declined during the following days. Double immunofluorescence staining revealed a widespread of GART, and the majority of GARTs are detected in astrocytes. After injury, GART expression was increased predominantly in astrocytes, positively correlated with the highly expressed proliferating cell nuclear antigen (PCNA). Knockdown of GART expression in cultured primary astrocytes by siRNA revealed that expression of GART in astrocytes plays a role in the LPS-induced release of pro-inflammatory factors, such as TNF-alpha and IL-6. These results showed that GART may participate in the pathophysiology of SCI, and more research is needed to have a good understanding of its function and mechanism. (C) 2014 Elsevier B.V. All rights reserved.	[Zhang, Dongmei; Tao, Tao] Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Peoples R China; [Zhang, Dongmei] Nantong Univ, Sch Med, Basic Med Res Ctr, Nantong 226001, Peoples R China; [Yue, Ying; Jiang, Shengyang; Gu, Xingxing] Nantong Univ, Sch Med, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Li, Aihong; Guo, Aisong; Wu, Xinming] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Peoples R China; [Xia, Xiaopeng; Cheng, Hongbing] Tradit Chinese Med Hosp Nantong City, Dept Orthopaed, Nantong 226001, Peoples R China; [Cheng, Hongbing] Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Peoples R China; [Tao, Tao] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Tao, Tao] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China		Tao, T (corresponding author), Nantong Univ, Sch Med, Dept Pathogen Biol, Nantong 226001, Peoples R China.	nttaotao@ntu.edu.cn; guxingxing@ntu.edu.cn			National Basic Research Program of ChinaNational Basic Research Program of China [2012CB822104]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81202368, 31072188]; Key Project Natural Science Foundation of Jiangsu University and College [11KJA310002]; Nantong City Social Development Projects funds [HS2012032]; Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Basic Research Program of China (973 Program, No. 2012CB822104); National Natural Science Foundation of China (81202368 and 31072188); Key Project Natural Science Foundation of Jiangsu University and College (No. 11KJA310002); Nantong City Social Development Projects funds (HS2012032); a Project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	AIMI J, 1990, NUCLEIC ACIDS RES, V18, P6665, DOI 10.1093/nar/18.22.6665; Aschner M, 1998, NEUROTOXICOLOGY, V19, P269; Banerjee D, 2007, CELL MOL NEUROBIOL, V27, P1117, DOI 10.1007/s10571-007-9217-2; Barcia C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.123; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Benveniste EN, 1997, CHEM IMMUNOL, V69, P31; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Beurel E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025804; Brodsky G, 1997, HUM MOL GENET, V6, P2043, DOI 10.1093/hmg/6.12.2043; Bronder JL, 2003, J BIOL CHEM, V278, P48861, DOI 10.1074/jbc.M304844200; Choi DC, 2010, NEUROBIOL DIS, V39, P272, DOI 10.1016/j.nbd.2010.04.003; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; FRISEN J, 1995, NEUROSCIENCE, V65, P293, DOI 10.1016/0306-4522(94)00467-J; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; HARDS RG, 1986, AM J HUM GENET, V39, P179; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Kang WF, 2011, MOL NEUROBIOL, V43, P147, DOI 10.1007/s12035-011-8163-7; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Liu Y, 2010, NEUROBIOL DIS, V37, P384, DOI 10.1016/j.nbd.2009.10.018; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Manieri W, 2007, BIOCHEMISTRY-US, V46, P156, DOI 10.1021/bi0619270; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; PATTERSON D, 1981, P NATL ACAD SCI-BIOL, V78, P405, DOI 10.1073/pnas.78.1.405; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rathbone MP, 1999, PROG NEUROBIOL, V59, P663, DOI 10.1016/S0301-0082(99)00017-9; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rivieccio MA, 2005, J IMMUNOL, V174, P3719, DOI 10.4049/jimmunol.174.6.3719; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Serrano-Pozo A, 2011, AM J PATHOL, V179, P1373, DOI 10.1016/j.ajpath.2011.05.047; Shen AU, 2008, NEUROCHEM INT, V52, P1266, DOI 10.1016/j.neuint.2008.01.011; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; WARREN L, 1957, J BIOL CHEM, V229, P613; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Wu G, 2011, NEUROMOL MED, V13, P187, DOI 10.1007/s12017-011-8150-1; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang SW, 2013, J CELL BIOCHEM, V114, P354, DOI 10.1002/jcb.24371; Zhao JA, 2011, NEUROCHEM RES, V36, P549, DOI 10.1007/s11064-010-0377-y; Zhao W, 2011, J MOL HISTOL, V42, P195, DOI 10.1007/s10735-011-9324-8	49	5	6	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 20	2014	1564						41	51		10.1016/j.brainres.2014.03.044			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AI2QU	WOS:000336703900005	24709117				2022-02-06	
J	Reisner, A; Chen, XX; Kumar, K; Reifman, J				Reisner, Andrew; Chen, Xiaoxiao; Kumar, Kamal; Reifman, Jaques			Prehospital Heart Rate and Blood Pressure Increase the Positive Predictive Value of the Glasgow Coma Scale for High-Mortality Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						heart rate; prehospital; Glasgow Coma Scale; traumatic brain injury; blood pressure	SCORING SYSTEM; FIELD TRIAGE; ALGORITHMS; INTUBATION; AGE	We hypothesized that vital signs could be used to improve the association between a trauma patient's prehospital Glasgow Coma Scale (GCS) score and his or her clinical condition. Previously, abnormally low and high blood pressures have both been associated with higher mortality for patients with traumatic brain injury (TBI). We undertook a retrospective analysis of 1384 adult prehospital trauma patients. Vital-sign data were electronically archived and analyzed. We examined the relative risk of severe head Abbreviated Injury Scale (AIS) 5-6 as a function of the GCS, systolic blood pressure (SBP), heart rate (HR), and respiratory rate (RR). We created multi-variate logistic regression models and, using DeLong's test, compared their area under receiver operating characteristic curves (ROC AUCs) for three outcomes: head AIS 5-6, all-cause mortality, and either head AIS 5-6 or neurosurgical procedure. We found significant bimodal relationships between head AIS 5-6 versus SBP and HR, but not RR. When the GCS was <15, ROC AUCs were significantly higher for a multi-variate regression model (GCS, SBP, and HR) versus GCS alone. In particular, patients with abnormalities in all parameters (GCS, SBP, and HR) were significantly more likely to have high-mortality TBI versus those with abnormalities in GCS alone. This could be useful for mobilizing resources (e.g., neurosurgeons and operating rooms at the receiving hospital) and might enable new prehospital management protocols where therapies are selected based on TBI mortality risk.	[Reisner, Andrew; Chen, Xiaoxiao; Kumar, Kamal; Reifman, Jaques] US Army, Biotechnol High Performance Comp Software Applica, Med Res & Mat Command, Telemed & Adv Technol Res Ctr, Ft Detrick, MD 21702 USA; [Reisner, Andrew] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA		Reifman, J (corresponding author), US Army, Biotechnol HPC Inst, Med Res & Mat Command, MCMR TT, 504 Scott St, Ft Detrick, MD 21702 USA.	jaques.reifman.civ@mail.mil		Kumar, Kamal/0000-0002-9470-6682	Defense Health Program; Combat Casualty Care Research Area Directorate of the U.S. Army Medical Research and Materiel Command (Fort Detrick, MD)U.S. Army Medical Research & Materiel Command (USAMRMC)	This work was supported by the Defense Health Program and the Combat Casualty Care Research Area Directorate of the U.S. Army Medical Research and Materiel Command (Fort Detrick, MD). The authors thank Christopher Jamieson for his support in formatting the manuscript and Kathleen McGuire Gilbert for editing the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; BTF Guidelines The Brain Trauma Foundation. The American Association of Neurological Surgeons, 2000, J NEUROTRAUM, V17, P563; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chen LY, 2006, PHYSIOL MEAS, V27, P797, DOI 10.1088/0967-3334/27/9/004; Chen LY, 2009, PREHOSP EMERG CARE, V13, P286, DOI 10.1080/10903120902935298; Cooke WH, 2006, J TRAUMA, V60, P363, DOI 10.1097/01.ta.0000196623.48952.0e; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dunham CM, 2003, J TRAUMA, V55, P162, DOI 10.1097/01.ta.0000083335.93868.2c; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; GORMICAN SP, 1982, ANN EMERG MED, V11, P132, DOI 10.1016/S0196-0644(82)80237-0; Green SM, 2011, ANN EMERG MED, V58, P427, DOI 10.1016/j.annemergmed.2011.06.009; Hug CW, 2011, CRIT CARE MED, V39, P1006, DOI 10.1097/CCM.0b013e31820eab8e; Kerby JD, 2007, J TRAUMA, V63, P1026, DOI 10.1097/TA.0b013e318157d9e8; Kobayashi L, 2012, SURG CLIN N AM, V92, P1403, DOI 10.1016/j.suc.2012.08.006; KOEHLER JJ, 1986, ANN EMERG MED, V15, P178, DOI 10.1016/S0196-0644(86)80016-6; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Ley EJ, 2011, J TRAUMA, V71, P1689, DOI 10.1097/TA.0b013e31823cc5df; Magazzini S, 2012, INTERN EMERG MED, V7, P359, DOI 10.1007/s11739-012-0765-1; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Mathew V, 2011, J THROID RES, V2011, DOI 10.4061/2011/493462; McKenna TM, 2007, COMPUT METH PROG BIO, V86, P62, DOI 10.1016/j.cmpb.2007.01.003; Reisner AT, 2013, APPL CLIN INFORM, V4, P392, DOI 10.4338/ACI-2013-04-RA-0023; Reisner AT, 2008, J TRAUMA, V65, P915, DOI 10.1097/TA.0b013e31815eb142; Reisner AT, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.01.006; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; TEASDALE G, 1974, LANCET, V2, P81; Yu CG, 2006, J AM MED INFORM ASSN, V13, P309, DOI 10.1197/jamia.M1925; Zafar SN, 2011, J TRAUMA, V71, P1179, DOI 10.1097/TA.0b013e3182140d38; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	33	5	6	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2014	31	10					906	913		10.1089/neu.2013.3128			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AH1ES	WOS:000335863200003	24372334	Green Submitted			2022-02-06	
J	Abraham, AP; Vidyasagar, A; Lakshmanan, J; Nair, S; Joseph, M				Abraham, Ananth P.; Vidyasagar, Ajay; Lakshmanan, Jayseelan; Nair, Shalini; Joseph, Mathew			Phenytoin toxicity in patients with traumatic brain injury	NEUROLOGY INDIA			English	Article						Ideal body weight; phenytoin; toxicity; traumatic brain injury	POSTTRAUMATIC SEIZURE PROPHYLAXIS; CLINICAL PHARMACOKINETICS; LEVETIRACETAM; ABSORPTION; FEEDINGS; SUPPORT	Background: We observed that in patients with traumatic brain injury (TBI) who did not improve as expected, serum levels of phenytoin were in the toxic range and that their sensorium improved with modification of the dose. This led us to study the usage of phenytoin in patients with TBI. Aims: To determine the prevalence of phenytoin toxicity in TBI patients and to study the suitability of using ideal body weight (IBW) to guide phenytoin dosing. Setting and Design: Neurotrauma unit of a tertiary care centre in India. Prospective data collection from an already established protocol of drug level monitoring. Materials and Methods: The study cohort included 100 consecutive adult patients with mild or moderate TBI who were administered phenytoin based on IBW. Trough serum phenytoin and albumin levels were measured on day 4 after administration of the loading dose and actual body weight obtained when it was possible. Statistical Analysis: Chi-square was used for comparing categorical variables, student's t-test for continuous variables and multivariate regression analysis to obtain independent risk factors. Results: Clinical toxicity was observed in 15% of patients and biochemical toxicity in 36%, with a significant association between the two (P < 0.01). Using multivariate analysis, abdominal girth <= 75 cm (P = 0.07), neck circumference <= 34 cm (P = 0.025) and IV dose proportion >= 80% (P = 0.003) were independent risk factors for biochemical toxicity. The plot between actual weight and IBW showed that toxicity occurred when IBW was higher than actual weight. Conclusion: The prevalence of biochemical phenytoin toxicity was high, with independent risk factors being a higher proportion of IV administration and overestimation of weight by IBW. Clinical suspicion of phenytoin toxicity was a good predictor of biochemical toxicity.	[Abraham, Ananth P.; Nair, Shalini; Joseph, Mathew] Christian Med Coll & Hosp, Dept Neurol Sci, Vellore, Tamil Nadu, India; [Lakshmanan, Jayseelan] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India; [Vidyasagar, Ajay] KMCH Special Hosp, Dept Intens Care Med, Erode, Tamil Nadu, India		Joseph, M (corresponding author), Christian Med Coll & Hosp, Dept Neurol Sci, Vellore 632004, Tamil Nadu, India.	mjoseph@cmcvellore.ac.in					BAUER LA, 1982, NEUROLOGY, V32, P570, DOI 10.1212/WNL.32.5.570; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P549, DOI DOI 10.1089/NEU.2000.17.549; Chisholm D, 2005, EPILEPSIA, V46, P751, DOI 10.1111/j.1528-1167.2005.52704.x; Cotton BA, 2011, J TRAUMA, V71, P375, DOI 10.1097/TA.0b013e318224d307; GUGLER R, 1976, CLIN PHARMACOL THER, V19, P135; Haltiner AM, 1999, J NEUROSURG, V91, P588, DOI 10.3171/jns.1999.91.4.0588; Krasowski MD, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-7; Markowsky SJ, 1996, ANN PHARMACOTHER, V30, P443, DOI 10.1177/106002809603000501; MARTIN E, 1977, J PHARMACOKINET BIOP, V5, P579, DOI 10.1007/BF01059685; Mlynarek VE, 1996, ANN PHARMACOTHER, V30, P219, DOI 10.1177/106002809603000301; OHAGAN M, 1994, BRAIN DEV-JPN, V16, P165, DOI 10.1016/0387-7604(94)90058-2; Pai MP, 2000, ANN PHARMACOTHER, V34, P1066, DOI 10.1345/aph.19381; Pieracci FM, 2012, J TRAUMA ACUTE CARE, V72, P276, DOI 10.1097/TA.0b013e31823df31f; Pillai LV, 2008, INDIAN J CRIT CARE M, V12, P24, DOI 10.4103/0972-5229.40946; RICHENS A, 1979, CLIN PHARMACOKINET, V4, P153, DOI 10.2165/00003088-197904030-00001; SALEM RB, 1981, AM J HOSP PHARM, V38, P354, DOI 10.1093/ajhp/38.3.354; Stowe CD, 2000, J CLIN PHARMACOL, V40, P1452; Tandon M, 2004, INT J CLIN PHARM TH, V42, P550; Yeung SCSA, 2000, ANN PHARMACOTHER, V34, P896	19	5	5	0	1	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0028-3886	1998-4022		NEUROL INDIA	Neurol. India	MAY-JUN	2014	62	3					285	289		10.4103/0028-3886.136929			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AN4XT	WOS:000340593800009	25033851				2022-02-06	
J	Donnarumma, P; Tarantino, R; Gennaro, P; Mitro, V; Valentini, V; Magliulo, G; Delfini, R				Donnarumma, Pasquale; Tarantino, Roberto; Gennaro, Paolo; Mitro, Valeria; Valentini, Valentino; Magliulo, Giuseppe; Delfini, Roberto			Penetrating Gunshot Wound to the Head: Transotic Approach to Remove the Bullet and Masseteric-Facial Nerve Anastomosis for Early Facial Reanimation	TURKISH NEUROSURGERY			English	Article						Gunshot wound; Head trauma; Facial palsy; Masseteric-facial neurorraphy	PROGNOSTIC-FACTORS; INJURIES	INTRODUCTION: Gunshot wounds to the head (GSWH) account for the majority of penetrating brain injuries, and are the most lethal. Since they are rare in Europe, the number of neurosurgeons who have experienced this type of traumatic injury is decreasing, and fewer cases are reported in the literature. CASE: We describe a case of gunshot to the temporal bone in which the bullet penetrated the skull resulting in the facial nerve paralysis. It was excised with the transotic approach. Microsurgical anastomosis among the masseteric nerve and the facial nerve was performed. CONCLUSION: GSWH are often devastating. The in-hospital mortality for civilians with penetrating craniocerebral injury is very high. Survivors often have high rate of complications. When facial paralysis is present, masseteric-facial direct neurorraphy represent a good treatment.	[Donnarumma, Pasquale; Tarantino, Roberto; Delfini, Roberto] Univ Roma La Sapienza, Dept Neurosurg, I-00185 Rome, Italy; [Gennaro, Paolo; Mitro, Valeria; Valentini, Valentino] Univ Roma La Sapienza, Dept Maxillofacial Surg, I-00185 Rome, Italy; [Magliulo, Giuseppe] Univ Roma La Sapienza, Dept Otorhinolaryngol, I-00185 Rome, Italy		Donnarumma, P (corresponding author), Univ Roma La Sapienza, Dept Neurosurg, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	padonnarumma@hotmail.it	Valentini, Valentino/AAO-7086-2020; gennaro, paolo/T-1169-2018	gennaro, paolo/0000-0002-1603-3697; DONNARUMMA, PASQUALE/0000-0003-0360-5147			Brenner E, 1998, CLIN ANAT, V11, P396; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Escat E, 1925, ANN MAL OREILLE LARY, V77, P1149; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; KAUFMAN HH, 1993, NEUROSURGERY, V32, P962, DOI 10.1227/00006123-199306000-00013; Lifchez SD, 2005, PLAST RECONSTR SURG, V115, P1472, DOI 10.1097/01.PRS.0000160266.81504.71; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Petridis AK, 2011, CENT EUR NEUROSURG, V72, P5, DOI 10.1055/s-0029-1241850; PIKUS HJ, 1995, NEUROSURG CLIN N AM, V6, P611; Rosenfeld JV, 2002, J CLIN NEUROSCI, V9, P9, DOI 10.1054/jocn.2001.0949; SELDEN BS, 1988, ANN EMERG MED, V17, P247, DOI 10.1016/S0196-0644(88)80117-3; Ulug T, 2005, AM J OTOLARYNG, V26, P230, DOI 10.1016/j.amjoto.2005.01.004; Zuker RM, 2000, PLAST RECONSTR SURG, V106, P1, DOI 10.1097/00006534-200007000-00001	13	5	6	0	3	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAY	2014	24	3					415	418		10.5137/1019-5149.JTN.7325-12.1			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AI5ZO	WOS:000336949700025	24848185	Bronze, Green Submitted			2022-02-06	
J	Padgett, CR; Skilbeck, CE; Summers, MJ				Padgett, Christine R.; Skilbeck, Clive E.; Summers, Mathew James			Missing Data: The Importance and Impact of Missing Data from Clinical Research	BRAIN IMPAIRMENT			English	Article						missing data; multiple imputation; traumatic brain injury	MULTIPLE IMPUTATION; PSYCHOLOGY	There is compelling evidence that traditional methods used to address the detrimental impacts of missing data are inadequate. Despite this, researchers have been slow to utilise newer statistical approaches known to be more effective. The aim of the current article is to offer a conceptual explanation of the rationale for using newer missing data techniques, with a focus on multiple imputation (MI). To illustrate the relative efficacy of deletion, single imputation and multiple imputation techniques in the clinical setting, 20 cases were selected randomly from a population study investigating the cognitive sequelae of traumatic brain injury (TBI), and 8 out of 20 cases had scores on one variable deleted to simulate a missing data set. Comparing the parameter estimates obtained by each technique to the known parameters of the complete data set revealed that MI outperformed deletion and single imputation approaches. It is therefore recommended that more sophisticated techniques such as MI should be considered in clinical research.	[Padgett, Christine R.; Skilbeck, Clive E.; Summers, Mathew James] Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia; [Skilbeck, Clive E.] Royal Hobart Hosp, Tasmanian Neurotrauma Register, Hobart, Tas, Australia; [Summers, Mathew James] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Tas, Australia		Padgett, CR (corresponding author), Univ Tasmania, Sch Psychol, Hobart, Tas 7001, Australia.	Christine.Padgett@utas.edu.au	Summers, Mathew J/G-3168-2011; Padgett, Christine/J-2774-2013	Summers, Mathew J/0000-0002-3869-4920; Padgett, Christine/0000-0003-4398-4268			Allison P. D, 2002, MISSING DATA; Baraldi AN, 2010, J SCHOOL PSYCHOL, V48, P5, DOI 10.1016/j.jsp.2009.10.001; Enders C.K., 2011, REHABILITATION PSYCH, V56; Enders C. K., 2010, APPL MISSING DATA AN; Graham, 2012, MISSING DATA ANAL DE; Graham J. W., 1999, STAT STRATEGIES SMAL, V1, P1, DOI DOI 10.1177/0013164496056006006; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hamsher K., 1989, MULTILINGUAL APHASIA; Hollows S. E., 1985, ADULT MEMORY INFORM; Howell D.C., 2012, MULTIPLE IMPUTATION; Jelicic H, 2010, J YOUTH ADOLESCENCE, V39, P816, DOI 10.1007/s10964-010-9542-5; Jelicic H, 2009, DEV PSYCHOL, V45, P1195, DOI 10.1037/a0015665; McKnight P. E., 2007, MISSING DATA GENTLE; Proust-Lima C, 2011, AM J EPIDEMIOL, V174, P1077, DOI 10.1093/aje/kwr243; ROTH PL, 1994, PERS PSYCHOL, V47, P537, DOI 10.1111/j.1744-6570.1994.tb01736.x; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Sinharay S, 2001, PSYCHOL METHODS, V6, P317, DOI 10.1037//1082-989X.6.4.317; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594	22	5	5	0	9	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2014	15	1					1	9		10.1017/BrImp.2014.2			9	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	AI9NO	WOS:000337259500001					2022-02-06	
J	Sullivan, CT; Gray, MA; Williams, GP; Green, DJ; Hession, CA				Sullivan, Craig Thomas; Gray, Marion A.; Williams, Gary P.; Green, Dion J.; Hession, Claire A.			THE USE OF REAL LIFE ACTIVITIES IN REHABILITATION: THE EXPERIENCE OF YOUNG MEN WITH TRAUMATIC BRAIN INJURIES FROM REGIONAL, RURAL AND REMOTE AREAS IN AUSTRALIA	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; qualitative research; rehabilitation; rural population; men	EXECUTIVE FUNCTION; FAMILY CAREGIVERS; MASCULINITY; INDIVIDUALS; TRANSITION; PEOPLE; CARE; HOME	Objective: This study aimed to explore the experience of young men with traumatic brain injuries from regional, rural and remote areas in Australia who had participated in real life activity rehabilitation. Design: A qualitative study. The primary data collection method was a semi-structured interview. Setting: The Townsville Hospital, Queensland, and private dwellings in rural and regional areas within North Queensland. Participants: Eight male participants aged between 18-28 years. Main outcome measure(s): Key qualitative themes identified via thematic analysis of the data. Results: This research identified 3 main themes regarding the patient's perspective of a real life activity intervention. These were: perceptions of the activities used in the intervention; insight into injury; and returning to previous activities of daily living. The findings of this study highlight incorporating real life activities assisted in engaging participants in rehabilitation. Participants expressed a desire for vocational activities to be included within rehabilitation activities. Conclusion: This study has clinical implications for real life activities to be incorporated as part of rehabilitation, and that this was preferred by young male traumatic brain injury patients. Therapists may consider using individualized real life activities with similar patient cohorts in the future.	[Sullivan, Craig Thomas] James Cook Univ, Sch Publ Hlth Trop Med & Rehabil Sci, Townsville, Qld 4811, Australia; [Gray, Marion A.] Univ Sunshine Coast, Cluster Hlth Improvement, FoSHEE, Sippy Downs, Qld 4556, Australia; [Williams, Gary P.] James Cook Univ, Discipline Publ Hlth & Trop Med, Townsville, Qld 4811, Australia; [Green, Dion J.] Queensland Hlth, Insight Therapy, Townsville, Qld, Australia; [Hession, Claire A.] Queensland Hlth, Townsville Hosp, Townsville, Qld, Australia		Gray, MA (corresponding author), Univ Sunshine Coast, Cluster Hlth Improvement, FoSHEE, Sippy Downs, Qld 4556, Australia.	Marion.Gray@usc.edu.au					BAUM C, 1993, AM J OCCUP THER, V47, P431, DOI 10.5014/ajot.47.5.431; Bennett TL, 2001, ARCH CLIN NEUROPSYCH, V16, P237, DOI 10.1016/S0887-6177(00)00082-2; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; Creswell J.W ., 2007, QUAL INQ; Eriksson G, 2006, J REHABIL MED, V38, P159, DOI 10.1080/16501970500415322; Fischer S, 2004, BRAIN INJURY, V18, P547, DOI 10.1080/02699050310001645793; Fisher AG, 1998, AM J OCCUP THER, V52, P509, DOI 10.5014/ajot.52.7.509; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Godbout L, 2005, BRAIN INJURY, V19, P337, DOI 10.1080/02699050400005093; Helps Y., 2008, INJURY RES STAT SERI; Hirschberg R, 2008, FUTUR NEUROL, V3, P483, DOI 10.2217/14796708.3.4.483; Jones JA, 2011, DISABIL REHABIL, V33, P1568, DOI 10.3109/09638288.2010.537803; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Medin J, 2006, DISABIL REHABIL, V28, P1051, DOI 10.1080/09638280500494819; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Ostrander RN, 2008, DISABIL SOC, V23, P585, DOI 10.1080/09687590802328451; Parsons L, 2008, AUST OCCUP THER J, V55, P231, DOI 10.1111/j.1440-1630.2008.00753.x; Patton M., 2003, QUALITATIVE RES EVAL; Pendleton H. M., 2006, PEDRETTIS OCCUPATION; Primeau L. A., 2003, WILLARD SPACKMANS OC, P567; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rayne R., 2006, AUSTR J PRIMARY HLTH, V12, P56, DOI [DOI 10.1071/PY06009, 10.1071/PY06009]; Ritchie J., 2005, QUALITATIVE RES PRAC; Shuttleworth R, 2012, MEN MASC, V15, P174, DOI 10.1177/1097184X12439879; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Turner B, 2007, BRAIN INJURY, V21, P1119, DOI 10.1080/02699050701651678; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Turner-Stokes L, 2009, COCHRANE DB SYST REV, V20; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010	34	5	5	0	9	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2014	46	5					424	429		10.2340/16501977-1788			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	AH9OS	WOS:000336472300007	24603845	gold, Green Accepted			2022-02-06	
J	Lamontagne, ME; Perreault, K; Gagnon, MP				Lamontagne, Marie-Eve; Perreault, Kadija; Gagnon, Marie-Pierre			Evaluation of the acceptability, feasibility and effectiveness of two methods of involving patients with disability in developing clinical guidelines: study protocol of a randomized pragmatic pilot trial	TRIALS			English	Article						Clinical practice guideline; Brain injury; Patient and population participation; Adaptation; Disabilities	TRAUMATIC BRAIN-INJURY; HEALTH-CARE; AGREE II; INVOLVEMENT; INDIVIDUALS; EXPERIENCES; TOOLS	Background: Despite growing interest in the importance of, and challenges associated with the involvement of patient and population (IPP) in the process of developing and adapting clinical practice guidelines (CPGs), there is a lack of knowledge about the best method to use. This is especially problematic in the field of rehabilitation, where individuals with disabilities might face many barriers to their involvement in the guideline development and adaptation process. The goal of this pilot trial is to document the acceptability, feasibility and effectiveness of two methods of involving patients with a disability (traumatic brain injury) in CPG development. Methods/Design: A single-blind, randomized, crossover pragmatic trial will be performed with 20 patients with traumatic brain injury (TBI). They will be randomized into two groups, and each will try two alternative methods of producing recommendations; a discussion group (control intervention) and a Wiki, a webpage that can be modified by those who have access to it (experimental intervention). The participants will rate the acceptability of the two methods, and feasibility will be assessed using indicators such as the number of participants who accessed and completed the two methods, and the number of support interventions required. Twenty experts, blinded to the method of producing the recommendations, will independently rate the recommendations produced by the participants for clarity, accuracy, appropriateness and usefulness. Discussion: Our trial will allow for the use of optimal IPP methods in a larger project of adapting guidelines for the rehabilitation of individuals with TBI. Ultimately the results will inform the science of CPG development and contribute to the growing knowledge about IPP in rehabilitation settings.	[Lamontagne, Marie-Eve] Ctr Interdisciplinary Res Rehabil & Social Integr, Inst Readaptat Deficience Phys Quebec, Quebec City, PQ G1M 2S8, Canada; [Lamontagne, Marie-Eve; Perreault, Kadija] Univ Laval, Fac Med, Dept Readaptat, Quebec City, PQ G1V 0A6, Canada; [Gagnon, Marie-Pierre] Univ Laval, Fac Sci Infirmieres, Quebec City, PQ G1V 0A6, Canada; [Gagnon, Marie-Pierre] Ctr Hosp Quebec Res Ctr, Quebec City, PQ G1L 3L5, Canada		Lamontagne, ME (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Inst Readaptat Deficience Phys Quebec, 525 Blvd Wilfrid Hamel, Quebec City, PQ G1M 2S8, Canada.	marie-eve.lamontagne@cirris.ulaval.ca	Gagnon, Marie-Pierre/I-3013-2019	Gagnon, Marie-Pierre/0000-0002-0782-5457; Lamontagne, Marie-Eve/0000-0002-3301-7429; Perreault, Kadija/0000-0002-8608-9661	Knowledge Translation Canada; Association TCC des Deux Rives; Veronique Gauthier	We wish to thank Knowledge Translation Canada for funding this study and the Association TCC des Deux Rives and Veronique Gauthier for their support in the project.	Archambault PM, 2013, J MED INTERNET RES, V15, P4, DOI 10.2196/jmir.2787; Archambault PM, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1961; Brouwers MC, 2010, J CLIN EPIDEMIOL, V63, P1308, DOI 10.1016/j.jclinepi.2010.07.001; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE472, DOI 10.1503/cmaj.091716; Brouwers MC, 2010, CAN MED ASSOC J, V182, P1045, DOI 10.1503/cmaj.091714; Craik C, 2006, CLIENT CTR PRACT OCC; den Breejen EME, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2080; del Campo PD, 2011, BMJ QUAL SAF, V20, P779, DOI 10.1136/bmjqs.2010.049031; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-60; Egan J, 2005, BRAIN INJURY, V19, P555, DOI 10.1080/02699050400013659; Fervers B, 2006, INT J QUAL HEALTH C, V18, P167, DOI 10.1093/intqhc/mzi108; Hakkennes S, 2008, QUAL SAF HEALTH CARE, V17, P296, DOI 10.1136/qshc.2007.023804; Health Council of Canada, UND CLIN PRACT GUID; Krueger, 1997, ANAL REPORTING FOCUS, VVol. 6; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2008, BRAIN INJURY, V22, P535, DOI 10.1080/02699050802158243; Legare F, 2011, MED DECIS MAKING, V31, pE45, DOI 10.1177/0272989X11424401; Mills EJ, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-27; Norman, 1995, HLTH MEASUREMENT SCA; Pett MA, 1997, NONPARAMETRIC STAT H; Portney LG, 1993, FDN CLIN RES APPL PR, V3rd; Scottish Intercollegiate Guideline Network (SIGN), 2013, BRIAN INJ REH AD; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Sidani S, 2011, DESIGN, EVALUATION, AND TRANSLATION OF NURSING INTERVENTIONS, P163; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Vaccaro M, 2007, DISABIL REHABIL-ASSI, V2, P85, DOI 10.1080/17483100601167586; van der Weijden T, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-10; van Wersch A, 2001, QUAL HEALTH CARE, V10, P10, DOI 10.1136/qhc.10.1.10; Whalley Hammell K., 2004, QUALITATIVE RES EVID, P51	29	5	5	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1745-6215			TRIALS	Trials	APR 10	2014	15								118	10.1186/1745-6215-15-118			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AF7DC	WOS:000334872700001	24721114	gold, Green Published			2022-02-06	
J	Bayley, PJ; Kong, JY; Helmer, DA; Schneiderman, A; Roselli, LA; Rosse, SM; Jackson, JA; Baldwin, J; Isaac, L; Nolasco, M; Blackman, MR; Reinhard, MJ; Ashford, JW; Chapman, JC				Bayley, Peter J.; Kong, Jennifer Y.; Helmer, Drew A.; Schneiderman, Aaron; Roselli, Lauren A.; Rosse, Stephanie M.; Jackson, Jordan A.; Baldwin, Janet; Isaac, Linda; Nolasco, Michael; Blackman, Marc R.; Reinhard, Matthew J.; Ashford, John Wesson; Chapman, Julie C.		MIND Study Grp	Challenges to be overcome using population-based sampling methods to recruit veterans for a study of post-traumatic stress disorder and traumatic brain injury	BMC MEDICAL RESEARCH METHODOLOGY			English	Article						MIND study; PTSD; Recruitment methods; Recruitment yields; TBI; Veteran	RANDOMIZED TRIALS; CLINICAL-TRIAL; HEALTH; ISSUES; IMPACT; DRUG; PARTICIPANTS; EXPERIENCE; RESOURCES; BARRIERS	Background: Many investigators are interested in recruiting veterans from recent conflicts in Afghanistan and Iraq with Traumatic Brain Injury (TBI) and/or Post Traumatic Stress Disorder (PTSD). Researchers pursuing such studies may experience problems in recruiting sufficient numbers unless effective strategies are used. Currently, there is very little information on recruitment strategies for individuals with TBI and/or PTSD. It is known that groups of patients with medical conditions may be less likely to volunteer for clinical research. This study investigated the feasibility of recruiting veterans returning from recent military conflicts-Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) - using a population-based sampling method. Methods: Individuals were sampled from a previous epidemiological study. Three study sites focused on recruiting survey respondents (n = 445) who lived within a 60 mile radius of one of the sites. Results: Overall, the successful recruitment of veterans using a population-based sampling method was dependent on the ability to contact potential participants following mass mailing. Study enrollment of participants with probable TBI and/or PTSD had a recruitment yield (enrolled/total identified) of 5.4%. We were able to contact 146 individuals, representing a contact rate of 33%. Sixty-six of the individuals contacted were screened. The major reasons for not screening included a stated lack of interest in the study (n = 37), a failure to answer screening calls after initial contact (n = 30), and an unwillingness or inability to travel to a study site (n = 10). Based on the phone screening, 36 veterans were eligible for the study. Twenty-four veterans were enrolled, (recruitment yield = 5.4%) and twelve were not enrolled for a variety of reasons. Conclusions: Our experience with a population-based sampling method for recruitment of recent combat veterans illustrates the challenges encountered, particularly contacting and screening potential participants. The screening and enrollment data will help guide recruitment for future studies using population-based methods.	[Bayley, Peter J.; Kong, Jennifer Y.; Baldwin, Janet; Isaac, Linda; Nolasco, Michael; Ashford, John Wesson] Veteran Affairs Palo Alto Hlth Care Syst, WRIISC, Palo Alto, CA 94304 USA; [Bayley, Peter J.; Isaac, Linda; Ashford, John Wesson] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA USA; [Helmer, Drew A.] Veteran Affairs New Jersey Hlth Care Syst, WRIISC, E Orange, NJ USA; [Helmer, Drew A.] Rutgers State Univ, New Jersey Med Sch, Univ Med & Dent, Newark, NJ 07102 USA; [Schneiderman, Aaron] Dept Vet Affairs, Program Epidemiol, Off Publ Hlth, Washington, DC USA; [Roselli, Lauren A.; Rosse, Stephanie M.; Jackson, Jordan A.; Reinhard, Matthew J.; Chapman, Julie C.] Vet Affairs Med Ctr, WRIISC, Washington, DC 20422 USA; [Blackman, Marc R.] Vet Affairs Med Ctr, Res Serv, Washington, DC 20422 USA; [Blackman, Marc R.] Georgetown Univ, Sch Med, Dept Med, Washington, DC USA; [Blackman, Marc R.] Georgetown Univ, Sch Med, Dept Rehabil Med, Washington, DC USA; [Blackman, Marc R.] Georgetown Univ, Sch Med, Dept Biochem & Mol Med, Washington, DC USA; [Reinhard, Matthew J.] Georgetown Univ, Sch Med, Dept Psychiat, Washington, DC USA; [Chapman, Julie C.] Georgetown Univ, Sch Med, Dept Neurol, Washington, DC USA		Bayley, PJ (corresponding author), Veteran Affairs Palo Alto Hlth Care Syst, WRIISC, 3801 Miranda Ave 151Y, Palo Alto, CA 94304 USA.	Peter.Bayley@va.gov	Blackman, Marc/AAT-5771-2021; Ashford, J. Wesson/D-3929-2009		U.S. Department of Veterans Affairs, Office of Public HealthUS Department of Veterans Affairs; War Related Illness and Injury Study Centers (WRIISC)	This research was supported by U.S. Department of Veterans Affairs, Office of Public Health and the War Related Illness and Injury Study Centers (WRIISC). The views expressed within are solely those of the authors, and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The authors wish to thank those veterans who participated in this study and all of the veterans and service members who have served in uniform. We also acknowledge Mohsen Jahani for his assistance with database management.	Adamson DM, 2008, INVISIBLE WOUNDS WAR; ASHERY RS, 1992, AM J DRUG ALCOHOL AB, V18, P305, DOI 10.3109/00952999209026069; Breslau Naomi, 2002, J Gend Specif Med, V5, P34; CHARLSON ME, 1984, BRIT MED J, V289, P1281, DOI 10.1136/bmj.289.6454.1281; Corrigan PW, 2004, COMMUNITY MENT HLT J, V40, P297, DOI 10.1023/B:COMH.0000035226.19939.76; Cosgrove N, 1999, CONTROL CLIN TRIALS, V20, P133, DOI 10.1016/S0197-2456(98)00055-5; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; Eber S, MIL MED IN PRESS; Eisen SA, 2005, ANN INTERN MED, V142, P881, DOI 10.7326/0003-4819-142-11-200506070-00005; Erickson LC, 2013, CLIN TRIALS, V10, P473, DOI 10.1177/1740774512470040; Folmar S, 2001, CONTROL CLIN TRIALS, V22, P13, DOI 10.1016/S0197-2456(00)00117-3; Grady C., 2008, BIRTH DEATH BENCH CL, P21; Hewison J, 2006, BMJ-BRIT MED J, V333, P300, DOI 10.1136/bmj.333.7562.300; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOLDEN G, 1993, SOC WORK HEALTH CARE, V19, P1, DOI 10.1300/J010v19n02_01; Hussain-Gambles M, 2004, HEALTH SOC CARE COMM, V12, P382, DOI 10.1111/j.1365-2524.2004.00507.x; Klitzman R, 2013, J MED ETHICS, V39, P224, DOI 10.1136/medethics-2011-100439; Mosenifar Zab, 2007, Proc Am Thorac Soc, V4, P185, DOI 10.1513/pats.200701-009GC; Presant CA, 2000, J NATL CANCER I, V92, P1441, DOI 10.1093/jnci/92.17.1441; RAND, 2008, INV WOUNDS WAR PSYCH, VMG-720-CCF; Resio MA, 2004, J CLIN EPIDEMIOL, V57, P1063, DOI 10.1016/j.jclinepi.2004.02.013; Royal C, 2000, ANN EPIDEMIOL, V10, pS68, DOI 10.1016/S1047-2797(00)00194-0; Ryan MAK, 2007, J CLIN EPIDEMIOL, V60, P181, DOI 10.1016/j.jclinepi.2006.05.009; Sartorius N, 1998, LANCET, V352, P1058, DOI 10.1016/S0140-6736(98)08008-8; Schneiderman A.I., 2008, AM J EPIDEMIOL; Smith B, 2007, AM J EPIDEMIOL, V166, P1345, DOI 10.1093/aje/kwm212; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; Thomson CL, 2008, DRUG ALCOHOL REV, V27, P115, DOI 10.1080/09595230701829561; Tillgren P, 2000, J HEALTH COMMUN, V5, P293, DOI 10.1080/10810730050199114; Treves TA, 2000, ALZ DIS ASSOC DIS, V14, P209, DOI 10.1097/00002093-200010000-00004; Unger JM, 2013, J CLIN ONCOL, V31, P536, DOI 10.1200/JCO.2012.45.4553; Villarruel AM, 2006, J SPEC PEDIATR NURS, V11, P244, DOI 10.1111/j.1744-6155.2006.00076.x; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Welch KE, 2009, EPIDEMIOLOGY, V20, P313, DOI 10.1097/EDE.0b013e3181931558; Woodall A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-103	35	5	5	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2288		BMC MED RES METHODOL	BMC Med. Res. Methodol.	APR 8	2014	14								48	10.1186/1471-2288-14-48			9	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	AF0YJ	WOS:000334440800001	24713131	Green Published, gold			2022-02-06	
J	Liao, JC; Ho, CH; Liang, FW; Wang, JJ; Lin, KC; Chio, CC; Kuo, JR				Liao, Jen-Chieh; Ho, Chung-Han; Liang, Fu-Wen; Wang, Jhi-Joung; Lin, Kao-Chang; Chio, Chung-Ching; Kuo, Jinn-Rung			One-Year Mortality Associations in Hemodialysis Patients after Traumatic Brain Injury-An Eight-Year Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; STAGE RENAL-DISEASE; LONG-TERM SURVIVAL; REPLACEMENT THERAPY; PROLONGED STAY; RESOURCE USE; IMPACT; DIALYSIS; OUTCOMES; RISK	Purpose: This study aimed to investigate the one-year mortality associations in hemodialysis patients who underwent neurosurgical intervention after traumatic brain injury (TBI) using a nationwide database in Taiwan. Materials and Methods: An age-and gender-matched longitudinal cohort study of 4416 subjects, 1104 TBI patients with end-stage renal disease (ESRD) and 3312 TBI patients without ESRD, was conducted using the National Health Insurance Research Database in Taiwan between January 2000 and December 2007. The demographic characteristics, length of stay (LOS), length of ICU stay, length of ventilation (LOV), and tracheostomy were collected and analyzed. The co-morbidities of hypertension (HTN), diabetes mellitus (DM), myocardial infarction (MI), stroke, and heart failure (HF) were also evaluated. Results: TBI patients with ESRD presented a shorter LOS, a longer length of ICU stay and LOV, and a higher percentage of comorbidities compared with those without ESRD. TBI patients with ESRD displayed a stable trend of one-year mortality rate, 75.82% to 76.79%, from 2000-2007. For TBI patients with ESRD, the median survival time was 0.86 months, and preexisting stroke was a significant risk factor of mortality (HR: 1.29, 95% C.I.: 1.08-1.55). Pre-existing DM (HR: 1.35, 95% C.I.: 1.12-1.63) and MI (HR: 1.61, 95% C.I.: 1.07-2.42) effect on the mortality in ESRD patients who underwent TBI surgical intervention in the younger (age < 65) and older (age >= 65) population, respectively. In addition, the length of ICU stay and tracheostomy may provide important information to predict the mortality risk. Conclusions: This is the first report indicating an increased risk of one-year mortality among TBI patients with a pre-existing ERSD insult. Comorbidities were more common in TBI patients with ESRD. Physicians should pay more attention to TBI patients with ESRD based on the status of age, comorbidities, length of ICU stay, and tracheostomy to improve their survival.	[Liao, Jen-Chieh; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Lin, Kao-Chang; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Inst Publ Hlth, Tainan 70101, Taiwan; [Lin, Kao-Chang; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan		Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.	kuojinnrung@gmail.com		Liang, Fu-Wen/0000-0002-3396-037X; Ho, Chung-Han/0000-0001-5925-8477			Arabi Y, 2002, INT J QUAL HEALTH C, V14, P403, DOI 10.1093/intqhc/14.5.403; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002; Bell M, 2008, CRIT CARE MED, V36, P2773, DOI 10.1097/CCM.0b013e318187815a; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chan M, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/715807; Chapman RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7867; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chien CC, 2012, AM J HYPERTENS, V25, P900, DOI 10.1038/ajh.2012.60; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; Dhanani J, 2013, J THORAC CARDIOV SUR, V146, P90, DOI 10.1016/j.jtcvs.2012.06.037; Freeman BD, 2005, CRIT CARE MED, V33, P2513, DOI 10.1097/01.CCM.0000186369.91799.44; Gale SC, 2007, AM SURGEON, V73, P454; Gogbashian A, 2004, EUR J CARDIO-THORAC, V25, P695, DOI 10.1016/j.ejcts.2004.02.022; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Heyland DK, 1998, CHEST, V114, P192, DOI 10.1378/chest.114.1.192; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; Huang SJ, 2000, ACTA NEPHROL, V14, P139; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Insurance BoNH, 2002, NAT HLTH INS ANN STA; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; Iseki K, 1996, KIDNEY INT, V50, P1672, DOI 10.1038/ki.1996.484; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Laupland KB, 2006, CHEST, V129, P954, DOI 10.1378/chest.129.4.954; Liu CY, 2006, J HEALTHC MANAG, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lok CE, 2004, NEPHROL DIAL TRANSPL, V19, P3098, DOI 10.1093/ndt/gfh540; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Murakami M, 2004, NEUROL MED-CHIR, V44, P225, DOI 10.2176/nmc.44.225; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Prevention CfDCa, 2010, GET STATS TRAUM BRAI; Rhodes A, 2011, INTENS CARE MED, V37, P1466, DOI 10.1007/s00134-011-2299-9; Rothen HU, 2007, INTENS CARE MED, V33, P1329, DOI 10.1007/s00134-007-0690-3; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Sood MM, 2011, NEPHROL DIAL TRANSPL, V26, P2965, DOI 10.1093/ndt/gfq835; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; *SYST USRD, 2005, USRDS 2005 ANN DAT R; System URD, 1998, USRDS 1998 ANN DAT R; System USRD, 2012, USRDS 2012 ANN DAT R; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; TOMITA J, 1995, AM J KIDNEY DIS, V25, P405, DOI 10.1016/0272-6386(95)90101-9; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Weissman C, 2000, INTENS CARE MED, V26, P1319, DOI 10.1007/s001340000612; Weissman C, 1997, CRIT CARE MED, V25, P1594, DOI 10.1097/00003246-199709000-00031; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93956	10.1371/journal.pone.0093956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	WOS:000334160900066	24714730	gold, Green Published, Green Submitted			2022-02-06	
J	Blohm, ME; Obrecht, D; Hartwich, J; Singer, D				Blohm, Martin E.; Obrecht, Denise; Hartwich, Jana; Singer, Dominique			Effect of cerebral circulatory arrest on cerebral near-infrared spectroscopy in pediatric patients	PEDIATRIC ANESTHESIA			English	Article						pediatrics; near-infrared spectroscopy; patient monitoring; brain death; brain infarction	TRAUMATIC BRAIN-INJURY; OXYGEN-SATURATION; TASK-FORCE; CHILDREN; SURGERY; DEATH; GUIDELINES; OXIMETRY; INFANTS; INDEX	Background/Aims The aim was to investigate whether cerebral transcutaneous near-infrared spectroscopy (NIRS) or two-site NIRS is a suitable monitoring tool to detect or confirm a cerebral circulatory arrest in pediatric intensive care unit (PICU) patients. Methods Prospective single-center pediatric observational study. Simultaneous NIRS measurements over forehead (cNIRS, crS02) and kidney (rNIRS, rrSO2), at the same time, the cardiac output were determined by transthoracic echocardiography. Area under the curve (AUC) in the receiver-operating curve (ROC) was analyzed for NIRS regarding cerebral circulatory arrest. Results There were two groups of patients (weight 2.1-73kg): Group A: patients with intact cerebral perfusion (n=36). Group B: patients with cerebral circulatory arrest (n=8) proven by Doppler ultrasound scan or perfusion scintigraphy. There was no difference in cardiac output between the groups. PICU mortality for Group A was 3/36 (8.3%), for Group B 8/8, (100%). Mean cNIRS values were significantly higher with 68.92 (sem=2.54, sd=15.25) in Group A compared with 34.63 (sem=5.36, sd=15.15) in Group B (P<0.001). ROC analysis for cNIRS detecting cerebral circulatory arrest was significant (AUC 0.948, 95% confidence interval 0.876-1.000, se=0.037, P<0.001). Discrimination was optimal at 46 for cNIRS, at 36.5 for the difference rNIRS-cNIRS and at 0.5646 for the quotient cNIRS/rNIRS. The probability of a cerebral circulatory arrest was 77.8% (cNIRS) and 87.5% (combinations of cNIRS and rNIRS) at these cutoffs. Conclusions cNIRS did detect cerebral circulatory arrest with high sensitivity. Specificity was, however, not high enough to confirm a cerebral circulatory arrest.	[Blohm, Martin E.; Obrecht, Denise; Hartwich, Jana; Singer, Dominique] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, Div Neonatol & Pediat Intens Care Med, D-20246 Hamburg, Germany		Blohm, ME (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pediat, Div Neonatol & Pediat Intens Care Med, Martinistr 52, D-20246 Hamburg, Germany.	m.blohm@uke.de			Covidien, Germany	Ethical approval by the local ethical review board and informed consent from parents or guardians were obtained. The ICMJE standards were adhered to. No specific funding, costs for consumables were covered by hospital funds during clinical routine. Martin E. Blohm has been supported for educational purposes by Covidien, Germany (600 Euro travel expenses). None of the authors has a financial interest in this study.	[Anonymous], 1998, DTSCH ARZTEBL, V30, pA 1861; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Billet N, 2012, CRIT CARE, V16, pP294; Fenton KN, 2007, ANN THORAC SURG, V83, P1431, DOI 10.1016/j.athoracsur.2006.10.013; Fenton KN, 2005, AM J SURG, V190, P260, DOI 10.1016/j.amjsurg.2005.05.023; Flowers WM, 1997, SOUTH MED J, V90, P1091, DOI 10.1097/00007611-199711000-00007; Gatto R, 2006, J NEUROSCI METH, V157, P274, DOI 10.1016/j.jneumeth.2006.04.013; Heringlake M, 2011, ANESTHESIOLOGY, V114, P58, DOI 10.1097/ALN.0b013e3181fef34e; Jones SR, 2003, EMERG MED J, V20, P453, DOI 10.1136/emj.20.5.453; Kasman N, 2011, PEDIATR ANESTH, V21, P473, DOI 10.1111/j.1460-9592.2011.03549.x; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS30, DOI 10.1097/PCC.0b013e31823f659a; Kussman BD, 2010, CIRCULATION, V122, P245, DOI 10.1161/CIRCULATIONAHA.109.902338; Lai WW, 2006, J AM SOC ECHOCARDIOG, V19, P1413, DOI 10.1016/j.echo.2006.09.001; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Maas AIR, 2010, INTENS CARE MED, V36, P1283, DOI 10.1007/s00134-010-1921-6; Murkin JM, 2011, ANESTHESIOLOGY, V114, P12, DOI 10.1097/ALN.0b013e3181fef5d2; Nagdyman N, 2004, INTENS CARE MED, V30, P468, DOI 10.1007/s00134-003-2101-8; Nakagawa TA, 2012, ANN NEUROL, V71, P573, DOI 10.1002/ana.23552; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P591, DOI 10.1089/neu.1995.12.591; Song JG, 2011, ANESTH ANALG, V112, P1347, DOI 10.1213/ANE.0b013e318214b2b0; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Toet MC, 2005, EXP BRAIN RES, V165, P343, DOI 10.1007/s00221-005-2300-3; WIELER H, 1993, CLIN NUCL MED, V18, P104, DOI 10.1097/00003072-199302000-00002; Willie CK, 2011, J NEUROSCI METH, V196, P221, DOI 10.1016/j.jneumeth.2011.01.011; Young G Bryan, 2006, Can J Anaesth, V53, P620	25	5	5	0	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645	1460-9592		PEDIATR ANESTH	Pediatr. Anesth.	APR	2014	24	4					393	399		10.1111/pan.12328			7	Anesthesiology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Pediatrics	AC8HG	WOS:000332773500005	24354795				2022-02-06	
J	Figueroa, SA; Merriman-Noesges, K				Figueroa, Stephen A.; Merriman-Noesges, Karen			Utility of Thromboelastography in Traumatic Brain Injury and the Neuroscience Intensive Care Unit	JOURNAL OF NEUROSCIENCE NURSING			English	Article							VENOUS THROMBOEMBOLISM; PLATELET DYSFUNCTION; SURGICAL-PATIENTS; HEAD-INJURY; COAGULOPATHY; THROMBELASTOGRAPHY; MODEL; HYPERCOAGULABILITY; HEMOSTASIS; ACTIVATION		[Figueroa, Stephen A.; Merriman-Noesges, Karen] Univ Texas Southwestern, Dallas, TX 75235 USA		Figueroa, SA (corresponding author), Univ Texas Southwestern, Dallas, TX 75235 USA.	stephen.figueroa@utsouthwestern.edu		Figueroa, Stephen/0000-0002-6363-8496			Barklin A, 2009, ANESTHESIOLOGY, V110, P1287, DOI 10.1097/ALN.0b013e3181a10352; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Despotis GJ, 1997, CLIN CHEM, V43, P1684; Elliott A, 2012, INT J STROKE, V27; Ettinger MG, 1970, STROKE, V1, P139, DOI 10.1161/01.STR.1.3.139; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Goh KYC, 1997, J NEUROL NEUROSUR PS, V63, P334, DOI 10.1136/jnnp.63.3.334; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Gonzalez E, 2010, J SURG RES, V163, P96, DOI 10.1016/j.jss.2010.03.058; HAMILTON MG, 1994, NEUROSURGERY, V34, P280, DOI 10.1227/00006123-199402000-00012; Hammond FM, 1998, J HEAD TRAUMA REHAB, V13, P36, DOI 10.1097/00001199-199802000-00007; Harr JN, 2013, SHOCK, V39, P45, DOI 10.1097/SHK.0b013e3182787122; HARTERT H, 1948, KLIN WOCHENSCHR, V26, P577, DOI 10.1007/BF01697545; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Kashuk JL, 2009, SURGERY, V146, P764, DOI 10.1016/j.surg.2009.06.054; Larsen CC, 2010, ACTA NEUROCHIR, V152, P1577, DOI 10.1007/s00701-010-0699-1; Luostarinen T, 2011, NEUROCRIT CARE, V14, P238, DOI 10.1007/s12028-010-9475-6; McCrath DJ, 2005, ANESTH ANALG, V100, P1576, DOI 10.1213/01.ANE.0000155290.86795.12; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; RUIZ AJ, 1991, AM J SURG, V162, P159, DOI 10.1016/0002-9610(91)90180-L; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; Shore-Lesserson L, 1999, ANESTH ANALG, V88, P312, DOI 10.1097/00000539-199902000-00016; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Toker S, 2011, THROMBOSIS, V2011; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	32	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	APR	2014	46	2					66	70		10.1097/JNN.0000000000000045			5	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	AB9DM	WOS:000332090000003	24556653				2022-02-06	
J	Joseph, B; Aziz, H; Pandit, V; Hays, D; Kulvatunyou, N; Tang, A; Wynne, J; O' Keeffe, T; Green, DJ; Friese, RS; Gruessner, R; Rhee, P				Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Hays, Daniel; Kulvatunyou, Narong; Tang, Andrew; Wynne, Julie; O' Keeffe, Terence; Green, Donald J.; Friese, Randall S.; Gruessner, Rainer; Rhee, Peter			Prothrombin Complex Concentrate Use in Coagulopathy of Lethal Brain Injuries Increases Organ Donation	AMERICAN SURGEON			English	Article; Proceedings Paper	8th Annual Academic Surgical Congress	FEB 05-07, 2013	New Orleans, LA	Assoc Acad Surg, Soc Univ Surg				Coagulopathy is a defined barrier for organ donation in patients with lethal traumatic brain injuries. The purpose of this study was to document our experience with the use of prothrombin complex concentrate (PCC) to facilitate organ donation in patients with lethal traumatic brain injuries. We performed a 4-year retrospective analysis of all patients with devastating gunshot wounds to the brain. The data were analyzed for demographics, change in international normalized ratio (INR), and subsequent organ donation. The primary end point was organ donation. Eighty-eight patients with lethal traumatic brain injury were identified from the trauma registry of whom 13 were coagulopathic at the time of admission (mean INR 2.2 +/- 0.8). Of these 13 patients, 10 patients received PCC in an effort to reverse their coagulopathy. Mean INR before PCC administration was 2.01 +/- 0.7 and 1.1 +/- 0.7 after administration (P < 0.006). Correction of coagulopathy was attained in 70 per cent (seven of 10) patients. Of these seven patients, consent for donation was obtained in six patients and resulted in 19 solid organs being procured. The cost of PCC per patient was $1022 +/- 544. PCC effectively reveres coagulopathy associated with lethal traumatic brain injury and enabled patients to proceed to organ donation. Although various methodologies exist for the treatment of coagulopathy to facilitate organ donation, PCC provides a rapid and cost-effective therapy for reversal of coagulopathy in patients with lethal traumatic brain injuries.	[Joseph, Bellal; Aziz, Hassan; Pandit, Viraj; Hays, Daniel; Kulvatunyou, Narong; Tang, Andrew; Wynne, Julie; O' Keeffe, Terence; Green, Donald J.; Friese, Randall S.; Gruessner, Rainer; Rhee, Peter] Univ Arizona, Div Trauma Burns Crit Care & Emergency Surg, Tucson, AZ 85724 USA		Joseph, B (corresponding author), Univ Arizona, Dept Surg, Div Trauma Burns Crit Care & Emergency Surg, 1501 N Campbell Ave,Room 5411,POB 245063, Tucson, AZ 85724 USA.	bjoseph@surgery.arizona.edu	Aziz, Hassan/ABA-5681-2021	Aziz, Hassan/0000-0003-0406-1946			Aiyagari V, 2005, J CRIT CARE, V20, P176, DOI 10.1016/j.jcrc.2005.02.004; Amin M, 2003, TRANSFUSION MED, V13, P275, DOI 10.1046/j.1365-3148.2003.00454.x; Jenkins DH, 1999, WORLD J SURG, V23, P644, DOI 10.1007/PL00012362; Joseph B, 2013, J TRAUMA ACUTE CARE, V74, P248, DOI 10.1097/TA.0b013e3182788a40; Joseph B, 2012, J TRAUMA ACUTE CARE, V72, P828, DOI 10.1097/TA.0b013e318247c944; Raoof M, 2011, AM J SURG, V202, P701, DOI 10.1016/j.amjsurg.2011.06.028; Saidi RF, 2012, WORLD J SURG, V36, P2909, DOI 10.1007/s00268-012-1748-0; Salim A, 2005, J TRAUMA, V58, P991, DOI 10.1097/01.TA.0000168708.78049.32; Stein DM, 2009, J AM COLL SURGEONS, V208, P120, DOI 10.1016/j.jamcollsurg.2008.09.027	9	5	5	0	2	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	APR	2014	80	4					335	338					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	AJ5RL	WOS:000337744400013	24887662				2022-02-06	
J	Kan'o, T; Han, JY; Nakahara, K; Konno, S; Shibata, M; Kitahara, T; Soma, K				Kan'o, Tomomichi; Han, Jing-Yan; Nakahara, Kuniaki; Konno, Shingo; Shibata, Mayuko; Kitahara, Takao; Soma, Kazui			Yokukansan improves distress of medical staff, and cognitive function and motivation in patients with destructive and aggressive behaviors after traumatic brain injury	ACUTE MEDICINE & SURGERY			English	Article						Cognitive function; destructive and aggressive behaviors; drug interactions; traumatic brain injury; yokukansan	YI-GAN-SAN; TRADITIONAL JAPANESE MEDICINE; PSYCHOLOGICAL SYMPTOMS; VISUAL HALLUCINATIONS; DEMENTIA; KAMPO; THERAPY; STATE	Aim: Yokukansan (a Japanese Kampo medicine) has been reported to be safe and useful in treating behavioral and psychological symptoms in dementia patients. This study aimed to investigate the effects of yokukansan on destructive and aggressive behaviors in patients after traumatic brain injury. Methods: From April 2008 to July 2010, 189 patients who suffered traumatic brain injury were admitted to our tertiary emergency center. Of these, patients with destructive and aggressive behaviors were treated with neuroleptics. Seven patients (five men and two women) who could not be controlled by neuroleptics were given yokukansan (2.5 g powder) three times a day before meals. Main underlying conditions included brain contusion in three patients, acute subdural hematoma in two, and acute epidural hematoma in two. The following assessments were carried out at baseline and 1 and 2 weeks after initiation of treatment: the Glasgow Coma Scale for the assessment of disturbed consciousness after traumatic brain injury; Neuropsychiatric Inventory for the distress of medical staff; Mini-Mental State Examination for cognitive function; Barthel Index for activities of daily living; Vitality Index for motivation; presence of adverse effects and drug interactions. Results: After treatment with yokukansan, patients showed significant improvements in Glasgow Coma Scale (P = 0.001), Neuropsychiatric Inventory (P = 0.016), Mini-Mental State Examination (P = 0.029), Barthel Index (P = 0.043), and Vitality Index (P = 0.013). No adverse effects or drug interactions between yokukansan and Western medicines were observed. Conclusion: Yokukansan improved the Glasgow Coma Scale, Neuropsychiatric Inventory, Mini-Mental State Examination, Barthel Index, and Vitality Index without any adverse effects or drug interactions with Western medicines in patients with destructive and aggressive behaviors after traumatic brain injury.	[Kan'o, Tomomichi; Nakahara, Kuniaki; Konno, Shingo; Shibata, Mayuko; Kitahara, Takao; Soma, Kazui] Kitasato Univ, Dept Emergency & Crit Care Med, 1-15-1 Kitasato,Minami, Sagamihara, Kanagawa 2520374, Japan; [Han, Jing-Yan] Beijing Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China		Kan'o, T (corresponding author), Kitasato Univ, Dept Emergency & Crit Care Med, 1-15-1 Kitasato,Minami, Sagamihara, Kanagawa 2520374, Japan.	tk119@kitasato-u.ac.jp					BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Egashira N, 2008, BIOL PSYCHIAT, V32, P1515; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Ikarashi Y, 2009, BIOL PHARM BULL, V32, P1701, DOI 10.1248/bpb.32.1701; Ito K, 2008, BIOL PHARM BULL, V31, P893, DOI 10.1248/bpb.31.893; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P248, DOI 10.4088/JCP.v66n0214; Iwasaki K, 2005, J CLIN PSYCHIAT, V66, P1612, DOI 10.4088/JCP.v66n1219a; Kanno H, 2009, J PHARM PHARMACOL, V61, P1249, DOI [10.1211/jpp/61.09.0016, 10.1211/jpp.61.09.0016]; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; Kimura T, 2010, PSYCHIAT CLIN NEUROS, V64, P207, DOI 10.1111/j.1440-1819.2010.02072.x; Liao Jyh-Fei, 1995, Proceedings of the National Science Council Republic of China Part B Life Sciences, V19, P151; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MAHONEY F I, 1965, Md State Med J, V14, P61; Matsumoto K, 2013, J PHARMACOL SCI, V122, P257, DOI 10.1254/jphs.13R03CR; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P761, DOI 10.1016/j.pnpbp.2007.12.003; Miyaoka T, 2009, CLIN NEUROPHARMACOL, V32, P6, DOI 10.1097/WNF.0b013e31817e08c3; Miyaoka T, 2008, PROG NEURO-PSYCHOPH, V32, P150, DOI 10.1016/j.pnpbp.2007.07.026; Miyaoka T, 2009, PROG NEURO-PSYCHOPH, V33, P382, DOI 10.1016/j.pnpbp.2008.12.005; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; Murakami Y, 2005, PHARMACOL BIOCHEM BE, V81, P616, DOI 10.1016/j.pbb.2005.05.004; Saito S, 2010, PSYCHOGERIATRICS, V10, P45, DOI 10.1111/j.1479-8301.2010.00313.x; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Takeda A, 2008, NEUROCHEM INT, V53, P230, DOI 10.1016/j.neuint.2008.07.009; Tanaka Y, 2009, NEUROSCIENCE, V164, P1224, DOI 10.1016/j.neuroscience.2009.08.060; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Toba K., 2002, GERIATR GERONTOL INT, V2, P23, DOI 10.1046/j.1444-1586.2002.00016.x; VIRKKUNEN M, 1976, ACTA PSYCHIAT SCAND, V53, P168, DOI 10.1111/j.1600-0447.1976.tb00072.x	30	5	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2052-8817			ACUTE MED SURG	Acute Med. Surg.	APR	2014	1	2					88	93		10.1002/ams2.24			6	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V3Y5P	WOS:000218704000005	29930828	Bronze, Green Published			2022-02-06	
J	Lin, CM; Li, CY				Lin, Chih-Ming; Li, Chung-Yi			Assessment of medical resource utilization for Taiwanese children hospitalized for intracranial injuries	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Intracranial injury; Medical resource utilization; Traumatic brain injury; Children; Length of stay; Mediator	TRAUMATIC BRAIN-INJURY; EPIDEMIOLOGY	Background: Compared to adults, children and adolescents are at greater risk for traumatic brain injury (TBI), with increased severity and prolonged recovery when compared to adults. It is a challenge to provide care for those children who are at risk for complications of TBI under health care resource constraints. Aim: To investigate hospitalization among children with intracranial injuries in terms of incidence and factors related to length of stay (LOS) and medical cost. Methods: Data from the National Health Insurance Research Database from 2007-2009 were used. In total 8632 children aged <= 18 years with acute traumatic intracranial injuries caused by accidents were discharged from hospitals in Taiwan. The associations between patient and hospital covariates (e.g., age, gender, accreditation level of hospital, surgical intervention, and number of comorbid conditions) and log-transferred hospitalization cost and length of stay (LOS) were examined with multivariable regression analysis and mediation analyses. Results: The incidence rate of hospitalization for acute intracranial injury was 63.3/100,000 per year. Motor vehicle crashes and falls accounted for 63.5% and 23.8% of intracranial injuries, respectively. The mean LOS for children was 5.0 days (median, 3 days), incurring a mean direct medical cost of $US 916.70 (median, $356.2). Boy sustained more injury (64.1%) and greater medicals cost ($965) occurred in boys. Patients with subarachnoid subdural and extradural haemorrhage tended to have a longer LOS and incur greater medical costs. Surgical intervention and type of healthcare institution were also significant predictors for medical costs. Additionally, LOS was the dominant mediator for the relationship between predictor and medical cost. Conclusions: Acute intracranial injuries among children incur a substantial health care burden. Therefore, health authorities need to optimally allocate medical resources in care. (C) 2013 Elsevier Ltd. All rights reserved.	[Lin, Chih-Ming] Ming Chuan Univ, Dept Healthcare Informat & Management, Tao Yuan, Taiwan; [Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept & Grad Inst Publ Hlth, Tainan 70101, Taiwan; [Li, Chung-Yi] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan		Lin, CM (corresponding author), 5 Teh Ming Rd, Gwei Shan 333, Taoyuan County, Taiwan.	cmlin@mail.mcu.edu.tw	LI, CHUNG-YI/ABI-1419-2020	LI, CHUNG-YI/0000-0002-0321-8908	Ming Chuan University	We thank Chu-Chen Chang for assistance with data analysis. This study was partially supported by a grant from Ming Chuan University.	BROOKES M, 1990, J EPIDEMIOL COMMUN H, V44, P147, DOI 10.1136/jech.44.2.147; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chu DC, 2009, BMC HEALTH SERV RES, V9, P1; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dias MS, 2004, PEDIATR CLIN N AM, V51, P271, DOI 10.1016/S0031-3955(03)00211-6; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Liao KH, 2009, SURG NEUROL, V72, P66, DOI 10.1016/j.surneu.2009.07.004; Liu TC, 2008, MED CARE, V46, P440, DOI 10.1097/MLR.0b013e31816493e9; Luerssen T G, 1991, Neurosurg Clin N Am, V2, P399; MacKinnon D, 2008, INTRO STAT MEDIATION, P47, DOI DOI 10.1080/00273171.2010.498290; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P627; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Sobel ME., 1982, SOCIOLOGICAL METHODO, V13, P290, DOI DOI 10.2307/270723; Tabish A, 2006, INJURY, V37, P410, DOI 10.1016/j.injury.2006.01.039; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TULLOUS M, 1992, PEDIAT CRITICAL CARE, P1165; van Pelt ED, 2011, EUR J PAEDIATR NEURO, V15, P519, DOI 10.1016/j.ejpn.2011.05.005; WALKER ML, 1985, EMERGENCY MANAGEMENT, P272; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; ZUCCARELLO M, 1985, CHILD NERV SYST, V1, P158, DOI 10.1007/BF00735731	26	5	5	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	APR	2014	45	4					690	695		10.1016/j.injury.2013.09.031			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	AA6HY	WOS:000331200600009	24125538				2022-02-06	
J	Pape, D; Hoffmann, A; Gerich, T; Van der Kerkhofe, M; Weber, M; Pape, HC				Pape, D.; Hoffmann, A.; Gerich, T.; Van der Kerkhofe, M.; Weber, M.; Pape, H. -C.			Fractures of the knee joint in the elderly. Osteosynthesis versus joint replacement	ORTHOPADE			German	Article						Osteoporosis; Geriatrics; Knee fractures; Open reduction and internal fixation; Primary knee prosthesis implantation	DISTAL FEMORAL FRACTURES; TIBIAL PLATEAU; OSTEOPOROTIC FRACTURES; PROXIMAL TIBIA; NECK FRACTURES; BONE-DENSITY; ARTHROPLASTY; OSTEOARTHRITIS; POINT; HEAD	The aim of open reduction and internal fixation (ORIF) of fractures around the knee joint is the exact anatomic reconstruction of joint surfaces in order to achieve an early and load stable bone situation. Primary endoprosthetics as the initial treatment can represent an alternative treatment option for a closely selected number of geriatric patients. The chances and risks of primary endoprosthetics in comparison to ORIF as the gold standard for initial treatment of fractures close to the knee joint in the elderly are presented A selective search of the literature was carried out in consideration of national recommendations and own experience gained as head of a center for geriatric traumatology. If the soft tissue coverage is not damaged by the injury, primary endoprosthetics can offer advantages compared to ORIF when a load stable joint is indispensable due to poor compliance, pre-existing arthritis and advanced age. The risk of postoperative loss of correction is minimized by the prosthesis but the revision possibilities are very limited due to voluminous prostheses with a high degree of coupling. The indications for primary prosthesis implantation for acute treatment of fractures close to the knee should therefore be closely controlled because this should be the first and last intervention for fracture treatment in geriatric patients.	[Pape, D.; Hoffmann, A.] Ctr Hosp Luxembourg, Orthopad Klin, L-1460 Luxembourg, Luxembourg; [Pape, D.; Hoffmann, A.] Fdn Norbert Metz, Ctr Med, Publ Res Ctr Hlth, Sports Med Res Lab, Luxembourg, Luxembourg; [Gerich, T.] Ctr Hosp Luxembourg, Unfallchirurg Klin, L-1460 Luxembourg, Luxembourg; [Van der Kerkhofe, M.; Weber, M.; Pape, H. -C.] Uniklinik RWTH Aachen, Klin Unfall & Wiederherstellungschirurg, Aachen, Germany		Pape, D (corresponding author), Ctr Hosp Luxembourg, Orthopad Klin, 78 Rue Eich, L-1460 Luxembourg, Luxembourg.	dietrichpape@yahoo.de		Pape, Hans-Christoph/0000-0002-2059-4980			Appleton P, 2006, J BONE JOINT SURG BR, V88B, P1065, DOI 10.1302/0301-620X.88B8; BELL KM, 1992, J BONE JOINT SURG BR, V74, P400, DOI 10.1302/0301-620X.74B3.1587887; Bogoch ER, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.00198; de Groot MH, 2014, GAIT POSTURE, V39, P767, DOI 10.1016/j.gaitpost.2013.10.015; Duncan RC, 2006, RHEUMATOLOGY, V45, P757, DOI 10.1093/rheumatology/kei270; Frangen TM, 2010, TRAUMA BERUFSKRANKH, V12, P43, DOI 10.1007/s10039-010-1598-7; Gerich T, 2001, UNFALLCHIRURG, V104, P414, DOI 10.1007/s001130050752; JONES G, 1995, J RHEUMATOL, V22, P921; Kilian U, 2003, UNFALLCHIRURG, V106, P1046, DOI 10.1007/s00113-003-0643-4; Kobbe P, 2008, Z ORTHOP UNFALLCHIR, V146, P580, DOI 10.1055/s-2008-1038542; Kosters C, 2010, TRAUMA BERUFSKRANKH, V12, P47, DOI 10.1007/s10039-010-1599-6; Kosters C, 2011, UNFALLCHIRURG, V114, P251, DOI 10.1007/s00113-010-1943-0; Malviya A, 2011, INJURY, V42, P1368, DOI 10.1016/j.injury.2011.06.198; Muller CA, 2008, ZBL CHIR, V133, P590, DOI 10.1055/s-0028-1098711; Muller-Mai C, 2006, CHIRURG, V77, P61, DOI 10.1007/s00104-005-1079-x; Nau T, 2003, J ARTHROPLASTY, V18, P968, DOI 10.1016/S0883-5403(03)00280-8; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Nourissat G, 2006, REV CHIR ORTHOP, V92, P242; Papadopoulos EC, 2002, KNEE, V9, P267, DOI 10.1016/S0968-0160(02)00046-7; Petersen W, 2006, UNFALLCHIRURG, V109, P219, DOI 10.1007/s00113-006-1066-9; Raunest J, 2001, UNFALLCHIRURG, V104, P325, DOI 10.1007/s001130050735; Runge M, 2002, Ther Umsch, V59, P351, DOI 10.1024/0040-5930.59.7.351; Saleh KJ, 2001, J BONE JOINT SURG AM, V83A, P1144, DOI 10.2106/00004623-200108000-00002; SCHARF S, 1994, AUST NZ J MED, V24, P725, DOI 10.1111/j.1445-5994.1994.tb01792.x; Schliemann B, 2009, Z ORTHOP UNFALLCHIR, V147, P689, DOI 10.1055/s-0029-1186204; Schwarz N, 2008, UNFALLCHIRURG, V111, P928, DOI 10.1007/s00113-008-1426-8; Smektala R, 2010, UNFALLCHIRURG, V113, P287, DOI 10.1007/s00113-009-1674-2; Starr AJ, 1999, J ORTHOP TRAUMA, V13, P138, DOI 10.1097/00005131-199902000-00012; Thomas TP, 2011, COMPUT METHOD BIOMEC, V14, P263, DOI 10.1080/10255841003762042; Tornetta P, 1996, CLIN ORTHOP RELAT R, P185; Vermeire J, 2010, ACTA ORTHOP BELG, V76, P785; Weiss NG, 2003, J BONE JOINT SURG AM, V85A, P218, DOI 10.2106/00004623-200302000-00006	32	5	6	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0085-4530	1433-0431		ORTHOPADE	Orthopade	APR	2014	43	4					365	373		10.1007/s00132-014-2267-5			9	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	AF0XK	WOS:000334438000010	24647771				2022-02-06	
J	Solis-Marcos, I; Castellano-Guerrero, AM; Dominguez-Morales, R; Leon-Carrion, J				Solis-Marcos, Ignacio; Castellano-Guerrero, Ana M.; Dominguez-Morales, Rosario; Leon-Carrion, Jose			Predictors of the recovery of cognitive functions in patients with traumatic brain injury	REVISTA DE NEUROLOGIA			Spanish	Article						Cognitive functional recovery; Functionality; Neurorehabilitation; Predictors; Time post-TBI; Traumatic brain injury	ACUTE MANAGEMENT; REHABILITATION; NEUROREHABILITATION; INTERVENTIONS; PROGRAM; MEMORY; ADULTS; RETURN; WORK	Introduction. After a traumatic brain injury (TBI), cognitive functionality may be severely altered. Some studies have aimed at identifying the best predictive variables for cognitive recovery, however, results still remain unclear. Aims. To assess the recovery of cognitive functionality in TBI patients after a rehabilitation programme, and to identify the variables that best predict the cognitive recovery. Patients and methods. We conducted a retrospective pre-post study with 58 adult TBI patients that underwent an intensive rehabilitation programme. All of them were assessed using the cognitive functions sub-scale from the FIM+FAM scale, at admission and discharge. Both scores were compared using non-parametric test Wilcoxon. Cognitive functionality gain percentage was calculated and correlated with all the collected data. A multiple linear regression analysis was carried out to identify the best predictors of cognitive functionality gain percentage by introducing all clinical, demographic and cognitive information. Results. The group's cognitive functionality increased significantly from 33,6% to 85% (p < 0,01). Patients with higher cognitive functionality gain percentage were those with younger age, shorter time post-TBI, and higher scores on cognitive functions sub-scale, conditional attention and Luria's memory word tests. The best predictors for cognitive functionality gain percentage were time post-TBI and cognitive functions at admission (adjusted R-2 = 55,8%). Conclusions. Patients who started rehabilitation sooner and had a higher cognitive functionality at admission, showed the greatest increase in cognitive functionality gain percentage. Other variables like age, or scores on cognitive tests must also be considered in future studies.	[Solis-Marcos, Ignacio; Castellano-Guerrero, Ana M.; Leon-Carrion, Jose] Univ Seville, Lab Neuropsicol Humana, E-41004 Seville, Spain; [Dominguez-Morales, Rosario; Leon-Carrion, Jose] CRECER, Ctr Rehabilitac Dano Cerebral, Seville, Spain		Leon-Carrion, J (corresponding author), Univ Seville, Lab Neuropsicol Humana, San Fernando 4, E-41004 Seville, Spain.	leoncarrion@us.es	Marcos, Ignacio Solis/AAE-9161-2019	Marcos, Ignacio Solis/0000-0001-9309-5552			Barroso y Martin J, 2001, REV ESPANOLA NEUROPS, V3, P63; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; de Norena D, 2010, REV NEUROLOGIA, V51, P687, DOI 10.33588/rn.5111.2009652; Fawcett J. W., 2001, BRAIN DAMAGE BRAIN R; Foy CML, 2013, NEUROREHABILITATION, V32, P671, DOI 10.3233/NRE-130890; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; Gil JAP, 1999, REV ESPANOLA NEUROPS, V1, P49; Ginarte-Arias Y, 2002, REV NEUROLOGIA, V35, P870, DOI 10.33588/rn.3509.2002418; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; HAMILTON B B, 1991, Archives of Physical Medicine and Rehabilitation, V72, P790; HERNANDEZMUELA S, 2004, REV NEUROL-FRANCE, V38, P58; Herrera-Guzman I, 2008, PSYCHIAT RES, V160, P72, DOI 10.1016/j.psychres.2007.04.012; Larsson L, 2002, BRAIN, V125, P2785; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; Leon-Carrion J, 2013, BRAIN INJURY, V27, P1119, DOI 10.3109/02699052.2013.804204; Leon-Carrion J, 2009, CLIN ENDOCRINOL, V70, P192, DOI 10.1111/j.1365-2265.2008.03355.x; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Machuca-Murga F, 2006, REV ESPANOLA NEUROPS, V8, P81; Marron E. M., 2011, ESTIMULACION COGNITI; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Meyer MJ, 2010, BRAIN INJURY, V24, P722, DOI 10.3109/02699051003692134; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Perez C, 2011, LESIONES MEDULARES T; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047	31	5	5	0	6	REVISTA DE NEUROLOGIA	BARCELONA	C/O CESAR VIGUERA, EDITOR, APDO 94121, 08080 BARCELONA, SPAIN	0210-0010	1576-6578		REV NEUROLOGIA	Rev. Neurologia	APR 1	2014	58	7					296	302		10.33588/rn.5807.2013514			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF6TU	WOS:000334848300002	24677152				2022-02-06	
J	Yamal, JM; Robertson, CS; Rubin, ML; Benoit, JS; Hannay, HJ; Tilley, BC				Yamal, Jose-Miguel; Robertson, Claudia S.; Rubin, M. Laura; Benoit, Julia S.; Hannay, H. Julia; Tilley, Barbara C.			Enrollment of racially/ethnically diverse participants in traumatic brain injury trials: Effect of availability of exception from informed consent	CLINICAL TRIALS			English	Article							CLINICAL-TRIALS; EMERGENCY RESEARCH; FUNCTIONAL OUTCOMES; MINORITY STATUS; WAIVER; IMPLEMENTATION; REGULATIONS; IMPACT; FOOD; CARE	Background The Final Rule regulations were developed to allow exception from informed consent (EFIC) to enable clinical trial research in emergency settings where major barriers exist for informed consent. There is little known evidence of the effect of the Final Rule in minority enrollment in clinical trials, particularly in traumatic brain injury (TBI) trials. A clinical trial funded by the National Institute of Neurological Disorders and Stroke was conducted to study the effects of erythropoietin on cerebral vascular dysfunction and anemia in subjects with TBI. There were periods of time when EFIC was and was not available for enrollment into the study. Purpose To explore the effect of EFIC availability on TBI trial enrollment of minority versus non-minority subjects. Methods Minority status of screened (n = 289) and enrolled (n = 191) TBI subjects was determined for this study. We tested for the presence of a minority and EFIC availability interaction in a multiple logistic regression model after controlling for EFIC and minority group main effects and other covariates. Results An interaction between the availability of EFIC minority and non-minority enrollment was not detected (odds ratio = 1.22; 95% confidence interval (CI) = 0.29-5.16). Limitations Our study was conducted at a single site, and the CI for the EFIC and minority interaction term was wide. Therefore, a small interaction effect cannot be ruled out. Conclusion EFIC increased the odds of being enrolled regardless of minority status.	[Yamal, Jose-Miguel; Rubin, M. Laura; Benoit, Julia S.; Tilley, Barbara C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Hannay, H. Julia] Univ Houston, Dept Psychol, Houston, TX USA		Yamal, JM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Div Biostat, 1200 Pressler St,RAS W928, Houston, TX 77030 USA.	Jose-Miguel.Yamal@uth.tmc.edu		Benoit, Julia/0000-0002-2734-5477; Hannay, H. Julia/0000-0001-7023-912X	National Institute of Neurological Disorders and Stroke, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS38660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS038660] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke, National Institutes of Health (Grant No. P01NS38660).	Adams JG, 1999, ANN EMERG MED, V33, P218, DOI 10.1016/S0196-0644(99)70398-7; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Biros MH, 2003, ANN EMERG MED, V42, P550, DOI 10.1067/S0196-0644(03)00490-6; Biros MH, 1999, ACAD EMERG MED, V6, P1272, DOI 10.1111/j.1553-2712.1999.tb00144.x; Blajchman MA, 2012, TRANSFUSION, V52, P1363, DOI 10.1111/j.1537-2995.2012.03640.x; Brasel KJ, 2008, J AM COLL SURGEONS, V206, P220, DOI 10.1016/j.jamcollsurg.2007.07.020; Burnett DM, 2000, BRAIN INJURY, V14, P713; Clifton GL, 2002, J NEUROTRAUM, V19, P1121, DOI 10.1089/08977150260337930; Contant C, 2006, CRIT CARE MED, V34, P2049, DOI 10.1097/01.CCM.0000227649.72651.F1; Dula A, 1997, HASTINGS CENT REP, V27, P11, DOI 10.2307/3528020; Faul M, 2010, TRAUMATIC BRAIN INJU; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P158, DOI 10.1097/00001199-200503000-00004; Holcomb JB, 2011, SHOCK, V35, P107, DOI 10.1097/SHK.0b013e3181f7fd01; Hosmer D. W., 2004, APPL LOGISTIC REGRES; Hussain-Gambles M, 2004, HEALTH SOC CARE COMM, V12, P382, DOI 10.1111/j.1365-2524.2004.00507.x; LURIE KG, 1994, JAMA-J AM MED ASSOC, V271, P1405, DOI 10.1001/jama.271.18.1405; Offices of the Secretary DHHS FDA, 1996, PROT HUM SUBJ INF CO, V61, P51497; OLSON CM, 1994, JAMA-J AM MED ASSOC, V271, P1445, DOI 10.1001/jama.271.18.1445; Prentice Ernest D, 1993, IRB, V15, P1, DOI 10.2307/3563728; Ramirez R.R., 2011, OVERVIEW RACE HISPAN; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Schmidt TA, 2004, ACAD EMERG MED, V11, P1082, DOI 10.1197/j.aem.2004.05.029; Schmotzer GL, 2012, ETHNIC DIS, V22, P226; Sen Biswas M, 2007, CLIN TRIALS, V4, P258, DOI 10.1177/1740774507079434; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; Silbergleit R, 2012, ACAD EMERG MED, V19, P448, DOI 10.1111/j.1553-2712.2012.01328.x; Sugarman J, 2009, RESUSCITATION, V80, P644, DOI 10.1016/j.resuscitation.2009.03.015; Wright DW, 2008, ANN EMERG MED, V51, P355, DOI 10.1016/j.annemergmed.2007.08.021	30	5	5	0	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1740-7745	1740-7753		CLIN TRIALS	Clin. Trials	APR	2014	11	2					187	194		10.1177/1740774514522560			8	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	AE0HT	WOS:000333645300006	24686108	Green Accepted			2022-02-06	
J	Zeng, JS; Zheng, P; Tong, WS; Fang, WM				Zeng, Jingsong; Zheng, Ping; Tong, Wusong; Fang, Weimin			Decreased risk of secondary brain herniation with intracranial pressure monitoring in patients with haemorrhagic stroke	BMC ANESTHESIOLOGY			English	Article						Intracranial-pressure monitoring; Hematoma enlargement; Brain herniation; Hemorrhagic stroke	INTRACEREBRAL HEMORRHAGE; MANAGEMENT; CARE	Background: Intracranial-pressure (ICP) monitoring is considered standard care for severe traumatic brain injury and is used frequently, but the efficacy of treatment based on monitoring in patients with hemorrhagic stroke has not been rigorously assessed. In this study, we investigated the clinical value of ICP monitoring in patients with hemorrhagic stroke. Methods: We conducted a randomized, unblinded, controlled trial in which 90 patients with hemorrhagic stroke were randomly assigned to ICP monitoring or a control group. The primary outcome was a composite of incidence rate of hematoma enlargement and secondary brain herniation. The secondary outcome was neurological status assessed using the Glasgow Outcome Scale scores at 6 months post-onset. Characteristics of the patients at baseline and outcome measurements were also compared between the two groups. Results: There was no significant between-group difference in the incidence of hematoma enlargement (control group, 38.6% vs. ICP monitoring group, 32.6%; P > 0.05). The incidence rate of secondary brain herniation in the ICP monitoring group was significantly lower compared with the control group (10.9% vs. 20.5%, P = 0.04). Six-month mortality was 6.5% in the ICP group and 9.1% in the control group (P < 0.05), and neurological outcome was better in the ICP group compared with the control group (P < 0.05). Conclusion: The dynamic ICP value may be more sensitive and effective in preventing secondary brain herniation in patients with hemorrhagic stroke compared with guidance directed by clinical signs and radiological indicators.	[Zeng, Jingsong; Zheng, Ping; Tong, Wusong; Fang, Weimin] Shanghai Pudong New Area Peoples Hosp, Dept Neurosurg, Shanghai, Peoples R China		Fang, WM (corresponding author), Shanghai Pudong New Area Peoples Hosp, Dept Neurosurg, 490 South Chuanhuan Rd, Shanghai, Peoples R China.	179058882@qq.com			Shanghai emergency trauma centre (Eastern) project [GWIII-08.3]; Shanghai Health Bureau Scientific Project: the establishment and management of regional traumatic service center [20124445]	This project was funded by Shanghai emergency trauma centre (Eastern) project (GWIII-08.3 and Shanghai Health Bureau Scientific Project: the establishment and management of regional traumatic service center (20124445).	Blaha M, 2005, J NEUROL NEUROSUR PS, V76, P147, DOI 10.1136/jnnp.2003.030817; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Brouwers HB, 2013, CEREBROVASC DIS, V35, P195, DOI 10.1159/000346599; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Sahni R, 2007, VASC HEALTH RISK MAN, V3, P701; Tong WS, 2011, NEURORADIOLOGY, V53, P305, DOI 10.1007/s00234-010-0659-8; Wartenberg KE, 2007, CRIT CARE CLIN, V23, P507, DOI 10.1016/j.ccc.2007.06.002; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131	9	5	5	0	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2253			BMC ANESTHESIOL	BMC Anesthesiol.	MAR 21	2014	14								19	10.1186/1471-2253-14-19			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	AF1EH	WOS:000334456700001	24650002	Green Published, gold			2022-02-06	
J	Broder, JS; Halabi, SS				Broder, Joshua S.; Halabi, Safwan S.			Improving the Application of Imaging Clinical Decision Support Tools: Making the Complex Simple	JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY			English	Article						Diagnostic imaging; clinical decision support; electronic health record; evidence-based medicine; quality of health care	MINOR HEAD-INJURY; PULMONARY-EMBOLISM; EMERGENCY-DEPARTMENT; RULE; CRITERIA; SCORE; APPENDICITIS; METAANALYSIS; ACCURACY; TRAUMA	With the promotion and incentivization of electronic health records and computerized order entry by CMS, there is a unique opportunity to catalyze the use of evidence-based guidelines with the inclusion of clinical decision support (CDS) tools. Imaging CDS tools have evolved from static paper algorithms, checklists, and scores to interactive systems that provide feedback and recommendations with the intent of directing health care providers to deliver best practices. Some of the major limitations of first generation imaging CDS tools include a lack of comprehensive evidence-based guidelines, limited ability to input detailed patient conditions and symptoms, and time-intensive user interfaces. Next-generation imaging CDS tools will attempt to close the information and interface gaps to provide more meaningful guidance to health care providers and improve the delivery of best practices to patients.	[Broder, Joshua S.] Duke Univ, Med Ctr, Dept Surg, Div Emergency Med, Durham, NC 27710 USA; [Halabi, Safwan S.] Henry Ford Hlth Syst, Dept Radiol, Detroit, MI USA; [Halabi, Safwan S.] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA		Broder, JS (corresponding author), Duke Univ, Med Ctr, Box 3096, Durham, NC 27710 USA.	joshua.broder@duke.edu	Halabi, Safwan S/H-2279-2018	Halabi, Safwan S/0000-0003-1317-984X; Broder, Joshua/0000-0001-8030-2831			Bachmann LM, 2003, BMJ-BRIT MED J, V326, P417, DOI 10.1136/bmj.326.7386.417; Bairstow PJ, 2010, INT J QUAL HEALTH C, V22, P194, DOI 10.1093/intqhc/mzq016; Bhatt M, 2009, ACAD EMERG MED, V16, P591, DOI 10.1111/j.1553-2712.2009.00445.x; Blackmore CC, 2011, J AM COLL RADIOL, V8, P19, DOI 10.1016/j.jacr.2010.07.009; Bowen S, 2011, J AM COLL RADIOL, V8, P251, DOI 10.1016/j.jacr.2010.11.020; Boyle A, 2004, EMERG MED J, V21, P426, DOI 10.1136/emj.2002.002063; Fitch K, 2001, RANDUCLA APPROPRIATE; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lucassen W, 2011, ANN INTERN MED, V155, P448, DOI 10.7326/0003-4819-155-7-201110040-00007; Moan R., 2010, DIAGNOSTIC IMAG 1206; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Ohle R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-139; Penaloza A, 2013, ANN EMERG MED, V62, P117, DOI 10.1016/j.annemergmed.2012.11.002; Radiological Society of North America, 2010, RSNA NEWS; Raja AS, 2012, RADIOLOGY, V262, P468, DOI 10.1148/radiol.11110951; Rosenthal Daniel I, 2006, J Am Coll Radiol, V3, P799, DOI 10.1016/j.jacr.2006.05.006; Singh B, 2012, ANN EMERG MED, V59, P517, DOI 10.1016/j.annemergmed.2011.10.022; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511; van Sonnenberg C., UTILIZATION SLOWDOWN; Zafar HM, 2012, J AM COLL RADIOL, V9, P907, DOI 10.1016/j.jacr.2012.09.014	24	5	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1546-1440			J AM COLL RADIOL	J. Am. Coll. Radiol.	MAR	2014	11	3					257	261		10.1016/j.jacr.2013.10.007			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	AC2SR	WOS:000332354800015	24589400				2022-02-06	
J	Galea, JP; Tyrrell, PJ; Patel, HP; Vail, A; King, AT; Hopkins, SJ				Galea, J. P.; Tyrrell, P. J.; Patel, H. P.; Vail, A.; King, A. T.; Hopkins, S. J.			Pitfalls in microdialysis methodology: an in vitro analysis of temperature, pressure and catheter use	PHYSIOLOGICAL MEASUREMENT			English	Article						microdialysis; cytokines; brain	INTERLEUKIN-1 RECEPTOR ANTAGONIST; TRAUMATIC BRAIN-INJURY; BODY-TEMPERATURE; STROKE; IL-1-BETA; RECOVERY	Microdialysis of macromolecules within the brain provides a unique insight into physiological and pathological processes occurring within an otherwise inaccessible cranial cavity. The physically restricted nature of the intracranial compartment may present wider variations of pressure and temperature than those experienced in the rest of the body. In this study we attempted to determine the effect of variation of temperature and pressure on a cytokine recovery in vitro. Our results demonstrate that the wide variation of recovery attributable to different catheter use outweighed any effects caused by temperature or pressure. Investigators performing cytokine microdialysis using the CMA 71 system should be aware of the wide inter-catheter variability and potential effects of temperature on recovery.	[Galea, J. P.; Tyrrell, P. J.; Patel, H. P.; Vail, A.; King, A. T.; Hopkins, S. J.] Univ Manchester, Vasc & Stroke Ctr, Inst Cardiovasc Sci, Salford Royal Fdn Trust, Salford M6 8HD, Lancs, England		Galea, JP (corresponding author), Univ Manchester, Vasc & Stroke Ctr, Inst Cardiovasc Sci, Salford Royal Fdn Trust, Clin Sci Bldg,Stott Lane, Salford M6 8HD, Lancs, England.	james.galea@manchester.ac.uk	Hopkins, Stephen/I-7363-2015; King, Andrew/AAR-1656-2020	Hopkins, Stephen/0000-0001-7644-2823; Vail, Andy/0000-0001-8274-2726; Patel, Hiren/0000-0002-1439-8801; King, Andrew/0000-0002-6546-7248	NIHRNational Institute for Health Research (NIHR); Academy of Medical SciencesAcademy of Medical Sciences (AMS); Stroke Association; neurosurgical department at Salford Royal NHS Foundation Trust; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0502030] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0502030] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [02JTA] Funding Source: researchfish	JG is supported by an NIHR Clinical Lectureship, Academy of Medical Sciences and the Stroke Association. The neurosurgical department at Salford Royal NHS Foundation Trust funded the consumables for the study.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; ARNER P, 1991, J INTERN MED, V230, P381, DOI 10.1111/j.1365-2796.1991.tb00461.x; Banwell V, 2009, J STROKE CEREBROVASC, V18, P269, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.009; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Bowen WR, 1996, J MEMBRANE SCI, V110, P229; Chen B, 2009, STROKE, V40, pE666, DOI 10.1161/STROKEAHA.109.551341; Emsley HCA, 2005, J NEUROL NEUROSUR PS, V76, P1366, DOI 10.1136/jnnp.2004.054882; FRITZSCHE AK, 1992, J APPL POLYM SCI, V45, P1945, DOI 10.1002/app.1992.070451109; Hamani C, 1997, NEUROL RES, V19, P281, DOI 10.1080/01616412.1997.11740814; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Henze D, 2007, J NEUROSCI METH, V164, P312, DOI 10.1016/j.jneumeth.2007.05.001; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Jansson K, 2003, SCAND J GASTROENTERO, V38, P1007, DOI 10.1080/00365520310004065; Karaszewski B, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-123; Krogstad AL, 1996, BRIT J DERMATOL, V134, P1005, DOI 10.1046/j.1365-2133.1996.d01-893.x; Langhelle A, 2012, EMERG MED J, V29, P239, DOI 10.1136/emj.2009.086967; Nowak G, 2002, BRIT J SURG, V89, P1169, DOI 10.1046/j.1365-2168.2002.02187.x; Sjogren S, 2002, BRIT J DERMATOL, V146, P375, DOI 10.1046/j.1365-2133.2002.04621.x; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Stenken JA, 2001, ANAL BIOCHEM, V290, P314, DOI 10.1006/abio.2000.4985; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X	22	5	5	0	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	MAR	2014	35	3					N21	N28		10.1088/0967-3334/35/3/N21			8	Biophysics; Engineering, Biomedical; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering; Physiology	AD3NK	WOS:000333152600001	24557147				2022-02-06	
J	Gist, TL; Rangel-Castilla, L; Krishna, C; Roman, GC; Cech, DA; Diaz, O				Gist, Taylor L.; Rangel-Castilla, Leonardo; Krishna, Chandan; Roman, Gustavo C.; Cech, David A.; Diaz, Orlando			Endovascular management of six simultaneous intracranial dural arteriovenous fistulas in a single patient	JOURNAL OF NEUROINTERVENTIONAL SURGERY			English	Article						Liquid Embolic Material; Technique; Fistula; Embolic; Angiography	CORTICAL VENOUS DRAINAGE; CLINICAL PRESENTATION; NATURAL-HISTORY; CLASSIFICATION; MALFORMATIONS; DEMENTIA; SHUNTS	A 64-year-old man with a history of traumatic brain injury 4 years previously presented with progressive cognitive decline and gait abnormality. MRI revealed diffusion restriction in the bilateral centrum semiovale and multiple serpiginous flow voids. Cerebral angiogram revealed a total of six intracranial dural arteriovenous fistulas with separate fistulas of the right and left sphenoid bones, left clival plexus, right transverse sinus, right sigmoid sinus, and superior sagittal sinus. A diffuse pseudophlebitic pattern of venous drainage indicating severe venous hypertension was also observed. The patient underwent a series of endovascular treatments over the next 10 months to achieve resolution of all arteriovenous shunting. Repeat MRI showed resolution of the diffusion restriction and marked reduction in T2 vascular flow voids. The patient's clinical status improved significantly over the course of treatment, paralleling the improvement in venous hypertension.	[Gist, Taylor L.; Rangel-Castilla, Leonardo; Krishna, Chandan; Cech, David A.] Methodist Neurol Inst, Dept Neurosurg, Houston, TX 77030 USA; [Roman, Gustavo C.] Methodist Neurol Inst, Dept Neurol, Houston, TX USA; [Diaz, Orlando] Methodist Neurol Inst, Dept Radiol, Houston, TX USA		Gist, TL (corresponding author), Methodist Neurol Inst, Dept Neurosurg, 6560 Fannin St,Scurlock Tower 944, Houston, TX 77030 USA.	tlgist@tmhs.org					BARNWELL SL, 1991, AM J NEURORADIOL, V12, P441; BORDEN JA, 1995, J NEUROSURG, V82, P166, DOI 10.3171/jns.1995.82.2.0166; Cognard C, 2008, AM J NEURORADIOL, V29, P235, DOI 10.3174/ajnr.A0817; COGNARD C, 1995, RADIOLOGY, V194, P671, DOI 10.1148/radiology.194.3.7862961; Davies MA, 1996, J NEUROSURG, V85, P830, DOI 10.3171/jns.1996.85.5.0830; Fiorella D, 2005, NEUROSURGERY, V57, P210, DOI 10.1227/01.NEU.0000163685.23846.DD; HERMAN JM, 1995, J NEUROSURG, V83, P539, DOI 10.3171/jns.1995.83.3.0539; Hurst RW, 1998, AM J NEURORADIOL, V19, P1267; KATAOKA K, 1984, J NEUROSURG, V60, P1275, DOI 10.3171/jns.1984.60.6.1275; KUWAYAMA N, 1989, J NEUROSURG, V71, P932, DOI 10.3171/jns.1989.71.6.0932; Li MC, 2012, WORLD NEUROSURG, V77, DOI 10.1016/j.wneu.2011.02.023; Mendonca N, 2012, NEUROLOGIST, V18, P130, DOI 10.1097/NRL.0b013e318251e695; Nakamura M, 1997, NEUROSURGERY, V41, P288, DOI 10.1097/00006123-199707000-00051; Nakase Hiroyuki, 2005, J Stroke Cerebrovasc Dis, V14, P152, DOI 10.1016/j.jstrokecerebrovasdis.2005.02.001; Natarajan SK, 2010, WORLD NEUROSURG, V73, P365, DOI 10.1016/j.wneu.2010.01.009; Saito A, 2008, J NEUROSURG, V109, P1103, DOI 10.3171/JNS.2008.109.12.1103; Shankar JJS, 2011, J NEUROSURG-SPINE, V15, P113, DOI 10.3171/2011.3.SPINE10315; Soderman M, 2008, STROKE, V39, P1735, DOI 10.1161/STROKEAHA.107.506485; Sugiura Y, 1996, NEUROL SURG TOKYO, V24, P379; TERADA T, 1994, J NEUROSURG, V80, P884, DOI 10.3171/jns.1994.80.5.0884; Ushikoshi S, 1999, AM J NEURORADIOL, V20, P728; van Dijk JMC, 2009, STROKE, V40, pE412, DOI 10.1161/STROKEAHA.108.545327; van Dijk JMC, 2002, STROKE, V33, P1233, DOI 10.1161/01.STR.0000014772.02908.44; van Dijk JMC, 2002, J NEUROSURG, V96, P76, DOI 10.3171/jns.2002.96.1.0076; van Rooij WJ, 2007, AM J NEURORADIOL, V28, P651; Waragai M, 2006, EUR J NEUROL, V13, P754, DOI 10.1111/j.1468-1331.2006.01318.x; Watanabe T, 2000, NEURORADIOLOGY, V42, P771, DOI 10.1007/s002340000332; Willinsky R, 1999, AM J NEURORADIOL, V20, P1031	28	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1759-8478	1759-8486		J NEUROINTERV SURG	J. NeuroInterventional Surg.	MAR	2014	6	2								10.1136/neurintsurg-2012-010619.rep			6	Neuroimaging; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AD8RP	WOS:000333533600008	23493339				2022-02-06	
J	Hedna, VS; Kumar, A; Miller, B; Bidari, S; Salardini, A; Waters, MF; Hella, M; Valenstein, E; Eisenschenk, S				Hedna, Vishnumurthy Shushrutha; Kumar, Abhay; Miller, Bayard; Bidari, Sharathchandra; Salardini, Arash; Waters, Michael F.; Hella, Maria; Valenstein, Edward; Eisenschenk, Stephan			Intracranial hypotension masquerading as nonconvulsive status epilepticus	JOURNAL OF NEUROSURGERY			English	Article						nonconvulsive status epilepticus; intracranial hypotension; epilepsy	CRITICALLY-ILL; SEIZURES	Intracranial hypotension (IH) has been a known entity in neurocritical care since 1938. Even though many cases are spontaneous, the incidence of intracranial hypotension in the neurocritical care setting is increasing by virtue of the increased number of neurosurgical interventions. Whether spontaneous or secondary in etiology, diagnosis of IH usually requires the presence of orthostatic symptoms, including headaches and nausea with low opening CSF pressure. However, typical clinical features in the appropriate clinical context and imaging, even with normal CSF pressure, can indicate IH. In the neurocritical care setting, challenges for accurate semiology include altered sensorium and reduced levels of responsiveness for which many etiologies may exist, including metabolic dysfunction, traumatic brain injury, IH, or nonconvulsive status epilepticus (NCSE). The authors describe 3 patients whose clinical picture and electroencephalography (EEG) findings initially suggested NCSE but who did not respond to treatment with antiepileptic drugs alone. Neuroimaging suggested IH, and subsequent treatment of 114 successfully improved the patient's clinical status. To the authors' knowledge this paper is the first in the literature that reports a correlation of IH with electrographic findings similar to NCSE as cause and effect. The authors' hypothesis is that thalamocortical dysfunction causes EEG findings that appear to be similar to those in NCSE but that these conditions do not coexist. The EEG activity is not epileptogenic, and IH results in blocking network pathways producing thalamocortical dysfunction. The authors discuss the hypothesis and pathophysiology of these epileptiform changes in relation to IH.	[Hedna, Vishnumurthy Shushrutha; Miller, Bayard; Salardini, Arash; Waters, Michael F.; Hella, Maria; Valenstein, Edward; Eisenschenk, Stephan] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32610 USA; [Bidari, Sharathchandra] Univ Florida, Coll Med, Dept Radiol, Gainesville, FL 32610 USA; [Kumar, Abhay] Washington Univ, Dept Neurol Intens Care, St Louis, MO USA		Eisenschenk, S (corresponding author), Univ Florida, Coll Med, Dept Neurol, POB 100236, Gainesville, FL 32610 USA.	stephan.eisenschenk@neurology.ufl.edu					Abend NS, 2010, NEUROCRIT CARE, V12, P382, DOI 10.1007/s12028-010-9337-2; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Maganti R, 2008, EPILEPSY BEHAV, V12, P572, DOI 10.1016/j.yebeh.2007.12.002; Mokri B, 2001, Curr Pain Headache Rep, V5, P284, DOI 10.1007/s11916-001-0045-7; Nguyen DK, 2006, ARCH NEUROL-CHICAGO, V63, P1321, DOI 10.1001/archneur.63.9.1321; Rahman M, 2011, NEUROSURGERY, V69, P4, DOI 10.1227/NEU.0b013e3182134399; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 2003, ARCH NEUROL-CHICAGO, V60, P1713, DOI 10.1001/archneur.60.12.1713; Tezer FI, 2009, EPILEPSY RES, V86, P228, DOI 10.1016/j.eplepsyres.2009.05.017; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Wiesemann E, 2006, EUR NEUROL, V56, P204, DOI 10.1159/000096487; Wittman JJ, 2005, NEUROCRIT CARE, V2, P330, DOI 10.1385/NCC:2:3:330; Young GB, 1996, NEUROLOGY, V47, P83	14	5	5	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2014	120	3					624	627		10.3171/2013.7.JNS112308			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	AB8OB	WOS:000332048800007	23971956				2022-02-06	
J	Houshian, S; Jing, SS				Houshian, S.; Jing, S. S.			A new technique for closed management of displaced intra-articular fractures of metacarpal and phalangeal head delayed on presentation: report of eight cases	JOURNAL OF HAND SURGERY-EUROPEAN VOLUME			English	Article						Metacarpal fracture; phalangeal; intra-articular; ligamentotaxis; external fixator; delayed	UNSTABLE METACARPAL; EXTERNAL FIXATION; HAND	We present the outcomes of the delayed management of eight displaced intra-articular fractures of the metacarpal and phalangeal heads treated with capsuloligamentotaxis using the Penning mini-external fixator. Closed anatomical reduction with a 2 mm over-distraction was achieved at the time of operation at an average of 20 days after the initial injury. Excellent outcomes in terms of function and pain were obtained at 6 month's follow-up in all cases. This technique is simple, minimally invasive, and effective, with minimal complications.	[Houshian, S.] Braintree Community Hosp, Braintree, Essex, England; [Jing, S. S.] Broomfield Hosp, Dept Orthopaed, Chelmsford, Essex, England		Houshian, S (corresponding author), 77 Elwill Way, Beckenham BR3 6RY, Kent, England.	sh_houshian@yahoo.dk					Dailiana Z, 2009, J HAND SURG-AM, V34A, P630, DOI 10.1016/j.jhsa.2008.12.017; Hastings II H, 1988, FRACTURES HAND WRIST, P145; Houshian S, 2008, J HAND SURG-EUR VOL, V33E, P345, DOI 10.1177/1753193408091351; JAMES J I, 1962, Acta Orthop Scand, V32, P401, DOI 10.3109/17453676208989599; Mumtaz MU, 2010, ULUS TRAVMA ACIL CER, V16, P334; PARSONS SW, 1992, J HAND SURG-BRIT EUR, V17B, P151, DOI 10.1016/0266-7681(92)90077-F; Pennig D, 2000, INJURY, V31, P102, DOI 10.1016/S0020-1383(99)00268-5; SCHUIND F, 1993, CLIN ORTHOP RELAT R, P77; Sudhakar JE, 1997, J HAND SURG-BRIT EUR, V22B, P672, DOI 10.1016/S0266-7681(97)80373-7; WRIGHT TA, 1968, CAN J SURG, V11, P491	10	5	6	0	2	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1753-1934	2043-6289		J HAND SURG-EUR VOL	J. Hand Surg.-Eur. Vol.	MAR	2014	39	3					232	236		10.1177/1753193413478350			5	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	AB3QI	WOS:000331704900002	23435489				2022-02-06	
J	Lebowitz, DC; Ko, MW; Cameron, EK; Ko, PY				Lebowitz, David C.; Ko, Melissa W.; Cameron, Ella K.; Ko, Paul Y.			Cerebral Sinus Thrombosis in a 6-Year- Old Boy After a Minor Head Injury	PEDIATRIC EMERGENCY CARE			English	Article						cerebral sinovenous thrombosis; magnetic resonance venography; anticoagulation; minor head injury	CHILDREN	Posttraumatic cerebral sinus thrombosis is an uncommon disease in children that is rarely seen in the setting of a closed head injury. We report a 6-year-old boy who developed cerebral sinus thrombosis after an apparent minor head injury. The clinical presentation, neuroimaging findings, and treatment strategies are discussed. Serial neurological evaluation and close observation are important, and the decision for anticoagulation should be carefully considered with hematological consultants.	[Lebowitz, David C.] Florida Hosp Med Ctr, Orlando, FL 32803 USA; [Ko, Melissa W.; Ko, Paul Y.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Cameron, Ella K.] Childrens Mercy Hosp, Kansas City, MO 64108 USA		Ko, PY (corresponding author), 550 E Genesse St 103, Syracuse, NY 13202 USA.	kop@upstate.edu		Ko, Melissa/0000-0002-2452-9684			Brors M, 2001, NEURORADIOLOGY, V43, P144, DOI 10.1007/PL00006045; BUONANNO FS, 1978, J COMPUT ASSIST TOMO, V2, P281, DOI 10.1097/00004728-197807000-00008; Daligic A, 2008, TURK NEUROSURG, V18, P70; FORD K, 1981, AM J NEURORADIOL, V2, P539; Jackson BF, 2011, PEDIATR EMERG CARE, V27, P874, DOI 10.1097/PEC.0b013e31822c9ccc; KINAL ME, 1967, J NEUROSURG, V27, P142, DOI 10.3171/jns.1967.27.2.0142; Muthukumar N, 2005, CHILD NERV SYST, V21, P86, DOI 10.1007/s00381-004-0926-2; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; Stam J, 2008, ARCH NEUROL-CHICAGO, V65, P984, DOI 10.1001/archneur.65.7.984; Stam J, 2005, NEW ENGL J MED, V352, P1791, DOI 10.1056/NEJMra042354; Stiefel D, 2000, EUR J PEDIATR SURG, V10, P41, DOI 10.1055/s-2008-1072321; TAHA JM, 1993, NEUROSURGERY, V32, P541, DOI 10.1227/00006123-199304000-00008	12	5	6	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	MAR	2014	30	3					177	179		10.1097/PEC.0000000000000088			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	AC6OR	WOS:000332644000008	24589805				2022-02-06	
J	Motorykin, I; Traber, MG; Tanguay, RL; Maier, CS				Motorykin, Ievgen; Traber, Maret G.; Tanguay, Robert L.; Maier, Claudia S.			Proteome-Driven Elucidation of Adaptive Responses to Combined Vitamin E and C Deficiency in Zebrafish	JOURNAL OF PROTEOME RESEARCH			English	Article						vitamin C; vitamin E; ion mobility; MSE; label-free quantification; zebrafish; glycolysis; glutaminolysis	ASCORBIC-ACID BIOSYNTHESIS; TANDEM MASS-SPECTROMETRY; TRAUMATIC BRAIN-INJURY; GAMMA-LACTONE OXIDASE; TELEOST FISH; GUINEA-PIGS; GLUTAMINE-METABOLISM; STATISTICAL-MODEL; PYRUVATE-KINASE; YEAST PROTEOME	The purpose of this study was to determine the system-wide consequences of deficiencies in two essential micronutrients, vitamins E and C, on the proteome using zebrafish (Danio rerio) as one of the few vertebrate models that similar to humans cannot synthesize vitamin C. We describe a label-free proteomics workflow to detect changes in protein abundance estimates dependent on vitamin regimes. We used ion-mobility-enhanced data-independent tandem mass spectrometry to determine differential regulation of proteins in response to low dietary levels of vitamin C with or without vitamin E. The detection limit of the method was as low as 20 amol, and the dynamic range was five orders of magnitude for the protein-level estimates. On the basis of the quantitative changes obtained, we built a network of protein interactions that reflect the whole organism's response to vitamin C deficiency. The proteomics-driven study revealed that in vitamin-E-deficient fish, vitamin C deficiency is associated with induction of stress response, astrogliosis, and a shift from glycolysis to glutaminolysis as an alternative mechanism to satisfy cellular energy requirements.	[Motorykin, Ievgen; Maier, Claudia S.] Oregon State Univ, Dept Chem, Corvallis, OR 97331 USA; [Traber, Maret G.] Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA; [Traber, Maret G.] Oregon State Univ, Sch Biol & Populat Hlth Sci, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA; [Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA		Maier, CS (corresponding author), Oregon State Univ, Dept Chem, 153 Gilbert Hall, Corvallis, OR 97331 USA.	claudia.maier@oregonstate.edu	Traber, Maret G./ABI-2511-2020	Traber, Maret G./0000-0002-2892-4024; Maier, Claudia S./0000-0003-0743-8956	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30ES000210, S10RR025628, R01HD062109]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD062109] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [S10RR025628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES000210] Funding Source: NIH RePORTER	We thank Dr. Cristobal Miranda for assistance in sample preparation. This study was partially made possible by grants from the National Institutes of Health, P30ES000210, S10RR025628, and R01HD062109.	Armour J, 2001, J APPL PHYSIOL, V90, P795, DOI 10.1152/jappl.2001.90.3.795; Azzi A, 2001, J NUTR, V131, p378S, DOI 10.1093/jn/131.2.378S; Banhegyi G, 1997, FREE RADICAL BIO MED, V23, P793, DOI 10.1016/S0891-5849(97)00062-2; Brigelius-Flohe R, 1999, FASEB J, V13, P1145, DOI 10.1096/fasebj.13.10.1145; Bruno RS, 2006, FREE RADICAL BIO MED, V40, P689, DOI 10.1016/j.freeradbiomed.2005.10.051; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Buettner GR, 2000, TERATOLOGY, V62, P234, DOI 10.1002/1096-9926(200010)62:4<234::AID-TERA10>3.3.CO;2-0; Burk RF, 2006, J NUTR, V136, P1576, DOI 10.1093/jn/136.6.1576; Chatterjee I. B., 1975, ACAD SCI, P24; Croker C G, 2000, J Biomol Tech, V11, P135; DABROWSKI K, 1990, BIOL CHEM H-S, V371, P207, DOI 10.1515/bchm3.1990.371.1.207; Dabrowski K, 1996, EXPERIENTIA, V52, P97, DOI 10.1007/BF01923351; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Delanghe JR, 2011, GENES NUTR, V6, P341, DOI 10.1007/s12263-011-0237-7; Diaz MN, 1997, NEW ENGL J MED, V337, P408, DOI 10.1056/NEJM199708073370607; Drouin G, 2011, CURR GENOMICS, V12, P371, DOI 10.2174/138920211796429736; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Frikke-Schmidt H, 2011, BRIT J NUTR, V105, P54, DOI 10.1017/S0007114510003077; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; GROLLMAN ARTHUR P., 1957, ARCH BIOCHEM AND BIOPHYS, V69, P458, DOI 10.1016/0003-9861(57)90510-6; Halliwell B, 1999, FREE RADICAL RES, V31, P261, DOI 10.1080/10715769900300841; Harrison FE, 2010, BRAIN RES, V1349, P143, DOI 10.1016/j.brainres.2010.06.037; Hill KE, 2003, AM J CLIN NUTR, V77, P1484, DOI 10.1093/ajcn/77.6.1484; Hoadlund-Hyzer CS, 2000, ANAL CHEM, V72, P2737; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KALYANARAMAN B, 1992, J BIOL CHEM, V267, P6789; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Lebold KM, 2013, COMP BIOCHEM PHYS C, V157, P382, DOI 10.1016/j.cbpc.2013.03.007; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Miller GW, 2012, J NUTR BIOCHEM, V23, P478, DOI 10.1016/j.jnutbio.2011.02.002; MYLLYLA R, 1978, BIOCHEM BIOPH RES CO, V83, P441, DOI 10.1016/0006-291X(78)91010-0; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NISHIKIMI M, 1994, J BIOL CHEM, V269, P13685; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; PETERKOF.B, 1965, P NATL ACAD SCI USA, V53, P335, DOI 10.1073/pnas.53.2.335; PHROMKUNTHONG W, 1994, J APPL ICHTHYOL, V10, P146, DOI 10.1111/j.1439-0426.1994.tb00154.x; PIYATHILAKE CJ, 1995, CANCER EPIDEM BIOMAR, V4, P751; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Purves RW, 1998, RAPID COMMUN MASS SP, V12, P695, DOI 10.1002/(SICI)1097-0231(19980615)12:11<695::AID-RCM220>3.3.CO;2-U; Ramsey F. L., 2012, STAT SLEUTH COURSE M, P760; Righetti PG, 2003, PROTEOMICS, V3, P1397, DOI 10.1002/pmic.200300472; Ritter S., 2007, CHEM ENG NEWS, V85, P61; Salbo R, 2012, RAPID COMMUN MASS SP, V26, P1181, DOI 10.1002/rcm.6211; Schiff L, 2012, MOL DIAGN THER, V16, P79, DOI 10.2165/11631580-000000000-00000; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Telang S, 2007, NEOPLASIA, V9, P47, DOI 10.1593/neo.06664; TOUHATA K, 1995, FISHERIES SCI, V61, P729, DOI 10.2331/fishsci.61.729; Toyohara H, 1996, BIOCHEM BIOPH RES CO, V223, P650, DOI 10.1006/bbrc.1996.0949; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Voyksner RD, 1999, RAPID COMMUN MASS SP, V13, P1427, DOI 10.1002/(SICI)1097-0231(19990730)13:14<1427::AID-RCM662>3.0.CO;2-5; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wilson JX, 2009, BIOFACTORS, V35, P5, DOI 10.1002/biof.7	58	5	5	0	12	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	MAR	2014	13	3					1647	1656		10.1021/pr401108d			10	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8AV	WOS:000332756300043	24476500	Green Published, Green Accepted, hybrid			2022-02-06	
J	Ulfarsson, T; Lundgren-Nilsson, A; Blomstrand, C; Nilsson, M				Ulfarsson, Trandur; Lundgren-Nilsson, Asa; Blomstrand, Christian; Nilsson, Michael			A history of unemployment or sick leave influences long-term functioning and health-related quality-of-life after severe traumatic brain injury	BRAIN INJURY			English	Article						Disability; outcome assessment; pre-morbid; prediction; rehabilitation; traumatic brain injury	REACTION LEVEL SCALE; GLASGOW COMA SCALE; HEAD-INJURY; PROSPECTIVE COHORT; PROGNOSTIC-FACTORS; FOLLOW-UP; DISABILITY; REHABILITATION; POPULATION; VALIDITY	Primary objective: The consequences of pre-morbid factors in adults with severe traumatic brain injury have not been widely addressed. This study aimed to determine whether being unemployed or on sick leave before injury influences long-term health-related quality-of-life (HRQoL) and functioning in patients with severe traumatic brain injury. Subjects: Fifty-one consecutive patients were studied; aged 16-65 years, with severe traumatic brain injury who were admitted to Sahlgrenska University Hospital, Gothenburg, from 1999-2002. Methods: The patients were assessed once, 2-11 years after trauma. Data from the time of injury were combined into a validated prognostic model to adjust for injury severity. Data on sick leave and unemployment before injury were gathered from the Swedish social insurance agency. Outcomes were measured with the Short Form-36 Health Survey, the Glasgow Outcome Scale-Extended, and a self-report questionnaire specifically designed for this study to measure functioning. Results: In a multivariate analysis, a history of sick leave/unemployment predicted a worse long-term global outcome, more problems with personal activities of daily living and worse HRQoL. Conclusion: These results should be considered when refining outcome predictions and optimizing rehabilitation interventions for patients with severe traumatic brain injury.	[Ulfarsson, Trandur; Lundgren-Nilsson, Asa; Blomstrand, Christian; Nilsson, Michael] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Ctr Brain Repair & Rehabil CBR, SE-41345 Gothenburg, Sweden; [Ulfarsson, Trandur; Lundgren-Nilsson, Asa] Sahlgrens Univ Hosp, Gothenburg, Sweden; [Nilsson, Michael] Hunter Med Res Inst HMRI, Newcastle, NSW, Australia; [Nilsson, Michael] Univ Newcastle, Newcastle, NSW 2300, Australia		Ulfarsson, T (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, SE-41345 Gothenburg, Sweden.	trandur.ulfarsson@vgregion.se	NILSSON, MICHAEL/ABE-7821-2020	NILSSON, MICHAEL/0000-0002-8826-1621; Blomstrand, Christian/0000-0003-3503-860X	Swedish Association of Persons with Neurological Disabilities; Lansforsakringar Alliance	The authors report no conflicts of interest. This work was supported by a grant from the Swedish Association of Persons with Neurological Disabilities and a grant from the Lansforsakringar Alliance. Stephen Ordway (Golden Gate Biomedical Communications) provided much appreciated scientific writing assistance.	Andelic N, 2010, DISABIL REHABIL, V32, P1122, DOI 10.3109/09638280903410722; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Figueras Josep, 2004, SOCIAL HLTH INSURANC; Fuhrer MJ, 2000, DISABIL REHABIL, V22, P481, DOI 10.1080/096382800413961; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE69, DOI 10.1097/HTR.0b013e3182738010; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jeon IC, 2008, J KOREAN NEUROSURG S, V44, P295, DOI 10.3340/jkns.2008.44.5.295; Jonsson CA, 2013, BRAIN INJURY, V27, P831, DOI 10.3109/02699052.2013.775493; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Larsson J, 2010, SCAND J PUBLIC HEALT, V38, P541, DOI 10.1177/1403494810371143; Macmillan PJ, 2002, BRAIN INJURY, V16, P41, DOI 10.1080/0269905011008812; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Parry-Jones BL, 2006, NEUROPSYCHOL REHABIL, V16, P537, DOI 10.1080/09602010500231875; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Persson LO, 1998, J CLIN EPIDEMIOL, V51, P1095, DOI 10.1016/S0895-4356(98)00101-2; Regeringkansliet, 2011, SWED GOV OFF REP SOU, P6; Roemer MI, 1997, SCAND J SOC MED, V25, P65, DOI 10.1177/140349489702500201; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Schonberger M, 2011, J NEUROL NEUROSUR PS, V82, P936, DOI 10.1136/jnnp.2010.210021; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Socialstyrelsen, 2001, STAT YB SWED; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Sullivan M, 1998, J CLIN EPIDEMIOL, V51, P1105, DOI 10.1016/S0895-4356(98)00102-4; SULLIVAN M, 1995, SOC SCI MED, V41, P1349, DOI 10.1016/0277-9536(95)00125-Q; SULLIVAN M, 2002, SF 36 HALS SVENSK MA; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; van der Zee J, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-94; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; World Health Organization W, 2001, INT CLASS FUNCT DIS	43	5	5	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2014	28	3					328	335		10.3109/02699052.2013.865274			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AC0RI	WOS:000332202100010	24354522				2022-02-06	
J	Bilgin, S; Kose, N; Karakaya, J; Mut, M				Bilgin, S.; Kose, N.; Karakaya, J.; Mut, M.			Traumatic brain injury shows better functional recovery than brain tumor: a rehabilitative perspective	EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE			English	Article						Rehabilitation; Outcome assessment, health care; Brain neoplasms; Brain injuries	INPATIENT REHABILITATION; STROKE REHABILITATION; OUTCOMES; ASSOCIATION; PREDICTION; DISCHARGE; SEVERITY	Background. The similar symptoms seen in the brain tumor (BT) and traumatic brain injury (TBI) population. However, functional comparisons between these two diagnostic groups have been limited. Aim. To compare functional outcomes in patients with supratentorial BT and TBI after early rehabilitation. Design. This was a retrospective database analysis. Setting. Patients admitted to an Acute Care Unit as impatient (Hacettepe Hospital, Ankara-Turkey). Population. The population included patients with BT and TBI. Methods. Thirty-four patients with BT and TBI were matched one-to-one by lesion side and sex. The Barthel Index was used to assess functional status at the pre- and postrehabilitation. The change rate and efficiency in BI were also calculated. The time between injury onset and admission to rehabilitation (the onset to admission interval, OAT) and length of stay in rehabilitation (LOS rehab) were recorded. In addition, the influence of lesion side (left and right) and age on functional outcome were analyzed. Results. The functional level was significantly lower in TBI patients than in patients BT before rehabilitation (P<0.05). The post-rehabilitation BI score was similar in patients with BT and TBI (P>0.05). Patients with TBI had greater the change rate and efficiency in BI (P<0.05). The OAT and LOS rehab was longer in patients with TBI (P<0.05). In terms of lesion side comparisons, no differences were found (P>0.05). The age had no effect on functional outcome in patients with TBI and BT (P>0.05), expect the age group 45-59 (P<0.05). Conclusion. The early rehabilitation program improved functional ability of patients with brain tumors, as well as patients with traumatic brain injury Despite the lower functional status, patients with TBI displayed better functional recovery than patients with BT. Lesion side had no effect on functional outcome in patients with TBI and BT. Differences in functional status begin to appear even in patients with TBI between 45 and 59 years. Further investigations with more detailed outcome instruments are required to better understand the qualitative limitations of a patient's recovery.	[Bilgin, S.; Kose, N.] Hacettepe Univ, Fac Hlth Sci, Dept Physiotherapy & Rehabil, Ankara, Turkey; [Karakaya, J.] Hacettepe Univ, Fac Med, Dept Biostat, TR-06100 Ankara, Turkey; [Mut, M.] Hacettepe Univ, Fac Med, Dept Neurosurg, TR-06100 Ankara, Turkey		Bilgin, S (corresponding author), Hacettepe Univ, Fac Hlth Sci, Dept Phys Therapy & Rehabil, TR-06100 Samanpazari Ankara, Turkey.	sevilcuvalci@yahoo.com	Mut, Melike/E-9938-2013	Mut, Melike/0000-0002-9601-9907			Al-Jarrah MD, 2009, NEUROSCIENCES, V14, P41; ANTONELLI M, 1994, CHEST, V105, P224, DOI 10.1378/chest.105.1.224; Aras MD, 2004, INT J REHABIL RES, V27, P257, DOI 10.1097/00004356-200412000-00001; Avesani R, 2011, EUR J PHYS REHAB MED, V47, P203; Bontke CF, 1996, PHYS MED REHABILITAT; Butcher JL, 1996, J TRAUMA, V41, P4, DOI 10.1097/00005373-199607000-00002; Chen I C, 2000, Chang Gung Med J, V23, P339; Cullen NK, 2009, PM&R, V1, P1069, DOI 10.1016/j.pmrj.2009.09.013; Garden FH, 1996, PHYS MED REHABILITAT; Geler-Kulcu D, 2009, J CLIN NEUROSCI, V16, P74, DOI 10.1016/j.jocn.2008.04.014; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; Holcomb JB, 2003, J AM COLL SURGEONS, V196, P549, DOI 10.1016/S1072-7515(02)01894-X; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; Huang ME, 2000, AM J PHYS MED REHAB, V79, P327, DOI 10.1097/00002060-200007000-00003; Huang ME, 2001, ARCH PHYS MED REHAB, V82, P1540, DOI 10.1053/apmr.2001.26613; JONGBLOED L, 1986, STROKE, V17, P765, DOI 10.1161/01.STR.17.4.765; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Landis SH, 1999, CA-CANCER J CLIN, V49, P8, DOI 10.3322/canjclin.49.1.8; Laufer Y, 2003, NEUROREHAB NEURAL RE, V17, P207, DOI 10.1177/0888439003259169; LEHMANN JF, 1975, ARCH PHYS MED REHAB, V56, P383; MAHONEY F I, 1965, Md State Med J, V14, P61; Mammi P, 2006, Eura Medicophys, V42, P17; Marciniak CM, 2001, ARCH PHYS MED REHAB, V82, P457, DOI 10.1053/apmr.2001.21862; Mukand JA, 2001, AM J PHYS MED REHAB, V80, P346, DOI 10.1097/00002060-200105000-00005; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; O'Dell MW, 1998, ARCH PHYS MED REHAB, V79, P1530, DOI 10.1016/S0003-9993(98)90414-2; Paolucci S, 2000, ARCH PHYS MED REHAB, V81, P695, DOI 10.1053/apmr.2000.5583; SAEKI S, 1994, ARCH PHYS MED REHAB, V75, P858, DOI 10.1016/0003-9993(94)90109-0; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Sherer M, 1997, CANCER, V80, P250, DOI 10.1002/(SICI)1097-0142(19970715)80:2<250::AID-CNCR13>3.3.CO;2-T; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tang V, 2008, J NEUROL, V255, P820, DOI 10.1007/s00415-008-0695-z; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430	33	5	5	1	6	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	1973-9087	1973-9095		EUR J PHYS REHAB MED	Eur. J. Phys. Rehabil. Med.	FEB	2014	50	1					17	23					7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	AI4GP	WOS:000336824000003	23558698				2022-02-06	
J	Kontos, P; Miller, KL; Colantonio, A; Cott, C				Kontos, Pia; Miller, Karen-Lee; Colantonio, Angela; Cott, Cheryl			Grief, Anger, and Relationality: The Impact of a Research-Based Theater Intervention on Emotion Work Practices in Brain Injury Rehabilitation	EVALUATION REVIEW			English	Article						client-centered care; relationality; interprofessional education; dementia; intimate partner violence; sexual orientation	INTIMATE PARTNER VIOLENCE; IMPAIRED SELF-AWARENESS; LONG-TERM-CARE; HEALTH-CARE; QUALITATIVE RESEARCH; PERFORMANCE; STRESS; SPACE; LABOR; PROFESSIONALS	Background: Therapeutic emotion work is performed by health care providers as they manage their own feelings as well as those of colleagues and patients as part of efforts to improve the physical and psychosocial health outcomes of patients. It has yet to be examined within the context of traumatic brain injury rehabilitation. Objective: To evaluate the impact of a research-based theater intervention on emotion work practices of neurorehabilitation staff. Research Design: Data were collected at baseline and at 3 and 12 months postintervention in the inpatient neurorehabilitation units of two rehabilitation hospitals in central urban Canada. Subjects: Participants (N = 33) were recruited from nursing, psychology, allied health, recreational therapy, and chaplaincy. Measures: Naturalistic observations (N - 204.5 hr) of a range of structured and unstructured activities in public and private areas, and semistructured interviews (N = 87) were conducted. Results: Preintervention analysis indicated emotion work practices were characterized by stringent self-management of empathy, suppression of client grief, adeptness with client anger, and discomfort with reactions of family and spouses. Postintervention analysis indicated significant staff changes in a relationality orientation, specifically improvements in outreach to homosexual and heterosexual family care partners, and support for sexual orientation and intimacy expression. No improvements were demonstrated in grief support. Conclusion: Emotion work has yet to be the focus of initiatives to improve neurorehabilitative care. Our findings suggest the dramatic arts are well positioned to improve therapeutic emotion work and effect cultures of best practice. Recommendations are made for interprofessional educational initiatives to improve responses to client grief and potential intimate partner violence.	[Kontos, Pia; Miller, Karen-Lee; Colantonio, Angela; Cott, Cheryl] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON M5G 2A2, Canada; [Kontos, Pia; Miller, Karen-Lee] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Cott, Cheryl] Univ Toronto, Dept Phys Therapy, Toronto, ON, Canada		Kontos, P (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, 550 Univ Ave,Suite 11-171, Toronto, ON M5G 2A2, Canada.	pia.kontos@uhn.ca		Miller, Karen-Lee/0000-0001-7583-6724; Colantonio, Angela/0000-0003-2094-4765; Kontos, Pia/0000-0002-8893-2544	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [87726-1, 86624-1] Funding Source: Medline		Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; Banja J. D., 1993, J HEAD TRAUMA REHAB, V8, P116; Bartram T, 2012, J ADV NURS, V68, P1567, DOI 10.1111/j.1365-2648.2012.05968.x; Beck CT, 1996, J ADV NURS, V23, P992; Blackmer J., 2003, BMC MED ETHICS, P4; BONE D, 2002, INT J PUBLIC SECTOR, V0015, P00140, DOI DOI 10.1108/09513550210419564; Bowen G., 2008, INT J QUAL METH, V5, P12; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bryant RA, 2001, J NERV MENT DIS, V189, P109, DOI 10.1097/00005053-200102000-00006; Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; Carpenter K. N., 2008, PSYCHOL APPROACHES R, P17; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Coeling H V, 1996, Rehabil Nurs, V21, P7; Coetzer B. R., 2003, GRIEF MATTERS AUSTR, V6, P31; Colantonio A., 2008, J CONTIN EDUC HEALTH, V28, P1; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Crowe SF, 2008, BEHAV EMOTIONAL COMP; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Currah P, 2006, TRANSGENDER RIGHTS; Davidson J, 2004, SOC CULT GEOGR, V5, P523, DOI 10.1080/1464936042000317677; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Dewing J, 2008, INT J OLDER PEOPLE N, V3, P3, DOI 10.1111/j.1748-3743.2007.00103.x; Dingwall R, 2001, Nurs Inq, V8, P64, DOI 10.1046/j.1440-1800.2001.00100.x; Dupuis SL, 2014, THER RECREAT J, V48, P113; Dupuis SL, 2012, J AGING STUD, V26, P162, DOI 10.1016/j.jaging.2011.12.001; Dupuis SL, 2011, FAM RELAT, V60, P104, DOI 10.1111/j.1741-3729.2010.00636.x; Dyck I, 2005, CAN GEOGR-GEOGR CAN, V49, P233, DOI 10.1111/j.0008-3658.2005.00092.x; Farley M, 2004, VIOLENCE AGAINST WOM, V10, P1087, DOI 10.1177/1077801204268607; Farrer TJ, 2012, TRAUMA VIOLENCE ABUS, V13, P77, DOI 10.1177/1524838012440338; Fitzgerald RP, 2013, HUM REPROD, V28, P1289, DOI 10.1093/humrep/det051; Fogel C., 2007, GENDER FORUM ISSUE, V17, P1; Freeland J, 1996, MAGAZINE, V4, P32; Gold R., 1997, QUALITATIVE INQUIRY, V3, P387, DOI DOI 10.1177/107780049700300401; Grandey A, 2012, J OCCUP HEALTH PSYCH, V17, P1, DOI 10.1037/a0025102; Gray J, 2011, CAN THEATRE REV, V146, P66, DOI 10.3138/CTR.146.66; Gray RE, 2003, J CANCER EDUC, V18, P223, DOI 10.1207/s15430154jce1804_10; Gray Ross, 2000, Health Expect, V3, P137, DOI 10.1046/j.1369-6513.2000.00071.x; Hammell K.W., 2006, PERSPECTIVES DISABIL; Hochschild AR., 1983, MANAGED HEART COMMER; Holmes D, 2005, PERSPECT PSYCHIATR C, V41, P3, DOI 10.1111/j.0031-5990.2005.00007.x; Holmes Morgan, 2009, CRITICAL INTERSEX; Hunter B, 2001, J ADV NURS, V34, P436, DOI 10.1046/j.1365-2648.2001.01772.x; Jamieson Margaret, 2006, Can J Occup Ther, V73, P76; Jennett B, 1981, MANAGEMENT HEAD INJU; Jonas-Simpson C, 2012, J ADV NURS, V68, P1944, DOI 10.1111/j.1365-2648.2011.05877.x; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jumisko E., 2005, J NEUROSCIENCE NURSI, V37, P3; Karlawish JHT, 2003, NEW ENGL J MED, V348, P1389, DOI 10.1056/NEJMsb030172; Kawale R, 2004, SOC CULT GEOGR, V5, P565, DOI 10.1080/1464936042000317703; Kim E, 2002, NEUROREHABILITATION, V17, P297; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kontos, 2005, DEMENTIA-LONDON, V4, P553, DOI DOI 10.1177/1471301205058311; Kontos P., 2015, RETHINKING THEORY PR; Kontos P., 2006, THINKING DEMENTIA CU, P195; Kontos P.C., 2007, DEMENTIA, V6, P549, DOI DOI 10.1177/1471301207084394; Kontos PC, 2004, AGEING SOC, V24, P829, DOI 10.1017/S0144686X04002375; Kontos PC, 2003, J AGING STUD, V17, P151, DOI 10.1016/S0890-4065(03)00006-9; Kontos P, 2013, DEMENTIA-LONDON, V12, P288, DOI 10.1177/1471301213479787; Kontos PC, 2007, QUAL HEALTH RES, V17, P799, DOI 10.1177/1049732307302838; Kontos PC, 2012, DEMENTIA-LONDON, V11, P329, DOI 10.1177/1471301211421073; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; Kontos PC, 2010, INT J OLDER PEOPLE N, V5, P159, DOI 10.1111/j.1748-3743.2010.00221.x; Kontos PC, 2010, GERONTOLOGIST, V50, P352, DOI 10.1093/geront/gnp165; Kontos PC, 2009, SOCIOL HEALTH ILL, V31, P688, DOI 10.1111/j.1467-9566.2009.01158.x; Kontos PC, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-1; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; Kreutzer JS, 1997, J HEAD TRAUMA REHAB, V12, P63, DOI 10.1097/00001199-199712000-00006; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; Langlois J. A., 2008, BRAIN INJURY PROFESS, V5, P8; Law M, 1995, Can J Occup Ther, V62, P250; LECOMPTE MD, 1993, ETHNOGRAPHIC QUALITA; Lewis P, 2008, BRIT J MANAGE, V19, pS130, DOI 10.1111/j.1467-8551.2008.00578.x; Lincoln Yvonna S., 1985, NATURALISTIC INQUIRY; Maitra KK, 2006, AM J OCCUP THER, V60, P298, DOI 10.5014/ajot.60.3.298; Mann S, 2004, BRIT J GUID COUNS, V32, P205, DOI 10.1080/0369880410001692247; Mann Sandi, 2005, J Health Organ Manag, V19, P304; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McCreight BS, 2005, INT J NURS STUD, V42, P439, DOI 10.1016/j.ijnurstu.2004.07.004; McGrath J. C., 2008, PSYCHOL APPROACHES R, P260; McKeever P, 2002, QUAL HEALTH RES, V12, P1020, DOI 10.1177/104973202129120421; MCLAUGHLIN A M, 1992, Brain Injury, V6, P59, DOI 10.3109/02699059209008123; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MIENCZAKOWSKI J, 1993, BUSTING CHALLENGE DR; MIENCZAKOWSKI J, 1992, SYNCING OUT LOUD JOU; Miller K.L., 2000, CANADIAN WOMAN STUDI, V20, P115; Miller KL, 2008, J ADV NURS, V64, P332, DOI 10.1111/j.1365-2648.2008.04768.x; Miller KL, 2014, VIOLENCE VICTIMS, V29, P797, DOI 10.1891/0886-6708.VV-D-13-00056; Miller KL, 2013, J ADV NURS, V69, P1797, DOI 10.1111/jan.12041; Miller L., 1994, J COGNITIVE REHABILI, V12, P12; Mirchandani K, 2003, ORGAN STUD, V24, P721, DOI 10.1177/0170840603024005003; Miyata H., 2009, INT J QUAL METH, V8, P64, DOI DOI 10.1177/160940690900800106; Myles SM, 2004, INT J PSYCHOL PSYCHO, V4, P487; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Noelker LS, 2001, GENERATIONS, V25, P85; Nolan M., 2002, DEMENTIA, V1, P193, DOI DOI 10.1177/147130120200100206; Papadimitriou C, 2008, DISABIL REHABIL, V30, P365, DOI 10.1080/09638280701336306; Patton M.Q., 1990, QUALITATIVE EVALUATI; Pegg PO, 2005, REHABIL PSYCHOL, V50, P366, DOI 10.1037/0090-5550.50.4.366; PIERCE JL, 1995, GENDER TRIALS EMOTIO; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1991, AWARENESS DEFICIT BR, P111; Rafaeli A, 2001, SOC SCI INFORM, V40, P95, DOI 10.1177/053901801040001006; Robins Paul M, 2009, J Pediatr Nurs, V24, P270, DOI 10.1016/j.pedn.2008.03.007; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rossiter K, 2008, J HEALTH PSYCHOL, V13, P277, DOI 10.1177/1359105307086707; Roth P, 2000, Crit Care Nurs Q, V23, P14; Sanders T, 2005, GENDER WORK ORGAN, V12, P319, DOI 10.1111/j.1468-0432.2005.00276.x; Shapiro J, 2003, MED EDUC, V37, P922, DOI 10.1046/j.1365-2923.2003.01634.x; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherwin ED, 2000, BRAIN INJURY, V14, P267; Skjorshammer Morten, 2003, J Interprof Care, V17, P377, DOI 10.1080/13561820310001608203; Smith P., 2000, EMOTIONAL LABOUR NUR; Sohlberg MM, 1998, J HEAD TRAUMA REHAB, V13, P62, DOI 10.1097/00001199-199810000-00008; Spano R, 2005, SOC SCI RES, V34, P591, DOI 10.1016/j.ssresearch.2004.05.003; Sumsion Thelma, 2006, Can J Occup Ther, V73, P153; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Turk M. A., 2007, BRAIN INJURY MED PRI, P27; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wadman MC, 1999, AM J EMERG MED, V17, P689, DOI 10.1016/S0735-6757(99)90161-4; Wharton AS, 2009, ANNU REV SOCIOL, V35, P147, DOI 10.1146/annurev-soc-070308-115944; White I., 2002, CHALLENGE SEXUALITY, P243; Williams A, 2012, NURS EDUC TODAY, V32, P368, DOI 10.1016/j.nedt.2011.05.008; Wilson S. R., 2009, INTIMATE PARTNER VIO, P183; Wood RL, 2005, BRAIN INJURY, V19, P845, DOI 10.1080/02699050500058778	131	5	5	4	36	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0193-841X	1552-3926		EVALUATION REV	Eval. Rev.	FEB	2014	38	1					29	67		10.1177/0193841X14531260			39	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	AL7OL	WOS:000339323700002	24743646	Green Accepted, Green Submitted			2022-02-06	
J	Shuttleworth-Edwards, AB; Radloff, SE; Whitefield-Alexander, VJ; Smith, IP; Horsman, M				Shuttleworth-Edwards, Ann B.; Radloff, Sarah E.; Whitefield-Alexander, Victoria J.; Smith, Ian P.; Horsman, Mark			Practice Effects Reveal Visuomotor Vulnerability in School and University Rugby Players	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Concussion; Sport; Rugby Union; ImPACT test; Mild traumatic brain injury	SPORTS-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; COUNSELING PSYCHOMETRIC ISSUES; PROFESSIONAL SOCCER PLAYERS; COGNITIVE IMPAIRMENT; FOOTBALL PLAYERS; IMPACT ASSESSMENT; PROCESSING SPEED; CLINICAL UTILITY; CONTACT SPORTS	This article reports on three pre- versus post-season prospective studies in which male university and high school contact sport players predominantly of Rugby Union (hereafter rugby) were compared with age, education, and IQ equivalent non-contact sport controls on the ImPACT (Immediate Postconcussion Assessment and Cognitive Testing) test. All analyses revealed a relative absence of practice effects on the Visual Motor Speed (VMS) composite for contact sport groups compared with controls. The VMS data for rugby players from each study were pooled and subjected to additional analysis (Rugby, n 145; Controls, n 106). Controls revealed significant improvement over the season (p .001), whereas no learning effect was in evidence for rugby players whose performance remained the same (interaction effect, p .028). It is apparent that practice effects have diagnostic potential in this context, implicating vulnerability on speeded visuomotor processing in association with participation in rugby. Pointers for further research and concussion management in the individual case are explored.	[Shuttleworth-Edwards, Ann B.; Whitefield-Alexander, Victoria J.; Smith, Ian P.; Horsman, Mark] Rhodes Univ, Dept Psychol, ZA-6139 Grahamstown, South Africa; [Radloff, Sarah E.] Rhodes Univ, Dept Stat, ZA-6140 Grahamstown, South Africa		Shuttleworth-Edwards, AB (corresponding author), Rhodes Univ, Dept Psychol, ZA-6139 Grahamstown, South Africa.	a.edwards@ru.ac.za			Rhodes University Joint Research Council; National Research Foundation (NRF) [38206 551 105, 6956 551 306]	This research was supported by a Rhodes University Joint Research Council annual research grant and National Research Foundation (NRF) incentive funding (38206 551 105 and 6956 551 306, respectively).	Abdel-Khalek AM, 2006, SOC BEHAV PERSONAL, V34, P169, DOI 10.2224/sbp.2006.34.2.169; Autti T, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63019-X; Barth JT, 1989, MILD HEAD INJURY, P257; Brandt J, 2007, CLIN NEUROPSYCHOL, V21, P553, DOI 10.1080/13854040600770800; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Delaney JS, 2008, BRIT J SPORT MED, V42, P110, DOI 10.1136/bjsm.2007.037689; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Demakis GJ, 2006, CLIN NEUROPSYCHOL, V20, P10, DOI 10.1080/13854040500203282; Duff K, 2007, ARCH CLIN NEUROPSYCH, V22, P15, DOI 10.1016/j.acn.2006.08.013; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Dykiert D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045759; Echemendia RJ, 2009, BRIT J SPORT MED, V43, pI32, DOI 10.1136/bjsm.2009.058164; Farace E, 2003, J INT NEUROPSYCH SOC, V9, P207; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gardner A, 2010, EVOLUTION, V64, P25, DOI 10.1111/j.1558-5646.2009.00842.x; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Horsman M., 2010, THESIS RHODES U GRAH; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jordan A., 1997, THESIS RHODES U GRAH; Kelly JP, 1997, NEUROLOGY, V48, P581; Kibby MY, 1996, BRAIN INJURY, V10, P159, DOI 10.1080/026990596124494; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; KNIGHT RG, 1992, NEUROPSYCHOLOGY DEGE; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell M. R., 2004, IMPACT VERSION 3 0 C; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; Micheli L J, 1974, J Sports Med, V2, P93; Moser R. S., 2005, NEUROSURGERY, V17, P91; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Pettersen JA, 2000, PSYCHOBIOLOGY, V28, P81; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Randolph C, 2005, J ATHL TRAINING, V40, P139; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Savica R, 2012, MAYO CLIN PROC, V87, P335, DOI 10.1016/j.mayocp.2011.12.016; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J CLIN EXP NEUROPSYC, V34, P428, DOI 10.1080/13803395.2012.667789; Schatz P, 2011, CLIN NEUROPSYCHOL, V25, P1042, DOI 10.1080/13854046.2011.556669; Schnirring L, 2001, PHYSICIAN SPORTSMED, V29, P11; Shuttleworth-Edwards A, 2004, STUD NEUROPSYCHOL DE, P149; Shuttleworth-Edwards A. B., 2013, PSYCHOL ASSESSMENT S, P17; Shuttleworth-Edwards AB, 2002, BRIT J SPORT MED, V36, P473, DOI 10.1136/bjsm.36.6.473-a; Shuttleworth-Edwards AB, 2008, J CLIN EXP NEUROPSYC, V30, P870, DOI 10.1080/13803390701846914; Shuttleworth-Edwards AB, 2008, CLIN J SPORT MED, V18, P403, DOI 10.1097/JSM.0b013e3181895910; Shuttleworth-Edwards AB, 2011, CURR SPORT MED REP, V10, P391, DOI 10.1249/JSR.0b013e318237c0d4; Shuttleworth-Jordan AB, 1993, P 5 NAT NEUR C S AFR, P38; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; SHUTTLEWORTHEDW.AB, 2007, S AFR J SPORTS MED, V19, P32; ShuttleworthJordan AB, 1996, S AFR J PSYCHOL, V26, P96, DOI 10.1177/008124639602600205; Smith I., 2006, THESIS RHODES U GRAH; Solomon GS, 2011, CLIN SPORT MED, V30, P165, DOI 10.1016/j.csm.2010.09.002; Spear J, 1995, INT J GERIATR PSYCH, V10, P1011, DOI 10.1002/gps.930101203; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; Tales A, 2012, J ALZHEIMERS DIS, V32, P457, DOI 10.3233/JAD-2012-120505; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whitefield V., 2007, THESIS RHODES U GRAH; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	75	5	5	1	21	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	FEB	2014	29	1					86	99		10.1093/arclin/act061			14	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	AA1CA	WOS:000330832700010	23917347	Bronze			2022-02-06	
J	Vespa, PM				Vespa, Paul M.			Imaging and Decision-Making in Neurocritical Care	NEUROLOGIC CLINICS			English	Article						Traumatic brain injury; Imaging modalities; Central nervous system	TRAUMATIC BRAIN-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; FRAMELESS STEREOTACTIC ASPIRATION; DEEP INTRACEREBRAL HEMORRHAGE; IN-HOSPITAL MORTALITY; N-ACETYLASPARTATE; CT ANGIOGRAPHY	Critically ill neurologic patients are common in the hospital practice of neurology and are often in extreme states requiring accurate and specific information. Imaging, especially using advanced imaging techniques, can provide an important means of garnering this information. This article focuses on the clinical utilization of selective imaging methods that are commonly used in critically ill neurologic patients to render diagnoses, to monitor effects of treatment, or have contributed to a better understanding of pathophysiology in the intensive care unit.	Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA		Vespa, PM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, 757 Westwood Blvd,Room 6236A, Los Angeles, CA 90095 USA.	Pvespa@mednet.ucla.edu					Almandoz JED, 2012, J NEUROINTERV SURG, V4, P442, DOI 10.1136/neurintsurg-2011-010061; Almandoz JED, 2010, STROKE, V41, P54, DOI 10.1161/STROKEAHA.109.565382; Ariza M, 2004, ARCH NEUROL-CHICAGO, V61, P541, DOI 10.1001/archneur.61.4.541; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; BIRKEN DL, 1989, NEUROSCI BIOBEHAV R, V13, P23, DOI 10.1016/S0149-7634(89)80048-X; Brooks WM, 2001, J HEAD TRAUMA REHAB, V16, P149, DOI 10.1097/00001199-200104000-00005; Chun KA, 2010, J NEUROTRAUM, V27, P325, DOI 10.1089/neu.2009.1115; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P191, DOI 10.1097/01.WCB.0000100045.07481.DE; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Dankbaar JW, 2009, NEURORADIOLOGY, V51, P813, DOI 10.1007/s00234-009-0575-y; Demchuk AM, 2012, LANCET NEUROL, V11, P307, DOI 10.1016/S1474-4422(12)70038-8; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Gasparovic C, 2001, J NEUROTRAUM, V18, P241, DOI 10.1089/08977150151070856; GENTRY LR, 1994, RADIOLOGY, V191, P1; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Gofton TE, 2009, EXP NEUROL, V217, P320, DOI 10.1016/j.expneurol.2009.03.011; Gonen O, 2000, MAGN RESON IMAGING, V18, P1255, DOI 10.1016/S0730-725X(00)00221-6; Gonen O, 1998, MAGNET RESON MED, V40, P684, DOI 10.1002/mrm.1910400506; Greenberg ED, 2010, AM J NEURORADIOL, V31, P1853, DOI 10.3174/ajnr.A2246; Greenberg Edward D, 2011, Imaging Med, V3, P287; Greer D, 2011, NEUROCRIT CARE, V14, P61, DOI 10.1007/s12028-010-9457-8; Greer DM, 2013, J STROKE CEREBROVASC, V22, P899, DOI 10.1016/j.jstrokecerebrovasdis.2012.08.006; Holshouser BA, 2000, J MAGN RESON IMAGING, V11, P9, DOI 10.1002/(SICI)1522-2586(200001)11:1<9::AID-JMRI2>3.3.CO;2-Y; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Huynh TJ, 2013, STROKE, V44, P972, DOI 10.1161/STROKEAHA.111.000410; Ionita CC, 2008, NEUROCRIT CARE, V9, P8, DOI 10.1007/s12028-007-9029-8; Jarnum H, 2009, RESUSCITATION, V80, P425, DOI 10.1016/j.resuscitation.2009.01.004; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Miller CM, 2008, SURG NEUROL, V69, P441, DOI 10.1016/j.surneu.2007.12.016; Miller CM, 2007, NEUROCRIT CARE, V6, P22, DOI 10.1385/NCC:6:1:22; MOFFETT JR, 1991, NEUROREPORT, V2, P131, DOI 10.1097/00001756-199103000-00005; Nael K, 2008, AM J ROENTGENOL, V190, P389, DOI 10.2214/AJR.07.2297; Nael K, 2013, STROKE, V44, P664, DOI 10.1161/STROKEAHA.112.672956; OBRIST WD, 1990, CEREBROVAS BRAIN MET, V2, P283; Parnetti L, 1997, MECH AGEING DEV, V97, P9, DOI 10.1016/S0047-6374(97)01877-0; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Rutgers DR, 2003, STROKE, V34, P648, DOI 10.1161/01.STR.0000058158.41581.41; Sanelli PC, 2011, AM J NEURORADIOL, V32, P2047, DOI 10.3174/ajnr.A2693; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Sinson G, 2001, AM J NEURORADIOL, V22, P143; SKLAR EML, 1992, RADIOL CLIN N AM, V30, P353; TAYLOR DL, 1995, J NEUROCHEM, V65, P275; Vespa P, 2005, NEUROCRIT CARE, V2, P274, DOI 10.1385/NCC:2:3:274; Vespa P, 2004, BRAIN PATHOL, V14, P210, DOI 10.1111/j.1750-3639.2004.tb00055.x; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Villablanca JP, 2002, AM J NEURORADIOL, V23, P1187; Wada R, 2007, STROKE, V38, P1257, DOI 10.1161/01.STR.0000259633.59404.f3; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Xu YQ, 2010, J CEREBR BLOOD F MET, V30, P883, DOI 10.1038/jcbfm.2009.263	61	5	5	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	FEB	2014	32	1					211	+		10.1016/j.ncl.2013.07.010			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	278VI	WOS:000328917600010	24287391				2022-02-06	
J	Yuan, Q; Liu, H; Xu, Y; Wu, X; Sun, YR; Hu, J				Yuan, Qiang; Liu, Hua; Xu, Yang; Wu, Xing; Sun, Yirui; Hu, Jin			Continuous Measurement of the Cumulative Amplitude and Duration of Hyperglycemia Best Predicts Outcome After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Hyperglycemia; Traumatic brain injury; Mortality; Outcome; Continuous glucose monitoring system	INTENSIVE INSULIN THERAPY; INTRACRANIAL HYPERTENSION; GLYCEMIC CONTROL; GLUCOSE VALUES; IMPACT	This study aimed to assess the accuracy and utility of high-resolution continuous glucose recording in patients with traumatic brain injury (TBI) and to establish whether a relationship exists between the cumulative amplitude and duration of hyperglycemia and outcome after TBI. Glucose data for 56 TBI patients were collected continuously at 5-min intervals. The degree and duration of hyperglycemia above treatment thresholds were calculated as "glucose times time dose" (GTD; mg/dL d) using continuous recordings (GTD) for early stage (first 3 days). Long-term neurological functional outcome was assessed using the extended Glasgow Outcome Scale (GOSE). Receiver operating characteristic (ROC) curves were constructed to determine the predictive values of GTD, percentage readings, mean, and range of glucose for in-hospital mortality and GOSE. All measurements of GTD were statistically significantly higher in the group that died. GTD of glucose > 150 and glucose > 180 had a high-predictive power for in-hospital mortality (areas under the ROC curve [AUC] = 0.917; 95 % CI, 0.837-0.998 and 0.876; 95 % CI, 0.784-0.967, respectively) and demonstrated significantly higher predictive power for mortality when compared with %reading > 150 and %reading > 180, respectively (p < 0.05). GTD of glucose > 150 also had a significantly higher predictive power for mortality than mean glucose and range of glucose. GTD of glucose > 150 and glucose > 180 also had a high-predictive power for poor outcome (areas under the ROC curve [AUC] = 0.913; 95 % CI, 0.843-0.983 and 0.858; 95 % CI, 0.760-0.956, respectively). Continuous collection of glucose recordings is more reliable and accurate than routine discontinuous recordings. Assessing both the duration and the amplitude of the episodes using continuous collection of glucose data helps in better predicting outcomes than the total duration of episodes.	[Yuan, Qiang] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Neurosurg, Shanghai 200030, Peoples R China; [Liu, Hua] Jiangsu Univ, Peoples Hosp Kunshan 1, Dept Neurosurg, Suzhou, Peoples R China; [Xu, Yang] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Wu, Xing; Sun, Yirui; Hu, Jin] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China		Hu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Wulumuqizhong Rd 12, Shanghai 200433, Peoples R China.	277089712@qq.com					Allen HF, 2008, PEDIATR CRIT CARE ME, V9, P153, DOI 10.1097/PCC.0b013e3181668b33; Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Brunkhorst FM, 2008, NEW ENGL J MED, V358, P125, DOI 10.1056/NEJMoa070716; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Corstjens AM, 2006, CRIT CARE, V10, P178; De Block C, 2006, DIABETES CARE, V29, P1750, DOI 10.2337/dc05-2353; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gale SC, 2007, AM SURGEON, V73, P454; Goldberg Philip A, 2004, Diabetes Technol Ther, V6, P339, DOI 10.1089/152091504774198034; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kahraman S, 2010, J TRAUMA, V69, P110, DOI 10.1097/TA.0b013e3181c99853; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Mastrototaro J J, 2000, Diabetes Technol Ther, V2 Suppl 1, pS13, DOI 10.1089/15209150050214078; Matsushima K, 2012, J CRIT CARE, V27, P125, DOI 10.1016/j.jcrc.2011.08.012; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Piper HG, 2006, PEDIATRICS, V118, P1176, DOI 10.1542/peds.2006-0347; Preiser JC, 2001, INTENS CARE MED, V35, P1738; Salim A, 2009, AM SURGEON, V75, P25; Souba WW, 1997, NEW ENGL J MED, V336, P41, DOI 10.1056/NEJM199701023360107; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vespa P, 2006, CRIT CARE MED, V34, P850, DOI 10.1097/01.CCM.0000201875.12245.6F; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wahl WL, 2008, J TRAUMA, V65, P42, DOI 10.1097/TA.0b013e318176c54e; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	29	5	5	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2014	20	1					69	76		10.1007/s12028-012-9730-0			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AB2RI	WOS:000331639400010	22810485				2022-02-06	
J	Yu, CG; Singh, R; Crowdus, C; Raza, K; Kincer, J; Geddes, JW				Yu, C. G.; Singh, R.; Crowdus, C.; Raza, K.; Kincer, J.; Geddes, J. W.			FENBENDAZOLE IMPROVES PATHOLOGICAL AND FUNCTIONAL RECOVERY FOLLOWING TRAUMATIC SPINAL CORD INJURY	NEUROSCIENCE			English	Article						pathogenic autoantibody; locomotor function; traumatic injury	BLOOD-BRAIN-BARRIER; IMMUNE-RESPONSE; ADULT-RAT; SYSTEM; MICE; BENZIMIDAZOLES; AUTOANTIBODIES; INHIBITION; COLCHICINE; APOPTOSIS	During a study of spinal cord injury (SCI), mice in our colony were treated with the anthelmintic fenbendazole to treat pinworms detected in other mice not involved in the study. As this was not part of the original experimental design, we subsequently compared pathological and functional outcomes of SCI in female C57BL/6 mice who received fenbendazole (150 ppm, 8 mg/kg body weight/day) for 4 weeks prior to moderate contusive SCI (50 kdyn force) as compared to mice on the same diet without added fenbendazole. The fenbendazole-treated mice exhibited improved locomotor function, determined using the Basso mouse scale, as well as improved tissue sparing following contusive SCI. Fenbendazole may exert protective effects through multiple possible mechanisms, one of which is inhibition of the proliferation of B lymphocytes, thereby reducing antibody responses. Autoantibodies produced following SCI contribute to the axon damage and locomotor deficits. Fenbendazole pretreatment reduced the injury-induced CD45R-positive B cell signal intensity and IgG immunoreactivity at the lesion epicenter 6 weeks after contusive SCI in mice, consistent with a possible effect on the immune response to the injury. Fenbendazole and related benzimadole antihelmintics are FDA approved, exhibit minimal toxicity, and represent a novel group of potential therapeutics targeting secondary mechanisms following SCI. (C) 2013 Published by Elsevier Ltd. on behalf of IBRO.	[Yu, C. G.; Singh, R.; Crowdus, C.; Raza, K.; Geddes, J. W.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Yu, C. G.; Singh, R.; Crowdus, C.; Geddes, J. W.] Univ Kentucky, Coll Med, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Kincer, J.] Univ Kentucky, Coll Med, Div Lab Anim Resources, Lexington, KY 40536 USA		Yu, CG (corresponding author), Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Dept Anat & Neurobiol, B465,Biomed & Biol Sci Res Bldg BBSRB,741 S Limes, Lexington, KY 40536 USA.	cyu4@uky.edu; ranjana.singh@uky.edu; cacrow3@uky.edu; rkashif79@hotmail.com; jfkinc2@email.uky.edu; jgeddes@uky.edu			KSCHIRT [7-6A, 11-19A]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 NS051220]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS051220, T32NS077889] Funding Source: NIH RePORTER	This research was supported by grants from KSCHIRT#7-6A and 11-19A, and NIH P30 NS051220. We thank Linda Simmerman for expert assistance with microscopy and imaging. The authors declare no conflict-of-interests.	Ankeny DP, 2010, TRENDS IMMUNOL, V31, P332, DOI 10.1016/j.it.2010.06.006; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; CABAJ W, 1994, NEW ZEAL VET J, V42, P216, DOI 10.1080/00480169.1994.35826; Cai YP, 2009, IMMUNOL CELL BIOL, V87, P623, DOI 10.1038/icb.2009.47; CAMPBELL WC, 1990, PARASITOL TODAY, V6, P130, DOI 10.1016/0169-4758(90)90231-R; Carvey PM, 2009, J NEUROCHEM, V111, P291, DOI 10.1111/j.1471-4159.2009.06319.x; Colburn RW, 1999, BRAIN RES BULL, V49, P419; Cray C, 2008, J AM ASSOC LAB ANIM, V47, P32; Crittenden DB, 2012, J RHEUMATOL, V39, P1458, DOI 10.3899/jrheum.111533; Cumino AC, 2009, PARASITOL INT, V58, P270, DOI 10.1016/j.parint.2009.03.005; Fehlings MG, 2010, J CLIN IMMUNOL, V30, pS109, DOI 10.1007/s10875-010-9404-7; FRIEDMAN PA, 1978, BIOCHIM BIOPHYS ACTA, V544, P605, DOI 10.1016/0304-4165(78)90334-3; Fuchs R, 1993, WHO TECHN REP SER, V832; Gadad BS, 2010, J AM ASSOC LAB ANIM, V49, P821; GIULIAN D, 1990, ANN NEUROL, V27, P33, DOI 10.1002/ana.410270107; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; JASRA N, 1990, VET PARASITOL, V35, P201, DOI 10.1016/0304-4017(90)90055-G; LACEY E, 1990, PARASITOL TODAY, V6, P112, DOI 10.1016/0169-4758(90)90227-U; Landin AM, 2009, J AM ASSOC LAB ANIM, V48, P251; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Magnuson DSK, 2005, J NEUROTRAUM, V22, P529, DOI 10.1089/neu.2005.22.529; Onifer SM, 2005, EXP NEUROL, V192, P25, DOI 10.1016/j.expneurol.2004.10.016; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Ramp AA, 2010, LAB ANIM-UK, V44, P271, DOI 10.1258/la.2010.009148; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; REISS CS, 1987, LAB ANIM SCI, V37, P773; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Saltzman JW, 2013, J NEUROTRAUM, V30, P434, DOI 10.1089/neu.2012.2501; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Spagnuolo PA, 2010, BLOOD, V115, P4824, DOI 10.1182/blood-2009-09-243055; Yu CG, 2007, NEUROCHEM RES, V32, P2046, DOI 10.1007/s11064-007-9347-4; Yu CG, 2010, J NEUROCHEM, V113, P131, DOI 10.1111/j.1471-4159.2010.06579.x; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013; Zhang Y, 2011, DISCOV MED, V11, P395	41	5	6	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JAN 3	2014	256						163	169		10.1016/j.neuroscience.2013.10.039			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	300SY	WOS:000330485500016	24183965	Green Accepted			2022-02-06	
J	Acres, MJ; Morris, JA				Acres, Meghan J.; Morris, James A.			The pathogenesis of retinal and subdural haemorrhage in non-accidental head injury in infancy: Assessment using Bradford Hill criteria	MEDICAL HYPOTHESES			English	Article							SHAKEN BABY SYNDROME; HYPOXIC-ISCHEMIC ENCEPHALOPATHY; LIFE-THREATENING EVENTS; BRAIN-INJURY; YOUNG-CHILDREN; TRAUMA; NEUROPATHOLOGY; PATTERNS; SHAKING; DEATHS	Fatal non-accidental head injury (NAHI) in infancy is characterised by severe bilateral retinal haemorrhage (sbRH), thin film diffuse bilateral subdural haemorrhage (dbSDH) and severe fatal hypoxic ischaemic encephalopathy (sfHIE). The Geddes hypothesis is that sfHIE is the direct cause of sbRH and dbSDH. The conventional hypothesis (post-Geddes) is that trauma precipitates hypoxia to cause sfHIE and independently tears veins to cause sbRH and dbSDH. These hypotheses are assessed using Bradford Hill criteria of causation. The triad (sbRH, dbSDH and sfHIE) is a strong, specific and consistent association which suggests a causative link. Furthermore sbRH and dbSDH are positively correlated with severity of HIE but negatively correlated with objective evidence of trauma. The conventional hypothesis (post-Geddes) fails the test of biological plausibility because trauma causes asymmetrical and focal bleeding not diffuse bilateral capillary and venular oozing. The conventional hypothesis lacks coherence since it was shown that the encephalopathy of the triad is not traumatic. Arguments by analogy also support the Geddes hypothesis. There is a paucity of experimental evidence for either hypothesis but this is likely to be rectified as molecular methods (genomics and proteomics) are used in the infant autopsy. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.	[Acres, Meghan J.] Univ Lancaster, Fac Hlth & Med, Lancaster LA1 4YW, England; [Morris, James A.] Univ Hosp Morecambe Bay NHS Fdn Trust, Royal Lancaster Infirm, Lancaster LA1 4RP, England		Morris, JA (corresponding author), Royal Lancaster Infirm, Lancaster LA1 4RP, England.	Jim.A.Morris@mbht.nhs.uk		Morris, James/0000-0001-7713-0004			Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Bradford Hill A., 1965, B WORLD HEALTH ORGAN, V58, P295; Byard RW, 2007, PEDIATR DEVEL PATHOL, V10, P348, DOI 10.2350/06-08-0154.1; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Cohen MC, 2009, PEDIATR DEVEL PATHOL, V12, P169, DOI 10.2350/08-08-0509.1; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; De Gruchy GC, 1970, CLIN HAEMATOLOGY MED, P616; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Finnie JW, 2012, J CLIN NEUROSCI, V19, P1159, DOI 10.1016/j.jocn.2011.12.019; Fleming P, 2000, SUDDEN UNEXPECTED DE; Geddes JF, 2004, FORENSIC SCI INT, V146, P83, DOI 10.1016/S0379-0738(03)00283-4; Geddes JF, 2003, NEUROPATH APPL NEURO, V29, P14, DOI 10.1046/j.1365-2990.2003.00434.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; Hymel KP, 1997, PEDIATRICS, V99, P371, DOI 10.1542/peds.99.3.371; Jaspan T, 2008, PEDIATR RADIOL, V38, pS378, DOI 10.1007/s00247-008-0896-8; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Krous HF, 2008, FORENSIC SCI INT, V176, P209, DOI 10.1016/j.forsciint.2007.09.009; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; McGovern MC, 2004, ARCH DIS CHILD, V89, P1043, DOI 10.1136/adc.2003.031740; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; Morris JA, 2011, FORENSIC PATHOL REV, V6, P121, DOI 10.1007/978-1-61779-249-6_6; Poets CF, 1999, PEDIATR RES, V45, P350, DOI 10.1203/00006450-199903000-00010; POETS CF, 1993, J PEDIATR-US, V123, P693, DOI 10.1016/S0022-3476(05)80842-X; Punt J, 2004, Pediatr Rehabil, V7, P173, DOI 10.1080/13638490410001711515; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; Scheimberg I, 2013, PEDIATR DEVEL PATHOL, V16, P149, DOI 10.2350/12-08-1232-OA.1	29	5	5	0	9	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	JAN	2014	82	1					1	5		10.1016/j.mehy.2013.09.017			5	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	295WZ	WOS:000330148400001	24139052	hybrid			2022-02-06	
J	Crandall, M; Rink, RA; Shaheen, AW; Butler, B; Unger, E; Zollman, FS				Crandall, Marie; Rink, Richard A.; Shaheen, Aisha Waris; Butler, Bennett; Unger, Erin; Zollman, Felise S.			Patterns and predictors of follow-up in patients with mild traumatic brain injury	BRAIN INJURY			English	Article						Concussion; costs; demographics; insurance; mild traumatic brain injury; traumatic brain injury	CLINICAL MANAGEMENT; CONCUSSION	Background: This study was undertaken to identify factors that influence follow-up for patients with mild traumatic brain injury (MTBI). Methods: One hundred and ninety-nine consecutive inpatients diagnosed with MTBI at a Trauma Centre (or TC) were monitored for establishment of care with a brain injury specialist after discharge. Bivariate statistics were calculated to determine subject characteristics impacting the decision to pursue TBI-related specialty care. Results: One hundred and nineteen patients (59.8%) followed up with the TC for routine post-injury care. Patients who followed up were older (age >40: OR=2.48, p=0.01, 95% CI=1.03-8.96) and had longer hospital lengths of stay (LOS>3 days: OR=2.99, p<0.001, 95% CI=1.33-7.67). Upon follow-up, providers identified 20 patients (16.8%) with persistent neurologic symptoms, seven (3.5%) of whom saw a brain injury specialist. Lack of insurance significantly decreased the likelihood of follow-up with the TC and/or establishment of care with a TBI specialist. (OR=0.76, p=0.01, 95% CI=0.62-0.95). Conclusions: Being insured was strongly predictive for follow-up at the TC and for establishing with a brain injury specialist post-MTBI. The TC post-injury visit identified MTBI patients with persistent symptoms, suggesting post-acute TC follow-up is an important venue for MTBI sequelae screening and referral.	[Crandall, Marie; Rink, Richard A.; Butler, Bennett; Unger, Erin] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Shaheen, Aisha Waris] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Gen Surg, Bronx, NY 10467 USA; [Zollman, Felise S.] NorthShore Univ HealthSyst, Dept Neurol, Glenview, IL 60026 USA		Zollman, FS (corresponding author), NorthShore Univ HealthSyst, Dept Neurol, 2180 Pfingston Rd, Glenview, IL 60026 USA.	felzol@rcn.com	Crandall, Marie/L-9066-2019	Crandall, Marie/0000-0002-6536-3123			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Congeni Joseph, 2009, Adolesc Med State Art Rev, V20, P41; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Evans RW, 1999, TXB CLIN NEUROLOGY, P1039; Finkelstein E., 2006, INCIDENCE EC BURDEN; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Olver John, 2005, Aust Fam Physician, V34, P269; Patel DR, 2010, PEDIATR CLIN N AM, V57, P649, DOI 10.1016/j.pcl.2010.03.006; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sosin DM, 1996, BRAIN INJURY, V10, P47; Weight DG, 1998, PSYCHIAT CLIN N AM, V21, P609, DOI 10.1016/S0193-953X(05)70026-5; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298	22	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1359	1364		10.3109/02699052.2014.919533			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200001	24945097				2022-02-06	
J	Grandinette, S				Grandinette, Sharon			Supporting students with brain tumors in obtaining school intervention services: The clinician's role from an educator's perspective	JOURNAL OF PEDIATRIC REHABILITATION MEDICINE			English	Article						Pediatric; brain tumors; CNS tumors; clinician; physician; allied health personnel; education; school reintegration; intervention; traumatic brain injury; IDEA: Individuals with Disabilities Education Act; IEP: Individual Education Plan; 504 Accommodation Plan		With an increase in the number of pediatric patients surviving the diagnosis and treatment of brain tumors, many children are returning to school with an alteration in their physical, cognitive, and social-emotional functioning and thus requiring school intervention or services. Physicians and clinicians in hospital and rehabilitation settings serving this population can play a key role in communicating the medical and functional needs these children present as a result of diagnosis and treatment as they transition to an educational setting. Medical and allied health personnel can best support successful school transition when they are aware of the information schools require in order to open the door for students to easily access the interventions, supports, and services available through 504 Accommodation Plans and special education supports and services under the Individuals with Disabilities Education Act. Clear communication between medical and school personnel is vital in improving educational, social, and vocational outcomes for students with brain tumors. A streamlined approach to accomplish this task is offered for consideration.	[Grandinette, Sharon] Acquired Traumat Brain Injury Educ Serv, 326 Via San Sebastian, Redondo Beach, CA 90277 USA		Grandinette, S (corresponding author), Acquired Traumat Brain Injury Educ Serv, 326 Via San Sebastian, Redondo Beach, CA 90277 USA.	Shargrand@aol.com					Anderson DM, 2001, CANCER-AM CANCER SOC, V92, P2709, DOI 10.1002/1097-0142(20011115)92:10<2709::AID-CNCR1625>3.0.CO;2-D; [Anonymous], 2001, FREQ ASK QUEST SECT; Barrera M, 2005, CANCER-AM CANCER SOC, V104, P1751, DOI 10.1002/cncr.21390; Bhat SR, 2005, J CLIN ONCOLOGY, V23; Butler RW, 2006, MENT RETARD DEV D R, V12, P184, DOI 10.1002/mrdd.20110; Clark E., 1997, CHILDHOOD TRAUMATIC, P191; Cohen S. B., 1986, J HEAD TRAUMA REHAB, V1, P22; DUFFNER PK, 1991, PEDIATR NEUROL, V7, P237, DOI 10.1016/0887-8994(91)90038-M; Ellenberg L, 2009, NEUROPSYCHOLOGY, V23, P705, DOI 10.1037/a0016674; GOLD EB, 1979, ANN NEUROL, V5, P569, DOI 10.1002/ana.410050613; Goldberg D., 2011, DISABILITY CATEGORIE; Heller K. W, 2009, UNDERSTANDING PHYS H; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; JOHNSON DL, 1994, J NEUROSURG, V80, P1004, DOI 10.3171/jns.1994.80.6.1004; Litzelman K, 2011, QUAL LIFE RES, V20, P1261, DOI 10.1007/s11136-011-9854-2; Packer RJ, 2003, J CLIN ONCOL, V21, P3255, DOI 10.1200/JCO.2003.01.202; Pierangelo R., 2007, SPECIAL ED ELIGIBILI; RIES LAG, 1975, SEER CANC STAT REV; Savage R. C., 2003, BRAIN INJ SOURCE, V6, P8; Savage RC, 1997, J HEAD TRAUMA REHAB, V12, P11, DOI 10.1097/00001199-199704000-00003; Schultz KAP, 2007, J CLIN ONCOL, V25, P3649, DOI 10.1200/JCO.2006.09.2486; Shiminski-Maher T, 2002, CHILDHOOD BRAIN SPIN; Talk About Curing Autism, 2010, HOM ED STAT STAT COM; Todis B., 2007, BRAIN INJURY PROFESS, V3, P33; Ylvisaker M, 1998, TRAUMATIC BRAIN INJU, P369; Ylvisaker M, 1991, J HEAD TRAUMA REHAB, V6, P10, DOI DOI 10.1097/00001199-199103000-00006; Zebrack BJ, 2004, J CLIN ONCOL, V22, P999, DOI 10.1200/JCO.2004.06.148; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	28	5	5	1	6	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1874-5393	1875-8894		J PEDIATR REHAB MED	J. Pediatr. Rehab. Med.		2014	7	4					307	321		10.3233/PRM-140301			15	Pediatrics	Emerging Sources Citation Index (ESCI)	Pediatrics	VG7KY	WOS:000448284800004	25547883				2022-02-06	
J	Jing, GJ; Yao, XT; Li, YY; Xie, YT; Li, WA; Liu, KJ; Jing, YC; Li, BS; Lv, YF; Ma, BX				Jing, Guojie; Yao, Xiaoteng; Li, Yiyi; Xie, Yituan; Li, Wang'an; Liu, Kejun; Jing, Yingchao; Li, Baisheng; Lv, Yifan; Ma, Baoxin			Mild hypothermia for treatment of diffuse axonal injury: a quantitative analysis of diffusion tensor imaging	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injury; mild hypothermia; diffuse axonal injury; diffusion tensor imaging; region of interest; fractional anisotropy; modified Rankin scale; the Natural Science Foundation of Guangdong Province in China; neural regeneration	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; MODERATE HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; METABOLISM; STROKE; ADULTS; MODEL	Fractional anisotropy values in diffusion tensor imaging can quantitatively reflect the consistency of nerve fibers after brain damage, where higher values generally indicate less damage to nerve fibers. Therefore, we hypothesized that diffusion tensor imaging could be used to evaluate the effect of mild hypothermia on diffuse axonal injury. A total of 102 patients with diffuse axonal injury were randomly divided into two groups: normothermic and mild hypothermic treatment groups. Patient's modified Rankin scale scores 2 months after mild hypothermia were significantly lower than those for the normothermia group. The difference in average fractional anisotropy value for each region of interest before and after mild hypothermia was 1.32-1.36 times higher than the value in the normothermia group. Quantitative assessment of diffusion tensor imaging indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury.	[Jing, Guojie; Yao, Xiaoteng; Li, Yiyi; Xie, Yituan; Li, Wang'an; Liu, Kejun; Jing, Yingchao; Lv, Yifan; Ma, Baoxin] Huizhou First Peoples Hosp, Dept Neurosurg, Huizhou, Guangdong, Peoples R China; [Jing, Guojie; Yao, Xiaoteng; Li, Yiyi; Xie, Yituan; Li, Wang'an; Liu, Kejun; Jing, Yingchao; Lv, Yifan; Ma, Baoxin] Huizhou Neurosurg Inst, Huizhou, Guangdong, Peoples R China; [Li, Baisheng] Huizhou Cent Peoples Hosp, Dept Neurosurg, Huizhou, Guangdong, Peoples R China		Jing, GJ (corresponding author), Huizhou First Peoples Hosp, Dept Neurosurg, Huizhou, Guangdong, Peoples R China.	jingguojie888@163.com			Natural Science Foundation of Guangdong Province in ChinaNational Natural Science Foundation of Guangdong Province [10151600101000002]	This study was supported by the Natural Science Foundation of Guangdong Province in China, No. 10151600101000002.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BURN JPS, 1992, STROKE, V23, P438, DOI 10.1161/str.23.3.438b; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Edwards P, 2005, LANCET, V365, P1957; Gal R, 2002, CLIN NEUROL NEUROSUR, V104, P318, DOI 10.1016/S0303-8467(02)00023-9; Gancia P, 2010, Minerva Pediatr, V62, P173; Geeraerts T, 2009, ANN FR ANESTH, V28, P339, DOI 10.1016/j.annfar.2009.02.016; Ghandehari K, 2012, ARYA ATHEROSCLER, V8, P153; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gulani V, 2006, J NEURO-OPHTHALMOL, V26, P51, DOI 10.1097/01.wno.0000205978.86281.3e; Hilton G, 1995, J Trauma Nurs, V2, P7; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Jang SH, 2010, NEUROREHABILITATION, V27, P367, DOI 10.3233/NRE-2010-0621; JENNETT B, 1977, LANCET, V1, P878; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kobbe P, 2009, UNFALLCHIRURG, V112, P1055, DOI 10.1007/s00113-009-1711-1; Kovacs Eniko, 2011, Orvosi Hetilap, V152, P171, DOI 10.1556/OH.2011.29006; Lee JE, 2005, J NEUROSURG, V103, P289, DOI 10.3171/jns.2005.103.2.0289; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Markgraf CG, 2001, J NEUROSURG, V95, P979, DOI 10.3171/jns.2001.95.6.0979; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; Sasaki T, 2010, ARTIF ORGANS, V34, P980, DOI 10.1111/j.1525-1594.2010.01131.x; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; SINARD JM, 1992, J APPL PHYSIOL, V72, P2428, DOI 10.1152/jappl.1992.72.6.2428; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Zhi DS, 2003, SURG NEUROL, V59, P381, DOI 10.1016/S0090-3019(03)00148-4	34	5	5	0	6	SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES	SHENYANG	PO BOX 1234, SHENYANG, LIAONING 110004, PEOPLES R CHINA	1673-5374			NEURAL REGEN RES	Neural Regen. Res.	JAN	2014	9	2					190	197		10.4103/1673-5374.125348			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	AB0MX	WOS:000331487700010	25206800	gold, Green Submitted, Green Published			2022-02-06	
J	Karumbaiah, L; Saxena, T; Betancur, M; Bellamkonda, RV				Karumbaiah, Lohitash; Saxena, Tarun; Betancur, Martha; Bellamkonda, Ravi V.			Chondroitin Sulfate Glycosaminoglycans for CNS Homeostasis-Implications for Material Design	CURRENT MEDICINAL CHEMISTRY			English	Article						Biomaterials; CNS deficits; CSPG; glycosaminoglycans; regenerative medicine	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ACETYLGALACTOSAMINE 4-SULFATE 6-O-SULFOTRANSFERASE; ASTROCYTE-ENDOTHELIAL INTERACTIONS; TYROSINE PHOSPHATASE-ZETA/BETA; PROMOTES FUNCTIONAL RECOVERY; HIGH-DOSE METHYLPREDNISOLONE; LEUCINE-RICH PROTEOGLYCANS	Chondroitin sulfate proteoglycans (CSPGs) are complex biomolecules that are known to facilitate patterning of axonal direction and cell migration during the early growth and development phase of the mammalian central nervous system (CNS). In adults, they continue to control neuronal plasticity as major constituents of the "peri-neuronal nets" (PNNs) that surround adult CNS neurons. CSPGs are also barrier-forming molecules that are selectively upregulated by invading reactive astroglia after injury to the CNS, and are responsible for the active repulsion of regenerating neurons post-injury. Recent evidence however suggests that the diverse sulfated glycosaminoglycan (GAG) side chains attached to CSPGs are key components that play paradoxical roles in influencing nerve regeneration post-injury to the CNS. Sulfated GAG repeats attached to the CSPG core protein help mediate cell migration, neuritogenesis, axonal pathfinding, and axonal repulsion by directly trapping and presenting a whole host of growth factors to cells locally, or by binding to specific membrane bound proteins on the cell surface to influence cellular function. In this review, we will present the current gamut of interventional strategies used to bridge CNS deficits, and discuss the potential advantages of using sulfated GAG based biomaterials to facilitate the repair and regeneration of the injured CNS.	[Karumbaiah, Lohitash; Betancur, Martha] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA; [Saxena, Tarun; Bellamkonda, Ravi V.] Emory Univ, Sch Med, Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA		Karumbaiah, L (corresponding author), Univ Georgia, Edgar L Rhodes Ctr Anim & Dairy Sci, Regenerat Biosci Ctr, Athens, GA 30602 USA.	lohitash@uga.edu; ravi@gatech.edu		Karumbaiah, Lohitash/0000-0001-7969-417X	Emory/University of Georgia; Georgia Institute of Technology/Emory University Regenerative Engineering and Medicine Center; University of Georgia Athletic Association; National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR00454]	We would like to acknowledge the Emory/University of Georgia partnership grant, and seed grant funding from the Georgia Institute of Technology/Emory University Regenerative Engineering and Medicine Center and The University of Georgia Athletic Association awarded to RVB and LK. This work is also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number UL1TR00454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2012.03696.x; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2005, INT CONGR SER, V1277, P3, DOI 10.1016/j.ics.2005.02.008; Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Agoston D.V., 2012, FRONT NEUROL, V3; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Allen AR, 1914, J NERV MENT DIS, V41, P141, DOI 10.1097/00005053-191403000-00002; Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; ANTONSSON P, 1989, J BIOL CHEM, V264, P16170; Aravamudhan S, 2011, J NEUROTRAUM, V28, P2329, DOI 10.1089/neu.2010.1542; Asher RA, 2000, J NEUROSCI, V20, P2427; Asimakopoulou AP, 2008, IN VIVO, V22, P385; Aspberg A, 1997, P NATL ACAD SCI USA, V94, P10116, DOI 10.1073/pnas.94.19.10116; BAKER JR, 1972, J BIOL CHEM, V247, P3838; Bakshi A, 2004, J NEUROSURG-SPINE, V1, P322, DOI 10.3171/spi.2004.1.3.0322; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7; Bartnik-Olson B.L., 2013, FRONT NEUROENERGETIC, V5; Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Becker CG, 2002, J NEUROSCI, V22, P842, DOI 10.1523/JNEUROSCI.22-03-00842.2002; Benoit JP, 2000, J CONTROL RELEASE, V65, P285, DOI 10.1016/S0168-3659(99)00250-3; Bergamaschini L, 2004, J NEUROSCI, V24, P4181, DOI 10.1523/JNEUROSCI.0550-04.2004; Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030; Bhalerao, 2010, BCMEDJ, V53, P26, DOI [10.1089/scd.2015.0160, DOI 10.1089/SCD.2015.0160]; BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616; Bosch KD, 2012, EXP NEUROL, V238, P64, DOI 10.1016/j.expneurol.2012.08.003; BOURDON MA, 1987, MOL CELL BIOL, V7, P33, DOI 10.1128/MCB.7.1.33; BOURDON MA, 1986, J BIOL CHEM, V261, P2534; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; BRACKEN MB, 1984, JAMA-J AM MED ASSOC, V251, P45, DOI 10.1001/jama.1984.03340250025015; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bradbury EJ, 2011, BRAIN RES BULL, V84, P306, DOI 10.1016/j.brainresbull.2010.06.015; Brodsky JL, 2014, DIS MODEL MECH, V7, P3, DOI 10.1242/dmm.014985; Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bucciantini M, 2014, J PHYS CHEM LETT, V5, P517, DOI 10.1021/jz4024354; Buchser E, 1996, ANESTHESIOLOGY, V85, P1005, DOI 10.1097/00000542-199611000-00007; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963; Burg MA, 1997, EXP CELL RES, V235, P254, DOI 10.1006/excr.1997.3674; Burns TC, 2009, J COMP NEUROL, V515, P125, DOI 10.1002/cne.22038; Burnside E.R., 2013, NEUROPATHOL APPL NEU; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Butterfield KC, 2010, NEUROSCI LETT, V478, P82, DOI 10.1016/j.neulet.2010.04.070; Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012; Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0; CARNEY SL, 1988, PHYSIOL REV, V68, P858, DOI 10.1152/physrev.1988.68.3.858; Carter LM, 2011, EXP NEUROL, V228, P149, DOI 10.1016/j.expneurol.2010.12.023; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chvatal SA, 2008, BIOMATERIALS, V29, P1967, DOI 10.1016/j.biomaterials.2008.01.002; Clarke Lorne A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000550; Conovaloff A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056003; Cooper JM, 2014, J NEUROTRAUM, V31, P713, DOI 10.1089/neu.2013.3101; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Coronado Victor G, 2010, TRAUMATIC BRAIN INJU; Courtine G, 2011, LANCET, V377, P1896, DOI 10.1016/S0140-6736(11)60711-3; Coutinho M.F, 2011, BIOCH RES INT, V2012; Crapo PM, 2012, BIOMATERIALS, V33, P3539, DOI 10.1016/j.biomaterials.2012.01.044; Cregg J.M., 2014, EXP NEUROL, V5, P146; Cui FZ, 2003, J BIOACT COMPAT POL, V18, P413, DOI 10.1177/0883911503040470; Cui H, 2013, IUBMB LIFE, V65, P108, DOI 10.1002/iub.1118; Dalton PD, 2009, FRONT BIOSCI-LANDMRK, V14, P769, DOI 10.2741/3277; Davies SJA, 1997, NATURE, V390, P680, DOI 10.1038/37776; de Aguiar CBNM, 2002, INT J DEV NEUROSCI, V20, P563, DOI 10.1016/S0736-5748(02)00081-3; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; DEBOECK H, 1987, BIOCHEM J, V247, P765, DOI 10.1042/bj2470765; Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200; Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Dergham P, 2002, J NEUROSCI, V22, P6570; Desnick RJ, 2002, NAT REV GENET, V3, P954, DOI 10.1038/nrg963; Diaz-Nido J, 2002, PEPTIDES, V23, P1323, DOI 10.1016/S0196-9781(02)00068-2; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; Dick G, 2013, J BIOL CHEM, V288, P27384, DOI 10.1074/jbc.M111.310029; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dietz V., 2013, BRAIN; Dityatev A, 2010, TRENDS NEUROSCI, V33, P503, DOI 10.1016/j.tins.2010.08.003; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Dominici N, 2012, NAT MED, V18, P1142, DOI 10.1038/nm.2845; DOU CL, 1994, J NEUROSCI, V14, P7616; Du JA, 2010, ADV DRUG DELIVER REV, V62, P671, DOI 10.1016/j.addr.2010.01.003; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ellingson BM, 2008, AM J NEURORADIOL, V29, P1976, DOI 10.3174/ajnr.A1272; Emerich DF, 1997, NATURE, V386, P395, DOI 10.1038/386395a0; Engel M, 1996, J COMP NEUROL, V366, P34; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Facts S.C.I., 2010, SPINAL CORD INJURY F; FADEN AI, 1984, J NEUROSURG, V60, P712, DOI 10.3171/jns.1984.60.4.0712; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fehlings MG, 2005, INJURY, V36, P113, DOI 10.1016/j.injury.2005.06.022; Fehlings MG, 2011, J NEUROTRAUM, V28, P787, DOI 10.1089/neu.2011.1765; Fidler PS, 1999, J NEUROSCI, V19, P8778, DOI 10.1523/JNEUROSCI.19-20-08778.1999; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; FISHER LW, 1983, J BIOL CHEM, V258, P6588; Forde CT, 2014, BRIT J NEUROSURG, V28, P8, DOI 10.3109/02688697.2013.815317; Frampton AE, 2006, EMERG MED J, V23, P550, DOI 10.1136/emj.2005.032698; Frankel P, 2008, EMBO REP, V9, P983, DOI 10.1038/embor.2008.151; Frantz S, 2012, NAT BIOTECHNOL, V30, P12, DOI 10.1038/nbt0112-12; FRIEDLANDER DR, 1994, J CELL BIOL, V125, P669, DOI 10.1083/jcb.125.3.669; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Garbayo E, 2009, J CONTROL RELEASE, V135, P119, DOI 10.1016/j.jconrel.2008.12.010; Garcia-Alias G, 2008, EXP NEUROL, V210, P331, DOI 10.1016/j.expneurol.2007.11.002; Gaugler J, 2013, ALZHEIMERS DIS FACTS; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006; GIORDANA MT, 1982, ACTA NEUROPATHOL, V57, P299, DOI 10.1007/BF00692187; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; Granger N., 2014, NEUROSCIENTIST; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035; GRUMET M, 1994, J BIOL CHEM, V269, P12142; Gu HG, 2009, NEUROSCI LETT, V453, P204, DOI 10.1016/j.neulet.2009.02.027; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Harkema SJ, 2012, ARCH PHYS MED REHAB, V93, P1508, DOI 10.1016/j.apmr.2011.01.024; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hatton J, 2008, J NEUROSURG, V109, P699, DOI 10.3171/JNS/2008/109/10/0699; HEINEGARD D, 1985, BIOCHEM J, V230, P181, DOI 10.1042/bj2300181; HELTING T, 1969, J BIOL CHEM, V244, P2799; HELTING T, 1969, J BIOL CHEM, V244, P2790; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133; Houweling DA, 1998, NEUROSCI LETT, V251, P193, DOI 10.1016/S0304-3940(98)00536-9; Hsieh-Wilson LC, 2012, ABSTR PAP AM CHEM S, V244; Huang S, 2010, J CONTROL RELEASE, V142, P149, DOI 10.1016/j.jconrel.2009.10.018; Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641; Hyatt AJT, 2010, J CONTROL RELEASE, V147, P24, DOI 10.1016/j.jconrel.2010.06.026; Ida M, 2006, J BIOL CHEM, V281, P5982, DOI 10.1074/jbc.M507130200; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Imamachi N, 2009, P NATL ACAD SCI USA, V106, P11330, DOI 10.1073/pnas.0905605106; Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Ito Y, 2000, J BIOL CHEM, V275, P34728, DOI 10.1074/jbc.M909633199; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P470; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Jain A, 2004, J NEUROSCI RES, V77, P299, DOI 10.1002/jnr.20161; Jeyakumar Mylvaganam, 2005, Nat Rev Neurosci, V6, P713; Jones LL, 2002, J NEUROSCI, V22, P4611, DOI 10.1523/JNEUROSCI.22-11-04611.2002; Jones LL, 2001, MICROSC RES TECHNIQ, V54, P317, DOI 10.1002/jemt.1144; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Kadoya K, 2009, NEURON, V64, P165, DOI 10.1016/j.neuron.2009.09.016; KALLUNKI P, 1992, J CELL BIOL, V116, P559, DOI 10.1083/jcb.116.2.559; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Karumbaiah L., 2013, NEURAL ENG, P765; Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kemp MM, 2009, BIOMACROMOLECULES, V10, P589, DOI 10.1021/bm801266t; Khaing Z, 2008, J NEUROTRAUM, V25, P931; Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033; KHAING ZZ, 2009, CELL TRANSPLANT, V18, P220; King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018; Kinoshita-Toyoda A, 2004, BIOCHEMISTRY-US, V43, P11063, DOI 10.1021/bi049622d; Kirker KR, 2002, BIOMATERIALS, V23, P3661, DOI 10.1016/S0142-9612(02)00100-X; Kirker KR, 2004, J POLYM SCI POL PHYS, V42, P4344, DOI 10.1002/polb.20299; Kitagawa H, 2000, J BIOL CHEM, V275, P21075, DOI 10.1074/jbc.M002101200; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Knoller N, 2005, J NEUROSURG-SPINE, V3, P173, DOI 10.3171/spi.2005.3.3.0173; Knoller N, 2002, CRIT CARE MED, V30, P548, DOI 10.1097/00003246-200203000-00009; Ko YG, 2010, MACROMOL BIOSCI, V10, P860, DOI 10.1002/mabi.200900468; Kobayashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054278; Kramer AS, 2013, CELL TRANSPLANT, V22, P571, DOI 10.3727/096368912X655208; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuzhandaivel A., 2011, FRONT CELL NEUROSCI, P5; Kwok JCF, 2011, DEV NEUROBIOL, V71, P1073, DOI 10.1002/dneu.20974; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Langham J, 2000, COCHRANE DB SYST REV; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larmagnac A, 2012, IFMBE PROC, V37, P1180; Lawrence R, 2012, NAT CHEM BIOL, V8, P197, DOI 10.1038/nchembio.766; Lazarov-Spiegler O, 1998, MOL MED TODAY, V4, P337, DOI 10.1016/S1357-4310(98)01298-2; Lemons, 2004, BIOMATERIALS SCI INT; Lemons ML, 2001, J NEUROSCI, V21, P4772, DOI 10.1523/JNEUROSCI.21-13-04772.2001; Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X; LEVINE JM, 1987, J NEUROSCI, V7, P2711; LEVINE JM, 1994, J NEUROSCI, V14, P4716; LEVINE JM, 1993, GLIA, V7, P307, DOI 10.1002/glia.440070406; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOHMANDER LS, 1986, ARCH BIOCHEM BIOPHYS, V250, P211, DOI 10.1016/0003-9861(86)90719-8; LOHMANDER S, 1988, BAILLIERE CLIN RHEUM, V2, P37, DOI 10.1016/S0950-3579(88)80004-9; Lu DY, 2007, NEUROSURGERY, V61, P596, DOI 10.1227/01.NEU.0000290908.38438.B2; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; Maeda Nobuaki, 2010, Front Biosci (Landmark Ed), V15, P626; Maeda Nobuaki, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P22; Man SM, 2007, BRAIN PATHOL, V17, P243, DOI 10.1111/j.1750-3639.2007.00067.x; Management of Concussion/m TBIWG, 2009, J REHABIL RES DEV, V46, pCP1; MARGOLIS RU, 1975, BIOCHEMISTRY-US, V14, P85, DOI 10.1021/bi00672a014; Margolis RU, 1997, CELL TISSUE RES, V290, P343, DOI 10.1007/s004410050939; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mason Christine Narad, 2013, Pediatr Nurs, V39, P267; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; McCreedy DA, 2012, NEUROSCI LETT, V519, P115, DOI 10.1016/j.neulet.2012.02.025; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MeyerPuttlitz B, 1996, J COMP NEUROL, V366, P44, DOI 10.1002/(SICI)1096-9861(19960226)366:1<44::AID-CNE4>3.0.CO;2-K; Milev P, 1997, J BIOL CHEM, V272, P15501, DOI 10.1074/jbc.272.24.15501; Milev P, 1998, J BIOL CHEM, V273, P21439, DOI 10.1074/jbc.273.34.21439; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; MILEV P, 1994, J CELL BIOL, V127, P1703, DOI 10.1083/jcb.127.6.1703; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; Miura R, 1999, J BIOL CHEM, V274, P11431, DOI 10.1074/jbc.274.16.11431; Mizumoto S, 2013, J BIOL CHEM, V288, P10953, DOI 10.1074/jbc.R112.437038; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Monsellier E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011363; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mothe AJ, 2013, INT J DEV NEUROSCI, V31, P701, DOI 10.1016/j.ijdevneu.2013.07.004; Mothe AJ, 2013, BIOMATERIALS, V34, P3775, DOI 10.1016/j.biomaterials.2013.02.002; Mountney A, 2013, J NEUROTRAUM, V30, P181, DOI 10.1089/neu.2012.2353; Muir H, 1977, Soc Gen Physiol Ser, V32, P87; Musienko P, 2012, EXP NEUROL, V235, P100, DOI 10.1016/j.expneurol.2011.08.025; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Nandini CD, 2004, J BIOL CHEM, V279, P50799, DOI 10.1074/jbc.M404746200; Nandini CD, 2006, ADV PHARMACOL, V53, P253, DOI 10.1016/S1054-3589(05)53012-6; Neame PJ, 2000, PROTEOGLYCANS STRUCT, P201; Nisbet DR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0002-x; Nishimura K, 2010, NEUROSCIENCE, V169, P1535, DOI 10.1016/j.neuroscience.2010.06.027; NISHIYAMA A, 1991, J CELL BIOL, V114, P359, DOI 10.1083/jcb.114.2.359; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496; Ohtake S, 2005, J BIOL CHEM, V280, P39115, DOI 10.1074/jbc.M508816200; Ohtake S, 2003, J BIOL CHEM, V278, P38443, DOI 10.1074/jbc.M306132200; Okano H, 2002, J NEUROSCI RES, V69, P698, DOI 10.1002/jnr.10343; Oohira A, 2000, ARCH BIOCHEM BIOPHYS, V374, P24, DOI 10.1006/abbi.1999.1598; OOHIRA A, 1986, J NEUROCHEM, V47, P588; Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Owen SC, 2013, LANGMUIR, V29, P7393, DOI 10.1021/la305000w; Pakulska M.M., 2012, BIOMED MATER, P7; Pantazaka E, 2014, BIOCH BIOPHYS ACTA; Park CH, 2005, J NEUROCHEM, V92, P1265, DOI 10.1111/j.1471-4159.2004.03006.x; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Petitjean ME, 1998, ANN FR ANESTH, V17, P114, DOI 10.1016/S0750-7658(98)80058-0; Petrie E.C., 2013, J NEUROTRAUMA; Pettikiriarachchi JTS, 2010, AUST J CHEM, V63, P1143, DOI 10.1071/CH10159; Pickford CE, 2011, STEM CELLS, V29, P629, DOI 10.1002/stem.610; Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1; Plenger PM, 1996, ARCH PHYS MED REHAB, V77, P536, DOI 10.1016/S0003-9993(96)90291-9; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053; Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007; Previtera ML, 2013, ANN BIOMED ENG, V41, P1193, DOI 10.1007/s10439-013-0765-y; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Properzi F, 2004, NEWS PHYSIOL SCI, V19, P33, DOI 10.1152/nips.01449.2003; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Ramon y Cajal S., 1959, DEGENERATION REGENER; Ramon y Cajal S., 1995, HISTOLOGY NERVOUS SY; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; RAUCH U, 1991, J BIOL CHEM, V266, P14785; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Roden L., 1980, BIOCH GLYCOPROTEINS, P267, DOI [10.1007/978-1-4684-1006-8_7, DOI 10.1007/978-1-4684-1006-8_7]; Rogers CJ, 2011, P NATL ACAD SCI USA, V108, P9747, DOI 10.1073/pnas.1102962108; ROHRMANN K, 1985, EUR J BIOCHEM, V148, P463, DOI 10.1111/j.1432-1033.1985.tb08862.x; Roitbak T., 1998, J PHYSL, V511P, p17p; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; ROSTAND KS, 1987, FASEB J, V46, P2094; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; RUDGE JS, 1990, J NEUROSCI, V10, P3594; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cb.04.110188.001305; RUOSLAHTI E, 1989, J BIOL CHEM, V264, P13369; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Saxena T, 2012, J NEUROTRAUM, V29, P1747, DOI 10.1089/neu.2011.1818; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; SCHWARTZ NB, 1975, J BIOL CHEM, V250, P5200; SCOTT JE, 1985, COLLAGEN REL RES, V5, P541; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; SELDIN DC, 1984, ANAL BIOCHEM, V141, P291, DOI 10.1016/0003-2697(84)90459-7; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shear DA, 2011, RESTOR NEUROL NEUROS, V29, P215, DOI 10.3233/RNN-2011-0593; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Short DJ, 2000, SPINAL CORD, V38, P273, DOI 10.1038/sj.sc.3100986; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silva GA, 2006, NAT REV NEUROSCI, V7, P65, DOI 10.1038/nrn1827; Silva GA, 2007, SURG NEUROL, V67, P113, DOI 10.1016/j.surneu.2006.08.033; Silva N.A., 2013, PROG NEUROBIOL; Silver DJ, 2013, J NEUROSCI, V33, P15603, DOI 10.1523/JNEUROSCI.3004-12.2013; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045; Sinson G, 1996, J NEUROSURG, V84, P655, DOI 10.3171/jns.1996.84.4.0655; Sirko S, 2007, DEVELOPMENT, V134, P2727, DOI 10.1242/dev.02871; SNOW DM, 1990, DEV BIOL, V138, P359, DOI 10.1016/0012-1606(90)90203-U; Snow DM, 2003, EXP NEUROL, V182, P310, DOI 10.1016/S0014-4886(03)00034-7; SNOW DM, 1991, DEVELOPMENT, V113, P1473; Snow DM, 1996, INT J DEV NEUROSCI, V14, P331, DOI 10.1016/0736-5748(96)00017-2; Sofroniew MV, 2012, METHODS MOL BIOL, V814, P531, DOI 10.1007/978-1-61779-452-0_35; Spuch C, 2010, BIOMATERIALS, V31, P5608, DOI 10.1016/j.biomaterials.2010.03.042; STALLCUP WB, 1983, COLD SPRING HARB SYM, V48, P761, DOI 10.1101/SQB.1983.048.01.078; STALLCUP WB, 1990, J CELL BIOL, V111, P3177, DOI 10.1083/jcb.111.6.3177; Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039; STOOLMILLER AC, 1972, J BIOL CHEM, V247, P3525; Strauss S, 2010, NAT BIOTECHNOL, V28, P989, DOI 10.1038/nbt1010-989; Sugahara K, 1996, J BIOL CHEM, V271, P26745, DOI 10.1074/jbc.271.43.26745; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015; Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381; Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004; Tadie M., 1999, Society for Neuroscience Abstracts, V25, P1090; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Tam RY, 2012, ABSTR PAP AM CHEM S, V243; Tan AM, 2006, J NEUROSCI, V26, P4729, DOI 10.1523/JNEUROSCI.3900-05.2006; Tauchi R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-53; Taylor SJ, 2004, J CONTROL RELEASE, V98, P281, DOI 10.1016/j.jconrel.2004.05.003; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; Thatcher RW, 1997, J NEUROTRAUM, V14, P1, DOI 10.1089/neu.1997.14.1; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; TONA A, 1993, J HISTOCHEM CYTOCHEM, V41, P593, DOI 10.1177/41.4.8450198; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tsuboi S, 2012, TRENDS MOL MED, V18, P224, DOI 10.1016/j.molmed.2012.02.001; Tully SE, 2004, J AM CHEM SOC, V126, P7736, DOI 10.1021/ja0484045; Tuszynski MH, 2004, EXP NEUROL, V187, P221; Tuszynski MH, 2003, FASEB J, V17, pA813; Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057; Vunjak-Novakovic G, 1999, J ORTHOP RES, V17, P130, DOI 10.1002/jor.1100170119; Wade A., 2013, FEBS J; Walker BA, 2012, J NEUROSCI, V32, P14442, DOI 10.1523/JNEUROSCI.0176-12.2012; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023062; Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031; WATANABE E, 1995, J BIOL CHEM, V270, P26876, DOI 10.1074/jbc.270.45.26876; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wilda M, 2000, J BONE MINER RES, V15, P2187, DOI 10.1359/jbmr.2000.15.11.2187; Wilson G J, 1990, ASAIO Trans, V36, pM340; WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011; Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9; Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yamada H, 1997, J NEUROSCI, V17, P7784; YAMADA H, 1994, J BIOL CHEM, V269, P10119; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Yamaguchi Y, 2000, CELL MOL LIFE SCI, V57, P276, DOI 10.1007/PL00000690; Yarnitsky D, 2004, J NEUROSURG, V101, P303, DOI 10.3171/jns.2004.101.2.0303; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538; Zhao Y, 2014, ADV MATER, V26, P436, DOI 10.1002/adma.201303387; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zhu H, 2001, MOL MED, V7, P517, DOI 10.1007/BF03401857; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	411	5	5	0	23	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2014	21	37					4257	4281		10.2174/0929867321666140815124447			25	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	AS0SZ	WOS:000343990100006	25139544				2022-02-06	
J	Kasem, M; Kanthimathinathan, HK; Mehta, C; Neal, R; Stumper, O				Kasem, Mohamed; Kanthimathinathan, Hari Krishnan; Mehta, Chetan; Neal, Richard; Stumper, Oliver			Transcatheter device closure of a traumatic ventricular septal defect	ANNALS OF PEDIATRIC CARDIOLOGY			English	Article						Chest trauma; extracorporeal membrane oxygenation; traumatic ventricular septal defect; transcatheter device closure		A traumatic ventricular septal defect (VSD) resulting from blunt chest injury is a very rare event in children. The clinical symptoms and timing of presentation are variable, so diagnosis and management of traumatic VSD may be challenging. Decision to close the traumatic VSD is usually based on a combination of severity of heart failure symptoms, hemodynamics, and defect size. We present a case of a 7-year-old boy who was run over by a truck and presented with head and liver injury initially. He was subsequently found to have a traumatic VSD. The VSD was closed percutaneously.	[Kasem, Mohamed; Kanthimathinathan, Hari Krishnan; Mehta, Chetan; Neal, Richard; Stumper, Oliver] Birmingham Childrens Hosp, Dept Cardiol, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England		Stumper, O (corresponding author), Birmingham Childrens Hosp, Dept Cardiol, Steelhouse Lane, Birmingham B4 6NH, W Midlands, England.	Oliver.stumper@bch.nhs.uk	Krishnan, Hari/ABH-5848-2020	Krishnan, Hari/0000-0001-5170-1534			Fraisse A, 2002, ANN THORAC SURG, V74, P582, DOI 10.1016/S0003-4975(02)03607-X; Jeon Kihyun, 2010, J Cardiovasc Ultrasound, V18, P28, DOI 10.4250/jcu.2010.18.1.28; LOCK JE, 1988, CIRCULATION, V78, P361, DOI 10.1161/01.CIR.78.2.361; Pesenti-Rossi D, 2003, CHEST, V123, P2144, DOI 10.1378/chest.123.6.2144; Pierli C, 2001, Heart, V86, pE6, DOI 10.1136/heart.86.1.e6; Ryan Lisa, 2012, J Emerg Trauma Shock, V5, P184, DOI 10.4103/0974-2700.96492; Suh WM, 2009, CATHETER CARDIO INTE, V74, P1120, DOI 10.1002/ccd.22141; Tatar T, 2011, TURKISH J PEDIATR, V53, P571; Tenzer ML, 1986, J TRAUMA, V28, P602	9	5	6	0	0	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	0974-2069	0974-5149		ANN PEDIAT CARDIOL	Ann. Pediat. Cardiol.	JAN-APR	2014	7	1					41	44		10.4103/0974-2069.126552			4	Cardiac & Cardiovascular Systems	Emerging Sources Citation Index (ESCI)	Cardiovascular System & Cardiology	V3U2G	WOS:000218591300009	24701085	Green Published, gold			2022-02-06	
J	Lampe, R; Blumenstein, T; Turova, V; Alves-Pinto, A				Lampe, Renee; Blumenstein, Tobias; Turova, Varvara; Alves-Pinto, Ana			Lung vital capacity and oxygen saturation in adults with cerebral palsy	PATIENT PREFERENCE AND ADHERENCE			English	Article						disability; lung function; spirometry; chest expansion; pulse oximetry	CHILDREN; SCOLIOSIS	Background: Individuals with infantile cerebral palsy have multiple disabilities. The most conspicuous syndrome being investigated from many aspects is motor movement disorder with a spastic gait pattern. The lung function of adults with spasticity attracts less attention in the literature. This is surprising because decreased thoracic mobility and longstanding scoliosis should have an impact on lung function. With increasing age and the level of disability, individuals become susceptible to lung infections and reflux illness, and these are accompanied by increased aspiration risk. This study examined, with different methods, to what extent adults with congenital cerebral palsy and acquired spastic paresis - following traumatic brain injury - showed restriction of lung function. It also assessed the contribution of disability level on this restriction. Methods: The oxygen saturation of 46 adults with a diagnosis of cerebral palsy was measured with an oximeter. Lung vital capacity was measured with a mobile spirometer and excursion of the thorax was clinically registered. The gross motor function levels and the presence or absence of scoliosis were determined. Results: A significantly positive correlation between lung vital capacity and chest expansion was established. Both the lung vital capacity and the thorax excursion decreased with increases in gross motor function level. Oxygen saturation remained within the normal range in all persons, in spite of reduced values of the measured lung parameters. No statistically significant dependency between lung vital capacity and oxygen saturation, and between chest expansion and oxygen saturation was found. The scoliotic deformities of the spine were associated with an additional decrease in the vital capacity, but this did not affect blood oxygen supply. Conclusion: Despite the decreased chest expansion and the significantly reduced lung volume in adults with cerebral palsy, sufficient oxygen supply was registered.	[Lampe, Renee] Tech Univ Munich, D-81675 Munich, Germany; [Lampe, Renee; Blumenstein, Tobias; Turova, Varvara; Alves-Pinto, Ana] Tech Univ Munich, Buhl Strohmaier Fdn, Dept Orthoped, Clin Rechts Isar,Res Unit Cerebral Palsy & Childr, D-81675 Munich, Germany		Lampe, R (corresponding author), Tech Univ Munich, Dept Orthoped, Clin Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany.	renee.lampe@irz.tu-muenchen.de		Turova, Varvara/0000-0002-6613-3311; Lampe, Renee/0000-0002-1016-0249	Stiftung Wurth and Buhl-Strohmaier Stiftung	The authors thank Stiftung Wurth and Buhl-Strohmaier Stiftung for their financial support. The authors are also grateful to Dr Nikolai Botkin, Center of Mathematics, Technical University of Munich, for his help with statistical analysis of the data.	Campbell RM, 2003, J BONE JOINT SURG AM, V85A, P399, DOI 10.2106/00004623-200303000-00001; Ersoz M, 2006, TURKISH J PEDIATR, V48, P344; Ezeugwu VE, 2013, PHYSIOTHER RES INT, V18, P212, DOI 10.1002/pri.1547; Hutzler Y, 1998, DEV MED CHILD NEUROL, V40, P176; KALEN V, 1992, J PEDIATR ORTHOPED, V12, P337, DOI 10.1097/01241398-199205000-00010; Kwon YH, 2013, J PEDIATR REHAB MED, V6, P113, DOI 10.3233/PRM-130246; Marques de Sa JP, APPL STAT USING SPSS; MOLL JMH, 1972, ANN RHEUM DIS, V31, P1, DOI 10.1136/ard.31.1.1; Odding E, 2006, DISABIL REHABIL, V28, P183, DOI 10.1080/09638280500158422; Reid SM, 2012, DEV MED CHILD NEUROL, V54, P353, DOI 10.1111/j.1469-8749.2012.04218.x; ROLLINGS RC, 1985, FACTS FORMULAS; ROTHMAN JG, 1978, PHYS THER, V58, P421, DOI 10.1093/ptj/58.4.421; Satou Y, 2013, J STROKE CEREBROVASC, V22, P185, DOI 10.1016/j.jstrokecerebrovasdis.2011.07.008; Tamura F, 1999, DYSPHAGIA, V14, P204, DOI 10.1007/PL00009607; Ting W., 2011, STUD MATH SCI, V3, P58	15	5	7	1	4	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-889X			PATIENT PREFER ADHER	Patient Prefer. Adherence		2014	8						1691	1697		10.2147/PPA.S72575			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW2RR	WOS:000346137000001	25525345	gold, Green Published, Green Submitted			2022-02-06	
J	Lupi, A; Bertagnoni, G; Borghero, A; Picelli, A; Cuccurullo, V; Zanco, P				Lupi, Andrea; Bertagnoni, Giannettore; Borghero, Anna; Picelli, Alessandro; Cuccurullo, Vincenzo; Zanco, Pierluigi			18FDG-PET/CT in Traumatic Brain Injury Patients: The Relative Hypermetabolism of Vermis Cerebelli as a Medium and Long Term Predictor of Outcome	CURRENT RADIOPHARMACEUTICALS			English	Article						Brain trauma; imaging; prognosis; vermis cerebelli		Purpose: Both, the constant presence of apparent hypermetabolism of the vermis cerebelli compared to the cerebellar hemispheres in traumatic brain injury, and the presence of a good relationship between the intensity of this sign and the severity of the clinical conditions have been addressed in previous studies. Aim of the present paper is to evaluate the possible correlation between the intensity of the finding and the medium and long term outcome in a group of patients. Materials and Methods: A group of 105 patients consecutively admitted to the Brain Injury Rehabilitation Center of our Hospital between 2005 and 2012 was studied with a 18FDG-PET/CT study of the brain after head trauma; the metabolic activity of the cerebellar vermis was semiquantitatively assessed (vermis/cerebellum ratio, V/C). After that, all patients received systematic monitoring of their performance status via the timely administration of commonly used tests (DRS, LCF and GOS) during one whole year after the head trauma. The V/C parameter was compared with the evolution of performance abilities, as shown by the rating scales. Results: Statistical analysis showed a significant direct association between the V/C ratio and the DRS score at each time point (3 months: P<0.001; 6 months: P<0.001; 12 months: P<0.001) and significant inverse association with the LCF score (3 months: P<0.001; 6 months: P<0.001; 12 months: P<0.001) and the GOS score (3 months: P<0.001; 6 months: P<0.001; 12 months: P<0.001) at each time point. Moreover, patients with a V/C ratio >= 1 have a significantly greater probability to achieve a good functional outcome as defined by a DRS score <= 3 points, a LCF score >= 7 points and and a GOS score =5 points. Conclusions: In our group of patients, the V/C parameter has demonstrated to be a predictor of outcome. If validated by more extensive experiences, this approach could offer the possibility of performing a reliable prognostic evaluation in a notoriously "difficult" class of patients with an acceptable technique and economical effort.	[Lupi, Andrea; Zanco, Pierluigi] Osp S Bortolo, UO Med Nucl, Vicenza, Italy; [Bertagnoni, Giannettore; Borghero, Anna] Osp S Bortolo, UO Recupero & Riabilitaz Funz, Vicenza, Italy; [Picelli, Alessandro] Univ Verona, Ctr Ric Riabilitaz Neuromotoria & Cognit, Dip Sci Neurol & Neuropsicol, Verona, Italy; [Cuccurullo, Vincenzo] Seconda Univ Napoli, UO Med Nucl, Dipartimento Internist Clin & Sperimentale F Magr, Naples, Italy		Lupi, A (corresponding author), Osped S Bortolo, Div Nucl Med, Via M Rodolfi, I-36100 Vicenza, Italy.	andrea.lupi@ulssvicenza.it	Picelli, Alessandro/K-5610-2016; Lupi, Andrea/AAI-8661-2020	Picelli, Alessandro/0000-0002-3558-8276; CUCCURULLO, Vincenzo/0000-0003-0474-7163			Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ANDREWS K, 1993, BRIT MED J, V306, P1597, DOI 10.1136/bmj.306.6892.1597; Beuthien-Baumann B, 2005, NEUROPSYCHOL REHABIL, V15, P276, DOI 10.1080/09602010443000290; Bonito V, 2002, NEUROL SCI, V23, P131, DOI 10.1007/s100720200040; Fischer C, 2004, NEUROLOGY, V63, P669, DOI 10.1212/01.WNL.0000134670.10384.E2; Gerber DJ, 2004, BRAIN INJURY, V18, P1083, DOI 10.1080/02699050410001672341; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; Guerit JM, 1997, ACTA NEUROL BELG, V97, P214; Guerit JM, 2000, ACTA NEUROL BELG, V100, P229; Hattori N, 2003, J NUCL MED, V44, P1709; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Lippert-Gruner M, 2003, BRAIN INJURY, V17, P49, DOI 10.1080/0269905021000010230; Logi F, 2003, CLIN NEUROPHYSIOL, V114, P1615, DOI 10.1016/S1388-2457(03)00086-5; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Lupi A, 2007, CLIN NUCL MED, V32, P445, DOI 10.1097/RLU.0b013e3180537621; Lupi A, 2011, CURR RADIOPHARM, V4, P167, DOI 10.2174/1874471011104020167; McLean SAM, 1999, J CLIN PATHOL, V52, P490, DOI 10.1136/jcp.52.7.490; Nakashima T, 2007, AM J NEURORADIOL, V28, P236; ODER W, 1991, INTENS CARE MED, V17, P149, DOI 10.1007/BF01704718; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Plum F, 1975, Ciba Found Symp, P121; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Wedekind C, 1999, J TRAUMA, V47, P44, DOI 10.1097/00005373-199907000-00010; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842	24	5	5	0	0	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1874-4710	1874-4729		CURR RADIOPHARM	Curr. Radiopharm.		2014	7	1					57	62		10.2174/1874471007666140411103819			6	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Pharmacology & Pharmacy; Radiology, Nuclear Medicine & Medical Imaging	V21IM	WOS:000214947900008	24725131				2022-02-06	
J	Melcer, T; Walker, J; Bhatnagar, V; Richard, E; Han, P; Sechriest, VF; Lebedda, M; Quinn, K; Galarneau, M				Melcer, Ted; Walker, Jay; Bhatnagar, Vibha; Richard, Erin; Han, Peggy; Sechriest, V. Franklin, II; Lebedda, Martin; Quinn, Kimberly; Galarneau, Michael			Glasgow Coma Scale scores, early opioids, and 4-year psychological outcomes among combat amputees	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						combat amputee; fentanyl; Glasgow Coma Scale; Iraq/Afghanistan conflicts; long-term psychological outcomes; loss of consciousness; military and VA health data; morphine; posttraumatic stress disorder; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; TRAUMATIC BRAIN-INJURY; OPERATION IRAQI FREEDOM; VETERANS; HEALTH; AFGHANISTAN; CARE; SOLDIERS; DIAGNOSES; CONFLICTS	Morphine and fentanyl are frequently used for analgesia after trauma, but there is debate over the advantages and disadvantages of these opioids. Among combat amputees, intravenous (IV) morphine (vs IV fentanyl) after injury was associated with reduced likelihood of posttraumatic stress disorder (PTSD). The previous results were based on military health diagnoses over 2 yr postinjury. The present study followed psychological diagnoses of patients with amputation for 4 yr using military and Department of Veterans Affairs health data. In-theater combat casualty records (n = 145) documented Glasgow Coma Scale (GCS) scores and/or morphine, fentanyl, or no opioid treatment within hours of injury. We found that (1) GCS scores were not significantly associated with PTSD; (2) longitudinal modeling using four (yearly) time points showed significantly reduced odds of PTSD for patients treated with morphine (vs fentanyl) across years (adjusted odds ratio = 0.40; 95% confidence interval = 0.17-0.94); (3) reduced PTSD prevalence for morphine (vs IV fentanyl; morphine = 25%, fentanyl = 59%, p < 0.05) was significant, specifically among patients with traumatic brain injury during the first 2 yr postinjury; and (4) PTSD prevalence, but not other disorders (e. g., mood), increased between year 1 (PTSD = 18%) and years 2 through 4 postinjury (PTSD range = 30%-32%).	[Melcer, Ted; Walker, Jay; Han, Peggy; Lebedda, Martin; Quinn, Kimberly; Galarneau, Michael] Naval Hlth Res Ctr, Dept Med Modeling Simulat & Mission Support, San Diego, CA 92106 USA; [Bhatnagar, Vibha; Richard, Erin] Dept Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Bhatnagar, Vibha; Richard, Erin] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Sechriest, V. Franklin, II] Naval Med Ctr San Diego, San Diego, CA USA		Melcer, T (corresponding author), Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	ted.melcer@med.navy.mil			Navy Bureau of Medicine Wounded Ill and Injured Program [61108]; VAUS Department of Veterans Affairs	Funding/Support: This material was based on work supported by the Navy Bureau of Medicine Wounded Ill and Injured Program (work unit 61108). This work was also supported by the VA.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Armed Forces Health Surveillance Center, 2011, MED SURVEILLANCE MON, V18, P17; Benedek DM, 2007, MIL MED, V172, P681; Black IH, 2009, PREHOSP EMERG CARE, V13, P223, DOI 10.1080/10903120802290778; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Centers for Disease Control and Prevention, BLAST INJ TRAUM BRAI; Cesur R., 2011, PSYCHOL COSTS WAR MI; Chiu KB, 2011, ACAD EMERG MED, V18, P1156, DOI 10.1111/j.1553-2712.2011.01206.x; Claxton AR, 1997, ANESTH ANALG, V84, P509, DOI 10.1097/00000539-199703000-00008; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Copeland LA, 2011, J AFFECT DISORDERS, V130, P226, DOI 10.1016/j.jad.2010.10.017; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Fletcher S, 2010, AUST NZ J PSYCHIAT, V44, P1064, DOI 10.3109/00048674.2010.509858; Forbes D, 2012, J ANXIETY DISORD, V26, P95, DOI 10.1016/j.janxdis.2011.09.004; Fox DJ, 1995, ANESTHESIA PERIOPERA, P211; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Gunderson EKE, 2005, MIL MED, V170, P172; Health Services Research & Development, 2012, COP DAT WAR; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook TL, 2010, NEW ENGL J MED, V362, P110, DOI 10.1056/NEJMoa0903326; Horesh D, 2011, SOC PSYCH PSYCH EPID, V46, P863, DOI 10.1007/s00127-010-0255-6; Kacprowicz R. F., 2008, J SPEC OPER MED, V8, P48, DOI [10.1097/TA. 0b013e3182754674, DOI 10.1097/TA.0B013E3182754674]; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; MacGregor AJ, 2009, MIL MED, V174, P224, DOI 10.7205/MILMED-D-03-9107; MacGregor AJ, 2009, INJURY, V40, P1004, DOI 10.1016/j.injury.2009.04.006; Malchow R. J., 2009, CARE COMBAT AMPUTEE, P229; Matis G, 2008, ACTA NEUROL BELG, V108, P75; Melcer T, 2014, J TRAUMA STRESS, V27, P152, DOI 10.1002/jts.21909; Melcer T, 2013, J TRAUMA ACUTE CARE, V75, pS247, DOI 10.1097/TA.0b013e318299d95e; Melcer T, 2010, MIL MED, V175, P147, DOI 10.7205/MILMED-D-09-00120; Pasternak GW, 2012, PAIN MED, V13, pS4, DOI 10.1111/j.1526-4637.2012.01335.x; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Potter Benjamin K, 2006, J Am Acad Orthop Surg, V14, pS188; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Stinner DJ, 2010, J TRAUMA, V68, P1476, DOI 10.1097/TA.0b013e3181bb9a6c; TEASDALE G, 1974, LANCET, V2, P81; The Congress of the United States Congressional Budget Office, 2012, CBO STUD VET ADM TRE; U.S. Department of Veterans Affairs, HLTH BEN RET SERV OI; Wain HJ, 2009, CARE COMBAT AMPUTEE, P265; Wedmore IS, 2012, J TRAUMA ACUTE CARE, V73, pS490, DOI 10.1097/TA.0b013e3182754674	48	5	6	0	4	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	5					697	709		10.1682/JRRD.2013.06.0143			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AP9FJ	WOS:000342383900005	25509056	Bronze			2022-02-06	
J	Moritz, KE; Geeck, K; Underly, RG; Searles, M; Smith, JS				Moritz, Kasey E.; Geeck, Katalin; Underly, Robert G.; Searles, Madeleine; Smith, Jeffrey S.			Post-operative environmental enrichment improves spatial and motor deficits but may not ameliorate anxiety- or depression-like symptoms in rats following traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; anxiety; depression; enriched environment; stereology	ELEVATED PLUS-MAZE; UNPREDICTABLE MILD STRESS; CLOSED-HEAD-INJURY; ANIMAL-MODEL; COGNITIVE DEFICITS; MAJOR DEPRESSION; FRONTAL-LOBE; ANTIDEPRESSANT TREATMENTS; SUCROSE CONSUMPTION; CORTICAL CONTUSION	Purpose: Anxiety-like (ANX) and depression-like (DEP) symptoms are common consequences of traumatic brain injury (TBI). Environmental enrichment (EE) attenuates many deficits, though its impact on ANX and DEP symptoms has yet to be described. Methods: Adult male Long-Evans rats were subject to a medial frontal cortex (mFC) cortical impact injury or sham preparation, then placed into EE or standard housing (SE). ANX symptoms were analyzed using the open field test (OFT) and elevated plus maze (EPM). The forced swim task (FST) and sucrose consumption task (SCT) were used to quantify DEP symptoms. In order to measure changes in spatial learning and motor performance, the Barnes maze (BM) and rotor rod (RR) were utilized. Results: Damage to the mFC resulted in functional losses in motor and cognitive behavior and an increase in ANX and DEP symptoms. Placement of injured rats into the EE improves motor functioning after TBI and resulted in an decreased latency to locate the escape box in the BM. Though the application of an EE attenuated deficits in BM and RR performance, the ANX and DEP behavioral symptoms persisted. Conclusions: Additional therapeutic approaches paired with EE may be necessary to address all functional changes post-TBI. Additionally, no single behavioral assessment appears to clearly identify symptoms of ANX or DEP in rats following TBI, however utilizing multiple tests can be potentially confounding.	[Moritz, Kasey E.; Geeck, Katalin; Underly, Robert G.; Searles, Madeleine; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, Malcolm & Lois Field Endowed Chair Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Smith, Jeffrey/0000-0001-5499-4475	Saginaw Valley State University Student Research and Creativity Institute (SRCI; Moritz)	This work was supported in part by the Saginaw Valley State University Student Research and Creativity Institute (SRCI; Moritz, 2012). The authors would also like to thank Jacob Dunkerson, David Mudd, Jennica Young, Justin Jacqmain, Kelsey Dubbs and Garrick Salois for their technical assistance on this project. This work was completed in the absence of any financial relationships that could be construed as a conflict of interest.	Andreatini R, 1999, BRAZ J MED BIOL RES, V32, P1121, DOI 10.1590/S0100-879X1999000900011; Baldini S, 2013, J NEUROSCI, V33, P11715, DOI 10.1523/JNEUROSCI.3541-12.2013; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bourin M, 2007, FUND CLIN PHARMACOL, V21, P567, DOI 10.1111/j.1472-8206.2007.00526.x; BRITTON KT, 1991, J PHARMACOL EXP THER, V258, P124; CAMPBELL JJ, 1994, J NEUROPSYCH CLIN N, V6, P411; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Cheeta S, 2001, BRIT J PHARMACOL, V132, P1389, DOI 10.1038/sj.bjp.0703991; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Crane AT, 2012, RESTOR NEUROL NEUROS, V30, P325, DOI 10.3233/RNN-2012-120232; Cui MH, 2006, NEUROSCI LETT, V404, P208, DOI 10.1016/j.neulet.2006.05.048; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; Fann JR, 2001, PSYCHOSOMATICS, V42, P48, DOI 10.1176/appi.psy.42.1.48; FILE SE, 1978, BRIT J PHARMACOL, V62, P19, DOI 10.1111/j.1476-5381.1978.tb07001.x; Forbes NF, 1996, PHYSIOL BEHAV, V60, P1481, DOI 10.1016/S0031-9384(96)00305-8; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Galani R, 1997, NEUROBIOL LEARN MEM, V67, P43, DOI 10.1006/nlme.1996.3745; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Greve KW, 2001, BRAIN INJURY, V15, P255; Griesbach GS, 2012, J NEUROTRAUM, V29, P1426, DOI 10.1089/neu.2011.2229; Grimm JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054164; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hill MN, 2003, PROG NEURO-PSYCHOPH, V27, P905, DOI 10.1016/S0278-5846(03)00149-0; Hoffman AN, 2008, NEUROSCI LETT, V431, P226, DOI 10.1016/j.neulet.2007.11.042; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.0.CO;2-5; Laviola G, 2004, EUR J NEUROSCI, V20, P1655, DOI 10.1111/j.1460-9568.2004.03597.x; Maller JJ, 2010, BRAIN RES REV, V64, P213, DOI 10.1016/j.brainresrev.2010.04.003; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Moncek F, 2004, J NEUROENDOCRINOL, V16, P423, DOI 10.1111/j.1365-2826.2004.01173.x; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; Ohl F, 2003, CLIN NEUROSCI RES, V3, P233, DOI 10.1016/S1566-2772(03)00084-7; Ohl F, 2003, EUR J NEUROSCI, V17, P128, DOI 10.1046/j.1460-9568.2003.02436.x; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; Peruzzaro ST, 2013, RESTOR NEUROL NEUROS, V31, P431, DOI 10.3233/RNN-120299; Pham TM, 1999, BEHAV BRAIN RES, V103, P63, DOI 10.1016/S0166-4328(99)00019-4; Pham TM, 1999, NEUROSCIENCE, V94, P279, DOI 10.1016/S0306-4522(99)00316-4; Pietropaolo S, 2014, COGN AFFECT BEHAV NE, V14, P996, DOI 10.3758/s13415-014-0253-3; Pijiman FTA, 2003, BEHAV BRAIN RES, V139, P131, DOI 10.1016/S0166-4328(02)00124-9; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Redei E E, 2001, Semin Clin Neuropsychiatry, V6, P43, DOI 10.1053/scnp.2001.20882; Rodgers KM, 2012, J NEUROTRAUM, V29, P1886, DOI 10.1089/neu.2011.2273; RODGERS RJ, 1993, PHYSIOL BEHAV, V54, P729, DOI 10.1016/0031-9384(93)90084-S; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Salzberg M, 2007, EPILEPSIA, V48, P2079, DOI 10.1111/j.1528-1167.2007.01246.x; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; SEMMES J, 1963, BRAIN, V86, P747, DOI 10.1093/brain/86.4.747; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Speisman RB, 2013, NEUROBIOL AGING, V34, P263, DOI 10.1016/j.neurobiolaging.2012.05.023; Spinella M, 2004, INT J NEUROSCI, V114, P95, DOI 10.1080/00207450490249347; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Veena J, 2009, NEUROSCI LETT, V455, P178, DOI 10.1016/j.neulet.2009.03.059; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358	85	5	5	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2014	32	5					701	716		10.3233/RNN-140414			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AR2NP	WOS:000343424900011	25079981				2022-02-06	
J	Nourollahi, S; Wille, J; Weiss, V; Wedekind, C; Lippert-Gruner, M				Nourollahi, Sabrina; Wille, Julia; Weiss, Verena; Wedekind, Christoph; Lippert-Gruener, Marcela			Quality-of-life in patients with post-traumatic hypopituitarism	BRAIN INJURY			English	Article						Earning capacity; hypopituitarism; quality-of-life; return-to-work; SF-36; traumatic brain injury	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE REPLACEMENT; SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; HEALTH-STATUS; MODERATE; RETURN; WORK; INSUFFICIENCY; DEPRESSION	Primary objective: Hypopituitarism is a frequent complication in patients after traumatic brain injury (TBI). Both TBI and hypopituitarism can lead to complex cognitive and affective deficits. This study was intended to examine the quality-of-life in patients with post-traumatic hypopituitarism (PTH) and to discern the effect of this endocrinological disorder on general outcome of patients after TBI including earning capacity. Research type: Retrospective analysis of clinical data. Methods and procedures: Ninety-seven symptomatic patients were screened after TBI for PTH. Their results were examined in the SF-36 [a standardized questionnaire for quality of life (QoL)] comparing the groups with or without PTH. After 6 months of hormone substitution (if necessary), patients were asked to repeat the SF-36. Main outcomes and results: Forty-six patients were diagnosed with PTH (47.5%). All patients included had a significantly lower QoL compared to the standard population. QoL was significantly worse in patients with PTH. There was no significant difference with regard to earning capacity. After hormone substitution, patients achieved better SF-36-results, albeit the difference was lacking statistical significance. Conclusions: PTH is frequent after TBI. PTH turns out to further diminish QoL, without affecting earning capacity. Hormone substitution might improve QoL in patients with PTH, but future research is needed to confirm this hypothesis.	[Nourollahi, Sabrina] St Elisabeth Krankenhaus Koln Hohenlind, Cologne, Germany; [Wille, Julia; Weiss, Verena] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50931 Cologne, Germany; [Wedekind, Christoph] Klinikum Bamberg, Dept Neurosurg, Bamberg, Germany; [Lippert-Gruener, Marcela] Ambulantes Neurol Rehazentrum Bonn, Bonn, Germany		Nourollahi, S (corresponding author), Severinstr 40, D-50678 Cologne, Germany.	sabrina.nourollahi@gmx.de			Pfizer Inc.Pfizer	We would like to thank Pfizer Inc. whose grant covered parts of the cost of our study.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Ceballos R, 1966, Ala J Med Sci, V3, P185; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; DANIEL PM, 1959, LANCET, V2, P927; Dijkers MP, 2004, ARCH PHYS MED REHAB, V85, pS21, DOI 10.1016/j.apmr.2003.08.119; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Einaudi S, 2006, J PEDIATR ENDOCR MET, V19, P691; Erlanger DM, 1999, NEUROPSYCHOL REV, V9, P175, DOI 10.1023/A:1021634622577; Gilchrist FJ, 2002, CLIN ENDOCRINOL, V57, P363, DOI 10.1046/j.1365-2265.2002.01608.x; Giordano Giulio, 2005, Pituitary, V8, P227, DOI 10.1007/s11102-006-6045-1; Guillamondegui OD, 2011, AHRQ PUBLICATION; Hahner S, 2007, J CLIN ENDOCR METAB, V92, P3912, DOI 10.1210/jc.2007-0685; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Jacobsson LJ, 2010, BRAIN INJURY, V24, P1075, DOI 10.3109/02699052.2010.494590; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Malik IA, 2003, CLIN ENDOCRINOL, V59, P75, DOI 10.1046/j.1365-2265.2003.01799.x; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Taniguchi Hisanori, 2009, Hinyokika Kiyo, V55, P741; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Vigario P, 2009, MED PRIN PRACT, V18, P317, DOI 10.1159/000215731	32	5	5	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1425	1429		10.3109/02699052.2014.917201			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200010	24911541				2022-02-06	
J	Ou, S; Liu, GD; Zhou, LS; Xia, X; Bai, SR; Li, J; Cui, J; Cheng, JM; Li, YM; Zhang, XY; Gu, JW				Ou, S.; Liu, G. -D.; Zhou, L. -S.; Xia, X.; Bai, S. -R.; Li, J.; Cui, J.; Cheng, J. -M.; Li, Y. -M.; Zhang, X. -Y.; Gu, J. -W.			Bioinformatics analysis of gene expression profiles in the rat cerebral cortex following traumatic brain injury	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Traumatic brain injury; Molecular mechanism; Gene expression profile; Bioinformatics analysis	IN-VITRO; ALTERED EXPRESSION; APOPTOSIS; INFLAMMATION; DATABASE; MOUSE	BACKGROUND: Traumatic brain injury (TBI) is a serious neurodisorder commonly caused by sports related events or violence. It is the leading cause of disability in people under 40. AIM: In order to elucidate the molecular mechanism of the secondary injury after TBI. MATERIALS AND METHODS: In this study, we downloaded gene expression profile on TBI model with sham controls for gene set enrichment analysis and pathway analysis. RESULTS: At a q-value of 5%, 361 genes were up-regulated and 373 were down-regulated in samples obtained at 48 hours after TBI. Functional analyses revealed that steroid biosynthesis, cell cycle, metal ion transport, inflammation and apoptosis were significantly dysregulated during the late period after trauma. In addition, MAPK3 (mitogen-activated protein kinase 3), was identified as the hub node in the proteinprotein interaction (PPI) network constructed by the differentially expressed genes (DEGs). CONCLUSIONS: Further elucidation of genes and proteins in our study may reveal their potential as novel therapeutic targets.	[Ou, S.; Zhou, L. -S.; Bai, S. -R.; Li, J.] Chengdu Mil Command, Gen Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Ou, S.; Xia, X.; Cheng, J. -M.; Li, Y. -M.; Zhang, X. -Y.; Gu, J. -W.] Chengdu Mil Command, Gen Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Liu, G. -D.] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Dept 8, Chongqing, Peoples R China; [Cui, J.] Third Mil Med Univ, Southwest Hosp, Dept Anesthesiol, Chongqing, Peoples R China		Gu, JW (corresponding author), Chengdu Mil Command, Gen Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.	euromountaingjw@hotmail.com		Li, Yunming/0000-0001-6363-4869	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81200964, 81271395]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2012M521940]; Foundation of General Hospital of Chengdu Military Command [2013YG-B002]; Foundation of State Key Laboratory of Trauma, Burns and Combined Injuries [SKLKF201325]	This study was supported by National Natural Science Foundation of China (No. 81200964 and No. 81271395), China Postdoctoral Science Foundation (2012M521940), Foundation of General Hospital of Chengdu Military Command (2013YG-B002) and Foundation of State Key Laboratory of Trauma, Burns and Combined Injuries (SKLKF201325).	Eppig JT, 2012, NUCLEIC ACIDS RES, V40, pD881, DOI 10.1093/nar/gkr974; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; HANSEN AJ, 1985, PHYSIOL REV, V65, P101, DOI 10.1152/physrev.1985.65.1.101; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; HERTZ L, 1973, BRAIN RES, V60, P517, DOI 10.1016/0006-8993(73)90814-7; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kelley BG, 2011, MOL CELL NEUROSCI, V48, P137, DOI 10.1016/j.mcn.2011.07.002; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Long Y, 2003, J NEUROSCI RES, V71, P710, DOI 10.1002/jnr.10524; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Matsushita Y, 2000, ACTA NEUROCHIR SUPPL, V76, P207; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Modi PK, 2012, MOL BIOL CELL, V23, P3722, DOI 10.1091/mbc.E12-02-0125; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Sharma Pushpa, 2012, Int J Crit Illn Inj Sci, V2, P172, DOI 10.4103/2229-5151.100931; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Ulbrich C, 2012, J STEROID BIOCHEM, V131, P10, DOI 10.1016/j.jsbmb.2012.01.007; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	33	5	5	1	3	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	JAN	2014	18	1					101	107					7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AA9TV	WOS:000331436700015	24452950				2022-02-06	
S	Panczykowski, DM; Pardini, JE		Niranjan, A; Lunsford, LD		Panczykowski, David M.; Pardini, Jamie E.			The Multidisciplinary Concussion Management Program	CONCUSSION	Progress in Neurological Surgery		English	Article; Book Chapter							MILD; REHABILITATION; SYMPTOMS; INJURY; SPORT	Over the past decade, research has increased scientific and public knowledge about the importance of identification and proper management of concussion. These concerns have prompted many state, regional, and private organizations to mandate the creation of, and strict adherence to, concussion management protocols, particularly with regard to sport-related concussion and subsequent return to play. Because of the individualized nature of the concussive injury and its recovery, a multidisciplinary approach provides comprehensive patient care that best addresses treatment and management of changing symptoms and their impact on multiple aspects of a patient's life and overall function. The current report will explore a model of multidisciplinary concussion management from program establishment and baseline testing to recovery from chronic postconcussion symptoms. (C) 2014 S. Karger AG, Basel	[Panczykowski, David M.; Pardini, Jamie E.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA 15213 USA		Pardini, JE (corresponding author), Univ Pittsburgh, Med Ctr, Dept Neurosurg, 200 Lothrop St Suite B-400, Pittsburgh, PA 15213 USA.	pardinij@upmc.edu					Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; *CDCP, 2007, HEADS FACTS PHYS MIL; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Cohen AH, 2013, NEUROREHABILITATION, V32, P483, DOI 10.3233/NRE-130871; Collins M, SCI CONCUSSION ADVAN; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Johnston Karen M, 2004, Curr Sports Med Rep, V3, P316; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P581; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2004, SPORTS MED UPDATE, V38, P369, DOI DOI 10.1001/JAMA.290.19.2556.[; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Reddy CC, 2011, PM&R, V3, pS396, DOI 10.1016/j.pmrj.2011.07.012; Scorza KA, 2012, AM FAM PHYSICIAN, V85, P123; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014	21	5	5	0	3	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	0079-6492		978-3-318-02649-8; 978-3-318-02648-1	PROG NEUROL SURG			2014	28						195	212		10.1159/000358780	10.1159/isbn.978-3-318-02649-8		18	Clinical Neurology; Surgery	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Surgery	BC8EJ	WOS:000355566000018	24923404				2022-02-06	
J	Perrin, PB; Morgan, M; Aretouli, E; Sutter, M; Snipes, DJ; Hoyos, GR; Buraye, JA; Arango-Lasprilla, JC				Perrin, Paul B.; Morgan, Matthew; Aretouli, Eleni; Sutter, Megan; Snipes, Daniel J.; Ramirez Hoyos, Guillermo; Arabia Buraye, Jacqueline; Carlos Arango-Lasprilla, Juan			Connecting Health-Related Quality of Life and Mental Health in Dementia Caregivers from Colombia, South America	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Dementia caregivers; health related quality of life; Latin America; mental health	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; FAMILY CAREGIVERS; PHYSICAL HEALTH; SURVEY SF-36; PSYCHOLOGICAL HEALTH; SOCIAL SUPPORT; SELF-EFFICACY; BURDEN; DEPRESSION	Research in Caucasian populations has begun to examine the broad associations between physical and mental health in dementia caregivers. However, the examination of this relationship in Latin America is largely absent from the literature despite the fact that the region will see a major increase in dementia cases over the next 20 years. The current study examined the associations between health-related quality of life (HRQOL) and mental health in 90 dementia caregivers from Colombia, South America. A canonical correlation found that higher caregiver HRQOL was related to better mental health, as expected. Caregivers with high vitality and low role limitations due to physical problems tended to have low depression and high satisfaction with life. Follow-up multiple regressions found that caregiver role limitations due to physical problems was uniquely associated with satisfaction with life, whereas vitality, role limitations due to physical problems, and pain were uniquely associated with burden (although the pain effect was likely error due to a suppressor effect). Additionally, vitality and social functioning were uniquely negatively related to depression. Because of the extremely high overlap between these two sets of variables, dementia interventions are needed in Latin America that target both caregiver mental and physical health, as both likely operate in unison and influence each other.	[Perrin, Paul B.; Morgan, Matthew; Sutter, Megan; Snipes, Daniel J.] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA 23284 USA; [Aretouli, Eleni; Carlos Arango-Lasprilla, Juan] Univ Deusto, Dept Psychol, Bilbao, Spain; [Ramirez Hoyos, Guillermo; Arabia Buraye, Jacqueline] Alzheimer Fdn, Cali, Colombia; [Carlos Arango-Lasprilla, Juan] Univ Deusto, IKERBASQUE, Basque Fdn Sci, Bilbao, Spain		Arango-Lasprilla, JC (corresponding author), Univ Deusto, IKERBASQUE, Basque Fdn Sci, Dept Psychol, Bilbao, Spain.	jcarango@deusto.es	Sutter, Megan/L-9770-2019; Morgan, Matthew Ryan/ABC-7078-2021; Conde-Sala, Josep Lluis/C-5995-2011; Perrin, Paul/L-5373-2015	Morgan, Matthew Ryan/0000-0003-2173-8437; Sutter, Megan/0000-0001-9816-9549; Conde-Sala, Josep Lluis/0000-0003-4139-0458; Perrin, Paul/0000-0003-2070-215X			Adams B., 2002, J CLIN GEROPSYCHOLOG, V8, P279, DOI DOI 10.1023/A:1019627323558; Allegri Ricardo F, 2006, Neuropsychiatr Dis Treat, V2, P105; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Alzheimer's Disease International, 2009, WORLD ALZH REP 2009; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Arango-Lasprilla JC, 2010, AM J ALZHEIMERS DIS, V25, P556, DOI 10.1177/1533317510382287; Argimon JM, 2004, FAM PRACT, V21, P454, DOI 10.1093/fampra/cmh418; Aschbacher K, 2008, BRAIN BEHAV IMMUN, V22, P493, DOI 10.1016/j.bbi.2007.10.002; Atienza FL, 2000, PSICOTHEMA, V12, P314; Au A, 2009, AGING MENT HEALTH, V13, P761, DOI 10.1080/13607860902918223; Bedard M, 2001, GERONTOLOGIST, V41, P652, DOI 10.1093/geront/41.5.652; Beery LC, 1997, OMEGA-J DEATH DYING, V35, P261, DOI 10.2190/9QT0-XBD0-V8E9-U650; Black SE, 2010, INT J GERIATR PSYCH, V25, P807, DOI 10.1002/gps.2421; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bruce DG, 2005, J GERONTOL A-BIOL, V60, P345, DOI 10.1093/gerona/60.3.345; Brzuzy S, 1997, SOC WORK HEALTH CARE, V26, P77, DOI 10.1300/J010v26n01_05; Gomez SC, 2012, EUR PSYCHIAT, V27; Cicchetti D., 1995, WILEY SERIES PERSONA, P618; Coen RF, 1997, INT J GERIATR PSYCH, V12, P331, DOI 10.1002/(SICI)1099-1166(199703)12:3<331::AID-GPS495>3.0.CO;2-J; Cohen J., 2013, STAT POWER ANAL BEHA; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diez-Quevedo C, 2001, PSYCHOSOM MED, V63, P679, DOI 10.1097/00006842-200107000-00021; Dilworth-Anderson P, 2002, GERONTOLOGIST, V42, P237, DOI 10.1093/geront/42.2.237; Donlan W, 2010, PSYCHOL REP, V106, P419, DOI 10.2466/PR0.106.2.419-432; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Fauth E, 2012, AGING MENT HEALTH, V16, P699, DOI 10.1080/13607863.2012.678482; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Gulin S, 2013, FAM SYST HE IN PRESS; Haley WE, 1996, J CONSULT CLIN PSYCH, V64, P121, DOI 10.1037/0022-006X.64.1.121; Haley William E, 2003, J Palliat Med, V6, P215; Harmell AL, 2011, BRIT J HEALTH PSYCH, V16, P317, DOI 10.1348/135910710X504932; Jacobson NS, 2001, CLIN PSYCHOL-SCI PR, V8, P255, DOI 10.1093/clipsy/8.3.255; Kasser VG, 1999, J APPL SOC PSYCHOL, V29, P935, DOI 10.1111/j.1559-1816.1999.tb00133.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lasprilla JCA, 2009, AM J ALZHEIMERS DIS, V24, P384, DOI 10.1177/1533317509341465; Lehan T, 2012, NEUROREHABILITATION, V30, P87, DOI 10.3233/NRE-2011-0730; Losada A, 2008, AGING MENT HEALTH, V12, P504, DOI 10.1080/13607860802224227; Machnicki G, 2009, DEMENT GERIATR COGN, V28, P206, DOI 10.1159/000236912; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Garcia-Alberca JM, 2011, INT J PSYCHIAT MED, V41, P57, DOI 10.2190/PM.41.1.f; Martin M., 1996, REV GERONTOLOGIA, V6, P338; Mausbach BT, 2011, CLIN PSYCHOL REV, V31, P900, DOI 10.1016/j.cpr.2011.04.004; MCDOWELL I, 1994, CAN J AGING, V13, P470; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Onishi J, 2005, ARCH GERONTOL GERIAT, V41, P159, DOI 10.1016/j.archger.2005.01.004; Papastavrou E, 2012, CANCER NURS, V35, P187, DOI 10.1097/NCC.0b013e31822cb4a0; Peters T, 2011, COLOMBIAS MINIMUM WA; Peters T, 2012, COLOMBIAS AVERAGE WA; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Rodriguez G, 2003, NEUROL SCI, V24, P329, DOI 10.1007/s10072-003-0184-1; Rosas-Carrasco O, 2014, GERIATR GERONTOL INT, V14, P146, DOI 10.1111/ggi.12072; Ryan RM, 2008, SOC PERSONAL PSYCHOL, V2, P702, DOI 10.1111/j.1751-9004.2008.00098.x; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Scholzel-Dorenhos CJM, 2009, ALZ DIS ASSOC DIS, V23, P171, DOI 10.1097/WAD.0b013e318190a260; Schubert CC, 2008, J GEN INTERN MED, V23, P1736, DOI 10.1007/s11606-008-0711-0; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; SCHULZ R, 1991, PSYCHOL AGING, V6, P569, DOI 10.1037/0882-7974.6.4.569; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Serrano-Aguilar PG, 2006, NEUROEPIDEMIOLOGY, V27, P136, DOI 10.1159/000095760; Slachevsky A, 2013, J ALZHEIMERS DIS, V35, P297, DOI 10.3233/JAD-122086; SPSS Inc, 2010, SPSS BAS 19 0 WIND; Stewart AL, 1992, MEASURING FUNCTIONIN; Truzzi A, 2012, REV BRAS PSIQUIATR, V34, P405, DOI 10.1016/j.rbp.2012.02.006; Valimaki TH, 2009, AGING MENT HEALTH, V13, P799, DOI 10.1080/13607860903046487; Vitaliano PP, 2003, PSYCHOL BULL, V129, P946, DOI 10.1037/0033-2909.129.6.946; Wakui T, 2012, AGING MENT HEALTH, V16, P500, DOI 10.1080/13607863.2011.644263; Ward A, 2012, ALZHEIMERS DEMENT, V8, P14, DOI 10.1016/j.jalz.2011.01.002; Ware J.E., 1993, SF 36 HLTH SURVEY MA; Ware JE, 1998, J CLIN EPIDEMIOL, V51, P1159, DOI 10.1016/S0895-4356(98)00107-3; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Williamson GM, 2000, PL S SOC CL, P173; Wulsin Lawson, 2002, Prim Care Companion J Clin Psychiatry, V4, P191; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; Zucchella C, 2012, ALZ DIS ASSOC DIS, V26, P55, DOI 10.1097/WAD.0b013e31821aa6de	77	5	6	1	14	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2014	39	3					499	509		10.3233/JAD-130764			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	AA5AW	WOS:000331108900004	24240638				2022-02-06	
J	Rousseaux, M; Daveluy, W; Kozlowski, O; Allart, E				Rousseaux, Marc; Daveluy, Walter; Kozlowski, Odile; Allart, Etienne			Onabotulinumtoxin-A injection for disabling lower limb flexion in hemiplegic patients	NEUROREHABILITATION			English	Article						Botulinum toxin type-A; lower limb; muscle spasticity; onabotulinumtoxinA	BOTULINUM TOXIN INJECTIONS; POSTSTROKE SPASTICITY; INTRATHECAL BACLOFEN; MULTIPLE-SCLEROSIS; STROKE; MUSCLES; NERVE; KNEE	BACKGROUND: Hemiplegic patients with supraspinal spasticity can present with a flexor pattern at the hip and knee that hampers both passive and active functions. OBJECTIVE: To investigate the efficacy of OnabotulinumtoxinA injections on this flexor scheme. METHODS: This open-label observational study included eleven patients who had suffered a unilateral stroke or traumatic brain injury. All had impairment in the activities of daily living caused by severe hip and knee flexion. OnabotulinumtoxinA injections of 300-400U (total dose) were administered to the iliopsoas (iliacus) and knee flexors and, when necessary, to other muscles of the hip and knee. Evaluations were performed pre-treatment (weeks -4 to -8, and day 1) and post-treatment (week 10 and week 21): spasticity, range of motion, limb positioning, passive functions and pain. RESULTS: A modest improvement in hip and knee extension was observed, as evidenced by the Modified Ashworth Score and range of passive extension movements. Limb positioning was also improved. Clear benefits were found on passive functioning, including toileting, dressing and bed facilities, as well as pain levels. Active functions remained unchanged. More definite improvement was found in patients with severe difficulties. CONCLUSIONS: OnabotulinumtoxinA injection can contribute to reducing the consequences of disabling lower limb flexion.	[Rousseaux, Marc; Daveluy, Walter; Kozlowski, Odile; Allart, Etienne] CHRU Lille, Hop Swynghedauw, Neurol Rehabil Unit, F-59037 Lille, France		Rousseaux, M (corresponding author), Univ Hosp Ctr, Hop Swynghedauw, Neurol Rehabil Unit, F-59037 Lille, France.	marc.rousseaux@chru-lille.fr	Allart, Etienne/D-5465-2015	Allart, Etienne/0000-0002-4220-0065			Bleyenheuft C, 2009, GAIT POSTURE, V30, P168, DOI 10.1016/j.gaitpost.2009.04.003; Bohannon R. W., 1987, PHYS THER, V67, P206; BORGSTEIN J, 1993, AM J PHYS MED REHAB, V72, P364; Brashear A, 2002, NEW ENGL J MED, V347, P395, DOI 10.1056/NEJMoa011892; British Medical Research Council, 1943, WAR MEMORANDUM, P1; Decq P, 1996, NEUROCHIRURGIE, V42, P275; Dvorak EM, 2011, TOP STROKE REHABIL, V18, P195, DOI 10.1310/tsr1803-195; Elovic EP, 2008, ARCH PHYS MED REHAB, V89, P799, DOI 10.1016/j.apmr.2008.01.007; Garcia Ruiz P., 2002, J NEUROL S1, V249, pS110; Gracies JM, 2007, DISABIL REHABIL, V29, P1789, DOI 10.1080/09638280701568437; Hyman N, 2000, J NEUROL NEUROSUR PS, V68, P707, DOI 10.1136/jnnp.68.6.707; Kahle W., 1984, ANATOMIE APPAREIL LO; KONSTANZER A, 1993, NERVENARZT, V64, P517; MERTENS P, 1991, NEUROSURGERY SPASTIC, P119; Meythaler JM, 2001, STROKE, V32, P2099, DOI 10.1161/hs0901.095682; Molenaers G., 1999, EUR J NEUROL, V6, P59; Montane E, 2004, NEUROLOGY, V63, P1357; Rosales RL, 2008, J NEURAL TRANSM, V115, P617, DOI 10.1007/s00702-007-0869-3; Sheean G, 2002, EUR J NEUROL, V9, P3, DOI 10.1046/j.1468-1331.2002.0090s1003.x; Urban PP, 2010, STROKE, V41, P2016, DOI 10.1161/STROKEAHA.110.581991; van Campenhout A, 2011, DEV MED CHILD NEUROL, V53, P108, DOI 10.1111/j.1469-8749.2010.03816.x; Viel EJ, 2002, EUR J PAIN-LONDON, V6, P97, DOI 10.1053/eujp.2001.0269	22	5	7	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	1					25	30		10.3233/NRE-141093			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP0PN	WOS:000341764700004	24990003				2022-02-06	
J	Sawamura, D; Ikoma, K; Yoshida, K; Inagaki, Y; Ogawa, K; Sakai, S				Sawamura, Daisuke; Ikoma, Katsunori; Yoshida, Kazuki; Inagaki, Yuji; Ogawa, Keita; Sakai, Shinya			Active inhibition of task-irrelevant sounds and its neural basis in patients with attention deficits after traumatic brain injury	BRAIN INJURY			English	Article						Active inhibition; distractor; NIRS; PASAT; traumatic brain injury; working memory	WORKING-MEMORY; PREFRONTAL CORTEX; DISTRACTION; SPEECH; FMRI	Primary objective: To examine active inhibition of irrelevant stimuli and evaluate its neural basis using functional near infrared spectroscopy in patients with attention deficits after traumatic brain injury (TBI). Research design: Case control study. Methods and procedures: Ten patients with TBI and 10 healthy control subjects participated in this study. The Paced Auditory Serial Addition Test (PASAT) was performed with (distracting PASAT) and without (PASAT) distracting Japanese kana phonetic characters presented between each number. A block design was used. Subjects alternately performed each task three times. Main outcomes and results: Healthy controls performed better than patients with TBI on both the tasks. When performing the PASAT, healthy controls showed significant activity in every region of interest except the right lateral prefrontal cortex (PFC), but patients with TBI showed significant activity only in the left anterior PFC and left lateral PFC. When performing the distracting PASAT, the right lateral PFC was active in healthy controls, but not in patients with TBI. Conclusion: These results confirm that patients with moderate-to-severe TBI were affected by distractors that influenced order processing. It is suggested that the working memory of patients with TBI was affected by distracting stimuli, whereas that of healthy individuals was not.	[Sawamura, Daisuke; Yoshida, Kazuki] Hokkaido Univ, Grad Sch Hlth Sci, Div Hlth Sci, Sapporo, Hokkaido 0600812, Japan; [Sawamura, Daisuke; Ogawa, Keita] Hokkaido Univ Hosp, Dept Rehabil, Sapporo, Hokkaido 060, Japan; [Ikoma, Katsunori] Hokkaido Univ, Dept Rehabil Med, Sapporo, Hokkaido 0600812, Japan; [Yoshida, Kazuki] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Occupat Therapy, Eniwa, Hokkaido, Japan; [Inagaki, Yuji] Hokkaido Univ, Grad Sch Med, Dept Rehabil & Phys Med, Sapporo, Hokkaido 0600812, Japan; [Sakai, Shinya] Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, Sapporo, Hokkaido 0600812, Japan		Sakai, S (corresponding author), Hokkaido Univ, Fac Hlth Sci, Dept Functioning & Disabil, Kita Ku, N-12 W-5, Sapporo, Hokkaido 0600812, Japan.	sakai@hs.hokudai.ac.jp	Sawamura, Daisuke/AAK-3975-2021; Sakai, Shinya/D-7474-2012	Sawamura, Daisuke/0000-0003-3180-3474; 			Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Baird BJ, 2004, THESIS CARLETON U OT; Cohen JA, 2000, NEUROLOGY, V54, P802, DOI 10.1212/WNL.54.4.802; Conway ARA, 2001, PSYCHON B REV, V8, P331, DOI 10.3758/BF03196169; Dolcos F, 2007, BRAIN RES, V1152, P171, DOI 10.1016/j.brainres.2007.03.059; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; Ellermeier W, 1997, J ACOUST SOC AM, V102, P2191, DOI 10.1121/1.419596; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Gilbert SJ, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00125; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Hughes RW, 2005, J EXP PSYCHOL LEARN, V31, P736, DOI 10.1037/0278-7393.31.4.736; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lockwood AH, 2004, J INT NEUROPSYCH SOC, V10, P26, DOI 10.1017/S1355617740410145; Lyyra P, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-12; Marsh JE, 2008, J EXP PSYCHOL LEARN, V34, P243, DOI 10.1037/0278-7393.34.1.243; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Neath I, 2003, Q J EXP PSYCHOL-A, V56, P1269, DOI 10.1080/02724980244000756; Ophir E, 2009, P NATL ACAD SCI USA, V106, P15583, DOI 10.1073/pnas.0903620106; Pyka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007198; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Sawamura D, 2012, HIGHER BRAIN FUNCTIO, V33, P533; Schneider D, 2013, BEHAV BRAIN RES, V256, P311, DOI 10.1016/j.bbr.2013.08.046; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Soderlund G, 2007, J CHILD PSYCHOL PSYC, V48, P840, DOI 10.1111/j.1469-7610.2007.01749.x; Sorqvist P, 2010, NOISE HEALTH, V12, P217, DOI 10.4103/1463-1741.70500; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; TREISMAN AM, 1960, Q J EXP PSYCHOL, V12, P242, DOI 10.1080/17470216008416732; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; Tsuzuki D, 2007, NEUROIMAGE, V34, P1506, DOI 10.1016/j.neuroimage.2006.10.043; Whyte J., 2004, REHABILITATION MED P, P1677	33	5	5	1	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	11					1455	1460		10.3109/02699052.2014.919531			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AP3IQ	WOS:000341969200015	24946201	Green Submitted			2022-02-06	
J	Shander, A; Michelson, EA; Sarani, B; Flaherty, ML; Shulman, IA				Shander, Aryeh; Michelson, Edward A.; Sarani, Babak; Flaherty, Matthew L.; Shulman, Ira A.			Use of Plasma in the Management of Central Nervous System Bleeding: Evidence-Based Consensus Recommendations	ADVANCES IN THERAPY			English	Article						Central nervous system bleeding; Cerebral hemorrhage; Intracranial hemorrhage; Plasma; Warfarin	FRESH-FROZEN PLASMA; PROTHROMBIN COMPLEX CONCENTRATE; VITAMIN-K ANTAGONISTS; INTERNATIONAL NORMALIZED RATIO; ORAL ANTICOAGULANT REVERSAL; RECOMBINANT FACTOR VIIA; TRAUMATIC BRAIN-INJURY; FACTOR-IX COMPLEX; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE	Central nervous system (CNS) hemorrhage is a potentially life-threatening condition, especially in patients with acquired coagulopathy. In this setting, treatment of CNS bleeding includes hemostatic therapy to replenish coagulation factors. There is currently a debate over the hemostatic efficacy of plasma in many clinical settings, alongside increasing concern about transfusion-associated adverse events. Despite these concerns, plasma is widely used. Moreover, plasma transfusion practice is variable and there is currently no uniform approach to treatment of traumatic, surgical or spontaneous CNS hemorrhage. This study addresses the need for guidance on the indications and potential risks of plasma transfusion in these settings. An Expert Consensus Panel was convened to develop recommendations guiding the use of plasma to treat bleeding and/or coagulopathy associated with CNS hemorrhage. The panel did not advise on the best treatment available but rather proposed recommendations to be used in the formulation of local procedures to support emergency physicians in their decision-making process. Evidence was systematically gathered from the literature and rated using methods established by the Scottish Intercollegiate Guidelines Network. The evidence was used to develop graded consensus recommendations, which are presented along with the evidence-based rationale for each in this report. Sixty-five articles were identified covering both vitamin K antagonist-anticoagulation reversal and treatment of bleeding/coagulopathy in non-anticoagulated patients. Recommendations were then developed in four clinical scenarios within each area, and agreed on unanimously by all members of the panel. The Panel considered plasma to be reasonable therapy for CNS hemorrhage requiring urgent correction of coagulopathy, although physicians should be prepared for potential cardiopulmonary complications, and evidence suggests that alternative therapies have superior risk-benefit profiles. Plasma could not be recommended in the absence of hemorrhage or coagulopathy. Consideration of the absolute risks and benefits of plasma therapy before transfusion is imperative.	[Shander, Aryeh] Englewood Hosp & Med Ctr, Dept Anesthesiol & Crit Care Med, Englewood, NJ USA; [Shander, Aryeh] Mt Sinai Sch Med, Dept Anesthesiol, New York, NY USA; [Shander, Aryeh] Mt Sinai Sch Med, Dept Med, New York, NY USA; [Shander, Aryeh] Mt Sinai Sch Med, Dept Surg, New York, NY USA; [Michelson, Edward A.] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA; [Michelson, Edward A.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Sarani, Babak] George Washington Univ, Dept Surg Trauma & Acute Care Surg, Washington, DC USA; [Flaherty, Matthew L.] Univ Cincinnati, Acad Hlth Ctr, Dept Neurol, Cincinnati, OH USA; [Shulman, Ira A.] Univ So Calif, Keck Sch Med, Transfus Med Serv Grp, Los Angeles, CA 90033 USA; [Shulman, Ira A.] Univ So Calif, Dept Pathol, Med Ctr, Los Angeles, CA 90089 USA		Shulman, IA (corresponding author), Univ So Calif, Keck Sch Med, Transfus Med Serv Grp, Los Angeles, CA 90033 USA.	ishulman@usc.edu		Sarani, Babak/0000-0001-6247-3004	CSL Behring	CSL Behring provided funding support for the following: honoraria payments and expenses reimbursement for Consensus Panel members for preparation and participation in the Panel; honoraria payment and administrative fee to The Society for the Advancement of Blood Management for independent review of the evidence-based recommendations; administrative/logistical support for the Consensus Panel meeting from Interactive Forums Inc.; and medical writing support for literature searches and manuscript preparation from Meridian HealthComms. All work, including the literature review, Panel meeting and manuscript development, was performed independently of the sponsor; the sponsor had no authorship or editorial control over the content of the meeting or any subsequent publication.	American Association of Blood Banks (AABB), 2013, CIRC INF US HUM BLOO; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Bechtel BF, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-40; Benjamin RJ, 2012, TRANSFUSION, V52, p9S, DOI 10.1111/j.1537-2995.2012.03622.x; Bershad EM, 2008, J NEUROSURG, V109, P664, DOI 10.3171/JNS/2008/109/10/0664; Bethel J, 2012, NURS STAND, V26, P8; Bethel James, 2012, Nurs Stand, V26, P49; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; Brackmann HH, 2000, BLOOD COAGUL FIBRIN, V11, pS39, DOI 10.1097/00001721-200004001-00009; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Brody DL, 2005, NEUROCRIT CARE, V2, P263, DOI 10.1385/NCC:2:3:263; Cartmill M, 2000, BRIT J NEUROSURG, V14, P458; Cervera A, 2012, J NEUROL, V259, P212, DOI 10.1007/s00415-011-6153-3; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Davis JW, 2004, J TRAUMA, V57, P1173, DOI 10.1097/01.TA.0000151257.79108.FB; Demeyere R, 2010, VOX SANG, V99, P251, DOI 10.1111/j.1423-0410.2010.01339.x; Etemadrezaie H, 2007, CLIN NEUROL NEUROSUR, V109, P166, DOI 10.1016/j.clineuro.2006.09.001; Flaherty ML, 2009, STROKE, V40, P1738, DOI 10.1161/STROKEAHA.108.538462; Francis R, 2011, WORLD NEUROSURG, V76, P484, DOI 10.1016/j.wneu.2011.09.053; FREDRIKSSON K, 1992, STROKE, V23, P972, DOI 10.1161/01.STR.23.7.972; Goldstein JN, 2006, STROKE, V37, P151, DOI 10.1161/01.STR.0000195047.21562.23; Gorlinger K, 2006, Hamostaseologie, V26, pS64; Grobler C, 2010, CAN J ANAESTH, V57, P458, DOI 10.1007/s12630-009-9250-3; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Holland LL, 2006, AM J CLIN PATHOL, V126, P133, DOI 10.1309/NQXHUG7HND78LFFK; Huttner HB, 2006, STROKE, V37, P1465, DOI 10.1161/01.STR.0000221786.81354.d6; Ivascu FA, 2005, J TRAUMA, V59, P1131, DOI 10.1097/01.ta.0000189067.16368.83; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; Kalina M, 2008, AM SURGEON, V74, P858; Karni A, 2001, AM SURGEON, V67, P1098; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Kozek-Langenecker S, 2011, CRIT CARE, V15, DOI 10.1186/cc10583; Lee SB, 2006, NEUROLOGY, V67, P1272, DOI 10.1212/01.wnl.0000238104.75563.2f; Li GX, 2011, TRANSFUSION, V51, P338, DOI 10.1111/j.1537-2995.2010.02816.x; Lier H, 2011, INTENS CARE MED, V37, P572, DOI 10.1007/s00134-011-2139-y; Linstone H.A., 2002, DELPHI METHOD TECHNI; Lubetsky A, 2003, ARCH INTERN MED, V163, P2469, DOI 10.1001/archinte.163.20.2469; Makris M, 1997, THROMB HAEMOSTASIS, V77, P477; May AK, 1997, AM SURGEON, V63, P233; Menzin J, 2012, J THROMB HAEMOST, V10, P596, DOI 10.1111/j.1538-7836.2012.04636.x; Menzin J, 2012, THROMB HAEMOSTASIS, V107, P662, DOI 10.1160/TH11-09-0646; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Mountain D, 2010, MED J AUSTRALIA, V193, P202, DOI 10.5694/j.1326-5377.2010.tb03868.x; Murad MH, 2010, TRANSFUSION, V50, P1370, DOI 10.1111/j.1537-2995.2010.02630.x; Naidech AM, 2011, AM J RESP CRIT CARE, V184, P998, DOI 10.1164/rccm.201103-0475CI; Narick C, 2012, TRANSFUSION, V52, P160, DOI 10.1111/j.1537-2995.2011.03247.x; Ostermann H, 2007, THROMB HAEMOSTASIS, V98, P790, DOI 10.1160/TH07-05-0367; Ouirke W, 2007, Ir Med J, V100, P402; Ozgonenel B, 2007, AM J HEMATOL, V82, P1091, DOI 10.1002/ajh.20902; Pandey S, 2012, TRANSFUSION, V52, p65S, DOI 10.1111/j.1537-2995.2012.03663.x; Perel P, 2009, BMC EMERG MED, V9, DOI 10.1186/1471-227X-9-15; Quinlan DJ, 2013, CIRCULATION, V128, P1179, DOI 10.1161/CIRCULATIONAHA.113.005107; Raj G, 1999, ARCH INTERN MED, V159, P2721, DOI 10.1001/archinte.159.22.2721; Roback JD, 2010, TRANSFUSION, V50, P1227, DOI 10.1111/j.1537-2995.2010.02632.x; Roberts I, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5839; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roitberg B, 2005, NEUROSURGERY, V57, P832, DOI 10.1227/01.NEU.0000180816.80626.C2; Sahni R, 2007, VASC HEALTH RISK MAN, V3, P701; Sarani B, 2008, CRIT CARE MED, V36, P1114, DOI 10.1097/CCM.0b013e318168f89d; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Sarode R, 2013, CIRCULATION, V128, P1234, DOI 10.1161/CIRCULATIONAHA.113.002283; Schochl H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-15; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Siddiq F, 2008, NEUROCRIT CARE, V8, P36, DOI 10.1007/s12028-007-9011-5; Sjoblom L, 2001, STROKE, V32, P2567, DOI 10.1161/hs1101.098523; Stanworth SJ, 2011, TRANSFUSION, V51, P62, DOI 10.1111/j.1537-2995.2010.02798.x; Stanworth SJ, 2004, BRIT J HAEMATOL, V126, P139, DOI 10.1111/j.1365-2141.2004.04973.x; Stead LG, 2010, CLIN NEUROL NEUROSUR, V112, P275, DOI 10.1016/j.clineuro.2009.12.002; Stein DM, 2009, J TRAUMA, V66, P63, DOI 10.1097/TA.0b013e318191bc8a; Steiner T, 2006, STROKE, V37, P256, DOI 10.1161/01.STR.0000196989.09900.f8; Steiner T, 2011, CEREBROVASC DIS, V32, P409, DOI 10.1159/000330653; Triulzi DJ, 2012, TRANSFUSION, V52, p5S, DOI 10.1111/j.1537-2995.2012.03643.x; U.S. Department of Health and Human Services Food and Drug Administration, GUID IND PROV CLIN E; US Department of Health and Human Services, NAT BLOOD COLL UT SU; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Watson DM, 2011, TRANSFUSION MED, V21, P124, DOI 10.1111/j.1365-3148.2010.01049.x; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x; Weber CF, 2012, ANESTHESIOLOGY, V117, P531, DOI 10.1097/ALN.0b013e318264c644; WINTER JP, 1989, ANN EMERG MED, V18, P553, DOI 10.1016/S0196-0644(89)80842-X; Xu CS, 2012, ARCH ORTHOP TRAUM SU, V132, P25, DOI 10.1007/s00402-011-1390-6; Yang L, 2012, TRANSFUSION, V52, P1673, DOI 10.1111/j.1537-2995.2011.03515.x; Yasaka M, 2003, THROMB HAEMOSTASIS, V89, P278; Yiu KH, 2006, AM J CARDIOL, V97, P409, DOI 10.1016/j.amjcard.2005.08.062	84	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0741-238X	1865-8652		ADV THER	Adv. Ther.	JAN	2014	31	1					66	90		10.1007/s12325-013-0083-7			25	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	AA0FN	WOS:000330771100004	24338742				2022-02-06	
J	Shaw, DR				Shaw, Dorothy R.			Pediatric cognitive rehabilitation: Effective treatments in a school-based environment	NEUROREHABILITATION			English	Article						Emotion recognition; brain injury; nonverbal communication; cognitive rehabilitation	TRAUMATIC BRAIN-INJURY	BACKGROUND: Many studies have investigated the impact of pediatric Cognitive Rehabilitation Therapy (CRT) upon intellectual functioning after traumatic brain injury; however, relatively few have identified efficacious treatment in a school setting. OBJECTIVE: The purpose is to present a variety of CRT strategies that would be useful to a teacher or therapist working with students who are learning disabled or who have who have had a traumatic brain injury (TBI). METHODS: This article investigates the particular challenges in learning which result from impaired cognition, and suggests techniques for improving memory and executive functioning. RESULTS: Students who are learning disabled or who have TBI face social and emotional issues that impact their learning. Special therapeutic interventions are necessary to assist with orienting to their setting, integrating with peers, and coping with distressing emotions. CONCLUSIONS: Students with TBI can adapt and flourish in a school based setting provided that therapies and learned strategies are targeted to their specific needs.	Baltimore City Publ Sch Syst, Baltimore, MD 21286 USA		Shaw, DR (corresponding author), Baltimore City Publ Sch Syst, 502 Epsom Rd, Baltimore, MD 21286 USA.	drshaw@bcps.k12.md.us					Dawson P., 2010, EXECUTIVE SKILLS CHI; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; Fuentes A, 2010, BRAIN INJURY, V24, P995, DOI 10.3109/02699052.2010.489791; Goyal A., 2008, RES DRAMA ED, V13, P337; Herrmann D, 2010, RETRAINING COGNITION; Klonoff PS, 2010, BRAIN INJURY, V24, P63, DOI 10.3109/02699050903512863; Matheson L, 2010, WORK, V36, P413, DOI 10.3233/WOR-2010-1043; Sample PL, 2007, SUBST USE MISUSE, V42, P705, DOI 10.1080/10826080701202536; Semrud-Clikeman M, 2010, APPL NEUROPSYCHOL, V17, P116, DOI 10.1080/09084281003708985; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099	11	5	5	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	1					23	28		10.3233/NRE-131005			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AA4JN	WOS:000331062000004	24284452				2022-02-06	
J	Talbot, LR; Levesque, A; Trottier, J				Talbot, Lise R.; Levesque, Annie; Trottier, Josee			Process of implementing collaborative care and its impacts on the provision of care and rehabilitation services to patients with a moderate or severe traumatic brain injury	JOURNAL OF MULTIDISCIPLINARY HEALTHCARE			English	Article						traumatic brain injury; collaborative care; rehabilitation; quality of care	FAMILY-MEMBERS; SATISFACTION; EXPERIENCES; SYSTEMS; UNIT	Objective: The introduction of new services in a rehabilitation center is a unique opportunity to introduce a new model of care and services between two institutions. A hospital and a rehabilitation center experienced a clinical management model inspired by an American approach - collaborative care. The purpose of this study was to describe the implementation of this approach and to provide a perception of the quality of care and services provided to patients with moderate or severe traumatic brain injury and to their caregivers. Materials and methods: In this qualitative study, individual semistructured interviews were conducted with patients and their caregivers in the hospital and rehabilitation center where the patients were treated. Individual semistructured interviews were conducted with administrators, and two focus groups were held with clinicians before and after the implementation. Results and conclusion: Ten days' waiting time were saved with the collaborative approach. Implementing the collaborative care approach has been found to have several benefits, including improved communication, coordination of services between institutions, and better preparation, awareness, and involvement of patients and their families. Administrators, clinicians, patients, and caregivers expressed their opinions on the organization of care and services, the needs and expectations of patients and their caregivers, their participation in terms of roles and responsibilities, their perception of continuity of care, their satisfaction with the care process, and their suggestions for improvements.	[Talbot, Lise R.; Levesque, Annie; Trottier, Josee] Univ Sherbrooke, Fac Med & Hlth Sci, Sch Nursing Sci, 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada; [Talbot, Lise R.] Etienne Le Bel Clin Res Ctr, Sherbrooke, PQ, Canada; [Talbot, Lise R.] Res Ctr Aging, Sherbrooke, PQ, Canada		Talbot, LR (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Sch Nursing Sci, 12e Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	lise.talbot@usherbrooke.ca			Fonds de recherche Quebecois en sante	The authors wish to thank the Fonds de recherche Quebecois en sante for its financial support, and the patients, caregivers, clinicians, and administrators for their time and wise suggestions. Many thanks to Jennifer Chambers for her excellent suggestions during the scientific review.	Alvarez GF, 2006, CURR OPIN CRIT CARE, V12, P614, DOI 10.1097/MCC.0b013e328010c7ef; [Anonymous], 2001, DIR SANT PUBL EV; [Anonymous], 2013, WHAT IS BRAIN INJ; Auerbach SM, 2005, AM J CRIT CARE, V14, P202, DOI 10.4037/ajcc2005.14.3.202; Azoulay E, 2004, CRIT CARE MED, V32, P1832, DOI 10.1097/01.CCM.0000139693.88931.59; Bergeson SC, 2006, JAMA-J AM MED ASSOC, V296, P2848, DOI 10.1001/jama.296.23.2848; Bond A Elaine, 2003, Crit Care Nurse, V23, P63; Canadian Institute for Health Information (CIHI), 2013, NAT TRAUM REG REP 20; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cohen JJ, 2000, ACAD MED, V75, P107, DOI 10.1097/00001888-200002000-00004; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Guba EG., 1989, 4 GENERATION EVALUAT; Henrich NJ, 2011, CRIT CARE MED, V39, P1000, DOI 10.1097/CCM.0b013e31820a92fb; Heyland DK, 2002, CRIT CARE MED, V30, P1413, DOI 10.1097/00003246-200207000-00002; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Lefebvre H, 2003, RUPTURES U MONTR GRO, V9, P127; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McKay Cheryl A, 2008, Nurs Adm Q, V32, P109, DOI 10.1097/01.NAQ.0000314539.44488.e6; Morgan D.L., 1998, ANAL REPORTING FOCUS; O'Callaghan AM, 2011, INT J SPEECH-LANG PA, V13, P218, DOI 10.3109/17549507.2011.549240; QSR International, 2006, NVIVO QUAL DAT AN SO; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Sinnakaruppan I, 2001, BRAIN INJURY, V15, P653; Sirois MJ, 2004, ARCH PHYS MED REHAB, V85, P184, DOI 10.1016/j.apmr.2003.06.009; Stebbins P, 1998, J REHABIL, V64, P15; Van der Merwe J.D., 2004, THESIS; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025; ZANDER K, 1995, MANAGING OUTCOMES CO	30	5	5	0	0	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1178-2390			J MULTIDISCIP HEALTH	J. Multidiscip. Healthc.		2014	7						313	320		10.2147/JMDH.S64897			8	Health Care Sciences & Services	Emerging Sources Citation Index (ESCI)	Health Care Sciences & Services	V06DW	WOS:000213921900036	25114538	Green Submitted, Green Published, gold			2022-02-06	
J	Thompson, A; Bertocci, G				Thompson, Angela; Bertocci, Gina			Pediatric bed fall computer simulation model: Parametric sensitivity analysis	MEDICAL ENGINEERING & PHYSICS			English	Article						Pediatric falls; Biomechanics; Computer simulation; Injury assessment	HUMAN CERVICAL-SPINE; MULTIBODY DYNAMICS ANALYSIS; TRAUMATIC BRAIN-INJURY; FEET-1ST FREE FALLS; LOW-HEIGHT FALLS; HEAD-INJURY; BIOMECHANICAL ANALYSIS; YOUNG-CHILDREN; FRACTURES; RECONSTRUCTION	Falls from beds and other household furniture are common scenarios that may result in injury and may also be stated to conceal child abuse. Knowledge of the biomechanics associated with short-distance falls may aid clinicians in distinguishing between abusive and accidental injuries. In this study, a validated bed fall computer simulation model of an anthropomorphic test device representing a 12-month-old child was used to investigate the effect of altering fall environment parameters (fall height, impact surface stiffness, initial force used to initiate the fall) and child surrogate parameters (overall mass, head stiffness, neck stiffness, stiffness for other body segments) on fall dynamics and outcomes related to injury potential. The sensitivity of head and neck injury outcome measures to model parameters was determined. Parameters associated with the greatest sensitivity values (fall height, initiating force, and surrogate mass) altered fall dynamics and impact orientation. This suggests that fall dynamics and impact orientation play a key role in head and neck injury potential. With the exception of surrogate mass, injury outcome measures tended to be more sensitive to changes in environmental parameters (bed height, impact surface stiffness, initiating force) than surrogate parameters (head stiffness, neck stiffness, body segment stiffness). (C) 2013 IPEM. Published by Elsevier Ltd. All rights reserved.	[Thompson, Angela; Bertocci, Gina] Univ Louisville, Dept Bioengn, Louisville, KY 40202 USA; [Bertocci, Gina] Univ Louisville, Louisville, KY 40202 USA		Bertocci, G (corresponding author), Univ Louisville, Dept Bioengn, 204 Res Tower,500 S Preston St, Louisville, KY 40202 USA.	g.bertocci@louisville.edu			Department of Justice (DOD, Office of Juvenile Justice and Delinquency Prevention (OJJDP) [2009-DD-BX-0086]	This study was funded by the Department of Justice (DOD, Office of Juvenile Justice and Delinquency Prevention (OJJDP) (Award #2009-DD-BX-0086). The opinions expressed herein are those of the authors and do not necessarily represent those of DOJ or OJJDP.	Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; [Anonymous], 2003, J211 SAE; [Anonymous], 2002, ACCIDENTAL INJURY BI; BADER DL, 1983, BIOMATERIALS, V4, P305, DOI 10.1016/0142-9612(83)90033-9; Bandak, 1999, DEV IMPROVED INJURY; Bertocci GE, 2004, INJURY, V35, P417, DOI 10.1016/S0020-1383(03)00062-7; Bertocci GE, 2003, ARCH PEDIAT ADOL MED, V157, P480, DOI 10.1001/archpedi.157.5.480; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Desantis Klinich Kathleen, 2002, Stapp Car Crash J, V46, P165; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly MC, 2009, INT J CRASHWORTHINES, V14, P503, DOI 10.1080/13588260902826554; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; Irwin AL, 1997, CHILD OCCUPANT PROT; Jun OY, 2005, SPINE, V30, pE716, DOI 10.1097/01.brs.0000192280.53831.70; Kumaresan S, 2000, J BIOMECH ENG-T ASME, V122, P60, DOI 10.1115/1.429628; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Loyd AM, 2011, STUDIES HUMAN HEAD N; MOHAN D, 1979, J BIOMECH ENG-T ASME, V101, P250, DOI 10.1115/1.3426254; National Center for Health Statistics, 2000, CDC GROWTH CHARTS; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Panjabi MM, 2001, SPINE, V26, P2692, DOI 10.1097/00007632-200112150-00012; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Scherl SA, 2000, CLIN ORTHOP RELAT R, P96; Schulz BW, 2008, J REHABIL RES DEV, V45, P1227, DOI 10.1682/JRRD.2007.06.0092; Schwab JS, 2006, SPINE, V31, P2439, DOI 10.1097/01.brs.0000239125.54761.23; SHEA M, 1991, J BIOMECH, V24, P95, DOI 10.1016/0021-9290(91)90354-P; Silver-Thorn M B, 1999, IEEE Trans Rehabil Eng, V7, P268, DOI 10.1109/86.788464; STRAIT RT, 1995, PEDIATRICS, V96, P667; Sturtz G, 1980, 24 STAPP CAR CRASH C; Thompson A, 2011, COMPUT METHODS BIOME; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Thompson AK, 2009, J TRAUMA, V66, P1019, DOI 10.1097/TA.0b013e31817dac8b; Van Ee C, 2009, ASME C P, P387; Wheeldon JA, 2006, J BIOMECH, V39, P375, DOI 10.1016/j.jbiomech.2004.11.014; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan Narayan, 2011, Ann Adv Automot Med, V55, P169; Zheng Y, 1999, IEEE Trans Rehabil Eng, V7, P257, DOI 10.1109/86.788463	42	5	5	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	JAN	2014	36	1					110	118		10.1016/j.medengphy.2013.10.006			9	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	297NC	WOS:000330261200016	24210851				2022-02-06	
J	van Vliet-Ruissen, C; McKinlay, A; Taylor, A				van Vliet-Ruissen, Cora; McKinlay, Audrey; Taylor, Annabel			Adult functioning of mothers with traumatic brain injury at high risk of child abuse: A pilot study	NEUROREHABILITATION			English	Article						Traumatic brain injury; prevalence; mothers; child abuse; parenting	PARENTS; FAMILY	BACKGROUND: There is little information regarding the impact that traumatic brain injury (TBI) has on the functioning of mothers at risk of child abuse. OBJECTIVE: This study evaluated adult functioning (e. g. child abuse, substance use, criminal convictions, and mental health problems) of mothers, at high risk for child abuse, who also had a history of TBI compared with those without TBI. It was hypothesised that mothers with a history of TBI would engage in higher rates of dysfunctional behaviour compared to those with no history of TBI. METHOD: Participants were 206 women engaged in a child abuse prevention programme for mothers who are highly socially disadvantaged, and at high risk for child abuse. Using historical data collected as part of the referral, and self report intake process, this study compared child abuse, mental health problems (depression, anxiety, substance use) and rates of criminal offending for mothers with a history of TBI versus those with no history of TBI. RESULTS: Mothers with TBI were no more likely than those without TBI to have engaged in child abuse. However, mothers with a history of TBI were significantly more likely to have one or more mental health problems, engage in substance use and have a history of criminal offending. CONCLUSIONS: Parents with TBI who have been identified as high risk for engaging in child abuse have increased risk for mental health problems and criminal offending. These issues need to be considered when designing parenting programmes in order for intervention strategies to be effective.	[van Vliet-Ruissen, Cora; Taylor, Annabel] Univ Canterbury, Dept Social Work & Human Serv, Christchurch 1, New Zealand; [McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [McKinlay, Audrey] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand		McKinlay, A (corresponding author), Monash Univ, Sch Psychol & Psychiat, Bldg 17, Clayton Campus, Vic 3800, Australia.	audrey.mckinlay@monash.edu		Taylor, Annabel/0000-0002-4646-9248; McKinlay, Audrey/0000-0001-9846-8514			Anderson M., 2008, CONT MODEL STRESS UN, P23; ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; Booth J., 2006, GOOD PRACTICE BRAIN; Charles N, 2007, NEUROREHABILITATION, V22, P61; Ducharme J. M., 2004, CLIN CASE STUD, V3, P95, DOI [10.1177/1534650103259626, DOI 10.1177/1534650103259626]; Ducharme JM, 2002, AM J ORTHOPSYCHIAT, V72, P585, DOI 10.1037/0002-9432.72.4.585; Ducharme JM, 2003, J HEAD TRAUMA REHAB, V18, P88, DOI 10.1097/00001199-200301000-00009; Ducharme JM, 2002, J EMOT BEHAV DISORD, V10, P241, DOI 10.1177/10634266020100040601; Ducharme JM, 2001, J APPL BEHAV ANAL, V34, P221, DOI 10.1901/jaba.2001.34-221; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; Kraus J. F., 1995, EPIDEMIOLOGICAL FEAT; Marques de Sa J. P., 2007, NONPARAMETRIC TESTS; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Miller L, 2001, FAMILY THERAPY AND MENTAL HEALTH, P311; Novack T., 2008, NEUROPSYCHOLOGY INPA, P13; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Satyanarayana Veena A, 2011, Indian J Psychiatry, V53, P351, DOI 10.4103/0019-5545.91911; Smith L. M., 1995, FAMILY SUPPORT PROGR, P109; URBACH JR, 1994, J NEUROPSYCH CLIN N, V6, P289; Uysal S, 1998, J HEAD TRAUMA REHAB, V13, P57, DOI 10.1097/00001199-199812000-00007; Weatherhead S., 2008, CLIN PSYCHOL FORUM, V182, P36	22	5	5	0	4	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	34	2					373	380		10.3233/NRE-131032			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG3NM	WOS:000335326300019	24401827				2022-02-06	
J	Weaver, SM; Portelli, JN				Weaver, Starla M.; Portelli, Jaclyn N.			Neurobiological Influences on Recovery from Traumatic Brain Injury: The Role of Genetic Polymorphisms	CURRENT PHARMACEUTICAL DESIGN			English	Article						Traumatic Brain Injury; Polymorphisms; Genes	CONVERTING-ENZYME GENE; BDNF VAL66MET POLYMORPHISM; APOLIPOPROTEIN-E POLYMORPHISM; NEUROTROPHIC FACTOR; HEAD-INJURY; SUSCEPTIBILITY FACTOR; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; ASSOCIATION; DOPAMINE	Recovery from traumatic brain injury (TBI) is variable despite similarities in the severity or mechanism of injury. The study of genetic polymorphisms offers an avenue for explaining individual differences in recovery and outcome following TBI. The current paper reviews the role that genetic polymorphisms may play in influencing recovery and quality of life following TBI. Investigating the role of polymorphisms on recovery from TBI may contribute to a better understanding of individual variations in outcome and has the potential to lead to earlier and more targeted interventions and rehabilitation based on a patient's genetic makeup. By outlining what has been discovered about the relationship between polymorphisms and TBI we hope to both inform the medical community about the potential for polymorphisms to influence recovery following TBI and provide a roadmap to researchers about the gaps in research within this population.			Weaver, SM (corresponding author), 1199 Pleasant Valley Way, W Orange, NJ 07052 USA.	sweaver@kesslerfoundation.org		Weaver, Starla/0000-0002-9559-8337			Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Alexander S, 2007, J NEUROTRAUM, V24, P790, DOI 10.1089/neu.2006.0133; Amouyel P, 1996, NEUROSCI LETT, V217, P203, DOI 10.1016/S0304-3940(96)13092-5; [Anonymous], 2013, AM J PSYCHIAT, V170, P207; ARA S, 1990, NUCLEIC ACIDS RES, V18, P4961, DOI 10.1093/nar/18.16.4961; Aragona CJD, 2012, NEUROREHABILITATION, V30, P55, DOI 10.3233/NRE-2011-0727; Ariza M, 2006, J NEUROPSYCH CLIN N, V18, P39, DOI 10.1176/appi.neuropsych.18.1.39; Bagnato S, 2012, J NEUROTRAUM, V29, P2050, DOI 10.1089/neu.2011.2184; Bales James W, 2010, Open Drug Discov J, V2, P119; Bales JW, 2011, J NEUROTRAUM, V28, pA101; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bonham JR, J INHERIT M IN PRESS; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Carter M, 2011, J NEUROTRAUM, V28, pA14; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Comings DE, 1998, ALCOHOL, V16, P61, DOI 10.1016/S0741-8329(97)00178-X; Conley YP, 2011, PM&R, V3, pS52, DOI 10.1016/j.pmrj.2011.04.004; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Dalla Libera AL, 2011, BRAIN INJURY, V25, P365, DOI 10.3109/02699052.2011.556107; Dardiotis E, 2006, SURG NEUROL, V66, P334, DOI 10.1016/j.surneu.2006.05.042; Dardiotis E, 2012, CURR OPIN PSYCHIATR, V25, P231, DOI 10.1097/YCO.0b013e3283523c0e; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Duprez DA, 2006, J HYPERTENS, V24, P983, DOI 10.1097/01.hjh.0000226182.60321.69; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Frenette AJ, 2012, J NEUROTRAUM, V29, P1, DOI 10.1089/neu.2011.1812; Galvin KA, 2003, NEUROSCIENCE, V118, P1023, DOI 10.1016/S0306-4522(03)00066-6; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hadjigeorgiou GM, 2005, NEUROLOGY, V65, P1077, DOI 10.1212/01.wnl.0000178890.93795.0e; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Hassan A, 2002, J NEUROL NEUROSUR PS, V72, P343, DOI 10.1136/jnnp.72.3.343; Hatz L, 2011, J NEUROTRAUM, V28, pA101; Hoofien D, 2001, BRAIN INJURY, V15, P189; HORN AS, 1990, PROG NEUROBIOL, V34, P387, DOI 10.1016/0301-0082(90)90033-D; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Kehoe AD, 2008, EMERG MED J, V25, P759, DOI 10.1136/emj.2006.045336; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kozlowski O, J NEUROTRAU IN PRESS; Kraus J. F., 1999, REHABILITATION ADULT, P3; Krueger F, 2011, J NEUROSCI, V31, P598, DOI 10.1523/JNEUROSCI.1399-10.2011; Lanctot KL, 2010, BRAIN INJURY, V24, P959, DOI 10.3109/02699051003789229; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martinez-Lucas P, 2005, INTENS CARE MED, V31, P1168, DOI 10.1007/s00134-005-2715-0; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McAllister TW, 2008, BRAIN INJURY, V22, P705, DOI 10.1080/02699050802263019; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McAllister TW, 2009, J HEAD TRAUMA REHAB, V24, P65, DOI 10.1097/HTR.0b013e3181996e6b; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; McDevitt JK, 2011, BRAIN INJURY, V25, P1108, DOI 10.3109/02699052.2011.607790; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Minambres E, 2003, CRIT CARE MED, V31, P933, DOI 10.1097/01.CCM.0000055370.66389.59; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Ost M, 2008, ACTA ANAESTH SCAND, V52, P1364, DOI 10.1111/j.1399-6576.2008.01675.x; Pal T, 2012, CANCER CONTROL, V19, P255, DOI 10.1177/107327481201900402; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Ponsford J, 2007, NEUROLOGY, V68, P619, DOI 10.1212/01.wnl.0000254609.04330.9d; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Raymont V, 2008, BRAIN, V131, P543, DOI 10.1093/brain/awm300; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Richard F, 2000, NEUROBIOL AGING, V21, P75, DOI 10.1016/S0197-4580(99)00102-5; Richard F, 2001, NEUROLOGY, V56, P1593, DOI 10.1212/WNL.56.11.1593; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rivera-Chavez FA, 2003, SHOCK, V20, P218, DOI 10.1097/00024382-200309000-00004; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; Rostami E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027389; Sabol SZ, 1998, HUM GENET, V103, P273, DOI 10.1007/s004390050816; Sadigh-Eteghad S, 2012, NEUROSCIENCES, V17, P321; Sanchez MM, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.47; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Sayed-Tabatabaei FA, 2003, STROKE, V34, P1634, DOI 10.1161/01.STR.0000077926.49330.64; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; Shimizu E, 2003, BIOL PSYCHIAT, V54, P70, DOI 10.1016/S0006-3223(03)00181-1; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; SORBI S, 1995, NAT MED, V1, P852, DOI 10.1038/nm0995-852; Starkstein SE, 2005, INT PSYCHOGERIATR, V17, pS93, DOI 10.1017/S1041610205001973; Tanriverdi T, 2006, SURG NEUROL, V65, P7, DOI 10.1016/j.surneu.2005.05.024; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; TIRET L, 1992, AM J HUM GENET, V51, P197; Uzan M, 2005, ACTA NEUROCHIR, V147, P715, DOI 10.1007/s00701-005-0529-z; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Weaver SM, 2012, NEUROSCIENTIST, V18, P631, DOI 10.1177/1073858411435706; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Willemse-Van Son AHP, 2008, J NEUROL NEUROSUR PS, V79, P426, DOI 10.1136/jnnp.2007.129460; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489	117	5	5	0	6	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2014	20	26					4275	4283					9	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	AK6AA	WOS:000338508000013	24025055				2022-02-06	
J	Winardi, W; Kwan, AL; Wang, TL; Su, YF; Yen, CP; Tsai, HP; Sheehan, J; Su, CY				Winardi, William; Kwan, Aij-Lie; Wang, Tse-Lun; Su, Yu-Feng; Yen, Chun-Po; Tsai, Hung-Pei; Sheehan, Jason; Su, Chwen-Yng			Predictors of Memory and Processing Speed Dysfunctions after Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							MODERATE; LEVEL	Background. The aims of this study were to evaluate the predictive value of admission Glasgow Coma Scale (GCS) scores, duration of unconsciousness, neurosurgical intervention, and countercoup lesion on the impairment of memory and processing speed functions six months after a traumatic brain injury (TBI) based on a structural equation modeling. Methods. Thirty TBI patients recruited from Neurosurgical Department at the Kaohsiung Medical University Hospital were administered the Wechsler Memory Scale-III (WMS-III) and the Wechsler Adult Intelligence Scale-III processing speed index to evaluate the memory and processing speed functions. Results. The study showed that GCS scores accounted for 40% of the variance in memory/ processing speed. No significant predictive effects were found for the other three variables. GCS classification at the time of TBI seems to correspond moderately to the severity of memory/ processing speed dysfunctions. Conclusions. The present study demonstrated that admission GCS score is a robust predictor of memory/ processing speed dysfunctions after TBI. The results should be replicated with a large sample of patients with TBI, or be extended by examining other potential clinical predictors.	[Winardi, William] Poznan Univ, Sch Med, PL-61701 Poznan, Poland; [Kwan, Aij-Lie; Su, Yu-Feng; Yen, Chun-Po; Sheehan, Jason] Univ Virginia Hlth Syst, Dept Neurosurg, Charlottesville, VA 22908 USA; [Kwan, Aij-Lie] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung 807, Taiwan; [Wang, Tse-Lun; Su, Yu-Feng] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung 807, Taiwan; [Yen, Chun-Po] Univ Virginia, Dept Neurosurg, Charlottesville, VA 22908 USA; [Tsai, Hung-Pei] Kaohsiung Med Univ Hosp, Coll Med, Kaohsiung 807, Taiwan; [Su, Chwen-Yng] Kaohsiung Med Univ Hosp, Coll Hlth Sci, Dept Occupat Therapy, Kaohsiung 807, Taiwan		Sheehan, J (corresponding author), Univ Virginia Hlth Syst, Dept Neurosurg, Charlottesville, VA 22908 USA.	jps2f@virginia.edu; cysu@cc.kmu.edu.tw		Su, Yu-feng/0000-0003-0355-3981			Arbuckle JL, 2003, AMOS 5 0 USERS GUIDE; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; BENTLER PM, 1980, ANNU REV PSYCHOL, V31, P419, DOI 10.1146/annurev.ps.31.020180.002223; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Hattori N, 2003, J NUCL MED, V44, P1709; Hawkins KA, 1998, CLIN NEUROPSYCHOL, V12, P535, DOI 10.1076/clin.12.4.535.7236; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kline R. B., 2016, PRINCIPLES PRACTICE, VFourth; Langeluddecke PM, 2005, J CLIN EXP NEUROPSYC, V27, P576, DOI 10.1080/13803390490918372; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; OMMAYA AK, 1995, J NEUROTRAUM, V12, P527, DOI 10.1089/neu.1995.12.527; ROSS BL, 1994, AM J PHYS MED REHAB, V73, P341, DOI 10.1097/00002060-199409000-00007; Santos ME, 1998, BRAIN INJURY, V12, P759, DOI 10.1080/026990598122151; Verger K, 2000, BRAIN INJURY, V14, P495; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird	26	5	5	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								129796	10.1155/2014/129796			7	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AG8PG	WOS:000335680100001	24877054	gold, Green Published, Green Submitted			2022-02-06	
J	Yang, ST; Lin, JW; Chiu, BY; Hsu, YC; Chang, CP; Chang, CK				Yang, Shun-Tai; Lin, Jia-Wei; Chiu, Bi-Ying; Hsu, Yao-Chin; Chang, Ching-Ping; Chang, Cheng-Kuei			Astragaloside Improves Outcomes of Traumatic Brain Injury in Rats by Reducing Microglia Activation	AMERICAN JOURNAL OF CHINESE MEDICINE			English	Article						Traumatic Brain Injury; Astragaloside; Tumor Necrosis Factor-Alpha; Microglia	TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; INHIBITION; MOTOR	Astragaloside (AST) is traditionally prescribed for the prevention and treatment of cerebrovascular diseases. We directly tested the therapeutic effects of AST in a rat model of traumatic brain injury (TBI). One hour after the onset of TBI rats were given Saline (1 ml/kg) or AST (20-80 mg/kg) via i.p. injection. AST causes the attenuation of TBI-induced cerebral contusion, neuronal apoptosis, and neurological motor dysfunction. TBI-induced microglial activation evidenced by the morphological transformation of microglia (or ameboid microglia) and the microglial overexpression of tumor necrosis factor-alpha was reduced by AST. Our results indicate that AST may protect against brain contusion and neuronal apoptosis after TBI by attenuating microglia activation in male rats.	[Yang, Shun-Tai; Lin, Jia-Wei; Chang, Cheng-Kuei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei City 23561, Taiwan; [Yang, Shun-Tai; Lin, Jia-Wei] Taipei Med Univ, Grad Inst Clin Med, Taipei 110, Taiwan; [Yang, Shun-Tai; Lin, Jia-Wei] Taipei Med Univ, Sch Med, Dept Surg, Taipei 110, Taiwan; [Chang, Ching-Ping] Taipei Med Univ, PhD Program Neural Regenerat Med, Taipei 110, Taiwan; [Chang, Cheng-Kuei] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei 110, Taiwan; [Chiu, Bi-Ying; Hsu, Yao-Chin] Chi Mei Med Ctr, Dept Chinese Med, Tainan 710, Taiwan; [Chang, Ching-Ping] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan 710, Taiwan		Chang, CP (corresponding author), Southern Taiwan Univ Sci & Technol, Dept Biotechnol, 1 Nan Tai St, Tainan 710, Taiwan.	jessica@mail.stust.edu.tw; chengkuei.chang@gmail.com		Chang, Ching-Ping/0000-0003-0890-9414	National Science Council of the Republic of China (Taipei, Taiwan)Ministry of Science and Technology, Taiwan [NSC101-2314-B-218-001-MY3]; Center of Excellence for Clinical Trial and Research in Neuroscience, Department of Health and Welfare of the Republic of China [DOH99-TD-B-111-003]	Dr. C.P.C. received grants (NSC101-2314-B-218-001-MY3) from the National Science Council of the Republic of China (Taipei, Taiwan) and grants from (DOH99-TD-B-111-003) the Center of Excellence for Clinical Trial and Research in Neuroscience, Department of Health and Welfare of the Republic of China.	Bao F, 2011, J NEUROTRAUM, V28, P1035, DOI 10.1089/neu.2010.1575; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Cheong CU, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/620837; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chiu BY, 2014, CELL MOL NEUROBIOL, V34, P825, DOI 10.1007/s10571-014-0059-4; d'Avila JC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-31; Fan LH, 2011, CELL MOL NEUROBIOL, V31, P1187, DOI 10.1007/s10571-011-9720-3; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; KIM KS, 1992, LYMPHOKINE CYTOK RES, V11, P293; Lei H, 2003, ACTA PHARMACOL SIN, V24, P230; Liu Dong-mei, 2007, Zhongguo Yaolixue Tongbao, V23, P543; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Luo YM, 2004, NEUROSCI LETT, V363, P218, DOI 10.1016/j.neulet.2004.03.036; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; Tohda C, 2006, BRIT J PHARMACOL, V149, P532, DOI 10.1038/sj.bjp.0706865; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yin YY, 2010, AM J CHINESE MED, V38, P517, DOI 10.1142/S0192415X10008020; [尹艳艳 YIN Yanyan], 2005, [中国药理学通报, Chinese Pharmacological Bulletin], V21, P1486	27	5	6	1	3	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0192-415X	1793-6853		AM J CHINESE MED	Am. J. Chin. Med.		2014	42	6					1357	1370		10.1142/S0192415X14500852			14	Integrative & Complementary Medicine; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine; General & Internal Medicine	AX6IT	WOS:000347026800005	25384449				2022-02-06	
J	Chen, R; Wang, JY; Jiang, B; Wan, X; Liu, HW; Liu, H; Yang, XS; Wu, XB; Zou, Q; Yang, WR				Chen, Rui; Wang, Junyu; Jiang, Bing; Wan, Xin; Liu, Hongwei; Liu, Huan; Yang, Xiaosheng; Wu, Xiaobing; Zou, Qin; Yang, Wenren			Study of cell apoptosis in the hippocampus and thalamencephalon in a ventricular fluid impact model	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						ventricular fluid; hippocampus; thalamencephalon; apoptosis; pathological change	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; THALAMUS; CORTEX	The aim of this study was to investigate the apoptosis of nerve cells in the hippocampal and thalamencephalon regions using a rabbit model of ventricular fluid impact. The results for the study demonstrated a variety of pathophysiological changes in the rabbit model, while changes in the hippocampal and thalamencephalon regions were observed under a light microscope following hematoxylin and eosin (H&E)/terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. Among the mild, moderate and severe injury groups, there were significant differences in the mortality rate and in the changes in vital signs and consciousness recovery time following trauma. Furthermore, H&E staining showed that pathological changes, such as hemorrhage and necrosis, occurred in the hippocampal and thalamencephalon regions at an early stage subsequent to trauma, while TUNEL staining showed that neuronal apoptosis occurred in the various injury groups. In traumatic brain injuries, the impact caused by cerebrospinal fluid moving with a certain energy results in marked damage to the contralateral periventricular structures and may generate a series of pathophysiological changes.	[Chen, Rui; Wang, Junyu; Jiang, Bing; Wan, Xin; Liu, Hongwei] Cent S Univ, Dept Neurosurg, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China; [Liu, Huan; Yang, Xiaosheng] Nanhua Univ, Dept Cardiol, Nanhua Hosp, Hengyang 421001, Hunan, Peoples R China; [Wu, Xiaobing; Zou, Qin; Yang, Wenren] Nanhua Univ, Dept Neurosurg, Nanhua Hosp, Hengyang 421001, Hunan, Peoples R China		Jiang, B (corresponding author), Cent S Univ, Dept Neurosurg, Xiangya Hosp, Xiangya Rd 87, Changsha 410008, Hunan, Peoples R China.	bingjiangcn@163.com		Chen, Rui/0000-0002-3813-1749			Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Alessandri B, 2006, BRAIN RES, V1111, P196, DOI 10.1016/j.brainres.2006.06.105; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Kao C, 2012, J NEUROSURG, V117, P316, DOI 10.3171/2012.4.JNS111170; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kockro RA, 2008, J NEUROSURG, V108, P601, DOI 10.3171/JNS/2008/108/3/0601; Li Yan, 2011, Stapp Car Crash J, V55, P25; Marbacher S, 2012, J NEUROSCI METH, V208, P138, DOI 10.1016/j.jneumeth.2012.05.010; Monea AG, 2012, J NEUROTRAUM, V29, P2305, DOI 10.1089/neu.2011.2271; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Ronning PA, 2011, J TRAUMA, V70, pE56, DOI 10.1097/TA.0b013e3181e80f0a; Rostami Elham, 2012, Front Neurol, V3, P115, DOI 10.3389/fneur.2012.00115; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Schwetye KE, 2010, NEUROBIOL DIS, V40, P555, DOI 10.1016/j.nbd.2010.06.018; Singleton RH, 2010, J NEUROTRAUM, V27, P1091, DOI 10.1089/neu.2010.1291; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Xing GQ, 2012, NEUROSCI LETT, V525, P140, DOI 10.1016/j.neulet.2012.07.055	23	5	5	1	4	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2013	6	6					1463	1468		10.3892/etm.2013.1342			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	AA0KA	WOS:000330782800021	24255676	Green Published, Green Submitted, gold			2022-02-06	
J	Gurcay, E; Ozturk, EA; Erdem, T; Gurcay, AG; Cakci, A				Gurcay, Eda; Ozturk, Erhan Arif; Erdem, Tuba; Gurcay, Ahmet Gurhan; Cakci, Aytul			Heterotopic ossification as rare complication of hemiplegia following stroke: Two cases	BRAIN INJURY			English	Article						Hemiplegia; heterotopic ossification; stroke	RISK-FACTORS	Background: Heterotopic ossification (HO), characterized by new bone formation in the periarticular regions of large joints, is frequently seen after spinal cord injury, traumatic brain injury, burn and trauma. It is a rare complication of hemiplegia following stroke, with a reported incidence of 1% or less. Case reports: This study reports two unusual presentations of HO: (1) A 56-year-old male with a history of atrial fibrillation on warfarin developed sudden-onset left hemiplegia. Eight months after the event, he was diagnosed with HO of the hip joint including both the affected and unaffected sides. (2) A 55-year-old female with left hemiplegia due to subarachnoid bleeding developed HO on the left hip joint 7 months later. In both cases, spasticity around the hip muscle groups, especially hip flexors, adductors and knee extensors, and limited range of motion accompanied by pain were present. X-ray and pelvic computed tomography revealed HO around the hip joints. After 4 weeks of inpatient rehabilitation, the ranges of hip joint motion improved, without exceeding 10 degrees in the direction of flexion and rotations, and ambulation levels were wheelchair-bound for the first case and dependent on a cane for the second case. Conclusions: Considering the presented cases, it is suggested that HO should be kept in mind in the differential diagnosis in stroke patients presenting with spontaneous joint pain or limitation. The clinical importance of HO development on both the affected and unaffected sides in post-stroke hemiplegia is emphasized, since it may worsen the patient's functional status.	[Gurcay, Eda; Ozturk, Erhan Arif; Erdem, Tuba; Cakci, Aytul] Ankara Diskapi Yildirim Beyazit Educ & Res Hosp, Minist Hlth, Dept Phys Therapy & Rehabil, Ankara, Turkey; [Gurcay, Ahmet Gurhan] Ankara Ataturk Educ & Res Hosp, Minist Hlth, Dept Neurosurg, Ankara, Turkey		Gurcay, E (corresponding author), Ankara Diskapi Yildirim Beyazit Educ & Res Hosp, Minist Hlth, Dept Phys Therapy & Rehabil, Ankara, Turkey.	dredagurcay@gmail.com	Ozturk, Erhan Arif/R-8066-2019; Sultanoglu, Tuba Erdem/AAB-1647-2021	Sultanoglu, Tuba Erdem/0000-0003-0021-5952; Ozturk, Erhan Arif/0000-0002-1669-7629			BARON M, 1983, J RHEUMATOL, V10, P961; BERROL S, 1987, ARCH PHYS MED REHAB, V68, P746; Botte M J, 1988, Orthop Rev, V17, P891; Brander V, 2006, AM J PHYS MED REHAB, V85, pS98, DOI 10.1097/01.phm.0000245569.70723.9d; BRAVOPAYNO P, 1992, PARAPLEGIA, V30, P740, DOI 10.1038/sc.1992.142; BUSCHBACHER R, 1992, AM J PHYS MED REHAB, V71, P86, DOI 10.1097/00002060-199204000-00005; Chua KSG, 2003, BRAIN INJURY, V17, P535, DOI 10.1080/0269905021000010104; Citak M, 2012, SPINE, V37, P1953, DOI 10.1097/BRS.0b013e31825ee81b; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; HAJEK VE, 1987, ARCH PHYS MED REHAB, V68, P313; Jehkonen M, 2006, RESTOR NEUROL NEUROS, V24, P209; Kesikburun S, 2011, BRAIN INJURY, V25, P127, DOI 10.3109/02699052.2010.536198; Kocaaga Z, 2007, J REHABIL MED, V39, P500, DOI 10.2340/16501977-0086; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Nakajo M, 1969, Seikei Geka, V20, P1193; Stover SL, 1986, MANAGEMENT SPINAL CO, P284; Subbarao J V, 1999, J Spinal Cord Med, V22, P273; Taly AB, 2001, NEUROL INDIA, V49, P37; Tsur A, 1996, BRAIN INJURY, V10, P259, DOI 10.1080/026990596124430; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628	23	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1727	1731		10.3109/02699052.2013.831123			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400033	24088051				2022-02-06	
J	Kim, J; Kemp, S; Kullas, K; Hitos, K; Dexter, MA				Kim, J.; Kemp, S.; Kullas, K.; Hitos, K.; Dexter, M. A.			Injury patterns in patients who "talk and die"	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Coagulopathy; Deterioration; Glasgow coma scale; Head injury; Prognosis; Talk and die	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; COAGULOPATHY; DETERIORATE; MANAGEMENT; DISORDERS; COMA	Despite advances in the quality of and access to cerebral imaging, patients with mild head injuries still deteriorate and die in neurotrauma units. The term "talk and die" was first used by Reilly et al. to describe a subset of patients with head injuries who died following what was initially thought to be only a mild traumatic brain injury. A retrospective review of a database from a major Australian trauma center was performed to identify 25 patients who met the "talk and die" criteria between January 2000 and December 2009. The medical records of these patients and their imaging studies were analyzed to identify potentially preventable factors and injury patterns in this group of patients. The factors analyzed included age, modality of injury, therapeutic narcotic usage, seizures, and hyponatremia. Two groups of patients are described herein based on intracranial pathology, with statistically significant differences in age, mechanism, and coagulopathy identified. (C) 2013 Elsevier Ltd. All rights reserved.	[Kim, J.; Kullas, K.; Dexter, M. A.] Westmead Hosp, Dept Neurosurg, Sydney, NSW 2145, Australia; [Kemp, S.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Hitos, K.] Univ Sydney, Dept Surg, Sydney, NSW 2006, Australia		Kim, J (corresponding author), Westmead Hosp, Dept Neurosurg, Hawkesbwy Rd, Sydney, NSW 2145, Australia.	yjkvision@gmail.com		Kim, Jun/0000-0001-8626-3167; Hitos, Kerry/0000-0002-6604-6218			Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Danne P, 1998, AUST NZ J SURG, V68, P50, DOI 10.1111/j.1445-2197.1998.tb04637.x; Davis DP, 2007, J TRAUMA, V62, P277, DOI 10.1097/TA.0b013e31802ef4a3; Dunn LT, 2003, J TRAUMA, V54, P497, DOI 10.1097/01.TA.0000030627.71453.CD; Fabbri A, 2004, J NEUROL NEUROSUR PS, V75, P1787, DOI 10.1136/jnnp.2004.041384; GALBRAITH S, 1987, BRIT MED J, V294, P325, DOI 10.1136/bmj.294.6568.325; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P624; Goldschlager T, 2007, J CLIN NEUROSCI, V14, P618, DOI 10.1016/j.jocn.2006.02.018; Hanif S, 2009, Ir Med J, V102, P255; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Havill J, 1998, EMERGEN MED, V10, P123; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P191, DOI 10.1007/BF01808958; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; Jennett B, 1998, ARCH DIS CHILD, V78, P403, DOI 10.1136/adc.78.5.403; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; Ratanalert S, 2002, J CLIN NEUROSCI, V9, P640, DOI 10.1054/jocn.2002.1085; REILLY PL, 1975, LANCET, V2, P375; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P540, DOI 10.1016/S0003-9993(97)90173-8	27	5	5	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	DEC	2013	20	12					1697	1701		10.1016/j.jocn.2013.02.021			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	261UO	WOS:000327690300011	23993454				2022-02-06	
J	Moreau, WJ; Nabhan, DC				Moreau, William J.; Nabhan, Dustin C.			Development of the 2012 American Chiropractic Board of Sports Physicians position statement on concussion in athletics	JOURNAL OF CHIROPRACTIC MEDICINE			English	Article						Brain concussion; Postconcussion syndrome; Athletic injuries; Chiropractic		Objective: The purpose of this article is to provide a summary of the development of the American Chiropractic Board of Sports Physicians (ACBSP) Position Statement on Concussion in Athletics regarding the management of concussion in sport and to offer suggestions to qualifying doctors of chiropractic (DCs) to make return-to-play decisions and clarify common concepts pertaining to evaluating and managing concussion in sport. Methods: A literature review of position statements from sports medicine organizations was performed. The authors reviewed each statement for content. Key issues in the management of concussion in sport were identified with special consideration to concussion management by DCs. A position statement on the management of concussion in sport was drafted by the authors and submitted to the Board of Directors of the ACBSP for review. The Board of Directors called for minor revision; and after all revisions were made, the document was resubmitted. The Board of Directors of the ACBSP accepted the document for publication and presentation. The document was presented and disseminated to certificants by the ACBSP at the 2011 Chiropractic Sports Sciences Symposium. Results: The 2012 ACBSP Position Statement on Concussion in Athletics was accepted by the ACBSP Board of Directors. Conclusion: The Position Statement on Concussion in Athletics has been accepted by the ACBSP. This document offers guidance on the management of concussion in sport and provides qualifying DCs information to make return-to-play decisions. (C) 2013 National University of Health Sciences.	[Moreau, William J.] US Olymp Comm, Sports Med, Colorado Springs, CO USA; [Nabhan, Dustin C.] US Olymp Comm, Multidisciplinary Clin Care, Colorado Springs, CO USA		Nabhan, DC (corresponding author), 7795 Julynn Rd, Colorado Springs, CO 80909 USA.	nabhandc@gmail.com					Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; [Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Cantu RC, 2011, PM&R, V3, pS440, DOI 10.1016/j.pmrj.2011.07.013; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; McAvoy K, 2012, CONCUSSION MANAGEMEN; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.4085/1062-6050-44.4.434, 10.1016/j.jocn.2009.02.002]	7	5	5	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0899-3467	1556-3715		J CHIROPR MED	J. Chiropr. Med.	DEC	2013	12	4			SI		269	273		10.1016/j.jcm.2013.07.002			5	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V03BP	WOS:000213713200006	24396329	Green Published			2022-02-06	
J	Price, M; Hertzberg, V; Wright, DW				Price, Megan; Hertzberg, Vicki; Wright, David W.			Does the sliding dichotomy result in higher powered clinical trials for stroke and traumatic brain injury research?	CLINICAL TRIALS			English	Article								Background Recent research has proposed a new method for defining a favorable outcome in traumatic brain injury and stroke research. Purpose This new method is called the sliding dichotomy, and it is suggested as a potential solution to the problem of underpowered clinical trials. Methods We present a brief simulation study and graphical comparison of the power of each method to detect varying treatment effect sizes. Results Simulations of a patient population similar to the National Acute Brain Injury Study: Hypothermia (NABISH) study indicate that the sliding dichotomy method does not result in higher power than traditional methods. Conclusions Although the sliding dichotomy may present gains in power in some cases, several aspects of the patient population need to be considered in choosing between sliding dichotomy and traditional definitions of favorable outcomes.	[Price, Megan] Benetech Human Rights Program, Palo Alto, CA 94306 USA; [Hertzberg, Vicki] Emory Univ, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Div Emergency Neurosci, Atlanta, GA USA		Price, M (corresponding author), Benetech Human Rights Program, 480 S Calif Ave Suite 201, Palo Alto, CA 94306 USA.	meganp@benetech.org	Wright, David/F-1209-2013	Wright, David/0000-0002-7145-9105			Barer D., 1998, EUR STROK C ED UK; Choi S C, 1998, J Biopharm Stat, V8, P367, DOI 10.1080/10543409808835246; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Hansen BB, 2006, WIN 2006 C U MISS CO; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Mendelow AD, 2005, LANCET, V365, P387; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Young FB, 2003, STROKE, V34, P2676, DOI 10.1161/01.STR.0000096210.36741.E7	15	5	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1740-7745	1740-7753		CLIN TRIALS	Clin. Trials	DEC	2013	10	6					924	934		10.1177/1740774512458601			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	275LB	WOS:000328676700011	23027647				2022-02-06	
J	Rostami, E; Rocksen, D; Ekberg, NR; Goiny, M; Ungerstedt, U				Rostami, Elham; Rocksen, David; Ekberg, Neda R.; Goiny, Michel; Ungerstedt, Urban			Brain metabolism and oxygenation in healthy pigs receiving hypoventilation and hyperoxia	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Brain injury; Brain metabolism; Hypoventilation; Hyperoxia; Hypercapnia; Neuromonitoring	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; PERMISSIVE HYPERCAPNIA; HYPERVENTILATION; MICRODIALYSIS; VENTILATION; LACTATE; IMPROVEMENT; REDUCTION	Modulation in ventilatory settings is one of the approaches and interventions used to treat and prevent secondary brain damage after traumatic brain injury (TBI). Here we investigate the effect of hyperoxia in combination with hypoventilation on brain oxygenation, metabolism and intracranial pressure. Twelve pigs were divided into three groups; groupl-100% hyperoxia (n=4), group 2-100% hyperoxia and 20% decrease in minute volume (MV) (n=4) and group 3-100% hyperoxia and 50% decrease in MV (n=4). Neither of the ventilator settings affected the lactate/pyruvate ratio significantly. However, there was a significant decrease of brain lactate (2.6+/-1.7 to 1.8+/-1.6 mM) and a rapid and marked increase in brain oxygenation (7.9+/-0.7 to 61.3+/-17.6 mmHg) in group 3. Intracranial pressure (ICP) was not significantly affected in this group, however, the ICP increased significantly in group 2 with 100% hyperoxia plus 20% reduction in minute volume. We conclude that hyperoxia in combination with 50% decrease in MV showed pronounced increase in partial brain oxygen tension (pbrO(2)) and decrease in brain lactate. The ventilatory modification, used in this study should be considered for further investigation as a possible therapeutic intervention for TBI patients. (C) 2013 Elsevier B.V. All rights reserved.	[Rostami, Elham; Rocksen, David] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Rostami, Elham] Univ Uppsala Hosp, Dept Neurosurg, Uppsala, Sweden; [Ekberg, Neda R.] Karolinska Inst, Dept Mol Med & Surg, S-17177 Stockholm, Sweden; [Goiny, Michel; Ungerstedt, Urban] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden		Rostami, E (corresponding author), Karolinska Inst, Dept Neurosci, Retzius Vag 8, S-17177 Stockholm, Sweden.	elham.rostami@ki.se; David.rocksen@ki.se; Neda.ekberg@ki.se; Michel.goiny@ki.se; Urban.ungerstedt@ki.se		Rajamand Ekberg, Neda/0000-0001-5597-2593			[Anonymous], 2000, J Neurotrauma, V17, P507; Berenbrink M, 2006, RESP PHYSIOL NEUROBI, V154, P165, DOI 10.1016/j.resp.2006.01.002; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; DOBERSTEIN CE, 1993, ANN EMERG MED, V22, P993, DOI 10.1016/S0196-0644(05)82740-4; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HICKLING KG, 1994, CRIT CARE MED, V22, P1568, DOI 10.1097/00003246-199422100-00011; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; KATSURA K, 1994, BIOCHEM SOC T, V22, P991, DOI 10.1042/bst0220991; KONTOS HA, 1977, STROKE, V8, P226, DOI 10.1161/01.STR.8.2.226; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntosh TK, 1996, LAB INVEST, V74, P315; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NATTIE EE, 1980, RESP PHYSIOL, V40, P309, DOI 10.1016/0034-5687(80)90031-6; Purves M J, 1972, Monogr Physiol Soc, P1; Pynnonen L, 2011, RESUSCITATION, V82, P1174, DOI 10.1016/j.resuscitation.2011.04.022; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; Reinert M, 2004, J NEUROSURG, V101, P323, DOI 10.3171/jns.2004.101.2.0323; Reinert M, 2003, ACTA NEUROCHIR, V145, P341, DOI 10.1007/s00701-003-0027-0; Rostami E, 2012, ADV MED SCI-POLAND, V57, P136, DOI 10.2478/v10039-012-0009-7; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; SIESJO BK, 1972, KIDNEY INT, V1, P360, DOI 10.1038/ki.1972.47; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; SLADEN R N, 1981, International Anesthesiology Clinics, V19, P39, DOI 10.1097/00004311-198119030-00006; Thorens JB, 1996, INTENS CARE MED, V22, P182, DOI 10.1007/BF01712235; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; van Hulst RA, 2002, INTENS CARE MED, V28, P68, DOI 10.1007/s00134-001-1157-6; Watson NA, 2000, EUR J ANAESTH, V17, P152, DOI 10.1046/j.1365-2346.2000.00640.x; White H, 2008, ANESTH ANALG, V107, P979, DOI 10.1213/ane.0b013e31817e7b1a	39	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	DEC 1	2013	189	3					537	542		10.1016/j.resp.2013.08.010			6	Physiology; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Respiratory System	267JR	WOS:000328094400011	24013004				2022-02-06	
J	Sick, J; Bray, E; Bregy, A; Dietrich, WD; Bramlett, HM; Sick, T				Sick, Justin; Bray, Eric; Bregy, Amade; Dietrich, W. Dalton; Bramlett, Helen M.; Sick, Thomas			EEGgui: a program used to detect electroencephalogram anomalies after traumatic brain injury	SOURCE CODE FOR BIOLOGY AND MEDICINE			English	Article								Background: Identifying and quantifying pathological changes in brain electrical activity is important for investigations of brain injury and neurological disease. An example is the development of epilepsy, a secondary consequence of traumatic brain injury. While certain epileptiform events can be identified visually from electroencephalographic (EEG) or electrocorticographic (ECoG) records, quantification of these pathological events has proved to be more difficult. In this study we developed MATLAB-based software that would assist detection of pathological brain electrical activity following traumatic brain injury (TBI) and present our MATLAB code used for the analysis of the ECoG. Methods: Software was developed using MATLAB(T) and features of the open access EEGLAB. EEGgui is a graphical user interface in the MATLAB programming platform that allows scientists who are not proficient in computer programming to perform a number of elaborate analyses on ECoG signals. The different analyses include Power Spectral Density (PSD), Short Time Fourier analysis and Spectral Entropy (SE). ECoG records used for demonstration of this software were derived from rats that had undergone traumatic brain injury one year earlier. Results: The software provided in this report provides a graphical user interface for displaying ECoG activity and calculating normalized power density using fast fourier transform of the major brain wave frequencies (Delta, Theta, Alpha, Beta1, Beta2 and Gamma). The software further detects events in which power density for these frequency bands exceeds normal ECoG by more than 4 standard deviations. We found that epileptic events could be identified and distinguished from a variety of ECoG phenomena associated with normal changes in behavior. We further found that analysis of spectral entropy was less effective in distinguishing epileptic from normal changes in ECoG activity. Conclusion: The software presented here was a successful modification of EEGLAB in the Matlab environment that allows detection of epileptiform ECoG signals in animals after TBI. The code allows import of large EEG or ECoG data records as standard text files and uses fast fourier transform as a basis for detection of abnormal events. The software can also be used to monitor injury-induced changes in spectral entropy if required. We hope that the software will be useful for other investigators in the field of traumatic brain injury and will stimulate future advances of quantitative analysis of brain electrical activity after neurological injury or disease.	[Sick, Justin; Bray, Eric; Bregy, Amade; Dietrich, W. Dalton; Bramlett, Helen M.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Bregy, Amade; Dietrich, W. Dalton; Bramlett, Helen M.] Lois Pope LIFE Ctr, Dept Neurosurg, Miami, FL 33136 USA; [Sick, Thomas] Lois Pope LIFE Ctr, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA; [Bramlett, Helen M.] Bruce W Carter Dept Vet Affairs, Miami, FL 33125 USA		Sick, T (corresponding author), Lois Pope LIFE Ctr, Dept Neurol, 1095 NW 14th Terrace, Miami, FL 33136 USA.	TSick@miami.edu			Veterans AffairsUS Department of Veterans Affairs [1 I01 BX000521-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS030291]	This works was supported by Veterans Affairs grant 1 I01 BX000521-01 and NIH NS030291.	Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; Bragin A, 2010, CURR OPIN NEUROL, V23, P151, DOI 10.1097/WCO.0b013e3283373ac8; Engel J, 2009, EPILEPSIA, V50, P598, DOI 10.1111/j.1528-1167.2008.01917.x; Jefferys JGR, 2012, PROG NEUROBIOL, V98, P250, DOI 10.1016/j.pneurobio.2012.02.005; Jiruska P, 2011, EPILEPSY RES, V97, P300, DOI 10.1016/j.eplepsyres.2011.09.023; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pitkanen A, 2012, JASPERS BASIC MECH E, P1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; SCHIFF SJ, 1994, ELECTROEN CLIN NEURO, V91, P442, DOI 10.1016/0013-4694(94)90165-1; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x	13	5	5	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1751-0473			SOURCE CODE BIOL MED	Source Code Biol. Med.	DEC	2013	8	1							12	10.1186/1751-0473-8-12			7	Mathematical & Computational Biology	Emerging Sources Citation Index (ESCI)	Mathematical & Computational Biology	V34VT	WOS:000215861200012	23692932	Green Published, hybrid			2022-02-06	
J	Topolovec-Vranic, J; Ennis, N; Ouchterlony, D; Cusimano, MD; Colantonio, A; Hwang, SW; Kontos, P; Stergiopoulos, V; Brenner, L				Topolovec-Vranic, Jane; Ennis, Naomi; Ouchterlony, Donna; Cusimano, Michael D.; Colantonio, Angela; Hwang, Stephen W.; Kontos, Pia; Stergiopoulos, Vicky; Brenner, Lisa			Clarifying the link between traumatic brain injury and homelessness: Workshop proceedings	BRAIN INJURY			English	Article						Health; homeless; outcome; traumatic brain injury	HEALTH; DISORDERS; MORTALITY; PEOPLE	Purpose: To disseminate the proceedings of a 1-day multidisciplinary stakeholder workshop aimed at examining the inter-relationship between traumatic brain injury (TBI) and homelessness. Methods: Thirty-seven stakeholders participated in the workshop, including frontline workers with individuals who are homeless, physicians, nurses and other healthcare workers, researchers, policy-makers, students and individuals with lived experience of homelessness. Didactic presentations, large group discussions and break-out sessions were used to disseminate knowledge, identify service and research gaps, develop a research agenda and facilitate networking. Results: The participants identified barriers to service provision for individuals who are homeless and have sustained TBI with a focus on age-and gender-related issues, co-morbid TBI and mental illness and jurisdictional differences. Challenges and strategies related to engaging stakeholders in research with this population, as well as disseminating knowledge were discussed and research questions were identified. Conclusion: There is very little empirical literature on the topic of TBI and homelessness. The workshop identified key issues for consideration, including gaps in knowledge related to this topic.	[Topolovec-Vranic, Jane; Ennis, Naomi] St Michaels Hosp, Li Ka Shing Knowledge Inst, Trauma & Neurosurg Program, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Ennis, Naomi] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Topolovec-Vranic, Jane; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Ouchterlony, Donna] St Michaels Hosp, Head Injury Clin, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg,Injury Prevent Res Off, Li Ka Shing Knowledge Inst,Keenan Res Ctr, Toronto, ON, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Saunderson Family Chair Acquired Brain Injury Res, Toronto, ON, Canada; [Hwang, Stephen W.; Stergiopoulos, Vicky] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Ctr Res Inner City Hlth, Toronto, ON M5B 1W8, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; [Kontos, Pia] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Kontos, Pia] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Stergiopoulos, Vicky] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Brenner, Lisa] Univ Colorado, Sch Med, Denver, CO USA		Topolovec-Vranic, J (corresponding author), St Michaels Hosp, Trauma & Neurosurg Program, 30 Bond St,Bond 3-012, Toronto, ON M5B 1W8, Canada.	topolovec-vranicj@smh.ca	Brenner, Lisa A./AAG-2442-2019; Cusimano, Michael/X-4059-2019; Topolovec-Vranic, Jane/A-5293-2013	Topolovec-Vranic, Jane/0000-0001-7695-4212; Cusimano, Michael/0000-0002-9989-0650; Colantonio, Angela/0000-0003-2094-4765; Kontos, Pia/0000-0002-8893-2544	Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [MHS-117769, TIR-103946]; Ontario Neurotrauma Foundation; St. Michael's Hospital Trauma and Neurosurgery Program, Head Injury Clinic; Li Ka Shing Knowledge InstituteUniversity of Toronto; Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Toronto Rehabilitation Institute Foundation; CIHR Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]	Funding for this project for JTV, AC, MDC, SWH, PCK, DO and VS was obtained from a Canadian Institutes for Health Research (CIHR) Planning Grant: Partnerships for Health System Improvement (Grant # MHS-117769). This research was also supported by the CIHR Strategic Team Grant in Applied Injury Research (Grant # TIR-103946) and the Ontario Neurotrauma Foundation. We recognize the support of the St. Michael's Hospital Trauma and Neurosurgery Program, Head Injury Clinic and Li Ka Shing Knowledge Institute. AC is also supported by a grant from the Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute-University Health Network, the Toronto Rehabilitation Institute Foundation, and a CIHR Chair in Gender, Work and Health (Grant # CGW-126580). The authors report no conflicts of interest.	Backer Thomas Earl, 2007, J Prim Prev, V28, P375, DOI 10.1007/s10935-007-0100-1; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bremner AJ, 1996, BRIT J PSYCHIAT, V169, P434, DOI 10.1192/bjp.169.4.434; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burra TA, 2009, CAN J PSYCHIAT, V54, P123, DOI 10.1177/070674370905400210; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Cotman A, 1997, J COGN REHABIL, V15, P16; Faul M, 2010, TRAUMATIC BRAIN INJU; FISCHER PJ, 1991, AM PSYCHOL, V46, P1115, DOI 10.1037/0003-066X.46.11.1115; Frankish CJ, 2005, CAN J PUBLIC HEALTH, V96, pS23, DOI 10.1007/BF03403700; General Manager SSaHA, 2012, 2012 PER DIEM RAT PU; Gonzalez EA, 2001, J NERV MENT DIS, V189, P176, DOI 10.1097/00005053-200103000-00006; Highley JL, 2008, TRAUMATIC BRAIN INJU, P1; Human Resources and Skills Development Canada, HOM SHELT BEDS HOUS; Human Resources and Skills Development Canada, 2010, 2009 SHELT CAP REP; Hux K, 2009, BRAIN INJURY, V23, P8, DOI 10.1080/02699050802590353; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2002, CAN J PUBLIC HEALTH, V93, P407, DOI 10.1007/BF03405026; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Kim DK, 2007, J KOREAN NEUROSURG S, V42, P191; Martens W H, 2001, Public Health Rev, V29, P13; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; National Center for Injury Prevention and Control, 2010, TRAUMATIC BRAIN INJU; Oddy M, 2012, BRAIN INJURY, V26, P1058, DOI 10.3109/02699052.2012.667595; Solliday-McRoy C, 2004, J NERV MENT DIS, V192, P471, DOI 10.1097/01.nmd.0000131962.30547.26; SUSSER E, 1993, EPIDEMIOL REV, V15, P546, DOI 10.1093/oxfordjournals.epirev.a036133; The Salvation Army, 2010, POV SHOULDN BE LIF S; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Topolovec-Vranic J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1059; U.S.Department of Housing and Urban Development, 2012, 2010 ANN HOM ASS REP; U.S. Department of Housing and Urban Development, 2013, 2012 ANN HOM ASS REP; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Wei WH, 2005, ARCH PHYS MED REHAB, V86, P905, DOI 10.1016/j.apmr.2004.09.026; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	34	5	5	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2013	27	13-14					1600	1605		10.3109/02699052.2013.823666			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	259BW	WOS:000327503400015	24131277				2022-02-06	
J	Young, G				Young, Gerald			Ill-Treatment of Pain in the DSM-5	PSYCHOLOGICAL INJURY & LAW			English	Article						Chronic pain; Pain disorder; Somatic symptom disorder; DSM-5; DSM-IV-TR		The just-published psychiatric diagnostic manual, the Diagnostic and StatisticalManual ofMentalDisorders, 5th edition (DSM-5), American Psychiatric Association (2013), has been lauded by its organizers (e.g., Regier, Kuhl, and Kupfer in World Psychiatry 12, pp. 92-98, 2013), but has been criticized on multiple grounds, as well. Several of its major diagnostic categories concern the area of psychological injury and law (e.g., tort cases involving posttraumatic stress disorder (PTSD), chronic pain, and traumatic brain injury (TBI)). The one for chronic pain seems the one most greatly changed. The approach to chronic pain in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision (American Psychiatric Association 2000) and the DSM-5 are compared, leading to an alternative diagnostic criteria list partly based on the changes in the DSM-5. The DSM-5 should be used with caution in forensic assessments. This applies especially to the psychological injury patient, including the pain one, given the high stakes involved and the need for accuracy in assessment based on a reliable and valid diagnostic system. Future iterations of the manual should be improved in both these regards.	[Young, Gerald] York Univ, Glendon Coll, Dept Psychol, York Hall 140,2275 Bayview Ave, Toronto, ON, Canada		Young, G (corresponding author), York Univ, Glendon Coll, Dept Psychol, York Hall 140,2275 Bayview Ave, Toronto, ON, Canada.	gyoung@glendon.yorku.ca		Young, Gerald/0000-0002-3689-6924			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Cosgrove L, 2013, FEM PSYCHOL, V23, P93, DOI 10.1177/0959353512467972; Cosgrove L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001190; First MB, 2010, PSYCHOL INJ LAW, V3, P255, DOI 10.1007/s12207-010-9096-6; First MB, 2011, CURR OPIN PSYCHIATR, V24, P1, DOI 10.1097/YCO.0b013e328340b594; Frances A., 2013, BRIT MED J; Frances A, 2013, J NERV MENT DIS, V201, P530, DOI 10.1097/NMD.0b013e318294827c; Frances A, 2013, AUST NZ J PSYCHIAT, V47, P483, DOI 10.1177/0004867413484525; Frances AJ, 2012, ANNU REV CLIN PSYCHO, V8, P109, DOI 10.1146/annurev-clinpsy-032511-143102; Gatchel RJ, 2007, PSYCHOL BULL, V133, P581, DOI 10.1037/0033-2909.133.4.581; Kessler RC, 2008, ANNU REV PUBL HEALTH, V29, P115, DOI 10.1146/annurev.publhealth.29.020907.090847; Melzack R, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P129, DOI 10.1007/0-387-25610-5_7; Melzack R, 2013, WIRES COGN SCI, V4, P1, DOI 10.1002/wcs.1201; Moffitt TE, 2010, PSYCHOL MED, V40, P899, DOI 10.1017/S0033291709991036; Regier DA, 2013, WORLD PSYCHIATRY, V12, P92, DOI 10.1002/wps.20050; Rief W, 2011, PSYCHOSOM MED, V73, P760, DOI 10.1097/PSY.0b013e318234eff6; Sirri L, 2013, INT REV PSYCHIATR, V25, P19, DOI 10.3109/09540261.2012.726923; Sykes R, 2012, PSYCHOSOMATICS, V53, P524, DOI 10.1016/j.psym.2012.06.004; Wollburg E, 2013, J PSYCHOSOM RES, V74, P18, DOI 10.1016/j.jpsychores.2012.09.015; Wortzel HS, 2013, J PSYCHIATR PRACT, V19, P238, DOI 10.1097/01.pra.0000430508.44768.9d; Young G, 2014, INT LIBR ETH LAW NEW, V56, P1, DOI 10.1007/978-94-007-7899-3; Young G., 2014, CAUSALITY NORMAL ABN; Young G., 2007, CAUSALITY PSYCHOL IN; Young G, 2010, PSYCHOL INJ LAW, V3, P289, DOI 10.1007/s12207-010-9089-5	25	5	5	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	DEC	2013	6	4			SI		307	313		10.1007/s12207-013-9178-3			7	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	VB4HA	WOS:000415471900004					2022-02-06	
J	Riascos, D; Buritica, E; Jimenez, E; Castro, O; Guzman, F; Palacios, M; Garcia-Cairasco, N; Geula, C; Escobar, M; Pimienta, H				Riascos, David; Buritica, Efrain; Jimenez, Eliecer; Castro, Olagide; Guzman, Francisco; Palacios, Mauricio; Garcia-Cairasco, Norberto; Geula, Changiz; Escobar, Martha; Pimienta, Hernan			Neurodegenerative Diversity in human cortical contusion: Histological analysis of tissue derived from decompressive craniectomy	BRAIN RESEARCH			English	Article						TBI; Cerebral contusion; NeuN; Fluoro-Jade; Neurodegeneration; Histologic correlation	TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; CELL LOSS; NEUN; PENUMBRA; CORTEX; EXPRESSION; PROTEIN; DYSFUNCTION; THRESHOLDS	The principal aim in the management of patients with cerebral contusion (CC) following severe traumatic brain injury (TBI) is the prevention, amelioration, and treatment of secondary neuronal dysfunction and pathology. Distinguishing between irreversibly damaged and surviving tissue could have considerable therapeutic and prognostic implications for patients. To characterize structurally the neuronal compartment of the contused region in samples derived from patients who suffered severe TBI and were subjected to decompressive craniectomy, we used NeuN, a neuronal marker. We determined that NeuN "patches", sectors with loss of NeuN immunoreactivity (NeuN-IR), represented 25% of the area among the analyzed cases. We also found a 67% decrease in NeuN levels via Western blot. Tissue adjoining patches of NeuN-IR were considered "preserved" due to the apparent normal density of neurons and conservation of the six cortical layers. Nevertheless, these sectors retained only 39% of their neurons with the classical pattern described for normal NeuN-IR. Using Fluorojade we identified a 16-fold increase in density of moribund neurons in "preserved" sectors when compared to controls. Additionally these abnormalities were enhanced 5-fold in "patches" of NeuN-IR when compared to preserved regions. Therefore, NeuN/Fluorojade abnormalities are indicative of different cell fates characteristic of CC tissue. This analysis addressed exclusively the neuronal compartment and provides new insights into the degenerative state of neurons in the contused region that is likely to contribute to clinical outcome and differentiate TBI from ischemia. (C) 2013 Elsevier B.V. All rights reserved.	[Riascos, David; Geula, Changiz] Northwestern Univ, Feinberg Med Sch, Cognit & Neurol Alzheimers Dis Ctr, Chicago, IL 60610 USA; [Riascos, David; Buritica, Efrain; Jimenez, Eliecer; Guzman, Francisco; Palacios, Mauricio; Escobar, Martha; Pimienta, Hernan] Univ Valle, Fac Salud, Ctr Estudios Cerebrales, Cali, Colombia; [Castro, Olagide; Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Sch Med, Neurophysiol & Expt Neuroetol Lab, Sao Paulo, Brazil		Riascos, D (corresponding author), Barrow Neurol Inst, Div Neurol, Barrow ALS & Neuromuscular Res Ctr, 350W Thomas Rd, Phoenix, AZ 85013 USA.	dariasmo@gmail.com	Buritica, Efrain/C-3315-2011; Escobar, Martha/E-4288-2015; Palacios, Mauricio/B-9905-2011; Castro, Olagide/ABA-6708-2020; Castro, Olagide/C-6781-2015; Cairasco, Norberto Garcia/E-3250-2015	Escobar, Martha/0000-0002-0036-7473; Palacios, Mauricio/0000-0001-8091-9954; Castro, Olagide/0000-0002-1874-509X; Castro, Olagide/0000-0002-1874-509X; Cairasco, Norberto Garcia/0000-0001-8857-3775; Pimienta, Hernan/0000-0002-8254-2078; Buritica Ramirez, Efrain/0000-0001-6747-9587; Jimenez Charris, Eliecer/0000-0001-6043-1521			ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Baron JC, 1999, CEREBROVASC DIS, V9, P193, DOI 10.1159/000015955; BULLOCK R, 1991, J NEUROL NEUROSUR PS, V54, P427, DOI 10.1136/jnnp.54.5.427; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Chieregato A, 2008, INTENS CARE MED, V34, P2125, DOI 10.1007/s00134-008-1182-9; Clark RSB, 1999, FASEB J, V13, P813, DOI 10.1096/fasebj.13.8.813; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Collombet JM, 2006, NEUROSCI LETT, V398, P337, DOI 10.1016/j.neulet.2006.01.029; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Dawodu S, 2005, EPILEPSIA, V46, P23, DOI 10.1111/j.0013-9580.2005.21804.x; Domorakova I, 2006, CELL MOL NEUROBIOL, V26, P1193, DOI 10.1007/s10571-006-9080-6; Fujimoto S, 2007, NEUROSCIENCE, V144, P694, DOI 10.1016/j.neuroscience.2006.09.049; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Heiss WD, 2010, INT J STROKE, V5, P290, DOI 10.1111/j.1747-4949.2010.00444.x; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Escobar MI, 2008, COLOMB MEDICA, V39, P51; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; LOBERG EM, 1989, MED SCI LAW, V29, P109, DOI 10.1177/002580248902900205; Love S., 2008, GREENFIELDS NEUROPAT, V1, P740; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3; McPhail LT, 2004, EXP NEUROL, V185, P182, DOI 10.1016/j.expneurol.2003.10.001; Menon DK, 2003, ANESTHESIOLOGY, V98, P805, DOI 10.1097/00000542-200304000-00002; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; OEHMICHEN M, 1980, Z RECHTSMED, V84, P79, DOI 10.1007/BF02114577; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Riascos D, 2008, COLOMB MEDICA, V39, P29; RIBAS GC, 1992, J NEUROTRAUM, V9, pS265; Robertson CL, 2006, EXP NEUROL, V197, P235, DOI 10.1016/j.expneurol.2005.09.014; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Seidberg NA, 2003, J NEUROCHEM, V84, P514, DOI 10.1046/j.1471-4159.2003.01547.x; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Woolf N., 2000, CELL TISSUE DIS BASI; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Zhang L, 2006, NEUROPATHOLOGY, V26, P99, DOI 10.1111/j.1440-1789.2006.00658.x; Zhang XP, 2003, FASEB J, V17, P1367, DOI 10.1096/fj.02-1067fje; Zsombok A, 2005, J NEUROSCI METH, V142, P145, DOI 10.1016/j.jneumeth.2004.08.005	42	5	5	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 6	2013	1537						86	99		10.1016/j.brainres.2013.09.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	264XV	WOS:000327915200010	24060647	Green Published			2022-02-06	
J	Fleck, SK; Wallaschofski, H; Rosenstengel, C; Matthes, M; Kohlmann, T; Nauck, M; Schroeder, HWS; Spielhagen, C				Fleck, Steffen Kristian; Wallaschofski, Henri; Rosenstengel, Christian; Matthes, Marc; Kohlmann, Thomas; Nauck, Matthias; Schroeder, Henry Werner Siegfried; Spielhagen, Christin			Prevalence of hypopituitarism after intracranial operations not directly associated with the pituitary gland	BMC ENDOCRINE DISORDERS			English	Article						Hypopituitarism; Pituitary deficiency; Intracranial operation; Neurosurgery	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE DEFICIENCY; INSULIN TOLERANCE-TEST; SUBARACHNOID HEMORRHAGE; CONSENSUS GUIDELINES; ENDOCRINE-SOCIETY; DYSFUNCTION; TUMORS; DIAGNOSIS	Background: Over the last few years, awareness and detection rates of hypopituitarism following traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) has steadily increased. Moreover, recent studies have found that a clinically relevant number of patients develop pituitary insufficiency after intracranial operations and radiation treatment for non-pituitary tumors. But, in a substantial portion of more than 40%, the hypopituitarism already exists before surgery. We sought to determine the frequency, pattern, and severity of endocrine disturbances using basal and advanced dynamic pituitary testing following non-pituitary intracranial procedures. Methods: 51 patients (29 women, 22 men) with a mean age of 55 years (range of 20 to 75 years) underwent prospective evaluation of basal parameters and pituitary function testing (combined growth hormone releasing hormone (GHRH)/arginine test, insulin tolerance test (ITT), low dose adrenocorticotropic hormone (ACTH) test), performed 5 to 168 months (median 47.2 months) after intracranial operation (4 patients had additional radiation and 2 patients received additional radiation combined with chemotherapy). Results: We discovered an overall rate of hypopituitarism with distinct magnitude in 64.7% (solitary in 45.1%, multiple in 19.6%, complete in 0%). Adrenocorticotropic hormone insufficiency was found in 51.0% (partial in 41.2%, complete in 9.8%) and growth hormone deficiency (GHD) occurred in 31.4% (partial in 25.5%, severe in 5.9%). Thyrotropic hormone deficiency was not identified. The frequency of hypogonadism was 9.1% in men. Pituitary deficits were associated with operations both in close proximity to the sella turcica and more distant regions (p = 0.91). Age (p = 0.76) and gender (p = 0.24) did not significantly differ across patients with versus those without hormonal deficiencies. Groups did not significantly differ across pathology and operation type (p = 0.07). Conclusion: Hypopituitarism occurs more frequently than expected in patients who have undergone neurosurgical intracranial procedures for conditions other then pituitary tumors or may already exists in a neurosurgical population before surgery. Pituitary function testing and adequate substitution may be warranted for neurosurgical patients with intracranial pathologies at least if unexplained symptoms like fatigue, weakness, altered mental activity, and decreased exercise tolerance are present.	[Fleck, Steffen Kristian; Rosenstengel, Christian; Matthes, Marc; Schroeder, Henry Werner Siegfried] Univ Med Greifswald, Dept Neurosurg, D-17475 Greifswald, Germany; [Wallaschofski, Henri; Nauck, Matthias; Spielhagen, Christin] Univ Med Greifswald, Inst Clin Chem & Lab Med, D-17475 Greifswald, Germany; [Kohlmann, Thomas] Univ Med Greifswald, Inst Community Med, D-17475 Greifswald, Germany		Fleck, SK (corresponding author), Univ Med Greifswald, Dept Neurosurg, Ferdinand Sauerbruch Str, D-17475 Greifswald, Germany.	sfleck@uni-greifswald.de			PfizerPfizer; Novo NordiskNovo Nordisk	H. Wallaschofski received travel and research grants from Pfizer and Novo Nordisk. He is a member of the German as well as the International KIMS board. C. Spielhagen received travel grants from Pfizer and Novo Nordisk. S. Fleck received a travel grant from Pfizer and Novo Nordisk.	Abdu TAM, 1999, J CLIN ENDOCR METAB, V84, P838, DOI 10.1210/jc.84.3.838; Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Altman D.G., 2000, BRIT MED J; Ambrosi B, 1998, EUR J ENDOCRINOL, V139, P575, DOI 10.1530/eje.0.1390575; ASA SKK, 1995, HYPOTHALAMIC PIUITAR; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; DANIEL PM, 1959, LANCET, V2, P927; Darzy KH, 2003, HORM RES, V59, P1, DOI 10.1159/000067834; De Marinis L, 2006, J ENDOCRINOL INVEST, V29, P516, DOI 10.1007/BF03344141; EDWARDS OM, 1986, MEDICINE, V65, P281; Gabellieri E, 2010, FRONT HORM RES, V38, P139, DOI 10.1159/000318503; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; JORGENSEN EV, 1993, J PEDIATR ENDOCRINOL, V6, P131; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; LITTLEY MD, 1989, Q J MED, V70, P145; Molitch ME, 2006, J CLIN ENDOCR METAB, V91, P1621, DOI 10.1210/jc.2005-2227; PARTSCH CJ, 1985, J CLIN ENDOCR METAB, V60, P1196, DOI 10.1210/jcem-60-6-1196; ROLIH CA, 1993, ENDOCRIN METAB CLIN, V22, P291, DOI 10.1016/S0889-8529(18)30167-1; Schmidt IL, 2003, J CLIN ENDOCR METAB, V88, P4193, DOI 10.1210/jc.2002-021897; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; Schneider HJ, 2006, ACTA NEUROCHIR, V148, P449, DOI 10.1007/s00701-005-0724-y; STEWART PM, 1988, LANCET, V1, P1208; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; Volzke H, 2010, HORM METAB RES, V42, P809, DOI 10.1055/s-0030-1263121; Wachter D, 2011, NEUROSURG REV, V34, P509, DOI 10.1007/s10143-011-0326-5	35	5	6	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1472-6823		BMC ENDOCR DISORD	BMC Endocr. Disord.	NOV 4	2013	13								51	10.1186/1472-6823-13-51			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	258GT	WOS:000327448000001	24188166	Green Published, gold			2022-02-06	
J	Jeyaraj, JA; Clendenning, A; Bellemare-Lapierre, V; Iqbal, S; Lemoine, MC; Edwards, D; Korner-Bitensky, N				Jeyaraj, Jerine Anton; Clendenning, Audrey; Bellemare-Lapierre, Valerie; Iqbal, Shabeena; Lemoine, Marie-Christine; Edwards, Dominique; Korner-Bitensky, Nicol			Clinicians' perceptions of factors contributing to complexity and intensity of care of outpatients with traumatic brain injury	BRAIN INJURY			English	Article						Clinicians perception; co-morbidities; complexity; community services; complexity determinants; continuum of care; cultural barriers; environmental barriers; funding sources barriers; heavy case; outpatient rehabilitation; pre-TBI situation; sequelae; TBI awareness; TBI diagnosis; TBI severity; therapeutic relationship; Traumatic brain injury	PATIENT COMPLEXITY; CENTER DESIGNATION; REHABILITATION; IMPACT; PARTICIPATION; PERSPECTIVE; DEPRESSION; OUTCOMES; THERAPY; SYSTEMS	Primary objective: This study investigated clinicians' perceptions on factors linked to patient complexity in traumatic brain injury (TBI) outpatient rehabilitation. Method: Twelve clinicians from various disciplines, working in TBI outpatient programmes from three rehabilitation institutions in Montreal, Quebec, were recruited using convenience and snowball sampling. Data was collected through focus groups and individual interviews and thematic analysis was used to identify themes. Main outcomes and results: Participants identified complexity factors falling under the following themes: sequelae of TBI (cognitive/behavioural/psychological impacts), personal factors (personality traits, pre-medical state, lifestyle and age), patients' environment (architectural, social, language, cultural and financial) and therapeutic relationship (mismatch, misunderstanding and personality clashes). Clinicians also reported facilitators to optimal treatment delivery such as quality of services and working in an interdisciplinary team. Limited time, training and resources were identified as barriers to treatment. Conclusion: A substantial proportion of patients in outpatient TBI programmes seem to follow an atypical evolution and exhibit added complexity. In order to optimize quality of care, clinicians recommended increased community awareness about TBI, increased resources for rehabilitation clinicians and specialized services post-discharge. These findings are insightful for stakeholders; providing a basis for discussions on policy changes that can better meet this population's needs.	[Jeyaraj, Jerine Anton; Clendenning, Audrey; Bellemare-Lapierre, Valerie; Iqbal, Shabeena; Lemoine, Marie-Christine; Edwards, Dominique; Korner-Bitensky, Nicol] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ H3G 1Y5, Canada		Korner-Bitensky, N (corresponding author), McGill Univ, Sch Phys & Occupat Therapy, 3654 Promenade Sir William Osler, Montreal, PQ H3G 1Y5, Canada.	nicol.korner-bitensky@mcgill.ca			School of Physical and Occupational Therapy, McGill University	We gratefully acknowledge the financial support for this study from the School of Physical and Occupational Therapy, McGill University. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	[Anonymous], 1998, NIH Consens Statement, V16, P1; BLACKERBY W F, 1990, Brain Injury, V4, P167, DOI 10.3109/02699059009026162; Bouchard P, 1999, CONTINUUM SERVICES P; Bricout John C, 2003, Work, V21, P45; Brown JB, 2010, J TRAUMA, V69, P263, DOI 10.1097/TA.0b013e3181e5d72e; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HUGHES D, 1993, AM J COMMUN PSYCHOL, V21, P775, DOI 10.1007/BF00942247; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Info-TCC, 2008, COMM PEUT ON DEF REA; Jay G W, 1996, J Insur Med, V27, P262; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Le College des medecins du Quebec, 2005, OR MIN TRAUM CRAN LE; Levine JM, 2010, PSYCHIAT CLIN N AM, V33, P877, DOI 10.1016/j.psc.2010.09.001; Lundqvist A, 2010, BRAIN INJURY, V24, P1173, DOI 10.3109/02699052.2010.498007; Lunsford T. R., 1995, J PROSTHET ORTHOT, V7, P105; McGregor K, 1997, SOC SCI MED, V45, P295, DOI 10.1016/S0277-9536(96)00345-0; Morgan D, 1997, FOCUS GROUP KIT; Peek CJ, 2009, FAM SYST HEALTH, V27, P287, DOI 10.1037/a0018048; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Safford MM, 2007, J GEN INTERN MED, V22, P382, DOI 10.1007/s11606-007-0307-0; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Servadei F, 1988, Brain Inj, V2, P87, DOI 10.3109/02699058809150935; Shiel A, 2001, CLIN REHABIL, V15, P501, DOI 10.1191/026921501680425225; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Turner-Strokes L, 2005, COCHRANE DB SYST REV, P30; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009	38	5	5	0	22	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1338	1347		10.3109/02699052.2013.823650			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500002	23923818				2022-02-06	
J	Kaufmann, PM				Kaufmann, Paul M.			Neuropsychologist Experts and Neurolaw: Cases, Controversies, and Admissibility Challenges	BEHAVIORAL SCIENCES & THE LAW			English	Article								Clinical neuropsychologists engage increasingly in forensic consulting activities because such expert opinions are generally relevant, reliable and helpful in resolving certain legal claims, especially those related to traumatic brain injury. Consequently, practitioners of law, medicine and psychology would benefit from understanding the nature of neuropsychological evidence, the standards for its admissibility, and its expanding role in neurolaw. This article reviews important evidentiary rules regulating relevance, preliminary questions, and expert testimony, while tracing federal key court decisions and progeny. Civil and criminal cases are detailed to illustrate the application of these rules and case law to neuropsychological evidence, with suggestions for overcoming motions to exclude such evidence. Expert neuropsychologists have a role in forensic consultation on brain trauma cases, even as the interdisciplinary dialog and understanding among law, medicine, and psychology continues to expand. Copyright (c) 2013 John Wiley & Sons, Ltd.			Kaufmann, PM (corresponding author), 31030 Foxridge Lane, Eugene, OR 97405 USA.	paul.m.kaufmann@gmail.com					DENNEY RL, 2008, CLIN NEUROPSYCHOLOGY; Desmond J, 2013, PSYCHOANALYTIC ACCOUNTS OF CONSUMING DESIRE: HEARTS OF DARKNESS, P1; Greenberg SA, 1997, PROF PSYCHOL-RES PR, V28, P50, DOI 10.1037/0735-7028.28.1.50; Greenberg SA, 2007, PROF PSYCHOL-RES PR, V38, P129, DOI 10.1037/0735-7028.38.2.129; Greiffenstein M., 2012, FORENSIC NEUROPSYCHO, P23; Hannay HJ, 1998, ARCH CLIN NEUROPSYCH, V13, P157, DOI 10.1016/S0887-6177(98)00003-1; Heilbronner RL, 2004, CLIN NEUROPSYCHOL, V18, P312, DOI 10.1080/13854040490501574; Heilbrun K., 2001, PRINCIPLES FORENSIC; Heltzel T, 2007, PROF PSYCHOL-RES PR, V38, P122, DOI 10.1037/0735-7028.38.2.122; Huber P.W, 1991, GALILEOS REVENGE JUN; Kaufmann P, 2012, FORENSIC NEUROPSYCHO, P70; Kaufmann P. M., 2013, NATL ACAD NEUROPSYCH, V27, P11; Kaufmann PM, 2009, CLIN NEUROPSYCHOL, V23, P1130, DOI 10.1080/13854040903107809; KAUFMANN PM, 2008, CLIN NEUROPSYCHOLOGY, P55; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; McCrystal L., 2012, CONCORD MONITOR 0923; Sweet JJ, 2002, CLIN NEUROPSYCHOL, V16, P481, DOI 10.1076/clin.16.4.481.13914; SWEET JJ, 2008, TXB CLIN NEUROPSYCHO, P869; Taylor JS, 1999, STUD NEUROPSYCHOL DE, P419; Woody RH, 2009, ETHICS BEHAV, V19, P79, DOI 10.1080/10508420802623690	20	5	5	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0735-3936	1099-0798		BEHAV SCI LAW	Behav. Sci. Law	NOV	2013	31	6			SI		739	755		10.1002/bsl.2085			17	Psychology, Applied; Law	Social Science Citation Index (SSCI)	Psychology; Government & Law	262KI	WOS:000327733400005	24115139				2022-02-06	
J	Matsukawa, H; Shinoda, M; Fujii, M; Takahashi, O; Murakata, A; Yamamoto, D				Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Takahashi, Osamu; Murakata, Atsushi; Yamamoto, Daisuke			Acute alcohol intoxication, diffuse axonal injury and intraventricular bleeding in patients with isolated blunt traumatic brain injury	BRAIN INJURY			English	Article						Blood alcohol level; corpus callosum injury; genu; outcome	GLASGOW COMA SCALE; SUBSTANCE-ABUSE; COMPUTED-TOMOGRAPHY; CORPUS-CALLOSUM; MORTALITY; ETHANOL; HEMORRHAGE; MODERATE; ASSOCIATION; GUIDELINES	Objective: The influence of blood alcohol level (BAL) on outcome remains unclear. This study investigated the relationships between BAL, type and number of diffuse axonal injury (DAI), intraventricular bleeding (IVB) and 6-month outcome. Methods: This study reviewed 419 patients with isolated blunt traumatic brain injury. First, it compared clinical and radiological characteristics between patients with good recovery and disability. Second, it compared BAL among DAI lesions. Third, it evaluated the correlation between the BAL and severity of IVB, number of DAI and corpus callosum injury lesions. Results: Regardless of BAL, older age, male gender, severe Glasgow Coma Scale score (59), abnormal pupil, IVB and lesion on genu of corpus callosum were significantly related to disability. There were no significant differences between the BAL and lesions of DAI. Simple regression analysis revealed that there were no significant correlation between BAL and severity of IVB, number of DAI and corpus callosum injury lesions. Conclusions: Acute alcohol intoxication was not associated with type and number of DAI lesion, IVB and disability. This study suggested that a specific type of traumatic lesion, specifically lesion on genu of corpus callosum and IVB, might be more vital for outcome.	[Matsukawa, Hidetoshi; Shinoda, Masaki; Fujii, Motoharu; Murakata, Atsushi; Yamamoto, Daisuke] St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, Tokyo 1048560, Japan; [Takahashi, Osamu] St Lukes Int Hosp, Dept Med, Div Gen Internal Med, Chuo Ku, Tokyo 1048560, Japan		Matsukawa, H (corresponding author), St Lukes Int Hosp, Dept Neurosurg, Chuo Ku, 9-1 Akashi Cho, Tokyo 1048560, Japan.	mahide@luke.or.jp			General Insurance Association of Japan	The authors report no conflicts of interest. This study was supported by a medical research grant on traffic accidents from The General Insurance Association of Japan 2010.	Alexander S, 2004, J NEUROTRAUM, V21, P575, DOI 10.1089/089771504774129900; Association AP, 2000, DIAGN STAT MAN MENT; Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Bigler ED, 1996, BRAIN INJURY, V10, P197, DOI 10.1080/026990596124511; BRICKLEY MR, 1995, INJURY, V26, P311, DOI 10.1016/0020-1383(95)00034-7; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Fletcher S.W, 2005, CLIN EPIDEMIOLOGY ES, V4th; GETTLER DT, 1963, ANN SURG, V158, P151, DOI 10.1097/00000658-196308000-00001; Golan JD, 2007, J TRAUMA, V63, P365, DOI 10.1097/TA.0b013e31811ec178; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Kelly DF, 2000, J NEUROTRAUM, V17, P261, DOI 10.1089/neu.2000.17.261; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; KNOTT DH, 1963, NEW ENGL J MED, V269, P292, DOI 10.1056/NEJM196308082690604; KNOTT DH, 1967, AM J MED SCI, V254, P178, DOI 10.1097/00000441-196708000-00007; Kolakowsky-Hayner SA, 1999, BRAIN INJURY, V13, P571; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MALT SH, 1971, J TRAUM, V11, P76, DOI 10.1097/00005373-197101000-00007; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Matsukawa H, 2011, J NEUROSURG, V115, P1019, DOI 10.3171/2011.6.JNS11513; Matsukawa H, 2011, ACTA NEUROCHIR, V153, P1687, DOI 10.1007/s00701-011-1002-9; MAX W, 1991, J HEAD TRAUMA REHAB, V6, P676; O'Phelan K, 2008, J TRAUMA, V65, P674, DOI 10.1097/TA.0b013e31817db0a5; Rosa CM, 2011, J TRAUMA, V70, P447, DOI 10.1097/TA.0b013e3182095e14; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Sperry JL, 2006, J TRAUMA, V61, P1305, DOI 10.1097/01.ta.0000240113.13552.96; Stuke L, 2007, ANN SURG, V245, P651, DOI 10.1097/01.sla.0000250413.41265.d3; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Tureci E, 2004, NEUROL RES, V26, P108, DOI 10.1179/016164104225013699; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]; Wilde EA, 2004, J NEUROTRAUM, V21, P137, DOI 10.1089/089771504322778604; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x	41	5	5	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	NOV	2013	27	12					1409	1414		10.3109/02699052.2013.823655			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	235UF	WOS:000325745500011	24102331				2022-02-06	
J	Minnick, JM; Bebarta, VS; Stanton, M; Lairet, JR; King, J; Torres, P; Aden, J; Ramirez, R				Minnick, Joanne M.; Bebarta, Vikhyat S.; Stanton, Marietta; Lairet, Julio R.; King, James; Torres, Pedro; Aden, James; Ramirez, Rosemarie			THE INCIDENCE OF FEVER IN US CRITICAL CARE AIR TRANSPORT TEAM COMBAT TRAUMA PATIENTS EVACUATED FROM THE THEATER BETWEEN MARCH 2009 AND MARCH 2010	JOURNAL OF EMERGENCY NURSING			English	Article						Fever; Flight medicine; Critical care transport; Trauma; Military medicine; Combat		Introduction: Most critically ill injured patients are transported out of the theater by Critical Care Air Transport Teams (CCATTs). Fever after trauma is correlated with surgical complications and infection. The purposes of this study are to identify the incidence of elevated temperature in patients managed in the CCATT environment and to describe the complications reported and the treatments used in these patients. Methods: We performed a retrospective review of available records of trauma patients from the combat theater between March 1, 2009, and March 31, 2010, who were transported by the US Air Force CCATT and had an incidence of hyperthermia. We then divided the cohort into 2 groups, patients transported with an elevation in temperature greater than 100.4 degrees F and patients with no documented elevation in temperature. We used a standardized, secure electronic data collection form to abstract the outcomes. Descriptive data collected included injury type, temperature, use of a mechanical ventilator, cooling treatment modalities, antipyretics, intravenous fluid administration, and use of blood products. We also evaluated the incidence of complications during the transport in patients who had a recorded elevation in temperature greater than 100.4 degrees F. Results: A total of 248 trauma patients met the inclusion criteria, and 101 trauma patients (40%) had fever. The mean age was 28 years, and 98% of patients were men. The mechanism of injury was an explosion in 156 patients (63%), blunt injury in 11 (4%), and penetrating injury in 45 (18%), whereas other trauma-related injuries accounted for 36 patients (15%). Of the patients, 209 (84%) had battle-related injuries and 39 (16%) had non-battle-related injuries. Traumatic brain injury was found in 24 patients (24%) with an incidence of elevated temperature. The mean temperature was 101.6 degrees F (range, 100.5 degrees F-103.9 degrees F). After evaluation of therapies and treatments, 80 trauma patients (51%) were intubated on a mechanical ventilator (P < .001). Of the trauma patients with documented fever, 22 (22%) received administration of blood products. Nineteen patients received antipyretics during their flight (19%), 9 received intravenous fluids (9%), and 2 received nonpharmacologic cooling interventions, such as cooling blankets or icepacks. We identified 1 trauma patient with neurologic changes (1%), 6 with hypotension (6%), 48 with tachycardia (48%), 33 with decreased urinary output (33%), and 1 with an episode of shivering or sweating (1%). We did not detect any transfusion reactions or deaths during flight. Conclusion: Fever occurred in 41% of critically ill combat-injured patients evacuated out of the combat theater in Iraq and Afghanistan. Fewer than 20% of patients with a documented elevated temperature received treatments to reduce the temperature. Intubation of patients with ventilators in use during the transport was the only factor significantly associated with fever. Serious complications were rare, and there were no deaths during these transports.	[Minnick, Joanne M.; Torres, Pedro] US Army Inst Surg Res, Air Force Enroute Care Res Ctr, San Antonio, TX USA; [Minnick, Joanne M.; King, James; Torres, Pedro] Mil Med Ctr, Ft Sam Houston, TX USA; [Bebarta, Vikhyat S.] USAF, Enroute Care Res Ctr, Ft Sam Houston, TX USA; [Bebarta, Vikhyat S.] San Antonio Mil Med Ctr, Dept Emergency Med, Ft Sam Houston, TX USA; [Stanton, Marietta] Univ Alabama, Capstone Coll Nursing, Tuscaloosa, AL USA; [Lairet, Julio R.] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA; [King, James] US Army Inst Surg Res, Air Force Enroute Care Res Ctr, Dept Emergency Med, San Antonio, TX USA; [Aden, James] US Army Inst Surg Res, Ft Sam Houston, TX USA; [Ramirez, Rosemarie] Wilford Hall Ambulatory Surg Ctr, MDW Off Chief Scientist 59, Lackland AFB, TX USA		Minnick, JM (corresponding author), Enroute Care Res Ctr, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA.	jodymm13@yahoo.com	Bebarta, Vikhyat S/L-9537-2015; Lairet, Julio/AAE-8406-2021; Bebarta, Vikhyat S/M-1513-2015				Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; Emergency Nurses Association, 2007, TRAUM NURS COR COURS; GRISSOM TE, 2005, CRIT CARE MED S, V33, P13; Kramer LW, 2010, DIMENS CRIT CARE NUR, V29, P20, DOI 10.1097/DCC.0b013e3181be4a74; Lustenberger T, 2009, EUR J TRAUMA EMERG S, V35, P538, DOI 10.1007/s00068-009-8128-y; Thompson HJ, 2005, J ADV NURS, V51, P484, DOI 10.1111/j.1365-2648.2005.03520.x	6	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0099-1767	1527-2966		J EMERG NURS	J. Emerg. Nurs.	NOV	2013	39	6					E101	E106		10.1016/j.jen.2013.02.001			6	Emergency Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Nursing	254EG	WOS:000327146600001	23684131				2022-02-06	
J	Pielmaier, L; Milek, A; Nussbeck, FW; Walder, B; Maercker, A				Pielmaier, Laura; Milek, Anne; Nussbeck, Fridtjof W.; Walder, Bernhard; Maercker, Andreas			Trajectories of Posttraumatic Stress Symptoms in Significant Others of Patients With Severe Traumatic Brain Injury	JOURNAL OF LOSS & TRAUMA			English	Article						PTSD; significant others; symptom trajectories; traumatic brain injury	MOTOR-VEHICLE ACCIDENT; FAMILY-MEMBERS; EVENT SCALE; PSYCHOMETRIC PROPERTIES; PSYCHOLOGICAL DISTRESS; HONG-KONG; DISORDER; RESILIENCE; IMPACT; RISK	Long-term psychological distress has been reported among significant others of patients who sustained a traumatic brain injury (TBI). This study examined the course and potential predictors of posttraumatic stress symptoms in a relative sample (N=135) drawn from a national cohort study on severe TBI in Switzerland. Latent growth mixture model analyses revealed two main groups: Across 3, 6, and 12 months after the accident, 63% of the sample indicated fairly low symptom severity (resilient course), whereas 37% showed persistence of higher distress as indicated by elevated scores on the Impact of Event ScaleRevised. Group membership was significantly associated with self-reported dysfunctional disclosure style. Implications for research and practice are discussed.	[Pielmaier, Laura] Swiss Natl Accid Insurance Fund, Div Insurance Med, Luzern, Switzerland; [Milek, Anne; Nussbeck, Fridtjof W.] Univ Zurich, Dept Psychol, Zurich, Switzerland; [Walder, Bernhard] Univ Hosp Geneva, Div Anesthesiol, Geneva, Switzerland; [Maercker, Andreas] Univ Zurich, Dept Psychol Psychopathol & Clin Intervent, Zurich, Switzerland		Pielmaier, L (corresponding author), Suva Lucerne, Versicherungsmed, Fluhmattstr 1, CH-6002 Luzern, Switzerland.	laura.pielmaier@suva.ch	Maercker, Andreas/D-2814-2017; Nussbeck, Fridtjof/I-8938-2016; Milek, Anne/K-3511-2019	Maercker, Andreas/0000-0001-6925-3266; Nussbeck, Fridtjof/0000-0003-4002-8916; Milek, Anne/0000-0001-6179-4869			Alcala-Lopez D, 2019, CORTEX, V118, P4, DOI 10.1016/j.cortex.2018.05.006; Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Armour Cherie, 2012, Traumatology (Tallahass Fla), V18, P20, DOI 10.1177/1534765610395627; Association for the Advancement of Automotive Medicine, 2001, ABBR INJ SCAL 1998 U; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Beck JG, 2008, J ANXIETY DISORD, V22, P187, DOI 10.1016/j.janxdis.2007.02.007; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bonanno GA, 2008, HEALTH PSYCHOL, V27, P659, DOI 10.1037/0278-6133.27.5.659; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bonanno GA, 2011, ANNU REV CLIN PSYCHO, V7, P511, DOI 10.1146/annurev-clinpsy-032210-104526; Bonanno George A, 2010, Psychol Sci Public Interest, V11, P1, DOI 10.1177/1529100610387086; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Bunzel B, 2007, J HEART LUNG TRANSPL, V26, P384, DOI 10.1016/j.healun.2007.01.025; Chui WYY, 2007, J CLIN NURS, V16, P372, DOI 10.1111/j.1365-2702.2005.01461.x; Courtney L. J., 1997, DISS ABSTR INT A, V58, P1916; Creamer M, 2003, BEHAV RES THER, V41, P1489, DOI 10.1016/j.brat.2003.07.010; Curran PJ, 2003, J ABNORM PSYCHOL, V112, P526, DOI 10.1037/0021-843X.112.4.526; DeRoon-Cassini TA, 2010, REHABIL PSYCHOL, V55, P1, DOI 10.1037/a0018601; Dew MA, 2004, PSYCHOL MED, V34, P1065, DOI 10.1017/S0033291703001387; Dickstein BD, 2010, J TRAUMA STRESS, V23, P331, DOI 10.1002/jts.20523; Elliott P, 2005, J TRAUMA STRESS, V18, P303, DOI 10.1002/jts.20041; Enders CK, 2001, EDUC PSYCHOL MEAS, V61, P713, DOI 10.1177/0013164401615001; Holgersen KH, 2011, J TRAUMA STRESS, V24, P334, DOI 10.1002/jts.20636; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jones C, 2004, INTENS CARE MED, V30, P456, DOI 10.1007/s00134-003-2149-5; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; Kaplan D., 2004, SAGE HDB QUANTITATIV, P345, DOI DOI 10.4135/9781412986311.N19; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; King DW, 2009, PSYCHOL TRAUMA-US, V1, P173, DOI 10.1037/a0016990; Lam WWT, 2010, PSYCHO-ONCOLOGY, V19, P1044, DOI 10.1002/pon.1658; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Maercker A, 1998, DIAGNOSTICA, V44, P130; Maercker A, 2013, CLIN PSYCHOL PSYCHOT, V20, P465, DOI 10.1002/cpp.1805; Marshall RD, 2001, AM J PSYCHIAT, V158, P1467, DOI 10.1176/appi.ajp.158.9.1467; McAdam JL, 2010, CRIT CARE MED, V38, P1078, DOI 10.1097/CCM.0b013e3181cf6d94; McLachlan GJ., 2000, WILEY SER PROB STAT, DOI 10.1002/0471721182; Mueller J., 2000, Z FUER POLITISCHE PS, V8, P413; Mueller J, 2008, CAN J PSYCHIAT, V53, P160, DOI 10.1177/070674370805300306; Muller M, 2011, PSYCHOL HEALTH MED, V16, P631, DOI 10.1080/13548506.2011.564192; MuthUn B.O., 2000, MPLUS USERS GUIDE; Noble AJ, 2008, J NEUROSURG, V109, P1027, DOI 10.3171/JNS.2008.109.12.1027; Norris FH, 2009, SOC SCI MED, V68, P2190, DOI 10.1016/j.socscimed.2009.03.043; Nugent NR, 2009, J TRAUMA STRESS, V22, P460, DOI 10.1002/jts.20440; Nylund KL, 2008, STRUCT EQU MODELING, V15, P182, DOI 10.1080/10705510701793320; Orcutt HK, 2004, J TRAUMA STRESS, V17, P195, DOI 10.1023/B:JOTS.0000029262.42865.c2; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Peleg T, 2006, CNS SPECTRUMS, V11, P589, DOI 10.1017/S109285290001364X; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pielmaier L, 2011, EUR J PSYCHOTRAUMATO, V2, DOI 10.3402/ejpt.v2i0.8749; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Sander AM, 2002, BRAIN INJURY, V16, P649, DOI 10.1080/02699050210128889; Sander AM, 2007, NEUROREHABILITATION, V22, P1; Schell TL, 2004, J ABNORM PSYCHOL, V113, P189, DOI 10.1037/0021-843X.113.2.189; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; van der Hart O., 2008, ENCY PSYCHOL TRAUMA, P29; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Westphal M, 2011, DEPRESS ANXIETY, V28, P686, DOI 10.1002/da.20842; Wilson JP, 1996, ASSESSING PSYCHOL TR, P399; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wu KK, 2006, J TRAUMA STRESS, V19, P923, DOI 10.1002/jts.20178	65	5	5	0	54	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1532-5024	1532-5032		J LOSS TRAUMA	J. Loss Trauma	NOV 1	2013	18	6					521	538		10.1080/15325024.2012.719342			18	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	120MV	WOS:000317175400002					2022-02-06	
J	Umschweif, G; Alexandrovich, AG; Trembovler, V; Horowitz, M; Shohami, E				Umschweif, Gali; Alexandrovich, Alexander G.; Trembovler, Victoria; Horowitz, Michal; Shohami, Esther			The Role and Dynamics of beta-Catenin in Precondition Induced Neuroprotection after Traumatic Brain Injury	PLOS ONE			English	Article							CLOSED-HEAD INJURY; GLYCOGEN-SYNTHASE KINASE-3; ACCLIMATION-INDUCED NEUROPROTECTION; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CELL-DEATH; CADHERIN; PATHWAY; MICE; ACTIVATION; INCREASES	Preconditioning via heat acclimation (34 degrees C 30 d) results in neuroprotection from traumatic brain injury due to constitutive as well as dynamic changes triggered by the trauma. Among these changes is Akt phosphorylation, which decreases apoptosis and induces HIF1 alpha. In the present study we investigated the Akt downstream GSK3 beta/beta -catenin pathway and focused on post injury alternations of beta catenin and its impact on the cellular response in preconditioned heat acclimated mice. We found that the reduction in motor disability is accompanied with attenuation of depressive like behavior in heat acclimated mice that correlates with the GSK3 beta phosphorylation state. Concomitantly, a robust beta catenin phosphorylation is not followed by its degradation, or by reduced nuclear accumulation. Enhanced tyrosine phosphorylation of beta catenin in the injured area weakens the beta catenin-N cadherin complex. Membrane beta catenin is transiently reduced in heat acclimated mice and its recovery 7 days post TBI is accompanied by induction of the synaptic marker synaptophysin. We suggest a set of cellular events following traumatic brain injury in heat acclimated mice that causes beta catenin to participate in cell-cell adhesion alternations rather than in Wnt signaling. These events may contribute to synaptogenesis and the improved motor and cognitive abilities seen heat acclimated mice after traumatic brain injury.	[Umschweif, Gali; Alexandrovich, Alexander G.; Trembovler, Victoria] Hebrew Univ Jerusalem, Dept Pharmacol, Jerusalem, Israel; [Umschweif, Gali; Horowitz, Michal; Shohami, Esther] Hebrew Univ Jerusalem, Environm Physiol Lab, Jerusalem, Israel		Horowitz, M (corresponding author), Hebrew Univ Jerusalem, Environm Physiol Lab, Jerusalem, Israel.	m.horowitz@mail.huji.ac.il; esty@cc.huji.ac.il			Yissum Research Development Company of the Hebrew University of Jerusalem [0334185]	This study was supported by Yissum Research Development Company of the Hebrew University of Jerusalem, budget number 0334185. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Aikin R, 2004, ENDOCRINOLOGY, V145, P4522, DOI 10.1210/en.2004-0488; Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bhuiyan MIH, 2011, ARCH PHARM RES, V34, P1023, DOI 10.1007/s12272-011-0620-3; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Eynan M, 2012, J APPL PHYSIOL, V113, P595, DOI 10.1152/japplphysiol.00228.2012; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Green HF, 2012, NEUROCHEM INT, V61, P666, DOI 10.1016/j.neuint.2012.07.003; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hillion JA, 2006, J CEREBR BLOOD F MET, V26, P1323, DOI 10.1038/sj.jcbfm.9600286; Horowitz M, 2007, PROG BRAIN RES, V162, P373, DOI 10.1016/S0079-6123(06)62018-9; Hu SX, 2009, NEUROBIOL DIS, V33, P193, DOI 10.1016/j.nbd.2008.10.007; Huang TT, 2009, J NEUROTRAUM, V26, P1535, DOI [10.1089/neu.2008.0743, 10.1089/neu.2008-0743]; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; LEVI E, 1993, J APPL PHYSIOL, V75, P833, DOI 10.1152/jappl.1993.75.2.833; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Maguschak KA, 2012, NEUROPHARMACOLOGY, V62, P78, DOI 10.1016/j.neuropharm.2011.08.032; Maloyan A, 1999, AM J PHYSIOL-REG I, V276, pR1506, DOI 10.1152/ajpregu.1999.276.5.R1506; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Neary JT, 2006, J NEUROSCI RES, V84, P515, DOI 10.1002/jnr.20969; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Perez M, 2003, BIOCHEM J, V372, P129, DOI 10.1042/BJ20021596; Raghupathi R, 2003, EXP NEUROL, V183, P438, DOI 10.1016/S0014-4886(03)00166-3; Roura S, 1999, J BIOL CHEM, V274, P36734, DOI 10.1074/jbc.274.51.36734; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Schwimmer H, 2004, MOL BRAIN RES, V130, P95, DOI 10.1016/j.molbrainres.2004.07.011; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shein NA, 2007, BRAIN RES, V1185, P313, DOI 10.1016/j.brainres.2007.09.024; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Shein NA, 2008, BRAIN RES, V1244, P132, DOI 10.1016/j.brainres.2008.09.032; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268; Zhang HF, 2008, BRAIN RES, V1198, P182, DOI 10.1016/j.brainres.2008.01.007; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	51	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2013	8	10							e76129	10.1371/journal.pone.0076129			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	232JF	WOS:000325489100091	24124534	Green Submitted, Green Published, gold			2022-02-06	
J	Barak, O; Vakil, E; Levy, DA				Barak, Ohr; Vakil, Eli; Levy, Daniel A.			Environmental context effects on episodic memory are dependent on retrieval mode and modulated by neuropsychological status	QUARTERLY JOURNAL OF EXPERIMENTAL PSYCHOLOGY			English	Article						Context; Memory; Recall; Recognition; Traumatic brain injury	ADULT AGE-DIFFERENCES; RECOGNITION MEMORY; REINSTATEMENT; FAMILIARITY; GENERATION; IMPLICIT	Contextual change or constancy between occasions of memory formation and retrieval are commonly assumed to affect retrieval success, yet such effects may be inconsistent, and the processes leading to the pattern of effects are still not well understood. We conducted a systematic investigation of environmental context effects on memory, using a range of materials (common objects, pictures of familiar and unfamiliar faces, words, and sentences), and four types of retrieval (free recall, cued recall, recognition, and order memory), all assessed within participants. Additionally, we examined the influence of mnemonic challenge on context effects by examining both healthy participants and a group of patients in rehabilitation following traumatic brain injury (TBI). We found no effects of contextual factors on tests of recognition for either group of participants, but effects did emerge for cued and free recall, with the most prominent effects being on memory for objects. Furthermore, while patients' memory abilities in general were impaired relative to the comparison group, they exhibited greater influences of contextual reinstatement on several recall tasks. These results support suggestions that environmental context effects on memory are dependent on retrieval mode and on the extent to which retrieval is challenging because of neurocognitive status. Additionally, findings of environmental context effects in memory-impaired TBI patients suggest that by harnessing such preserved indirect memory (e.g., using reminder technologies), it may be possible to ameliorate TBI patients' difficulties in explicit remembering.	[Barak, Ohr] Tel Aviv Jaffa Acad Coll, Sch Behav Sci, Tel Aviv, Israel; [Barak, Ohr] Brain Injury Rehabil Trust, York, N Yorkshire, England; [Vakil, Eli] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Vakil, Eli] Bar Ilan Univ, Gonda Multidisciplinary Brain Res Ctr, Ramat Gan, Israel; [Levy, Daniel A.] Interdisciplinary Ctr IDC, Sch Psychol, Herzliyya, Israel		Levy, DA (corresponding author), Interdisciplinary Ctr, Sch Psychol, Herzliyya, Israel.	daniel.levy@idc.ac.il		Levy, Daniel/0000-0003-3086-4355	Tel-Aviv Jaffa Academic College; Israel Ministry of Health-Chief Scientist's Office; Israel Science FoundationIsrael Science Foundation [611/09]	The authors wish to thank Tal Moses, Michal Stern, and Inbar Marom for conducting the research reported here as part of their graduate studies. This research was supported by a grant from the Tel-Aviv Jaffa Academic College. E. V. is supported by Israel Ministry of Health-Chief Scientist's Office; D. A. L. is supported by Israel Science Foundation, Grant 611/09.	BADDELEY A, 1982, CAN J PSYCHOL, V36, P148, DOI 10.1037/h0080635; BALCH WR, 1992, MEM COGNITION, V20, P21, DOI 10.3758/BF03208250; Berry E, 2007, NEUROPSYCHOL REHABIL, V17, P582, DOI 10.1080/09602010601029780; Bjork RA, 1988, CURRENT ISSUES COGNI, P313; CANAS JJ, 1986, B PSYCHONOMIC SOC, V24, P407; CANN A, 1989, AM J PSYCHOL, V102, P91, DOI 10.2307/1423118; Chu S, 2003, PSYCHOL REC, V53, P549, DOI 10.1007/BF03395452; Craik FIM, 2011, PSYCHOL AGING, V26, P671, DOI 10.1037/a0022203; DALTON P, 1993, MEM COGNITION, V21, P223, DOI 10.3758/BF03202735; Davidson PSR, 2006, J INT NEUROPSYCH SOC, V12, P210, DOI 10.1017/S1355617706060334; DAVIES G, 1985, CRIM JUSTICE BEHAV, V12, P209, DOI 10.1177/0093854885012002004; Dougal S, 1999, AM J PSYCHOL, V112, P277, DOI 10.2307/1423354; Drori S., 2005, WORD NORMS HEBREW, P35; Earles JL, 1996, EXP AGING RES, V22, P267, DOI 10.1080/03610739608254011; FERNANDEZ A, 1985, MEM COGNITION, V13, P333, DOI 10.3758/BF03202501; Fernandez A, 2001, PSICOLOGICA, V22, P253; Fisher R. P., 1995, MEMORY TESTIMONY CHI, P141; GODDEN D, 1980, BRIT J PSYCHOL, V71, P99, DOI 10.1111/j.2044-8295.1980.tb02735.x; GODDEN DR, 1975, BRIT J PSYCHOL, V66, P325, DOI 10.1111/j.2044-8295.1975.tb01468.x; Herz RS, 1997, MEM COGNITION, V25, P375, DOI 10.3758/BF03211293; HUPPERT FA, 1976, CORTEX, V12, P3, DOI 10.1016/S0010-9452(76)80024-X; JANOWSKY JS, 1989, NEUROPSYCHOLOGIA, V27, P1043, DOI 10.1016/0028-3932(89)90184-X; Kinsbourne M., 1975, SHORT TERM MEMORY, P257; McDowall J, 1996, NEW ZEAL J PSYCHOL, V25, P2; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Mulligan NW, 2004, J EXP PSYCHOL LEARN, V30, P838, DOI 10.1037/0278-7393.30.4.838; MURNANE K, 1993, J EXP PSYCHOL LEARN, V19, P882, DOI 10.1037/0278-7393.19.4.882; MURNANE K, 1994, MEM COGNITION, V22, P584, DOI 10.3758/BF03198397; PHILLIPS PL, 1992, EXP AGING RES, V18, P41, DOI 10.1080/03610739208253909; Russo R, 1999, J EXP PSYCHOL LEARN, V25, P488, DOI 10.1037/0278-7393.25.2.488; Rutherford A, 2004, Q J EXP PSYCHOL-A, V57, P107, DOI 10.1080/02724980343000152; SCHAB FR, 1990, J EXP PSYCHOL LEARN, V16, P648, DOI 10.1037/0278-7393.16.4.648; SLAMECKA NJ, 1978, J EXP PSYCHOL-HUM L, V4, P592, DOI 10.1037/0278-7393.4.6.592; Smith S. M., 1987, CSCS004 TEX A M U; Smith S.M., 2007, SCI MEMORY CONCEPTS, P111; SMITH SM, 1978, MEM COGNITION, V6, P342, DOI 10.3758/BF03197465; Smith SM, 2001, PSYCHON B REV, V8, P203, DOI 10.3758/BF03196157; SMITH SM, 1979, J EXP PSYCHOL-HUM L, V5, P460, DOI 10.1037/0278-7393.5.5.460; Vakil E, 2005, J CLIN EXP NEUROPSYC, V27, P977, DOI 10.1080/13803390490919245; Vakil E, 1996, NEUROPSY NEUROPSY BE, V9, P176; Vakil E, 1997, NEUROPSYCHOLOGY, V11, P545, DOI 10.1037/0894-4105.11.4.545; VAKIL E, 1994, J CLIN EXP NEUROPSYC, V16, P539, DOI 10.1080/01688639408402665; Vakil E, 2007, Q J EXP PSYCHOL, V60, P916, DOI 10.1080/17470210701357568; Wechsler D., 1997, WECHSLER MEMORY SCAL; WILHITE SC, 1991, BRIT J PSYCHOL, V82, P325, DOI 10.1111/j.2044-8295.1991.tb02403.x; Winocur G., 1992, HDB AGING COGNITION, P315	46	5	5	2	18	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1747-0218	1747-0226		Q J EXP PSYCHOL	Q. J. Exp. Psychol.	OCT 1	2013	66	10					2008	2022		10.1080/17470218.2013.772647			15	Psychology, Biological; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Physiology	254SG	WOS:000327186700010	23480476				2022-02-06	
J	Cecchetti, C; Elli, M; Stoppa, F; Di Nardo, M; Pasotti, E; Gentile, I; Paoli, S; Pirozzi, N; Lubrano, R				Cecchetti, C.; Elli, M.; Stoppa, F.; Di Nardo, M.; Pasotti, E.; Gentile, I.; Paoli, S.; Pirozzi, N.; Lubrano, R.			Neurogenic pulmonary edema and variations of hemodynamic volumetric parameters in children following head trauma	MINERVA ANESTESIOLOGICA			English	Article						Pulmonary edema; Extravascular lung water; Intracranial pressure; Child	EXTRAVASCULAR LUNG WATER; BRAIN-TISSUE OXYGENATION; CEREBRAL-BLOOD-FLOW; INTRACRANIAL-PRESSURE; CARDIAC-OUTPUT; INJURY; PATHOPHYSIOLOGY; HYPERTENSION; THRESHOLDS; DAMAGE	Background. Currently there is no clear evidence of how changes in hemodynamic parameters are involved in the onset of neurogenic pulmonary edema. Aim of the study has been to correlate the principal variations of the intracranial pressure and volumetric hemodynamic parameters with the variations of extravascular lung water following severe head trauma in children. Methods. We studied 28 children, 16 males and 12 females, mean +/- SD age 71 +/- 29 months (range 24-130 months), admitted for traumatic head injury with Glasgow Coma scale <= 8. All patients received volumetric hemodynamic, and intracranial pressure monitoring follnwing initial resuscitation and every four hours thereafter or whenever a hemodynamic deterioration was suspected. All readings were divided in 2 groups: with intracranial pressure (ICP) >15 mmHg or <= 1.5 mmHg. Results. During the cumulative in hospital stay a total 508 sets of measurements were done. In the group with ICP >15 mmHg vs. that with ICP <= 15 mmHg we observed increased Extravascular Lung Water Index (EVLWi) (11.05 +/- 2.28 vs. 6.96 +/- 0.87 P<0.0001) and pulmonary permeability (8.50 +/- 1.19 vs. 5.08 +/- 0.90, P<0.0001), and decreased systemic vascular resistances, (1,451 +/- 371 vs. 1,602 +/- 447 P<0.0001) cerebral perfusion (48.87 +/- 18.67 vs. 69.72 +/- 11.36 P<0.0001) and PaO2/FiO(2) ratio (349 +/- 122 vs. 490 +/- 96 P<0.0001). There was a significant correlation between EVLWi and pulmonary permeability (R-2=0.83, P<0.0001). Fluid overload and cardiac functional index did not change significantly. Conclusion. The increased EVLWi observed in children following severe head trauma seems mainly related with pulmonary vascular permeability which is significantly increased when ICP is >15 mmHg.	[Cecchetti, C.; Stoppa, F.; Di Nardo, M.; Pasotti, E.; Pirozzi, N.] IRCS Bambino Gesu, Dipartimento Emergenza & Accettaz, Rome, Italy; [Elli, M.] Univ Milan, Osped Luigi Sacco, Dipartimento Sci Clin, Milan, Italy; [Gentile, I.; Paoli, S.; Lubrano, R.] Univ Roma La Sapienza, Dipartimento Pediat, I-00161 Rome, Italy		Lubrano, R (corresponding author), Univ Roma La Sapienza, Dipartimento Clin Pediat, Policlin Umberto I, Viale Regina Elena 324, I-00161 Rome, Italy.	riccardo.lubrano@uniroma1.it	Cecchetti, Corrado/AAH-9972-2019; Di NARDO, Matteo/AAI-1781-2019; ELLI, MARCO/S-5561-2017	ELLI, MARCO/0000-0003-2752-0156			Bahloul M, 2006, AM J CRIT CARE, V15, P462; Baumann A, 2007, ACTA ANAESTH SCAND, V51, P447, DOI 10.1111/j.1399-6576.2007.01276.x; Bayreuther J, 2009, ARCH DIS CHILDHOOD-E, V94, P37, DOI 10.1136/adc.2007.132787; Cecchetti C, 2008, CRIT CARE MED, V36, P928, DOI 10.1097/CCM.0B013E31816536F7; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; DETTBARN CL, 1989, HEART LUNG, V18, P583; Figaji AA, 2009, J NEUROSURG-PEDIATR, V4, P420, DOI 10.3171/2009.6.PEDS096; FRANCIS DB, 1977, IEEE T BIO-MED ENG, V24, P482, DOI 10.1109/TBME.1977.326196; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Heuer JF, 2011, INTENS CARE MED, V37, P1182, DOI 10.1007/s00134-011-2232-2; Jabot J, 2009, CRIT CARE MED, V37, P2913, DOI 10.1097/CCM.0b013e3181b01fd9; Kuzkov VV, 2006, CRIT CARE MED, V34, P1647, DOI 10.1097/01.CCM.0000218817.24208.2E; Lamia B, 2007, INTENS CARE MED, V33, P1125, DOI 10.1007/s00134-007-0646-7; Lemson J, 2010, CRIT CARE, V14, DOI 10.1186/cc9054; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Lubrano R, 2011, INTENS CARE MED, V37, P124, DOI 10.1007/s00134-010-2047-6; MEIER P, 1954, J APPL PHYSIOL, V6, P731, DOI 10.1152/jappl.1954.6.12.731; Muench E, 2007, CRIT CARE MED, V35, P1844, DOI 10.1097/01.CCM.0000275392.08410.DD; NOVITZKY D, 1987, ANN THORAC SURG, V43, P288, DOI 10.1016/S0003-4975(10)60615-7; Pauli C, 2002, INTENS CARE MED, V28, P947, DOI 10.1007/s00134-002-1334-2; ROGERS FB, 1995, J TRAUMA, V39, P860, DOI 10.1097/00005373-199511000-00009; Sakka SG, 2000, INTENS CARE MED, V26, P180, DOI 10.1007/s001340050043; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Smith WS, 1997, CHEST, V111, P1326, DOI 10.1378/chest.111.5.1326; Theodore J, 1976, LANCET, V25, P762; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	29	5	5	0	4	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0375-9393	1827-1596		MINERVA ANESTESIOL	Minerva Anestesiol.	OCT	2013	79	10					1140	1146					7	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	263KS	WOS:000327808100009	23811625				2022-02-06	
J	Ding, J; Yuan, F; Guo, JY; Chen, H; Tian, HL				Ding, Jun; Yuan, Fang; Guo, Jian-Yi; Chen, Hao; Tian, Heng-Li			Influence of glibenclamide on outcome in patients with type 2 diabetes and traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Traumatic brain injury; Glibenclamide; Outcome; Progressive secondary hemorrhage	NONSELECTIVE CATION CHANNEL; LONG-TERM DISABILITY; REACTIVE ASTROCYTES; UNITED-STATES; ATP; VALIDATION; PREDICTORS; EDEMA	Background and purpose: The influence of sulfonylurea receptor 1 (SUR1) and its inhibitor glibenclamide on progressive secondary hemorrhage (PSH), progressive hemorrhagic necrosis (PHN), and brain edema has been studied in rat models of traumatic brain injury (TBI) and ischemia. These studies indicate that blocking SUR1 may exert protective effects in terms of outcome. Methods: We discuss the effects of glibenclamide on outcome in patients with type 2 diabetes mellitus and TBI. We collected demographic, clinical, and imaging data from the clinical records of TBI patients with type 2 diabetes who were admitted to the neurosurgery department at Shanghai 6th People's Hospital between 2001 and 2012. Data from patients who met the inclusion criteria were analyzed. Patients were divided into glibenclamide group and insulin group. Results: Of 70 patients fit criteria for inclusion, no significant difference was observed except for age and fasting plasma glucose between the two groups. Outcome indicators, including GCS discharge, GOS discharge, length of study in hospital (LOS-H), and the presence of PSH showed no significant difference too (p > 0.05), except for length of stay in neuro-intensive care unit (LOS-NICU) (p < 0.05). Age, hours between the initial CT scan and the injury (HCT1) and GCS at admission were observed as factors associated with PSH after logistic regression. Conclusions: In general, the use of glibenclamide to control plasma glucose after TBI had no significant effect on patient outcome at discharge but it could reduce the LOS-NICU (p < 0.05). Glibenclamide also had no apparent effect on the presence of PSH in TBI patients with type 2 diabetes mellitus. (C) 2013 Elsevier B.V. All rights reserved.	[Ding, Jun; Yuan, Fang; Guo, Jian-Yi; Chen, Hao; Tian, Heng-Li] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China		Tian, HL (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Neurosurg, Shanghai 200233, Peoples R China.	tianhengli1964@yahoo.com.cn	Viani, Rafael/V-1196-2018		National Nature and Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271383]; Shanghai Science and Technique Committee [13411951400, 13411951401, 10JC1412500]	Grant support was provided by National Nature and Science Foundation of China (grant no. 81271383) and the Shanghai Science and Technique Committee (grant no. 13411951400, 13411951401 and 10JC1412500).	Abdallah DM, 2011, BRAIN RES, V1385, P257, DOI 10.1016/j.brainres.2011.02.007; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen MK, 2003, J NEUROSCI, V23, P8568; Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; Kunte H, 2007, STROKE, V38, P2526, DOI 10.1161/STROKEAHA.107.482216; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Popovich PG, 2012, EXP NEUROL, V233, P615, DOI 10.1016/j.expneurol.2010.11.016; Sanus GZ, 2004, NEUROSURG QUART, V14, P97, DOI 10.1097/01.wnq.0000127718.06183.12; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Yuan F, 2012, J NEUROTRAUM, V29, P2137, DOI 10.1089/neu.2011.2233; Yuan F, 2012, J TRAUMA ACUTE CARE, V73, P137, DOI 10.1097/TA.0b013e31824b00ac; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zhou YL, 2009, BRAIN RES, V1270, P131, DOI 10.1016/j.brainres.2009.03.010	22	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	OCT	2013	115	10					2166	2169		10.1016/j.clineuro.2013.08.010			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	236XQ	WOS:000325833200042	23998719				2022-02-06	
J	Hu, YC; Wang, F; Zhang, DD; Sun, Q; Li, W; Dai, YX; Zhou, ML; Hang, CH				Hu, Yang-Chun; Wang, Fan; Zhang, Ding-Ding; Sun, Qing; Li, Wei; Dai, Yu-Xiang; Zhou, Meng-Liang; Hang, Chun-Hua			Expression of intestinal CD40 after experimental traumatic brain injury in rats	JOURNAL OF SURGICAL RESEARCH			English	Article						Traumatic brain injury; Intestine; CD40; Inflammatory response	NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; TNF-ALPHA; RECEPTOR SUPERFAMILY; ACTIVATION; CELLS; GUT; PROTEINS; CYTOKINES; ADHESION	Background: Nuclear factor kappa B (NF-kappa B) has been shown to be activated in the intestine after traumatic brain injury (TBI), and results in gastrointestinal mucosal injury. In addition, CD40 has a major role in the activation of NF-kappa B and is up-regulated in inflammatory bowel disease. However, we found no study in the literature investigating the intestinal expression of CD40 after TBI. Hence, we designed the current study to explore the intestinal expression pattern of CD40 after TBI in rats. We hypothesized that CD40 could mediate inflammation and ultimately contribute to acute intestinal mucosal injury after TBI. Methods: We randomly divided rats into control and TBI groups at 3, 6, 12, 24, and 72 h, respectively. We assessed the expression of CD40 by quantitative real-time polymerase chain reaction, Western blotting, and immunohistochemical study, and detected the levels of tumor necrosis factor-alpha (TNF-alpha), intracellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) by enzyme-linked immunosorbent assay. Results: The mRNA and protein levels of -CD40 increased by 3 and 6 h, peaked at 6 and 12 h, and remained elevated until 24 and 72 h post-injury, respectively. Levels of TNF-alpha, VCAM-1, and ICAM-1 also markedly increased in jejunum tissue after TBI. Interestingly, there was a positive relationship between the expression of CD40 and that of TNF-alpha, VCAM-1, and ICAM-1. Conclusions: CD40 could be markedly elevated in intestine after TBI in rats, and it might have an important role in the pathogenesis of acute intestinal mucosal injury mediated by inflammatory response. (C) 2013 Elsevier Inc. All rights reserved.	[Hu, Yang-Chun; Zhang, Ding-Ding; Sun, Qing; Li, Wei; Dai, Yu-Xiang; Zhou, Meng-Liang; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China; [Hu, Yang-Chun; Wang, Fan] Guiyang Med Coll, Dept Neurosurg, Affiliated Hosp, Guiyang, Guizhou Provinc, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com	Li, Wei/ABE-4301-2021	Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation, ChinaNational Natural Science Foundation of China (NSFC) [81171170]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	This study was supported by the National Natural Science Foundation, China (grant 81171170) and the Natural Science Foundation of Jiangsu Province, China (grant BK2010459). The authors gratefully acknowledge the generous assistance of Dr. Gen-Bao Feng.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; Danese S, 2006, J IMMUNOL, V176, P2617, DOI 10.4049/jimmunol.176.4.2617; Danese S, 2004, GUT, V53, P1035, DOI 10.1136/gut.2003.026278; Fotin-Mleczek M, 2004, J BIOL CHEM, V279, P677, DOI 10.1074/jbc.M310969200; Gao D, 2005, GUT, V54, P70, DOI 10.1136/gut.2003.029587; Gelbmann CM, 2003, GUT, V52, P1448, DOI 10.1136/gut.52.10.1448; Gong JP, 2002, WORLD J GASTROENTERO, V8, P923, DOI 10.3748/wjg.v8.i5.923; Gotoh H, 2004, J RHEUMATOL, V31, P1506; Grotz MRW, 1999, ANN SURG, V229, P478, DOI 10.1097/00000658-199904000-00005; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; Hang CH, 2003, WORLD J GASTROENTERO, V9, P2776; Hehlgans T, 2005, IMMUNOLOGY, V115, P1, DOI 10.1111/j.1365-2567.2005.02143.x; Islam KN, 2002, MOL ENDOCRINOL, V16, P1428, DOI 10.1210/me.16.6.1428; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Kosaka Y, 1999, EUR J IMMUNOL, V29, P1353, DOI 10.1002/(SICI)1521-4141(199904)29:04<1353::AID-IMMU1353>3.0.CO;2-2; Li W, 2013, NEUROL SCI, V34, P847, DOI 10.1007/s10072-012-1131-9; Ling HP, 2013, J SURG RES, V179, pE227, DOI 10.1016/j.jss.2012.03.030; Liu ZJ, 1999, J IMMUNOL, V163, P4049; Pilitsis JG, 2001, NEUROL RES, V23, P227, DOI 10.1179/016164101101198389; Pinto TF, 2012, BRAIN INJURY, V26, P1113, DOI 10.3109/02699052.2012.666369; Sans M, 1999, GASTROENTEROLOGY, V116, P874, DOI 10.1016/S0016-5085(99)70070-3; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schottelius AJG, 1999, INT J COLORECTAL DIS, V14, P18, DOI 10.1007/s003840050178; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Song ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023239; Spies M, 2002, AM J PHYSIOL-GASTR L, V283, pG703, DOI 10.1152/ajpgi.00149.2001; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; Swank GM, 1996, WORLD J SURG, V20, P411, DOI 10.1007/s002689900065; Tone M, 2001, P NATL ACAD SCI USA, V98, P1751, DOI 10.1073/pnas.98.4.1751; Zhou ML, 2007, J SURG RES, V137, P103, DOI 10.1016/j.jss.2006.06.023	36	5	6	0	7	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	OCT	2013	184	2					1022	1027		10.1016/j.jss.2013.04.005			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	215XE	WOS:000324243500051	23647802				2022-02-06	
J	Jeremitsky, E; St Germain, N; Rao, AH; Ong, AW; Smith, RS				Jeremitsky, Elan; St Germain, Natasha; Rao, Amy H.; Ong, Adrian W.; Smith, R. Stephen			Risk of pulmonary embolism in trauma patients: Not all created equal	SURGERY			English	Article							BRAIN-INJURY; VENOUS THROMBOEMBOLISM; ENOXAPARIN PROPHYLAXIS; HEMORRHAGE PROGRESSION; SAFETY; ANTICOAGULATION; THROMBOSIS; EFFICACY; HEPARIN	Introduction. Patients with traumatic brain injury (TBI) are assumed to be at an increased risk for pulmonary embolism (PE). Delay in the initiation of chemoprophylaxis and prophylactic placement of inferior vena cava filters have been advocated by some because of concerns for increased intracranial hemorrhage in the presence of prophylactic anticoagulation. We hypothesized that patients with isolated TBI would not be at increased risk for the development of PE compared with the general trauma population. Methods. Patients from the National Trauma Data Bank from the year 2008 were analyzed. Patient demographics, Injury Severity Score, and the prevalence of deep-vein thrombosis and PE were extracted. Studied injuries were assigned to six categories: thorax, abdominal solid organs, pelvic fracture, lower extremity fracture, spine fracture, and TBI. Results. Of a total of 627,775 injured patients, 2,182 (0.35%) had a documented PE. The prevalence of PE in patients with isolated TBI, lower extremity, pelvic fracture, liver and/or spleen, thorax, spine, multiple injuries, and none of the studied injuries were 0.25%, 0.36%, 0.35%, 0.37%, 0.52%, 0.37%, 1.1%, and 0.12%, respectively. Using an, age-, sex- and race-adjusted multivariable logistic regression model and controlling for interaction between inferior vena cava filters and injury types, we found that isolated TBI was not associated with PE. Conclusion. Isolated TBI does not appear to be associated with an increased incidence of PE compared with other injuries. Patients with isolated TBI may not require early aggressive prophylaxis as is the standard for other high-risk groups.	[Jeremitsky, Elan; St Germain, Natasha] Allegheny Gen Hosp, Dept Surg, Pittsburgh, PA 15212 USA; [Rao, Amy H.] Allegheny Gen Hosp, Dept Med, Pittsburgh, PA 15212 USA; [Ong, Adrian W.] Reading Hosp, Dept Surg, Reading, PA USA; [Smith, R. Stephen] Univ S Carolina, Sch Med, Dept Surg, Columbia, SC USA		Jeremitsky, E (corresponding author), Allegheny Gen Hosp, Dept Surg, 320 East North Ave, Pittsburgh, PA 15212 USA.	ejeremit@wpahs.org	Ong, Adrian W./AAA-8275-2021				[Anonymous], 2007, J NEUROTRAUMA, V24, pS32; Committee on. Trauma American College of Surgeons, 2008, NTDB VERS 2008; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Guyatt GH, 2012, CHEST, V141, P1129; Knudson MM, 2011, ANN SURG, V254, P625, DOI 10.1097/SLA.0b013e3182300209; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Levy AS, 2010, J TRAUMA, V68, P886, DOI 10.1097/TA.0b013e3181d27dd5; Macdonald RL, 1999, NEUROSURGERY, V45, P245, DOI 10.1097/00006123-199908000-00008; Maung AA, 2011, J TRAUMA, V71, P1241, DOI 10.1097/TA.0b013e318235ded0; Minshall CT, 2011, J TRAUMA, V71, P396, DOI 10.1097/TA.0b013e31822734c9; Niemi T, 2010, CURR OPIN ANESTHESIO, V23, P558, DOI 10.1097/ACO.0b013e32833e1589; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Saadeh Y, 2012, J TRAUMA ACUTE CARE, V73, P426, DOI 10.1097/TA.0b013e31825a758b; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Stanwicki SP, 2005, AM SURGEON, V71, P387	16	5	5	1	3	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	OCT	2013	154	4					810	814		10.1016/j.surg.2013.04.045			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	232QS	WOS:000325509700040	24074419				2022-02-06	
J	Liu, N; Krassioukov, AV				Liu, N.; Krassioukov, A. V.			Postpartum hypogalactia in a woman with Brown-Sequard-plus syndrome: a case report	SPINAL CORD			English	Article						autonomic function; lactation; hypogalactia; Brown-Sequard-plus syndrome; spinal cord injury	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; WOMEN; MILK	Study design: A case report. Objectives: To present a case of postpartum hypogalactia in a woman with Brown-Sequard-plus syndrome (BSPS). Setting: Outpatient spinal cord injury (SCI) clinic. Case report: A 33-year-old woman with C4 AIS D tetraplegia (American Spinal Injury Association Impairment Scale) was followed at the outpatient SCI clinic for the past 5 years. Her right side presents with increased tone, increased spasticity and decreased sensitivity to light touch. Conversely, her left side presents with minimal changes in tone and no motor function deficits, but decreased sensitivity to pinprick and temperature sensation. These findings are consistent with BSPS. After inpatient rehabilitation, she was engaged, married, and 8 months ago delivered a healthy child. After an uncomplicated delivery, breastfeeding was attempted, but a significant lack of lactation was noted the first month postpartum from the right breast. Despite the implementation of measures to increase lactation, the lack of lactation from the right breast persisted, and required initiation of formula feeding. The right breast in this case lost not only sensory proprioception, but also autonomic control, which could contribute to this instance of asymmetric lactation. Conclusion: In addition to motor and sensory dysfunctions following SCI, autonomic dysfunctions are commonly seen in individuals with these devastating injuries. The lactation on the right side, which had interrupted descending spinal autonomic pathways, was decreased by approximately 83%. This case provides us with interesting information regarding attention that clinicians should be paying when discussing the breastfeeding options for women with SCI.	[Liu, N.] Peking Univ, Dept Rehabil Med, Hosp 3, Beijing 100871, Peoples R China; [Liu, N.; Krassioukov, A. V.] Univ British Columbia, Int Collaborat Repair Discoveries, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Krassioukov, A. V.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC V5Z 1M9, Canada; [Krassioukov, A. V.] Vancouver Coastal Hlth, GF Strong Rehabil Ctr, Vancouver, BC, Canada		Krassioukov, AV (corresponding author), Univ British Columbia, Int Collaborat Repair Discoveries BSCC, 818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	krassioukov@icord.org	Krassioukov, Andrei V/K-3131-2017				Alexander MS, 2009, SPINAL CORD, V47, P36, DOI 10.1038/sc.2008.121; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cox DB, 1996, EXP PHYSIOL, V81, P1007, DOI 10.1113/expphysiol.1996.sp003985; DALY SEJ, 1993, EXP PHYSIOL, V78, P209, DOI 10.1113/expphysiol.1993.sp003681; Garcia-Manzanares MD, 2000, SPINAL CORD, V38, P705, DOI 10.1038/sj.sc.3101062; Halbert L A, 1998, J Hum Lact, V14, P327, DOI 10.1177/089033449801400425; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Pouw MH, 2010, SPINAL CORD, V48, P614, DOI 10.1038/sc.2009.189	8	5	5	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393			SPINAL CORD	Spinal Cord	OCT	2013	51	10					794	796		10.1038/sc.2013.51			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	230FY	WOS:000325323500016	23752266	Bronze			2022-02-06	
J	Mauiliu, M; Derrett, S; Samaranayaka, A; Sopoaga, F; Kokaua, J; Davie, G				Mauiliu, Melbourne; Derrett, Sarah; Samaranayaka, Ari; Sopoaga, Faafetai; Kokaua, Jesse; Davie, Gabrielle			Pacific peoples three months after injury: a comparison of outcomes between Pacific and non-Pacific participants in a NZ cohort study	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH			English	Article						Pacific peoples; New Zealand; injury outcomes	TRAUMATIC BRAIN-INJURY; NEW-ZEALAND; RISK-FACTORS; DISABILITY; FIJI	Objectives: To: describe pre-injury characteristics of Pacific (n=239) and non-Pacific (n=2,611) participants and compare their outcomes three months after injury. Methods: Participants were New Zealand residents aged 18-64 years referred to the Accident Compensation Corporation's injury entitlement claims register. Univariate and multivariable analyses compared pre-injury and injury-related characteristics of Pacific and non-Pacific people and assessed the unadjusted and adjusted relative risks for selected outcomes. Results: Of the 2,856 participants, 239 identified at least one Pacific ethnicity. Adjusted relative risks (aRR; 95% confidence intervals) for Pacific peoples, with the non-Pacific group as the reference, indicate Pacific peoples were: less likely to have no/lesser problems with disability (aRR=0.82; 0.70,0.95); less likely to have no problems with EQ-5D self-care (aRR=0.88; 0.80,0.98); less likely not to report EQ-5D anxiety/depression (aRR=0.84; 0.76,0.93); and less satisfied with social relationships three months after injury (aRR=0.89; 0.83,0.95). Conclusions: Evidence does not suggest Pacific peoples' likelihood of paid employment differs from non-Pacific people three months after injury. However, Pacific peoples appear to have an increased likelihood of problems with disability, self-care, anxiety/depression and social relationships. Implications: This study provides information about a range of previously unknown outcomes following injury for Pacific peoples in New Zealand, and suggests areas of possible focus for health and rehabilitation service providers and policy-makers interested in improving outcomes for injured Pacific peoples.	[Mauiliu, Melbourne; Derrett, Sarah; Samaranayaka, Ari; Davie, Gabrielle] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin 9054, New Zealand; [Sopoaga, Faafetai; Kokaua, Jesse] Univ Otago, Div Hlth Sci, Pacific Isl Res & Student Support Unit, Dunedin 9054, New Zealand		Derrett, S (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, POB 56, Dunedin 9054, New Zealand.	sarah.derrett@otago.ac.nz		Davie, Gabrielle/0000-0001-5466-5364; Derrett, Sarah/0000-0003-2867-0498	Health Research Council of New ZealandHealth Research Council of New Zealand; Accident Compensation Corporation, New Zealand	We are most grateful to the study participants for sharing their information with us. We are grateful to Suzanne Wilson and Radilaite Cammock for their comments on an earlier draft of this paper. This study was funded by the Health Research Council of New Zealand (2007-2013), and was co-funded by the Accident Compensation Corporation, New Zealand (2007-2010). The views and conclusions of this paper are those of the authors and may not reflect those of the funders.	Accident Compensation Corporation, 2006, TALKS PAC COMM CONT; Accident Compensation Corporation, 2012, ANN REP 2012 ACC COM; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Bascand G., 2012, INJURY STAT WORK REL; Bismark MM, 2006, MED J AUSTRALIA, V185, P203, DOI 10.5694/j.1326-5377.2006.tb00532.x; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Chalmers DJ, 2012, BRIT J SPORT MED, V46, P95, DOI 10.1136/bjsports-2011-090272; Clapham KF, 2006, MED J AUSTRALIA, V184, P217, DOI 10.5694/j.1326-5377.2006.tb00205.x; Delaibatiki Cammock R, 2012, AUSTRALAS EPIDEMIOL, V19, P17; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558, 10.1136/ip.2009.022558a]; Derrett S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044909; Derrett S, 2012, INJURY PREV, V18, P343, DOI 10.1136/injuryprev-2011-040266; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Faleafa Monique, 2009, Pac Health Dialog, V15, P28; Fugl-Meye KS., 1991, CLIN REHABIL, V5, P25, DOI [10.1177/026921559100500105, DOI 10.1177/026921559100500105]; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Herman J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-479; Herman J, 2012, AUST NZ J PUBL HEAL, V36, P427, DOI 10.1111/j.1753-6405.2012.00911.x; Irie F, 2010, INJURY, V41, P964, DOI 10.1016/j.injury.2009.09.002; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Medical Council of New Zealand, 2010, BEST HLTH OUTC PAC P; Ministry of Business Innovations and Employment, 2012, HARMS WAY CAS STUD P; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Ministry of Health, 2008, PAC PEOPL EXP DIS PA; Ministry of Health, 2012, TUP OL MOUI PAC HLTH; Ministry of Social Development, 2002, DIR MEAS LIV STAND N; Mulford JS, 2001, AUST NZ J SURG, V71, P32, DOI 10.1046/j.1440-1622.2001.02021.x; Portney KE, 1997, AM BEHAV SCI, V40, P632, DOI 10.1177/0002764297040005009; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; *STAT NZ, 2007, PAC PROF 2006; StataCorp, STAT STAT SOFTW REL; Statistics New Zealand, 2006, 2006 CENS QUEST; Statistics New Zealand, 2006, 2006 CENS POP DWELL; Statistics New Zealand Ministry of Pacific Island Affairs, 2010, DEM NZ PAC POP; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Taoi M, 2012, BURNS, V38, P758, DOI 10.1016/j.burns.2011.11.005; Uppal S, 2006, SOC SCI MED, V63, P525, DOI 10.1016/j.socscimed.2006.01.016; Ustun T, 2010, MEASURING HLTH DISAB; Wilson R, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-68; World Health Organization, 2013, BMI CLASS; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	44	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1326-0200	1753-6405		AUST NZ J PUBL HEAL	Aust. N. Z. Publ. Health	OCT	2013	37	5					463	469		10.1111/1753-6405.12124			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	227YS	WOS:000325152200011	24090330	Bronze			2022-02-06	
J	Murphy, TE; Baker, DI; Leo-Summers, LS; Allore, HG; Tinetti, ME				Murphy, Terrence E.; Baker, Dorothy I.; Leo-Summers, Linda S.; Allore, Heather G.; Tinetti, Mary E.			Association Between Treatment or Usual Care Region and Hospitalization for Fall-Related Traumatic Brain Injury in the Connecticut Collaboration for Fall Prevention	JOURNAL OF THE AMERICAN GERIATRICS SOCIETY			English	Article						Connecticut Collaboration for Fall Prevention; fall-related traumatic brain injury; hospitalization; Bayesian; spatial model	OLDER-ADULTS; CONTROLLED-TRIAL; RISK-MANAGEMENT; DISSEMINATION; EPIDEMIOLOGY; PROVIDERS; STRATEGY	ObjectivesTo evaluate the association between the treatment region (TR) or usual care region (UCR) of the Connecticut Collaboration for Fall Prevention (CCFP), a clinical intervention for prevention of falls, and the rate of hospitalization for fall-related traumatic brain injury (FR-TBI) in persons aged 70 and older and to describe the Medicare charges for FR-TBI hospitalizations. DesignUsing a quasi-experimental design, rates of hospitalization for FR-TBI were recorded over an 8-year period (2000-2007) in two distinct geographic regions (TR and UCR) chosen for their similarity in characteristics associated with occurrence of falls. SettingTwo geographical regions in Connecticut. ParticipantsMore than 200,000 persons aged 70 and older. InterventionClinicians in the TR translated research protocols from the Yale Frailty and Injuries: Cooperative Studies of Intervention Techniques, a successful fall-prevention randomized clinical trial, into discipline- and site-specific fall-prevention procedures for integration into their clinical practices. MeasurementsRate of hospitalization for FR-TBI in persons aged 70 and older. ResultsConnecticut Collaboration for Fall Prevention's TR exhibited lower rates of hospitalization for FR-TBI than the UCR (risk ratio=0.84, 95% credible interval=0.72-0.99). ConclusionThe significantly lower rate of hospitalization for FR-TBI in CCFP's TR suggests that the engagement of practicing clinicians in the implementation of evidence-based fall-prevention practices may reduce hospitalizations for FR-TBI.	[Murphy, Terrence E.; Baker, Dorothy I.; Leo-Summers, Linda S.; Allore, Heather G.; Tinetti, Mary E.] Yale Univ, Sch Med, Dept Internal Med, Sect Geriatr, New Haven, CT 06511 USA		Murphy, TE (corresponding author), Yale Univ, Sch Med, 300 George St,Suite 775, New Haven, CT 06511 USA.	terrence.murphy@yale.edu		Allore, Heather/0000-0001-7685-8175	Aging Services Division of the State of Connecticut Department of Social Services; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R21AG033130-01A2]; CTSA from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 RR024139]; NIH roadmap for medical researchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG033130, P30AG021342] Funding Source: NIH RePORTER	The authors have no conflicts relevant to this research. This study was supported by a grant from the Aging Services Division of the State of Connecticut Department of Social Services to the CCFP at Yale University School of Medicine (PI, Baker) and by a grant from the National Institute on Aging (1R21AG033130-01A2; PI, Murphy). The views and opinions expressed are those of the authors. The study was conducted at the Yale Claude D. Pepper Older Americans Independence Center (P30AG21342; PI, Tinetti). The original CCFP efforts were supported by the Donaghue Medical Research Foundation (DF#00-206, PIs, Tinetti and Baker). This publication was also made possible in part by CTSA Grant UL1 RR024139 (Murphy) from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and the NIH roadmap for medical research. Its contents are solely the views and opinions of the authors and not those of the Connecticut Department of Social Services, the State of Connecticut, the NCRR, or the NIH.	Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P201; [Anonymous], 2010, POP 65 YEARS OLD POP; Baker DI, 2005, J AM GERIATR SOC, V53, P675, DOI 10.1111/j.1532-5415.2005.53218.x; Baker DI, 2007, GERONTOLOGIST, V47, P548, DOI 10.1093/geront/47.4.548; Brown CJ, 2005, PHYS THER, V85, P394, DOI 10.1093/ptj/85.5.394; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Centers for Medicare and Medicaid Services, 2013, DEN FIL CMS; CHIME, 2013, CHIM DAT 2013; CHIME, 2013, AB CHA 2013; Chou WC, 2006, J GEN INTERN MED, V21, P117, DOI 10.1111/j.1525-1497.2005.00298.x; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Faul M, 2010, TRAUMATIC BRAIN INJU; Fortinsky RH, 2004, J AM GERIATR SOC, V52, P1522, DOI 10.1111/j.1532-5415.2004.52416.x; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Li FZ, 2005, J GERONTOL A-BIOL, V60, P187, DOI 10.1093/gerona/60.2.187; Liu-Ambrose T, 2004, J AM GERIATR SOC, V52, P657, DOI 10.1111/j.1532-5415.2004.52200.x; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Murphy TE, 2008, CONTEMP CLIN TRIALS, V29, P343, DOI 10.1016/j.cct.2007.10.004; Murphy TE, 2011, STAT MED, V30, P522, DOI 10.1002/sim.3912; Murphy TE, 2013, GERONTOLOGIST, V53, P508, DOI 10.1093/geront/gns122; National Center for Health Statistics, 2007, CLASSIFICATION; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; TINETTI ME, 1993, J AM GERIATR SOC, V41, P315, DOI 10.1111/j.1532-5415.1993.tb06710.x; U.S. Census, 2000, FACTFINDER 2000	28	5	5	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-8614	1532-5415		J AM GERIATR SOC	J. Am. Geriatr. Soc.	OCT	2013	61	10					1763	1767		10.1111/jgs.12462			5	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	233FG	WOS:000325551500017	24083593	Green Accepted			2022-02-06	
J	Petzold, A; Girbes, A				Petzold, Axel; Girbes, Armand			Pain Management in Neurocritical Care	NEUROCRITICAL CARE			English	Article						Intensive care; Pain; Analgesia; Neurocritical care	NEUROLEPTIC MALIGNANT SYNDROME; GUILLAIN-BARRE-SYNDROME; ROOT ENTRY ZONE; CENTRAL POSTSTROKE PAIN; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; REVERSIBLE ENCEPHALOPATHY SYNDROME	The core challenge of pain management in neurocritical care is to keep the patient comfortable without masking or overlooking any neurological deterioration. Clearly in patients with a neurological problem there is a conflict of clinical judgement and adequate pain relief. Here we review the presentation, assessment, and development of pain in the clinical spectrum of patients with associated neurological problems seen in a general intensive care setting. Many conditions predispose to the development of chronic pain. There is evidence that swift and targeted pain management may improve the outcome. Importantly pain management is multidisciplinary. The available non-invasive, pharmacological, and invasive treatment strategies are discussed.	[Petzold, Axel] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Girbes, Armand] Vrije Univ Amsterdam Med Ctr, Dept Intens Care, Amsterdam, Netherlands		Petzold, A (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Neurol, De Boelelaan 1117, Amsterdam, Netherlands.	a.petzold@ucl.ac.uk; a.girbes@vumc.nl	Petzold, Axel/C-1090-2009	Petzold, Axel/0000-0002-0344-9749			ADDONIZIO G, 1987, BIOL PSYCHIAT, V22, P1004, DOI 10.1016/0006-3223(87)90010-2; Adudu OP, 2007, ANN AFR MED, V6, P174, DOI 10.4103/1596-3519.55701; Agarwal-Kozlowski K, 2011, ANAESTHESIA, V66, P699, DOI 10.1111/j.1365-2044.2011.06765.x; Akman C, 2003, EPILEPSIA, V44, P855, DOI 10.1046/j.1528-1157.2003.49502.x; Alpsoy E, 2009, ARCH DERMATOL RES, V301, P693, DOI 10.1007/s00403-009-0990-2; American Pain Society, 1998, PRINC AN US TREATM A; ANDERSEN G, 1995, PAIN, V61, P187, DOI 10.1016/0304-3959(94)00144-4; [Anonymous], 1992, AHCPR PUBL, V92-0032; Arienta C, 1986, J Neurosurg Sci, V30, P81; Aruna AS, 2005, ANN PHARMACOTHER, V39, P1131, DOI 10.1345/aph.1E492; Attal N, 2004, J NEUROL NEUROSUR PS, V75, P1025, DOI 10.1136/jnnp.2003.026674; Attal N, 2000, NEUROLOGY, V54, P564, DOI 10.1212/WNL.54.3.564; Attal N, 1998, EUR NEUROL, V40, P191, DOI 10.1159/000007979; AWERBUCH GI, 1990, INT J NEUROSCI, V55, P129, DOI 10.3109/00207459008985960; Aykutlu E, 2006, CEPHALALGIA, V26, P180, DOI 10.1111/j.1468-2982.2005.01017.x; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; BACKONJA M, 1992, J PAIN SYMPTOM MANAG, V7, P172, DOI 10.1016/S0885-3924(06)80010-2; Baker David J, 2005, Crit Care Med, V33, pS66, DOI 10.1097/01.CCM.0000151069.06678.A5; Bakshi R, 1998, EPILEPSIA, V39, P295, DOI 10.1111/j.1528-1157.1998.tb01376.x; Barber Janet M, 2003, Crit Care Nurs Q, V26, P192; BarrientosVega R, 1997, CRIT CARE MED, V25, P33, DOI 10.1097/00003246-199701000-00009; Basak M, 1998, ANGIOLOGY, V49, P403, DOI 10.1177/000331979804900510; Benarroch EE, 2013, NEUROLOGY, V80, P304, DOI 10.1212/WNL.0b013e31827dec42; Benninger F, 2013, J NEURAL TRANSM, V120, P339, DOI 10.1007/s00702-012-0938-0; BERGBOMENGBERG I, 1989, CRIT CARE MED, V17, P1068, DOI 10.1097/00003246-198910000-00021; Bernsen RAJAM, 2001, J NEUROL, V248, P483, DOI 10.1007/s004150170157; Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x; Bloomfield EL, 1998, ANESTH ANALG, V87, P579, DOI 10.1097/00000539-199809000-00015; Blum J, 2006, ACTA TROP, V97, P55, DOI 10.1016/j.actatropica.2005.08.001; Blum J, 2001, TROP MED INT HEALTH, V6, P390, DOI 10.1046/j.1365-3156.2001.00710.x; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; BOIVIE J, 2006, WALL MELZACKS TXB PA, P1057; BONICA JJ, 1991, SYMP PAIN R, P13; Bovie J., 1992, HYPERALGESIA ALLODYN, P363; BOWSHER D, 1995, POSTGRAD MED J, V71, P598, DOI 10.1136/pgmj.71.840.598; Bowsher D, 1998, NEUROLOGY, V51, P1352, DOI 10.1212/WNL.51.5.1352; Budrys V, 2006, EUR NEUROL, V55, P4, DOI 10.1159/000091136; CAMPBELL W G, 1952, Am J Phys Med, V31, P316; Canavero S, 1999, J NEUROSURG, V91, P715; CANAVERO S, 1995, J NEUROL, V242, P561, DOI 10.1007/BF00868808; Canhao P, 2013, EUR J NEUROL, V20, P1075, DOI 10.1111/ene.12136; Canhao PC, 2005, STROKE, V36, P1720, DOI 10.1161/01.STR.0000173152.84438.1c; Carroll K C, 1999, Am J Crit Care, V8, P105; CARTER BD, 1993, MOL PHARMACOL, V43, P465; Casey SO, 2000, AM J NEURORADIOL, V21, P1199; Cassinari V, 1969, CENTRAL PAIN NEUROSU; Chamorro C, 1996, CRIT CARE MED, V24, P932, DOI 10.1097/00003246-199606000-00010; Chanques G, 2006, CRIT CARE MED, V34, P1691, DOI 10.1097/01.CCM.0000218416.62457.56; Chen WH, 2005, BRAIN INJURY, V19, P949, DOI 10.1080/02699050500109936; Cheng MY, 2008, CEREBROVASC DIS, V26, P502, DOI 10.1159/000155988; Collins MP, 2004, CURR OPIN NEUROL, V17, P587, DOI 10.1097/00019052-200410000-00009; Cook DJ, 2001, CHEST, V120, p469S, DOI 10.1378/chest.120.6_suppl.469S; Couzin J, 2005, SCIENCE, V307, P1183; Creange A, 2008, NAT CLIN PRACT NEURO, V4, P686, DOI 10.1038/ncpneuro0942; Cremer OL, 2001, LANCET, V357, P117, DOI 10.1016/S0140-6736(00)03547-9; Cull RE, 2003, CEPHALALGIA, V23, P556, DOI 10.1046/j.1468-2982.2003.00513.x; Cumurciuc R, 2005, J NEUROL NEUROSUR PS, V76, P1084, DOI 10.1136/jnnp.2004.056275; Custodio CM, 2004, ARCH PHYS MED REHAB, V85, P502, DOI 10.1016/S0003-9993(03)00471-4; da Silva-Nunes M, 2007, MEM I OSWALDO CRUZ, V102, P341, DOI 10.1590/S0074-02762007005000051; Daniels S, 2013, CLIN J PAIN, V29, P655, DOI 10.1097/AJP.0b013e318270f957; Davenport R, 2002, J NEUROL NEUROSUR PS, V72, P33; Dawson L, 1999, J ADV NURS, V30, P875, DOI 10.1046/j.1365-2648.1999.01161.x; de la Sayette V, 1999, NEUROLOGY, V53, P632, DOI 10.1212/WNL.53.3.632; de la Sayette V, 1999, J NEUROL NEUROSUR PS, V66, P397, DOI 10.1136/jnnp.66.3.397; de Wildt SN, 2003, CRIT CARE MED, V31, P1952, DOI 10.1097/01.CCM.0000084806.15352.da; Dejerine J, 1906, REV NEUROL-FRANCE, V14, P521; DELLER JJ, 1960, NEW ENGL J MED, V262, P1078, DOI 10.1056/NEJM196005262622108; Denker P., 1944, NY STATE J MED, V44, P379; Denkers Matthew R, 2002, Spine (Phila Pa 1976), V27, pE177, DOI 10.1097/00007632-200204010-00018; Desai PM, 1999, CRIT CARE CLIN, V15, P151, DOI 10.1016/S0749-0704(05)70045-2; Dias MS, 1999, PEDIATR NEUROSURG, V30, P146, DOI 10.1159/000028783; DINKEN H, 1952, Am J Phys Med, V31, P329; Donnelly C, 2005, SPINAL CORD, V43, P278, DOI 10.1038/sj.sc.3101702; Dorffler-Melly J, 2002, LANCET, V359, P849, DOI 10.1016/S0140-6736(02)07920-5; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Drazen JM, 2005, NEW ENGL J MED, V352, P1131, DOI 10.1056/NEJMe058038; Ducreux D, 2006, BRAIN, V129, P963, DOI 10.1093/brain/awl016; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; EDMONDSON EA, 1993, SOUTHERN MED J, V86, P1093, DOI 10.1097/00007611-199310000-00002; Edwards JE, 2000, COCHRANE DB SYST REV; Ehde DM, 2003, MULT SCLER J, V9, P605, DOI 10.1191/1352458503ms939oa; EIDE PK, 1995, NEUROSURGERY, V37, P1080, DOI 10.1227/00006123-199512000-00007; Einhaupl K, 2010, EUR J NEUROL, V17, P1229, DOI 10.1111/j.1468-1331.2010.03011.x; El-Dawlatly Abdelazeem A., 2005, Middle East Journal of Anesthesiology, V18, P339; Elahi A, 2004, NEUROCRIT CARE, V1, P465, DOI 10.1385/NCC:1:4:465; Epstein J, 1999, CRIT CARE CLIN, V15, P17, DOI 10.1016/S0749-0704(05)70037-3; Erickson JC, 2006, EPILEPSIA, V47, P202, DOI 10.1111/j.1528-1167.2006.00388.x; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Ferguson J, 1997, J ADV NURS, V26, P1065, DOI 10.1111/j.1365-2648.1997.tb00796.x; Fernandez-Melo R, 2003, REV NEUROLOGIA, V37, P870, DOI 10.33588/rn.3709.2003122; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; FINDLER G, 1982, J NEUROSURG, V57, P267, DOI 10.3171/jns.1982.57.2.0267; Finnerup NB, 2002, PAIN, V96, P375, DOI 10.1016/S0304-3959(01)00484-5; Fitt G J, 1998, Aust Fam Physician, V27, P194; Foix C, 1927, CR SOC NEUROL, V35, P68; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; French Society of Anesthesia and Intensive Care, 2000, ANN FR ANESTH, V19, P98; Frese A, 2006, CLIN J PAIN, V22, P252, DOI 10.1097/01.ajp.0000173020.10483.13; Fukuhara T, 1999, J NEUROSURG, V90, P575, DOI 10.3171/jns.1999.90.3.0575; Gallagher AC, 1998, DEV MED CHILD NEUROL, V40, P349; Gamble GE, 2000, EUR J PAIN-LONDON, V4, P313, DOI 10.1053/eujp.2000.0192; Gameiro J, 2012, CEPHALALGIA, V32, P407, DOI 10.1177/0333102412439353; Garcia LS, 2010, CLIN LAB MED, V30, P93, DOI 10.1016/j.cll.2009.10.001; GARLAND DE, 1981, CLIN ORTHOP RELAT R, P162; GERSTEN J W, 1952, Am J Phys Med, V31, P317; GHONEIM MM, 1990, ANESTHESIOLOGY, V72, P926; Glusker P, 2006, NEW ENGL J MED, V354, P980; GLYNN CJ, 1986, LANCET, V2, P1249; Goadsby PJ, 2008, CURR OPIN NEUROL, V21, P323, DOI 10.1097/WCO.0b013e3282fa6d76; Goadsby PJ, 2006, NAT CLIN PRACT NEURO, V2, P401, DOI 10.1038/ncpneuro0236; Gonzales GR, 2003, J PAIN, V4, P351, DOI 10.1016/S1526-5900(03)00639-4; Gorski JC, 1998, CLIN PHARMACOL THER, V64, P133, DOI 10.1016/S0009-9236(98)90146-1; Gosselink R, 2000, ARCH PHYS MED REHAB, V81, P747, DOI 10.1053/apmr.2000.5616; Goto H, 2008, BONE MARROW TRANSPL, V42, P627, DOI 10.1038/bmt.2008.223; Gottschalk A, 2009, NEUROCRIT CARE, V10, P387, DOI 10.1007/s12028-008-9150-3; Gowers W, 1901, EPILEPSY OTHER CHRON, P29; Graham Glenn D., 2002, Curr Treat Options Neurol, V4, P435, DOI 10.1007/s11940-002-0011-7; GREENBLATT DJ, 1989, J PHARMACOL EXP THER, V250, P134; Griffin JW, 2001, CURR OPIN NEUROL, V14, P655, DOI 10.1097/00019052-200110000-00016; Grimsby GM, 2012, MAYO CLIN PROC, V87, P1089, DOI 10.1016/j.mayocp.2012.07.018; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Gust R, 1999, CRIT CARE MED, V27, P2218, DOI 10.1097/00003246-199910000-00025; Hadden R, 2006, J PERIPHER NERV SYST, V11, P9; Haddow AM, 2004, BRIT MED J, V329, P1333, DOI 10.1136/bmj.329.7478.1333; Haller H, 2003, J NEURAL TRANSM, V110, P977, DOI 10.1007/s00702-003-0022-x; Hamaoka N, 1999, CLIN PHARMACOL THER, V66, P110, DOI 10.1016/S0009-9236(99)90047-4; Hamill-Ruth RJ, 1999, CRIT CARE CLIN, V15, P35, DOI 10.1016/S0749-0704(05)70038-5; Hansson P, 2004, EUR J NEUROL, V11, P22, DOI 10.1111/j.1471-0552.2004.00793.x; Hasan Najmul, 2004, J Coll Physicians Surg Pak, V14, P366; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hendrickson RG, 2005, CRIT CARE CLIN, V21, P641, DOI 10.1016/j.ccc.2005.05.009; Hillier SL, 1997, BRAIN INJURY, V11, P661; Hinchey J, 1996, NEW ENGL J MED, V334, P494, DOI 10.1056/NEJM199602223340803; Hirayama A, 2006, PAIN, V122, P22, DOI 10.1016/j.pain.2005.12.001; Hoffmann O, 2004, MICROSC RES TECHNIQ, V53, P188; Hofmeister C, 2000, STROKE, V31, P1307, DOI 10.1161/01.STR.31.6.1307; Hogarth D Kyle, 2004, Curr Opin Crit Care, V10, P40, DOI 10.1097/00075198-200402000-00007; Holtom N, 2000, PALLIATIVE MED, V14, P167, DOI 10.1177/026921630001400216; HOWARD RS, 1992, BRAIN, V115, P479, DOI 10.1093/brain/115.2.479; Huang Y, 2013, EUR J NEUROL, V20, P1184, DOI 10.1111/ene.12155; Hughes RAC, 2005, ARCH NEUROL-CHICAGO, V62, P1194, DOI 10.1001/archneur.62.8.1194; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Ishii Wataru, 2003, No To Shinkei, V55, P963; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Jacob JT, 2012, NEUROCRIT CARE, V16, P311, DOI 10.1007/s12028-011-9667-8; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jereb M, 2005, WIEN KLIN WOCHENSCHR, V117, P495, DOI 10.1007/s00508-005-0324-0; Johnson JR, 2013, J PAIN SYMPTOM MANAG, V46, P207, DOI 10.1016/j.jpainsymman.2012.07.014; *JOINT COMM ACCR H, 2001, STAND INT SED AN CAR; Jonsson AC, 2006, J NEUROL NEUROSUR PS, V77, P590, DOI 10.1136/jnnp.2005.079145; Kadyan V, 2003, BRAIN INJURY, V17, P631, DOI 10.1080/0269905031000070224; Kalpakjian CZ, 2013, SPINAL CORD, V51, P289, DOI 10.1038/sc.2012.142; Kalso E, 2001, ACTA ANAESTH SCAND, V45, P935, DOI 10.1034/j.1399-6576.2001.450803.x; Keidel M, 1997, NERVENARZT, V68, P769, DOI 10.1007/s001150050193; Kennedy P, 1997, SPINAL CORD, V35, P814, DOI 10.1038/sj.sc.3100569; Kennedy PGE, 2006, J NEUROL, V253, P411, DOI 10.1007/s00415-006-0093-3; Kennedy WR, 1996, NEUROLOGY, V47, P1042, DOI 10.1212/WNL.47.4.1042; KENNEDY WR, 1993, J NEUROL SCI, V115, P184, DOI 10.1016/0022-510X(93)90223-L; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Kidd D, 2003, ADV EXP MED BIOL, V528, P377; Kinton L, 2002, ANN NEUROL, V51, P740, DOI 10.1002/ana.10221; Klein MG, 2004, ARCH PHYS MED REHAB, V85, P1679, DOI 10.1016/j.apmr.2004.01.041; Kleppel JB, 2002, AM J PHYS MED REHAB, V81, P114, DOI 10.1097/00002060-200202000-00007; Kluger G, 2000, J CHILD NEUROL, V15, P406, DOI 10.1177/088307380001500610; Knibbe CAJ, 2002, CLIN PHARMACOL THER, V72, P670, DOI 10.1067/mcp.2002.129500; Kocher L, 1999, DEV MED CHILD NEUROL, V41, P704, DOI 10.1017/S0012162299001437; Kress JP, 1996, AM J RESP CRIT CARE, V153, P1012, DOI 10.1164/ajrccm.153.3.8630539; Kumral E, 2011, EUR J NEUROL, V18, P232, DOI 10.1111/j.1468-1331.2010.02994.x; KUMRAL E, 1995, STROKE, V26, P964, DOI 10.1161/01.STR.26.6.964; Lampl C, 2002, STROKE, V33, P3030, DOI 10.1161/01.STR.0000037674.95228.86; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Latronico N, 2002, LANCET, V359, P1206, DOI 10.1016/S0140-6736(02)08219-3; Lee Choong Won, 2002, Korean J Intern Med, V17, P51; Lefaucheur JP, 2001, NEUROREPORT, V12, P2963, DOI 10.1097/00001756-200109170-00041; Lefaucheur JP, 2004, J NEUROL NEUROSUR PS, V75, P612, DOI 10.1136/jnnp.2003.022236; LEIJON G, 1989, PAIN, V36, P27, DOI 10.1016/0304-3959(89)90108-5; Leis A Arturo, 2005, Curr Treat Options Neurol, V7, P15, DOI 10.1007/s11940-005-0002-6; Levendorf M, 2000, AM FAM PHYSICIAN, V61, P50; LEVIN S, 1952, Am J Phys Med, V31, P332; Li Pi-Hsien, 2000, Acta Paediatrica Taiwanica, V41, P33; Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014; LINSKEY ME, 1990, NEUROSURGERY, V26, P933, DOI 10.1227/00006123-199006000-00002; Liu LL, 2003, DRUGS, V63, P755, DOI 10.2165/00003495-200363080-00003; Liu YP, 2005, AM J EMERG MED, V23, P164, DOI 10.1016/j.ajem.2004.03.013; LO TCN, 1989, POSTGRAD MED J, V65, P653, DOI 10.1136/pgmj.65.767.653; Lundberg PO, 1998, J NEUROL NEUROSUR PS, V65, P836, DOI 10.1136/jnnp.65.6.836; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MacLaren R, 2006, EXPERT OPIN PHARMACO, V7, P2047, DOI 10.1517/14656566.7.15.2047; Mailman RB, 2010, CURR PHARM DESIGN, V16, P488, DOI 10.2174/138161210790361461; Mallory GW, 2012, MAYO CLIN PROC, V87, P1025, DOI 10.1016/j.mayocp.2012.02.029; Mandavilli A, 2003, NAT MED, V9, P1227, DOI 10.1038/nm1003-1227; Mascia MF, 2000, CRIT CARE MED, V28, P2300, DOI 10.1097/00003246-200007000-00019; Masjuan J, 1997, STROKE, V28, P649, DOI 10.1161/01.STR.28.3.649; Mason L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858; Mason L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004308.PUB2; Masson C, 2004, J NEUROL NEUROSUR PS, V75, P1431, DOI 10.1136/jnnp.2003.031724; Mateo O M, 1992, J Post Anesth Nurs, V7, P15; MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848; McCollam JS, 1999, CRIT CARE MED, V27, P2454, DOI 10.1097/00003246-199911000-00022; McDonough C M, 2000, Ir Med J, V93, P152; McKeage K, 2003, CNS DRUGS, V17, P235, DOI 10.2165/00023210-200317040-00003; McLean DE, 2004, ARCH PHYS MED REHAB, V85, P466, DOI 10.1016/S0003-9993(03)00484-2; Melzack R., 2006, WALL MELZACKS TXB PA, P291; Michael BD, 2010, QJM-INT J MED, V103, P749, DOI 10.1093/qjmed/hcq121; Michalets EL, 1998, PHARMACOTHERAPY, V18, P84; Mickeviciene D, 2004, EUR J NEUROL, V11, P411, DOI 10.1111/j.1468-1331.2004.00816.x; Milhorat TH, 1996, NEUROSURGERY, V38, P940, DOI 10.1097/00006123-199605000-00017; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; MINDERHOUD JM, 1980, CLIN NEUROL NEUROSUR, V82, P127, DOI 10.1016/0303-8467(80)90007-4; Mittal MK, 2012, NEUROLOGY, V78, pE57, DOI 10.1212/WNL.0b013e318248df51; MOOSSY JJ, 1987, J NEUROSURG, V66, P835, DOI 10.3171/jns.1987.66.6.0835; Moulin DE, 1997, NEUROLOGY, V48, P328, DOI 10.1212/WNL.48.2.328; MULLER EW, 1993, LANCET, V341, P1037, DOI 10.1016/0140-6736(93)91138-C; MURRAY NMF, 1980, MUSCLE NERVE, V3, P444; Nachreiner R, 2006, J BURN CARE RES, V27, P237, DOI 10.1097/01.BCR.0000202644.17987.3F; Nair DR, 2001, NEUROLOGY, V57, P700, DOI 10.1212/WNL.57.4.700; NASHOLD BS, 1981, J NEUROSURG, V55, P414, DOI 10.3171/jns.1981.55.3.0414; NASHOLD BS, 1979, J NEUROSURG, V51, P59, DOI 10.3171/jns.1979.51.1.0059; Nelson JE, 2001, CRIT CARE MED, V29, P277, DOI 10.1097/00003246-200102000-00010; New PW, 1997, SPINAL CORD, V35, P658, DOI 10.1038/sj.sc.3100472; Newton M., 2002, GUIDELINES MANAGEMEN; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; Nitecki SS, 2004, ISRAEL MED ASSOC J, V6, P152; Novaes MAFP, 1999, INTENS CARE MED, V25, P1421, DOI 10.1007/s001340051091; Novy J, 2006, ARCH NEUROL-CHICAGO, V63, P1113, DOI 10.1001/archneur.63.8.1113; O'Riordan JI, 1998, EUR J NEUROL, V5, P137, DOI 10.1046/j.1468-1331.1998.520137.x; Oda Y, 1999, BRIT J ANAESTH, V82, P900, DOI 10.1093/bja/82.6.900; Ogilvy CS, 2001, STROKE, V32, P1458, DOI 10.1161/01.STR.32.6.1458; Okie S, 2005, NEW ENGL J MED, V352, P1283, DOI 10.1056/NEJMp058055; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; On AY, 2005, NEUROREHABILITATION, V20, P245; Orton SL, 2006, TRANSFUSION, V46, P272, DOI 10.1111/j.1537-2995.2006.00710.x; OSTERMAN PO, 1975, BRAIN, V98, P189, DOI 10.1093/brain/98.2.189; PACCAGNELLA A, 1989, THORAC CARDIOV SURG, V37, P320, DOI 10.1055/s-2007-1020343; Palmirotta R, 2013, HEADACHE, V53, P540, DOI 10.1111/head.12043; Pan CL, 2003, BRAIN, V126, P386, DOI 10.1093/brain/awg039; Panayiotopoulos CP, 1999, J NEUROL NEUROSUR PS, V66, P536, DOI 10.1136/jnnp.66.4.536; Pandey CK, 2005, ANESTH ANALG, V101, P220, DOI 10.1213/01.ANE.0000152186.89020.36; Pandey CK, 2002, ANESTH ANALG, V95, P1719, DOI 10.1097/00000539-200212000-00046; Patel A, 2010, ANESTH ANALG, V111, P1004, DOI 10.1213/ANE.0b013e3181ee82fa; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Peter EA, 2001, CAN MED ASSOC J, V165, P1203; Petzold A, 2006, STROKE, V37, P331, DOI 10.1161/01.STR.0000199644.76930.dc; Petzold A, 2004, NEW ENGL J MED, V351, P1695, DOI 10.1056/NEJM200410143511627; Petzold A, 2011, J STROKE CEREBROVASC, V20, P489, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.021; Pfausler B, 2013, J NEURAL TRANSM, V120, P343, DOI 10.1007/s00702-012-0939-z; Pryce G, 2003, BRAIN, V126, P2191, DOI 10.1093/brain/awg224; PUNTILLO KA, 1990, HEART LUNG, V19, P526; Puntillo KA, 1997, CRIT CARE MED, V25, P1159, DOI 10.1097/00003246-199707000-00017; Quigley C., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003447; Raisman G, 2011, EXP NEUROL, V229, P168, DOI 10.1016/j.expneurol.2010.05.007; Raslan AM, 2010, CURR PAIN HEADACHE R, V14, P477, DOI 10.1007/s11916-010-0135-5; Rath SA, 1997, STEREOT FUNCT NEUROS, V68, P161, DOI 10.1159/000099917; Ratnaike RN, 2003, POSTGRAD MED J, V79, P391, DOI 10.1136/pmj.79.933.391; Ravenscroft A, 2000, SPINAL CORD, V38, P611, DOI 10.1038/sj.sc.3101073; Reade MC, 2009, CRIT CARE, V13, DOI 10.1186/cc7890; Rees JH, 2004, J NEUROL NEUROSUR PS, V75, P43, DOI 10.1136/jnnp.2004.040378; REKATE HL, 1979, SURG NEUROL, V11, P442; Riddoch G, 1938, LANCET, V1, P1205; Riddoch G, 1938, LANCET, V1, P1150; Riddoch G, 1938, LANCET, V1, P1093; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Roberts DJ, 2011, CRIT CARE MED, V39, P2743, DOI 10.1097/CCM.0b013e318228236f; Robertson CE, 2012, NEUROLOGY, V78, P114, DOI 10.1212/WNL.0b013e31823efc93; ROPPER AH, 1984, ARCH NEUROL-CHICAGO, V41, P511, DOI 10.1001/archneur.1984.04050170057018; Rostasy KM, 2005, NEUROPEDIATRICS, V36, P260, DOI 10.1055/s-2005-865774; Rostedt A, 2004, NEUROLOGY, V62, P835, DOI 10.1212/01.WNL.0000113756.23340.2F; Roth T, 2002, EUR J CARDIO-THORAC, V21, P664, DOI 10.1016/S1010-7940(02)00031-3; Rusyniak DE, 2002, ANN EMERG MED, V39, P307, DOI 10.1067/mem.2002.122008; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ruts L, 2010, NEUROLOGY, V75, P1439, DOI 10.1212/WNL.0b013e3181f88345; Saarto T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005454, 10.1002/14651858.CD005454.pub2]; Sahu S, 2010, SINGAP MED J, V51, P226; Saip S, 2005, HEADACHE, V45, P911, DOI 10.1111/j.1526-4610.2005.05160.x; SALANOVA V, 1995, BRAIN, V118, P607, DOI 10.1093/brain/118.3.607; Samii M, 2001, NEUROSURGERY, V48, P1269, DOI 10.1097/00006123-200106000-00016; Sarkar Pralay K, 2010, J Intensive Care Med, V25, P93, DOI 10.1177/0885066609356052; SCADDING JW, 1982, PAIN, V14, P283, DOI 10.1016/0304-3959(82)90135-X; SCHALLER B, 2001, SCHWEIZ RUNDSCH MED, V90, P1420; Scheschonka A, 2003, PAIN, V104, P423, DOI 10.1016/S0304-3959(03)00004-6; Seixas J, 2010, COCHRANE DB SYST REV, V8; Serrano-Pozo A, 2005, J NEUROL NEUROSUR PS, V76, P1584, DOI 10.1136/jnnp.2004.062455; SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021; Shehabi Y, 2010, ANAESTH INTENS CARE, V38, P82, DOI 10.1177/0310057X1003800115; SHELLY MP, 1987, ANAESTHESIA, V42, P619, DOI 10.1111/j.1365-2044.1987.tb03086.x; Shimodozono M, 2002, INT J NEUROSCI, V112, P1173, DOI 10.1080/00207450290026139; Shrestha S, 2006, QJM-INT J MED, V99, P253, DOI 10.1093/qjmed/hcl034; SHY G M, 1952, Am J Phys Med, V31, P323; Siddall PJ, 2001, SPINAL CORD, V39, P63, DOI 10.1038/sj.sc.3101116; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; Siddall PJ, 1999, PAIN, V81, P187, DOI 10.1016/S0304-3959(99)00023-8; Siegel AM, 1999, EPILEPSIA, V40, P845, DOI 10.1111/j.1528-1157.1999.tb00790.x; Silberstein SD, 2005, CEPHALALGIA, V25, P460, DOI 10.1111/j.1468-2982.2005.00878.x; Sindou M, 2001, PAIN, V92, P159, DOI 10.1016/S0304-3959(00)00487-5; Sindou MP, 2005, J NEUROSURG, V102, P1018, DOI 10.3171/jns.2005.102.6.1018; Siniscalchi A, 2012, PHARMACOL RES, V65, P171, DOI 10.1016/j.phrs.2011.09.003; Siva A, 2009, J NEUROL, V256, P513, DOI 10.1007/s00415-009-0145-6; Solaro C, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0320-5; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2003, CURR OPIN NEUROL, V16, P411, DOI 10.1097/00019052-200306000-00023; Son BC, 2006, PAIN, V123, P210, DOI 10.1016/j.pain.2006.02.028; Spagnuolo E, 2009, NEUROCIRUGIA, V20, P5; Spiller WG, 1909, J NERV MENT DIS, V36, P0601, DOI 10.1097/00005053-190910000-00003; Stapf C, 2003, STROKE, V34, P2664, DOI 10.1161/01.STR.0000094824.03372.9B; Stapf C, 2000, STROKE, V31, P2365, DOI 10.1161/01.STR.31.10.2365; Steck AJ, 1999, BRAIN PATHOL, V9, P361; Steck AJ, 2008, NEUROTHERAPEUTICS, V5, P528, DOI 10.1016/j.nurt.2008.08.012; STENAGER E, 1991, ACTA NEUROL SCAND, V84, P197, DOI 10.1111/j.1600-0404.1991.tb04937.x; Straube S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008183.pub2; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P253, DOI 10.1136/bmj.38149.566979.AE; Swart EL, 1999, CRIT CARE MED, V27, P1461, DOI 10.1097/00003246-199908000-00009; Swart EL, 2004, BRIT J CLIN PHARMACO, V57, P135, DOI 10.1046/j.1365-2125.2003.01957.x; Tai Qing, 2002, J Spinal Cord Med, V25, P100; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; TAYLOR WAS, 1995, J NEUROSURG, V82, P48, DOI 10.3171/jns.1995.82.1.0048; Teasell RW, 2010, ARCH PHYS MED REHAB, V91, P816, DOI 10.1016/j.apmr.2010.01.022; Teitelbaum JS, 2011, CAN J NEUROL SCI, V38, P815, DOI 10.1017/S0317167100012385; THOMAIDES TN, 1992, EUR NEUROL, V32, P274, DOI 10.1159/000116841; THOMAS DGT, 1994, J NEUROL NEUROSUR PS, V57, P737, DOI 10.1136/jnnp.57.6.737; Tipps LB, 2000, NEUROSURGERY, V46, P596, DOI 10.1097/00006123-200003000-00015; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Toker A, 2005, THORAC CARDIOV SURG, V53, P110, DOI 10.1055/s-2004-830424; Tomas R, 2005, PAIN, V116, P159, DOI 10.1016/j.pain.2005.03.015; TRIGGS WJ, 1992, BRAIN, V115, P189, DOI 10.1093/brain/115.1.189; Tripathi M, 2000, CRIT CARE MED, V28, P655, DOI 10.1097/00003246-200003000-00009; Tsubokawa T, 1998, TXB STEREOTACTIC FUN, P1547; TUCKER WS, 1978, CAN J NEUROL SCI, V5, P331, DOI 10.1017/S0317167100024446; TURNER JS, 1990, CRIT CARE MED, V18, P966, DOI 10.1097/00003246-199009000-00012; Tyler Kenneth L, 2004, Herpes, V11 Suppl 2, p57A; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Vestergaard K, 2001, NEUROLOGY, V56, P184, DOI 10.1212/WNL.56.2.184; Vetrugno R, 2011, J NEUROL, V258, P146, DOI 10.1007/s00415-010-5681-6; WAKAYAMA Y, 1991, TOHOKU J EXP MED, V164, P285, DOI 10.1620/tjem.164.285; Walder B, 2004, SWISS MED WKLY, V134, P333; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walker WC, 2004, J HEAD TRAUMA REHAB, V19, P72, DOI 10.1097/00001199-200401000-00007; Welch SP, 2012, BIOCHEM PHARMACOL, V84, P1551, DOI 10.1016/j.bcp.2012.08.010; Werhagen L, 2004, SPINAL CORD, V42, P665, DOI 10.1038/sj.sc.3101641; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHITEHEAD R, 1952, Am J Phys Med, V31, P321; Widar M, 2002, J REHABIL MED, V34, P165, DOI 10.1080/16501970213237; Widerstrom-Noga E, 2004, J NEUROTRAUM, V21, P195, DOI 10.1089/089771504322778659; Wiffen PJ, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005452, 10.1002/14651858.CD005451]; WIJDICKS EFM, 1988, LANCET, V2, P68; Wilkins K B, 1999, Adv Surg, V32, P105; Willoch F, 1999, AM J NEURORADIOL, V20, P686; Wilmshurst JM, 2001, ACTA PAEDIATR, V90, P691, DOI 10.1080/080352501750258784; Wiwanitkit Viroj, 2009, Acta Neurol Taiwan, V18, P56; Xiao SH, 2010, ADV PARASIT, V73, P231, DOI 10.1016/S0065-308X(10)73009-8; Yamamoto K, 1997, Eur J Paediatr Neurol, V1, P41, DOI 10.1016/S1090-3798(97)80010-4; Yazawa S, 2003, INTERNAL MED, V42, P875, DOI 10.2169/internalmedicine.42.875; Yim APC, 2002, ANZ J SURG, V72, P40, DOI 10.1046/j.1445-2197.2002.02294.x; Zinkin NT, 2005, BEST PRACT RES CL GA, V19, P263, DOI 10.1016/j.bpg.2004.10.001	358	5	6	0	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2013	19	2					232	256		10.1007/s12028-013-9851-0			25	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	221GB	WOS:000324644800016	23893074				2022-02-06	
J	Tsai, TH; Huang, TY; Kung, SS; Su, YF; Hwang, SL; Lieu, AS				Tsai, Tai-Hsin; Huang, Tzuu-Yuan; Kung, Sui-Sum; Su, Yu-Feng; Hwang, Shiuh-Lin; Lieu, Ann-Shung			Intraoperative intracranial pressure and cerebral perfusion pressure for predicting surgical outcome in severe traumatic brain injury	KAOHSIUNG JOURNAL OF MEDICAL SCIENCES			English	Article						Intracranial pressure; Cerebral perfusion pressure; Severe traumatic brain injury	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; MANAGEMENT; HYPERTENSION; VALIDATION; DISABILITY; THRESHOLD; PROGNOSIS; PROTOCOL; SCALE	Intraoperative intracranial pressure (ICP) and cerebral perfusion pressure (CPP) were evaluated for use as prognostic indicators after surgery for severe traumatic brain injury (TBI), and threshold ICP and CPP values were determined to provide guidelines for patient management. This retrospective study reviewed data for 66 patients (20 females and 46 males) aged 13-83 years (average age, 48 years) who had received decompressive craniectomy and hematoma evacuation for severe TBI. The analysis of clinical characteristics included Glascow Coma Scale score, trauma mechanism, trauma severity, cerebral hemorrhage type, hematoma thickness observed on computed tomography scan, Glasgow Outcome Scale score, and mortality. Patients whose treatment included ICP monitoring had significantly better prognosis (p < 0.001) and significantly lower mortality (p = 0.016) compared to those who did not receive ICP monitoring. At all three major steps of the procedure, i.e., creation of the burr hole, evacuation of the hematoma, and closing of the wound, intraoperative ICP and CPP values significantly differed. The ICP and CPP values were also significantly associated with surgical outcome in the severe TBI patients. Between hematoma evacuation and wound closure, ICP and CPP values differed by 6.8 +/- 4.5 and 6.5 +/- 4.6 mmHg, respectively (mean difference, 6 mmHg). Intraoperative thresholds were 14 mmHg for ICP and 56mmH for CPP. Monitoring ICP and CPP during surgery improves management of severe TBI patients and provides an early prognostic indicator. During surgery for severe TBI, early detection of increased ICP is also crucial for enabling sufficiently early treatment to improve surgical outcome. However, further study is needed to determine the optimal intraoperative ICP and CPP thresholds before their use as subjective guidelines for managing severe TBI patients. Copyright (c) 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.	[Tsai, Tai-Hsin; Kung, Sui-Sum; Su, Yu-Feng; Hwang, Shiuh-Lin; Lieu, Ann-Shung] Kaohsiung Med Univ Hosp, Div Neurosurg, Dept Surg, Kaohsiung 80708, Taiwan; [Hwang, Shiuh-Lin; Lieu, Ann-Shung] Kaohsiung Med Univ, Coll Med, Dept Surg, Kaohsiung, Taiwan; [Huang, Tzuu-Yuan] Sinlau Hosp, Dept Neurosurg, Tainan, Taiwan; [Tsai, Tai-Hsin] Kaohsiung Med Univ, Inst Med, Kaohsiung, Taiwan		Tsai, TH (corresponding author), Kaohsiung Med Univ Hosp, Div Neurosurg, Dept Surg, 100 Tzyou 1st Rd, Kaohsiung 80708, Taiwan.	teishin8@hotmail.com		Su, Yu-feng/0000-0003-0355-3981			Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bao YH, 2010, J NEUROTRAUM, V27, P341, DOI 10.1089/neu.2009.1040; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Huang SJ, 2007, J CLIN NEUROSCI, V14, P449, DOI 10.1016/j.jocn.2005.12.012; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; King JT, 2005, J NEUROTRAUM, V22, P947, DOI 10.1089/neu.2005.22.947; Low D, 2009, J NEUROTRAUM, V26, P1177, DOI [10.1089/neu.2008.0841, 10.1089/neu.2008-0841]; Marion DW, 1997, CONT NEUROSURG, V19, P1; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Morgalla MH, 2008, J NEUROSURG, V109, P685, DOI 10.3171/JNS/2008/109/10/0685; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Murphy LS, 1999, BRIT J NEUROSURG, V13, P564, DOI 10.1080/02688699943060; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Oncel D, 2007, J TRAUMA, V63, P1010, DOI 10.1097/TA.0b013e318156ee64; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Ratanalert S, 2004, SURG NEUROL, V61, P429, DOI 10.1016/S0090-3019(03)00579-2; Ronning PA, 2011, J TRAUMA, V70, pE56, DOI 10.1097/TA.0b013e3181e80f0a; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wardlaw JM, 2002, J NEUROL NEUROSUR PS, V72, P188, DOI 10.1136/jnnp.72.2.188; Winter CD, 2005, J CLIN NEUROSCI, V12, P619, DOI 10.1016/j.jocn.2005.02.002	38	5	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1607-551X	2410-8650		KAOHSIUNG J MED SCI	Kaohsiung J. Med. Sci.	OCT	2013	29	10					540	546		10.1016/j.kjms.2013.01.010			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	231NG	WOS:000325423000003	24099108	gold			2022-02-06	
J	Chen, JJ; Cui, ZM; Li, WD; Shen, AG; Xu, GH; Bao, GF; Sun, YY; Wang, LL; Fan, JB; Zhang, JL; Yang, LF; Cui, ZM				Chen, Jiajia; Cui, Zhiming; Li, Weidong; Shen, Aiguo; Xu, Guanhua; Bao, Guofeng; Sun, Yuyu; Wang, Lingling; Fan, Jianbo; Zhang, Jinlong; Yang, Longfei; Cui, Zhiming			MCM7 Expression Is Altered in Rat After Spinal Cord Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Spinal cord injury; MCM7; Neuronal apoptosis; Proliferation; Rat	NEURONAL CELL-DEATH; MINICHROMOSOME MAINTENANCE PROTEIN-7; PRE-REPLICATION COMPLEX; TRAUMATIC BRAIN-INJURY; DNA-REPLICATION; PROGNOSTIC-SIGNIFICANCE; CYCLE ACTIVATION; CNS INJURY; S-PHASE; CANCER	Minichromosome maintenance protein 7 (MCM7), a member of the minichromosome maintenance protein family, is essential for eukaryotic DNA replication initiation and the early stage of the elongation process. MCM7 participates in the cell cycle control of genome duplication. While it is ubiquitously expressed in all tissues, the biological function of MCM7 in the central nervous system is still with limited acquaintance. In the present study, we performed a spinal cord injury (SCI) model in adult rats. Western blotting indicated a marked alteration of MCM7 after SCI. Immunohistochemistry analysis revealed a wide distribution of MCM7 in the spinal cord. Double immunofluorescence staining showed that MCM7 immunoreactivity was increased predominantly in neurons, astrocytes, and microglia after SCI. We also examined the expression profiles of active caspase-3, proliferating cell nuclear antigen (PCNA), and Ki67, whose changes were correlated with the expression profiles of MCM7. Moreover, colocalization of MCM7/active caspase-3 was detected in neuronal nuclei (NeuN), and colocalization of MCM7/PCNA was detected in NeuN, glial fibrillary acidic protein, and CD11b, respectively. Our results suggest that MCM7 might be implicated in the apoptosis of neuron and proliferation of astrocytes and microglia after SCI.	[Chen, Jiajia; Cui, Zhiming; Li, Weidong; Xu, Guanhua; Bao, Guofeng; Sun, Yuyu; Wang, Lingling; Fan, Jianbo; Zhang, Jinlong; Yang, Longfei; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China; [Shen, Aiguo] Nantong Univ, Coll Med, Dept Immunol, Nantong 226001, Jiangsu, Peoples R China		Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Spine Surg, Nantong 226001, Jiangsu, Peoples R China.	cuizhiming2012@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271367]	This work was supported by the National Natural Science Foundation of China (no. 81271367).	Ambrozaitis Kazys Vytautas, 2006, Medicina (Kaunas), V42, P255; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Byrnes KR, 2007, NEUROCHEM RES, V32, P1799, DOI 10.1007/s11064-007-9312-2; Cernak I, 2005, CELL CYCLE, V4, P1286, DOI 10.4161/cc.4.9.1996; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P25, DOI 10.2174/156720206775541741; DALTON S, 1995, P NATL ACAD SCI USA, V92, P2514, DOI 10.1073/pnas.92.7.2514; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Fitch MJ, 2003, J BIOL CHEM, V278, P25408, DOI 10.1074/jbc.M300699200; Folch J, 2012, NEUROTOX RES, V22, P195, DOI 10.1007/s12640-011-9277-4; Fujita M, 1996, J BIOL CHEM, V271, P4349; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Huan WP, 2012, J MOL HISTOL, V43, P527, DOI 10.1007/s10735-012-9411-5; Khalatbary AR, 2012, IRAN RED CRESCENT ME, V14, P229; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lau KM, 2010, ONCOGENE, V29, P5475, DOI 10.1038/onc.2010.287; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Marnerides A, 2011, ANTICANCER RES, V31, P3585; Martin LJ, 2009, CEREB CORTEX, V19, P1273, DOI 10.1093/cercor/bhn167; Min KJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-100; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nguyen MD, 2003, J NEUROSCI, V23, P2131; Nguyen MD, 2002, CELL DEATH DIFFER, V9, P1294, DOI 10.1038/sj.cdd.4401108; Nishihara K, 2008, INT J ONCOL, V33, P245, DOI 10.3892/ijo_00000003; OKANO HJ, 1993, J NEUROSCI, V13, P2930; Ota T, 2011, MODERN PATHOL, V24, P277, DOI 10.1038/modpathol.2010.202; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Rodriguez-Zayas AE, 2010, INT J DEV NEUROSCI, V28, P413, DOI 10.1016/j.ijdevneu.2010.07.001; Romanowski P, 1996, P NATL ACAD SCI USA, V93, P10189, DOI 10.1073/pnas.93.19.10189; Sakurai M, 2000, STROKE, V31, P200, DOI 10.1161/01.STR.31.1.200; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Stoica BA, 2009, NEUROTOX RES, V16, P221, DOI 10.1007/s12640-009-9050-0; Tachibana KEK, 2005, J PATHOL, V205, P123, DOI 10.1002/path.1708; Takisawa H, 2000, CURR OPIN CELL BIOL, V12, P690, DOI 10.1016/S0955-0674(00)00153-8; Thangavel C, 2013, CELL CYCLE, V12, P98, DOI 10.4161/cc.23029; Tian DS, 2007, BRAIN RES, V1135, P177, DOI 10.1016/j.brainres.2006.11.085; Toyokawa G, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-65; Tsai HY, 2004, HUM PATHOL, V35, P1397, DOI 10.1016/j.humpath.2004.07.014; Wallace DM, 2009, J NEUROSCI RES, V87, P887, DOI 10.1002/jnr.21910; Wartiovaara K, 2002, J NEUROSCI, V22, P815, DOI 10.1523/JNEUROSCI.22-03-00815.2002; White RE, 2011, J NEUROSCI, V31, P15173, DOI 10.1523/JNEUROSCI.3441-11.2011; Xu DW, 2011, J NEUROL SCI, V309, P141, DOI 10.1016/j.jns.2011.06.024; Yang Y, 2003, J NEUROSCI, V23, P2557	49	5	5	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	SEP	2013	51	1					82	91		10.1007/s12031-013-0003-y			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	211PJ	WOS:000323921000009	23526403				2022-02-06	
J	Ghonemi, MO; Rabah, AA; Saber, HM; Radwan, W				Ghonemi, Moh Omar; Rabah, Amany Ahmed; Saber, Hamdy Mohamed; Radwan, Wahid			Role of Phosphorylated Neurofilament H as a diagnostic and prognostic marker in traumatic brain injury	EGYPTIAN JOURNAL OF CRITICAL CARE MEDICINE			English	Article						Neurofilament H; Traumatic brain injury; Rankin score; Glasgow coma score; Acute brain insults		Background and purpose: One of the main drawbacks in the management of patients with traumatic brain injuries (TBI) is the absence of a widely available and rapid diagnostic test. The objective of our study was to assess whether Phosphorylated Neurofilament H (pNF-H) might provide useful diagnostic information as an indication of axonal injury in the early evaluation of such patients and whether levels of the pNF-H correlated with different clinical variables. Methods: A total of 30 patients presenting to the critical care department of Cairo University diagnosed with traumatic brain injury were prospectively studied. Blood samples for pNF-H were assayed on admission and after 7 days. Neurofilament levels correlated with Glasgow coma scale and CT findings on admission and after 7 days. Rankin score at 3 months was used to detect the degree of disability. Results: Phosphorylated Neurofilament H levels showed a negative correlation with GCS on admission and after 7 days in traumatic brain injury; hence higher neuromarker levels were associated with lower GCS on admission and after 7 days. There was a negative correlation between neurofilament levels and Marshal CT scores on admission and after 7 days (r = 0.56.0.4) hence higher neurofilament levels correlated with worse CT findings. Patients who died or had the greatest Rankin 6 and 5 after 3 months had the highest levels of pNF-H on admission and after 7 days. The cut off level of pNF-H to detect death and disability was 35 pg/ml on admission (sensitivity 82%,specificity 78%) and was 11 pg/ml after 7 days (sensitivity87%, and specificity 92%). Conclusion: Phosphorylated Neurofilament H can be used as a diagnostic and prognostic marker in patients with TBI as seen by the presence of significant correlations between the marker levels and different clinical and radiological tools. (C) 2013 The Egyptian College of Critical Care Physicians. Production and hosting by Elsevier B.V.	[Ghonemi, Moh Omar; Radwan, Wahid] Cairo Univ, Dept Crit Care, Cairo, Egypt; [Rabah, Amany Ahmed] Cairo Univ, Dept Neurol, Cairo, Egypt; [Saber, Hamdy Mohamed] Beniswif Univ, Dept Crit Care, Bani Suwayf, Egypt		Ghonemi, MO (corresponding author), Cairo Univ, Dept Crit Care, Cairo, Egypt.	elghonemi@yahoo.com					Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; GOLDSTEIN ME, 1987, J NEUROIMMUNOL, V14, P149, DOI 10.1016/0165-5728(87)90049-X; GREENWOOD JA, 1993, J NEUROCHEM, V61, P191, DOI 10.1111/j.1471-4159.1993.tb03555.x; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; HSIEH ST, 1994, BRAIN RES, V642, P316, DOI 10.1016/0006-8993(94)90937-7; JOHNSON GVW, 1991, NEUROCHEM RES, V16, P869, DOI 10.1007/BF00965535; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Strong MJ, 2001, J NEUROCHEM, V76, P1315, DOI 10.1046/j.1471-4159.2001.00094.x; Traumatic Brain Injury Committee of the Head Injury Interdisciplinary Special Interest Group of the American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD	17	5	5	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2090-7303			EGYPT J CRIT CARE ME	Egypt. J. Crit. Care Med.	SEP	2013	1	3					139	144		10.1016/j.ejccm.2013.03.002			6	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V24YI	WOS:000215191900006		gold			2022-02-06	
J	Hawkins, SC; Caudell, MJ; Deloughery, TG; Murray, W				Hawkins, Seth C.; Caudell, Michael J.; Deloughery, Thomas G.; Murray, William			Participation of Iatrogenically Coagulopathic Patients in Wilderness Activities	WILDERNESS & ENVIRONMENTAL MEDICINE			English	Article						coagulopathy; warfarin; wilderness activities; anticoagulation; outdoor sports; outdoor activities	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; PREINJURY WARFARIN USE; VITAMIN-K; INTRACRANIAL HEMORRHAGE; ANTICOAGULATED PATIENTS; COMPETITIVE SPORTS; ELDERLY-PATIENTS; CLOPIDOGREL USE; MANAGEMENT	An increasing number of patients routinely undergo long-term anticoagulation with warfarin or other pharmacological agents. There is little evidence and no consensus documents in the literature regarding the appropriateness and relative risk of their participation in wilderness activities. We present a case report, conduct an analysis of the limited literature that is available, and make recommendations for wilderness medicine practitioners and screening personnel.	[Hawkins, Seth C.] UNC Chapel Hill Sch Med, Dept Emergency Med, Morganton, NC 28655 USA; [Caudell, Michael J.] Georgia Hlth Sci Univ, Dept Emergency Med, Augusta, GA USA; [Deloughery, Thomas G.] Oregon Hlth & Sci Univ, Div Hematol Oncol, Portland, OR 97201 USA; [Murray, William] NC Outward Bound Sch, Asheville, NC USA		Hawkins, SC (corresponding author), UNC Chapel Hill Sch Med, Dept Emergency Med, 2201 South Sterling St, Morganton, NC 28655 USA.	hawk@aya.yale.edu					Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; [Anonymous], 2012, PRIVATE JOURNEY  SPR; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Booth SL, 1999, NUTR REV, V57, P288; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Bungard TJ, 2011, CAN PHARM J, V144, P21, DOI 10.3821/1913-701X-144.1.21; Claudia C, 2011, J TRAUMA, V70, P906, DOI 10.1097/TA.0b013e3182031ab7; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; DeLoughery TG, 2005, CRIT CARE CLIN, V21, P531, DOI 10.1016/j.ccc.2005.05.003; DeLoughery TG, 2011, AM J HEMATOL, V86, P586, DOI 10.1002/ajh.22021; Depenbrock PJ, 2011, CURR SPORT MED REP, V10, P78, DOI 10.1249/JSR.0b013e318214d828; Fabbri A, 2005, J NEUROTRAUM, V22, P1419, DOI 10.1089/neu.2005.22.1419; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Galanis T, 2011, J THROMB THROMBOLYS, V31, P310, DOI 10.1007/s11239-011-0559-8; Garra G, 1999, ACAD EMERG MED, V6, P121, DOI 10.1111/j.1553-2712.1999.tb01048.x; Gennari L, 2008, BLOOD, P112; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Karni A, 2001, AM SURGEON, V67, P1098; Lavoie A, 2004, J TRAUMA, V56, P802, DOI 10.1097/01.TA.0000066183.02177.AF; Leiblich A, 2011, EMERG MED J, V28, P115, DOI 10.1136/emj.2009.079442; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Li J, 2012, ANN EMERG MED, V59, P469, DOI 10.1016/j.annemergmed.2012.04.017; Li J, 2012, ANN EMERG MED, V59, P457, DOI 10.1016/j.annemergmed.2012.01.010; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Matchar DB, 2010, NEW ENGL J MED, V363, P1608, DOI 10.1056/NEJMoa1002617; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Medzon R, 2010, J EMERG MED, V39, P399, DOI 10.1016/j.jemermed.2007.11.059; Mellwig KP, 2008, EUR J CARDIOV PREV R, V15, P95, DOI 10.1097/HJR.0b013e3282ef9973; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Mina AA, 2003, J TRAUMA, V54, P842, DOI 10.1097/01.TA.0000063271.05829.15; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; National Collaborating Centre for Acute Care (UK), 2007, HEAD INJ TRIAG ASS I; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Nutescu E, 2011, J THROMB THROMBOLYS, V31, P326, DOI 10.1007/s11239-011-0561-1; Ott MM, 2010, J TRAUMA, V68, P560, DOI 10.1097/TA.0b013e3181ad6600; Pelliccia A, 2005, EUR HEART J, V26, P1422, DOI 10.1093/eurheartj/ehi325; Schulman S, 2011, ANN INTERN MED, V155, P653, DOI 10.7326/0003-4819-155-10-201111150-00003; Sconce E, 2005, THROMB HAEMOSTASIS, V93, P872, DOI 10.1160/TH04-12-0773; Servadei F, 2001, J NEUROTRAUM, V18, P657, DOI 10.1089/089771501750357609; Sodium Warfarin, 1974, WARF SOD DRUGPOINT S; Van Patot MCT, 2006, HIGH ALT MED BIOL, V7, P39; Volans AP, 1998, J ACCID EMERG MED, V15, P159; Weitz JI, 2012, CHEST, V141; White Pamela J, 2010, J Pharm Pract, V23, P194, DOI 10.1177/0897190010362177; Wojcik R, 2001, J TRAUMA, V51, P1147, DOI 10.1097/00005373-200112000-00021	52	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1080-6032			WILD ENVIRON MED	Wildern. Environ. Med.	FAL	2013	24	3					257	266		10.1016/j.wem.2012.12.002			10	Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Sport Sciences	225LU	WOS:000324965200010	23590929	Bronze			2022-02-06	
J	Ho, NSP; Lee, TMC				Ho, Nerissa S. P.; Lee, Tatia M. C.			Alexithymia: The story of a survivor of childhood traumatic brain injury	BRAIN INJURY			English	Article						Alexithymia; occipital lobe; social cognition; TBI; traumatic brain injuries; visual cortex	HIGH-FUNCTIONING AUTISM; MENTAL-IMAGERY; ASPERGER-SYNDROME; EMPATHY; ATTENTION; AMYGDALA; EMOTION; SCALE; RECOGNITION; RELIABILITY	Introduction: Affective abnormalities resulting from traumatic brain injuries can pose major threats to the long-term outcomes of neurorehabilitation, especially when they have gone unattended in the process of rehabilitation. This study reports a case of a 46-year-old woman who survived a severe traumatic brain injury to the right occipital cortex (BA18/19) at the age of 10. While her cognitive recovery was remarkable, she has been living with a significant affective disturbance: difficulty with feeling others' feelings. Method: Neuropsychological tests and self-reported questionnaires capturing the patient's neuropsychological profile, social cognitive abilities, emotional responses, affective awareness and visual imager were administered to the patient. Results: While cognitive functioning beside attention has recovered well, findings clearly indicate that she is indeed suffering from a high level of alexithymia. Conclusion: It is speculated that the alexithymia observed may relate to the damage to the visual cortex, which is an important neural substrate for visual imagery and/or damage to the bottom-up stimulus-driven attention system in the right hemisphere. This case exemplified a possible organic basis of social affective disturbance, which may be overlooked in the process of neurorehabilitation.	[Ho, Nerissa S. P.; Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Ho, Nerissa S. P.; Lee, Tatia M. C.] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, Inst Clin Neuropsychol, Hong Kong, Hong Kong, Peoples R China		Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, C656,Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	tmclee@hku.hk		Ho, Nerissa/0000-0001-7520-7549	University of Hong KongUniversity of Hong Kong; Research Grant Council of Hong KongHong Kong Research Grants Council [HKU747612H]	This project was supported by the Endowed Professorship of The University of Hong Kong and the General Research Fund of Research Grant Council of Hong Kong (HKU747612H).	Arango-Lasprilla JC, 2008, BRAIN INJURY, V22, P565, DOI 10.1080/02699050802172004; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bermond Bob, 2006, Cogn Neuropsychiatry, V11, P332, DOI 10.1080/13546800500368607; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Campos A, 2000, PERS INDIV DIFFER, V29, P787, DOI 10.1016/S0191-8869(99)00231-7; Compton Rebecca J, 2003, Behav Cogn Neurosci Rev, V2, P115, DOI 10.1177/1534582303255278; Cui X, 2007, VISION RES, V47, P474, DOI 10.1016/j.visres.2006.11.013; DAMASIO Antonio, 2003, LOOKING SPINOZA JOY; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; de Sousa A, 2010, NEUROPSYCHOLOGIA, V48, P3585, DOI 10.1016/j.neuropsychologia.2010.08.008; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Golden J. C., 1978, STROOP COLOR WORD TE; Holmes EA, 2005, EMOTION, V5, P489, DOI 10.1037/1528-3542.5.4.489; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Lewis R, 1979, MANUAL REPEATABLE CO; Mantani T, 2005, BIOL PSYCHIAT, V57, P982, DOI 10.1016/j.biopsych.2005.01.047; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MILLER PA, 1988, PSYCHOL BULL, V103, P324, DOI 10.1037/0033-2909.103.3.324; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Nemiah J. C., 1976, MODERN TRENDS PSYCHO, V3, P430; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Raven J.C., 2008, STANDARD PROGR MATRI; REYNOLDS WM, 1982, J CLIN PSYCHOL, V38, P119, DOI 10.1002/1097-4679(198201)38:1<119::AID-JCLP2270380118>3.0.CO;2-I; RUSSELL EW, 1987, J CONSULT CLIN PSYCH, V55, P898, DOI 10.1037/0022-006X.55.6.898; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Smith A., 1982, SYMBOL DIGIT MODALIT; Tamietto M, 2012, CURR BIOL, V22, P1449, DOI 10.1016/j.cub.2012.06.006; Taylor GJ, 2004, PSYCHOTHER PSYCHOSOM, V73, P68, DOI 10.1159/000075537; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Wechsler D., 1997, WECHSLER MEMORY SCAL; White T., 1996, COLOR TRAILS TEST PR; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	46	5	5	1	23	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1199	1205		10.3109/02699052.2013.804198			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200013	23895444				2022-02-06	
J	Nigrovic, LE; Schonfeld, D; Dayan, PS; Fitz, BM; Mitchell, SR; Kuppermann, N				Nigrovic, Lise E.; Schonfeld, Deborah; Dayan, Peter S.; Fitz, Brianna M.; Mitchell, Shannon R.; Kuppermann, Nathan			Nurse and Physician Agreement in the Assessment of Minor Blunt Head Trauma	PEDIATRICS			English	Article						minor blunt head trauma; clinical prediction rule; kappa statistic; traumatic brain injury; PECARN	CLINICAL DECISION RULES; ACUTE ANKLE INJURIES; OTTAWA ANKLE; INTEROBSERVER AGREEMENT; APPROPRIATELY INTERPRET; EMERGENCY; CHILDREN; RELIABILITY; RADIOGRAPHY	OBJECTIVE: The Pediatric Emergency Care Applied Research Network (PECARN) traumatic brain injury (TBI) clinical prediction rules identify children with minor blunt head trauma who are at low risk for clinically important traumatic brain injuries. We measured the agreement between the registered nurse (RN) and physician (MD) assessments. METHODS: We performed a cross-sectional study of all children <18 years of age with minor blunt head trauma who presented to a single emergency department. RNs and MDs independently assessed each child and recorded age-based PECARN predictors. As symptoms can change over time, we included cases only when both evaluations were completed within 60 minutes. We used the kappa statistic to measure RN-MD agreement, with the main analysis focusing on the overall PECARN rule agreement. RESULTS: Of the 1624 eligible children, 1191 (73%) had evaluations completed by both RN and ED providers, of which 437 (37%) were in children <2 years of age. The median time between completions of the provider forms was 12 minutes (interquartile range 4-25 minutes). The overall agreement between the RN and MD was higher for the older children (kappa 0.55, 95% confidence interval 0.49-0.61 for children 2-18 years versus kappa 0.32, 95% confidence interval 0.23-0.41 for children <2 years). CONCLUSIONS: The overall agreement between RN and MD for the PECARN TBI prediction rules was moderate for older children and fair for younger children. Initial RN assessments should be verified by the MD before clinical application, especially for the youngest children.	[Nigrovic, Lise E.; Schonfeld, Deborah; Mitchell, Shannon R.] Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Div Emergency Med, New York, NY 10032 USA; [Fitz, Brianna M.] Boston Coll, Dept Psychol, Boston, MA USA; [Kuppermann, Nathan] Univ Calif Davis, Dept Emergency Med & Pediat, Davis, CA 95616 USA		Nigrovic, LE (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	lise.nigrovic@childrens.harvard.edu		Nigrovic, Lise/0000-0002-6369-3997	Hood Foundation, Child Health Grant	Funded by a Hood Foundation, Child Health Grant to Dr Nigrovic.	Cicchetti D, 2006, J NERV MENT DIS, V194, P557, DOI 10.1097/01.nmd.0000230392.83607.c5; Dayan PS, 2011, PEDIATRICS, V127, pE1266, DOI 10.1542/peds.2010-1752; Derksen RJ, 2005, AM J EMERG MED, V23, P725, DOI 10.1016/j.ajem.2005.02.054; Derksen RJ, 2005, AM J EMERG MED, V23, P201, DOI 10.1016/j.ajem.2004.08.021; Durkalski VL, 2003, STAT MED, V22, P2417, DOI 10.1002/sim.1438; Fiesseler F, 2004, AM J EMERG MED, V22, P145, DOI 10.1016/j.ajem.2004.02.001; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Karpas A, 2002, ACAD EMERG MED, V9, P130, DOI 10.1111/j.1553-2712.2002.tb00229.x; Kharbanda AB, 2012, PEDIATRICS, V129, P695, DOI 10.1542/peds.2011-2037; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; STIELL IG, 1993, JAMA-J AM MED ASSOC, V269, P1127, DOI 10.1001/jama.269.9.1127; STIELL IG, 1992, ANN EMERG MED, V21, P384, DOI 10.1016/S0196-0644(05)82656-3	15	5	5	0	4	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	SEP	2013	132	3					E689	E694		10.1542/peds.2013-0909			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	226ZX	WOS:000325077800015	23979081				2022-02-06	
J	Scherer, MR; Claro, PJ; Heaton, KJ				Scherer, Matthew R.; Claro, Pedro J.; Heaton, Kristin J.			Sleep Deprivation Has No Effect on Dynamic Visual Acuity in Military Service Members Who Are Healthy	PHYSICAL THERAPY			English	Article							UNILATERAL VESTIBULAR HYPOFUNCTION; TRAUMATIC BRAIN-INJURY; VESTIBULOOCULAR REFLEX; EYELID MOVEMENTS; OCULAR REFLEX; REHABILITATION; RECOVERY; BLAST; RELIABILITY; AFGHANISTAN	Background. The risk of traumatic brain injury (TBI) and comorbid posttraumatic dizziness is elevated in military operational environments. Sleep deprivation is known to affect a service member's performance while deployed, although little is known about its effects on vestibular function. Recent findings suggest that moderate acceleration step rotational stimuli may elicit a heightened angular vestibulo-ocular reflex (aVOR) response relative to low-frequency sinusoidal stimuli after 26 hours of sleep deprivation. There is concern that a sleep deprivation-mediated elevation in aVOR function could confound detection of comorbid vestibular pathology in service members with TBI. The term "dynamic visual acuity" (DVA) refers to an individual's ability to see clearly during head movement and is a behavioral measure of aVOR function. The Dynamic Visual Acuity Test (DVAT) assesses gaze instability by measuring the difference between head-stationary and head-moving visual acuity. Objective. The purpose of this study was to investigate the effects of 26 hours of sleep deprivation on DVA as a surrogate for aVOR function. Design. This observational study utilized a repeated-measures design. Methods. Twenty soldiers with no history of vestibular insult or head trauma were assessed by means of the DVAT at angular head velocities of 120 to 180 degrees/s. Active and passive yaw and pitch impulses were obtained before and after sleep deprivation. Results. Yaw DVA remained unchanged as the result of sleep deprivation. Active pitch DVA diminished by -0.005 LogMAR (down) and -0.055 LogMAR (up); passive pitch DVA was degraded by -0.06 LogMAR (down) and -0.045 LogMAR (up). Limitations. Sample homogeneity largely confounded accurate assessment of test-retest reliability in this study, resulting in intraclass correlation coefficients lower than those previously reported. Conclusions. Dynamic visual acuity testing in soldiers who are healthy revealed no change in gaze stability after rapid yaw impulses and subclinical changes in pitch DVA after sleep deprivation. Findings suggest that DVA is not affected by short-term sleep deprivation under clinical conditions.	[Scherer, Matthew R.; Claro, Pedro J.; Heaton, Kristin J.] US Army Res Inst Environm Med, Mil Performance Div, Natick, MA 01760 USA		Scherer, MR (corresponding author), US Army Res Inst Environm Med, Mil Performance Div, 15 Kansas St, Natick, MA 01760 USA.	matthew.scherer@us.army.mil			Congressionally Directed Medical Research Programs (CDMRP) through an Advanced Technology Award [W81XWH-08-2-0,177]; US Army Medical Research and Materiel Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-08-1-0,021]	This work was supported by Congressionally Directed Medical Research Programs (CDMRP) through an Advanced Technology Award (W81XWH-08-2-0,177) to Jamshid Ghajar and by the US Army Medical Research and Materiel Command (USAMRMC) through W81XWH-08-1-0,021 to Dr Heaton.	AKBARIAN S, 1993, J COMP NEUROL, V332, P89, DOI 10.1002/cne.903320107; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; BRANDT T, 1994, ANN NEUROL, V36, P337, DOI 10.1002/ana.410360304; Chee MWL, 2004, J NEUROSCI, V24, P4560, DOI 10.1523/JNEUROSCI.0007-04.2004; Collins W., 1988, SPACE ENV MED, V59, P523; Couyoumdjian A, 2010, J SLEEP RES, V19, P64, DOI 10.1111/j.1365-2869.2009.00774.x; Crevits L, 2003, EUR NEUROL, V50, P176, DOI 10.1159/000073060; Das E, 2000, J VESTIBUL RES-EQUIL, V10, P51; Della Santina CC, 2001, ANN NY ACAD SCI, V942, P465; EVINGER C, 1991, INVEST OPHTH VIS SCI, V32, P387; Gottshall KR, 2007, MIL MED, V172, P852, DOI 10.7205/MILMED.172.8.852; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; Hain TC, 2007, ANATOMY PHYSL NORMAL; Halmagyi GM, 1988, ARCH NEUROL-CHICAGO, V45, P737; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Herdman SJ, 2001, ARCH OTOLARYNGOL, V127, P1205, DOI 10.1001/archotol.127.10.1205; Herdman SJ, 1998, AM J OTOL, V19, P790; Hettich Thomas, 2010, J Spec Oper Med, V10, P48; Hoffer Michael E, 2009, Int Tinnitus J, V15, P115; Kathleen EC, 2004, CURR OPIN NEUROBIOL, V14, P698; LAHEY MA, 1983, PSYCHOL BULL, V93, P586, DOI 10.1037/0033-2909.93.3.586; Leigh J.R., 2006, NEUROLOGY EYE MOVEME; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Miller NL, 2011, BEHAV SLEEP MED, V9, P53, DOI 10.1080/15402002.2011.533994; Minor LB, 1999, J NEUROPHYSIOL, V82, P1254, DOI 10.1152/jn.1999.82.3.1254; Mohammad MT, 2011, J VESTIBUL RES-EQUIL, V21, P277, DOI 10.3233/VES-2011-0430; Morris T, 1984, THESIS A M U; Okie S, 2006, NEW ENGL J MED, V355, P2609, DOI 10.1056/NEJMp068235; PAIGE GD, 1989, ACTA OTO-LARYNGOL, V108, P1, DOI 10.3109/00016488909107385; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Quarck G, 2006, J SLEEP RES, V15, P369, DOI 10.1111/j.1365-2869.2006.00550.x; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Scherer M, 2008, J VESTIBUL RES-EQUIL, V18, P147; Scherer MR, 2011, OTOL NEUROTOL, V32, P571, DOI 10.1097/MAO.0b013e318210b8fa; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schubert MC, 2002, OTOL NEUROTOL, V23, P372, DOI 10.1097/00129492-200205000-00025; Schubert MC, 2008, ARCH PHYS MED REHAB, V89, P500, DOI 10.1016/j.apmr.2007.11.010; Schubert MC, 2006, JARO-J ASSOC RES OTO, V7, P329, DOI 10.1007/s10162-006-0047-6; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; STERN JA, 1994, HUM FACTORS, V36, P285, DOI 10.1177/001872089403600209; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tucker AJ, 2005, SLEEP, V28, pA122; Ventre-Dominey J, 2003, NEUROPSYCHOLOGIA, V41, P1884, DOI 10.1016/S0028-3932(03)00126-X; Wainner RS, 2003, J ORTHOP SPORT PHYS, V33, P488, DOI 10.2519/jospt.2003.33.9.488; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; WOLFE JW, 1968, AEROSPACE MED, V39, P947; Zimmerman DW, 2000, APPL PSYCH MEAS, V24, P267, DOI 10.1177/01466210022031741	51	5	6	2	14	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	0031-9023			PHYS THER	Phys. Ther.	SEP	2013	93	9			SI		1185	1196		10.2522/ptj.20120144			12	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation	212OM	WOS:000323992700008	23162043	Bronze			2022-02-06	
J	Sommer, JB; Norup, A; Poulsen, I; Mogensen, J				Sommer, Jens Bak; Norup, Anne; Poulsen, Ingrid; Mogensen, Jesper			COGNITIVE ACTIVITY LIMITATIONS ONE YEAR POST-TRAUMA IN PATIENTS ADMITTED TO SUB-ACUTE REHABILITATION AFTER SEVERE TRAUMATIC BRAIN INJURY	JOURNAL OF REHABILITATION MEDICINE			English	Article						traumatic brain injury; TBI; acute brain injury; vegetative state; minimally conscious state; confusional state; consciousness disorders; rehabilitation outcome	MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; FOLLOW-UP; UNRESPONSIVE WAKEFULNESS; PRACTICAL SCALE; HEAD-INJURY; RECOVERY; DISORDERS; NAME; MORTALITY	Objective: To examine cognitive activity limitations and predictors of outcome 1 year post-trauma in patients admitted to sub-acute rehabilitation after severe traumatic brain injury. Subjects: The study included 119 patients with severe traumatic brain injury admitted to centralized sub-acute rehabilitation in the Eastern part of Denmark during a 5-year period from 2005 to 2009. Methods: Level of consciousness was assessed consecutively during rehabilitation and at 1 year post-trauma. Severity of traumatic brain injury was classified according to duration of post-traumatic amnesia. The cognitive subscale of Functional Independence Measure (TM) (Cog-FIM) was used to assess cognitive activity limitations. Multivariate logistic regression analyses were performed to identify predictors of an independent level of functioning. Results: The majority of patients progressed to a post-confusional level of consciousness during the first year post-trauma. At follow-up 33-58% of patients had achieved functional independence within the cognitive domains on the Cog-FIM. Socio-economic status, duration of acute care and post-traumatic amnesia were significant predictors of outcome. Conclusion: Substantial recovery was documented among patients with severe traumatic brain injury during the first year post-trauma. The results of the current study suggest that absence of consciousness at discharge from acute care should not preclude patients from being referred to specialized sub-acute rehabilitation.	[Sommer, Jens Bak; Norup, Anne; Poulsen, Ingrid] Univ Hosp, Dept Neurorehabil, Traumat Brain Injury Unit, Res Unit BRain Injury Rehabil,Copenhagen RUBRIC, Glostrup, Denmark; [Sommer, Jens Bak] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-1168 Copenhagen, Denmark; [Sommer, Jens Bak; Mogensen, Jesper] Univ Copenhagen, Dept Psychol, Unit Cognit Neurosci, DK-1168 Copenhagen, Denmark		Sommer, JB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark.	jens.sommer@sund.ku.dk	Poulsen, ingrid/AAH-2052-2019	Poulsen, ingrid/0000-0002-0342-017X; Norup, Anne/0000-0002-5598-6116; Mogensen, Jesper/0000-0003-1959-581X			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Berube J, 2006, MOHONK REPORT REPORT; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Engberg AW, 2007, J HEAD TRAUMA REHAB, V22, P221, DOI 10.1097/01.HTR.0000281837.62226.54; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Engberg AW, 2007, UGESKRIFT LAEGER, V169, P199; Estraneo A, 2010, NEUROLOGY, V75, P239, DOI 10.1212/WNL.0b013e3181e8e8cc; Fins JJ, 2009, PROG BRAIN RES, V177, P371, DOI 10.1016/S0079-6123(09)17726-9; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Godbolt AK, 2011, AM J PHYS MED REHAB, V90, P482, DOI 10.1097/PHM.0b013e31820f9768; Gosseries O, 2011, NEUROREHABILITATION, V28, P3, DOI 10.3233/NRE-2011-0625; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Gray DS, 2000, BRAIN INJURY, V14, P1003, DOI 10.1080/02699050050191940; Hagen C., 1972, LEVELS COGNITIVE FUN; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Jennett B, 2005, PROG BRAIN RES, V150, P537, DOI 10.1016/S0079-6123(05)50037-2; JENNETT B, 1972, LANCET, V1, P734; Jennett B, 1981, MANAGEMENT HEAD INJU; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kosch Y, 2010, BRAIN INJURY, V24, P479, DOI 10.3109/02699051003610417; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Luaute J, 2010, NEUROLOGY, V75, P246, DOI 10.1212/WNL.0b013e3181e8e8df; Majerus S, 2005, PROG BRAIN RES, V150, P397, DOI 10.1016/S0079-6123(05)50028-1; Nakase-Richardson R, 2012, J NEUROTRAUM, V29, P59, DOI 10.1089/neu.2011.1829; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; TEASDALE G, 1974, LANCET, V2, P81; Tengvar Christer, 2006, Lakartidningen, V103, P3685; von Wild K, 2007, EUR J TRAUMA EMERG S, V33, P268, DOI 10.1007/s00068-007-6138-1; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	40	5	5	0	3	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	SEP	2013	45	8					778	784		10.2340/16501977-1208			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	243ZS	WOS:000326357500013	24002314	Green Submitted, gold			2022-02-06	
J	Sudlow, A; McConnell, N; Egan, G; Jansen, JO				Sudlow, Alexis; McConnell, Nicola; Egan, Gerry; Jansen, Jan O.			Destination healthcare facility of patients with suspected traumatic brain injury in Scotland: Analysis of pre-hospital data	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Traumatic brain injury; Trauma system; Triage	OUTCOMES	Background: Traumatic brain injury is common. Guidelines from the Brain Trauma Foundation and the Scottish Intercollegiate Guidelines Network recommend that patients with suspected severe traumatic brain injury should be treated in centres with neurosurgical expertise. Scotland does not have a framework for the delivery of trauma care. The aim of this study was to examine the demographic characteristics of incidents involving patients who have suffered a suspected traumatic brain injury, and to evaluate the level of the destination healthcare facility which patients are currently taken to. Methods: Retrospective analysis of prospectively collected Scottish Ambulance Service data on incidents involving traumatic injury, between Nov 2008 and Oct 2010. Two groups of casualties were analysed: those who had a Glasgow coma scale of less than 14 (GCS < 14), and those who had a Glasgow coma scale of less than 9 (GCS < 9). Results: 126,934 incidents were identified and analysed. 3890 (3.1%) patients had a GCS of less than 14, and 657 (0.5% of total) had a GCS of less than 9. Almost one-third of incidents involving patients with either a GCS < 14 or GCS < 9 occurred in the greater Glasgow health board area. The Lothian health board region had the second-highest number of patients with either a GCS < 14 or GCS < 9. Only 13.8% of patients with a GCS < 14, and 16.7% of those with a GCS < 9, were taken to a hospital with a neurosurgical service. Conclusions: Many patients who may harbour a traumatic brain injury are taken to a facility which may not be equipped or staffed to deal with such injuries. This mismatch needs to be addressed. However, the care of patients with head injuries is only one aspect of trauma care. The UK has long lagged behind North America in terms of the quality of trauma care provided, although the provision of trauma care in England is currently undergoing major changes. Scotland should consider the development of a similar service delivery framework. (C) 2011 Elsevier Ltd. All rights reserved.	[Sudlow, Alexis] Univ Aberdeen, Aberdeen, Scotland; [McConnell, Nicola; Jansen, Jan O.] Aberdeen Royal Infirm, Aberdeen AB25 2ZN, Scotland; [Egan, Gerry] Scottish Ambulance Serv, Edinburgh, Midlothian, Scotland		Jansen, JO (corresponding author), Aberdeen Royal Infirm, Foresterhill, Aberdeen AB25 2ZN, Scotland.	j.o.jansen@gmx.com					*AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Brohi K, 2009, REGIONAL TRAUMA SYST; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; *DEP HLTH, 2008, HLTH PROF ENGL; Findlay G., 2007, TRAUMA WHO CARES; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jansen JO, 2010, SURG-J R COLL SURG E, V8, P237, DOI 10.1016/j.surge.2010.05.004; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2008, J BONE JOINT SURG AM, V90A, P101, DOI 10.2106/JBJS.F.01225; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; NHS Clinical Advisory Groups Report, 2010, REG NETW MAJ TRAUM; *ROY COLL SURG ENG, 1999, REP WORK PART MAN PA; Royal College of Surgeons of England, 2007, PROV TRAUM CAR POL B; Royal College of Surgeons of England. British Orthopaedic Association, 2003, BETT CAR SEV INJ; Scottish Intercollegiate Guidelines Network, 2009, EARL MAN PAT HEAD IN; Tai NRM, 2006, BMJ-BRIT MED J, V332, P805, DOI 10.1136/bmj.332.7545.805	17	5	5	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2013	44	9					1237	1240		10.1016/j.injury.2011.11.021			4	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	211VX	WOS:000323940600018	22177458				2022-02-06	
J	Tsushima, M; Tsushima, W; Tsushima, V; Lim, N; Madrigal, E; Jackson, C; Mendler, MH				Tsushima, Matthew; Tsushima, William; Tsushima, Vincent; Lim, Nelson; Madrigal, Erika; Jackson, Christian; Mendler, Michel Henry			Use of ImPACT to Diagnose Minimal Hepatic Encephalopathy: An Accurate, Practical, User-Friendly Internet-Based Neuropsychological Test Battery	DIGESTIVE DISEASES AND SCIENCES			English	Article						Cirrhosis; Minimal hepatic encephalopathy; ImPACT; Computer testing; Sickness impact profile	QUALITY-OF-LIFE; INHIBITORY CONTROL TEST; CIRRHOTIC-PATIENTS; LACTULOSE; MODULATION; REVISION; EFFICACY; VEHICLE	Background and Aims An effective, user-friendly neurocognitive test to diagnose minimal hepatic encephalopathy (MHE) is needed. Immediate Post-concussion Assessment and Cognitive Testing (ImPACT) is a brief, validated, Web-based, neuropsychological test battery resulting in four composite scores [Verbal Memory (VrbM), Visual Memory, Visual Motor Speed (VMS), Reaction Time (RT)]. We compared ImPACT to traditional paper-and-pencil tests in patients at risk for MHE versus controls. Methods Ninety cirrhotic patients with no history of overt hepatic encephalopathy were compared with 131 controls on standard psychometric tests (SPT) [Trail Making Test-A, Trail Making Test-B, Digit Symbol Test], 4 ImPACT composite scores, and the Sickness Impact Profile (SIP). MHE+ was defined by a score 2 SD below the normative mean on at least one of the SPT. ImPACT (ImP+) scores of patients were defined as 2 SD from the control mean. Results Cirrhotic patients scored more poorly than controls on 3/4 of ImPACT scores: VrbM (78.88 vs. 71.37, p < 0.001), VMS (26.47 vs. 22.68, p < 0.001) and RT (0.89 vs. 1.00, p < 0.01), as well as on all 3 SPT. Of the 90 cirrhotics, 16 (18 %) were MHE+, who performed more poorly (p < 0.001) than patients without MHE on VrbM (58.13 vs. 74.19), VMS (16.77 vs. 23.95) and RT (1.24 vs. 0.95). Of the 90 cirrhotics, 25 (27.8 %) were ImP+. MHE+ and ImP+ patients had increased SIP scores versus controls (p < 0.001). Conclusions Compared to paper-and-pencil testing, ImPACT provides a brief, user-friendly, neuropsychological evaluation of MHE. ImPACT could become a new standard for MHE diagnosis.	[Tsushima, Matthew; Lim, Nelson; Madrigal, Erika; Mendler, Michel Henry] Loma Linda Univ, Med Ctr, Div GI & Liver Dis, Loma Linda, CA USA; [Tsushima, William] Straub Clin & Hosp, Dept Psychiat & Psychol, Honolulu, HI USA; [Tsushima, Vincent] Hawaii Pacific Univ, Dept Psychol, Honolulu, HI USA; [Jackson, Christian] Loma Linda VA Med Ctr, Div GI & Liver Dis, Loma Linda, CA USA; [Mendler, Michel Henry] Loma Linda Univ, Med Ctr, Inst Transplantat, Loma Linda, CA USA; [Mendler, Michel Henry] UC San Diego Hlth Syst, Div GI & Liver Dis, Ctr Hepatobiliary Dis & Abdominal Transplantat, San Diego, CA 92101 USA		Mendler, MH (corresponding author), UC San Diego Hlth Syst, Div GI & Liver Dis, Ctr Hepatobiliary Dis & Abdominal Transplantat, 200W Arbor Dr,8413, San Diego, CA 92101 USA.	mtsushima@hawaii.rr.com; wtsushima@aim.com; vtsushima@gmail.com; nlim@me.com; madrigal.gastro@gmail.com; christian.jackson@va.gov; mmendler@ucsd.edu			Salix Pharmaceuticals	Investigator-initiated research grant from Salix Pharmaceuticals. Salix was not involved in protocol design and implementation, data collection, analysis, or interpretation of the study results.	Bajaj JS, 2008, GASTROENTEROLOGY, V135, P1591, DOI 10.1053/j.gastro.2008.07.021; Bajaj JS, 2008, AM J GASTROENTEROL, V103, P1707, DOI 10.1111/j.1572-0241.2008.01861.x; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P1903, DOI 10.1111/j.1572-0241.2007.01424.x; Bajaj JS, 2007, AM J GASTROENTEROL, V102, P754, DOI 10.1111/j.1572-0241.2007.01048.x; Bajaj JS, 2009, HEPATOLOGY, V50, P1175, DOI 10.1002/hep.23128; Bajaj JS, 2007, HEPATOLOGY, V45, P833, DOI 10.1002/hep.21515; Bao ZJ, 2007, WORLD J GASTROENTERO, V13, P3003, DOI 10.3748/wjg.v13.i21.3003; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crook T. H., 2009, NEUROPSYCHOLOGICAL A, P84; CUELLAR I, 1995, HISPANIC J BEHAV SCI, V17, P275, DOI 10.1177/07399863950173001; Das A, 2001, J GASTROEN HEPATOL, V16, P531, DOI 10.1046/j.1440-1746.2001.02487.x; Dhiman RK, 2010, DIGEST DIS SCI, V55, P2381, DOI 10.1007/s10620-010-1249-7; Dhiman RK, 2000, DIGEST DIS SCI, V45, P1549, DOI 10.1023/A:1005556826152; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Groeneweg M, 1998, HEPATOLOGY, V28, P45, DOI 10.1002/hep.510280108; Groeneweg M, 2000, J HEPATOL, V32, P748, DOI 10.1016/S0168-8278(00)80243-3; Iduru S, 2008, GASTROENTEROLOGY, V135, P1455, DOI 10.1053/j.gastro.2008.09.040; Iverson GL, 2003, IMPACT TEST; Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194; Llorente AM, 2008, ISSUES DIVERS CLIN N, P1, DOI 10.1007/978-0-387-71758-6; Lovell M. R., 2006, SPORTS NEUROPSYCHOLO, P193; Lovell MR, 2000, IMMEDIATE POSTCONCUS; Malaguarnera M, 2007, DIGEST DIS SCI, V52, P3259, DOI 10.1007/s10620-006-9687-y; Mardini H, 2008, GASTROENTEROLOGY, V135, P1582, DOI 10.1053/j.gastro.2008.06.043; McCrea M, 1996, ARCH NEUROL-CHICAGO, V53, P758, DOI 10.1001/archneur.1996.00550080076015; Ortiz M, 2005, J HEPATOL, V42, pS45, DOI 10.1016/j.jhep.2004.11.028; Prasad S, 2007, HEPATOLOGY, V45, P549, DOI 10.1002/hep.21533; Randolph C, 2009, LIVER INT, V29, P629, DOI 10.1111/j.1478-3231.2009.02009.x; Romero-Gomez M, 2001, AM J GASTROENTEROL, V96, P2718, DOI 10.1016/S0002-9270(01)02692-2; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2002, J HEAD TRAUMA REHAB, V17, P395, DOI 10.1097/00001199-200210000-00003; Schomerus H, 2001, METAB BRAIN DIS, V16, P37, DOI 10.1023/A:1011610427843; Sharma P, 2008, EUR J GASTROEN HEPAT, V20, P506, DOI 10.1097/MEG.0b013e3282f3e6f5; Tan HH, 2009, SINGAP MED J, V50, P255; TARTER RE, 2001, MED NEUROPSYCHOLOGY; Watanabe A, 1997, HEPATOLOGY, V26, P1410; Wechsler D., 1999, WECHSLER ADULT INTEL; Wein C, 2004, HEPATOLOGY, V39, P739, DOI 10.1002/hep.20095; Weissenborn K, 1998, J HEPATOL, V28, P646, DOI 10.1016/S0168-8278(98)80289-4; Weissenborn K, 2003, J HEPATOL, V39, P320, DOI 10.1016/S0168-8278(03)00295-2; Weissenborn K, 2001, J HEPATOL, V34, P768, DOI 10.1016/S0168-8278(01)00026-5	44	5	6	0	8	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0163-2116	1573-2568		DIGEST DIS SCI	Dig. Dis. Sci.	SEP	2013	58	9					2673	2681		10.1007/s10620-013-2668-z			9	Gastroenterology & Hepatology	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology	215YE	WOS:000324246300053	23625285				2022-02-06	
J	Du, AL; Ji, TL; Yang, B; Cao, JF; Zhang, XG; Li, Y; Pan, S; Zhang, B; Hu, ZB; Zeng, XW				Du Ai-ling; Ji Tai-ling; Yang Bin; Cao Jian-feng; Zhang Xing-guang; Li Yu; Pan Shun; Zhang Bo; Hu Zhen-bo; Zeng Xian-wei			Neuroprotective effect of AG490 in experimental traumatic brain injury of rats	CHINESE MEDICAL JOURNAL			English	Article						AG490; traumatic brain injury; brain edema; CD40; neurological severity score	CD40; ACTIVATION; EXPRESSION; PATHWAY; EDEMA	Background Traumatic brain injury (TBI) is a major cause of death and disability in children and young adults worldwide. Therefore, we investigated the role of AG490 in regulating brain oedema, expression of CD40 and neurological function after TBI. Methods Sprague Dawley rats (n=240) were randomly divided into a sham operation group, TBI+saline group and TBI+AG490 (JAK/STAT inhibitor) group. Members of each group were euthanized at 6, 12, 24 or 72 hours after injury. Neurological severity score (NSS) was used to evaluate the severity of neurological damage. Brain water was quantitated by wet/dry weight method. The expression of CD40 was assessed by flow cytometry. Results In both the TBI+saline group and the TBI+AG490 group, the brain water content was elevated after TBI, reached a peak at 24-hour and remained high for the rest of the period investigated; the expression of CD40 reached a peak 24 hours after TBI; the NSS was elevated after TBI and then decreased after 6 hours. Elevations in the level of CD40, degree of brain edema and NSS after TBI were significantly reduced in TBI+AG490 group. Conclusion Inhibition of the JAK/STAT signalling pathway reduces brain oedema, decreases the expression of CD40 and exerts neuroprotective effects after TBI.	[Du Ai-ling; Ji Tai-ling; Yang Bin; Cao Jian-feng; Zhang Xing-guang; Li Yu; Pan Shun; Zhang Bo; Zeng Xian-wei] Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261031, Shandong, Peoples R China; [Hu Zhen-bo] Weifang Med Coll, Affiliated Hosp, Dept Stem Cell Transplantat, Weifang 261031, Shandong, Peoples R China; [Hu Zhen-bo] Weifang Med Coll, Affiliated Hosp, Res Ctr, Weifang 261031, Shandong, Peoples R China		Zeng, XW (corresponding author), Weifang Med Coll, Affiliated Hosp, Dept Neurosurg, Weifang 261031, Shandong, Peoples R China.	zengxwei@163.com			Natural Science Foundation of Shandong ProvinceNatural Science Foundation of Shandong Province [ZR2011HM008]; Science and Technology Research Program of Shandong Province [2011GFS11829]	This study was supported by grants from the Natural Science Foundation of Shandong Province (No. ZR2011HM008) and the Science and Technology Research Program of Shandong Province (No. 2011GFS11829).	Benveniste EN, 2004, BRAIN BEHAV IMMUN, V18, P7, DOI 10.1016/j.bbi.2003.09.001; Beziaud T, 2011, CRIT CARE MED, V39, P2300, DOI 10.1097/CCM.0b013e3182227e4a; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Delgado M, 2003, J BIOL CHEM, V278, P27620, DOI 10.1074/jbc.M303199200; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fenyo IM, 2011, VASC PHARMACOL, V54, P100, DOI 10.1016/j.vph.2011.03.006; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Kawabe T, 2011, NAGOYA J MED SCI, V73, P69; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Linnekin D, 1997, LEUKEMIA LYMPHOMA, V27, P439, DOI 10.3109/10428199709058310; Losiniecki A, 2010, CURR TREAT OPTION NE, V12, P142, DOI 10.1007/s11940-010-0063-z; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Singh K, 2010, BIOCHEM BIOPH RES CO, V391, P1255, DOI 10.1016/j.bbrc.2009.12.055; Tan J, 2002, EMBO J, V21, P643, DOI 10.1093/emboj/21.4.643; Townsend KP, 2004, J NEUROSCI RES, V78, P167, DOI 10.1002/jnr.20234; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Zhao JB, 2011, NEUROSCI LETT, V498, P147, DOI 10.1016/j.neulet.2011.05.001; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018	20	5	6	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999	2542-5641		CHINESE MED J-PEKING	Chin. Med. J.	AUG 5	2013	126	15					2934	2937		10.3760/cma.j.issn.0366-6999.20121193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	280GA	WOS:000329015500027	23924471				2022-02-06	
J	Larson, E; Zollman, F; Kondiles, B; Starr, C				Larson, Eric; Zollman, Felise; Kondiles, Bethany; Starr, Christine			Memory Deficits, Postconcussive Complaints, and Posttraumatic Stress Disorder in a Volunteer Sample of Veterans	REHABILITATION PSYCHOLOGY			English	Article						post-concussion syndrome; stress disorders; memory; cognition disorders; brain concussion	TRAUMATIC BRAIN-INJURY; SERIAL-ADDITION TASK; PTSD; CONCUSSION; SYMPTOMS; METAANALYSIS; PRETRAUMA; PASAT; RISK; WAR	Purpose: To better understand how memory impairment is related to postconcussive complaints and to posttraumatic stress disorder (PTSD) and whether these relationships remain after controlling for premorbid cognitive ability. Method: We examined memory impairment, premorbid cognitive ability, postconcussive complaints, and symptoms of PTSD in 205 veterans, 135 of who gave a self-reported history of concussion and exposure to a traumatic life event: We limited our sample to those who gave good effort on cognitive testing according to a symptom validity measure. Results: Although memory impairment was not associated with a history of concussion, it was associated with severity of postconcussive complaints. That association was no longer significant after controlling for premorbid IQ. A similar analysis yielded slightly different findings for PTSD. Memory impairment was associated with PTSD diagnosis, although it was not associated with severity of PTSD symptoms after controlling for premorbid ability. Conclusions: These data are consistent with multifactorial models of the etiology of postconcussion disorder and PTSD such as the "burden of adversity hypothesis" described by Brenner, Vanderploeg, and Terrio (2009). In such models, symptom severity and course of recovery are determined not only by trauma severity but (also) premorbid risk factors and postonset complications.	[Larson, Eric] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Larson, Eric] Rehabil Inst Chicago, Brain Injury Med & Rehabil Program, Chicago, IL 60611 USA; [Zollman, Felise] NorthShore Univ Hlth Syst, Memory & Cognit Disorders Program, Dept Neurol, Evanston, IL USA; [Kondiles, Bethany; Starr, Christine] Rehabil Inst Chicago, Chicago, IL 60611 USA		Larson, E (corresponding author), Rehabil Inst Chicago, 345 East Super St, Chicago, IL 60611 USA.	elarson@ric.org	Larson, Eric/AAD-9567-2021	Starr, Christine/0000-0002-8662-0387			ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benish SG, 2008, CLIN PSYCHOL REV, V28, P746, DOI 10.1016/j.cpr.2007.10.005; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Daniels JK, 2010, J PSYCHIATR NEUROSCI, V35, P258, DOI 10.1503/jpn.090010; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Emdad R, 2006, PSYCHOTHER PSYCHOSOM, V75, P122, DOI 10.1159/000090897; Engelhard IM, 2006, GEN HOSP PSYCHIAT, V28, P414, DOI 10.1016/j.genhosppsych.2006.07.001; Golden CJ, 1978, STROOP COLOR WORD TE; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hart J, 2008, J NEUROPSYCH CLIN N, V20, P309, DOI 10.1176/appi.neuropsych.20.3.309; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Keane T.M., 1991, PCL M DSM 4; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kremen WS, 2007, ARCH GEN PSYCHIAT, V64, P361, DOI 10.1001/archpsyc.64.3.361; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Li XM, 2010, NEUROL RES, V32, P579, DOI 10.1179/016164110X12556180206194; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; Parslow RA, 2007, AM J PSYCHIAT, V164, P509, DOI 10.1176/appi.ajp.164.3.509; Randolph C., 1998, REPEATABLE BATTERY A; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Vanderploeg RD, 2006, PSYCHOLOGICAL KNOWLEDGE IN COURT: PTSD, PAIN, AND TBI, P279, DOI 10.1007/0-387-25610-5_16; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; WechslerD, 2001, WECHSLER TEST ADULT; Woodward SH, 2009, J INT NEUROPSYCH SOC, V15, P830, DOI 10.1017/S1355617709990476	35	5	5	0	14	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550			REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2013	58	3					245	252		10.1037/a0032953			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	204ZB	WOS:000323408700003	23978082				2022-02-06	
J	Platt, SR; Coates, JR; Eifler, DM; Edwards, GL; Kent, M; Bulsara, KR				Platt, Simon R.; Coates, Joan R.; Eifler, Danielle M.; Edwards, Gaylen L.; Kent, Marc; Bulsara, Ketan R.			Effect of treatment with simvastatin and cyclosporine on neurotransmitter concentrations in cerebrospinal fluid after subarachnoid hemorrhage in dogs	AMERICAN JOURNAL OF VETERINARY RESEARCH			English	Article							CEREBRAL-ARTERY OCCLUSION; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN-INJURY; ISCHEMIC-STROKE; CEREBROVASCULAR-DISEASE; EXCITOTOXIN HYPOTHESIS; NEUROLOGICAL DEFICIT; GLUTAMATE RELEASE; CORTICAL-NEURONS; NMDA RECEPTOR	Objective-To measure concentrations of glutamate, aspartate, gamma-aminobutyric acid (GABA), and glycine in CSF of dogs with experimentally induced subarachnoid hemorrhage (SAH) and to assess effects of cyclosporine and simvastatin on these concentrations. Sample-CSF samples from 13 dogs. Procedures-In a previous study, SAH was induced in dogs via 2 injections of autologous blood into the cerebellomedullary cistern 24 hours apart. Dogs were untreated (control; n = 5) or received simvastatin alone (4) or simvastatin in combination with cyclosporine (4). Samples of CSF were collected before the first blood injection (baseline; time 0), before the second blood injection, and on days 3, 7, and 10. For the study reported here, neurotransmitter concentrations in CSF were analyzed via high-performance liquid chromatography. Data were analyzed with a repeated-measures model with adjustments for multiple comparisons by use of the Tukey method. Results-In control dogs, the glutamate concentration peaked on day 3 and there was a significant increase in GABA and glutamate concentrations. Glutamate concentrations were significantly lower and glycine concentrations significantly higher on day 3 after administration of simvastatin alone or simvastatin in combination with cyclosporine, compared with concentrations for the control group. No significant differences in GABA and aspartate concentrations were detected among treatment groups at any time point. Conclusions and Clinical Relevance-Glutamate concentrations were increased in the CSF of dogs with SAH. Simvastatin administration attenuated high glutamate concentrations. A combination of immunosuppression and upregulation of nitric oxide synthase may be useful in lowering high glutamate concentrations in ischemic CNS conditions.	[Platt, Simon R.; Kent, Marc] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA 30602 USA; [Edwards, Gaylen L.] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA; [Coates, Joan R.; Eifler, Danielle M.] Univ Missouri, Coll Vet Med, Dept Vet Med & Surg, Columbia, MO 65211 USA; [Bulsara, Ketan R.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA		Platt, SR (corresponding author), Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA 30602 USA.	srplatt@uga.edu		Platt, Simon/0000-0002-7818-1011	University of Georgia College of Veterinary Medicine Veterinary Medical Experiment Station; University of Missouri Research Board [05-072]	Supported by University of Georgia College of Veterinary Medicine Veterinary Medical Experiment Station start-up funds and University of Missouri Research Board grant No. 05-072.	Attwell D, 2000, J NUTR, V130, p1023S, DOI 10.1093/jn/130.4.1023S; AUER RN, 1988, ANN NEUROL, V24, P699, DOI 10.1002/ana.410240602; BAKER AJ, 1993, J NEUROSURG, V79, P369, DOI 10.3171/jns.1993.79.3.0369; BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Bulsara Ketan R, 2006, Neurosurg Focus, V21, pE11; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; Castillo J, 1997, LANCET, V349, P79, DOI 10.1016/S0140-6736(96)04453-4; Castillo J, 1996, STROKE, V27, P1060, DOI 10.1161/01.STR.27.6.1060; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Davalos A., 1997, Methods and Findings in Experimental and Clinical Pharmacology, V19, P65; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47; Dennler M, 2007, VET RADIOL ULTRASOUN, V48, P138, DOI 10.1111/j.1740-8261.2007.00220.x; Dietrich HH, 2000, NEUROSURGERY, V46, P517, DOI 10.1097/00006123-200003000-00001; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; FANKHAUSER R., 1965, ANN N Y ACAD SCI, V127, P817, DOI 10.1111/j.1749-6632.1965.tb49447.x; FERN R, 1995, J NEUROSCI, V15, P699; Ferro JM, 2008, J NEUROL, V255, P465, DOI 10.1007/s00415-008-0606-3; Gagliardi RJ, 2000, ARQ NEURO-PSIQUIAT, V58, P583, DOI 10.1590/S0004-282X2000000300030; Garosi L, 2006, J VET INTERN MED, V20, P311, DOI 10.1892/0891-6640(2006)20[311:CATMRC]2.0.CO;2; Garosi L, 2005, J VET INTERN MED, V19, P725, DOI 10.1892/0891-6640(2005)19[725:RODIAL]2.0.CO;2; Garosi LS, 2005, J SMALL ANIM PRACT, V46, P521, DOI 10.1111/j.1748-5827.2005.tb00281.x; GERSON RJ, 1991, FUND APPL TOXICOL, V16, P320, DOI 10.1016/0272-0590(91)90116-L; GREENAMYRE JT, 1994, NEUROLOGY, V44, P7; Guyot LL, 2001, NEUROSCI LETT, V299, P37, DOI 10.1016/S0304-3940(01)01510-5; Hacein-Bey L, 2006, AM J NEURORADIOL, V27, P1350; HOSSMANN KA, 1994, BRAIN PATHOL, V4, P23; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kaminska B, 2004, J CELL MOL MED, V8, P45, DOI 10.1111/j.1582-4934.2004.tb00259.x; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; KOH JY, 1987, NEUROLOGY, V37, P319, DOI 10.1212/WNL.37.2.319; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; MATSUMOTO K, 1993, J CEREBR BLOOD F MET, V13, P586, DOI 10.1038/jcbfm.1993.76; McConnell JF, 2005, VET RADIOL ULTRASOUN, V46, P1, DOI 10.1111/j.1740-8261.2005.00001.x; McGirt MJ, 2002, STROKE, V33, P2950, DOI 10.1161/01.STR.0000038986.68044.39; Melani A, 1999, STROKE, V30, P2448, DOI 10.1161/01.STR.30.11.2448; MINEMATSU K, 1993, STROKE, V24, P2074, DOI 10.1161/01.STR.24.12.2074; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; MUIR KW, 1995, STROKE, V26, P503, DOI 10.1161/01.STR.26.3.503; Myseros JS, 1995, ANN NY ACAD SCI, V765, P262, DOI 10.1111/j.1749-6632.1995.tb16583.x; O'Regan C, 2008, AM J MED, V121, P24, DOI 10.1016/j.amjmed.2007.06.033; Packer RA, 2007, VET RADIOL ULTRASOUN, V48, P323, DOI 10.1111/j.1740-8261.2007.00250.x; PETERSON JW, 1990, STROKE, V21, P133, DOI 10.1161/01.STR.21.1.133; PETERSON JW, 1990, J NEUROSURG, V72, P767, DOI 10.3171/jns.1990.72.5.0767; Petroff OAC, 2002, NEUROSCIENTIST, V8, P562, DOI 10.1177/1073858402238515; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; Platt SR, 2003, J AM ANIM HOSP ASSOC, V39, P337, DOI 10.5326/0390337; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Puig N, 2000, CEREBROVASC DIS, V10, P449, DOI 10.1159/000016106; Qureshi AI, 2003, CRIT CARE MED, V31, P1482, DOI 10.1097/01.CCM.0000063047.63862.99; Rossmeisl JH, 2007, VET OPHTHALMOL, V10, P23, DOI 10.1111/j.1463-5224.2007.00487.x; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SAGE JI, 1984, STROKE, V15, P46, DOI 10.1161/01.STR.15.1.46; Serena J, 2001, STROKE, V32, P1154, DOI 10.1161/01.STR.32.5.1154; TAKAGI K, 1993, J CEREBR BLOOD F MET, V13, P575, DOI 10.1038/jcbfm.1993.75; Thomas WB, 1996, VET CLIN N AM-SMALL, V26, P925, DOI 10.1016/S0195-5616(96)50112-9; Tseng MY, 2007, STROKE, V38, P1545, DOI 10.1161/STROKEAHA.106.475905; Tseng MY, 2005, STROKE, V36, P1627, DOI 10.1161/01.STR.0000176743.67564.5d; Vaughan CJ, 1999, STROKE, V30, P1969, DOI 10.1161/01.STR.30.9.1969; VICKERS S, 1990, DRUG METAB DISPOS, V18, P138; Yin W, 2001, NEUROL RES, V23, P87, DOI 10.1179/016164101101198181; Zacco A, 2003, J NEUROSCI, V23, P11104; Zhang H, 2001, CLIN CHEM, V47, P1458	67	5	5	0	9	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA	0002-9645			AM J VET RES	Am. J. Vet. Res.	AUG	2013	74	8					1111	1117					7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	191QB	WOS:000322426600008	23879849				2022-02-06	
J	Potter, WM; Wang, L; McCully, KK; Zhao, Q				Potter, W. M.; Wang, L.; McCully, K. K.; Zhao, Q.			Evaluation of a new H-1/P-31 dual-tuned birdcage coil for P-31 spectroscopy	CONCEPTS IN MAGNETIC RESONANCE PART B-MAGNETIC RESONANCE ENGINEERING			English	Article						dual-tuned birdcage; spectroscopy; magnetic resonance imaging; chemical shift imaging	B-1 FIELD HOMOGENEITY; SPINAL-CORD-INJURY; HUMAN HEAD; QUADRATURE BIRDCAGE; MUSCLE METABOLISM; SKELETAL-MUSCLE; 11.7 T; SAR; H-1; INHOMOGENEITY	We introduce a new dual-tuned hydrogen/phosphorus (H-1/P-31) birdcage coil, referred to as split birdcage coil, and evaluate its performance using both simulations and magnetic resonance (MR) experiments on a 3 T MR scanner. The proposed coil simplifies the practical matters of tuning and matching, which makes the coil easily reproducible. Simulations were run with the finite difference in time domain method to evaluate the sensitivity and homogeneity of the magnetic field generated by the proposed H-1 coils. Following simulations, MR experiments were conducted using both a phantom and human thigh to compare the proposed design with a currently available commercial dual-tuned flexible surface coil, referred to as flex surface coil, for signal to noise ratio (SNR) as well as homogeneity for the P-31 coil. At regions deep within the human thigh, the split birdcage coil was able to acquire spectroscopic signal with a higher average SNR than the flex surface coil. For all regions except those close to the flex surface coil, the split birdcage coil matched or exceeded the performance of the flex surface coil. (c) 2013 Wiley Periodicals, Inc.	[Potter, W. M.; Wang, L.; Zhao, Q.] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Potter, W. M.; Wang, L.; Zhao, Q.] Univ Georgia, BioImaging Res Ctr, Athens, GA 30602 USA; [McCully, K. K.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Zhao, Q (corresponding author), Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA.	qzhao@physast.uga.edu	Wang, Luning/B-2780-2016; McCully, Kevin K./P-5141-2015; Zhao, Qun/C-3813-2011	McCully, Kevin K./0000-0001-9850-487X; Zhao, Qun/0000-0003-0784-1024	NIH Child Health and Human Development Research Grant [HD039676]; University of Georgia Faculty Research Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD039676] Funding Source: NIH RePORTER	This work was supported by NIH Child Health and Human Development Research Grant HD039676 (KKM) and The University of Georgia Faculty Research Grant (QZ).	Balanis CA, 2012, ADV ENG ELECTROMAGNE, Vxx; Chen J, 1998, IEEE T BIO-MED ENG, V45, P650, DOI 10.1109/10.668756; Collins CM, 1998, MAGNET RESON MED, V40, P847, DOI 10.1002/mrm.1910400610; Cureton KJ, 2009, J APPL PHYSIOL, V107, P1095, DOI 10.1152/japplphysiol.00234.2009; Duan Y, 2009, J MAGN RESON IMAGING, V29, P13, DOI 10.1002/jmri.21509; FITZSIMMONS JR, 1993, MAGNET RESON MED, V30, P107, DOI 10.1002/mrm.1910300116; Forbes SC, 2009, NMR BIOMED, V22, P1063, DOI 10.1002/nbm.1413; Forbes SC, 2009, AM J PHYSIOL-REG I, V296, pR161, DOI 10.1152/ajpregu.90704.2008; Goldstein G, 2009, J INT NEUROPSYCH SOC, V15, P671, DOI 10.1017/S1355617709990233; GONEN O, 1994, MAGN RESON MED, V32, P104, DOI 10.1002/mrm.1910320114; GONEN O, 1994, J MAGN RESON SER B, V104, P26, DOI 10.1006/jmrb.1994.1050; Greenman RL, 2005, J MAGN RESON IMAGING, V22, P427, DOI 10.1002/jmri.20372; Haacke EM, 1999, MAGNETIC RESONANCE I, pxxvii; Hayes CE, 2009, NMR BIOMED, V22, P908, DOI 10.1002/nbm.1431; Hoult D I, 2011, J Magn Reson, V213, P329, DOI 10.1016/j.jmr.2011.09.018; Hudson AMJ, 2000, MAGN RESON MATER PHY, V10, P61; Hudson AMJ, 2000, MAGN RESON MATER PHY, V10, P69; Ibrahim TS, 2007, J MAGN RESON IMAGING, V25, P1235, DOI 10.1002/jmri.20919; Ibrahim TS, 2001, PHYS MED BIOL, V46, P609, DOI 10.1088/0031-9155/46/2/324; Inan US, 2000, ELECTROMAGNETIC WAVE, Vxv, P507; Jin JM, 1997, MAGNET RESON MED, V38, P953, DOI 10.1002/mrm.1910380615; JOSEPH PM, 1989, IEEE T MED IMAGING, V8, P286, DOI 10.1109/42.34719; Jost G, 2005, J MAGN RESON IMAGING, V21, P66, DOI 10.1002/jmri.20236; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Lattanzi R, 2009, MAGN RESON MED, V61, P315, DOI 10.1002/mrm.21782; Leifer MC, 1997, J MAGN RESON, V124, P51, DOI 10.1006/jmre.1996.7488; Liu WZ, 2004, MAGNET RESON MED, V51, P217, DOI 10.1002/mrm.10683; Lupu M, 2004, MAGN RESON MATER PHY, V17, P363, DOI 10.1007/s10334-004-0059-3; Matson GB, 1999, MAGNET RESON MED, V42, P173; McCully KK, 2011, J APPL PHYSIOL, V111, P143, DOI 10.1152/japplphysiol.00094.2011; McCully Kevin K, 2009, Dyn Med, V8, P5, DOI 10.1186/1476-5918-8-5; McCully KK, 2004, J APPL PHYSIOL, V96, P871, DOI 10.1152/japplphysiol.00141.2003; MURPHYBOESCH J, 1994, J MAGN RESON SER B, V103, P103, DOI 10.1006/jmrb.1994.1017; Olive JL, 2003, MED SCI SPORT EXER, V35, P901, DOI 10.1249/01.MSS.0000069755.40046.96; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.3.CO;2-L; RATH AR, 1990, J MAGN RESON, V86, P488, DOI 10.1016/0022-2364(90)90026-6; Solivera J, 2009, NMR BIOMED, V22, P663, DOI 10.1002/nbm.1387; Tomanek B, 2005, CONCEPT MAGN RESON B, V26B, P16, DOI 10.1002/cmr.b.20038; Wang CS, 2006, J MAGN RESON IMAGING, V24, P439, DOI 10.1002/jmri.20635; Wright SM, 1997, NMR BIOMED, V10, P394, DOI 10.1002/(SICI)1099-1492(199712)10:8<394::AID-NBM494>3.0.CO;2-0	40	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1552-5031	1552-504X		CONCEPT MAGN RESON B	Concepts Magn. Reson. Part B	AUG	2013	43	3					90	99		10.1002/cmr.b.21239			10	Chemistry, Physical; Instruments & Instrumentation; Physics, Atomic, Molecular & Chemical; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Instruments & Instrumentation; Physics; Spectroscopy	198JO	WOS:000322919200002	24039555	Green Accepted			2022-02-06	
J	Sabirzhanova, I; Liu, CL; Zhao, JW; Bramlett, H; Dietrich, WD; Hu, BR				Sabirzhanova, Inna; Liu, Chunli; Zhao, Jingwei; Bramlett, Helen; Dietrich, W. Dalton; Hu, Bingren			Changes in the GEF-H1 Pathways after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain remodeling; Cool2/alpha Pix; GEF-H1; Rho GTPases; traumatic brain injury	NUCLEOTIDE EXCHANGE FACTOR; RHO-FAMILY GTPASES; TRANSIENT CEREBRAL-ISCHEMIA; DENDRITIC SPINE DEVELOPMENT; ACTIN CYTOSKELETON; NEURITE OUTGROWTH; BETA-PIX; MENTAL-RETARDATION; SIGNALING CASCADE; BINDING PROTEINS	Brains undergo significant remodeling after traumatic brain injury (TBI). The Rho guanine triphosphate (GTP) ase pathways control brain remodeling during development and under pathological conditions. How the Rho GTPase pathways are regulated in the brain after TBI remains largely unknown, however. This study used the rat fluid percussion injury model to investigate changes in the Rho GTPase pathways after TBI. The results showed that TBI leads to activation and translocation of RhoA and Rac1 proteins from cytosolic fraction to the membrane fraction after injury. Consistently, the Rho guanine nucleotide exchange factors GEF-H1 and Cool-2/alpha Pix are significantly activated by dephosphorylation and accumulation in the cytosolic fractions during the post-TBI phase. Because the Rho GTPase pathways are key regulators of brain remodeling, these results depict regulatory mechanisms of the Rho GTPase pathways after TBI, and pave the way for the study of therapeutic agents targeting the Rho GTPase pathways for functional recovery after TBI.	[Sabirzhanova, Inna; Liu, Chunli; Zhao, Jingwei; Hu, Bingren] Univ Maryland, Sch Med, Dept Anesthesiol, Neurochem Lab Brain Injury, Baltimore, MD 21201 USA; [Sabirzhanova, Inna; Liu, Chunli; Zhao, Jingwei; Hu, Bingren] Univ Maryland, Sch Med, Shock Trauma & Anesthesiol Res Ctr, Baltimore, MD 21201 USA; [Zhao, Jingwei] Jilin Univ, China Japan Union Hosp, Dept Neurosurg, Changchun 130023, Jilin Province, Peoples R China; [Bramlett, Helen; Dietrich, W. Dalton] Univ Miami, Sch Med, Miami Project Cure Paralysis, Miami, FL USA		Hu, BR (corresponding author), Univ Maryland, Sch Med, Dept Anesthesiol, Shock Trauma & Anesthesiol Res Ctr, 685 West Baltimore St, Baltimore, MD 21201 USA.	bhu@anes.umm.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS040407, NS030291]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030291, R01NS040407] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grants NS040407 and NS030291. The authors thank Mrs. Ofelia F. Alonso for her assistance in producing the TBI model.	Allen MJ, 2000, MOL CELL NEUROSCI, V16, P754, DOI 10.1006/mcne.2000.0903; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Baird D, 2005, CURR BIOL, V15, P1, DOI 10.1016/j.cub.2004.12.040; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Chang FM, 2007, MOL BIOL CELL, V18, P253, DOI 10.1091/mbc.E06-03-0207; Ciani L, 2008, NEURON, V57, P3, DOI 10.1016/j.neuron.2007.12.017; Conde C, 2010, J NEUROSCI, V30, P6793, DOI 10.1523/JNEUROSCI.5420-09.2010; D'Ambrosio R, 1999, J NEUROSCI, V19, P8152; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; Dubreuil CI, 2006, EXP NEUROL, V198, P361, DOI 10.1016/j.expneurol.2005.12.002; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Hu BR, 1998, J NEUROSCI, V18, P625; Iwasato T, 2007, CELL, V130, P742, DOI 10.1016/j.cell.2007.07.022; Kang MG, 2009, P NATL ACAD SCI USA, V106, P3549, DOI 10.1073/pnas.0812861106; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kubo T, 2007, CURR PHARM DESIGN, V13, P2493; Kuhn TB, 1998, J NEUROBIOL, V37, P524, DOI 10.1002/(SICI)1097-4695(199812)37:4<524::AID-NEU3>3.0.CO;2-H; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Liu C, 2005, NEUROSCIENCE, V134, P69, DOI 10.1016/j.neuroscience.2005.03.036; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Momboisse F, 2009, J CELL SCI, V122, P798, DOI 10.1242/jcs.038109; Neubrand VE, 2010, J CELL SCI, V123, P2110, DOI 10.1242/jcs.064055; Node-Langlois R, 2006, J CELL SCI, V119, P4986, DOI 10.1242/jcs.03273; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; PONTEN U, 1973, J NEUROCHEM, V21, P1121, DOI 10.1111/j.1471-4159.1973.tb07566.x; Ramakers GJA, 2012, HUM MOL GENET, V21, P268, DOI 10.1093/hmg/ddr457; Ruchhoeft ML, 1999, J NEUROSCI, V19, P8454; Ryan XZP, 2005, NEURON, V47, P85, DOI 10.1016/j.neuron.2005.05.013; Samuel F, 2010, MOL NEUROBIOL, V42, P133, DOI 10.1007/s12035-010-8144-2; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tolias KF, 2007, P NATL ACAD SCI USA, V104, P7265, DOI 10.1073/pnas.0702044104; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Tybulewicz VLJ, 2009, NAT REV IMMUNOL, V9, P630, DOI 10.1038/nri2606; Wegmeyer H, 2007, NEURON, V55, P756, DOI 10.1016/j.neuron.2007.07.038; Yamaguchi Y, 2001, J BIOL CHEM, V276, P18977, DOI 10.1074/jbc.M100254200; Zhang G, 2011, J NEUROSCI, V31, P1664, DOI 10.1523/JNEUROSCI.3829-10.2011	50	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2013	30	16					1449	1456		10.1089/neu.2012.2673			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	199JB	WOS:000322989500009	23611588	Green Published			2022-02-06	
J	Xu, SX; Wang, L; Zhou, GJ; Zhang, M; Gan, JX				Xu, Shan-Xiang; Wang, Lian; Zhou, Guang-Ju; Zhang, Mao; Gan, Jian-Xin			Risk factors and clinical significance of trauma-induced coagulopathy in ICU patients with severe trauma	EUROPEAN JOURNAL OF EMERGENCY MEDICINE			English	Article						prognosis; risk factor; severe injury; trauma-induced coagulopathy	BRAIN-INJURY; MORTALITY; HYPOTHERMIA; HYPOPERFUSION; TRANSFUSION; MECHANISMS; REGISTRY	Objective To investigate the incidence and risk factors for trauma-induced coagulopathy (TIC) and the impact of TIC on outcomes of patients with severe trauma admitted to an emergency intensive care unit.Methods We retrospectively reviewed clinical data from 223 patients with severe trauma admitted to emergency intensive care unit within 24 h after injury. Injury Severity Score (ISS), Acute Physiology and Chronic Health Evaluation II score, coagulation function, routine blood and biochemical tests, and blood gas parameters were obtained from medical records. Patients were divided into two groups according to the presence or absence of coagulopathy. ISS, Acute Physiology and Chronic Health Evaluation II score, and the incidence rates of hypothermia and tissue hypoperfusion were compared. The risk factors of TIC were analyzed and a multivariate logistic regression equation was developed. Coagulation function and the incidence of TIC were also compared between surviving and dead patients.Results Overall, 52/223 (23.3%) patients fulfilled the diagnostic criteria for TIC. Their mortality rate was significantly higher than that of patients without coagulopathy (36.5 vs. 9.4%, P<0.01). ISS, incidence rates of hypothermia and tissue hypoperfusion, and the prevalence of severe traumatic brain injury were significantly higher (P<0.01), whereas Glasgow Coma Scale, hemoglobin, hematocrit, and platelet counts were significantly lower (P<0.01) in patients with coagulopathy than those without. Base deficit at least 6, Glasgow Coma Scale 8 or less, and platelet count were independent risk factors for TIC. Compared with surviving patients, the patients who died had significantly reduced coagulation function.Conclusion The incidence of TIC is particularly high among patients with severe trauma. TIC is associated with increased ISS, brain injury, shock and hypothermia, and mortality. (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Xu, Shan-Xiang; Wang, Lian; Zhou, Guang-Ju; Zhang, Mao; Gan, Jian-Xin] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China		Zhang, M (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China.	zmhz@hotmail.com		Wang, Lian/0000-0001-9201-6517	Department of EducationUS Department of Education [Y201119819]; Department of Science and Technology, Zhejiang Province, China [2009C03010-3]	This work was supported by the Department of Education (Y201119819) and the Department of Science and Technology (2009C03010-3), Zhejiang Province, China.	Beilman GJ, 2009, ANN SURG, V249, P845, DOI 10.1097/SLA.0b013e3181a41f6f; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Charles A, 2007, AM SURGEON, V73, P1; Davis JW, 1996, J TRAUMA, V41, P769, DOI 10.1097/00005373-199611000-00001; Fries D, 2009, CURR OPIN ANESTHESIO, V22, P267, DOI 10.1097/ACO.0b013e32832678d9; Halpern CH, 2008, J NEUROTRAUM, V25, P997, DOI 10.1089/neu.2008.0548; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; MacLeod JBA, 2008, ARCH SURG-CHICAGO, V143, P797, DOI 10.1001/archsurg.143.8.797; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Martini WZ, 2009, J TRAUMA, V67, P202, DOI 10.1097/TA.0b013e3181a602a7; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024; 徐少文, 2009, [中华急诊医学杂志, Chinese Journal of Emergency Medicine], V18, P344	19	5	7	1	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0969-9546			EUR J EMERG MED	Eur. J. Emerg. Med.	AUG	2013	20	4					286	290		10.1097/MEJ.0b013e328358bec7			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	202NC	WOS:000323223200010	22976461				2022-02-06	
J	Carrillo-Ruiz, JD; Juarez-Montemayor, V; Mendez-Viveros, A; Frade-Garcia, A; Bolanos-Jimenez, R				Carrillo-Ruiz, J. D.; Juarez-Montemayor, V.; Mendez-Viveros, A.; Frade-Garcia, A.; Bolanos-Jimenez, R.			Skull stab wound from a metal railroad nail perforating the right frontal lobe	BRAIN INJURY			English	Article						Brain lesion; railroad nail; Skull stab wound	TRAUMATIC BRAIN-INJURY	Study design: Case report and review of literature. Objective: To present the rare case of a 70-year-old man with a punctured cranial lesion, who was treated with surgery and had a positive recovery. Summary of background data: Cerebral trauma as the serious consequence of urban aggressiveness. Method: Clinical and imagery review of a cranial puncture trauma caused by a metal railroad nail, which penetrated the cranium, duramater, frontal cerebral parenchyma and deep structures, lodging itself next to the midline, without damaging the superior sagittal sinus. Results: The patient underwent a frontal craniotomy to remove the metal nail. He was hospitalized 2 weeks post-surgery and discharged. During external consultations, he manifested no neurologic deficit. A post-surgical CT ruled-out a brain abscess or other complications. Conclusions: Skull and brain stab wound lesions are highly infrequent, but evaluating the mechanism of injury and the successful medical and surgical treatment employed is illustrative of how post-traumatic recovery of this severe head injury can be achieved. The site of the injury and the position of the object were decisive for establishing an adequate diagnosis and prognosis. The patient reported an exemplary recovery without any secondary complications.	[Carrillo-Ruiz, J. D.; Juarez-Montemayor, V.; Mendez-Viveros, A.; Frade-Garcia, A.; Bolanos-Jimenez, R.] Mexico Gen Hosp, Neurosurg Unit, Mexico City, DF, Mexico; [Carrillo-Ruiz, J. D.] Psychophysiol & Neurosci Coordinat Anahuac Univ M, Mexico City, DF, Mexico		Carrillo-Ruiz, JD (corresponding author), Perifer Sur 3707-780, Mexico City, DF, Mexico.	josecarrilloruiz@yahoo.com					Becker DP, 1982, NEUROLOGICAL SURG, P2034; BURSICK DM, 1981, SURG NEUROL, V16, P427, DOI 10.1016/0090-3019(81)90235-4; Carrillo-Ruiz J, 2010, TRAUMA; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Davis GA, 2000, J CLIN NEUROSCI, V7, P545, DOI 10.1054/jocn.2000.0692; De Villiers JC, 1976, BRIT J OPHTALMOLOGRA, V59, P52; De Villiers JC., 1975, HDB CLIN NEUROLOGY, V23, P477; DEVILLIERS JC, 1985, NEUROSURGERY, V17, P930, DOI 10.1227/00006123-198512000-00010; DUJOVNY M, 1975, J TRAUMA, V15, P981, DOI 10.1097/00005373-197511000-00007; DUTREVOU MD, 1992, NEUROSURGERY, V31, P905, DOI 10.1227/00006123-199211000-00012; GUTHKELCH AN, 1960, BRIT MED J, V2, P842, DOI 10.1136/bmj.2.5202.842; HAWORTH CS, 1988, NEUROSURGERY, V23, P431, DOI 10.1227/00006123-198810000-00004; HUNGERFORD J, 1982, J NEUROL NEUROSUR PS, V45, P1072, DOI 10.1136/jnnp.45.11.1072-a; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KHALIL N, 1991, SURG NEUROL, V35, P294, DOI 10.1016/0090-3019(91)90008-W; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; LACQUA MJ, 1992, HOSP PRACT, V27, P30; Liau LM, 1996, NEUROLOGICAL SURG, P1552; Lichter H, 1999, J PEDIAT OPHTH STRAB, V36, P44; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MACEWEN CJ, 1986, BRIT J OPHTHALMOL, V70, P147, DOI 10.1136/bjo.70.2.147; MEZUE WC, 1991, NEUROSURGERY, V28, P428, DOI 10.1227/00006123-199103000-00015; Myers W C, 1993, Bull Am Acad Psychiatry Law, V21, P435	24	5	5	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2013	27	7-8					973	977		10.3109/02699052.2013.794959			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	169UO	WOS:000320806200028	23782299				2022-02-06	
J	Henry, GK; Algina, J				Henry, George K.; Algina, James			Use of the Color Trails Test as an Embedded Measure of Performance Validity	CLINICAL NEUROPSYCHOLOGIST			English	Article						Color Trails Test; Performance validity; Embedded validity measures	TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY; RESPONSE BIAS; NEUROPSYCHOLOGICAL ASSESSMENT; MALINGERING DETECTION; AMERICAN-ACADEMY; TEST-II; SCORES; SPECIFICITY; SENSITIVITY	One hundred personal injury litigants and disability claimants referred for a forensic neuropsychological evaluation were administered both portions of the Color Trails Test (CTT) as part of a more comprehensive battery of standardized tests. Subjects who failed two or more free-standing tests of cognitive performance validity formed the Failed Performance Validity (FPV) group, while subjects who passed all free-standing performance validity measures were assigned to the Passed Performance Validity (PPV) group. A cutscore of 45 seconds to complete Color Trails 1 (CT1) was associated with a classification accuracy of 78%, good sensitivity (66%) and high specificity (90%), while a cutscore of 84 seconds to complete Color Trails 2 (CT2) was associated with a classification accuracy of 82%, good sensitivity (74%) and high specificity (90%). A CT1 cutscore of 58 seconds, and a CT2 cutscore 100 seconds was associated with 100% positive predictive power at base rates from 20 to 50%.	[Henry, George K.] Los Angeles Neuropsychol Grp, Los Angeles, CA 90025 USA; [Algina, James] Univ Florida, Gainesville, FL USA		Henry, GK (corresponding author), Los Angeles Neuropsychol Grp, 1950 Sawtelle Blvd,Suite 342, Los Angeles, CA 90025 USA.	GHenry0249@aol.com					Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Bauer L, 2006, ARCH CLIN NEUROPSYCH, V21, P121, DOI 10.1016/j.acn.2005.06.010; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Buchner A., 2012, G POWER VERSION 3 1; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; DElia LF, 1996, COLOR TRAILS TEST; Green P., 2007, ASSESSMENT FEIGNED C; Green P, 1996, WORD MEMORY TEST; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Larrabee G. J., 2007, FORENSIC NEUROPSYCHO; Larrabee GJ, 2012, FORENSIC NEUROPSYCHO, P2; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Lee R. M., 2003, NORMATIVE DATA NEURO; Lu P. H., 2003, CLIN NEUROPSYCHOL, V19, P105; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Neter J., 1996, APPL LINEAR REGRESSI, V3rd ed; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Solomon RE, 2010, CLIN NEUROPSYCHOL, V24, P1243, DOI 10.1080/13854046.2010.514864; Tombaugh T.N., 1996, TEST MEMORY MALINGER; TRUEBLOOD W, 1993, J CLIN EXP NEUROPSYC, V15, P578, DOI 10.1080/01688639308402580; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Victor TL, 2004, PROF PSYCHOL-RES PR, V35, P373, DOI 10.1037/0735-7028.35.4.373; West S. G., 1991, MULTIPLE REGRESSION; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	34	5	5	0	5	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1385-4046			CLIN NEUROPSYCHOL	Clin. Neuropsychol.	JUL 1	2013	27	5					864	876		10.1080/13854046.2013.786758			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	170OR	WOS:000320863200009	23581577				2022-02-06	
J	Liu, JB; Liu, ZY; Zhang, ZJ; Ding, WG				Liu Jinbo; Liu Zhiyuan; Zhang Zhijian; Ding WenGe			Olfactory Ensheathing Cell-Conditioned Medium Protects Astrocytes Exposed to Hydrogen Peroxide Stress	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Olfactory ensheathing cell; Astrocytes; H2O2; Apoptosis	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; IN-VITRO; REACTIVE ASTROCYTES; NEUROTROPHIC FACTOR; TRANSPLANTATION; GLIA; APOPTOSIS; GROWTH; RAT	The purpose of this study was to observe the effects of olfactory ensheathing cell conditioned medium (OECCM) on damaged astrocytes after exposure to H2O2 in vitro. OECCM was used to treat astrocytes after injury, which was induced by exposure to 500 mu mol/L H2O2 for 20 min. The cell morphology was then observed under a light microscope, cell viability assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay, cell ultrastructure observed with transmission electron microscopy (TEM), and apoptosis assessed by Annexin V staining followed by cytometry and Western blot. H2O2 induced severe damage to astrocytes as evidenced by decreased cell number, pathological changes in cell morphology, and significantly elevated cell apoptosis. Cells incubated with OECCM displayed significantly improved cell viability and decreased cell apoptotic rate. Under TEM, H2O2-treated cells showed partially broken plasma membranes, swollen rough endoplasmic reticula, visible vacuoles, and swollen or deformed mitochondria with ruptured cristae. Incubation with OECCM significantly ameliorated these pathological changes in astrocytes. These results suggest that OECCM may protect astrocytes from oxidative damage by promoting cell survival while reducing apoptosis of the damaged cells.	[Liu Jinbo; Liu Zhiyuan; Ding WenGe] Suzhou Univ, Affiliated Hosp 3, Dept Orthoped, Changzhou 213003, Jiangsu, Peoples R China; [Zhang Zhijian] Jiangsu Univ, Sch Med, Zhenjiang 212013, Peoples R China		Ding, WG (corresponding author), Suzhou Univ, Affiliated Hosp 3, Dept Orthoped, Changzhou 213003, Jiangsu, Peoples R China.	zjljb@163.com			Jiangsu Province Health Department [KF200956]	This study was supported by the grants from Jiangsu Province Health Department (KF200956).	Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y; Cunha JD, 2007, WOUND REPAIR REGEN, V15, P134, DOI 10.1111/j.1524-475X.2006.00194.x; De Keyser J, 2008, J NEUROL SCI, V267, P3, DOI 10.1016/j.jns.2007.08.044; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Fauconneau B, 2002, J NEUROCHEM, V83, P1338, DOI 10.1046/j.1471-4159.2002.01230.x; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Feng L, 2008, INT J DEV NEUROSCI, V26, P323, DOI 10.1016/j.ijdevneu.2008.01.003; Franssen EHP, 2007, BRAIN RES REV, V56, P236, DOI 10.1016/j.brainresrev.2007.07.013; Friedman J, 2011, OXID STRESS APPL BAS, P19, DOI 10.1007/978-1-60327-514-9_2; Garcia-Alias G, 2004, J NEUROSCI RES, V75, P632, DOI 10.1002/jnr.20029; GIULIAN D, 1993, GLIA, V7, P102, DOI 10.1002/glia.440070116; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Huang HY, 2012, CELL TRANSPLANT, V21, pS23, DOI 10.3727/096368912X633734; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; Lakatos A, 2000, GLIA, V32, P214, DOI 10.1002/1098-1136(200012)32:3<214::AID-GLIA20>3.0.CO;2-7; Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X; Li Y, 2004, EXP NEUROL, V188, P300, DOI 10.1016/j.expneurol.2004.04.021; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; O'Toole DA, 2007, CELL MOL LIFE SCI, V64, P1303, DOI 10.1007/s00018-007-7106-y; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Ramon-Cueto A, 1998, BRAIN RES BULL, V46, P175, DOI 10.1016/S0361-9230(97)00463-2; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tharion G, 2011, NEUROL INDIA, V59, P77, DOI 10.4103/0028-3886.84339; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Verdu E, 2001, NEUROREPORT, V12, P2303, DOI 10.1097/00001756-200108080-00005; Wewetzer K, 2001, NEUROSCI LETT, V306, P165, DOI 10.1016/S0304-3940(01)01891-2; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Yu XD, 2007, CHINESE MED J-PEKING, V120, P1438, DOI 10.1097/00029330-200708020-00011; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zhu DH, 2005, J CELL SCI, V118, P3695, DOI 10.1242/jcs.02507; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	32	5	5	0	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JUL	2013	33	5					699	705		10.1007/s10571-013-9937-4			7	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	155KJ	WOS:000319746400011	23584685				2022-02-06	
J	Maguen, S; Madden, E; Lau, KM; Seal, KH				Maguen, Shira; Madden, Erin; Lau, Karen M.; Seal, Karen H.			Service Utilization among Iraq and Afghanistan Veterans Screening Positive for Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; health services; mental health; post-traumatic; stress disorders; veterans	AUDIT-C; SYMPTOMS; VALIDITY	We compared mental health outpatient, primary care, and emergency care service utilization among veterans screening TBI positive (S-TBI+) versus those screening TBI negative (S-TBI-) and describe associations between TBI-related symptoms and health service utilization. Our study population consisted of 1746 Iraq and Afghanistan veterans in VA care screened for TBI between April 1, 2007 and June 1, 2010. Rates of mental health outpatient, primary care, and emergency services utilization were greater for S-TBI+ veterans, compared with S-TBI- veterans, even after adjusting for mental health screen results. Irritability on the initial TBI screen was associated with increased mental health outpatient utilization rates [incidence rate ratio (IRR), 1.64; 95% confidence interval (CI), 1.18-2.3; p < 0.01]. Reports of dizziness (IRR, 1.24; 95% CI, 1.02-1.51; p < 0.05) and headaches (IRR, 1.41; 95% CI, 1.16-1.7; p < 0.001) were associated with increased primary care utilization rates. Higher utilization rates among veterans who screened positive for TBI were not better explained by screening positive for comorbid mental health problems. Knowing that certain symptoms are more strongly associated with increased utilization in certain health service domains will help to better plan for the care of returning veterans who screen positive for TBI.	[Maguen, Shira; Madden, Erin; Lau, Karen M.; Seal, Karen H.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Maguen, Shira; Seal, Karen H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Seal, Karen H.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA		Maguen, S (corresponding author), San Francisco VA Med Ctr, 4150 Clement St 116-P, San Francisco, CA 94121 USA.	Shira.Maguen@va.gov			Department of Defense Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program; VA Health Sciences Research and Development (HSR&D) Career Development Award	This research was supported by the Department of Defense Psychological Health and Traumatic Brain Injury (PH/TBI) Research Program (to S.M.) and a VA Health Sciences Research and Development (HSR&D) Career Development Award (to S.M.). The authors thank Gary Abrams, Tatjana Agopian-Novokovic, Daniel Bertenthal, Jeane Bosch, Julie Dinh, Don Donati, Thomas Neylan, and Richard Pham for their contributions.	Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Corby-Edwards A.K., 2009, TRAUMATIC BRAIN INJU; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hart T, 2012, J HEAD TRAUMA REHAB, V27, P113, DOI 10.1097/HTR.0b013e31820e686c; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Maguen S, 2012, J REHABIL RES DEV, V49, P1115, DOI 10.1682/JRRD.2011.02.0015; Maguen S, 2012, PSYCHIAT SERV, V63, P1206, DOI 10.1176/appi.ps.201200051; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; U.S. Department of Veteran Affairs, 2010, OEF OIF ROST RMTPRD; U. S. Government Accountability Office. VA Health Care, 2008, GAO08276 VA HLTH CAR	28	5	5	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1123	1128		10.1089/neu.2012.2744			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400003	23327186				2022-02-06	
J	Pellicano, C; Kane, RL; Gallo, A; Li, XB; Stern, SK; Ikonomidou, VN; Evangelou, IE; Ohayon, JM; Ehrmantraut, M; Cantor, FK; Bagnato, F				Pellicano, Clelia; Kane, Robert L.; Gallo, Antonio; Li Xiaobai; Stern, Susan K.; Ikonomidou, Vasiliki N.; Evangelou, Iordanis E.; Ohayon, Joan M.; Ehrmantraut, Mary; Cantor, Fredric K.; Bagnato, Francesca			Cognitive Impairment and Its Relation to Imaging Measures in Multiple Sclerosis: A Study Using a Computerized Battery	JOURNAL OF NEUROIMAGING			English	Article						Multiple sclerosis; 3TMRI; cognitive impairment; ANAM; computerized batteries	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL ASSESSMENT; PROCESSING SPEED; CORTICAL ATROPHY; GREY-MATTER; DYSFUNCTION; DISABILITY; DEFICITS; GRAY; MS	BACKGROUND AND PURPOSE Cognitive impairment (CI) is an important component of multiple sclerosis (MS) disability. A complex biological interplay between white matter (WM) and gray matter (GM) disease likely sustains CI. This study aims to address this issue by exploring the association between the extent of normal WM and GM disease and CI. METHODS Cognitive function of 24 MS patients and 24 healthy volunteers (HVs) was studied using the Automated Neuropsychological Assessment Metrics (ANAM) battery. WM focal lesions and normal appearing WM (NAWM) volume in patients, cortical thickness (CTh) and deep GM structure volumes in both patients and HVs were measured by high field strength (3.0-Tesla; 3T) imaging. RESULTS An analysis of covariance showed that patients performed worse than HVs on Code Substitution Delayed Memory (P = .04) and Procedural Reaction Time (P =.05) indicative of reduced performance in memory, cognitive flexibility, and processing speed. A summary score (Index of Cognitive Efficiency) indicating global test battery performance was also lower for the patient group (P =.04). Significant associations, as determined by the Spearman rank correlation tests, were noted between each of these 3 cognitive scores and measures of NAWM volume [CDD-TP1(r =.609; P =.0035), PRO-TP1 (r =.456; P = .029) and ICE (r =.489; P =.0129)], CTh (r =.5; P <= .05) and volume of subcortical normal appearing GM (NAGM) structures (r =.4; P <= .04), but not WM lesions. CONCLUSIONS Both NAWM and NAGM volumes are related to CI in MS. The results highlight once again the urgent need to develop pharmacological strategies protecting patients from widespread neurodegeneration as possible preventive strategies of CI development.	[Pellicano, Clelia; Gallo, Antonio; Stern, Susan K.; Ikonomidou, Vasiliki N.; Evangelou, Iordanis E.; Ohayon, Joan M.; Ehrmantraut, Mary; Cantor, Fredric K.; Bagnato, Francesca] NINDS, Neuroimmunol Branch NIB, NIH, Bethesda, MD 20892 USA; [Kane, Robert L.] VA Maryland Healthcare Syst, Baltimore, MD USA; [Li Xiaobai] NINDS, Off Clin Director, NIH, Bethesda, MD 20892 USA		Bagnato, F (corresponding author), Vanderbilt Univ, Inst Imaging Sci, Dept Radiol & Radiol Sci, 1161 21st Ave S,AA 1105 MCN, Nashville, TN 37232 USA.	francesca.r.bagnato@vanderbilt.edu	Pellicano, Clelia/K-1062-2016	Pellicano, Clelia/0000-0002-3272-1094; Ikonomidou, Vasiliki/0000-0001-8557-8204	NINDS, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)	This research was supported by the Intramural Research Program of the NINDS, NIH.	Amato MP, 2010, NEUROL SCI, V31, P211, DOI 10.1007/s10072-010-0376-4; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Benedict RHB, 2009, J NEUROL NEUROSUR PS, V80, P201, DOI 10.1136/jnnp.2008.148403; Benedict RHB, 2002, CLIN NEUROPSYCHOL, V16, P381, DOI 10.1076/clin.16.3.381.13859; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; Bomboi G, 2011, J NEUROIMAGING, V21, pe57, DOI 10.1111/j.1552-6569.2010.00488.x; Brass SD, 2006, MULT SCLER J, V12, P437, DOI 10.1191/135248506ms1301oa; Calabrese M, 2010, NEUROLOGY, V74, P321, DOI 10.1212/WNL.0b013e3181cbcd03; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Di Filippo M, 2009, BEHAV BRAIN RES, V199, P108, DOI 10.1016/j.bbr.2008.09.025; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Edgar C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-68; Filippi M, 2000, J NEUROL NEUROSUR PS, V68, P157, DOI 10.1136/jnnp.68.2.157; GOODKIN DE, 1988, ARCH PHYS MED REHAB, V69, P850; Hillary FG, 2010, BRAIN IMAGING BEHAV, V4, P141, DOI 10.1007/s11682-010-9094-z; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lund H, 2011, ACTA NEUROL SCAND; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Pennartz CMA, 2009, J NEUROSCI, V29, P12831, DOI 10.1523/JNEUROSCI.3177-09.2009; Ranjeva JP, 2006, J NEUROL SCI, V245, P161, DOI 10.1016/j.jns.2005.09.019; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Reeves DL, 2007, ARCH CLIN NEUROPSYCH, V22, pS15, DOI 10.1016/j.acn.2006.10.013; Richert ND, 2001, MULT SCLER, V7, P49, DOI 10.1191/135245801669116174; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Sanfilipo MP, 2006, NEUROLOGY, V66, P685, DOI 10.1212/01.wnl.0000201238.93586.d9; Short P, 2007, ARCH CLIN NEUROPSYCH, V22, pS63, DOI 10.1016/j.acn.2006.10.012; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Stankiewicz JM, 2011, J NEUROIMAGING, V21, pe50, DOI 10.1111/j.1552-6569.2009.00449.x; Stebbins GT, 2000, BRAIN COGNITION, V42, P348, DOI 10.1006/brcg.1999.1109; Stevenson VL, 2002, J NEUROL, V249, P171, DOI 10.1007/PL00007860; Tekok-Kilic A, 2007, NEUROIMAGE, V36, P1294, DOI 10.1016/j.neuroimage.2007.04.017; Thorne DR, 2006, BEHAV RES METHODS, V38, P569; Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; WEINSTOCKGUTTMA.B, 2010, PATHOPHYSIOLOGY, V18, P43; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME	45	5	5	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1051-2284	1552-6569		J NEUROIMAGING	J. Neuroimaging	JUL	2013	23	3					445	452		10.1111/j.1552-6569.2011.00687.x			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	175EN	WOS:000321213500024	23227967				2022-02-06	
J	Tazarourte, K; Cesareo, E; Sapir, D; Atchabahian, A; Tourtier, JP; Briole, N; Vigue, B				Tazarourte, K.; Cesareo, E.; Sapir, D.; Atchabahian, A.; Tourtier, J. -P.; Briole, N.; Vigue, B.			Update on prehospital emergency care of severe trauma patients	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			English	Article; Proceedings Paper	Monothematic Meeting of Societe-Francaise-d'Anesthesie-et-de-Reanimation - Severe Trauma - The First 24 Hours	MAY 29, 2013	Paris, FRANCE	Soc Francaise Anesthesie & Reanimat		Advanced trauma life support; Trauma system; Traumatic brain injury; Major trauma; Prehospital care	SYSTOLIC BLOOD-PRESSURE; SEVERE BLUNT TRAUMA; BRAIN-INJURY; MEDICAL-SERVICES; MORTALITY; MANAGEMENT; HELICOPTER; SURVIVAL; RESUSCITATION; INTUBATION	The prognosis of severe trauma patients is determined by the ability of a healthcare system to provide high intensity therapeutic treatment on the field and to transport patients as quickly as possible to the structure best suited to their condition. Direct admission to a specialized center ("trauma center") reduces the mortality of the most severe trauma at 30 days and one year. Triage in a non-specialized hospital is a major risk of loss of chance and should be avoided whenever possible. Medical dispatching plays a major role in determining patient care. The establishment of a hospital care network is an important issue that is not formalized enough in France. The initial triage of severe trauma patients must be improved to avoid taking patients to hospitals that are not equipped to take care of them. For this purpose, the MGAP score can predict severity and help decide where to transport the patient. However, it does not help predict the need for urgent resuscitation procedures. Hemodynamic management is central to the care of hemorrhagic shock and severe head trauma. Transport helicopter with a physician on board has an important role to allow direct admission to a specialized center in geographical areas that are difficult to access. (c) 2013 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Tazarourte, K.; Cesareo, E.] Hop Marc Jacquet, Pole Samu Urgence Reanimat, F-77000 Melun, France; [Sapir, D.; Briole, N.] Ctr Hosp Sud Francilien, Samu 91, F-91000 Corbeil Essonnes, France; [Atchabahian, A.] NYU Sch Med, Dept Anesthesiol, New York, NY USA; [Tourtier, J. -P.] Brigade Sapeurs Pompiers Paris, Serv Med Urgence, F-75017 Paris, France; [Tazarourte, K.; Vigue, B.] CHU Le Kremlin Bicetre, Dept Anesthesie Reanimat, F-94276 Le Kremlin Bicetre, France		Tazarourte, K (corresponding author), Hop Marc Jacquet, Pole Samu Urgence Reanimat, F-77000 Melun, France.	Karim.tazarourte@ch-melun.fr		tazarourte, karim/0000-0002-3376-1258; Hertling, Arthur/0000-0002-1634-6538			Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Bulger EM, 2007, ANN EMERG MED, V49, P293, DOI 10.1016/j.annemergmed.2006.06.038; Bulger Eileen M, 2012, Adv Surg, V46, P73; Chesters A, 2014, EMERG MED J, V31, P65, DOI 10.1136/emermed-2012-201846; Desmettre T, 2012, CRIT CARE, V16, DOI 10.1186/cc11647; Dominguez KM, 2013, AM J SURG, V205, P329, DOI 10.1016/j.amjsurg.2013.01.004; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Galvagno SM, 2012, JAMA-J AM MED ASSOC, V307, P1602, DOI 10.1001/jama.2012.467; Gomez D, 2013, ANN SURG, V257, P160, DOI 10.1097/SLA.0b013e31827b9649; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Haas B, 2008, CRIT CARE, V12, DOI 10.1186/cc6980; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Lawson FL, 2013, HEALTH PLACE, V19, P131, DOI 10.1016/j.healthplace.2012.10.011; Lossius HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11189; Mabry RL, 2012, J TRAUMA ACUTE CARE, V73, pS32, DOI 10.1097/TA.0b013e3182606001; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; MacKenzie EJ, 2003, JAMA-J AM MED ASSOC, V289, P1515, DOI 10.1001/jama.289.12.1515; Masella CA, 2008, J TRAUMA, V65, P653, DOI 10.1097/TA.0b013e3181802077; McDermott FT, 2007, J TRAUMA, V63, P331, DOI 10.1097/TA.0b013e31806dc5c4; Nakahara S, 2010, J TRAUMA, V68, P1044, DOI 10.1097/TA.0b013e3181aca144; Nathens AB, 2004, LANCET, V363, P1794, DOI 10.1016/S0140-6736(04)16307-1; Newgard CD, 2010, ANN EMERG MED, V55, P235, DOI 10.1016/j.annemergmed.2009.07.024; Nirula R, 2010, J TRAUMA, V69, P595, DOI 10.1097/TA.0b013e3181ee6e32; Perel P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub6; Poloujadoff MP, 2007, ANESTHESIOLOGY, V107, P591, DOI 10.1097/01.anes.0000281926.54940.6a; Raux M, 2011, J TRAUMA, V71, P754, DOI 10.1097/TA.0b013e3181fd0dae; Redelmeier DA, 2012, NEW ENGL J MED, V367, P1228, DOI 10.1056/NEJMsa1114310; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Sailliol A, 2013, TRANSFUSION, V53, p65S, DOI 10.1111/trf.12038; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Seamon MJ, 2007, J TRAUMA, V63, P113, DOI 10.1097/TA.0b013e31806842a1; Shafi S, 2008, J TRAUMA, V65, P1122, DOI 10.1097/TA.0b013e318189a821; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Stiell IG, 2007, NEW ENGL J MED, V356, P2156, DOI 10.1056/NEJMoa060334; Tallon JM, 2012, CAN J SURG, V55, P8, DOI 10.1503/cjs.016710; Tazarourte K, 2011, ACTA ANAESTH SCAND, V55, P422, DOI 10.1111/j.1399-6576.2010.02372.x; Tazarourte K, 2012, URGENCE; Tazarourte K, 2010, CRIT CARE MED, V38, P1501, DOI 10.1097/CCM.0b013e3181d8c077; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Theusinger OM, 2012, CURR OPIN CRIT CARE, V18, P661, DOI 10.1097/MCC.0b013e328357b209; Trimmel H, 2011, CRIT CARE MED, V39, P489, DOI 10.1097/CCM.0b013e318206b69b; Vandromme MJ, 2010, J AM COLL SURGEONS, V210, P861, DOI 10.1016/j.jamcollsurg.2010.01.012; White CE, 2009, INJURY, V40, P1023, DOI 10.1016/j.injury.2008.11.023; Wilson C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004607; Yeguiayan JM, 2011, CRIT CARE, V15, DOI 10.1186/cc9982	50	5	6	1	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	JUL-AUG	2013	32	7-8					477	482		10.1016/j.annfar.2013.07.005			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Anesthesiology	218SM	WOS:000324452800004	23916517				2022-02-06	
J	Campbell, TF; Dollaghan, C; Janosky, J; Rusiewicz, HL; Small, SL; Dick, F; Vick, J; Adelson, PD				Campbell, Thomas F.; Dollaghan, Christine; Janosky, Janine; Rusiewicz, Heather Leavy; Small, Steven L.; Dick, Frederic; Vick, Jennell; Adelson, P. David			Consonant Accuracy After Severe Pediatric Traumatic Brain Injury: A Prospective Cohort Study	JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH			English	Article						neurologic disorders; pediatric traumatic brain injury; consonant production; speech sound disorders; speech recovery; neuroimaging; phonology	CLOSED-HEAD-INJURY; EXPRESSIVE LANGUAGE; SPEECH DELAY; CHILDREN; OUTCOMES; AGE; EXTENSIONS; PERCENTAGE; PLASTICITY; SEQUELAE	Purpose: The authors sought to describe longitudinal changes in Percentage of Consonants Correct-Revised (PCC-R) after severe pediatric traumatic brain injury (TBI), to compare the odds of normal-range PCC-R in children injured at older and younger ages, and to correlate predictor variables and PCC-R outcomes. Method: In 56 children injured between age 1 month and 11 years, PCC-R was calculated over 12 monthly sessions beginning when the child produced >= 10 words. At each session, the authors compared odds of normal-range PCC-R in children injured at younger (>= 60 months) and older (> 60 months) ages. Correlations were calculated between final PCC-R and age at injury, injury mechanism, gender, maternal education, residence, treatment, Glasgow Coma Score, and intact brain volume. Results: PCC-Rs varied within and between children. Odds of normal-range PCC-R were significantly higher for the older than for the younger group at all sessions but the first; odds of normal-range PCC-R were 9 to 33 times higher in the older group in sessions 3 to 12. Age at injury was significantly correlated with final PCC-R. Conclusion: Over a 12-month period, severe TBI had more adverse effects for children whose ages placed them in the most intensive phase of PCC-R development than for children injured later.	[Campbell, Thomas F.; Dollaghan, Christine] Univ Texas Dallas, Callier Ctr Commun Disorders, Dallas, TX 75235 USA; [Janosky, Janine] Austen BioInnovat Inst, Akron, OH USA; [Rusiewicz, Heather Leavy] Duquesne Univ, Pittsburgh, PA 15219 USA; [Small, Steven L.] Univ Calif Irvine, Irvine, CA USA; [Dick, Frederic] Univ London, London WC1E 7HU, England; [Vick, Jennell] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA		Campbell, TF (corresponding author), Univ Texas Dallas, Callier Ctr Commun Disorders, 1966 Inwood Rd, Dallas, TX 75235 USA.	thomas.f.campbell@utdallas.edu	Adelson, David/W-2083-2019	Small, Steven/0000-0002-5293-6172; Dick, Frederic/0000-0002-2933-3912	National Institute on Deafness and Other Communication DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [ROlDC0368]; General Clinical Research Center at the Children's Hospital of Pittsburgh, Pennsylvania [MO1RR00084]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0400341] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0400341] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000084] Funding Source: NIH RePORTER	This research was supported by National Institute on Deafness and Other Communication Disorders Grant ROlDC0368 and by Grant MO1RR00084 from the General Clinical Research Center at the Children's Hospital of Pittsburgh, Pennsylvania. We thank Lawrence Shriberg and the staff of the Phonology Project at the University of Wisconsin-Madison for assistance with the speech analyses. We would also like to extend our appreciation to Heidi Feldman for her guidance and consultation throughout this project. We are also indebted to Denise Balason, Jennifer Black, Jill Brady, Stacy Carr, Sharon Gretz, Tammy Nash, Stephanie Nixon, and Dayna Pitcairn for their assistance in completing this study.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2009, PEDIATRICS, V124, pE1064, DOI 10.1542/peds.2009-0365; Ashwal S, 2006, DEV NEUROSCI-BASEL, V28, P309, DOI 10.1159/000094157; Bagnato S. J., 1989, INFANT YOUNG CHILD, V2, P1; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Beauchamp MH, 2011, INT J DEV NEUROSCI, V29, P137, DOI 10.1016/j.ijdevneu.2010.12.003; Bernthal J., 1994, CHILD PHONOLOGY CHAR, P140; Bigler ED, 2007, BRAIN INJURY MED PRI, P201; Cahill LM, 2005, BRAIN INJURY, V19, P41, DOI 10.1080/02699050410001719961; Campbell T., 2010, SPEECH SOUND DISORDE, P205; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; Campbell TF, 2003, CHILD DEV, V74, P346, DOI 10.1111/1467-8624.7402002; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Campbell TF, 2007, J SPEECH LANG HEAR R, V50, P1110, DOI 10.1044/1092-4388(2007/077); Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; Chapman SB, 1998, BRAIN LANG, V61, P420, DOI 10.1006/brln.1997.1885; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L., 2008, HDB DEV COGNITIVE NE, P399; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; Forsyth R, 2010, CHILD CARE HLTH DEV, V36, P1, DOI 10.1111/j.1365-2214.2009.01044.x; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Grunwell P., 1987, CHILD PHONOLOGY; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; James DGH, 2002, INVESTIGATIONS IN CLINICAL PHONETICS AND LINGUISTICS, P287; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Kochanek PM, 2010, DEV NEUROSCI-BASEL, V32, P335, DOI 10.1159/000323016; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; Kuruvilla M, 2007, BRAIN INJURY, V21, P601, DOI 10.1080/02699050701427525; Kuruvilla MS, 2008, CLIN LINGUIST PHONET, V22, P703, DOI 10.1080/02699200802176378; Lah S, 2011, BRAIN INJURY, V25, P44, DOI 10.3109/02699052.2010.531693; Langlois JA, 2006, TRAUMATIC BRAIN INJU; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; McSweeny J. L., 2000, PEPPER PROGRAMS EXAM; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Olswang L. B., 1987, ASSESSING PRELINGUIS, P120; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Paradise JL, 2001, NEW ENGL J MED, V344, P1179, DOI 10.1056/NEJM200104193441601; Porter JH, 2001, LANG SPEECH HEAR SER, V32, P165, DOI 10.1044/0161-1461(2001/015); Power T, 2007, BRAIN INJURY, V21, P279, DOI 10.1080/02699050701253095; Sackett DL., 1991, CLIN EPIDEMIOLOGY BA, V2; Shin SS, 2012, J NEUROSURG, V116, P1062, DOI 10.3171/2012.1.JNS111282; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; SHRIBERG LD, 1984, J SPEECH HEAR RES, V27, P456, DOI 10.1044/jshr.2703.456; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P708, DOI 10.1044/jslhr.4004.708; Shriberg LD, 1997, J SPEECH LANG HEAR R, V40, P723, DOI 10.1044/jslhr.4004.723; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; SMIT AB, 1990, J SPEECH HEAR DISORD, V55, P779, DOI 10.1044/jshd.5504.779; Sonnenberg LK, 2010, BRAIN INJURY, V24, P1003, DOI 10.3109/02699052.2010.489033; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Wetherington CE, 2010, J PEDIATR PSYCHOL, V35, P662, DOI 10.1093/jpepsy/jsp081; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	58	5	5	0	10	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1092-4388	1558-9102		J SPEECH LANG HEAR R	J. Speech Lang. Hear. Res.	JUN 1	2013	56	3					1023	1034		10.1044/1092-4388(2012/12-0077)			12	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	191WU	WOS:000322446400020	23275427				2022-02-06	
J	He, M; Liu, WG; Wen, L; Du, HG; Yin, LC; Chen, L				He Min; Liu Wei-guo; Wen Liang; Du Hang-gen; Yin Li-chun; Chen Li			Influence of acute ethanol intoxication on neuronal apoptosis and Bcl-2 protein expression after severe traumatic brain injury in rats	CHINESE JOURNAL OF TRAUMATOLOGY			English	Article						Craniocerebral trauma; Apoptosis; Alcoholism		Objective: To study the influence and mechanism of acute ethanol intoxication (AEI) on rat neuronal apoptosis after severe traumatic brain injury (TBI). Methods: Ninety-six Sprague-Dawley rats were randomly divided into four groups: normal control, AEI-only, TBI-only and TBI+AEI (n=24 for each). Severe TBI model was developed according to Feeney's method. Rats in TBI+AEI group were firstly subjected to AEI, and then suffered head trauma. In each group, animals were sacrificed at 6 h, 24 h, 72 h, and 168 h after TBI. The level of neuronal apoptosis and the expression of Bcl-2 protein were determined by TUNEL assay and immunohistochemical method, respectively. Results: Apoptotic cells mainly distributed in the cortex and white matter around the damaged area. Neuronal apoptosis significantly increased at 6 h after trauma and peaked at 72 h. Both the level of neuronal apoptosis and expression of Bcl-2 protein in TBI-only group and TBI+AEI group were higher than those in control group (P<0.05). Compared with TBI-only group, the two indexes were much higher in TBI+AEI group at all time points (P<0.05). Conclusion: Our findings suggest that AEI can increase neuronal apoptosis after severe TBI.	[He Min; Du Hang-gen; Yin Li-chun; Chen Li] Zhejiang Chinese Med Univ, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310005, Zhejiang, Peoples R China; [Liu Wei-guo] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurosurg, Hangzhou 310009, Zhejiang, Peoples R China; [Wen Liang] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China		He, M (corresponding author), Zhejiang Chinese Med Univ, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310005, Zhejiang, Peoples R China.	hm197005@sina.com					Altura BM, 2002, NEUROSCI LETT, V325, P95, DOI 10.1016/S0304-3940(02)00264-1; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; Duan YX, 2012, CHIN J PEST CONTROL, V28, P594; Eriksson CJP, 2007, METABOLISM, V56, P895, DOI 10.1016/j.metabol.2007.01.019; Feng HL, 2000, CHIN J TRAUMA, V16, P97; Lu HY, 2008, MODERN MED J CHINA, V10, P141; Pekcetin C, 2009, ACTA BIOL HUNG, V60, P137, DOI 10.1556/ABiol.60.2009.2.1; Tang CH, 2009, EXPT STUDY INVESTIGA; [汤崇辉 TANG Chong-hui], 2010, [中华急诊医学杂志, Chinese Journal of Emergency Medicine], V19, P52; Wan DF, 2011, CHIN J MINIMALLY INV, V16, P419; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Xu XL, 2010, CHIN J TRAUMA, V269, P848; [张荣军 ZHANG Rongjun], 2005, [中国修复重建外科杂志, Chinese Journal of Reparative and Reconstructive Surgery], V19, P1015; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7	15	5	5	0	1	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	1008-1275			CHIN J TRAUMATOL	Chin. J. Traumatol.	JUN	2013	16	3					136	139		10.3760/cma.j.issn.1008-1275.2013.03.002			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	VF1HG	WOS:000442015600002	23735546				2022-02-06	
J	Miller, JH; Zywicke, HA; Fleming, JB; Griessenauer, CJ; Whisenhunt, TR; Okor, MO; Harrigan, MR; Pritchard, PR; Hadley, MN				Miller, Joseph H.; Zywicke, Holly A.; Fleming, James B.; Griessenauer, Christoph J.; Whisenhunt, Thomas R.; Okor, Mamerhi O.; Harrigan, Mark R.; Pritchard, Patrick R.; Hadley, Mark N.			Neurosurgical injuries resulting from the 2011 tornados in Alabama: the experience at the University of Alabama at Birmingham Medical Center Clinical article	JOURNAL OF NEUROSURGERY			English	Article						tornado; trauma; spine injury; spinal cord; traumatic brain injury	DISASTER; FATALITIES; ECOLOGY; DEATH; RISK	Object. The April 27, 2011, tornados that affected the southeastern US resulted in 248 deaths in the state of Alabama. The University of Alabama at Birmingham (UAB) Medical Center, the largest Level I trauma center in the state, triaged and treated a large number of individuals who suffered traumatic injuries during these events, including those requiring neurosurgical assessment and treatment. Methods. A retrospective review of all adult patients triaged at UAB Medical Center during the April 27, 2011, tornados was conducted. Those patients who were diagnosed with and treated for neurosurgical injuries were included in this cohort. Results. The Division of Neurosurgery at UAB Medical Center received 37 consultations in the 36 hours following the tornado disaster. An additional patient presented 6 days later, having suffered a lumbar spine fracture that ultimately required operative intervention. Twenty-seven patients (73%) suffered injuries as a direct result of the tornados. Twenty-three (85%) of these 27 patients experienced spine and spinal cord injuries. Four patients (15%) suffered intracranial injuries and 2 patients (7%) suffered combined intracranial and spinal injuries. The spinal fractures that were evaluated and treated were predominantly thoracic (43.5%) and lumbar (43.5%). The neurosurgery service performed 14 spinal fusions, 1 ventriculostomy, 2 halo placements, 1 diagnostic angiogram, 1 endovascular embolectomy, and 1 wound debridement and lavage. Twenty-two patients (81.5%) were neurologically intact at discharge and all but 4 had 1 year of follow-up. Three patients had persistent deficits from spinal cord injuries and there was 1 death in a patient with multisystem injuries in whom no procedures were performed. Two patients experienced postoperative complications in the form of 1 wound infection and 1 stroke. Conclusions. The April 27, 2011, tornados in Alabama produced significant neurosurgical injuries that primarily involved the spine. There were a disproportionate number of patients with thoracolumbar fractures, a finding possibly due to the county medical examiner's postmortem findings that demonstrated a high prevalence of fatal cervical spine and traumatic brain injuries. The UAB experience can be used to aid other institutions in preparing for the appropriate allotment of resources in the event of a similar natural disaster.	[Miller, Joseph H.; Zywicke, Holly A.; Fleming, James B.; Griessenauer, Christoph J.; Whisenhunt, Thomas R.; Okor, Mamerhi O.; Harrigan, Mark R.; Pritchard, Patrick R.; Hadley, Mark N.] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Med Ctr, Birmingham, AL 35294 USA		Hadley, MN (corresponding author), Univ Alabama Birmingham, Dept Surg, FOT 1030, Div Neurosurg, 1720 2nd Ave South, Birmingham, AL 35294 USA.	spinal@uab.edu		Griessenauer, Christoph/0000-0002-2952-3812			AGUIRRE BE, 1993, DEMOGRAPHY, V30, P623, DOI 10.2307/2061810; Augustine JJ, 2011, EMS WORLD, V40, P30; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Bohonos JJ, 1999, J EMERG MED, V17, P67, DOI 10.1016/S0736-4679(98)00125-5; BRENNER SA, 1992, AM J PUBLIC HEALTH, V82, P1296, DOI 10.2105/AJPH.82.9.1296-a; CARTER AO, 1989, AM J EPIDEMIOL, V130, P1209, DOI 10.1093/oxfordjournals.aje.a115449; Casey-Lockyer Mary, 2012, Morbidity and Mortality Weekly Report, V61, P529; Chern JJ, 2011, J NEUROSURG-PEDIATR, V8, P588, DOI 10.3171/2011.9.PEDS11207; Daley WR, 2005, AM J EPIDEMIOL, V161, P1144, DOI 10.1093/aje/kwi142; Donner WR, 2007, DEMOGRAPHY, V44, P669, DOI 10.1353/dem.2007.0024; Friedrick Joanne, 2012, J Healthc Prot Manage, V28, P50; Lee JY, 2005, J ORTHOP SCI, V10, P671, DOI 10.1007/s00776-005-0956-y; MANDELBAUM I, 1966, J TRAUM, V6, P353, DOI 10.1097/00005373-196605000-00005; May Beth M., 2002, Journal of the American Osteopathic Association, V102, P225; Millie M, 2000, AM SURGEON, V66, P223; Oliver M, 2011, BIRMINGHAM NEWS 1204; Stephens C, 2011, HUNTSVILLE TIME 0508; Sugimoto JD, 2011, DISASTERS, V35, P329, DOI 10.1111/j.1467-7717.2010.01214.x	18	5	5	0	6	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	JUN	2013	118	6					1356	1362		10.3171/2013.3.JNS121656			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	150BY	WOS:000319366400036	23611044	Bronze			2022-02-06	
J	Okumura, MS; Cooper, SL; Ferrara, MS; Tomporowski, PD				Okumura, Michelle S.; Cooper, Stephanie L.; Ferrara, Michael S.; Tomporowski, Phillip D.			Global Switch Cost as an Index for Concussion Assessment: Reliability and Stability	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						COGNITION; DUAL TASKING; EXECUTIVE FUNCTION; RETURN TO PLAY	TRAUMATIC BRAIN INJURY; TASK TESTING PARADIGM; COGNITIVE TASK; BALANCE PERFORMANCE; WORKING-MEMORY; GAIT; ATTENTION; DEMANDS; LOAD	Purpose: The objective of this study is to determine the stability and sensitivity of a dual-task (DT) methodology that can be used to assess the effects of concussion in athletes. Methods: Fifty-nine healthy young adults (M-age = 20.32 +/- 1.84 yr, 19 males) who volunteered to participate completed auditory switch tasks that varied in length (30, 40, and 60 items) at baseline, 1 wk later, and approximately 7 months later. During sessions 2 and 3, the participants completed one of three switch tasks while concurrently performing a modified Harvard Step Test. Global switch cost indices and percentage error were calculated for each switch task. The stability reliability of the global switch cost indices was assessed under single-task conditions, and the sensitivity of the global switch costs to interference effects was assessed under DT conditions. Results: The stability reliability was 0.64, 0.84, and 0.83 for the 30-, 40-, and 60-item tests, respectively. ANOVA revealed a main effect for condition (single task vs DT) for both global switch costs (F(1,55) = 44.53, P < 0.0001) and percentage error (F(1,56) = 64.69, P < 0.001). The magnitude of the global switch cost interference effects was nearly identical across the three DT conditions. Conclusions: The current concussion testing models test athletes' cognitive and physical function in isolation. The stability reliability of the global switch cost index obtained under DT conditions suggests that it may be a useful measure for clinicians. The DT paradigm presents another test methodology that may be useful for making return-to-play decisions as part of a comprehensive concussion management plan.	[Okumura, Michelle S.; Cooper, Stephanie L.; Ferrara, Michael S.; Tomporowski, Phillip D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Tomporowski, PD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	ptomporo@uga.edu	Meijer, Anna/K-5118-2016				Azouvi P, 1996, J CLIN EXP NEUROPSYC, V18, P317, DOI 10.1080/01688639608408990; Barr W., 2011, HDB SPORT NEUROPSYCH, P91; Beauchet O, 2005, GERONTOLOGY, V51, P48, DOI 10.1159/000081435; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2005, MED SCI SPORT EXER, V37, P689, DOI 10.1249/01.MSS.0000159019.14919.09; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Cedrus, SUPERLAB; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; EBERSBACH G, 1995, PERCEPT MOTOR SKILL, V81, P107, DOI 10.2466/pms.1995.81.1.107; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Kahneman D., 1973, ATTENTION EFFORT; Li KZH, 2002, NEUROSCI BIOBEHAV R, V26, P777, DOI 10.1016/S0149-7634(02)00073-8; Lovden M, 2008, J GERONTOL B-PSYCHOL, V63, pP121; May B, 2009, MIL MED, V174, P1308, DOI 10.7205/MILMED-D-00-0809; MONSELL S, 2000, CONTROL COGNITIVE PR, V18; *NEUR INT, 2001, NEUR SYST OP MAN, pPO1; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Resch JE, 2011, J ATHL TRAINING, V46, P170, DOI 10.4085/1062-6050-46.2.170; Rogers DR, 1995, J EXPT PSYCHOL GEN, V124, P207; Schaefer S, 2011, GERONTOLOGY, V57, P239, DOI 10.1159/000322197; Schatz P., 2011, HDB SPORT NEUROPSYCH, P173; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Shumway-Cook A, 2000, J GERONTOL A-BIOL, V55, pM10; Wasylyshyn C, 2011, PSYCHOL AGING, V26, P15, DOI 10.1037/a0020912; Wickens CD, 2008, HUM FACTORS, V50, P449, DOI 10.1518/001872008X288394	28	5	5	0	14	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0195-9131			MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2013	45	6					1038	1042		10.1249/MSS.0b013e318281e1fb			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	149MF	WOS:000319323300003	23274605				2022-02-06	
J	Sanganalmath, PU; Nagaraju, PM; Mohan, BM				Sanganalmath, Praveen U.; Nagaraju, Purigali M.; Mohan, Bannur M.			HPTLC method for the assay of thiopental in post-mortem blood in a fatal case of suicide	JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS			English	Article; Proceedings Paper	International Symposium for High-Performance Thin-Layer Chromatography (HPTLC)	JUL 06-08, 2011	Basel, SWITZERLAND			Post-mortem blood; Extraction yield; Thiopental; Fatal dose; HPTLC	PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; HUMAN-SERUM; TISSUES; SAMPLES; QUANTIFICATION; DEATH	Thiopental is an ultra-short-acting barbiturate, used as an induction agent during general anesthesia and to manage intra cranial pressure in traumatic brain injuries. Because of its rapid onset of action, the potential for accidental or intentional abuse of thiopental is high. In this paper, a case is presented in which a 25-year-old female deliberately injected a fatal dose of thiopental. A method is developed for the evaluation of thiopental levels in the post-mortem blood (PMB) by simple and rapid HPTLC. Three different extraction procedures were compared for optimum recovery of thiopental from spiked blood samples. The effect of pH on the extraction yield of thiopental over a pH range of 5-6.5 was examined. An average analytical recovery of 90.5% was achieved from an ethyl acetate extract at pH 5.5. Chromatographic separation was achieved on silica gel 60F(254) plates with an optimized mobile phase consisted of hexane-dichloromethane-ethyl acetate in the ratio 7.5:2:0.5 (v/v). Densitometric detection was carried out at 290 nm in absorbance mode. No significant chromatographic interference was observed from other drugs used to diagnose the brain death. Calibration curve for thiopental in blood were linear from 1 to 100 mu g ml(-1) with r(2) = 0.994. The detection limit was 0.5 mu g ml(-1) and its lower limit of quantification was 1.5 mu g ml(-1). The method showed excellent intra-assay precision (R.S.D. 1.07-6.28%) and inter-assay precision (R.S.D. 0.39-1.43%) for spiked blood samples at concentration of 1, 10, and 50 mu g ml(-1). The toxicological analysis revealed high concentrations of thiopental in PMB (204.75 mu g ml(-1) +/- 0.34), which is of immense help to conclude that the death occurred due to fatal doses of thiopental. (C) 2013 Elsevier B.V. All rights reserved.	[Sanganalmath, Praveen U.; Nagaraju, Purigali M.; Mohan, Bannur M.] Forens Sci Lab, Bangalore 560068, Karnataka, India		Sanganalmath, PU (corresponding author), Forens Sci Lab, Bangalore 560068, Karnataka, India.	praveen_usp@yahoo.com					Abourashed EA, 2009, JPC-J PLANAR CHROMAT, V22, P183, DOI 10.1556/JPC.22.2009.3.4; Abu-Qare AW, 2001, J CHROMATOGR B, V754, P533, DOI 10.1016/S0378-4347(01)00028-7; Aitkenhead A.R., 2007, TXB ANAESTHESIA, P37; Ali AMM, 2000, ANAL CHIM ACTA, V412, P99, DOI 10.1016/S0003-2670(00)00770-4; [Anonymous], THIOP SOD; [Anonymous], 1999, EMEAMRL70899 COMM VE; Anthony C.M., 2004, CLARKES ANAL DRUGS P, V2, P1619; BACKER RC, 1975, CLIN TOXICOL, V8, P283, DOI 10.3109/15563657508988077; Barroso M, 2006, FORENSIC SCI INT, V162, P121, DOI 10.1016/j.forsciint.2006.02.056; BRUCE AM, 1977, FORENSIC SCI, V9, P205, DOI 10.1016/0300-9432(77)90092-9; Coppa G, 2001, CLIN CHIM ACTA, V305, P41, DOI 10.1016/S0009-8981(00)00417-4; Dershwitz M., PHARMACOKINETICS PHA, P931; FDA, GUID IND BIOAN METH; HOSOTSUBO H, 1988, CHROMATOGRAPHIA, V25, P887, DOI 10.1007/BF02311423; Huynh F, 2009, THER DRUG MONIT, V31, P153, DOI 10.1097/FTD.0b013e318196fb9f; JUNG D, 1981, CLIN CHEM, V27, P113; KULPMANN WR, 1982, FRESEN Z ANAL CHEM, V311, P409, DOI 10.1007/BF00481775; LEVINE B, 1983, J ANAL TOXICOL, V7, P207, DOI 10.1093/jat/7.4.207; LEVINE BS, 1984, J FORENSIC SCI, V29, P131; MARTY P, 1988, ANAL LETT, V21, P2241, DOI 10.1080/00032718808059906; MEIER P, 1991, J CHROMATOGR, V559, P505, DOI 10.1016/0021-9673(91)80098-2; Peters FT, 2005, THER DRUG MONIT, V27, P334, DOI 10.1097/01.ftd.0000158079.53577.46; Reich E., 2006, HIGH PERFORMANCE THI, P197; SCHMID RW, 1989, J PHARMACEUT BIOMED, V7, P1749, DOI 10.1016/0731-7085(89)80190-6; Tanaka E, 1997, FORENSIC SCI INT, V85, P73, DOI 10.1016/S0379-0738(96)02081-6; Tsoukali H, 2004, FORENSIC SCI INT, V143, P127, DOI 10.1016/j.forsciint.2004.02.032; VANHAMME MJ, 1978, BRIT J ANAESTH, V50, P143, DOI 10.1093/bja/50.2.143; Vassallo S., THIOPENTAL LETHAL IN, P957; YASUDA T, 1993, INT J LEGAL MED, V105, P239, DOI 10.1007/BF01642801	29	5	5	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0731-7085	1873-264X		J PHARMACEUT BIOMED	J. Pharm. Biomed. Anal.	JUN	2013	80						89	93		10.1016/j.jpba.2013.02.042			5	Chemistry, Analytical; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Chemistry; Pharmacology & Pharmacy	141TH	WOS:000318748900011	23542731				2022-02-06	
J	Wang, YX; You, Q; Su, WL; Li, Q; Hu, ZQ; Wang, ZG; Sun, YP; Zhu, WX; Ruan, CP				Wang, Yi Xin; You, Qing; Su, Wen Li; Li, Qi; Hu, Zhi Qian; Wang, Zhi Guo; Sun, Yan Ping; Zhu, Wen Xian; Ruan, Can Ping			A study on inhibition of inflammation via p75TNFR signaling pathway activation in mice with traumatic brain injury	JOURNAL OF SURGICAL RESEARCH			English	Article						Trauma; Inflammation; p75TNFR; Monoclonal antibody; p38MAPK; NF-kappa B	TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FACTOR TNF RECEPTORS; RHEUMATOID-ARTHRITIS; INDUCED APOPTOSIS; ALPHA; ETANERCEPT	Objective: To investigate the effects of and mechanisms underlying the activation of the p75 tumor necrosis factor receptor (p75TNFR) signaling pathway in inflammatory responses in mice with traumatic brain injury. Methods: We first generated hybridomas that produced antibodies specific for p75TNFR, by inoculating BALB/c mice with antigenic peptides derived from mouse p75TNFR, which is critical to the binding of tumor necrosis factor-alpha (TNF-alpha) and p75TNFR. The isotype, epitope, titer, specificity, and affinity constant of monoclonal antibodies (mAbs) were determined using commercial kits and enzyme-linked immunosorbent assay. We then screened the agonist antibody via L929 cytotoxicity assay. The levels of inflammatory factors were detected in C57BL/6 mice with traumatic brain injury and then the mice were injected with either saline (control) or p75TNFR agonist mAb. Furthermore, we investigated the effects of p75TNFR agonist mAb on p38MAPK and nuclear factor-kappa B signals. Results: Seven mAbs against p75TNFR were generated. Among them, the mAb D8F2 could markedly enhance the cytotoxicity of TNF-alpha on L929 cells. In a traumatic brain injury model, D8F2 could inhibit the levels of inflammatory factors and downregulate RNA transcription of these factors by suppressing the activation of p38 mitogen-activated protein kinase and nuclear factor-kappa B. Conclusion: The mAb D8F2 could inhibit posttraumatic inflammatory responses effectively. In this study, we developed an agonist anti-mouse p75TNFR mAb, which may be used in the future to devise new strategies for the clinical treatment of inflammation after trauma. (C) 2013 Elsevier Inc. All rights reserved.	[Wang, Yi Xin; Su, Wen Li; Zhu, Wen Xian] Shanghai Univ Tradit Chinese Med, Shanghai Putuo Hosp, Aid Ctr 1, Shanghai 200062, Peoples R China; [You, Qing; Li, Qi; Hu, Zhi Qian; Wang, Zhi Guo; Sun, Yan Ping; Ruan, Can Ping] Second Mil Med Univ, Shanghai Chang Zheng Hosp, Dept Gen Surg, Shanghai 200003, Peoples R China		Zhu, WX (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai Putuo Hosp, Aid Ctr 1, 164 Lanxi Rd, Shanghai 200062, Peoples R China.	baby51@126.com; Rcipng@hotmail.com			Shanghai Science and Technology Commission, Shanghai, ChinaScience & Technology Commission of Shanghai Municipality (STCSM) [2010PTKW003]	This work was supported by a grant from Shanghai Science and Technology Commission, Shanghai, China (no. 2010PTKW003).	CHOUAIB S, 1992, B CANCER, V79, P935; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Dhillon S, 2007, DRUGS, V67, P1211, DOI 10.2165/00003495-200767080-00011; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Genovese MC, 2004, RHEUM DIS CLIN N AM, V30, P311, DOI 10.1016/j.rdc.2004.01.004; Ghezzi P, 2005, MOL BIOTECHNOL, V31, P239, DOI 10.1385/MB:31:3:239; HELLER RA, 1994, J CELL BIOL, V126, P5, DOI 10.1083/jcb.126.1.5; HOHMANN HP, 1990, J BIOL CHEM, V265, P22409; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Medvedev AE, 1996, J BIOL CHEM, V271, P9778, DOI 10.1074/jbc.271.16.9778; Neunaber C, 2011, RECENT PATENTS INFLA, V5, P17, DOI 10.2174/187221311794474892; TARTAGLIA LA, 1993, J BIOL CHEM, V268, P18542; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang YX, 2010, J SURG RES, V161, P119, DOI 10.1016/j.jss.2008.10.030; Yang T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000669	16	5	6	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804			J SURG RES	J. Surg. Res.	JUN 1	2013	182	1					127	133		10.1016/j.jss.2012.07.071			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	139WU	WOS:000318616500026	22935315				2022-02-06	
J	Horsburgh, A; Matys, T; Kirollos, RW; Massoud, TF				Horsburgh, Avril; Matys, Tomasz; Kirollos, Ramez W.; Massoud, Tarik F.			Tuber cinereum proximity to critical major arteries: a morphometric imaging analysis relevant to endoscopic third ventriculostomy	ACTA NEUROCHIRURGICA			English	Article						Basilar artery; Hemorrhage; Morphometry; Neuroendoscopy; Tuber cinereum; Third ventriculostomy	TRAUMATIC BASILAR ANEURYSM; OBSTRUCTIVE HYDROCEPHALUS; 3RD-VENTRICULOSTOMY; COMPLICATIONS; MANAGEMENT; VENTRICLE; SHUNT	Arterial bleeding in the interpeduncular fossa is a dreaded complication of endoscopic third ventriculostomy (ETV). When the "safe zone" of the tuber cinereum (TC) is fenestrated, the basilar artery tip (BT) or its branches may be encountered below the third ventriclular floor. Major arterial injuries might be avoided by careful preoperative planning. We aimed to establish previously unavailable normal magnetic resonance imaging (MRI) and MR angiographic (MRA) morphometry and configuration of the BT and posterior cerebral artery P1 segments relative to the TC. We analyzed images of 82 patients with non-dilated ventricles (mean Evans' index 0.26), and lying in a neutral head position (mean cervico-medullary angle 141A degrees). We cross-referenced axial MRAs with sagittal MRIs to measure distances of BT and P1 segments from the TC, and to classify the location of the BT in the interpeduncular and suprasellar cisterns. We correlated the sagittal areas of these cisterns and patients' ages with the TC-to-artery distances using regression analysis. The BT, right P1 and left P1 segments were a mean 4.9 mm, 5.5 mm, and 5.7 mm respectively from the TC. Seventy-four percent of BTs were anterior to the mammillary bodies. These distances and locations did not correlate with age (mean 53 years) or size of basal cisterns. The normal BT and P1 segments are anatomically close to the TC and potentially at risk during ETV in adults of all ages. The new morphometric data presented, along with cross-referencing of preoperative multiplanar images, could help reduce vascular complications during ETV.	[Horsburgh, Avril; Matys, Tomasz; Massoud, Tarik F.] Addenbrookes Hosp, Neuroradiol Sect, Cambridge, England; [Kirollos, Ramez W.] Addenbrookes Hosp, Dept Neurosurg, Cambridge, England; [Massoud, Tarik F.] Univ Cambridge, Dept Radiol, Cambridge, England; [Massoud, Tarik F.] Stanford Univ, Lab Expt & Mol Neuroimaging LEMNI, MIPS, Sect Neuroradiol,Dept Radiol,Sch Med, Stanford, CA 94305 USA; [Massoud, Tarik F.] James H Clark Ctr, Med Ctr, Stanford, CA 94305 USA		Massoud, TF (corresponding author), Stanford Univ, Lab Expt & Mol Neuroimaging LEMNI, MIPS, Sect Neuroradiol,Dept Radiol,Sch Med, E153,318 Campus Dr,East Wing,1st Floor, Stanford, CA 94305 USA.	tmassoud@stanford.edu		Matys, Tomasz/0000-0003-2285-5715			Abtin K, 1998, PEDIATR NEUROSURG, V28, P35, DOI 10.1159/000028616; Amini Amin, 2005, Neurosurg Focus, V19, pE9; Baykan N, 2005, J NEUROSURG ANESTH, V17, P33; Romero ADB, 2011, NEUROSURGERY, V68, P347, DOI 10.1227/NEU.0b013e318211449a; Bilginer B, 2009, CHILD NERV SYST, V25, P683, DOI 10.1007/s00381-008-0779-1; Bouras T, 2013, WORLD NEUROSURG, V79, DOI 10.1016/j.wneu.2012.02.014; Brockmeyer D, 2004, NEUROSURG CLIN N AM, V15, P51, DOI 10.1016/S1042-3680(03)00066-4; Buxton N, 1999, NEUROSURGERY, V45, P957, DOI 10.1097/00006123-199910000-00066; Buxton N, 2000, NEUROSURGERY, V46, P999; Chernov MF, 2005, J NEUROSURG, V102, P260, DOI 10.3171/ped.2005.102.3.0260; de Ribaupierre S, 2007, CHILD NERV SYST, V23, P527, DOI 10.1007/s00381-006-0283-4; Fabiano AJ, 2010, J NEUROL NEUROSUR PS, V81, P374, DOI 10.1136/jnnp.2009.177360; Fushimi Y, 2003, RADIOLOGY, V229, P360, DOI 10.1148/radiol.2292021507; Gangemi M, 2004, NEUROSURGERY, V55, P129, DOI 10.1227/01.NEU.0000126938.12817.DC; Garton HJL, 2002, NEUROSURGERY, V51, P69, DOI 10.1097/00006123-200207000-00012; Hayashi N, 1999, MINIM INVAS NEUROSUR, V42, P79, DOI 10.1055/s-2008-1053375; Hellwig D, 2005, NEUROSURG REV, V28, P1, DOI 10.1007/s10143-004-036-2; Horowitz M, 2001, NEUROSURGERY, V49, P1461, DOI 10.1097/00006123-200112000-00031; Kim SK, 2000, CHILD NERV SYST, V16, P161, DOI 10.1007/s003810050485; Lang J, 1992, Acta Neurochir Suppl (Wien), V54, P1; Lawlor DA, 2001, INT J EPIDEMIOL, V30, P1221, DOI 10.1093/ije/30.6.1221; McLaughlin MR, 1997, NEUROSURGERY, V41, P1400, DOI 10.1097/00006123-199712000-00034; Morota N, 2000, J NEUROL NEUROSUR PS, V69, P531, DOI 10.1136/jnnp.69.4.531; Ogiwara H, 2010, CHILD NERV SYST, V26, P343, DOI 10.1007/s00381-009-1019-z; OKA K, 1993, SURG NEUROL, V40, P273, DOI 10.1016/0090-3019(93)90137-P; Peltier J., 2008, Morphologie, V92, P31, DOI 10.1016/j.morpho.2008.02.002; Ray Pulak, 2005, Neurosurg Focus, V19, pE8; Reijnierse M, 2000, SKELETAL RADIOL, V29, P85, DOI 10.1007/s002560050015; Ruggiero C, 2004, CHILD NERV SYST, V20, P828, DOI 10.1007/s00381-004-0938-y; Schmidt RH, 1999, J NEUROSURG, V90, P156, DOI 10.3171/jns.1999.90.1.0156; Schroeder HWS, 1999, J NEUROSURG, V90, P153, DOI 10.3171/jns.1999.90.1.0153; Schroter S, 2006, J MED ETHICS, V32, P718, DOI 10.1136/jme.2005.015115; Beijnum J, 2008, NEUROSURGERY, V62, P437, DOI [10.1227/01.NEU.0000297058.27777.07, 10.1227/01.neu.0000316011.13174.b1]; Vandertop PW, 1998, NEUROSURGERY, V43, P647, DOI 10.1097/00006123-199809000-00157; Vinas FC, 1996, MINIM INVAS NEUROSUR, V39, P116, DOI 10.1055/s-2008-1052230; Yadav YR, 2010, MINIM INVAS NEUROSUR, V53, P155, DOI 10.1055/s-0030-1263107	36	5	5	0	2	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	MAY	2013	155	5					891	900		10.1007/s00701-013-1661-9			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	127EP	WOS:000317679800021	23468037				2022-02-06	
J	Bugaev, N; Arabian, S; Rabinovici, R				Bugaev, Nikolay; Arabian, Sandra; Rabinovici, Reuven			Admission patterns of stable patients with isolated orthopedic or neurosurgical injuries	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Trauma systems; orthopedic injuries; neurosurgical injuries; admissions		OBJECTIVE: Although the disposition of stable patients with isolated orthopedic or neurosurgical injuries affects care and resource utilization, no guidelines for optimal admission are available. This study aims to provide the platform for developing such guidelines for these patients by characterizing their admission patterns in trauma centers (TCs). METHODS: This study is a Web-based survey of Trauma Medical Directors of Level I and Level II American College of Surgeons (ACS)-verified TCs. RESULTS: E-questionnaire was sent to 234 (98%) of 240 ACS-verified Level I and Level II TCs, and 122 (52%) responded. Responses indicate that stable patients with isolated orthopedic injuries and no indication or with an indication for emergent surgery are mostly (58 vs. 31%, p < 0.0001, 59 vs. 37%, p < 0.0001) admitted to the trauma service (TS). Conversely, when surgery was urgent, patients are equally admitted to the TS and orthopedic service (OS). When specific injuries were queried, patients with closed pelvic fractures are mostly admitted to the TS (81 vs. 18%, p < 0.0001), whereas patients with upper extremity injuries are preferentially admitted to the OS (58% vs. 31%, p < 0.05). Patients with isolated lower extremity fractures are equally admitted to the two services. Patients with isolated major traumatic brain injury (TBI) are mostly (78.6% vs. 21.4%, p < 0.0001) admitted to the TS, regardless of the need for emergent surgery. Similarly, most patients with minor TBI are admitted to the TS, independent of the presence of CT scan findings. The majority (73.9% vs. 26.1%, p < 0.0001) of patients with isolated spine injury are admitted to the TS, independent of the level of injury, the presence of multilevel injury, an indication for surgery, or the existence of neurological deficits. CONCLUSION: Most stable patients with isolated neurosurgical injuries in ACS-verified Level I and Level II TCs are initially admitted to the TS. The admission of patients with isolated orthopedic injuries is selective. These findings can facilitate investigating the clinical, logistical, and financial effect of this practice. (J Trauma Acute Care Surg. 2013;74: 1151-1155. Copyright (C) 2013 by Lippincott Williams & Wilkins)	[Bugaev, Nikolay; Arabian, Sandra; Rabinovici, Reuven] Tufts Med Ctr, Div Trauma & Acute Care Surg, Boston, MA 02111 USA		Rabinovici, R (corresponding author), Tufts Med Ctr, Div Trauma & Acute Care Surg, Boston, MA 02111 USA.	rrabinovici@tufts-nemc.org	Bugaev, Nikolay/AAE-2835-2021; Bugaev, Nikolay/AAC-6963-2022	Bugaev, Nikolay/0000-0001-6325-6837; Arabian, Sandra Strack/0000-0002-4957-3788			Houshian S, 2002, J TRAUMA, V52, P715, DOI 10.1097/00005373-200204000-00018; Pfeifer R, 2008, PATIENT SAF SURG, V2, DOI 10.1186/1754-9493-2-20; Thomson CB, 2008, INJURY, V39, P107, DOI 10.1016/j.injury.2007.07.030	3	5	5	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2013	74	4					1151	1155		10.1097/TA.0b013e3182827191			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	123SS	WOS:000317411700035	23511159				2022-02-06	
J	Gritti, P; Lanterna, LA; Re, M; Martchenko, S; Olivotto, P; Brembilla, C; Agostinis, C; Paganoni, G; Lorini, FL				Gritti, Paolo; Lanterna, Luigi Andrea; Re, Mariachiara; Martchenko, Svetlana; Olivotto, Paola; Brembilla, Carlo; Agostinis, Cristina; Paganoni, Guido; Lorini, Ferdinando Luca			The use of inhaled nitric oxide and prone position in an ARDS patient with severe traumatic brain injury during spine stabilization	JOURNAL OF ANESTHESIA			English	Article						Inhaled nitric oxide; Prone position; ARDS; Traumatic brain injury	RESPIRATORY-DISTRESS-SYNDROME; PNEUMONIA; PRESSURE; THERAPY	The use of inhaled nitric oxide in patients with traumatic brain injury, intracranial hypertension, and acute respiratory distress syndrome (ARDS) has been reported in an intensive care unit setting only in a few case reports. The use of the prone position for patients with traumatic brain injury and lung impairment has been reported only in selected cases. Here we report our experience with the use of both inhaled nitric oxide and the prone position together in the operating room in a patient with head injury and ARDS who underwent column stabilization.	[Gritti, Paolo; Re, Mariachiara; Martchenko, Svetlana; Olivotto, Paola; Paganoni, Guido; Lorini, Ferdinando Luca] Osped Riuniti Bergamo, Dept Anaesthesia, I-24100 Bergamo, Italy; [Lanterna, Luigi Andrea; Brembilla, Carlo] Osped Riuniti Bergamo, Dept Neurosci, I-24100 Bergamo, Italy; [Agostinis, Cristina] Osped Riuniti Bergamo, Dept Neuroradiol, I-24100 Bergamo, Italy		Gritti, P (corresponding author), Osped Riuniti Bergamo, Dept Anaesthesia, Largo Barozzi 1, I-24100 Bergamo, Italy.	grittip@libero.it		lorini, luca ferdinando/0000-0002-2711-3377; Brembilla, Carlo/0000-0003-3356-3144; lanterna, luigi andrea/0000-0001-9484-4834; Gritti, Paolo/0000-0001-9870-1507			Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cuthbertson BH, 1997, INTENS CARE MED, V23, P1212, DOI 10.1007/s001340050488; Dimar JR, 2010, SPINE, V35, pS187, DOI 10.1097/BRS.0b013e3181f32bcd; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Flaatten H, 1996, ACTA ANAESTH SCAND, V40, P376, DOI 10.1111/j.1399-6576.1996.tb04449.x; Gattinoni L, 2010, MINERVA ANESTESIOL, V76, P448; Griffiths MJD, 2005, NEW ENGL J MED, V353, P2683, DOI 10.1056/NEJMra051884; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Muldoon SM, 1994, CURR OPIN ANAESTH, V7, P87; Nekludov M, 2006, ACTA ANAESTH SCAND, V50, P932, DOI 10.1111/j.1399-6576.2006.01099.x; Papadimos TJ, 2009, SCAND J TRAUMA RESUS, V17, DOI 10.1186/1757-7241-17-5; Peillon D, 1999, ANN FR ANESTH, V18, P225, DOI 10.1016/S0750-7658(99)80073-2; Vavilala MS, 2001, ANESTH ANALG, V93, P351, DOI 10.1097/00000539-200108000-00023; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	15	5	5	0	2	SPRINGER JAPAN KK	TOKYO	SHIROYAMA TRUST TOWER 5F, 4-3-1 TORANOMON, MINATO-KU, TOKYO, 105-6005, JAPAN	0913-8668	1438-8359		J ANESTH	J. Anesth.	APR	2013	27	2					293	297		10.1007/s00540-012-1495-2			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	123CR	WOS:000317366400019	23065049				2022-02-06	
J	Kamochi, H; Kusaka, G; Ishikawa, M; Ishikawa, S; Tanaka, Y				Kamochi, Haruna; Kusaka, Gen; Ishikawa, Mami; Ishikawa, Sane; Tanaka, Yuichi			Late Onset Cerebrospinal Fluid Leakage Associated With Past Head Injury-Two Case Reports	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						late onset cerebrospinal fluid leakage; delayed rhinorrhea; delayed otorrhea; pedicled flap; intradural approach	MENINGITIS; RHINORRHEA	Late onset cerebrospinal fluid (CSF) leakage, such as rhinorrhea or otorrhea, is a rare complication of closed head injury. We encountered two cases of delayed CSF leakage more than 10 years after head injury. In both cases, surgical treatments were performed using intradural approaches, and the dural defects were closed with viable pedicled flaps. After surgery, the CSF leakage was completely cured and no remarkable complication was observed in either case. The present two cases of late onset CSF leakage suggest that surgical repair procedures should be performed as soon as the leaks are discovered. A bifrontal intracranial approach is recommended to treat frontal cranial base leakage. Temporal craniotomy is recommended to treat temporal base leakage. All cases should be treated using an intradural approach, and the dural defect is best repaired with viable pedicled flaps.	[Kamochi, Haruna; Kusaka, Gen; Ishikawa, Mami; Tanaka, Yuichi] Jichi Med Univ, Saitama Med Ctr, Dept Neurosurg, Saitama 3308503, Japan; [Ishikawa, Sane] Jichi Med Univ, Saitama Med Ctr, Dept Endocrinol & Metab, Saitama 3308503, Japan		Kamochi, H (corresponding author), Jichi Med Univ, Saitama Med Ctr, Dept Neurosurg, Oomiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	kamochi@jichi.ac.jp					Bernal-Sprekelsen M, 2000, AM J RHINOL, V14, P257, DOI 10.2500/105065800779954473; CRAWFORD C, 1994, J INFECTION, V28, P93, DOI 10.1016/S0163-4453(94)94378-8; Friedman JA, 2001, WORLD J SURG, V25, P1062, DOI 10.1007/s00268-001-0059-7; KAMERER DB, 1982, LARYNGOSCOPE, V92, P878; LEWIN W, 1954, BRIT J SURG, V42, P1, DOI 10.1002/bjs.18004217102; Lewin W, 1964, CLIN NEUROSURG, V12, P237; Linell EA, 1941, J NEUROL PSYCHIATRY, V4, P23, DOI 10.1136/jnnp.4.1.23; OKADA J, 1991, SURG NEUROL, V35, P213, DOI 10.1016/0090-3019(91)90073-I; Pendya PM, 1991, INJURY, V22, P492; Salca HC, 1997, SURG NEUROL, V47, P132, DOI 10.1016/S0090-3019(96)00393-X; SCHNEIDER RC, 1957, ANN SURG, V145, P517, DOI 10.1097/00000658-195704000-00008; Scholsem M, 2008, NEUROSURGERY, V62, P463, DOI [10.1227/01.NEU.0000297037.51609.07, 10.1227/01.neu.0000316014.97926.82, 10.1227/01.neu.0000325884.05871.aa]; STEWART BT, 1992, AUST NZ J SURG, V62, P818, DOI 10.1111/j.1445-2197.1992.tb06927.x; Taha M, 2009, J NEUROSURG, V111, P393, DOI 10.3171/2008.9.17662; Uemura K, 1972, SHUJUTSU, V26, P733	15	5	6	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	APR	2013	53	4					217	220		10.2176/nmc.53.217			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	128WT	WOS:000317801100004	23615410	Bronze			2022-02-06	
J	Keller, JJ; Liu, SP; Lin, HC				Keller, Joseph J.; Liu, Shih-Ping; Lin, Herng-Ching			Traumatic brain injury increases the risk of female urinary incontinence	NEUROUROLOGY AND URODYNAMICS			English	Article						urinary incontinence; traumatic brain injury; epidemiology	NERVE GROWTH-FACTOR; BLADDER OVERACTIVITY; DISEASE	Aims According to our knowledge, no study has attempted to explore the risk of urinary incontinence (UI) after traumatic brain injury (TBI). This study aimed to examine the relationship between TBI in Taiwanese women and their risk of developing UI. Methods The study was based on 2,416 female patients newly diagnosed with TBI together with 12,080 matched enrollees without a history of TBI as a comparison group. All patients were tracked for a 1-year period from their index date to identify those who developed subsequent UI. The stratified Cox proportional hazards models were performed to compute the risk of UI between groups. Results Of 14,496 patients, 104 (4.30%) from the TBI group and 192 (1.59%) from the comparison group had a diagnosis of UI during the follow-up period. The incidence rate of UI was 4.50 (95% CI: 3.695.43) per 100 person-years in patients with TBI and 1.62 (95% CI: 1.401.86) per 100 person-years in patients without TBI. The stratified Cox proportional analysis showed that after adjusting for socioeconomic status, obesity, hypertension, diabetes, and hysterectomy, the increased UI risk of patients with TBI persisted at about the same level as in the unadjusted analysis (hazard ratio=2.78; 95% CI=2.163.53). In addition, although patients with severe and moderate TBI had higher incidence rates of UI than patients with mild TBI, the difference did not reach a statistically significant level (P=0.090). Conclusions Our results suggest that an increased risk of UI exists at the first year follow-up in patients with a TBI diagnosis. Neurourol. Urodynam. 32: 354358, 2013. (c) 2012 Wiley Periodicals, Inc.	[Keller, Joseph J.] Taipei Med Univ, Sch Publ Hlth, Taipei 110, Taiwan; [Liu, Shih-Ping] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Shih-Ping] Coll Med, Taipei, Taiwan; [Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei 110, Taiwan		Lin, HC (corresponding author), Taipei Med Univ, Sch Hlth Care Adm, 250 Wu Hsing St, Taipei 110, Taiwan.	henry11111@tmu.edu.tw		LIU, SHIH-PING/0000-0002-8015-0695			Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chua K, 2003, BRAIN INJURY, V17, P469, DOI 10.1080/02699050210154268; Leary SM, 2006, CLIN REHABIL, V20, P1094, DOI 10.1177/0269215506071258; Liu HT, 2009, BJU INT, V104, P1158, DOI 10.1111/j.1464-410X.2009.08533.x; Liu HT, 2009, BJU INT, V103, P1668, DOI 10.1111/j.1464-410X.2009.08380.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Randall M, 1998, REHABILITATION TRAUM; Safaz I, 2008, BRAIN INJURY, V22, P733, DOI 10.1080/02699050802304714; Sakakibara R, 1996, J NEUROL SCI, V137, P47, DOI 10.1016/0022-510X(95)00322-S; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Tadic SD, 2008, NEUROIMAGE, V39, P1647, DOI 10.1016/j.neuroimage.2007.10.059; Yokoyama O, 1998, J UROLOGY, V159, P577, DOI 10.1016/S0022-5347(01)63987-9; Zvara Peter, 2007, BMC Physiology, V7, P9, DOI 10.1186/1472-6793-7-9	13	5	6	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0733-2467			NEUROUROL URODYNAM	Neurourol. Urodyn.	APR	2013	32	4					354	358		10.1002/nau.22309			5	Urology & Nephrology	Science Citation Index Expanded (SCI-EXPANDED)	Urology & Nephrology	132NN	WOS:000318075800009	22965745				2022-02-06	
J	Lind, K; Laurent-Vannier, A; Toure, H; Brugel, DG; Chevignard, M				Lind, K.; Laurent-Vannier, A.; Toure, H.; Brugel, D-G.; Chevignard, M.			Outcome after a shaken baby syndrome	ARCHIVES DE PEDIATRIE			French	Article							TRAUMATIC BRAIN-INJURY	The Shaken Baby Syndrome (SBS) is a severe inflicted brain injury due to an adult violently shaking an infant. Diagnostic guidelines have been recently published by the "Haute Autorite de sante". The mortality rate after SBS is 21.6% and the long-term outcome is good for only 8 to 36 % patients followed over more than 5 years. The aim of this article is to describe sequelae after a SBS, their mechanisms, prognostic factors and recommendations for a better long-term care of the patients. (C) 2012 Elsevier Masson SAS. All rights reserved.	[Lind, K.; Laurent-Vannier, A.; Toure, H.; Brugel, D-G.; Chevignard, M.] Hop St Maurice, Serv Reeduc Pathol Neurol Acquises, F-94410 St Maurice, France		Lind, K (corresponding author), Hop St Maurice, Serv Reeduc Pathol Neurol Acquises, 14 Rue Val dOsne, F-94410 St Maurice, France.	k.lind@hopitaux-st-maurice.fr					Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Barlow Karen, 2004, Pediatr Rehabil, V7, P195, DOI 10.1080/13638490410001715331; Bloch J, 2011, MORTS INATTENDUES NO; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Fanconi M, 2010, EUR J PEDIATR, V169, P1023, DOI 10.1007/s00431-010-1175-x; Jayawant S, 2007, ARCH DIS CHILD, V92, P343, DOI 10.1136/adc.2005.084988; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; King WJ, 2003, CAN MED ASSOC J, V168, P155; Laurent-Vannier A., 2011, Annals of Physical and Rehabilitation Medicine, V54, P600, DOI 10.1016/j.rehab.2011.10.002; Laurent-Vannier A, 2009, Ann Phys Rehabil Med, V52, P436, DOI 10.1016/j.rehab.2009.03.001	11	5	5	0	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0929-693X	1769-664X		ARCH PEDIATRIE	Arch. Pediatr.	APR	2013	20	4					446	448		10.1016/j.arcped.2012.04.019			3	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	125JD	WOS:000317535200022	23466403				2022-02-06	
J	Tadesse, T; Cheng, Q; Xu, M; Baro, DJ; Young, LJ; Pallas, SL				Tadesse, Tizeta; Cheng, Qi; Xu, Mei; Baro, Deborah J.; Young, Larry J.; Pallas, Sarah L.			Regulation of ephrin-A expression in compressed retinocollicular maps	DEVELOPMENTAL NEUROBIOLOGY			English	Article						retinotectal; population matching; topographic map; axon guidance; neural plasticity	GANGLION-CELL AXONS; HAMSTERS MESOCRICETUS-AURATUS; RECEPTOR TYROSINE KINASES; HALF RETINAL PROJECTION; PARTIAL TECTAL ABLATION; SUPERIOR COLLICULUS; RETINOTECTAL PROJECTION; VISUAL-SYSTEM; TOPOGRAPHIC MAPS; GOLDEN-HAMSTER	Retinotopic maps can undergo compression and expansion in response to changes in target size, but the mechanism underlying this compensatory process has remained a mystery. The discovery of ephrins as molecular mediators of Sperry's chemoaffinity process allows a mechanistic approach to this important issue. In Syrian hamsters, neonatal, partial (PT) ablation of posterior superior colliculus (SC) leads to compression of the retinotopic map, independent of neural activity. Graded, repulsive EphA receptor/ephrin-A ligand interactions direct the formation of the retinocollicular map, but whether ephrins might also be involved in map compression is unknown. To examine whether map compression might be directed by changes in the ephrin expression pattern, we compared ephrin-A2 and ephrin-A5 mRNA expression between normal SC and PT SC using in situ hybridization and quantitative real-time PCR. We found that ephrin-A ligand expression in the compressed maps was low anteriorly and high posteriorly, as in normal animals. Consistent with our hypothesis, the steepness of the ephrin gradient increased in the lesioned colliculi. Interestingly, overall levels of ephrin-A2 and -A5 expression declined immediately after neonatal target damage, perhaps promoting axon outgrowth. These data establish a correlation between changes in ephrin-A gradients and map compression, and suggest that ephrin-A expression gradients may be regulated by target size. This in turn could lead to compression of the retinocollicular map onto the reduced target. These findings have important implications for mechanisms of recovery from traumatic brain injury. (c) 2012 Wiley Periodicals, Inc. Develop Neurobiol, 2013	[Tadesse, Tizeta; Cheng, Qi; Baro, Deborah J.; Pallas, Sarah L.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [Tadesse, Tizeta; Xu, Mei; Baro, Deborah J.; Pallas, Sarah L.] Georgia State Univ, Grad Program Neurobiol & Behav, Dept Biol, Atlanta, GA 30303 USA; [Young, Larry J.] Emory Univ, Dept Psychiat & Behav Sci, Yerkes Natl Primate Res Ctr, Ctr Translat Social Neurosci, Atlanta, GA 30322 USA		Pallas, SL (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	spallas@gsu.edu	Pallas, Sarah L/W-1860-2019	Pallas, Sarah L/0000-0002-1760-7437	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY-12696, NS-38770]; NSFNational Science Foundation (NSF) [0078110, STC IBN-9876754]; GSU Research Foundation; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY012696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K02MH064692] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038770] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P51OD011132] Funding Source: NIH RePORTER	Contract grant sponsor: NIH; contract grant numbers: EY-12696 (to S.L.P.), NSF 0078110 ( to S.L.P.).; Contract grant sponsor: NSF; contract grant number: STC IBN-9876754 (to L.J.Y.).; Contract grant sponsor: NIH; contract grant number: NS-38770 (to D.J.B.).; Contract grant sponsor: GSU Research Foundation (to S.L.P. and D.J.B.).	ATTARDI DG, 1963, EXP NEUROL, V7, P46, DOI 10.1016/0014-4886(63)90093-1; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; CHALUPA LM, 1977, J PHYSIOL-LONDON, V270, P595, DOI 10.1113/jphysiol.1977.sp011971; Chen Y, 2009, NEURON, V62, P773, DOI 10.1016/j.neuron.2009.05.023; CHENG HJ, 1994, CELL, V79, P157, DOI 10.1016/0092-8674(94)90408-1; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Ciossek T, 1998, EUR J NEUROSCI, V10, P1574, DOI 10.1046/j.1460-9568.1998.00180.x; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; CONSTANTINEPATON M, 1983, TRENDS NEUROSCI, V6, P32, DOI 10.1016/0166-2236(83)90012-7; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Dickinson ME, 1992, CURR OPIN GENET DEV, V2, P562, DOI 10.1016/S0959-437X(05)80172-8; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; FINLAY BL, 1979, NATURE, V280, P153, DOI 10.1038/280153a0; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; FINLAY BL, 1978, BRAIN RES, V142, P223, DOI 10.1016/0006-8993(78)90632-7; FINLAY BL, 1981, EXP NEUROL, V72, P308, DOI 10.1016/0014-4886(81)90225-9; Flenniken AM, 1996, DEV BIOL, V179, P382, DOI 10.1006/dbio.1996.0269; Friedman GC, 1996, J NEUROSCI, V16, P5498; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Fritzsche P, 2006, BEHAV ECOL SOCIOBIOL, V60, P220, DOI 10.1007/s00265-006-0159-3; FROST DO, 1979, NEUROSCIENCE, V4, P1649, DOI 10.1016/0306-4522(79)90026-5; Frugier T, 2012, J NEUROPATH EXP NEUR, V71, P242, DOI 10.1097/NEN.0b013e3182496149; Gattermann R, 2001, J ZOOL, V254, P359, DOI 10.1017/S0952836901000851; GAZE R M, 1970, Experimental Brain Research, V10, P171; Gebhardt C, 2012, DEVELOPMENT, V139, P335, DOI 10.1242/dev.070474; Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Gosse NJ, 2009, P NATL ACAD SCI USA, V106, P2236, DOI 10.1073/pnas.0803202106; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Honda H, 2004, DEV GROWTH DIFFER, V46, P425; HOPE RA, 1976, PROC R SOC SER B-BIO, V194, P447, DOI 10.1098/rspb.1976.0088; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Huang L, 2001, J NEUROPHYSIOL, V86, P1179, DOI 10.1152/jn.2001.86.3.1179; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7; Knoll B, 2001, MECH DEVELOP, V106, P119, DOI 10.1016/S0925-4773(01)00431-2; Koulakov AA, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-30; Lai KO, 1999, FEBS LETT, V458, P265, DOI 10.1016/S0014-5793(99)01159-X; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Li JYH, 2001, DEVELOPMENT, V128, P4979; Logan C, 1996, CURR BIOL, V6, P1006, DOI 10.1016/S0960-9822(02)00645-0; Lukehurst SS, 2006, EXP BRAIN RES, V173, P546, DOI 10.1007/s00221-006-0615-3; Mortimer D, 2010, P NATL ACAD SCI USA, V107, P5202, DOI 10.1073/pnas.0909254107; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; Pallas S. L., 2007, THEORIES DEV INVERTE, V1, P153, DOI 10.1016/b0-12-370878-8/00101-4; PALLAS SL, 1989, VISUAL NEUROSCI, V2, P121, DOI 10.1017/S0952523800011986; PALLAS SL, 1991, VISUAL NEUROSCI, V6, P271, DOI 10.1017/S0952523800006271; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Picker A, 1999, DEVELOPMENT, V126, P2967; Razak KA, 2003, J NEUROPHYSIOL, V90, P110, DOI 10.1152/jn.01029.2002; Razak KA, 2003, SOC NEUR ABSTR, V29, P3724; Razak KA, 2007, J NEUROSCI, V27, P7275, DOI 10.1523/JNEUROSCI.1143-07.2007; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Rodger J, 2005, EUR J NEUROSCI, V22, P1840, DOI 10.1111/j.1460-9568.2005.04381.x; Rodger J, 2001, EUR J NEUROSCI, V14, P1929, DOI 10.1046/j.0953-816x.2001.01822.x; ROELINK H, 1990, P NATL ACAD SCI USA, V87, P4519, DOI 10.1073/pnas.87.12.4519; Rosentreter SM, 1998, J NEUROBIOL, V37, P541, DOI 10.1002/(SICI)1097-4695(199812)37:4<541::AID-NEU4>3.0.CO;2-L; Rosoff WJ, 2004, NAT NEUROSCI, V7, P678, DOI 10.1038/nn1259; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; SCHMIDT JT, 1978, J COMP NEUROL, V177, P257, DOI 10.1002/cne.901770206; SCHMIDT JT, 1983, J EMBRYOL EXP MORPH, V77, P39; SCHMIDT JT, 1982, TRENDS NEUROSCI, V5, P111, DOI 10.1016/0166-2236(82)90069-8; SCHMIDT JT, 1978, J COMP NEUROL, V177, P279, DOI 10.1002/cne.901770207; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shigetani Y, 1997, NEUROSCI RES, V27, P211, DOI 10.1016/S0168-0102(96)01151-0; Simpson HD, 2011, BIOL CYBERN, V104, P9, DOI 10.1007/s00422-011-0417-y; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STEIN BE, 1979, J COMP NEUROL, V183, P269, DOI 10.1002/cne.901830205; Stevens CF, 2001, NATURE, V411, P193, DOI 10.1038/35075572; Sugiyama S, 1998, DEV GROWTH DIFFER, V40, P157; Symonds ACE, 2007, EUR J NEUROSCI, V25, P744, DOI 10.1111/j.1460-9568.2007.05321.x; Symonds ACE, 2000, EXP NEUROL, V170, P364, DOI 10.1006/exnr.2001.7722; TIAO YC, 1976, J COMP NEUROL, V168, P483; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Triplett JW, 2011, P NATL ACAD SCI USA, V108, P19060, DOI 10.1073/pnas.1102834108; UDIN SB, 1988, ANNU REV NEUROSCI, V11, P289, DOI 10.1146/annurev.ne.11.030188.001445; von Philipsborn AC, 2006, DEVELOPMENT, V133, P2487, DOI 10.1242/dev.02412; WALTER J, 1987, DEVELOPMENT, V101, P685; WALTER J, 1987, DEVELOPMENT, V101, P909; WIKLER KC, 1986, DEV BRAIN RES, V28, P11, DOI 10.1016/0165-3806(86)90060-X; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Willshaw D, 2006, DEVELOPMENT, V133, P2705, DOI 10.1242/dev.02430; WILLSHAW DJ, 1979, PHILOS T ROY SOC B, V287, P203, DOI 10.1098/rstb.1979.0056; XIONG MJ, 1994, J COMP NEUROL, V344, P581, DOI 10.1002/cne.903440407; XIONG MJ, 1993, J COMP NEUROL, V330, P455, DOI 10.1002/cne.903300402; Yamada T, 2001, J NEUROBIOL, V47, P245, DOI 10.1002/neu.1032; YOON MG, 1976, J PHYSIOL-LONDON, V257, P621, DOI 10.1113/jphysiol.1976.sp011388	96	5	5	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-8451			DEV NEUROBIOL	Dev. Neurobiol.	APR	2013	73	4					274	296		10.1002/dneu.22059			23	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	104CF	WOS:000315966500002	23008269	Green Accepted			2022-02-06	
J	Zhang, J; Groff, RF; Dayawansa, S				Zhang, J.; Groff, R. F.; Dayawansa, S.			Imipramine treatment increases cell proliferation following fluid percussion brain injury in rats	NEUROLOGICAL RESEARCH			English	Article						Imipramine; Neurogenesis; Traumatic brain injury; Rats; FPI	HIPPOCAMPAL NEUROGENESIS; SEROTONIN; PREVALENCE; EXPRESSION; MODELS	Objective: Researchers have observed unsustainable neurogenesis of the dentate gyrus of the hippocampus, as well as cognitive improvements in short-term imipramine-treated mice following a controlled cortical impact (CCI) model of traumatic brain injury (TBI). But they have yet to investigate the effects of a longer-duration imipramine treatment. In this study, we investigated the effects of a longer treatment regimen on rats following a fluid percussion injury (FPI) model, which creates a brain injury that more closely resembles those incurred by human patients. Methods: We administered imipramine to rats for 8 weeks following FPI. Brain histology was performed to measure neurogenesis and cognitive recovery was evaluated using the Morris water maze (MWM). Results: The Injury+imipramine group demonstrated 172% neurogenesis relative to the injury alone group at 9+ weeks in the dentate gyrus of the hippocampus. Neurogenesis observed here involved both the injured and the uninjured sides of the brain. All four groups (FPI+imipramine, FPI, sham, sham+imipramine) showed a similar performance in the MWM task. Discussion: Longer duration of treatment with imipramine promotes sustained increase in hippocampal cell proliferation and survival. Global neurogenesis corresponds to the diffuse nature of FPI injury. Cognitive outcome can be due to a delay in our behavior testing as much as an absence of cognitive benefit of imipramine at this stage of neurogenesis. Nevertheless, exploring the potential benefits of prophylactic antidepressant treatment in human TBI patients is worthwhile.	[Zhang, J.] Peoples Liberat Army Gen Hosp, Dept Neurosurg, Beijing, Peoples R China; [Groff, R. F.] Stanford Univ, Dept Anesthesiol, Stanford, CA 94305 USA; [Dayawansa, S.] Univ Rochester, Dept Neurosurg, Rochester, NY 14642 USA; [Dayawansa, S.] Univ Rochester, Ctr Neural Dev & Dis, Rochester, NY 14642 USA		Dayawansa, S (corresponding author), Univ Rochester, Dept Neurosurg, 575 Elmwood Ave,Box 670, Rochester, NY 14642 USA.	samantha_dayawansa@URMC.Rochester.edu					Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Amos-Kroohs RM, 2011, NEUROSCI LETT, V502, P152, DOI 10.1016/j.neulet.2011.07.013; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bijak M, 1996, EUR J PHARMACOL, V305, P79, DOI 10.1016/0014-2999(96)00151-3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Chen FH, 2010, HIPPOCAMPUS, V20, P1376, DOI 10.1002/hipo.20718; Chen XH, 2003, J NEUROTRAUM, V20, P623, DOI 10.1089/089771503322144545; Clausen F, 2007, ACTA NEUROCHIR WIEN, V147, P775; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Duman RS, 2004, NEUROMOL MED, V5, P11, DOI 10.1385/NMM:5:1:011; Duman RS, 2001, NEUROPSYCHOPHARMACOL, V25, P836, DOI 10.1016/S0893-133X(01)00358-X; Fuchs E, 2000, EUR J NEUROSCI, V12, P2211, DOI 10.1046/j.1460-9568.2000.00130.x; Gambarana C, 2001, BRAIN RES PROTOC, V7, P11, DOI 10.1016/S1385-299X(00)00056-8; Gould E, 1999, NEUROPSYCHOPHARMACOL, V21, pS46, DOI 10.1038/sj.npp.1395369; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Hata M, 2011, SURG TODAY, V41, P791, DOI 10.1007/s00595-010-4357-2; Imielski Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030838; JEFFERY KJ, 1993, HIPPOCAMPUS, V3, P133, DOI 10.1002/hipo.450030205; Knuuttila JEA, 2004, NEUROCHEM RES, V29, P1235, DOI 10.1023/B:NERE.0000023610.89631.d6; Lu DY, 2003, J NEUROSURG, V99, P351, DOI 10.3171/jns.2003.99.2.0351; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Michelson D, 1997, J CLIN ENDOCR METAB, V82, P2601, DOI 10.1210/jc.82.8.2601; MILLER MW, 1988, BRAIN RES, V457, P44, DOI 10.1016/0006-8993(88)90055-8; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; RICHTER-LEVIN G, 1991, J NEUROSCI, V11, P1585; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schiavon AP, 2010, NEUROSCI LETT, V470, P43, DOI 10.1016/j.neulet.2009.12.052; Serretti A, 2010, EUR NEUROPSYCHOPHARM, V20, P433, DOI 10.1016/j.euroneuro.2009.11.009; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Thome J, 2000, J NEUROSCI, V20, P4030; Tokarski K, 1996, Acta Physiol Hung, V84, P343; Van Hoomissen JD, 2003, BRAIN RES, V974, P228, DOI 10.1016/S0006-8993(03)02584-8; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	38	5	5	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	APR	2013	35	3					247	254		10.1179/1743132813Y.0000000164			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	104QW	WOS:000316010700005	23485052				2022-02-06	
J	Ahmed, SI; Burns, TC; Landt, C; Hayda, R				Ahmed, Syed I.; Burns, Travis C.; Landt, Cristy; Hayda, Roman			Heterotopic Ossification in High-Grade Open Fractures Sustained in Combat: Risk Factors and Prevalence	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						heterotopic ossification; open fracture; war; combat	TRAUMATIC BRAIN-INJURY; TOTAL HIP-ARTHROPLASTY; BONE-FORMATION; ECTOPIC OSSIFICATION; ORTHOPEDIC INJURIES; OPERATIVE TREATMENT; KNEE DISLOCATION; PROGENITOR CELLS; CALLUS FORMATION; SEVERITY SCORE	Objectives: To determine the prevalence and identify the risk factors for heterotopic ossification (HO) formation in high-grade open fractures sustained during combat and to report on the results of HO excision. Design: Retrospective. Setting: United States Army level-1 trauma center. Patients/Participants: Seventy-six consecutive patients with 91 combat-related open Gustilo and Anderson type II and higher fractures were identified from March 1, 2003, through January 30, 2005. Fifty-nine patients with 71 fractures met criteria for study inclusion. Main Outcome Measurements: Fractures were categorized into HO-present and HO-absent groups based on radiographic imaging. Risk factors such as injury mechanism, injury severity score (ISS), Gustilo and Anderson type, injury location, closed head injury, burn, and infection were compared between the groups. Results: HO was present in 27 of 71 open fractures (38.1%). Variables associated with HO formation included ISS (p = 0.02) and injury location although infection and use of negative pressure therapy were not. Ten of 27 fractures with HO underwent excision. HO did not occur or was mild in 25 tibiae. Conclusions: HO is a common sequela of high-grade open fractures sustained in combat. High ISS and injury location to the shoulder, hip, and femur are risk factors for HO formation. The most common regions for HO excision were the elbow, forearm, and hip with mixed results. Importantly, HO did not seem to be a complication of open high-grade tibia fractures.	[Ahmed, Syed I.] Landstuhl Reg Med Ctr, Dept Orthopaed Surg, Landstuhl, Germany; [Burns, Travis C.] Brooke Army Med Ctr, Dept Orthopaed & Rehabil, Ft Sam Houston, TX 78234 USA; [Landt, Cristy] Brooke Army Med Ctr, Dept Clin Invest, Ft Sam Houston, TX 78234 USA; [Hayda, Roman] Brown Univ, Rhode Isl Hosp, Warren Alpert Sch Med, Div Orthoped Trauma, Providence, RI 02903 USA		Ahmed, SI (corresponding author), Med Corps, CMR 402 Box 636, Apo, AE 09180 USA.	ahmedi01@yahoo.com	Hayda, Roman/AAN-6001-2020				BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barrack RL, 2002, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000030497.43495.3f; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Boes M, 2006, J BONE JOINT SURG AM, V88A, P738, DOI 10.2106/JBJS.D.02648; BOSSE MJ, 1988, J BONE JOINT SURG AM, V70A, P1231, DOI 10.2106/00004623-198870080-00016; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P938; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Covey CDC, 2002, J BONE JOINT SURG AM, V84A, P1221, DOI 10.2106/00004623-200207000-00022; de Palma L, 2002, ORTHOPEDICS, V25, P665; Della Valle AG, 2002, J ARTHROPLASTY, V17, P870, DOI 10.1054/arth.2002.34819; Ebinger T, 2000, J TRAUMA, V48, P1058, DOI 10.1097/00005373-200006000-00010; EVANS EB, 1991, CLIN ORTHOP RELAT R, P94; Forsberg JA, 2009, J BONE JOINT SURG AM, V91A, P1084, DOI 10.2106/JBJS.H.00792; Fransen M, 2009, HIP INT, V19, P41, DOI 10.1177/112070000901900108; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P219; GARLAND DE, 1980, CLIN ORTHOP RELAT R, P198; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Giannoudis PV, 2007, INJURY, V38, P1224; GUSTILO RB, 1984, J TRAUMA, V24, P742, DOI 10.1097/00005373-198408000-00009; GUSTILO RB, 1987, ORTHOPEDICS, V10, P1781; GUSTILO RB, 1976, J BONE JOINT SURG AM, V58, P453, DOI 10.2106/00004623-197658040-00004; HASTINGS H, 1994, HAND CLIN, V10, P417; Hildebrand F, 2004, INJURY, V35, P678, DOI 10.1016/j.injury.2004.03.004; Hunt JL, 2006, J BURN CARE RES, V27, P535, DOI 10.1097/01.BCR.0000226023.58438.14; Ilahi OA, 1998, ORTHOPEDICS, V21, P265; Ilahi OA, 2001, ORTHOPEDICS, V24, P1075; Iorio Richard, 2002, J Am Acad Orthop Surg, V10, P409; Islinger RB, 2000, MIL MED, V165, P463, DOI 10.1093/milmed/165.6.463; Jupiter JB, 1998, J BONE JOINT SURG AM, V80A, P248, DOI 10.2106/00004623-199802000-00012; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; King JB, 1998, BRIT J SPORT MED, V32, P287, DOI 10.1136/bjsm.32.4.287; Lane JE, 2002, POSTGRAD MED J, V78, P494, DOI 10.1136/pmj.78.922.494; Lin DL, 2004, MIL MED, V169, P807, DOI 10.7205/MILMED.169.10.807; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; McCarthy EF, 2005, SKELETAL RADIOL, V34, P609, DOI 10.1007/s00256-005-0958-z; Mills WJ, 2003, J ORTHOP TRAUMA, V17, P338, DOI 10.1097/00005131-200305000-00004; Mitchell EJ, 2010, J ORTHOP TRAUMA, V24, P530, DOI 10.1097/BOT.0b013e3181ed147b; Muller M., 1990, COMPREHENSIVE CLASSI; Nesti LJ, 2008, J BONE JOINT SURG AM, V90A, P2390, DOI 10.2106/JBJS.H.00049; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Pape HC, 2001, J ORTHOP TRAUMA, V15, P229, DOI 10.1097/00005131-200105000-00001; Potter BK, 2007, J BONE JOINT SURG AM, V89A, P476, DOI 10.2106/JBJS.F.00412; PUZAS JE, 1989, CLIN ORTHOP RELAT R, P269; ROUTT MLC, 1990, J BONE JOINT SURG AM, V72A, P897, DOI 10.2106/00004623-199072060-00016; Simonsen LL, 2007, INJURY, V38, P1146, DOI 10.1016/j.injury.2007.03.019; Stannard JP, 2002, ARTHROSCOPY, V18, P835, DOI 10.1053/jars.2002.32842; STEINBERG GG, 1993, J ORTHOP TRAUMA, V7, P536, DOI 10.1097/00005131-199312000-00009; THOMAS BJ, 1992, ORTHOP CLIN N AM, V23, P347; Thompson H C 3rd, 1967, Clin Orthop Relat Res, V50, P129; Tsionos I, 2004, J BONE JOINT SURG BR, V86B, P396, DOI 10.1302/0301-620X.86B3.14480; VINCE KG, 1987, J BONE JOINT SURG AM, V69A, P640, DOI 10.2106/00004623-198769050-00002; Viola RW, 2000, CLIN ORTHOP RELAT R, P65; WENNER SM, 1986, CLIN ORTHOP RELAT R, P231; WHARTON GW, 1975, CLIN ORTHOP RELAT R, P142; Zagaja GP, 1999, J UROLOGY, V161, P1950, DOI 10.1016/S0022-5347(05)68862-3	59	5	6	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	MAR	2013	27	3					162	169		10.1097/BOT.0b013e31825cf742			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	098CD	WOS:000315521400013	22584683				2022-02-06	
J	Ihrig, C				Ihrig, Carolyn			Vision Rehabilitation Team Management of Acquired Monocular Vision	OPTOMETRY AND VISION SCIENCE			English	Article						perception; decreased visual field; traumatic brain injury; independence; safety; depression; monocular motility skills; Monocular Visual Functioning Questionnaire; polycarbonate lenses; mirrors; accessing peripheral visual field; orientation and mobility training; Wii therapy	VISUAL ANGLE; DEPTH; SIZE; CUES; MOTION	Purpose. Existing low-vision programs do not readily meet the needs of the monocular patient. This case report illustrates the implementation and benefits of an Acquired Monocular Vision Rehabilitation (AMVR) evaluation and training program from the patient's perspective. The AMVR program guides and teaches specific skills to each monocular patient. Adaptive skills are demonstrated to enhance and maximize the person's remaining monocular vision; to teach visual skills; to acquire and maintain independence, living, and functioning; and prevent depression. The purpose of this article is to illustrate the potential for monocular vision rehabilitation and justify adding monocular rehabilitation therapy to current vision rehabilitation programs and encourage future clinical case studies to measure functional outcomes. Case Report. This case report illustrates one example of concurrent vision rehabilitation team management including low-vision optometrists, ophthalmologists, blind rehabilitation specialists (also known as vision rehabilitation therapist), and orientation and mobility instructors (O&M) of a later stage acquired monocular patient within a 1-year period. Conclusions. After completion of the AMVR program (detailed components available in Appendices, available at http://links.lww.com/OPX/A114), our patient expressed an increase in self-confidence, improved motor skills, and less depression since learning more about his condition and adaptations he can maintain. He stated that he feels he is a "better me.'' The patient's positive feedback encourages further data to be collected with future monocular patients evaluated at an earlier stage of their vision loss and to continue to structure supportive services by demonstrating new adaptive techniques and exercises to show each person "is-able'' and not "dis-abled.'' (Optom Vis Sci 2013; 90:e89-e94)	[Ihrig, Carolyn] Buffalo Vet Affairs Med Ctr, VISOR, Buffalo, NY USA; [Ihrig, Carolyn] SUNY Buffalo, Sch Med & Biomed Sci, Ira G Ross Eye Inst, Buffalo, NY 14260 USA		Ihrig, C (corresponding author), 3495 Bailey Ave MC 117, Buffalo, NY 14215 USA.	carolyn.ihrig@va.gov					Bradshaw MF, 1996, VISION RES, V36, P3457, DOI 10.1016/0042-6989(96)00072-7; Brady FrankB, 1994, SINGULAR VIEW ART SE; Coday MP, 2002, OPHTHALMIC PLAST REC, V18, P56, DOI 10.1097/00002341-200201000-00009; COLLETT TS, 1991, PERCEPTION, V20, P733, DOI 10.1068/p200733; Cutting J. E., 1995, HDB PERCEPTION COGNI, P69, DOI DOI 10.1016/B978-012240530-3/50005-5; Dijkerman HC, 1996, EXP BRAIN RES, V112, P442; ERIE JC, 1992, AM J OPHTHALMOL, V113, P138, DOI 10.1016/S0002-9394(14)71525-9; Gogel WC, 1997, PERCEPT PSYCHOPHYS, V59, P783, DOI 10.3758/BF03206024; Ihrig C, 2007, J REHABIL RES DEV, V44, P593, DOI 10.1682/JRRD.2006.06.0071; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Knill DC, 2005, J VISION, V5, P103, DOI 10.1167/5.2.2; Marotta JJ, 1997, EXP BRAIN RES, V116, P113, DOI 10.1007/PL00005731; MCCREADY D, 1985, PERCEPT PSYCHOPHYS, V37, P323, DOI 10.3758/BF03211355; McTigue JW, 1994, SINGULAR VIEW ART SE; ReinhardtRutland AH, 1996, J GEN PSYCHOL, V123, P237, DOI 10.1080/00221309.1996.9921276; Stelmack JA, 2006, INVEST OPHTH VIS SCI, V47, P3253, DOI 10.1167/iovs.05-1319	16	5	5	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	MAR	2013	90	3					E89	E94		10.1097/OPX.0b013e3182820d74			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	097FH	WOS:000315458900001	23400025				2022-02-06	
J	Raghubar, KP; Barnes, MA; Prasad, M; Johnson, CP; Ewing-Cobbs, L				Raghubar, Kimberly P.; Barnes, Marcia A.; Prasad, Mary; Johnson, Chad P.; Ewing-Cobbs, Linda			Mathematical Outcomes and Working Memory in Children With TBI and Orthopedic Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Head injury; Cognitive addition; Math fluency; Calculation; Math problem solving; Verbal working memory; Visual-spatial working memory	TRAUMATIC BRAIN-INJURY; ACADEMIC-ACHIEVEMENT; HEAD-INJURY; SKILLS; PERFORMANCE; DEFICIT; MILD; ADOLESCENTS; COMPUTATION; PREDICTORS	This study compared mathematical outcomes in children with predominantly moderate to severe traumatic brain injury (TBI; n=50) or orthopedic injury (OI; n=47) at 2 and 24 months post-injury. Working memory and its contribution to math outcomes at 24 months post-injury was also examined. Participants were administered an experimental cognitive addition task and standardized measures of calculation, math fluency, and applied problems; as well as experimental measures of verbal and visual-spatial working memory. Although children with TBI did not have deficits in foundational math fact retrieval, they performed more poorly than OIs on standardized measures of math. In the TBI group, performance on standardized measures was predicted by age at injury, socioeconomic status, and the duration of impaired consciousness. Children with TBI showed impairments on verbal, but not visual working memory relative to children with OI. Verbal working memory mediated group differences on math calculations and applied problems at 24 months post-injury. Children with TBI have difficulties in mathematics, but do not have deficits in math fact retrieval, a signature deficit of math disabilities. Results are discussed with reference to models of mathematical cognition and disability and the role of working memory in math learning and performance for children with TBI. (JINS, 2013, 19, 254-263)	[Raghubar, Kimberly P.] Univ Houston, Dept Psychol, Houston, TX USA; [Barnes, Marcia A.; Prasad, Mary; Johnson, Chad P.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Dept Pediat, Houston, TX USA; [Barnes, Marcia A.; Prasad, Mary; Johnson, Chad P.; Ewing-Cobbs, Linda] Univ Texas Hlth Sci Ctr Houston, Childrens Learning Inst, Houston, TX USA		Ewing-Cobbs, L (corresponding author), Univ Texas Houston Hlth Sci Ctr, Childrens Learning Inst, Dept Pediat, 7000 Fannin UCT 2401, Houston, TX 77030 USA.	linda.ewing-cobbs@uth.tmc.edu		Raghubar, Kimberly/0000-0002-9332-181X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS046308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046308] Funding Source: NIH RePORTER	This publication was supported by Grant Number R01 NS046308 from the National Institute of Neurological Disorders and Stroke. The authors report no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health.	Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; ASHCRAFT MH, 1992, COGNITION, V44, P75, DOI 10.1016/0010-0277(92)90051-I; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL; Ayr LK, 2005, J INT NEUROPSYCH SOC, V11, P249, DOI 10.1017/S1355617705050307; Barnes M. A., 2007, WHY IS MATH SO HARD, P195; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Barnes MA, 2006, J LEARN DISABIL-US, V39, P174, DOI 10.1177/00222194060390020601; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bisanz J., 2005, HDB MATH COGNITION, P143; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2009, NEUROPSYCHOL REHABIL, V19, P716, DOI 10.1080/09602010902732868; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Chein JM, 2010, PSYCHON B REV, V17, P193, DOI 10.3758/PBR.17.2.193; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; Cornoldi C, 2001, CHILD NEUROPSYCHOL, V7, P230, DOI 10.1076/chin.7.4.230.8735; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1995, TRAUMATIC HEAD INJUR, P3; Fuchs LS, 2006, J EDUC PSYCHOL, V98, P29, DOI 10.1037/0022-0663.98.1.29; Fuchs LS, 2008, J EDUC PSYCHOL, V100, P30, DOI 10.1037/0022-0663.100.1.30; GEARY DC, 1990, J EXP CHILD PSYCHOL, V49, P363, DOI 10.1016/0022-0965(90)90065-G; GEARY DC, 1992, PSYCHOL SCI, V3, P180, DOI 10.1111/j.1467-9280.1992.tb00023.x; Gorman S., 2011, J INT NEUROPSYCH SOC, V17, P1; Hanich LB, 2001, J EDUC PSYCHOL, V93, P615, DOI 10.1037/0022-0663.93.3.615; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hecht SA, 2001, J EXP CHILD PSYCHOL, V79, P192, DOI 10.1006/jecp.2000.2586; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Holmes J., 2006, EDUC PSYCHOL-UK, V26, P339, DOI [10.1080/01443410500341056, DOI 10.1080/01443410500341056]; Holmes J, 2008, EUR J COGN PSYCHOL, V20, P272, DOI 10.1080/09541440701612702; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; HUTTENLOCHER J, 1994, J EXP PSYCHOL GEN, V123, P284, DOI 10.1037/0096-3445.123.3.284; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Mabbott DJ, 2008, J LEARN DISABIL-US, V41, P15, DOI 10.1177/0022219407311003; Mazzocco M. M. M., 2007, WHY IS MATH SO HARD, P173; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Menon V, 2002, HUM BRAIN MAPP, V16, P119, DOI 10.1002/hbm.10035; MURRAY R, 1992, BRAIN COGNITION, V18, P99, DOI 10.1016/0278-2626(92)90072-T; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; RIVERABATIZ FL, 1992, J HUM RESOUR, V27, P313, DOI 10.2307/145737; Roncadin C, 2004, DEV NEUROPSYCHOL, V25, P21; Shah, 1999, MODELS WORKING MEMOR, DOI DOI 10.1017/CBO9781139174909.005; Swanson HL, 2006, REV EDUC RES, V76, P249, DOI 10.3102/00346543076002249; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Woodcock R.W., 2001, WOODCOCK JOHNSON PSY; [No title captured]	61	5	5	1	18	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2013	19	3					254	263		10.1017/S1355617712001312			10	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	107DV	WOS:000316195900003	23164058	Green Accepted			2022-02-06	
J	Rowson, S; Duma, SM				Rowson, Steven; Duma, Stefan M.			The temperature inside football helmets during head impact: a five-year study of collegiate football games	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Impact biomechanics; helmet testing; concussion; brain injury; STAR evaluation system; head acceleration	CHRONIC TRAUMATIC ENCEPHALOPATHY; BIOMECHANICAL RESPONSE; PULMONARY CONTUSION; INJURY; ACCELERATION; EPIDEMIOLOGY; CONCUSSIONS; KINEMATICS; LOCATION; PLAYERS	The objective of this study was to measure in-helmet temperature at the time of impact in a large cohort of football players, as such data can provide new insight to the temperatures helmets should be evaluated at during experimental testing that assess helmet safety. A large cohort of Virginia Tech football players were instrumented with the HIT System (Simbex, Lebanon, NH, USA), which recorded in-helmet temperature and head acceleration for head impacts experienced during 60 games between 2006 and 2010. The average in-helmet temperature at time of impact was 76.4 degrees F +/- 10.1 degrees F (24.6 degrees C +/- 65.6 degrees C). In-helmet temperature was strongly correlated to the ambient temperature of the game. Head acceleration resulting from impact varied less than 10% across temperatures, and temperature did not significantly influence head acceleration. These data have implications for the testing conditions used in the laboratory when evaluating the safety of helmets.	[Rowson, Steven; Duma, Stefan M.] Wake Forest Univ, Virginia Tech, Ctr Injury Biomech, Blacksburg, VA 24061 USA		Rowson, S (corresponding author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Ctr Injury Biomech, 440 ICTAS Bldg,Stanger St, Blacksburg, VA 24061 USA.	srowson@vt.edu	Duma, Stefan/A-8368-2012; Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	National Institutes of Health (National Institute for Child Health and Human Development)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD048638]	The authors gratefully acknowledge the National Institutes of Health (National Institute for Child Health and Human Development) R01HD048638 for sponsoring this research.	Beeman SM, 2011, ANN BIOMED ENG, V39, P2998, DOI 10.1007/s10439-011-0379-1; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Crisco JJ, 2004, J BIOMECH ENG-T ASME, V126, P849, DOI 10.1115/1.1824135; Crisco JJ, 2011, CURR SPORT MED REP, V10, P7, DOI 10.1249/JSR.0b013e318205e063; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Daly M, 2008, CLIN IMAG, V32, P346, DOI 10.1016/j.clinimag.2008.02.026; Duma SM, 2011, CLIN ANAT, V24, P327, DOI 10.1002/ca.21130; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Duma SM, 2011, EXERC SPORT SCI REV, V39, P2, DOI 10.1097/JES.0b013e318203dfdb; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gayzik FS, 2011, BIOMECH MODEL MECHAN, V10, P505, DOI 10.1007/s10237-010-0251-5; Gayzik FS, 2009, J TRAUMA, V66, P840, DOI 10.1097/TA.0b013e318186251e; Gayzik FS, 2008, J BIOMECH, V41, P1545, DOI 10.1016/j.jbiomech.2008.02.006; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hackney JR, 1995, 851245 SAE; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hoth JJ, 2006, J TRAUMA, V61, P32, DOI 10.1097/01.ta.0000224141.69216.aa; Kemper AR, 2011, ANN BIOMED ENG, V39, P2141, DOI 10.1007/s10439-011-0311-8; Kemper AR, 2012, J BIOMECH, V45, P348, DOI 10.1016/j.jbiomech.2011.10.022; Kemper AR, 2009, J APPL BIOMECH, V25, P165, DOI 10.1123/jab.25.2.165; Laituri TR, 2010, TRAFFIC INJ PREV, V11, P371, DOI 10.1080/15389581003739685; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Manoogian SJ, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3194694; Manoogian SJ, 2008, J BIOMECH, V41, P3436, DOI 10.1016/j.jbiomech.2008.09.020; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2007, NEUROSURGERY, V61, P35; NOCSAE, 2011, STAND PERF SPEC NEWL; NOCSAE (National Operating Committee on Standards for Athletic Equipment), 2011, STAND TEST METH EQ U; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Rowson S, 2008, CLIN J SPORT MED, V18, P316, DOI 10.1097/JSM.0b013e31817f016a; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Rowson S, 2010, CLIN J SPORT MED, V20, P344, DOI 10.1097/JSM.0b013e3181ed7e50; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Stitzel J, 2005, INVEST OPHTH VIS SCI, V46	42	5	5	0	8	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	MAR	2013	227	P1					12	19		10.1177/1754337112442620			8	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	149UJ	WOS:000319346600002					2022-02-06	
J	Vandenberk, N; Unluer, EE; Gokmen, N; Yurekli, I; Okmen, E; Yilmaz, O; Yigit, S; Kara, PH				Vandenberk, Nergiz; Unluer, Erden Erol; Gokmen, Necati; Yurekli, Ismail; Okmen, Elvan; Yilmaz, Osman; Yigit, Seyran; Kara, Pinar Hanife			Neuroprotective effects of progesterone in spinal cord ischemia in rabbits	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; METHYLPREDNISOLONE; TRIAL; RATS; EXPRESSION; INFARCTION; RECEPTORS; ESTRADIOL; RECOVERY; EDEMA	Background: This experimental study was performed to investigate the neuroprotective effects of progesterone on spinal cord ischemia in rabbits. Methods: Eighteen female New Zealand white rabbits were used in this study. Rabbits were randomized into 3 groups. Spinal cord ischemia was induced by clamping the abdominal aorta from a point just inferior to the left renal artery to the aortic bifurcation for a period of 30 minutes. Group 1 served as the control group, and groups 2 and 3 received intraperitoneal progesterone immediately after the onset of reperfusion, at a dose of 8 mg/kg. Two hours after reperfusion, the animals in group 1 were killed. Four hours after reperfusion, the animals in group 2 were killed, and 6 hours after reperfusion, the group 3 rabbits were killed. Spinal cords were removed and fixed in 10% formalin in a phosphate buffer. Neuronal injury was evaluated by a pathologist who was blinded to the treatment groups, and 5 sections per animal were evaluated. The number of intact large motor neuron cells in the ventral grey matter region was counted. Results: The analysis revealed that the average mean arterial pressure for group 1 was significantly higher than that for group 2, and the mean sacrificed pressure value for group 1 was significantly higher than that for group 3 (P < .05). The number of intact neurons in group 1 was significantly lower than the number of intact neurons found in both groups 2 and 3 (P < .05). No other statistically significant differences were found between the groups. Conclusion: The findings from the present study indicate that progesterone effectively protects the spinal cord tissues against ischemic damage in the setting of decreased perfusion. (C) 2013 Elsevier Inc. All rights reserved.	[Vandenberk, Nergiz; Unluer, Erden Erol; Kara, Pinar Hanife] Izmir Katip Celebi Univ, Ataturk Egitim Arastirma Hastanesi, Acil Tip Klin, Basin Sitesi Karabaglar, Turkey; [Gokmen, Necati; Okmen, Elvan] Dokuz Eylul Univ, Tip Fak, Anestezi Reanimasyon Anabilim Dali Balcova Izmir, Izmir, Turkey; [Yurekli, Ismail] Izmir Katip Celebi Univ, Izmir Ataturk Egitim Arastirma Hastanesi, Kalp Damar Cerrahisi Anabilim Dali, Basin Sitesi Karabaglar, Turkey; [Yilmaz, Osman] Dokuz Eylul Univ, Tip Fak, Lab Hayvanlari Anabilim Dali, TR-35210 Alsancak, Turkey; [Yigit, Seyran] Izmir Katip Celebi Univ, Izmir Ataturk Egitim Arastirma Hastanesi Patoloji, Izmir, Turkey		Vandenberk, N (corresponding author), Izmir Katip Celebi Univ, Ataturk Egitim Arastirma Hastanesi, Acil Tip Klin, Basin Sitesi Karabaglar, Turkey.	nvandenberk@yahoo.com; erdenun@mynet.com; drnecatigokmen@deu.edu.tr; ismailyurekli@hotmail.com; elvanokmen@deu.edu.tr; osmanyilmaz@deu.edu.tr; seyranyigit@hotmail.com	ocmen, elvan/Q-2497-2019; Gokmen, Necati/J-9761-2019; Gokmen, Necati/B-1775-2008; YILMAZ, Osman/V-3632-2019	ocmen, elvan/0000-0003-1188-0667; Gokmen, Necati/0000-0002-3225-7666; Gokmen, Necati/0000-0002-3225-7666; YILMAZ, Osman/0000-0001-7817-7576; Gokmen, Necati/0000-0003-1835-4133			Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Aebi S, 1999, CANCER CHEMOTH PHARM, V44, P259, DOI 10.1007/s002800050976; BABA H, 1993, INT ORTHOP, V17, P353; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 2000, J NEUROSURG, V93, P175; CUEVAS P, 1990, ACTA ANAT, V137, P303; de la Barrera SS, 2001, SPINAL CORD, V39, P520, DOI 10.1038/sj.sc.3101201; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; FERRINI M, 1993, CELL MOL NEUROBIOL, V13, P387, DOI 10.1007/BF00711579; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 2000, J NEUROCYTOL, V29, P425, DOI 10.1023/A:1007125626308; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HALL ED, 1992, J NEUROSURG, V76, P13, DOI 10.3171/jns.1992.76.1.0013; Jones KJ, 2001, BRAIN RES REV, V37, P372, DOI 10.1016/S0165-0173(01)00107-2; Labombarda F, 2003, J NEUROCHEM, V87, P902, DOI 10.1046/j.1471-4159.2003.02055.x; Lin Vernon W., 2010, SPINAL CORD MED PRIN, V254; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Restrepo L, 2006, TEX HEART I J, V33, P74; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Schultz DM, 2000, MON WEATHER REV, V128, P4143, DOI 10.1175/1520-0493(2000)129<4143:TIOI>2.0.CO;2; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Wiliams GR, 2001, BMC NEUROL, V1, P2; Wise PM, 2001, BRAIN RES REV, V37, P313, DOI 10.1016/S0165-0173(01)00136-9; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; WYATT JD, 1989, LAB ANIM SCI, V39, P411	25	5	6	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	MAR	2013	31	3					581	584		10.1016/j.ajem.2012.09.025			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	110SU	WOS:000316466800023	23159424				2022-02-06	
J	Wen, L; Li, QC; Wang, SC; Lin, Y; Li, G; Gong, JB; Wang, F; Su, L; Zhan, RY; Yang, XF				Wen, Liang; Li, Quan-Cheng; Wang, Shu-Chao; Lin, Yu; Li, Gu; Gong, Jiang-Biao; Wang, Fang; Su, Lin; Zhan, Ren-Ya; Yang, Xiao-Feng			Contralateral haematoma secondary to decompressive craniectomy performed for severe head trauma: A descriptive study of 15 cases	BRAIN INJURY			English	Article						Traumatic brain injury; decompressive craniectomy; surgical complication; intracranial haematoma	ACUTE SUBDURAL-HEMATOMA; ACUTE EPIDURAL HEMATOMA; BRAIN-INJURY; EXTRADURAL HEMATOMA; CEREBRAL HEMATOMAS; COMPLICATIONS; EVACUATION; SURGERY; COAGULOPATHY; THERAPY	Background: Contralateral haematoma is an infrequent but severe complication of decompressive craniectomy for head trauma. Method: A retrospective study was performed of patients developing this complication after decompressive craniectomy for head trauma in the institute. Demographics, mechanism of trauma, time interval between trauma and first operation, time interval between first operation and onset of contralateral haematoma and patients' outcomes were recorded for further analysis. Results: Fifteen patients developed this complication in the study; most had epidural haematomas, which appeared within the first 12 hours after decompressive craniectomy in 13 patients, including three haematomas that developed during surgical decompression. Contralateral cranial fracture is a major risk factor for this condition. Only one patient recovered to mild disability. All remaining patients had poor outcomes, with Glasgow coma scale scores <= 3, except for one patient who was lost to follow-up. A literature review of similar studies including 36 patients revealed similar characteristics. Conclusion: Contralateral haematoma secondary to surgical decompression in head trauma can lead to a poor outcome. The prompt detection and removal of the haematoma are keys to management and routine recurrent computed tomography is recommended after the first operation.	[Wen, Liang; Li, Quan-Cheng; Li, Gu; Gong, Jiang-Biao; Wang, Fang; Su, Lin; Zhan, Ren-Ya; Yang, Xiao-Feng] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Shu-Chao] PLA 117 Hosp, Hangzhou, Zhejiang, Peoples R China; [Lin, Yu] Zhejiang Univ City Coll, Sch Med, Hangzhou, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurosurg, Coll Med, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com					Armand R, 2003, TRANSFUS MED REV, V17, P223, DOI 10.1016/S0887-7963(03)00022-1; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; BOROVICH B, 1985, J NEUROSURG, V63, P30, DOI 10.3171/jns.1985.63.1.0030; Cohen JE, 2004, NEUROL RES, V26, P763, DOI 10.1179/016164104225015930; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Fridley J, 2011, J CLIN NEUROSCI, V18, P422, DOI 10.1016/j.jocn.2010.05.004; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; HIRSH LF, 1979, NEUROSURGERY, V5, P653, DOI 10.1227/00006123-197912000-00001; Huang APH, 2011, J TRAUMA, V70, P1578, DOI 10.1097/TA.0b013e3182178c71; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KOULOURIS S, 1980, NEUROSURGERY, V7, P608, DOI 10.1227/00006123-198012000-00014; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; PIEPMEIER JM, 1982, J TRAUMA, V22, P455, DOI 10.1097/00005373-198206000-00003; Saberi Hooshang, 2009, Cases J, V2, P6282, DOI 10.4076/1757-1626-2-6282; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Schneider GH, 2002, ACT NEUR S, V81, P77; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Tomycz Nestor D, 2010, J Trauma, V68, pE11, DOI 10.1097/TA.0b013e31811eaaf5; Yague L G, 1991, J Neurosurg Sci, V35, P107; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	30	5	7	0	13	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAR	2013	27	3					286	292		10.3109/02699052.2012.743180			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	096OG	WOS:000315413400005	23414258				2022-02-06	
J	Kang, SH; Kim, DK				Kang, Si Hyun; Kim, Don-Kyu			Drug Induced Parkinsonism Caused by the Concurrent Use of Donepezil and Risperidone in a Patient With Traumatic Brain Injuries	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Parkinsonian disorders; Donepezil; Risperidone; Brain injuries		A 69-year-old male patient with previous history of traumatic brain injury 5 months ago was admitted to the Department of Neuropsychiatry because of aggressive behavior and delusional features. After starting on 2 mg of risperidone per day, his delusion, anxiety, and aggressive behavior gradually improved. Two weeks later, he was given 10 mg of donepezil per day for his mild cognitive impairment. After 6 weeks of admission in the Department of Neuropsychiatry, he showed parkinsonian features including difficulty in walking, decreased arm swing during walking, narrowed step width, scooped posture, bradykinesia, tremor, and sleep disorder. To rule out the primary Parkinsonism, dopamine transporter imaging technique [18F] fluoropropyl-carbomethoxy-iodopropyl-nor-beta-tropane positron emission tomography-computed tomography (18F]FP(IT PET-CT)) was performed, and dopamine transporter activity was not decreased. We considered that his parkinsonian features were associated with the combination of risperidone and donepezil. Both drugs were stopped and symptoms rapidly disappeared in several days.	[Kang, Si Hyun; Kim, Don-Kyu] Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, Seoul, South Korea		Kim, DK (corresponding author), Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, Chung Ang Univ Hosp, 102 Heukseok Ro, Seoul 156755, South Korea.	donkim21@gmail.com					Arai M, 2000, INTERNAL MED, V39, P863, DOI 10.2169/internalmedicine.39.863; Brown CS, 1999, ANN PHARMACOTHER, V33, P210, DOI 10.1345/aph.17216; Daiello Lori A, 2007, Med Health R I, V90, P191; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Liu HC, 2002, PSYCHIAT CLIN NEUROS, V56, P479, DOI 10.1046/j.1440-1819.2002.01040.x; Maany I, 1996, AM J PSYCHIAT, V153, P1504; MCSWAIN ML, 1995, J CLIN PSYCHOPHARM, V15, P284, DOI 10.1097/00004714-199508000-00008; Reyes JF, 2004, BRIT J CLIN PHARMACO, V58, P50, DOI 10.1111/j.1365-2125.2004.01817.x; Takada-Takatori Y, 2009, BIOL PHARM BULL, V32, P318, DOI 10.1248/bpb.32.318; Zhao QY, 2003, J CLIN PHARMACOL, V43, P180, DOI 10.1177/0091270002239827	10	5	5	0	1	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	FEB	2013	37	1					147	150		10.5535/arm.2013.37.1.147			4	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC6CV	WOS:000433876900022	23526695	Green Published, Green Submitted, gold			2022-02-06	
J	Lafave, MR; Butterwick, DJ; Murray, RP; Freeman, T; Lau, BHS				Lafave, M. R.; Butterwick, D. J.; Murray, R. P.; Freeman, T.; Lau, B. H. S.			Content Validity of the Rodeo-SCAT	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						content validation; concussion evaluation; SCAT; rodeo	INTERNATIONAL-CONFERENCE; AGREEMENT STATEMENT; CONSENSUS STATEMENT; CONCUSSION; SPORT; INJURIES; PERFORMANCE; GUIDELINES; MANAGEMENT; RETURN	The purpose of this study was to establish the content validity of the Rodeo SCAT for the sport of rodeo and bull riding. The study design was comprised of expert consensus and content validation. A modified Ebel procedure was employed to content validate the rodeo SCAT. Content validation using this method includes experts agreeing on the importance of each item that comprises the rodeo SCAT. This 3-stage process involved: 1) face validation by a local committee: 2) initial expert consensus measurement via distance; and 3) a face-to-face discussion for items that did not originally achieve 80 % consensus of the group. Experts were chosen from the Canadian Professional Rodeo Sport Medicine Team (Canada) and the Justin Sports Medicine Team (USA). 27 out of a total possible 68 items achieved 80 % consensus in the second stage. In the third stage, 4 of the 68 items were removed with consensus from the expert group. All remaining items achieved 80 % consensus for inclusion. In summary, the rodeo SCAT is content valid and thus, appropriate for use in the sport of rodeo context or environment.	[Lafave, M. R.; Lau, B. H. S.] Mt Royal Univ, Calgary, AB T3E 6K6, Canada; [Butterwick, D. J.] Univ Calgary, Calgary, AB, Canada; [Murray, R. P.] Mt Orthoped, Orthoped, Bountiful, UT USA; [Freeman, T.] Texas Orthoped Associates, Orthoped, Dallas, TX USA		Lafave, MR (corresponding author), Mt Royal Univ, 4825 Mt Royal Gate SW, Calgary, AB T3E 6K6, Canada.	mlafave@mtroyal.ca					Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; ARNHEIM DD, 2000, PRINCIPLES ATHLETIC; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Brandenburg MA, 2007, INT SPORTMED J, V8, P78; Butterwick DJ, 2002, AM J SPORT MED, V30, P193, DOI 10.1177/03635465020300020801; CANTOR JA, 1989, EDUC PSYCHOL MEAS, V49, P709, DOI 10.1177/001316448904900326; CANTU RC, 1986, PHYSICIAN SPORTSMED, V14, P75, DOI 10.1080/00913847.1986.11709197; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Colorado Medical Society, 1994, SCH HLTH SPORTS MED, P10; de Vellis RF, 2003, SCALE DEV THEORY APP, V2nd; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Gioia GA, 2009, TOP LANG DISORD, V29, P266, DOI 10.1097/TLD.0b013e3181b5322b; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Hodges B, 2003, MED TEACH, V25, P250, DOI 10.1080/01421590310001002836; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Jordan B, 1989, SPORTS NEUROLOGY; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kuland D, 1982, INJURED ATHLETE; Lafave L, 25 OTT C P 2010; Lafave M, 2008, ADV HEALTH SCI EDUC, V13, P397, DOI 10.1007/s10459-006-9050-2; Lafave MR, 2009, CLIN J SPORT MED, V19, P512, DOI 10.1097/JSM.0b013e3181c0afae; LYNN MR, 1986, NURS RES, V35, P382; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MEYERS MC, 1990, AM J SPORT MED, V18, P87, DOI 10.1177/036354659001800114; Meyers MC, 2010, SPORTS MED, V40, P817, DOI 10.2165/11535330-000000000-00000; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; Ommaya A, 1994, P MILD BRAIN INJ SPO, P72; Ommaya A, 1974, BRAIN, P97; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Ptito A, 2007, NEUROREHABILITATION, V22, P217; SAAL JA, 1991, SPORTS MED, V12, P132, DOI 10.2165/00007256-199112020-00005; Torg JS, 1995, CURRENT THERAPY SPOR; Torg JS, 1991, ATHLETIC INJURIES HE, Vsecond; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; Young CC, 1997, CLIN J SPORT MED, V7, P196, DOI 10.1097/00042752-199707000-00008	39	5	5	0	9	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	FEB	2013	34	2					170	175		10.1055/s-0032-1311651			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	075TB	WOS:000313908300012	22960990				2022-02-06	
J	Pan, AH; Li, M; Gao, JY; Xue, ZQ; Li, ZY; Yuan, XY; Luo, DW; Luo, XG; Yan, XX				Pan, Aihua; Li, Ming; Gao, Jun-Yan; Xue, Zhi-Qin; Li, Zhiyuan; Yuan, Xian-Yui; Luo, Duan-Wu; Luo, Xue-Gang; Yan, Xiao-Xin			Experimental epidural hematoma causes cerebral infarction and activates neocortical glial and neuronal genesis in adult guinea pigs	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						traumatic brain injury; neuronal death; neurogenesis; doublecortin; neocortex	DOUBLECORTIN-EXPRESSING CELLS; VITAL PHYSIOLOGICAL VARIABLES; NEURAL STEM/PROGENITOR CELLS; FIBRILLARY ACIDIC PROTEIN; EXTRADURAL HEMATOMA; POSTTRAUMATIC VASOSPASM; QUANTITATIVE-ANALYSIS; BRAIN COMPRESSION; IMMATURE NEURONS; EXPERIMENTAL MR	Epidural hematoma (EDH) is a type of life-threatening traumatic brain injury. Little is known about the extent to which EDH may cause neural damage and regenerative response in the cerebral cortex. Here we attempted to explore these issues by using guinea pigs as an experimental model. Unilateral EDH was induced by injection of 0.1 ml autologous blood into the extradural space, with experimental effects examined at 7, 14, 30, and 60 days postlesion. An infarct developed in the cortex deep to the EDH largely after 7 days postlesion, with neuronal death occurred from layers I to V in the central infarct region, as evidenced by loss of immunoreactivity (IR) for neuron-specific nuclear antigen (NeuN). Glial fibrillary acidic protein (GFAP) IR appeared as a cellular band surrounding the infarct and extending into the periinfarct cortex along the pia. Doublecortin (DCX) IR emerged in these same areas, with labeled cells appearing as astrocytic and neuronal profiles. DCX/GFAP colocalization was found in these regions commonly at 7 and 14 days postlesion, whereas DCX/NeuN-colabeled neurons were detectable at 30 and 60 days postlesion. Subpopulations of GFAP-, DCX-, or NeuN-immunoreactive cells colocalized with the endogenous proliferative marker Ki-67 or bromodeoxyuridine (BrdU) after pulse-chase with this birth-dating marker. The results suggest that experimental EDH can cause severe neuronal loss, induce significant glial activation, and promote a certain degree of local neuronal genesis in adult guinea pig neocortex. These findings point to potential therapeutic targets for improving neuronal recovery in clinical management of EDH. (C) 2012 Wiley Periodicals, Inc.	[Pan, Aihua; Li, Ming; Gao, Jun-Yan; Xue, Zhi-Qin; Li, Zhiyuan; Luo, Xue-Gang; Yan, Xiao-Xin] Cent S Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Changsha 410013, Hunan, Peoples R China; [Li, Ming; Gao, Jun-Yan] Changzhi Med Coll, Dept Anat, Changzhi, Shangxi, Peoples R China; [Xue, Zhi-Qin] Xinjiang Med Univ, Dept Anat, Urumqi, Xinjiang, Peoples R China; [Yuan, Xian-Yui; Luo, Duan-Wu] Cent S Univ, Sch Med, Xiangya Hosp, Dept Neurosurg, Changsha 410013, Hunan, Peoples R China		Yan, XX (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Changsha 410013, Hunan, Peoples R China.	yanxiaoxin@csu.edu.cn			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171091, 81171160, 30771135]; Hunan Provincial Natural Science FoundationNatural Science Foundation of Hunan Province [09JJ3070]; Central South University	Contract grant sponsor: National Nature Science Foundation of China; Contract grant number: 81171091 (to X.-X.Y.); Contract grant number: 81171160 (to X.-G. L.); Contract grant number: 30771135 (to A. P.); Contract grant sponsor: Hunan Provincial Natural Science Foundation; Contract grant number: 09JJ3070 (to A. P.); Contract grant sponsor: Central South University (to X.-X.Y.).	Agrawal Amit, 2011, J Surg Tech Case Rep, V3, P34, DOI 10.4103/2006-8808.78469; Ahmed AI, 2012, J NEUROTRAUM, V29, P828, DOI 10.1089/neu.2011.1923; Balikci M, 2008, NEUROL RES, V30, P450, DOI 10.1179/016164107X251637; Bergstrom K, 1986, Acta Radiol Suppl, V369, P350; Bloch J, 2011, J COMP NEUROL, V519, P775, DOI 10.1002/cne.22547; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Cai Y, 2009, EXP NEUROL, V216, P342, DOI 10.1016/j.expneurol.2008.12.008; Case ME, 2008, BRAIN PATHOL, V18, P583, DOI 10.1111/j.1750-3639.2008.00203.x; Chadwick D, 2000, J NEUROL NEUROSUR PS, V68, P251, DOI 10.1136/jnnp.68.2.251; Cheung PSY, 2007, INJURY, V38, P76, DOI 10.1016/j.injury.2006.08.059; CHIAMULERA C, 1993, BRAIN RES, V606, P251, DOI 10.1016/0006-8993(93)90992-V; Chowdhury SMNK, 2012, TURK NEUROSURG, V22, P39, DOI 10.5137/1019-5149.JTN.4550-11.1; Douzinas EE, 1999, CRIT CARE MED, V27, P978, DOI 10.1097/00003246-199905000-00040; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; GANZ JC, 1990, ACTA NEUROCHIR, V102, P164, DOI 10.1007/BF01405433; GANZ JC, 1993, ACTA RADIOL, V34, P279; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hua R, 2008, J NEUROSCI RES, V86, P883, DOI 10.1002/jnr.21546; Irie F, 2011, J TRAUMA, V71, P847, DOI 10.1097/TA.0b013e3182032c9a; Jung SW, 2012, J KOREAN NEUROSURG S, V51, P215, DOI 10.3340/jkns.2012.51.4.215; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; Kreuzberg M, 2010, EXP NEUROL, V226, P90, DOI 10.1016/j.expneurol.2010.08.006; Li DR, 2012, LEGAL MED-TOKYO, V14, P84, DOI 10.1016/j.legalmed.2011.12.007; Li Y, 2010, TRANSL STROKE RES, V1, P184, DOI 10.1007/s12975-010-0016-6; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Louzada PR, 2007, ARQ NEURO-PSIQUIAT, V65, P1237, DOI 10.1590/S0004-282X2007000700029; Louzada PR, 2012, BRAIN INJURY, V26, P95, DOI 10.3109/02699052.2011.635356; Luzzati F, 2009, CEREB CORTEX, V19, P1028, DOI 10.1093/cercor/bhn145; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nakagomi T, 2012, STEM CELLS DEV, V21, P2350, DOI 10.1089/scd.2011.0657; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Pizza V, 2011, CNS NEUROL DISORD-DR, V10, P621, DOI 10.2174/187152711796235014; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; SCHMIDTKASTNER R, 1993, INT J DEV NEUROSCI, V11, P157, DOI 10.1016/0736-5748(93)90076-P; Sencer A, 2012, J NEUROSURG-PEDIATR, V9, P139, DOI 10.3171/2011.11.PEDS11177; SERVADEI F, 1995, ACTA NEUROCHIR, V133, P50, DOI 10.1007/BF01404947; Servadei F, 1988, Brain Inj, V2, P87, DOI 10.3109/02699058809150935; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; Shapiro LA, 2007, BRAIN STRUCT FUNCT, V212, P133, DOI 10.1007/s00429-007-0151-3; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Srikandarajah N, 2009, EPILEPSIA, V50, P2619, DOI 10.1111/j.1528-1167.2009.02194.x; THUOMAS KA, 1993, ACTA RADIOL, V34, P289; von Bohlen und Halbach O, 2011, CELL TISSUE RES, V345, P1, DOI 10.1007/s00441-011-1196-4; Xiong K, 2008, EXP NEUROL, V211, P271, DOI 10.1016/j.expneurol.2008.02.003; Xiong K, 2010, MOL CELL NEUROSCI, V45, P180, DOI 10.1016/j.mcn.2010.06.009; XU BN, 1993, NEUROSURGERY, V32, P289, DOI 10.1227/00006123-199302000-00019; Xue JH, 2009, STROKE, V40, pE606, DOI 10.1161/STROKEAHA.109.560334; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang Jing, 1999, Hunan Yike Daxue Xuebao, V24, P516; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Zhang JZ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-158; ZWETNOW NN, 1983, ACTA NEUROCHIR, V67, P67, DOI 10.1007/BF01401669	57	5	10	2	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	FEB	2013	91	2					249	261		10.1002/jnr.23148			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	056JS	WOS:000312485300010	23151870				2022-02-06	
J	Velikonja, D; Warriner, EM; Coulson, S; Brum, C				Velikonja, Diana; Warriner, Erin M.; Coulson, Sherry; Brum, Christine			The relationship between coping styles and affective/behavioural symptoms among individuals with an acquired brain injury	BRAIN INJURY			English	Article						Acquired brain injury (ABI); traumatic brain injury (TBI); personality assessment inventory (PAI); coping response inventory (CRI); coping strategies; emotional profiles	PERSONALITY-ASSESSMENT INVENTORY; PSYCHIATRIC-DISORDERS; BEHAVIORAL SEQUELAE; DEPRESSION; STRATEGIES; REHABILITATION	Primary objective: To evaluate the impact of combined Axis I and II emotional profiles, demographic and psychosocial variables on coping responses in an Acquired Brain Injury (ABI) population using the Personality Assessment Inventory (PAI) and the Coping Response Inventory (CRI). Research design: This was a retrospective study examining the relationship between coping styles with affective, demographic and psychosocial variables using a multi-dimensional profile analysis. Methods and procedures: Participants completed the PAI and CRI during a regular clinical visit at the ABI Program (n = 100). Profile data was divided into seven established sub-types and analysed with coping responses. Traumatic (TBI; n = 78) and non-traumatic (n = 24) brain-injured individuals comprised the sample. Main outcomes and results: Previous findings were confirmed showing that highly symptomatic patients primarily use negative coping strategies. Also, affective symptoms, gender, relationship status, perceived stress and psychosocial supports mediate the use of different negative coping responses. Interesting, anxiety-based symptoms were associated with positive responses similar to asymptomatic ABI patients. Conclusions: Coping strategies adopted by brain-injured individuals are mediated by Axis I and II symptoms as well as psychosocial support, stress, marital status and gender. As a result, this has implications for developing treatment strategies.	[Velikonja, Diana; Warriner, Erin M.; Brum, Christine] Hamilton Hlth Sci, Hamilton, ON L8L 0A4, Canada; [Velikonja, Diana; Warriner, Erin M.] McMaster Univ, Hamilton, ON, Canada; [Coulson, Sherry] Middlesex London Hlth Unit, London, ON, Canada		Velikonja, D (corresponding author), Hamilton Hlth Sci, Reg Rehabil Ctr, 300 Wellington St N, Hamilton, ON L8L 0A4, Canada.	velikonja@hhsc.ca					Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Bryant RA, 2000, BRAIN INJURY, V14, P175, DOI 10.1080/026990500120826; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Dawson DR, 2006, BRAIN COGNITION, V60, P214; Demakis GJ, 2007, ARCH CLIN NEUROPSYCH, V22, P123, DOI 10.1016/j.acn.2006.09.004; Evered L, 2003, ASSESSMENT, V10, P420, DOI 10.1177/1073191103259539; Finset A, 2000, BRAIN INJURY, V14, P887; Hibbard MR, 2000, BRAIN INJURY, V14, P45, DOI 10.1080/026990500120925; Kalpakjian CZ, 2004, AM J PHYS MED REHAB, V83, P255, DOI 10.1097/01.PHM.0000118033.07952.8C; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, J HEAD TRAUMA REHAB, V16, pV, DOI 10.1097/00001199-200108000-00001; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Moos R.H., 1993, COPING RESPONSES INV; Morey, 1991, PERSONALITY ASSESSME; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Velikonja D, 2010, J CLIN EXP NEUROPSYC, V32, P610, DOI 10.1080/13803390903401302; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Warriner EM, 2010, NEUROSCI RES PROG SE, P71; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa	22	5	5	0	16	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2013	27	2					158	168		10.3109/02699052.2012.729289			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	083PX	WOS:000314478500004	23324048				2022-02-06	
J	Banja, JD; Eisen, A				Banja, John D.; Eisen, Arri			Ethical Perspectives on Knowledge Translation in Rehabilitation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Ethics; Rehabilitation	TRAUMATIC BRAIN-INJURY; CLINICAL-TRIALS; BOBATH CONCEPT; STROKE; THERAPY; TRANSPLANTATION; RECOVERY; OUTCOMES	Although the literature on the ethical dimensions of knowledge creation, use, and dissemination is voluminous, it has not particularly examined the ethical dimensions of knowledge translation in rehabilitation. Yet, whether research is done in a wet lab or treatments are provided to patients in therapeutic settings, rehabilitation professionals commonly use (as well as create) knowledge and disseminate it to peers, patients, and various others. This article will refer to knowledge creation, use, and transfer as knowledge translation and examine some of its numerous ethical challenges. Three ethical dimensions of knowledge translation will particularly attract our attention: (1) the quality of knowledge disseminated to rehabilitationists; (2) ethical challenges in being too easily persuaded by or unreasonably resistant to putative knowledge; and (3) organizational barriers to knowledge translation. We will conclude with some recommendations on facilitating the ethical soundness of knowledge translation in rehabilitation. Archives of Physical Medicine and Rehabilitation 2013;94(1 Suppl 1):S55-60 (C) 2013 by the American Congress of Rehabilitation Medicine	[Banja, John D.] Emory Univ, Ctr Eth, Atlanta Clin & Translat Sci Inst, Atlanta, GA 30322 USA; [Eisen, Arri] Emory Univ, Dept Biol, Inst Liberal Arts, Atlanta, GA 30322 USA		Banja, JD (corresponding author), Emory Univ, Ctr Eth, Atlanta Clin & Translat Sci Inst, 1531 Dickey Dr, Atlanta, GA 30322 USA.	jbanja@emory.edu			National Center for Advancing Translational Sciences of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000454] Funding Source: NIH RePORTER	Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health (Award no. UL1TR000454).	Beauchamp TL, 2009, PRINCIPLES BIOMEDICA, V6th; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; BRODY H, 2007, HOOKED ETHICS MED PR; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Harting J, 2009, PHYS THER, V89, P221, DOI 10.2522/ptj.20080185; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Johnson RT, 2007, NAT CLIN PRACT NEURO, V3, P590, DOI 10.1038/ncpneuro0618; Kimmelman J, 2010, GENE TRANSFER ETHICS; Kinney ED, 2001, J LAW MED ETHICS, V29, P323, DOI 10.1111/j.1748-720X.2001.tb00351.x; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; Komaroff E, 2009, J SPINAL CORD MED, V32, P3, DOI 10.1080/10790268.2009.11760747; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Lindvall O, 2004, STROKE, V35, P2691, DOI 10.1161/01.STR.0000143323.84008.f4; Lo B., 2005, RESOLVING ETHICAL DI; Luke C, 2004, CLIN REHABIL, V18, P888, DOI 10.1191/0269215504cr793oa; Manns PJ, 2006, PHYSIOTHERAPY, V92, P88, DOI 10.1016/j.physio.2005.09.006; Marco CA, 2000, ACAD EMERG MED, V7, P691, DOI 10.1111/j.1553-2712.2000.tb02049.x; MILLS JL, 1993, NEW ENGL J MED, V329, P1196, DOI 10.1056/NEJM199310143291613; Nelkin D., 1995, SELLING SCI PRESS CO; Resnik D, 2000, ACCOUNT RES, V8, P163, DOI DOI 10.1080/08989620008573971; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rogers E., 1995, DIFFUSION INNOVATION, V4th edn.; Schreiber J, 2009, PHYS THER, V89, P918, DOI 10.2522/ptj.20080260; SHAMOO AE, 2003, RESPONSIBLE CONDUCT; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Whyte J, 2003, AM J PHYS MED REHAB, V82, pS16, DOI 10.1097/01.PHM.0000086992.95121.C2; WHYTE J, 1997, ASSESSING MED REHABI, P43; Wikipedia, BOB CONC; Wikipedia, DOM POL GW BUSH ADM; Zhu J, 2005, CURR DRUG TARGETS, V6, P97, DOI 10.2174/1389450053345055; Zoloth Laurie, 2002, American Journal of Bioethics, V2, P3, DOI 10.1162/152651602317267772	32	5	5	0	18	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JAN	2013	94	1		1			S55	S60		10.1016/j.apmr.2012.08.218			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	067PU	WOS:000313308400008	23168302	Green Accepted			2022-02-06	
J	Chen, W; Cockrell, CH; Ward, K; Najarian, K				Chen, Wenan; Cockrell, Charles H.; Ward, Kevin; Najarian, Kayvan			Predictability of intracranial pressure level in traumatic brain injury: features extraction, statistical analysis and machine learning-based evaluation	INTERNATIONAL JOURNAL OF DATA MINING AND BIOINFORMATICS			English	Article						intracranial pressure prediction; texture analysis; statistical analysis; machine learning; nested cross validation	SELECTION	This paper attempts to predict Intracranial Pressure (ICP) based on features extracted from non-invasively collected patient data. These features include midline shift measurement and textural features extracted from Computed axial Tomography (CT) images. A statistical analysis is performed to examine the relationship between ICP and midline shift. Machine learning is also applied to estimate ICP levels with a two-stage feature selection scheme. To avoid overfitting, all feature selections and parameter selections are performed using a nested 10-fold cross validation within the training data. The classification results demonstrate the effectiveness of the proposed method in ICP prediction.	[Chen, Wenan; Najarian, Kayvan] Virginia Commonwealth Univ, Dept Comp Sci, Reanimat Engn Sci VCURES Ctr, Richmond, VA 23298 USA; [Cockrell, Charles H.] Virginia Commonwealth Univ, Dept Radiol, Reanimat Engn Sci VCURES Ctr, Richmond, VA 23298 USA; [Ward, Kevin] Virginia Commonwealth Univ, Dept Emergency Med, Reanimat Engn Sci VCURES Ctr, Richmond, VA 23298 USA		Najarian, K (corresponding author), Virginia Commonwealth Univ, Dept Comp Sci, Reanimat Engn Sci VCURES Ctr, Med Coll Virginia Campus, Richmond, VA 23298 USA.	knajarian@vcu.edu					Chen WN, 2009, 2009 ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, P15; CONNERS RW, 1980, IEEE T PATTERN ANAL, V2, P204, DOI 10.1109/TPAMI.1980.4767008; Galloway MM., 1974, COMPUT VISION GRAPH, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Goldberg DE., 1989, GENETIC ALGORITHM SE; Gonzalez RC., 2003, DIGITAL IMAGE PROCES; Gruen P, 2002, NEUROIMAG CLIN N AM, V12, P339, DOI 10.1016/S1052-5149(02)00013-8; Ingo Mierswa, 2006, KDD 06, P935, DOI DOI 10.1145/1150402.1150531; Kabara S. A., 2003, P 2003 FINN SIGN PRO, P190; Kingsbury N, 2001, APPL COMPUT HARMON A, V10, P234, DOI 10.1006/acha.2000.0343; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kutner MH., 2004, APPL LINEAR STAT MOD; Langley P, 1994, P AAAI FALL S REL, P140; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Moore Ernest E., 2003, TRAUMA; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Svolos A E, 1998, IEEE Trans Inf Technol Biomed, V2, P48, DOI 10.1109/4233.720522; WESZKA JS, 1976, IEEE T SYST MAN CYB, V6, P269, DOI 10.1109/TSMC.1976.5408777	19	5	5	0	11	INDERSCIENCE ENTERPRISES LTD	GENEVA	WORLD TRADE CENTER BLDG, 29 ROUTE DE PRE-BOIS, CASE POSTALE 856, CH-1215 GENEVA, SWITZERLAND	1748-5673			INT J DATA MIN BIOIN	Int. J. Data Min. Bioinform.		2013	8	4					480	494		10.1504/IJDMB.2013.056617			15	Mathematical & Computational Biology	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology	228RH	WOS:000325204400007	24400523				2022-02-06	
B	Collins, MW; Iverson, GL; Gaetz, MB; Meehan, WP; Lovell, MR		Zasler, ND; Katz, DI; Zafonte, RD		Collins, Michael W.; Iverson, Grant L.; Gaetz, Michael B.; Meehan, William P., III; Lovell, Mark R.			Sport-Related Concussion	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; AMATEUR BOXING LEAD; MILD HEAD-INJURY; COLLEGIATE FOOTBALL PLAYERS; 2ND IMPACT SYNDROME; RETURN-TO-PLAY; HIGH-SCHOOL; PROFESSIONAL FOOTBALL; POSTURAL STABILITY; COGNITIVE IMPAIRMENT		[Collins, Michael W.] Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; [Collins, Michael W.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Collins, Michael W.] Univ Pittsburgh, Med Ctr, Sports Med Concuss Program, Pittsburgh, PA USA; [Iverson, Grant L.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Gaetz, Michael B.] Univ Fraser Valley, Dept Kinesiol & Phys Educ, Chilliwack, BC, Canada; [Meehan, William P., III] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Childrens Hosp, Dept Orthoped, Boston, MA 02115 USA; [Lovell, Mark R.] ImPACT Applicat Inc, Pittsburgh, PA USA		Collins, MW (corresponding author), Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA.						Asplund CA, 2004, CLIN J SPORT MED, V14, P339, DOI 10.1097/00042752-200411000-00003; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Autti T, 1997, LANCET, V349, P1144, DOI 10.1016/S0140-6736(05)63019-X; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Blignaut J B, 1987, Br J Sports Med, V21, P5; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; BRETON F, 1990, BIOL PSYCHOL, V31, P57, DOI 10.1016/0301-0511(90)90078-B; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2007, NEUROSURGERY, V61, P223, DOI 10.1227/01.NEU.0000255514.73967.90; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; CASSON IR, 1982, J NEUROL NEUROSUR PS, V45, P170, DOI 10.1136/jnnp.45.2.170; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Chadwick D, 1997, BRIT J SPORT MED, V31, P173, DOI 10.1136/bjsm.31.3.173; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Cheatle MD, 2011, PAIN MED, V12, pS43, DOI 10.1111/j.1526-4637.2011.01131.x; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Collie A, 2006, BRIT J SPORT MED, V40, P550, DOI 10.1136/bjsm.2005.019802; Collie A, 2006, J NEUROL NEUROSUR PS, V77, P241, DOI 10.1136/jnnp.2005.073155; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; DALE GE, 1991, J NEUROL NEUROSUR PS, V54, P116, DOI 10.1136/jnnp.54.2.116; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Daneshvar DH, 2011, CLIN SPORTS MED, V30, px; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Dicheskul ML, 2011, NEUROSCI BEHAV PHYSL, V41, P64; DUNCANJOHNSON CC, 1977, PSYCHOPHYSIOLOGY, V14, P456, DOI 10.1111/j.1469-8986.1977.tb01312.x; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gaetz MB, 2009, BRIT J SPORT MED, V43, P508, DOI 10.1136/bjsm.2008.051748; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; Giza CC, 2004, STUD NEUROPSYCHOL DE, P45; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon AG, 1997, CAN J NEUROL SCI, V24, P359, DOI 10.1017/S0317167100033084; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz K. M., 2011, CLIN SPORTS MED, V30, pix; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P353; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P245; HAGLUND Y, 1990, ACTA NEUROL SCAND, V82, P297; Hallberg M, 2011, MINI-REV MED CHEM, V11, P399, DOI 10.2174/138955711795445961; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Houston AS, 1998, J NUCL MED, V39, P425; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson G. L., 2011, HDB SPORT NEUROPSYCH, P131; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2000, ARCH CLIN NEUROPSYCH, V15, P643, DOI 10.1016/S0887-6177(99)00048-7; Iverson GL, 2009, BRIT J SPORT MED, V43, pi101; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; JORDAN BD, 1988, ARCH NEUROL-CHICAGO, V45, P1207, DOI 10.1001/archneur.1988.00520350045014; Kanayama G, 2010, DRUG ALCOHOL DEPEN, V109, P6, DOI 10.1016/j.drugalcdep.2010.01.011; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; KAPLAN HA, 1954, JAMA-J AM MED ASSOC, V156, P1138, DOI 10.1001/jama.1954.02950120012004; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; KEMP PM, 1995, J NEUROL NEUROSUR PS, V59, P368, DOI 10.1136/jnnp.59.4.368; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; KROSS R, 1983, EEG-EMG-Z ELEK ELEKT, V14, P209; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lavoie ME, 2004, J CLIN EXP NEUROPSYC, V26, P55, DOI 10.1076/jcen.26.1.55.23936; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; LEVIN HS, 1987, J NEUROSURG, V67, P657, DOI 10.3171/jns.1987.67.5.0657; Livingston SC, 2010, BRAIN INJURY, V24, P904, DOI 10.3109/02699051003789245; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Loosemore M, 2007, BMJ-BRIT MED J, V335, P809, DOI 10.1136/bmj.39342.690220.55; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR, 1999, SPORTS-RELATED CONCUSSION, P200; Lovell MR, 2002, NEUROLOGIC ATHLETIC, P32; Lovell MR, 2004, NEW DEV SPORTS REL C; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354; Mangus Brent C, 2004, Sports Biomech, V3, P209, DOI 10.1080/14763140408522841; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McCaffrey MA, 2007, NEUROSURGERY, V61, P1236, DOI 10.1227/01.neu.0000306102.91506.8b; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 2000, NEUROLOGY, V54, P1488, DOI 10.1212/WNL.54.7.1488; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McCrory PR, 1998, SPORTS MED, V25, P131, DOI 10.2165/00007256-199825020-00005; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; MCQUILLEN JB, 1988, AM J FOREN MED PATH, V9, P12, DOI 10.1097/00000433-198803000-00004; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; Meehan WP3rd, 2011, CLIN SPORTS MED, V30, pix; Miele Vincent J, 2006, Neurosurg Focus, V21, pE10; Miele VJ, 2004, MED SCI SPORT EXER, V36, P1852, DOI 10.1249/01.MSS.0000145470.16938.7A; Mihalik JP, 2010, PEDIATRICS, V125, pE1394, DOI 10.1542/peds.2009-2849; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Moriarity J, 2004, NEUROLOGY, V62, P1497, DOI 10.1212/WNL.62.9.1497; Moser RS, 2007, ARCH CLIN NEUROPSYCH, V22, P909, DOI 10.1016/j.acn.2007.09.004; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Moser RS, 2002, ARCH CLIN NEUROPSYCH, V17, P91, DOI 10.1016/S0887-6177(01)00108-1; MURELIUS O, 1991, ACTA NEUROL SCAND, V83, P9; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2006, NEUROSURGERY, V58, P263, DOI 10.1227/01.NEU.0000200272.56192.62; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; POLICH J, 1986, ELECTROEN CLIN NEURO, V63, P251, DOI 10.1016/0013-4694(86)90093-3; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Pulsipher DT, 2011, CURR SPORT MED REP, V10, P14, DOI 10.1249/JSR.0b013e31820711b8; Putukian M, 2000, CLIN J SPORT MED, V10, P104, DOI 10.1097/00042752-200004000-00004; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rodriguez G, 1998, ITAL J NEUROL SCI, V19, P367, DOI 10.1007/BF02341784; ROSS RJ, 1983, JAMA-J AM MED ASSOC, V249, P211, DOI 10.1001/jama.249.2.211; Rutherford A, 2003, NEUROPSYCHOL REV, V13, P153, DOI 10.1023/A:1025525613477; Sander JWAS, 1997, BRIT MED J, V314, P158, DOI 10.1136/bmj.314.7075.158; Schmitt DM, 2004, INT J SPORTS MED, V25, P326, DOI 10.1055/s-2004-819941; Sironi V A, 1982, J Neurosurg Sci, V26, P165; Slobounov S, 2005, NEUROSCI LETT, V383, P251, DOI 10.1016/j.neulet.2005.04.039; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P185, DOI 10.1016/S1388-2457(01)00737-4; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2009, CLIN NEUROPHYSIOL, V120, P862, DOI 10.1016/j.clinph.2009.03.009; Slobounov SM, 2010, EXP BRAIN RES, V202, P341, DOI 10.1007/s00221-009-2141-6; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1037/0894-4105.21.6.796; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stephens R, 2010, J NEUROPSYCH CLIN N, V22, P295, DOI 10.1176/appi.neuropsych.22.3.295; Stephenson J, 1997, BRIT MED J, V314, P1283, DOI 10.1136/bmj.314.7089.1283a; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; SUNAMI K, 1989, Neurosurgical Review, V12, P400, DOI 10.1007/BF01790682; Tanriverdi F, 2008, ANN INTERN MED, V148, P827, DOI 10.7326/0003-4819-148-11-200806030-00005; Theriault M, 2011, J CLIN EXP NEUROPSYC, V33, P30, DOI 10.1080/13803391003772873; Theriault M, 2009, BRAIN INJURY, V23, P899, DOI 10.1080/02699050903283189; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Thornton AE, 2008, J CLIN EXP NEUROPSYC, V30, P398, DOI 10.1080/13803390701443662; TYSVAER AT, 1989, AM J SPORT MED, V17, P573, DOI 10.1177/036354658901700421; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Van Kampen DA, 2006, AM J SPORT MED, V34, P1630, DOI 10.1177/0363546506288677; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; YAMAKAMI I, 1989, J CEREBR BLOOD F MET, V9, P117, DOI 10.1038/jcbfm.1989.16; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhang LJ, 2003, AM J NEURORADIOL, V24, P52; Zillmer EA, 2003, APPL NEUROPSYCHOL, V10, P23, DOI 10.1207/S15324826AN1001_4; [No title captured]	243	5	5	0	17	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							498	516					19	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100031					2022-02-06	
B	Costanzo, RM; Reiter, ER; Yelverton, JC		Zasler, ND; Katz, DI; Zafonte, RD		Costanzo, Richard M.; Reiter, Evan R.; Yelverton, Joshua C.			Smell and Taste	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							OF-PENNSYLVANIA SMELL; TRAUMATIC BRAIN-INJURY; OLFACTORY DYSFUNCTION; IDENTIFICATION TEST; HEAD-INJURY; UNIVERSITY; ANOSMIA; DISORDERS; DISCRIMINATION; PERFORMANCE		[Costanzo, Richard M.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Dept Otolaryngol Head & Neck Surg, Richmond, VA 23284 USA; [Reiter, Evan R.] Virginia Commonwealth Univ Hlth Syst, Residency Program, Dept Otolaryngol Head & Neck Surg, Richmond, VA USA; [Yelverton, Joshua C.] Virginia Commonwealth Univ Hlth Syst, Dept Otolaryngol Head & Neck Surg, Richmond, VA USA		Costanzo, RM (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Dept Otolaryngol Head & Neck Surg, Richmond, VA 23284 USA.						Ahne G, 2000, LARYNGOSCOPE, V110, P1396, DOI 10.1097/00005537-200008000-00033; Aiba T, 1998, ACTA OTO-LARYNGOL, P202; Association, 2008, GUIDES EVALUATION PE; Atighechi S, 2009, AM J RHINOL ALLERGY, V23, P409, DOI 10.2500/ajra.2009.23.3345; Auerbach SH, 1989, TRAUMATIC BRAIN INJU; Bartoshuk L, 1989, Ear Nose Throat J, V68, P331; Brunjes PC, 2005, BRAIN RES REV, V50, P305, DOI 10.1016/j.brainresrev.2005.08.005; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cain W S, 1989, Ear Nose Throat J, V68, P322; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; CAIN WS, 1983, AM J OTOLARYNG, V4, P252, DOI 10.1016/S0196-0709(83)80068-4; Cain WS, 1989, ENT-EAR NOSE THROAT, V68, P322; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Chen XY, 2004, J COMP NEUROL, V469, P457, DOI 10.1002/cne.11031; Costanzo R., 2003, HDB OLFACTION GUSTAT, P629; Costanzo R. M., 2003, Handbook of olfaction and gustation, P959; Costanzo R. M., 1995, NEUROL DIS, P493; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; COSTANZO RM, 1987, ANN NY ACAD SCI, V510, P242; COSTANZO RM, 1983, J COMP NEUROL, V215, P370, DOI 10.1002/cne.902150403; COSTANZO RM, 1985, BRAIN RES, V361, P258, DOI 10.1016/0006-8993(85)91297-1; Costanzo RM, 2000, CHEM SENSES, V25, P199, DOI 10.1093/chemse/25.2.199; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; Darrouzet V, 2001, OTOLARYNG HEAD NECK, V125, P77, DOI 10.1067/mhn.2001.116182; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Delank K.-W., 1998, Rhinology (Utrecht), V36, P15; Doty RL, 2009, SEMIN NEUROL, V29, P74, DOI 10.1055/s-0028-1124025; DOTY RL, 1989, LARYNGOSCOPE, V99, P402, DOI 10.1288/00005537-198904000-00008; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; Doty RL, 2006, HEAD NECK SURG OTOLA, V1, P289; DUFFY V B, 1989, Ear Nose and Throat Journal, V68, P395; Formaker BK, 1998, ANN NY ACAD SCI, V855, P776, DOI 10.1111/j.1749-6632.1998.tb10657.x; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Frank M.E., 1991, SMELL TASTE HLTH DIS, P503; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; FURUKAWA M, 1988, Auris Nasus Larynx, V15, P25; Gottfried JA, 2002, J NEUROSCI, V22, P10819; GRAZIADEI AGM, 1989, BRAIN RES, V484, P157; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green P, 2001, NEUROREHABILITATION, V16, P237; HENKIN RI, 1971, J AMER MED ASSOC, V217, P434, DOI 10.1001/jama.217.4.434; HERBERHOLD C, 1980, LARYNG RHINOL OTOL V, V59, P570, DOI 10.1055/s-2007-1008898; HEYWOOD PG, 1986, AM J OTOLARYNG, V7, P194, DOI 10.1016/S0196-0709(86)80006-0; Holbrook EH, 2001, VIRGINIA SOC OTOLARY; Hummel T., 1997, Rhinology (Utrecht), V35, P146; Ikeda K, 1995, TOHOKU J EXP MED, V177, P343, DOI 10.1620/tjem.177.343; Ikeda K, 1999, Auris Nasus Larynx, V26, P435, DOI 10.1016/S0385-8146(99)00023-1; Jackson JH, 1864, LOND HOSP REP, V1, P470; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Kern RC, 2004, LARYNGOSCOPE, V114, P2200, DOI 10.1097/01.mlg.0000149458.21501.6f; Kobayashi M, 2009, INT UN PHYS SCI 36 W; Kondo H, 1998, AM J RHINOL, V12, P353, DOI 10.2500/105065898780182390; KRAUS JF, 1986, AM J PUBLIC HEALTH, V76, P1345, DOI 10.2105/AJPH.76.11.1345; Kveton JF, 2006, HEAD NECK SURG OTOLA, P567; Leigh AD, 1943, LANCET, V1, P38; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; MATTES RD, 1994, J AM DIET ASSOC, V94, P50, DOI 10.1016/0002-8223(94)92041-9; MIFKA P, 1964, Wien Med Wochenschr, V114, P793; MILLER IJ, 1990, PHYSIOL BEHAV, V47, P1213, DOI 10.1016/0031-9384(90)90374-D; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497, DOI 10.1001/archotol.127.5.497; MONTIGRAZIADEI GA, 1980, BRAIN RES, V189, P343, DOI 10.1016/0006-8993(80)90095-5; MOTT AE, 1991, MED CLIN N AM, V75, P1321, DOI 10.1016/S0025-7125(16)30391-1; Nakayama Hirobumi, 2011, No Shinkei Geka, V39, P263; Obrebowski A, 1976, Otolaryngol Pol, V30, P391; Ogawa T, 1999, ACTA OTO-LARYNGOL, P50; Ogle W, 1870, Med Chir Trans, V53, P263; PEVSNER J, 1990, J BIOL CHEM, V265, P6118; Pierce J, 1996, CHEM SENSES, V21, P529, DOI 10.1093/chemse/21.5.529; Pritchard TC, 1999, BEHAV NEUROSCI, V113, P663, DOI 10.1037/0735-7044.113.4.663; Reiter ER, 2004, OTOLARYNG CLIN N AM, V37, P1167, DOI 10.1016/j.otc.2004.06.005; Renzi G, 2002, ANN PLAS SURG, V48, P355, DOI 10.1097/00000637-200204000-00003; Roberts M A, 1996, Appl Neuropsychol, V3, P86, DOI 10.1207/s15324826an0302_7; ROTCH TM, 1878, BOSTON MED SURG J, V99, P130; Rousseaux M, 1996, STROKE, V27, P2328, DOI 10.1161/01.STR.27.12.2328; Saito T, 2001, LARYNGOSCOPE, V111, P2064, DOI 10.1097/00005537-200111000-00037; Santos DV, 2004, ARCH OTOLARYNGOL, V130, P317, DOI 10.1001/archotol.130.3.317; Schiffman SS, 1999, PHYSIOL BEHAV, V66, P183, DOI 10.1016/S0031-9384(98)00263-7; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Schwob JE, 2008, OLFACTION TASTE, P591; SEMERIA C, 1957, Minerva Otorinolaringol, V7, P111; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Smith CG, 1942, J COMP NEUROL, V77, P589, DOI 10.1002/cne.900770306; Sofferman PA, 1993, SURG EAR TEMPORAL BO, P329; SUMNER D, 1967, BRAIN, V90, P187, DOI 10.1093/brain/90.1.187; Sumner D, 1975, HDB CLIN NEUROLOGY, P1; Sunada I, 1995, NEURORADIOLOGY, V37, P659; Swann IJ, 2006, EMERG MED J, V23, P618, DOI 10.1136/emj.2005.029017; Szmeja Z, 1974, Patol Pol, V25, P469; TAKAGI SF, 1987, ANN NY ACAD SCI, V510, P113; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Van Toller S, 1999, CHEM SENSES, V24, P705, DOI 10.1093/chemse/24.6.705; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Wong KK, 2010, NEUROSCI LETT, V484, P163, DOI 10.1016/j.neulet.2010.08.037; Wrobel BB, 2004, OTOLARYNG CLIN N AM, V37, P1127, DOI 10.1016/j.otc.2004.06.010; Yagi S, 2009, AM J RHINOL ALLERGY, V23, P239, DOI 10.2500/ajra.2009.23.3307; Yamauchi Y, 1995, Nihon Jibiinkoka Gakkai Kaiho, V98, P119; Yamauchi Y, 2002, ACTA OTO-LARYNGOL, V122, P39, DOI 10.1080/00016480260046409; Yee KK, 1998, CHEM SENSES, V23, P513, DOI 10.1093/chemse/23.5.513; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZASLER ND, 1992, J HEAD TRAUMA REHAB, V7, P66; Zasler ND, 1992, J HEAD TRAUMA REHABI; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	111	5	5	0	0	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							794	808					15	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100048					2022-02-06	
J	Hart, T; Brockway, JA; Whyte, J; Bell, KR; Neuberger, S; Chervoneva, I				Hart, Tessa; Brockway, Jo Ann; Whyte, John; Bell, Kathleen R.; Neuberger, Shira; Chervoneva, Inna			Analyzing the ingredients of a telephone counseling intervention for traumatic brain injury	DISABILITY AND REHABILITATION			English	Article						Brain injuries; counseling; psychotherapeutic processes; telemedicine; treatment outcome	DISEASE SELF-MANAGEMENT; FAMILY NEEDS; REHABILITATION; MODERATE; PSYCHOTHERAPY; DISTURBANCES; ORIENTATION; DEFINITION; EDUCATION; SYMPTOMS	Purpose: To develop reliable coding for five treatment ingredients hypothesized to be "active" in a scheduled telephone intervention (STI) for traumatic brain injury (TBI); to examine factors associated with delivery of ingredients over the first year post-injury. Method: Operational definitions of directive and non-directive action planning; TBI education; reinforcement; and reframing, were refined until kappa >0.80 across multiple coders. Codes were assigned for presence/absence of ingredients in 253 recorded calls delivered to 49 participants in a randomized controlled trial on effects of STI versus usual care. Using multivariate analyses, we tested hypotheses about effects of TBI severity, time and other factors on delivery of ingredients. Results: Longitudinal analyses revealed that TBI education decreased over time, as expected. Non-directive action planning increased over time, according to hypotheses; unexpectedly, directive action planning did not concurrently decline. Reinforcement and reframing both increased over time, with reframing also increasing with TBI severity. Therapist differences were pronounced, despite extensive supervision designed to promote uniform treatment delivery. Conclusions: Reliable operational definitions of therapist behavior for each ingredient were achieved, but at the sacrifice of sensitivity in the coding scheme. Behavioral operational definitions of ingredients may be useful for treatment specification, for therapist training and supervision, and for testing hypotheses about the strength of specific components within the "black box" of rehabilitation.	[Hart, Tessa; Whyte, John; Neuberger, Shira] Moss Rehabil Res Inst, Elkins Pk, PA 19027 USA; [Brockway, Jo Ann; Bell, Kathleen R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Chervoneva, Inna] Thomas Jefferson Univ, Div Biostat, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA		Hart, T (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	thart@einstein.edu		Bell, Kathleen/0000-0002-0928-2046; Whyte, John/0000-0002-4381-1474	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133G070143, H133A040004]	This study was supported by National Institute on Disability and Rehabilitation Research, US Department of Education, grant nos H133G070143 and H133A040004. The authors report no declarations of interest.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Bandura A., 1997, SELF EFFICACY EXERCI; Bell KR, 2008, J NEUROL NEUROSUR PS, V79, P1275, DOI 10.1136/jnnp.2007.141762; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; BURNS DD, 1992, J CONSULT CLIN PSYCH, V60, P441, DOI 10.1037/0022-006X.60.3.441; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Coetzer R, 2009, CNS SPECTRUMS, V14, P632, DOI 10.1017/S1092852900023877; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Duncan Barry L., 2003, J BRIEF THERAPY, V3, P3; Hart T, 2012, ARCH PHYS MED REHAB, V93, pS117, DOI 10.1016/j.apmr.2011.11.039; Hart T, 2010, J VOCAT REHABIL, V32, P135, DOI 10.3233/JVR-2010-0505; Hart T, 2009, NEUROPSYCHOL REHABIL, V19, P824, DOI 10.1080/09602010902995945; Harwood TM, 2006, PSYCHOL PSYCHOTHER-T, V79, P365, DOI 10.1348/147608305X67571; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jones F, 2006, DISABIL REHABIL, V28, P841, DOI 10.1080/09638280500534952; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; Kolden GG, 2006, J CONSULT CLIN PSYCH, V74, P327, DOI 10.1037/0022-006X.74.2.327; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lewington PJ, 1993, CANADIAN J COUNSELIN, V1993, P274; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; May L, 2006, DISABIL REHABIL, V28, P1041, DOI 10.1080/09638280500494744; McPherson KM, 2000, INT J REHABIL RES, V23, P295, DOI 10.1097/00004356-200023040-00005; Michie S, 2010, HEALTH PSYCHOL, V29, P1, DOI 10.1037/a0016939; Moyers TB, 2005, J CONSULT CLIN PSYCH, V73, P590, DOI 10.1037/0022-006X.73.4.590; Pantalon MV, 2004, AM J DRUG ALCOHOL AB, V30, P353, DOI 10.1081/ADA-120037382; Prigatano GP, 2003, INT REV PSYCHIATR, V15, P371, DOI 10.1080/09540260310001606755; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575	33	5	5	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	19					1668	1675		10.3109/09638288.2012.751131			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	197BO	WOS:000322823000011	23336123				2022-02-06	
J	Hocker, SE; Fogelson, J; Rabinstein, AA				Hocker, Sara E.; Fogelson, Jeremy; Rabinstein, Alejandro A.			Refractory intracranial hypertension due to fentanyl administration following closed head injury	FRONTIERS IN NEUROLOGY			English	Article						closed head injury; intracranial hypertension; opioids; fentanyl; morphine; traumatic brain injury		Background: Although the effects of opioids on intracranial pressure (ICP) have long been a subject of controversy, they are frequently administered to patients with severe head trauma. We present a patient with an uncommon paradoxical response to opioids. Case Report: A patient with refractory intracranial hypertension after closed head injury was managed with standard medical therapy with only transient decreases in the ICP. Only after discontinuation of opiates did the ICP become manageable without metabolic suppression and rescue osmotic therapy, implicating opiates as the etiology of refractory intracranial hypertension in this patient. Conclusion: Clinicians should consider opioids as a contributing factor in malignant intracranial hypertension when findings on neuroimaging do not explain persistent and refractory intracranial hypertension.	[Hocker, Sara E.; Rabinstein, Alejandro A.] Mayo Clin, Div Crit Care Neurol, Mayo W8-B,200 First St SW, Rochester, MN 55905 USA; [Fogelson, Jeremy] Mayo Clin, Dept Neurol Surg, Rochester, MN 55905 USA		Hocker, SE (corresponding author), Mayo Clin, Div Crit Care Neurol, Mayo W8-B,200 First St SW, Rochester, MN 55905 USA.	hocker.sara@mayo.edu					Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; BENTHUYSEN JL, 1988, ANESTHESIOLOGY, V68, P438, DOI 10.1097/00000542-198803000-00021; CUILLERIER DJ, 1990, ANESTH ANALG, V70, pS75; de Nadal M, 2000, ANESTHESIOLOGY, V92, P11, DOI 10.1097/00000542-200001000-00008; FLACKE JW, 1987, ANESTH ANALG, V66, P723; MARKOVITZ BP, 1992, ANESTHESIOLOGY, V76, P71, DOI 10.1097/00000542-199201000-00011; Marx W, 1989, J Neurosurg Anesthesiol, V1, P3, DOI 10.1097/00008506-198903000-00002; MOSS E, 1978, BRIT J ANAESTH, V50, P779, DOI 10.1093/bja/50.8.779; SHAPIRO BA, 1995, CRIT CARE MED, V23, P1596, DOI 10.1097/00003246-199509000-00021; SPERRY RJ, 1992, ANESTHESIOLOGY, V77, P416, DOI 10.1097/00000542-199209000-00002; THOROGOOD MC, 1995, AM J PHYSIOL-HEART C, V269, pH1776; TOBIAS JD, 1994, PEDIATR EMERG CARE, V10, P89, DOI 10.1097/00006565-199404000-00007; WAHL M, 1985, J CEREBR BLOOD F MET, V5, P451, DOI 10.1038/jcbfm.1985.61; WEINSTABL C, 1991, ANAESTHESIA, V46, P837, DOI 10.1111/j.1365-2044.1991.tb09596.x; WERNER C, 1995, ANESTHESIOLOGY, V83, P721, DOI 10.1097/00000542-199510000-00011	15	5	6	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2013	4								3	10.3389/fneur.2013.00003			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QT	WOS:000209629000003	23372564	Green Published, gold			2022-02-06	
J	Hoffman, K; West, A; Nott, P; Cole, E; Playford, D; Liu, C; Brohi, K				Hoffman, Karen; West, Anita; Nott, Philippa; Cole, Elaine; Playford, Diane; Liu, Clarence; Brohi, Karim			Measuring acute rehabilitation needs in trauma: Preliminary evaluation of the Rehabilitation Complexity Scale	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Rehabilitation; Disability; Dependency; Therapy; Outcomes; Measures	BARTHEL INDEX; MAJOR TRAUMA; STROKE REHABILITATION; PATIENT OUTCOMES; RELATIVE MERITS; BRAIN-INJURY; CARE; PERFORMANCE; SCORE; DEPENDENCY	Background: Injury severity, disability and care dependency are frequently used as surrogate measures for rehabilitation requirements following trauma. The true rehabilitation needs of patients may be different but there are no validated tools for the measurement of rehabilitation complexity in acute trauma care. The aim of the study was to evaluate the potential utility of the Rehabilitation Complexity Scale (RCS) version 2 in measuring acute rehabilitation needs in trauma patients. Methods: A prospective observation study of 103 patients with traumatic injuries in a Major Trauma Centre. Rehabilitation complexity was measured using the RCS and disability was measured using the Barthel Index. Demographic information and injury characteristics were obtained from the trauma database. Results: The RCS was closely correlated with injury severity (r = 0.69, p < 0.001) and the Barthel Index (r = 0.91, p < 0.001). However the Barthel was poor at discriminating between patients rehabilitation needs, especially for patients with higher injury severities. Of 58 patients classified as 'very dependent' by the Barthel, 21 (36%) had low or moderate rehabilitation complexity. The RCS correlated with acute hospital length of stay (r = 0.64, p = < 0.001) and patients with a low RCS were more likely to be discharged home. The Barthel which had a flooring effect (56% of patients classified as very dependent were discharged home) and lacked discrimination despite close statistical correlation. Conclusion: The RCS outperformed the ISS and the Barthel in its ability to identify rehabilitation requirements in relation to injury severity, rehabilitation complexity, length of stay and discharge destination. The RCS is potentially a feasible and useful tool for the assessment of rehabilitation complexity in acute trauma care by providing specific measurement of patients' rehabilitation requirements. A larger longitudinal study is needed to evaluate the RCS in the assessment of patient need, service provision and trauma system performance. (C) 2011 Elsevier Ltd. All rights reserved.	[Hoffman, Karen; Cole, Elaine; Liu, Clarence; Brohi, Karim] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, Trauma Clin Acad Unit, London, England; [West, Anita; Nott, Philippa; Brohi, Karim] Barts & London NHS Trust, Royal London Hosp, London, England; [Playford, Diane] Natl Hosp Neurol & Neurosurg, Inst Neurol, London WC1N 3BG, England		Hoffman, K (corresponding author), Royal London Hosp, Trauma Clin Acad Unit, London E1 1BB, England.	Karen.hoffman@bartsandthelondon.nhs.uk		Playford, E Diane/0000-0001-7314-787X; Cole, Elaine/0000-0002-3642-3537			[Anonymous], SSNDS DEFINITION 7 S; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bradley LJ, 2006, BRIT J NEUROSURG, V20, P36, DOI 10.1080/02688690600600855; Bryant D, 2011, INJURY, V42, P232, DOI 10.1016/j.injury.2010.11.049; Cameron PA, 2006, INJURY, V37, P1178, DOI 10.1016/j.injury.2006.07.015; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Eichhorn-Kissel J, 2010, CLIN REHABIL, V24, P363, DOI 10.1177/0269215509346091; GRANGER CV, 1989, ARCH PHYS MED REHAB, V70, P100; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Greenwood RJ, 2004, BRIT J NEUROSURG, V18, P462, DOI 10.1080/02688690400012327; GRESHAM GE, 1980, ARCH PHYS MED REHAB, V61, P355; Grill E, 2011, J REHABIL MED, V43, P123, DOI 10.2340/16501977-0646; Halcomb Elizabeth, 2005, Aust Crit Care, V18, P17, DOI 10.1016/S1036-7314(05)80020-7; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Horwitz DA, 2008, CURR OPIN CRIT CARE, V14, P445, DOI 10.1097/MCC.0b013e328307f25f; Houlden H, 2006, CLIN REHABIL, V20, P153, DOI 10.1191/0269215506cr917oa; Jette DU, 2004, AM J PHYS MED REHAB, V83, P704, DOI 10.1097/01.PHM.0000137312.06545.D0; Kosar Sevginur, 2009, J Trauma Manag Outcomes, V3, P1, DOI 10.1186/1752-2897-3-1; Kreder H, 2003, CURR ORTHOPAED, V17, P331, DOI 10.1016/S0268-0890(03)00096-3; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Leistner K, 2005, PHYS MED REHAB KUROR, V15, P157, DOI 10.1055/s-2004-834762; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; MAHONEY F I, 1965, Md State Med J, V14, P61; Marshall SC, 2007, AM J PHYS MED REHAB, V86, P114, DOI 10.1097/01.phm.0000253256.11686.23; Pickering SAW, 1999, INJURY, V30, P703, DOI 10.1016/S0020-1383(99)00188-6; Quinn TJ, 2011, STROKE, V42, P1146, DOI 10.1161/STROKEAHA.110.598540; Regionaltrauma systems interim guidance for commissioners, 2009, REG SYST INT GUID CO; ROY CW, 1988, INT J REHABIL RES, V11, P67, DOI 10.1097/00004356-198803000-00010; Schluter PJ, 2005, J TRAUMA, V58, P259, DOI 10.1097/01.TA.0000154283.88208.9C; Scholtes VA, 2011, INJURY, V42, P236, DOI 10.1016/j.injury.2010.11.042; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sinoff G, 1997, J AM GERIATR SOC, V45, P832, DOI 10.1111/j.1532-5415.1997.tb01510.x; Sirois MJ, 2009, AM J PHYS MED REHAB, V88, P387, DOI 10.1097/PHM.0b013e31819c592f; Stucki G, 2005, DISABIL REHABIL, V27, P353, DOI 10.1080/09638280400014105; Tallon JM, 2006, J TRAUMA, V60, P548, DOI 10.1097/01.ta.0000209336.66283.ea; Turner-Stokes L, 2006, J NEUROL NEUROSUR PS, V77, P634, DOI 10.1136/jnnp.2005.073411; Turner-Stokes L, 2006, BRIT SOC REHABIL DEC; Turner-Stokes L, 2009, NEUROL NEUROSURG PSY, V81, P146; Turner-Stokes L, 2007, CLIN MED, V7, P593, DOI 10.7861/clinmedicine.7-6-593; Wagner AK, 2003, AM J PHYS MED REHAB, V82, P526, DOI 10.1097/00002060-200307000-00006; Weninger P, 2008, J TRAUMA, V65, P799, DOI 10.1097/TA.0b013e3181820dae; Wilson S, 2001, INJURY, V32, P525, DOI 10.1016/S0020-1383(00)00199-6; Wynia MK, 2009, J GEN INTERN MED, V24, P884, DOI 10.1007/s11606-009-0984-y	43	5	5	1	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	JAN	2013	44	1					104	109		10.1016/j.injury.2011.11.001			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	051MZ	WOS:000312132700019	22130452				2022-02-06	
J	Kamaraj, DC; Dicianno, BE; Cooper, RA; Hunter, J; Tang, JL				Kamaraj, Deepan C.; Dicianno, Brad E.; Cooper, Rory A.; Hunter, John; Tang, Jennifer L.			Acute mountain sickness in athletes with neurological impairments	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						acute mountain sickness; altitude sickness; AMS; disability; Lake Louis Score; multiple sclerosis; neurological impaimients; paraplegia; spinal cord injury; sports; tetraplegia; traumatic brain injury; veterans	ALTITUDE; PATHOPHYSIOLOGY; PREVENTION	Acute mountain sickness (AMS) is a symptom complex noticed commonly among high altitude travelers. The occurrence of AMS depends on multiple factors that have been studied extensively. However, AMS in individuals with neurological impairments has not been considered in detail. A total of 168 subjects, including active controls, inactive controls, and those with spinal cord injury (SCI), multiple sclerosis, and traumatic brain injury (TBI), were studied at the National Veterans Winter Sports Clinic in Snowmass, Colorado, from 2007 to 2009 for the occurrence of AMS. Lake Louise Score was used to quantify symptoms. A higher than anticipated occurrence of AMS (42.85%) among the study population was noted, with significantly higher Lake Louis Scores among athletes with neurological impairments. Disability group, prior history of AIMS, and prior occurrence of headache at high altitude could be used as predictors for the development of AMS symptoms. More research is warranted specifically targeting the interaction between factors affecting AMS and the pathophysiology of neurological impairments like SCI and TBI to further our understanding about prophylactic medications and treatments for AMS, especially because many military personnel with neurological impairments continue on Active Duty.	[Kamaraj, Deepan C.; Dicianno, Brad E.; Cooper, Rory A.] Dept Vet Affairs VA Pittsburgh Healthcare Syst, Ctr Excellence Wheelchairs & Related Technol, Pittsburgh, PA USA; [Kamaraj, Deepan C.; Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Human Engn Res Labs, Pittsburgh, PA USA; [Kamaraj, Deepan C.; Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Dept Rehabil Sci & Technol, Pittsburgh, PA USA; [Dicianno, Brad E.; Cooper, Rory A.] Univ Pittsburgh, Pittsburgh, PA USA; [Hunter, John] Grand Junct VA Med Ctr, Dept Internal Med, Grand Junction, CO USA; [Tang, Jennifer L.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA		Dicianno, BE (corresponding author), VA Pittsburgh Healthcare Syst, Human Engn Res Labs, 6425 Penn Ave,Suite 400,Bakery Sq, Pittsburgh, PA 15206 USA.	dicianno@pitt.edu	Dicanno, Brad/AAC-5918-2019; Kamaraj, Dr.C/D-6771-2012	Dicanno, Brad/0000-0003-0738-0192; Kamaraj, Deepan C/0000-0003-1241-1723; Kamaraj, Dr.C/0000-0003-0639-8518	Center of Excellence for Wheelchairs and Associated Rehabilitation Engineering [B3142C]	This material was based on work supported by the Center of Excellence for Wheelchairs and Associated Rehabilitation Engineering (grant B3142C).	Anderson PJ, 2011, CLIN MED INSIGHTS-CI, V5, P27, DOI 10.4137/CCRPM.S6882; Barat M., 2006, Annales de Readaptation et de Medecine Physique, V49, P365, DOI 10.1016/j.annrmp.2006.04.014; Barry PW, 2003, BRIT MED J, V326, P915, DOI 10.1136/bmj.326.7395.915; Berens SA, 2005, AM J NEURORADIOL, V26, P1612; Bravo Guadalupe, 2004, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V2, P133, DOI 10.2174/1568016043477242; Croughs M, 2011, J TRAVEL MED, V18, P337, DOI 10.1111/j.1708-8305.2011.00537.x; Dicianno BE, 2008, J REHABIL RES DEV, V45, P479, DOI 10.1682/JRRD.2007.08.0136; Finnoff JT, 2008, CURR SPORT MED REP, V7, P28, DOI 10.1097/01.CSMR.0000308669.99816.71; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Imray C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4943; Imray C, 2010, PROG CARDIOVASC DIS, V52, P467, DOI 10.1016/j.pcad.2010.02.003; Jackson SJ, 2010, HIGH ALT MED BIOL, V11, P217, DOI 10.1089/ham.2010.1003; Maggiorini M, 1998, AVIAT SPACE ENVIR MD, V69, P1186; Maggiorini M, 2010, PROG CARDIOVASC DIS, V52, P500, DOI 10.1016/j.pcad.2010.03.001; Merkelbach S, 2006, J NEUROL, V253, P21, DOI 10.1007/s00415-005-1105-z; Muza SR, 2010, HIGH ALT MED BIOL, V11, P87, DOI 10.1089/ham.2010.1006; Queiroz Luiz P, 2007, Curr Pain Headache Rep, V11, P293, DOI 10.1007/s11916-007-0206-4; Rodway GW, 2003, HEART LUNG, V32, P353, DOI 10.1016/j.hrtlng.2003.08.002; Wilson MH, 2011, J CEREBR BLOOD F MET, V31, P2019, DOI 10.1038/jcbfm.2011.81	21	5	5	0	9	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	2					253	261		10.1682/JRRD.2012.03.0042			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	149FF	WOS:000319303700014	23761006	Bronze			2022-02-06	
J	Kim, H; Bayley, M; Dawson, D; Mollayeva, T; Colantonio, A				Kim, Hwan; Bayley, Mark; Dawson, Deirdre; Mollayeva, Tatyana; Colantonio, Angela			Characteristics and functional outcomes of brain injury caused by physical assault in Canada: a population-based study from an inpatient rehabilitation setting	DISABILITY AND REHABILITATION			English	Article						Brain injuries; discharge planning; outcome measures; rehabilitation; violence	MODEL SYSTEMS; RISK-FACTORS; VIOLENCE; VARIABLES; ETIOLOGY; LENGTH; STAY; TBI	Purpose: To investigate the characteristics and inpatient rehabilitation outcomes of persons who sustained a traumatic brain injury (TBI) resulting from physical assault - a form of intentional TBI - and compare these outcomes to those of persons with TBI resulting from other aetiologies. Method: A prospective population-based cohort study using inpatient rehabilitation data from Canadian population-based administrative databases for the fiscal years 2001-2006. Outcome measures were measures of functional independence (motor and cognitive), as measured by the FIM (TM) Instrument, and discharge destinations. Results: Characteristics associated with intentional TBI were being male, younger in age and unemployed; living alone and having a greater likelihood of alcohol/drug abuse prior to admission. The intentional TBI group showed poorer total functional gains at discharge from inpatient rehabilitation. Multivariate regression analyses showed that persons with intentional injury were less likely to be discharged home. Conclusions: Persons with TBI from physical assault are a distinct clinical group in Canadian inpatient rehabilitation settings. These findings can support clinicians in determining proper assessment, management, discharge planning and post-rehabilitation care that target specific needs of persons with TBI resulting from physical assault.	[Kim, Hwan] Daegu Univ, Dept Occupat Therapy, Coll Rehabil Sci, Gyeongbuk, South Korea; [Bayley, Mark] UHN, Toronto Rehabil Inst, Neuro Rehabil Program, Toronto, ON, Canada; [Bayley, Mark] Univ Toronto, Div Physiatry, Toronto, ON, Canada; [Dawson, Deirdre] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Dawson, Deirdre; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON M5G 1V7, Canada; [Mollayeva, Tatyana] Univ Toronto, Grad Dept Rehabil Sci, Toronto, ON M5G 1V7, Canada; [Colantonio, Angela] Univ Toronto, UHN, Toronto Rehabil Inst, Toronto, ON M5G 1V7, Canada		Colantonio, A (corresponding author), Univ Toronto, Toronto Rehabil Inst, Saunderson Family Chair Acquired Brain Injury Res, UHN, 160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca	, Mollayeva/A-4522-2018; Dawson, Deirdre R/I-8882-2014	Dawson, Deirdre R/0000-0001-7517-6121; Colantonio, Angela/0000-0003-2094-4765; Bayley, Mark/0000-0001-7860-9463; Mollayeva, Tatyana/0000-0002-2787-1848	Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Toronto Rehabilitation Institute fellowship; Canadian Traumatic Brain Injury and Violence Research Team through the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation	The authors acknowledge support from a grant from the Ontario Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute, and a Toronto Rehabilitation Institute fellowship. The Canadian Traumatic Brain Injury and Violence Research Team provided additional support through the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research (#TIR-103946) and the Ontario Neurotrauma Foundation.	Bogner JA, 2001, ARCH PHYS MED REHAB, V82, P571, DOI 10.1053/apmr.2001.22340; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Canadian Institute for Health Information, 2009, NAT REH REP SYST DAT; Canadian Institute for Health Information, 2012, NAT REH REP SYST DAT; Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; Centers for Disease Control and Prevention, 2009, WEB BAS INJ STAT QUE; Chen AQ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-85; Colantonio A, 2008, J TRAUMA, V64, P876, DOI 10.1097/TA.0b013e31804d493e; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2010, J REHABIL MED, V42, P773, DOI 10.2340/16501977-0582; Corrigan John D., 2003, American Journal of Obstetrics and Gynecology, V188, pS71, DOI 10.1067/mob.2003.404; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; Dagher JH, 2010, BRAIN INJURY, V24, P1389, DOI 10.3109/02699052.2010.523042; Esselman PC, 2004, ARCH PHYS MED REHAB, V85, P1445, DOI 10.1016/j.apmr.2003.10.018; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Gerhart KA, 2003, J TRAUMA, V55, P1045, DOI 10.1097/01.TA.0000044353.69681.96; Hammond FM, 2010, EUR J PHYS REHAB MED, V46, P545; Hanks RA, 2003, ARCH PHYS MED REHAB, V84, P249, DOI 10.1053/apmr.2003.50096; Harrison-Felix C, 1998, ARCH PHYS MED REHAB, V79, P730, DOI 10.1016/S0003-9993(98)90348-3; HEINEMANN AW, 1995, AM J PHYS MED REHAB, V74, P315, DOI 10.1097/00002060-199507000-00011; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Heruti RJ, 1999, ARCH PHYS MED REHAB, V80, P432, DOI 10.1016/S0003-9993(99)90281-2; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Jiang JY, 2007, SURG NEUROL, V68, P2, DOI 10.1016/j.surneu.2007.09.016; Kim H, 2013, CAN J OCCUP THER, V80, P49, DOI 10.1177/0008417412473262; Kim H, 2008, J TRAUMA, V65, P1287, DOI 10.1097/TA.0b013e31817196f5; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Mammi P, 2006, Eura Medicophys, V42, P17; Munce SEP, 2013, SPINAL CORD, V51, P64, DOI 10.1038/sc.2012.81; Nobunaga AI, 1999, ARCH PHYS MED REHAB, V80, P1372, DOI 10.1016/S0003-9993(99)90247-2; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Redpath SJ, 2010, BRAIN INJURY, V24, P802, DOI 10.3109/02699051003709623; Schopp LH, 2006, J HEAD TRAUMA REHAB, V21, P213, DOI 10.1097/00001199-200605000-00002; Tooth L, 2001, BRAIN INJURY, V15, P613, DOI 10.1080/02699050010013923; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; Wenden FJ, 1998, CLIN REHABIL, V12, P53, DOI 10.1191/026921598675567949; Zafonte RD, 1997, BRAIN INJURY, V11, P403; Zwecker M, 2002, ARCH PHYS MED REHAB, V83, P342, DOI 10.1053/apmr.2002.29641	44	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2013	35	26					2213	2220		10.3109/09638288.2013.774063			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	269YY	WOS:000328282400005	23480674				2022-02-06	
J	Kuhne, CA; Mand, C; Lefering, R; Lendemans, S; Ruchholtz, S				Kuehne, C. A.; Mand, C.; Lefering, R.; Lendemans, S.; Ruchholtz, S.			Urgency of neurosurgical interventions for severe traumatic brain injury	UNFALLCHIRURG			German	Article						Traumatic brain injury; Mortality; Outcome; Trauma registry; Emergency surgery	ACUTE SUBDURAL-HEMATOMA; HEAD-INJURY; COMATOSE PATIENTS; DECOMPRESSIVE CRANIECTOMY; EPIDURAL HEMATOMA; MORTALITY; SURGERY; MANAGEMENT; MORBIDITY; PROGNOSIS	The aim of this study was to assess whether the time interval between accident and neurosurgical intervention has an influence on functional neurological outcome and mortality in severe traumatic brain injury (sTBI) or whether the further clinical course has already been determined by the initial severity of the injury. Data were derived from the Trauma Registry of the German Society of Trauma Surgery. A total of 770 patients were identified who had undergone decompressive surgery, had an ISSa parts per thousand yen9 and for whom time of accident and start of surgery had been documented. To evaluate the possible influence of the time factor on outcome and mortality, these patients were subdivided into five groups according to time until decompression (I: < 2 h, II: 2-3 h, III: 3-6 h, IV: 6-24 h and V: > 24 h). Aside from mortality we analysed AIS, GCS, age and ISS in survivors and non-survivors. Complete data were available for 770 patients with sTBI (AIS skull a parts per thousand yen3). The average age was 39.9 years and 71.6% were male. The average overall injury severity was reflected by an ISS score of 31.3 and the average AIS head score was 4.51. Of the 570 who underwent surgery in less than 6 h (groups 1-III), 33% died (188/570). Of the remaining 200 patients 40 died (20%). Mortality decreased throughout the groups (49 to 14%), as did the severity of the head injury (AIS 4.66 to 4.23); GCS on the other hand increased with the time between accident and surgery (5.9 to 8.8). We could not substantiate that reducing the time between accident and neurosurgical decompression could decrease mortality. It rather seems that the initial magnitude of brain damage determines prognosis and outcome after sTBI. The interval between the appearance of neurological symptoms (e.g. anisocoria) and neurosurgical intervention plays an important role and should be kept as short as possible.	[Kuehne, C. A.; Mand, C.; Ruchholtz, S.] Univ Giessen Klinikum, Klin Unfall Hand & Wiederherstellungschirurg, D-35043 Marburg, Germany; [Kuehne, C. A.; Mand, C.; Ruchholtz, S.] Marburg GmbH, Standort Marburg, D-35043 Marburg, Germany; [Mand, C.; Lefering, R.] Univ Witten Herdecke, IFOM, Cologne, Germany; [Lendemans, S.] Univ Klinikum Essen, Klin & Poliklin Unfallchirurg, Essen, Germany		Kuhne, CA (corresponding author), Univ Giessen Klinikum, Klin Unfall Hand & Wiederherstellungschirurg, Baldingerstr 1, D-35043 Marburg, Germany.	kuehnec@med.uni-marburg.de					Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Doll D, 2010, ORTHOP UNFALLCHIR, V5, P87, DOI 10. 1055/s-0029-1244075; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Firsching R, 2007, AWMF LEITLINIE SCHAD; GENNARELLI TA, 1989, J TRAUMA, V29, P1193, DOI 10.1097/00005373-198909000-00002; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hanif S, 2009, Ir Med J, V102, P255; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; Lu J, 2005, ACT NEUR S, V95, P281; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Martins ET, 2009, J TRAUMA, V67, P85, DOI 10.1097/TA.0b013e318187acee; Massaro F, 1996, ACTA NEUROCHIR, V138, P185, DOI 10.1007/BF01411359; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Neugebauer E, 2000, UNFALLCHIRURG, V103, P122, DOI 10.1007/s001130050023; Poon WS, 2005, ACT NEUR S, V93, P207; Quigley MR, 1997, J TRAUMA, V42, P7, DOI 10.1097/00005373-199701000-00003; Rickels E, 2009, CHIRURG, V80, P153, DOI 10.1007/s00104-008-1655-y; Rickels E, 2006, SCHADEL HIRN TRAUMA; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Ruchholtz S, 2002, CHIRURG, V73, P194, DOI 10.1007/s00104-002-0424-6; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1983, SURG NEUROL, V19, P216, DOI 10.1016/S0090-3019(83)80005-6; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tian HL, 2008, CHINESE MED J-PEKING, V121, P1080, DOI 10.1097/00029330-200806020-00007; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Wester T, 1999, J TRAUMA, V46, P914, DOI 10.1097/00005373-199905000-00023; WILBERGER JE, 1990, J TRAUMA, V30, P733, DOI 10.1097/00005373-199006000-00014; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; Wong GKC, 2010, ACTA NEUROCHIR SUPPL, V106, P235, DOI 10.1007/978-3-211-98811-4_44; Zulu BMW, 2007, INJURY, V38, P576, DOI 10.1016/j.injury.2007.01.002	38	5	5	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537			UNFALLCHIRURG	Unfallchirurg	JAN	2013	116	1					39	46		10.1007/s00113-011-2042-6			8	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	072YM	WOS:000313710100009	21604029				2022-02-06	
J	Lau, YL; Ting, SH				Lau, Yih-Long; Ting, Su-Hie			Chinese vendors' code-switching in service encounters in Sarawak, Malaysia	SOCIOLINGUISTIC STUDIES			English	Article						LANGUAGE CHOICE; CODE-SWITCHING; SERVICE ENCOUNTERS; RETAIL ENCOUNTERS	TRAUMATIC BRAIN-INJURY; IMPACT; RETAIL	The study examined the language of service encounters in a bakery operated by Chinese vendors in a Foochow-dominant town in Malaysia. Naturally occurring data of one hundred service encounters were digitally recorded (83 with Chinese customers and 17 with non-Chinese customers). In intraethnic interactions, Foochow is the default language choice but Mandarin is emerging as a viable option. In interethnic interactions, the Chinese vendors accommodated by speaking either Bahasa Malaysia or Bazaar Malay. A majority of the service encounters took place in one language as code-switching was identified in only 19 encounters. In interethnic interactions, the vendors switched to thank customers in English but in intraethnic interactions, the functions vary with the staging of service encounters. The main functions are emphasis on attributes of goods in Sale Enquiry, attributes and quantity of goods to buy in Sale Request, and attributes, quantity and price of goods to sell in Sale Compliance. Code-switching in the Purchase Closure stage brings in expression of thanks which is not an integral feature of service encounters in Eastern settings. Using stages of service encounters to explain code-switching functions provides a less context-dependent framework which shows how code-switching brings about efficiency in service encounters.	[Lau, Yih-Long] Univ Teknol Mara, English, Acad Language Studies, Campus Samarahan, Sarawak, Malaysia; [Ting, Su-Hie] Univ Malaysia Sarawak, Ctr Language Studies, English, Kota Samarahan, Malaysia		Lau, YL (corresponding author), Univ Teknol Mara, English, Acad Language Studies, Campus Samarahan, Sarawak, Malaysia.	kimberley@sarawak.uitm.edu.my; shting@cls.unimas.my	TING, Su-Hie/J-2212-2019	TING, Su-Hie/0000-0002-2479-6395			Altehenger-Smith S., 1987, ANAL INTERCULTURAL C, P75; APTE ML, 1974, LINGUISTICS, P67; Attan Anie, 1998, THESIS; Bailey B., 2001, LINGUISTIC ANTHR REA, P119; Blom J.-P., 1986, DIRECTIONS SOCIOLING, P407; Burhanudeen H., 2006, LANGUAGE SOCIAL BEHA; Callahan Laura, 2007, SW J LINGUISTICS, V26, P15; Clarke RJ, 2008, IBM SYST J, V47, P129, DOI 10.1147/sj.471.0129; Department of Statistics Malaysia Sarawak, 2012, MONTHL STAT B SAR MA; Dumanig F., 2010, LANGUAGE CHOICE INTE; Eggins S., 1997, ANAL CASUAL CONVERSA; Gumperz J., 1982, DISCOURSE STRATEGIES; Hall E.T., 1987, HIDDEN DIFFERENCES D; Halliday Michael Alexander Kirkwood, 1989, LANGUAGE CONTEXT TEX; Hamers J.F., 2000, BILINGUALITY BILINGU, V2nd; Hartman KB, 2009, J HOSP MARKET MANAG, V18, P197, DOI 10.1080/19368620802591934; Jalaluddin Nor Hashimah, 2007, BAHASA DALAM PERNIAG; Jefferson G., 1985, HDB DISCOURSE ANAL, VVol. 3, P25; KONG KCC, 1998, PRAGMATICS, V8, P555, DOI DOI 10.1075/PRAG.8.4.04KON; Legal Research Board, 1997, FED CONST; Liu A., 2009, SHE IS KIND CLUELESS; Mahadhir M., 2008, P 6 INT MAL STUD C M; MERRITT M, 1976, LANG SOC, V5, P315, DOI 10.1017/S0047404500007168; Omar A. H., 1979, LANGUAGE PLANNING UN; Omar A. H., 1982, LANGUAGE SOC MALAYSI; Orr WWF, 2007, LANG SOC, V36, P73, DOI 10.1017/S0047404507070042; PAN Y, 2000, INT J SOCIOL LANG, V146, P21, DOI DOI 10.1515/IJSL.2000.146.21; Platt J., 1980, ENGLISH SINGAPORE MA; PLATT JT, 1975, ANTHROPOL LINGUIST, V17, P363; Schau HJ, 2007, J RETAILING, V83, P65, DOI 10.1016/j.jretai.2006.10.008; Shanta Nair-Venugopal, 2000, LANGUAGE CHOICE COMM; Tan A.S., 1993, THESIS; Ting S. H., 2001, THESIS; Ting S. H., 2008, 15 INT ASS APPL LING; Ting S. H., 2001, ENGL TODAY, V65, P54; Ting S. H., 2010, P LANG SPEC PURP PRO; Ting S. H., 2012, INT P EC DEV RES KNO, P23; Ting S. H., 2010, P INT C MIN MAJ LANG; Ting S. H., 2010, P 7 INT MAL STUD C M; Ting SH, 2009, AUST REV APPL LINGUI, V32, DOI 10.2104/aral0911; Ting SH, 2010, CURR ISS LANG PLAN, V11, P397, DOI 10.1080/14664208.2010.545573; Togher L, 1997, APHASIOLOGY, V11, P491, DOI 10.1080/02687039708248486; Togher L, 2004, APHASIOLOGY, V18, P313, DOI 10.1080/02687030344000535; Torras M. C., 1998, 97 CTR LANG SOC LIF; Torras MC, 2002, LANG SOC, V31, P527, DOI 10.1017/S0047404502314027; Wong J. K. L., 2000, SABAH MALAY DIALECT; [No title captured]	47	5	5	0	0	EQUINOX PUBLISHING LTD	SHEFFIELD	415, THE WORKSTATION, 15 PATERNOSTER ROW, SHEFFIELD, S1 2BX, ENGLAND	1750-8649	1750-8657		SOCIOLING STUD	Socioling. Stud.		2013	7	3					199	223		10.1558/sols.v7i3.199			25	Linguistics	Emerging Sources Citation Index (ESCI)	Linguistics	V3M6F	WOS:000218393600001					2022-02-06	
J	Medici, R				Medici, Rochelle			The Use of Multiple Performance Validity Tests	JOURNAL OF FORENSIC PSYCHOLOGY PRACTICE			English	Article						performance validity; multiple PVTs; traumatic brain injury		Performance validity tests (PVTs) have become an important part of the neuropsychologist's armamentarium, especially where financial gain is an issue. It has been argued that the addition of more and more PVTs to a battery strengthens the confirmation of an overall diagnosis of lack of credibility. It has been suggested that a criterion of two or more, or three or more, failed PVTs is a good predictor of a genuine lack of effort on the part of the client. However, the validity of a diagnosis of lack of performance validity depends upon the number of tests administered as well as the number of tests failed. This can be calculated by computing the binomial equation across the specific number of tests administered relative to the specific number of failed tests. This computation assumes that false-positives for a given PVT can be estimated at 10% and that most PVTs are relatively independent of one another. Although it is counter-intuitive, adding more and more PVTs does not automatically increase the likelihood of a true positive diagnosis of non-credible performance.			Medici, R (corresponding author), 2220 El Molino Pl, San Marino, CA 91108 USA.	rmedici@socal.rr.com					Boone K. B., 2008, PRESENTED AT THE 18T; Boone KB, 2007, ASSESSMENT OF FEIGNE; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Centers for Disease Control and Prevention, 2012, REPORT TO CONGRESS O; Larrabee G. J., 2007, ASSESSMENT OF MALING; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Slick DJ, 2004, ARCH CLIN NEUROPSYCH, V19, P465, DOI 10.1016/j.acn.2003.04.001; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Steiger J., 2008, VERDICT SEARCH, V8, P3	10	5	5	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXFORDSHIRE, ENGLAND	1522-8932			J FORENSIC PSYCHOL P	J. Forensic Psychol. Pract.	JAN 1	2013	13	1					68	78		10.1080/15228932.2013.746909			11	Criminology & Penology; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Psychology	105HR	WOS:000316058000005					2022-02-06	
J	Miller, RM; Haws, NA; Murphy-Tafiti, JL; Hubner, CD; Curtis, TD; Rupp, ZW; Smart, TA; Thompson, LM				Miller, Ronald Mellado; Haws, Nathan A.; Murphy-Tafiti, Jason L.; Hubner, Carlyn D.; Curtis, Thomas D.; Rupp, Zachary W.; Smart, Taylor A.; Thompson, Lisa M.			Are Self-Ratings of Functional Difficulties Objective or Subjective?	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						diagnosis; neuropsychology; tests	TRAUMATIC BRAIN-INJURY; VALIDITY ASSESSMENT; COMPETENCE; VALIDATION; AWARENESS; HEALTH; SCALE; SCL-90-R	In this study, we compared objective neuropsychological data using the Meyers Neuropsychological Battery (MNB; Meyers & Rohling, 2004) and self-report measures of emotional distress using the Symptom Checklist 90-Revised (SCL-90-R; Derogatis, 1994) with self-ratings of functional difficulties as measured by the Patient Competency Rating Scale (PCRS; Prigatano, 1986). The results showed a high correlation between the PCRS and scales on the SCL-90-R (r=.65), whereas correlation with the overall test battery mean of the MNB was quite small (r=.18). Our results indicate that self-report of cognitive difficulties is more related to current emotional distress than to objective measures. Therefore, any diagnostic considerations that rely on self-report need to be tempered by considerations of current emotional status. This has implications for diagnoses such as posttraumatic stress disorder and other diagnoses that rely on self-report as a source of diagnostic information.	[Miller, Ronald Mellado; Haws, Nathan A.; Murphy-Tafiti, Jason L.; Hubner, Carlyn D.; Curtis, Thomas D.; Rupp, Zachary W.; Smart, Taylor A.; Thompson, Lisa M.] Brigham Young Univ Hawaii, Dept Psychol, Laie, HI 96762 USA		Miller, RM (corresponding author), Brigham Young Univ Hawaii, Dept Psychol, 55-220 Kulanui St 1896, Laie, HI 96762 USA.	ronald.miller@byuh.edu					ANDREWS FM, 1981, GUIDE SELECTING STAT; Bell-McGinty S, 2002, INT J GERIATR PSYCH, V17, P828, DOI 10.1002/gps.646; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BRANDT J, 1985, ANN NY ACAD SCI, V444, P502, DOI 10.1111/j.1749-6632.1985.tb37625.x; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cahn-Weiner DA, 2000, CLIN NEUROPSYCHOL, V14, P187, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT187; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Cohen J., 2013, STAT POWER ANAL BEHA; Derogatis L.R., 1994, SYMPTOM CHECKLIST 90, V3rd ed.; FELSON RB, 1981, SOC PSYCHOL QUART, V44, P64, DOI 10.2307/3033866; Fidell L.S., 2007, USING MULTIVARIATE S, V5, P481; Gill TM, 1997, J GEN INTERN MED, V12, P757, DOI 10.1046/j.1525-1497.1997.07161.x; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2010, CLIN NEUROPSYCHOL, V24, P137, DOI 10.1080/13854040902927546; HOFFMANN NG, 1978, J CONSULT CLIN PSYCH, V46, P1187, DOI 10.1037/0022-006X.46.6.1187; Hoofien D, 2006, ISR J PSYCHIATR REL, V43, P296; Kozel JJ, 1998, ARCH CLIN NEUROPSYCH, V13, P327, DOI 10.1016/S0887-6177(97)00036-X; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Magaziner J, 1996, AM J EPIDEMIOL, V143, P283; Marshall MB, 2006, ASSESSMENT, V13, P417, DOI 10.1177/1073191106290842; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Meyers J E, 1999, Appl Neuropsychol, V6, P208, DOI 10.1207/s15324826an0604_3; Meyers J. E., 1999, ELECT MANUAL MNB; Meyers JE, 2004, ARCH CLIN NEUROPSYCH, V19, P637, DOI 10.1016/j.acn.2003.08.007; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Meyers JE, 2003, ARCH CLIN NEUROPSYCH, V18, P261, DOI 10.1016/S0887-6177(02)00136-1; Meyers JE, 2002, ARCH CLIN NEUROPSYCH, V17, P79, DOI 10.1016/S0887-6177(00)00105-0; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 1998, APPL NEUROPSYCHOL, V5, P120, DOI 10.1207/s15324826an0503_2; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Monaci L., 2011, PSIGE NEWSLETTER, V51, P53; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Ransom D, 2010, SURG OBES RELAT DIS, V6, P622, DOI 10.1016/j.soard.2010.02.039; Reitan R, 1985, HALSTEAD REITAN NEUR; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Schmitz N, 1999, SOC PSYCH PSYCH EPID, V34, P360, DOI 10.1007/s001270050156; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; StatSoft Inc, 2011, STAT VERS 10; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; VIDEBECK R, 1960, SOCIOMETRY, V23, P351, DOI 10.2307/2785689; Volbrecht ME, 2000, ARCH CLIN NEUROPSYCH, V15, P251, DOI 10.1016/S0887-6177(99)00016-5; Wechsler, 2008, WAIS 4 ADM SCORING M; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Yesavage J.A., 1983, ASSESSMENT GERIATRIC, P153	51	5	5	0	3	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2013	20	3					179	186		10.1080/09084282.2012.670172			8	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	298SL	WOS:000330344600003	23383984				2022-02-06	
S	Raffin, E; Dyrby, TB		Naritomi, H; Krieger, DW		Raffin, Estelle; Dyrby, Tim B.			Diagnostic Approach to Functional Recovery: Diffusion-Weighted Imaging and Tractography	CLINICAL RECOVERY FROM CNS DAMAGE	Frontiers of Neurology and Neuroscience		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; CHRONIC STROKE PATIENTS; ISCHEMIC-STROKE; MONTE-CARLO; MRI; LESION; VALIDATION; PREDICTION; SCHEMES; DENSITY	There is evidence showing that white matter changes are clinically relevant and can be associated with cognitive disorders, slower mental processing speed or motor impairment. The complex structural organization of the white matter can be depicted in vivo in great detail with advanced diffusion-weighted imaging (DWI). From the simplest and most commonly used technique (e.g. the mapping of apparent diffusion coefficient values) to more advanced techniques (e.g. diffusion tensor imaging), it is now possible to visualize white matter fibers of the brain in a noninvasive way. This chapter will first provide a basic understanding of the principles of these techniques and describe the current clinical applications of DWI and tractography in two common brain diseases, stroke and traumatic brain injury. We will emphasise on what these techniques may add to our understanding of the natural course of the pathology and especially, how they can help in predicting the outcomes of the rehabilitation phase. We will discuss how DWI and tractography techniques can shed light on possible compensatory disease mechanisms and propose future developments of these techniques in a clinical setting. Copyright (C) 2013 S. Karger AG, Basel	[Raffin, Estelle; Dyrby, Tim B.] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark		Raffin, E (corresponding author), Hvidovre Univ Hosp, DRCMR, Kettegaard Alle 30, DK-2659 Hvidovre, Denmark.	esteller@drcmr.dk	Dyrby, Tim Bjorn/M-4823-2015	Dyrby, Tim Bjorn/0000-0003-3361-9734; Raffin, Estelle/0000-0003-3262-5251			Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Allen LM, 2012, RADIOGRAPHICS, V32, P1285, DOI 10.1148/rg.325115760; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Cercignani M, 2006, MAGN RESON MED, V56, P803, DOI 10.1002/mrm.21003; Chen JT, 2007, NEUROIMAGE, V36, P1152, DOI 10.1016/j.neuroimage.2007.03.073; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Davis DP, 2006, J EMERG MED, V31, P269, DOI 10.1016/j.jemermed.2005.10.003; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Hand PJ, 2006, NEUROLOGY, V66, P1159, DOI 10.1212/01.wnl.0000202524.43850.81; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Jang SH, 2005, RESTOR NEUROL NEUROS, V23, P325; Jang SH, 2010, NEUROREHABILITATION, V27, P367, DOI 10.3233/NRE-2010-0621; Jayaram G, 2012, CLIN NEUROPHYSIOL, V123, P2422, DOI 10.1016/j.clinph.2012.04.026; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, NEUROIMAGE; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lindberg PG, 2007, NEUROREHAB NEURAL RE, V21, P551, DOI 10.1177/1545968307301886; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Newton JM, 2006, BRAIN, V129, P1844, DOI 10.1093/brain/awl106; Nilsson M, 2012, NMR BIOMED, V25, P795, DOI 10.1002/nbm.1795; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Porto L, 2011, EUR J PAEDIATR NEURO, V15, P493, DOI 10.1016/j.ejpn.2011.06.004; Schaechter JD, 2009, HUM BRAIN MAPP, V30, P3461, DOI 10.1002/hbm.20770; Schwamm LH, 1998, STROKE, V29, P2268, DOI 10.1161/01.STR.29.11.2268; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Song F, 2012, J INT MED RES, V40, P126, DOI 10.1177/147323001204000113; Thijs VN, 2000, STROKE, V31, P2597, DOI 10.1161/01.STR.31.11.2597; Wendell BA, 2011, ANN NY ACAD SCI, V1224, P63, DOI 10.1111/j.1749-6632.2010.05954.x; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	37	5	6	0	3	KARGER	BASEL	POSTFACH, CH-4009 BASEL, SWITZERLAND	1660-4431	1662-2804	978-3-318-02309-1; 978-3-318-02308-4	FRONT NEUROL NEUROSC	Front. Neurol. Neurosci.		2013	32						26	35		10.1159/000348818			10	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BGG55	WOS:000322844300004	23859960				2022-02-06	
B	Sandel, ME; Delmonico, R; Kotch, MJ		Zasler, ND; Katz, DI; Zafonte, RD		Sandel, M. Elizabeth; Delmonico, Richard; Kotch, Mary Jean			Sexuality and Intimacy Following Traumatic Brain Injury	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							REPRODUCTIVE ENDOCRINE DISORDERS; NOCTURNAL PENILE TUMESCENCE; TOPICAL ALPROSTADIL CREAM; L-ARGININE GLUTAMATE; ERECTILE-DYSFUNCTION; DOUBLE-BLIND; INTRACAVERNOUS INJECTION; YOHIMBINE HYDROCHLORIDE; SILDENAFIL CITRATE; PARTIAL SEIZURES		[Sandel, M. Elizabeth] Napa Solano Serv Area, Vallejo, CA USA; [Sandel, M. Elizabeth] Kaiser Fdn Rehabil Ctr, Dept Phys Med & Rehabil, Vallejo, CA USA; [Sandel, M. Elizabeth; Delmonico, Richard] Univ Calif Davis, Sch Med, Dept Phys Med & Rehabil, Sacramento, CA 95817 USA; [Delmonico, Richard] Dept Phys Med & Rehabil, Vallejo, CA USA; [Kotch, Mary Jean] Kaiser Fdn Rehabil Ctr, Dept Nursing, Vallejo, CA USA		Sandel, ME (corresponding author), Napa Solano Serv Area, Vallejo, CA USA.						ABBOUD CF, 1986, MAYO CLIN PROC, V61, P35, DOI 10.1016/S0025-6196(12)61397-4; Allgeier WE, 1995, SEXUAL INTERACTIONS; Aloni A, 1999, BRAIN INJURY, V13, P89, DOI 10.1080/026990599121755; Aloni R, 1999, BRAIN INJURY, V13, P269, DOI 10.1080/026990599121647; Aloni R, 2003, SEXUAL DIFFICULTIES, P9; Althof SE, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P242; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Anastasiadis Aristotelis G, 2002, Curr Opin Urol, V12, P503, DOI 10.1097/00042307-200211000-00011; Angier N., 1999, WOMAN INTIMATE GEOGR; Annon JS., 1976, J SEX EDUC THER, V2, P1, DOI [10.1080/01614576.1976.11074483, DOI 10.1080/01614576.1976.11074483]; [Anonymous], 1983, MED LETT DRUGS THER, V25, P73; [Anonymous], 2010, HASTINGS CENT REP, V40, P14; [Anonymous], 1995, Neurology, V45, P2287; Apperloo MJA, 2003, J SEX MARITAL THER, V29, P87, DOI 10.1080/00926230390155005; Atmaca M, 2002, INT J IMPOT RES, V14, P547, DOI 10.1038/sj.ijir.3900906; Avis N E, 2000, J Gend Specif Med, V3, P37; Avis NE, 2000, MENOPAUSE, V7, P297, DOI 10.1097/00042192-200007050-00004; Basson R, 2000, J UROLOGY, V163, P888, DOI 10.1016/S0022-5347(05)67828-7; Basson R, 2000, J SEX MARITAL THER, V26, P51, DOI 10.1080/009262300278641; Baumeister RF, 2001, PERS SOC PSYCHOL REV, V5, P242, DOI 10.1207/S15327957PSPR0503_5; Bechara A, 2003, J SEX MARITAL THER, V29, P1, DOI 10.1080/00926230390154862; Bell K R, 2001, Phys Med Rehabil Clin N Am, V12, P169; BENKERT O, 1972, PSYCHOPHARMACOLOGIA, V23, P91, DOI 10.1007/BF00414417; BERARD EJJ, 1989, PARAPLEGIA, V27, P99, DOI 10.1038/sc.1989.16; Bezeau SC, 2004, BRAIN INJURY, V18, P299, DOI 10.1080/02699050310001617398; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; Britton KR, 1998, BRAIN INJURY, V12, P703, DOI 10.1080/026990598122269; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Burnett AL, 2003, J UROLOGY, V170, pS31, DOI 10.1097/01.ju.0000075604.60090.60; Butcher J. N., 2001, MMPI 2 MINNESOTA MUL; BUVAT J, 1987, UROLOGY, V30, P216, DOI 10.1016/0090-4295(87)90237-8; Carrier Serge, 2003, Can J Urol, V10 Suppl 1, P12; Center for Research on Women with Disabilities, 1999, NAT STUD WOM PHYS DI; Cole S, 1986, SEX DISABIL, V7, P71; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; CRENSHAW TL, 1987, J SEX MARITAL THER, V13, P239; DANJOU P, 1988, BRIT J CLIN PHARMACO, V26, P733, DOI 10.1111/j.1365-2125.1988.tb05312.x; Deliganis AV, 2002, RADIOLOGY, V225, P791, DOI 10.1148/radiol.2253011160; Delmonico RL, 2001, BRAIN INJ SOURCE, V5, P24; Derogatis L, 1987, DEROGATIS INTERVIEW; Derogatis LR, 2002, J SEX MARITAL THER, V28, P317, DOI 10.1080/00926230290001448; Dombrowski LK, 2000, REHABIL PSYCHOL, V45, P299, DOI 10.1037/0090-5550.45.3.299; Drewes SE, 2003, PHYTOCHEMISTRY, V62, P1019, DOI 10.1016/S0031-9422(02)00621-0; Duldt B W, 1999, Nurse Educ, V24, P27, DOI 10.1097/00006223-199909000-00014; EMORY LE, 1995, J HEAD TRAUMA REHAB, V10, P47; FABBRI A, 1989, PSYCHONEUROENDOCRINO, V14, P103, DOI 10.1016/0306-4530(89)90059-0; Ferguson DM, 2003, J SEX MARITAL THER, V29, P33, DOI 10.1080/713847125; Fink HA, 2002, ARCH INTERN MED, V162, P1349, DOI 10.1001/archinte.162.12.1349; Fourcroy JL, 2003, DRUGS, V63, P1445, DOI 10.2165/00003495-200363140-00002; Fyffe CE, 2004, J APPL BEHAV ANAL, V37, P401, DOI 10.1901/jaba.2004.37-401; Gans W H, 2001, J Spinal Cord Med, V24, P35; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; Garnets Linda D, 2002, Cultur Divers Ethnic Minor Psychol, V8, P115, DOI 10.1037/1099-9809.8.2.115; GARTRELL N, 1986, AM J PSYCHIAT, V143, P781; Gaudet L, 2001, SEX DISABIL, V19, P111, DOI 10.1023/A:1010673722429; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; GIULIANO FA, 1995, UROL CLIN N AM, V22, P747; Glass C, 1999, BRIT MED J, V318, P518, DOI 10.1136/bmj.318.7182.518; GOLDSTEIN JA, 1986, ANN INTERN MED, V105, P799, DOI 10.7326/0003-4819-105-5-799_1; Gonzalgo ML, 2003, J UROLOGY, V170, P503, DOI 10.1097/01.ju.0000071478.69480.fd; Goscinski I, 1997, J Neurosurg Sci, V41, P269; Griffith ER, 1993, SEXUALITY PERSON TRA; Guay AT, 2002, INT J IMPOT RES, V14, P25, DOI 10.1038/sj.ijir.3900803; Gutman S, 1997, OCCUP THER MENT HLTH, V13, P51; Hagemann JH, 2003, EUR UROL, V43, P412, DOI 10.1016/S0302-2838(03)00002-2; Haseltine F, 1993, REPROD ISSUES PERSON; Heiman J. R, 1978, HDB SEX THERAPY, P103; Herschorn Sender, 2003, Can J Urol, V10 Suppl 1, P23; Herson L, 1999, Rehabil Nurs, V24, P148; HERZOG AG, 1986, ARCH NEUROL-CHICAGO, V43, P347, DOI 10.1001/archneur.1986.00520040035015; HERZOG AG, 1986, ARCH NEUROL-CHICAGO, V43, P341, DOI 10.1001/archneur.1986.00520040029014; HERZOG AG, 1982, ARCH NEUROL-CHICAGO, V39, P133, DOI 10.1001/archneur.1982.00510150003001; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Hong B, 2002, J UROLOGY, V168, P2070, DOI 10.1016/S0022-5347(05)64298-X; Horn LJ, 1990, J HEAD TRAUMA REHAB, V5, P1; HOUGH S, 1989, PSYCHOL REP, V65, P745, DOI 10.2466/pr0.1989.65.3.745; HULTER B, 1994, ARCH SEX BEHAV, V23, P171, DOI 10.1007/BF01542097; ISHII N, 1989, J UROLOGY, V141, P323, DOI 10.1016/S0022-5347(17)40754-3; Johnson C, 2006, BRAIN INJURY, V20, P687, DOI 10.1080/02699050600744137; Kaiser Permanente, 2004, PROV HDB CULT COMP C; Kalsi JS, 2003, HOSP MED, V64, P292, DOI 10.12968/hosp.2003.64.5.1762; KANEKO S, 1986, J UROLOGY, V136, P1026, DOI 10.1016/S0022-5347(17)45195-0; KAPLAN HS, 1977, J SEX MARITAL THER, V3, P3; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kotch MJ, 2001, BRAIN INJ SOURCE, V5, P8; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Kreuter M, 1998, BRAIN INJURY, V12, P349, DOI 10.1080/026990598122494; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; Kroll K, 1992, ENABLING ROMANCE GUI; LAL S, 1984, PROG NEURO-PSYCHOPH, V8, P695, DOI 10.1016/0278-5846(84)90040-X; LAL S, 1988, PROG NEURO-PSYCHOPH, V12, P117, DOI 10.1016/0278-5846(88)90033-4; Lammers PI, 2002, INT J IMPOT RES, V14, P54, DOI 10.1038/sj.ijir.3900816; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Layman DE, 2005, BRAIN INJURY, V19, P909, DOI 10.1080/02699050500109928; Lebret T, 2002, EUR UROL, V41, P608, DOI 10.1016/S0302-2838(02)00175-6; Leiblum S R, 1999, J Gend Specif Med, V2, P41; Leiblum SR, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P1; Levine SB, 2003, CLEV CLIN J MED, V70, P241, DOI 10.3949/ccjm.70.3.241; LEVINE SB, 1989, J UROLOGY, V141, P54, DOI 10.1016/S0022-5347(17)40585-4; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LILLY R, 1983, NEUROLOGY, V33, P1141, DOI 10.1212/WNL.33.9.1141; Liverman CT, 2003, COMMITTEE ASSESSING; LoPiccolo J., 1978, HDB SEX THERAPY, P1; Lundberg PO, 2001, EUR J NEUROL, V8, P2, DOI 10.1046/j.1468-1331.2001.0080s3002.x; Lusk MD, 1982, MED ASPECTS HUM SEX, V16, P22; MACLEAN PD, 1975, SEXUAL BEHAV PHARM B; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; MARSON L, 1993, NEUROSCIENCE, V55, P263, DOI 10.1016/0306-4522(93)90471-Q; Masters W.H., 1966, HUMAN SEXUAL RESPONS; MATHEWS A, 1983, PSYCHOL MED, V13, P83, DOI 10.1017/S0033291700050091; McKenna K, 1999, INT J IMPOT RES, V11, pS48, DOI 10.1038/sj.ijir.3900484; Medlar T, 1998, SEX DISABIL, V16, P11, DOI 10.1023/A:1023067630449; MEDLAR T, 1990, J HEAD TRAUMA REHAB, V5, P46; Meston CM, 2002, ARCH SEX BEHAV, V31, P323, DOI 10.1023/A:1016220225392; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; Millon, 1997, MANUAL MILLON CLIN M; Montorsi F, 2003, INT J IMPOT RES, V15, P203, DOI 10.1038/sj.ijir.3900999; Montorsi F, 2003, EUR UROL, V43, P405, DOI 10.1016/S0302-2838(03)00053-8; MORALES A, 1987, J UROLOGY, V137, P1168, DOI 10.1016/S0022-5347(17)44436-3; MORALES A, 1990, J UROLOGY, V143, P441, DOI 10.1016/S0022-5347(17)39986-X; Nurnberg HG, 2003, JAMA-J AM MED ASSOC, V289, P56, DOI 10.1001/jama.289.1.56; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; O'Dell M. W., 2001, BRAIN INJ SOURCE, V5, P22; OCARROLL R, 1991, J SEX RES, V28, P607, DOI 10.1080/00224499109551628; OCARROLL R, 1984, BRIT J PSYCHIAT, V145, P146, DOI 10.1192/bjp.145.2.146; Olkin R, 1999, WHAT PSYCHOTHERAPIST, P226; Padma-Nathan H, 2003, INT J IMPOT RES, V15, P10, DOI 10.1038/sj.ijir.3900940; Polonsky DC, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P305; Porst H, 2003, UROLOGY, V62, P519, DOI 10.1016/S0090-4295(03)00491-6; Pridal CG, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P57; Quirk FH, 2002, J WOMEN HEALTH GEN-B, V11, P277, DOI 10.1089/152460902753668475; Ramos AS, 2001, SPINAL CORD, V39, P637, DOI 10.1038/sj.sc.3101210; REID K, 1987, LANCET, V2, P421; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Rosen RC, 1999, J CLIN PSYCHOPHARM, V19, P67, DOI 10.1097/00004714-199902000-00013; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; RUST J, 1985, BRIT J CLIN PSYCHOL, V24, P63, DOI 10.1111/j.2044-8260.1985.tb01314.x; Sandel ME, 1996, BRAIN INJURY, V10, P719, DOI 10.1080/026990596123981; Schover LR, 2000, PRINCIPLES AND PRACTICE OF SEX THERAPY, THIRD EDITION, P398; SCHOVER LR, 1982, ARCH GEN PSYCHIAT, V39, P614; Seidman SN, 2003, J CLIN PSYCHIAT, V64, P721, DOI 10.4088/JCP.v64n0616; SHERWIN BB, 1987, PSYCHOSOM MED, V49, P397, DOI 10.1097/00006842-198707000-00009; SIDI AA, 1988, UROL CLIN N AM, V15, P95; Simpson G, 2004, J HEAD TRAUMA REHAB, V19, P413, DOI 10.1097/00001199-200409000-00006; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; SIOSTEEN A, 1990, PARAPLEGIA, V28, P285; Sipski M, 1997, SEXUAL FUNCTION PEOP; Sipski ML, 2001, J SEX MARITAL THER, V27, P215, DOI 10.1080/00926230152052012; Sipski ML, 2001, CLIN AUTON RES, V11, P279, DOI 10.1007/BF02332972; Sitsen JMA, 1988, HDB SEXOLOGY, V6, P425; SONDA LP, 1990, J SEX MARITAL THER, V16, P15; SPARADEO FR, 1992, HDB ASSESSING TREATI; STACKL W, 1988, J UROLOGY, V140, P66, DOI 10.1016/S0022-5347(17)41488-1; Steers WD, 2003, J UROLOGY, V170, pS20, DOI 10.1097/01.ju.0000075120.89700.9b; Steidle C, 2002, UROLOGY, V60, P1077, DOI 10.1016/S0090-4295(02)01980-5; STEVENSON RWD, 1990, J CLIN PSYCHOPHARM, V10, P69, DOI 10.1097/00004714-199002000-00026; SUSSET JG, 1989, J UROLOGY, V141, P1360, DOI 10.1016/S0022-5347(17)41308-5; Tan Robert S, 2003, Curr Opin Investig Drugs, V4, P435; THASE ME, 1988, BIOL PSYCHIAT, V24, P33, DOI 10.1016/0006-3223(88)90119-9; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Walker A E, 1976, Neurol India, V24, P1; WEINSTEIN E, 1981, MED ASPECTS HUM SEX, V15, P158; Weinstein E A, 1974, Med Aspects Hum Sex, V8, ppassim; WEINSTEIN EA, 1961, PSYCHIATR, V24, P69; Weinstein EA, 1974, MED ASPECTS HUM SEX, V8, P18; Weinstein EA, 1981, MED ASPECTS HUM SEX, V15, P163; Weinstein EA, 1974, MED ASPECTS HUM SEX, V8, P16; World Health Organization, 2004, ICD 10 INT STAT CLAS; Yap Ronald L, 2002, Curr Urol Rep, V3, P471, DOI 10.1007/s11934-002-0100-x; ZAJECKA J, 1991, J CLIN PSYCHIAT, V52, P66; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004; ZENCIUS A, 1990, Brain Injury, V4, P175, DOI 10.3109/02699059009026163; ZUMOFF B, 1995, J CLIN ENDOCR METAB, V80, P1429, DOI 10.1210/jc.80.4.1429	175	5	5	0	6	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							915	930					16	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100055					2022-02-06	
J	Sharma, D; Siriussawakul, A; Dooney, N; Hecker, JG; Vavilala, MS				Sharma, Deepak; Siriussawakul, Arunotai; Dooney, Neil; Hecker, James G.; Vavilala, Monica S.			Clinical experience with intraoperative jugular venous oximetry during pediatric intracranial neurosurgery	PEDIATRIC ANESTHESIA			English	Article						jugular venous oximetry; intraoperative; pediatric; neurosurgery	TRAUMATIC BRAIN-INJURY; BULB OXYGEN-SATURATION; CEREBRAL-BLOOD-FLOW; CARDIOPULMONARY BYPASS; CARBON-DIOXIDE; CHILDREN; ANESTHESIA; REACTIVITY; PRESSURE; PROPOFOL	Aim To report our institutional experience with intraoperative jugular venous oximetry during pediatric intracranial surgery to guide anesthetic care. Background The utility of intraoperative jugular venous oximetry in adults undergoing intracranial surgery is well known. However, there is a little information on its' application in children during intracranial surgery. Methods After IRB approval, we examined patient, equipment, placement, and sampling characteristics for jugular bulb catheters in children aged <18years who were monitored with jugular oximetry during elective intracranial surgery between 2006 and 2010. We also determined the prevalence of intraoperative cerebral desaturation (SjvO2<55%), its causes, and the interventions based on jugular oximetry values. Results Data from 19 children (10 males and nine females), aged 12 +/- 1years (range 717) who underwent craniotomy for arteriovenous malformation (AVM) resection (68%), tumor removal (21%), or aneurysm clipping (11%), were reviewed. We analyzed 88 coincident SjvO2, PaCO2, and mean arterial pressure data points. Eleven (58%) patients experienced at least one episode of cerebral desaturation. There were 25 (28%) episodes of cerebral desaturation, six of which we attributed to relative hypotension, four to hypocarbia, and 15 to a combination of both. There were no intraoperative or immediate postoperative (first 24h) complications because of jugular oximetry. Conclusion Findings from this series indicate that (i) intraoperative jugular venous oximetry in children is feasible in experienced hands, (ii) cerebral desaturation detected by jugular oximetry is common during pediatric intracranial procedures, and (iii) monitoring jugular venous saturation can impact anesthetic interventions to optimize cerebral physiology.	[Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Siriussawakul, Arunotai] Mahidol Univ, Dept Anesthesiol, Bangkok 10700, Thailand; [Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Box 359724,325,9th Ave, Seattle, WA 98195 USA.	vavilala@uw.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5R01NS072308-02] Funding Source: Medline		Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Gelb AW, 2008, ANESTH ANALG, V106, P585, DOI 10.1213/01.ane.0000295804.41688.8a; Gupta AK, 1999, ANESTH ANALG, V88, P549, DOI 10.1097/00000539-199903000-00016; Highton D, 2010, CURR OPIN ANESTHESIO, V23, P576, DOI 10.1097/ACO.0b013e32833e1536; Iwata M, 2008, J CARDIOTHOR VASC AN, V22, P71, DOI 10.1053/j.jvca.2007.03.012; Karsli C, 2003, PAEDIATR ANAESTH, V13, P26, DOI 10.1046/j.1460-9592.2003.01017.x; Kawano Y, 2004, J NEUROSURG ANESTH, V16, P6, DOI 10.1097/00008506-200401000-00002; KENNEDY C, 1957, J CLIN INVEST, V36, P1130, DOI 10.1172/JCI103509; KERN FH, 1993, J NEUROSURG ANESTH, V5, P213; Kimiwada Tomomi, 2003, Masui, V52, P1074; Macmillan CSA, 2001, J NEUROL NEUROSUR PS, V70, P101, DOI 10.1136/jnnp.70.1.101; MATTA BF, 1994, ANESTH ANALG, V79, P745; Morris RW, 2005, QUAL SAF HEALTH CARE, V14, DOI 10.1136/qshc.2002.004440; MOSS E, 1995, BRIT J ANAESTH, V75, P527, DOI 10.1093/bja/75.5.527; Perez Augusto, 2003, Pediatr Crit Care Med, V4, P33; SCHELL RM, 1992, ANESTH ANALG, V74, P627; Schell RM, 2000, ANESTH ANALG, V90, P559, DOI 10.1097/00000539-200003000-00012; Sharma D, 2010, J CLIN NEUROSCI, V17, P1583, DOI 10.1016/j.jocn.2010.04.009; Sharma D, 2010, J NEUROSURG ANESTH, V22, P132, DOI 10.1097/ANA.0b013e3181c9fbf1; Siriussawakul A, 2011, PEDIATR ANESTH, V21, P141, DOI 10.1111/j.1460-9592.2010.03498.x; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Souter MJ, 1996, BRIT J ANAESTH, V76, P744, DOI 10.1093/bja/76.5.744; Wintermark M, 2004, PEDIATRICS, V113, P1642, DOI 10.1542/peds.113.6.1642	25	5	5	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645	1460-9592		PEDIATR ANESTH	Pediatr. Anesth.	JAN	2013	23	1					84	90		10.1111/pan.12031			7	Anesthesiology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Pediatrics	051OI	WOS:000312136400014	23004361				2022-02-06	
J	Soble, JR; Donnell, AJ; Belanger, HG				Soble, Jason R.; Donnell, Alison J.; Belanger, Heather G.			TBI and Nonverbal Executive Functioning: Examination of a Modified Design Fluency Test's Psychometric Properties and Sensitivity to Focal Frontal Injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						design fluency; neuropsychological assessment; nonverbal executive functioning; psychometrics; traumatic brain injury	INTERRATER RELIABILITY; LESIONS; CRITERIA	The purpose of this study was to investigate a modified version of the Design Fluency Test (DFT; Jones-Gotman & Milner, 1977) to establish its psychometric properties and clinical sensitivity to frontal traumatic brain injury (TBI). Twenty-five participants with moderate-to-severe TBI and focal frontal injury confirmed on magnetic resonance imaging or computed tomography, and 25 participants with TBI and nonfrontal focal injury were administered a modified fixed version of the DFT (Russell & Starkey, 1993). Analyses revealed that this modified DFT demonstrated excellent interrater agreement and consistency. This measure also demonstrated modest convergent validity with established measures of executive function abilities and discriminant validity with measures of other cognitive domains. Lastly, participants with frontal TBI generated significantly fewer novel designs compared with participants with nonfrontal focal injury. However, no significant differences were detected with regard to the total number of errors committed. Collectively, these results suggest that this fixed version of the DFT is a reliable measure of nonverbal executive functioning sensitive to frontal TBI.	[Soble, Jason R.; Donnell, Alison J.; Belanger, Heather G.] James A Haley Vet Affairs Med Ctr, Dept Mental Hlth & Behav Sci, Tampa, FL 33612 USA; [Donnell, Alison J.; Belanger, Heather G.] Def & Vet Brain Injury Ctr, Tampa, FL USA; [Belanger, Heather G.] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA		Soble, JR (corresponding author), James A Haley Vet Affairs Med Ctr, Dept Mental Hlth & Behav Sci Psychol 116B, 13000 N Bruce B Downs Blvd, Tampa, FL 33612 USA.	Jason.Soble@va.gov					Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Butler R.W., 1993, NEUROPSYCHOLOGY, V7, P519, DOI [DOI 10.1037/0894-4105.7.4.519, 10.1037/0894-4105.7.4.519]; Carter SL, 1998, CLIN NEUROPSYCHOL, V12, P531, DOI 10.1076/clin.12.4.531.7239; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Delis D, 2000, DELIS KAPLAN EXECUTI; Delis D.C., 2000, CALIFORNIA VERBAL LE; Demakis GJ, 1997, PSYCHOL REP, V81, P443; Elfgren CI, 1998, NEUROPSYCHOLOGIA, V36, P505, DOI 10.1016/S0028-3932(97)00146-2; Green P, 2004, GREENS MED SYMPTOM V; Hanks R. A., 1996, ASSESSMENT, V4, P459; Harter SL, 1999, ARCH CLIN NEUROPSYCH, V14, P419, DOI 10.1016/S0887-6177(98)00033-X; Heaton R., 2000, WISCONSIN CARD SORTI; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; JONESGOTMAN M, 1991, EPILEPSIA, V32, pS41; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kingery LR, 2006, CLIN NEUROPSYCHOL, V20, P729, DOI 10.1080/13854040500350992; LEVIN HS, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P318; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lucas J. A., 2008, CLIN NEUROPSYCHOLOGY, P351; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Reitan R, 1985, HALSTEAD REITAN NEUR; Russell E.W., 1993, HALSTEAD RUSSELL NEU; Shamay-Tsoory SG, 2004, J CLIN EXP NEUROPSYC, V26, P1113, DOI 10.1080/13803390490515531; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Thurstone, 1943, CHICAGO TESTS PRIMAR; Varney NR, 1996, ARCH CLIN NEUROPSYCH, V11, P345, DOI 10.1016/0887-6177(95)00015-1; Wechsler D., 1997, ADM SCORING MANUAL W; Woodard JL, 1992, NEUROPSYCHOLOGY, V6, P173, DOI DOI 10.1037/0894-4105.6.2.173	28	5	5	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2013	20	4					257	262		10.1080/09084282.2012.713056			6	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	298ST	WOS:000330345400004	23590283				2022-02-06	
J	Virk, J; Li, J; Lauritsen, J; Olsen, J				Virk, Jasveer; Li, Jiong; Lauritsen, Jens; Olsen, Jorn			Risk of childhood injuries after prenatal exposure to maternal bereavement: a Danish National Cohort Study	BMJ OPEN			English	Article						Cohort Study; Longitudinal	GLUTAMATE RECEPTORS; HIPPOCAMPAL VOLUME; STRESS; FETAL; GLUCOCORTICOIDS; ANXIETY; DOPAMINE; BEHAVIOR; BRAIN; LIFE	Objectives The aim of this study was to assess the risk of injuries among children exposed to a stressful life exposure (defined as bereavement) before conception or during fetal life. Design Population-based cohort study. Setting Denmark. Participants All singleton births in Denmark between 1 January 1995 and 31 December 2006 were identified. These newborns were then linked to mothers, fathers, grandparents and siblings using individually assigned civil personal registration numbers. Primary and secondary outcome measures We identified that data on childhood injuries were obtained from the Danish National Patient Registry, which contains data on all hospital stays and outpatient visits. Incidence rate ratios (IRRs) were estimated from birth using log-linear Poisson regression models, and person-years were used as the offset variable. Age, residence, calendar period, maternal education, maternal income and parental-cohabitation status are treated as time-dependent variables (records were extracted from the offspring's birth year). Results Exposure to maternal bereavement due to a father's death had the strongest association with childhood injuries, especially when the cause of death was due to a traumatic event (adjusted estimates of IRR (aIRR): 1.25, 95%CI: 0.99 to 1.58). We did not find an association for childhood injuries and maternal bereavement due to grandparent's death, and we only found an association for sibling death when restricting to deaths due to traumatic events (aIRR: 1.20, 95%CI:1.03 to 1.39). Conclusions The aetiology of childhood injuries is complex and may be related to events that take place during prenatal life. This study suggests that exposure to a stressful life event during gestation may be linked to injury susceptibility in childhood. However, changes in postnatal family conditions related to loss or genetic factors may also play a role. Background Developmental plasticity related to early life exposures leading to disease programming in offspring is a theory with substantial theoretical and empirical support. Prenatal stress exposure has been linked to neurological outcomes, such as temperament, behavioural problems, cognitive function and affective disorders. If exposure modifies risk-seeking behaviour, perceived danger and reaction time, it is also expected to modify injury risk.	[Virk, Jasveer; Li, Jiong] Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark; [Lauritsen, Jens] Univ Southern Denmark, Inst Publ Hlth, Biostat Unit, Odense, Denmark; [Lauritsen, Jens] Odense Univ Hosp, Dept Orthoped, DK-5000 Odense, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA		Virk, J (corresponding author), Aarhus Univ, Epidemiol Sect, Dept Publ Hlth, Aarhus, Denmark.	jasvirk@ucla.edu	li, jiong/L-6534-2014	li, jiong/0000-0002-1716-8067; Lauritsen, Jens/0000-0001-9281-8990	European Research CouncilEuropean Research Council (ERC)European Commission [260242]; European Union Seventh Framework Programme (EU FP7))European Commission; Nordic Cancer Union; NordForsk [070331]; Danish Medical Research CouncilDanish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [09-060229, 09-063494, 09-072986]	European Research Council (ERC-2010-StG no. 260242, the European Union Seventh Framework Programme (EU FP7)). The study is supported by grants from the Nordic Cancer Union, the NordForsk (070331) and the Danish Medical Research Council (projects no. 09-060229, 09-063494, and 09-072986). The funders had no roles in the study's design and interpretation.	Andersen TF, 1999, DAN MED BULL, V46, P263; Antonow-Schlorke I, 2003, J PHYSIOL-LONDON, V547, P117, DOI 10.1113/jphysiol.2002.025700; Barros VG, 2004, J NEUROSCI RES, V76, P488, DOI 10.1002/jnr.20119; Berger MA, 2002, NEUROCHEM RES, V27, P1525, DOI 10.1023/A:1021656607278; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Gutteling BM, 2006, J ABNORM CHILD PSYCH, V34, P789, DOI 10.1007/s10802-006-9054-7; Gutteling BM, 2005, EUR CHILD ADOLES PSY, V14, P41, DOI 10.1007/s00787-005-0435-1; Hosking J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-695; Huang WL, 1999, OBSTET GYNECOL, V94, P213, DOI 10.1016/S0029-7844(99)00265-3; Huang WL, 2001, INT J DEV NEUROSCI, V19, P415, DOI 10.1016/S0736-5748(01)00026-0; Huang WL, 2001, INT J DEV NEUROSCI, V19, P487, DOI 10.1016/S0736-5748(01)00035-1; Kinney DK, 2008, J AUTISM DEV DISORD, V38, P481, DOI 10.1007/s10803-007-0414-0; Knudsen LB, 1998, DAN MED BULL, V45, P221; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kofman O, 2002, NEUROSCI BIOBEHAV R, V26, P457, DOI 10.1016/S0149-7634(02)00015-5; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; Matthews SG, 2000, PEDIATR RES, V47, P291, DOI 10.1203/00006450-200003000-00003; Matthews SG, 2002, TRENDS ENDOCRIN MET, V13, P373, DOI 10.1016/S1043-2760(02)00690-2; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; MEYER JS, 1983, EXP NEUROL, V82, P432, DOI 10.1016/0014-4886(83)90415-6; O'Connor TG, 2002, BRIT J PSYCHIAT, V180, P502, DOI 10.1192/bjp.180.6.502; Osler M, 2007, INT J EPIDEMIOL, V36, P212, DOI 10.1093/ije/dyl261; Owen D, 2005, NEUROSCI BIOBEHAV R, V29, P209, DOI 10.1016/j.neubiorev.2004.10.004; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Phillips DIW, 2002, TRENDS ENDOCRIN MET, V13, P363, DOI 10.1016/S1043-2760(02)00696-3; Roberts AD, 2004, NEUROTOXICOL TERATOL, V26, P169, DOI 10.1016/j.ntt.2003.12.003; Russell VA, 2002, BEHAV BRAIN RES, V130, P191, DOI 10.1016/S0166-4328(01)00425-9; Schwebel DC, 1999, CHILD DEV, V70, P700, DOI 10.1111/1467-8624.00050; Seckl Jonathan R, 2008, Prog Brain Res, V167, P17; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Sun YL, 2010, EPIDEMIOLOGY, V21, P650, DOI 10.1097/EDE.0b013e3181e94253; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Tegethoff M, 2009, ENDOCR REV, V30, P753, DOI 10.1210/er.2008-0014; Van Den Bergh BRH, 2006, PEDIATR RES, V59, P78, DOI 10.1203/01.pdr.0000191143.75673.52; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P259, DOI 10.1016/j.neubiorev.2004.10.010; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Watson JB, 1999, DEV PSYCHOPATHOL, V11, P457, DOI 10.1017/S0954579499002151; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006; Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x	47	5	5	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2013	3	4							e002357	10.1136/bmjopen-2012-002357			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	291DZ	WOS:000329809200011	23613570	Green Published, gold			2022-02-06	
J	von Holst, H; Li, XG				von Holst, Hans; Li, Xiaogai			Consequences of the dynamic triple peak impact factor in traumatic brain injury as measured with numerical simulation	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; kinetic energy transfer; finite element modeling; intracranial pressure; strain energy density and first principal strain; dynamic triple peak impact		There is a lack of knowledge about the direct neuromechanical consequences in traumatic brain injury (TBI) at the scene of accident. In this study we use a finite element model of the human head to study the dynamic response of the brain during the first milliseconds after the impact with velocities of 10, 6, and 2 meters/second (m/s), respectively. The numerical simulation was focused on the external kinetic energy transfer, intracranial pressure (ICP), strain energy density and first principal strain level, and their respective impacts to the brain tissue. We show that the oblique impacts of 10 and 6 m/s resulted in substantial high peaks for the ICP strain energy density, and first principal strain levels, however, with different patterns and time frames. Also, the 2 m/s impact showed almost no increase in the above mentioned investigated parameters. More importantly, we show that there clearly exists a dynamic triple peak impact factor to the brain tissue immediately after the impact regardless of injury severity associated with different impact velocities. The dynamic triple peak impacts occurred in a sequential manner first showing strain energy density and ICP and then followed by first principal strain.This should open up a new dimension to better understand the complex mechanisms underlying TBI. Thus, it is suggested that the combination of the dynamic triple peak impacts to the brain tissue may interfere with the cerebral metabolism relative to the impact severity thereby having the potential to differentiate between severe and moderate TBI from mild TBI.	[von Holst, Hans] Karolinska Inst, Div Clin Neurosci, Neurosurg Sect, Stockholm, Sweden; [von Holst, Hans; Li, Xiaogai] Royal Inst Technol KTH, Sch Technol & Hlth, Div Neuron Engn, Stockholm, Sweden		von Holst, H (corresponding author), Karolinska Univ Hosp, Dept Neurosurg, SE-17176 Stockholm, Sweden.	hans.vonholst@karolinska.se	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Li, Xiaogai/0000-0001-8522-4705	Royal Institute of Technology, Stockholm, Sweden	The present study was supported by research funds from the Royal Institute of Technology, Stockholm, Sweden.	Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Anderson RWG, 1999, P INT IRCOBI C BIOM, P107; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Belytschko T., 2000, NONLINEAR FINITE ELE, V26; Casey PA, 2008, J NEUROTRAUM, V25, P603, DOI 10.1089/neu.2007.0481; Fahlstedt M., 2012, 2012 IRCOBI C P INT, P787; Hillson N, 1999, P NATL ACAD SCI USA, V96, P14848, DOI 10.1073/pnas.96.26.14848; Hummer G, 1998, P NATL ACAD SCI USA, V95, P1552, DOI 10.1073/pnas.95.4.1552; Jha SK, 2009, P NATL ACAD SCI USA, V106, P11113, DOI 10.1073/pnas.0812564106; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; KLEIVEN S, 2002, THESIS ROYAL I TECHN; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Narayan R.K., 1995, NEUROTRAUMA; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; von Holst H, 2013, J NEUROTRAUM, V30, P1192, DOI 10.1089/neu.2012.2730; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2; Ward C., 1980, STAPP CAR CRASH J, P163; Ward C., 1997, STAPP CAR CRASH J, V973335, P277; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; Yang KH, 2011, STUD MECHANOBIOL TIS, V3, P69, DOI 10.1007/8415_2010_62; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	25	5	5	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2013	4								23	10.3389/fneur.2013.00023			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QT	WOS:000209629000023	23487153	gold, Green Published			2022-02-06	
J	Wang, XJ; Yu, H; Cai, ZH; Wang, ZF; Ma, BJ; Zhang, Y				Wang, Xuejian; Yu, Hao; Cai, Zhenhua; Wang, Zhifeng; Ma, Baojun; Zhang, Yi			Nonketotic hyperglycemia-related epileptic seizures	EPILEPSY & BEHAVIOR CASE REPORTS			English	Article						Nonketotic hyperglycemia; Seizure; Etiology; Epileptic seizures; Partial seizures		Nonketotic hyperglycemia- related seizures (NKH) are rare. We report a case of NKH- related seizures in a patient following a traumatic brain injury. (C) 2013 The Authors. Published by Inc.	[Wang, Xuejian; Yu, Hao; Cai, Zhenhua; Wang, Zhifeng; Ma, Baojun; Zhang, Yi] Nantong Univ, Affiliated Hosp 2, Dept Neurosurg, Nantong 226363, Jiangsu, Peoples R China		Wang, XJ (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Neurosurg, Nantong 226363, Jiangsu, Peoples R China.	6841441@163.com.cn		Wang, Xuejian/0000-0003-0389-5674			BRICK JF, 1989, NEUROLOGY, V39, P394, DOI 10.1212/WNL.39.3.394; DUCKROW RB, 1985, ANN NEUROL, V17, P267, DOI 10.1002/ana.410170308; MACCARIO M, 1965, NEUROLOGY, V15, P195, DOI 10.1212/WNL.15.3.195; SINGH BM, 1973, ARCH NEUROL-CHICAGO, V29, P187, DOI 10.1001/archneur.1973.00490270069011; SINGH BM, 1980, ANN NEUROL, V8, P155, DOI 10.1002/ana.410080205	5	5	6	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2213-3232			EPILEPSY BEHAV CASE	Epilepsy Behav. Case Rep.		2013	1						77	78		10.1016/j.ebcr.2013.03.001			2	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3S1S	WOS:000218537900022	25667834	Green Published, gold			2022-02-06	
B	Wenzel, T; Zhu, LJ		Baron, DA; Reardon, CL; Baron, SH		Wenzel, Thomas; Zhu, Li Jing			Posttraumatic Stress in Athletes	CLINICAL SPORTS PSYCHIATRY: AN INTERNATIONAL PERSPECTIVE			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; SLEEP DISTURBANCES; MENTAL-ILLNESS; SEXUAL-ABUSE; CHRONIC PAIN; DISORDER; PTSD; PREDICTORS; SYMPTOMS; VETERANS		[Wenzel, Thomas; Zhu, Li Jing] Med Univ Vienna, Div Social Psychiat, Vienna, Austria; [Zhu, Li Jing] Zheng Zhou Univ, Coll Phys Educ, Zhengzhou, Henan, Peoples R China		Wenzel, T (corresponding author), Med Univ Vienna, Div Social Psychiat, Vienna, Austria.		, TW/ABB-9614-2020				Adams RE, 2006, J NERV MENT DIS, V194, P485, DOI 10.1097/01.nmd.0000228503.95503.e9; Adkins JW, 2008, J ANXIETY DISORD, V22, P1393, DOI 10.1016/j.janxdis.2008.02.002; Alschuler KN, 2012, EUR J PAIN, V16, P312, DOI 10.1016/j.ejpain.2011.06.010; Asmundson GJG, 2002, CAN J PSYCHIAT, V47, P930, DOI 10.1177/070674370204701004; Barnette V., 2001, J COLL STUDENT PSYCH, V16, P27, DOI DOI 10.1300/J035V16N01_03; Basser DS, 2012, MED HYPOTHESES, V78, P79, DOI 10.1016/j.mehy.2011.09.045; Baum AL, 2005, CLIN SPORT MED, V24, P853, DOI 10.1016/j.csm.2005.06.006; Belleville G, 2009, J NERV MENT DIS, V197, P126, DOI 10.1097/NMD.0b013e3181961d8e; Bernardy NC, 2012, J CLIN PSYCHIAT, V73, P297, DOI 10.4088/JCP.11m07311; Birmes P, 2003, AM J PSYCHIAT, V160, P1337, DOI 10.1176/appi.ajp.160.7.1337; Bisson J., 2007, COCHRANE DB SYST REV, V2007; BRAVERMAN M, 1977, J FORENSIC SCI, V22, P654; BREWER BW, 1993, J PERS, V61, P343, DOI 10.1111/j.1467-6494.1993.tb00284.x; Canton-Cortes D, 2012, J NERV MENT DIS, V200, P329, DOI 10.1097/NMD.0b013e31824cc078; Carlier IVE, 2000, PSYCHIAT RES, V97, P29, DOI 10.1016/S0165-1781(00)00211-0; David WS, 2006, J INTERPERS VIOLENCE, V21, P555, DOI 10.1177/0886260505285723; Easton Simon, 2003, Med Leg J, V71, P130; Fontana A, 1999, J TRAUMA STRESS, V12, P111, DOI 10.1023/A:1024750417154; Glick ID, 2005, CLIN SPORT MED, V24, P771, DOI 10.1016/j.csm.2005.03.007; Hammermeister J., 2012, Journal of Sport Behavior, V35, P40; HARDY L, 1992, BRIT MED BULL, V48, P615, DOI 10.1093/oxfordjournals.bmb.a072567; Hawker DM, 2011, CLIN PSYCHOL PSYCHOT, V18, P453, DOI 10.1002/cpp.730; Heil J., 1993, PSYCHOL SPORT INJURY; HENDIN H, 1991, AM J PSYCHIAT, V148, P586; Herman J., 1997, TRAUMA RECOVERY; Hollan Douglas, 2004, Transcult Psychiatry, V41, P62, DOI 10.1177/1363461504041354; Ide N, 2000, Int J Emerg Ment Health, V2, P43; Jonas S, 2011, PSYCHOL MED, V41, P709, DOI 10.1017/S003329171000111X; Kamm RL, 2005, CLIN SPORT MED, V24, P745, DOI 10.1016/j.csm.2005.06.002; Kazantzis N, 2012, CULT MED PSYCHIAT, V36, P442, DOI 10.1007/s11013-012-9265-z; KENT GG, 1992, MED EDUC, V26, P87, DOI 10.1111/j.1365-2923.1992.tb00131.x; Kolt Gregory, 1996, Aust J Physiother, V42, P121; Kristensen P, 2012, PSYCHIATRY, V75, P76, DOI 10.1521/psyc.2012.75.1.76; Lin KM, 2010, PHARMACOGENOMICS, V11, P1535, DOI 10.2217/PGS.10.128; Linden M, 2007, PSYCHOPATHOLOGY, V40, P159, DOI 10.1159/000100005; Lowe B, 2006, PSYCHOTHER PSYCH MED, V56, P182, DOI 10.1055/s-2005-915463; Maher MJ, 2006, CNS DRUGS, V20, P567, DOI 10.2165/00023210-200620070-00003; Marks S, 2012, BRIT J SPORT MED, V46, P905, DOI 10.1136/bjsports-2011-090345; Melissa D., 2012, COPING EMOTIONS SPOR; Mellman TA, 2009, DEPRESS ANXIETY, V26, P993, DOI 10.1002/da.20627; Meyer EC, 2012, PSYCHOL SERV, V9, P1, DOI 10.1037/a0026414; Peck DF, 1996, J PSYCHOSOM RES, V41, P55, DOI 10.1016/0022-3999(96)00050-5; Ranby KW, 2009, J PEDIATR PSYCHOL, V34, P1069, DOI 10.1093/jpepsy/jsp025; Reardon CL, 2010, SPORTS MED, V40, P961, DOI 10.2165/11536580-000000000-00000; RIDER SP, 1995, PERCEPT MOTOR SKILL, V81, P499, DOI 10.2466/pms.1995.81.2.499; Shearer DA, 2011, J CLIN SPORT PSYCHOL, V5, P134, DOI 10.1123/jcsp.5.2.134; Simmons AN, 2012, NEUROPHARMACOLOGY, V62, P598, DOI 10.1016/j.neuropharm.2011.03.016; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; Sommer I, 2004, J PSYCHOSOM RES, V57, P329, DOI 10.1016/j.jpsychores.2004.01.010; Subica AM, 2012, SCHIZOPHR RES, V136, P104, DOI 10.1016/j.schres.2011.10.018; Sundgot-Borgen J, 2010, SCAND J MED SCI SPOR, V20, P112, DOI 10.1111/j.1600-0838.2010.01190.x; Taheri M, 2012, J SPORTS MED, V3, P15, DOI DOI 10.5812/ASJSM.34719; Tarrier N, 2004, SOC PSYCH PSYCH EPID, V39, P927, DOI 10.1007/s00127-004-0828-3; Taylor AH, 1996, J SPORT SCI, V14, P471, DOI 10.1080/02640419608727734; TEFF H, 1992, MED SCI LAW, V32, P251, DOI 10.1177/002580249203200311; Tural U, 2012, COMMUNITY MENT HLT J, V48, P161, DOI 10.1007/s10597-010-9359-4; Udwin O, 2000, J CHILD PSYCHOL PSYC, V41, P969, DOI 10.1111/1469-7610.00685; van Zuiden M, 2012, BIOL PSYCHIAT, V71, P309, DOI 10.1016/j.biopsych.2011.10.026; Wenzel T, 2007, CURR OPIN PSYCHIATR, V20, P491, DOI 10.1097/YCO.0b013e3282c3a5c1; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Zohar Joseph, 2011, Dialogues Clin Neurosci, V13, P301	61	5	5	0	4	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND			978-1-118-40488-1				2013							102	114			10.1002/9781118404904		13	Psychology, Clinical; Psychiatry; Sport Sciences	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Psychology; Psychiatry; Sport Sciences	BGS34	WOS:000323967900013					2022-02-06	
B	Zasler, ND; Martelli, MF; Nicholson, K; Horn, LJ		Zasler, ND; Katz, DI; Zafonte, RD		Zasler, Nathan D.; Martelli, Michael F.; Nicholson, Keith; Horn, Lawrence J.			Post-Traumatic Pain Disorders: Medical Assessment and Management	BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION			English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; NEUROPATHIC PAIN; REGIONAL PAIN; NERVOUS-SYSTEM; OPIOID THERAPY; STIMULATION; HEADACHE; EXERCISE; TERM; ELECTROTHERAPY		[Zasler, Nathan D.] Concuss Care Ctr Virginia Ltd, Richmond, VA USA; [Zasler, Nathan D.] Tree Life Serv Inc, Richmond, VA USA; [Zasler, Nathan D.] Sheltering Arms Hosp, iWalk Program, Richmond, VA USA; [Zasler, Nathan D.] VCU Dept Phys Med & Rehabil, Richmond, VA USA; [Zasler, Nathan D.] Univ Virginia, Dept Phys Med & Rehabil, Charlottesville, VA USA; [Martelli, Michael F.] Chapman Senior Care, Senior Serv, NeuroLife Rehab, Richmond, VA USA; [Nicholson, Keith] Toronto Western Hosp, Comprehens Pain Program, Toronto, ON M5T 2S8, Canada; [Horn, Lawrence J.] Wayne State Univ, Sch Med, Dept Phys Med & Rehabil, Rehabil Inst Michigan, Detroit, MI USA		Zasler, ND (corresponding author), Concuss Care Ctr Virginia Ltd, Richmond, VA USA.						Alba-Delgado C, PAIN; Almeida TF, 2004, BRAIN RES, V1000, P40, DOI 10.1016/j.brainres.2003.10.073; Anderson AV, OPIOID PRESCRIBING C; Annaswamy TM, 2011, PM&R, V3, P940, DOI 10.1016/j.pmrj.2011.06.013; [Anonymous], 2004, MOD POL US CONTR SUB; Apkarian AV, 2011, PAIN MANAG, V1, P577, DOI 10.2217/PMT.11.53; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Argoff Charles E, 2004, Curr Pain Headache Rep, V8, P261, DOI 10.1007/s11916-004-0005-0; Attal N, 2002, NEUROLOGY, V58, P554, DOI 10.1212/WNL.58.4.554; Attal N, 2000, NEUROLOGY, V54, P564, DOI 10.1212/WNL.54.3.564; Backonja M, 2006, WALL MELZACKS TXB PA, P1075, DOI [DOI 10.1016/B0-443-07287-6/50073-4, 10.1016/b0-443-07287-6/50073-4]; Baidya Dalim Kumar, 2011, J Anaesthesiol Clin Pharmacol, V27, P307, DOI 10.4103/0970-9185.83672; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Bartsch T, 2003, BRAIN, V126, P1801, DOI 10.1093/brain/awg190; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; Bolay H, 2002, NEUROLOGY, V59, pS2, DOI 10.1212/WNL.59.5_suppl_2.S2; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Burstein R, 2004, HEADACHE CURRENTS, V1, P25; Calvino B, 2006, JOINT BONE SPINE, V73, P10, DOI 10.1016/j.jbspin.2004.11.006; Canavero S, 2002, NEUROLOGY, V58, P831, DOI 10.1212/WNL.58.5.831-a; Canavero S, 2007, Expert Rev Neurother, V7, P1485, DOI 10.1586/14737175.7.11.1485; Chapman CR, 2010, J PAIN, V11, P807, DOI 10.1016/j.jpain.2010.02.019; Chapman CR, 1996, PROG BRAIN RES, V110, P63; Chapman SL, 2002, CLIN J PAIN, V18, pS83, DOI 10.1097/00002508-200207001-00010; Chou R, 2004, OHSU; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Department of Justice Drug Enforcement Administration Office of diversion Control, STAT PRESCR DRUG MON; Department of Veterans Affairs Technology Assessmnt Program Office of Patient Care Services, BIBL TRANSC EL NERV; Devor M, 2011, PAIN MANAGEMENT, P905; Donohue CD, 2011, PAIN MANAGEMENT, P36; Eisenberg E, 2005, JAMA-J AM MED ASSOC, V293, P3043, DOI 10.1001/jama.293.24.3043; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Elliot S, 2004, J HEADACHE PAIN, V5, P12, DOI DOI 10.1007/s10194-004-0062-0; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Finnerup Nanna B, 2002, Expert Opin Pharmacother, V3, P1411, DOI 10.1517/14656566.3.10.1411; Firestone LL, 1996, ANESTH ANALG, V82, P1247, DOI 10.1097/00000539-199606000-00025; Flores MP, 2012, REV BRAS ANESTESIOL, V62, P244, DOI 10.1016/S0034-7094(12)70122-8; Frontera W, 2000, PHYS MED REHABILITAT, P487; Gabriel, 1993, NEUROBIOLOGY CINGULA, P313; Gabriel M, 1995, FRONTIER PAIN RES, P197; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Gallagher RM, 2005, ARCH PHYS MED REH S3, V84, P64; Garcia-Larrea L, NEUROSCI LETT; Gatchel RJ, 2006, WEINERS PAIN MANAGEM, P1501; Goadsby PJ, 1997, PAIN, V73, P23, DOI 10.1016/S0304-3959(97)00074-2; Gonzales VA, 2000, NEUROREHABILITATION, V14, P69; Greenberg Eric N, 2011, J Pain Palliat Care Pharmacother, V25, P380, DOI 10.3109/15360288.2011.625468; Hauser W, 2012, CNS DRUGS, V26, P297, DOI 10.2165/11598970-000000000-00000; Hammer WI., 2007, FUNCTIONAL SOFT TISS; Hansen H, 2006, WEINERS PAIN MANAGEM, P1417; Harden RN, 2005, AM J PHYS MED REHAB, V84, pS17; Harvey Victoria L, 2008, Curr Opin Support Palliat Care, V2, P133, DOI 10.1097/SPC.0b013e328300eb24; Hewitt DJ, 2004, PRINCPLES PRACTICE B, P737; Hoffman MD, 2005, J REHABIL RES DEV, V42, P183, DOI 10.1682/JRRD.2004.06.0065; Hopkins ME, 2012, NEUROSCIENCE, V215, P59, DOI 10.1016/j.neuroscience.2012.04.056; Hughes D, 2012, CHALLENGES USING INT; Iannetti GD, 2010, EXP BRAIN RES, V205, P1, DOI 10.1007/s00221-010-2340-1; Jamison RN, 2003, J PAIN SYMPTOM MANAG, V26, P913, DOI 10.1016/S0885-3924(03)00310-5; Jamot L, 2003, GENES BRAIN BEHAV, V2, P80, DOI 10.1034/j.1601-183X.2003.00013.x; Kirsch DL, 2000, NEUROREHABILITATION, V14, P85; Knight Y, HEADACHE CURRENTS, V2, P108; Kroeling P, 2005, SPINE, V30, pE641, DOI 10.1097/01.brs.0000184302.34509.48; Kumar B, 2009, ANESTH ANALG, V108, P1645, DOI 10.1213/ane.0b013e31819d644c; Lahz S, 1996, ARCH PHYS MED REHAB, V77, P889, DOI 10.1016/S0003-9993(96)90275-0; Lake AE, 2002, NEUROLOGY, V59, pS8, DOI 10.1212/WNL.59.5_suppl_2.S8; LEIJON G, 1989, PAIN, V36, P27, DOI 10.1016/0304-3959(89)90108-5; Leong M., 2004, PRACTICAL PAIN M AUG, P43; Li J, 1999, PAIN, V79, P75, DOI 10.1016/S0304-3959(98)00154-7; MAILIS A, 2002, PHYS MED REHABIL STA, V16, P131; Malangat G, 2008, EXPERT OPIN PHARMACO, V9, P2209, DOI [10.1517/14656560802252595, 10.1517/14656566.9.12.2209 ]; McCarberg Bill H, 2012, Am J Med, V125, pS1, DOI 10.1016/j.amjmed.2011.10.004; McMahon SB, 2006, TXB PAIN, V5, P49, DOI DOI 10.1016/B0-443-07287-6/50008-4; Miller L, 2000, NEUROREHABILITATION, V14, P25; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Nichols L, NEUROREHABI IN PRESS; Nicholson BD, 2004, NEUROLOGY, V62, pS30, DOI 10.1212/WNL.62.5_suppl_2.S30; Nicholson K, 2000, NEUROREHABILITATION, V14, P3; Nicholson K, 2002, PAIN MANAGEMENT PRAC, P465; Nnoaham KE, 2010, EFFECTIVENESS TRANSC; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Patterson DR, 2004, BURNS, V30, pA10, DOI 10.1016/j.burns.2004.08.004; Pearce JMS, 2005, SPINAL CORD, V43, P263, DOI 10.1038/sj.sc.3101709; Perez RS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-20; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Rhodes C., 2012, PAIN PRACTITIONER, V22, P43; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; Schnakers C, AAPS J; Schnakers C, 2007, CURR OPIN NEUROL, V20, P620, DOI 10.1097/WCO.0b013e3282f169d9; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnitzler A, 2000, J CLIN NEUROPHYSIOL, V17, P592, DOI 10.1097/00004691-200011000-00005; Shneker BF, 2005, ANN PHARMACOTHER, V39, P2029, DOI 10.1345/aph.1G078; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SINGH MK, CHRONIC PAIN SYNDROM; Sjogren P, 2005, EUR J PAIN, V9, P453, DOI 10.1016/j.ejpain.2004.10.005; Son BC, 2006, PAIN, V123, P210, DOI 10.1016/j.pain.2006.02.028; Taghaddosinejad F, 2011, J MED TOXICOL, V7, P183, DOI 10.1007/s13181-011-0168-0; Tai Qing, 2002, J Spinal Cord Med, V25, P100; Tepper SJ, 2012, HEADACHE, V52, P30, DOI 10.1111/j.1526-4610.2012.02140.x; Ter Horst GJ, 2001, CEPHALALGIA, V21, P963, DOI 10.1046/j.1468-2982.2001.00285.x; Tetzlaff J, 2004, PAIN MANAGEMENT  JUL, P12; Turk Dennis C, 2004, Spine J, V4, P1, DOI 10.1016/S1529-9430(03)00068-8; Turner-Stokes L, 2011, CLIN MED, V11, P596, DOI 10.7861/clinmedicine.11-6-596; United States Food and Drug Administration, POSTM DRUG SAF INF P; Vaynman S, 2005, NEUROREHAB NEURAL RE, V19, P283, DOI 10.1177/1545968305280753; Von Korff M, 2011, ANN INTERN MED, V155, P325, DOI 10.7326/0003-4819-155-5-201109060-00011; Waldman SD, 2011, PAIN MANAGEMENT; Waldman SD, 2011, PAIN MANAGEMENT, P978; Walker W, 2004, JHTR, V19, P72; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; Walsh NE, 2010, DELISAS PHYS MED REH, P1291; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Welch KMA, 2003, NEUROLOGY, V61, pS2, DOI 10.1212/WNL.61.8_suppl_4.S2; Wiffen P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001133.pub2; Wikipedia, PAT CONTR AN; Wikipedia, OX NAL; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; Woolf CJ, PAIN HYPERSENSITIVIT; Yaksh TL, 2011, PAIN MANAGEMENT, P10; Yaksh TL, 2011, PAIN MANAGEMENT, P19; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x; YOUNG RF, 1992, J NEUROSURG, V76, P979, DOI 10.3171/jns.1992.76.6.0979; Zasler N, 2002, PAIN MANAGEMENT PRAC, P313; Zasler ND, 1999, J HEAD TRAUMA REHAB, V14, P81; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P375; Zhou Y, 2012, BRADLEYS NEUROLOGY C, P783; [No title captured]	129	5	5	0	0	DEMOS MEDICAL PUBLICATIONS	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA			978-1-936287-27-7				2013							954	973					20	Clinical Neurology	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology	BDJ25	WOS:000313536100057					2022-02-06	
J	Rzezak, P; Antunes, HKM; Tufik, S; de Mello, MT				Rzezak, Patricia; Moreira Antunes, Hanna Karen; Tufik, Sergio; de Mello, Marco Tulio			Translation and cultural adaptation of the Game Dice Task to Brazilian population	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						cognition; psychometrics; decision making	OBSESSIVE-COMPULSIVE DISORDER; DECISION-MAKING; GAMBLING TASK; EXECUTIVE FUNCTION; AGE; ACTIVATION; DEFICITS; FUTURE; MEMORY; DAMAGE	Objective: The Game Dice Task (GDT) was developed to measure decision making under known risk. The aim of this study was to translate and adapt the GDT to a Brazilian population. Method: After the GDT was translated and back-translated to Brazilian Portuguese and evaluated by eight bilingual judges, 175 Brazilian adults were divided into two groups -160 healthy volunteers and 15 traumatic brain injury (TBI) patients - and had completed the GDT. Results: Differences between genders, but not age, were observed in the healthy volunteer sample. Males more frequently chose a combination of three dice while females preferred four dice. TBI patients were more impulsive than healthy volunteers; they less frequently chose a combination of three dice and made more risky decisions. Conclusion: Because of the rigorous process used to translate and adapt the GDT and the differences observed between patients with TBI and healthy volunteers, the Brazilian GDT was considered satisfactory for research purposes.	[Rzezak, Patricia; Moreira Antunes, Hanna Karen; Tufik, Sergio; de Mello, Marco Tulio] Univ Fed Sao Paulo UNIFESP, Dept Psychobiol, Sao Paulo, Brazil		de Mello, MT (corresponding author), Rua Prof Francisco de Castro 93, BR-04020050 Sao Paulo, Brazil.	tmello@demello.net.br	Rzezak, Patricia/P-5274-2017; Antunes, Hanna K/C-8070-2012; de Mello, Marco Tulio/G-3237-2010	Rzezak, Patricia/0000-0001-9023-9733; Antunes, Hanna K/0000-0001-6648-0957; de Mello, Marco Tulio/0000-0003-3896-2208	Associacao Fundo de Incentivo a Pesquisa (AFIP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [98/14303-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowshipConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	This work was supported by grants from Associacao Fundo de Incentivo a Pesquisa (AFIP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (CEPID no 98/14303-3 to ST). Marco Tulio de Mello and Sergio Tufik are recipients of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship.	Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1690, DOI 10.1016/S0028-3932(02)00016-7; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Brand M, 2005, NEUROPSYCHOLOGY, V19, P267, DOI 10.1037/0894-4105.19.3.267; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Cavedini P, 2002, NEUROPSYCHOLOGIA, V40, P205, DOI 10.1016/S0028-3932(01)00077-X; Cavedini P, 2004, PSYCHIAT RES, V127, P259, DOI 10.1016/j.psychres.2004.03.012; Cummings SR, 2001, DESIGNING CLIN RES E, P231; Dror IE, 1998, GERONTOLOGY, V44, P67, DOI 10.1159/000021986; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; *INT TEST COMM, 2000, ITC GUID AD TESTS; Labudda K, 2009, NEUROPSYCHOLOGIA, V47, P50, DOI 10.1016/j.neuropsychologia.2008.08.014; Lejbak L, 2011, BRAIN COGNITION, V76, P191, DOI 10.1016/j.bandc.2010.12.002; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Malloy-Diniz LF, 2008, REV BRAS PSIQUIATR, V30, P144, DOI 10.1590/S1516-44462008005000009; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; Mata R, 2011, CHILD DEV, V82, P687, DOI 10.1111/j.1467-8624.2010.01535.x; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Stout JC, 2001, J INT NEUROPSYCH SOC, V7, P92, DOI 10.1017/S1355617701711095; Thiel A, 2003, J NEURAL TRANSM, V110, P1289, DOI 10.1007/s00702-003-0041-7; West LK, 2011, J NEUROPSYCHOL, V5, P114, DOI 10.1348/174866410X521434; Whitney KA, 2004, SCHIZOPHR RES, V69, P75, DOI 10.1016/j.schres.2003.08.013; Worthy DA, 2011, PSYCHOL SCI, V22, P1375, DOI 10.1177/0956797611420301	29	5	5	0	5	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	DEC	2012	70	12					929	933		10.1590/S0004-282X2012001200005			5	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	067GG	WOS:000313281600006	23295420	gold, Green Published, Green Submitted			2022-02-06	
J	Yang, CC; Kao, CJ; Cheng, TW; Yang, CC; Wang, WH; Yu, RL; Hsu, YH; Hua, MS				Yang, Cheng-Chang; Kao, Chen-Jay; Cheng, Ting-Wen; Yang, Chi-Cheng; Wang, Wei-Han; Yu, Rwei-Ling; Hsu, Yen-Hsuan; Hua, Mau-Sun			Cross-cultural Effect on Suboptimal Effort Detection: An Example of the Digit Span Subtest of the WAIS-III in Taiwan	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Wechsler scales; Intelligence tests; Traumatic brain injury; Neuropsychological tests; Incentives; Cross-cultural comparison	ADULT INTELLIGENCE SCALE; MALINGERED NEUROCOGNITIVE DYSFUNCTION; CLASSIFICATION ACCURACY; LINGUISTIC DIFFERENCES; PERFORMANCE PATTERNS; INCOMPLETE EFFORT; HEAD-INJURY; MEMORY; NEUROPSYCHOLOGY; SPECIFICITY	Suppressed Digit Span performance has been proposed as an embedded indicator for suboptimal effort detection in neuropsychological evaluations in Western societies, particularly in the USA. However, its effectiveness in Chinese countries remains unexplored. The purposes of this study were first to explore normative Digit Span performance patterns between the Taiwan and American standardization samples, then to examine performances of patients with traumatic brain injury and with psychiatric diseases on the embedded measures (the Digit Span Scaled Score, Vocabulary minus Digit Span difference score, Reliable Digit Span, and the longest string of digits forward and backward) through retrospective data analysis. The normative Digit Span performance differs between the two cultural populations. Although litigating and nonlitigating participants perform differently on these measures, further prospective studies are needed to explore this issue with comprehensive external corroborating validity data.	[Yang, Cheng-Chang; Wang, Wei-Han; Yu, Rwei-Ling; Hsu, Yen-Hsuan; Hua, Mau-Sun] Natl Taiwan Univ, Dept Psychol, Taipei 10617, Taiwan; [Kao, Chen-Jay] Taipei City Hosp, Songde Branch, Dept Clin Psychol, Taipei, Taiwan; [Cheng, Ting-Wen] Natl Taiwan Univ Hosp, Clin Psychol Ctr, Taipei, Taiwan; [Cheng, Ting-Wen; Hua, Mau-Sun] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10617, Taiwan; [Hua, Mau-Sun] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Taipei 10617, Taiwan; [Yang, Chi-Cheng] Chang Gung Univ, Div Clin Psychol, Dept Occupat Therapy, Tao Yuan, Taiwan		Hua, MS (corresponding author), Natl Taiwan Univ, Dept Psychol, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.	huams@ntu.edu.tw		Wang, Wei-Han/0000-0003-1898-7627; Yang, Cheng-Chang/0000-0002-3538-3430; Hsu, Yen-Hsuan/0000-0002-2585-3339	National Science CouncilMinistry of Science and Technology, Taiwan [NSC-98-2410-H-002-026-MY3]; Taipei City Hospital, Taipei, Taiwan [10101-62-010]	This work was partially supported by grants from the National Science Council (NSC-98-2410-H-002-026-MY3) and Taipei City Hospital (10101-62-010), Taipei, Taiwan.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; BADDELEY AD, 1975, J VERB LEARN VERB BE, V14, P575, DOI 10.1016/S0022-5371(75)80045-4; Beggs B., 2008, CURRENT PERSPECTIVES, P193; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Binder L. M., 2003, J FORENSIC NEUROPSYC, V2, P27; BINDER LM, 1993, ARCH CLIN NEUROPSYCH, V8, P137, DOI 10.1016/0887-6177(93)90031-U; Chan ME, 2011, AUST PSYCHOL, V46, P25, DOI 10.1111/j.1742-9544.2010.00007.x; Chen, 2005, WECHSLER MEMORY SCAL; CHEN CS, 1988, J EXP CHILD PSYCHOL, V46, P150, DOI 10.1016/0022-0965(88)90027-6; Chen H., 2008, CHINESE J PSYCHOL, V50, P91, DOI [10.6129/CJP.2008.5001.06, DOI 10.6129/CJP.2008.5001.06, DOI 10.6129/cjp.2008.5001.06]; Chen H.J., 2002, WECHSLER ADULT INTEL; Chen H. Y., 2006, ESTIMATING WAI UNPUB; Chen ZY, 2009, J CLIN EXP NEUROPSYC, V31, P385, DOI 10.1080/13803390802195195; Chiang Y.-C., 2006, TAIWANESE J PSYCHIAT, V20 , P145; CHINCOTTA D, 1995, EUR J COGN PSYCHOL, V7, P201, DOI 10.1080/09541449508403100; Chiu VWY, 2002, REHABIL PSYCHOL, V47, P194, DOI 10.1037//0090-5550.47.2.194; Cohen J., 2013, STAT POWER ANAL BEHA; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; [高北陵 Gao Beilin], 2002, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V10, P256; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Harrison AG, 2010, ASSESSMENT, V17, P283, DOI 10.1177/1073191109348590; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; HOOSAIN R, 1979, J GENET PSYCHOL, V135, P263, DOI 10.1080/00221325.1979.10534079; HOOSAIN R, 1984, PERCEPT MOTOR SKILL, V58, P21, DOI 10.2466/PMS.58.1.21-22; Hsieh SLJ, 2007, ARCH CLIN NEUROPSYCH, V22, P283, DOI 10.1016/j.acn.2007.01.004; Iverson G. L., 2010, HDB FORENSIC NEUROPS, P91; Iverson GL, 2003, ARCH CLIN NEUROPSYCH, V18, P1, DOI 10.1016/S0887-6177(01)00176-7; Iverson GL, 1996, J CLIN EXP NEUROPSYC, V18, P38, DOI 10.1080/01688639608408260; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Killgore WDS, 2000, J CLIN EXP NEUROPSYC, V22, P761; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P80; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2007, ASSESSMENT MALINGERE, P44; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; *PSYCH CORP, 1997, WAIS 3 WMS 3 TECHN M; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; Schwarz LR, 2006, CLIN NEUROPSYCHOL, V20, P741, DOI 10.1080/13854040590967054; STIGLER JW, 1986, COGNITION, V23, P1, DOI 10.1016/0010-0277(86)90051-X; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh T.N., 1996, TEST MEMORY MALINGER; U.S. Census Bureau, 2011, PROF GEN POP HOUS CH; U.S. Census Bureau, 2011, SEL POP PROF US; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wong TM, 2011, STUD NEUROPSYCHOL NE, P29; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	58	5	5	0	19	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2012	27	8					869	878		10.1093/arclin/acs081			10	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	044RO	WOS:000311641000006	23018018				2022-02-06	
J	Zuckerman, SL; Kuhn, A; Dewan, MC; Morone, PJ; Forbes, JA; Solomon, GS; Sills, AK				Zuckerman, Scott L.; Kuhn, Andrew; Dewan, Michael C.; Morone, Peter J.; Forbes, Jonathan A.; Solomon, Gary S.; Sills, Allen K.			Structural brain injury in sports-related concussion	NEUROSURGICAL FOCUS			English	Article						concussion; sports; subarachnoid hemorrhage; epidural hemorrhage; subdural hemorrhage; malignant cerebral edema; second-impact syndrome	CHRONIC SUBDURAL-HEMATOMA; 2ND IMPACT SYNDROME; SPINAL-CORD-INJURY; TRAUMATIC SUBARACHNOID HEMORRHAGE; ARACHNOID CYST SECONDARY; REPETITIVE HEAD-INJURY; FOR-DISEASE-CONTROL; STATES HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; CEREBRAL AUTOREGULATION	Object. Sports-related concussions (SRCs) represent a significant and growing public health concern. The vast majority of SRCs produce mild symptoms that resolve within 1-2 weeks and are not associated with imaging-documented changes. On occasion, however, structural brain injury occurs, and neurosurgical management and intervention is appropriate. Methods. A literature review was performed to address the epidemiology of SRC with a targeted focus on structural brain injury in the last half decade. MEDLINE and PubMed databases were searched to identify all studies pertaining to structural head injury in sports-related head injuries. Results. The literature review yielded a variety of case reports, several small series, and no prospective cohort studies. Conclusions. The authors conclude that reliable incidence and prevalence data related to structural brain injuries in SRC cannot be offered at present. A prospective registry collecting incidence, management, and follow-up data after structural brain injuries in the setting of SRC would be of great benefit to the neurosurgical community. (http://thejns.org/doi/abs/10.3171/2012.10.FOCUS12279)	[Zuckerman, Scott L.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Vanderbilt Sports Concuss Ctr,Sch Med, Nashville, TN 37232 USA; [Kuhn, Andrew] Boston Univ, Coll Arts & Sci, Boston, MA 02215 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Vanderbilt Sports Concuss Ctr,Sch Med, T-4224 Med Ctr N, Nashville, TN 37232 USA.	scott.zuckerman@vanderbilt.edu	Solomon, Gary/K-9011-2019; Kuhn, Andrew W/AAM-4820-2020	Kuhn, Andrew W/0000-0003-1836-7575			Adler RH, 2011, PM&R, V3, pS468, DOI 10.1016/j.pmrj.2011.08.006; Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; Aoki N, 1996, NEUROL RES, V18, P145; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bilginer B, 2009, CHILD NERV SYST, V25, P119, DOI 10.1007/s00381-008-0728-z; Boden BP, 2007, AM J SPORT MED, V35, P1075, DOI 10.1177/0363546507299239; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1984, BRIT MED J, V289, P715, DOI 10.1136/bmj.289.6447.715; Brunelle C, 2012, ARCH PEDIATRIE, V19, P815, DOI 10.1016/j.arcped.2012.05.010; Bruzzone E, 2000, AM J SPORT MED, V28, P901, DOI 10.1177/03635465000280062201; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2003, NEUROSURGERY, V52, P846, DOI 10.1227/01.NEU.0000053210.76063.E4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Carmont MR, 2002, BRIT J SPORT MED, V36, P306, DOI 10.1136/bjsm.36.4.306; Carson J, 2006, CAN FAM PHYSICIAN, V52, P756; Choi JU, 1998, PEDIATR NEUROSURG, V29, P260, DOI 10.1159/000028733; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Cohen JE, 2010, ISR MED ASSOC J, V12, P509; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Covassin T, 2012, J SCHOOL HEALTH, V82, P233, DOI 10.1111/j.1746-1561.2012.00692.x; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; DATTI R, 1995, BRIT J SPORT MED, V29, P95, DOI 10.1136/bjsm.29.2.95; Deepika A, 2012, J HEAD TRAUMA REHABI; Demetriades AK, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2003.005710; DEMIRCIVI F, 1993, ACTA NEUROCHIR, V122, P45, DOI 10.1007/BF01446985; Depreitere B, 2004, ACCIDENT ANAL PREV, V36, P561, DOI 10.1016/S0001-4575(03)00062-9; Dijkers MPJM, 1999, ARCH PHYS MED REHAB, V80, P867, DOI 10.1016/S0003-9993(99)90076-X; Ellenbogen RG, 2010, WORLD NEUROSURG, V74, P560, DOI 10.1016/j.wneu.2010.11.016; Faul M, 2010, TRAUMATIC BRAIN INJU; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; Fewel ME, 1996, PEDIATR NEUROSURG, V25, P165, DOI 10.1159/000121119; Galvez JC, 2011, CURR SPORT MED REP, V10, P11, DOI 10.1249/JSR.0b013e318205e0a1; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gliklich RE, 2010, REGISTRIES EVALUATIN; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Haykowsky MJ, 1996, CLIN J SPORT MED, V6, P52, DOI 10.1097/00042752-199601000-00011; ILDAN F, 1994, NEUROSURG REV, V17, P229, DOI 10.1007/BF00418441; Jackson AB, 2004, ARCH PHYS MED REHAB, V85, P1740, DOI 10.1016/j.apmr.2004.04.035; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Keller TM, 1998, BRIT J SPORT MED, V32, P338, DOI 10.1136/bjsm.32.4.338; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; Kersey RD, 1998, J ATHL TRAINING, V33, P264; Kushi H, 2009, J TRAUMA, V66, P298, DOI 10.1097/TA.0b013e3181715dba; Lin TK, 2012, J TRAUMA ACUTE CARE, V73, P131, DOI 10.1097/TA.0b013e31824aff74; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Litt David W., 1995, Journal of Athletic Training, V30, P69; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Logan SM, 2001, J ATHL TRAINING, V36, P433; Lutfi R, 2009, PEDIATR EMERG CARE, V25, P582, DOI 10.1097/PEC.0b013e3181b4f5f7; Malek AM, 2000, J TRAUMA, V48, P143, DOI 10.1097/00005373-200001000-00027; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsuda W, 2008, J TRAUMA, V65, P461, DOI 10.1097/01.ta.0000202465.13784.2a; McAbee GN, 1998, PEDIATR NEUROL, V15, P235; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2001, CLIN J SPORT MED, V11, P144, DOI 10.1097/00042752-200107000-00004; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; McCrory PR, 2000, MED J AUSTRALIA, V172, P217, DOI 10.5694/j.1326-5377.2000.tb123912.x; MOHANTY A, 1995, PEDIATR NEUROSURG, V23, P57, DOI 10.1159/000120936; Mori K, 2002, J NEUROTRAUM, V19, P1017, DOI 10.1089/089771502760341938; Mori T, 2006, ACTA NEUROCHIR SUPPL, V96, P40; Mueller FO, 1977, ANN SURVEY CATASTROP; National Operating Committee on Standards for Athletic Equipment, NOCSAE STAND PERF SP; Nemecek AN, 2005, PEDIATR NEUROSURG, V41, P170, DOI 10.1159/000085880; NeuroPoint Alliance, NAT NEUR QUAL OUTC D; Nishio M, 1998, NEUROL SURG TOKYO, V26, P425; Noonan VK, 2012, SPINAL CORD, V50, P22, DOI 10.1038/sc.2011.109; Parsch CS, 1997, NEUROSURGERY, V40, P483, DOI 10.1097/00006123-199703000-00010; Petraglia AL, 2012, NEUROSURGERY, V70, P1520, DOI 10.1227/NEU.0b013e31824cebe8; Potts MA, 2012, PM&R, V4, P530, DOI 10.1016/j.pmrj.2012.01.015; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prabhu VC, 2002, NEUROSURGERY, V50, P195; Rajan GP, 2004, BRIT J SPORT MED, V38, DOI 10.1136/bjsm.2004.011882; Raschka V C, 1995, Sportverletz Sportschaden, V9, P24; Reddy CC, 2012, J HEAD TRAUMA REHABI; Rughani AI, 2011, J NEUROSURG-PEDIATR, V7, P268, DOI 10.3171/2010.12.PEDS10415; Sahjpaul RL, 1998, J NEUROSURG, V89, P822, DOI 10.3171/jns.1998.89.5.0822; Sarmiento K, 2010, J SCHOOL HEALTH, V80, P112, DOI 10.1111/j.1746-1561.2010.00491.x; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Sawyer RJ, 2010, HEALTH PROMOT PRACT, V11, P34, DOI 10.1177/1524839907309377; Schneider RC., 1973, HEAD NECK INJURIES F; Schwartz MF, 2005, ARCH PHYS MED REHAB, V86, P1807, DOI 10.1016/j.apmr.2005.03.009; Sener RN, 1997, COMPUT MED IMAG GRAP, V21, P341; Shahlaie K, 2011, J NEUROSURG, V115, P602, DOI 10.3171/2011.5.JNS101667; SNOEK JW, 1984, BRAIN, V107, P15, DOI 10.1093/brain/107.1.15; Solomon GS, 2012, J SURG ORTH IN PRESS; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Sullivan SJ, 2012, BRIT J SPORT MED, V46, P258, DOI 10.1136/bjsm.2010.080341; Thomas M, 2011, PEDIATRICS, V128, pE1, DOI 10.1542/peds.2010-2743; Tsuzuki N, 2003, NEUROSURGERY, V53, P242, DOI 10.1227/01.NEU.0000072303.16102.E1; Turkoglu E, 2008, TURK NEUROSURG, V18, P39; Uzura M, 2003, BRIT J SPORT MED, V37, P82, DOI 10.1136/bjsm.37.1.82; Vassilyadi M, 2009, CAN J NEUROL SCI, V36, P761, DOI 10.1017/S0317167100008404; Vigil DV, 1998, CLIN J SPORT MED, V8, P234, DOI 10.1097/00042752-199807000-00013; Wang A, 2011, J NEUROSURG-PEDIATR, V7, P111, DOI 10.3171/2010.10.PEDS10283; Wester K, 1999, NEUROSURGERY, V45, P775, DOI 10.1097/00006123-199910000-00008; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Yang SN, 2012, J KOREAN MED SCI, V27, P691, DOI 10.3346/jkms.2012.27.6.691; Zeng T, 2011, CHIN J TRAUMATOL, V14, P174, DOI 10.3760/cma.j.issn.1008-1275.2011.03.010; Zhang H, 2007, CHINESE MED J-PEKING, V120, P2339, DOI 10.1097/00029330-200712020-00042; Zuckerman SL, 2012, SURG NEUROL IN PRESS	105	5	5	0	21	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	DEC	2012	33	6							E6	10.3171/2012.10.FOCUS12279			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	048GI	WOS:000311898500007	23199429	Bronze			2022-02-06	
J	Auxemery, Y				Auxemery, Yann			Etiopathogenic perspectives on chronic psycho traumatic and chronic psychotic symptoms: The hypothesis of a hyperdopaminergic endophenotype of PTSD	MEDICAL HYPOTHESES			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COMBAT VETERANS; DRD2 GENE; POLYMORPHISM; SEVERITY; SCHIZOPHRENIA; METAANALYSIS; ENVIRONMENT; RISPERIDONE; PREVALENCE	Post traumatic stress disorder (PTSD) is a complex and heterogeneous disorder, which specific symptoms are re-experiencing, increased arousal and avoidance of stimuli associated with the trauma. PTSD has much comorbidity like depression, substance abuse, somatic complaints, repeated dissociative phenomena and transitory or chronic psychotic reactions. PTSD can manifest itself in different clinical forms: some patients present higher symptoms in one domain as compared to another, probably because of abnormalities in different neurobiological systems. Hyposerotonergic and hypernoradrenergic PTSD endophenotypes have been previously identified and the purpose of this paper is to focus on the hypothesis of a hyperdopaminergic endophenotype. The current review discusses several entities: PTSD with psychotic features with or without depression, the comorbide use of psychoactive substances that increase psychotic symptoms and traumatic brain injuries as agents of psycho traumatic and psychotic features. For all of these nosographic entities, the dopaminergic neuromodulation may play a central role. The hypothesis of a hyperdopaminergic endophenotype of FTSD opens up new research and therapeutic perspectives. Although antipsychotics are frequently used for people with PTSD further studies are needed to develop a consensus on the guidelines for treating the psychotic forms of PTSD. (C) 2012 Elsevier Ltd. All rights reserved.	[Auxemery, Yann] Ecole Valde de Grace, F-75005 Paris, France; [Auxemery, Yann] Univ Paris 06, Paris, France		Auxemery, Y (corresponding author), Ecole Valde de Grace, 1 Pl Alphonse Laveran, F-75005 Paris, France.	yann.auxemery@hotmail.fr					ACHTE K, 1991, PSYCHOPATHOLOGY, V24, P309, DOI 10.1159/000284731; Adeponle AB, 2012, PSYCHIAT SERV, V63, P147, DOI 10.1176/appi.ps.201100280; Ahearn Eileen P, 2003, Ann Clin Psychiatry, V15, P193, DOI 10.1023/B:ACLI.0000008173.01153.4e; American Psychiatric Association, DIAGN STAT MAN MENT, V4a; Bowman ES, 1996, AM J PSYCHIAT, V153, P57; Braakman MH, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01252.x; Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001; Brunelin J, 2008, SCHIZOPHR RES, V100, P206, DOI 10.1016/j.schres.2007.11.009; Calhoun PS, 2007, SCHIZOPHR RES, V91, P210, DOI 10.1016/j.schres.2006.12.011; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Cerbone A, 2003, SCHIZOPHR RES, V63, P59, DOI 10.1016/S0920-9964(02)00341-9; David D, 1999, J CLIN PSYCHIAT, V60, P29, DOI 10.4088/JCP.v60n0106; Drury SS, 2009, J TRAUMA STRESS, V22, P534, DOI 10.1002/jts.20475; Egerton A, 2012, CURR PHARM DESIGN, V18, P466, DOI 10.2174/138161212799316244; Friedman MJ, 2000, J CLIN PSYCHIAT, V61, P44; Fujii Daryl, 2002, Cogn Neuropsychiatry, V7, P41, DOI 10.1080/135468000143000131; Ghafoori B, 2012, J TRAUMA STRESS, V25, P106, DOI 10.1002/jts.21663; Goodson J, 2011, PSYCHOL REP, V109, P573, DOI 10.2466/02.09.15.16.PR0.109.5.573-599; Hainsworth C, 2011, J TRAUMA STRESS, V24, P491, DOI 10.1002/jts.20666; Hamner MB, 1998, PSYCHIAT RES, V77, P175, DOI 10.1016/S0165-1781(98)00002-X; Hamner MB, 1999, BIOL PSYCHIAT, V45, P846, DOI 10.1016/S0006-3223(98)00301-1; Hides L, 2009, SCHIZOPHR RES, V112, P130, DOI 10.1016/j.schres.2009.04.001; Ivezic S, 1999, MIL MED, V164, P73, DOI 10.1093/milmed/164.1.73; Jacobsen LK, 2001, AM J PSYCHIAT, V158, P1184, DOI 10.1176/appi.ajp.158.8.1184; Johns LC, 2004, BRIT J PSYCHIAT, V185, P298, DOI 10.1192/bjp.185.4.298; Jovanovic Tanja, 2011, Front Behav Neurosci, V5, P44, DOI 10.3389/fnbeh.2011.00044; Kennedy Barbara L, 2002, J Ky Med Assoc, V100, P395; Kolassa IT, 2010, J CLIN PSYCHIAT, V71, P543, DOI 10.4088/JCP.08m04787blu; Kolassa IT, 2010, BIOL PSYCHIAT, V67, P304, DOI 10.1016/j.biopsych.2009.10.009; Kozaric-Kovacic D, 2005, J CLIN PSYCHIAT, V66, P922, DOI 10.4088/JCP.v66n0716; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lawford BR, 2006, EUR PSYCHIAT, V21, P180, DOI 10.1016/j.eurpsy.2005.01.006; Morgan C, 2007, SCHIZOPHRENIA BULL, V33, P3, DOI 10.1093/schbul/sbl053; Mueser KT, 2002, SCHIZOPHR RES, V53, P123, DOI 10.1016/S0920-9964(01)00173-6; Myin-Germeys I, 2005, BIOL PSYCHIAT, V58, P105, DOI 10.1016/j.biopsych.2005.02.012; Pae CU, 2008, INT CLIN PSYCHOPHARM, V23, P1, DOI 10.1097/YIC.0b013e32825ea324; Pantelis C, 2003, LANCET, V361, P281, DOI 10.1016/S0140-6736(03)12323-9; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Resnick SG, 2003, J ABNORM PSYCHOL, V112, P415, DOI 10.1037/0021-843X.112.3.415; Roncero C, EUR PSYCHIA IN PRESS; Rosenberg HJ, 2000, EPILEPSIA, V41, P447, DOI 10.1111/j.1528-1157.2000.tb00187.x; Sareen J, 2005, J TRAUMA STRESS, V18, P313, DOI 10.1002/jts.20040; Sautter FJ, 1999, J TRAUMA STRESS, V12, P73, DOI 10.1023/A:1024794232175; Sautter FJ, 2002, AM J PSYCHIAT, V159, P1775, DOI 10.1176/appi.ajp.159.10.1775; Seedat S, 2003, J NERV MENT DIS, V191, P675, DOI 10.1097/01.nmd.0000092177.97317.26; Shaw K, 2002, J TRAUMA STRESS, V15, P39, DOI 10.1023/A:1014331211311; Sher L, 2005, MED HYPOTHESES, V65, P205, DOI 10.1016/j.mehy.2005.03.014; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Smeltzer Donald J., 1994, P251; Sokolski KN, 2003, MIL MED, V168, P486, DOI 10.1093/milmed/168.6.486; Southwick SM, 1997, ARCH GEN PSYCHIAT, V54, P749; Spauwen J, 2006, BRIT J PSYCHIAT, V188, P527, DOI 10.1192/bjp.bp.105.011346; Takahashi T, 2009, ARCH GEN PSYCHIAT, V66, P366, DOI 10.1001/archgenpsychiatry.2009.12; TIEN AY, 1991, SOC PSYCH PSYCH EPID, V26, P287, DOI 10.1007/BF00789221; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; van Winkel R, 2008, AM J MED GENET B, V147B, P10, DOI 10.1002/ajmg.b.30559; Villarreal G, 2007, PSYCHOPHARMACOL BULL, V40, P6; Voisey J, 2009, DEPRESS ANXIETY, V26, P28, DOI 10.1002/da.20517; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Young RM, 2002, ALCOHOL ALCOHOLISM, V37, P451, DOI 10.1093/alcalc/37.5.451; Yung AR, 2009, AUST NZ J PSYCHIAT, V43, P118, DOI 10.1080/00048670802607188; Zhang L, 2009, MED HYPOTHESES, V73, P404, DOI 10.1016/j.mehy.2009.02.038; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0; Zimmerman M, 1999, J CLIN PSYCHIAT, V60, P311, DOI 10.4088/JCP.v60n0508	65	5	8	0	13	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	NOV	2012	79	5					667	672		10.1016/j.mehy.2012.08.005			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Research & Experimental Medicine	033AS	WOS:000310765300026	22939767				2022-02-06	
J	Gordan, W; Gerber, D; David, DS; Adornato, V; Brougham, R; Gassaway, J; Kreider, SED; Whiteneck, G				Gordan, Wendy; Gerber, Donald; David, Dana Spivack; Adornato, Viki; Brougham, Rebecca; Gassaway, Julie; Kreider, Scott E. D.; Whiteneck, Gale			Relationship of speech-language pathology inpatient rehabilitation interventions and patient characteristics to outcomes following spinal cord injury: The SCIRehab Project	JOURNAL OF SPINAL CORD MEDICINE			English	Article						Spinal cord injuries; Rehabilitation; Traumatic brain injury; Dual diagnosis; Practice-based evidence; Speech-language pathology; Participation; Cognitive outcomes	TRAUMATIC BRAIN-INJURY; FUNCTIONAL INDEPENDENCE MEASURE; CLOSED HEAD-INJURY; COGNITIVE DYSFUNCTION; TREATMENT TIME; DEFICITS	Background/objective: Describe associations of patient characteristics and speech-language pathology (SLP) interventions provided during impatient rehabilitation for spinal cord injury (SCI) to outcomes at discharge and 1-year post-injury. Methods: Speech-language pathologists at six inpatient rehabilitation centers documented details of treatment provided. Least squares regression modeling was used to predict outcomes at discharge and 1-year injury anniversary. Cognitive, participation, and mood outcomes for a subsample of patients with traumatic brain injury (TBI) and cognitive-communication limitations (CCLs) were examined. Results: SLP treatment factors explain a small amount of variation in cognitive Functional Independence Measure (FIM), participation, and mood. Variation explained by treatment factors for cognitive outcomes at the time of discharge increased when the patient group was more homogeneous (patients with TBI and CCLs). More time in SLP cognitive-communication interventions had a negative relationship, while longer length of stay was positive. The added explanatory power was not seen for similar outcomes at 1-year post-injury. Conclusion: Patients with SCI who have the greatest need for interventions to address cognitive limitations due to TBI receive the most SLP cognitive-communication treatment and show the greatest amount of improvement during rehabilitation. Their cognitive functioning remained impaired at discharge; this likely accounts for the consistent finding that more hours of SLP cognitive-communication treatment is associated with lower cognitive FIM scores at discharge. Future research on individuals with dual SCI and TBI should include more comprehensive assessment of individual differences in cognitive performance in order to better examine the complex relationships between SLP treatments and outcomes.	[Gordan, Wendy; Gerber, Donald; Kreider, Scott E. D.; Whiteneck, Gale] Craig Hosp, Englewood, CO 80113 USA; [David, Dana Spivack] Mt Sinai Med Ctr, New York, NY 10029 USA; [Adornato, Viki] Carolinas Rehabil, Charlotte, NC USA; [Brougham, Rebecca] Shepherd Ctr, Atlanta, GA USA; [Gassaway, Julie] Inst Clin Outcomes Res, Salt Lake City, UT USA		Whiteneck, G (corresponding author), Craig Hosp, 3425 S Clarkson St, Englewood, CO 80113 USA.	gale@craig-hospital.org					AVERILL RF, 1992, HEALTH SERV RES, V27, P587; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Brougham R, 2011, J SPINAL CORD MED, V34, P186, DOI 10.1179/107902611X12971826988174; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF G, 1987, PAIN, V29, P39, DOI 10.1016/0304-3959(87)90176-X; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DAVIDOFF GN, 1990, ARCH PHYS MED REHAB, V71, P326; Fiedler R., 1996, FUNCTIONAL ELEVATION, P75; Gassaway J, 2009, J SPINAL CORD MED, V32, P260, DOI 10.1080/10790268.2009.11760780; Gordan W, 2009, J SPINAL CORD MED, V32, P307, DOI 10.1080/10790268.2009.11760784; Hall K., 1998, TOP SPINAL CORD INJ, V4, P16, DOI DOI 10.1310/V5RU-FRFE-50E6-E2NA; Hall KM, 1999, ARCH PHYS MED REHAB, V80, P1471, DOI 10.1016/S0003-9993(99)90260-5; Horn SD, 1996, NUTRITION, V12, P384; HORN SD, 1997, CLIN PRACTICE IMPROV; Horn SD, 2007, MED CARE, V45, pS50, DOI 10.1097/MLR.0b013e318070c07b; Horn SD, 2010, MED CARE, V48, pS17, DOI 10.1097/MLR.0b013e3181d57473; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kutner MH., 2004, APPL LINEAR STAT MOD; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; MICHAEL D B, 1989, Journal of Neurotrauma, V6, P177; National Spinal Cord Injury Statistical Center, 2011, SPINAL CORD INJURY F, V34, P620; Nizam A, 1998, APPL REGRESSION ANAL; RICHARDS JS, 1991, ARCH PHYS MED REHAB, V72, P275; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Whiteneck G, 2012, J SPINAL CORD MED, V35, P484, DOI 10.1179/2045772312Y.0000000057; Whiteneck G, 2011, J SPINAL CORD MED, V34, P133, DOI 10.1179/107902611X12971826988011; Whiteneck G, 2009, J SPINAL CORD MED, V32, P251, DOI 10.1080/10790268.2009.11760779; Whiteneck GG, 1992, GUIDE USE CHART CRAI; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0	33	5	5	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1079-0268	2045-7723		J SPINAL CORD MED	J. Spinal Cord. Med.	NOV	2012	35	6					565	577		10.1179/2045772312Y.0000000063			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	058YF	WOS:000312670400007	23318037	Green Published			2022-02-06	
J	Padayachy, LC; Rohlwink, U; Zwane, E; Fieggen, G; Peter, JC; Figaji, AA				Padayachy, Llewellyn C.; Rohlwink, Ursula; Zwane, Eugene; Fieggen, Graham; Peter, Jonathan C.; Figaji, Anthony A.			The frequency of cerebral ischemia/hypoxia in pediatric severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Cerebral ischemia; Hypoxia; Secondary brain injury	SEVERE HEAD-INJURY; TISSUE OXYGEN-TENSION; BLOOD-FLOW; INTRACRANIAL-PRESSURE; COMATOSE PATIENTS; METABOLISM; CHILDREN; SATURATION; DAMAGE; HYPERVENTILATION	The frequency of adverse events, such as cerebral ischemia, following traumatic brain injury (TBI) is often debated. Point-in-time monitoring modalities provide important information, but have limited temporal resolution. This study examines the frequency of an adverse event as a point prevalence at 24 and 72 h post-injury, compared with the cumulative burden measured as a frequency of the event over the full duration of monitoring. Reduced brain tissue oxygenation (PbtO(2) < 10 mmHg) was the adverse event chosen for examination. Data from 100 consecutive children with severe TBI who received PbtO(2) monitoring were retrospectively examined, with data from 87 children found suitable for analysis. Hourly recordings were used to identify episodes of PbtO(2) less than 10 mmHg, at 24 and 72 h post-injury, and for the full duration of monitoring. Reduced PbtO(2) was more common early than late after injury. The point prevalence of reduced PbtO(2) at the selected time points was relatively low (10 % of patients at 24 h and no patients at the 72-h mark post-injury). The cumulative burden of these events over the full duration of monitoring was relatively high: 50 % of patients had episodes of PbtO(2) less than 10 mmHg and 88 % had PbtO(2) less than 20 mmHg. Point-in-time monitoring in a dynamic condition like TBI may underestimate the overall frequency of adverse events, like reduced PbtO(2), particularly when compared with continuous monitoring, which also has limitations, but provides a dynamic assessment over a longer time period.	[Padayachy, Llewellyn C.; Rohlwink, Ursula; Fieggen, Graham; Peter, Jonathan C.; Figaji, Anthony A.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Sch Child & Adolescent Hlth, ZA-8001 Cape Town, South Africa; [Zwane, Eugene] Univ Swaziland, Dept Biostat, Mbabane, Swaziland		Padayachy, LC (corresponding author), Univ Cape Town, Red Cross War Mem Childrens Hosp, Sch Child & Adolescent Hlth, ZA-8001 Cape Town, South Africa.	llewesp@yahoo.com	Rohlwink, Ursula/AAE-2513-2020; Rohlwink, Ursula Karin/U-8917-2019; Fieggen, Anthony Graham/AAT-6510-2021; Padayachy, Llewellyn/AAD-3821-2019	Rohlwink, Ursula Karin/0000-0002-4469-4935; Fieggen, Anthony Graham/0000-0001-6541-8377; Figaji, Anthony/0000-0002-3357-6490			Adamides AA, 2009, ACTA NEUROCHIR, V151, P1399, DOI 10.1007/s00701-009-0398-y; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS2, DOI 10.1097/01.CCM.0000066600.71233.01; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; BARCLAY L, 1985, BIOL PSYCHIAT, V20, P146, DOI 10.1016/0006-3223(85)90074-5; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRUCE DA, 1973, J NEUROSURG, V38, P131, DOI 10.3171/jns.1973.38.2.0131; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Figaji AA, 2008, NEUROSURGERY, V63, P83, DOI 10.1227/01.NEU.0000335074.39728.00; Figaji AA, 2010, CHILD NERV SYST, V26, P431, DOI 10.1007/s00381-009-1036-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1335, DOI 10.1007/s00381-009-0821-y; Figaji AA, 2009, CHILD NERV SYST, V25, P1325, DOI 10.1007/s00381-009-0822-x; GRAHAM DI, 1971, LANCET, V1, P265; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hlatky R., 2003, NEUROSURG FOCUS, V14, P1; Imberti R, 2002, J NEUROSURG, V96, P97, DOI 10.3171/jns.2002.96.1.0097; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kochanek PM, 2001, PEDIATR CLIN N AM, V48, P661, DOI 10.1016/S0031-3955(05)70333-3; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; McCarthy MC, 2009, SURGERY, V146, P585, DOI 10.1016/j.surg.2009.06.059; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; OBRIST WD, 1967, CIRC RES, V20, P124, DOI 10.1161/01.RES.20.1.124; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Scheufler KM, 2004, J NEUROSURG ANESTH, V16, P210, DOI 10.1097/00008506-200407000-00005; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 2000, NEUROSURG FOCUS, V9, P1; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vigue B, 1999, INTENS CARE MED, V25, P445, DOI 10.1007/s001340050878; Yundt KD, 1997, CRIT CARE CLIN, V13, P163, DOI 10.1016/S0749-0704(05)70300-6	45	5	5	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	NOV	2012	28	11					1911	1918		10.1007/s00381-012-1837-2			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	021FY	WOS:000309871900013	22706985				2022-02-06	
J	Chen, YC; Hung, TH; Tseng, TC; Hsieh, CC; Chen, FC; Stoffregen, TA				Chen, Yi-Chou; Hung, Ting-Hsuan; Tseng, Tzu-Chiang; Hsieh, City C.; Chen, Fu-Chen; Stoffregen, Thomas A.			Pre-Bout Standing Body Sway Differs between Adult Boxers Who Do and Do Not Report Post-Bout Motion Sickness	PLOS ONE			English	Article							CONSOLE VIDEO GAMES; STANCE WIDTH; CEREBRAL CONCUSSION; VIRTUAL-REALITY; QUIET STANCE; INSTABILITY; PERFORMANCE; STABILITY; BALANCE; SEA	Background: Motion sickness is characterized by subjective symptoms that include dizziness and nausea. Studies have shown that subjective symptoms of motion sickness are preceded by differences in standing body sway between those who experience the symptoms and those who are not. Boxers often report dizziness and nausea immediately after bouts. We predicted that pre-bout standing body sway would differ between boxers who experienced post-bout motion sickness and those who did not. Methodology/Principal Findings: We collected data on standing body sway before bouts. During measurement of body sway participants performed two visual tasks. In addition, we varied stance width (the distance between the heels). Postural testing was conducted separately before and after participants' regular warm-up routines. After bouts, we collected self-reports of motion sickness incidence and symptoms. Results revealed that standing body sway was greater after warm-up than before warm-up, and that wider stance width was associated with reduced sway. Eight of 15 amateur boxers reported motion sickness after a bout. Two statistically significant interactions revealed that standing body sway before bouts differed between participants who reported post-bout motion sickness and those who did not. Conclusions/Significance: The results suggest that susceptibility to motion sickness in boxers may be manifested in characteristic patterns of body sway. It may be possible to use pre-bout data on postural sway to predict susceptibility to post-bout motion sickness.	[Chen, Yi-Chou; Stoffregen, Thomas A.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA; [Hung, Ting-Hsuan] Edgewood Coll, Off Inst Res, Madison, WI USA; [Tseng, Tzu-Chiang] Chinese Cultural Univ, Grad Inst Sport Coaching Sci, Taipei, Taiwan; [Hsieh, City C.] YuanPei Univ, Coll Well Being, Hsinchu, Taiwan; [Chen, Fu-Chen] Natl Pingtung Univ Sci & Technol, Dept Recreat Sport & Hlth Promot, Pingtung, Taiwan		Stoffregen, TA (corresponding author), Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA.	tas@umn.edu	Stoffregen, Thomas/ABC-8710-2021				Akiduki H, 2003, NEUROSCI LETT, V340, P197, DOI 10.1016/S0304-3940(03)00098-3; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chang CH, 2012, EXP BRAIN RES, V217, P299, DOI 10.1007/s00221-011-2993-4; Chang CH, 2010, RES DEV DISABIL, V31, P1536, DOI 10.1016/j.ridd.2010.06.003; Chen FC, 2011, RES DEV DISABIL, V32, P1948, DOI 10.1016/j.ridd.2011.03.027; Chen FC, 2012, J EXP PSYCHOL-APPL, V18, P203, DOI 10.1037/a0026661; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Dong X, 2011, J EXP PSYCHOL-APPL, V17, P128, DOI 10.1037/a0024097; Draper MH, 2001, HUM FACTORS, V43, P129, DOI 10.1518/001872001775992552; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; GADSBY R, 1993, BRIT J GEN PRACT, V43, P245; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Jang J, 2008, CLIN BIOMECH, V23, P468, DOI 10.1016/j.clinbiomech.2007.11.011; Kennedy RS, 1997, AVIAT SPACE ENVIR MD, V68, P13; KENNEDY RS, 1993, AVIAT SPACE ENVIR MD, V64, P912; Kennedy RS, 1996, INT J HUM-COMPUT INT, V8, P25, DOI 10.1080/10447319609526139; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Kinsella-Shaw JM, 2006, J MOTOR BEHAV, V38, P251, DOI 10.3200/JMBR.38.4.251-264; Kondo T, 2001, APPETITE, V36, P119, DOI 10.1006/appe.2000.0391; KRAEMER WJ, 1987, INT J SPORTS MED, V8, P247, DOI 10.1055/s-2008-1025663; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Mackey DC, 2005, CLIN BIOMECH, V20, P776, DOI 10.1016/j.clinbiomech.2005.05.002; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Merhi O, 2007, HUM FACTORS, V49, P920, DOI 10.1518/001872007X230262; Moriarity JM, 2012, BRIT J SPORT MED, V46, P1011, DOI 10.1136/bjsports-2011-090893; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; Ohhashi G, 2002, BRIT J SPORT MED, V36, P346, DOI 10.1136/bjsm.36.5.346; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Stoffregen TA, 2000, HUM FACTORS, V42, P458, DOI 10.1518/001872000779698097; Stoffregen TA, 1998, BRAIN RES BULL, V47, P437, DOI 10.1016/S0361-9230(98)00102-6; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA., 2011, SCI MOTRICITE, V74, P19, DOI [DOI 10.1051/SM/2011111, 10.1051/sm/2011111]; Stoffregen TA, 2008, HUM FACTORS, V50, P322, DOI 10.1518/001872008X250755; Stoffregen TA, 2007, J MOTOR BEHAV, V39, P126, DOI 10.3200/JMBR.39.2.126-138; Stoffregen TA, 2011, ECOL PSYCHOL, V23, P19, DOI 10.1080/10407413.2011.539102; Stoffregen TA, 2010, ECOL PSYCHOL, V22, P169, DOI 10.1080/10407413.2010.496645; Stoffregen TA, 2009, AVIAT SPACE ENVIR MD, V80, P845, DOI 10.3357/ASEM.2572.2009; Troost B Todd, 2004, Curr Pain Headache Rep, V8, P310, DOI 10.1007/s11916-004-0014-z; Villard SJ, 2008, HUM FACTORS, V50, P332, DOI 10.1518/001872008X250728; Winer B.J., 1971, STAT PRINCIPLES EXPT; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yu Y, 2012, GAIT POSTUR IN PRESS; Yu YW, 2010, AVIAT SPACE ENVIR MD, V81, P375, DOI 10.3357/ASEM.2638.2010	52	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e46136	10.1371/journal.pone.0046136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	015NU	WOS:000309454000019	23056250	Green Published, Green Submitted, gold			2022-02-06	
J	Bramley, H; Melinosky, C; Silvis, M; Ross, S				Bramley, Harry; Melinosky, Christopher; Silvis, Matthew; Ross, Stephen			Pediatric Posttraumatic Headache Two Cases Using Steroids as Abortive Therapy	PEDIATRIC EMERGENCY CARE			English	Article						concussion; traumatic brain injury; posttraumatic headache	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; MIGRAINE HEADACHE; CONCUSSION; CHILDREN; DEXAMETHASONE; METAANALYSIS	Pediatric traumatic brain injury is a common occurrence, and even an ostensibly mild injury may result in disabling posttraumatic headaches. The headache may result in a number of subsequent unremitting symptoms refractory to many standard headache therapies. Current treatment recommendations are sparse because there is a lack of clinical trial data recommendations and outcomes. From these 2 cases, we report the effectiveness of steroids for severe posttraumatic headache, along with recommended treatment strategies for acute pain management and prevention.	[Bramley, Harry] Penn State Milton S Hershey Med Ctr, Dept Pediat, Hershey, PA 17033 USA; [Melinosky, Christopher] Univ Maryland, Med Ctr, Dept Med, Baltimore, MD 21201 USA; [Silvis, Matthew] Penn State Milton S Hershey Med Ctr, Dept Family & Community Med, Hershey, PA 17033 USA; [Silvis, Matthew] Penn State Milton S Hershey Med Ctr, Dept Orthoped & Rehabil, Hershey, PA 17033 USA; [Ross, Stephen] Penn State Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA		Bramley, H (corresponding author), Penn State Milton S Hershey Med Ctr, Dept Pediat, Mail Code H085,500 Univ Dr, Hershey, PA 17033 USA.	hbramley@hmc.psu.edu					Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Colman I, 2008, BMJ-BRIT MED J, V336, P1359, DOI 10.1136/bmj.39566.806725.BE; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Erickson Jay C, 2010, Continuum (Minneap Minn), V16, P55, DOI 10.1212/01.CON.0000391453.37923.83; Evans RW, 2004, NEUROL CLIN, V22, P237, DOI 10.1016/S0733-8619(03)00097-5; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Fiesseler FW, 2011, J EMERG MED, V40, P463, DOI 10.1016/j.jemermed.2009.08.022; Friedman BW, 2007, NEUROLOGY, V69, P2038, DOI 10.1212/01.WNL.0000281105.78936.1d; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; Lainez MJA, 2011, CURR PAIN HEADACHE R, V15, P467, DOI 10.1007/s11916-011-0220-4; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lee LK, 2007, PEDIATR EMERG CARE, V23, P580, DOI 10.1097/PEC.0b013e31813444ea; Lenaerts Marc E, 2004, Curr Treat Options Neurol, V6, P507, DOI 10.1007/s11940-004-0008-5; Lenaerts ME, 2009, EXPERT OPIN PHARMACO, V10, P1261, DOI 10.1517/14656560902942046; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Margulies S, 2000, J CLIN NEUROSCI, V7, P400, DOI 10.1054/jocn.1999.0681; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Packard RC, 1999, J HEAD TRAUMA REHAB, V14, P9, DOI 10.1097/00001199-199902000-00004; Rothner AD, 1999, CHILD ADOL PSYCH CL, V8, P727; Rozen Todd D., 2002, Curr Treat Options Neurol, V4, P395, DOI 10.1007/s11940-002-0050-0; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Singh A, 2008, ACAD EMERG MED, V15, P1223, DOI 10.1111/j.1553-2712.2008.00283.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Varney Nils R, 1999, EVALUATION TREATMENT; Wilson Maria-Carmen B, 2006, Curr Pain Headache Rep, V10, P387, DOI 10.1007/s11916-006-0065-4; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	41	5	5	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	OCT	2012	28	10					1081	1084		10.1097/PEC.0b013e31826ceeeb			4	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Emergency Medicine; Pediatrics	018JR	WOS:000309656900029	23034499				2022-02-06	
J	Inamasu, J; Nakatsukasa, M; Miyatake, S; Hirose, Y				Inamasu, Joji; Nakatsukasa, Masashi; Miyatake, Satoru; Hirose, Yuichi			Influence of warfarin and low-dose aspirin on the outcomes of geriatric patients with traumatic intracranial hemorrhage resulting from ground-level fall	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						elderly; low-dose aspirin; outcome; traumatic intracranial hemorrhage; warfarin	HEAD-INJURY; BRAIN-INJURY; PREINJURY WARFARIN; ELDERLY-PATIENTS; ANTIPLATELET; MORTALITY; ANTICOAGULATION; RISK; COMPLICATIONS; CLOPIDOGREL	Aim: Ground-level fall is the most common cause of traumatic intracranial hemorrhage (TICH) in the elderly, and is a major cause of morbidity and mortality in that population. A retrospective study was carried out to evaluate whether the use of warfarin/low-dose aspirin (LDA) is predictive of unfavorable outcomes in geriatric patients who sustain a fall-induced TICH. Methods: Charts of 76 geriatric patients (=65 years-of-age) with fall-induced TICH were reviewed. The number of patients taking warfarin and LDA was 12 and 21, respectively, whereas the other 43 took neither medication (non-user group). The frequency of patients with unfavorable outcomes (Glasgow Outcome Scale score of 13) at discharge was calculated. Furthermore, variables predictive of unfavorable outcomes were identified by logistic regression analysis. Results: The frequency of patients with unfavorable outcomes was 75% in the warfarin group, 33% in the LDA group and 27% in the non-user group, respectively. The risk of having unfavorable outcomes was significantly higher in the warfarin group compared with the LDA group (P = 0.03) and non-user group (P < 0.01). Logistic regression analysis showed that variables predictive of unfavorable outcomes were: age, initial Glasgow Coma Scale score = 13 and presence of midline shift = 5 mm. Conclusion: The use of warfarin, but not of LDA, might be associated with unfavorable outcomes in elderly with fall-induced TICH. The risk of TICH should be communicated properly to elderly taking warfarin. The information might be important not only to trauma surgeons who take care of injured elderly, but also to geriatric physicians who prescribe warfarin/LDA to them. Geriatr Gerontol Int 2012; 12: 667-672.	[Inamasu, Joji; Hirose, Yuichi] Fujita Hlth Univ, Dept Neurosurg, Sch Med, Toyoake, Aichi 4701192, Japan; [Inamasu, Joji; Nakatsukasa, Masashi] Saiseikai Utsunomiya Hosp, Dept Neurosurg, Utsunomiya, Tochigi, Japan; [Miyatake, Satoru] Saiseikai Utsunomiya Hosp, Dept Emergency Med, Utsunomiya, Tochigi, Japan		Inamasu, J (corresponding author), Fujita Hlth Univ, Dept Neurosurg, Sch Med, 1-98 Kutsukake, Toyoake, Aichi 4701192, Japan.	ginamasu@aol.com	Hirose, Yuichi/P-1731-2019; Inamasu, Joji/R-7314-2019	Hirose, Yuichi/0000-0002-1305-1830; 			Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Downey DM, 2009, AM SURGEON, V75, P1100; Fortuna GR, 2008, SURGERY, V144, P598, DOI 10.1016/j.surg.2008.06.009; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; Gerber Linda M, 2009, J Trauma Manag Outcomes, V3, P9, DOI 10.1186/1752-2897-3-9; Hartshorne NJ, 1997, AM J FOREN MED PATH, V18, P258, DOI 10.1097/00000433-199709000-00006; Howard JL, 2009, J TRAUMA, V66, P1518, DOI 10.1097/TA.0b013e3181a59728; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Ivascu FA, 2006, J TRAUMA, V61, P318, DOI 10.1097/01.ta.0000223944.25922.91; JENNETT B, 1976, LANCET, V1, P1031; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Ohm C, 2005, J TRAUMA, V58, P518, DOI 10.1097/01.TA.0000151671.35280.8B; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Sarani B, 2009, J TRAUMA, V67, P954, DOI 10.1097/TA.0b013e3181ae6d39; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Spektor S, 2003, J NEUROSURG, V99, P661, DOI 10.3171/jns.2003.99.4.0661; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234	23	5	6	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586			GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	OCT	2012	12	4					667	672		10.1111/j.1447-0594.2012.00838.x			6	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	010AP	WOS:000309067100011	22348411				2022-02-06	
J	Victoroff, J; Baron, D				Victoroff, Jeff; Baron, David			Diagnosis and Treatment of Sports-Related Traumatic Brain Injury	PSYCHIATRIC ANNALS			English	Article							FOOTBALL PLAYERS; PUNCH DRUNK; ENCEPHALOPATHY; EPIDEMIOLOGY; COLLEGIATE		[Victoroff, Jeff] Univ So Calif, Keck Sch Med, Dept Neurol, Torrance, CA 90503 USA; [Victoroff, Jeff] Univ So Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Torrance, CA 90503 USA; [Baron, David] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Baron, David] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA		Victoroff, J (corresponding author), Univ So Calif, Keck Sch Med, Dept Neurol, 4305 Torrance Blvd,Suite 508, Torrance, CA 90503 USA.	victorof@usc.edu					[Anonymous], 2011, SPORTS RELATED HEAD; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; CDC, 2011, SPORTS REL CONC, P60; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Critchley M., 1949, HOMMAGE CLOVIS VINCE, P131; Critchley M, 1937, MED ANNU, P318; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Kirkendall DT, 2001, SPORTS MED, V31, P369, DOI 10.2165/00007256-200131050-00006; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Victoroff J, 2012, NEUROREHABI IN PRESS; Victoroff J, 2011, NFL NEUR CAR PROGR C; Weir D. R., 2009, STUDY RETIRED NFL PL	24	5	5	0	1	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0048-5713	1938-2456		PSYCHIAT ANN	Psychiatr. Ann.	OCT	2012	42	10					365	370		10.3928/00485713-20121003-04			6	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	065SM	WOS:000313169300004					2022-02-06	
J	Argandona, EG; Bengoetxea, H; Bulnes, S; Rico-Barrio, I; Ortuzar, N; Lafuente, JV				Argandona, Enrike G.; Bengoetxea, Harkaitz; Bulnes, Susana; Rico-Barrio, Irantzu; Ortuzar, Naiara; Lafuente, Jose V.			Effect of intracortical vascular endothelial growth factor infusion and blockade during the critical period in the rat visual cortex	BRAIN RESEARCH			English	Article						Neurovascular unit; Diaschisis; VEGF; Neuroprotection; Neurorestoration	TRAUMATIC BRAIN-INJURY; POSTNATAL-DEVELOPMENT; CEREBRAL-ISCHEMIA; FACTOR EXPRESSION; PLASTICITY MECHANISMS; BARRIER PERMEABILITY; NEUROVASCULAR UNIT; FACTOR RECEPTOR; FOCAL ISCHEMIA; TISSUE-DAMAGE	VEGF is the major angiogenic and vascular permeability factor in health and disease. Vascular development depends on function, and in sensory areas is experience-dependent. Our aim was to investigate, qualitatively and quantitatively, the effects of intracortical infusion and neutralisation of VEGF during the first days of the critical visual period, when peak levels of endogenous VEGF secretion are reached. VEGF was intracortically delivered into middle cortical layers of P18 Long-Evans rats. Another cohort received anti-VEGF. Vehicle (PBS)-infused and non-operated animals were used as controls. Various immunopathological analyses were performed: Endothelial Barrier Antigen (EBA) for the BBB integrity and GFAP for astroglial response. Vascular density was measured by Butyryl Cholinesterase Histochemistry, neuronal density by NeuN immunohistochemistry and apoptosis by TUNEL staining. VEGF levels were measured by Western Blot. Decreased vascular permeability was evoked in VEGF-infused rats whilst EBA expression remained constant, suggesting a preserved BBB function. When VEGF was blocked, tissue showed a higher degree of extravasation and a decreased number of EBA-positive vessels surrounding the injury. Lesion induced by cannula implantation annulled the normal increase in vascular density and the decrease in neuronal density during this time. VEGF rescued in part the vascular increase, and also prevented physiological and pathological neuronal death. VEGF blockade induced a higher amount of neural loss and lower astrocytic reaction. Our results support the role of VEGF as extending beyond vascularization, preventing physiological and pathological neuronal death, not only in the injured hemisphere but also in the intact one suggesting a process of transhemispheric diaschisis. (C) 2012 Elsevier By. All rights reserved.	[Argandona, Enrike G.] Univ Fribourg, Dept Med, Unit Anat, CH-1700 Fribourg, Switzerland; [Bengoetxea, Harkaitz; Bulnes, Susana; Rico-Barrio, Irantzu; Ortuzar, Naiara; Lafuente, Jose V.] Univ Basque Country UPV EHU, Dept Neurosci, Lab Expt Neurosci LaNCE, E-48940 Leioa, Spain		Argandona, EG (corresponding author), Univ Fribourg, Dept Med, Unit Anat, Rue Albert Gockel 1, CH-1700 Fribourg, Switzerland.	enrique.argandona@unifr.ch	Lafuente, Jose-Vicente/O-6395-2014; Bulnes, Susana/AAJ-3381-2020; Bulnes, Susana/F-4130-2016; Rico Barrio, Irantzu/H-6757-2015; Bengoetxea, Harkaitz/AAD-5751-2021	Lafuente, Jose-Vicente/0000-0001-7246-0987; Bulnes, Susana/0000-0002-9059-0758; Rico Barrio, Irantzu/0000-0003-4908-1182; 	SAIOTEK from the Government of the Basque Country; UPV-EHU [UFI 11/32]; Spanish Ministry of EducationSpanish Government;  [491/10]	This work has been partially supported by grants 491/10 and SAIOTEK from the Government of the Basque Country and UFI 11/32 (UPV-EHU). N. Ortuzar is supported by a predoctoral grant (FPU) from the Spanish Ministry of Education. Confocal microscopy analysis was performed at the "Servicio de Microscopia Analtica y de Alta Resolucion en Biomedicina" (High Resolution Analytical Microscopy Services for Biomedicine) at the University of the Basque Country.	Adelson PD, 2001, J NEUROTRAUM, V18, P967, DOI 10.1089/08977150152693674; Albayrak S, 1997, ACTA NEUROPATHOL, V94, P158, DOI 10.1007/s004010050688; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Argandona E.G., 2006, INT J NEUROPROT NEUR, V3, P45; Argandona EG, 2005, DEV BRAIN RES, V156, P158, DOI 10.1016/j.devbraines.2005.02.007; Argandona EG, 2002, REV NEUROLOGIA, V34, P983, DOI 10.33588/rn.3410.2001258; Argandona EG, 1996, BRAIN RES, V732, P43, DOI 10.1016/0006-8993(96)00485-4; Argandona EG, 2000, BRAIN RES, V855, P137, DOI 10.1016/S0006-8993(99)02361-6; Argandona EG, 2012, CURR NEUROVASC RES, V9, P72; Argandona EG, 2009, J ANAT, V215, P132, DOI 10.1111/j.1469-7580.2009.01103.x; Bastide M, 2007, PSYCHONEUROENDOCRINO, V32, pS36, DOI 10.1016/j.psyneuen.2007.03.015; Bengoetxea H, 2008, CEREB CORTEX, V18, P1630, DOI 10.1093/cercor/bhm190; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Chu TW, 2009, J TRAUMA, V66, P1180, DOI 10.1097/TA.0b013e31818b4e61; Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Dobrogowska DH, 1998, J NEUROCYTOL, V27, P163, DOI 10.1023/A:1006907608230; Duchen L. W., 1992, GREENFIELDS NEUROPAT, P1; Dvorak HF, 2000, SEMIN PERINATOL, V24, P75, DOI 10.1016/S0146-0005(00)80061-0; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 1996, Curr Opin Nephrol Hypertens, V5, P35, DOI 10.1097/00041552-199601000-00008; Fineman I, 2000, J NEUROTRAUM, V17, P739, DOI 10.1089/neu.2000.17.739; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Fischer S, 1999, AM J PHYSIOL-CELL PH, V276, pC812; Geretti E, 2008, ANGIOGENESIS, V11, P31, DOI 10.1007/s10456-008-9097-1; Ghabriel MN, 2000, BRAIN RES, V878, P127, DOI 10.1016/S0006-8993(00)02721-9; Ghabriel MN, 2002, BRAIN RES, V934, P140, DOI 10.1016/S0006-8993(02)02416-2; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Greifzu F, 2011, P NATL ACAD SCI USA, V108, P15450, DOI 10.1073/pnas.1016458108; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hensch TK, 2005, CURR TOP DEV BIOL, V69, P215, DOI 10.1016/S0070-2153(05)69008-4; Hermann DM, 2009, J CEREBR BLOOD F MET, V29, P1620, DOI 10.1038/jcbfm.2009.100; Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026; Hoffmeyer HW, 2007, J CEREBR BLOOD F MET, V27, P575, DOI 10.1038/sj.jcbfm.9600372; Hu TT, 2011, CEREB CORTEX, V21, P2883, DOI 10.1093/cercor/bhr079; Jin K, 2001, NEUROSCIENCE, V108, P351, DOI 10.1016/S0306-4522(01)00154-3; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Kaya D, 2005, J CEREBR BLOOD F MET, V25, P1111, DOI 10.1038/sj.jcbfm.9600109; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kolb B, 2003, BEHAV BRAIN RES, V144, P67, DOI 10.1016/S0166-4328(03)00068-8; Krum JM, 2002, NEUROSCIENCE, V110, P589, DOI 10.1016/S0306-4522(01)00615-7; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Lafuente JV, 2006, J NEURAL TRANSM, V113, P487, DOI 10.1007/s00702-005-0407-0; Lecrux C, 2011, ACTA PHYSIOL, V203, P47, DOI 10.1111/j.1748-1716.2011.02256.x; Lin B, 2001, J NEUROTRAUM, V18, P389, DOI 10.1089/089771501750170958; Lodovichi C, 2000, J NEUROSCI, V20, P2155; Lok J, 2007, NEUROCHEM RES, V32, P2032, DOI 10.1007/s11064-007-9342-9; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mani N, 2005, EXP NEUROL, V192, P394, DOI 10.1016/j.expneurol.2004.12.022; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Maurer MH, 2003, NEUROSCI LETT, V344, P165, DOI 10.1016/S0304-3940(03)00407-5; Moser KV, 2005, BRAIN RES BULL, V65, P125, DOI 10.1016/j.brainresbull.2004.12.005; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nordal RA, 2005, INT J RADIAT ONCOL, V62, P279, DOI 10.1016/j.ijrobp.2005.01.039; Norsted E, 2008, J CHEM NEUROANAT, V36, P107, DOI 10.1016/j.jchemneu.2008.06.002; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Ortuzar N, 2010, ACTA NEUROCHIR SUPPL, V106, P55, DOI 10.1007/978-3-211-98811-4_9; Ortuzar N, 2011, J NEURAL TRANSM, V118, P135, DOI 10.1007/s00702-010-0496-2; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Payne BR, 2002, NEUROSCIENTIST, V8, P174, DOI 10.1177/107385840200800212; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Reitmeir R, 2012, ACTA NEUROPATHOL, V123, P273, DOI 10.1007/s00401-011-0914-z; Rosenstein JM, 2003, J NEUROSCI, V23, P11036; Schoch HJ, 2002, BRAIN, V125, P2549, DOI 10.1093/brain/awf257; SIREVAAG AM, 1988, DEV BRAIN RES, V43, P299, DOI 10.1016/0165-3806(88)90107-1; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Tieman SB, 2004, BRAIN RES, V998, P100, DOI 10.1016/j.brainres.2003.11.023; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Unal-Cevik I, 2004, BRAIN RES, V1015, P169, DOI 10.1016/j.brainres.2004.04.032; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; VanGilder RL, 2011, PHARMACOL THERAPEUT, V130, P239, DOI 10.1016/j.pharmthera.2010.12.004; Lafuente JV, 2012, INT REV NEUROBIOL, V102, P317, DOI 10.1016/B978-0-12-386986-9.00012-0; von Monakow C., 1914, DIASCHISIS LOKALISAT, P26; Wick A, 2002, J NEUROSCI, V22, P6401; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Yang JP, 2012, NEUROCHEM INT, V60, P592, DOI 10.1016/j.neuint.2012.02.020; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336	93	5	6	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	SEP 14	2012	1473						141	154		10.1016/j.brainres.2012.07.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	011DO	WOS:000309145100015	22824331	Green Submitted			2022-02-06	
J	Abdelkafy, A				Abdelkafy, Ashraf			Protection of the Medial Femoral Condyle Articular Cartilage During Drilling of the Femoral Tunnel Through the Accessory Medial Portal in Anatomic Anterior Cruciate Ligament Reconstruction	ARTHROSCOPY TECHNIQUES			English	Article								Accurate positioning of the femoral tunnel in the native femoral anterior cruciate ligament (ACL) footprint requires drilling through an accessory medial portal (AMP). The AMP is located far medial and at a low level. Despite the benefits of drilling through the AMP, it is possible that the drill bit head will injure the articular cartilage of the medial femoral condyle as it slides along the guide pin to the femoral insertion of the ACL. Because more surgeons are now performing anatomic ACL reconstructions and shifting from transtibial drilling toward transportal drilling, the risk of this injury might be increasing, especially during the beginning of their learning curve. To avoid such injury, a bio-interference screw sheath is used. It is inserted through the AMP over the guide pin until it reaches near the medial wall of the lateral femoral condyle. The drill bit is inserted over the guide pin and through the bio-interference screw sheath. Using the bio-interference screw sheath not only protects the articular cartilage of the medial femoral condyle but also protects the medial meniscus, posterior cruciate ligament, and skin of the AMP from injury because of the close proximity of the drill bit head to these structures during transportal drilling.	[Abdelkafy, Ashraf] Suez Canal Univ, Fac Med, Orthoped Surg Dept, Circular Rd, Ismailia 41522, Egypt		Abdelkafy, A (corresponding author), Suez Canal Univ, Fac Med, Orthoped Surg Dept, Circular Rd, Ismailia 41522, Egypt.	ashrafkafy@hotmail.com	Abdelkafy, Ashraf/AAF-9198-2019	Abdelkafy, Ashraf/0000-0003-2040-9121			Araujo PH, 2011, KNEE SURG SPORT TR A, V19, P1239, DOI 10.1007/s00167-011-1426-z; Bedi A, 2010, ARTHROSCOPY, V26, P342, DOI 10.1016/j.arthro.2009.12.006; Forsythe B, 2010, J BONE JOINT SURG AM, V92A, P1418, DOI 10.2106/JBJS.I.00654; Harner CD, 2008, ARTHROSCOPY, V24, P113, DOI 10.1016/j.arthro.2007.07.019; Hensler D, 2011, J BONE JOINT SURG AM, V93A, P2063, DOI 10.2106/JBJS.J.01705; Karlsson J, 2011, AM J SPORT MED, V39, P2016, DOI 10.1177/0363546511402660; Kopf S, 2011, KNEE SURG SPORTS TRA; Lubowitz JH, 2009, ARTHROSCOPY, V25, P95, DOI 10.1016/j.arthro.2008.10.012; Nakamura M, 2009, ARTHROSCOPY, V25, P481, DOI 10.1016/j.arthro.2008.11.010; Siebold R, 2010, KNEE SURG SPORT TR A, V18, P64, DOI 10.1007/s00167-009-0967-x; Tompkins M, 2012, AM J SPORT MED, V40, P1313, DOI 10.1177/0363546512443047; Yasuda K, 2011, AM J SPORT MED, V39, P1789, DOI 10.1177/0363546511402659; Zantop T, 2008, ARCH ORTHOP TRAUM SU, V128, P509, DOI 10.1007/s00402-007-0480-y; Zeman P, 2012, ACTA CHIR ORTHOP TR, V79, P41	14	5	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2212-6287			ARTHROSC TEC	Arthrosc. Tec.	SEP	2012	1	2					E149	E154		10.1016/j.eats.2012.05.008			6	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	V4D0N	WOS:000218820800002	23766987	Green Published, gold			2022-02-06	
J	Arun, P; Valiyaveettil, M; Biggemann, L; Alamneh, Y; Wei, YL; Oguntayo, S; Wang, Y; Long, JB; Nambiar, MP				Arun, Peethambaran; Valiyaveettil, Manojkumar; Biggemann, Lionel; Alamneh, Yonas; Wei, Yanling; Oguntayo, Samuel; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.			Modulation of hearing related proteins in the brain and inner ear following repeated blast exposures	INTERVENTIONAL MEDICINE AND APPLIED SCIENCE			English	Article						blast exposure; calcium signaling; calretinin; cerebellum; inner ear; NMDA receptor; parvalbumin; traumatic brain injury		Emerging studies show that blast exposure causes traumatic brain injury (TBI) and auditory dysfunction without rupture of tympanic membrane, suggesting central auditory processing impairment after blast exposure. There is limited information on the mechanisms of blastinduced TBI and associated peripheral and central auditory processing impairments. We utilized a repetitive blast exposure mouse model to unravel the mechanisms of blast TBI and auditory impairment. C57BL/6J mice were exposed to three repeated blasts (20.6 psi) using a shock tube, and the cerebellum was subjected to proteomic analysis. The data showed that calretinin and parvalbumin, two major calcium buffering proteins, were significantly up-regulated after repeated blast exposures, and this was confirmed by Western blotting. Since these proteins are reportedly involved in auditory dysfunction, we examined the inner ear and found both calretinin and parvalbumin were up-regulated, suggesting that modulation of these proteins plays a role in blast-induced peripheral and central auditory processing impairments. Expression of cleaved caspase-3 was also up-regulated in both regions indicating ongoing cellular apoptosis, possibly due to altered calcium homeostasis. These results provide a molecular basis for changes in central and peripheral auditory processing involving abnormal calcium homeostasis resulting in hearing impairment after blast exposure.	[Arun, Peethambaran; Valiyaveettil, Manojkumar; Biggemann, Lionel; Alamneh, Yonas; Wei, Yanling; Oguntayo, Samuel; Wang, Ying; Long, Joseph B.; Nambiar, Madhusoodana P.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA		Nambiar, MP (corresponding author), Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Blast Induced Neurotrauma Branch, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	Peethambaran.arun@amedd.army.mil; Madhusoodana.nambiar@amedd.army.mil					ALTMAN JA, 1976, EXP BRAIN RES, V26, P285; Basile AS, 1996, NAT MED, V2, P1338, DOI 10.1038/nm1296-1338; Bochicchio GV, 2008, AM SURGEON, V74, P267; Boyiri T, 2009, INT J ONCOL, V35, P559, DOI 10.3892/ijo_00000367; Caicedo A, 1996, ANAT EMBRYOL, V194, P465; Caicedo A, 1997, J COMP NEUROL, V378, P1, DOI 10.1002/(SICI)1096-9861(19970203)378:1<1::AID-CNE1>3.0.CO;2-8; Alvarado JC, 2009, HEARING RES, V247, P78, DOI 10.1016/j.heares.2008.10.005; Chen GD, 2001, HEARING RES, V154, P108, DOI 10.1016/S0378-5955(01)00228-3; Coppens AG, 2000, HEARING RES, V145, P101, DOI 10.1016/S0378-5955(00)00077-0; Diao Mingfang, 2005, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V19, P27; Eshraghi AA, 2006, ANAT REC PART A, V288A, P473, DOI 10.1002/ar.a.20305; Fausti SA, 2005, J REHABIL RES DEV, V42, P45, DOI 10.1682/JRRD.2005.02.0039; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; FRISINA RD, 1995, HEARING RES, V85, P53, DOI 10.1016/0378-5955(95)00029-4; Fuentes-Santamaria V, 2003, J COMP NEUROL, V460, P585, DOI 10.1002/cne.10676; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Haase GM, 2011, AM J OTOLARYNG, V32, P55, DOI 10.1016/j.amjoto.2009.09.002; Hackney CM, 2005, J NEUROSCI, V25, P7867, DOI 10.1523/JNEUROSCI.1196-05.2005; HEIZMANN CW, 1992, GEN PHYSIOL BIOPHYS, V11, P411; HUANG CM, 1982, BRAIN RES, V244, P1, DOI 10.1016/0006-8993(82)90897-6; Idrizbegovic E, 2004, NEUROBIOL AGING, V25, P1085, DOI 10.1016/j.neurobiolaging.2003.11.004; Idrizbegovic E, 1999, NEUROSCI LETT, V259, P49, DOI 10.1016/S0304-3940(98)00911-2; Idrizbegovic E, 1998, BRAIN RES, V800, P86, DOI 10.1016/S0006-8993(98)00504-6; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; [陆佳圆 Lu Jiayuan], 2011, [机械设计, Journal of Machine Design], V28, P1; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mao JC, 2012, J NEUROTRAUM, V29, P430, DOI 10.1089/neu.2011.1934; Maskey D, 2012, BRAIN RES, V1437, P58, DOI 10.1016/j.brainres.2011.12.009; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Puel JL, 1998, NEUROREPORT, V9, P2109, DOI 10.1097/00001756-199806220-00037; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; Sens Patricia Maria, 2007, Braz J Otorhinolaryngol, V73, P266; Shen HY, 2007, HEARING RES, V226, P52, DOI 10.1016/j.heares.2006.12.011; SNIDER R S, 1946, Anat Rec, V94, P498; TERAMOTO S, 1966, EXP NEUROL, V16, P191, DOI 10.1016/0014-4886(66)90098-7; Uemaetomari I, 2009, TOHOKU J EXP MED, V218, P41, DOI 10.1620/tjem.218.41; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wolfe J W, 1975, Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol, V80, P314; YLIKOSKI ME, 1994, SCAND J WORK ENV HEA, V20, P93, DOI 10.5271/sjweh.1415	43	5	5	0	0	AKADEMIAI KIADO ZRT	BUDAPEST	BUDAFOKI UT 187-189-A-3, H-1117 BUDAPEST, HUNGARY	2061-1617	2061-5094		INTERV MED APPL SCI	Interv. Med. Appl. Sci.	SEP	2012	4	3					125	131		10.1556/IMAS.4.2012.3.2			7	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V26LC	WOS:000215292700002		gold			2022-02-06	
J	Hassanzadeh, P; Arbabi, E				Hassanzadeh, Parichehr; Arbabi, Elham			The Effects of Progesterone on Glial Cell Line-derived Neurotrophic Factor Secretion from C6 Glioma Cells	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						C6 glioma cells; GDNF; Progesterone	TRAUMATIC BRAIN-INJURY; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; FACTOR EXPRESSION; NERVOUS-SYSTEM; MESSENGER-RNA; STEM-CELLS; GDNF; ALLOPREGNANOLONE; NEUROPROTECTION	Objective(s) Progesterone is a steroid hormone whose biology has been greatly studied within the confines of reproductive function. In recent years, the neuroprotective effects of progesterone have attracted growing interest. Glial cell line-derived neurotrophic factor (GDNF), is a neurotrophic factor which plays a crucial role in the development and maintenance of distinct sets of central and peripheral neurons. In the present study, we investigated the potential implication of GDNF in the neuroprotective action of progesterone. Materials and Methods Cultured rat C6 glioma cells were treated with progesterone (100 nm, 1 mu M, and 10 mu M) or its vehicle. After 24, 36, 48 and 72 hr, GDNF protein levels were measured in the cell-conditioned media and cell lysates using a GDNF ELISA kit. Cell numbers were determined by a cell-counting assay kit. Results Forty-eight hr treatment with progesterone (10 mu M) resulted in a significant elevation of GDNF secretion from C6 glioma cells that remained elevated up to 72 hr. The intracellular content of GDNF and cell numbers were not affected by progesterone treatment. Conclusion Stimulation of GDNF release from glial cells appears as a potential mechanism through which progesterone exerts its neuroprotective effects.	[Hassanzadeh, Parichehr; Arbabi, Elham] Shahid Beheshti Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran		Hassanzadeh, P (corresponding author), Shahid Beheshti Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran.	Pari_has@yahoo.com		Hassanzadeh, Parichehr/0000-0001-7465-2640	Shahid Beheshti University of Medical Sciences, Tehran, Iran	This work was financially supported by Shahid Beheshti University of Medical Sciences, Tehran, Iran. Authors thank Dr Masoud Alebouyeh, Research Center for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, for helpful discussion.	Akan P, 2009, CHEM-BIOL INTERACT, V177, P65, DOI 10.1016/j.cbi.2008.09.016; Bai O, 2003, J NEUROSCI RES, V71, P127, DOI 10.1002/jnr.10440; Bemelmans AP, 2006, J NEUROSCI RES, V83, P50, DOI 10.1002/jnr.20704; BITRAN D, 1995, J NEUROENDOCRINOL, V7, P171, DOI 10.1111/j.1365-2826.1995.tb00744.x; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Chlan-Fourney J, 2002, BRAIN RES, V954, P11, DOI 10.1016/S0006-8993(02)03215-8; Coughlan T, 2009, INT J NEUROSCI, V119, P1718, DOI 10.1080/00207450903116430; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; De Nicola AF, 2009, FRONT NEUROENDOCRIN, V30, P173, DOI 10.1016/j.yfrne.2009.03.001; Deniselle MCG, 2002, NEUROBIOL DIS, V11, P457, DOI 10.1006/nbdi.2002.0564; Desarnaud F, 1998, J NEUROCHEM, V71, P1765; Di Cosmo A, 1998, MOL REPROD DEV, V50, P451, DOI 10.1002/(SICI)1098-2795(199808)50:4<451::AID-MRD9>3.3.CO;2-T; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Freeman MR, 2006, CURR OPIN NEUROBIOL, V16, P119, DOI 10.1016/j.conb.2005.12.004; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Gibson CL, 2004, J CEREBR BLOOD F MET, V24, P805, DOI 10.1097/01.WCB.0000125365.83980.00; Gibson CL, 2009, NEUROSCIENTIST, V15, P324, DOI 10.1177/1073858409333069; Gonzalez SL, 2005, J STEROID BIOCHEM, V94, P143, DOI 10.1016/j.jsbmb.2005.01.016; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; HASSANZADEH P, 2010, BIOMED REV, V21, P31; Hassanzadeh P, 2011, EUR NEUROPSYCHOPHARM, V21, P905, DOI 10.1016/j.euroneuro.2011.01.002; Hassanzadeh P, 2011, PSYCHOPHARMACOLOGY, V215, P129, DOI 10.1007/s00213-010-2120-4; Hassanzadeh P, 2010, IRAN J BASIC MED SCI, V13, P202; Hauck SM, 2006, MOL CELL BIOL, V26, P2746, DOI 10.1128/MCB.26.7.2746-2757.2006; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hisaoka K, 2001, J NEUROCHEM, V79, P25, DOI 10.1046/j.1471-4159.2001.00531.x; Inoue T, 2002, J CLIN ENDOCR METAB, V87, P5325, DOI 10.1210/jc.2002-012096; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Kumon Y, 2000, J NEUROSURG, V92, P848, DOI 10.3171/jns.2000.92.5.0848; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Lara J, 2003, EXP NEUROL, V180, P32, DOI 10.1016/S0014-4886(02)00028-6; Leonelli E, 2007, NEUROSCIENCE, V144, P1293, DOI 10.1016/j.neuroscience.2006.11.014; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Logan A, 2006, BRAIN, V129, P490, DOI 10.1093/brain/awh706; McKay SE, 1999, LEARN MEMORY, V6, P193; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Obara Y, 2002, DRUG NEWS PERSPECT, V15, P290, DOI 10.1358/dnp.2002.15.5.840042; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; Pettus EH, 2005, BRAIN RES, V1049, P112, DOI 10.1016/j.brainres.2005.05.004; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Sakamoto H, 2003, NEUROSCI LETT, V343, P163, DOI 10.1016/S0304-9340(03)000362-8; Sawada H, 2000, J NEUROCHEM, V74, P1175; Sayeed L, 2007, RESTOR NEUROL NEUROS, V25, P151; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Singh M, 2006, ENDOCRINE, V29, P271, DOI 10.1385/ENDO:29:2:271; Slezak M, 2006, J PHYSIOLOGY-PARIS, V99, P84, DOI 10.1016/j.jphysparis.2005.12.082; Slezak M, 2003, TRENDS NEUROSCI, V26, P531, DOI 10.1016/j.tins.2003.08.005; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Ugarte SD, 2003, J NEUROSCI RES, V73, P105, DOI 10.1002/jnr.10632; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Xu HY, 2002, NEUROSCI LETT, V321, P65, DOI 10.1016/S0304-3940(02)00034-4; Zhang Y, 2006, BRAIN RES, V1111, P227, DOI 10.1016/j.brainres.2006.07.005	62	5	5	0	2	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	SEP-OCT	2012	15	5					1046	1052					7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	042XN	WOS:000311505600007	23493386				2022-02-06	
J	Heather, NL; Derraik, JGB; Brennan, C; Jefferies, C; Hofman, PL; Kelly, P; Jones, RG; Rowe, DL; Cutfield, WS				Heather, Natasha L.; Derraik, Jose G. B.; Brennan, Christine; Jefferies, Craig; Hofman, Paul L.; Kelly, Patrick; Jones, Rhys G.; Rowe, Deborah L.; Cutfield, Wayne S.			Cortisol response to synacthen stimulation is attenuated following abusive head trauma	CLINICAL ENDOCRINOLOGY			English	Article							BODY-MASS INDEX; SALIVARY CORTISOL; MORNING CORTISOL; NEW-ZEALAND; INDIVIDUAL-DIFFERENCES; HORMONE CHALLENGE; CHILDHOOD TRAUMA; PUBERTAL CHANGES; CHILDREN; STRESS	Background Child abuse and other early-life environmental stressors are known to affect the hypothalamicpituitaryadrenal axis. We sought to compare synacthen-stimulated cortisol responses in children who suffered inflicted or accidental traumatic brain injury (TBI). Methods Children with a history of early-childhood TBI were recruited from the Starship Children's Hospital database (Auckland, New Zealand, 1992-2010). All underwent a low-dose ACTH124 (synacthen 1 mu g IV) test, and serum cortisol response was compared between inflicted (TBII) and accidental (TBIA) groups. Results We assessed 64 children with TBII and 134 with TBIA. Boys were more likely than girls to suffer accidental (P < 0.001), but not inflicted TBI. TBII children displayed a 14% reduction in peak stimulated cortisol in comparison with the TBIA group (P < 0.001), as well as reduced cortisol responses at + 30 (P < 0.01) and + 60 min (P < 0.001). Importantly, these differences were not associated with severity of injury. The odds ratio of TBII children having a mother who suffered domestic violence during pregnancy was 6.2 times that of the TBIA group (P < 0.001). However, reported domestic violence during pregnancy or placement of child in foster care did not appear to affect cortisol responses. Conclusion Synacthen-stimulated cortisol response is attenuated following inflicted TBI in early childhood. This may reflect chronic exposure to environmental stress as opposed to pituitary injury or early-life programming.	[Heather, Natasha L.; Derraik, Jose G. B.; Brennan, Christine; Hofman, Paul L.; Rowe, Deborah L.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Jefferies, Craig; Kelly, Patrick] Starship Childrens Hosp, Auckland Dist Hlth Board, Auckland, New Zealand; [Jones, Rhys G.] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Rowe, Deborah L.] Univ Auckland, Sch Nursing, Fac Med & Hlth Sci, Auckland 1, New Zealand		Cutfield, WS (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019, Auckland 1, New Zealand.	w.cutfield@auckland.ac.nz	Heather, Natasha/AAV-8425-2020; Jefferies, craig/ABA-1921-2021; Derraik, Jose Guilherme Behrensdorf/A-1925-2008	Derraik, Jose Guilherme Behrensdorf/0000-0003-1226-1956; Jefferies, Craig/0000-0002-0541-6094; Kelly, Patrick/0000-0002-8813-8877	Health Research Council of New ZealandHealth Research Council of New Zealand; Australasian Paediatric Endocrine Group; Starship Fellowship Foundation; Paykel Trust	We thank participants and our advisory Kaitiaki group. We also thank Rangi Dansey (Auckland City Hospital) for his assistance with the Starship Trauma database. The study was supported by grants from the Health Research Council of New Zealand and the Australasian Paediatric Endocrine Group. Natasha Heather was supported by the Starship Fellowship Foundation. The authors have no financial or nonfinancial interests to declare that may be relevant to this submitted work. We acknowledge the Paykel Trust for long-term funding of the Maurice & Agnes Paykel Clinical Research Unit at the Liggins Institute.	Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; Bruce J, 2009, DEV PSYCHOBIOL, V51, P14, DOI 10.1002/dev.20333; Carlson M, 1997, ANN NY ACAD SCI, V807, P419, DOI 10.1111/j.1749-6632.1997.tb51936.x; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; DEBELLIS MD, 1994, J CLIN ENDOCR METAB, V78, P249, DOI 10.1210/jc.78.2.249; DICKSTEIN G, 1991, J CLIN ENDOCR METAB, V72, P773, DOI 10.1210/jcem-72-4-773; Douglas NM, 2007, J PAEDIATR CHILD H, V43, P173, DOI 10.1111/j.1440-1754.2007.01038.x; EDLESON JL, 1999, VIOLENCE WOMEN, V0005; Fernald LCH, 2008, DEV PSYCHOPATHOL, V20, P423, DOI 10.1017/S0954579408000205; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Heim C., 2001, AM J PSYCHIAT, V1, P282; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Heim C, 2008, BIOL PSYCHIAT, V63, P398, DOI 10.1016/j.biopsych.2007.07.002; Kaufman J, 1997, BIOL PSYCHIAT, V42, P669, DOI 10.1016/S0006-3223(96)00470-2; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kelly P, 2011, ACTA PAEDIATR, V100, P14, DOI 10.1111/j.1651-2227.2010.02000.x; Koupil I, 2005, CLIN ENDOCRINOL, V62, P661, DOI 10.1111/j.1365-2265.2005.02275.x; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; McFarlane J, 1996, NURS RES, V45, P37, DOI 10.1097/00006199-199601000-00007; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; O'Connor TG, 2005, BIOL PSYCHIAT, V58, P211, DOI 10.1016/j.biopsych.2005.03.032; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; Oskis A, 2009, PSYCHONEUROENDOCRINO, V34, P307, DOI 10.1016/j.psyneuen.2008.09.009; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Rosmalen JGM, 2005, PSYCHONEUROENDOCRINO, V30, P483, DOI 10.1016/j.psyneuen.2004.12.007; Salmond C, 2007, NZDEP2006 INDEX DEPR; Stroud LR, 2011, PSYCHONEUROENDOCRINO, V36, P1226, DOI 10.1016/j.psyneuen.2011.02.017; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tornhage CJ, 2006, J PEDIATR ENDOCR MET, V19, P843; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; [No title captured]	36	5	5	0	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	SEP	2012	77	3					357	362		10.1111/j.1365-2265.2012.04376.x			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Endocrinology & Metabolism	989TL	WOS:000307583300004	22372641				2022-02-06	
J	Huang, W; Li, ZB; Li, Z; Yang, RT				Huang, Wei; Li, Zubing; Li, Zhi; Yang, Rongtao			Does Traumatic Brain Injury Result in Accelerated Mandibular Fracture Healing?	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							HEAD-INJURY; CALLUS FORMATION; EXPRESSION; RECEPTOR; SERUM	Purpose: To investigate the occurrence of accelerated bone healing evidenced by early callus formation in patients with mandibular fractures and traumatic brain injury (TBI). Materials and Methods: A retrospective cohort study was performed in patients who presented for mandibular fracture evaluation and management over a 6-year period. Subjects eligible for the study included those who underwent a computed tomographic examination of the mandible more than 2 weeks after the injury and had not undergone surgery with rigid internal fixation. TBI was used as the predictor variable. Time to callus formation as detected on computed tomographic scans was recorded as the primary outcome variable. Other variables considered included age, gender, coma duration, and fracture distribution. Appropriate statistical analyses were performed to determine the influencing factors. Results: Forty-five patients with mandibular fractures (24 with severe TBI and 21 without TBI) were retrospectively analyzed. Twelve patients with TBI and 6 without TBI exhibited a visible callus on their computed tomographic scans. Statistical analysis showed no significant differences in age, gender, examination time, and fracture distribution between the groups. Cox proportional hazards regression analysis indicated a positive correlation of time to callus formation with TBI and coma duration but not with age, gender, and fracture distribution. Conclusions: These findings suggest that patients with severe TBI and mandibular fractures exhibit increased fracture healing as evidenced by early callus formation. A more exhaustive study is required to advance the understanding of this phenomenon and provide additional clinical significance. (C) 2012 Published by Elsevier Inc on behalf of the American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 70:2135-2142, 2012	[Li, Zubing; Li, Zhi] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430079, Hubei Province, Peoples R China; [Huang, Wei; Yang, Rongtao] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430079, Hubei Province, Peoples R China; [Huang, Wei; Yang, Rongtao] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430079, Hubei Province, Peoples R China; [Huang, Wei] Hubei Univ Med, Taihe Hosp, Dept Oral & Maxillofacial Surg, Shiyan City, Hubei Province, Peoples R China		Li, ZB (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Surg, 237 Luoyu Rd, Wuhan 430079, Hubei Province, Peoples R China.	lizubing0827@163.com					Beeton CA, 2004, J BONE JOINT SURG BR, V86B, P912, DOI 10.1302/0301-620x.86b6.14176; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; Cadosch D, 2010, J BONE JOINT SURG AM, V92A, P645, DOI 10.2106/JBJS.I.00097; Cadosch D, 2009, J BONE JOINT SURG AM, V91A, P282, DOI 10.2106/JBJS.G.01613; Gautschi OP, 2009, ANZ J SURG, V79, P449, DOI 10.1111/j.1445-2197.2008.04803.x; Giannoudis PV, 2006, INJURY, V37, pS18, DOI 10.1016/j.injury.2006.08.020; Goransson H, 1995, SCAND J PLAST RECONS, V29, P281; Jiang Xiaohua, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P1227; Malcangio M, 1997, EUR J NEUROSCI, V9, P1101, DOI 10.1111/j.1460-9568.1997.tb01462.x; Nakase T, 2009, J TRAUMA, V66, P550, DOI 10.1097/01.ta.0000229979.06520.72; NEWMAN RJ, 1987, INJURY, V18, P241, DOI 10.1016/0020-1383(87)90006-4; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; RAMESHWAR P, 1995, BLOOD, V86, P482, DOI 10.1182/blood.V86.2.482.bloodjournal862482; Scherbel U, 2001, U PENNSYLVANIA ORTHO, V14, P85; Song Y, 2011, MOL MED REP, V26, P645; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; Walter HJ, 1997, ENDOCRINOLOGY, V138, P3024, DOI 10.1210/en.138.7.3024; Wei YZ, 2008, J PHARM PHARMACOL, V60, P1667, DOI 10.1211/jpp/60.12.0013	19	5	7	0	9	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391	1531-5053		J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	SEP	2012	70	9					2135	2142		10.1016/j.joms.2012.04.016			8	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	999NG	WOS:000308319900025	22907111				2022-02-06	
J	Kawasaki, Y; Fujiki, M; Ooba, H; Sugita, K; Hikawa, T; Abe, T; Ishii, K; Kobayashi, H				Kawasaki, Yukari; Fujiki, Minoru; Ooba, Hiroshi; Sugita, Kenji; Hikawa, Takamitsu; Abe, Tatsuya; Ishii, Keisuke; Kobayashi, Hidenori			Short latency afferent inhibition associated with cortical compression and memory impairment in patients with chronic subdural hematoma	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Chronic subdural hematoma; Traumatic brain injury; Transcranial magnetic stimulation; Short latency afferent inhibition	TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; ALZHEIMER-DISEASE; EXCITABILITY; FACILITATION; CIRCUITS; INJURY	Objective: To evaluate the cortical excitability in patients with mild cortical compression. Methods: The present study used short interval intracortical inhibition (SICI), intracortical facilitation (ICF), and short latency afferent inhibition (SAI) to evaluate motor cortex excitability in 16 chronic subdural hematoma (CSDH) patients with memory impairment and compared the data with those of 16 healthy controls. Results: SAI was reduced in patients compared with controls (99 +/- 14 vs. 47 +/- 11% of the test size; p <0.0001. unpaired t-test). CSDH patients tended to have a high resting motor threshold and less pronounced SICI and ICF than controls, but these differences were not significant. Treatment of hematoma improved memory impairment and SAI in CSDH patients with wide individual variations that ranged from an increase of 74% to 17% of test size. Conclusion: These findings suggest that measuring SAL may provide a means of probing the integrity of cortical cholinergic networks in a compressed human brain. (C) 2012 Elsevier B.V. All rights reserved.	[Kawasaki, Yukari; Fujiki, Minoru; Ooba, Hiroshi; Sugita, Kenji; Hikawa, Takamitsu; Abe, Tatsuya; Ishii, Keisuke; Kobayashi, Hidenori] Oita Univ, Sch Med, Dept Neurosurg, Oita 8795593, Japan		Fujiki, M (corresponding author), Oita Univ, Sch Med, Dept Neurosurg, 1-1 Idaigaoka, Oita 8795593, Japan.	fujiki@oita-u.ac.jp			Japan Science and Technology AgencyJapan Science & Technology Agency (JST); Ministry of Education, Culture, Sports, Science and TechnologyMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	This work was supported by a grant from the Japan Science and Technology Agency and the Ministry of Education, Culture, Sports, Science and Technology. The authors are grateful to Ms. Y. Hagimori for her technical assistance.	Alagona G, 2001, NEUROSCI LETT, V314, P57, DOI 10.1016/S0304-3940(01)02288-1; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Di Lazzaro V, 2005, J NEUROL NEUROSUR PS, V76, P1064, DOI 10.1136/jnnp.2004.051334; Di Lazzaro V, 2004, J NEUROL NEUROSUR PS, V75, P555, DOI 10.1136/jnnp.2003.018127; Di Lazzaro V, 2002, NEUROLOGY, V59, P392, DOI 10.1212/WNL.59.3.392; Di Lazzaro V, 2000, EXP BRAIN RES, V135, P455, DOI 10.1007/s002210000543; Kessler KR, 2005, MOVEMENT DISORD, V20, P238, DOI 10.1002/mds.20295; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Little AJ, 1996, J CLIN PSYCHOL, V52, P455, DOI 10.1002/(SICI)1097-4679(199607)52:4<455::AID-JCLP11>3.0.CO;2-F; Nardone R, 2011, J NEUROTRAUM, V28, P1165, DOI 10.1089/neu.2010.1748; Pennisi G, 2002, NEUROSCI LETT, V329, P293, DOI 10.1016/S0304-3940(02)00701-2; Tokimura H, 2000, J PHYSIOL-LONDON, V523, P503, DOI 10.1111/j.1469-7793.2000.t01-1-00503.x; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	15	5	6	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467			CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	SEP	2012	114	7					976	980		10.1016/j.clineuro.2012.02.037			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	993JU	WOS:000307855800028	22482870				2022-02-06	
J	Rashid, B; Destrade, M; Gilchrist, MD				Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.			A high rate tension device for characterizing brain tissue	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Traumatic brain injury; tensile; shear; strain; axon; impact	FINITE-ELEMENT MODELS; HUMAN HEAD; SLICE CULTURES; INJURY; STRETCH; IMPACT	The mechanical characterization of brain tissue at high loading velocities is vital for understanding and modeling traumatic brain injury. The most severe form of traumatic brain injury is diffuse axonal injury, which involves damage to individual nerve cells (neurons). Diffuse axonal injury in animals and humans occurs at strains > 10% and strain rates > 10 s(-1). The mechanical properties of brain tissues at these strains and strain rates are of particular significance, as they can be used in finite element human head models to accurately predict brain injuries under different impact conditions. Existing conventional tensile testing machines can only achieve maximum loading velocities of 500 mm/min, whereas the Kolsky bar apparatus is more suitable for strain rates > 100 s(-1). In this study, a custom-designed high rate tension device is developed and calibrated to estimate the mechanical properties of brain tissue in tension at strain rates <= 90 s(-1), while maintaining a uniform velocity. The range of strain can also be extended to 100% depending on the thickness of a sample. The same apparatus can be used to characterize the dynamic behavior of skin and other soft biological tissues by using appropriately sized load cells with a capacity of 10N and above.	[Rashid, Badar; Destrade, Michel; Gilchrist, Michael D.] Natl Univ Ireland Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland; [Destrade, Michel] Natl Univ Ireland Univ Coll Galway, Sch Math Stat & Appl Math, Galway, Ireland		Gilchrist, MD (corresponding author), Natl Univ Ireland Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 4, Ireland.	michael.gilchrist@ucd.ie	Destrade, Michel/O-5825-2019; Gilchrist, Michael D/B-6100-2017	Destrade, Michel/0000-0002-6266-1221; Gilchrist, Michael D/0000-0003-1765-429X	Irish Research Council for Science, Engineering and Technology (IRCSET), IrelandIrish Research Council for Science, Engineering and Technology	The authors thank John Gahan, Tony Dennis and Pat McNally of University College Dublin for their assistance in machining components and developing electronic circuits for the experimental setup. This work was supported for the first author by a Postgraduate Research Scholarship awarded by the Irish Research Council for Science, Engineering and Technology (IRCSET), Ireland.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Kleiven Svein, 2002, Stapp Car Crash J, V46, P123; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Meaney D. F., 1990, INT C BIOM IMP IRCOB; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Ogden RW, 2004, COMPUT MECH, V34, P484, DOI 10.1007/s00466-004-0593-y; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Raul JS, 2008, INT J LEGAL MED, V122, P359, DOI 10.1007/s00414-008-0248-0; Raul JS, 2006, INT J LEGAL MED, V120, P212, DOI 10.1007/s00414-005-0018-1; RUAN JS, 1994, J BIOMECH ENG-T ASME, V116, P44, DOI 10.1115/1.2895703; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Tamura A, 2008, J BIOMECH SCI ENG, V3, P263, DOI DOI 10.1299/JBSE.3.263; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Zhang L, 2001, Stapp Car Crash J, V45, P369	21	5	5	1	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371	1754-338X		P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		170	176		10.1177/1754337112436900			7	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000003		Green Submitted			2022-02-06	
J	Schilling, EJ; Getch, YQ				Schilling, Ethan J.; Getch, Yvette Q.			Getting My Bearings, Returning to School Issues Facing Adolescents With Traumatic Brain Injury	TEACHING EXCEPTIONAL CHILDREN			English	Article								Consider three adolescents who recently suffered traumatic brain injury (TBI), and put yourself in their positions as they face academic, social, and behavioral challenges. This article examines five case examples, but for now, let's look at Angelica, who received a direct blow to the head and has difficulty organizing her day. She received a "tardy" because she was late to a class, and decided she would rather take punishment than be perceived as confused. Another student, Sarah, was injured in a car accident and has trouble staying on task. Her grades have suffered, and she gives the impression of wasting time, rather than not succeeding. A third student, Rodney, a good student before his injury from a rock climbing fall, has behavioral issues, making inappropriate remarks in class and wandering around. All of these students, and many like them, can be helped. Strategies and solutions include providing the students with regular breaks from routines, supplying outlines of lectures and content of classes, and giving alternative assessments. When educators reuse or retool the strategies that have worked with many other students with disabilities, students with TBI benefit.	[Schilling, Ethan J.; Getch, Yvette Q.] Univ Georgia, Dept Counseling & Human Dev Serv, Athens, GA 30602 USA		Schilling, EJ (corresponding author), Univ Georgia, Sch Psychol, Dept Educ Psychol, 325 Aderhold Hall, Athens, GA 30602 USA.	eschill@uga.edu					Arroyos-Jurado E, 2008, INTERV SCH CLIN, V43, P252, DOI 10.1177/1053451208314907; Bowen JM, 2005, PREV SCH FAIL, V49, P34, DOI 10.3200/PSFL.49.4.34-41; Brain Injury Association of America, 2009, FACTS TRAUM BRAIN IN; Bullock LM, 2005, PREV SCH FAIL, V49, P6, DOI 10.3200/PSFL.49.4.6-10; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ US R; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; DePompei R., 2004, TRAUMATIC BRAIN INQU, V2nd, P559; Glang A, 2008, NEUROREHABILITATION, V23, P477; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Hooper S., 2006, EXCEPTIONALITY, V14, P171, DOI [DOI 10.1207/S15327035EX1403_5, DOI 10.1207/s15327035ex1403_5]; Jantz PB, 2007, SUPPORT LEARN, V22, P84, DOI 10.1111/j.1467-9604.2007.00452.x; Kaffenberger C., 2006, PROFESSIONAL SCH COU, V9, P223, DOI [10.5330/prsc.9.3.xr27748161346325, DOI 10.5330/PRSC.9.3.XR27748161346325]; Keyser-Marcus L., 2002, TEACHING EXCEPTIONAL, V34, P62; Lewandowski LJ, 2009, J APPL SCH PSYCHOL, V25, P95, DOI 10.1080/15377900802484547; Mayfield J, 2005, PREV SCH FAIL, V49, P17, DOI 10.3200/PSFL.49.4.17-22; McCaleb K. N., 2006, PHYS DISABILITIES ED, V25, P61; Mohr JD, 2005, PREV SCH FAIL, V49, P53, DOI 10.3200/PSFL.49.4.53-57; National Institutes of Health Consensus Development Panel on Rehabilitation of Persons with Traumatic Brain Injury, 2009, JAMA-J AM MED ASSOC, V282, P974; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Rubin K. H., 2007, HDB CHILD PSYCHOL, VIII, P571, DOI DOI 10.1002/9780470147658.CHPSY0310; Schutz LE, 2010, INT J SPEC EDUC, V25, P55; Sexson S, 1995, SCHOOL PSYCHOL QUART, V10, P359, DOI 10.1037/h0088311; Shiu, 2001, INT J DISABIL DEV ED, V48, P269, DOI [10.1080/10349120120073412, DOI 10.1080/10349120120073412]	24	5	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0040-0599	2163-5684		TEACH EXCEPT CHILD	Teach. Except. Child.	SEP-OCT	2012	45	1					54	63		10.1177/004005991204500108			10	Education, Special	Emerging Sources Citation Index (ESCI)	Education & Educational Research	VH5ZB	WOS:000453573900008					2022-02-06	
J	Whyte, J; Ward, P; Eccles, DW; Harris, KR; Nandagopal, K; Torof, JM				Whyte, James; Ward, Paul; Eccles, David W.; Harris, Kevin R.; Nandagopal, Kiruthiga; Torof, Jason M.			Nurses' immediate response to the fall of a hospitalized patient: A comparison of actions and cognitions of experienced and novice nurses	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						Nursing performance; Patient falls; Decision making	EMERGENCY ASSISTANCE; VERBAL REPORTS; DECISIONS; TASK	Background: Falls represent a significant threat to patient safety for hospitalized patients throughout the world. Little is known, however, regarding nurses' immediate responses to the discovery of a fallen patient. Objectives: The objective of this study was to perform an experimental examination of experienced and novice nurses' reaction to the discovery of a fallen patient who has sustained a closed head injury. Design: The study was based upon the expert performance approach, which utilizes a mixed methods approach to determining performance characteristics of individuals performing in a variety of domains. Setting: The study was accomplished using a simulated task environment developed specifically for research concerning the performance of health professionals. Participants: The study included 12 experienced and 10 novice nurses, all of whom were currently employed in critical care settings. Methods: The study used directly observed performance, which was quantified through the use of direct coding of clinical behaviors and the analysis of verbal reports of thought. Results: The data indicate that experienced participants were not only more likely to call for help but that they were more likely to precede this action by checking for responsiveness, and then, after calling for help, establish the effectiveness of the patient's airway, breathing and circulation. These data confirmed that experienced participants were more likely to engage in the appropriate sequence of actions when faced with this unexpected and highly stressful situation. Conclusions: Novice nurses' superficial assessment of the situation and subsequent failure to react properly implied an overall pattern of superior performance by the experienced nurses. The results indicated that, compared with novice nurses, experienced nurses are more likely to initiate standard treatment protocols in situations such as the one reported in this study. (C) 2012 Elsevier Ltd. All rights reserved.	[Whyte, James] Florida State Univ, Coll Nursing, Tallahassee, FL 32306 USA; [Ward, Paul] Michigan Technol Univ, Dept Cognit & Learning Sci, Houghton, MI 49931 USA; [Eccles, David W.] Univ Durham, Sch Appl Social Sci, Durham DH1 3HP, England; [Harris, Kevin R.] Austin Peay State Univ, Dept Psychol, Clarksville, TN 37044 USA; [Nandagopal, Kiruthiga] Stanford Univ, Sch Educ, Stanford, CA 94305 USA; [Torof, Jason M.] Florida State Univ, Coll Educ, Tallahassee, FL 32306 USA		Whyte, J (corresponding author), Florida State Univ, Coll Nursing, Tallahassee, FL 32306 USA.	jwhyte@fsu.edu	Ward, Paul/K-4145-2012	Ward, Paul/0000-0003-1223-5782			Aitken L M, 2000, Intensive Crit Care Nurs, V16, P209, DOI 10.1054/iccn.2000.1498; Alspach J.G., 2005, CORE CURRICULUM CRIT; Bucknall T, 1995, Aust J Adv Nurs, V13, P10; Bucknall T, 2003, J ADV NURS, V43, P310, DOI 10.1046/j.1365-2648.2003.02714.x; CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; Cioffi J, 2000, J ADV NURS, V32, P108, DOI 10.1046/j.1365-2648.2000.01414.x; Cioffi J, 2000, HEART LUNG, V29, P262, DOI 10.1067/mhl.2000.108327; Cioffi J., 2010, AUSTR CRITICAL CARE, V22, P178; Cioffi J, 2010, AUST CRIT CARE, V23, P188, DOI 10.1016/j.aucc.2010.04.002; Cioffi J, 2009, AUST CRIT CARE, V22, P178, DOI 10.1016/j.aucc.2009.07.001; CORCORAN SA, 1986, NURS RES, V35, P107; Cranley L, 2009, WORLDV EVID-BASED NU, V6, P3, DOI 10.1111/j.1741-6787.2008.00138.x; Daffurn K, 1994, Intensive Crit Care Nurs, V10, P115, DOI 10.1016/0964-3397(94)90007-8; Ericsson K. A., 1991, GEN THEORY EXPERTISE, P1; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; ERICSSON KA, 1980, PSYCHOL REV, V87, P215, DOI 10.1037/0033-295X.87.3.215; Ericsson KA, 2007, ADV NURS SCI, V30, P58; Hoffman KA, 2009, INT J NURS STUD, V46, P1335, DOI 10.1016/j.ijnurstu.2009.04.001; Kohn L.T., 1999, ERR IS HUMAN BUILDIN; Leonard M., 2010, ACHIEVING SAFE RELIA; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Schwendimann R, 2008, GERONTOLOGY, V54, P342, DOI 10.1159/000129954; Schwendimann R, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-69; Simon, 1993, PROTOCOL ANAL VERBAL; TANNER CA, 1987, NURS RES, V36, P358; Thompson C., 2001, DECISION MAKING JUDG, P1; THOMPSON C, 2001, CLIN DECISION MAKING; Thompson C, 2008, NURS RES, V57, P302, DOI 10.1097/01.NNR.0000313504.37970.f9; Thompson C, 2008, J CLIN NURS, V17, P2174, DOI 10.1111/j.1365-2702.2008.02303.x; Thompson C, 2009, J CLIN NURS, V18, P601, DOI 10.1111/j.1365-2702.2007.02191.x; Ward P., 2010, P HUM FACT ERG SOC 5; Ward P., 2009, TECHNOLOGY INSTRUCTI, V7, P121; Ward P, 2007, HIGH ABIL STUD, V18, P119, DOI 10.1080/13598130701709715; Whyte J, 2009, HEART LUNG, V38, P517, DOI 10.1016/j.hrtlng.2008.12.006; Williams AM, 2002, J EXP PSYCHOL-APPL, V8, P259, DOI 10.1037/1076-898X.8.4.259; Yang H., 2010, INT J NURS STUD, V48, P4429; Yang HQ, 2010, J ADV NURS, V66, P2751, DOI 10.1111/j.1365-2648.2010.05437.x	37	5	5	0	15	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	SEP	2012	49	9					1054	1063		10.1016/j.ijnurstu.2012.03.005			10	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	022VF	WOS:000309991200002	22534491				2022-02-06	
J	Zlotnik, A; Tsesis, S; Gruenbaum, BF; Ohayon, S; Gruenbaum, SE; Boyko, M; Sheiner, E; Brotfain, E; Shapira, Y; Teichberg, VI				Zlotnik, Alexander; Tsesis, Svetlana; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Gruenbaum, Shaun Evan; Boyko, Matthew; Sheiner, Eyal; Brotfain, Evgeny; Shapira, Yoram; Teichberg, Vivian Itzhak			Relationship between glutamate, GOT and GPT levels in maternal and fetal blood: A potential mechanism for fetal neuroprotection	EARLY HUMAN DEVELOPMENT			English	Article						Fetal and maternal glutamate; Glutamate-pyruvate transaminase (GPT); Glutamate-oxaloacetate transaminase (GOT); Neurotoxicity	AMINO-ACID-CONCENTRATIONS; TRAUMATIC BRAIN-INJURY; CLOSED-HEAD INJURY; OXALOACETATE TRANSAMINASE; SCAVENGING ACTIVITY; ISCHEMIC-STROKE; TRANSPORTERS; PLASMA; DAMAGE	Background: Excess glutamate in the brain is thought to be implicated in the pathophysiology of fetal anoxic brain injury, yet little is known about the mechanisms by which glutamate is regulated in the fetal brain. This study examines whether there are differences between maternal and fetal glutamate concentrations, and whether a correlation between them exists. Methods: 10 ml of venous blood was extracted from 87 full-term (>37 weeks gestation) pregnant women in active labor. Immediately after delivery of the neonate, 10 ml of blood from the umbilical artery and vein was extracted. Samples were analyzed for levels of glutamate, glutamate-oxaloacetate transaminase (GOT), and glutamate pyruvate transaminase (GPT). Results: Fetal blood glutamate concentrations in both the umbilical artery and vein were found to be significantly higher than maternal blood (p<0.001). Similarly, fetal serum GOT levels in the umbilical artery and vein were found to be significantly higher than maternal GOT levels (p<0.001). The difference in GPT levels between maternal and fetal serum was not statistically significant. There was no difference in fetal glutamate, GOT or GPT between the umbilical artery and vein. There was an association observed between glutamate levels in maternal blood and glutamate levels in both venous (R=0.32, p<0.01) and arterial (R=0.33, p<0.05) fetal blood. Conclusions: This study demonstrated that higher baseline concentrations of blood glutamate are present in fetal blood compared with maternal blood, and this was associated with elevated GOT, but not GPT levels. An association was observed between maternal and fetal blood glutamate levels. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Zlotnik, Alexander; Tsesis, Svetlana; Gruenbaum, Benjamin Fredrick; Ohayon, Sharon; Boyko, Matthew; Brotfain, Evgeny; Shapira, Yoram] Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Gruenbaum, Shaun Evan] Yale Univ, Sch Med, Dept Anesthesiol, New Haven, CT 06510 USA; [Sheiner, Eyal] Ben Gurion Univ Negev, Dept Obstet & Gynecol, Soroka Med Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Teichberg, Vivian Itzhak] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel		Zlotnik, A (corresponding author), Ben Gurion Univ Negev, Dept Anesthesiol & Crit Care, Soroka Med Ctr, Fac Hlth Sci, POB 151, IL-84105 Beer Sheva, Israel.	zlotnika@bgu.ac.il	SHEINER, EYAL/F-1488-2012	Boyko, Matthew/0000-0003-3116-1643			Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1387, DOI 10.1038/jcbfm.2011.4; Campos F, 2011, CLIN SCI, V121, P11, DOI 10.1042/CS20100427; Cetin I, 2005, AM J OBSTET GYNECOL, V192, P610, DOI 10.1016/j.ajog.2004.08.011; Chuang CK, 2002, CLIN CHEM LAB MED, V40, P378; FUKUDA K, 1984, J PEDIATR GASTR NUTR, V3, P432, DOI 10.1097/00005176-198406000-00022; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; GRAHAM LT, 1966, ANAL BIOCHEM, V15, P487, DOI 10.1016/0003-2697(66)90110-2; HAGBERG H, 1992, DEV PHARMACOL THERAP, V18, P139, DOI 10.1159/000480613; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hays SP, 2007, PEDIATR RES, V62, P353, DOI 10.1203/PDR.0b013e318123f719; HERRUZO AJ, 1993, INT J GYNECOL OBSTET, V41, P37, DOI 10.1016/0020-7292(93)90152-M; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jensen A, 2003, EUR J OBSTET GYN R B, V110, pS70, DOI 10.1016/S0301-2115(03)00175-1; Khashaba MT, 2006, BRAIN DEV-JPN, V28, P375, DOI 10.1016/j.braindev.2005.11.010; Klin Y, 2010, BIOCHEM BIOPH RES CO, V399, P694, DOI 10.1016/j.bbrc.2010.07.144; Lepage N, 1997, CLIN CHEM, V43, P2397; Murphy KM, 2005, DEV PSYCHOBIOL, V46, P209, DOI 10.1002/dev.20053; Noorlander CW, 2004, PLACENTA, V25, P489, DOI 10.1016/j.placenta.2003.10.018; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Teichberg VI, 2009, NEUROSCIENCE, V158, P301, DOI 10.1016/j.neuroscience.2008.02.075; YOUNG M, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P333, DOI 10.1111/j.1471-0528.1969.tb05842.x; Yurkewicz L, 2005, J NEUROTRAUM, V22, P1428, DOI 10.1089/neu.2005.22.1428; Zlotnik A, 2010, BIOL REPROD; Zlotnik A, 2008, NEUROCHEM RES, V33, P1044, DOI 10.1007/s11064-007-9548-x; Zlotnik A, 2007, EXP NEUROL, V203, P213, DOI 10.1016/j.expneurol.2006.08.021; Zlotnik A, 2011, J NEUROSURG ANESTH, V23, P45, DOI 10.1097/ANA.0b013e3181f82a8f; Zlotnik A, 2009, J NEUROSURG ANESTH, V21, P235, DOI 10.1097/ANA.0b013e3181a2bf0b	28	5	7	2	10	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	SEP	2012	88	9					773	778		10.1016/j.earlhumdev.2012.05.001			6	Obstetrics & Gynecology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Pediatrics	990DI	WOS:000307610800012	22633534				2022-02-06	
J	Eynan, M; Ertracht, O; Gancz, H; Kashi, Y; Arieli, Y				Eynan, Mirit; Ertracht, Offir; Gancz, Hanan; Kashi, Yechezkel; Arieli, Yehuda			Prolonged latency to CNS-O-2 toxicity induced by heat acclimation in rats is associated with increased antioxidative defenses and metabolic energy preservation	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						proteomic; heat shock protein	CENTRAL-NERVOUS-SYSTEM; CNS OXYGEN-TOXICITY; PROTEIN EXPRESSION PROTECTS; CUZN-SUPEROXIDE DISMUTASE; TRAUMATIC BRAIN-INJURY; HSP70 MESSENGER-RNA; ALPHA-SYNUCLEIN; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; CARDIAC MECHANICS	We have previously shown that heat acclimation provides protection against central nervous system oxygen toxicity (CNS-OT). This was well correlated with increased levels of heat shock protein 72 (HSP72). We now examine other antioxidative defenses against CNS-OT that are correlated with heat acclimation. Two groups of male Sprague-Dawley rats were used. The heat-acclimated group (HA) was exposed for 4 wk to 32 degrees C, and the control group (C) was maintained at 24 degrees C. At the end of the acclimation period, rats were exposed to oxygen at 608 kPa. EEG was recorded continuously until appearance of the first electrical discharge. Brain samples were taken from each group after exposure to pressure. Levels of the antioxidant enzymes CuZnSOD, MnSOD, catalase, and glutathione peroxidase, as well as levels of HSP72, were quantified by Western blot. Comparative proteome analysis of the brains of HA and C rats was carried out using two-dimensional electrophoresis and mass spectrometry to define protein spot alterations. Levels of HSP72 and CuZnSOD were higher in HA rats. Levels of the other antioxidant enzymes were not affected significantly by heat acclimation. Differences in the levels of four protein spots identified as alpha-synuclein, valosin-containing protein, adenylate kinase 1 (AK1), and the mitochondrial H+-ATP synthase alpha subunit were found between HA and C rats. We conclude that elevation of HSP72, CuZnSOD, AK1, and the mitochondrial H+-ATP synthase alpha subunit and possible phosphorylation of alpha-synuclein-all proteins involved in oxidative stress or energy conservation-might contribute to the prolongation of latency to CNS-OT induced by heat acclimation.	[Eynan, Mirit; Ertracht, Offir; Arieli, Yehuda] Israel Def Forces Med Corps, Israel Naval Med Inst, IL-31080 Haifa, Israel; [Gancz, Hanan; Kashi, Yechezkel] Technion Israel Inst Technol, Fac Food Engn & Biotechnol, Haifa, Israel		Eynan, M (corresponding author), Israel Def Forces Med Corps, Israel Naval Med Inst, POB 8040, IL-31080 Haifa, Israel.	emirit@netvision.net.il	Kashi, Yechezkel/D-5433-2013; Gancz, Hanan/C-4330-2011	Gancz, Hanan/0000-0003-1107-3718	Dead Sea Research Center	Funding for this study was provided by the Dead Sea Research Center.	Alm P, 2000, AMINO ACIDS, V19, P383, DOI 10.1007/s007260070069; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Arieli R, 1999, EUR J APPL PHYSIOL O, V80, P598, DOI 10.1007/s004210050640; Arieli R, 1998, EUR J APPL PHYSIOL O, V78, P454, DOI 10.1007/s004210050445; Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Beer I, 2004, PROTEOMICS, V4, P950, DOI 10.1002/pmic.200300652; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; BITTERMAN N, 1994, J APPL PHYSIOL, V76, P1073, DOI 10.1152/jappl.1994.76.3.1073; Bitterman N, 1998, J APPL PHYSIOL, V84, P1633, DOI 10.1152/jappl.1998.84.5.1633; Choi S, 2005, J BIOCHEM MOL BIOL, V38, P111; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; Demchenko IT, 2006, UNDERSEA HYPERBAR M, V33, P169; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P14, DOI 10.1016/S0028-3908(03)00140-0; Donald KW, 1945, THESIS U CAMBRIDGE U; Elayan IM, 2000, J NEUROPHYSIOL, V83, P2022, DOI 10.1152/jn.2000.83.4.2022; Eynan M, 2002, J APPL PHYSIOL, V93, P2095, DOI 10.1152/japplphysiol.00304.2002; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Gorbatyuk OS, 2008, P NATL ACAD SCI USA, V105, P763, DOI 10.1073/pnas.0711053105; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Horowitz M, 1997, ANN NY ACAD SCI, V813, P617, DOI 10.1111/j.1749-6632.1997.tb51755.x; Horowitz M, 1996, ENV ERGONOMICS RECEN, P3; KAMII H, 1994, J CEREBR BLOOD F MET, V14, P478, DOI 10.1038/jcbfm.1994.59; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kodesh E, 2010, MED SCI SPORT EXER, V42, P943, DOI 10.1249/MSS.0b013e3181c3ac3f; Kondo T, 1996, BRAIN RES, V737, P321, DOI 10.1016/0006-8993(96)00949-3; LEVI E, 1993, J APPL PHYSIOL, V75, P833, DOI 10.1152/jappl.1993.75.2.833; Levy E, 1997, AM J PHYSIOL-HEART C, V272, pH2085, DOI 10.1152/ajpheart.1997.272.5.H2085; Luk KC, 2008, BIOCHEMISTRY-US, V47, P12614, DOI 10.1021/bi801475r; Maloyan A, 1999, AM J PHYSIOL-REG I, V276, pR1506, DOI 10.1152/ajpregu.1999.276.5.R1506; Malyshev IY, 2000, PHYSIOL RES, V49, P99; Mirit E, 2000, AM J PHYSIOL-REG I, V279, pR77, DOI 10.1152/ajpregu.2000.279.1.R77; OHTSUKI T, 1992, BRAIN RES, V599, P246, DOI 10.1016/0006-8993(92)90398-S; OURY TD, 1992, P NATL ACAD SCI USA, V89, P9715, DOI 10.1073/pnas.89.20.9715; Schwimmer H, 2006, J APPL PHYSIOL, V100, P1992, DOI 10.1152/japplphysiol.00850.2005; Shein NA, 2007, PROG BRAIN RES, V161, P353, DOI 10.1016/S0079-6123(06)61025-X; Shimshek DR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010014; Siesjo BK, 1999, ACTA NEUROCHIR SUPPL, V73, P7; TORBATI D, 1992, FREE RADICAL BIO MED, V13, P101, DOI 10.1016/0891-5849(92)90070-W; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Wang JL, 2005, SHOCK, V23, P161, DOI 10.1097/01.shk.0000150779.47107.d5; Yang YL, 1999, AM J PHYSIOL-HEART C, V276, pH1961, DOI 10.1152/ajpheart.1999.276.6.H1961; Yang YL, 1998, NEUROSCI LETT, V252, P9, DOI 10.1016/S0304-3940(98)00508-4; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3; Yoo HY, 1999, J BIOL CHEM, V274, P23887, DOI 10.1074/jbc.274.34.23887	47	5	6	0	3	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587	1522-1601		J APPL PHYSIOL	J. Appl. Physiol.	AUG	2012	113	4					595	601		10.1152/japplphysiol.00228.2012			7	Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Physiology; Sport Sciences	995IF	WOS:000308000800010	22723627				2022-02-06	
J	Bauer, K				Bauer, Kris			Prehospital Airway Management: High Tech Meets Trauma An Air Medical Perspective	CRITICAL CARE NURSING QUARTERLY			English	Article						direct laryngoscopy; endotracheal intubation; GlideScope Ranger; prehospital; video laryngoscopy		Trauma is the leading cause of death in the United States for those younger than 35 years and injuries sustained from trauma are a significant source of moderate to severe disability. The inability to establish, secure, or maintain a definitive airway is a major cause of preventable death and secondary injury due to inadequate oxygenation and ventilation. Prehospital airway management is an essential skill of any prehospital care provider. A critical component to providing excellent airway management is the ability of the provider to quickly establish endotracheal intubation without complications such as hypoxia, hyper/hypocapnea, or hypotension. These complications have been shown to cause increased morbidity and mortality, especially in patients suffering from traumatic brain injury. This article presents some of the challenges faced by flight nurses in the air medical environment and how Airlift Northwest has developed a structured, standardized approach to airway management both in training and it the prehospital setting. We will discuss the process improvements that lead to the implementation of video laryngoscopy as our first-line intubation tool. The ultimate goal of any air medical or prehospital emergency medical services program is to manage 100% of airways without complications, which will decrease morbidity and mortality, ultimately improving patient outcomes.	[Bauer, Kris] Univ Washington Med, Airlift Northwest, Seattle, WA USA		Bauer, K (corresponding author), Univ Washington Med, Airlift Northwest, Seattle, WA USA.; Bauer, K (corresponding author), Airlift Northwest, 6505 Perimeter Rd S,Ste 200, Seattle, WA 98108 USA.	Kris.bauer@airliftnw.org					*ACCR COUNC GRAD M, EM MED GUID PROC RES; American College of Surgeons Committe on Trauma, 2008, ADV TRAUM LIF SUPP D; Bathory I, 2009, ANAESTHESIA, V64, P1337, DOI 10.1111/j.1365-2044.2009.06075.x; Cooper RM, 2005, CAN J ANAESTH, V52, P191, DOI 10.1007/BF03027728; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Ghabash MB, 1997, ANESTH ANALG, V84, P230, DOI 10.1097/00000539-199701000-00054; Gruen RL, 2006, ANN SURG, V244, P371, DOI 10.1097/01.sla.0000234655.83517.56; Konrad C, 1998, ANESTH ANALG, V86, P635; Mulcaster JT, 2003, ANESTHESIOLOGY, V98, P23, DOI 10.1097/00000542-200301000-00007; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Nouruzi-Sedeh P, 2009, ANESTHESIOLOGY, V110, P32, DOI 10.1097/ALN.0b013e318190b6a7; Pacey JA, 2008, JEMS S, V33, P9; Standards General, 2010, ACCR STAND COMM ACCR, P26; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; Walls RM, 2008, MANUAL EMERGENCY AIR, P8; Wang Henry E, 2005, Prehosp Emerg Care, V9, P156; Warner KJ, 2010, PREHOSP EMERG CARE, V14, P103, DOI 10.3109/10903120903144858; Wayne MA, 2008, JEMS S, V33, P11; Wayne MA, 2010, PREHOSP EMERG CARE, V14, P278, DOI 10.3109/10903120903537189; World Health Organization, **NON-TRADITIONAL**	20	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0887-9303	1550-5111		CRIT CARE NURS Q	Crit. Care Nurs. Q.	JUL-SEP	2012	35	3					281	291		10.1097/CNQ.0b013e3182542eb5			11	Critical Care Medicine	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V2A3S	WOS:000217399100014	22669002				2022-02-06	
J	Williams, JL; McDevitt-Murphy, ME; Murphy, JG; Crouse, EM				Williams, Joah L.; McDevitt-Murphy, Meghan E.; Murphy, James G.; Crouse, Ellen M.			Deployment Risk Factors and Postdeployment Health Profiles Associated With Traumatic Brain Injury in Heavy Drinking Veterans	MILITARY MEDICINE			English	Article								Along with post-traumatic stress disorder (PTSD), mild traumatic brain injury (mTBI) is considered one of the "signature wounds" of combat operations in Iraq (Operation Iraqi Freedom [OM) and Afghanistan (Operation Enduring Freedom [OEF]), but the role of mTBI in the clinical profiles of Veterans with other comorbid forms of postdeployment psychopathology is poorly understood. The current study explored the deployment risk and postdeployment health profiles of heavy drinking OIF and OEF Veterans as a function of mTBI. Sixty-nine heavy-drinking OIF/OEF Veterans were recruited through a Veterans' Affairs Medical Center and completed questionnaires and structured interviews assessing war-zone experiences, postdeployment drinking patterns, and PTSD symptoms. Veterans with positive mTBI screens and confirmed mTBI diagnoses endorsed higher rates of combat experiences, including direct and indirect killing, and met criteria for PTSD at a higher rate than Veterans without a history of mTBI. Both PTSD and combat experiences independently predicted screening positive for mTBI, whereas only combat experiences predicted receiving a confirmed mTBI diagnosis. mTBI was not associated with any dimension of alcohol use. These results support a growing body of literature linking mTBI with PTSD.	[Williams, Joah L.; McDevitt-Murphy, Meghan E.; Murphy, James G.] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Williams, Joah L.; McDevitt-Murphy, Meghan E.; Murphy, James G.; Crouse, Ellen M.] Memphis Vet Affairs Med Ctr, Memphis, TN 38104 USA		Williams, JL (corresponding author), Univ Memphis, Dept Psychol, 202 Psychol Bldg, Memphis, TN 38152 USA.				National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23AA016120]; Memphis VAMC Office of Research and Development; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K23AA016120] Funding Source: NIH RePORTER	This research was supported by the National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIAAA), grant number K23AA016120 (to Meghan McDevitt-Murphy, PhD) and by the Memphis VAMC Office of Research and Development.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bigler E. D., 2012, PTSD MILD TRAUMATIC, P15; Blake D.D., 1990, CLIN ADM PTSD SCALE; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Defense and Veterans Brain Injury Center, DEF VET BRAIN INJ CT; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; McHugh L, 2008, BRAIN INJURY, V22, P715, DOI 10.1080/02699050802263027; Miller WR, 1995, DRINKER INVENTORY CO; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	31	5	5	0	1	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	JUL	2012	177	7					789	796		10.7205/MILMED-D-12-00019			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V33NZ	WOS:000209026800006	22808885	Bronze, Green Accepted			2022-02-06	
J	Wilson, MJ; Harkrider, AW; King, KA				Wilson, Matthew J.; Harkrider, Ashley W.; King, Kristin A.			Effects of Complexity of Visual Distracters on Attention and Information Processing Speed Reflected in Auditory P300	EAR AND HEARING			English	Article							EVENT-RELATED POTENTIALS; MILD HEAD-INJURY; TASK-DIFFICULTY; SELECTIVE-ATTENTION; BRAIN; STIMULI; PERFORMANCE; COMPONENT; ODDBALL; CONCUSSION	Objectives: The primary aim of this study was to assess the effects of continuous, visual distracters that change systematically in complexity on P300 responses generated by an auditory oddball paradigm. In addition, the type of attention given to the visual distracter was explored. It was hypothesized that P300 amplitudes would be smallest, latencies longest, and changes in scalp distribution greatest when the most complex visual distracter requiring active attention was used versus the simple visual distracter requiring passive attention. Design: Auditory-evoked P300s were collected in a sample of 10 healthy adults (mean age = 19.90 years) using a two-toned oddball paradigm (1500 Hz "frequent" tone, probability of occurrence: 0.88, and 2000 Hz "rare" target tone, probability of occurrence: 0.12). The oddball paradigm was paired with three different visual distracters, increasing in complexity. The simplest was a black fixation cross on a white background that participants were asked to view passively as they performed the auditory task of counting the target stimulus. The second visual distracter increased in complexity by introducing color and motion, as tan and medium pink squares were alternated on the screen. Participants had to actively attend to the alternating squares by looking for a hidden text message while simultaneously counting the target auditory stimulus. The third visual distracter condition increased complexity again by introducing not only color and motion, but also biological relevance as participants viewed a mouth producing nonsense syllables. Participants had to actively attend to the moving mouth to determine what it was producing while simultaneously counting the rare auditory stimulus. Results: The two more complex visual distracters that required active attention caused reductions in auditory-evoked P300 amplitudes relative to those recorded while the participants passively viewed a fixation cross. P300 amplitudes were similar whether the two more complex visual distracters (squares versus mouth) were used. P300 latencies and scalp distribution were not influenced by complexity of, or type of attention to, the visual distracter. Regardless of distracter condition, P300 amplitude was significantly smaller and P300 latency was significantly shorter at frontal sites when compared with central and parietal sites. Conclusions: Findings indicate that endogenous attentional resource allocation abilities can be effectively monitored through the addition of a complex, visually distracting task to a "classic" auditory P300 paradigm. Biological relevance of the distracting task does not seem to have an effect on the event-related potentials measured in this study, suggesting other aspects, such as whether or not a stimulus contains color or motion, may determine the efficiency of the distracter. Last, by increasing the complexity of, and amount of attention to, a visual distracter while evoking P300s using auditory stimuli, the cognitive load for the normal, healthy listener seems to be increased and the response amplitude subsequently reduced. Evoking P300s under similar conditions from disordered populations with subtle cognitive deficits (e. g., mild traumatic brain injury) may allow for increased diagnostic specificity and sensitivity over that found for P300s to classic, auditory oddball paradigms alone.	[Wilson, Matthew J.; Harkrider, Ashley W.; King, Kristin A.] Univ Tennessee, Hlth Sci Ctr, Dept Audiol & Speech Pathol, Knoxville, TN 37996 USA		Wilson, MJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Audiol & Speech Pathol, 578 S Stadium Hall, Knoxville, TN 37996 USA.	mwilso56@utk.edu			American Auditory Society; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	The authors thank A. Bowers for his assistance with data collection. The authors also thank S. Niemann, B. Wilson, and Dr. Mark Hedrick for their valuable input on previous versions of this article. The authors thank the American Auditory Society and the National Institutes of Health for their support.	American National Standards Institute (ANSI), 1996, AM NAT STAND SPEC HE; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Crawcour S, 2009, NEUROPSYCHOLOGIA, V47, P2558, DOI 10.1016/j.neuropsychologia.2009.05.001; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Davis H, 1939, J NEUROPHYSIOL, V2, P500, DOI 10.1152/jn.1939.2.6.500; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Deslandes AC, 2005, BRAZ J MED BIOL RES, V38, P1077, DOI 10.1590/S0100-879X2005000700011; Deslandes AC, 2004, ARQ NEURO-PSIQUIAT, V62, P385, DOI 10.1590/S0004-282X2004000300002; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; DUNCANJOHNSON CC, 1981, PSYCHOPHYSIOLOGY, V18, P207; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Houlihan M, 1998, INTELLIGENCE, V26, P9, DOI 10.1016/S0160-2896(99)80049-X; Isoglu-Alkac U, 2007, INT J NEUROSCI, V117, P487, DOI 10.1080/00207450600773509; Jasper HH, 1958, CLIN NEUROPHYSIOL, V10, p371 ; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; Jocoy EL, 1998, INT J PSYCHOPHYSIOL, V30, P319, DOI 10.1016/S0167-8760(98)00029-4; Just MA, 2008, BRAIN RES, V1205, P70, DOI 10.1016/j.brainres.2007.12.075; Keil A, 2007, COGN AFFECT BEHAV NE, V7, P18, DOI 10.3758/CABN.7.1.18; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; MCDOWD JM, 1988, J EXP PSYCHOL HUMAN, V14, P267, DOI 10.1037/0096-1523.14.2.267; MCDOWD JM, 1986, J GERONTOL, V41, P764, DOI 10.1093/geronj/41.6.764; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Muller-Gass A, 2007, BRAIN RES, V1136, P169, DOI 10.1016/j.brainres.2006.12.020; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NAYLOR H, 1985, PSYCHOPHARMACOLOGY, V86, P90, DOI 10.1007/BF00431690; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oray S, 2002, INT J PSYCHOPHYSIOL, V43, P213, DOI 10.1016/S0167-8760(01)00174-X; Patten CJD, 2004, ACCIDENT ANAL PREV, V36, P341, DOI 10.1016/S0001-4575(03)00014-9; POLICH J, 1986, ELECTROEN CLIN NEURO, V65, P236, DOI 10.1016/0168-5597(86)90059-6; Polich J, 1997, BRAIN TOPOGR, V9, P275, DOI 10.1007/BF01464482; Polich J, 1996, INT J PSYCHOPHYSIOL, V23, P55, DOI 10.1016/0167-8760(96)00028-1; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SCHUCKIT MA, 1988, BIOL PSYCHIAT, V24, P310, DOI 10.1016/0006-3223(88)90199-0; Schupp HT, 1997, PSYCHOPHYSIOLOGY, V34, P1, DOI 10.1111/j.1469-8986.1997.tb02409.x; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Sivak S, 2008, BRAIN INJURY, V22, P193, DOI 10.1080/02699050801895431; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; TEDER W, 1993, PSYCHOPHYSIOLOGY, V30, P71; Wronka E, 2007, ACTA NEUROBIOL EXP, V67, P155; Wunderlich JL, 2006, HEARING RES, V212, P212, DOI 10.1016/j.heares.2005.11.008	50	5	6	0	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0196-0202			EAR HEARING	Ear Hear.	JUL-AUG	2012	33	4					480	488		10.1097/AUD.0b013e3182446a42			9	Audiology & Speech-Language Pathology; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Audiology & Speech-Language Pathology; Otorhinolaryngology	967LZ	WOS:000305910700006	22343547				2022-02-06	
J	Brown, JM; Deriso, DM; Tansey, KE				Brown, Justin M.; Deriso, David M.; Tansey, Keith E.			From contemporary rehabilitation to restorative neurology	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Stroke; Spinal cord injury; Traumatic brain injury; Restorative neurology; Neurorehabilitation; Functional electrical stimulation	STIMULATION; STROKE	Recent years have witnessed significant advances in the treatment of neurological injuries such as stroke, traumatic brain injuries (TBI), and spinal cord injuries (SCI). The current approach includes acute intervention to curb the primary insult, prevention of secondary complications and early rehabilitation to optimize residual function to ultimately enhance quality of life and independence. While this is effective in providing a degree of independence to many patients, we believe that further functional gains are possible for many patients who have plateaued followed a contemporary rehabilitation program. Complementary methods are available today that are not widely used, but have demonstrated great promise in augmenting function and quality of life in patients who cannot benefit further from currently available treatment options. (C) 2012 Published by Elsevier B.V.	[Brown, Justin M.] Univ Calif San Diego, Ctr Neurophysiol & Restorat Neurol, Div Neurosurg, San Diego, CA 92103 USA; [Deriso, David M.] Univ Calif San Diego, Inst Neural Computat, San Diego, CA 92103 USA; [Tansey, Keith E.] Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Neurol, Atlanta, GA 30309 USA; [Tansey, Keith E.] Emory Univ, Sch Med, Atlanta Vet Adm Med Ctr, Crawford Res Inst,Shepherd Ctr,Dept Physiol, Atlanta, GA 30309 USA		Brown, JM (corresponding author), Univ Calif San Diego, Ctr Neurophysiol & Restorat Neurol, Div Neurosurg, San Diego, CA 92103 USA.	jmbrown@ucsd.edu					Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Barbeau H, 2003, SPINAL CORD, V41, P137, DOI 10.1038/sj.sc.3101374; Bell MDD, 2010, COMPET-BASE CRIT CAR, P1, DOI 10.1007/978-1-84882-070-8_1; Bodine C, 2005, PHYS MED REHABILITAT, P1306; Brown J.M., 2012, RESTORATIVE NEUROLOG, P134; Christiansen C. H, 2005, PHYS MED REHABILITA, P975; Collin C, 1988, Int Disabil Stud, V10, P61; Dillingham Timothy R, 2002, Phys Med Rehabil Clin N Am, V13, P1, DOI 10.1016/S1047-9651(03)00069-X; Dimitrijevic MM, 1996, ARCH PHYS MED REHAB, V77, P252; DIMITRIJEVIC MR, 1995, J NEUROL REHABIL, V9, P97; Esquenazi A, 2004, Eura Medicophys, V40, P111; Francisco GE, 2005, PHYS MED REHABILITAT, P809; Frid?n J, 2005, TENDON TRANSFERS REC; Gunasekera WL, 2011, NEUROSURGERY PRINCIP, P407; Huang H, 2006, IEEE T NEUR SYS REH, V14, P14, DOI 10.1109/TNSRE.2005.862694; Jilge B, 2004, BIOL CYBERN, V91, P359, DOI 10.1007/s00422-004-0511-5; Maarrawi J, 2006, J NEUROSURG, V104, P215, DOI 10.3171/jns.2006.104.2.215; Middleton JW, 2004, SPINAL CORD, V42, P359, DOI 10.1038/sj.sc.3101601; Pape KE, 2012, CLIN NEUROLOGY NEURO; SHERWOOD AM, 1992, J NEUROL SCI, V110, P90, DOI 10.1016/0022-510X(92)90014-C; Songcharoen P, 2008, SCAND J SURG, V97, P317, DOI 10.1177/145749690809700408; Umphred D, 2006, NEUROLOGICAL REHABIL, P187	22	5	5	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	JUN	2012	114	5			SI		471	474		10.1016/j.clineuro.2012.04.009			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	941EN	WOS:000303946600009	22538268				2022-02-06	
J	Jamison, L; Kolakowsky-Hayner, SA; Wright, J				Jamison, Laura; Kolakowsky-Hayner, Stephanie A.; Wright, Jerry			Preliminary investigation of longitudinal sociodemographic, injury and psychosocial characteristics in a group of non-English speaking Latinos with brain injury	BRAIN INJURY			English	Article						Outcome; minority; language; Latino; Spanish-speaking	DISABILITY RATING-SCALE; FUNCTIONAL OUTCOMES; MINORITY STATUS; REHABILITATION; RECOVERY; COMA	Primary objective: To describe the sociodemographic and injury characteristics and psychosocial outcomes at 1 and 10 years post-injury in a group of Spanish-speaking individuals with traumatic brain injury. Research design: Descriptive cross-sectional and longitudinal analyses of prospectively collected data. Methods and procedures: Assessments were completed on 57 non-English speaking Latinos with TBI, injured between March 1991 and January 2008, who were treated at a Traumatic Brain Injury Model System of Care acute rehabilitation facility. Follow-up data was collected cross-sectionally at 1 year (n = 41) and 10 years (n = 23) post-injury. Longitudinal data (both Y1 and Y10) were available for 17 of those individuals. Main outcomes: Post injury employment and residence, Disability Rating Scale, Functional Independence Measure. Results: At 1 year, the majority of participants were unemployed (63.4%) and did not require assistance of another individual (58.5%) as measured by the DRS Level of Functioning. FIM scores showed that the greatest difficulty was in the area of problem-solving and memory with over half the sample needing assistance in these areas. At 10 years post-injury, 47.8% were unemployed and remained independent of assistance from a caretaker (56.5%) as measured by the DRS. FIM results revealed that slightly less than half continued to need assistance in areas of problem-solving and memory. Longitudinal changes were seen in that, over time, individuals reported more difficulties in areas of bathing and dressing, but fewer difficulties in areas including social interaction, comprehension and memory. Conclusions: Non-English-speaking Latinos with brain injury are at a double disadvantage with regard to obtaining much-needed ongoing services, ultimately impacting long-term outcomes post-injury. If such issues are not adequately addressed, as the Latino population continues to grow, disparities in service delivery and unsuccessful outcomes will continue to grow.	[Jamison, Laura; Kolakowsky-Hayner, Stephanie A.; Wright, Jerry] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA		Kolakowsky-Hayner, SA (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	stephanie.hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909	National Institute on Disability and Rehabilitation Research (NIDRR), Northern California Traumatic Brain Injury Model System of Care [H133A070038]	This study was partially supported through funding by the National Institute on Disability and Rehabilitation Research (NIDRR), Northern California Traumatic Brain Injury Model System of Care Grant #H133A070038. The authors report no conflicts of interest.	Agency for Healthcare Research and Quality, NAT HEALTHC DISP REP; Arango-Lasprilla JC, 2008, ARCH PHYS MED REHAB, V89, P988, DOI 10.1016/j.apmr.2008.02.012; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Burnett DM, 2000, BRAIN INJURY, V14, P713; Case L, 2000, J CONSULT CLIN PSYCH, V68, P1107, DOI 10.1037/0022-006X.68.6.1107; *CDCP, 2004, MMWR-MORBID MORTAL W, V53, P755; Englander J, 2003, ARCH PHYS MED REHAB, V84, P214, DOI 10.1053/apmr.2003.50094; Gary KW, 2009, ARCH PHYS MED REHAB, V90, P1699, DOI 10.1016/j.apmr.2009.04.014; Granger CV, 1986, TOPICS GERIATRIC REH; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Ho CJ, 2000, J GERONTOL SOC WORK, V33, P67, DOI 10.1300/J083v33n01_06; Jordan M., 2007, WALL STREET J B 1218, P1; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; TEASDALE G, 1974, LANCET, V2, P81; The Traumatic Brain Injury Model Systems National Data and Statistical Center (TBINDSC), 2010, 2010 TBI MOD SYST PR; U. S. Census Bureau, 1990 CENS POP GEN PO; U.S. Census Bureau, 2005 2009 AM COMM SU; US Census Bureau, US SUMM 2000 CENS 20; Yancey AK, 2006, ANNU REV PUBL HEALTH, V27, P1, DOI 10.1146/annurev.publhealth.27.021405.102113	24	5	5	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2012	26	6					805	813		10.3109/02699052.2012.655367			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	943EO	WOS:000304103500002	22583171				2022-02-06	
J	MacInnis, MJ; Rupert, JL; Koehle, MS				MacInnis, Martin J.; Rupert, Jim L.; Koehle, Michael S.			Evaluation of the Balance Error Scoring System (BESS) in the Diagnosis of Acute Mountain Sickness at 4380 m	HIGH ALTITUDE MEDICINE & BIOLOGY			English	Article						acute mountain sickness; balance error scoring system; hypoxia; hypobaria; balance; ataxia; altitude illness	HIGH-ALTITUDE ILLNESS; POSTURAL STABILITY; EPISODIC ATAXIA; CONCUSSION; INJURY	MacInnis, Martin J., Jim L. Rupert, Michael S. Koehle. Evaluation of the Balance Error Scoring System (BESS) in the diagnosis of acute mountain sickness at 4380 m. High Alt. Med. Biol. 13: 93-97.-Ascent to altitude is associated with a decrease in balance; however, the effect of acute mountain sickness (AMS) status on balance is variable depending on the test used and the altitude at which the test is performed. Here, we report preliminary findings on the relationship between the balance error scoring system (BESS) and AMS at the 2010 Janai Purnima festival at Gosainkunda, Nepal (4380 m). All subjects (n = 37) completed a shortened BESS test (mBESS) while a subset completed the full BESS test (n = 27). Pulse oximetry was used to measure heart rate and oxygen saturation, and blood pressure was measured by sphygmomanometer. Balance test scores (BESS and mBESS) and physiological measurements were compared between groups with AMS (AMS(+)) and without AMS (AMS(-)). Receiver-operator characteristic (ROC) curves were used to compare the abilities of the BESS and mBESS tests to correctly identify the AMS status of subjects. The AMS(+) group had significantly higher Lake Louise scores than the AMS(-) group (mean = 4.0 (standard deviation = 1.3) vs. 0.3 (0.6), p < 0.001). The AMS(+) group also scored significantly higher on both the mBESS (6.6 (3.5) vs. 2.7 (1.7) errors, p = 0.018) and the BESS tests (19.2 (8.8) vs. 10.4 (6.0) errors, p = 0.001) compared to the AMS(-) group, indicating inferior balance in the AMS(+) group. The area under the ROC curve was significantly greater for the BESS test (0.895) compared to the mBESS test (0.690, p = 0.02), implying that the full BESS test more accurately identified a subject's AMS status. Additional studies are needed to determine if BESS could be a useful adjunct to the clinical diagnosis of AMS.	[MacInnis, Martin J.; Rupert, Jim L.; Koehle, Michael S.] Univ British Columbia, Sch Kinesiol, Vancouver, BC V6T 1Z1, Canada; [Koehle, Michael S.] Univ British Columbia, Fac Med, Div Sport Med, Vancouver, BC V6T 1Z1, Canada		Koehle, MS (corresponding author), Univ British Columbia, Sch Kinesiol, 6081 Univ Blvd, Vancouver, BC V6T 1Z1, Canada.	michael.koehle@ubc.ca	Koehle, Michael S/C-7850-2013; MacInnis, Martin/J-5080-2012	Koehle, Michael S/0000-0001-7026-8422; MacInnis, Martin/0000-0002-0377-5800	Natural Science and Engineering Research Council of Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); NSERCNatural Sciences and Engineering Research Council of Canada (NSERC)	MK and JR are Natural Science and Engineering Research Council of Canada (NSERC) funded researchers. MM is a recipient of a NSERC Graduate Scholarship. MM, JR, and MK have no conflicts of interest or financial ties to disclose.	Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Basnyat B, 2000, WILD ENVIRON MED, V11, P89, DOI 10.1580/1080-6032(2000)011[0089:DAAPAE]2.3.CO;2; Baumgartner RW, 2002, HIGH ALT MED BIOL, V3, P283, DOI 10.1089/152702902320604269; Baumgartner RW, 2002, EUR J APPL PHYSIOL, V86, P322, DOI 10.1007/s00421-001-0534-8; Calandriello L, 1997, BRAIN, V120, P805, DOI 10.1093/brain/120.5.805; Conkin J, 2008, AVIAT SPACE ENVIR MD, V79, P975, DOI 10.3357/ASEM.2331.2008; Cymerman A, 2001, HIGH ALT MED BIOL, V2, P509, DOI 10.1089/152702901753397072; Dellasanta P, 2007, HIGH ALT MED BIOL, V8, P184, DOI 10.1089/ham.2007.8305; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Denier C, 1999, NEUROLOGY, V52, P1816, DOI 10.1212/WNL.52.9.1816; Eng J., 2007, ROC ANAL WEB BASED C; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hoshikawa M, 2010, EUR J APPL PHYSIOL, V110, P539, DOI 10.1007/s00421-010-1530-7; Iverson GL, 2008, BRAIN INJURY, V22, P147, DOI 10.1080/02699050701867407; Johnson BG, 2005, WILD ENVIRON MED, V16, P62, DOI 10.1580/PR02-04.1; Johnson BG, 2005, WILD ENVIRON MED, V16, P42, DOI 10.1580/1080-6032(2005)16[42:AAAMOA]2.0.CO;2; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Riemann BL, 2000, J ATHL TRAINING, V35, P19; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SAMPSON JB, 1983, AVIAT SPACE ENVIR MD, V54, P1063; Valovich TC, 2003, J ATHL TRAINING, V38, P51; Wang SH, 2010, HIGH ALT MED BIOL, V11, P43, DOI 10.1089/ham.2009.1063	23	5	5	0	4	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1527-0297			HIGH ALT MED BIOL	High Alt. Med. Biol.	JUN	2012	13	2					93	97		10.1089/ham.2011.1085			5	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Public, Environmental & Occupational Health; Sport Sciences	965JR	WOS:000305764400004	22724611				2022-02-06	
J	Thaler, NS; Allen, DN; Hart, JS; Boucher, JR; McMurray, JC; Mayfield, J				Thaler, Nicholas S.; Allen, Daniel N.; Hart, Jacqueline S.; Boucher, James R.; McMurray, Janice C.; Mayfield, Joan			Neurocognitive Correlates of the Trail Making Test for Older Children in Patients with Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Assessment; Childhood brain insult; Childhood neurologic disorders; Intelligence; Statistical methods; Learning and Memory	WORKING-MEMORY; COMPREHENSIVE TRAIL; CRITERION VALIDITY; FRONTAL-LOBE; PERFORMANCE; SPEED; SCHIZOPHRENIA; ADOLESCENTS; SENSITIVITY; IMPAIRMENT	Studies have found that processing speed and working memory influence performance on the Trail Making Test (TMT), though little research is available in this regard for the TMT for Children (TMT-C), particularly in clinical populations. The purpose of the present study was to examine cognitive mechanisms that are thought to underline performance on the TMT-C in a sample of children who sustained traumatic brain injury. Sixty-one children and adolescents with moderate to severe brain injuries completed the TMT-C and performed a battery of neuropsychological tests. Regression analysis was used to analyze the relationship between cognitive constructs and TMT-C performance. Results indicated that processing speed predicted Trails A performance while backwards span tasks predicted Trails B performance. These findings corroborate with previous studies and provide evidence of the mechanisms that underlie TMT-C performance in brain injured children.	[Thaler, Nicholas S.; Allen, Daniel N.; Hart, Jacqueline S.; Boucher, James R.; McMurray, Janice C.] Univ Nevada, Dept Psychol, Las Vegas, NV 89073 USA; [Mayfield, Joan] Our Childrens House Baylor, Dallas, TX USA		Allen, DN (corresponding author), Univ Nevada, Dept Psychol, 4505 S Maryland Pkwy MS 5030, Las Vegas, NV 89073 USA.	daniel.allen@unlv.edu		Allen, Daniel/0000-0003-4868-2242			Allen DN, 2010, ARCH CLIN NEUROPSYCH, V25, P618, DOI 10.1093/arclin/acq051; Allen DN, 2009, CHILD NEUROPSYCHOL, V15, P543, DOI 10.1080/09297040902748234; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Armstrong CM, 2008, ARCH CLIN NEUROPSYCH, V23, P351, DOI 10.1016/j.acn.2007.11.004; Army Individual Test Battery, 1944, MAN DIR SCOR; Atchison TB, 2004, CLIN NEUROPSYCHOL, V18, P249, DOI 10.1080/13854040490501475; Bello DT, 2008, ARCH CLIN NEUROPSYCH, V23, P329, DOI 10.1016/j.acn.2007.12.002; Brandling-Bennett EM, 2003, DEV NEUROPSYCHOL, V24, P423, DOI 10.1207/S15326942DN2401_01; Catroppa C, 2003, NEUROPSYCHOL REHABIL, V13, P517, DOI 10.1080/09602010343000084; Conners C. K., 2000, CONTINUOUS PERFORMAN; Crowe SF, 1998, J CLIN PSYCHOL, V54, P585, DOI 10.1002/(SICI)1097-4679(199808)54:5<585::AID-JCLP4>3.3.CO;2-M; DAVIDS A, 1957, J CONSULT PSYCHOL, V21, P429, DOI 10.1037/h0039926; Demakis GJ, 2004, J CLIN EXP NEUROPSYC, V26, P441, DOI 10.1080/13803390490510149; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Donders J, 2004, J INT NEUROPSYCH SOC, V10, P482, DOI 10.1017/S1355617704104025; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Egeland J, 2010, J ATTEN DISORD, V13, P347, DOI 10.1177/1087054709332477; Egeland J, 2010, J ATTEN DISORD, V13, P339, DOI 10.1177/1087054708323019; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Jacobs R, 2011, CORTEX, V47, P808, DOI 10.1016/j.cortex.2010.06.002; Johnstone B, 1995, Appl Neuropsychol, V2, P24, DOI 10.1207/s15324826an0201_4; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Langenecker SA, 2007, J CLIN EXP NEUROPSYC, V29, P842, DOI 10.1080/13803390601147611; Llorente AM., 2003, CHILDRENS COLOR TRAI; Mahurin RK, 2006, CLIN NEUROPSYCHOL, V20, P271, DOI 10.1080/13854040590947498; MITTELMEIER C, 1989, INT J CLIN NEUROPSYC, V11, P163; Moll J, 2002, ARQ NEURO-PSIQUIAT, V60, P900, DOI 10.1590/S0004-282X2002000600002; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; OLEARY DS, 1983, J NERV MENT DIS, V171, P624, DOI 10.1097/00005053-198310000-00006; Owen AM, 2000, PSYCHOBIOLOGY, V28, P146; Pa J, 2010, J INT NEUROPSYCH SOC, V16, P640, DOI 10.1017/S1355617710000408; Pennington B. F., 1997, DEV PREFRONTAL CORTE, P265; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Ramsay MC, 1995, NEUROPSYCHOL REV, V5, P151, DOI 10.1007/BF02214760; Reitan R. M., 1992, NEUROPSYCHOLOGICAL E; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Reitan RM, 2004, ARCH CLIN NEUROPSYCH, V19, P281, DOI 10.1016/S0887-6177(03)00042-8; Reitan RM, 1992, TRAIL MAKING TEST MA; Reynolds C.R., 1994, TEST MEMORY LEARNING; Reynolds C.R., 2002, COMPREHENSIVE TRAIL; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P29, DOI 10.1016/S0887-6177(96)00015-7; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; ROURKE BP, 1975, J ABNORM PSYCHOL, V84, P412; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Sroufe NS, 2010, PEDIATRICS, V125, pE1331, DOI 10.1542/peds.2008-2364; Stuss DT, 2001, PSYCHOL ASSESSMENT, V13, P230, DOI 10.1037//1040-3590.13.2.230; TEASDALE G, 1974, LANCET, V2, P81; WILLIAMS J, 1995, ARCH CLIN NEUROPSYCH, V10, P211, DOI 10.1016/0887-6177(94)00041-N; Wolfson, 1993, HALSTEAD REITAN NEUR	52	5	5	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	JUN	2012	27	4					446	452		10.1093/arclin/acs042			7	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	944JX	WOS:000304198300008	22512933	Bronze			2022-02-06	
J	Wiebe, DJ; Collins, MW; Nance, ML				Wiebe, Douglas J.; Collins, Michael W.; Nance, Michael L.			Identification and Validation of Prognostic Criteria for Persistence of Mild Traumatic Brain Injury-Related Impairment in the Pediatric Patient	PEDIATRIC EMERGENCY CARE			English	Article						concussion; mild traumatic brain injury; prognostic; cohort study	EPIDEMIOLOGY; CONCUSSION; IMPACT	Objectives: This study aimed to develop and validate prognostic criteria to identify children at risk for persistence of mild traumatic brain injury (MTBI) impairment. Methods: A prospective cohort study was conducted among 11- to 17-year-old emergency department (ED) patients admitted for MTBI. The Immediate Postconcussion Assessment and Cognitive Testing neurocognitive test was administered during hospitalization and at routine clinic follow-up (ImPACT(C)). Logistic regression and receiver operating characteristic (ROC) analyses were used to develop prognostic criteria for MTBI-related impairment in 1 group and validate the criteria in a second group. Mild traumatic brain injury-related impairment was defined as any impairment (symptom score >8 or <25th percentile on at least 1 of 4 neurocognitive composite domains) or severe impairment (symptom score >12 or <25th percentile on at least 2 of 4 neurocognitive composite domains) present on follow-up. Results: The derivation and validation cohorts were 42 and 21 patients (median age, 14 years; 71.4% male). Using the mean of the validation cohort patients' 4 neurocognitive deficit composite percentiles at baseline, a cut point of less than 39 percentile had high sensitivity (0.89) and specificity (0.80) and an area under the ROC curve of 0.85 in predicting the presence of any impairment at follow-up; it discriminated equally well in the validation cohort. A cut point of less than 27 percentile had good sensitivity (0.67) and specificity (0.67) and area under the ROC curve of 0.67 in predicting the presence of severe impairment in the derivation cohort at follow-up; it discriminated equally well in the validation cohort. Conclusions: This is the first study demonstrating prognostic criteria that may greatly help physicians identify patients who would benefit from structured follow-up care after MTBI.	[Wiebe, Douglas J.] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Collins, Michael W.] Univ Pittsburgh, Med Ctr, Sports Concuss Program, Pittsburgh, PA USA; [Nance, Michael L.] Childrens Hosp Philadelphia, Dept Surg, Philadelphia, PA 19104 USA		Wiebe, DJ (corresponding author), Univ Penn, Sch Med, Dept Biostat & Epidemiol, Blockley Hall Room 902,423 Guardian Dr, Philadelphia, PA 19104 USA.	dwiebe@mail.med.upenn.edu	Wiebe, Douglas J/Q-1168-2017		Josephine J. and John M. Templeton Jr. Endowed Chair in Pediatric Trauma	This research was supported in part with funds from the Josephine J. and John M. Templeton Jr. Endowed Chair in Pediatric Trauma.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Field M, 2003, J PEDIAT, V13, P222; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson G, 2002, ARCH CLIN NEUROPSYCH, V17, P769; Iverson GL, 2008, 3 INT C CONC SPORT O; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrory PR, 1998, NEUROLOGY, V50, P677, DOI 10.1212/WNL.50.3.677; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Sosin DM, 1996, BRAIN INJURY, V10, P47; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	14	5	6	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0749-5161	1535-1815		PEDIATR EMERG CARE	Pediatr. Emerg. Care	JUN	2012	28	6					498	502		10.1097/PEC.0b013e3182586f76			5	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	955JP	WOS:000305014700003	22653462				2022-02-06	
J	Al-Habib, A; Attabib, N; Hurlbert, RJ				Al-Habib, Amro; Attabib, Najmedden; Hurlbert, R. John			Recreational helmet use as a predictor of noncranial injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Head protection; helmet; traumatic brain injury; trauma; prevention	SEVERITY SCORE; HEAD-INJURIES; SAFETY GEAR; RISK; TRAUMA; BEHAVIORS; PATHOPHYSIOLOGY	BACKGROUND: The effect of helmet use in the prevention of head injury has been clearly shown. However, the relationship between helmet compliance and other bodily (noncranial) injury has not been explored, yet may have important impact on strategies for injury prevention. The purpose of this study was to examine helmet use in an injured population to evaluate its association with noncranial trauma. METHODS: All entries in the Canadian National Trauma Registry were surveyed from 2000 to 2004 and limited to injuries sustained in recreational sports associated with helmet use. RESULTS: Over the 5-year period, 2,205 injuries met inclusion criteria. Cycling-related injuries were most frequent (43.5%). Alcohol consumption correlated significantly with lack of helmet use. Nonhelmeted individuals suffered significantly more noncranial injuries (85% vs. 68%, p < 0.0001) and had twice as many severe head injuries (Glasgow Coma Scale score <= 8) (odds ratio [OR]: 2.13, 95% confidence interval [CI]: 1.35-3.37) or any abnormal Glasgow Coma Scale score (OR: 1.96, 95% CI: 1.55-2.47). While controlling for age, sex, or type of sport activity performed, multivariate regression confirmed a reduction in associated noncranial injuries when helmets were used (OR: 0.86, 95% CI: 0.83-0.89). CONCLUSIONS: Within an injured population from sports-related activities, helmet use is associated with fewer noncranial injuries of all types suggesting reduced overall risk of injury in this group. In addition, use of helmets is associated with less frequent and less severe head injury. Alcohol consumption is related to increased risk of injury and is more prevalent in injured individuals who abstain from helmet use. (J Trauma. 2012;72: 1356-1362. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Al-Habib, Amro; Attabib, Najmedden; Hurlbert, R. John] Univ Calgary, Dept Clin Neurosci, Div Neurosurg, Calgary, AB T2N 2T9, Canada; [Al-Habib, Amro] King Saud Univ, Div Neurosurg, Riyadh, Saudi Arabia; [Al-Habib, Amro] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Attabib, Najmedden] Dalhousie Univ, St John Reg Hosp, Div Neurosurg, St John, NB, Canada		Hurlbert, RJ (corresponding author), Univ Calgary, Dept Clin Neurosci, Div Neurosurg, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	jhurlber@ucalgary.ca	Alhabib, Amro F/F-1778-2018				Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balthrop PM, 2009, J EMERG MED, V36, P121, DOI 10.1016/j.jemermed.2007.05.013; Barnes J. E., 2001, NY TIMES; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Dresing K., 2001, EUR J TRAUMA, V27, P137; Finch C F, 1996, Inj Prev, V2, P126, DOI 10.1136/ip.2.2.126; Finnoff JT, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e4; FRANK E, 1995, ACAD EMERG MED, V2, P200, DOI 10.1111/j.1553-2712.1995.tb03198.x; Gebhard F, 2008, LANGENBECK ARCH SURG, V393, P825, DOI 10.1007/s00423-008-0334-2; Hillman M, 1993, CYCLE HELMETS CASE; Keel M, 2005, INJURY, V36, P691, DOI 10.1016/j.injury.2004.12.037; Li GH, 1996, ALCOHOL CLIN EXP RES, V20, P1553, DOI 10.1111/j.1530-0277.1996.tb01698.x; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; MACKENZIE EJ, 1984, AM J EMERG MED, V2, P537, DOI 10.1016/0735-6757(84)90081-0; Macpherson A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005401.pub3; MCCARTHY M, 1992, BRIT MED J, V305, P881, DOI 10.1136/bmj.305.6858.881; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; MOCK CN, 1995, J TRAUMA, V39, P29, DOI 10.1097/00005373-199507000-00004; Morrongiello BA, 2002, INJ PREV, V8, P27, DOI 10.1136/ip.8.1.27; Morrongiello BA, 2007, J PEDIATR PSYCHOL, V32, P926, DOI 10.1093/jpepsy/jsm027; Morrongiello BA, 2007, ACCIDENT ANAL PREV, V39, P618, DOI 10.1016/j.aap.2006.10.006; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Pless IB, 2006, ARCH PEDIAT ADOL MED, V160, P610, DOI 10.1001/archpedi.160.6.610; Rosenkranz KA, 2003, INJURY, V34, P825, DOI 10.1016/S0020-1383(02)00389-3; RUTLEDGE R, 1995, J TRAUMA, V38, P590, DOI 10.1097/00005373-199504000-00022; Spain DA, 1997, J TRAUMA, V43, P423, DOI 10.1097/00005373-199709000-00006; Stahel P., 2005, EUR J TRAUMA, V31, P200, DOI [10.1007/s00068-005-2028-6, DOI 10.1007/S00068-005-2028-6]; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Suris JC, 2005, EUR J PEDIATR, V164, P371, DOI 10.1007/s00431-005-1649-4; Sutherland AG, 2006, VALUE HEALTH, V9, P24, DOI 10.1111/j.1524-4733.2006.00077.x; Thompson DC., 1999, COCHRANE DB SYST REV, V308, DOI 10.1002/14651858.CD001855; Upperman JS, 2003, J PEDIATR SURG, V38, P1284, DOI 10.1016/S0022-3468(03)00383-X; Wilde G J, 1998, Inj Prev, V4, P89; Wilde GJS, 2002, BRIT MED J, V324, P1149, DOI 10.1136/bmj.324.7346.1149; YELON JA, 1995, AM SURGEON, V61, P202	37	5	5	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1356	1362		10.1097/TA.0b013e318250b537			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	944JD	WOS:000304195100045	22673266				2022-02-06	
J	Ensign, J; Maricle, DE; Brown, C; Mayfield, JW				Ensign, Jonelle; Maricle, Denise E.; Brown, Carmen; Mayfield, Joan W.			Psychosocial Subtypes on the Behavior Assessment System for Children, Second Edition Following Pediatric Traumatic Brain Injury	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Traumatic Brain Injury; Assessment; Children and Behavioral Disorders	SELF-REGULATION; ADOLESCENTS; DISORDER; PSYCHOLOGY; ANXIETY	This study identified the subtypes of psychosocial functioning in children who had sustained traumatic brain injury using the Behavior Assessment System for Children, Second Edition. Participants (N 91) were aged 620. Using hierarchical agglomerative clustering techniques, a reliable typology emerged that consisted of two subtypes, which were labeled as Normal and Pervasive Emotional Difficulties. Using further exploratory analyses, other less statistically reliable subtypes were also observed, which were thought to have clinical significance. These were labeled as Mild Externalizing/Depression, Mild Externalizing/Attention Problems, Mild Depression, and Mild Anxiety. The majority of participants were assigned to the Normal subtype. Relationships between subtypes and other variables, including gender, time elapsed since injury, age at injury, and age at testing were also analyzed, with time elapsed since injury being the only variable to significantly differentiate the subtypes.	[Ensign, Jonelle; Maricle, Denise E.; Brown, Carmen] Texas Womans Univ, Dept Psychol & Philosophy, Denton, TX 76204 USA; [Mayfield, Joan W.] Our Childrens House Baylor, Dallas, TX USA		Ensign, J (corresponding author), Ft Worth Independent Sch Dist, Psychol Serv, Ft Worth, TX 76107 USA.	jonelle.ensign@fwisd.org					Achenbach TM, 1991, MANUAL CHILD BEHAV C; BIDAUTRUSSELL M, 1995, J ABNORM CHILD PSYCH, V23, P641, DOI 10.1007/BF01447667; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; BORGEN FH, 1987, J COUNS PSYCHOL, V34, P456, DOI 10.1037/0022-0167.34.4.456; Butler K, 1997, CHILD NEUROPSYCHOL, V3, P98, DOI 10.1080/09297049708401371; DiBartolo PM, 2006, J ANXIETY DISORD, V20, P630, DOI 10.1016/j.janxdis.2005.06.003; Doherty N. N., 2005, ED CHILD PSYCHOL, V22, P29; FUERST DR, 1989, J CONSULT CLIN PSYCH, V57, P275, DOI 10.1037/0022-006X.57.2.275; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Grados MA, 2008, DEPRESS ANXIETY, V25, P398, DOI 10.1002/da.20398; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hayman-Abello SE, 2003, J INT NEUROPSYCH SOC, V9, P887, DOI 10.1017/S1355617703960097; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 2000, J INT NEUROPSYCH SOC, V6, P279, DOI 10.1017/S1355617700633039; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Saunders CD, 2000, CHILD NEUROPSYCHOL, V6, P129, DOI 10.1076/chin.6.2.129.7057; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wirt RD, 1990, MULTIDIMENSIONAL DES; Yeates KO, 2007, PSYCHOL BULL, V133, P535, DOI 10.1037/0033-2909.133.3.535	23	5	5	0	11	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2012	27	3					277	292		10.1093/arclin/acs030			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	930SA	WOS:000303158400004	22389318	Bronze			2022-02-06	
J	Leitgeb, J; Mauritz, W; Brazinova, A; Matula, C; Majdan, M; Wilbacher, I; Rusnak, M				Leitgeb, Johannes; Mauritz, Walter; Brazinova, Alexandra; Matula, Christian; Majdan, Marek; Wilbacher, Ingrid; Rusnak, Martin			Outcome of patients with severe brain trauma who were treated either by neurosurgeons or by trauma surgeons	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; severe; neurosurgeons; trauma surgeons; outcomes.	ACUTE SUBDURAL-HEMATOMA; INTRACRANIAL-PRESSURE; INJURY; EPIDEMIOLOGY; MORTALITY; ADMISSION; IMPACT	BACKGROUND: In Central Europe, patients with severe traumatic brain injury (TBI) are frequently treated by trauma surgeons rather than neurosurgeons. The objective of this study was to compare outcomes of patients with TBI by trauma surgeons or neurosurgeons. This study is a retrospective analysis of prospectively collected data. METHODS: Between January 2001 and December 2005, 10 centers enrolled 311 operatively treated patients with severe TBI and no significant other injuries into observational studies. Data on accident, treatment, and outcomes were collected. Using the Glasgow Outcome Scale, 1-year outcomes were classified as "favorable" (scores 5 and 4) or "unfavorable" (scores < 4). Data from patients operated by trauma surgeons ("group T") were compared with those from patients operated by neurosurgeons ("group N") using univariate and multivariate statistics. The scores published by Hukkelhoven et al. were used to estimate expected rates of death and unfavorable outcomes. RESULTS: There were 191 patients in group N and 120 in group T. There were no significant differences regarding age, sex, and trauma mechanisms between the two groups. Patients from group N had significantly higher trauma severity. The observed versus expected hospital mortality ratio was 0.84 for group N and 0.97 for group T (p = 0.051). One-year outcome was better in group T (28% vs. 19% good recovery, 1.7% vs. 9.4% vegetative status; p = 0.017), whereas mortality was not different (43% in both groups). Multivariate analysis revealed that outcomes were influenced by age and severity of TBI, whereas surgical specialty and treatment factors had no effects. CONCLUSION: With respect to operatively treated patients with TBI, trauma surgeons and neurosurgeons achieve comparable results. (J Trauma. 2012;72: 1263-1270. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, A-1090 Vienna, Austria; [Matula, Christian] Med Univ Vienna, Dept Neurosurg, A-1090 Vienna, Austria; [Mauritz, Walter] Trauma Hosp Lorenz Boehler, Vienna, Austria; [Mauritz, Walter; Brazinova, Alexandra; Majdan, Marek; Wilbacher, Ingrid; Rusnak, Martin] INRO, Vienna, Austria; [Brazinova, Alexandra; Rusnak, Martin] Trnava Univ, Fac Hlth & Social Serv, Dept Publ Hlth, Trnava, Slovakia		Leitgeb, J (corresponding author), Med Univ Vienna, Dept Traumatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	johannes.leitgeb@meduniwien.ac.at	Rusnak, Martin/K-9349-2016; Majdan, Marek/K-5017-2012; Brazinova, Alexandra/C-4265-2016	Rusnak, Martin/0000-0003-3321-1042; Majdan, Marek/0000-0001-8037-742X; Brazinova, Alexandra/0000-0003-0625-256X; Mauritz, Walter/0000-0001-9043-3712			Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; DENT DL, 1995, J TRAUMA, V39, P36, DOI 10.1097/00005373-199507000-00005; Esposito Thomas J, 2006, Adv Surg, V40, P213, DOI 10.1016/j.yasu.2006.06.002; Hatashita Shizuo, 1993, Neurologia Medico-Chirurgica, V33, P13, DOI 10.2176/nmc.33.13; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; JENNETT B, 1975, LANCET, V1, P480; Jin PHPFK, 2008, J NEUROTRAUM, V25, P1003, DOI 10.1089/neu.2007.0463; Ko K, 2003, J TRAUMA, V55, P480, DOI 10.1097/01.TA.0000074111.04885.28; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lenartova L, 2007, WIEN KLIN WOCHENSCHR, V119, P35, DOI 10.1007/s00508-006-0762-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Mauritz W, 2008, INTENS CARE MED, V34, P1208, DOI 10.1007/s00134-008-1079-7; Mauritz W, 2007, WIEN KLIN WOCHENSCHR, V119, P46, DOI 10.1007/s00508-006-0763-2; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Rosso A, 2007, WIEN KLIN WOCHENSCHR, V119, P29, DOI 10.1007/s00508-006-0761-4; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tallon JM, 2008, CAN J SURG, V51, P339; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212	34	5	5	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2012	72	5					1263	1270		10.1097/TA.0b013e318248ed83			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	944JD	WOS:000304195100030	22673253				2022-02-06	
J	Paes-Branco, D; Abreu-Villaca, Y; Manhaes, AC; Filgueiras, CC				Paes-Branco, Danielle; Abreu-Villaca, Yael; Manhaes, Alex C.; Filgueiras, Claudio C.			Unilateral hemispherectomy at adulthood asymmetrically affects motor performance of male Swiss mice	EXPERIMENTAL BRAIN RESEARCH			English	Article						Cerebral asymmetry; Hemispherectomy; Laterality; Motor control	ROTATIONAL SIDE PREFERENCE; TRAUMATIC BRAIN-INJURY; PAW PREFERENCE; CALLOSAL AGENESIS; NEONATAL TRANSECTION; CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY; IMMOBILE BEHAVIOR; CIRCLING BEHAVIOR; ROTAROD TEST	Evidence exists indicating that cerebral lateralization is a fundamental feature of all vertebrates. In humans, a series of studies demonstrated that the left hemisphere plays a major role in controlling movement. No such asymmetries have been identified in rodents, in spite of the fact that these animals have been frequently used in studies assessing motor behavior. In this regard, here, we used unilateral hemispherectomy to study the relative importance of each hemisphere in controlling movement. Adult Swiss mice were submitted to right unilateral hemispherectomy (RH), left unilateral hemispherectomy (LH) or sham surgery. Fifteen days after surgery, motor performance was assessed in the accelerating rotarod test and in the foot-fault test (in which performance depends on skilled limb use) and in the elevated body swing test (in which performance depends on trunk movements). The surgical removal of the right hemisphere caused a more pronounced impairment in performance than the removal of the left hemisphere both in the rotarod and in the foot-fault tests. In the rotarod, the RH group presented smaller latencies to fall than both LH and sham groups. In the foot-fault test, while both the sham and the LH groups showed no differences between left and right hind limbs, the RH group showed significantly worse performance with the left hind limb than with the right one. The elevated body swing test revealed a similar impairment in the two hemispherectomized groups. Our data suggest a major role of the right hemisphere in controlling skilled limb movements in mice.	[Paes-Branco, Danielle; Abreu-Villaca, Yael; Manhaes, Alex C.; Filgueiras, Claudio C.] Univ Estado Rio De Janeiro, Lab Neurofisiol, Dept Ciencias Fisiol, Inst Roberto Alcantara Gomes,Ctr Biomed, BR-20550170 Rio De Janeiro, RJ, Brazil		Filgueiras, CC (corresponding author), Univ Estado Rio De Janeiro, Lab Neurofisiol, Dept Ciencias Fisiol, Inst Roberto Alcantara Gomes,Ctr Biomed, Ave Prof Manoel de Abreu 444,5 Andar, BR-20550170 Rio De Janeiro, RJ, Brazil.	ccfilg@pq.cnpq.br	ManhAes, Alex C/F-5499-2011	ManhAes, Alex C/0000-0003-4629-8343; Abreu-Villaca, Yael/0000-0002-9801-6179; Filgueiras, Claudio/0000-0003-4522-4799	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Sub-reitoria de Posgraduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2-UERJ); FAPERJFundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)	Funding for this study was provided by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and by Sub-reitoria de Posgraduacao e Pesquisa da Universidade do Estado do Rio de Janeiro (SR2-UERJ). DPB receives a FAPERJ M.Sc. fellowship, while Yael Abreu-Villaca, Alex C. Manhaes and Claudio C. Filgueiras are CNPq and FAPERJ research fellows. The authors are thankful to Edson Oliveira and Ulisses Risso Siqueira for animal care.	Al-Izki S, 2008, EXP NEUROL, V212, P118, DOI 10.1016/j.expneurol.2008.03.020; Annett M., 2002, HANDEDNESS BRAIN ASY; ANTAL M, 1992, J COMP NEUROL, V325, P22, DOI 10.1002/cne.903250103; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Bisazza A, 1998, NEUROSCI BIOBEHAV R, V22, P411, DOI 10.1016/S0149-7634(97)00050-X; Bona E, 1997, PEDIATR RES, V42, P678, DOI 10.1203/00006450-199711000-00021; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Borlongan CV, 1998, NEUROREPORT, V9, P3615, DOI 10.1097/00001756-199811160-00012; BRACHA HS, 1987, BIOL PSYCHIAT, V22, P995, DOI 10.1016/0006-3223(87)90009-6; Bradshaw JL, 2001, TRENDS COGN SCI, V5, P184, DOI 10.1016/S1364-6613(00)01656-9; Bradshaw John L., 1996, P33; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Brosamle C, 2000, J NEUROCYTOL, V29, P499, DOI 10.1023/A:1007297712821; Budilin S Yu, 2008, Neurosci Behav Physiol, V38, P991, DOI 10.1007/s11055-008-9082-6; COLLINS RL, 1968, J HERED, V59, P9, DOI 10.1093/oxfordjournals.jhered.a107656; Corballis MC, 2008, CORTEX, V44, P3, DOI 10.1016/j.cortex.2007.10.001; Corballis MC, 2009, PHILOS T R SOC B, V364, P867, DOI 10.1098/rstb.2008.0232; de Bode S, 2005, J CHILD NEUROL, V20, P64, DOI 10.1177/08830738050200011101; Deumens R, 2005, PROG NEUROBIOL, V77, P57, DOI 10.1016/j.pneurobio.2005.10.004; DOWLING GA, 1982, EXP NEUROL, V75, P51, DOI 10.1016/0014-4886(82)90005-X; Farr TD, 2006, J NEUROSCI METH, V153, P104, DOI 10.1016/j.jneumeth.2005.10.011; Filgueiras CC, 2005, BEHAV BRAIN RES, V162, P289, DOI 10.1016/j.bbr.2005.04.002; Filgueiras CC, 2004, BEHAV BRAIN RES, V155, P13, DOI 10.1016/j.bbr.2004.03.028; Filgueiras CC, 2006, BEHAV BRAIN RES, V172, P33, DOI 10.1016/j.bbr.2006.04.015; Fink M, 2009, NEUROIMAGE, V45, P598, DOI 10.1016/j.neuroimage.2008.11.033; Ghirlanda S, 2004, P ROY SOC B-BIOL SCI, V271, P853, DOI 10.1098/rspb.2003.2669; Ghirlanda S, 2009, PHILOS T R SOC B, V364, P861, DOI 10.1098/rstb.2008.0227; GOODALE MA, 1988, BEHAV BRAIN RES, V30, P203, DOI 10.1016/0166-4328(88)90149-0; Haaland KY, 2006, CLIN NEUROPSYCHOL, V20, P609, DOI 10.1080/13854040590967577; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; Haaland KY, 1996, CURR OPIN NEUROBIOL, V6, P796, DOI 10.1016/S0959-4388(96)80030-4; Haaland KY, 2004, J COGNITIVE NEUROSCI, V16, P621, DOI 10.1162/089892904323057344; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HARRINGTON DL, 1991, NEUROPSYCHOLOGIA, V29, P147, DOI 10.1016/0028-3932(91)90017-3; He Y, 2006, NEUROREPORT, V17, P5, DOI 10.1097/01.wnr.0000192737.92911.a4; Heim S, 2004, NEUROPSYCHOLOGIA, V42, P692, DOI 10.1016/j.neuropsychologia.2003.09.007; Herbert MR, 2005, BRAIN, V128, P213, DOI 10.1093/brain/awh330; HERNANDEZ TD, 1988, EXP NEUROL, V102, P318, DOI 10.1016/0014-4886(88)90226-9; HICKS S P, 1970, Experimental Neurology, V29, P416, DOI 10.1016/0014-4886(70)90069-5; Hirnstein M, 2008, BEHAV BRAIN RES, V187, P297, DOI 10.1016/j.bbr.2007.09.023; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Hurtado O, 2007, NEUROBIOL DIS, V26, P105, DOI 10.1016/j.nbd.2006.12.005; Huynh H., 1976, J EDUC STAT, V1, P69, DOI [10.3102/10769986001001069, DOI 10.3102/10769986001001069, 10.2307/1164736]; Ishibashi S, 2003, STROKE, V34, P1501, DOI 10.1161/01.STR.0000074034.32371.13; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; Jang SH, 2009, NEUROREHABILITATION, V24, P315, DOI 10.3233/NRE-2009-0484; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Josse G, 2004, BRAIN RES REV, V44, P1, DOI 10.1016/j.brainresrev.2003.10.001; Keller SS, 2009, BRAIN LANG, V109, P29, DOI 10.1016/j.bandl.2008.11.005; Klimkeit EI, 2006, CORTEX, V42, P113, DOI 10.1016/S0010-9452(08)70334-4; KOLB B, 1982, EXP NEUROL, V78, P348, DOI 10.1016/0014-4886(82)90053-X; Krahe TE, 2002, PROG NEURO-PSYCHOPH, V26, P169, DOI 10.1016/S0278-5846(01)00248-2; Krahe TE, 2001, INT J NEUROSCI, V108, P21, DOI 10.3109/00207450108986502; KUBOS KL, 1984, BEHAV BRAIN RES, V11, P89, DOI 10.1016/0166-4328(84)90011-1; Lalonde R, 2007, PROG NEUROBIOL, V81, P45, DOI 10.1016/j.pneurobio.2006.11.005; LENT R, 1993, PROG NEUROBIOL, V40, P249, DOI 10.1016/0301-0082(93)90024-M; Levy J, 1977, Ann N Y Acad Sci, V299, P264, DOI 10.1111/j.1749-6632.1977.tb41913.x; Loscher W, 2010, NEUROSCI BIOBEHAV R, V34, P31, DOI 10.1016/j.neubiorev.2009.07.001; Machado AGG, 2003, EPILEPSIA, V44, P500, DOI 10.1046/j.1528-1157.2003.37602.x; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Manhaes AC, 2005, BEHAV BRAIN RES, V159, P43, DOI 10.1016/j.bbr.2004.09.023; MANHAES AC, 1993, BRAZ J MED BIOL RES, V26, P1213; Manhaes AC, 2003, NEUROSCI LETT, V348, P69, DOI 10.1016/S0304-3940(03)00746-8; Manhaes AC, 2007, NEUROSCI LETT, V415, P159, DOI 10.1016/j.neulet.2007.01.012; Marino R, 2001, STEREOT FUNCT NEUROS, V76, P83; MCMAHON FJ, 1989, BRAIN RES, V503, P185, DOI 10.1016/0006-8993(89)91662-4; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; NATHAN PW, 1990, BRAIN, V113, P303, DOI 10.1093/brain/113.2.303; Piot-Grosjean O, 2001, NEUROBIOL DIS, V8, P1082, DOI 10.1006/nbdi.2001.0450; Pirko I, 2009, J NEUROL SCI, V282, P34, DOI 10.1016/j.jns.2008.12.013; Powell HWR, 2006, NEUROIMAGE, V32, P388, DOI 10.1016/j.neuroimage.2006.03.011; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Ribeiro-Carvalho A, 2010, ANIM BEHAV, V80, P51, DOI 10.1016/j.anbehav.2010.03.024; RINGO JL, 1994, CEREB CORTEX, V4, P331, DOI 10.1093/cercor/4.4.331; ROBINSON RG, 1979, SCIENCE, V205, P707, DOI 10.1126/science.462179; Rogers BP, 2004, NEUROIMAGE, V22, P855, DOI 10.1016/j.neuroimage.2004.02.027; Rogers LJ, 2004, P ROY SOC B-BIOL SCI, V271, pS420, DOI 10.1098/rsbl.2004.0200; Rogers LJ., 2002, COMP VERTEBRATE LATE; ROSEN GD, 1992, PROG NEUROBIOL, V39, P507, DOI 10.1016/0301-0082(92)90004-X; Rotenberg VS, 2004, PROG NEURO-PSYCHOPH, V28, P1, DOI 10.1016/S0278-5846(03)00163-5; Schaefer SY, 2007, BRAIN, V130, P2146, DOI 10.1093/brain/awm145; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Schmanke TD, 1996, J NEUROTRAUM, V13, P293, DOI 10.1089/neu.1996.13.293; SCHMIDT SL, 1991, BRAIN RES, V545, P123, DOI 10.1016/0006-8993(91)91277-8; Schmidt SL, 1999, PHYSIOL BEHAV, V65, P607; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shelton SB, 2008, J NEUROSCI METH, V168, P431, DOI 10.1016/j.jneumeth.2007.11.003; Shen H, 2010, J NEUROSCI METH, V186, P150, DOI 10.1016/j.jneumeth.2009.11.008; Stashkevich I S, 2010, Neurosci Behav Physiol, V40, P225, DOI 10.1007/s11055-009-9234-3; STROEMER RP, 1995, STROKE, V26, P2135, DOI 10.1161/01.STR.26.11.2135; SZECHTMAN H, 1985, NEUROSCIENCE, V14, P783, DOI 10.1016/0306-4522(85)90143-5; Vallortigara G, 2005, BEHAV BRAIN SCI, V28, P575, DOI 10.1017/S0140525X05000105; Vallortigara G, 2006, DEV PSYCHOBIOL, V48, P418, DOI 10.1002/dev.20166; Vallortigara G, 2011, WIRES COGN SCI, V2, P146, DOI 10.1002/wcs.100; Villablanca JR, 2000, NEUROSCIENCE, V95, P625; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	98	5	5	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	MAY	2012	218	3					465	476		10.1007/s00221-012-3034-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	925II	WOS:000302754500012	22367398				2022-02-06	
J	Al-Sarraj, S; Fegan-Earl, A; Ugbade, A; Bodi, I; Chapman, R; Poole, S; Swift, B; Jerreat, P; Cary, N				Al-Sarraj, Safa; Fegan-Earl, Ashley; Ugbade, Antonia; Bodi, Istvan; Chapman, Rob; Poole, Simon; Swift, Ben; Jerreat, Peter; Cary, Nat			Focal traumatic brain stem injury is a rare type of head injury resulting from assault: A forensic neuropathological study	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Head injury; Focal traumatic brainstem injury; Diffuse axonal injury; Mechanism of head injury	BETA-APP; LESIONS; DAMAGE	Introduction: Brainstem haemorrhage is common in cases of head injury when it is associated with space-occupying lesion and increases in the intracranial pressure (duret haemorrhage), in cases of diffuse axonal injury (in dorso-lateral quadrant) and diffuses vascular injury (in the periventricular tissue). However focal traumatic brainstem injury is rare. Material and method: We identified 12 cases of focal traumatic brainstem injury from review of 319 case of head injury. The head trauma had been caused by different mechanisms of complex fall from height and assault. 10/12 are associated with skull fracture. 11/12 with contre coup contusions in the frontal and temporal lobes, 5/12 direct contusions to cerebellum, 5/12 haemorrhage in corpus callosum and 2/11 have gliding contusions. None of the cases had pathological evidence of increase in the intracranial pressure. The bleeding in the pons was at the edge in 2/12 and cross the section in 10/12. The majority of patients were unconscious immediately after the incident (10/12) and 9/12 died within one day. Conclusion: Focal traumatic brainstem injury occurs most likely due to direct impact at the back of the head or stretching forces affecting the brainstem in cases of complex fall from height and after assault, particularly those associated with kicks. It is a serious and commonly fatal brain damage, which needed to be differentiated from other causes of brainstem haemorrhages. (C) 2012 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Al-Sarraj, Safa; Ugbade, Antonia; Bodi, Istvan] Kings Coll Hosp NHS Fdn Trust, Dept Clin Neuropathol, London SE5 9RS, England; [Fegan-Earl, Ashley; Chapman, Rob; Poole, Simon; Swift, Ben; Jerreat, Peter; Cary, Nat] Culham Sci Ctr, Forens Pathol Serv, Oxford, England		Al-Sarraj, S (corresponding author), Kings Coll Hosp NHS Fdn Trust, Dept Clin Neuropathol, Denmark Hill, London SE5 9RS, England.	safa.al-sarraj@nhs.net	Bodi, Istvan/H-8092-2019	Bodi, Istvan/0000-0002-2533-4758			ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adams JH, 1990, HDB CLIN NEUROLOGY, P43; EZZAT W, 1995, AM J FOREN MED PATH, V16, P336, DOI 10.1097/00000433-199512000-00008; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; FREYTAG E, 1963, ARCH PATHOL, V75, P402; GEORGE B, 1981, ACTA NEUROCHIR, V59, P35, DOI 10.1007/BF01411189; GOSCINSKI I, 1995, ACTA NEUROCHIR, V134, P16, DOI 10.1007/BF01428496; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; Mannion RJ, 2007, J NEUROTRAUM, V24, P128, DOI 10.1089/neu.2006.0127; PILZ P, 1982, J NEUROL NEUROSUR PS, V45, P422, DOI 10.1136/jnnp.45.5.422; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; ROPPER AH, 1985, ANN NEUROL, V18, P80, DOI 10.1002/ana.410180114; Saeki N, 1998, BRIT J NEUROSURG, V12, P151, DOI 10.1080/02688699845302; Shukla D, 2007, CLIN NEUROPATHOL, V26, P197; SIMPSON DA, 1989, J TRAUMA, V29, P1519, DOI 10.1097/00005373-198911000-00011; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	28	5	5	3	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	APR	2012	19	3					144	151		10.1016/j.jflm.2011.12.015			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	922DD	WOS:000302526100007	22391000				2022-02-06	
J	de La Coussaye, JE; Adnet, F				de La Coussaye, J.-E.; Adnet, F.		Grp Experts Sfar-SFMU	Sedation and analgesia in emergency structure. Which sedation and/or analgesia for tracheal intubation?	ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION			French	Article						Endotracheal intubation; Rapid sequence induction; Full stomach; Preoxygenation; Etomidate; Ketamine; Succinylcholine; Awake tracheal intubation; Topical anaesthesia; Lidocaine	RAPID-SEQUENCE INTUBATION; NEUROMUSCULAR BLOCKING-AGENTS; TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; PREHOSPITAL ENDOTRACHEAL INTUBATION; CHANGES FOLLOWING ETOMIDATE; BLOOD-FLOW VELOCITY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; AIRWAY MANAGEMENT		[de La Coussaye, J.-E.] Univ Montpellier I, CHU Nimes, Fac Med, Div Anesthesie Reanimat Douleur Urgence, F-30029 Nimes 9, France; [Adnet, F.] Univ Paris 13, CHU Avicenne, EA 3409, Samu 93, F-93009 Bobigny, France		de La Coussaye, JE (corresponding author), Univ Montpellier I, CHU Nimes, Fac Med, Div Anesthesie Reanimat Douleur Urgence, Pl Prof Robert Debre, F-30029 Nimes 9, France.	j.emmanuel.de.la.coussaye@chu-nimes.fr; frederic.adnet@avc.aphp.fr	CHERON, GERARD/F-9051-2019	Orliaguet, Gilles/0000-0003-0930-2251			Adnet F, 1998, ANN EMERG MED, V32, P454, DOI 10.1016/S0196-0644(98)70175-1; Adnet F, 1998, Eur J Emerg Med, V5, P415; Adnet F, 1997, ANESTHESIOLOGY, V87, P1290, DOI 10.1097/00000542-199712000-00005; Adnet F, 2001, CRIT CARE, V5, P290; Adnet F, 1996, LANCET, V348, P123, DOI 10.1016/S0140-6736(05)64630-2; Adnet F, 1998, ACAD EMERG MED, V5, P123, DOI 10.1111/j.1553-2712.1998.tb02596.x; Adnet F, 1998, ANN FR ANESTH, V17, P688, DOI 10.1016/S0750-7658(98)80106-8; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; ALLOLIO B, 1985, CLIN ENDOCRINOL, V22, P281, DOI 10.1111/j.1365-2265.1985.tb03241.x; Andrews JI, 1999, ACTA ANAESTH SCAND, V43, P4, DOI 10.1034/j.1399-6576.1999.430102.x; Angelini G, 2001, CRIT CARE CLIN, V17, P863, DOI 10.1016/S0749-0704(05)70184-6; Annane D, 2005, INTENS CARE MED, V31, P325, DOI 10.1007/s00134-005-2560-1; Baillard C, 2006, AM J RESP CRIT CARE, V174, P171, DOI 10.1164/rccm.200509-1507OC; Bair AE, 2010, J EMERG MED, V38, P677, DOI 10.1016/j.jemermed.2008.12.019; Baker CC, 2005, J TRAUMA, V58, P723; Bazin JE, 1998, BRIT J ANAESTH, V81, P430, DOI 10.1093/bja/81.3.430; Bazin JE, 1997, ANN FR ANESTH, V16, P445, DOI 10.1016/S0750-7658(97)81477-3; Benumof JL, 1997, ANESTHESIOLOGY, V87, P979, DOI 10.1097/00000542-199710000-00034; BENUMOF JL, 1991, ANESTHESIOLOGY, V75, P1087; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; BERTHOUD M, 1983, ANAESTHESIA, V38, P96, DOI 10.1111/j.1365-2044.1983.tb13925.x; BoissonBertrand D, 1996, ANN FR ANESTH, V15, P207; BONICA JJ, 1949, ANESTHESIOLOGY, V10, P736, DOI 10.1097/00000542-194911000-00010; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Bowdle TA, 1998, ANESTHESIOLOGY, V88, P82, DOI 10.1097/00000542-199801000-00015; Bozeman William P, 2002, Air Med J, V21, P32, DOI 10.1067/mmj.2002.125935; Bozeman WP, 2005, J TRAUMA, V58, P278, DOI 10.1097/01.TA.0000152536.71932.85; Brochard L, 2001, C ACT C NAT AN REAN, P443; BROCKMEYER DM, 1995, BRIT J ANAESTH, V74, P79, DOI 10.1093/bja/74.1.79; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bulger EM, 2002, J EMERG MED, V23, P183, DOI 10.1016/S0736-4679(02)00490-0; Cantineau JP, 1997, ANN FR ANESTH, V16, P878, DOI 10.1016/S0750-7658(97)89837-1; CAPLAN RA, 1993, ANESTHESIOLOGY, V78, P597; CARLI F, 1983, ANAESTHESIA, V38, P784, DOI 10.1111/j.1365-2044.1983.tb12204.x; Carli P, 1995, CURR OPIN ANESTHESIO, V8, P157; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; CROZIER TA, 1987, ANESTHESIOLOGY, V66, P628, DOI 10.1097/00000542-198705000-00006; Darrouj J, 2009, AM J THER, V16, P339, DOI 10.1097/01.pap.0000249925.76324.47; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; de Boer HD, 2007, ANESTHESIOLOGY, V107, P239, DOI 10.1097/01.anes.0000270722.95764.37; Debaene B, 2005, ESSENTIELS, P263; DEGENT GE, 1993, CRIT CARE CLIN, V9, P377, DOI 10.1016/S0749-0704(18)30201-X; den Brinker M, 2008, INTENS CARE MED, V34, P163, DOI 10.1007/s00134-007-0836-3; Dhungana Y, 2008, Nepal Med Coll J, V10, P16; DIAGO MC, 1988, ANAESTHESIA, V43, P644, DOI 10.1111/j.1365-2044.1988.tb04148.x; DRONEN SC, 1987, ANN EMERG MED, V16, P650, DOI 10.1016/S0196-0644(87)80063-X; Dufour Daniel G., 1995, Journal of Emergency Medicine, V13, P705, DOI 10.1016/0736-4679(95)00089-S; DUNCAN JAT, 1977, BRIT J ANAESTH, V49, P619, DOI 10.1093/bja/49.6.619; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; DUTHIE DJR, 1985, BRIT J ANAESTH, V57, P156, DOI 10.1093/bja/57.2.156; Duvaldestin P, 1989, PHARM PRATIQUE ANEST; ELBEHEIRY H, 1995, CAN J ANAESTH, V42, P875, DOI 10.1007/BF03011034; Escarment J, 1995, Cah Anesthesiol, V43, P31; Farmery AD, 1996, BRIT J ANAESTH, V76, P284, DOI 10.1093/bja/76.2.284; Fletcher D, 2002, EMC; FRAGEN RJ, 1987, ANESTHESIOLOGY, V66, P839, DOI 10.1097/00000542-198706000-00026; Fuchs-Buder T, 1998, BRIT J ANAESTH, V80, P504, DOI 10.1093/bja/80.4.504; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GENTLEMAN D, 1993, BRIT MED J, V307, P547, DOI 10.1136/bmj.307.6903.547; GERMOND M, 1994, ANN FR ANESTH, V13, P609, DOI 10.1016/S0750-7658(05)80710-5; Gindre S, 2002, ANN FR ANESTH, V21, P760, DOI 10.1016/S0750-7658(02)00795-5; GOTTA AW, 1981, BRIT J ANAESTH, V53, P1055, DOI 10.1093/bja/53.10.1055; Green H, 1852, SURG TREATMENT POLYP, P46; Harris C E, 1988, Anaesthesia, V43 Suppl, P32, DOI 10.1111/j.1365-2044.1988.tb09065.x; Hayes AH, 2001, ACTA ANAESTH SCAND, V45, P746, DOI 10.1034/j.1399-6576.2001.045006746.x; Heier T, 2001, ANESTHESIOLOGY, V94, P754, DOI 10.1097/00000542-200105000-00011; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hirota K, 1996, BRIT J ANAESTH, V77, P441, DOI 10.1093/bja/77.4.441; Ihmsen H, 2001, CLIN PHARMACOL THER, V70, P431, DOI 10.1067/mcp.2001.119722; Jabre P, 2009, CRIT CARE S1, V13, pP405; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jacoby J, 2006, ANN EMERG MED, V47, P525, DOI 10.1016/j.annemergmed.2005.12.009; Jaffrelot M, 2007, AM J EMERG MED, V25, P529, DOI 10.1016/j.ajem.2006.09.016; Juvin P, 1996, ANN FR ANESTH, V15, P1231, DOI 10.1016/S0750-7658(97)85886-8; Karch SB, 1996, AM J EMERG MED, V14, P617, DOI 10.1016/S0735-6757(96)90073-X; KATES RA, 1986, ANESTH ANALG, V65, P815; KOENIG KL, 1992, ANN EMERG MED, V21, P929, DOI 10.1016/S0196-0644(05)82930-0; Kohrs R, 1998, ANESTH ANALG, V87, P1186, DOI 10.1097/00000539-199811000-00039; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; KOPRIVA CJ, 1974, ANESTHESIOLOGY, V40, P596, DOI 10.1097/00000542-197406000-00017; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; Krisanda T J, 1992, Prehosp Disaster Med, V7, P121; Kundra P, 2000, ACTA ANAESTH SCAND, V44, P511, DOI 10.1034/j.1399-6576.2000.00503.x; Lallemand MA, 2003, BRIT J ANAESTH, V91, P341, DOI 10.1093/bja/aeg175; Laurent D, 1998, PHARM ANESTHESIE REA; LAXENAIRE MC, 1990, ANN FR ANESTH, V9, P501, DOI 10.1016/S0750-7658(05)80222-9; Laxenaire MC, 1996, ANN FR ANESTH, V15, P1211, DOI 10.1016/S0750-7658(97)85882-0; Le Pelley E, 1995, C ACT SFAR, P199; LEDINGHAM IM, 1983, LANCET, V1, P1270; Lee C, 2009, ANAESTHESIA, V64, P73, DOI 10.1111/j.1365-2044.2008.05873.x; Lee C, 2007, ANESTHESIOLOGY, V107, pA988; Lee C, 2009, J CRIT CARE, V24, P43, DOI 10.1016/j.jcrc.2008.08.009; Levitan RM, 2004, ANN EMERG MED, V44, P307, DOI 10.1016/j.annemergmed.2004.05.006; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; Liberman M, 2003, ANN SURG, V237, P153, DOI 10.1097/00000658-200302000-00001; Liberman M, 2000, J TRAUMA, V49, P584, DOI 10.1097/00005373-200010000-00003; LIENHART A, 2003, C ACTUALISATION, P203; Lin CC, 2008, AM J EMERG MED, V26, P845, DOI 10.1016/j.ajem.2007.11.027; LOSEK J D, 1989, Pediatric Emergency Care, V5, P1, DOI 10.1097/00006565-198903000-00001; LOWENSTEIN E, 1969, NEW ENGL J MED, V281, P1389, DOI 10.1056/NEJM196912182812503; Ma OJ, 1998, AM J EMERG MED, V16, P125, DOI 10.1016/S0735-6757(98)90027-4; MA OJ, 1995, AM J EMERG MED, V13, P501, DOI 10.1016/0735-6757(95)90156-6; MAGORIAN T, 1993, ANESTHESIOLOGY, V79, P913, DOI 10.1097/00000542-199311000-00007; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; MAYBERG TS, 1995, ANESTH ANALG, V81, P84, DOI 10.1097/00000539-199507000-00017; McCourt KC, 1998, ANAESTHESIA, V53, P867, DOI 10.1046/j.1365-2044.1998.00342.x; Meyniel D, 2002, REANIMATION, V11, P477; MILDE LN, 1985, ANESTHESIOLOGY, V63, P371, DOI 10.1097/00000542-198510000-00005; Mirakhur RK, 2009, ANAESTHESIA, V64, P45, DOI 10.1111/j.1365-2044.2008.05870.x; Morris C, 2005, ANAESTHESIA, V60, P737, DOI 10.1111/j.1365-2044.2005.04325.x; MOULTON C, 1991, BRIT MED J, V303, P1240, DOI 10.1136/bmj.303.6812.1240; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; MURPHYMACABOBBY M, 1992, ANN EMERG MED, V21, P664, DOI 10.1016/S0196-0644(05)82776-3; Neilipovitz DT, 2007, CAN J ANAESTH, V54, P748, DOI 10.1007/BF03026872; Orliaguet G, 1997, JEUR, V1, P27; Patil V, 2002, BRIT J ANAESTH, V89, P586, DOI 10.1093/bja/aef226; PEPE PE, 1993, ANN EMERG MED, V22, P17, DOI 10.1016/S0196-0644(05)80244-6; PEPE PE, 1985, ANN EMERG MED, V14, P1085, DOI 10.1016/S0196-0644(85)80927-6; Perry JJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub2; PETIT P, 1994, ANN FR ANESTH, V13, P643, DOI 10.1016/S0750-7658(05)80719-1; Plaud B, 2009, ANESTHESIOLOGY, V110, P284, DOI 10.1097/ALN.0b013e318194caaa; Ray DC, 2007, CRIT CARE, V11, DOI 10.1186/cc5916; Regel G, 1997, Acta Anaesthesiol Scand Suppl, V110, P71; RHEE KJ, 1994, ANN EMERG MED, V23, P37, DOI 10.1016/S0196-0644(94)70005-2; Ricard-Hibon A, 2003, AM J EMERG MED, V21, P461, DOI 10.1016/S0735-6757(03)00095-0; Ricard-Hibon A, 2002, EUR J ANAESTH, V19, P361, DOI 10.1017/S0265021502000583; RIOU B, 1994, ANN FR ANESTH, V13, P556, DOI 10.1016/S0750-7658(05)80696-3; Riou B, 1997, JEUR, V1, P38; ROBERTS DJ, 1986, ANN EMERG MED, V15, P152, DOI 10.1016/S0196-0644(86)80010-5; Rose W D, 1994, Air Med J, V13, P475, DOI 10.1016/S1067-991X(05)80289-5; ROUSSEAU JM, 1995, ANN FR ANESTH, V14, P261, DOI 10.1016/S0750-7658(95)80004-2; SAARNIVAARA L, 1991, ACTA ANAESTH SCAND, V35, P19, DOI 10.1111/j.1399-6576.1991.tb03235.x; Sakles JC, 1998, ANN EMERG MED, V31, P325, DOI 10.1016/S0196-0644(98)70342-7; SARMA VJ, 1992, ACTA ANAESTH SCAND, V36, P106, DOI 10.1111/j.1399-6576.1992.tb03432.x; Sayre MR, 1998, ANN EMERG MED, V31, P228, DOI 10.1016/S0196-0644(98)70312-9; SCHELLER MS, 1992, ANESTH ANALG, V75, P788; Sehdev Rajesh S, 2006, Emerg Med Australas, V18, P37; SHAPIRA Y, 1992, J NEUROSURG ANESTH, V4, P231, DOI 10.1097/00008506-199210000-00001; Silber SH, 1997, AM J EMERG MED, V15, P263, DOI 10.1016/S0735-6757(97)90010-3; Sitzman BT, 1997, ANESTHESIOLOGY, V86, P34, DOI 10.1097/00000542-199701000-00006; Sivilotti MLA, 1998, ANN EMERG MED, V31, P313, DOI 10.1016/S0196-0644(98)70341-5; Smith DC, 2000, J EMERG MED, V18, P13, DOI 10.1016/S0736-4679(99)00154-7; Spandou E, 1999, BRAIN RES, V819, P1, DOI 10.1016/S0006-8993(98)01333-X; Sparr HJ, 1996, ACTA ANAESTH SCAND, V40, P425, DOI 10.1111/j.1399-6576.1996.tb04464.x; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; STEPT WJ, 1970, ANESTH ANAL CURR RES, V49, P633; STUTTMANN R, 1988, ANAESTHESIST, V37, P576; SYVERUD SA, 1988, ANN EMERG MED, V17, P236, DOI 10.1016/S0196-0644(88)80114-8; TAKESHITA H, 1972, ANESTHESIOLOGY, V36, P69, DOI 10.1097/00000542-197201000-00013; Tekwani KL, 2009, ACAD EMERG MED, V16, P11, DOI 10.1111/j.1553-2712.2008.00299.x; Thibodeau LG, 1997, AM J EMERG MED, V15, P562, DOI 10.1016/S0735-6757(97)90157-1; Thompson C B, 1995, Air Med J, V14, P55; Ufberg JW, 2005, AM J EMERG MED, V23, P379, DOI 10.1016/j.ajem.2005.02.005; Ujhelyi MR, 2001, CRIT CARE MED, V29, P1006, DOI 10.1097/00003246-200105000-00025; Vijayakumar E, 1998, J CRIT CARE, V13, P1, DOI 10.1016/S0883-9441(98)90022-3; Vilke Gary M., 1994, Journal of Emergency Medicine, V12, P217, DOI 10.1016/0736-4679(94)90702-1; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202; WAGNER RL, 1984, ANESTHESIOLOGY, V61, P647, DOI 10.1097/00000542-198412000-00003; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; WHITE PF, 1982, ANESTHESIOLOGY, V56, P119, DOI 10.1097/00000542-198202000-00007; WHITE PF, 1982, ANESTHESIOLOGY, V57, P242, DOI 10.1097/00000542-198209000-00019; Wilbur K, 2001, CJEM, V3, P302; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; Woodall NM, 2008, BRIT J ANAESTH, V100, P850, DOI 10.1093/bja/aen076; YAMAMURA T, 1990, ANESTHESIOLOGY, V72, P704, DOI 10.1097/00000542-199004000-00021; Yeung Janice K, 2002, CJEM, V4, P194; Zed PJ, 2006, ACAD EMERG MED, V13, P378, DOI 10.1197/j.aem.2005.11.076; ZINK BJ, 1995, ACAD EMERG MED, V2, P974, DOI 10.1111/j.1553-2712.1995.tb03124.x	169	5	7	0	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0750-7658	1769-6623		ANN FR ANESTH	Ann. Fr. Anest. Reanim.	APR	2012	31	4					313	321		10.1016/j.annfar.2012.01.008			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	939DB	WOS:000303786300004	22440814				2022-02-06	
J	Houston, R; Pearson, GA				Houston, Rosie; Pearson, Gale A.			Hospital facilities for head injured children: UK national survey	EMERGENCY MEDICINE JOURNAL			English	Article							TRAUMATIC-BRAIN-INJURY; PEDIATRIC INTENSIVE-CARE; DEATH	Aim To assess how child emergency department (ED) attendances are distributed between hospitals across England, Wales and Northern Ireland and how care is organised for children with a head injury. Methods A cross-sectional survey was performed of the 245 hospitals in England Wales, Northern Ireland and the Crown Dependencies (Channel Islands and Isle of Man) which were eligible to participate in the enquiry from September 2009 to April 2010. The survey covered hospital details, departments and procedures, ED activity, imaging, admission and discharge procedures, referral and transfer, documentation, training and audit, information and advice, and non-accidental head injuries. Results 64% of hospitals have an established pathway for management of head injured children. Not infrequently hospitals asserting designation as specialist trauma or specialist neurosurgical centres do not offer an intensive care service for children. 82% of child ED attendances are to hospitals that would not care for a critically ill child on-site. Hospitals that do offer such care are much more likely to have children's trained staff available in the ED. They are also more likely to have access to surgical support beyond neurosurgery. Conclusion Given the extent of variation between hospitals in the facilities available for head injured children, further comparative studies into the standards of care delivered and outcomes (including a confidential enquiry) are indicated.	[Houston, Rosie; Pearson, Gale A.] CMACE, London NW1 5SD, England		Houston, R (corresponding author), CMACE, 188 Baker St, London NW1 5SD, England.	rosie.houston@yahoo.co.uk			National Patient Safety Agency	This work was undertaken by the Centre for Maternal and Child Enquiries (CMACE) as part of the Child Health Enquiry under the Confidential Enquiry into Maternal and Child Health (CEMACH) programme. The CEMACH programme of work is funded by the National Patient Safety Agency. Additional contributors to the Child Health Enquiry include the Department of Health, Social Services and Public Safety of Northern Ireland, the Isle of Man and the States of Jersey and Guernsey. The views expressed in this publication are those of the authors and not those of the funding bodies.	Cowley NJ, 2008, TRAUMA, V10, P35, DOI 10.1177/1460408608089322; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Fanning E, 2006, PRACTICAL ASSESSMENT, V10, P1; Gore-Felton C, 2002, EVAL HEALTH PROF, V25, P152, DOI 10.1177/01678702025002002; Hall JR, 1996, J PEDIATR SURG, V31, P72, DOI 10.1016/S0022-3468(96)90322-X; HALL JR, 1993, AM J DIS CHILD, V147, P102, DOI 10.1001/archpedi.1993.02160250104031; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hawley CA, 2010, EMERG NURSE, V17; Hawley Carol, 2010, Emerg Nurse, V17, P32; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; Nakash Rachel A, 2006, BMC Med Res Methodol, V6, P5, DOI 10.1186/1471-2288-6-5; National Collaborating Centre for Acute Care, 2007, NIC CG 56 HEAD INJ T; Office for National Statistics, 2004, MORT STAT INJ POIS, V37; Office for National Statistics, 2004, MORT STAT CHILDH INF, V35; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; POLLACK MM, 1991, CRIT CARE MED, V19, P150, DOI 10.1097/00003246-199102000-00007; SHARPLES PM, 1990, BRIT MED J, V300, P87, DOI 10.1136/bmj.300.6717.87; Tasker RC, 2006, EMERG MED J, V23, P519, DOI 10.1136/emj.2005.028779; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631	20	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205			EMERG MED J	Emerg. Med. J.	APR	2012	29	4					309	315		10.1136/emj.2011.112110			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	908VQ	WOS:000301521500013	21609945				2022-02-06	
J	Lehan, TJ; Arango-Lasprilla, JC; Aragon, CJD; Quijano, MC; Godwin, E				Lehan, Tara J.; Carlos Arango-Lasprilla, Juan; de los Reyes Aragon, Carlos Jose; Cristina Quijano, Maria; Godwin, Emilie			Dyadic Consensus and Well-Being in Individuals With Traumatic Brain Injury and Their Caregivers in Colombia	FAMILY JOURNAL			English	Article						traumatic brain injury; family; neurobehavioral functioning; satisfaction with life; agreement; consensus	NEUROBEHAVIORAL SYMPTOMS; DEFICITS; AWARENESS; PARTNER; REHABILITATION; SATISFACTION; CONCORDANCE; TYPOLOGIES; RELATIVES; PATIENT	More individuals are living with traumatic brain injury due to medical and technological advancements. Consequently, family researchers and clinicians will likely work with families facing this type of injury. It is important to examine how family members' perceptions of challenges associated with brain injury influence their outcomes and whether families experience difficulties when members have differing perceptions. Results of hierarchical linear modeling analyses showed that survivors' and caregivers' satisfaction with life was negatively influenced by their own, but not the other's, perceptions of survivor functioning. Survivors and caregivers with similar perceptions of survivor neurobehavioral functioning also reported greater satisfaction with life. Research and clinical implications are discussed.	[Lehan, Tara J.] Northcent Univ, Prescott Valley, AZ USA; [Carlos Arango-Lasprilla, Juan] Univ Deusto, Basque Fdn Sci, Ikerbasque, Bilbau, Spain; [de los Reyes Aragon, Carlos Jose] Univ Norte, Dept Psychol, Barranquilla, Colombia; [Cristina Quijano, Maria] Pontificia Univ Javeriana Cali, Cali, Colombia; [Godwin, Emilie] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA		Lehan, TJ (corresponding author), 730 East Broad St,POB 843038, Richmond, VA 23219 USA.	tlehan@ncu.edu	Lehan, Tara/AAO-4793-2020; De los Reyes Aragon, Carlos Jose/P-3516-2019	De los Reyes Aragon, Carlos Jose/0000-0003-4472-0635; Quijano Martinez, Maria Cristina/0000-0003-3548-1628			Baca Zinn Maxine, 1982, HUMBOLDT J SOCIAL RE, V10, P224, DOI DOI 10.1086/493962; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; Campbell L, 2002, PERS RELATIONSHIP, V9, P327, DOI 10.1111/1475-6811.00023; Cannon BJ, 2000, ARCH CLIN NEUROPSYCH, V15, P327; Cauce AM, 2002, PRAEG S APPL PSYCHOL, P3; CAVALLO M M, 1992, Brain Injury, V6, P327, DOI 10.3109/02699059209034947; Cavallo M.M., 2011, TXB TRAUMATIC BRAIN, P483; Cohen J., 2013, STAT POWER ANAL BEHA; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Durkheim E., 1933, DIVISION LABOR SOC; Falicov, 2000, LATINO FAMILIES THER; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleming JM, 1996, BRAIN INJURY, V10, P1; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Galanti Geri-Ann, 2003, J Transcult Nurs, V14, P180, DOI 10.1177/1043659603014003004; Gan C, 2002, BRAIN INJURY, V16, P311, DOI 10.1080/02699050110104426; GANS JS, 1983, ARCH PHYS MED REHAB, V64, P176; Garcia-Merita M. L., 2002, REV IBEROAMERICANA D, V13, P71; Groom KN, 1998, ARCH CLIN NEUROPSYCH, V13, P695, DOI 10.1016/S0887-6177(98)00005-5; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Hill R., 1949, FAMILIES STRESS; Kenny DA, 1999, PERS RELATIONSHIP, V6, P433, DOI 10.1111/j.1475-6811.1999.tb00202.x; Kenny DA., 2006, DYADIC DATA ANAL; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lucas RE, 2003, POSITIVE PSYCHOLOGICAL ASSESSMENT: HANDBOOK OF MODELS AND MEASURES, P201, DOI 10.1037/10612-013; Luna I, 1996, WESTERN J NURS RES, V18, P267, DOI 10.1177/019394599601800304; MCGLYNN SM, 1989, J CLIN EXP NEUROPSYC, V11, P143, DOI 10.1080/01688638908400882; MCKINLAY WW, 1984, J CLIN NEUROPSYCHOL, V6, P87, DOI 10.1080/01688638408401199; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Najenson T, 1980, Int Rehabil Med, V2, P17; Ortiz Alonso T, 2009, REV ESP GERIATR GERO, V44, P146, DOI DOI 10.1016/J.REGG.2009.01.002; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; Pereira F., 2007, AVANCES PSIQUIATRIA, V8, P153; Pruchno RA, 1997, GERONTOLOGIST, V37, P157, DOI 10.1093/geront/37.2.157; Raudenbush SW, 2004, HLM 6 WINDOWS COMPUT; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; Seel RT, 1997, ARCH PHYS MED REHAB, V78, P1254, DOI 10.1016/S0003-9993(97)90340-3; TEASDALE G, 1974, LANCET, V2, P81; Wallace CA, 2000, BRAIN INJURY, V14, P549; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3	50	5	5	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1066-4807	1552-3950		FAM J	Fam. J.	APR	2012	20	2					179	186		10.1177/1066480712441469			8	Family Studies	Emerging Sources Citation Index (ESCI)	Family Studies	V66TS	WOS:000211259100008					2022-02-06	
J	Chiou, KS; Hillary, FG				Chiou, Kathy S.; Hillary, Frank G.			Benefits of Order: The Influence of Item Sequencing on Metacognition in Moderate and Severe Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Awareness; Self-assessment; Judgment; Adult; Brain injury; Task performance and analysis	TEXT DIFFICULTY; COMPREHENSION; PREDICTIONS; CALIBRATION; METAMEMORY; AWARENESS; ACCURACY; ADULTS	The ability to appraise one's own ability has been found to have an important role in the recovery and quality of life of clinical populations. Examinee and task variables have been found to influence metacognition in healthy students; however the effect of these variables on the metacognitive accuracy of adults with neurological insult, such as traumatic brain injury (TBI), remains unknown. Twenty-two adults with moderate and severe TBI and a matched sample of healthy adults participated in this study examining the influence of item sequencing on metacognitive functioning. Retrospective confidence judgments were collected while participants completed a modified version of the Matrix Reasoning subtest. Significant influence of item sequence order was found, revealing better metacognitive abilities and performance when participants completed tasks where item difficulty progressed in order from easy to difficult. We interpret these findings to suggest that the sequencing of item difficulty offers "anchors" for gauging and adjusting to task demands. (JINS, 2012, 18, 379-383)	[Chiou, Kathy S.; Hillary, Frank G.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA		Hillary, FG (corresponding author), 347 Moore Bldg, University Pk, PA 16802 USA.	fhillary@psu.edu	Hillary, Frank/AAN-8622-2021		New Jersey Commission on Brain Injury Research [0120090178]	The authors thank Neal M. Fitzpatrick, Tia Bochnakova, Julia Slocomb, and Britney Wardecker for their assistance in recruitment and data collection. The authors declare that there are no conflicts of interest associated with this study and manuscript. This study was funded in part by a grant from the New Jersey Commission on Brain Injury Research (grant number 0120090178).	Anderson JW, 2009, J CLIN EXP NEUROPSYC, V31, P425, DOI 10.1080/13803390802232667; Boone D.E., 1993, J CLIN PSYCHOL, V43, P860; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Cosentino S, 2005, J INT NEUROPSYCH SOC, V11, P910, DOI 10.1017/S1355617705050964; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Kennedy MRT, 2003, BRAIN INJURY, V17, P1043, DOI 10.1080/0269905031000110436; Kennedy MRT, 2001, BRAIN INJURY, V15, P469, DOI 10.1080/02699050010007380; Lin LM, 1998, CONTEMP EDUC PSYCHOL, V23, P345, DOI 10.1006/ceps.1998.0972; Lin LM, 2002, AM J PSYCHOL, V115, P187, DOI 10.2307/1423434; MAKI RH, 1987, MEM COGNITION, V15, P72, DOI 10.3758/BF03197713; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; WEAVER CA, 1995, MEM COGNITION, V23, P12, DOI 10.3758/BF03210553; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Whyte J., 2005, REHABILITATION MED P, P1677; Zhao Q, 2008, EDUC PSYCHOL REV, V20, P191, DOI 10.1007/s10648-008-9073-8	20	5	5	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177			J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	MAR	2012	18	2					379	383		10.1017/S1355617711001846			5	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	899DI	WOS:000300794600023	22317853				2022-02-06	
J	Harris, AW; Voaklander, DC; Jones, CA; Rowe, BH				Harris, Andrew W.; Voaklander, Donald C.; Jones, C. Allyson; Rowe, Brian H.			Time-to-Subsequent Head Injury From Sports and Recreation Activities	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						subsequent head injuries; concussions; sports and recreation; emergency department; population based	COLLEGIATE FOOTBALL PLAYERS; WEST-UNIVERSITY FOOTBALL; ICE HOCKEY PLAYERS; PROFESSIONAL FOOTBALL; RECURRENT CONCUSSION; SOCCER PLAYERS; NEUROCOGNITIVE PERFORMANCE; MULTIPLE CONCUSSIONS; NCAA CONCUSSION; RUGBY PLAYERS	Objective: To provide population-based risk estimates for sustaining subsequent head injuries (HIs), which occur in sports and recreation (SR). Design: Population-based, retrospective, cross-sectional study. Setting: Retrospective review of data from 2 tertiary care and 3 community care emergency departments (EDs) in Edmonton, Alberta, Canada. Patients: Individuals younger than 36 years presenting to an ED with an SR-related injury between April 1, 1997, and March 31, 2008. There were 9246 subsequent ED records identified for 8958 patients in the main analysis. Main Outcome Measures: Clinically diagnosed HI occurring in SR activities after an index presentation, and the number of days between ED presentations for diagnosed SR-HIs. Results: Individuals with 1 and 2 previous SR-related HIs were 2.62 [95% confidence interval (CI), 2.23-3.07] and 5.94 times, respectively, more likely (95% CI, 3.43-10.29) to sustain a subsequent HI than those without a previous HI. The median time-to first HI was 758 days from an initial injury and decreased to 613 days and 303 days for those at risk of second and third SR-related HIs (P < 0.0001). Individuals aged 7 to 13 years were 4.29 times more likely (95% CI, 2.65-6.92) to sustain an HI when presenting with a subsequent SR injury, compared with those aged 30 to 35 years. Conclusions: The odds of sustaining a subsequent HI substantially increase with each successive HI. Time between SR-related HIs shortens as the number of HIs increases. Initial HI may be a key marker to institute high-risk injury prevention measures directed at young persons who present to EDs.	[Harris, Andrew W.; Voaklander, Donald C.; Jones, C. Allyson] Univ Alberta, Alberta Ctr Injury Control & Res, Sch Publ Hlth, Edmonton, AB T6G 2E1, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Fac Med & Dent, Edmonton, AB T6G 2E1, Canada		Harris, AW (corresponding author), Univ Alberta, Alberta Ctr Injury Control & Res, Sch Publ Hlth, 4075 RTF,8308-114 St, Edmonton, AB T6G 2E1, Canada.	awharris@ualberta.ca			Western Regional Training Centre for Health Services Research; Alberta Heritage FoundationAlberta Heritage Foundation for Medical Research; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Canadian Institutes of Health Research through the Government of Canada (Ottawa, Ontario)Canadian Institutes of Health Research (CIHR)	Mr Harris was supported by a graduate studentship from the Western Regional Training Centre for Health Services Research. Dr Jones was supported by a Population Health Investigator Award from the Alberta Heritage Foundation and a New Investigator Award from the Canadian Institutes of Health Research. Dr Rowe was supported by the 21st Century Canada Research Chairs program of the Canadian Institutes of Health Research through the Government of Canada (Ottawa, Ontario).	[Anonymous], 2009, INT CLASS DIS HLTH R, P765; [Anonymous], 2007, STAT STAT SOFTW COMP; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; Delaney JS, 2000, CLIN J SPORT MED, V10, P9, DOI 10.1097/00042752-200001000-00003; Delaney TS, 2002, CLIN J SPORT MED, V12, P331, DOI 10.1097/00042752-200211000-00003; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Gaetz M, 2000, BRAIN INJURY, V14, P1077; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagel BE, 2003, AM J EPIDEMIOL, V157, P825, DOI 10.1093/aje/kwg050; Hamilton GM, 2011, AM J EPIDEMIOL, V173, P941, DOI 10.1093/aje/kwq461; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kleinbaum DG, 2005, RECURRENT EVENT ANAL; Macciocchi SN, 2001, J ATHL TRAINING, V36, P303; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meeuwisse WH, 2003, AM J SPORT MED, V31, P379, DOI 10.1177/03635465030310030901; Meeuwisse WH, 2000, AM J SPORT MED, V28, P516, DOI 10.1177/03635465000280041201; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Puckett CD, 1998, ED ANNOTATION ICD 9, P927; Purcell L, 2009, BRIT J SPORT MED, V43, pI51, DOI 10.1136/bjsm.2009.058214; Rogers W, 1993, STATA TECHNICAL B, V2; Sahai VS, 2005, CAN J PUBLIC HEALTH, V96, P328, DOI 10.1007/BF03404025; SCHOENFELD D, 1980, BIOMETRIKA, V67, P145; Statistics Canada, 1996, COMM HIGHL EDM POP S; Statistics Canada, 2007, EDM ALB CODE835 TABL; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	52	5	5	1	21	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2012	22	2					91	97		10.1097/JSM.0b013e31823776cb			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	908RG	WOS:000301507200004	22252163				2022-02-06	
J	Yanagawa, Y; Sakamoto, T				Yanagawa, Youichi; Sakamoto, Toshihisa			Results of Single Burr Hole Drainage for Acute Subdural Hematoma with Non-Reactive Pupil	TURKISH NEUROSURGERY			English	Article						Acute subdural hematoma; Single burr hole drainage; Pupil; Herniation; Surgical outcome	GLASGOW COMA SCALE; SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; MANNITOL	AIM: To investigate the effects of emergency burr hole drainage for acute subdural hematoma (ASDH) with bilateral non-reactive pupils. MATERIAL and METHODS: A retrospective study was conducted by reviewing medical records from 1998 to 2007. Patients meeting the following criteria were included: 1) head injury with unconsciousness (Glasgow Coma Scale score 8); 2) bilateral non-reactive pupils on arrival; 3) ASDH with disappearance of basal cistern on computed tomography (CT); and 4) performance of emergency single burr hole drainage. Subjects were divided into survival and non-survival groups. RESULTS: Pupil size on the small side was significantly smaller in the survival group than in the non-survival group. All pupils on the small side in the survival group were 4 mm. CONCLUSION: Emergency burr hole drainage should still be considered in patients with ASDH showing bilateral non-reactive pupils and one pupil 4 mm.	[Yanagawa, Youichi] Juntendo Univ, Bunkyo Ku, Tokyo, Japan; [Sakamoto, Toshihisa] Natl Def Med Coll, Saitama, Japan		Yanagawa, Y (corresponding author), Juntendo Univ, Bunkyo Ku, Tokyo, Japan.	yyanaga@juntendo.ac.jp					Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Chibbaro S, 2007, SURG NEUROL, V68, P632, DOI 10.1016/j.surneu.2006.12.046; Cremer OL, 2006, J TRAUMA, V61, P1484, DOI 10.1097/01.ta.0000195981.63776.ba; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Cruz J, 2001, NEUROSURGERY, V49, P864; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Matsuyama T, 1997, SURG NEUROL, V47, P423, DOI 10.1016/S0090-3019(96)00398-9; MEYER S, 1993, ANN EMERG MED, V22, P1052, DOI 10.1016/S0196-0644(05)82750-7; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Skoglund TS, 2005, ACTA ANAESTH SCAND, V49, P337, DOI 10.1111/j.1399-6576.2005.00624.x; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4	14	5	5	0	2	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2012	22	2					196	199		10.5137/1019-5149.JTN.5206-11.0			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	920ZF	WOS:000302447100010	22437294	Bronze			2022-02-06	
J	Yang, CW; Selassie, AW; Carter, RE; Tilley, BC				Yang, Chengwu; Selassie, Anbesaw W.; Carter, Rickey E.; Tilley, Barbara C.			Measuring QoL with SF-36 in Older Americans with TBI	APPLIED RESEARCH IN QUALITY OF LIFE			English	Article						SF-36; Traumatic brain injury; Reliability; Differential item functioning (DIF); Confirmatory factor analysis (CFA); Multiple-indicator multiple-causes (MIMIC) models	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; AFRICAN-AMERICAN; FOLLOW-UP; HEALTH; POPULATION; REHABILITATION; VALIDATION; DISABILITY; DEPRESSION	This study demonstrated reliability and factor structure of the Medical Outcomes Study Short-Form Health Survey (SF-36) among older Americans with Traumatic brain injury (TBI), and evaluated effects of injury severity and race on SF-36's items and latent domains. A representative sample of 654 older, racially diverse patients with TBI was selected from the South Carolina Traumatic Brain Injury Follow-up Registry. Reliability and factor structure of SF-36 were evaluated using Cronbach's alpha and confirmatory factor analysis (CFA). Multiple-indicator multiple-causes (MIMIC) models were used to study effects of injury severity and race on items (differential item functioning, DIF) and latent domains (population heterogeneity) of SF-36. SF-36 was reliable and its current eightfactor structure was confirmed. While TBI severity did not impact latent domain scores of SF-36, race did. Blacks had higher vitality and lower role-emotional scores than whites. The measurement model was invariant to injury severity and race (free of DIF), and DIF did not contribute to the differences of vitality and role-emotional between black and white older TBI patients. SF-36 was valid to measure quality of life (OoL) after TBI in racially diverse elderly population. Blacks tend to assert to strong coping behaviors in the presence of physical stress while admitting low performance due to emotional stress. In QoL research where the primary outcomes are usually composite scores from instruments, MIMIC models have advantages over conventional multivariable regression models in testing the validity of the instruments and assessing covariate effects on latent traits of instruments while controlling for DIF effects.	[Selassie, Anbesaw W.] Med Univ S Carolina, Charleston, SC 29425 USA; [Yang, Chengwu] Penn State Univ, Coll Med, Hershey, PA 17033 USA; [Carter, Rickey E.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Tilley, Barbara C.] Univ Texas Sch Publ Hlth Houston, Houston, TX 77030 USA		Selassie, AW (corresponding author), Med Univ S Carolina, 135 Cannon St,Suite 302M, Charleston, SC 29425 USA.	selassie@musc.edu	Yang, Chengwu/X-6178-2018	Yang, Chengwu/0000-0003-0561-2340	NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG021677] Funding Source: NIH RePORTER; AHRQ HHSUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [P01 HS010871] Funding Source: Medline; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG021677] Funding Source: Medline		Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Brown SA, 2004, APPL NEUROPSYCHOL, V11, P54, DOI 10.1207/s15324826an1101_7; Brown TA, 2006, CONFIRMATORY FACTOR, P103; Bullinger M, 2002, RESTOR NEUROL NEUROS, V20, P111; Center for Injury Research and Policy of The Johns Hopkins University School of Public Health, 1997, ICMAP 90 SOFTW COMP; Coker AL, 2006, ETHNIC DIS, V16, P978; Cook DA, 2006, AM J MED, V119, pe7, DOI DOI 10.1016/J.AMJMED.2005.10.036; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Cummins RA, 2010, J FLUENCY DISORD, V35, P161, DOI 10.1016/j.jfludis.2010.05.009; de Vet HCW, 2005, QUAL LIFE RES, V14, P1203, DOI 10.1007/s11136-004-5742-3; DeVellis R., 2003, SCALE DEV THEORY APP, P27; Dimopoulou I, 2004, AM J PHYS MED REHAB, V83, P171, DOI 10.1097/01.PHM.0000107497.77487.C1; Findler M, 2001, BRAIN INJURY, V15, P715, DOI 10.1080/02699050010013941; Flanagan Steven R, 2005, Phys Med Rehabil Clin N Am, V16, P163, DOI 10.1016/j.pmr.2004.06.012; Horner MD, 2008, J HEAD TRAUMA REHAB, V23, P74, DOI 10.1097/01.HTR.0000314526.01006.c8; Iacobucci D, 2010, J CONSUM PSYCHOL, V20, P90, DOI 10.1016/j.jcps.2009.09.003; JAMES SA, 1984, J BEHAV MED, V7, P259, DOI 10.1007/BF00845359; JAMES SA, 1994, CULT MED PSYCHIAT, V18, P163, DOI 10.1007/BF01379448; Jones RN, 2006, MED CARE, V44, pS124, DOI 10.1097/01.mlr.0000245250.50114.0f; JORGE RE, 1994, J NEUROSURG, V81, P726, DOI 10.3171/jns.1994.81.5.0726; Kennepohl S, 2004, J INT NEUROPSYCH SOC, V10, P566, DOI 10.1017/S1355617704104128; Kline RB, 2005, PRINCIPLES PRACTICE, V2nd, P93; Langlois JA., 2004, TRAUMATIC BRAIN INJU; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Muthen B. O, 2002, LATENT VARIABLE ANAL; Muthen LK, 2008, MPLUS USERS GUIDE 19; Muthen LK., 2003, MPLUS SHORT COURSES; Nestvold K, 2009, BRAIN INJURY, V23, P15, DOI 10.1080/02699050802530540; Pickelsimer EE, 2006, J HEAD TRAUMA REHAB, V21, P491, DOI 10.1097/00001199-200611000-00004; Savitz SI, 1998, NEUROSURGERY, V42, P555, DOI 10.1097/00006123-199803000-00026; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Tilley B., 2003, SCI INCLUSION RECRUI; US Census Bureau, 2000, RAC 2000 US CENS; Walter S., 2009, QUALITY LIFE OUTCOME; Ware J.E., 1994, SF 36 PHYS MENTAL SU; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Whitfield KE, 2010, J NATL MED ASSOC, V102, P95, DOI 10.1016/S0027-9684(15)30496-X; Zumbo BD, 2007, J MOD APPL STAT METH, V6, P21, DOI 10.22237/jmasm/1177992180; Zumbo BD, 2007, HANDB STAT, V26, P45, DOI 10.1016/S0169-7161(06)26003-6	44	5	5	0	5	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1871-2584	1871-2576		APPL RES QUAL LIFE	Appl. Res. Qual. Life	MAR	2012	7	1					63	81		10.1007/s11482-011-9148-4			19	Social Sciences, Interdisciplinary	Social Science Citation Index (SSCI)	Social Sciences - Other Topics	892VT	WOS:000300314400004	25411585	Green Accepted			2022-02-06	
J	Elder, H				Elder, Hinemoa			An examination of Maori tamariki (child) and taiohi (adolescent) traumatic brain injury within a global cultural context	AUSTRALASIAN PSYCHIATRY			English	Article						Child and adolescent; disparities; epidemiology; Maori; traumatic brain injury	ETHNIC DISPARITIES; NEW-ZEALAND; FUNCTIONAL OUTCOMES; HEALTH-CARE; AMERICAN; TBI; REHABILITATION; TRENDS	Objective: This paper provides a pragmatic review of the literature to describe the size and shape of Maori tamariki (child) and taiohi (adolescent) traumatic brain injury (TBI) and highlight issues pertinent to psychiatrists. A review of the literature describing cultural aspects of international TBI research further contextualises these findings. Methodology: Literature searches using the words indigenous, ethnic, culture, native, native American, native Alaskan, native Hawaiian, Maori, aboriginal, traumatic brain injury, rehabilitation, paediatric, disparities and epidemiology were undertaken. Reference lists were also examined. Results: The literature is adult-centric and selected papers are summarised. Significant gaps in the literature were found. Recent local epidemiological studies describe Maori tamariki and taiohi as being significantly over-represented in TBI populations, with poorer outcomes including higher mortality rates. International research shows evidence of 'minority' culture being a risk factor for certain causes of injury and a differential rehabilitation service response. Conclusions: These findings are important for psychiatrists working with Maori. They underscore the importance of asking effectively about possible TBI history. Implications for future research to address literature gaps are evident. Kaupapa Maori rangahau (research) could be used to explore application of tikanga Maori (cultural lore) in prevention, rehabilitation and psychiatric management.	Hauora Waikato Grp, Auckland, New Zealand		Elder, H (corresponding author), Hauora Waikato Grp, POB 334, Auckland, New Zealand.	hinemoa@xtra.co.nz					Accident Compensation Corporation, 2006, TRAUM BRAIN INJ DIAG; Advisory Group on Conduct Problems, 2009, COND DIS BEST PRACT; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2009, NEUROREHABILITATION, V24, P5, DOI 10.3233/NRE-2009-0449; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Blackmer J, 1999, BRAIN INJURY, V13, P627; Burnett DM, 2003, ARCH PHYS MED REHAB, V84, P263, DOI 10.1053/apmr.2003.50091; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P303; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Deb S, 1999, AM J PSYCHIAT, V156, P374; Dickson N, 2000, NEW ZEAL MED J, V113, P241; Fergusson DM, 2005, J CHILD PSYCHOL PSYC, V46, P837, DOI 10.1111/j.1469-7610.2004.00387.x; Flores G, 2010, PEDIATRICS, V125, pE979, DOI 10.1542/peds.2010-0188; Gary KW, 2009, BRAIN INJURY, V23, P775, DOI 10.1080/02699050903200563; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hoofien D, 2001, BRAIN INJURY, V15, P189; Jansen P, 2008, HE RITENGA WHAKAARO; Keightley M, 2011, BRAIN INJURY, V25, P142, DOI 10.3109/02699052.2010.541898; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; Kelly P, 2009, CHILD ABUSE NEGLECT, V33, P393, DOI 10.1016/j.chiabu.2008.09.008; Kokiri Le Puni, 2007, TIROHANGA KI REO MA; Kolakowsky-Hayner SA, 2010, BRAIN INJURY, V24, P1428, DOI 10.3109/02699052.2010.523039; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Langlois J, 2003, MORBIDITY MORTALITY, V52, pSS; MA Oakley-Brown, 2006, RAU HINENGARO NZ MEN; de la Plata CM, 2007, J HEAD TRAUMA REHAB, V22, P113, DOI 10.1097/01.HTR.0000265099.29436.56; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Nelson LA, 2007, J HEAD TRAUMA REHAB, V22, P105, DOI 10.1097/01.HTR.0000265098.52306.a9; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Robson B, 2007, HAUORA MAORI STANDAR; Rutland-Brown W, 2005, J HEAD TRAUMA REHAB, V20, P205, DOI 10.1097/00001199-200505000-00004; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Shafi S, 2008, ARCH SURG-CHICAGO, V143, P1057, DOI 10.1001/archsurg.143.11.1057; Starkey NJ, 2009, PAED SOC NZ C; Statistics New Zealand, NAT ETHN POP PROJ; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	45	5	5	0	11	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1039-8562	1440-1665		AUSTRALAS PSYCHIATRY	Australas. Psychiatry	FEB	2012	20	1					20	23		10.1177/1039856211430147			4	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	884VT	WOS:000299737600004	22357670				2022-02-06	
J	Hsiao, KY; Chen, IC; Yang, CJ; Hsiao, CT; Chen, KH				Hsiao, Kuang-Yu; Chen, I-Chuan; Yang, Chia-Jung; Hsiao, Cheng-Ting; Chen, Kai-Hua			Is direct transport to a trauma centre best for patients with severe traumatic brain injury? A study in south-central Taiwan	EMERGENCY MEDICINE JOURNAL			English	Article							ENDOTRACHEAL INTUBATION; MORTALITY; IMPLEMENTATION; FACILITIES; SURVIVAL; SYSTEMS; IMPACT	Objective This study attempted to identify any differences between the outcomes of patients with severe traumatic brain injury (TBI) who were directly transported to Chang Gung Memorial Hospital and those who were stabilised initially at other hospitals in south-central Taiwan. Methods A retrospective review of the records of 254 patients with isolated severe TBI who visited this hospital's emergency department from July 2003 to June 2008, of whom 167 were referred from other hospitals. Logistic regression was used to assess the effects of transfer and its components on mortality. Results Transfer from another hospital was not significantly correlated with mortality in this study (OR 0.513, 95% CI 0.240 to 1.097). Moreover, neither intubation (OR 1.356, 95% CI 0.445 to 4.133) nor transfer time over 4 h (OR 0.549, 95% CI 0.119 to 1.744) had a significant effect on mortality. Conclusion No differences in outcome were found between patients with isolated severe TBI who were directly transported and those transferred to this hospital's emergency room.	[Chen, Kai-Hua] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Putz City 613, Chiayi County, Taiwan; [Hsiao, Kuang-Yu; Chen, I-Chuan; Yang, Chia-Jung; Hsiao, Cheng-Ting] Chang Gung Mem Hosp, Dept Emergency Med, Putz City 613, Chiayi County, Taiwan; [Hsiao, Kuang-Yu; Chen, I-Chuan; Hsiao, Cheng-Ting; Chen, Kai-Hua] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hsiao, Kuang-Yu; Chen, I-Chuan] Chang Gung Inst Technol, Chiayi, Taiwan		Chen, KH (corresponding author), Chang Gung Mem Hosp, Dept Phys Med & Rehabil, 6 West Sec,Chia Pu Rd, Putz City 613, Chiayi County, Taiwan.	karenkhchen@mail2000.com.tw					Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; CALES RH, 1984, ANN EMERG MED, V13, P1, DOI 10.1016/S0196-0644(84)80375-3; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Davis DP, 2003, J TRAUMA, V54, P444, DOI 10.1097/01.TA.0000053396.02126.CD; DiRusso S, 2001, J TRAUMA, V51, P294, DOI 10.1097/00005373-200108000-00011; Harrington DT, 2005, ANN SURG, V241, P961, DOI 10.1097/01.sla.0000164178.62726.f1; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hsiao KY, 2008, EMERG MED J, V25, P670, DOI 10.1136/emj.2007.053405; Mann NC, 2001, MED CARE, V39, P643, DOI 10.1097/00005650-200107000-00001; Murray JA, 2000, J TRAUMA, V49, P1065, DOI 10.1097/00005373-200012000-00015; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; Sampalis JS, 1999, J TRAUMA, V46, P565, DOI 10.1097/00005373-199904000-00004; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; Stockinger ZT, 2004, J TRAUMA, V56, P531, DOI 10.1097/01.TA.0000111755.94642.29; Svenson J, 2008, AM J EMERG MED, V26, P465, DOI 10.1016/j.ajem.2007.05.013; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592	20	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1472-0205	1472-0213		EMERG MED J	Emerg. Med. J.	FEB	2012	29	2					156	159		10.1136/emj.2010.097295			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	879DS	WOS:000299310500018	21045218				2022-02-06	
J	Odland, RM; Venugopal, S; Borgos, J; Coppes, V; McKinney, AM; Rockswold, G; Shi, J; Panter, S				Odland, Rick M.; Venugopal, Sandya; Borgos, John; Coppes, Valerie; McKinney, Alexander M.; Rockswold, Gaylan; Shi, Jian; Panter, Scott			Efficacy of Reductive Ventricular Osmotherapy in a Swine Model of Traumatic Brain Injury	NEUROSURGERY			English	Article						Cerebral edema; Hollow fibers; Osmotherapy; Porcine; Reductive ventricular osmotherapy; Traumatic brain injury	INCREASED INTRACRANIAL-PRESSURE; HYPERTONIC SALINE; INTRAVENTRICULAR ALBUMIN; CELLULAR EDEMA; MANNITOL; MARKER; OXYGEN; TRIAL	BACKGROUND: The presence of osmotic gradients in the development of cerebral edema and the effectiveness of osmotherapy are well recognized. A modification of ventriculostomy catheters described in this article provides a method of osmotherapy that is not currently available. The reductive ventricular osmotherapy (RVOT) catheter removes free water from ventricular cerebrospinal fluid (CSF) by incorporating hollow fibers that remove water vapor, thereby providing osmotherapy without increasing osmotic load. OBJECTIVE: To increase osmolarity in the ventricular CSF through use of RVOT in vivo. METHODS: Twelve Yorkshire swine with contusional injury were randomized to external ventricular drainage (EVD) or RVOT for 12 hours. MR imaging was obtained. Serum, CSF, and brain ultrafiltrate were analyzed. Histology was compared using Fluor-Jade B and hematoxylin and eosin (H & E) stains. RESULTS: With RVOT, CSF osmolality increased from 292 +/- 2.7 to 345 +/- 8.0 mOsmol/kg (mean +/- SE, P = 0.0006), and the apparent diffusion coefficient (ADC) in the injury region increased from 0.735 +/- 0.047 to 1.135 +/-.063 (P = 0.004) over 24 hours. With EVD controls, CSF osmolarity and ADC were not significantly changed. Histologically, all RVOT pigs showed no evidence of neuronal degeneration (Grade 1/4) compared to moderate degeneration (Grade 2.6 +/- .4/4) seen in EVD treated animals (P = 0.02). The difference in intracranial pressure (ICP) by area under the curve approached significance at P = .065 by Mann Whitney test. CONCLUSION: RVOT can increase CSF osmolarity in vivo after experimental traumatic brain injury (TBI). In anticipated clinical use, only a slight increase in CSF osmolarity may be required to reduce cerebral edema.	[Odland, Rick M.] Hennepin Cty Med Ctr, Dept Otolaryngol, Minneapolis, MN 55415 USA; [Odland, Rick M.; Borgos, John] Twin Star Med, Minneapolis, MN USA; [Venugopal, Sandya; Coppes, Valerie; Shi, Jian; Panter, Scott] UCSF, San Francisco Vet Adm Hosp No Calif Inst Res & Ed, San Francisco, CA USA; [McKinney, Alexander M.] Hennepin Cty Med Ctr, Dept Radiol, Minneapolis, MN 55415 USA; [Rockswold, Gaylan] Hennepin Cty Med Ctr, Dept Neurosurg, Minneapolis, MN 55415 USA; [Odland, Rick M.; McKinney, Alexander M.; Rockswold, Gaylan] Univ Minnesota, Minneapolis, MN USA		Odland, RM (corresponding author), Hennepin Cty Med Ctr, Dept Otolaryngol Head & Neck Surg, 701 Pk Ave, Minneapolis, MN 55415 USA.	odlan007@umn.edu		mckinney, alexander/0000-0003-2530-5970	National Institute of Neurologic Disorders and Stroke (NIH/SBIR) [NS43832]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R44NS043832, R43NS043832] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurologic Disorders and Stroke (NIH/SBIR Grant # NS43832 to Twin Star Medical, Inc.). All authors received grant support through this NIH grant.	BANDARANAYAKE NM, 1978, STROKE, V9, P249, DOI 10.1161/01.STR.9.3.249; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen KC, 2000, P NATL ACAD SCI USA, V97, P8306, DOI 10.1073/pnas.150338197; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Harutjunyan L, 2005, CRIT CARE, V9, pR530, DOI 10.1186/cc3767; HATASHITA S, 1986, J CEREBR BLOOD F MET, V6, P546, DOI 10.1038/jcbfm.1986.100; Hossman K, 1976, DYNAMICS BRAIN EDEMA, P219; Huyette DR, 2008, J NEUROSURG, V108, P88, DOI 10.3171/JNS/2008/108/01/0088; Is M, 2005, NEUROL RES, V27, P67, DOI 10.1179/016164105X18296; Kawamata Tatsuro, 2007, Neurosurg Focus, V22, pE5, DOI 10.3171/foc.2007.22.5.6; Kerwin AJ, 2009, J TRAUMA, V67, P277, DOI 10.1097/TA.0b013e3181acc726; LeRoux PD, 1997, J NEUROSURG, V87, P1, DOI 10.3171/jns.1997.87.1.0001; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Odland RM, 2011, J NEUROTRAUM, V28, P135, DOI 10.1089/neu.2010.1282; Odland RM, 1999, NEUROL RES, V21, P500, DOI 10.1080/01616412.1999.11740965; Onal C, 1997, ACTA NEUROCHIR, V139, P661, DOI 10.1007/BF01412002; Paredes-Andrade E, 2011, NEUROCRITICAL CARE; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; SEVICK RJ, 1992, RADIOLOGY, V185, P687, DOI 10.1148/radiology.185.3.1438745; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Sutton RS, 1999, J NEUROTRAUM, V16, P987; Tyagi R, 2007, NEUROSURG REV, V30, P277, DOI 10.1007/s10143-007-0091-7; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Venugopal S, 2008, J NEUROTRAUM, V25, P930; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF	32	5	5	0	9	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	FEB	2012	70	2					445	454		10.1227/NEU.0b013e318230ee5e			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	879IK	WOS:000299322700054	21826032	Green Accepted			2022-02-06	
J	Sharpe, S; Kool, B; Shepherd, M; Dalziel, S; Ameratunga, S				Sharpe, Sarah; Kool, Bridget; Shepherd, Michael; Dalziel, Stuart; Ameratunga, Shanthi			Mild traumatic brain injury: Improving quality of care in the paediatric emergency department setting	JOURNAL OF PAEDIATRICS AND CHILD HEALTH			English	Article						child; closed head injury; quality of health care; traumatic brain injury	HEAD-INJURY; EARLY-CHILDHOOD; NEW-ZEALAND; CHILDREN; DIAGNOSIS; ACCURACY; OUTCOMES; COHORT; IDENTIFICATION; PERFORMANCE	Aim: Traumatic brain injury (TBI) in childhood can impose a significant threat to life and longer-term disability. This study investigated the extent to which the documentation of key indicators of healthcare quality in the emergency department (ED) setting was consistent with clinical guidelines for the management of children with mild TBI (MTBI). Methods: The clinical records of a random sample of 60 children (stratified by ethnicity and age group), who were seen and discharged from a large metropolitan paediatric hospital ED following a head injury, were systematically reviewed to examine the processes of care and follow-up. Results: Based on the documentation in clinical records, processes designed to identify and manage potentially life-threatening acute complications (e. g. computed tomography scanning to identify intracranial haemorrhage) were consistent with best practice standards. However gaps existed between current and best practice for some aspects of care that could minimise risks of longer-term disability from MTBI. For example, relevant clinical criteria were well documented, but this information did not appear to be applied systematically to identify and to follow up children with definite or possible MTBI. Conclusion: The apparent absence of a systematic approach to the diagnosis and follow-up of MTBI in children presenting to ED suggests a missed opportunity to minimise the risk of disability following these injuries. Greater attention to an integrated care pathway that improves the identification, documentation, and follow-up of children with MTBI presenting to ED is required.	[Sharpe, Sarah; Kool, Bridget; Ameratunga, Shanthi] Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1142, New Zealand; [Shepherd, Michael; Dalziel, Stuart] Starship Childrens Hlth Serv, Childrens Emergency Dept, Auckland, New Zealand		Kool, B (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Private Bag 92019, Auckland 1142, New Zealand.	b.kool@auckland.ac.nz		Ameratunga, Shanthi/0000-0001-8042-2251	School of Population Health, University of Auckland, New Zealand; New Zealand Population Health Charitable Trust	This study was partially funded by a performance based research fund grant allocated by the School of Population Health, University of Auckland, New Zealand. Sarah Sharpe received funding from the New Zealand Population Health Charitable Trust, which provides the Public Health Medicine Training Programme in New Zealand.	Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P32, DOI 10.1159/000170090; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Blostein P, 2003, J TRAUMA, V55, P450, DOI 10.1097/01.TA.0000038545.24879.4D; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centers for Disease Control and Prevention National Center for Injury Prevention and Control, 2008, HEAD BRAIN INJ YOUR; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; CROMBIE IK, 1992, BRIT J HOSP MED, V48, P182; Day Heather, 2006, Minn Med, V89, P40; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gronwall D, 1997, J Int Neuropsychol Soc, V3, P592; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Jansen P, 2008, HE RITENGA WHAKAARO; Kennedy JE, 2006, MIL MED, V171, P516, DOI 10.7205/MILMED.171.6.516; Kool B, 2004, COMPREHENSIVE NATL R; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Law A, 2009, MANAGEMENT PAEDIAT H; Mateo Magdalena A, 2003, Lippincotts Case Manag, V8, P203, DOI 10.1097/00129234-200309000-00005; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McNaughton H, 2000, NEW ZEAL MED J, V113, P184; Ministry of Health, 2002, CLIN EXC INTR CLIN A; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; National Institute for Clinical Excellence, 2002, PRINC BEST PRACT CLI; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2001, PEDIATRICS, V108, P1297, DOI 10.1542/peds.108.6.1297; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Ragoo M, 2005, SCOT MED J, V50, P99, DOI 10.1177/003693300505000303; Seddon M, 2006, NZ MED J, V119; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Smylie J, 2009, INDIGENOUS CHILDRENS; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Swaine BR, 2007, PEDIATRICS, V119, P749, DOI 10.1542/peds.2006-1186; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; WALLACE SA, 1994, J ACCID EMERG MED, V11, P25; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375	48	5	5	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1034-4810	1440-1754		J PAEDIATR CHILD H	J. Paediatr. Child Health	FEB	2012	48	2					170	176		10.1111/j.1440-1754.2011.02068.x			7	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	889BT	WOS:000300049200032	21470335				2022-02-06	
J	Abbate, C; Trimarchi, PD; Salvi, GP; Quarenghi, AM; Vergani, C; Luzzatti, C				Abbate, Carlo; Trimarchi, Pietro Davide; Salvi, Gian Pietro; Quarenghi, Anna Maria; Vergani, Carlo; Luzzatti, Claudio			Delusion of inanimate doubles: Description of a case of focal retrograde amnesia	NEUROCASE			English	Article						Delusion of inanimate doubles; Misidentification of inanimate objects; Misidentification syndrome; Capgras; Retrograde amnesia	CAPGRAS-SYNDROME; NORMATIVE VALUES; TEST SCORE; MEMORY; MISIDENTIFICATION; PATIENT; VARIANT; PEOPLE; RECOGNITION; ABNORMALITY	This paper reports the case of a patient, M. P., who developed delusion of inanimate doubles, without Capgras syndrome, after traumatic brain injury. His delusional symptoms were studied longitudinally and the cognitive impairments associated with delusion were investigated. Data suggest that M. P. did 'perceive' the actual differences between doubles and originals rather than 'confabulate' them. The cognitive profile, characterized by retrograde episodic amnesia, but neither object processing impairment nor confabulations, supports this hypothesis. The study examines the nature of object misidentification based on Ellis' and Staton's account and proposes a new account based on concurrent unbiased retrieval of semantic memory traces and biased recollection of episodic memory traces.	[Abbate, Carlo; Vergani, Carlo] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Med Interna, Unita Geriatria, I-20122 Milan, Italy; [Abbate, Carlo; Salvi, Gian Pietro; Quarenghi, Anna Maria] Casa Cura Dr Quarenghi, Bergamo, Italy; [Trimarchi, Pietro Davide; Luzzatti, Claudio] Univ Milano Bicocca, Milan, Italy; [Vergani, Carlo] Univ Milan, Milan, Italy		Abbate, C (corresponding author), Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dipartimento Med Interna, Unita Geriatria, Via Pace 9, I-20122 Milan, Italy.	carlo.abbate@guest.unimi.it	Abbate, Carlo/M-3116-2018	Abbate, Carlo/0000-0002-0368-3834; LUZZATTI, CLAUDIO GIUSEPPE/0000-0001-6334-6293			ABED RT, 1990, BRIT J PSYCHIAT, V157, P915, DOI 10.1192/bjp.157.6.915; ANDERSON DN, 1994, PSYCHOPATHOLOGY, V27, P220, DOI 10.1159/000284873; ANDERSON DN, 1988, BRIT J PSYCHIAT, V153, P694, DOI 10.1192/bjp.153.5.694; Andreani O., 1990, MLT 88 TEST MEMORIA; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; Benton A. L., 1992, TEST RICONOSCIMENTO; BERSON RJ, 1983, AM J PSYCHIAT, V140, P969; Bidault E., 1986, BIBL PSYCHIAT, V164, P80; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; CASTILLO PM, 1994, BRIT J PSYCHIAT, V164, P693, DOI 10.1192/bjp.164.5.693; CHRISTODOULOU GN, 1978, AM J PSYCHIAT, V135, P249; Coleman SM, 1933, J MENT SCI, V79, P42, DOI 10.1192/bjp.79.324.42; Cotard J., 1882, ARCH NEUROL-CHICAGO, V4, P152; Courbon P., 1927, B SOC CLIN MED MENTA, V15, P121; Courbon P., 1932, ANN MED-PSYCHOL, V90, P401; Crawford JR, 1998, J CLIN EXP NEUROPSYC, V20, P898, DOI 10.1076/jcen.20.6.898.1112; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; CROVITZ HF, 1974, B PSYCHONOMIC SOC, V4, P517; DALLABARBA G, 1993, CORTEX, V29, P567, DOI 10.1016/S0010-9452(13)80281-X; DALLABARBA G, 1993, COGN NEUROPSYCHOL, V10, P1; De Agostini Iniziative Speciali, 2001, MOND 100 ANN UOM FAT; De Renzi E., 1985, NEUROPSYCHOLOGICAL S, V23, P45; De Tanti A., 1998, EUR MED PHYS, V34, P211; Della Sala S, 2003, NEUROL SCI, V24, P10, DOI 10.1007/s100720300015; DELLASALA S, 1995, ARCH CLIN NEUROPSYCH, V10, P511, DOI 10.1016/0887-6177(94)00049-V; Devinsky O, 2009, NEUROLOGY, V72, P80, DOI 10.1212/01.wnl.0000338625.47892.74; Doran JM, 1990, NEUROPSYCHOLOGY, V4, P29; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; ELLIS AW, 1989, BRAIN, V112, P1469, DOI 10.1093/brain/112.6.1469; Ellis H D, 1996, Cogn Neuropsychiatry, V1, P27, DOI 10.1080/135468096396686; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Enoch M. D., 1979, UNCOMMON PSYCHIAT SY; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardiner JM., 2000, OXFORD HDB MEMORY, P229; Gentileschi V, 2001, COGN NEUROPSYCHOL, V18, P439, DOI 10.1080/02643290125835; Ghidoni E., 1995, Archivio di Psicologia Neurologia e Psichiatria, V56, P428; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Humphreys GW., 1993, BORB BIRMINGHAM OBJE; Kapur N, 1999, PSYCHOL BULL, V125, P800, DOI 10.1037/0033-2909.125.6.800; Kimura S, 1986, Bibl Psychiatr, P121; Kopelman MD, 2002, BRAIN, V125, P2152, DOI 10.1093/brain/awf229; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Laiacona M., 1993, ARCH PSICOLOGIA NEUR, V2, P209; MACKIE J, 1994, BEHAV NEUROL, V7, P211, DOI 10.3233/BEN-1994-73-417; Manera M, 2006, P ANN M SOC IT RIAB, P106; Markowitsch HJ, 2003, NEUROIMAGE, V20, pS132, DOI 10.1016/j.neuroimage.2003.09.010; Mattioli F, 1999, CORTEX, V35, P413, DOI 10.1016/S0010-9452(08)70809-8; Mauri M., 1997, ARCH PSICOL NEUROL P, V58, P621; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; MCCARTHY RA, 1992, NEUROPSYCHOLOGIA, V30, P633, DOI 10.1016/0028-3932(92)90068-W; Nejad AG, 2006, ACTA NEUROPSYCHIATR, V18, P52, DOI 10.1111/j.0924-2708.2006.00114.x; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; PICK A, 1903, BRAIN, V26, P260; RASTOGI SC, 1990, BRIT J PSYCHIAT, V156, P883, DOI 10.1192/bjp.156.6.883; Raven J. C., 1984, MANUALE ISTRUZIONI M; Reboul-Lachaux J, 1923, B SOC CLIN MED MENTA, V11, P6; REID I, 1993, BEHAV NEUROL, V6, P225, DOI 10.3233/BEN-1993-6409; Rosler A, 2001, J NEUROPSYCH CLIN N, V13, P429, DOI 10.1176/appi.neuropsych.13.3.429; Sautter S. W., 1991, NEUROPSYCHOLOGY, V5, P139; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SHRABERG D, 1979, J CLIN PSYCHIAT, V40, P313; SILVA JA, 1995, CAN J PSYCHIAT, V40, P277; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; Spinnler M., 1987, ITAL J NEUROL SCI, V6, P1; STATON RD, 1982, CORTEX, V18, P23, DOI 10.1016/S0010-9452(82)80016-6; Verga R, 1996, METHOD MADNESS CASE, P187; Vignolo, 1966, CORTEX, V2, P50, DOI [10.1016/S0010-9452(66)80028-X, DOI 10.1016/S0010-9452(66)80028-X]; Visch-Brink E. G., 1993, DEV ASSESSMENT REHAB, P211; WEINSTEIN EA, 1954, BRAIN, V77, P45, DOI 10.1093/brain/77.1.45; WRIGHT B, 1994, IRISH J PSYCHOL MED, V11, P31, DOI 10.1017/S0790966700016037; YOUNG AW, 1993, BRIT J PSYCHIAT, V162, P695, DOI 10.1192/bjp.162.5.695; [No title captured]	75	5	5	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2012	18	6					457	477		10.1080/13554794.2011.627344			21	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	040LC	WOS:000311323100003	22229550				2022-02-06	
J	Buck, PW; Laster, RG; Sagrati, JS; Kirzner, RS				Buck, Page Walker; Laster, Rebecca G.; Sagrati, Jocelyn Spencer; Kirzner, Rachel Shapiro			Working with Mild Traumatic Brain Injury: Voices from the Field	REHABILITATION RESEARCH AND PRACTICE			English	Article							SERVICE MEMBERS; THERAPY; IMPACT; CARE	Mild traumatic brain injury (mTBI), also known as concussion, is an emerging public health issue in the United States. The estimated annual 1.2 million individuals who sustain this injury face a range of cognitive, psychological, and physical consequences for which rehabilitation protocols are being developed and implemented. On the frontlines of this developing area of rehabilitation work are professionals in a range of therapeutic settings whose practice wisdom has yet to be shared in the professional literature. This qualitative study aimed to fill this gap by exploring the experiences and insights of rehabilitation professionals serving mTBI patients in outpatient, civilian settings. An analysis of the qualitative data revealed five themes common in mTBI work, providing an in-depth look at this often challenging field of rehabilitation.	[Buck, Page Walker] West Chester Univ, Grad Social Work Dept, W Chester, PA 19383 USA; [Laster, Rebecca G.] Bryn Mawr Coll, Grad Sch Social Work & Social Res, Bryn Mawr, PA 19010 USA; [Sagrati, Jocelyn Spencer] Survivors Abuse Recovery Inc, Direct Clin Serv, Wilmington, DE 19803 USA; [Kirzner, Rachel Shapiro] Public Hlth Management Corp, Specialized Hlth Serv, Philadelphia, PA 19102 USA		Buck, PW (corresponding author), West Chester Univ, Grad Social Work Dept, W Chester, PA 19383 USA.	pbuck@wcupa.edu			Faculty Grants Development program at West Chester University of Pennsylvania	This research project was funded through the Faculty Grants Development program at West Chester University of Pennsylvania and would not have been possible without the excellent research assistance of Cathy Allen Plaisted. The authors would also like to thank S. Walker, J. Martin, L. Alexander, and S. Nath for their support.	ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Connelly F M, 1990, EDUC RESEARCHER, V19, P2, DOI DOI 10.3102/0013189X019005002; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; Gordon WA, 2000, BRAIN INJURY, V14, P21, DOI 10.1080/026990500120907; Greenwald B. D., 2009, MED MANAGEMENT ADULT, P129; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Kennedy JE, 2006, MIL MED, V171, P516, DOI 10.7205/MILMED.171.6.516; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Radomski MV, 2009, AM J OCCUP THER, V63, P646, DOI 10.5014/ajot.63.5.646; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Smith R, 2001, BMJ-BRIT MED J, V322, P1073, DOI 10.1136/bmj.322.7294.1073; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3	19	5	5	0	0	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-2867	2090-2875		REHABIL RES PRACT	Rehabil. Res. Pract.		2012	2012								625621	10.1155/2012/625621			6	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V18NK	WOS:000214757900025	22448333	Green Submitted, gold, Green Published			2022-02-06	
J	Charbonneau, S; Lemarie, CA; Peng, HT; Ganopolsky, JG; Shek, PN; Blostein, MD				Charbonneau, Sophie; Lemarie, Catherine A.; Peng, Henry T.; Ganopolsky, Jorge G.; Shek, Pang N.; Blostein, Mark D.			Surface-attached amphipathic peptides reduce hemorrhage in vivo	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Amphipathic peptide; coagulation; hemorrhage	MODEL; INJURY; HEMOSTASIS; MORPHOLOGY; DRESSINGS; HYDROGEL; GLUE	BACKGROUND: The leading causes of death for trauma patients in civilian and combat settings are traumatic brain injury and uncontrolled hemorrhage, respectively. This study examines the hemostatic activity of an ideal amphipathic peptide (IAP) attached to a biocompatible surface. METHODS: Procoagulant properties of IAP attached to a surface were first tested, in vitro, using factor Xa and thrombin generation assays and thromboelastography. Rabbits and swine were used for in vivo studies. Injuries were performed using scalpel blade 11, and free bleeding was allowed for five seconds. While bleeding, IAP coupled to a hydrogel or QuikClot were applied to the wound and the time was recorded until bleeding stopped. RESULTS: Results show that when IAP is attached to a surface, both factor IXa and factor Xa activities are promoted. Thromboelastography shows that surface-attached IAP results in earlier onset and stronger clot formation. In rabbits, the incorporation of IAP onto a biocompatible hydrogel reduces bleeding times by 40% (p < 0.03). In pigs, bleeding times are reduced 30% to 50% (p < 0.02) by surface-coupled IAP. Finally, using a rabbit liver laceration model, the properties of surface-coupled IAP are less damaging when compared with QuikClot, a currently used material in external hemorrhagic injuries. CONCLUSIONS: This study provides a relevant proof of concept for the development of IAP coupled to a biocompatible surface as a hemostatic agent, that is potentially safer than the commercially available QuikClot. (J Trauma. 2012;72: 136-142. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Charbonneau, Sophie; Lemarie, Catherine A.; Ganopolsky, Jorge G.; Blostein, Mark D.] McGill Univ, Jewish Gen Hosp, Dept Med, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Peng, Henry T.; Shek, Pang N.] Def Res & Dev Canada Toronto, Toronto, ON, Canada		Blostein, MD (corresponding author), SMDB Jewish Gen Hosp, Room E-156,3755 Cote St Catherine Rd, Montreal, PQ H3T 1E2, Canada.	mark.blostein@mcgill.ca	Peng, Henry/ABA-1912-2021	Peng, Henry/0000-0001-5276-9573; Lemarie, Catherine/0000-0002-3897-4287	Defense Research and Development Canada	Supported by a research contract with Defense Research and Development Canada.	Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251; Alam HB, 2005, MIL MED, V170, P63, DOI 10.7205/MILMED.170.1.63; Alam HB, 2005, J TRAUMA, V59, P34; Alam HB, 2004, J TRAUMA, V56, P974, DOI 10.1097/01.TA.0000127763.90890.31; Alam HB, 2003, J TRAUMA, V54, P1077, DOI 10.1097/01.TA.0000068258.99048.70; Artzi N, 2009, ADV MATER, V21, P3399, DOI 10.1002/adma.200900340; Bennett SL, 2003, J CARDIAC SURG, V18, P494, DOI 10.1046/j.0886-0440.2003.00303.x; Blostein MD, 2000, BIOCHEMISTRY-US, V39, P12000, DOI 10.1021/bi000655c; Ganopolsky JG, 2008, BIOCHEM J, V412, P545, DOI 10.1042/BJ20071448; Grotenhuis JA, 2005, SURG NEUROL, V64, P490, DOI 10.1016/j.surneu.2005.03.041; Gustafson SB, 2007, PREHOSP EMERG CARE, V11, P172, DOI 10.1080/10903120701205893; Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115; Kacher DF, 2006, NEUROSURGERY, V58, P140, DOI 10.1227/01.NEU.0000193518.71825.D7; Kheirabadi BS, 2005, J TRAUMA, V59, P25, DOI 10.1097/01.TA.0000171458.72037.EE; Kofinas P, 1997, BIOMATERIALS, V18, P1361, DOI 10.1016/S0142-9612(97)00077-X; Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013; Malmquist JP, 2008, J ORAL MAXIL SURG, V66, P1177, DOI 10.1016/j.joms.2007.12.023; Neuffer MC, 2004, MIL MED, V169, P716, DOI 10.7205/MILMED.169.9.716; Oliveira ED, 2003, MACROMOLECULES, V36, P6189, DOI 10.1021/ma021468k; Patila T, 2008, J SURG RES, V148, P181, DOI 10.1016/j.jss.2007.07.002; Peng HT, 2009, J BIOMED MATER RES B, V89B, P199, DOI 10.1002/jbm.b.31206; Rhee WM, 1999, US Patent, Patent No. [5,874,500, 5874500]; SILVER FH, 1995, J APPL BIOMATER, V6, P175, DOI 10.1002/jab.770060306; Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44; Wright JK, 2004, J TRAUMA, V57, P224, DOI 10.1097/01.TA.0000105916.30158.06	25	5	5	0	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					136	142		10.1097/TA.0b013e31823183b4			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	898IF	WOS:000300734800029	22027883				2022-02-06	
J	Chu, JJ; Beckwith, JG; Leonard, DS; Paye, CM; Greenwald, RM				Chu, Jeffrey J.; Beckwith, Jonathan G.; Leonard, Daniel S.; Paye, Corey M.; Greenwald, Richard M.			Development of a Multimodal Blast Sensor for Measurement of Head Impact and Over-pressurization Exposure	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Brain injury; Military; Blast; Head	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; ACCELERATION; CONCUSSION; FOOTBALL; ACCELEROMETERS; MECHANISM; IRAQ	It is estimated that 10-20% of United States soldiers returning from Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) have suffered at least one instance of blast-induced traumatic brain injury (bTBI) with many reporting persistent symptomology and long-term effects. This variation in blast response may be related to the complexity of blast waves and the many mechanisms of injury, including over-pressurization due to the shock wave and potential for blunt impacts to the head from shrapnel or from other indirect impacts (e.g., building, ground, and vehicle). To help differentiate the effects of primary, secondary, and tertiary effects of blast, a custom sensor was developed to simultaneously measure over-pressurization and blunt impact. Moreover, a custom, complementary filter was designed to differentiate the measurements of blunt (low-frequency bandwidth) from over-pressurization (high-frequency bandwidth). The custom sensor was evaluated in the laboratory using a shock tube to simulate shock waves and a drop fixture to simulate head impacts. Both bare sensors and sensor embedded within an ACH helmet coupon were compared to laboratory reference transducers under multiple loading conditions (n = 5) and trials at each condition (n = 3). For all comparative measures, peak magnitude, peak impulse, and cross-correlation measures, R-2 values, were greater than 0.900 indicating excellent agreement of peak measurements and time-series comparisons with laboratory measures.	[Chu, Jeffrey J.; Beckwith, Jonathan G.; Leonard, Daniel S.; Paye, Corey M.; Greenwald, Richard M.] Simbex, Lebanon, NH 03766 USA; [Greenwald, Richard M.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Beckwith, JG (corresponding author), Simbex, 10 Water St,Suite 410, Lebanon, NH 03766 USA.	jbeckwith@simbex.com			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-10-CD-0018]	This study was supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-10-CD-0018.	Bandak F. A., 1994, SAE TECHNICAL PAPER, P145; Bolander R., 2011, ANN BIOMED ENG; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dionne J.-P., 2010, APPL SCI BIOM COMM T, P1; Duma S., 2004, AM SOC BIOMECH; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Mertz H. J., 1967, THESIS WAYNE STATE U; Mital N. K., 1979, J APPL MECH, V46, P552; National Research Council, 2006, 08104M04 NAT COMM ST, P1; National Telecommunications and Information Administration, 1037C NAT TEL INF AD; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson S, 2011, J APPL BIOMECH, V27, P8, DOI 10.1123/jab.27.1.8; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; Winter D, 1990, BIOMECHANICS MOTOR C, P41; Zappa B, 2001, J DYN SYST-T ASME, V123, P552, DOI 10.1115/1.1386649	25	5	5	0	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964			ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2012	40	1			SI		203	212		10.1007/s10439-011-0410-6			10	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	895HJ	WOS:000300486700018	21994064				2022-02-06	
S	Dambinova, SA		Dambinova, SA; Hayes, RL; Wang, KKW		Dambinova, Svetlana A.			Neurodegradomics: The Source of Biomarkers for Mild Traumatic Brain Injury	BIOMARKERS FOR TRAUMATIC BRAIN INJURY	RSC Drug Discovery Series		English	Article; Book Chapter							TRANSIENT ISCHEMIC ATTACK; GLUTAMATE-RECEPTOR; AMPA RECEPTOR; LIMBIC ENCEPHALITIS; NMDA RECEPTOR; RASMUSSENS ENCEPHALITIS; TERMINAL DOMAIN; AUTOANTIBODIES; BLOOD; ANTIBODIES		Kennesaw State Univ, WellStar Coll Hlth & Human Serv, Lab Brain Biomarkers, Kennesaw, GA 30144 USA		Dambinova, SA (corresponding author), Kennesaw State Univ, WellStar Coll Hlth & Human Serv, Lab Brain Biomarkers, 1000 Chastain Rd, Kennesaw, GA 30144 USA.	sdambino@kennesaw.edu					Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Alves O. L., 2001, MOL CELLULAR BIOL CR, P1; Amor S., 2011, AUTOIMMUNITY NEURONA; Andrews PI, 1996, CURR OPIN NEUROBIOL, V6, P673; Ashby Michael C., 2008, P1; Basten A, 2010, CURR OPIN IMMUNOL, V22, P566, DOI 10.1016/j.coi.2010.08.001; Bataller L, 2010, NEUROLOGY, V74, P265, DOI 10.1212/WNL.0b013e3181cb3e52; Bechtereva N. P., 2007, MAGIC BRAIN LABYRINT, P56; Bergles DE, 2010, BRAIN RES REV, V63, P130, DOI 10.1016/j.brainresrev.2009.12.003; BESEDIN V I, 1985, Biokhimiya, V50, P363; Betzen C, 2009, FREE RADICAL BIO MED, V47, P1212, DOI 10.1016/j.freeradbiomed.2009.07.034; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOBRYSHEV YV, 1989, TSITOLOGIYA+, V31, P176; Bokesch PM, 2006, STROKE, V37, P1432, DOI 10.1161/01.STR.0000221295.14547.c8; Busija D. W., 1996, NERVOUS CONTROL BLOO, P177; Capone F, 2008, PSYCHOPHARMACOLOGY, V197, P535, DOI 10.1007/s00213-007-1062-y; Carlson NG, 2001, J NEUROSCI RES, V63, P480, DOI 10.1002/jnr.1042; CHOI DW, 1985, NEUROSCI LETT, V58, P293, DOI 10.1016/0304-3940(85)90069-2; Dalmau J, 2011, LANCET NEUROL, V10, P63, DOI 10.1016/S1474-4422(10)70253-2; DAMBINOVA S A, 1987, Biokhimiya, V52, P1642; Dambinova S. A., 1992, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V28, P201; DAMBINOVA S A, 1984, Biokhimiya, V49, P67; Dambinova S. A., 1982, NEIROKHIMIYA, V1, P352; Dambinova S. A., 2008, THERAPEUTIC ELECT ST, P346; Dambinova S. A., 2010, U.S. patent, Patent No. [7,658,911 B2, 7658911]; Dambinova S. A., 2007, IVD TECHNOLOGY, V3, P15; Dambinova S. A., 1986, NEUROKHIMIA, V5, P115; Dambinova S. A., 1988, GLUTAMATE NEURORECEP, P176; Dambinova S. A., 2002, PCT patent, Patent No. [WO 02012892, 02012892]; Dambinova S. A., 2005, PCT Application, Patent No. [WO2005046442, 2005046442]; Dambinova SA, 1997, J NEUROL SCI, V152, P93, DOI 10.1016/S0022-510X(97)00150-0; Dambinova SA, 1997, ZH VYSSH NERV DEYAT+, V47, P439; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Dambinova SA, 2002, ANN NY ACAD SCI, V965, P497; Dambinova SA, 2002, STROKE, V33, P1181, DOI 10.1161/01.STR.0000014922.83673.86; Dambinova SA, 2008, CLIN LAB INT, V32, P7; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Dickerson F, 2007, PROG NEURO-PSYCHOPH, V31, P952, DOI 10.1016/j.pnpbp.2007.02.018; Dickerson F, 2011, BIPOLAR DISORD, V13, P52, DOI 10.1111/j.1399-5618.2011.00894.x; Dickerson F, 2010, BIOL PSYCHIAT, V68, P100, DOI 10.1016/j.biopsych.2010.03.021; Doeuvre L, 2009, J NEUROCHEM, V110, P457, DOI 10.1111/j.1471-4159.2009.06163.x; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Gahring LC, 1997, NEUROLOGY, V48, P494, DOI 10.1212/WNL.48.2.494; Gappoeva MU, 2003, BIOCHEMISTRY-MOSCOW+, V68, P696, DOI 10.1023/A:1024678112357; Garey L, 2010, J ANAT, V217, P324, DOI 10.1111/j.1469-7580.2010.01231.x; Gill S, 2005, GLUTAMATE RECEPTORS IN PERIPHERAL TISSUE: EXCITATORY TRANSMISSION OUTSIDE THE CNS, P3, DOI 10.1007/0-306-48644-X_1; Golde Todd E., 2007, V6, P17; Goryunova A V, 2007, Neurosci Behav Physiol, V37, P761, DOI 10.1007/s11055-007-0079-3; Granstrem O, 2006, NEUROSCI LETT, V403, P1, DOI 10.1016/j.neulet.2006.04.017; Graus F, 2010, NEUROLOGY, V74, P857, DOI 10.1212/WNL.0b013e3181d3e404; Gromov SA, 1997, ZH NEVROPATOL PSIKH, V97, P46; Gusev E. I., 2003, BRAIN ISCHEMIA, P151; Gusev EI, 1996, ZH NEVROPATOL PSIKH, V96, P68; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Inst Med, 2010, EVALUATION OF BIOMARKERS AND SURROGATE ENDPOINTS IN CHRONIC DISEASE, P1; Irani SR, 2010, BRAIN, V133, P1655, DOI 10.1093/brain/awq113; Jean YY, 2008, NEURON GLIA BIOL, V4, P35, DOI 10.1017/S1740925X09000052; Jin XT, 2011, ADV EXP MED BIOL, V717, P27, DOI 10.1007/978-1-4419-9557-5_3; Knoblach SM, 2005, PROTEAS BIOL DIS, V3, P79, DOI 10.1007/0-387-23101-3_4; Kowal C, 2006, P NATL ACAD SCI USA, V103, P19854, DOI 10.1073/pnas.0608397104; Lai MZ, 2009, ANN NEUROL, V65, P424, DOI 10.1002/ana.21589; Lai TW, 2011, TRENDS MOL MED, V17, P266, DOI 10.1016/j.molmed.2010.12.008; Laterra J., 2000, PRINCIPLES NEURAL SC, P1288; Li B, 2010, BRAIN RES, V1327, P91, DOI 10.1016/j.brainres.2010.02.030; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; Mantegazza R, 2002, J NEUROIMMUNOL, V131, P179, DOI 10.1016/S0165-5728(02)00261-8; Mochizuki Y, 2006, NEUROSCI LETT, V394, P5, DOI 10.1016/j.neulet.2005.08.070; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nakanishi H, 2005, PROTEAS BIOL DIS, V3, P303, DOI 10.1007/0-387-23101-3_12; Odinak MM, 1996, ZH NEVROPATOL PSIKH, V96, P45; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; ORLOVA EA, 1989, DOKL AKAD NAUK SSSR+, V307, P495; Pelkey Kenneth A., 2008, P179; Petralia Ronald S., 2008, P45; Pleasure D, 2008, ARCH NEUROL-CHICAGO, V65, P589, DOI 10.1001/archneur.65.5.589; Rapley R., 2005, PRINCIPLES TECHNIQUE, P225; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; Schulte L, 2005, EXPERT REV MOL DIAGN, V5, P145, DOI 10.1586/14737159.5.2.145; Sharp CD, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-28; Shikuev A, 2011, J NEUROTRAUM, V28, pA55; Skoromets AA, 1997, ZH NEVROPATOL PSIKH, V97, P53; SMIRNOVA T, 1993, SCIENCE, V262, P433, DOI 10.1126/science.8105538; SMIRNOVA T, 1993, SCIENCE, V262, P430, DOI 10.1126/science.8105537; SMIRNOVA TM, 1989, DOKL AKAD NAUK SSSR+, V309, P745; SMIRNOVA TM, 1988, DOKL AKAD NAUK SSSR+, V303, P756; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; Sorokina E. G., 2009, BEHAV PHYSL, V39, P329; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Takahashi Y, 2003, NEUROLOGY, V61, P891, DOI 10.1212/01.WNL.0000086819.53078.70; Tekkok SB, 2007, J CEREBR BLOOD F MET, V27, P1540, DOI 10.1038/sj.jcbfm.9600455; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; TWYMAN RE, 1995, NEURON, V14, P755, DOI 10.1016/0896-6273(95)90219-8; Watson R, 2004, NEUROLOGY, V63, P43, DOI 10.1212/01.WNL.0000132651.66689.0F; Weissman JD, 2011, J NEUROL SCI, V300, P97, DOI 10.1016/j.jns.2010.09.023; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wiendl H, 2001, NEUROLOGY, V57, P1511, DOI 10.1212/WNL.57.8.1511; Wolf ME, 2010, NEUROTOX RES, V18, P393, DOI 10.1007/s12640-010-9176-0; Wright BR, 2009, ARCH NEUROL-CHICAGO, V66, P1456, DOI 10.1001/archneurol.2009.262; Yolken R., 2011, 6 INT C BIOCH MARK B, VO, P24; Yuan HJ, 2009, J BIOL CHEM, V284, P12862, DOI 10.1074/jbc.M805123200; Zamalloa T, 2009, BRIT J PHARMACOL, V156, P649, DOI 10.1111/j.1476-5381.2008.00004.x; Zhang Y, 2011, DISCOV MED, V11, P395	110	5	5	1	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND	2041-3203	2041-3211	978-1-84973-389-2; 978-1-84973-474-5	RSC DRUG DISCOV	RSC Drug Discov.		2012	24						66	86		10.1039/9781849734745-00066	10.1039/9781849734745		21	Chemistry, Medicinal; Pharmacology & Pharmacy	Book Citation Index – Science (BKCI-S)	Pharmacology & Pharmacy	BJQ29	WOS:000329653900006					2022-02-06	
J	Darke, S; McDonald, S; Kaye, S; Torok, M				Darke, Shane; McDonald, Skye; Kaye, Sharlene; Torok, Michelle			Prevalence and correlates of traumatic brain injury amongst heroin users	ADDICTION RESEARCH & THEORY			English	Article						Heroin; traumatic brain injury; neuropsychology; trauma; treatment	METHADONE-MAINTENANCE PATIENTS; INJECTING DRUG-USERS; EPIDEMIOLOGY; ASSOCIATION; DEPENDENCE; AUSTRALIA; ABUSE; RISK	The study aimed to determine the prevalence and severity of traumatic brain injury (TBI) amongst heroin users, and its associations with cognitive functioning and drug use histories. TBI and drug use histories were taken from 175 heroin users enrolled in maintenance or residential treatment, and neuropsychological tests administered measuring executive function, working memory, information processing speed, verbal learning and non-verbal learning. A TBI had been suffered by 55%, 37% had suffered multiple injuries, and 15% had suffered a moderate-severe injury. Males were significantly more likely to have had a TBI (odds ratio [OR] 2.59) and to have experienced multiple TBIs (OR 3.04). Maintenance patients were significantly more likely than therapeutic community clients to have experienced a TBI (61.6 vs. 40.0%). A higher number of TBIs was associated with poorer global cognitive performance, as well as poorer executive functioning, information processing speed and verbal learning. Treatment providers should be aware that a large proportion of those they treat have experienced TBI. TBI should be considered as one of the harms likely to accompany the transition into heroin use.	[Darke, Shane; Kaye, Sharlene; Torok, Michelle] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [McDonald, Skye] Univ New S Wales, Sch Psychol, Sydney, NSW 2052, Australia		Darke, S (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	s.darke@unsw.edu.au	Torok, Michelle/R-3231-2018; McDonald, Skye/G-4118-2014; Kaye, Sharlene/A-3815-2012	Torok, Michelle/0000-0003-3741-8075; McDonald, Skye/0000-0003-0723-6094; Kaye, Sharlene/0000-0002-7657-5105			Aitken C, 2000, DRUG-EDUC PREV POLIC, V7, P39, DOI 10.1080/713660097; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Brand M, 2008, DRUG ALCOHOL DEPEN, V97, P64, DOI 10.1016/j.drugalcdep.2008.03.017; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 1997, HAYLING BRIXTON TEST; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Darke, 2011, LIFE HEROIN USER TYP; Darke S, 2000, ADDICTION, V95, P687, DOI 10.1046/j.1360-0443.2000.9556874.x; Darke S, 2004, ADDICTION, V99, P175, DOI 10.1046/j.1360-0443.2003.00604.x; Darke S, 2010, ADDICTION, V105, P916, DOI 10.1111/j.1360-0443.2009.02872.x; Davis PE, 2002, DRUG ALCOHOL DEPEN, V67, P105, DOI 10.1016/S0376-8716(02)00012-1; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P357, DOI 10.1080/09595230701750643; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Fishbein DH, 2007, DRUG ALCOHOL DEPEN, V90, P25, DOI 10.1016/j.drugalcdep.2007.02.015; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Gossop M, 2002, ADDICT BEHAV, V27, P155, DOI 10.1016/S0306-4603(00)00174-X; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovibond P., 1995, BEHAV RES THER, V3, P335, DOI DOI 10.1016/0005-7967(94)00075-U; Meyers JE., 1995, REY COMPLEX FIGURE T; Mills KL, 2004, J SUBST ABUSE TREAT, V27, P67, DOI 10.1016/j.jsat.2004.05.001; Mintzer MZ, 2005, DRUG ALCOHOL DEPEN, V78, P225, DOI 10.1016/j.drugalcdep.2004.10.008; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; SPSS Inc., 2009, PASW STAT 18 0; STEVENS A, 2007, EUR J CRIMINOL, V4, P385, DOI DOI 10.1177/1477370807080719; Verdejo A, 2005, DRUG ALCOHOL DEPEN, V78, P283, DOI 10.1016/j.drugalcdep.2004.11.006; Weschler D., 1997, WESCHLER MEMORY SCAL; Weschler D., 2001, WESCHLER TEST ADULT; Weschler D., 1997, WESCHLER ADULT INTEL	30	5	5	0	5	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1606-6359			ADDICT RES THEORY	Addict. Res. Theory		2012	20	6					522	528		10.3109/16066359.2012.672600			7	Substance Abuse; Social Issues	Social Science Citation Index (SSCI)	Substance Abuse; Social Issues	032HG	WOS:000310705200008					2022-02-06	
J	Donders, J; Larsen, T				Donders, Jacobus; Larsen, Tory			Clinical Utility of the Tower of London-Drexel University, Second Edition (TOLDX) After Adolescent Traumatic Brain Injury	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							NEUROPSYCHOLOGICAL ASSESSMENT; CRITERION VALIDITY; EXECUTIVE FUNCTION; CHILDREN; MEMORY; PERFORMANCE	The performance of 43 adolescents with traumatic brain injury was evaluated on the Tower of London-Drexel University, second edition (TOLDX; Culbertson & Zillmer, 2005), and compared to that of 43 demographically matched healthy controls. TOLDX variables had a classification accuracy of 69.77%, with clinical patients demonstrating deficits in pre-planning of a schema as well as keeping subgoals in spatial working memory during execution. Time to follow commands and diffuse lesions on neuroimaging accounted for moderate amounts of variance in TOLDX variables. The findings support the clinical utility of the TOLDX in the assessment of adolescents with traumatic brain injury.	[Donders, Jacobus] Mary Free Bed Rehabil Hosp, Psychol Serv, Grand Rapids, MI 49503 USA; [Larsen, Tory] Calvin Coll, Dept Psychol, Grand Rapids, MI 49506 USA		Donders, J (corresponding author), Mary Free Bed Rehabil Hosp, Psychol Serv, 235 Wealthy St SE, Grand Rapids, MI 49503 USA.	jacobus.donders@maryfreebed.com					[American Educational Research Association American Psychological Association National Council on Measurement in Education], 1999, STAND ED PSYCH TESTS; Anderson P. J., 2008, EXECUTIVE FUNCTIONS, P3; Anderson V., 2008, NEUROPSYCHOLOGY NEUR, P269; Baker K, 2001, CLIN NEUROPSYCHOL, V15, P309; Conant LL, 2010, EPILEPSY BEHAV, V18, P414, DOI 10.1016/j.yebeh.2010.05.010; Culbertson W C, 2005, TOWER LONDON DREXEL; Donders J, 2008, J INT NEUROPSYCH SOC, V14, P651, DOI 10.1017/S1355617708080752; Donders J, 2010, J NEUROPSYCHOL, V4, P197, DOI 10.1348/174866409X478970; Gioia GA IP, 2000, BEHAV RATING INVENTO; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Kirkwood M.W., 2010, PRINCIPLES PRACTICE, P299; Kizilbash A, 1999, CHILD NEUROPSYCHOL, V5, P224, DOI 10.1076/0929-7049(199912)05:04;1-R;FT224; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Levin H. S., 1994, NEUROPSYCHOLOGY, V87, P171, DOI DOI 10.1037/0894-4105.8.2.171; Lindquist B, 2008, ACTA PAEDIATR, V97, P596, DOI 10.1111/j.1651-2227.2008.00747.x; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Robinson S, 2009, BRAIN COGNITION, V71, P362, DOI 10.1016/j.bandc.2009.06.007; Semrud-Clikeman M, 2008, NEUROPSYCHOLOGY, V22, P329, DOI 10.1037/0894-4105.22.3.329; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Shum D, 2000, BRAIN COGNITION, V44, P59; Silver CH, 2000, J HEAD TRAUMA REHAB, V15, P973, DOI 10.1097/00001199-200008000-00002; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Ward H, 2007, CHILD NEUROPSYCHOL, V13, P219, DOI 10.1080/09297040600910003	26	5	5	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2012	37	4					333	342		10.1080/87565641.2011.646448			10	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	946CQ	WOS:000304327400003	22612545				2022-02-06	
S	Hamouda, AMS; Sohaimi, RM; Zaidi, AMA; Abdullah, S		Sparks, E		Hamouda, A. M. S.; Sohaimi, R. M.; Zaidi, A. M. A.; Abdullah, S.			Materials and design issues for military helmets	ADVANCES IN MILITARY TEXTILES AND PERSONAL EQUIPMENT	Woodhead Publishing Series in Textiles		English	Article; Book Chapter						ballistic helmets; materials; manufacturing; modelling	TRAUMATIC BRAIN-INJURY; BALLISTIC IMPACT; MOTORCYCLE HELMET; FIBER COMPOSITES; MECHANICAL-PROPERTIES; HEAD RESPONSE; PENETRATION; POLYETHYLENE; BIOMECHANICS; CARBON	As weaponry technology has advanced, the ballistic threat to humans has increased significantly. As well as the military, civilians who are exposed to these threats as part of their everyday work require adequate protective equipment. This increasing demand for body armour and ballistic helmets is driving the protective equipment industry to create lightweight, reliable protection adapted for specific applications and marketable to a wide range of consumers. This chapter focuses on a few theoretical aspects of head impact mechanics and related head injury criteria, considering design, manufacturing and testing procedures, with particular emphasis on the modern materials and tools used in the search for lightweight, cost-efficient and effective equipment.	[Sohaimi, R. M.; Zaidi, A. M. A.; Abdullah, S.] Natl Def Univ Malaysia, Fac Engn, Protect & Survivabil Res Unit PROTECT, Kuala Lumpur 57000, Malaysia; [Hamouda, A. M. S.] Qatar Univ, Coll Engn, Mech & Ind Engn Dept, Doha, Qatar		Sohaimi, RM (corresponding author), Natl Def Univ Malaysia, Fac Engn, Protect & Survivabil Res Unit PROTECT, Kuala Lumpur 57000, Malaysia.	hamouda@qu.edu.qa; risby@upnm.edu.my; mujahid@upnm.edu.my; shohaimi@upnm.edu.my	Hamouda, Abdel Magid/B-3538-2013	Hamouda, Abdel Magid/0000-0001-8022-4319			Aare M, 2007, INT J IMPACT ENG, V34, P596, DOI 10.1016/j.ijimpeng.2005.08.001; Aghion E. E., ADV PERFORMANCE MAT, V5, P201; Altmann J., 2004, IEEE TECHNOLOGY SOC, P0278; Andrew R., 1999, CARB 99 24 BIENN C C, P194; Balandin DV, 2007, SHOCK VIB, V14, P355, DOI 10.1155/2007/175156; Balandin DV, 2004, SHOCK VIB, V11, P547, DOI 10.1155/2004/182739; Bandak FA, 1997, NATO ADV SCI I E-APP, V332, P53; Bishop P.J.A, ASTM STP, V3; Bledzki AK, 1999, PROG POLYM SCI, V24, P221, DOI 10.1016/S0079-6700(98)00018-5; Bless S., 1999, P 22 SAMPE TECH C BO; Bullock R., SCI FDN TRAUMA; Campbell S., ADA514190 ARM EV CTR; Campbell S., 2009, INT TEST EVALUATION, V30, P557; Carey ME, 2000, NEUROSURGERY, V47, P678, DOI 10.1097/00006123-200009000-00031; Cooper G., BALLISTIC TRAUMA PRA; Dai J.C., THESIS TEXAS TU; Derler S.C., COST TEST PROCEDURES; Folgar F., 2007, 23 INT S BALL TARR S; Forster-Knight E., 1995, 10 INT C COMP MAT ST, P751; GILCHRIST A, 1987, J MATER SCI, V22, P2397, DOI 10.1007/BF01082122; GILCHRIST A, 1988, ERGONOMICS, V31, P1395, DOI 10.1080/00140138808966784; Gilchrist A, 2001, INT J IMPACT ENG, V25, P767, DOI 10.1016/S0734-743X(01)00009-4; GILCHRIST A, 1994, INT J IMPACT ENG, V15, P201, DOI 10.1016/S0734-743X(05)80013-2; Glaister D., SCI FDN TRAUMA, P314; Gooch, 2007, ARLTR4327; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Hamouda AMS, 1997, J MATER PROCESS TECH, V64, P189, DOI 10.1016/S0924-0136(96)02567-8; Hamouda AMS, 1996, J MATER PROCESS TECH, V56, P847, DOI 10.1016/0924-0136(95)01897-2; Hamouda AMS, 1996, J MATER PROCESS TECH, V56, P743, DOI 10.1016/0924-0136(95)01888-3; HAMOUDA AMS, 1992, STRUCTURES UNDER SHOCK AND IMPACT II, P51; HASHMI MSJ, 1994, J STRAIN ANAL ENG, V29, P117, DOI 10.1243/03093247V292117; Hayhurst C., 1999, HYP IMP S HUNTSV AL; Hsieh A. J., ARLTR4764, P21005; Hume A., INT IRCOBI C BIOM IM; Ivins BJ, 2008, MIL MED, V173, P1168, DOI 10.7205/MILMED.173.12.1168; JONAS GH, 1978, INT J ENG SCI, V16, P879, DOI 10.1016/0020-7225(78)90073-3; Jones Tyrone L., 2007, 23 INT S BALL TARR S; Kang H., SAE T, P849; KHALIL TB, 1977, J BIOMECH, V10, P119, DOI 10.1016/0021-9290(77)90075-6; Larsson F, 2002, COMPOS PART A-APPL S, V33, P221, DOI 10.1016/S1359-835X(01)00095-1; Lawrence R. M., AD0756418 NATO; Lee BL, 2001, J COMPOS MATER, V35, P1605, DOI 10.1106/YRBH-JGT9-U6PT-L555; Lee H. P., 2010, COMPUTER METHODS BIO, V13; LEE SWR, 1993, COMPOS SCI TECHNOL, V49, P369, DOI 10.1016/0266-3538(93)90069-S; Lim CT, 2003, INT J IMPACT ENG, V28, P13, DOI 10.1016/S0734-743X(02)00031-3; Liming Voo, SAE T, P178; Lourie O, 1998, PHYS REV LETT, V81, P1638, DOI 10.1103/PhysRevLett.81.1638; Magnier S., MECH COHESIVE FRICTI, V3, P257; Marissen R, 2010, COMPOS SCI TECHNOL, V70, P1184, DOI 10.1016/j.compscitech.2010.03.003; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Nandlall D., 2006, ADA359041; Newman J.A., IRCOBI C; Nielsen E., 2008, TACTICAL RESPONS SEP; Nocchi M., European Patent, Patent No. [EP0188747, 0188747]; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Risby MS, 2008, DEFENCE SCI J, V58, P248, DOI 10.14429/dsj.58.1645; Salvaterra G, 2006, Foundations of Sport-Related Brain Injuries, P391, DOI 10.1007/0-387-32565-4_17; Sarron JC, 2004, J TRAUMA, V57, P236, DOI 10.1097/01.TA.0000133575.48065.3F; SAVAGE SJ, 2004, FOIR1456SE SWED DEF; Scharine A. A., ADA432092 ARM RES LA; Scheetz H. A., AD774833 HUM ENG LAB; SHIM VPW, 1995, INT J IMPACT ENG, V16, P585, DOI 10.1016/0734-743X(94)00063-3; Shim VPW, 2001, INT J IMPACT ENG, V25, P1, DOI 10.1016/S0734-743X(00)00038-5; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P406, DOI 10.1016/S0924-0136(02)00048-1; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P432; Shuaeib FM, 2002, J MATER PROCESS TECH, V123, P422, DOI 10.1016/S0924-0136(02)00047-X; Silva MAG, 2005, INT J IMPACT ENG, V31, P289, DOI 10.1016/j.ijimpeng.2004.01.011; Simmonds K. E., ADA520727 NAV RES LA; Tham CY, 2008, INT J IMPACT ENG, V35, P304, DOI 10.1016/j.ijimpeng.2007.03.008; Thilagavathi G, 2008, DEFENCE SCI J, V58, P451, DOI 10.14429/dsj.58.1667; Tracy H. J., 1978, US Patent, Patent No. [05/909648, 05909648]; Tubbs F. R., STAHLHELM EVOLUTION; Turner D. D., ADA439392 ARM RES LA; van den Akker L.S., THESIS DELFT U TECHN; Viano D., CRASHWORTHINESS TRAN; Vizzini AJ, 2003, INT J ENG EDUC, V19, P902; Walker J. D., 1999, P 18 INT S BALL, P1231; Walsh S. M., 2008, P 26 ARM SCI C HELD; Walsh S. M., ADA441165; Wambua P, 2007, COMPOS STRUCT, V77, P232, DOI 10.1016/j.compstruct.2005.07.006; White M. R., 1986, patent, Patent No. 4778638; Woodward R. L., 1994, COMPOSITE MAT, V4; WU EB, 1994, J COMPOS MATER, V28, P1783, DOI 10.1177/002199839402801803; YETTRAM AL, 1994, PLAST RUB COMPOS PRO, V22, P215; Yoganandan N, 2005, SOLID MECH APPL, V124, P173; Yoganandan N., SAE T, P184; ZHU GQ, 1992, INT J SOLIDS STRUCT, V29, P399	87	5	5	0	14	WOODHEAD PUBL LTD	CAMBRIDGE	ABINGTON HALL ABINGTON, CAMBRIDGE CB1 6AH, CAMBS, ENGLAND	2042-0803		978-0-85709-557-2; 978-1-84569-699-3	WOODHEAD PUBL SER TE			2012		122					103	138			10.1533/9780857095572		36	Materials Science, Textiles	Book Citation Index – Science (BKCI-S)	Materials Science	BCU76	WOS:000311514800007					2022-02-06	
J	Hana, V; Kosak, M; Masopust, V; Netuka, D; Lacinova, Z; Krsek, M; Marek, J; Pecen, L				Hana, V.; Kosak, M.; Masopust, V.; Netuka, D.; Lacinova, Z.; Krsek, M.; Marek, J.; Pecen, L.			Hypothalamo-Pituitary Dysfunction in Patients With Chronic Subdural Hematoma	PHYSIOLOGICAL RESEARCH			English	Article						Hypopituitarism; Subdural hematoma; Brain injury; Growth hormone deficiency	TRAUMATIC BRAIN-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; ANTIPITUITARY ANTIBODIES; GH DEFICIENCY; HYPOPITUITARISM; INSUFFICIENCY; DIAGNOSIS; CHILDREN; ADULTS	Relatively frequent pituitary hormone deficiencies are observed after traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) and according to the published studies the neuroendocrine consequenses of traumatic brain injury are underdiagnosed. In a cohort of 59 patients (49 males, mean age 68.3 years, 36-88 years) after evacuation of subdural hematoma (SDH) were evaluated hypothalamo-pituitary functions one week after surgery, after three months and after one year. Hypogonadism was present in 26 % of patients in an acute phase, but in the majority had a transient character. Less than half of patients was GH deficient (GHD) according to the GHRH+arginine test. We did not find any serious case of hypocortisolism, hypothyroidism, diabetes insipidus centralis nor syndrome of inappropriate secretion of ADH (SIADH). Transient partial hypocortisolism was present in two cases, but resolved. We did not find relation between extension of SDH or clinical severity and development of hypopituitarism. In conclusion, in some patients with SDH growth hormone deficiency or hypogonadism was present. No serious hypocortisolism, hypothyroidism, diabetes insipidus nor SIADH was observed. The possibility of neuroendocrine dysfunction should be considered in patients with SDH, although the deficits are less frequent than in patients after TBI or SAH.	[Hana, V.; Kosak, M.; Lacinova, Z.; Krsek, M.; Marek, J.] Charles Univ Prague, Gen Fac Hosp, Dept Internal Med 3, Nemocnice 1, Prague 12808 2, Czech Republic; [Hana, V.; Kosak, M.; Masopust, V.; Netuka, D.; Lacinova, Z.; Krsek, M.; Marek, J.] Charles Univ Prague, Fac Med 1, Prague 12808 2, Czech Republic; [Masopust, V.; Netuka, D.] Mil Hosp, Dept Neurosurg, Prague, Czech Republic; [Pecen, L.] Acad Sci Czech Republ, Inst Comp Sci, Prague, Czech Republic		Hana, V (corresponding author), Charles Univ Prague, Gen Fac Hosp, Dept Internal Med 3, Nemocnice 1, Prague 12808 2, Czech Republic.	vhana@lf1.cuni.cz	Masopust, Vaclav/N-5196-2017; Krsek, Michal/L-6054-2017; Marek, Josef/S-6166-2016; Netuka, David/N-8022-2017; Kosak, Mikulas/A-2573-2017; Hana, Vaclav/N-3853-2017; Lacinova, Zdenka/R-9637-2016; Krsek, Michal/ABE-3124-2020; Pecen, Ladislav/G-7057-2014; Kosak, Mikulas/AAJ-5546-2020	Masopust, Vaclav/0000-0002-5070-0692; Krsek, Michal/0000-0002-5941-3489; Marek, Josef/0000-0002-3257-2025; Netuka, David/0000-0001-8609-4789; Kosak, Mikulas/0000-0001-5947-5340; Hana, Vaclav/0000-0002-6690-1413; Lacinova, Zdenka/0000-0003-4916-7031; Krsek, Michal/0000-0002-8985-3151	Czech Ministry of HealthMinistry of Health, Czech Republic [NS 9794-4]	We thank doctors L. Pekar and R. Lesko for referring patients. We very acknowledge analyses of blood samples managed by Ing. Springer and Mgr. Uhrova and technical laboratory assistance of Hana Frydlova. The project was supported by a grant of Czech Ministry of Health NS 9794-4.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; AGHA A, 2005, AM J MED, V118; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Aimaretti G, 1998, J CLIN ENDOCR METAB, V83, P1615, DOI 10.1210/jc.83.5.1615; Aleksijevic D, 2010, CESK SLOV NEUROL N, V73, P409; Araujo AB, 2011, J CLIN ENDOCR METAB, V96, P3007, DOI 10.1210/jc.2011-1137; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Cap J, 2006, Vnitr Lek, V52, P941; Clark PM, 1998, CLIN ENDOCRINOL, V49, P287; De Marinis L, 2006, J ENDOCRINOL INVEST, V29, P516, DOI 10.1007/BF03344141; HARPER CG, 1986, J CLIN PATHOL, V39, P769, DOI 10.1136/jcp.39.7.769; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; Kanat A, 2010, J NEUROSURG SCI, V54, P99; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Kosak M, 2011, CESK SLOV NEUROL N, V74, P286; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Salehi F, 2007, BRAIN INJURY, V21, P651, DOI 10.1080/02699050701426956; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2008, EUR J ENDOCRINOL, V159, P7, DOI 10.1530/EJE-08-0050; Tanriverdi F, 2010, EUR J ENDOCRINOL, V162, P861, DOI 10.1530/EJE-09-1024; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601; Zapletalova J, 2010, CESK SLOV NEUROL N, V73, P398	29	5	5	0	6	ACAD SCIENCES CZECH REPUBLIC, INST PHYSIOLOGY	PRAGUE 4	VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC	0862-8408	1802-9973		PHYSIOL RES	Physiol. Res.		2012	61	2					161	167		10.33549/physiolres.932290			7	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	975JK	WOS:000306507400005	22292726	gold			2022-02-06	
J	Hejcl, A; Bolcha, M; Prochazka, J; Huskova, E; Sames, M				Hejcl, A.; Bolcha, M.; Prochazka, J.; Huskova, E.; Sames, M.			Elevated Intracranial Pressure, Low Cerebral Perfusion Pressure, and Impaired Brain Metabolism Correlate with Fatal Outcome After Severe Brain Injury	JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY			English	Article						head injury; multimodal monitoring; microdialysis; tissue oxymetry; outcome	SEVERE HEAD-INJURY; MICRODIALYSIS; EXPERIENCE; THERAPY	Background New brain tissue monitoring techniques (tissue oxymetry, microdialysis) provide direct information about the state of brain oxygenation and brain metabolism in patients with severe traumatic brain injury (TBI). Despite this information being limited to a small region of the brain surrounding the probes, it could be associated with such global parameters as the clinical outcome. Objective To study the predictive value of monitoring brain oxygenation and metabolism on clinical outcome in patients in the acute phase of severe TBI. Methods An observational study of 20 patients with a severe TBI was undertaken, utilizing intracranial pressure (ICP), cerebral perfusion pressure (CPP), brain tissue oxygenation, and brain metabolism monitoring. We correlated the clinical outcome of the patients with the following parameters: ICP, CPP, brain tissue oxymetry (PbtO(2)), glucose and glycerol levels, and the lactate/pyruvate (LP) ratio. Further, we analyzed the relationship between ICP, CPP, PbtO(2), and the metabolism parameters. Results We found a correlation of the mean ICP values (8.73 +/- 1.18 in group A vs. 26.32 +/- 5.01mmHg in group B, p < 0.005), themean CPP values (84.82 +/- 2.02 in group A vs. 66.62 +/- 4.64 mmHg, p < 0.005), the LP ratio (37.36 +/- 3.44 vs. 199 +/- 87.97, p < 0.05), and glycerol levels (62.07 +/- 12.14 vs. 215 +/- 46.52 mu mol/l, p < 0.05) with the clinical outcome. High ICP correlated with both a high LP ratio (Spearman R = 0.61, p < 0.05), and elevated glycerol concentrations (Spearman R = 0.48, p < 0.05). A low CPP correlated with a high LP ratio (Spearman R = -0.57, p < 0.05), while a low PbtO(2) correlated with a high LP ratio (Spearman R = -0.49, p < 0.05). Conclusions High ICP, low CPP, an elevated mean LP ratio, and high glycerol concentrations in the acute phase predict fatal outcome 6 months after TBI. Further, high ICP, low CPP, and low PbtO(2) correlate with impaired brain metabolism.	[Hejcl, A.; Bolcha, M.; Sames, M.] Masaryk Hosp, Dept Neurosurg, Usti Nad Labem 40011, Czech Republic; [Prochazka, J.] Masaryk Hosp, Cent Intens Care Unit, Usti Nad Labem 40011, Czech Republic; [Huskova, E.] Masaryk Hosp, Dept Anesthesiol & Resuscitat, Usti Nad Labem 40011, Czech Republic		Hejcl, A (corresponding author), Masaryk Hosp, Dept Neurosurg, Socialni Pece 12A, Usti Nad Labem 40011, Czech Republic.	ales.hejcl@mnul.cz	sames, martin/AAJ-2845-2021; Hejcl, Ales/H-2858-2014	Hejcl, Ales/0000-0002-9206-1980			Alessandri B, 2000, ACTA NEUROCHIR SUPPL, V76, P425; Belli A, 2008, ACTA NEUROCHIR, V150, P461, DOI 10.1007/s00701-008-1580-3; Bratton SL, 2007, J NEUROTRAUMA S1, pS7; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; De Georgia MA, 2005, NEUROLOGIST, V11, P45, DOI 10.1097/01.nrl.0000149993.99956.09; Firsching RJ, 2010, CENT EUR NEUROSURG, V71, P134, DOI 10.1055/s-0030-1248256; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Li AL, 2008, CHIN J TRAUMATOL, V11, P84, DOI 10.1016/S1008-1275(08)60018-8; Meixensberger J, 2003, J NEUROL NEUROSUR PS, V74, P760, DOI 10.1136/jnnp.74.6.760; Oddo M, 2008, CRIT CARE MED, V36, P3233, DOI 10.1097/CCM.0b013e31818f4026; Peerdeman SM, 2003, INTENS CARE MED, V29, P1825, DOI 10.1007/s00134-003-1850-8; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Stahl N, 2003, ACTA NEUROL SCAND, V108, P211, DOI 10.1034/j.1600-0404.2003.00095.x; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; van den Brink WA, 1998, ACT NEUR S, V71, P190; Zauner A, 1997, NEUROSURGERY, V41, P1082, DOI 10.1097/00006123-199711000-00011	17	5	5	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6315			J NEUROL SURG PART A	J. Neurol. Surg. Part A	JAN	2012	73	1					10	17		10.1055/s-0032-1304500			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	175UH	WOS:000321258600003	22105660				2022-02-06	
J	Holena, DN; Tolstoy, NS; Mills, AM; Fox, AD; Levine, JM				Holena, Daniel N.; Tolstoy, Nikolai S.; Mills, Angela M.; Fox, Adam D.; Levine, Joshua M.			THERAPEUTIC HYPOTHERMIA FOR TREATMENT OF INTRACTABLE INTRACRANIAL HYPERTENSION AFTER LIVER TRANSPLANTATION	AMERICAN JOURNAL OF CRITICAL CARE			English	Article							FULMINANT HEPATIC-FAILURE; TRAUMATIC BRAIN-INJURY; MODERATE HYPOTHERMIA; WOUND-INFECTION; CLINICAL-TRIAL; PRESSURE; NORMOTHERMIA; RECIPIENTS; MORTALITY; CHILDREN	A comatose 23-year-old woman with acute liver failure due to an overdose of acetaminophen had indications of intracranial hypertension and underwent liver transplantation. Her level of arousal did not improve, and on postoperative day 1, clinical signs of cerebral herniation became apparent. An intracranial pressure monitor was placed, and intracranial hypertension was documented. Elevations in intracranial pressure persisted despite maximal osmotherapy, and therapeutic hypothermia was started. Normalization of intracranial pressure was rapid. Findings on neurological examination improved and the patient was discharged from the hospital with no neurological impairment. (American Journal of Critical Care. 2012;21:75,72-74)	[Tolstoy, Nikolai S.] Penn State Hershey Coll Med, Hershey, PA 17033 USA; [Levine, Joshua M.] Hosp Univ Penn, Philadelphia, PA 19104 USA; [Fox, Adam D.] Univ Med & Dent New Jersey, Newark, NJ 07103 USA		Tolstoy, NS (corresponding author), Penn State Hershey Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	ntolstoy@hmc.psu.edu		Holena, Daniel/0000-0003-3424-5754; Mills, Angela/0000-0003-0798-6848			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Blei AT, 2005, NEUROCHEM INT, V47, P71, DOI 10.1016/j.neuint.2005.04.009; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; CHAPMAN RW, 1990, LANCET, V335, P32, DOI 10.1016/0140-6736(90)90150-4; Clemmesen JO, 1997, HEPATOLOGY, V26, P1423; Fan ST, 2003, ANN SURG, V238, P864, DOI 10.1097/01.sla.0000098618.11382.77; FORBES A, 1989, HEPATOLOGY, V10, P306, DOI 10.1002/hep.1840100309; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; HOOFNAGLE JH, 1995, HEPATOLOGY, V21, P240, DOI 10.1002/hep.1840210137; Inaba K, 2009, WORLD J SURG, V33, P864, DOI 10.1007/s00268-009-9936-2; Jalan R, 2003, TRANSPLANTATION, V75, P2034, DOI 10.1097/01.TP.0000066240.42113.FF; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Lo C M, 2002, Hong Kong Med J, V8, P240; Melling AC, 2001, LANCET, V358, P876, DOI 10.1016/S0140-6736(01)06071-8; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Paterson DL, 1999, TRANSPLANTATION, V67, P1151, DOI 10.1097/00007890-199904270-00011; Prunet Bertrand, 2009, Cases J, V2, P8857, DOI 10.1186/1757-1626-0002-0000008857; Vaquero J, 2005, J CLIN GASTROENTEROL, V39, pS147, DOI 10.1097/01.mcg.0000155515.94843.55; Winkler M, 2000, ANESTH ANALG, V91, P978, DOI 10.1097/00000539-200010000-00039; Yanagawa Y, 2007, J TRAUMA, V62, P287, DOI 10.1097/01.ta.0000223023.98182.d9	21	5	6	0	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1062-3264			AM J CRIT CARE	Am. J. Crit. Care	JAN 1	2012	21	1					72	75		10.4037/ajcc2012924			4	Critical Care Medicine; Nursing	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Nursing	031KW	WOS:000310639500012	22210703				2022-02-06	
J	Kim, HJ				Kim, Hun Joo			The Prognostic Factors Related to Traumatic Brain Stem Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Traumatic brain stem injury (TBSI); Diffuse axonal injury (DAI); Glasgow Coma Score (GCS); Glasgow Outcome Score (GOS)	CLOSED HEAD-INJURY; MAGNETIC-RESONANCE; LESIONS; HEMATOMA; CT; CLASSIFICATION; PATHOLOGY; CHILDREN; DAMAGE; PALSY	Objective : This study was conducted to assess the clinical significance of traumatic brain stem injury (TBSI) reflected on Glasgow Coma Score (GCS) and Glasgow Outcome Score (GOS) by various clinical variables. Methods : A total of 136 TBSI patients were selected out of 2695 head-injured patients. All initial computerized tomography and/or magnetic resonance imaging studies were retrospectively analyzed according to demographic- and injury variables which result in GCS and GOS. Results : In univariate analysis, mode of injury showed a significant effect on combined injury (p<0.001), as were the cases with skull fracture on radiologic finding (p<0.000). The GCS showed a various correlation with radiologic finding (p<0.000), mode of injury (p<0.002), but less favorably with impact site (p<0.052), age (p<0.054) and skull fracture (p<0.057), in order of statistical significances. However, only GOS showed a definite correlation to radiologic finding (p<0.000). In multivariate analysis, the individual variables to enhance an unfavorable effect on GCS were radiologic finding [odds ratio (OR) 7.327, 95% confidence interval (CI)], mode of injury (OR; 4.499, 95% CI) and age (OR; 3.141, 95% CI). Those which influence an unfavorable effect on GOS were radiologic finding (OR; 25.420, 95% Cl) and age (OR; 2.674, 95% Cl). Conclusion : In evaluation of TBSI on outcome, the variables such as radiological finding, mode of injury, and age were revealed as three important ones to have an unfavorable effect on early stage outcome expressed as GCS. However, mode of injury was shown not to have an unfavorable effect on late stage outcome as GOS. Among all unfavorable variables, radiological finding was confirmed as the only powerful prognostic variable both on GCS and GOS.	Yonsei Univ, Dept Neurosurg, Wonju Coll Med, Wonju 220701, South Korea		Kim, HJ (corresponding author), Yonsei Univ, Dept Neurosurg, Wonju Coll Med, 20 Ilsan Ro, Wonju 220701, South Korea.	khj0322@hanmail.net			Wonju College of Medicine [YUMCM-2008-27]	This study was supported by a grant (YUMCM-2008-27) from Wonju College of Medicine.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; Adler DE, 2002, J NEUROSURG, V96, P1103, DOI 10.3171/jns.2002.96.6.1103; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Bouras T, 2007, J NEUROSURG, V107, P158, DOI 10.3171/JNS-07/07/0158; Carpentier A, 2006, J NEUROTRAUM, V23, P674, DOI 10.1089/neu.2006.23.674; Courville CB, 1945, TRAUMA; CROMPTON MR, 1971, LANCET, V1, P669; Eder HG, 2000, CHILD NERV SYST, V16, P21, DOI 10.1007/s003810050005; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; HASHIMOTO T, 1993, NEUROSURG REV, V16, P291, DOI 10.1007/BF00383839; Hirano A, 1995, No To Shinkei, V47, P281; Kara A, 2008, TURK NEUROSURG, V18, P1; Katsuno Makoto, 2008, Brain and Nerve (Tokyo), V60, P89; Kim YS, 1986, J KOREAN NEUROSURG S, V15, P439; Kinoshita Y, 2000, No To Shinkei, V52, P320; MITCHELL DE, 1973, LANCET, V2, P215; Moskala M, 2007, NEUROL NEUROCHIR POL, V41, P234; Okuchi Kazuo, 1993, Neurological Surgery, V21, P799; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; ROSENBLUM WI, 1981, NEUROSURGERY, V9, P613, DOI 10.1227/00006123-198112000-00001; SAEKI N, 1981, Neurological Surgery, V9, P1193; Saeki N, 1998, BRIT J NEUROSURG, V12, P151, DOI 10.1080/02688699845302; Sato M, 1999, SURG NEUROL, V51, P613, DOI 10.1016/S0090-3019(98)00091-3; Se YB, 2009, J KOREAN NEUROSURG S, V45, P176, DOI 10.3340/jkns.2009.45.3.176; Shibata Y, 2000, CLIN NEUROL NEUROSUR, V102, P124, DOI 10.1016/S0303-8467(00)00095-0; Shukla D, 2007, CLIN NEUROPATHOL, V26, P197; Soldner F, 2001, ACTA NEUROCHIR, V143, P873, DOI 10.1007/s007010170017; Stewart W A, 1973, Surg Neurol, V1, P303; TANDON PN, 1964, ACTA NEUROL SCAND, V40, P375; TSAI FY, 1980, AM J ROENTGENOL, V134, P717, DOI 10.2214/ajr.134.4.717; Wedekind C, 2002, BRIT J NEUROSURG, V16, P256, DOI 10.1080/02688690220148842; Woischneck D, 2003, CHILD NERV SYST, V19, P174, DOI 10.1007/s00381-002-0703-z; WONG CW, 1993, SURG NEUROL, V39, P37, DOI 10.1016/0090-3019(93)90107-C; WRIGHT RL, 1966, J NEUROSURG, V25, P402, DOI 10.3171/jns.1966.25.4.0402	37	5	6	0	3	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711	1598-7876		J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	JAN	2012	51	1					24	30		10.3340/jkns.2012.51.1.24			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	896WE	WOS:000300601300005	22396839	Green Published, Green Submitted, gold			2022-02-06	
J	Kochanek, PM; Carney, N; Adelson, PD; Ashwal, S; Bell, MJ; Bratton, S; Carson, S; Chesnut, RM; Ghajar, J; Goldstein, B; Grant, GA; Kissoon, N; Peterson, K; Selden, NR; Tong, KA; Tasker, RC; Vavilala, MS; Wainwright, MS; Warden, CR				Kochanek, Patrick M.; Carney, Nancy; Adelson, P. David; Ashwal, Stephen; Bell, Michael J.; Bratton, Susan; Carson, Susan; Chesnut, Randall M.; Ghajar, Jamshid; Goldstein, Brahm; Grant, Gerald A.; Kissoon, Niranjan; Peterson, Kimberly; Selden, Nathan R.; Tong, Karen A.; Tasker, Robert C.; Vavilala, Monica S.; Wainwright, Mark S.; Warden, Craig R.			Chapter 3. Indications for intracranial pressure monitoring	PEDIATRIC CRITICAL CARE MEDICINE			English	Article							TRAUMATIC-BRAIN-INJURY; SEVERE HEAD-INJURY; CEREBRAL PERFUSION-PRESSURE; PEDIATRIC-PATIENTS; TARGETED THERAPY; BLOOD-FLOW; CHILDREN; HYPERTENSION; COMA; MANAGEMENT		[Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Carney, Nancy; Carson, Susan; Peterson, Kimberly] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Adelson, P. David] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Ashwal, Stephen] Loma Linda Univ, Sch Med, Div Child Neurol, Dept Pediat, Loma Linda, CA 92350 USA; [Bratton, Susan] Univ Utah, Sch Med, Salt Lake City, UT 84112 USA; [Chesnut, Randall M.; Vavilala, Monica S.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Ghajar, Jamshid] Weill Cornell Med Coll, New York, NY USA; [Goldstein, Brahm] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Newark, NJ 07103 USA; [Grant, Gerald A.] Duke Univ, Sch Med, Durham, NC 27706 USA; [Kissoon, Niranjan] Univ British Columbia, British Columbias Childrens Hosp, Vancouver, BC V5Z 1M9, Canada; [Tasker, Robert C.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Tasker, Robert C.] Childrens Hosp Boston, Boston, MA USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; [Warden, Craig R.] Oregon Hlth & Sci Univ, Doernbecher Childrens Hosp, Portland, OR 97201 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA.		Adelson, David/W-2083-2019; Bratton, Susan L./O-2353-2013; Kochanek, Patrick M/D-2371-2015; Kissoon, Niranjan/AAC-6140-2021; Tasker, Robert C/R-5837-2019	Bratton, Susan L./0000-0002-4605-8078; Kochanek, Patrick M/0000-0002-2627-913X; 			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; BARZILAY Z, 1988, INTENS CARE MED, V14, P417, DOI 10.1007/BF00262899; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Chambers IR, 2000, BRIT J NEUROSURG, V14, P424; Chambers IR, 2001, J NEUROSURG, V94, P412, DOI 10.3171/jns.2001.94.3.0412; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Cruz J, 2002, NEUROSURGERY, V50, P774, DOI 10.1097/00006123-200204000-00017; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; GHAJAR JBG, 1993, ADV NEUROS, V21, P173; Gopinath S, 1993, CRITICAL THRESHOLDS; Grinkeviciute DE, 2008, MEDICINA-LITHUANIA, V44, P119, DOI 10.3390/medicina44020015; HUMPHREYS RP, 1990, CHILD NERV SYST, V6, P139, DOI 10.1007/BF00308490; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KASOFF SS, 1988, PEDIATR NEUROSCI, V14, P241, DOI 10.1159/000120397; KAUFMANN AM, 1992, J NEUROSURG, V77, P584, DOI 10.3171/jns.1992.77.4.0584; Keenan Heather T, 2005, Pediatr Crit Care Med, V6, P537, DOI 10.1097/01.PCC.0000164638.44600.67; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; Morris KP, 2006, INTENS CARE MED, V32, P1606, DOI 10.1007/s00134-006-0285-4; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Pfenninger J, 2002, SWISS MED WKLY, V132, P116; Prabhakaran P, 2004, J NEUROSURG, V100, P454, DOI 10.3171/ped.2004.100.5.0454; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; Schoon P, 2002, ACT NEUR S, V81, P285; Segal S, 2001, INTENS CARE MED, V27, P236, DOI 10.1007/s001340000717; SHAPIRO K, 1982, J NEUROSURG, V56, P819, DOI 10.3171/jns.1982.56.6.0819; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Tilford JM, 2001, CRIT CARE MED, V29, P1056, DOI 10.1097/00003246-200105000-00037; Tilford JM, 2005, CRIT CARE MED, V33, P2074, DOI 10.1097/01.CCM.0000171839.65687.F5; Wahlstrom MR, 2005, INTENS CARE MED, V31, P832, DOI 10.1007/s00134-005-2632-2; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	50	5	5	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2012	13	1		S			S11	S17		10.1097/PCC.0b013e31823f440c			7	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	982DS	WOS:000307022500003					2022-02-06	
J	Kolakowsky-Hayner, SA; Wright, J; Bellon, K				Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Bellon, Kimberly			A Brief Overview of the Patient Competency Rating Scale: Updates and Additions to the COMBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							TRAUMATIC BRAIN-INJURY; IMPAIRED SELF-AWARENESS; TERM-FOLLOW-UP; MULTIPLE-SCLEROSIS; PREDICTORS; INDIVIDUALS; CAREGIVER; ADULTS; REHABILITATION; DEFICITS		[Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Bellon, Kimberly] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA		Kolakowsky-Hayner, SA (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bascom Ave, San Jose, CA 95128 USA.	Stephanie.Hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			Alexander T, 2010, REHABIL PSYCHOL, V55, P159, DOI 10.1037/a0019253; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Baier B, 2005, J NEUROL NEUROSUR PS, V76, P358, DOI 10.1136/jnnp.2004.036731; Barskova T, 2006, BRAIN INJURY, V20, P1431, DOI 10.1080/02699050600976317; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; Gan C, 2006, BRAIN INJURY, V20, P587, DOI 10.1080/02699050600743725; Hall KM, 2001, ARCH PHYS MED REHAB, V82, P367, DOI 10.1053/apmr.2001.21525; Kieffaber PD, 2007, J CLIN PSYCHOL MED S, V14, P206, DOI 10.1007/s10880-007-9075-6; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Ownsworth T, 2009, BRAIN IMPAIR, V10, P149, DOI 10.1375/brim.10.2.149; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 2003, NEUROREHABILITATION, V18, P47; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Ryan KA, 2007, CLIN NEUROPSYCHOL, V21, P239, DOI 10.1080/13854040600582460; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherman TE, 2007, MULT SCLER, V13, P238, DOI 10.1177/1352458506070754; Sherman TE, 2008, J CLIN EXP NEUROPSYC, V30, P301, DOI 10.1080/13803390701380617; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742	31	5	5	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2012	27	1					83	85		10.1097/HTR.0b013e31823645db			3	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	879JV	WOS:000299326400009	22218203				2022-02-06	
S	Kou, ZF; Benson, RR; Haacke, EM		Dambinova, SA; Hayes, RL; Wang, KKW		Kou, Zhifeng; Benson, Randall R.; Haacke, E. Mark			Magnetic Resonance Imaging Biomarkers of Mild Traumatic Brain Injury	BIOMARKERS FOR TRAUMATIC BRAIN INJURY	RSC Drug Discovery Series		English	Article; Book Chapter							PROTON MR SPECTROSCOPY; DIFFUSE AXONAL INJURY; CEREBRAL-BLOOD-FLOW; CORPUS-CALLOSUM; HEAD-INJURY; CHILDREN; DAMAGE; TIME; ABNORMALITIES; MODERATE		[Kou, Zhifeng; Haacke, E. Mark] Wayne State Univ, Sch Med, Dept Biomed Engn, Detroit, MI 49098 USA; [Kou, Zhifeng; Haacke, E. Mark] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI 49098 USA; [Benson, Randall R.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Benson, Randall R.] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI 48201 USA		Kou, ZF (corresponding author), Wayne State Univ, Sch Med, Dept Biomed Engn, Detroit, MI 49098 USA.	zhifeng_kou@yahoo.com					Alessandri B, 1999, ACT NEUR S, V75, P25; Alves W, 1993, J HEAD TRAUMA REHABI, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2005, PEDIATR NEUROL, V33, P184, DOI 10.1016/j.pediatrneurol.2005.03.015; Babikian T, 2006, J MAGN RESON IMAGING, V24, P801, DOI 10.1002/jmri.20696; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Blumbergs PC, 1997, HEAD INJURY PATHOPHY, P39; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Brenner T, 2003, PEDIATR NEUROL, V28, P104, DOI 10.1016/S0887-8994(02)00491-5; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; CDC, 2003, REP C MILD TRAUM BRA; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cohen BA, 2007, AM J NEURORADIOL, V28, P907; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Faul X. L., 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Garnett MR, 2000, BRAIN, V123, P1403, DOI 10.1093/brain/123.7.1403; Garnett MR, 2000, BRAIN, V123, P2046, DOI 10.1093/brain/123.10.2046; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Grossman E.J., 2011, J NEUROTRAUM; Holli KK, 2010, ACAD RADIOL, V17, P1096, DOI 10.1016/j.acra.2010.04.009; Holli Kirsi K, 2010, BMC Med Imaging, V10, P8, DOI 10.1186/1471-2342-10-8; Holshouser BA, 2000, J MAGN RESON IMAGING, V11, P9, DOI 10.1002/(SICI)1522-2586(200001)11:1<9::AID-JMRI2>3.3.CO;2-Y; Holshouser BA, 1997, RADIOLOGY, V202, P487, DOI 10.1148/radiology.202.2.9015079; Holshouser BA, 2006, J MAGN RESON IMAGING, V24, P33, DOI 10.1002/jmri.20607; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kim J, 2010, J NEUROTRAUM, V27, P1399, DOI 10.1089/neu.2009.1215; Kirov I, 2007, BRAIN INJURY, V21, P1147, DOI 10.1080/02699050701630383; Kou Z, 2010, CLIN MR NEUROIMAGING; Kou Z., 2008, P INT SOC MAG RESON, V16, P2272; Kou Z., 2007, JOINT ANN ISMRM ESMR, P186; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2010, J HEAD TRAUMA REHAB, V25, P31, DOI 10.1097/HTR.0b013e3181bff331; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; MENDELOW AD, 1997, HEAD INJURY PATHOPHY, P71; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Muller K, 2009, NEUROSURGERY, V64, P698, DOI 10.1227/01.NEU.0000340978.42892.78; National Academy of Neuropsychology, 2002, MILD TRAUM BRAIN INJ; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Signoretti S, 2002, ACT NEUR S, V81, P373; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Teasdale E., 1997, HEAD INJURY, P167; Tellier A, 1999, BRAIN INJURY, V13, P463; THULBORN KR, 1990, AM J NEURORADIOL, V11, P291; Tong KA, 2004, ANN NEUROL, V56, P36, DOI 10.1002/ana.20123; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Topal NB, 2008, NEUROL RES, V30, P974, DOI 10.1179/016164108X323799; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578; Yoon SJ, 2005, CLIN REHABIL, V19, P209, DOI 10.1191/0269215505cr813oa; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	102	5	5	0	1	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, CAMBRIDGE CB4 4WF, CAMBS, ENGLAND	2041-3203		978-1-84973-389-2; 978-1-84973-474-5	RSC DRUG DISCOV	RSC Drug Discov.		2012	24						19	44		10.1039/9781849734745-00019	10.1039/9781849734745		26	Chemistry, Medicinal; Pharmacology & Pharmacy	Book Citation Index – Science (BKCI-S)	Pharmacology & Pharmacy	BJQ29	WOS:000329653900004					2022-02-06	
J	Schnabel, R; Kydd, R				Schnabel, Ralf; Kydd, Rob			Neuropsychological Assessment of Distractibility in Mild Traumatic Brain Injury and Depression	CLINICAL NEUROPSYCHOLOGIST			English	Article						Environmental distraction; Neuropsychological assessment; Ecological validity; Traumatic brain injury; Major depressive episode	POSTCONCUSSION-LIKE SYMPTOMS; POST-CONCUSSION SYMPTOMS; ECOLOGICAL VALIDITY; WORKING-MEMORY; MAJOR DEPRESSION; HEAD-INJURY; BASE-RATE; TESTS; RUMINATION; CHILDREN	Traditional neuropsychological assessments are conducted exclusively in a quiet, distraction-free environment; clients' abilities to operate under busy and distracting conditions remain untested. Environmental distractions, however, are typical for a multitude of real-life situations and present a challenge to clients with frontal-temporal brain injury. In an effort to improve ecological validity, an extension of the traditional neuropsychological assessment was developed, comprising a standardized distraction condition. This allowed cognitive functions to be tested both in the traditional setting and with exposure to a specified audio-visual distraction. The present study (n = 240) investigated how clients with mild Traumatic Brain Injury (mTBI) (n = 80), Major Depression (MDE) (n = 80), and a healthy control sample (n = 80) performed on sub-tests of the Wechsler Adult Intelligence Scale-IV and the Wechsler Memory Scale-IV both in the standard and the distraction conditions. Test effort was controlled. Significant deterioration of performance in the distraction setting was observed among clients with mTBI. In contrast the performance of a healthy control sample remained unchanged. Significant improvement of performance in the distraction setting was documented for clients with MDE. Contrary to their improved performance, depressed clients experienced the distraction setting as more distressing than the control and mTBI group.	[Schnabel, Ralf; Kydd, Rob] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand		Schnabel, R (corresponding author), Univ Auckland, Dept Psychol Med, Private Bag 92019, Auckland 1, New Zealand.	rsch087@aucklanduni.ac.nz					American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Attix D. K., 2005, GERIATRIC NEUROPSYCH; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Beck T. A., 1996, BECK DEPRESSION INVE; Berman M. G., 2010, MEMORY INTERFERENCE; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brewer T. L, 1998, SCI ENG, V59, P0599; Brewer TL, 2002, RES NURS HEALTH, V25, P269, DOI 10.1002/nur.10045; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Campbell T, 2005, TRENDS COGN SCI, V9, P3, DOI 10.1016/j.tics.2004.11.002; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Couillet J, 2010, NEUROPSYCHOL REHABIL, V20, P321, DOI 10.1080/09602010903467746; Donaldson C, 2004, PSYCHOL MED, V34, P1309, DOI 10.1017/S0033291704001904; Elinson L, 2004, PSYCHIAT SERV, V55, P29, DOI 10.1176/appi.ps.55.1.29; Franzen M. D., 1996, CONCEPTUAL FDN ECOLO; Franzen M. D., 2000, RELIABILITY VALIDITY; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Gisselgard J, 2004, NEUROIMAGE, V22, P1107, DOI 10.1016/j.neuroimage.2004.02.031; Gisselgard J, 2003, NEUROPSYCHOLOGIA, V41, P1899, DOI 10.1016/S0028-3932(03)00122-2; Goldberg TE, 2010, NEUROPSYCHOPHARMACOL, V35, P1053, DOI 10.1038/npp.2009.211; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; HAAHR M, 2002, TRUE RANDOM NUMBER S; Hartnedy S, 2000, BEHAV INTERVENT, V15, P261, DOI 10.1002/1099-078X(200007/09)15:3<261::AID-BIN60>3.0.CO;2-N; Harvey PO, 2005, NEUROIMAGE, V26, P860, DOI 10.1016/j.neuroimage.2005.02.048; Heaton, 2010, NEUROPSYCHOLOGY PRED; Hugdahl K, 2007, COGNITIVE THER RES, V31, P147, DOI 10.1007/s10608-006-9116-8; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2006, ARCH CLIN NEUROPSYCH, V21, P303, DOI 10.1016/j.acn.2005.12.008; Kibby MY, 1998, ARCH CLIN NEUROPSYCH, V13, P523, DOI 10.1016/S0887-6177(97)00038-3; Knight RG, 2006, J INT NEUROPSYCH SOC, V12, P8, DOI 10.1017/S1355617706060048; Krawczyk DC, 2008, NEUROPSYCHOLOGIA, V46, P2020, DOI 10.1016/j.neuropsychologia.2008.02.001; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Long C.J., 1995, ADV MED PSYCHOTHERAP, V8, P59; Long C. J., 1997, ECOLOGICAL VALIDITY; Lutz R. L, 1999, VOCATIONAL EVALUATIO, V32, P47; Lyubomirsky S, 2003, COGNITIVE THER RES, V27, P309, DOI 10.1023/A:1023918517378; McClintock SA, 2010, NEUROPSYCHOLOGY, V24, P9, DOI 10.1037/a0017336; New Zealand Guidelines Group, 2006, TRAUM BRAIN INJ DIAG; Rees RJ, 2007, NEUROREHABILITATION, V22, P229; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sbordone RJ, 1996, ECOLOGICAL VALIDITY; Schnabel R, 2012, CLIN NEUROPSYCHOL, V26, P102, DOI 10.1080/13854046.2011.640642; Shugars S. L., 2007, FUNCTIONAL ASSESSMEN; Silverberg ND, 2007, J INT NEUROPSYCH SOC, V13, P898, DOI 10.1017/S1355617707071135; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Spooner DM, 2006, ARCH CLIN NEUROPSYCH, V21, P327, DOI 10.1016/j.acn.2006.04.004; Statistics New Zealand, 2010, SOC REP; SWEET JJ, 1992, CLIN PSYCHOL REV, V12, P21, DOI 10.1016/0272-7358(92)90090-U; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TOMBAUGH TN, 2003, J FORENSIC NEUROPSYC, V2, P69, DOI DOI 10.1300/J151V02N03_04; Trudel TM, 1998, REHABIL PSYCHOL, V43, P267, DOI 10.1037/0090-5550.43.4.267; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Watkins E, 2002, J NEUROL NEUROSUR PS, V72, P400, DOI 10.1136/jnnp.72.3.400; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilson B.A., 2003, J OCCUP PSYCHOL EMPL, V5, P33; WONG JL, 1994, ARCH CLIN NEUROPSYCH, V9, P411, DOI 10.1016/0887-6177(94)90004-3; Wood RL, 2006, ARCH CLIN NEUROPSYCH, V21, P429, DOI 10.1016/j.acn.2005.06.014; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE	73	5	5	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2012	26	5					769	789		10.1080/13854046.2012.693541			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	970EU	WOS:000306111700002	22694212				2022-02-06	
J	Wu, XJ; Shi, W; Zhao, W; Shao, B; Yuan, Q; Li, CM; Zhang, SW; Sun, BB; Wu, QY; Chen, J				Wu, Xiujie; Shi, Wei; Zhao, Wei; Shao, Bai; Yuan, Qin; Li, Chunmiao; Zhang, Shuangwei; Sun, Binbin; Wu, Qiyun; Chen, Jian			Changes in Pirh2 and p27(kip1) Expression Following Traumatic Brain Injury in Adult Rats	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; Pirh2; p27(kip1); Glial proliferation; Rat	UBIQUITIN-PROTEIN LIGASE; CDK INHIBITOR P27; NEURONAL DIFFERENTIATION; DEPENDENT DEGRADATION; KINASE; CELLS; SKP2; PHOSPHORYLATION; SCFSKP2	Pirh2, a p53-induced ubiquitin-protein ligase, has been reported to promote ubiquitin-dependent degradation of p27(kip1), which plays an essential role in mammalian cell cycle regulation and neurogenesis in the developing central nervous system (CNS). However, their distributions and functions in the nervous system lesion and repair remain unclear. In this study, we observed that the up-regulated expression of Pirh2 was concomitant with decreased p27(kip1) level after traumatic brain injury by Western blot and immunohistochemistry. Immunofluorescence double-labeling revealed that Pirh2 was mainly co-expressed with GFAP and CD11b. Meanwhile, we also examined the expression profiles of proliferating cell nuclear antigen (PCNA) whose changes were correlated with the expression of Pirh2. In addition, Pirh2 colocalized with p27(kip1) and PCNA. Immunoprecipitation further showed that they interacted with each other in the pathophysiology process. In summary, our data indicated Pirh2 might be a negative regulator of p27(kip1) and associated with glial proliferation.	[Wu, Xiujie; Shi, Wei; Zhao, Wei; Shao, Bai; Yuan, Qin; Li, Chunmiao; Zhang, Shuangwei; Sun, Binbin; Wu, Qiyun; Chen, Jian] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China		Wu, QY (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong 226001, Jiangsu, Peoples R China.	QiyunWu@yahoo.cn; chenjian_no1@yahoo.cn					Beitel LK, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290041; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Carruthers S, 2003, MECH DEVELOP, V120, P607, DOI 10.1016/S0925-4773(03)00010-8; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Chiariello M, 2000, BIOCHEM J, V349, P869, DOI 10.1042/bj3490869; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Fillies T, 2007, ONCOL REP, V17, P355; Hattori T, 2007, CANCER RES, V67, P10789, DOI 10.1158/0008-5472.CAN-07-2033; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Konigsmark B.W., 1970, CONT RES METHODS NEU, P315, DOI DOI 10.1007/978-3-642-85986-1_14; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Liu YH, 2010, J NEUROTRAUM, V27, P361, DOI 10.1089/neu.2008.0581; LOGAN A, 1992, J NEUROSCI, V12, P3828; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Nguyen L, 2006, CELL CYCLE, V5, P2314, DOI 10.4161/cc.5.20.3381; Nieto-Sampedro M, 1999, ADV EXP MED BIOL, V468, P207; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Shen AG, 2008, CELL MOL NEUROBIOL, V28, P713, DOI 10.1007/s10571-007-9167-8; Sheng Y, 2008, NAT STRUCT MOL BIOL, V15, P1334, DOI 10.1038/nsmb.1521; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.3.CO;2-9; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334	31	5	5	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	JAN	2012	46	1					184	191		10.1007/s12031-011-9572-9			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	879MA	WOS:000299332200020	21728064				2022-02-06	
J	Ortega, JM				Ortega, J. M.			Non-lethal blast wave interactions with a human head	COMPUTERS & FLUIDS			English	Article						Blast wave; Shock wave interaction; Traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; SHOCK; SIMULATION; DIFFRACTION; SPHERE	Numerical simulations are used to investigate the transient shock physics and loads that arise when a non-lethal blast wave impinges upon an unprotected human head located atop a complete, anatomically-correct body. Two non-lethal, hemispherical blast waves, each of which corresponds to the detonation of a high explosive charge, are considered for configurations in which the body is facing either towards or away from the explosive charge. The shock wave interactions that arise when the blast wave impinges upon the head are characterized and correlated with the resulting transient surface pressures, forces, and moments on the head. The transient forces and moments are compared to those of an analytical model based upon the work of Zaslavskii et al. [J Appl Mech Tech Phys 2001:42(3):533-7]. who derived expressions for the drag force on an arbitrary-shaped body due to the interaction with a weak to moderate strength shock wave. The results of this study indicate that Zaslavskii et al.'s model provides a straightforward means of estimating the transient loads on the head during a non-lethal blast wave interaction.(C) 2011 Elsevier Ltd. All rights reserved.	Lawrence Livermore Natl Lab, Livermore, CA 94551 USA		Ortega, JM (corresponding author), Lawrence Livermore Natl Lab, POB 808,L-090, Livermore, CA 94551 USA.	ortega17@llnl.gov			US DOE by LLNLUnited States Department of Energy (DOE) [DE-AC52-07NA27344]	The author thanks W. Moss and M. King of Lawrence Liver-more National Laboratory (LLNL) for the opportunity to collaborate on the traumatic brain injury research effort at LLNL, J. Hartman for his clinical input on cranio-vertebral biomechanics, D. Maitland for his discussion on shock wave-solid body interactions, J. Rodriguez for her assistance in the background literature survey and in the preparation of the human model geometry, K. Salari for his guidance on the simulations, and W. Small for his helpful feedback in the manuscript preparation. This work was performed under the auspices of the US DOE by LLNL under Contract DE-AC52-07NA27344. LLNL-JRNL-428242.	[Anonymous], 1998, US ARMY TECHNICAL MA; [Anonymous], 2008, STAR CCM 3 06 CD ADA; Ben-Dor G, 2007, SHOCK WAVE HIGH PRES, P1; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Bowen IG, 1968, DASA2113; BRYSON AE, 1961, J FLUID MECH, V10, P1, DOI 10.1017/S0022112061000019; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; CHAPMAN TC, 1995, INT J IMPACT ENG, V16, P777, DOI 10.1016/0734-743X(95)00012-Y; Chavko M, 2007, J NEUROSCI METH, V159, P277, DOI 10.1016/j.jneumeth.2006.07.018; Courant R., 1948, SUPERSONIC FLOW SHOC; Dobratz DM, 1985, UCRL52997; Elsayed NM, 1997, TOXICOLOGY, V121, P81, DOI 10.1016/S0300-483X(97)03657-3; Friedlander F. G., 1958, SOUND PULSES; Greer A, 2005, SOLID MECH APPL, V124, P263; Gutierrez-Cadavid JE., 2005, IMAGING NERVOUS SYST, P869; HEILIG WH, 1969, PHYS FLUIDS, V12, pI154; Held M., 1983, PROPELLANTS EXPLOS P, V8, P1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Imielinska C., 2006, INFORM VISUAL, V5, P279, DOI DOI 10.1057/PALGRAVE.IVS.9500137; Jameson A., P 14 FLUID PLASM DYN; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Krzywicki HJ, 1966, 297 US ARM MED RES N; Lee E., 1968, UCRL50422; Lemonick MD, 2008, WAR HEAD INJURIES LO; Lyakhov VN, 1979, IZV AKAD NAUK MEKH Z, V2, P113; Mathis JT, 2007, APPL ERGON, V38, P567, DOI 10.1016/j.apergo.2006.08.006; McCracken DL, 2005, TRAUMATIC BRAIN INJU; Menezes AH, 2008, CHILD NERV SYST, V24, P1091, DOI 10.1007/s00381-008-0606-8; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Moss WC, 2009, PRL, V103; Mott DR SD, 2008, 20 INT S MIL ASP BLA; MUNSON BR, 1994, FUNDAMENTALS FLUID M; Ofengeim DK, 1997, SHOCK WAVES, V7, P305, DOI 10.1007/s001930050085; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Sun M, 2005, SHOCK WAVES, V14, P3, DOI 10.1007/s00193-004-0235-4; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taber KH, 2005, IMAGING INTRACRANIAL, P555; Tanno H, 2003, SHOCK WAVES, V13, P191, DOI 10.1007/s00193-003-0209-y; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Weiss JM, 1999, AIAA J, V37, P29, DOI 10.2514/2.689; WEISS JM, 1995, AIAA J, V33, P2050, DOI 10.2514/3.12946; Wensheng H, 1991, ACTS MECH SINICA, V7, P295; YANG JY, 1987, AIAA J, V25, P683, DOI 10.2514/3.9683; Zaslavskii B. I., 2001, Journal of Applied Mechanics and Technical Physics, V42, P533, DOI 10.1023/A:1019223426721; Zeitzer MB, 2008, AAOHN J, V56, P347, DOI 10.3928/08910162-20080801-03; Zoltak J, 1998, COMPUT METHOD APPL M, V162, P165, DOI 10.1016/S0045-7825(97)00342-3	47	5	5	0	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0045-7930	1879-0747		COMPUT FLUIDS	Comput. Fluids	DEC 30	2011	52						92	103		10.1016/j.compfluid.2011.09.002			12	Computer Science, Interdisciplinary Applications; Mechanics	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Mechanics	852XL	WOS:000297390700009		Green Submitted			2022-02-06	
J	Raja Beharelle, A; Tisserand, D; Stuss, DT; McIntosh, AR; Levine, B				Raja Beharelle, Anjali; Tisserand, Danielle; Stuss, Donald T.; McIntosh, Anthony R.; Levine, Brian			Brain activity patterns uniquely supporting visual feature integration after traumatic brain injury	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						traumatic brain injury; diffuse axonal injury; attention; feature integration; fMRI; partial least squares	PARTIAL LEAST-SQUARES; DIFFUSE AXONAL INJURY; WORKING-MEMORY LOAD; CLOSED-HEAD INJURY; COGNITIVE-CONTROL; EPISODIC RETRIEVAL; PREFRONTAL CORTEX; SPATIAL ATTENTION; FUNCTIONAL MRI; QUANTIFIED MRI	Traumatic brain injury (TBI) patients typically respond more slowly and with more variability than controls during tasks of attention requiring speeded reaction time. These behavioral changes are attributable, at least in part, to diffuse axonal injury (DAI), which affects integrated processing in distributed systems. Here we use a multivariate method sensitive to distributed neural activity to compare brain activity patterns of patients with chronic phase moderate to severe TBI to those of controls during performance on a visual feature integration task assessing complex attentional processes that has previously shown sensitivity to TBI. The TBI patients were carefully screened to be free of large focal lesions that can affect performance and brain activation independently of DAI. The task required subjects to hold either one or three features of a Target in mind while suppressing responses to distracting information. In controls, the multi-feature condition activated a distributed network including limbic, prefrontal, and medial temporal structures. TBI patients engaged this same network in the single-feature and baseline conditions. In multi-feature presentations, TBI patients alone activated additional frontal, parietal, and occipital regions. These results are consistent with neuroimaging studies using tasks assessing different cognitive domains, where increased spread of brain activity changes was associated with TBI. Our results also extend previous findings that brain activity for relatively moderate task demands in TBI patients is similar to that associated with of high task demands in controls.	[Raja Beharelle, Anjali; Tisserand, Danielle; Stuss, Donald T.; McIntosh, Anthony R.; Levine, Brian] Univ Toronto, Rotman Res Inst, Baycrest Ctr, Toronto, ON, Canada; [Raja Beharelle, Anjali; Tisserand, Danielle; Stuss, Donald T.; McIntosh, Anthony R.; Levine, Brian] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Stuss, Donald T.; Levine, Brian] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada		Raja Beharelle, A (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	anjali.raja@utoronto.ca	Raja Beharelle, Anjali/A-3756-2013; Levine, Brian/O-2725-2019; Levine, Brian/G-4328-2010	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; McIntosh, Anthony/0000-0002-1784-5662	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R01 HD42385-01]	The study was supported by NIH 1R01 HD42385-01 to Brian Levine.	Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Chen AJW, 2006, J HEAD TRAUMA REHAB, V21, P107, DOI 10.1097/00001199-200603000-00004; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Chastelaine M, 2011, CEREB CORTEX, V21, P2166, DOI 10.1093/cercor/bhq294; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Edgington E. S., 1980, RANDOMIZATION TESTS; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; Grady CL, 2008, ANN NY ACAD SCI, V1124, P127, DOI 10.1196/annals.1440.009; Huang CM, 2012, NEUROPSYCHOLOGIA, V50, P55, DOI 10.1016/j.neuropsychologia.2011.10.022; Kim Y.-H., 2008, NEUROREHAB NEURAL RE, V10, P1; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2002, J NEUROL NEUROSUR PS, V73, P173, DOI 10.1136/jnnp.73.2.173; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 2004, NEUROIMAGE, V23, P764, DOI 10.1016/j.neuroimage.2004.05.018; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Morcom AM, 2007, CEREB CORTEX, V17, P2491, DOI 10.1093/cercor/bhl155; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Petrides M, 1999, EUR J NEUROSCI, V11, P1011, DOI 10.1046/j.1460-9568.1999.00518.x; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Sakai K, 2006, J NEUROSCI, V26, P1211, DOI 10.1523/JNEUROSCI.3887-05.2006; SAMPSON PD, 1989, NEUROTOXICOL TERATOL, V11, P477, DOI 10.1016/0892-0362(89)90025-1; Scheibel RS, 2009, J NEUROTRAUM, V26, P1447, DOI 10.1089/neu.2008.0736; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Spikman JM, 2001, BRAIN COGNITION, V47, P446, DOI 10.1006/brcg.2001.1320; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 2002, NEUROPSYCHOLOGY, V16, P500, DOI 10.1037//0894-4105.16.4.500; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; Stuss DT, 1994, NEUROPSYCHOLOGY, V8, P316, DOI DOI 10.1037/0894-4105.8.3.316; Talairach P., 1988, 3 DIMENSIONAL PROPOR; TEASDALE G, 1974, LANCET, V2, P81; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Turner GR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00009; Vallesi A, 2011, J COGNITIVE NEUROSCI, V23, P801, DOI 10.1162/jocn.2010.21490; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Zachary R. A., 1986, SHIPLEY I LIVING SCA	61	5	5	0	5	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	DEC 9	2011	5								164	10.3389/fnhum.2011.00164			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	882IY	WOS:000299558400001	22180740	Green Published, Green Accepted, gold			2022-02-06	
J	Bertolizio, G; Bissonnette, B; Mason, L; Ashwal, S; Hartman, R; Marcantonio, S; Obenaus, A				Bertolizio, Gianluca; Bissonnette, Bruno; Mason, Linda; Ashwal, Stephen; Hartman, Richard; Marcantonio, Suzzanne; Obenaus, Andre			Effects of hemodilution after traumatic brain injury in juvenile rats	PEDIATRIC ANESTHESIA			English	Article						behavior; hemodilution; juvenile rats; laser Doppler flowmetry; magnetic resonance imaging; traumatic brain injury	CORTICAL IMPACT INJURY; CEREBRAL-BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; ACUTE NORMOVOLEMIC HEMODILUTION; ISOVOLEMIC HEMODILUTION; PLASMA VISCOSITY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; HEAD-INJURY	Background: Normovolemic hemodilution (HD) in adult animal studies has shown exacerbation of traumatic brain injury (TBI) lesion volumes. Similar studies in juvenile rats have not been reported and outcomes are likely to be different. This study investigated the effects of normovolemic hemodilution (21% hematocrit) in a juvenile TBI (jTBI) model. Methods: Twenty 17-day-old rats underwent moderate cortical contusion impact injury (CCI) and were divided into four groups: CCI/hemodilution (HD) (group HD), CCI/no HD (group C), Sham/HD (group SHD), and Sham/no HD (group S). Regional laser Doppler flowmetry (LDF), edema formation (MRI-T2WI), water mobility assessed using diffusion weighted imaging (MRI-DWI), open field activity tests, and histological analyses were evaluated for lesion characteristics. Results: Hemodilution significantly increased blood flow in the HD compared to the C group after TBI. T2WI revealed a significantly increased extravascular blood volume in HD at 1, 7, and 14 days post-CCI. Edematous tissue and total contusional lesion volume were higher in HD-treated animals at 1 and 14 days. DWI revealed that HD, SHD, and C groups had elevated water mobility compared to S groups in the ipsilateral cortex and striatum. Histology showed a larger cortical lesion in the C than HD group. Open field activity was increased in HD, C, and SHD groups compared to the S group. Conclusions: Hemodilution results in significant brain hyperemia with increased edema formation, extravascular blood volume, and water mobility after jTBI. Hemodilution results in less cortical damage but did not alter behavior. Hemodilution is likely not to be clinically beneficial following jTBI.	[Obenaus, Andre] Loma Linda Univ, Dept Pediat & Radiat Med, Loma Linda, CA 92354 USA; [Obenaus, Andre] Loma Linda Univ, Dept Radiol, Loma Linda, CA 92354 USA; [Obenaus, Andre] Loma Linda Univ, Dept Biophys, Loma Linda, CA 92354 USA; [Obenaus, Andre] Loma Linda Univ, Dept Bioengn, Loma Linda, CA 92354 USA; [Bertolizio, Gianluca; Mason, Linda] Loma Linda Univ, Dept Anesthesiol, Loma Linda, CA 92354 USA; [Bissonnette, Bruno] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Bissonnette, Bruno] Children World Anesthesia Fdn, Toronto, ON, Canada; [Mason, Linda; Ashwal, Stephen] Loma Linda Univ, Dept Pediat, Loma Linda, CA 92354 USA; [Hartman, Richard] Loma Linda Univ, Dept Psychol, Sch Sci & Technol, Loma Linda, CA 92354 USA		Obenaus, A (corresponding author), Loma Linda Univ, Dept Radiat Med, Loma Linda, CA 92354 USA.	aobenaus@llu.edu	Hartman, Richard/C-5767-2008; Bertolizio, Gianluca/AAM-7595-2020	Hartman, Richard/0000-0001-9235-3169; 	Department of Anesthesiology, Loma Linda University, Loma Linda, CA, USA; Department of Anesthesiology	Sources of financial support for the work: Department of Anesthesiology, Loma Linda University, Loma Linda, CA 92354, USA.; Funding was provided from the Department of Anesthesiology.	Albensi BC, 2000, EXP NEUROL, V162, P61, DOI 10.1006/exnr.2000.7256; Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bertolizio G, 2011, PEDIATR ANESTH, V21, P347, DOI 10.1111/j.1460-9592.2011.03542.x; Cabrales P, 2006, AM J PHYSIOL-HEART C, V291, pH581, DOI 10.1152/ajpheart.01279.2005; Chambers IR, 2005, CHILD NERV SYST, V21, P195, DOI 10.1007/s00381-004-1060-x; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Creteur J, 2001, J APPL PHYSIOL, V91, P1701, DOI 10.1152/jappl.2001.91.4.1701; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Dietrich WD, 1996, J CEREBR BLOOD F MET, V16, P481, DOI 10.1097/00004647-199605000-00015; Dijkhuizen RM, 2003, J CEREBR BLOOD F MET, V23, P1383, DOI 10.1097/01.WCB.0000100341.78607.EB; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Ge YL, 2007, ACTA ANAESTH SCAND, V51, P1331, DOI 10.1111/j.1399-6576.2007.01448.x; Gibson JB, 2002, SHOCK, V17, P234, DOI 10.1097/00024382-200203000-00013; HANSTOCK CC, 1994, STROKE, V25, P843, DOI 10.1161/01.STR.25.4.843; Hare GMT, 2008, ANESTH ANALG, V107, P1356, DOI 10.1213/ane.0b013e318184cfe9; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; HEROS RC, 1989, STROKE, V20, P423, DOI 10.1161/01.STR.20.3.423; HYODO A, 1989, STROKE, V20, P534, DOI 10.1161/01.STR.20.4.534; Inoue RY, 2000, AM J PHYSIOL-REG I, V279, pR2243, DOI 10.1152/ajpregu.2000.279.6.R2243; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Karadibak K, 2002, EUR J ANAESTH, V19, P330, DOI 10.1017/S0265021502000534; KIMURA M, 1994, STROKE, V25, P2227, DOI 10.1161/01.STR.25.11.2227; Kimura M, 1994, STROKE, V25, P2233; Kramer MS, 1996, NEUROSURGERY, V38, P355, DOI 10.1097/00006123-199602000-00024; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Li M, 2006, J NEUROSURG ANESTH, V18, P125, DOI 10.1097/00008506-200604000-00006; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Marik PE, 2002, CHEST, V122, P699, DOI 10.1378/chest.122.2.699; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Marmarou A, 2000, ACT NEUR S, V76, P349; Martini J, 2006, CLIN HEMORHEOL MICRO, V35, P51; Mendez DR, 2004, J TRAUMA, V57, P244, DOI 10.1097/01.TA.0000103983.22362.67; MESSMER K, 1975, SURG CLIN N AM, V55, P659; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Obenaus A, 2007, J NEUROTRAUM, V24, P1147, DOI 10.1089/neu.2006.0211; Palmer J, 2000, Intensive Crit Care Nurs, V16, P319, DOI 10.1054/iccn.2000.1511; Philip S, 2009, J TRAUMA, V67, pS128, DOI 10.1097/TA.0b013e3181ad32c7; Rafols JA, 2007, NEUROL RES, V29, P339, DOI 10.1179/016164107X204648; Rebel A, 2003, AM J PHYSIOL-HEART C, V285, pH1600, DOI 10.1152/ajpheart.00077.2003; Roseff SD, 2002, TRANSFUSION, V42, P1398, DOI 10.1046/j.1537-2995.2002.00208.x; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Shen H, 2002, ANESTHESIOLOGY, V96, P142, DOI 10.1097/00000542-200201000-00027; Spahn DR, 2000, ANESTHESIOLOGY, V93, P242, DOI 10.1097/00000542-200007000-00035; Szabo EZ, 2009, PEDIATR ANESTH, V19, P108, DOI 10.1111/j.1460-9592.2008.02826.x; TANAKA K, 1991, NEUROSCI LETT, V127, P129, DOI 10.1016/0304-3940(91)90911-C; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Thomale UW, 2004, J NEUROTRAUM, V21, P1737; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; TODD MM, 1992, AM J PHYSIOL, V263, pH75, DOI 10.1152/ajpheart.1992.263.1.H75; Tonnesen J, 2005, EXP PHYSIOL, V90, P349, DOI 10.1113/expphysiol.2004.029512; Tsai AG, 1998, AM J PHYSIOL-HEART C, V275, pH2170, DOI 10.1152/ajpheart.1998.275.6.H2170; Vallee M, 1997, J NEUROSCI, V17, P2626; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; WANG P, 1994, AM J PHYSIOL, V266, pR368, DOI 10.1152/ajpregu.1994.266.2.R368; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Xiong L, 2008, EUR J ANAESTH, V25, P581, DOI 10.1017/S0265021508004067	71	5	5	1	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1155-5645			PEDIATR ANESTH	Pediatr. Anesth.	DEC	2011	21	12					1198	1208		10.1111/j.1460-9592.2011.03695.x			11	Anesthesiology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Pediatrics	854RF	WOS:000297511200005	21929525				2022-02-06	
J	Borkar, SA; Sinha, S; Agrawal, D; Satyarthee, GD; Gupta, D; Mahapatra, AK				Borkar, Sachin A.; Sinha, Sumit; Agrawal, Deepak; Satyarthee, Guru Dutt; Gupta, Deepak; Mahapatra, Ashok Kumar			Severe head injury in the elderly: risk factor assessment and outcome analysis in a series of 100 consecutive patients at a Level 1 trauma centre	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						brain injury; diffuse axonal injury; elderly; head injury; intracranial hematoma		severe head injury in the elderly. We aimed to study the epidemiology, mode of injury, clinical profile, management, complications and outcome in severe head injury occurring in the elderly (age e"60years). One hundred consecutive patients of severe head injury(GCSd"8) admitted at a Level 1 trauma centre from 2006 through 2008 were retrospectively analysed. The cases were reviewed in the light of epidemiology, clinico-radiological findings, associated injuries, comorbidities, surgical intervention, post-operative complications and long-term outcome. Mean age was 63.5 years +/- 4.64(60-85 years, 74% male). Road traffic accident was the most common mode of injury(72%). Median GCS at admission was 5(range-3-8). CT scan revealed acute subdural hematoma in 53 (53%) patients, cerebral contusion in 53, SAH in 20, extradura hematoma in 10 and diffuse axonal injury in 11 patients. Associated comorbidities included DM in 17%, CAD in 10%, hypertension in 9%, alcoholic liver disease in 8%. Associated spinal injury was observed in 10%, abdominal solid organ injury in 5, pneumothorax in 6 patients. Eighty two patients underwent operative intervention. Remaining 18 patients were managed conservatively. Forty patients(40%) developed ventilator -associated pneumonia (VAP), meningitis(16%), septicemia(20%), coagulopathy(11%) and multi-organ dysfunction syndrome (MODS)(20%). Overall mortality was 70%. Follow up was available for 24 out of the 30 survivors (80%). Median GOS score for those patients who survived was 4(3-5) at 6m follow-up period was positively correlated with pre-admission GCS score (Correlation coefficient +0.78). Mean time interval from injury to intervention, associated comorbidities, associated spinal, orthopaedic and abdominal injury; traumatic SAH on CT head all were more common in patients with ultimate unfavourable outcome as compared to patients who survived and this difference was statistically significant (p value<0.05). Severe head injury in elderly carries a high mortality owing to associated comorbidities. Pre-admission GCS score bears a positive correlation to GOS score at 6 months follow-up. VAP with resultant septicemia is the foremost post-operative cause of death in severe head injury in the elderly. In this regard, there is a need for an integrated multi-modality multidepartmental dedicated teamwork.	[Borkar, Sachin A.; Sinha, Sumit; Agrawal, Deepak; Satyarthee, Guru Dutt; Gupta, Deepak; Mahapatra, Ashok Kumar] All India Inst Med Sci, Jai Prakash Narayan Apex Trauma Ctr, Dept Neurosurg, New Delhi 110029, India		Mahapatra, AK (corresponding author), All India Inst Med Sci, Dept Neurosurg, CN Ctr, Room 720,7th Floor, New Delhi 110029, India.	akmahapatra_22000@yahoo.com	/AAG-3032-2021	/0000-0002-5499-0746			Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Cummings JL, 1992, DEMENTIA CLIN APPROA; GALBRAITH S, 1976, BMJ-BRIT MED J, V1, P1438, DOI 10.1136/bmj.1.6023.1438; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Hanif S, 2009, Ir Med J, V102, P255; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Le Roux AA, 2007, BRIT J NEUROSURG, V21, P16, DOI 10.1080/02688690601170692; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Park K., 2005, TXB PREVENTIVE SOCIA, P434; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; ROY CW, 1986, INJURY, V17, P220, DOI 10.1016/0020-1383(86)90222-6; Servadei F, 1997, ACTA NEUROCHIR, V139, P273, DOI 10.1007/BF01808821; Sinha A K, 2000, JANE, V4, P27; Sinha VD, 2008, INDIAN J NEUROTRAUM, V5, P69; TEASDALE G, 1982, HEAD INJURY BASIC CL, P213	16	5	5	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2011	8	2					77	82		10.1016/S0973-0508(11)80004-3			6	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M2O	WOS:000218384100004					2022-02-06	
J	Clond, MA; Mirocha, J; Singer, MB; Bukur, M; Salim, A; Marguiles, DR; Ley, EJ				Clond, Morgan A.; Mirocha, James; Singer, Matthew B.; Bukur, Marko; Salim, Ali; Marguiles, Daniel R.; Ley, Eric J.			Gender influences outcomes in trauma patients with elevated systolic blood pressure	AMERICAN JOURNAL OF SURGERY			English	Article; Proceedings Paper	63rd Annual Meeting of the Southwestern-Surgical-Congress	APR 03-08, 2011	HI	SW Surg Congress		Trauma; Gender; Men; Women; Systolic blood pressure; Traumatic brain injury; Adrenergic activation; Sympathetic hyperactivity; Beta-adrenergic receptor; Sex hormones	HORMONALLY ACTIVE WOMEN; BRAIN-INJURY; HEAD-INJURY; MALE-RATS; SEX; MEN; AGE; PROGESTERONE; IMPACT; CATECHOLAMINES	BACKGROUND: This analysis explored the association between gender and systolic blood pressure (SBP) in trauma patients and then established how gender influenced outcomes in those with elevated SBP. METHODS: Demographics and outcomes were compared using the Los Angeles County Trauma System Database and multivariable modeling determined predictors for SBP, pneumonia, and mortality. RESULTS: Age and male sex were significant predictors for increased SBP, whereas the Injury Severity Score (ISS) >= 16 was a significant predictor for decreased SBP. In both male and female TBI patients, SBP >= 160 mmHg was associated with increased pneumonia (Adjusted odds ratio [AOR] = 1.74, P = .002 and AOR = 2.37, P = .046, respectively), whereas SBP >= 160 mmHg was a predictor for mortality only among male TBI patients (AOR = 1.48, P = .03). In non-TBI patients, SBP >= 160 mmHg was not a predictor for pneumonia or mortality in either sex. CONCLUSIONS: In this retrospective review of trauma registry data, men presented with higher SBP. In patients with TBI, regardless of gender, increased SBP was associated with increased pneumonia, and in men with TBI increased SBP was associated with increased mortality. The cause and relevance of these epidemiological findings require further investigation. Crown Copyright (C) 2011 Published by Elsevier Inc. All rights reserved.	[Clond, Morgan A.; Mirocha, James; Singer, Matthew B.; Bukur, Marko; Salim, Ali; Marguiles, Daniel R.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215 N Tower, Los Angeles, CA 90048 USA.	eric.ley@cshs.org		Bukur, Marko/0000-0002-1850-7147; Clond, Morgan/0000-0002-3036-4193			Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Butcher I, 2007, J NEUROTRAUM, V24, P294, DOI 10.1089/neu.2006.0032; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; Combes A, 2009, CRIT CARE MED, V37, P2506, DOI 10.1097/CCM.0b013e3181a569df; COUPADE C, 2004, BRIT J PHARMACOL, V143, P1033; Deitch EA, 2007, ANN SURG, V246, P447, DOI 10.1097/SLA.0b013e318148566; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Hsieh YC, 2007, CRIT CARE MED, V35, pS621, DOI 10.1097/01.CCM.0000278603.18687.4F; Hurn PD, 2005, STROKE, V36, P193, DOI 10.1161/01.STR.0000153064.41332.f6; Jeschke MG, 2005, ANN SURG, V241, P759, DOI 10.1097/01.sla.0000161028.43338.cd; KHOURY S, 1992, AM J HYPERTENS, V5, P616, DOI 10.1093/ajh/5.9.616; Knoferl MW, 2000, ARCH SURG-CHICAGO, V135, P425, DOI 10.1001/archsurg.135.4.425; LEY EJ, 2011, J TRAUMA IN PRESS; Llompart-Pou JA, 2007, J TRAUMA, V62, P1457, DOI 10.1097/01.ta.0000219143.69483.71; Mannick JA, 2002, J AM COLL SURGEONS, V194, P104, DOI 10.1016/S1072-7515(01)01123-1; Menke A, 2010, AM J EPIDEMIOL, V171, P583, DOI 10.1093/aje/kwp415; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Napolitano LM, 2001, J TRAUMA, V50, P274, DOI 10.1097/00005373-200102000-00013; Olsen TS, 2010, GENDER MED, V7, P284, DOI 10.1016/j.genm.2010.08.001; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; ROOF RL, 1993, BEHAV BRAIN RES, V57, P47, DOI 10.1016/0166-4328(93)90060-4; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Rupprecht R, 2003, PSYCHONEUROENDOCRINO, V28, P139, DOI 10.1016/S0306-4530(02)00064-1; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1988, AM J PHYSIOL, V254, pE287, DOI 10.1152/ajpendo.1988.254.3.E287; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46; ZAFAR SN, 2011, J TRAUMA IN PRESS	37	5	5	0	4	EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC	BRIDGEWATER	685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA	0002-9610			AM J SURG	Am. J. Surg.	DEC	2011	202	6					823	827		10.1016/j.amjsurg.2011.06.044			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	868TL	WOS:000298548500058	22137141				2022-02-06	
J	Finch, WH; Chang, M; Davis, AS; Holden, JE; Rothlisberg, BA; McIntosh, DE				Finch, W. Holmes; Chang, Mei; Davis, Andrew S.; Holden, Jocelyn E.; Rothlisberg, Barbara A.; McIntosh, David E.			The prediction of intelligence in preschool children using alternative models to regression	BEHAVIOR RESEARCH METHODS			English	Article						Prediction; Regression; CART; MARS; Neural networks; GAM; Boosting	TRAUMATIC BRAIN-INJURY; ESTIMATING PREMORBID IQ; ADULT READING TEST; WAIS-R; DEMOGRAPHIC-VARIABLES; ALZHEIMERS-DISEASE; PROPOSED METHOD; WECHSLER TEST; PERFORMANCE; OPIE-3	Statistical prediction of an outcome variable using multiple independent variables is a common practice in the social and behavioral sciences. For example, neuropsychologists are sometimes called upon to provide predictions of preinjury cognitive functioning for individuals who have suffered a traumatic brain injury. Typically, these predictions are made using standard multiple linear regression models with several demographic variables (e.g., gender, ethnicity, education level) as predictors. Prior research has shown conflicting evidence regarding the ability of such models to provide accurate predictions of outcome variables such as full-scale intelligence (FSIQ) test scores. The present study had two goals: (1) to demonstrate the utility of a set of alternative prediction methods that have been applied extensively in the natural sciences and business but have not been frequently explored in the social sciences and (2) to develop models that can be used to predict premorbid cognitive functioning in preschool children. Predictions of Stanford-Binet 5 FSIQ scores for preschool-aged children is used to compare the performance of a multiple regression model with several of these alternative methods. Results demonstrate that classification and regression treesprovided more accurate predictions of FSIQ scores than does the more traditional regression approach. Implications of these results are discussed.	[Finch, W. Holmes; Chang, Mei; Davis, Andrew S.; Holden, Jocelyn E.; Rothlisberg, Barbara A.; McIntosh, David E.] Ball State Univ, Dept Educ Psychol, Muncie, IN 47306 USA		Finch, WH (corresponding author), Ball State Univ, Dept Educ Psychol, Muncie, IN 47306 USA.	whfinch@bsu.edu					Almkvist O, 2009, NEUROPSYCHOLOGY, V23, P117, DOI 10.1037/a0014074; Baade LE, 2004, ARCH CLIN NEUROPSYCH, V19, P227, DOI 10.1016/S0887-6177(03)00092-1; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; Berk RA, 2008, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-77501-2_1; Breiman L., 1984, CLASSIFICATION REGRE; Buhlmann P, 2007, STAT SCI, V22, P477, DOI 10.1214/07-STS242; Buhlmann P, 2003, J AM STAT ASSOC, V98, P324, DOI 10.1198/016214503000125; Cheung CK, 2010, EVAL PROGRAM PLANN, V33, P255, DOI 10.1016/j.evalprogplan.2009.08.006; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; Dana J, 2004, J EDUC BEHAV STAT, V29, P317, DOI 10.3102/10769986029003317; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Garson GD, 1998, NEURAL NETWORKS INTR; GOLDBERG LR, 1972, MULTIVARIATE BEHAV R, V7; Granello DH, 2010, J COUNS DEV, V88, P92, DOI 10.1002/j.1556-6678.2010.tb00155.x; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Griffin SL, 2002, ARCH CLIN NEUROPSYCH, V17, P497, DOI 10.1016/S0887-6177(01)00136-6; Hastie T., 2008, RANDOM FORESTS, DOI DOI 10.1007/978-0-387-84858-7_15; Krull K R, 1995, Appl Neuropsychol, V2, P35, DOI 10.1207/s15324826an0201_6; Lavigne JV, 2010, BEHAV THER, V41, P198, DOI 10.1016/j.beth.2009.02.006; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; MARKS MR, 1966, M AM PSYCH ASS; Marshall DB, 2000, PSYCHOL METHODS, V5, P102, DOI 10.1037/1082-989X.5.1.102; Mathias JL, 2007, BRIT J CLIN PSYCHOL, V46, P457, DOI 10.1348/014466507X190197; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nistor N, 2010, COMPUT EDUC, V55, P663, DOI 10.1016/j.compedu.2010.02.026; Pavlik VN, 2006, DEMENT GERIATR COGN, V22, P367, DOI 10.1159/000095640; Powell BD, 2003, ARCH CLIN NEUROPSYCH, V18, P277, DOI 10.1016/S0887-6177(02)00135-X; Pungello EP, 2009, DEV PSYCHOL, V45, P544, DOI 10.1037/a0013917; Reynolds CR, 1997, ARCH CLIN NEUROPSYCH, V12, P769, DOI 10.1016/S0887-6177(97)00051-6; Roberts E, 1999, INFANT CHILD DEV, V8, P49, DOI 10.1002/(SICI)1522-7219(199903)8:1<49::AID-ICD188>3.0.CO;2-1; Roid G., 2003, STANFORD BINET INTEL, V5th ed.; SCHINKA JA, 2000, CLIN GUIDE NEUROPSYC, P43; Schoenberg MR, 2007, J CLIN EXP NEUROPSYC, V29, P867, DOI 10.1080/13803390601147678; Schoenberg MR, 2007, J CHILD NEUROL, V22, P379, DOI 10.1177/0883073807301925; Schoenberg MR, 2006, ARCH CLIN NEUROPSYCH, V21, P469, DOI 10.1016/j.acn.2006.06.006; Schoenberg MR, 2008, PSYCHOL ASSESSMENT, V20, P377, DOI 10.1037/a0014010; Schoenberg MR, 2003, CLIN NEUROPSYCHOL, V17, P308, DOI 10.1076/clin.17.3.308.18088; Schoenberg MR, 2002, CLIN NEUROPSYCHOL, V16, P426, DOI 10.1076/clin.16.4.426.13913; Schumacher M, 1996, COMPUT STAT DATA AN, V21, P661, DOI 10.1016/0167-9473(95)00032-1; SELLERS AH, 1996, APPL NEUROPSYCHOL, V9, P65; Sellers Alfred H, 2002, Appl Neuropsychol, V9, P65, DOI 10.1207/S15324826AN0902_1; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Vanderploeg RD, 1996, PSYCHOL ASSESSMENT, V8, P404, DOI 10.1037/1040-3590.8.4.404; Vanderploeg RD, 1998, PSYCHOL ASSESSMENT, V10, P277, DOI 10.1037/1040-3590.10.3.277; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Wechsler D, 1983, WECHSLER ADULT INTEL; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D, 1989, MANUAL WECHSLER PRES; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WILLSHIRE D, 1991, J CLIN EXP NEUROPSYC, V13, P204, DOI 10.1080/01688639108401038; Wood S.N., 2017, GEN ADDITIVE MODELS, DOI [10.1201/978131537027, DOI 10.1201/9781315370279]; Yeates KO, 1997, J CLIN EXP NEUROPSYC, V19, P825, DOI 10.1080/01688639708403763	54	5	5	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1554-351X			BEHAV RES METHODS	Behav. Res. Methods	DEC	2011	43	4					942	952		10.3758/s13428-011-0102-z			11	Psychology, Mathematical; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	850BK	WOS:000297169200005	21553177	Bronze			2022-02-06	
J	Helms, JM; Walkowski, SA; Elkiss, M; Pittman, D; Kouchis, NS; Lawrence, B				Helms, Joseph M.; Walkowski, Stevan A.; Elkiss, Mitchell; Pittman, Donna; Kouchis, Nick S.; Lawrence, Bradley			HMI Auricular Trauma Protocol: An Acupuncture Approach for Trauma Spectrum Symptoms	MEDICAL ACUPUNCTURE			English	Article						Trauma spectrum; auricular acupuncture; post-traumatic stress disorder; PTSD; traumatic brain injury; TBI	POSTTRAUMATIC-STRESS-DISORDER	This article describes a six-point auricular acupuncture protocol to influence the neuroanatomical and psychoemotional targets of trauma. This protocol can be used immediately or years following the noxious experience. The article addresses the rationale for combining these points, their locations, and methods of stimulation, as well as briefly discussing anecdotal experience in military and civilian populations. The protocol is presented as a simple and safe intervention of potential value for addressing the multiple manifestations of the trauma spectrum.	[Helms, Joseph M.; Walkowski, Stevan A.; Elkiss, Mitchell; Pittman, Donna; Kouchis, Nick S.; Lawrence, Bradley] HMI, 2520 Milvia St, Berkeley, CA 94704 USA; [Walkowski, Stevan A.] Ohio Univ, Heritage Coll Osteopath Med, Dept Family Med, Athens, OH 45701 USA		Helms, JM (corresponding author), HMI, 2520 Milvia St, Berkeley, CA 94704 USA.	mafp@hmieducation.com					American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andersen P, 2007, HIPPOCAMPUS BOOK, P751; [Anonymous], COMMUNICATION; Bisson J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub3; Hollifield M, 2007, J NERV MENT DIS, V195, P504, DOI 10.1097/NMD.0b013e31803044f8; Holmes EA, 2008, ACTA PSYCHOL, V127, P553, DOI 10.1016/j.actpsy.2007.11.002; Johnson C, 2001, J CLIN PSYCHOL, V57, P1237, DOI 10.1002/jclp.1090; KRAKOW B, 1993, J BEHAV THER EXP PSY, V24, P325, DOI 10.1016/0005-7916(93)90057-4; Maciocia G, 1989, FDN CHINESE MED, P132; Miller BL, 2007, HUMAN FRONTAL LOBES, P540; Oleson T., 2003, AURICULOTHERAPY MANU; Ponniah K, 2009, DEPRESS ANXIETY, V26, P1086, DOI 10.1002/da.20635; Roman Marian, 2010, Issues Ment Health Nurs, V31, P302, DOI 10.3109/01612841003642741; Tick E., 2005, WAR SOUL HEALING OUR; Wendling P, ACUPUNCTURE LESSENS; Whalen PJ, 2009, HUMAN AMYGDALA; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158	17	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1933-6586	1933-6594		MED ACUPUNCT	Med. Acupunct.	DEC	2011	23	4					209	213		10.1089/acu.2011.0859			5	Integrative & Complementary Medicine	Emerging Sources Citation Index (ESCI)	Integrative & Complementary Medicine	V2D3S	WOS:000217477100003					2022-02-06	
J	Kaushal, R; Kataria, R; Gupta, A; Sinha, VD				Kaushal, Ronyl; Kataria, Rashim; Gupta, Ashok; Sinha, V. D.			Traumatic bilateral (mirror image) basal ganglia bleed	INDIAN JOURNAL OF NEUROTRAUMA			English	Article						basal ganglia; contusion; head injury; hemorrhage; traumatic brain		Bilateral traumatic hemorrhage of the basal ganglia is an extremely rare neuropathologic entity. Hematomas of the basal ganglia in head injury have long been recognized with an interest but their mechanism has not been revealed clearly. It is presumed to be secondary to rupture of the lenticulostriate or anterior choroidal artery by shearing as a result of acceleration/deceleration forces. Outcome of traumatic basal ganglia haemorrhage (TBGH) appears favourable unless it is large or associated with coagulation disorders or when it is associated with other intracranial injuries such as diffuse axonal injury, cerebral contusion etc. We present a rare case of 42 yrs old male with isolated bilateral (mirror-image) traumatic basal ganglia bleed. Mechanism, clinical features and management is discussed and available literature reviewed.	[Kaushal, Ronyl; Kataria, Rashim; Gupta, Ashok; Sinha, V. D.] SMS Med Coll & Hosp, Dept Neurosurg, Jaipur, Rajasthan, India		Kataria, R (corresponding author), 53,Mauji Colony, Jaipur, Rajasthan, India.	rashim_kat@yahoo.com					ADAMS JH, 1986, J NEUROL NEUROSUR PS, V49, P1039, DOI 10.1136/jnnp.49.9.1039; Boto GR, 2001, J NEUROSURG, V94, P224, DOI 10.3171/jns.2001.94.2.0224; JELLINGER K, 1990, NEUROLOGY, V40, P862, DOI 10.1212/WNL.40.5.862-a; KATZ DI, 1989, NEUROLOGY, V39, P897, DOI 10.1212/WNL.39.7.897; Lindenberg R, 1964, Clin Neurosurg, V12, P129; Lindenberg R, 1971, PATHOLOGY NERVOUS SY, V2, P1705; MACPHERSON P, 1986, J NEUROL NEUROSUR PS, V49, P29, DOI 10.1136/jnnp.49.1.29; MOSBERG WH, 1959, J NEUROSURG, V16, P209, DOI 10.3171/jns.1959.16.2.0209; MUNEMOTO S, 1985, Neurological Surgery, V13, P1027; YANAKA K, 1991, Neurological Surgery, V19, P369	10	5	5	0	0	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0973-0508	2213-3739		INDIAN J NEUROTRAUM	Indian J. Neurotrauma	DEC	2011	8	2					109	110		10.1016/S0973-0508(11)80010-9			2	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	V3M2O	WOS:000218384100010					2022-02-06	
J	Lee, C; Wallerstedt, D; Duncan, A; York, A; Hollifield, M; Niemtzow, RC; Burns, SM; Jonas, WB				Lee, Courtney; Wallerstedt, Dawn; Duncan, Alaine; York, Alexandra; Hollifield, Michael; Niemtzow, Richard C.; Burns, Stephen M.; Jonas, Wayne B.			Design and Rationale of a Comparative Effectiveness Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated with Traumatic Brain Injury	MEDICAL ACUPUNCTURE			English	Article						Acupuncture; TBI; Headaches; Military; Trauma Spectrum Response	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; LOW-BACK-PAIN; AURICULAR ACUPUNCTURE; CONTROLLED-TRIAL; ELECTROACUPUNCTURE; IRAQ; ACUPRESSURE; INSOMNIA; ANXIETY	Background: Exposure to deployment and battle can induce a constellation of physical, cognitive, psychological, and behavioral symptoms, also referred to as war-related Trauma Spectrum Response (wrTSR). One prevalent cause of this response is traumatic brain injury (TBI) and its ensuing sequelae, such as pain and suffering caused by post-traumatic headache. Current pharmacologic treatment of these headaches is often inadequate and complicated by the multi-component nature of wrTSR. Acupuncture has been found to reduce pain, improve health-related quality of life, prevent migraine headaches, and reduce tension-type and chronic daily headaches. Objective: An ongoing study is endeavoring to advance understanding of the speed and depth of healing induced by two acupuncture approaches, compared to current standard practice and with the aim of providing insights to guide future implementation of acupuncture treatment in the military. Design: A comparative effectiveness study protocol will be used to determine if auricular acupuncture (AA) or semi-standardized traditional Chinese acupuncture (TCA) alleviates headaches and reduces associated comorbidities more effectively than usual care alone in a cohort of active duty military personnel with mild-tomoderate TBI. Summary: Given that the study is currently underway, no results or conclusions can be reported at present. While current evidence from acupuncture research demonstrates its promising healing impact across the wrTSR, a number of unanswered questions and information gaps remain. It is hoped that the proposed study will address some of these questions and gaps.	[Lee, Courtney; Wallerstedt, Dawn; York, Alexandra; Jonas, Wayne B.] Samueli Inst, 1737 King Sreet,Suite 600, Alexandria, VA 22314 USA; [Duncan, Alaine] Healingworks Restoring & Renewing Mil Families, Silver Spring, MD USA; [Hollifield, Michael] Pacific Inst Res & Evaluat, Albuquerque, NM USA; [Niemtzow, Richard C.; Burns, Stephen M.] US Air Force Acupuncture Ctr, Joint Base Andrews, MD USA		Jonas, WB (corresponding author), Samueli Inst, 1737 King Sreet,Suite 600, Alexandria, VA 22314 USA.	wjonas@siib.org		Bellanti, Dawn/0000-0003-4507-2625	DoD Telemedicine and Advanced Technology Research Center [W81XWH-08-2-0212]	The authors would like to thank Cindy Crawford, BA, and Jarrad Davis, BA, for assistance in preparation of the manuscript. This study and paper was partially funded by a grant from the DoD Telemedicine and Advanced Technology Research Center (Grant No. W81XWH-08-2-0212).	Acupuncture Vickers A., 2001, EFF HLTH CARE, V7, P1; Alimi D, 2003, J CLIN ONCOL, V21, P4120, DOI 10.1200/JCO.2003.09.011; Allam H, 2008, J ALTERN COMPLEM MED, V14, P109, DOI 10.1089/acm.2007.0508; Audette Joseph F, 2004, Phys Med Rehabil Clin N Am, V15, P749, DOI 10.1016/j.pmr.2004.03.009; Barker R, 2006, ACAD EMERG MED, V13, P19, DOI 10.1197/j.aem.2005.07.014; Barker R, 1998, AURICULOTHERAPY MANU; Beck JG, 2007, BEHAV THER, V38, P39, DOI 10.1016/j.beth.2006.04.001; Beck JG, 2003, J PSYCHOPATHOL BEHAV, V25, P219, DOI 10.1023/A:1025817111293; BENSON H, 1975, INT J PSYCHIAT MED, V6, P87, DOI 10.2190/376W-E4MT-QM6Q-H0UM; Birch S, 2004, J ALTERN COMPLEM MED, V10, P468, DOI 10.1089/1075553041323894; BLITZER L, 2003, CLIN ACUPUNCT ORIENT, V4, P144; Boon H, 2004, ALTERN THER HEALTH M, V10, P48; Cao HJ, 2009, J ALTERN COMPLEM MED, V15, P1171, DOI 10.1089/acm.2009.0041; Chen HY, 2007, J ALTERN COMPLEM MED, V13, P669, DOI 10.1089/acm.2006.6400; CHO ZH, 2002, MED ACUPUNCTURE, V14, P16; Coeytaux RR, 2005, HEADACHE, V45, P1113, DOI 10.1111/j.1526-4610.2005.00235.x; Cummings Mike, 2003, Acupunct Med, V21, P105; Cutler MJ, 2005, J ALTERN COMPLEM MED, V11, P103, DOI 10.1089/acm.2005.11.103; de Hoyos JAG, 2004, PAIN, V112, P289, DOI 10.1016/j.pain.2004.08.030; Defense and Veterans Brain Injury Center (DVBIC), UPD MILD TRAUM BRAIN; Donnellan Clare P, 2006, Acupunct Med, V24, P129; Eich H, 2000, FORTSCHR NEUROL PSYC, V68, P137, DOI 10.1055/s-2000-11624; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; ERNST E, 1999, ACUPUNCTURE SCI APPR, P107; Ezzo J, 2000, PAIN, V86, P217, DOI 10.1016/S0304-3959(99)00304-8; Giordano J., 2007, PRACT PAIN MANAGE, V7, P34; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Goertz CMH, 2006, MIL MED, V171, P1010, DOI 10.7205/MILMED.171.10.1010; Green S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005319; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Han Cui, 2004, J Tradit Chin Med, V24, P172; HELMS JM, 1996, ACUPUNCTURE ENERGETI; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hollifield M, 2007, J NERV MENT DIS, V195, P504, DOI 10.1097/NMD.0b013e31803044f8; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; icasualties, OP IR FREED OP END F; Jones N, 2003, OCCUP MED-OXFORD, V53, P469, DOI 10.1093/occmed/kqg093; Kalavapalli Ramprasad, 2007, Complement Ther Clin Pract, V13, P184, DOI 10.1016/j.ctcp.2007.01.001; Kober A, 2003, ANESTHESIOLOGY, V98, P1328, DOI 10.1097/00000542-200306000-00005; Kober A, 2002, ANESTH ANALG, V95, P723, DOI 10.1097/00000539-200209000-00035; Kong JA, 2002, J ALTERN COMPLEM MED, V8, P411, DOI 10.1089/107555302760253603; Langevin H, 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1155/2011/180805; LEBARS D, 1979, PAIN, V6, P283, DOI 10.1016/0304-3959(79)90049-6; Lewis S., 2005, ADV MIND BODY MED, V21, P29; Li Y, 1993, J Tradit Chin Med, V13, P5; Linde K, 2001, BMC Complement Altern Med, V1, P3; Linde K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub2; Manber R, 2004, J AFFECT DISORDERS, V83, P89, DOI 10.1016/j.jad.2004.05.009; Manheimer E, 2007, ANN INTERN MED, V146, P868, DOI 10.7326/0003-4819-146-12-200706190-00008; Martin DP, 2006, MAYO CLIN PROC, V81, P749, DOI 10.4065/81.6.749; Molsberger AF, 2002, PAIN, V99, P579, DOI 10.1016/S0304-3959(02)00269-5; Montakab H, 1999, FORSCH KOMPLEMENTMED, V6, P29, DOI 10.1159/000057127; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; NG M, 1999, DISS ABSTR INT B SCI, V60; Niemtzow RC, 2006, J ALTERN COMPLEM MED, V12, P597, DOI 10.1089/acm.2006.597; Osuch E, 2004, J ALTERN COMPLEM MED, V10, pS211; Phillips K D, 2001, J Assoc Nurses AIDS Care, V12, P27, DOI 10.1016/S1055-3290(06)60168-4; Pilkington Karen, 2007, Acupunct Med, V25, P1; Pomeranz B., 2001, ACUPUNCTURE ANALGESI; Public Committee on the Use of Complementary and Alter- native Medicine by the American Public Prevention Board on Health Promotion and Disease Prevention, 2005, COMPL ALT MED US; Qu F, 2007, EVID-BASED COMPL ALT, V4, P125, DOI 10.1093/ecam/nel053; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Raub JA, 2002, J ALTERN COMPLEM MED, V8, P797, DOI 10.1089/10755530260511810; Roschke J, 2000, J AFFECT DISORDERS, V57, P73, DOI 10.1016/S0165-0327(99)00061-0; Sator-Katzenschlager SM, 2004, ANESTH ANALG, V98, P1359, DOI 10.1213/01.ANE.0000107941.16173.F7; Schnyer R. N, 2001, ACUPUNCTURE TREATMEN; Shen J, 2001, J ALTERN COMPLEM MED, V7, pS121; Shipherd JC, 2007, J REHABIL RES DEV, V44, P153, DOI 10.1682/JRRD.2006.06.0065; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; SMITH CA, 2005, COCHRANE DB SYST REV, V2; Sok SR, 2003, J ADV NURS, V44, P375, DOI 10.1046/j.0309-2402.2003.02816.x; SOLOMON Z, 1989, J TRAUMA STRESS, V2, P59; Spence DW, 2004, J NEUROPSYCH CLIN N, V16, P19, DOI 10.1176/appi.neuropsych.16.1.19; TAIT PL, 2002, ACUPUNCTURE EVIDENCE; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor Daniel J, 2003, Behav Sleep Med, V1, P227, DOI 10.1207/S15402010BSM0104_5; Tkachuk V N, 1991, Ortop Travmatol Protez, P33; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Usichenko TI, 2007, CAN MED ASSOC J, V176, P179, DOI 10.1503/cmaj.060875; Usichenko TI, 2005, PAIN, V114, P320, DOI 10.1016/j.pain.2004.08.021; Villano CL, 2007, J REHABIL RES DEV, V44, P167, DOI 10.1682/JRRD.2006.05.0052; Wang SM, 2004, ANESTHESIOLOGY, V100, P1399, DOI 10.1097/00000542-200406000-00011; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warden DL, 2005, NEW ENGL J MED, V353, P633; White A, 2007, RHEUMATOLOGY, V46, P384, DOI 10.1093/rheumatology/kel413; White Adrian, 2004, Acupunct Med, V22, P122; Yang X, 1994, J Tradit Chin Med, V14, P14; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; [No title captured]	92	5	5	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1933-6586	1933-6594		MED ACUPUNCT	Med. Acupunct.	DEC	2011	23	4					237	247		10.1089/acu.2011.0836			11	Integrative & Complementary Medicine	Emerging Sources Citation Index (ESCI)	Integrative & Complementary Medicine	V2D3S	WOS:000217477100007		Green Published			2022-02-06	
J	Caracuel, A; Bateman, A; Teasdale, TW; Verdejo-Garcia, A; Perez-Garcia, M				Caracuel, Alfonso; Bateman, Andrew; Teasdale, Thomas W.; Verdejo-Garcia, Antonio; Perez-Garcia, Miguel			Spanish, French, and British Cross-Cultural Validation of the European Brain Injury Questionnaire	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						adults; acquired brain injury; behavior; cognition; construct validity; cross-cultural validity; EBIQ; emotion; factor analysis; outcome assessment; questionnaire; Rasch analysis; stroke; subjective assessment; traumatic brain injury	SUBJECTIVE EXPERIENCE; CLOSE RELATIVES; RASCH ANALYSIS; REHABILITATION; AWARENESS; VALIDITY; PATTERNS; EBIQ	Objective: To explore the factor structure of the European Brain Injury Questionnaire and to assess the cross-cultural and construct validity of this questionnaire by using Rasch analysis. Participants: A total of 366 individuals with traumatic brain injury or stroke were recruited from 3 different countries: Spain (116 participants), the United Kingdom (110 participants), and France (140 participants). Analyses: We first performed a factor analysis and then applied Rasch analysis to the resulting factors to examine construct and cross-cultural validity. Results: Three subscales labeled Depressive Mood, Cognitive Dysfunction, and Poor Social and Emotional Self-regulation were extracted using the factor analysis. In the Rasch analyses, 8 items were removed because of misfit and 7 items showed differential item functioning by country. Conclusion: Rasch analyses showed good fit to the model, unidimensionality, construct validity, and good reliability of the 3 European Brain Injury Questionnaire subscales. However, only the Depressive and Cognitive subscales showed cross-cultural validity.	[Caracuel, Alfonso] Univ Granada, Personal Evaluac & Tratamiento Psicol Dept, Neurosci Inst F Oloriz, Fac Psicol, Granada 18710, Spain; [Bateman, Andrew] Oliver Zangwill Ctr Neuropsychol Rehabil, Ely, Cambs, England; [Teasdale, Thomas W.] Univ Copenhagen, Dept Psychol, DK-1168 Copenhagen, Denmark		Caracuel, A (corresponding author), Univ Granada, Personal Evaluac & Tratamiento Psicol Dept, Neurosci Inst F Oloriz, Fac Psicol, Granada 18710, Spain.	acaracuel@ugr.es	Caracuel, Alfonso/V-3695-2019; Garcia, Miguel Perez/F-9630-2010; Verdejo-Garcia, Antonio/AAV-1147-2021	Caracuel, Alfonso/0000-0002-9738-8456; Garcia, Miguel Perez/0000-0003-4775-7556; Verdejo-Garcia, Antonio/0000-0001-8874-9339; Bateman, Andrew/0000-0002-2547-5921			Andrich D., 2003, RUMM2020; Bateman A, 2009, NEUROPSYCHOL REHABIL, V19, P941, DOI 10.1080/09602010903021170; Bjorkdahl Ann, 2004, J Stroke Cerebrovasc Dis, V13, P122, DOI 10.1016/j.jstrokecerebrovasdis.2004.04.004; Bode RK, 2000, J HEAD TRAUMA REHAB, V15, P637, DOI 10.1097/00001199-200002000-00004; Boman IL, 2004, BRAIN INJURY, V18, P985, DOI 10.1080/02699050410001672396; Caracuel A, 2008, ARCH CLIN NEUROPSYCH, V23, P447, DOI 10.1016/j.acn.2008.03.004; Chen CPLH, 2004, J NEUROL SCI, V226, P45, DOI 10.1016/j.jns.2004.09.010; Christensen, 2000, INT HDB NEUROPSYCHOL, P81; Christensen A, 2005, ACTA NEUROPSYCHOLOGI, V3, P60; Coetzer R, 2005, INT J REHABIL RES, V28, P361, DOI 10.1097/00004356-200512000-00010; Davidson M, 2008, MANUAL THER, V13, P222, DOI 10.1016/j.math.2007.01.008; Deloche G., 1996, Annales de Readaptation et de Medecine Physique, V39, P1, DOI 10.1016/0168-6054(96)88044-5; Dewar BK, 2005, BRAIN INJURY, V19, P1285, DOI 10.1080/02699050500309536; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Embretson S.E., 2013, ITEM RESPONSE THEORY; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fisher W., 1992, RASCH MEAS T, V6, P238; Gorsuch RL, 1997, J PERS ASSESS, V68, P532, DOI 10.1207/s15327752jpa6803_5; Hagquist C, 2009, INT J NURS STUD, V46, P380, DOI 10.1016/j.ijnurstu.2008.10.007; Holm S, 2009, NEUROPSYCHOL REHABIL, V19, P444, DOI 10.1080/09602010802296402; Lawton G, 2006, SPINAL CORD, V44, P746, DOI 10.1038/sj.sc.3101895; Linacre JM, 1994, RASCH MEAS T, V7; Linacre John M, 2002, J Appl Meas, V3, P85; Martin C, 2001, BRAIN INJURY, V15, P947, DOI 10.1080/02699050110065655; Martin Claudine, 2002, Appl Neuropsychol, V9, P148, DOI 10.1207/S15324826AN0903_3; Mathiesen Birgit Bork, 2004, Cogn Neuropsychiatry, V9, P249, DOI 10.1080/13546800344000237; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; PUENTE A, 2004, COMPREHENSIVE HDB PS, V1, P321; Rasch Georg, 1980, PROBABILISTIC MODELS; Santos ME, 2001, ANALISE PSICOLOGICA, V19, P219; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Smith R M, 2000, J Appl Meas, V1, P199; Smith R.M., 1994, OBJECTIVE MEASUREMEN, P316; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Svendsen HA, 2004, NEUROPSYCHOL REHABIL, V14, P495, DOI 10.1080/09602010343000318; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Teasdale TW, 1997, BRAIN INJURY, V11, P543, DOI 10.1080/026990597123250; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Tennant A, 2004, MED CARE, V42, P37, DOI 10.1097/01.mlr.0000103529.63132.77; Tennant A., 2006, RASCH MEAS T, V20, P1048; Tennant A., 2007, RASCH MEASUREMENT T, V20, P1082; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Tucker DM, 1995, ANN NY ACAD SCI, V769, P213, DOI 10.1111/j.1749-6632.1995.tb38141.x; Williams WH, 1999, NEUROPSYCHOL REHABIL, V9, P421, DOI 10.1080/096020199389482; Wilson M., 2005, CONSTRUCTING MEASURE; Wright BD., 1982, RATING SCALE ANAL	51	5	5	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2011	26	6					478	488		10.1097/HTR.0b013e3181fc042c			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	859AC	WOS:000297845000004	21169861				2022-02-06	
J	Han, SR; Yee, GT; Choi, CY; Lee, CH				Han, Seong-Rok; Yee, Gi-Taek; Choi, Chan-Young; Lee, Chae-Heuck			Cortical Laminar Necrosis in an Infant with Severe Traumatic Brain Injury	JOURNAL OF KOREAN NEUROSURGICAL SOCIETY			English	Article						Cortical laminar necrosis; Hypoxia; Infant	SEQUENTIAL-CHANGES; MR-IMAGES; INFARCTION	Cortical laminar necrosis appears as hyperinense lesions with a laminar pattern on T1 weighted magnetic resonance (MR) imaging, without signs of hemorrhage or calcification on T2 weighted MR imaging or computed tomography. It has been reported to be associated with hypoxia, metabolic disturbances, drugs, and infections. We present a 12 month-old male infant who suffered diffuse brain injuries following car accident and showed laminar necrosis of cortex.	[Han, Seong-Rok; Yee, Gi-Taek; Choi, Chan-Young; Lee, Chae-Heuck] Inje Univ, Dept Neurosurg, Ilsan Paik Hosp, Coll Med, Goyang 411706, South Korea		Han, SR (corresponding author), Inje Univ, Dept Neurosurg, Ilsan Paik Hosp, Coll Med, 2240 Daehwa Dong, Goyang 411706, South Korea.	hsrkmj@paik.ac.kr					Akiyama M, 2008, NEUROL MED-CHIR, V48, P326, DOI 10.2176/nmc.48.326; Donaire A, 2006, J NEUROL NEUROSUR PS, V77, P104, DOI 10.1136/jnnp.2004.058701; Garcia JH, 1996, STROKE, V27, P761, DOI 10.1161/01.STR.27.4.761; Kashihara K, 1999, CLIN NEUROL NEUROSUR, V101, P145, DOI 10.1016/S0303-8467(99)00022-0; Kesavadas C, 2009, NEURORADIOLOGY, V51, P293, DOI 10.1007/s00234-009-0497-8; Lovblad KO, 2004, NEURORADIOLOGY, V46, P175, DOI 10.1007/s00234-003-1133-7; NABATAME H, 1990, J COMPUT ASSIST TOMO, V14, P521, DOI 10.1097/00004728-199007000-00004; Niwa T, 2008, AM J NEURORADIOL, V29, P1795, DOI 10.3174/ajnr.A1184; Saito Y, 2008, BRAIN DEV-JPN, V30, P77, DOI 10.1016/j.braindev.2007.05.007; SAWADA H, 1990, NEURORADIOLOGY, V32, P319, DOI 10.1007/BF00593053; Siskas N, 2003, NEURORADIOLOGY, V45, P283, DOI 10.1007/s00234-002-0887-7	11	5	6	0	2	KOREAN NEUROSURGICAL SOC	SEOUL	#402 POSCO # OFFICE BUILDING 151 SUNHWA-DONG, JUNG-GU, SEOUL, 100-130, SOUTH KOREA	2005-3711			J KOREAN NEUROSURG S	J. Korean. Neurosurg. Soc.	NOV	2011	50	5					472	474		10.3340/jkns.2011.50.5.472			3	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	868HN	WOS:000298514400014	22259698	Green Published, gold			2022-02-06	
J	Klemenc-Ketis, Z; Bacovnik-Jansa, U; Ogorevc, M; Kersnik, J				Klemenc-Ketis, Zalika; Bacovnik-Jansa, Urska; Ogorevc, Marko; Kersnik, Janko			Outcome predictors of Glasgow Outcome Scale score in patients with severe traumatic brain injury	ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY			English	Article						Traumatic brain injury/outcome/predictors	REHABILITATION; RELIABILITY; POPULATION; TBI	BACKGROUND Traumatic brain injury is a major public health problem due to high mortality and morbidity among survivors. METHODS We performed a retrospective cohort study of patients with severe traumatic brain injury. We recorded the attending physician's evaluation of the patient's consciousness, the patient's demographics, routine physical measurements, and medical interventions. We used Glasgow Coma Scale and Extended Glasgow Outcome Scale. RESULTS We included 60 patients (83.3% males, mean age: 49.5 years). The Glasgow Coma Scale score was 4.8+/-1.9 and the Extended Glasgow Outcome Scale score was 2.9+/-2.5 points. Linear regression for higher Extended Glasgow Outcome Scale score explained 59.8% of the variance and revealed the duration of hospital stay and the presence of epidural hematoma as significant predictors. The classification tree for the higher Extended Glasgow Outcome Scale score revealed the following variables to be important: the duration of hospital stay, Glasgow Coma Scale score, partial pressure of carbon dioxide, surgery, response time of out-of-hospital emergency team, systolic and diastolic blood pressure, fall, and basis fracture. CONCLUSION Standardized inpatient protocol on monitoring, intervention and outcome recording should be adopted to make future comparisons more useful and to promote benchmarking between trauma centers in order to improve care for patients with severe traumatic brain injury.	[Klemenc-Ketis, Zalika] Univ Maribor, Dept Family Med, Sch Med, SLO-2000 Maribor, Slovenia; [Bacovnik-Jansa, Urska; Kersnik, Janko] Univ Ljubljana, Dept Family Med, Sch Med, Ljubljana, Slovenia; [Ogorevc, Marko] Inst Econ Res, Ljubljana, Slovenia		Klemenc-Ketis, Z (corresponding author), Kersnikova Cesta 1, Velenje 3320, Slovenia.	zalika.klemenc-ketis@uni-mb.si	Klemenc-Ketis, Zalika/V-6251-2019	Klemenc-Ketis, Zalika/0000-0002-0270-1754			Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Corral L, 2007, BRAIN INJURY, V21, P1225, DOI 10.1080/02699050701727460; Grmec S, 2004, CRIT CARE, V30, pS74; Hawley CA, 2008, BRAIN INJURY, V22, P427, DOI 10.1080/02699050802064607; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Klemen P, 2009, CROAT MED J, V50, P133, DOI 10.3325/cmj.2009.50.133; Kraus J F, 2000, Neurosurg Focus, V8, pe5; LeGrand SA, 2007, J NEUROTRAUM, V24, P1437, DOI 10.1089/neu.2007.0293; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; *MRC CRASH TRIAL N, 2003, CURR OPIN CRIT CARE, V9, P92; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; *SLOV ZDR INT MED, 2004, ZDR VESTN, V73, P31; Sorbo A, 2005, BRAIN INJURY, V19, P493, DOI 10.1080/02699050400013709; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; von Wild KRH, 2008, ACT NEUR S, V101, P55; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941	23	5	6	1	5	TURKISH ASSOC TRAUMA EMERGENCY SURGERY	ISTANBUL	KOPRULU MEHMET PASA SOC, DENIZ ABDAL MAH, DADASOGLU AP, 25-1 SEHREMINI, ISTANBUL, 00000, TURKEY	1306-696X			ULUS TRAVMA ACIL CER	Ulus. Travma Acil Cerrahi Derg.	NOV	2011	17	6					509	515		10.5505/tjtes.2011.35336			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	865LS	WOS:000298313000007	22290003				2022-02-06	
J	Lamontagne, ME; Swaine, BR; Lavoie, A; Careau, E				Lamontagne, Marie-Eve; Swaine, Bonnie R.; Lavoie, Andre; Careau, Emmanuelle			Analysis of the strengths, weaknesses, opportunities and threats of the network form of organization of traumatic brain injury service delivery systems	BRAIN INJURY			English	Article						brain injuries; brain injuries/rehabilitation; community networks/organization and administration; network; trauma centers/organization and administration	SWOT ANALYSIS; PERFORMANCE-MEASUREMENT; HEALTH-SERVICES; UNITED-STATES; CARE; IMPLEMENTATION; INTEGRATION; PROGRAM; QUALITY	Networks are an increasingly popular way to deal with the lack of integration of traumatic brain injury (TBI) care. Knowledge of the stakes of the network form of organization is critical in deciding whether or not to implement a TBI network to improve the continuity of TBI care. Goals of the study: To report the strengths, weaknesses, opportunities, and threats of a TBI network and to consider these elements in a discussion about whether networks are a suitable solution to fragmented TBI care. Methods: In-depth interviews with 12 representatives of network organization members. Interviews were qualitatively analyzed using the EGIPSS model of performance. Results: The majority of elements reported were related to the network's adaptation to its environment and more precisely to its capacity to acquire resources. The issue of value maintenance also received considerable attention from participants. Discussion: The network form of organization seems particularly sensitive to environmental issues, such as resource acquisition and legitimacy. The authors suggest that the network form of organization is a suitable way to increase the continuity of TBI care if the following criteria are met: (1) expectations toward network effectiveness to increase continuity of care are moderate and realistic; (2) sufficient resources are devoted to the design, implementation, and maintenance of the network; (3) a network's existence and actions are deemed legitimate by community and organization member partners; and (4) there is a good collaborative climate between the organizations.	[Lamontagne, Marie-Eve; Swaine, Bonnie R.] Univ Montreal, Fac Med, Ecole Readaptat, Montreal, PQ H3C 3J7, Canada; [Lamontagne, Marie-Eve; Swaine, Bonnie R.] Ctr Rech Interdisciplinaire Readaptat Montreal CR, Montreal, PQ, Canada; [Lamontagne, Marie-Eve; Lavoie, Andre] Univ Quebec, Unite Traumatol Urgence Soins Intensifs, Ctr Rech FRSQ, Ctr Hosp Affilie, Quebec City, PQ, Canada; [Careau, Emmanuelle] CIRRIS, Quebec City, PQ, Canada		Swaine, BR (corresponding author), Univ Montreal, Fac Med, Ecole Readaptat, CP 6128 Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	bonnie.swaine@umontreal.ca		Lamontagne, Marie-Eve/0000-0002-3301-7429	Canadian Institutes for Health ResearchCanadian Institutes of Health Research (CIHR); ANEIS; Programme de recherche en readaptation et en Integration sociale (PRISST); TBI consortium Mauricie-Centre-du-Quebec	Preparation of this article was supported by scholarships awarded to the first author by the Canadian Institutes for Health Research, the ANEIS program, and the Programme de recherche en readaptation et en Integration sociale (PRISST). We'd like to thank all the representatives of the TBI consortium Mauricie-Centre-du-Quebec for their contribution and support of this study. A special thank to Suzanne Bouille, whose advice and great knowledge of the Quebec TBI organization of care were especially helpful in the realization of this work.	Bazzoli GJ, 2003, MED CARE RES REV, V60, p63S, DOI 10.1177/1077558703259082; Bazzoli GJ, 1999, J TRAUMA, V47, pS22, DOI 10.1097/00005373-199909001-00006; Bente JR, 2005, REHABIL PSYCHOL, V50, P87, DOI 10.1037/0090-5550.50.1.87; Borgatti SP, 2003, J MANAGE, V29, P991, DOI 10.1016/S0149-2063(03)00087-4; Brass DJ, 2004, ACAD MANAGE J, V47, P795, DOI 10.2307/20159624; Bryson JM, 2006, PUBLIC ADMIN REV, V66, P44, DOI 10.1111/j.1540-6210.2006.00665.x; Camden C, 2009, DISABIL REHABIL, V31, P1373, DOI 10.1080/09638280802532696; CASEBEER A, 1993, BRIT J HOSP MED, V49, P430; Champagne F, 2004, CADRE EVALUATION PER; Commitee on Brain Injury, 2006, SERV NEEDS SOURC FUN; Cope DN, 2005, J HEAD TRAUMA REHAB, V20, P128, DOI 10.1097/00001199-200503000-00002; DePompei R, 2001, J HEAD TRAUMA REHAB, V16, P217, DOI 10.1097/00001199-200106000-00002; Fleury M.J, 2005, INT J INTEGR CARE, V13, pe07, DOI DOI 10.5334/IJIC.127; Fleury MJ, 2006, HEALTH SERV MANAG RE, V19, P153, DOI 10.1258/095148406777888080; Fleury MJ, 2002, ADM POLICY MENT HLTH, V30, P55, DOI 10.1023/A:1021227600823; Fleury MJ, 2002, INT J HEALTH PLAN M, V17, P315, DOI 10.1002/hpm.684; Goddard M, 2002, J ROY SOC MED, V95, P508, DOI 10.1258/jrsm.95.10.508; Goowdin N, MANAGING DIVERSE NET; Gordon J, 2000, MED EDUC, V34, P841, DOI 10.1046/j.1365-2923.2000.00759.x; Grone O, 2001, Int J Integr Care, V1, pe21; Haggerty JL, 2003, BRIT MED J, V327, P1219, DOI 10.1136/bmj.327.7425.1219; Huerta T, 2006, HEALTHCAREPAPERS, V7, P18; Huerta Timothy R, 2006, Healthc Pap, V7, P10; Keast R, 2004, PUBLIC ADMIN REV, V64, P363, DOI 10.1111/j.1540-6210.2004.00380.x; Kenis P, 2009, PUBLIC ADMIN, V87, P440, DOI 10.1111/j.1467-9299.2009.01775.x; Lamontagne M-E, 2010, INT J INTERGRATED CA, V10, pe1; Lamontagne ME, 2010, BRAIN INJURY, V24, P812, DOI 10.3109/02699051003789252; Lamontagne ME, 2011, THESIS U MONTREAL; Leutz WN, 1999, MILBANK Q, V77, P77, DOI 10.1111/1468-0009.00125; Mandell M, 2008, PUBLIC MANAG REV, V10, P715, DOI 10.1080/14719030802423079; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Miles M.B., QUALITATIVE DATA ANA; Pearce Chris, 2007, Nurs Manag (Harrow), V14, P25; PROVAN KG, 1995, ADMIN SCI QUART, V40, P1, DOI 10.2307/2393698; Provan KG, 2001, PUBLIC ADMIN REV, V61, P414, DOI 10.1111/0033-3352.00045; Ragnarsson KT, 1993, J HEAD TRAUMA REHAB, V8, P1, DOI DOI 10.1097/00001199-199308020-00003; Sharma M, 1996, J COMMUN HEALTH, V21, P453, DOI 10.1007/BF01702605; Toivanen T, 1999, COMMUNITY DENT ORAL, V27, P386, DOI 10.1111/j.1600-0528.1999.tb02035.x; Van Raaij D.P.A.M., 2006, INT PUBLIC MANAG J, V9, P249, DOI [10.1080/10967490600899549, DOI 10.1080/10967490600899549]; Vander Laan R, 2001, NEUROREHABILITATION, V16, P17; Waldfogel J, 1997, SOC SERV REV, V71, P463, DOI 10.1086/604266; Williams CM, 2000, MIL MED, V165, P809, DOI 10.1093/milmed/165.11.809; Yin R.K., 2008, CASE STUDY RES DESIG; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zasler ND, 2002, MODEL SYSTEMS CONTIN	45	5	5	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2011	25	12					1188	1197		10.3109/02699052.2011.608211			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	829WF	WOS:000295615200005	21939374				2022-02-06	
J	McCullough, BJ; Jarvik, JG				McCullough, Brendan J.; Jarvik, Jeffrey G.			Diagnosis of Concussion: The Role of Imaging Now and in the Future	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Concussion; Mild traumatic brain injury; Youth; Sports; Computed tomography; Magnetic resonance imaging	TRAUMATIC BRAIN-INJURY; MILD HEAD-INJURY; MAGNETIC-RESONANCE-SPECTROSCOPY; AAPM/RSNA PHYSICS TUTORIAL; DIFFUSE AXONAL INJURY; COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; CT; CHILDREN; MR	The primary role of neuroimaging in the clinical context of sports-related concussion is the exclusion of a more severe, unsuspected intracranial injury. Computed tomography remains the test of choice for this purpose. Magnetic resonance imaging is more commonly used as a secondary test for the investigation of persistent symptoms. New imaging techniques are currently being developed to detect the molecular and cellular changes underlying concussion that are invisible with standard structural imaging. In the future, these techniques may be used as tools for directing rehabilitation after concussion and aiding in the decision of when it is safe for an athlete to return to play.	[Jarvik, Jeffrey G.] Univ Washington, Harborview Med Ctr, Dept Radiol, Comparat Effectiveness Cost & Outcomes Res Ctr, Seattle, WA 98104 USA; [McCullough, Brendan J.] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Radiol Neurol Surg & Hlth Serv, Seattle, WA 98195 USA		Jarvik, JG (corresponding author), Univ Washington, Harborview Med Ctr, Dept Radiol, Comparat Effectiveness Cost & Outcomes Res Ctr, 325 9th Ave,Box 359728, Seattle, WA 98104 USA.	jarvikj@uw.edu	Jarvik, Jeffrey/AAL-4292-2021				Abu-Judeh HH, 1999, NUCL MED COMMUN, V20, P505, DOI 10.1097/00006231-199906000-00003; af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; AFGEIJERSTAM JL, 2003, ACTA NEUROCHIR WIEN, V145, P850; [Anonymous], 2005, MED SCI SPORT EXER, V37, P2012, DOI 10.1249/01.mss.0000186726.18341.70; Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Bushberg JT., 2002, ESSENTIAL PHYS MED I, V2nd edn; *CDCP, 2007, MORTALITY MORBIDITY, V0056; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Chen SHA, 2003, J NEUROL NEUROSUR PS, V74, P326, DOI 10.1136/jnnp.74.3.326; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; de la Plata CM, 2007, J NEUROTRAUM, V24, P591, DOI 10.1089/neu.2006.0214; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Govindaraju V, 2004, AM J NEURORADIOL, V25, P730; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Gross H, 1996, J NEUROPSYCH CLIN N, V8, P324; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Holbourn AHS, 1943, LANCET, V2, P438; Huda W, 2007, AM J ROENTGENOL, V188, P540, DOI 10.2214/AJR.06.0101; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; JORDAN BD, 1990, JAMA-J AM MED ASSOC, V263, P1670, DOI 10.1001/jama.263.12.1670; Kelly JP, 1997, NEUROLOGY, V48, P581; King MA, 2009, PEDIATR RADIOL, V39, P1059, DOI 10.1007/s00247-009-1327-1; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McNitt-Gray MF, 2002, RADIOGRAPHICS, V22, P1541, DOI 10.1148/rg.226025128; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; National Academies/National Research Council, 2006, HLTH RISKS EXP LOW L; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; ORRISON WW, 1994, AM J NEURORADIOL, V15, P351; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pooley RA, 2005, RADIOGRAPHICS, V25, P1087, DOI 10.1148/rg.254055027; Ptito A, 2007, NEUROREHABILITATION, V22, P217; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; Thiruppathy SP, 2004, ACTA NEUROCHIR, V146, P1075, DOI 10.1007/s00701-004-0335-z; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wetjen NM, 2010, J AM COLL SURGEONS, V211, P553, DOI 10.1016/j.jamcollsurg.2010.05.020; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Yeo RA, 2006, J NEUROTRAUM, V23, P1427, DOI 10.1089/neu.2006.23.1427	70	5	5	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	NOV	2011	22	4					635	+		10.1016/j.pmr.2011.08.005			19	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	858SI	WOS:000297822600006	22050940				2022-02-06	
J	Rubin, EB; Bernat, JL				Rubin, Emily B.; Bernat, James L.			Ethical Aspects of Disordered States of Consciousness	NEUROLOGIC CLINICS			English	Article						Disordered consciousness; Coma; Minimally conscious state; Vegetative state; Traumatic brain injury; Ethics; Surrogate decision making; End-of-life care	PERSISTENT VEGETATIVE STATE; LIFE-SUSTAINING TREATMENT; ARTIFICIAL NUTRITION; MEDICAL FUTILITY; DECISION-MAKING; CRITICAL-CARE; BRAIN-INJURY; SUPPORT; PATIENT; LAWS	The medical care of patients in disordered states of consciousness, including vegetative and minimally conscious states, raises some of the most intricate ethical questions in medicine. There is inherent ambiguity and uncertainty involved in diagnosing such patients and evaluating their level of awareness and prognosis for recovery. The care of these patients requires the weighing of competing ethical values, including respect for personal autonomy, protection of vulnerable patients, nonmaleficence, and the just use of limited medical resources. We highlight some of the major ethical issues in caring for patients with severe brain injury.	[Rubin, Emily B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bernat, James L.] Dartmouth Med Sch, Hanover, NH 03755 USA; [Bernat, James L.] Dartmouth Hitchcock Med Ctr, Dept Neurol, Lebanon, NH 03756 USA		Rubin, EB (corresponding author), 29 Lawrence St,Apartment B, Cambridge, MA 02139 USA.	erubin3@partners.org					Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; ASHWAL S, 1994, NEW ENGL J MED, V330, P1572; Bacon D, 2007, NEUROLOGY, V68, P1097, DOI 10.1212/01.wnl.0000259410.15317.f3; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bernat JL, 2004, NEUROCRIT CARE, V1, P107, DOI 10.1385/NCC:1:1:107; Bernat JL, 2001, NEUROLOGY, V56, P144, DOI 10.1212/WNL.56.2.144; BROCK DW, 1990, NEW ENGL J MED, V322, P1595, DOI 10.1056/NEJM199005313222209; Cantor NL, 2010, AM J BIOETHICS, V10, P58, DOI 10.1080/15265160903581858; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Di HB, 2007, NEUROLOGY, V68, P895, DOI 10.1212/01.wnl.0000258544.79024.d0; Fins JJ, 2008, AM J BIOETHICS, V8, P46, DOI 10.1080/15265160802334490; Fins JJ, 2008, AM J BIOETHICS, V8, P3, DOI 10.1080/15265160802318113; FRANKL D, 1989, AM J MED, V86, P645, DOI 10.1016/0002-9343(89)90436-1; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; JECKER NS, 1992, AM J MED, V92, P189, DOI 10.1016/0002-9343(92)90111-N; JENNETT B, 1972, LANCET, V1, P734; Jotkowitz A, 2010, AM J BIOETHICS, V10, P50, DOI 10.1080/15265160903581700; KINNEY HC, 1994, J NEUROPATH EXP NEUR, V53, P548, DOI 10.1097/00005072-199411000-00002; Lammi MH, 2005, ARCH PHYS MED REHAB, V86, P746, DOI 10.1016/j.apmr.2004.11.004; Larriviere D, 2006, NEUROLOGY, V66, P1624, DOI 10.1212/01.wnl.0000217133.21665.55; Lo B, 2002, NEW ENGL J MED, V346, P1489, DOI 10.1056/NEJM200205093461912; Medical futility in end-of-life care, 1999, JAMA, V281, P937; MENIKOFF JA, 1992, NEW ENGL J MED, V327, P1165, DOI 10.1056/NEJM199210153271612; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; ORENTLICHER D, 1991, JAMA-J AM MED ASSOC, V265, P1868; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Pape TLB, 2005, J REHABIL RES DEV, V42, P19, DOI 10.1682/JRRD.2004.03.0033; Pape TLB, 2005, J REHABIL RES DEV, V42, P1, DOI 10.1682/JRRD.2004.03.0032; PARIS JJ, 1990, NEW ENGL J MED, V322, P1012, DOI 10.1056/NEJM199004053221420; Paris JJ, 2010, AM J BIOETHICS, V10, P54, DOI 10.1080/15265160903581916; Payne K, 1996, ANN INTERN MED, V125, P104, DOI 10.7326/0003-4819-125-2-199607150-00004; PEARLMAN RA, 1993, J CLIN ETHIC, V4, P33; Pew Center report, 2006, MOR AM DISC PLANN EN; Posner JB, 2007, PLUM POSNERS DIAGNOS; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, DEC FOR LIF SUST TRE; Quill TE, 2005, NEW ENGL J MED, V352, P1630, DOI 10.1056/NEJMp058062; ROSENBERG JH, 1995, NEUROLOGY, V45, P1015; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Strens LHA, 2004, BRAIN INJURY, V18, P213, DOI 10.1080/0269905031000149533; Truog RD, 2001, CRIT CARE MED, V29, P2332, DOI 10.1097/00003246-200112000-00017; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Volicer L, 1997, ARCH NEUROL-CHICAGO, V54, P1382, DOI 10.1001/archneur.1997.00550230051016; Voss HU, 2006, J CLIN INVEST, V116, P2005, DOI 10.1172/JCI27021; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; Wilkinson DJ, 2009, J MED ETHICS, V35, P508, DOI 10.1136/jme.2008.029165	48	5	5	0	11	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8619	1557-9875		NEUROL CLIN	Neurol. Clin.	NOV	2011	29	4					1055	+		10.1016/j.ncl.2011.07.007			18	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	853BN	WOS:000297401300019	22032673				2022-02-06	
J	Cui, G; Yu, ZH; Li, Z; Wang, W; Lu, T; Qian, CH; Li, JL; Ding, YL				Cui, Gang; Yu, Zhihua; Li, Zhen; Wang, Wei; Lu, Ting; Qian, Chunhui; Li, Jiliang; Ding, Yunlin			Increased Expression of Foxj1 after Traumatic Brain Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Foxj1; Traumatic brain injury; Rats; Neurogenesis	NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; SUBVENTRICULAR ZONE; GENE-EXPRESSION; EPENDYMAL CELLS; CNS INJURY; STROKE; RAT; NEUROGENESIS	Foxj1 is a member of the Forkhead/winged-helix (Fox) family of transcription factors, which is required for postnatal differentiation of ependymal cells and a subset of astrocytes in the subventricular zone. The subpopulation of astrocytes has the ability of self-renew and neurogenic potential differentiated into astrocytes, oligodendrocytes, and neurons. However, its expression and function in the central nervous system lesion are not well understood. In this study, we performed a traumatic brain injury (TBI) model in adult rats and investigated the changed expression of Foxj1 in the brain cortex. Western blot and immunohistochemistry analysis showed that the expression of Foxj1 gradually increased, reached a peak at day 3 after TBI, and declined during the following days. Double immunofluorescence staining revealed that Foxj1 was co-expressed with MAP-2 and GFAP. In addition, we detected that Ki67 had the co-localization with NeuN, GFAP, and Foxj1. All our findings suggested that Foxj1 may be involved in the pathophysiology of brain after TBI.	[Cui, Gang; Yu, Zhihua; Li, Zhen; Wang, Wei; Lu, Ting; Qian, Chunhui] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Li, Jiliang; Ding, Yunlin] Soochow Univ, Dept Burn Surg, Affiliated Hosp 1, Suzhou 215006, Peoples R China		Cui, G (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, Suzhou 215006, Peoples R China.	cuigang33@yahoo.com.cn					Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bendel O, 2005, J CEREBR BLOOD F MET, V25, P1586, DOI 10.1038/sj.jcbfm.9600153; Brody SL, 2000, AM J RESP CELL MOL, V23, P45, DOI 10.1165/ajrcmb.23.1.4070; Bullock R, 1992, Acta Neurochir Suppl (Wien), V55, P14; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; CERVOSNAVARRO J, 1991, J NEUROL SCI, V103, pS3; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; CLEVIDENCE DE, 1993, P NATL ACAD SCI USA, V90, P3948, DOI 10.1073/pnas.90.9.3948; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; GLULIAN D, 1991, MICROGLIANEURON INTE, P73; HACKETT BP, 1995, P NATL ACAD SCI USA, V92, P4249, DOI 10.1073/pnas.92.10.4249; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Katayama Y, 1998, ACT NEUR S, V71, P289; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lin L, 2005, J IMMUNOL, V175, P951, DOI 10.4049/jimmunol.175.2.951; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Marshall L F, 2000, Clin Neurosurg, V46, P105; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; PAGHUPATHI R, 2000, J NEURONTRAUMA, V17, P927; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Peterson DA, 2002, CURR OPIN PHARMACOL, V2, P34, DOI 10.1016/S1471-4892(01)00118-7; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; RU X, 2008, J PHARMACOL EXP THER, V326, P966; Smith C, 2001, EUR J NEUROSCI, V13, P443, DOI 10.1046/j.1460-9568.2001.01400.x; Srivatsan S, 2005, J IMMUNOL, V175, P7805, DOI 10.4049/jimmunol.175.12.7805; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; Yagita Y, 2001, STROKE, V32, P1890, DOI 10.1161/01.STR.32.8.1890; Zhang RL, 2002, STROKE, V33, P2675, DOI 10.1161/01.STR.0000034399.95249.59; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	45	5	5	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696			J MOL NEUROSCI	J. Mol. Neurosci.	OCT	2011	45	2					145	153		10.1007/s12031-011-9504-8			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	824BH	WOS:000295173600009	21347518	Green Published, hybrid			2022-02-06	
J	Flint, AC; Gean, AD; Manley, GT; Rao, VA; Sheridan, WF; von Koch, CS				Flint, Alexander C.; Gean, Alisa D.; Manley, Geoffrey T.; Rao, Vivek A.; Sheridan, William F.; von Koch, Cornelia S.			Temporizing treatment of hyperacute subdural hemorrhage by subdural evacuation port system placement Case report	JOURNAL OF NEUROSURGERY			English	Article						subdural hematoma; hyperacute; subdural evacuation port system; intracranial pressure; emergency treatment; traumatic brain injury	CONTRAST EXTRAVASATION; INTRACRANIAL-PRESSURE; HEAD-INJURY; HEMATOMA; MORTALITY; BRAIN; BLOOD	An acute subdural hematoma (SDH) requiring surgical intervention is treated with craniotomy or craniectomy, in part because it is generally accepted that coagulated blood present in the acute phase cannot be adequately evacuated by less-invasive means such as bur hole drainage. However, a hyperacute SDH in the first few hours after trauma can have mixed-density components on CT scans that are thought to represent subdural blood that is not yet fully coagulated. The authors report a case in which a hyperacute SDH in a patient receiving antiplatelet therapy was treated with the novel technique of temporizing subdural evacuation port system (SEPS) placement. Placement of an SEPS in the intensive care unit allowed for rapid surgical treatment of the patient's elevated intracranial pressure (ICP) by drainage of 70 ml of fresh subdural blood. After initial SEPS-induced stabilization, the patient underwent operative treatment of the SDH by craniotomy. The combined approach of emergency SEPS placement followed by craniotomy resulted in a dramatic recovery, with improvement from coma and extensor posturing to a normal status on neurological evaluation 5 weeks later. In appropriately selected cases, patients with a hyperacute SDH may benefit from SEPS placement to quickly treat elevated ICP, as a bridge to definitive surgical treatment by craniotomy. (DOI: 10.3171/2011.5.JNS1123)	[Flint, Alexander C.; Rao, Vivek A.; Sheridan, William F.; von Koch, Cornelia S.] Kaiser Permanente, Dept Neurosurg, Redwood City, CA 94063 USA; [Gean, Alisa D.] Univ Calif San Francisco, San Francisco Gen Hosp, Brain & Spinal Injury Ctr, Dept Radiol, San Francisco, CA USA; [Manley, Geoffrey T.] Univ Calif San Francisco, San Francisco Gen Hosp, Brain & Spinal Injury Ctr, Dept Neurosurg, San Francisco, CA USA		Flint, AC (corresponding author), Kaiser Permanente, Dept Neurosurg, 1150 Vet Blvd, Redwood City, CA 94063 USA.	alexander.c.flint@kp.org		Flint, Alexander/0000-0002-3721-2694			Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Allkemper T, 2004, RADIOLOGY, V232, P874, DOI 10.1148/radiol.2323030322; Arrese I, 2004, ACTA NEUROCHIR, V146, P193, DOI 10.1007/s00701-003-0171-6; Barnes PD, 2000, PEDIATR RADIOL, V30, P74, DOI 10.1007/s002470050018; Becker KJ, 1999, STROKE, V30, P2025, DOI 10.1161/01.STR.30.10.2025; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Bullock MR, 2007, J NEUROTRAUMA S1, V24, P7; Dalfino JC, 2010, CLIN NEUROL NEUROSUR, V112, P737, DOI 10.1016/j.clineuro.2010.06.011; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; GREENBERG J, 1985, NEUROSURGERY, V17, P48, DOI 10.1227/00006123-198507000-00008; Gupta DK, 2008, INDIAN J NEUROTRAUM, V5, P45, DOI 10.1016/S0973-0508(08)80029-9; Kim J, 2008, AM J NEURORADIOL, V29, P520, DOI 10.3174/ajnr.A0859; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; MCLAURIN RL, 1961, J NEUROSURG, V18, P61, DOI 10.3171/jns.1961.18.1.0061; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; Otani N, 2010, ACTA NEUROCHIR SUPPL, V106, P257, DOI 10.1007/978-3-211-98811-4_48; PALMIERI A, 1981, NEURORADIOLOGY, V21, P163; Sargent S, 1996, J FORENSIC SCI, V41, P314; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei E, 2000, BRIT J NEUROSURG, V14, P110; Subramanian SK, 2002, NEUROL RES, V24, P125, DOI 10.1179/016164102101199657; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; WILBERGER JE, 1991, J NEUROSURG, V74, P212, DOI 10.3171/jns.1991.74.2.0212; YASUI T, 1995, SURG NEUROL, V43, P61, DOI 10.1016/0090-3019(95)80041-E; Zhao H, 2009, CHIN J TRAUMATOL, V12, P296, DOI 10.3760/cma.j.issn.1008-1275.2009.05.008	26	5	5	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2011	115	4					844	848		10.3171/2011.5.JNS1123			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	825SD	WOS:000295301500033	21682569				2022-02-06	
J	Hadrich, C; Bock, S; Dressler, J				Haedrich, C.; Bock, S.; Dressler, J.			Necropsy after 1,000 years	RECHTSMEDIZIN			German	Article						Forensic anthropology; Age determination by skeleton; Sex determination by skeleton; Skeletal trauma; Thuringia		A skeleton from the tenth century, with numerous head injuries was investigated by anthropologists and forensic pathologists. The well-preserved bones belonged to a man aged about 30-40 years and a height between 170 and 180 cm. The fatal blunt and sharp head injuries were received close to the time of death. Through an interdisciplinary collaboration between forensic medicine and anthropology the possible sequence of events and the kind of weapon could be largely reconstructed.	[Haedrich, C.; Dressler, J.] Univ Leipzig, Inst Rechtsmed, D-04103 Leipzig, Germany; [Bock, S.] Thuring Landesamt Denkmalpflege & Archaol, Weimar, Germany		Hadrich, C (corresponding author), Univ Leipzig, Inst Rechtsmed, Johannisallee 28, D-04103 Leipzig, Germany.	Carsten.Haedrich@medizin.uni-leipzig.de					Breitinger E., 1937, ANTHROPOL ANZ, V14, P249; Byers S, 2005, INTRO FORENSIC ANTHR, pS; Dettmeyer R, 2009, RECHTSMEDIZIN, V19, P391, DOI 10.1007/s00194-009-0634-z; Dolinek V, 1999, HIST WAFFEN; Ferembach D, 1979, J COMP HUM BIOL, V30, P1; GOCKEL M, 2000, DTSCH KONIGSPFALZEN; Hadrich C, 2004, ARZTEBL THURING, V8, P400; Herrmann B, 1990, PRAHISTORISCHE ANTHR, pS; Mueller G, 1991, BERICHT UNTERS UNPUB; R?sing FW., 2005, RECHTSMEDIZIN, V15, P32; Verhoff MA, 2009, RECHTSMEDIZIN, V19, P357, DOI 10.1007/s00194-009-0633-0; Verhoff M.A., 2004, RECHTSMEDIZIN, V14, P417, DOI DOI 10.1007/S00194-004-0271-5	12	5	5	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9819			RECHTSMEDIZIN	Rechtsmedizin	OCT	2011	21	5					465	468		10.1007/s00194-011-0776-7			4	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	881TQ	WOS:000299512600005					2022-02-06	
J	Wachter, D; Gondermann, N; Oertel, MF; Nestler, U; Rohde, V; Boker, DK				Wachter, Dorothee; Gondermann, Nicole; Oertel, Matthias F.; Nestler, Ulf; Rohde, Veit; Boeker, Dieter-Karsten			Pituitary insufficiency after operation of supratentorial intra- and extraaxial tumors outside of the sellar-parasellar region?	NEUROSURGICAL REVIEW			English	Article						Pituitary insufficiency; Non-sellar brain tumor; Quality of life; Brain tumor surgery	TRAUMATIC BRAIN-INJURY; LONG-TERM SURVIVORS; ENDOCRINE DYSFUNCTION; GH DEFICIENCY; HYPOPITUITARISM; THERAPY; SURGERY; PREVALENCE; CHILDHOOD; RADIATION	Recent studies investigating pituitary function after non-sellar brain tumor surgery showed that up to 38.2% of patients have pituitary insufficiency (PI). It has been assumed that the operation causes the PI, but preoperative hormone testing, which would have been necessary to prove this assumption, was not performed. The objective of this study is to answer the question if indeed microsurgery is the culprit of PI in patients with operatively treated non-sellar brain tumors. In this prospective trial, 54 patients with supratentorial non-sellar tumors were included. The basal levels of cortisol, prolactin, testosterone, estrogen, IGF-1, fT3, fT4, STH, TSH, ACTH, FSH, and LH were recorded preoperatively on days 1 and 7 after surgery. If basal hormone screening revealed an abnormality, a releasing hormone assay was performed. Before surgery, 24 of the 54 patients (44.4%) already had PI. Additional 25 patients showed either hypocortisolism or hypothyreoidism. As those patients had been pre-treated with dexamethasone and l-thyroxine, these findings were considered not to represent PI but drug effects. Hormone testing on days 1 and 7 after surgery revealed no changes. With 44.4% PI is a frequent finding in brain tumor patients already before surgery. The factors causing preoperative PI remain yet to be identified. The endocrine results after surgery are unchanged which rules out that surgery is the cause of PI.	[Wachter, Dorothee; Rohde, Veit] Univ Gottingen, Dept Neurosurg, D-37075 Gottingen, Germany; [Wachter, Dorothee; Gondermann, Nicole; Oertel, Matthias F.; Nestler, Ulf; Boeker, Dieter-Karsten] Univ Clin Giessen, Dept Neurosurg, D-35392 Giessen, Germany; [Wachter, Dorothee; Gondermann, Nicole; Oertel, Matthias F.; Nestler, Ulf; Boeker, Dieter-Karsten] Marburg GmbH, D-35392 Giessen, Germany		Wachter, D (corresponding author), Univ Gottingen, Dept Neurosurg, Robert Koch Str 40, D-37075 Gottingen, Germany.	dorothee.wachter@gmx.de	Mielke, Dorothee/AAU-6776-2021; Nestler, Ulf/D-6503-2014	Nestler, Ulf/0000-0002-2963-4344			Agha A, 2005, J CLIN ENDOCR METAB, V90, P6355, DOI 10.1210/jc.2005-1525; Arlt W, 1997, NEUROLOGY, V49, P498, DOI 10.1212/WNL.49.2.498; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; Cornelia G, 2003, GROWTH HORM IGF RES, V13, P104, DOI 10.1016/S1096-6374(03)00010-8; Da Silva AN, 2007, SURG NEUROL, V67, P508, DOI 10.1016/j.surneu.2006.07.018; DANIEL PM, 1959, LANCET, V2, P927; Darzy Ken H, 2005, Pituitary, V8, P203, DOI 10.1007/s11102-006-6042-4; De Marinis L, 2006, J ENDOCRINOL INVEST, V29, P516, DOI 10.1007/BF03344141; Deijen JB, 1996, PSYCHONEUROENDOCRINO, V21, P313, DOI 10.1016/0306-4530(95)00050-X; Dusick JR, 2008, SURG NEUROL, V70, P482, DOI 10.1016/j.surneu.2008.03.027; Dziurzynski K, 2009, ENDOCR PRACT, V15, P240, DOI 10.4158/EP.15.3.240; Fatemi N, 2008, NEUROSURGERY, V63, P709, DOI 10.1227/01.NEU.0000325725.77132.90; Hartman ML, 2002, J CLIN ENDOCR METAB, V87, P477, DOI 10.1210/jc.87.2.477; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Jayasena CN, 2009, CLIN CHEM, V55, P972, DOI 10.1373/clinchem.2008.117374; Kelly DF, 2006, J NEUROTRAUM, V23, P928, DOI 10.1089/neu.2006.23.928; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Kristof RA, 2008, ACTA NEUROCHIR, V150, P329, DOI 10.1007/s00701-008-1517-x; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lippert-Gruener M, 2007, BRAIN INJURY, V21, P1001, DOI 10.1080/02699050701468933; Martinez R, 2003, EXP CLIN ENDOCR DIAB, V111, P162, DOI 10.1055/s-2003-39788; Marx M, 2000, KLIN PADIATR, V212, P224, DOI 10.1055/s-2000-9682; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Nishioka H, 2002, NEUROPATHOLOGY, V22, P19, DOI 10.1046/j.0919-6544.2001.00426.x; Oberfield SE, 2000, PEDIATR NEUROSURG, V32, P264, DOI 10.1159/000028949; Popovic V, 2004, J ENDOCRINOL INVEST, V27, P1048, DOI 10.1007/BF03345308; Schneider HJ, 2006, EUR J ENDOCRINOL, V155, P559, DOI 10.1530/eje.1.02272; TAPHOORN MJB, 1995, J NEURO-ONCOL, V25, P97, DOI 10.1007/BF01057753; Vernet M, 2001, CRIT CARE MED, V29, P2220, DOI 10.1097/00003246-200111000-00028; Wachter D, 2009, J CLIN NEUROSCI, V16, P202, DOI 10.1016/j.jocn.2008.01.009	30	5	6	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5607			NEUROSURG REV	Neurosurg. Rev.	OCT	2011	34	4					509	515		10.1007/s10143-011-0326-5			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	819PK	WOS:000294838800020	21674148	Green Published, hybrid			2022-02-06	
